model	606
cells	574
protein	407
proteins	381
patients	278
genes	276
enzyme	272
cell	256
brain	225
system	204
species	202
nucleus	198
field	188
cancer cells	188
structure	182
complex	174
pathway	174
structures	166
genome	166
membrane	164
enzymes	163
gene	157
environment	156
region	148
plasma membrane	146
models	134
stem cells	132
host	130
assay	126
membrane proteins	122
cell surface	122
patient	120
population	116
Escherichia coli	114
mammalian cells	110
heart	108
platform	106
immune system	106
framework	102
virus	100
healthy controls	99
liver	98
receptor	98
site	96
cytoplasm	94
mouse model	90
parasite	88
cell types	84
receptors	84
tumor cells	82
crystal structure	82
pathways	82
endothelial cells	82
groups	82
group	80
T cells	78
asthmatic patients	78
human cells	78
mice	78
sites	78
amino acids	78
compounds	78
cytosol	78
molecules	78
sample	78
drug	76
tissues	76
transcription factors	74
embryo	74
reactive oxygen species (ROS)	73
extracellular matrix	72
animal models	72
individuals	72
reactive oxygen species	71
parasites	70
animals	70
organism	70
actin cytoskeleton	70
simulations	70
skeletal muscle	70
neurons	68
cancer patients	68
small molecules	68
substrate	68
samples	68
immune cells	66
network	66
living cells	66
interface	66
organisms	66
regions	66
biological systems	65
strains	64
drugs	64
systems	64
in vitro and in vivo	62
microbial communities	62
ER	62
signaling pathways	62
Saccharomyces cerevisiae	62
cell lines	62
CNS	60
single cells	60
substrates	60
domain	60
transcription factor	60
affected individuals	60
DNA	58
ribosome	58
host cells	58
tissue	58
tool	58
strain	58
mouse models	58
locus	58
isolates	56
induced pluripotent stem cells (iPSCs)	56
vaccine	56
active site	56
peptide	56
binding sites	56
genomes	56
cohort	56
tools	54
components	54
targets	54
model system	54
control group	54
tumor microenvironment	52
clinic	52
β-catenin	52
latter	52
assays	52
sequence	52
residues	52
domains	52
crystal structures	52
eukaryotic cells	52
somatic cells	50
intestine	50
Ca2+	50
factors	50
gene expression	50
viruses	50
variants	50
general population	50
protein complexes	48
complexes	48
live cells	48
nervous system	48
molecular dynamics simulations	48
populations	48
skin	48
proteasome	48
study	48
Treg cells	46
target cells	46
individual cells	46
cell membranes	46
mouse	46
NF-κB	46
human genome	46
loci	46
sequences	44
pathogen	44
niche	44
resource	44
binding site	44
gut microbiota	44
mutants	44
mutant	44
technology	44
Drosophila melanogaster	44
B cells	44
panel	44
Z. tritici	42
target	42
therapeutic target	42
lipid bilayer	42
vector	42
country	42
epithelial cells	42
hosts	41
healthy subjects	41
bacteria	41
protein kinases	40
database	40
human cancers	40
body	40
community	40
daughter cells	40
ligand	40
tumor	40
E. coli	40
TGF-β	40
subset	40
set	40
transcriptome	38
lung cancer	38
wild-type mice	38
key regulators	38
literature	38
target genes	38
dataset	38
allele	38
pluripotent stem cells	36
laboratory	36
metabolic pathways	36
host cell	36
bacterium	36
data	36
HeLa cells	36
embryonic stem cells (ESCs)	36
C. albicans	36
adipose tissue	36
fatty acids	34
eukaryotes	34
patients with COPD	34
soil	34
different cell types	34
NK cells	34
ligands	34
pathogens	34
budding yeast	34
promoter	34
promoters	34
inhibitor	34
Gram-negative bacteria	34
mathematical model	34
lipids	34
nucleic acids	34
combination	34
transgenic mice	34
surface	34
metabolites	34
healthy individuals	34
scaffold	34
lung	34
family	34
area	34
gut	34
two groups	33
cell growth	32
malaria parasites	32
mitochondria	32
tumors	32
breast cancer	32
human pluripotent stem cells	32
DNA methylation	32
murine model	32
compound	32
template	32
extracellular matrix (ECM)	32
model organisms	32
products	32
dimer	32
diet	32
cell culture	32
kidney	32
zebrafish	32
blood	32
peptides	32
synapse	32
retina	32
cases	32
elements	31
human pluripotent stem cells (hPSCs)	30
hippocampus	30
therapeutic targets	30
CRISPR/Cas9	30
myeloid cells	30
miRNAs	30
healthy control subjects	30
genomic DNA	30
target proteins	30
Bacillus subtilis	30
Mycobacterium tuberculosis	30
DNA lesions	30
innate immune system	30
software	30
pore	30
microenvironment	30
blood vessels	30
culture medium	30
bone marrow	30
Pol II	30
Th17 cells	30
nuclear envelope	30
placenta	30
channel	30
agents	30
control	30
world	30
participants	28
synthetic biology	28
elderly	28
clinical setting	28
new drugs	28
embryonic stem cells	28
CD8+ T cells	28
clinical samples	28
periphery	28
antigens	28
T-cells	28
gastrointestinal tract	28
Trypanosoma brucei	28
animal model	28
C. elegans	28
tumor growth	28
core	28
mathematical models	28
model organism	28
signals	28
healthy volunteers	28
recombinant proteins	28
hydrogen peroxide	28
drinking water	28
different species	28
wild type	28
ion channels	28
living organisms	28
cell membrane	28
control cells	28
individual	28
variant	28
human proteins	27
15d-PGJ2	26
naive pluripotency	26
hematopoietic stem cells (HSCs)	26
replication forks	26
datasets	26
infected cells	26
goats	26
secondary metabolites	26
vectors	26
markers	26
tumor suppressor	26
C. elegans	26
endoplasmic reticulum (ER)	26
architecture	26
metal ions	26
cysteine residues	26
normal cells	26
pregnant women	26
peripheral blood	26
apicoplast	26
young mice	26
mouse embryonic stem cells (ESCs)	26
organs	26
Caenorhabditis elegans	26
differentiated cells	26
cancers	26
RNAs	26
central nervous system	26
family members	26
two proteins	26
multiple tissues	26
in vitro	26
offspring	26
molecule	26
centrosome	26
endoplasmic reticulum	26
families	26
Blood samples	25
microRNAs (miRNAs)	24
fungus	24
T. brucei	24
DNA sequences	24
microbiome	24
other	24
fission yeast	24
trial	24
organelles	24
epitope	24
particles	24
adaptive immune system	24
technologies	24
screen	24
pancreas	24
microtubule cytoskeleton	24
progenitor cells	24
murine models	24
mitotic spindle	24
controls	24
several proteins	24
vasculature	24
serum samples	24
brain tissue	24
Arabidopsis thaliana	24
antibodies	24
media	24
satellite cells	24
potential therapeutic target	24
mRNA	24
TNF-α	24
epidermis	24
C-terminus	24
membranes	24
small intestine	24
bacterial cells	24
machinery	24
key residues	24
human body	24
different tissues	24
control subjects	24
class	24
list	24
Plasmodium falciparum	24
theory	22
CRISPR/Cas9 system	22
RNA molecules	22
cancer cell lines	22
isolate	22
CaSR	22
clones	22
regulator	22
neighboring cells	22
circulation	22
intestinal microbiota	22
(miRNAs)	22
cancer	22
innate immunity	22
fungal communities	22
pluripotent cells	22
multicellular organisms	22
proteome	22
whole blood	22
young children	22
oleic acid	22
infection	22
transcripts	22
key regulator	22
organ	22
human host	22
presence	22
building blocks	22
chromosome	22
biological samples	22
misfolded proteins	22
actin filaments	22
regulators	22
extracellular environment	22
organelle	22
medium	22
MicroRNAs (miRNAs)	22
carriers	22
matrix	22
genetic material	22
transporter	22
channels	22
three groups	22
lipid bilayers	22
UK	22
product	22
lineage	22
wild-type	22
one patient	22
many genes	22
thymus	20
aptamers	20
cigarette smoke	20
APC/C	20
hnRNP A1	20
elosulfase alfa	20
placebo group	20
RNA polymerase II	20
cell wall	20
expression	20
genotypes	20
human induced pluripotent stem cells (hiPSCs)	20
DNA double-strand breaks (DSBs)	20
SNPs	20
single nucleotide polymorphisms (SNPs)	20
pro-inflammatory cytokines	20
complement system	20
rhesus macaques	20
transplanted cells	20
cancer types	20
genetic diversity	20
alleles	20
epigenome	20
potential therapeutic targets	20
SH2 domain	20
two patients	20
computational tools	20
older adults	20
bronchial epithelium	20
cellular proteins	20
lymphocytes	20
S. cerevisiae	20
microbiota	20
bacterial pathogens	20
inhibitors	20
scientific community	20
data sets	20
E-cadherin	20
antibody	20
antigen	20
NE	20
sister chromatids	20
notochord	20
germline	20
pipeline	20
motifs	20
renal progenitors	20
neural crest	20
vertebrates	20
germ cells	20
data set	20
macromolecular complexes	20
cytoskeleton	20
RNA	20
library	20
plasmid	20
F-actin	20
specimen	20
many proteins	20
extracellular space	20
intermediate	20
ternary complex	20
innate immune cells	20
bloodstream	20
host immune system	20
two enzymes	20
M cells	20
MCF7 cells	20
substrate proteins	20
protein-coding genes	20
key enzyme	20
downstream effectors	20
residue	20
map	20
therapeutic agents	20
bilayer	20
novel genes	20
children	20
enhancer	20
several genes	20
subjects	20
rare variants	20
candidate genes	20
test	19
cancer cases	18
brain regions	18
gastric cancer	18
PKU patients	18
neutralizing antibodies	18
computational modeling	18
ECM	18
fibrinolytic enzyme	18
antioxidant enzymes	18
new technologies	18
older patients	18
donor cells	18
age groups	18
farm	18
rat model	18
histone modifications	18
single cell	18
RNA-binding proteins	18
P. pastoris	18
normal tissues	18
therapeutic proteins	18
higher eukaryotes	18
adult brain	18
solid tumors	18
central nervous system (CNS)	18
review	18
adult tissues	18
essential genes	18
mouse ESCs	18
secretory pathway	18
stalled replication forks	18
gut microbiome	18
dendritic cells	18
differentially expressed genes	18
developed countries	18
animal	18
older people	18
HIV-infected individuals	18
bacterial growth	18
soils	18
areas	18
lesion	18
cell nucleus	18
Xenopus laevis oocytes	18
P. aeruginosa	18
Pseudomonas aeruginosa	18
P. falciparum	18
regulatory network	18
nitric oxide (NO)	18
various tissues	18
blood samples	18
constructs	18
IFN-γ	18
cytokines	18
compartment	18
clock	18
link	18
mouse embryo	18
model systems	18
spinal cord	18
analytes	18
lipid rafts	18
magnetic field	18
protein domains	18
assemblies	18
endothelium	18
amyloid fibrils	18
mRNAs	18
hypothalamus	18
mammalian species	18
plant cells	18
cell-cell junctions	18
HepG2 cells	18
lysosome	18
knockout mice	18
specific inhibitors	18
Golgi	18
mitochondrion	18
individual proteins	18
biological macromolecules	18
colon	18
integral membrane proteins	18
cultured cells	18
E. coli	18
cell type	18
genomic regions	18
cerebellum	18
regulatory elements	18
human brain	18
different populations	18
genetic variants	18
sexes	18
developing countries	18
hypothesis	17
HPV vaccine	16
α-SNAP	16
hiPSC-CMs	16
mathematical modeling	16
protein sequences	16
blood cells	16
breast cancer cells	16
AgRP neurons	16
immunodeficient mice	16
countries	16
replication fork	16
antigen-presenting cells	16
chromatin	16
pathogenic bacteria	16
AML cells	16
mesenchymal stem cells	16
metabolome	16
intestinal epithelium	16
human patients	16
nucleolus	16
D. nodosus	16
wild type strain	16
NADPH oxidase	16
natural products	16
farms	16
vitro model	16
reservoir	16
Staphylococcus aureus	16
DNA sequence	16
flagellum	16
nanoparticles	16
NKT cells	16
kinetochore	16
transposable elements	16
sister DNAs	16
transcriptional network	16
proinflammatory cytokines	16
mutant mice	16
patients with AD	16
drug targets	16
in vivo	16
case study	16
motif	16
secreted proteins	16
atomic models	16
histone H3	16
tetramer	16
N-terminal domain	16
three proteins	16
promoter regions	16
antibiotic	16
adult mice	16
three patients	16
high-fat diet	16
cleavage site	16
vaccines	16
stromal cells	16
wild-type cells	16
cell populations	16
Rho GTPases	16
two sites	16
atmosphere	16
repertoire	16
imprinted genes	16
sensory neurons	16
networks	16
progeny	16
reporter	16
ectoderm	16
subunit	16
Wnt pathway	16
specific genes	16
multiple sites	16
plants	16
conserved residues	16
partners	16
receptor tyrosine kinases	16
specific sites	16
cortex	16
eye	16
cornea	16
ASM cells	16
two species	16
protein molecules	16
human serum	16
Xenopus oocytes	16
pancreatic cancer	16
context	16
bacterial species	16
oral cavity	16
Xenopus embryos	16
Wnt/β-catenin signaling	16
target gene	16
monoclonal antibodies	16
lncRNAs	16
kinase	16
critical regulator	16
signal	16
signalling pathways	16
Special Issue	16
human subjects	16
cofactor	16
research community	16
primary tumors	16
RNA exosome	16
regulatory regions	16
isoforms	16
Schwann cells	16
cell line	16
mitochondrial proteins	16
wild-type protein	16
stool samples	16
simulation	16
disease	16
F. hepatica	16
plasma samples	15
light mask	14
human embryonic stem cells (hESCs)	14
hematopoietic cells	14
biological networks	14
tumor samples	14
short telomeres	14
outbreak	14
circadian clock	14
c-Myc	14
hemogenic endothelium	14
WNT signaling	14
CD4+ T cells	14
epidemic	14
Y RNAs	14
infected individuals	14
nascent transcripts	14
ubiquitin-proteasome system	14
CENP-ACnp1	14
AA-MF	14
Klebsiella pneumoniae	14
Tfh cells	14
Th2 cells	14
factor	14
nuclear periphery	14
final product	14
different models	14
neural stem cells	14
primary tumor	14
SAC	14
host population	14
molecular machinery	14
collection	14
kinases	14
cytoplasmic membrane	14
pentose phosphate pathway	14
stem cell	14
S. aureus	14
human health	14
Bacillus sp.	14
plant species	14
biomass	14
crude glycerol	14
F. necrophorum	14
open reading frame	14
epidermal growth factor receptor (EGFR)	14
parasitic nematodes	14
molecular tools	14
larvae	14
ascorbic acid	14
plant	14
eukaryotic genomes	14
healthy tissue	14
experimental system	14
damaged mitochondria	14
complex I	14
rodent models	14
female mice	14
bioactive molecules	14
different cells	14
humans and mice	14
glial cells	14
mouse embryonic stem cells	14
Notch signaling	14
cancer genomes	14
breast cancers	14
ring	14
human tumors	14
mammalian brain	14
individual patients	14
novel therapeutic targets	14
signaling pathway	14
TH2 cells	14
biomarkers	14
multiprotein complexes	14
transcriptional regulators	14
adult stem cells	14
barrier	14
exocrine pancreas	14
purified proteins	14
α-syn	14
multiple genes	14
RNA polymerase	14
intracellular pathogens	14
protein structures	14
virion	14
PDB	14
Z-band	14
construct	14
Crystal structures	14
effectors	14
subunits	14
Zn2+	14
helix III	14
old animals	14
natural populations	14
diseases	14
Toxoplasma gondii	14
many species	14
cluster	14
signaling networks	14
transmembrane domains	14
CpG sites	14
transcriptomes	14
mechanistic framework	14
early embryo	14
lineages	14
apical domain	14
early endosomes	14
target sites	14
adult	14
two genes	14
biomarker	14
clinical laboratory	14
muscle cells	14
red blood cells	14
DNA template	14
periplasm	14
spindle	14
n-alcohols	14
base	14
diabetic patients	14
lipid	14
intrinsically disordered proteins	14
airway	14
transporters	14
microscope	14
malignant cells	14
master regulator	14
mAbs	14
phosphorylation sites	14
cellular components	14
vacuole	14
spindle microtubules	14
small RNAs	14
pre-mRNA	14
inflammatory cytokines	14
pancreatic β cells	14
kinase domain	14
HEK293 cells	14
important regulators	14
AMP-activated protein kinase (AMPK)	14
N-terminus	14
outer membrane	14
loop	14
cellular membranes	14
precursors	14
cardiovascular system	14
kingdoms of life	14
mutant protein	14
multiple organs	14
culture	14
transcriptional repressor	14
patient population	14
scientific literature	14
primary cilia	14
NMJ	14
total protein	14
array	14
cone photoreceptors	14
humans and animals	14
contacts	14
house	14
T. cruzi	14
effector proteins	13
oral cancers	12
alcohol-dependent subjects	12
whey protein	12
British Heart Foundation	12
urinary albumin	12
O-GlcNAcylation	12
copper ions	12
T6SS	12
reductive carboxylation	12
dendritic spines	12
hippocampal neurons	12
melanoma cells	12
C. glutamicum	12
food	12
non-carriers	12
donor	12
SPVL	12
potential targets	12
T2D patients	12
T1D patients	12
cells and tissues	12
mature neurons	12
mesoderm	12
CD34+ cells	12
PD-L1	12
M. agalactiae	12
DNA damage sites	12
S. cerevisiae	12
oxidized proteins	12
NP-C cases	12
cell factories	12
fusion proteins	12
Zymoseptoria tritici	12
fungal pathogens	12
wheat straw	12
Candida albicans	12
hospitalized patients	12
clinical isolates	12
C. difficile	12
T-bet	12
hematopoietic system	12
key genes	12
target RNA	12
instrument	12
Xenopus egg extracts	12
somatic nuclei	12
centromere	12
Respreeza/Zemaira	12
prostate cancer	12
facial photoaging	12
core proteins	12
HD-PTP	12
RNase E	12
chromosomes	12
metabolic enzymes	12
ESCRT machinery	12
Notch pathway	12
basement membranes	12
nail	12
intestinal epithelial cells	12
transmembrane proteins	12
new therapeutic targets	12
Cancer cells	12
lung fibroblasts	12
reducing equivalents	12
precipitates	12
agent	12
disulfide bonds	12
sugarcane bagasse	12
suspended solids	12
lipopolysaccharide (LPS)	12
leukemic cells	12
cellular machinery	12
reactive species	12
Eimeria species	12
cattle	12
CEN1HC-Br	12
COS PIVCs	12
Dendritic cells (DCs)	12
setting	12
five genes	12
Mathematical models	12
treatment groups	12
filamentous fungi	12
bone marrow microenvironment	12
cancer stem cells	12
neuronal cells	12
client proteins	12
negative regulator	12
hIP	12
T. gondii	12
microbial pathogens	12
protein complex	12
African trypanosomes	12
study population	12
human vaccines	12
selected genes	12
modules	12
iPSC-CM	12
tumour cells	12
bioreactor	12
neural cells	12
neural circuits	12
seeds	12
important pathogen	12
dividing cells	12
survey	12
clusters	12
conceptual framework	12
transgene	12
brown adipose tissue (BAT)	12
fat body	12
cancer genes	12
genus	12
protein families	12
patients with severe asthma	12
healthy cells	12
atopic eczema	12
resource-limited settings	12
mammalian genome	12
aged mice	12
human fibroblasts	12
human tissues	12
adult animals	12
free radicals	12
animal cells	12
growth	12
pancreatic islets	12
seed	12
neurofibrillary tangles	12
disordered proteins	12
various cancers	12
lesions	12
RNAP	12
viral RNA	12
macromolecular assemblies	12
nuclease	12
replisome	12
superfamilies	12
stem	12
R-loops	12
genetic code	12
groove	12
monomer	12
filaments	12
collagen fibrils	12
C-terminal domain	12
causative agent	12
filament	12
var genes	12
infected erythrocytes	12
transcription factors (TFs)	12
C-terminal region	12
chaperone	12
helix	12
two domains	12
water	12
beads	12
fluorescent markers	12
patient samples	12
chemokine	12
pigs	12
axis	12
malaria parasite	12
prokaryotes and eukaryotes	12
cultures	12
dopaminergic neurons	12
progenitors	12
key components	12
cystic EBs	12
signalling molecules	12
D. melanogaster	12
neural crest cells	12
control mice	12
Hippo pathway	12
airways	12
origins	12
complex tissues	12
Abd-B	12
hair cells	12
Wnt signaling	12
sugars	12
fluorescence microscopy	12
microtubule	12
repeats	12
many cell types	12
fields	12
native environment	12
ATPase	12
single molecules	12
fluorophores	12
signaling proteins	12
environments	12
membrane surface	12
various cell types	12
device	12
application	12
hydrogen bonds	12
B. subtilis	12
skeletal muscles	12
charged residues	12
different proteins	12
probes	12
cardiac muscle	12
mechanistic models	12
cardiac myocytes	12
vesicles	12
KO mice	12
normal controls	12
materials	12
mitochondrial ROS	12
mesenchymal cells	12
heterodimer	12
cell sheets	12
yeast Saccharomyces cerevisiae	12
influenza virus	12
monoclonal antibody	12
many tissues	12
glycans	12
component	12
polymer	12
α-synuclein	12
ubiquitin chains	12
Th1 cells	12
linker	12
wild type cells	12
control animals	12
conditioned media	12
structural model	12
fusion protein	12
subtypes	12
subtype	12
specific targets	12
MD simulations	12
SC lipids	12
helices	12
lipid membranes	12
amino acid residues	12
EPS	12
catalytic site	12
living systems	12
potential biomarkers	12
E3 ligase	12
Caco-2 cells	12
Gram-positive bacteria	12
mitochondrial matrix	12
human and mouse	12
binding pocket	12
computer simulations	12
mouse embryos	12
neuronal circuits	12
two families	12
affected individual	12
α-DG	12
unrelated individuals	12
subject	12
common variants	12
hospital	12
mosquito	12
environmental samples	12
communities	12
two regions	12
P. vivax	12
3n hybrids	10
Dgcr2-KO mice	10
inducible promoter	10
W614A-3S Abs	10
B2 cells	10
S2R	10
JQ1(+)	10
HbSC patients	10
HIV reservoir	10
CKD animals	10
vehicle-treated cells	10
oncolytic viruses	10
Au NPs	10
Lyso-PC 26:0	10
combination group	10
south Asian women	10
metformin group	10
capacitive barrier	10
contractile proteins	10
TEX cells	10
RNMT-RAM	10
human neurons	10
parents	10
N1-Box	10
basal cells	10
MEC	10
multipotent progenitors	10
germline genes	10
human cancer	10
MDA-MB-231 cells	10
hematopoietic stem and progenitor cells (HSPCs)	10
in vitro model	10
dystrophin gene	10
diabetic mice	10
reagents	10
Breast cancer	10
specific sequences	10
Kir2 channels	10
pluripotent stem cells (PSCs)	10
LT-HSCs	10
human cytomegalovirus (HCMV)	10
mRNA cap	10
matrisomal proteins	10
current smokers	10
biological replicates	10
differentially expressed proteins	10
pro-Th2 DCs	10
pro-Th1 DCs	10
school holidays	10
tropical countries	10
P-TEFb	10
R. praetor	10
MC-I	10
multiple pathways	10
male mice	10
Drosophila embryo	10
Repo-Man	10
neural progenitors	10
HCC patients	10
microRNA-532-5p	10
sa-RNA	10
adeno-associated viral (AAV) vectors	10
PF exosomes	10
intermediate hosts	10
S. semivirescens	10
phylogenetic tree	10
DNA strand breaks	10
15nm-SiO2	10
vitro γH2AX assay	10
high-throughput sequencing technologies	10
people	10
nitric oxide	10
combinations	10
spleen	10
chromatin landscape	10
N6-methyladenosine (m6A)	10
tumor suppressor p53	10
chromatin modifiers	10
DNA breaks	10
transposable elements (TEs)	10
transcriptional machinery	10
β-arrestin1	10
specific miRNAs	10
centromeric chromatin	10
blood Phe	10
younger patients	10
classical homocystinuria	10
MMACHC-wt	10
individual enzymes	10
fish	10
Nos3as NAT	10
mixed cultures	10
RIP plc-1 mutant	10
libraries	10
Clostridium difficile	10
established tumors	10
homologs	10
naive T cells	10
origin	10
primary cells	10
soluble proteins	10
sex chromosomes	10
pluripotency genes	10
CRISPR/Cas9 technology	10
anticancer agents	10
food-related components	10
network models	10
pneumococcus	10
envelope	10
several groups	10
viral genome	10
vitamin D	10
roles	10
stable cell lines	10
gynoecium	10
CENP-A	10
emerging pathogens	10
connective tissues	10
tendon-like tissue	10
lactic acid	10
epidermal growth factor (EGF)	10
eEF2K	10
UPR	10
stem cell niche	10
PCTAIRE-tide	10
exosporium	10
central hub	10
adult patients	10
recombinant protein	10
sole carbon source	10
ovary	10
carbon dioxide	10
V. parahaemolyticus	10
biosynthetic pathway	10
carbon source	10
J. curcas	10
phenolic compounds	10
silver nanoparticles	10
different organs	10
age group	10
infective endocarditis	10
M. hyopneumoniae	10
DRB1	10
human populations	10
leaf	10
antibiotics	10
binding partners	10
teichoic acids	10
wall	10
mitochondrial bioenergetics	10
M. tuberculosis	10
lead compounds	10
protein spots	10
ABC transporters	10
parasite species	10
plasma pepsinogen	10
C. daubneyi	10
different regions	10
lungs	10
small ruminants	10
aorta	10
adult worms	10
cell of origin	10
poultry industry	10
loop regions	10
mammalian systems	10
one-carbon units	10
new compounds	10
L-cells	10
low-income countries	10
hub	10
soft tissues	10
males	10
clinical trials	10
biomedical sciences	10
noncoding RNAs	10
laboratories	10
sequencing technologies	10
molecular pathways	10
kinase inhibitors	10
three germ layers	10
inclusion bodies	10
functional modules	10
clinical applications	10
tumor antigens	10
expression systems	10
transformants	10
others	10
colon cancer cells	10
bone	10
soma	10
cell body	10
subsarcolemmal ATP	10
RCAN1-4	10
CHO cells	10
mutant strains	10
Plasmodium berghei	10
worms	10
inner body	10
CD4+	10
inflammatory mediators	10
superfamily	10
hydrazone	10
many areas	10
resistance genes	10
pUltra plasmids	10
mesenchymal stromal cells (MSCs)	10
thermoresponsive surfaces	10
biochemical assays	10
lymph nodes	10
tumor tissues	10
C57BL/6 mice	10
lung adenocarcinoma	10
hESC-CMs	10
liver tissue	10
cartilage defects	10
binary complex	10
different hosts	10
studies	10
X chromosome	10
blood-brain barrier	10
specific cell types	10
germ-free mice	10
diverse cell types	10
ribosomal proteins	10
26S proteasome	10
INM	10
signaling molecule	10
maps	10
CpG islands	10
recycling endosomes	10
rich resource	10
RNase H2	10
oligomers	10
CTCF binding	10
endocytic vesicles	10
dietary protein	10
large datasets	10
multiple sources	10
atopic wheeze	10
CD8 T cells	10
neonatal mice	10
asthmatic children	10
functional assays	10
bronchial biopsy specimens	10
subgroups	10
allergen	10
house dust mite	10
severe asthma	10
dendritic cells (DCs)	10
CRACM channels	10
aureus	10
African children	10
G protein-coupled receptors (GPCRs)	10
11β-HSD1	10
challenging targets	10
postmenopausal women	10
cortical neurons	10
inputs	10
bacteria and fungi	10
pore waters	10
microbial community	10
remainder	10
simple model	10
organic matter	10
individual species	10
soil microorganisms	10
surrounding tissues	10
majority of patients	10
element	10
growth factors	10
new model	10
primer	10
molecular simulations	10
small molecule	10
cytoplasmic material	10
hierarchy	10
C. jejuni	10
bacterial RNAP	10
molecular framework	10
eukaryotic species	10
specific proteins	10
solvent	10
cap	10
majority	10
genetic tools	10
14-3-3-ζ	10
protease	10
biological system	10
secondary structure	10
virulence genes	10
membrane protein	10
citric acid	10
N-terminal region	10
fibrils	10
X-ray structures	10
three genes	10
PH domains	10
focal adhesions	10
G-proteins	10
metal	10
bacterial genomes	10
eukaryotic cell	10
restriction enzymes	10
hydrophobic core	10
senescent cells	10
iPS cells	10
PE stimulated NRVCs	10
t-tubules	10
mdx mice	10
myocardium	10
temperate regions	10
three species	10
assay system	10
different samples	10
Chlamydia trachomatis	10
natural killer (NK) cells	10
effective vaccine	10
soluble form	10
antibody fragments	10
CD4+ T cells	10
alveolar macrophages	10
mammary gland	10
free fatty acids	10
T. brucei	10
wild type mice	10
small GTPases	10
DNA double-strand breaks	10
clock genes	10
transgenic lines	10
transposon	10
egg	10
primordial germ cells	10
zebrafish pronephros	10
cell population	10
dermal fibroblasts	10
limbs	10
adherens junctions	10
essential regulator	10
gene regulatory networks	10
regulatory sequences	10
ES cells	10
nematode Caenorhabditis elegans	10
early embryos	10
cavity	10
ectopic follicles	10
double mutants	10
transgenic mouse model	10
stalk	10
direct target	10
specimens	10
vascular endothelium	10
signaling molecules	10
iNKT cells	10
computational models	10
cytoskeletal vesicles	10
LH	10
surfaces	10
biological membranes	10
different lineages	10
Transcription factors	10
cell cortex	10
center	10
protein surface	10
dimer interface	10
automated system	10
KATP channels	10
protein sequence	10
three-dimensional structures	10
Stem cells	10
brain circuits	10
potential drug target	10
homodimer	10
hearts	10
erythrocyte cytoskeleton	10
G-protein-coupled receptors (GPCRs)	10
NPC	10
anionic lipids	10
SNARE proteins	10
lab	10
thyroid hormone	10
major components	10
untreated controls	10
nuclear DNA	10
different combinations	10
DNA polymerases	10
in vivo and in vitro	10
active form	10
functional groups	10
former	10
RNase H1	10
small animals	10
rat	10
proliferating cells	10
long non-coding RNAs (lncRNAs)	10
peritubular cells	10
two lineages	10
derivatives	10
WT mice	10
inflammatory cells	10
age-matched controls	10
NKX2-5	10
Raddeanin A	10
associated proteins	10
budding yeast Saccharomyces cerevisiae	10
C-terminal tail	10
COPD patients	10
Ca2	10
potential target	10
individual subunits	10
specific residues	10
ventricular myocytes	10
vitro assays	10
SC	10
number of proteins	10
synthetic peptides	10
TM helices	10
different sites	10
plant pathogenic fungi	10
detergent solution	10
constituents	10
human plasma	10
triglyceride-rich lipoproteins	10
biology	10
motor neurons	10
exosome	10
foci	10
endothelial barrier	10
synaptic vesicles	10
oncogene	10
regulated genes	10
mutant allele	10
pathogenic variants	10
disease models	10
transcription start sites	10
older individuals	10
protein product	10
methyltransferase	10
two individuals	10
causal variants	10
DNA samples	10
neuromuscular junction (NMJ)	10
mutant alleles	10
essential enzyme	10
neuroepithelial cells	10
subset of patients	10
unrelated patients	10
T. solium	10
Taenia solium	10
members	10
study area	10
helminth eggs	10
Madrassa teachers	10
primers	10
canine rabies	10
10 patients	9
N-glycans	9
natural zeolite	8
C + T + S trial	8
protein diets	8
gills	8
grass carp	8
ballast water	8
crude flocculants	8
foodborne parasites	8
cold climates	8
Cryptosporidium spp.	8
MO seed extract	8
nanoparticle	8
USC-CM	8
oral cancer cells	8
layered cell sheets	8
AC-DC circuit	8
RGD-LNP	8
oncolytic paramyxoviruses	8
CS-5100	8
MSL	8
TNF inhibitors	8
VV alleles	8
children with SAM	8
GBM	8
cirrhotic liver	8
TYK2 promoter variant	8
MRJ-L	8
Scl-Ab	8
DPSCs overexpressing HGF	8
β-thalassemia	8
anti-HMGB1 monoclonal antibody	8
empty particles	8
viral particles	8
textile wastewater	8
weeds	8
Phe-free milk	8
two siblings	8
human skin cells	8
sham mask	8
hydrochlorothiazide group	8
white British women	8
observational studies	8
FundingWellcome Trust	8
human HSCs	8
rBC2LCN-PE23	8
iPS-MSCs	8
hPSC lines	8
pluripotent stem cells (hPSCs)	8
exogenous irisin	8
RBH assay	8
CDK4/6 inhibitors	8
PSP-MSCs	8
ovarian cancer cells	8
redox switches	8
γ-GC	8
activated macrophages	8
non-malignant liver tissues	8
RTA dh404	8
old MPCs	8
Draxxin®	8
astin C	8
IFT trains	8
cyclin F	8
α-catenin	8
embryonic β-like globin expression	8
definitive hematopoiesis	8
foundation	8
SLIM-ChIP	8
xenograft model	8
pluripotent stem cells (iPSCs)	8
BF SOM neurons	8
living neurons	8
TSCM cells	8
BM	8
BET inhibitors	8
PARP inhibitors	8
Merlin/NF2	8
transcriptional programs	8
paper	8
multiple cell types	8
presynaptic terminals	8
hematopoietic progenitors	8
mouse fibroblasts	8
human iPSCs	8
5S RNP	8
place fields	8
somatic genes	8
C/EBPα	8
olfactory bulb	8
REP 2139	8
cellular models	8
reservoirs	8
Hadley circulation	8
magnetoreceptor	8
Aspergillus, Penicillium and Talaromyces	8
computational framework	8
human microbiome	8
DegP-trimer	8
genes of interest	8
endothelin, cystatin C, and interleukin	8
polymorphic sites	8
Corynebacterium glutamicum	8
receptor complex	8
lipid IVa	8
genes and proteins	8
homo-oligomers	8
predictive models	8
pathogenic microorganisms	8
distant organs	8
homotypic clusters	8
cerebrospinal fluid	8
breast lump	8
urinary extracellular vesicles	8
matrisome	8
aquaculture industry	8
proteomes	8
monozygotic twins	8
symptomatic individuals	8
two models	8
format	8
complex models	8
metapopulation models	8
m6Afreq genes	8
different datasets	8
significant genes	8
colon cancer	8
omics technologies	8
KEGG pathways	8
MinION	8
heavy metals	8
β1AR autoantibodies	8
DNA repair pathways	8
proteostasis network	8
CDR	8
haemoplasmas	8
sickle cell	8
C. rodentium	8
β cells	8
multiple myeloma (MM)	8
antimicrobial peptides	8
single-cell transcriptomics	8
LPM	8
cell-matrix adhesions	8
chromatin structures	8
WAVE regulatory complex (WRC)	8
VEGF-A	8
tip cells	8
spindle midzone	8
human cancer cells	8
Mathematical modeling	8
forebrain	8
hindbrain	8
non-human primates	8
solid cancers	8
iPSC-CMs	8
mesenchymal stem cells (MSCs)	8
CAR	8
platforms	8
vitro and in vivo	8
viral vectors	8
hepatic stellate cells (HSCs)	8
human CD34+ cells	8
lentiviral vectors	8
c-MYC	8
clinical specimens	8
white adipose tissue	8
peripheral tissues	8
elderly subjects	8
PyVAN patients	8
respiratory viruses	8
renal transplant recipients	8
protozoan parasites	8
55nm-SiO2	8
cell therapy products	8
[1].	8
murine cells	8
host organisms	8
reactive oxygen and nitrogen species	8
gene products	8
latent α1-antitrypsin	8
J-domains	8
keratinocyte serum-free medium	8
host immune cells	8
Rab GTPases	8
mosquito-borne viruses	8
whole cohort	8
Xist RNA	8
macro domain	8
upregulated genes	8
serine ADPr	8
M. tuberculosis	8
activator	8
adaptor	8
In vitro	8
prion protein	8
protein thiols	8
sister chromatid cohesion	8
histone marks	8
human embryonic stem cells	8
basal transcription machinery	8
matched controls	8
body fluids	8
ketogenic diet	8
MMACHC-R161Q	8
chemical chaperones	8
regulatory genes	8
C. pasteurianum	8
IGF axis	8
inorganic nitrate	8
wild populations	8
wheat pathogen Zymoseptoria tritici	8
intracellular organelles	8
Golgi apparatus	8
PI3K pathway	8
human tumours	8
A-type lamins	8
l-lactate	8
regimen	8
day	8
HIV-infected cells	8
triploid Atlantic salmon	8
ribbon	8
helical assemblies	8
enzyme assays	8
individual synapses	8
chemical probes	8
NORs	8
Ndc80 complex	8
stomach	8
film	8
manuscript	8
RNA-binding proteins (RBPs)	8
ice	8
human genes	8
spindle pole	8
functional protein	8
gap junctions	8
non-coding RNAs	8
induced pluripotent stem cells	8
zygote	8
multiple cancers	8
BH3 mimetics	8
VISCODERM®	8
predictions	8
protein-ligand complexes	8
dodecamer	8
series	8
protein targets	8
R2TP complex	8
Hsp90 system	8
beta blockers	8
interaction network	8
-I	8
cSH2	8
free atoms	8
LD motifs	8
histone H4	8
native environments	8
sialic acid	8
influenza viruses	8
DNA molecules	8
allogeneic HSCT	8
anti-ETAR antibodies	8
infections	8
three pathways	8
serum 25-hydroxyvitamin D3	8
PC-3 cells	8
affinity reagents	8
PcG proteins	8
fly	8
metabolomics data	8
Synthetic biology	8
endosomal network	8
developing embryos	8
distant sites	8
coding regions	8
Aurora A	8
miR-324-5p	8
key proteins	8
CCN proteins	8
endochondral ossification	8
corneal centre	8
therapeutic agent	8
polymers	8
ovarian cancer	8
cell cultures	8
interacting proteins	8
focal adhesion kinase (FAK)	8
catalytic pocket	8
autophagy proteins	8
E3 ubiquitin ligase	8
autosomes	8
opportunistic pathogen	8
A. fumigatus	8
two media	8
breath	8
new species	8
foreign gene	8
third VR	8
amarantin acidic subunit	8
microorganisms	8
16S rRNA	8
ω-secalin genes	8
ω-secalin gene family	8
immobilized enzyme	8
κ-carrageenase	8
plant pathogens	8
fungi	8
many tumors	8
conventional assays	8
Tan sheep	8
DNA templates	8
L. chinensis	8
MS medium	8
P<0.05)	8
sdw1/denso locus	8
pheasant SSCs	8
endangered birds	8
wastewater	8
young and older adults	8
preclinical models	8
four genes	8
household	8
effective drugs	8
carer	8
statistical model	8
serum and tissue	8
diversity	8
accessions	8
T. thermophila	8
transgene expression	8
CpG island	8
case	8
several cancer types	8
HSC pool	8
long non-coding RNAs	8
PC12 cells	8
basic residues	8
BBB	8
Faecal samples	8
geographic regions	8
3 farms	8
immature worms	8
temperate climates	8
infected cats	8
TGF-β1	8
definitive hosts	8
Toxocara spp.	8
host species	8
individual animals	8
DEVGRP goats	8
authentic standards	8
brite/beige tissues	8
AP sites	8
telomeres	8
new elements	8
P. acnes	8
participant	8
GM-CSF	8
B. burgdorferi	8
c-Rel	8
K. pneumoniae	8
two SNPs	8
mammalian mitochondria	8
gene networks	8
de novo genes	8
source of cells	8
pre-mRNAs	8
animal kingdom	8
lipidome	8
crops	8
plant genomes	8
metabolic networks	8
genetic elements	8
vitro models	8
expression cassette	8
131I-mIBG	8
Cancer Research UK	8
primary tumour	8
living cell	8
Amplidiag® Bacterial GE	8
microbes	8
Haemophilus influenzae	8
HEK293T cells	8
[Ca2+]o	8
connections	8
soluble factors	8
Guest Editors	8
nucleoid	8
cultured human cells	8
protein kinase	8
infectious agents	8
protozoan parasite	8
TbKif13-2	8
herd	8
protein family	8
crystalloids	8
vertebrate host	8
exogenous DNA	8
small molecule inhibitors	8
Variant 3	8
Schistosoma mansoni	8
murine neutrophils	8
human neutrophils	8
HLA-C	8
Fallopian tube	8
metal ion	8
microbial growth	8
Ga(III)	8
plasmid genomes	8
defect	8
inflamed sites of intestine	8
patches	8
human mesenchymal stem cells	8
cortical bone	8
host tissue	8
cardiac progenitors	8
squamous cell carcinoma	8
human stem cells	8
hydrogels	8
native tissues	8
NPs	8
human macrophages	8
ECM components	8
plasmid DNA	8
scaffolds	8
fixed-length fibrin gels	8
collagen fibrillogenesis	8
distant metastases	8
bacteriophages	8
membrane phospholipids	8
brainstem	8
fly brain	8
principles	8
proxy	8
cellular systems	8
whole genomes	8
host environment	8
endogenous proteins	8
mitotic chromosomes	8
gut microbes	8
colorectal cancer	8
transcription start site	8
GTPase	8
antibiotic resistance genes	8
nuclear envelope (NE)	8
synaptic inputs	8
lineage-specific genes	8
infected macrophages	8
K2P channels	8
tumor suppressors	8
spliceosome	8
multiple cell lines	8
epiblast cells	8
epiblast	8
structural framework	8
genes and pathways	8
miRNA	8
Ly6Clow monocytes	8
ubiquitinated proteins	8
tripartite ring	8
epigenetic marks	8
target loci	8
commensal bacteria	8
inner cell mass	8
N terminus	8
multiple proteins	8
replication origins	8
fruit odors	8
lysosomal enzymes	8
human gut microbiota	8
NET complexes	8
molecular pathway	8
biological pathways	8
immunologic synapse	8
allergenic foods	8
12 patients	8
type 2 cytokines	8
PS patients	8
important therapeutic target	8
different pathways	8
atopic dermatitis	8
allergens	8
cytokine	8
inflammasome	8
peanut allergy	8
population-based birth cohort	8
fluorescent reporters	8
cardiac cell models	8
pair	8
cardiac electrophysiology	8
analogues	8
Computer simulations	8
CDKN2A expression	8
dose	8
direct assays	8
yeast and mammalian cells	8
soil microbes	8
bulk soil	8
extract	8
links	8
essential nutrients	8
microbial biomass	8
soil solution	8
biofilms	8
subsoil	8
experimental model	8
crystal lattice	8
gene bodies	8
conserved motif	8
novel targets	8
interaction partners	8
single-stranded DNA	8
RNA-binding sites	8
interfaces	8
expression of genes	8
resident microbiota	8
initiation factors	8
volume	8
Npu DnaE intein	8
paracellular channels	8
replicative helicase	8
barriers	8
pores	8
human proteome	8
triple-helical collagen	8
many enzymes	8
ligase	8
DNA fragments	8
vitro systems	8
potent inhibitor	8
important human pathogen	8
molecular basis	8
visceral leishmaniasis	8
eukaryotic proteins	8
talin FERM domain	8
sugar	8
phosphatases	8
acidic residues	8
wild-type receptor	8
polypeptide chain	8
active sites	8
molecular machines	8
alternative carbon sources	8
progenitor	8
folding nucleus	8
chaperones	8
dimers	8
muscle fibres	8
mechanistic model	8
computational model	8
pocket	8
promising therapeutic target	8
damaged organelles	8
science	8
experiment	8
young adults	8
selected proteins	8
intracellular cAMP	8
concept	8
creatine kinase	8
implant	8
N-cadherin	8
tropics	8
amino acid	8
specific antibodies	8
different laboratories	8
two	8
CD8 T cells	8
effector cells	8
microarray	8
subsets	8
kits	8
ELISA	8
memory T cells	8
female genital tract	8
mast cells	8
many organisms	8
adult population	8
young	8
Lapland longspurs	8
gonads	8
changing environments	8
regulatory proteins	8
green fluorescent protein	8
flagellar pocket	8
brain tumors	8
microRNAs	8
master regulators	8
external environment	8
eukaryotic organisms	8
yeast cells	8
stem/progenitor cells	8
lipid droplets	8
cohesin complex	8
Omi/HtrA2	8
breast cancer patients	8
secondary cartilage	8
lines	8
head	8
negative regulators	8
regions of the genome	8
coding genes	8
vascular endothelial cells	8
jaw	8
expression vectors	8
tubule	8
spongiotrophoblast	8
placental glycogen	8
oocyte	8
retinoic acid	8
male	8
nuclei	8
current models	8
gene regulatory network	8
craniofacial skeleton	8
different substrates	8
N-WASP	8
lumen	8
epidermal cells	8
NC cells	8
nerves	8
optic cup	8
mesenchyme	8
vertebrate species	8
bulge	8
Xenopus tropicalis	8
developing heart	8
cardiogenic mesoderm	8
neuron	8
lower cup	8
mutant cells	8
ventricular surface	8
limited resources	8
cohorts	8
EDTA-plasma	8
Vantera Clinical Analyzer	8
/L	8
whole blood samples	8
phosphatase	8
inner cell mass (ICM)	8
nucleosomal DNA	8
membrane cholesterol	8
lipid vesicles	8
nucleosome	8
material	8
toolbox	8
leaflets	8
cellular protrusions	8
boundary	8
toxin	8
isolated cells	8
surface-sarcolemmal caveolae	8
aqueous solutions	8
ensemble	8
co-chaperones	8
chromosomal DNA	8
bacterial strains	8
different domains	8
location	8
secondary structures	8
Ion channels	8
TCR	8
SOD1 gene	8
leading edge	8
protein interaction networks	8
KATP channel	8
conformation	8
microfluidic device	8
water molecule	8
water molecules	8
images	8
examples	8
rotor	8
motor	8
distant ceRNAs	8
homology models	8
amyloid plaques	8
2D crystals	8
excitatory synapses	8
hydrophobic patch	8
promising therapeutic targets	8
HFD-fed mice	8
fatty liver	8
Toll-1 receptor	8
number of cells	8
pancreatic cancer cells	8
higher plants	8
basement membrane	8
physical barrier	8
SAMP1 mtDNA	8
mediators	8
Protein Data Bank	8
hydrogen peroxide (H2O2)	8
OPN-KO group	8
OM rats	8
structural models	8
microfluidic devices	8
metabolite	8
injured spinal cord	8
small peptides	8
human skin	8
forms	8
K+ channels	8
target RNAs	8
epitopes	8
Xenopus laevis	8
chimeric proteins	8
mevalonate pathway	8
mitotic cells	8
gene family	8
extracellular loops	8
C1qtnf3−/− mice	8
apoptotic cells	8
islets	8
treated animals	8
resulting cells	8
dystrophic muscle	8
specific genomic regions	8
cell viability	8
/c mice	8
dietary supplement	8
X-ray structure	8
bile acids	8
Pichia pastoris	8
purified enzyme	8
four groups	8
C57BL/6J mice	8
dyes	8
atomistic simulations	8
target protein	8
model membranes	8
Membrane proteins	8
different environments	8
experiments	8
membrane lipids	8
lipid molecules	8
integral membrane protein	8
inner mitochondrial membrane	8
intermembrane space	8
insect cells	8
immunological synapse	8
plasma membranes	8
plasma proteins	8
cell-free system	8
cytochrome c	8
globular proteins	8
natural environment	8
butyric acid	8
wild-type enzyme	8
vivo and in vitro	8
missense variants	8
nuclear receptors	8
NKX6-2	8
who	8
unrelated families	8
three families	8
breast cancer cell lines	8
breast tumors	8
diverse populations	8
sub-Saharan Africa	8
basal ganglia	8
large cohorts	8
compound heterozygotes	8
primary human cells	8
NF-κB.	8
nuclear genes	8
human population	8
affected subjects	8
association	8
cortical actin cytoskeleton	8
ethnic groups	8
helicase	8
mutant transcripts	8
four patients	8
transfected cells	8
neuromuscular junction	8
siblings	8
white matter	8
patient cells	8
nine patients	8
Lebanese Christians	8
CTD	8
L. donovani	8
Leishmania donovani	8
blood meal	8
settings	8
human dengue cases	8
Leishmania species	8
Trypanosoma cruzi	8
animal reservoirs	8
different genotypes	8
sand flies	8
infected animals	8
AMH assay	7
host proteins	7
mouse brain	7
joints	7
P-Rex1	6
PerfluoroC8 stationary phase	6
S. staphylococcus	6
S. putrefaciens and S. staphylococcus	6
main-panel	6
otter-board	6
dried fish	6
CIK cells	6
SMF	6
head kidney	6
fish species	6
2n gynogens	6
H. cumingii	6
digestive gland	6
E. fuscoguttatus	6
LED lights	6
assessment models	6
dominant species	6
flocculants	6
chitin chains	6
HPV vaccines	6
controlled housing	6
human cases	6
boiling herbal water extracts	6
rats	6
3D cardiac tissues	6
Multi-PK antibodies	6
Shc proteins	6
Met35 residue	6
fruit juices	6
repressilator	6
CAR-T cells	6
TRAD-DNIκBα	6
intratumoral infectious centers	6
paramyxoviruses	6
zoonotic diseases	6
anti-A1	6
PerFix EXPOSE kit	6
PIVO™	6
Elecsys® Cyclosporine and Elecsys®	6
WNR scattergram	6
HR patients	6
GC-KLF15-BCAA pathway	6
C. trachomatis	6
*13:02	6
Gulf War veterans	6
culture media	6
lower fat, higher carbohydrate group	6
tau mRNA	6
CRE strains	6
adolescent patients	6
CLL cells	6
sickle-cell trait	6
CIDP patients	6
MSRV-Env	6
non-diabetic subjects	6
diabetic subjects	6
mutation carriers	6
RBC ascorbate	6
W ST-11 strains	6
Hajj clone	6
BRCA1/2 mutation carriers	6
F508del-CFTR	6
non-remitters	6
breast cancer mortality	6
inorganic arsenic	6
amino acid mixture	6
urban farmers	6
gastric mucosa	6
OVX animals	6
proximal tibia	6
bone samples	6
mouse strains	6
mouse and human sera	6
allantoic fluid	6
neonatal hemophilia B mice	6
hemophilia B	6
AAV vectors	6
undifferentiated hPSCs	6
NBD peptide	6
biogas yields	6
VP1 pentamers	6
food waste	6
16S rRNA gene copies	6
NAD(P)H oxidase p22 phox gene	6
cataract cases	6
FABP2 and PPARG2 gene polymorphisms	6
Japanese patients	6
disease-affected individuals	6
SVP-Rapa	6
PORCN gene	6
Ab+ patients	6
new EO blend	6
essential oils	6
job strain	6
new cases	6
cholecalciferol group	6
UK Medical Research Council	6
National Institute	6
Heart Foundation	6
amiloride group	6
bariatric surgery patients	6
Medical Research Council	6
Eligible patients	6
BAF complexes	6
NTE cells	6
NF-E2	6
mouse embryonic stem cells (mESCs)	6
hESC-CVPs	6
C-MYC	6
cell preparations	6
iPSC-derived DA neurons	6
Sca1-derived cells	6
rat ESCs	6
DA neurons	6
Sco proteins	6
urine samples	6
3T3-L1 preadipocytes	6
mt-roGFP	6
cancer drugs	6
(PhSe)2	6
brain of mice	6
phenolic extract	6
thiol redox metabolome	6
HF erythrocytes	6
ROS scavengers	6
urinary 8-oxoGuo	6
SGZ	6
L-cysteine	6
redox targets	6
vitreous	6
Hydrogen peroxide (H2O2)	6
cytoprotective enzymes	6
redox environment	6
female VSMC	6
Nrf2 pathway	6
skeletal muscle cells	6
UDP-GlcNAc	6
reactive intermediates	6
inositol pyrophosphates	6
bone marrow adipocytes	6
E. histolytica and T. vaginalis	6
thioredoxin reductase	6
γ-secretase	6
activin E	6
envelope protein	6
glycan holes	6
AxD astrocytes	6
iPSC-derived cardiomyocytes	6
Ser-ADPr	6
β-TrCP	6
Japanese population	6
lung metastasis	6
different cell lines	6
synaptic contacts	6
WIPΔABD B cells	6
CAST/ELKS	6
autophagy-deficient cells	6
two areas	6
functional neurons	6
myosin IIa	6
endometrial cancer	6
Munc13-3	6
wind tunnel	6
HCN1 channels	6
limb buds	6
nanodomains	6
colonic mucosa	6
brown adipocytes	6
iPSC-derived neurons	6
mouse xenograft model	6
spleen marginal zone	6
iPSC genomes	6
optic nerve	6
Drosophila models	6
microglia	6
Th2-like Tregs	6
polyQ proteins	6
thalamic inputs	6
experimental platform	6
EZH2-deficient hESCs	6
enhancer regions	6
distinct cell types	6
shortened telomeres	6
L-proline	6
Zika virus (ZIKV)	6
precancerous lesions	6
synaptic connections	6
humanized mice	6
human hepatocytes	6
primed pluripotency	6
β-arrestins	6
SummaryT cells	6
antisense SUTs	6
hemogenic endothelium (HE)	6
leader cells	6
three conserved phosphorylation sites	6
RPE	6
glycan shield	6
human dermal fibroblasts	6
spindle assembly checkpoint (SAC)	6
bivalent genes	6
[SWI+] cells	6
JAK2V617F mutant cells	6
metastatic tumors	6
colon-CSCs	6
large polyQ repeats	6
IFITM proteins	6
stereocilia tips	6
condensed chromatin	6
authors	6
D. melanogaster	6
LMC-MNs	6
PML-RARα	6
memory T cells	6
L cells	6
STP axis	6
human TNBC	6
signaling axis	6
neural stem cells (NSCs)	6
Bcl6RD2MUT mice	6
single neurons	6
biochemical pathways	6
ROS	6
cyclin-dependent kinases	6
mutation clusters	6
DNA-binding protein	6
integrin β1	6
iPSCs	6
primary hepatocytes	6
model protein	6
SOSS1 complex	6
resistant mutants	6
human induced pluripotent stem cells (iPSCs)	6
Wnt ligands	6
principal neurons	6
mTORΔ/Δ mice	6
5S rRNA	6
iPSC technology	6
multicellular organism	6
foreign nucleic acids	6
H1 subtypes	6
spine growth	6
three SNARE proteins	6
secretory cells	6
IL-6 amplifier	6
MLL-AF4	6
patient neurons	6
Reissner's membrane	6
otoacoustic emissions	6
CR-vectors	6
mutant huntingtin	6
EGS variant	6
antisense oligonucleotides	6
REP 2165	6
human breast cancer cells	6
cationic polymers	6
ASO	6
mouse liver	6
short interfering RNA (siRNA)	6
space groups	6
external magnetic field	6
traditional Chinese medicine	6
question	6
therapeutic candidates	6
Lung cancer	6
differential gene modules	6
variant combinations	6
related sequences	6
glycolytic enzymes	6
chimeric peptides	6
CST complex	6
variables	6
biological fluids	6
linear model	6
LA loop	6
polymerase-1 (PARP-1)	6
granule neurons	6
albumin-binding domain	6
alignment	6
exons 11–13	6
class of proteins	6
family 10 xylanases	6
Arthrospira cell factories	6
m2G	6
phosphate groups	6
P2X1 receptors	6
supraspliceosome	6
representation	6
coding and non-coding regions	6
PLS models	6
elderly patients	6
prospective mates	6
lymphatic endothelial cells	6
super-enhancers	6
retinal pigment epithelium (RPE)	6
multipotent cells	6
catalog	6
H. hepaticus	6
host cytosol	6
infectious virus	6
PfRH5-based vaccines	6
hepatic cells	6
spiroindolones	6
serum	6
virulence effectors	6
UK Biobank	6
anti-diabetic medications	6
specific pathways	6
Drp1 expression	6
different cancer types	6
eluted peptides	6
chloroplast	6
wheat gluten	6
MS/MS spectra	6
mass spectrometers	6
[EuPA 2012].	6
East Asia	6
feed	6
patients and their families	6
CNVs	6
without	6
nucleotide sequences of pathogens	6
single models	6
sea lice abundance	6
lifetime partners	6
multiple epitopes	6
new host	6
child	6
stochastic simulations	6
live diagnostic test	6
clinical cases	6
infectious faeces	6
S. hermonthica	6
‘Foxy-2’	6
anticancer drugs	6
metabolic enzyme	6
circRNAs	6
Circular RNAs (circRNAs)	6
pre-miRNAs	6
extracellular milieu	6
adjacent normal tissues	6
blood-based biomarkers	6
topic	6
A. thaliana	6
plant proteins	6
functional units	6
tree	6
COX-2-/- cells	6
viral communities	6
annotated genes	6
PacBio sequencing	6
multiple datasets	6
glomerulus	6
databases	6
agonistic β1AR autoantibodies	6
undamaged cells	6
PARG inhibitors	6
PARP proteins	6
poly(ADP-ribose)	6
DNA ends	6
genomic uracil	6
genetic information	6
partner proteins	6
uncapped telomeres	6
BCPP compounds	6
human samples	6
Genotype IV	6
individual genes	6
SSR loci	6
α cells	6
Tumor cells	6
transcriptional networks	6
new therapeutic target	6
transcription factor genes	6
adult Drosophila	6
granules	6
POMC neurons	6
direct targets	6
hematological malignancies	6
resistant cells	6
MM cells	6
pioneer factor	6
DDR	6
chromosome ends	6
autophagic machinery	6
RAB11A-positive membranes	6
fat body cells	6
adult β cells	6
cell cycle	6
epigenetic modifiers	6
daughter centrioles	6
MVB	6
active enhancers	6
central regulator	6
δ-adaptin	6
cell-surface proteins	6
late endosomes/lysosomes	6
lysosomal membranes	6
microtubule end	6
primitive streak	6
intercellular complexes	6
p53 pathway	6
neural progenitor cells	6
BMP signaling	6
body cavity	6
tissue growth	6
HAC	6
cryopreserved hepatocytes	6
HCC cells	6
hepatoma cells	6
engineered T cells	6
immunocompetent mice	6
triple AAV vectors	6
promising platform	6
HIV-1 packaging sequences	6
transcription factor Nrf2	6
non-human primate model	6
world population	6
IDLV-Env	6
APT-F2P	6
NKA	6
Tat-R5M4	6
viral reservoir	6
engineered nucleases	6
conditioned medium	6
DNA aptamers	6
dystrophin reading frame	6
PTEN expression	6
SK-N-AS cells	6
mosquito bite	6
FAZ	6
public health problem	6
FBS-containing medium	6
FBS-based culture	6
hematopoietic stem cells	6
normal tissue	6
synovial MSCs	6
sources	6
ESBL-PE	6
atypical pneumonia	6
common serotypes	6
Mycoplasma agalactiae	6
deletion mutants	6
O-antigens	6
P. multocida OMVs	6
P. multocida	6
lives	6
AP	6
M. braseltonii	6
COS-7 cells	6
oxidized phospholipids	6
lipid domains	6
ethanolamine phospholipids	6
excess cholesterol	6
viral populations	6
community patients	6
histological material	6
influenza season	6
G10P[11] strains	6
CMV antigenemia	6
PIGRET assay	6
clean meat	6
laccase-HBT system	6
laccase-mediator systems	6
bioprocess economics model	6
decisional tool	6
two donors	6
different donors	6
direct gas sparging	6
pathogenic microbes	6
epigenetic regulators	6
synthetic microbial communities	6
new hosts	6
diagnostic laboratory	6
drug target	6
insect vectors	6
distinct targets	6
foundations	6
public repositories	6
medicinal plants	6
intact proteins	6
researchers	6
arteries	6
CCM proteins	6
susceptible individuals	6
Non-coding RNAs	6
plasma	6
rate-limiting enzymes	6
dietary nitrogen	6
E. coli OD259	6
molecular chaperones	6
epidermal growth factor	6
ZIKV infection	6
ΔsecA2 mutant	6
MSD cases	6
Xpert MTB/RIF assay	6
subclinical malaria	6
World Health Organization (WHO)	6
interaction landscape	6
opposite side	6
molecular species	6
newly synthesized DNA	6
many mRNAs	6
mitochondrial respiratory chain	6
necrosis factor (TNF)	6
PARylated PARP1	6
Smc arms	6
basis	6
arm	6
heterochromatic regions	6
MCC	6
RC	6
transcript	6
TE-related sequences	6
mark	6
FA pathway	6
interacting partners	6
DNA replication machinery	6
aberrant mRNAs	6
pluripotency network	6
nucleases	6
chromatin remodelers	6
interaction networks	6
death-inducing signaling complex (DISC)	6
Caulobacter crescentus	6
fission yeast Schizosaccharomyces pombe	6
G4 DNA	6
REV1-deficient cells	6
avian cell line DT40	6
parental histones	6
junction	6
gene promoters	6
X chromosomes	6
nucleoprotein complexes	6
activation loop	6
promoter DNA	6
apical domains	6
poly(A) tails	6
novel murine model	6
various organ systems	6
study drug	6
pooled pegvaliase group	6
adults with PKU	6
adverse events	6
7 patients	6
One patient	6
different age groups	6
eligible patients	6
young patients	6
mutant enzymes	6
two mutants	6
German patients	6
comorbid conditions	6
UCD patients	6
Gaucher disease patients	6
HO mice	6
cbs (−/−) mice	6
kinetic models	6
P. putida EM42	6
metabolic pathway	6
metabolic models	6
genome-scale metabolic models	6
FH-deficient cells	6
nucleic acids and proteins	6
n-butanol	6
Western blots	6
hyphal tip	6
Agrobacterium tumefaciens	6
inducers	6
hyphal growth	6
fungal cells	6
Chinese H. minnesotensis population	6
lessons	6
public	6
general public	6
Manchester Fly Facility	6
mechanical signals	6
ear	6
one cell	6
B-type lamins	6
fruit flies	6
small non-coding RNAs	6
ENRIA project	6
C. difficile	6
chemicals and fuels	6
CCEY egg yolk agar	6
naive B cells	6
E3 ubiquitin ligases	6
Kupffer cells	6
plasma cells	6
PD-L1 expression	6
human immune system	6
gingiva	6
intestinal Th17 cells	6
virus-infected cells	6
pre-existing antibodies	6
Breg cells	6
secondary lymphoid organs	6
NF-κB signaling	6
+ cells	6
environmental stimuli	6
GC B cells	6
WT cells	6
γδ T cells	6
inflammatory molecules	6
cSMAC	6
inflammatory cytokine	6
control fish	6
diploid and triploid Atlantic salmon	6
industry	6
peripheral blood cells	6
resulting models	6
regulatory switches	6
acute brain slices	6
plant parts	6
carbon support film	6
Structural Genomics Consortium (SGC)	6
trimers	6
receptor tyrosine kinase	6
competent NORs	6
protein antigens	6
tagged proteins	6
modified nucleotides	6
transcription activator-like effector nucleases (TALENs)	6
zinc finger nucleases (ZFNs)	6
host cell genome	6
poly(A) tail	6
cellular environment	6
primary transcripts	6
multiple donors	6
double-membrane autophagosomes	6
egg extracts	6
D-antigen content	6
B. thuringiensis	6
F. tularensis	6
electrical synapses	6
cancer stem cells (CSCs)	6
clonal lineages	6
outer mitochondrial membrane	6
Burkitt's lymphoma	6
subset of genes	6
neutrophil elastase 2	6
chain	6
JM region	6
crosslinked residues	6
native membranes	6
small-molecule inhibitors	6
transport systems	6
transmembrane protein	6
integrin	6
rotary ATPases	6
homologous proteins	6
bacterial cell	6
AMPAR NTDs	6
actively transcribed genes	6
AAA+ ring	6
monoclonal antibodies (mAbs)	6
certain cancers	6
centromeric DNA	6
nSH2	6
monomeric proteins	6
peptide arrays	6
attractive drug targets	6
extracellular ATP	6
RNA viruses	6
ecological niches	6
many viruses	6
respiratory infections	6
types	6
new vaccines	6
mammalian counterparts	6
men and women	6
vitamin D metabolites	6
skin cells	6
known metabolites	6
16th Vitamin D Workshop	6
vitamin D system	6
PXR	6
PXR activator	6
cyclosporin A	6
TFs	6
core autophagy machinery	6
lysosomes	6
organic molecules	6
specimen supports	6
spliced mRNA	6
C-type lectins	6
large proteins	6
contexts	6
homeodomain proteins	6
otic placode	6
DNA and RNA	6
biosphere	6
high-risk populations	6
renewable feedstocks	6
YAP/TAZ	6
emerging field	6
nutrient transporters	6
integrin receptors	6
endocytic pathway	6
homologous chromosomes	6
steroid hormone ecdysone	6
migrating cells	6
mouse and human islets	6
collagen fibers	6
stroma	6
centre	6
collagen IV	6
GVMGFO motif	6
discoidin domain receptors, DDR1 and DDR2	6
BM-MNCs	6
acellular zones	6
one group	6
β-galactosidase	6
C-reactive protein	6
DCM tube	6
donepezil hydrochloride	6
MN arrays	6
ionic liquid	6
large aggregates	6
64Cu-cyclam-RAFT-c(-RGDfK-)4	6
rDNA trees	6
problem	6
formulation	6
new genes	6
PACE proteins	6
pumps	6
solid tumours	6
C. botulinum Groups I and II	6
promoter region	6
operon	6
3′ UTR	6
miR-382-5p	6
acute myeloid leukemia (AML)	6
POPDC proteins	6
hormone	6
downstream targets	6
c-Jun	6
pharmacological agents	6
lipid metabolism	6
platelet-derived SDF-1α	6
3D model	6
human platelets	6
amoeba pathogens	6
activated fibroblasts	6
p38 MAPK	6
P2X7 receptor	6
set of genes	6
Magnaporthe oryzae	6
obese individuals	6
habitats	6
UV light	6
Y. lipolytica	6
cytoskeletal filaments	6
pharmaceutical industry	6
downstream target genes	6
Burkholderia spp.	6
gold standard	6
users	6
three samples	6
B. elkanii	6
Code	6
P. vulgaris	6
rhizobial isolates	6
eukaryotic genome	6
C. guilliermondii strain	6
L. japonica	6
late-flowering cultivar	6
early-flowering cultivar	6
surrounding environment	6
endophytic bacterial strains	6
two classes	6
d-CpHPG	6
testis	6
B. subtilis SF4-3	6
immobilized κ-carrageenase	6
various combinations	6
amplicons	6
growth medium	6
biosurfactants	6
plant growth	6
fruit set	6
C. chinensis	6
microorganism	6
Xyl II	6
Xyl I	6
by-products	6
transgenic plants	6
biosynthetic pathways	6
biomass production	6
NPST-AK15	6
reference strains	6
Z. mobilis	6
mature peptide	6
rare minnow hepcidin	6
clavulanic acid	6
chemical	6
commercial kits	6
individual samples	6
improved RAPD fragments	6
soybean flour	6
SSR markers	6
Rfo gene	6
known genes	6
control plants	6
peanut roots	6
full-length cDNA	6
C. borivilianum	6
SRAP markers	6
several species	6
predatory mite	6
culture broth	6
yeast extract	6
nitrogen source	6
individual components	6
one cluster	6
three populations	6
single genes	6
AD patients	6
pro-inflammatory mediators	6
fruit fly Drosophila	6
laboratory animals	6
adult children	6
patent ductus arteriosus	6
several organs	6
TOV-serotyped BTV	6
nodes	6
A. centrale	6
healthy feet	6
Dichelobacter nodosus	6
bacterial populations	6
reassortant viruses	6
genotype	6
metagenomic libraries	6
opportunistic pathogens	6
subtype A	6
P32 gene	6
Group HF	6
GRP genes	6
I. trifida	6
period	6
microsatellite markers	6
yeast	6
tRNA precursors	6
host and pathogen	6
classifiers	6
polymorphism	6
multiple binding sites	6
critical regulators	6
luciferase reporter gene	6
Meis homeoproteins	6
recipient cells	6
immortalized cells	6
MDCT cells	6
cellular protein	6
gene sets	6
different aminoglycosides	6
pharmacological chaperones	6
vivo-induced antigens	6
four species	6
hydrophobic TPP compounds	6
two variants	6
3′ UTRs	6
resistance alleles	6
G. truncatula populations	6
ewes and lambs	6
PCR-RFLPs	6
pooled samples	6
larval cultures	6
stochastic model	6
T. circumcincta	6
herds	6
Teladorsagia circumcincta	6
small interfering RNAs (siRNAs)	6
T. cati	6
O. armillata	6
chromosomes 1 and 2	6
molecular markers	6
tick cells	6
transposase	6
A. phagocytophilum	6
one of the strains	6
Haemonchus contortus	6
livestock species	6
new acinar cells	6
classical brown adipose tissue	6
genetic background	6
substrate binding pocket	6
diverse organisms	6
translational machinery	6
cell extracts	6
ribosomal RNA	6
MOFs	6
phenylacetylide compound	6
food intake	6
upper small intestine	6
GPR119 agonists	6
intestinal L-cells	6
female reproductive tract	6
high-income countries	6
Ebola virus	6
S. aureus	6
hand hygiene	6
MOS PIVCs	6
FAE	6
immunocompromised individuals	6
blockchain technology	6
anthropogenic environments	6
team	6
extinct organisms	6
species diversity	6
vessel wall	6
human retina	6
formulations	6
drug delivery systems	6
lymphocyte populations	6
various organisms	6
nascent transcript	6
multiple factors	6
quantitative trait loci (QTL)	6
cell wall components	6
varieties	6
Arabidopsis seedlings	6
biomass yield	6
aqueous environment	6
microbial cell factories	6
Vf-ATA	6
ocean	6
given environment	6
antenna size mutants	6
bacterial enzymes	6
plant biomass	6
co-cultures	6
primary tissues	6
different countries	6
head and neck cancer	6
esophageal cancer	6
inguinal nodes	6
consecutive patients	6
NTCP modeling	6
oral mucosa	6
synthetic biologists	6
project	6
two technologies	6
membrane transporters	6
test compounds	6
individual antibodies	6
immunoblot	6
genomic targets	6
qPCR assays	6
M. pachydermatis	6
stool culture	6
LRE qPCR	6
cellular material	6
synthetic biology standard	6
B. subtilis chromosome	6
stored samples	6
Strain Solution	6
serotypes	6
Penicillium spp.	6
fungal species	6
M. mycoides subsp.	6
extracellular stimuli	6
CaV1.2 channels	6
standard diet	6
calcium-sensing receptor (CaSR)	6
peroxisomal membrane proteins	6
chemotherapy drugs	6
dendritic and somatic regions	6
dendritic regions	6
sensors	6
fruit fly	6
nucleus and the cytoplasm	6
Gli1/2 proteins	6
J-domain	6
Okazaki fragments	6
candidate proteins	6
Transgenic mice	6
FP receptor	6
nude mice	6
endometrial adenocarcinoma cells	6
endometrial adenocarcinomas	6
DNA-PK	6
proteins of interest	6
termini	6
intermediate filaments	6
extracellular vesicles	6
trypanosome exosome	6
Eukaryotic cells	6
obligate intracellular parasites	6
malaria parasite Plasmodium falciparum	6
erythrocyte periphery	6
African trypanosome	6
essential components	6
apicomplexan parasites	6
phylum	6
VSG coat	6
genotoxic agents	6
Leishmania major	6
signaling cascades	6
RNA interference (RNAi)	6
bioinformatics tools	6
human African trypanosomiasis	6
live parasites	6
molecular regulators	6
asexual blood stages	6
wild type protein	6
effector T cells	6
signal transduction pathways	6
glycoprotein	6
TG	6
siglec-F	6
CD8αint DCs	6
HLA antibodies	6
trophoblast cells	6
cervix	6
caesarean section	6
dNK cells	6
CD11c+ cells	6
preeclamptic women	6
new biomarkers	6
E. coli cells	6
catalytic metal site	6
DLasiL lectin	6
Ru(II)	6
supernatant samples	6
health care	6
enteric pathogens	6
specific DNA sequences	6
Co3+	6
surroundings	6
CM	6
cellular microenvironment	6
injury/graft site	6
MSC-derived neural network tissue	6
biomedical applications	6
BALB/cJ mice	6
collagen-binding integrins	6
DNA-Gd@AuNPs	6
A549 cells	6
H-NDs	6
MWNTs-NH3+	6
serum proteins	6
biomaterial	6
fluorescent probes	6
liver cells	6
end user	6
crypts	6
corpus callosum	6
cationic RTNs	6
articular cartilage	6
embryonic tendon	6
G6PD variants	6
structural motifs	6
intermediate bulk	6
bioactive mediators	6
invading pathogens	6
essential fatty acids	6
histone deacetylation	6
stumpy formation	6
BLA	6
tissue-specific exons	6
RBPs	6
circuit	6
cohesin rings	6
reversed replication forks	6
resident macrophages	6
Trim-Away	6
condensin complexes	6
underlying signaling pathways	6
attractive therapeutic target	6
multiprotein complex	6
neural networks	6
certain tissues	6
genomic loci	6
start codon	6
conjugative pili	6
 vitro and in vivo	6
three-dimensional (3D) structures	6
Drosophila macrophages	6
mycobacterial growth	6
dying cells	6
phagosome	6
ventral tegmental area (VTA)	6
rod	6
first author	6
ancient DNA	6
etiological agent	6
adult tissue	6
bridge	6
peripheral nervous system	6
Rad51 paralogs	6
single-stranded DNA (ssDNA)	6
in vivo experiments	6
functional mRNA	6
40S ribosomal subunit	6
cholinergic neurons	6
aberrant proteins	6
mammalian ribosome	6
specific mRNAs	6
exogenous norspermidine	6
B. subtilis	6
imprinted loci	6
important regulator	6
multiple signaling pathways	6
developing tissues	6
rat strains	6
OTU DUBs	6
nuclear factor κB (NF-κB) signaling	6
Ub chains	6
14-3-3 proteins	6
14-3-3	6
SummaryEmbryonic stem cells (ESCs)	6
Alu elements	6
signal transducers	6
domains of life	6
developmental genes	6
somatic mutations	6
nuclear membrane	6
mouse genetics	6
dynein motor domain	6
selective inhibitors	6
TA proteins	6
parasite proteins	6
antennal lobe	6
cohort of patients	6
differentially methylated regions	6
experimental models	6
pathogenic TH17 cells	6
NLRC4 inflammasome complex	6
nuclear factor κB	6
cortical actin	6
2 patients	6
 T cells	6
convalescent samples	6
human ILC2s	6
nasal polyps	6
host immunity	6
small interfering RNAs	6
ILC2s and TH2 cells	6
single center	6
regulatory T cells	6
potential confounders	6
different patients	6
CG	6
HDM allergens	6
nonasthmatic children	6
Hydrogen peroxide	6
lentiviral vector	6
B-cell compartment	6
patients with SR asthma	6
novel therapeutic target	6
hospital admissions	6
household dust	6
impaired skin barrier	6
6 patients	6
allergen-specific IgE	6
peanut and its components	6
whole transcriptome	6
chimeras	6
(NK) cells	6
adaptive immunity	6
mTOR pathway	6
growth media	6
FLG mutations	6
stratum corneum	6
filaggrin gene (FLG)	6
lymphocyte subsets	6
healthy children	6
gland	6
11β-HSD2	6
minor groove	6
small-molecule drugs	6
multiple technologies	6
case studies	6
complex biological systems	6
Scn3b−/− hearts	6
plant parasitic nematodes	6
imaging modalities	6
Lothian Birth Cohort	6
homologous regions	6
cell systems	6
cell repertoire	6
colonic crypts	6
multiple mouse models	6
prospective studies	6
greenhouse gas emissions	6
ecosystem	6
river	6
soil microbial diversity	6
ecosystems	6
organic acids	6
tropical peatlands	6
ca.	6
soil microbial community	6
wetted area	6
soil food web	6
°C	6
soil organic matter	6
summer fallow	6
invasive species	6
soil organic matter (SOM)	6
root exudates	6
biomass growth	6
extracted protein	6
organic horizons	6
topsoil	6
organic material	6
Arctic	6
soil microcosms	6
liquid cultures	6
G. intraradices	6
G. mosseae	6
tumours	6
insulin receptor	6
European populations	6
co-crystal	6
benchmark	6
cryptic splice sites	6
terminal regions	6
virtual reality	6
eukaryotic and prokaryotic cells	6
fibers	6
tau protein	6
coiled coil	6
peroxisomal ubiquitination machinery	6
single subunit	6
Parkinson's disease patients	6
substantia nigra	6
Leishmania parasites	6
TCA cycle intermediates	6
protein crystallography	6
key signalling pathways	6
EGFR	6
patients with asthma	6
web server	6
N-terminal end	6
transcription-blocking DNA lesions	6
fluorescent protein	6
polymerase	6
large set	6
hexadecamer	6
transmembrane helices	6
interactome	6
heterospecific PPIs	6
particle	6
new antimicrobials	6
epithelium	6
three components	6
k-turns	6
APC/C.	6
anaphase-promoting complex/cyclosome (APC/C)	6
complex molecular machines	6
D. discoideum	6
histone chaperone	6
different genes	6
matrix proteins	6
detergents	6
G protein-coupled receptors	6
human enzyme	6
DNA strands	6
atomic model	6
ligases	6
landscape	6
three-dimensional models	6
AE1 membrane domain	6
Clostridium species	6
pilus subunits	6
NMR structure	6
molecular model	6
ENTH domain aggregates	6
ENTH domains	6
synaptic cleft	6
virus-like particles	6
immunodominant epitope	6
NuRD complex	6
NTDs	6
individual domain	6
cytoplasmic proteins	6
human gut	6
inhibitory complex	6
genetically identical cells	6
end	6
repressor	6
dimer of dimers	6
agonist	6
hinge region	6
histone deacetylase inhibitors	6
C-terminal catalytic domain	6
salt bridge	6
two drugs	6
whole	6
genomic RNA	6
high-resolution crystal structures	6
various proteins	6
amino acid sequence	6
variety of proteins	6
unfolded ensemble	6
intermediates	6
Zn2	6
distal end	6
PspA subunits	6
α-LA molten globule	6
molten globule	6
protein L	6
on-pathway intermediate	6
double-stranded DNA	6
recombined var gene	6
host receptors	6
neck domains	6
septal ring	6
NTD	6
N-terminal domain (NTD)	6
CpG dinucleotides	6
animal genomes	6
first crystal structure	6
regulatory pathways	6
R16 domain	6
tandem C2 domains	6
Shigella flexneri	6
family of proteins	6
hydrophobic pocket	6
hinge	6
patch	6
Nab2 N-terminal domain	6
individual domains	6
HsdR subunit	6
MHC-II-1	6
polar residues	6
toxic compounds	6
molecular dynamics simulation	6
metal binding site	6
intermediate ensemble	6
clinical practice	6
CaP particles	6
vascular smooth muscle cells (VSMCs)	6
contact sites	6
sarcomere assembly	6
IGF1 stimulated NRVCs	6
adult zebrafish heart	6
[Na]i	6
Sham myocytes	6
fatty acid	6
Nanog expression	6
aging heart	6
pump	6
sarcoplasmic reticulum	6
subcellular compartments	6
intercalated disc	6
cardiac cells	6
inferior vena cava	6
SAN	6
SHR control	6
North America	6
continent	6
critical proteins	6
functions	6
mechanism	6
mRNA transcripts	6
many animals	6
six sites	6
adjuvant	6
CD4 T cells	6
cytotoxic molecules	6
infected patients	6
human intestine	6
questions	6
LFA	6
pHAb dye	6
flow cytometry	6
NOD mice	6
contact	6
buffer	6
leukocytes	6
multiple populations	6
multiple biomarkers	6
periplasmic space	6
human gastric biopsies	6
preparations	6
CD8+ T cells	6
lung T cells	6
hair	6
storm	6
hormones	6
Thyroid hormones	6
large intestine	6
stress hormones	6
pituitary	6
regions of the world	6
urban areas	6
taxa	6
faecal samples	6
coding region	6
kidneys	6
healthy adults	6
conserved regions	6
EOMA cells	6
L. infantum	6
causative agents	6
Ascaris lumbricoides	6
ecological niche	6
multiplex assay	6
Babesia bovis	6
native protein	6
two cell lines	6
differentially-expressed genes	6
protein coding sequences	6
cytoskeletal components	6
Endothelial cells	6
novel regulators	6
N-terminal nesprin-2 variants	6
cytoplasm and nucleus	6
uric acid	6
mitochondrial genome	6
DISC	6
perinuclear region	6
cell surface receptors	6
knockout cells	6
serine protease	6
lung cancer cells	6
High-Ki67 High-HER2 subgroup	6
two molecules	6
CDKN2A-mutated patients	6
Hippo signaling pathway	6
surface fish	6
planet	6
powerful system	6
glomus cells	6
carotid body	6
Neural crest cells	6
null mutants	6
transgenic animals	6
neocortex	6
inhibitory neurons	6
NvLWamide-like	6
myotome	6
neurite outgrowth	6
coding sequences	6
one gene	6
CRISPR technology	6
glands	6
Solanum lycopersicum	6
elevated CO2	6
variety of organisms	6
jawed vertebrates	6
HSCs	6
vascular wall	6
Mnx factors	6
ORF	6
maternal mRNAs	6
surface ectoderm	6
methylome	6
granulocytes and macrophages	6
cellular structures	6
prostate	6
oocyte posterior	6
ZRS	6
enhancer elements	6
occipital lateral mesoderm and ectoderm	6
pharynx	6
trophoblast lineage	6
TE	6
retinoic acid (RA)	6
migrating ENCC	6
neural tissues	6
DP	6
Merkel cells	6
Skeletal muscle	6
Wnt/β-catenin pathway	6
tight junctions	6
PSM	6
neural plate	6
skin reconstitution assays	6
CR cells	6
NP	6
external cues	6
early mouse embryo	6
pstB cells	6
lrrB- mutant	6
ventral nerve cord	6
Va neurons	6
two compartments	6
placental mammals	6
scleral cartilage	6
blastocyst	6
cochlea	6
axons	6
lens	6
old mice	6
muscle	6
coiled-coil domain	6
sperm	6
single mutants	6
adjacent cells	6
protein products	6
transgenic embryos	6
cis-regulatory elements	6
developing cortex	6
progenitor pool	6
apical progenitors	6
sandwich ELISA	6
Vantera® Clinical Analyzer	6
dominant model	6
CAD patients	6
arachidonic acid	6
macrophages	6
different macrophage populations	6
acetyl group	6
human pathogens	6
2-naphthyl β-d-GlcNAc	6
lactic acid bacteria	6
C4-oxidized gluco-oligosaccharides	6
recombinant enzyme	6
carbohydrate active enzymes	6
l-Fuc groups	6
molecular motors	6
actin cortex	6
essential proteins	6
linker DNA	6
macromolecular structures	6
bacterial communities	6
protein-lipid interactions	6
distinct binding sites	6
PI3K	6
structural biology	6
experimental systems	6
ventricular myocardium	6
freshly isolated cells	6
support	6
nanoscale	6
ensembles	6
focal adhesion kinase	6
theoretical model	6
fluorescent proteins	6
formalism	6
CTLs	6
target cell	6
two ligands	6
chlorophyll f	6
chlorophyll a	6
transient intermediate species	6
large data sets	6
N-terminal domains	6
full-length protein	6
daughters	6
mother cell	6
molecular-dynamics simulations	6
designs	6
arrangement	6
tip	6
blood plasma	6
new models	6
ordinary differential equations	6
many molecules	6
cardiomyocytes	6
chemical compounds	6
fluorescent fusion proteins	6
cancerous cells	6
phosphatidylethanolamine (PE)	6
TMD	6
gonad	6
spinal cord tissue	6
neurons and glial cells	6
Molecular dynamics simulations	6
extracellular domain	6
heads	6
all-atom molecular dynamics simulations	6
two cells	6
apex	6
merozoite	6
membrane environment	6
locations	6
RNA transcripts	6
nuclear pore complex (NPC)	6
lipid environment	6
signaling complexes	6
multiscale molecular dynamics simulations	6
k-turn	6
homology model	6
colony-forming cells	6
CRC patients	6
ceRNA network	6
G proteins	6
extracellular signals	6
Neu5Gc glycans	6
SubB2M	6
cancer biomarkers	6
dilution series	6
mother	6
human HCC	6
liver cancer	6
polyubiquitin chains	6
Pancreatic ductal adenocarcinoma (PDAC)	6
immune microenvironment	6
meniscus cells	6
sensitive biomarker	6
donors	6
two assays	6
WBCA	6
in vitro assay	6
non-neuronal cells	6
surrounding matrix	6
hydrogel	6
primary human macrophages	6
thalamus	6
mitotic kinases	6
in vitro assays	6
CDK1, Aurora-B, and Rho-kinase	6
nucleic acid	6
actin–myosin XI cytoskeleton	6
two structures	6
peroxisomal proteins	6
motor domains	6
selected compounds	6
key transcription factor	6
Euglena gracilis Z and paramylon	6
P29mt(sp)B6 cybrids	6
P29mtSAMP1 cybrids	6
mitochondrial DNA (mtDNA)	6
LSC	6
collagen Π and aggrecan expression	6
metazoans	6
cytosolic calcium	6
RNA polymerase II (Pol II)	6
donor T cells	6
l-arginine	6
apo form	6
Deep Vent DNA polymerase	6
proteins and nucleic acids	6
applications	6
entire cytoplasm	6
cleavage furrow	6
mouse small intestine	6
adult zebrafish	6
adipose tissues	6
several signaling pathways	6
P-gps	6
aqueous solution	6
molecular modeling	6
stabilization centers	6
mRNA expression	6
human colon	6
hepatocellular carcinoma (HCC)	6
autophagosome	6
double-membrane vesicles	6
cytoplasmic components	6
adaptor protein	6
immunized mice	6
IgA	6
 vivo	6
blood–brain barrier	6
HFD group	6
HeLa and Vero cells	6
affected patients	6
specialized regions	6
damaged proteins	6
C–H bonds	6
CRAC channels	6
mammalian cells and tissues	6
HIF PHD2	6
antioxidant	6
reagent	6
25-hydroxyvitamin D3	6
package	6
wild-type (WT) mice	6
key mediator	6
three domains	6
IL-3-dependent hematopoietic cells	6
vascular cells	6
Cx30.2 mRNA	6
pancreatic beta cells	6
Tg mice	6
SR proteins	6
natural compound	6
loops	6
phosphorylated LGN peptide	6
industrial applications	6
Escherichia coli cells	6
host tissues	6
TLR4−/− mice	6
monocyte-derived macrophages	6
Nuclear factor erythroid 2-related factor 2 (Nrf2)	6
target sequence	6
adult offspring	6
Pb2+	6
nuclear bodies	6
fixed cells	6
reporter gene	6
target mRNA	6
several miRNAs	6
regulatory networks	6
CES1 expression	6
human adipose tissue	6
cellular pathways	6
myosin	6
human adipocytes	6
dye	6
lattice	6
dermis	6
hydrophobic surfaces	6
omega-3 fatty acids	6
virus particles	6
enveloped viruses	6
X-ray crystal structures	6
local environment	6
SMALP scaffold	6
protein subunits	6
CB motifs	6
HA-epitope	6
bacillomycin L	6
[2].	6
chronic wounds	6
bodies	6
stable trimers	6
two compounds	6
blood sample	6
protein biomarkers	6
β-carotene	6
background	6
ferulic acid	6
visual system	6
variant H103Y	6
water-soluble proteins	6
hydroxyl radicals	6
control population	6
zebrafish models	6
long bones	6
large cohort	6
corneal endothelium	6
epithelial-to-mesenchymal transition (EMT)	6
three children	6
genetic loci	6
mitochondrial DNA	6
mixture	6
Y chromosomes	6
candidate gene	6
FADS domain	6
large collection	6
specific amino acid residues	6
viral antigens	6
group of genes	6
SNP	6
specific loci	6
Kalash	6
Inuit	6
case subjects	6
Affected individuals	6
PX domain	6
exon 11	6
genetic architecture	6
centrioles	6
[p.	6
motile cilia	6
upstream region	6
membrane protrusions	6
modern humans	6
developing brain	6
striatum	6
deleterious variants	6
three unrelated families	6
serum albumin	6
study subjects	6
muscle biopsies	6
Parents and Children	6
cortical lamination	6
retinitis pigmentosa	6
neuronal networks	6
heterotrimeric G proteins	6
older mice	6
anomaly	6
consanguineous families	6
seven families	6
live births	6
Arabian Peninsula	6
treatment group	6
three sites	6
leprosy patients	6
household members	6
An.	6
vector-borne diseases	6
untreated net	6
dengue cases	6
endemic areas	6
Stool samples	6
dogs	6
biological control agents	6
fragments	6
Plasmodium vivax	6
tsetse flies	6
pools of worms	6
parasitic helminths	6
genetic markers	6
O. viverrini	6
solution	5
ionising radiation	5
healthy women	5
personalised medicine	5
damaged DNA	5
Elecsys®	5
mixtures	5
RT-qPCR	4
CASP9 -293del SNPs	4
CASP9 -712C	4
G polymorphism	4
G allele	4
P-Rex2 PH domain	4
stationary phase	4
DFT simulations	4
stationary phases	4
mobile phases	4
study participants	4
BCL-2 family proteins	4
Baishishan Island	4
steroids	4
enriched rotifers	4
coastal areas	4
S. putrefaciens	4
immune-related genes	4
tags	4
holometabolous insects	4
compound eye	4
Sc-EGFR-1b	4
Sc-EGFR-1a	4
samples of SIS	4
tilapia RBCs	4
fish RBCs	4
floating feces	4
kidney cells	4
GCRV 096	4
protein VP6	4
fishery resources	4
large yellow croakers	4
farming households	4
F1 group	4
Edwardsiella ictaluri	4
Hcfem-1c gene	4
primitive cells and young cells	4
alkaline phosphatase	4
2n gynogens and 2n hybrid individuals	4
2n hybrids	4
water lettuce	4
HcHSP90 mRNA	4
O. niloticus	4
three mitten crabs	4
Atlantic halibut	4
snow crab	4
open reading frame (ORF)	4
large yellow croaker	4
gelatin-CEO films	4
fish catches	4
China's fisheries	4
F. columnare	4
freshwater fish	4
operating model	4
aquaculture production	4
Cu-NPs	4
juvenile cannibalism	4
Zgc:112210-201	4
YZ-4 conchospores	4
testes	4
untreated samples	4
alternative solutes	4
Cg-Emb	4
biological datasets	4
1-dose schedule	4
three PCR assays	4
Nagoya City	4
HC2-negative cases	4
data dictionary	4
state leaders	4
free vaccine	4
coverage surveys	4
national programmes	4
cervical cells	4
less developed refrigeration facilities	4
vaccine eligible children	4
men with HSIL-AIN3	4
HSIL-AIN3	4
p16 expression	4
HPV types	4
Xpert HPV Assay	4
cat faeces	4
horse	4
human trichinellosis cases	4
non-controlled housing	4
PrioCHECK Trichinella AAD assay	4
mouse bioassay	4
different stakeholders	4
G. duodenalis assemblages A and B	4
industrialized nations	4
Cryptosporidium spp	4
Cryptosporidium surrogates	4
Trichinella spiralis	4
dry cured pork sausage	4
Approved, Restricted, and Prohibited zones	4
Asian strains	4
Echinococcus spp.	4
north	4
fish products	4
human infections	4
glycine buffer	4
elution solution	4
non-viable eggs	4
Cryptosporidium oocysts	4
turbidity	4
treated wastewater	4
untreated wastewater	4
stream water	4
infected meat	4
head and neck	4
Trans-CHHiP	4
oxysterols	4
synthesized ZnO nanoparticles	4
ZnO nanoparticles	4
LEA model peptide	4
urogenital sinus	4
MD mesenchyme	4
late-onset DSBs	4
deaminase APOBEC3B	4
immunostimulant nanoparticle	4
herbal medicine	4
HSC-2 parental cells	4
Radix Fici Hirtae	4
3-D culture model	4
ubiquitin ligase Nedd4-1	4
soyasapogenol-treated cell media	4
AhR antagonist	4
MDCK cells	4
female offspring	4
group II	4
Podocalyxin (PODXL)	4
predicted epitopes	4
enolase isoenzymes	4
oral squamous cell carcinomas	4
transmembrane glycoprotein	4
S. grandiflora	4
S. grandiflora extract	4
Bacillus species	4
two octameric rings	4
chimeric ribosomes	4
highly expressed miRNAs	4
differentiating C2C12 cells	4
PB2 627 in solution	4
hydride	4
poly-arginines	4
PI3K inhibitor	4
Caki-2 cells	4
common microbes	4
LysoPS analogs	4
Cinnamic acid	4
lysine 372	4
Dmrt1 KO mouse	4
cross-link proteins	4
ShcKO versus WT mice	4
fish oil	4
transcribed region of SLC2A5	4
Brd4+/− mice	4
TiO2 nanoparticle	4
THP-1 macrophages	4
recombinant PTX3	4
Immobilized enzyme	4
embryonic neurospheres	4
Calp	4
rod cells	4
3T3-L1 cells	4
NTP MD simulations	4
standard-mass NTP MD simulations	4
CM2 cytoplasmic tail	4
up-regulated genes	4
3-D tissues	4
zinc ion	4
mammalian protein complexes	4
synthetic genetic oscillators	4
toggle switch	4
intracellular signal transduction networks	4
key molecular species	4
SummaryProtein complexes	4
network architecture	4
GWAS loci	4
causal genes	4
bone co-expression network	4
simulated data	4
N. furzeri	4
network components	4
stochastic mathematical model	4
ICOVIR17K-iRGD	4
conventional TRAD	4
TRAD	4
oncolytic Ads	4
residual cancer	4
field trip	4
nasal swabs	4
One Health	4
A. ceylanicum	4
Lyme Borreliosis	4
private farms	4
livestock officers	4
goat keepers	4
Goat keepers	4
goat keepers and livestock officers	4
novel potential pathogens	4
clinical study samples	4
PLT VASP/P2Y12 kit	4
Texas Children's Hospital	4
Cystic Fibrosis Foundation	4
GEM analyzers	4
PIVO™ device	4
two institutions	4
cirrhotic liver and healthy subjects	4
Tacrolimus assays	4
instruments	4
WNR channel	4
Roche Total Mycophenolic Acid® assay	4
prospective samples	4
PCP IgG	4
PCP IgM, IgG, and IgA	4
RIDA Allergy Screen	4
delivery room	4
plasma lactate	4
BRAHMS PCT Kryptor	4
never smoker–enriched cluster	4
FundThis work	4
IgM anti-MDA-LDL	4
tumour necrosis factor (TNF)	4
bradycardia or tachycardia	4
LR patients	4
EMT marker genes	4
omega-3 fatty acid group	4
blood lipids	4
omega-3 fatty acid supplements	4
given allergen	4
13:02 group	4
total gray matter, cerebrocortical gray matter, and subcortical gray matter	4
neutrophil MVs	4
rheumatoid arthritis patients	4
28 loci	4
immune checkpoint genes	4
external antigens	4
carriers of DRB1*13:02	4
DRB1*13:02	4
Aurora A SNPs	4
secondary CNN	4
endoscopic images	4
apparently healthy children	4
apparently healthy adults	4
P. jirovecii	4
Korean patients	4
primo-infection	4
early life environment	4
brain injuries	4
ventilated patients	4
mucosal lining fluid	4
Hq mice	4
PKCθ inhibitor Compound 20 (C20)	4
young mdx mice	4
Protein Kinase C θ (PKCθ)	4
pedigree	4
microcrystalline cellulose	4
symptoms	4
left auditory cortex	4
ASSR-BOLD signals	4
brain gray matter	4
cell signaling and innate immunity related pathways	4
rare deleterious SNVs	4
innate immune genes	4
ebv-miR-BART13-3p	4
salivary epithelial cells	4
demethylated MOG cfDNA	4
pannexin 1	4
DHPs	4
CAD antihistamines	4
pediatric solid tumors	4
various tumors	4
e-learning system	4
e-learning group	4
24 subjects	4
MSRV-env and -pol transcripts	4
nonstunted children	4
cells and monocytes	4
men who have sex with men (MSM)	4
dp-ucMGP	4
oral squamous cell carcinoma (OSCC)	4
epithelial and post-EMT sub-populations	4
NP-C.	4
allele copies	4
G heterozygotes	4
95,871 individuals	4
primary cohort	4
underserved patients	4
dehydroascorbic acid	4
mouse and human RBCs	4
intimal hyperplasia	4
HbSS patients	4
red cells	4
left hemisphere	4
in-patients	4
CD8+HLA-DR/DP/DQ+ cells	4
residual plasma HIV-1 RNA	4
ER-negative tumors	4
Citizen Scientists	4
trained pathologists	4
Japanese	4
neural plate border/neural fold	4
mutated proteins	4
Cyclin D1	4
metHb+LTA complex	4
LTNP/EC	4
SCA infants	4
TXA2 pathway	4
decision trees	4
simple assay	4
autophagic membranes	4
standard doses	4
systemic organs	4
3 aborted fetuses	4
unique amino acid sequences	4
N-450 region of the N gene	4
distinct cluster	4
N gene	4
122 patients	4
Region II	4
graft	4
transplantable vascular grafts	4
rats fed a PF diet	4
PF diet	4
breastfed infants	4
formula fed infants	4
breastmilk studies	4
n-3 PUFA supplements	4
synovial tissues	4
saffron extract	4
irrigation water	4
food and water	4
small systems	4
QMRA	4
HFFr-fed wild-type mice	4
Proximal colon DC	4
CD103+SIRPα+ DC	4
serum oxLDL	4
H pylori	4
FGF receptor 1c	4
CatKi-H	4
vitamin A	4
tibial cortex	4
femoral cortex	4
fracture surface	4
bone fragility	4
distal radius	4
resting zone	4
growth plate chondrocytes	4
IgG-OPG positive	4
OPG autoantibodies	4
serum osteocalcin	4
immature bone	4
titanium surfaces	4
proximal femur	4
aged females	4
males and young females	4
wide variety of species	4
first osteogenic cells	4
Cstb−/− mice	4
trabecular bone	4
cathepsin K	4
EPM1 patients	4
fracture	4
wild-type-VDR	4
father	4
treadmill	4
persons	4
SCI cohort	4
CD19+ cells	4
A3B1 CAR T cells	4
adherent HEK293 cells	4
AAV2/9 vectors	4
FKRP-related disorders	4
GLOBE LV	4
erythrocyte encapsulated thymidine phosphorylase	4
anti-thymidine phosphorylase antibodies	4
tight junction proteins	4
FIX Padua	4
rAAV vectors	4
rAAV-mediated transgene expression	4
biotinylated lipid donor	4
virus preparations	4
DNA vaccines	4
Ad-E4-122aT	4
Ad genes	4
Naglu−/−mouse brain	4
neutrophil extracellular traps	4
pre-existing Abs	4
Adeno-associated virus (AAV) vectors	4
salivary gland proteome	4
γ-globin lentivirus vector	4
A549 carrier cells	4
IAI.3B promoter	4
carrier cells	4
empty virions	4
promising gene delivery vector	4
therapeutic protein	4
VLPs	4
m-CRAs	4
novel antitumorigenic agents	4
molecular target	4
algal biomass	4
nitrogen supplemented (NS) media	4
TISTR 8583	4
genus Aequorivita	4
Wild type Weissella confusa EPS	4
ligand Gas6	4
river water	4
water samples	4
EOLa and citral	4
Wistar rats	4
tracheal smooth muscle	4
terrestrial weeds	4
DNA contamination	4
BSA aggregates	4
gas–liquid interface	4
synthetic operon	4
neurotoxins	4
internal amplification control	4
patients with solid tumors	4
affected pathways	4
primer and probe chemistry	4
different analytes	4
sequencing reads	4
plant magnetoreceptor	4
16O radiation	4
primary T1D association locus	4
non-HLA genes	4
electronic databases	4
best model	4
SCoT markers	4
Brahman cows	4
35 patients	4
chromosome 19	4
hOSCP1 gene	4
regenerated plants	4
Delhi population	4
truncated form	4
Han Chinese males	4
MELAS syndrome	4
healthy neonates	4
Italian adult PKU patients	4
NP-GSD IV patient	4
NP-GSD IV	4
NPC-affected individuals	4
plasma lysophingomyelin-509	4
plasma SPC	4
Fabry families	4
population of disease-affected individuals	4
MPS IVA	4
pseudodeficiency alleles	4
MCD patients	4
idursulfase beta	4
Ab− patients	4
six enzymes	4
GAGs	4
Agps knock-out mice	4
bs2 mice	4
DBT gene	4
Lebanese population	4
Lebanese MSUD patients	4
3-methylglutaric acid	4
3-methylglutaconic acid	4
oils	4
studied oils	4
gamma interferon (MIG)	4
skin care products	4
global gene expression	4
important protein biomarkers	4
full study population	4
never-smokers	4
oral sulfonylureas	4
younger individuals	4
urban women	4
adults	4
FundingNIHR and Wellcome Trust	4
whole populations and individual patients	4
high BMI-related cancers	4
diabetes-related cancers	4
incident cancers	4
site-specific cancers	4
12 cancers	4
INTERMAP UK cohort	4
Biomedical Research Centre	4
study devices	4
general ward	4
POWeR+R group	4
primary care	4
Health Research	4
cholecalciferol 1000 IU/day	4
European Clinical Trials Database	4
hypertensive patients	4
doses	4
infant adiposity	4
Health Research partnership	4
obese women	4
matched placebo	4
obese pregnant women	4
insulin or oral hypoglycaemic drugs	4
previously undiagnosed individuals	4
comparison group	4
four SNPs	4
low socioeconomic status group	4
Medical Research Council Epidemiology Unit	4
closed-loop group	4
normal counterpart	4
Ala263Val mutant TRα1	4
intervention group	4
total cholesterol	4
tissue plasminogen activator	4
111In-DTPA-exendin-4 SPECT/CT	4
Ctrl-EHTs	4
RA-EHT	4
FOP-ACVR1	4
two sons	4
COUP-TFI 3′UTR	4
Raptor-deficient mice	4
undifferentiated mesenchymal cells	4
non-HE	4
subtype-specific markers	4
human RGCs	4
Laminin 411	4
proprietary line	4
NHP and human iPSC-CMs	4
PBC-iPSCs	4
fetal and stem cell-derived cones	4
RNA exosome complex	4
NOD/SCID mice	4
murine phagocytic cells	4
pancreatic endoderm cells	4
naive cells	4
master transcription factor	4
artificial skin	4
heterogeneous stem cell populations	4
adult HSCs	4
iPS-DCregs	4
completed trials	4
non-ALS cells	4
motor neurons (MNs)	4
iCaspase9 system	4
NSC transplantation	4
SEZ-derived cells	4
hematopoietic stem/progenitor cells (HSPCs)	4
USP10-KO mice	4
transplanted hiPSC-NS/PCs	4
hiPSC-NS/PCs	4
embryonic stem cells (hESCs)	4
multiple therapeutic targets	4
key molecular pathways	4
Activin A	4
erythroid cells	4
irradiated mice	4
infarcted heart	4
hBM-MNCs	4
inducible transgenic mice	4
de novo enhancers	4
human pluripotency	4
Asian patients	4
blood stream	4
exon knockin	4
iPSC platelets	4
mouse HSCs	4
terminally differentiated cells	4
long-term culture	4
mature cardiac myocyte	4
CPM+ cells	4
carboxypeptidase M (CPM)	4
epithelium of the small intestine	4
cell source	4
glial-rich neural progenitors	4
ROSA26 locus	4
GFAP+ NSCs	4
adult hRPESC-derived RPE	4
CpG methylation sites	4
mammalian heart	4
cohesin and condensin II	4
active genes	4
nonhuman primates	4
dTF activator	4
oxidized nucleic acid products	4
Heat shock proteins (HSPs)	4
identified proteins	4
hair cells and SGNs	4
gate	4
intermediate hyperhomocysteinemia	4
NF-κB p65	4
bacterial and mammalian cells	4
PC12 cell line	4
plasma of symptomatic ALS rats	4
superoxide dismutase	4
vastus lateralis muscle of master athletes	4
hyperphosphorylated tau protein	4
PINK1-dependent pathway	4
glycolipid metabolism	4
Plasma samples	4
oxysterol esters	4
antioxidant N-acetylcysteine (NAC)	4
G1-arrested cells	4
CIBP rats	4
short chain hydroperoxides	4
UCB-hMSCs	4
xenobiotics	4
oxidative phosphorylation system	4
vivo rat model	4
novel xenobiotics	4
hippocampal NSPCs	4
protein carbonyls	4
FTDP-17 neurons	4
4R tau	4
MAPT gene	4
HYP-PDT	4
metabolic sources and sinks of H2O2	4
young adult worms	4
1mM DEM	4
protein carbonylation	4
vitreous of PDR patients	4
free radicals in cells and tissues	4
biological free radicals	4
human lens cells	4
MB231 cells	4
sublingual GSH group	4
new sublingual form of GSH	4
cell death receptors	4
hepatoblastoma cells	4
membrane-associated catalase	4
singlet oxygen	4
oxidant environment	4
cytosolic ionized calcium	4
Lyme borreliosis patients	4
male (P<0.05)	4
male versus female rodents	4
electrophile	4
phase II enzymes	4
palmitate-induced ROS	4
mitochondrial networking	4
shPRX3 MM cells	4
estrogen receptor (ER)	4
antimycin A	4
THP-1 monocytes and peritoneal macrophages	4
majority of cancers	4
ZDF rat brain	4
EMRT group	4
diabetic rat aorta	4
NADPH oxidase (NOX)	4
untreated CKD rats	4
biopsy samples	4
redox chemistries	4
basic research	4
xanthine oxidoreductase (XOR)	4
adenovirus (Ad)	4
hypoxic group	4
antioxidant system	4
manganese superoxide dismutase (SOD2)	4
synthetic tools	4
robotic platform	4
glycan structures	4
larger network	4
uncharacterized enzymes	4
food plants	4
glucosides	4
thiyl radical	4
Gly-32 radical	4
adducts	4
FosB enzymes	4
monomeric enzymes	4
publications	4
papers	4
p85 subunit	4
FRAX®	4
BMD alone	4
skeleton	4
immature flukes	4
liver fluke	4
ICs/NTRs	4
ML	4
oral gavage	4
E. multilocularis metacestodes	4
partner drug	4
5-AzaC-treated females	4
L-glutamate	4
CYPs	4
Malaria Box Compounds	4
Malaria Box	4
[3H]-inosine	4
[3H]-uridine	4
L. major and L. mexicana	4
nematodes	4
A. ceylanicum L4s	4
microfluidic EPG platform	4
FEC data	4
farm B	4
filter paper blood spots	4
human parasites	4
onchocerciasis and LF	4
new formulation	4
one human trial	4
Flubendazole (FLBZ), a benzimidazole anthelmintic	4
macrofilaricidal drug	4
tested compounds	4
female worms	4
G. lamblia	4
intracellular thiol pools	4
thioredoxin-mediated redox network	4
parasite immunologists	4
RAS-PI3K interaction	4
tumor-draining LNs	4
Cnn and γ-tubulin	4
aged LT-HSCs	4
myeloid leukemias	4
myelin sheath	4
lactate dehydrogenase	4
distinct neuronal subtypes	4
SuM	4
injected PSCs	4
scar	4
TGF-β signaling	4
technical replicates	4
DGUOK-deficient hepatocyte-like cells	4
tumor suppressor genes	4
intact glycan shields	4
human astrocytes	4
functional cortical neurons	4
interneurons	4
olfactory interneurons	4
stereocilia base	4
adult hippocampus	4
benign mutational neighborhood	4
olfactory bulb (OB)	4
layered microcircuits	4
liver Trm cells	4
lung parenchyma	4
modulator	4
demyelinated axons	4
Caucasian populations	4
PGC determinant genes	4
somatic developmental genes	4
histone deacetylase 3 (HDAC3)	4
germ cells (PGCs)	4
iPSC-MGLCs	4
transcription factories	4
Cobl KO mice	4
Paneth cells	4
Lgr5+ stem cells	4
epiblast-like cells (EpiLCs)	4
tau inclusions	4
target muscles	4
pathogenic self-reactive cells	4
ARE	4
proline 359	4
G1 phase	4
iPSC lines	4
repressive marks	4
higher-order chromatin structures	4
hiPSC-ECs	4
target antigen	4
cell-cycle kinases	4
central node	4
presynaptic terminal	4
cKO hypothalamus	4
RA patients	4
two BF subregions	4
melanin pathway	4
mutant p53 cells	4
α-synuclein oligomers	4
PlGF-DE knockin mice	4
NLS	4
fetal hemoglobin expression	4
Na+-K+ pump	4
TDP1 proteostasis	4
insulin-responsive cells	4
VGSC current	4
adult flies	4
larval and adult flies	4
noradrenergic neurons	4
rheumatoid arthritis (RA)	4
human models	4
cellular prion protein	4
Aβ peptides	4
RNA/DNA hybrid interactome	4
major NL2 binding partner	4
sessile perivascular macrophages	4
isolated nuclei	4
T cell subsets	4
FGF21 gene	4
enhancer-docking site	4
MYC oncogene	4
Ras pathway	4
antigen-specific CD8+ T cells	4
prefrontal cortex	4
medial prefrontal cortex	4
astrocyte reactivity	4
enriched pathways	4
homomers	4
Hsf1 phosphorylation	4
LIS1/NDE1 complex	4
C-LTMRs	4
association cortex	4
 macrophages	4
surrogate	4
Cav2.1 and Cav2.2 channels	4
preferred substrate	4
extracellular matrix proteins	4
fluorescent dye	4
stellate cells	4
histone readers	4
stable synapses	4
IDH1 mutants	4
isocitrate dehydrogenase 1 (IDH1)	4
dorsal pallium	4
neuronal populations	4
in vitro system	4
Polycomb repressive complex 2 (PRC2)	4
cecal lumen	4
Hlf-deficient HSCs	4
CHRNA3+ nociceptors	4
white adipocytes	4
potential therapeutic agents	4
therapies	4
metastatic site	4
VEE	4
human NMJ	4
perivascular fibroblasts	4
mechanistic target of rapamycin complex 1 (mTORC1)	4
host amino acids	4
folate cycle	4
octopaminergic neurons	4
body fat	4
chow diet	4
refined high-fat diet	4
SMA mice	4
ubiquitously expressed proteins	4
PanIN-like lesions	4
direct Notch target genes	4
lowered IIS	4
nTH21 cells	4
Sarm1 deletion	4
inhibitory synapses	4
V2-apex bnAbs	4
potential off-targets	4
dynamic organellar maps	4
memory CD8 T cells	4
c-Myb	4
dopamine neurons	4
SET1 complex	4
protein networks	4
primitive hematopoiesis	4
NKX2-1	4
HOXD binding sites	4
exhausted T cells	4
candidate regulators	4
hematopoietic lineages	4
multiple sclerosis	4
HCMV miR-UL112-5p	4
GOP synthesis	4
COPII genes	4
ependyma	4
GABAergic signaling	4
co-receptor	4
NDP receptor complex	4
ventromedial hypothalamus (VMH)	4
obesity epidemic	4
VCP-mutant MNs	4
live imaging	4
peripheral blood mononuclear cells (PBMCs)	4
types of AML	4
IL-NAc circuitry	4
HLA-B∗46:01	4
normal subjects	4
dopamine D1-class receptors	4
NACHO knockout mice	4
distal axons	4
ubiquitylated CMG	4
presynaptic boutons	4
high-fructose diet	4
α cell-derived GLP-1	4
clear cell renal cell carcinoma (ccRCC)	4
AZ clustering	4
capacity	4
Rab4-associated vesicles	4
eliminated sequences	4
somatic genome	4
heterochromatin-euchromatin borders	4
PTEN-deficient cells	4
plasma of individuals	4
different genetic backgrounds	4
acetyl moiety	4
ZIKV RFs	4
BCSC enrichment	4
transformed B cell precursors	4
human leukemia	4
somite derivatives	4
human somitogenesis	4
 vivo and in vitro	4
DNA demethylation	4
prefrontal cortex and hippocampus	4
BC-PC synapses	4
release sensor	4
male germ cells	4
H3t	4
+ stores	4
ER Ca2	4
T cell receptor	4
gene body	4
microglial cells	4
microglial population	4
intracellular target	4
diets	4
activators and repressors	4
patient-derived induced pluripotent stem cells (iPSCs)	4
LRP6 ectodomain	4
neuron-specific genes	4
presynaptic interneurons	4
SummaryAMP-activated protein kinase (AMPK)	4
replication-competent virus	4
latent reservoirs	4
depolarized mitochondria	4
mammalian retina	4
edited CAPS1	4
certain mRNAs	4
disease-relevant cell types	4
Genome Atlas	4
Cancer	4
neonatal CD8+ T cells	4
adult counterparts	4
ALT telomeres	4
telomeric DNA	4
damaged cells	4
hyperthermophilic archaeon	4
differentiated neurons	4
CD4+ CTLs	4
deacetylase	4
myeloid leukemia (AML)	4
FA core proteins	4
FA proteins	4
heterochromatin formation	4
primed pluripotency gene network	4
third-instar larvae	4
distal dendrites	4
ZIKV NS5 methyltransferase	4
recurrent connections	4
recurrent network	4
visual cortex	4
RAG complex	4
specific substrates	4
LINE-1 gene	4
AP-3A complex	4
VTA non-DA neurons	4
Tcf4(+/−) mice	4
tumor necrosis factor (TNF)	4
RELA binding	4
super-enhancer	4
polarity regulators	4
polymerases	4
degenerating axons	4
fluorescence-activated cell sorting (FACS)	4
inguinal adipocytes	4
hPSC growth	4
striatopallidal MSNs	4
dentate gyrus	4
isomeric phosphoubiquitin dimers	4
cytokine receptor	4
intracellular domain of IL-11R1	4
desmoid tumors	4
bone and soft tissue sarcomas	4
mesenchymal tumors	4
versatile platform	4
B cell lymphomas	4
functional astrocytes	4
Nodal signaling	4
trans-Golgi	4
calcium channels	4
neuromast hair cells	4
release sites	4
type I IFN	4
PD neurons	4
endothelial progenitors	4
CNC cells	4
heterogeneous population	4
MCU complex	4
scaffold factor	4
early hematopoietic progenitors	4
mTOR signaling	4
metformin	4
prediabetic individuals	4
liver T-ICs	4
normal stem cells	4
immature hiPSC-Astros	4
recipient	4
adaptive NK cells	4
V. cholerae	4
isolated islets	4
mammary glands	4
mature oligodendrocytes	4
dorsally derived OPs	4
PV neurons	4
ATP-dependent chromatin-remodeling enzymes	4
different origins	4
N terminus of Bora	4
Cyclin binding sites	4
several sites	4
Cyclin B/Cdk1	4
cone functional structures	4
RNA Pol II	4
MLL-ENL	4
imprinting control regions (ICRs)	4
proline-rich transmembrane protein 2 (PRRT2)	4
deubiquitinase CYLD	4
individual sites	4
oligomannose glycans	4
mouse and human macrophages	4
saturated fatty acids (SFAs)	4
potential substrates	4
gurken mRNA	4
nurse cells	4
Siglec-G	4
transcription unit	4
multiple subtypes	4
FGFR inhibitors	4
functional interaction networks	4
wedge region	4
TET enzymes	4
hippocampal pyramidal neurons	4
Oct4 binding	4
SAC proteins	4
target promoters	4
one another	4
activated CD8+ T cells	4
L-selectin	4
virus-infected tissues	4
continuum	4
hematopoietic stem and progenitor cells	4
innate immunity genes	4
embryonic mesoderm	4
glycolipid antigen	4
LckCre/+Map3k1f/fmice	4
LGR5+ cells	4
E-cadherin-GFP mouse	4
bone matrix	4
sensory neuron	4
individual NE cells	4
distinct gene expression programs	4
MukBEF clusters	4
decay-promoting introns	4
identified regions	4
reference genome	4
contractile actin stress fibers	4
PI3K-C2β	4
liver sinusoids	4
Aim2−/− mice	4
conserved pathway	4
Lactobacillus species	4
CD4 T cells	4
AIS	4
axon initial segment (AIS)	4
serotonergic axons	4
yeast centromere	4
unfolded protein response (UPR)	4
GABAergic synapses	4
DE-cadherin	4
damaged chromatin	4
persistent DSBs	4
ER target genes	4
the TCA cycle	4
IgA+ PCs	4
muscle-specific genes	4
HIV-1 Env	4
miR-combo	4
nodes of Ranvier	4
vertebrate fidgetin	4
axon	4
microtubules (MTs)	4
aged flies	4
relay cell dendrites	4
Dnmt3 methyltransferases	4
maternal Gtl2-Rian-Mirg locus	4
IG-DMR	4
cytosolic Ca2+	4
ERK1/2 pathway	4
limb mesenchyme	4
sliding clamp PCNA	4
important resource	4
many GPCRs	4
Caenorhabditis elegans embryos	4
early embryogenesis	4
(Ca2+)	4
germ plasm	4
hepatic SirT1	4
filopodia formation	4
molecular clock	4
M1 output	4
Vif complexes	4
HIV-1 Vif	4
transition zone	4
human lincRNAs	4
RNA sequencing (RNA-seq) data	4
Aβ burden	4
microtubule-associated protein tau	4
E. coli strains	4
broth culture	4
pericentric heterochromatin and telomeres	4
short IRs	4
conserved protein complex	4
inhibitory interneurons	4
axon growth	4
living animals	4
functional networks	4
CD8 lineage	4
hub genes	4
ligand-engaged α5β1 integrins	4
α5β1 integrin	4
brain areas	4
core components	4
mesenteries	4
androgen-stimulated genes	4
leukemic mice	4
neutralizing antibody	4
FR axons	4
luminal tumors	4
voltage-gated K+ channels	4
glucagon-like peptide-1 (GLP-1)	4
TN/TX	4
functionality	4
molecular networks	4
MEC rats	4
flap loop	4
epididymal tubule	4
P-bodies	4
cytosolic glutamate	4
transmembrane AMPAR regulatory proteins (TARPs)	4
head and neck squamous cell carcinoma (HNSCC)	4
enteroendocrine cells	4
intestinal stem cells	4
major cell type	4
uninjured retina	4
hypoxic tumor cells	4
intestinal adenomas	4
matched primary tumors	4
SURF complex	4
key transcriptional regulatory elements	4
SVZ NSCs	4
in vitro, in vivo	4
major regulator	4
α-chimaerin	4
large ribosomal subunit	4
mammary tumors	4
PNETs	4
apoptotic and autophagic proteins	4
stress-response genes	4
peripheral clocks	4
irradiated tumors	4
naked DNA	4
mammalian cell	4
DDX5 expression	4
Mpc2Δ16 mice	4
DSR-HSCs	4
different individuals	4
gap junction blockers	4
retained introns	4
tricarboxylic acid (TCA) cycle	4
CST components	4
steroidogenic factor-1	4
Ctcf+/− tumors	4
mammalian cerebral cortex	4
cortical projection neurons	4
mammalian circadian clock	4
daf-2 mutants	4
tumor suppressor PTEN	4
Nedd4-1	4
CMs	4
wild-type animals	4
T7 helicase	4
PP1 phosphatases	4
male pronucleus	4
cloned embryos	4
endocrine cells	4
Cp1-mutant ddaC neurons	4
dendritic arbors	4
condensed chromosomes	4
hinge domain	4
GluA1 S567	4
human nucleus	4
mammalian nucleus	4
open chromatin regions	4
94 genes	4
sensory axons	4
TrpV3−/− eggs	4
posterior parietal cortex	4
cortical responses	4
interscapular brown adipose tissue	4
monosynaptic connections	4
mammalian spinal cord	4
specific connections	4
neuronal connections	4
retinal inputs	4
neuronal differentiation	4
second-order projection neurons	4
barrelette	4
metabolic tissues	4
A-EJ	4
PDXs	4
individual neurons	4
ancestral strain	4
subepidermal cells	4
SWI/SNF chromatin remodeling complex	4
transcriptional activators	4
Kit promoter	4
Dido3 PHD	4
BACE1 null mice	4
Hdm2-inhibitory complex	4
(MM)	4
induced pluripotent stem cell (iPSC) lines	4
human PDAC cells	4
ductal adenocarcinoma (PDAC)	4
adult Drosophila brain	4
six	4
cytosolic DNA	4
COX enzyme complex	4
Developmental regulators	4
peripheral targets	4
hindbrain neurons	4
Sendai virus	4
perinuclear space	4
readily releasable pool	4
histone chaperones	4
dietary nutrients	4
proinflammatory genes	4
IPL	4
synaptic neuropil	4
oncogenic fusion proteins	4
cancer cell	4
CD38 knockout	4
NAADP signaling pathway	4
chemical inhibitors	4
PGRN S116X neurons	4
gp91phox expression	4
phagocyte NADPH oxidase	4
α5GABAA receptors	4
floxed alleles	4
wild-type environment	4
cerebellar Purkinje cells	4
brain synapses	4
motor nerve terminals	4
transcription units	4
CD169+ macrophages	4
cell lineage	4
single experiment	4
SummarySynaptic NMDA receptors (NMDARs)	4
olfactory cues	4
vinegar fly	4
electrical signals	4
cell-surface receptors	4
in vivo functions	4
signaling network	4
specific target genes	4
frontal cortex	4
risk allele	4
placebo-treated patients	4
miRNA hairpins	4
pancreatic ductal adenocarcinoma (PDAC)	4
liver tumors	4
CIRBP and HADHB	4
14q32 microRNAs	4
mismatch DNA	4
stromal cell tumorigenicity	4
BC tissues	4
similar drugs	4
therapeutic tool	4
miRNA-370-3p	4
aptamer technology	4
mdx serum	4
HIV patients	4
C2C12 cells	4
Hepatocyte growth factor (HGF)	4
primary RDEB cells	4
responder cells	4
CEP290 transcripts	4
Leber congenital amaurosis type 10 (LCA10)	4
serum exosomes	4
bacteriophage particles	4
engineered bacteriophage	4
frataxin protein	4
intron 1	4
distinct delivery systems	4
interesting genes	4
RPI-SAN model	4
osteosarcoma cells	4
nuclear factor κB (NF-κB)	4
natural tRNA	4
EGS	4
four ASOs	4
small drug molecules	4
Argonaute 2	4
gapmer AONs	4
cytokine-stimulated cells	4
RNase H	4
FOXO1 mRNA	4
human BC cells	4
small noncoding RNAs	4
HIV RNA	4
iNOS plasmids	4
Akt and Erk pathway	4
RRV-miRPDL1	4
therapeutically relevant genes	4
gene electrotransfer	4
sensitive in vivo assay	4
cellular miRNAs	4
vesicular stomatitis virus	4
selected DNA aptamers	4
Oncolytic viruses	4
ministring DNA	4
oligonucleotides	4
cells of interest	4
targeted cells	4
AIR-3A-ce6	4
/ds siRNA	4
PEG-lipids	4
Lipid nanoparticles (LNPs)	4
choroidal neovascularization	4
Clcn7G213R-specific siRNA	4
HIV-1-infected cells	4
multi-NLS ZFN proteins	4
cancer tissues	4
HIV-1 promoter region	4
α-tocopherol–conjugated chimeric ASO	4
α-tocopherol	4
OR6 cells	4
quantum simulation	4
OTOC	4
ocean modeling	4
eAbs	4
general-circulation models	4
cultured hippocampal neurons	4
Yangtze River	4
rarely expressed genes	4
widely expressed genes	4
young women	4
dense breasts	4
various populations	4
breast suspicious calcifications	4
given protein sequence	4
SEM	4
Acinar cells	4
blood glucose	4
E325K	4
prenyl ferulate	4
hydrophilic polymers	4
chondrogenesis	4
magnetic nanoparticles	4
DNA origami nanostructures	4
steatotic livers	4
IFIE-sum	4
prophylactic vaccines	4
liquid biopsy	4
protein cores	4
several models	4
Genomic DNA	4
omnivorous cattle	4
12 clusters	4
majority of cases	4
anti-hypertensive drugs	4
somatic mutated genes	4
k-mers	4
big biological data analytics	4
metavirome data	4
lipid-laden macrophages	4
alkaliphilic cyanobacteria	4
protein moveable atoms	4
MMFF94 force field	4
protein-ligand complex	4
flexible ligand	4
closely related species	4
multiple pathogens	4
current technologies	4
NID research	4
biomedical imaging	4
Chagas disease	4
various applications	4
genome editing reagents	4
powerful genetic tool	4
control persons	4
drug product	4
TME	4
extracellular microRNAs	4
phenotypic screens	4
splice variants	4
existing drugs	4
(NH4	4
protein titer	4
lipid supplement	4
specific applications	4
Chimeric peptides	4
swinger RNAs	4
medical time series	4
medical domain	4
SDB samples	4
vaccine antigens	4
novel vaccines	4
Genomics APIs	4
genomic data	4
differing chemoattractant gradients	4
mutated structures	4
various sources	4
gastric adenocarcinoma	4
ribosomal subunits	4
functional associations	4
unannotated genes	4
target compound	4
minimum set	4
four miRNAs	4
amplicon sequencing	4
endospore-forming Firmicutes	4
endospore formers	4
E. coli K-12	4
KEGG database	4
β1 subunit	4
Poly(ADP-ribose)	4
mitochondrial membranes	4
postsynaptic neurons	4
hydrocarbon seeps	4
gaseous alkanes	4
various SENP isoforms	4
cysteine proteases	4
SUMO proteins	4
α-secretase activity	4
uncharacterized proteins	4
P2Y13 receptor	4
CD4+ T-cells	4
acto-myosin sheath	4
complex structures	4
CFTR gene	4
RecQ homologs	4
C. pseudotuberculosis	4
sensor molecules	4
nanofabricated membrane	4
high flux hemodialyzer	4
beta-blockers	4
synonymous codons	4
hematopoietic progenitor cells	4
GH61 proteins	4
corresponding proteins	4
reduced biochemicals	4
genome-scale models	4
biorenewable fuels and chemicals	4
food and pharmaceutical industries	4
NAD+ metabolites	4
reference database	4
main ingredients	4
biological sample	4
mini review	4
two datasets	4
chemical fragments	4
different algorithms	4
mouse cells	4
SCS Package	4
amino acid sequences	4
unknown compound	4
protein loops	4
cysteine residue	4
biological parts	4
silent mating type loci	4
human system	4
edge strands	4
protein sub-sequences	4
affinity moiety	4
mammalian gastrointestinal tract	4
A2AR agonists	4
agonists	4
entire microbial communities	4
P2X1−/− mice	4
different subunits	4
embryonic and induced pluripotent stem cells	4
massive amounts of data	4
E. histolytica	4
native spliceosome	4
patch pipette	4
regulatory molecules	4
human CYP450	4
porcine CYP450	4
endocannabinoid system	4
Computational tools	4
new products	4
MCF	4
renewable substrates	4
many drugs	4
small molecular inhibitors	4
chimeric RNAs	4
iPSC-derived dopamine neurons	4
Cell lines	4
stem cell clones	4
stem cell pool	4
colonic crypt	4
single-cell transplantation assays	4
HSC compartment	4
endosteal endothelium	4
 neurons	4
active SMAD2/3	4
desired cell types	4
mammalian germline	4
serum ESCs	4
hypo-phosphorylated RB	4
SSEA4+ hSSCs	4
NT embryos	4
H3K4 methylation	4
active X chromosomes	4
human preimplantation embryo	4
optic cups	4
embryonic chimeras	4
aging intestine	4
aging tissues	4
several mRNAs	4
haploid ESCs	4
mature intestinal organoids	4
Wnt antagonist Dkk1	4
human induced pluripotent stem cells	4
sequence motifs	4
GATA1, GATA2, and PU.1	4
tissue stem cells	4
p27 null mice	4
Esrrb deletion	4
early germ cells	4
functional screen	4
Jak/Stat3	4
human orthologs	4
chromatin-modifying complexes	4
Oct4 interactome	4
Ink4a/Arf	4
adult hematopoietic stem cells (HSCs)	4
hair follicle junctional zone	4
cage-like structures	4
conserved epitopes	4
infecting viruses	4
infant	4
infant microbiome	4
 sites	4
DNA motifs	4
P. falciparum intraerythrocytic stages	4
Plasmodium falciparum malaria parasites	4
Pla2g1b−/− mice	4
envelope protein gene	4
envelope proteins	4
hepatitis C virus (HCV)	4
methyltransferases and demethylases	4
NF-κB activation	4
phagolysosome	4
Wolbachia-harboring mosquitoes	4
humans and livestock	4
RNA virus	4
plasma membrane proteins	4
microbial environment	4
pathogenic fungi	4
several protein kinases	4
Clecsf8−/− mice	4
endothelial protein C receptor (EPCR)	4
three models	4
kinases and phosphatases	4
peripheral organs	4
transcriptomic network	4
intraerythrocytic parasite	4
infected cell	4
cytoplasmic tail	4
P. falciparum	4
palmitoylated proteins	4
F. pedrosoi	4
F. pedrosoi infection	4
commensal microbes	4
L-PAC	4
N. aromaticivorans	4
small bile ducts	4
PubMed database	4
electronic health records	4
younger men	4
mouth cancer	4
established patient cohort	4
high-grade tumors	4
non-diabetics	4
cytosine bases	4
epigenetic inhibitors	4
FLO1 promoter	4
long noncoding RNAs (lncRNAs)	4
post-translational histone modifications	4
histone variants	4
RNA degradosomes	4
wild-type counterparts	4
muscle proteome	4
candidate biomarkers	4
gene ontology terms	4
matrisome-associated proteins	4
SWATH MS	4
redox sensitive proteins	4
Reactive oxygen species (ROS)	4
MHC class	4
immunogenic peptides	4
unique peptides	4
duplicate peptides	4
MHC class I-loaded peptides	4
Al(OH)3 in primary monocytes	4
complex biological mixtures	4
diGly peptides	4
protein assemblies	4
medically relevant protein assemblies	4
Genes encoding proteins	4
foods	4
pMRTP aerosol	4
lung proteome	4
single biomarker	4
lung cancer patients	4
never smokers	4
former smokers	4
individual phosphorylation sites	4
experimental animals	4
CDDO-me	4
Nrf2 inducers	4
Nrf2:Keap1 signalling pathway	4
WT animals	4
Nrf2(−/−) mice	4
candidates	4
TH-MYCN mice	4
hemopexin, transferrin, and apolipoprotein	4
Antigen 85	4
final products	4
immunohistochemical staining	4
TOF patients	4
static proteinaceous structures	4
mass spectrometer	4
contaminants	4
panel of proteins	4
Numerous proteins	4
major proteins	4
trousers	4
T-shirts	4
unstained socks	4
laundered semen stains	4
semen-stained clothing	4
likeLTD software	4
Y-STRs	4
hairy root cultures	4
S. latifolia	4
bioeconomy	4
D. alaskensis	4
hedgehog pathway	4
patients/parents	4
case series	4
publicly available databases	4
Aboriginal population	4
Aboriginal populations	4
heterozygous carrier	4
array CGH	4
relevant mouse models	4
RSV groups	4
casual contacts	4
casual partnerships	4
different sea lice stages	4
dynamic transmission models	4
nucleotide sequences	4
foot	4
pre-existing immunity	4
B. elizabethae 1 and 2	4
arthropod vectors	4
whole population	4
outcomes	4
two mathematical models	4
analytical tools	4
stratify contacts	4
Sea lice	4
salmon farms	4
ethnic group	4
HRB	4
epidemiological data	4
discipline	4
M. bovis	4
cytotoxic T lymphocytes	4
serological time series	4
public health	4
novel pathogens	4
livestock diseases	4
contact networks	4
human and animal populations	4
number of tools	4
recovered individuals	4
diverse virus population	4
new founder strain	4
virus population	4
virus strains	4
within- and between-host models	4
donor and recipient pairs	4
different regions of India	4
sheep flock	4
tropical Guinea Bissau	4
parsimonious model	4
Termitomyces cultivars	4
distinct lineages	4
individual genotypes	4
EM fungi	4
pure culture	4
life stages	4
possible therapeutic targets	4
3Rs	4
non-human primates (NHPs)	4
PhAT	4
systems biology	4
relevant species	4
metabolic filaments	4
5′ UTR	4
novel enzyme genes	4
rich resources	4
pre-implantation embryos	4
scRNA-seq data	4
Hi-C data	4
computational tool	4
co-regulated genes	4
putative targets	4
HLA class	4
tumor types	4
updated database	4
CIRCpedia v2	4
HO+ samples	4
tumor patients	4
identified miRNAs	4
m6Aocca genes	4
hepatocellular carcinoma	4
control samples	4
CRC samples	4
filters	4
2-DGE images	4
GI cancers	4
associated metabolites	4
recipient target cells	4
primary targets	4
interphase microtubules	4
imputed datasets	4
HIV-1 TAR	4
ribosome footprints	4
RNA structuromes	4
many miRNAs	4
Cancer biomarkers	4
cancer type	4
genetic polymorphisms	4
SOX regimen	4
Clinical data	4
GCGR and	4
two paralogs	4
Non-coding RNAs (ncRNAs)	4
Transposable elements (TEs)	4
specific metabolic pathways	4
contributions	4
amino acids in cell culture (SILAC)	4
PIK3CA-mutated luminal A tumors	4
FAC	4
twin pair	4
twin	4
big data	4
sequence reads	4
unigenes of B. hookeriana	4
B. hookeriana	4
nondiabetic controls	4
CD8+	4
pancreatic cells	4
fecal metagenomic DNA	4
microbial genes	4
international community	4
Oxford Nanopore Technologies (ONT)	4
heart catheterization	4
specific compartments	4
absent miRNAs	4
deregulated miRNAs	4
Long non-coding RNAs (lncRNAs)	4
various types of cancers	4
UFM1 cascade	4
full model	4
animal and human cells	4
cytoplasmic lncRNAs	4
hibernating animals	4
cardiovascular tissues	4
CHD-Biobank	4
selected circRNAs	4
public databases	4
potential lncRNA–interacting proteins	4
long ncRNAs (lncRNAs)	4
FokI polymorphism	4
rRNA gene core promoters	4
Chinese Han population	4
Asian populations	4
public domain	4
software tools	4
Fungal communities	4
rhizosphere	4
metagenomic datasets	4
Proteomic microarray	4
Esophageal squamous cell carcinoma (ESCC)	4
current model	4
antioxidant defenses	4
aroused lemurs	4
brown adipose tissue	4
optimal model	4
non-shivering thermogenesis	4
specialized functions	4
fatty acid metabolism	4
gray mouse lemur (Microcebus murinus)	4
mating system	4
possible species complex	4
variational neuroethology	4
intact organ	4
glomus cell	4
acetylcholine receptor (AChR)	4
Cochrane Library	4
lupus offspring	4
included studies	4
real world	4
VGKC-positive patients	4
three VGKC-positive subgroups	4
neutrophil extracellular traps (NETs)	4
ASCIZ/ATMIN	4
aged yeast cells	4
aging yeast cells	4
ATM kinase	4
essential cofactor	4
poly(ADP-ribose) (PAR)	4
recombination mediator	4
DNA adducts	4
bulky DNA adducts	4
AP site	4
NAD biosynthetic enzymes	4
Poly(ADP-ribosyl)ation	4
ends	4
broken ends	4
human lymphoblastoid cell lines	4
Pol η and Pol κ	4
various substrates	4
trinucleotide repeats	4
proliferating cell nuclear antigen (PCNA)	4
extended primer	4
double-strand DNA breaks	4
processes	4
“	4
post-incision complex	4
DNA lesion	4
telomere capping	4
phosphoinositide 3-kinase (PI3K)-Akt pathway	4
major electronic databases	4
larger cohorts	4
mtDNA haplogroups	4
computer model	4
mitoribosomal LSU	4
∆fzo1, ∆ref2, and ∆dnm1 mutants	4
cell bodies	4
mitochondrial fractions	4
disorders	4
whole body metabolism	4
PGC-1 family coactivators	4
LHON mtDNA mutation carriers	4
MIRU-VNTR data	4
Indian subcontinent (ISC)	4
CPLP	4
circular genomes	4
hemagglutinin (HA)	4
A(H1N1)pdm09 viruses	4
season	4
subjects with BV	4
partial genomes	4
pooled swabs	4
European countries	4
large dataset	4
HCV genotype 1b	4
hepatitis B virus (HBV)	4
human and animal health	4
liver flukes	4
liver fluke, Fasciola hepatica	4
emerging technologies	4
Mycoplasma genus	4
VgrG proteins	4
type VI secretion system (T6SS)	4
CF patients	4
genomic sites	4
sheep isolates	4
human papillomavirus (HPV)	4
source	4
metapopulation model	4
beta thalassaemia	4
local population	4
subtype B	4
serotype	4
Phylogenetic trees	4
tetranucleotide SSRs	4
sub-populations	4
C. parvum	4
sub-groups	4
CHIT1 genotype	4
genes and molecular pathways	4
differentially regulated genes	4
specific glial subtypes	4
dendrites	4
new tools	4
haemocytes and fat body	4
low-to-intermediate-risk patients	4
hs-CRP and Lp-PLA2	4
patients with type 2 diabetes	4
energy stores	4
high-OXPHOS HGSOCs	4
SLC1A3 expression	4
supercomplex	4
individual complexes	4
electron transport chain	4
thermogenic adipocytes	4
aerobic glycolysis	4
theoretical framework	4
obese subjects	4
effector T cells	4
β cell lncRNAs	4
critical mediator	4
PPP	4
pentose phosphate pathway (PPP)	4
human BAT	4
dog breeds	4
β-catenin signaling	4
AA metabolome	4
pancreatic islet α cells	4
dysfunctional mitochondria	4
neurons and astrocytes	4
single-cell type	4
visceral fat	4
primary RNA transcripts	4
RNase P	4
threonine residue	4
mitochondrial H2O2	4
Drosophila intestine	4
autonomic nervous system	4
PYY−/− mice	4
single L cells	4
old rats	4
t(8;21) acute myeloid leukemia (AML)	4
SASP	4
druggable targets	4
inflammatory secretome	4
Tasmanian devils	4
single-cell RNA sequencing	4
destruction complex	4
Hoxa9/Meis1-driven leukemia	4
anti-FcRH5/CD3 TDB	4
pediatric and adult patients	4
relapse-inducing cells	4
PI3Kα inhibitors	4
MYCN-amplified neuroblastomas	4
valuable platform	4
central players	4
multiple cancer types	4
hematopoietic malignancies	4
myeloma (MM)	4
nuclear compartment	4
gene regulatory circuits	4
pericentriolar matrix (PCM)	4
ciliary axoneme	4
human mammary cells	4
junctions	4
intestinal stem cells (ISCs)	4
mouse pancreas	4
limb	4
cell-cell adhesions	4
inner nuclear membrane	4
rate-limiting enzyme	4
transferrin receptor	4
specific membranes	4
screens	4
positive regulators	4
ER-phagy	4
margin	4
small RNA pathways	4
Ngn3 protein	4
bipotential progenitors	4
yolk sac	4
previous models	4
mammalian tissues	4
XY males	4
XX females	4
TAD	4
Drosophila brain	4
mushroom body	4
epiblast-like cells	4
SummaryEukaryotic cells	4
floor	4
stem cells (HSCs)	4
Shot/Patronin foci	4
Plk1/Polo kinase	4
low-density lipoprotein-cholesterol	4
annexin A1	4
chemoattractant	4
morphogen gradient	4
airway epithelium	4
ventral neural tube	4
RAB-A5c	4
dynamic tissue	4
phytochrome system	4
heterochromatin body	4
ciliated protozoan Tetrahymena	4
Nodal signaling domain	4
developing nervous system	4
actomyosin cortex	4
Myosin-II	4
IIBA	4
VE-cadherin	4
nonpolar progenitors	4
many Rabs	4
Rab effectors	4
JNK signaling	4
WRC	4
Ena/VASP	4
blood-neural barriers	4
CENP-A nucleosome	4
centromeres	4
lysosomal exocytosis	4
Polo/Plk1	4
Cnn scaffold	4
pericentriolar material (PCM)	4
lola mutants	4
neural stem cell genes	4
multiple regulators	4
new microtubules	4
microtubules	4
early-acting CRM	4
late-acting CRM	4
septin ring	4
neocentromeres form	4
ectopic sites	4
cyclin B2	4
cyclin B1	4
essential switch	4
cable	4
c-Abl	4
midline	4
lost cells	4
epithelial surface	4
cell periphery	4
uninfected cells	4
surrounding normal cells	4
asymmetric contacts	4
core planar polarity proteins	4
Pum-Nos	4
subset of tubule cells	4
chromosome recoiling	4
residual cohesion	4
multiple phosphorylation sites	4
opposite poles	4
mitochondrial targeting signal	4
muscle connective tissue	4
Drosophila insulin-like peptides (Dilps)	4
retromer complex	4
postmitotic neurons	4
actin mesh	4
mesh	4
oocyte cytoplasm	4
Drosophila oocyte	4
polarized microtubule network	4
pesticides in farmed fish	4
vascular endothelial growth factor	4
Mucopolysaccharidosis type	4
bleb survival	4
parental BCG	4
rBCG-Japan/PhoPR	4
human pericytes	4
HIF1α-PPAR axis	4
hESC-ECP	4
TCR-engineered T cells	4
FRB and FKBP12	4
CARD domain	4
adeno-associated virus (AAV) vectors	4
competing strand	4
CpG-STAT3dODN	4
γδT cells	4
codon-optimized sequence	4
AAV8 vector	4
patients with XLRP	4
LTR1 vectors	4
multiple types of cancer	4
anti-miRs	4
large animal model	4
PF	4
Chrnb4-EGFP mouse line	4
urinary glycosaminoglycans	4
human dendritic cells	4
memory cells	4
young infants	4
transduced cells	4
LV-encoded antigen	4
LV-encoded antigens	4
HSC-derived myofibroblasts	4
vaccinia virus	4
focused ultrasound	4
resting memory CD4+	4
plasma viremia	4
Gambia	4
Modified Vaccinia Ankara	4
intron 11 of the CFTR gene	4
functional dystrophin protein	4
repair template	4
NSC34 cells	4
Lentiviral vectors	4
mutant SOD1	4
secreted factors	4
antisense transcript	4
paternal UBE3A	4
genome-editing technologies	4
human sensory neurons	4
mVChR1-expressing cells	4
transgene product	4
human T-cells	4
human MSCs (hMSCs)	4
hESCs-WASKO	4
zinc finger nucleases	4
rare cells	4
volunteers	4
essential regulators	4
miR-101 mimic	4
eight patients	4
peripheral blood mononuclear cells	4
gene-modified cells	4
corrected cells	4
clonal population	4
genomic sequence	4
exon 51	4
exon 51 of the dystrophin gene	4
dystrophin protein expression	4
untreated mice	4
SMNΔ7 mice	4
EAC patients	4
colorectal cancer cells	4
Apicomplexa parasites	4
Southeast Asia	4
onchocerciasis and lymphatic filariasis	4
variety of systems	4
drugs and vaccines	4
Genetic diversity	4
cells and organisms	4
individual host	4
nitro drugs	4
Plasmodium species	4
chemotherapeutic agents	4
old drugs	4
new antimalarials	4
tsetse	4
vaccine strains	4
different NTDs	4
Vδ1 T cells	4
chicken MHC	4
oral mucosal barrier	4
Sexually transmitted infections (STIs)	4
human cohorts	4
CTLA-4 cytoplasmic domain	4
circulating neutrophils	4
neurodegenerative conditions	4
neuronal survival	4
relevant models	4
medical imaging	4
BM-hMSCs	4
two BM-hMSC donors	4
PRIME-XV SFM	4
cirrhotic patients	4
CD14+ monocytes	4
human monocyte-derived macrophages	4
MSC-flT cells	4
cord blood banks	4
hospital settings	4
new protocol group	4
two animals	4
aimsMesenchymal stromal cells (MSCs)	4
resistant strains	4
antibiotic stewardship	4
centres	4
PLM	4
six PLMs	4
wild type M. agalactiae	4
wildtype strain	4
clonal complexes	4
resistance determinants	4
NDM-1 gene	4
antimicrobial classes	4
plasma metabolites	4
S. sonnei	4
GMMA	4
hyphal elongation	4
zinc nanoparticles	4
vitro and in vivo studies	4
immunocompetent host	4
strain Rd KW20	4
M. haemolytica OMVs	4
M. haemolytica	4
BALB/c mice	4
resting spores	4
Plasmodium apicoplast	4
frameworks	4
T. copemani G2	4
large subunit	4
cellulose synthase	4
transcripts encoding proteins	4
mitochondrial electron transport chain	4
FAZ ER	4
cellular architecture	4
oculomotor neurons	4
7α-hydroxycholest-4-en-3-one	4
(25R)26,7α- and (25S)26,7α-dihydroxy epimers of oxysterols and cholestenoic acids	4
lipid and energy metabolism	4
blood derived samples	4
Lal−/− mice	4
H9c2 cells	4
human erythrocytes	4
binary and ternary complexes	4
binary complexes	4
p-JNK1	4
experimental tool	4
SM-rich domains	4
diacylglycerol acyltransferase 1 (DGAT1)	4
structural elements	4
HF diet	4
Tg2576 mouse model	4
A0H0 macrophages	4
Adipose triglyceride lipase (ATGL)	4
RE stores	4
PI3	4
ethanolamine plasmalogens	4
Pdr16pE235A, K267A mutant	4
azole and morpholine antifungals	4
human skin fibroblasts	4
BODIPY-SM	4
apolipoprotein E	4
axon terminals	4
additional biomarkers	4
cytospin-prepared slides	4
antibody titres	4
five samples	4
individual DPS	4
HCV RNA	4
mother-infant pairs	4
RSV antibody	4
vaccine strain	4
influenza-like illness (ILI)	4
FFPE material	4
cervical metastasis	4
symptomatic and asymptomatic children	4
stool specimens	4
rural communities	4
Norovirus (NoV)	4
ICU	4
referral population	4
false-positive samples	4
false-negative samples	4
symptomatic children	4
live-attenuated VZV vaccine	4
multiple, reassortant lineages	4
Influenza C virus	4
influenza A and B viruses	4
human respiratory samples	4
influenza D virus	4
viral pathogens	4
PNG highlands	4
high risk group	4
intermediate risk groups	4
D+R− group	4
D+R− patients	4
single infections	4
NSP2 sequences	4
donor serostatus	4
seropositive recipients	4
donor and recipient serostatus	4
laboratory strains	4
blood stage parasites	4
membranous structures	4
P. truncatum	4
PoDHFR-TS	4
human lymphocytes	4
different solvents	4
micronucleated cells/1000 cells	4
TK6 cells	4
chemicals	4
PIGRET and RBC Pig-a assays	4
many compounds	4
correlation	4
non-carcinogens	4
rodent carcinogens	4
rat lung	4
Alkaline unwinding assay	4
V79 cells	4
Cr(VI)	4
crypt compartment	4
B6C3F1 mice	4
mainstream cigarette-smoke	4
γH2AX assay	4
spinning membrane filtration technology	4
rocking motion bioreactors	4
culture platforms	4
cell therapy industry	4
directed graph	4
herbicide isoproturon	4
cellular growth	4
spent B. subtilis cells	4
mPBr	4
surface markers	4
Q-Sepharose	4
free BbgIV	4
amino-ethyl agarose	4
covalent attachment	4
DEAE-Cellulose and Q-Sepharose	4
three embryonic germ layers	4
metagenomic sequencing	4
replication machinery	4
mycobiome	4
RXLR effectors	4
vivo situation	4
nutrients	4
specific pathogen	4
exchanged metabolites	4
natural systems	4
reference databases	4
microbial genomes	4
long reads	4
synthetic communities	4
natural microbial communities	4
microbial contamination	4
important genes	4
novel viruses	4
patients with melioidosis	4
commensal	4
changing climates	4
plant tissue	4
puzzle cells	4
RZ	4
rib zone (RZ)	4
organ systems	4
transcriptional targets	4
new TE insertions	4
polarity cues	4
‘omics’ technologies	4
S-nitrosothiols	4
epitranscriptome	4
powerful platform	4
analytical chemistry	4
natural isolates	4
novel biocatalysts	4
short peptide	4
heterologous systems	4
analogous systems	4
metallo-enzymes	4
post-translational modifications (PTMs)	4
biological structures	4
natural enzymes	4
naturally occurring enzymes	4
smooth muscle cells	4
plaques	4
foam cells	4
westernized societies	4
cell-based therapeutics	4
NF-κB pathway	4
CCM lesions	4
Multiple factors	4
novel monoclonal antibody	4
integrins and associated proteins	4
Wiskott Aldrich Syndrome Protein (WASP)	4
cell–substratum adhesion	4
lysine residues	4
proteolytic systems	4
lipid species	4
brain structures	4
TFIZ1 expression	4
normal gastric mucosa	4
mammalian proton-coupled peptide transporter PepT1	4
yolk ferritin	4
HPD motif of the J-domain	4
mammary epithelium	4
epidermal growth factor and pituitary gland extract	4
liver proteins	4
Williams’ medium E	4
primate lentiviruses	4
Host factors	4
Zika virus	4
Chlamydia-related bacteria	4
key receptors	4
second model	4
fungal conidia	4
West Africa	4
HIV-infected children	4
LSD cases	4
HIV-infected patients	4
IgM and IgG antibodies	4
eight NICUs	4
CR K. pneumoniae	4
reference laboratories	4
endemic settings	4
concentric rings	4
pyrethroid resistance	4
TB patients	4
new antibiotics	4
Gram-negatives	4
relationships	4
mass gatherings	4
critical care facilities	4
neonatal tetanus	4
25 patients	4
rural African setting	4
promising target	4
DPC polyubiquitylation	4
bulky lesions	4
Cancer samples	4
leading strand	4
noncoding transcription	4
highly expressed genes	4
sequence-specific transcription factor	4
lncRNA genes	4
long noncoding RNA	4
exon-exon junctions	4
exon junction complex (EJC)	4
cryptic RS-exons	4
K63-linked ubiquitin chains	4
unligated Okazaki fragments	4
phase poly(ADP-ribose)	4
PARP enzymes	4
loading sites	4
CTD-binding site	4
DNA replication origins	4
stalled forks	4
huntingtin protein	4
’s disease	4
overexpression	4
non-coding RNA	4
XR-PID	4
non-coding RNA Xist	4
Class I PI3Ks	4
E3 ligases	4
cohort of genes	4
transcription bubble	4
checkpoint	4
cytosolic RIPK1	4
histone deacetylase	4
Circ-ZNF609	4
SMX tri-nuclease	4
arginine methyltransferase PRMT5	4
poly(A) sequences	4
ubiquitin ligase ZNF598	4
mammalian native elongating transcript sequencing (mNET-seq)	4
long intervening noncoding RNAs (lincRNAs)	4
DNA polymerase δ	4
eukaryotic replisome	4
nascent DNA	4
toxin-antitoxin (TA) systems	4
high cell density populations	4
RNA-seq	4
RC components	4
RAD51 paralogs	4
metaphase chromosomes	4
chromosome periphery	4
DNA-protein crosslinks (DPCs)	4
DPC-inducing agents	4
metalloprotease SPRTN	4
DPC protease	4
live cell imaging	4
cohesed chromatids	4
transient intermediates	4
linear ubiquitin chain assembly complex (LUBAC)	4
protein interaction network	4
destruction complexes	4
ubiquitin-binding domain	4
which	4
DNA helicase	4
eukaryotic replication forks	4
dimer contacts	4
Chl1 helicase	4
client	4
known DUBs	4
new family of DUBs	4
UHRF1 protein	4
main drivers	4
bacterial persisters	4
Human cells	4
c-FLIPL/S	4
c-FLIP isoforms	4
chromatid cohesion	4
pSPxF motif	4
HR-defective cells	4
BRCA2-deficient cells	4
replication-timing domains	4
phagophore	4
Fanconi anemia (FA) proteins	4
DNA and proteins	4
40S	4
PIC	4
IESs	4
active TEs	4
many eukaryotes	4
chains	4
K29 chains	4
K29-linked polyubiquitin	4
mitochondrial outer membrane	4
Polycomb Repressive Complex 2 (PRC2)	4
stalled ribosomes	4
ID complex	4
reactive metabolites	4
nascent chain	4
ribosomal protein genes	4
Embryonic stem cells (ESCs)	4
oocyte-specific factors	4
sn/snoRNAs	4
Atg12–5-16L1 complex	4
B cell	4
Arabidopsis FLOWERING LOCUS C (FLC)	4
HOIP PUB domain	4
XPF-ERCC1	4
ubiquitin E3 ligase	4
SUMO chains	4
SUMO protease SENP6	4
polySUMO substrates	4
protein substrates	4
primary sequences	4
three-dimensional model	4
CSM complex	4
kinetochore assembly	4
functional categories	4
animal gonads	4
ribosomes	4
5-hydroxymethylcytosine (5hmC)	4
mitochondrial Bax	4
BH3 proteins	4
autophagy machinery	4
autophagy receptors	4
cytosolic components	4
sRNA seed region	4
endoribonuclease RNase E	4
RNA chaperone Hfq	4
individual TFs	4
disordered segments	4
respective tissues	4
alternatively spliced exons	4
protein kinase CK2	4
unstressed cells	4
damage sites	4
casein kinase 2 (CK2)	4
RNMT (RNA guanine-7 methyltransferase)	4
5′ end of mRNA	4
Ripoptosome	4
autophagic substrates	4
G-rich pause sites	4
inhibitory contact	4
nascent RNA	4
newly synthesized histones	4
large-scale chromatin structures	4
molecular chaperone Hsp90	4
bulk chromatin	4
CpG island chromatin	4
mutant animals	4
released transcripts	4
collapsed replication forks	4
cytotoxic drugs	4
multiple nucleases	4
potent blocks	4
specific sequence	4
αC helix	4
multiple protein kinases	4
aberrant transcripts	4
NRD complex	4
NBD1 ring	4
proteasome substrates	4
intracellular proteins	4
terminator elements	4
poly(A)	4
PIWI/MID domain	4
pri-miRNAs	4
RNAP-σ54	4
open complex	4
Fanconi anemia	4
transcribed region	4
protein kinase clients	4
c-fos	4
certain proteins	4
mammalian RNA polymerase II (Pol II)	4
FANCD2 monoubiquitination	4
USP1 autocleavage	4
FANCD2 and PCNA	4
I-dsRNA	4
class I release factors	4
paralogs	4
inlet	4
β-gal−/− mice	4
β-gal enzyme activity	4
general population (non-PKU controls	4
GSD patients	4
40 mg/day placebo group	4
matching placebo	4
phenylbutyrate (GPB)	4
multiple organ systems	4
35 cases	4
five cases	4
conditions	4
study sites	4
kynurenine pathway	4
AA-MF or GMP-MF	4
NLSDM-iPSCs	4
adipose triglyceride lipase (ATGL)	4
PNPLA2 gene	4
lipid droplets (LDs)	4
healthcare professionals	4
PKU clinics	4
-nine patients	4
asfotase alfa	4
patients receiving asfotase alfa	4
patients with HPP	4
NP-C	4
causes	4
medium chain triglyceride (MCT) oil	4
Ten patients	4
Home infusions	4
investigational drug	4
FBN1 mRNA	4
NBS laboratory	4
native enzyme	4
two clinical variants	4
different medications	4
patients with GD1	4
20 subjects	4
LC-FAOD	4
novel energy source	4
commercial enzymes	4
mitochondrial genes	4
Valproic acid (VPA)	4
different transcription factors	4
multiple promoters	4
treatment-naïve patients	4
mucopolysaccharidosis II	4
plasma thiols	4
X-ALD	4
long-chain fatty acids	4
patient cohort	4
hepatopathy	4
wild-type controls	4
Metab.	4
I278T	4
plant material	4
fusions	4
octanoic acid	4
first engineered strain	4
PCC 6803	4
natural colourants	4
soil bacterium	4
microbial strains	4
microbial species	4
comprehensive mathematical framework	4
p-coumaric acid	4
toxic intermediates	4
screening tool	4
genetically-encoded malonyl-CoA sensor	4
drug leads	4
carboxylic acids	4
producer cells	4
Yarrowia lipolytica	4
pathway genes	4
glucose or ethanol	4
many secondary metabolites	4
final strain	4
renewable sources	4
Δ5-elongase	4
transgenic strains	4
molecular link	4
nuclear Spry2	4
Nitric oxide (NO)	4
children with SCD	4
oomycetes	4
conserved amino acids	4
primary hosts	4
potato and tomato	4
oomycete Phytophthora infestans	4
later isolates	4
Aspergillus fumigatus	4
T. indicum complex	4
ascomycete fungi	4
oral ecosystem	4
epiphytic growth	4
partner	4
mixed populations	4
2-day-old conidia	4
early endosomes (EEs)	4
conidial outgrowth	4
septal pores	4
T. reesei	4
multiple strains	4
class I enzymes	4
sites of polarized growth	4
three strains	4
wildtype and the KO plc-1 mutant	4
confocal laser scanning microscopy	4
qualitative genes	4
apical Spitzenkörper	4
new targets	4
tip growth	4
wheat genes	4
causal agent	4
fungal plant pathogens	4
wheat pathogen	4
GFP variants	4
green-fluorescent proteins	4
sdi1 locus	4
protein-coding regions of the genome	4
wheat pathogen Z. tritici	4
alcohols	4
Chinese population	4
reaction products	4
plant polysaccharides	4
N. fischeri	4
rice blast fungus	4
host plants	4
host macrophages	4
opportunistic human fungal pathogen Candida albicans	4
hyphal C. albicans	4
Aspergillus nidulans	4
cell walls	4
echinocandins	4
mammalian hosts	4
different programs	4
muscle stem cells	4
issue	4
disciplines	4
fiber	4
model animals	4
droso4schools project	4
university students	4
γδ T cell ligands	4
γδ T cells	4
homologous DNA strand	4
many RNAs	4
non-coding RNAs (ncRNAs)	4
protein isoforms	4
predisposition	4
presynaptic compartment	4
many epithelia	4
right place	4
Smad transcription factors	4
nuclear interior	4
lamina network	4
excellent models	4
metazoan species	4
trypanosomatids	4
animal systems	4
hem and the antihem	4
45 patients	4
patients with acute myeloid leukemia (AML)	4
3 samples	4
poultry meat	4
MSPs	4
abscess	4
Bifidobacterium catenulatum	4
Ruminococcus gauvreauii	4
microflora	4
therapeutic genes	4
biomass deconstruction	4
D. nodosus	4
Env immunogens	4
N276 glycan	4
endothelial junctions	4
distinct cellular sources	4
inflamed tissues	4
intestinal epithelial cells (IECs)	4
Env apex	4
inflammatory stimuli	4
large number of genes	4
many cancers	4
infected tissues	4
peptide residues	4
potent bnAbs	4
tumor-infiltrating Treg cells	4
IL-1β expression	4
skin and gut	4
naive monocytes	4
target organs	4
SummaryBroadly neutralizing antibodies (bnAbs)	4
cl-CD95L	4
CF null mice	4
SummaryEpithelial cells	4
glucose transporter GLUT1	4
VSMC-LTβRs	4
naive CD4+ T cells	4
EC junctions	4
endothelial cells (ECs)	4
central supramolecular activation cluster (cSMAC)	4
(Treg) cells	4
transcription factor FOXO1	4
JAK-STAT pathway	4
lipid-rich diet	4
pathway(s)	4
human tissue	4
CD14+ cells	4
helper 1 (Th1) cells	4
microRNAs (miRNA)	4
miRNA-containing exosomes	4
aryl hydrocarbon receptor (AhR)	4
interleukin-6 (IL-6)	4
glycolipid antigens	4
BCR	4
pro-IL-1α	4
innate and adaptive immunity	4
sterol metabolic network	4
transcription factor T-bet	4
stromal surfaces	4
exogenous antigens	4
thymic medulla	4
PPARγ target genes	4
interleukin-4 (IL-4)	4
Il23r−/−T cells	4
activated Lck	4
lymphoid organs	4
E-cadherin+ DCs	4
cytotoxic T lymphocytes (CTLs)	4
IL-10-producing Th1 cells	4
SummaryCD4+	4
naive Th cells	4
Bcl2l11−/−Faslpr/lprmice	4
antigen-stimulated T cells	4
complement C3	4
cell monolayer	4
gIi	4
vaccinated fish	4
Aeromonas salmonicida	4
commercial furunculosis vaccine	4
leucine-rich repeats	4
Toll-like receptors (TLRs)	4
cryo-EM maps	4
new proteins	4
70S ribosome	4
MAINMAST software	4
α-synucleinopathies	4
compact SBMV	4
biological volumes	4
implementation	4
cardiac troponin	4
lacunae	4
osteocyte network	4
actively transcribing genes	4
MLV Env	4
isolation membranes	4
cargo	4
multiple databases	4
all-gold supports	4
program	4
proteolytic core	4
recombinant polymers	4
EF-Tu	4
Rspo proteins	4
effective platform	4
dinucleotide	4
obligate anaerobe	4
ultrathin sections	4
ultrastructure	4
brain cells	4
3D density map	4
six AAA+ domains	4
different forms	4
ZYMV-infected cells	4
grid	4
eyelash	4
human enamel	4
web interface	4
maps, tomograms and models	4
amorphous calcium carbonate	4
human input	4
novel binding sites	4
purified human proteins	4
Bacillus licheniformis	4
oligomeric forms	4
CTF	4
proteins or protein complexes	4
core subunits	4
central cavity	4
tissue sections	4
replicated DNA	4
two protein complexes	4
replication origin	4
chromosome territories/chromatin	4
nuclear space	4
nuclear pore complexes	4
Ribosomal genes	4
transmission-blocking vaccines	4
murine IgG1 signal peptide	4
two sub-complexes	4
SpyTag/SpyCatcher	4
functionally active protein	4
His-tagged recombinant CES1	4
recombinant CES1	4
hexa-lysine tag	4
premature polyadenylation	4
3′ untranslated region	4
dystrophin complex	4
Fukutin-I	4
yeast and animal cells	4
tandem affinity purification (TAP) tag	4
powerful model system	4
designer endonucleases	4
acquired projections	4
AG1478 and Dynasore treated cells	4
leptomeninx	4
dura mater	4
meninges	4
synthetic guide RNAs	4
double-stranded break	4
guide RNAs	4
blood-brain barrier (BBB)	4
sleeping sickness patients	4
E. coli RNAP	4
end users	4
large multi-protein complexes	4
Poly(A) tails	4
open-source software	4
vitro selection	4
autophagosomal membranes	4
coarse-grained modeling	4
RNA 3D structures	4
RNA secondary structures	4
bound proteins	4
DNA or RNA	4
tRNA molecules	4
multiple lineages	4
VAST BioImager	4
intercellular adhesion	4
Induced pluripotent stem cells (iPSCs)	4
Cas9 system	4
biological imaging	4
populations of cells	4
high-throughput format	4
oligomeric species	4
protein variants	4
unfolded variant	4
associations	4
DISEASES resource	4
different assays	4
cytoplasmic constituents	4
resulting datasets	4
human brain tissue	4
5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)	4
Notch intracellular domain (NICD)	4
protein–RNA complexes	4
recombinantly expressed proteins	4
important class of enzymes	4
cow’s milk allergy	4
cow’s milk allergens	4
cow’s milk	4
conformational epitopes	4
individual Notch receptors	4
pool	4
epigenetic mark	4
transplanted nuclei	4
somatic cell nuclei	4
commercial ELISA	4
IS	4
7 days	4
α1-PI products	4
Apobiologix pegfilgrastim	4
US-licensed pegfilgrastim	4
Gram-negative bacterium	4
human embryonic kidney (HEK)	4
hemophilia A.	4
Waddington’s landscape	4
blastomere	4
subgroup	4
cell lineages	4
fusion transcription factors	4
alveolar rhabdomyosarcoma	4
prime targets	4
primary and metastatic tumors	4
tumour suppressor	4
surviving cancer cells	4
particular patient	4
alternative compounds	4
network nodes	4
reproductive tract	4
P-IC	4
oral formulation	4
four markers	4
UVB radiation	4
multiple residues	4
several residues	4
copper complex	4
CT-DNA	4
ligand and Cu (II) complex	4
dietary supplement group	4
active treatment group	4
Skin Tester	4
second cohort of patients	4
first cohort of patients	4
sun	4
lipid interaction sites	4
green algae	4
BAR domains	4
cleft	4
respective ligands	4
Robo1 ectodomain	4
type 1 pilus rod	4
conduit	4
binding interface	4
yeast R2TP	4
SARA/endofin	4
canonical RING E3s	4
L-histidine	4
metal ion-dependent adhesion site	4
γ1 chain tail	4
M-band	4
short- and long-chain FOSs	4
sorting complexes	4
functionally closed (i.e., non-conductive) state	4
Ca2+ ions	4
receptor multimerization	4
hepatocyte growth factor	4
neuronal synaptic vesicles	4
PIP molecules	4
13 PH domains	4
adhesion complexes	4
SummaryG-protein-coupled receptors (GPCRs)	4
species genome	4
Neisseria meningitidis	4
kinase active site	4
outer domain	4
antibody-dependent cellular cytotoxicity (ADCC)	4
Notch receptor	4
translocon	4
NAK kinases	4
transmembrane region	4
transmembrane receptors	4
BART-like domain	4
three classes	4
large extracellular domain	4
consecutive SRCR domains	4
phenylalanine residues	4
TREX-2 complex	4
active trGTPases	4
cofactors	4
free energy landscape	4
wild-type Latrophilin3	4
novel antibiotics	4
V-ATPases	4
theoretical models	4
Eukaryotic genomes	4
bacterial effectors	4
second helix	4
allosteric proteins	4
short peptides	4
multiple protein-protein interactions	4
active site of β-gal	4
specific interactions	4
N and C termini	4
lateral cleft	4
Numerous inhibitors	4
silenced genes	4
β-catenin-dependent transcription	4
effector	4
heparan sulfate	4
binding motifs	4
cytochrome P450 reductase	4
two forms	4
tyrosine	4
interaction	4
ribosomal A site	4
double-strand breaks	4
transmembrane helix 7	4
Arg/Gly3898.56 polymorphism	4
export-competent mRNPs	4
workshop	4
molecular models	4
endosomal sorting complexes	4
larger RNA structure	4
axis of duplex RNA	4
kink turn	4
orthologs	4
analysis	4
transmembrane α helices	4
SH2 domains	4
molecular surface	4
thiamine cofactor	4
dynamic signaling complexes	4
5′-monophosphate	4
extended loop	4
substates	4
Colicin N	4
autophosphorylation sites	4
SummaryApoptosis signal-regulating kinase 1 (ASK1)	4
glycoproteins	4
activation segment	4
C terminus	4
biological environment	4
mitochondrial ribosome	4
central channel	4
RNA substrates	4
exosome complex	4
viral RNAs	4
carbohydrates	4
highly pathogenic avian influenza viruses	4
current host	4
picture	4
CF lung	4
complex regulatory networks	4
assembly site	4
narrow channel	4
specific biomarkers	4
genetically-modified mice	4
single agent	4
renal transplant	4
cell receptor	4
surface coatings	4
conditioning agents	4
complex systems	4
vivo platform	4
Smc complexes	4
existence	4
Yamanaka factors	4
scaffold proteins	4
histone tails	4
cell protrusions	4
small Rho GTPases	4
another cell	4
mammalian biology	4
rodents and primates	4
benign group	4
malignant group	4
15 patients	4
30 patients	4
free 1,25(OH)2D	4
VDR gene	4
mothers/newborn pairs	4
25-hydroxyvitamin D	4
Illumina HumanMethylation450 BeadChip	4
Hispanic women	4
overall population	4
CA1 neurons	4
bolus IV	4
oral MR calcifediol	4
CYP24A1 expression	4
endogenous calcitriol	4
blood PTH	4
parathyroid hormone	4
serum 25(OH)D	4
vitamin D target gene	4
clinical studies	4
diverse structures	4
Vitamin D Workshop	4
vitamin D receptor (VDR)	4
nuclear receptor	4
PXR activators	4
cellular context	4
extant enzymes	4
structural biologists	4
large genomes	4
different types of CRISPR-Cas systems	4
crRNP effectors	4
invading genetic elements	4
Recent crystal structures	4
protein therapeutics	4
U5 snRNA	4
protein-coding information	4
bacterial outer membrane	4
well-diffracting crystals	4
natural proteins	4
expression plasmid	4
methylotrophic yeast Pichia pastoris	4
Tat system	4
many pathogens	4
T4S systems	4
eukaryotic host cells	4
heparan sulphate chains	4
allosteric activators	4
human kinome	4
Computational modeling	4
explosive fruit	4
distinct environments	4
genetic lesions	4
programs	4
Model organisms	4
conserved signaling pathways	4
biomedical science	4
developmental hourglass model	4
plant organs	4
local tissue	4
evolutionary conserved proteins	4
obligate parasites	4
different organ systems	4
repetitive elements	4
extracellular matrix components	4
inner ear	4
edge	4
vertebrate inner ear	4
eyes	4
rules	4
DNA repair enzymes	4
base pairs	4
non-coding sequences	4
human lineage	4
striated muscle	4
Cell types	4
specific elements	4
Polycomb group (PcG) proteins	4
cancer patient	4
sequence-specific DNA-binding proteins	4
spoilage organisms	4
microbial metabolism	4
new biomolecules	4
new pathways	4
individuals who	4
total body iron	4
at-risk populations	4
field of metabolomics	4
billions of cells	4
drug development pipelines	4
cancer models	4
promising compounds	4
complex biological matrices	4
inorganic fertilisers	4
internal organs	4
skin keratinocytes	4
epithelial tissues	4
molecular machineries	4
neighbouring cells	4
winner cells	4
mature B cells	4
main target	4
rhizomer	4
root	4
accessory proteins	4
damaged tissues	4
lower eukaryotes	4
cellular compartments	4
signalling receptors	4
multivesicular bodies (MVBs)	4
different contexts	4
stem and progenitor cells	4
lamina	4
CENP-A nucleosomes	4
CENP-A chromatin	4
transcribed genes	4
isolated mitotic chromosomes	4
chromatin fiber	4
RNA polymerases	4
long-lived proteins	4
II	4
recycling proteins	4
new indications	4
new generation adjuvants	4
mucosal surfaces	4
tumor environment	4
classical MHC molecules	4
HLA-DO	4
cytomegalovirus (CMV)	4
antigen-SIT	4
mice and humans	4
site A	4
ACB assay	4
SQ-LNS	4
gC1q domain	4
structural modulator	4
IQGAP1 with β-arr1	4
full-length BMPER	4
OA cartilage	4
inter-α-inhibitor heavy chains	4
structural support	4
vice versa	4
Age-related macular degeneration (AMD)	4
highly polarized cells	4
collagen III	4
α-helix	4
stable dimer	4
skeletal muscle stem cells	4
MMP14 and MMP2	4
variable region	4
CCN3 (Nov) and CCN5 (WISP2)	4
LF domain	4
cluster II	4
human chondrocytes	4
N-linked glycans	4
secreted glycoproteins	4
bovine cornea	4
sulphated GAG	4
tetrameric assembly	4
dimer of the N_PTX3	4
multimeric protein	4
two receptors	4
fibrillar collagens	4
time in culture	4
cell-to-cell contacts	4
growth factors and cytokines	4
ADAMTS-4 mRNA	4
tissue extracts	4
chronic painful tendinopathy	4
normal tendon	4
P. capsici	4
conserved tryptophan	4
hydrophobic residues	4
SH3 domains	4
adult organism	4
lymphatic endothelial cells (LECs)	4
Many of the proteins	4
anatomical studies	4
anatomical sciences	4
RABV antigenicity	4
pediatric patients	4
NP-loaded dissolving MNs	4
MNs	4
dissolving MNs	4
different serotypes	4
trivalent vaccine	4
three drugs	4
commercial products	4
conjugates	4
tumour necrosis factor-α	4
film forming systems	4
free base	4
novel target	4
Epithelial ovarian cancer	4
proximal colon	4
fluid	4
delivery platform	4
microfibers	4
approved drugs	4
Etoreat patch	4
solutions	4
nail plate	4
devices	4
human saliva	4
encapsulated dyes	4
Scytomonas saepesedens	4
18S rRNA	4
rDNA sequences	4
foodborne botulism	4
recA mutant	4
NB4 cell line	4
NB4 and HL-60 cells	4
NCBI database	4
acute promyelocytic leukemia (APL)	4
HTT expression	4
cell-to-cell junctions	4
normal and cancer cells	4
family of enzymes	4
mouse hypoxic model	4
sphingosine kinase 1	4
crucial regulators	4
β-amyloid	4
PDE4 isoforms	4
AP-1 target genes	4
AP-1 pathway	4
GPCRs	4
adenylyl cyclase	4
specific siRNA	4
p-Src	4
Akt-p70S6K-S6 pathway	4
cadherin junctions	4
nuclear pore complex	4
monocytes and T cells	4
intracellular signaling	4
local microenvironment	4
dialysed GOK/STIM1 antibody	4
plasma membrane (PM)	4
new players	4
molecular players	4
specific regions of the genome	4
differentiating cells	4
myosin 1c	4
LNCaP cells	4
siRNAs	4
P2X7 receptors	4
novel drug targets	4
SLIGKV-OH	4
parental cells	4
FP and EP2 receptors	4
tagged protein	4
DT40 cells	4
three cysteines	4
heat shock proteins	4
many plant species	4
fungal pathogen	4
taxon	4
bovine DNA	4
LCR22-2	4
DIL NOD	4
CHORI-29 library	4
DIL NOD library	4
adult mouse brain	4
transcription initiation sites	4
human BDNF gene	4
putative proteins	4
starter culture	4
scientific papers	4
tryptic peptides	4
hairy nap	4
apple juice	4
nanoemulsifiedd-limonene	4
L. monocytogenes	4
Clostridium sporogenes	4
adolescent brain	4
human neonates	4
P. aeruginosa infections	4
cystic fibrosis patients	4
roadmap	4
otherwise promising products	4
cell and gene therapies (CGTs)	4
animal-derived monoclonal antibodies	4
market	4
healthy tissues	4
plant cell	4
vegetative tissues	4
homologous sequences	4
Pyrazinamide (PZA)	4
fecal isolates	4
Americas	4
A. lentulus and A. felis	4
respiratory samples	4
antimicrobial agents	4
S. suis serotype 2 infection	4
whole mouse body	4
aquatic environment	4
DCE-MRI	4
TMJ	4
TMJ disc	4
one Scottish sample	4
phantoms	4
live animals	4
short-axis view	4
type material	4
higher taxa	4
root nodules	4
South Africa	4
known type strains	4
housekeeping genes	4
recombinant vaccine	4
preferred carbon source	4
biomass yields	4
beef extract	4
sodium alginate	4
Bacillus strain	4
L. japonica feedstuff	4
HEK293T cell line	4
capitulum bud	4
industrial strains	4
pathogenic bacterium	4
multiple genomes	4
sea	4
marine organisms	4
marine environment	4
2 strains	4
different geographical regions	4
spacers	4
main population	4
Sec-1 locus	4
known structures	4
immobilized beads	4
Escherichia coli strain	4
glucose yield	4
spotted scat	4
effective thrombolytic agent	4
Schizochytrium species	4
mineral medium	4
5-L fermenter	4
Z. mobilis ZM4	4
basic zinc carbonate	4
cellulase enzyme	4
fermentable sugars	4
AIV-infected cells	4
free enzyme	4
methanogenic bacteria	4
tap water	4
(+)	4
tea clone Iran 100	4
12 clones	4
tlh primers	4
R. glutinis	4
potato wastewater and glycerol	4
potato wastewater	4
biosurfactant	4
C. sphaerica	4
synthetic surfactants	4
motor oil	4
motor oil contaminated sand	4
two biosurfactants	4
ABTS and DMP	4
brown rot fungi	4
uncoated strawberries	4
strawberries	4
6 compounds	4
huperzine A.	4
Endophytic fungi	4
Non Pareil	4
pollen tube growth	4
AHAS gene	4
multiple copies of the AHAS gene	4
F4 follicles	4
PRLR mRNA	4
prolactin receptor (PRLR)	4
wild-type plants	4
JcCPI gene	4
breeds	4
Taq Pol Ι	4
ammonium sulfate	4
two-copy strain GSKZαFA20	4
highest feruloyl esterase activity	4
one-copy strain GSKFA3	4
feruloyl esterase	4
β-glucosidase	4
xylanases	4
oat spelts xylan	4
liquid medium	4
therapeutic antibodies	4
C. anguria	4
vivo plants	4
vitro regenerated plants	4
1.0μM IBA	4
studied cell lines	4
standard 2-PE sample	4
rMBP-NAP	4
SVM	4
seedlings	4
tomato seeds	4
transgenic technology	4
corn meal	4
medium components	4
medium constituents	4
hyper saline soda lakes	4
new enzymes	4
invasive mycoses	4
YZ1 and YF31 strains	4
biofilm	4
repeated batch	4
lignocellulosic hydrolysates	4
polysaccharides	4
new cultivars	4
polymorphic loci	4
E. faecalis	4
E. faecalis isolates	4
clade	4
total soluble protein	4
solid phase	4
secondary metabolite	4
basal medium	4
dry substrate	4
C. butyricum DSP1	4
detergent industry	4
sugarcane bagasse and corn steep liquor	4
recombinant endoglucanase	4
wild-type strain	4
cluster dendrogram	4
Angelica species	4
present study	4
animal facilities	4
accession	4
crop	4
Sardinian accessions	4
stable SCAR markers	4
monomeric enzyme	4
6-PP production	4
fuels and chemicals	4
second generation ethanol	4
Amazon lichens	4
DPUA 1576	4
new markers	4
microsatellite loci	4
Clostridium butyricum DSP1	4
Crude glycerol	4
rapeseed oil	4
making of biodiesel	4
various by-products	4
renewable energy sources	4
plant extracts	4
SSH cDNA library	4
roots and leaves	4
banana ASR1	4
SjLys-C	4
aquaculture animals	4
sea cucumber lysozyme	4
rare species	4
Tibetan pig's intestine	4
cellulolytic bacterium	4
Tibetan pig	4
Peking duck FAS	4
Homo sapiens	4
simulated acid rain	4
acid rain	4
heterologous proteins	4
Kyoto Encyclopedia of Genes and Genomes (KEGG)	4
pEGFP-FST	4
germ line chimeras	4
interspecies germ line chimeras	4
anthocyanin and phenolic compounds	4
food sources	4
GR/CS/CPE	4
D. zingiberensis	4
co-culture system	4
main pigments	4
natural compounds	4
assimilable nitrogen	4
bioactive metabolites	4
Molecular markers	4
genomic DNA sequences	4
reducing agent	4
common ancestor	4
geographical regions	4
three SNPs	4
diverse tissues	4
CDIPT gene	4
muscle biopsy	4
right lower leg	4
elderly population	4
transcriptomics and metabolomics data	4
clinical prediction models	4
ear cartilage	4
long-lived species	4
rotarod test	4
MFGM-VR group	4
campaign	4
SED and LEX	4
foundress queens	4
vitamin B-12	4
hip fracture patients	4
colonic epithelium	4
complex IV	4
fly heads	4
one	4
informal caregivers	4
substances	4
Czech women	4
person	4
later life	4
younger cohorts	4
‘chronic’ group	4
underweight women	4
UK poultry flocks	4
O-antigen genes	4
Actinobacillus pleuropneumoniae	4
single BTV positive animal	4
EDTA blood samples	4
selected samples	4
plasmids	4
single strains	4
Fusobacterium necrophorum	4
M. hyorhinis	4
CC isolates	4
wild type (WT)	4
S. suis isolates	4
/C plasmids	4
broiler production chain	4
fetus	4
seven genes	4
control sheep	4
Israeli vaccine strain of A. centrale	4
vitro culture system	4
tick cell lines	4
floR gene	4
members of the Pasteurellaceae	4
either group	4
FIV-positive cats	4
Group 1	4
viral RNA genome	4
SSBP/1 scrapie	4
one isolate	4
UK pigs	4
known sequences	4
WWTP	4
Aspergillus flavus	4
immunocompromised hosts	4
Aspergillus spp.	4
honey bee larvae	4
OURT88/3 and mock-infected macrophages	4
low and high virulence isolates	4
African swine fever virus (ASFV)	4
rickettsial inclusions	4
IRE/CTVM20 cells	4
subtype C	4
red blood cells (RBCs)	4
domestic cats	4
complete genome sequences	4
original depositors	4
primary databases	4
Mhc and CMhp	4
erythrocyte-bound antibodies	4
eight groups	4
numerous cancers	4
Cholangiocarcinoma (CCA)	4
CG and FSH group	4
FSH group	4
six groups	4
flies	4
transgenes	4
aged	4
down-regulated genes	4
undesirable alleles	4
major histocompatibility complex (MHC)	4
maf1Δ mutant	4
QTL clusters	4
RyRs	4
identified markers	4
obese and lean individuals	4
Toll-like receptor 2	4
Toll-like receptors	4
cassette	4
transformed cells	4
ciliate Tetrahymena thermophila	4
Mexico City	4
Mexican population	4
Drosophila embryos	4
synaptic complex	4
long TIRs	4
Persian population	4
HPR rs2000999	4
nuclear extract	4
RecQ-like helicase	4
contralateral proximal blastemas	4
wild type promoter	4
haplogroups	4
TATA-box	4
TATA box	4
non-promoter sequences	4
pod tissues	4
single assay	4
driver genes	4
lung adenocarcinomas	4
one case	4
important targets	4
176 cases	4
HSDA model	4
erythrocytes	4
heat-stressed rats	4
many cancer types	4
cancer genome	4
HSC niches	4
perisinusoidal compartment	4
periarteriolar compartment	4
DNA methyltransferases	4
transcription factor binding	4
different instruments	4
veins	4
pro-inflammatory genes	4
enterococci	4
suf operon	4
cyanobacterium Synechocystis sp.	4
boomslang SVMPs	4
CroFab™ antivenom	4
BackgroundG-quadruplexes (G4s)	4
multiple sources of data	4
sequence variants	4
IscS-IscU complex	4
antibody glycoengineering	4
RT+100μM eGCG	4
electric field	4
insulator	4
external electric field	4
Keap1–Nrf2 pathway	4
human pathogen	4
key enzymes	4
trehalose-6-phosphate synthase	4
ADP-glucose	4
ADP-glucose pyrophosphorylase	4
JM-A dimer	4
protein data bank	4
promiscuity	4
cellular frequency decoding molecules	4
purified samples	4
oxidizing environment	4
pre-adsorbed sera	4
mouse embryonic fibroblasts	4
partial agonist	4
promising leads	4
Zn2+-binding	4
major protein component	4
mitochondrial hydrogen peroxide	4
reactive molecules	4
protein bands	4
vitro assay	4
lipophilic drugs	4
tert-butyl hydroperoxide	4
untreated population	4
new environment	4
C. daubneyi and F. hepatica	4
G. truncatula snails	4
non-infected control sows	4
humans and pigs	4
zoonotic parasite Taenia solium	4
quantitative PCR	4
quarantined animals	4
flock	4
lambs	4
respondents	4
sheep farmers	4
E. tenella populations	4
Ehrlichia/Anaplasma spp.	4
active compound	4
one genus	4
3 species	4
abundant species	4
IVM-PYR-IVM group	4
MOX-PYR-MOX group	4
ERP	4
resistant hosts	4
anthelmintic drugs	4
Ostertagia ostertagi	4
fraction	4
many parasite species	4
two pigs	4
brains	4
close circuit television cameras	4
Neurocysticercosis (NCC)	4
smallholder farmers	4
class of small RNAs	4
study site	4
tick-borne diseases	4
Advocate®	4
C. boehmi eggs	4
canine nasal capillariosis	4
5/6)	4
specific locations	4
definitive host	4
arrested larvae	4
somatic tissue	4
new drug targets	4
lectins	4
T. canis larvae	4
Foxp3+ CD4+CD25+ Treg cells	4
eggs in the environment	4
T. canis	4
two parasites	4
human toxocarosis	4
Toxocara canis	4
zoonosis	4
IgM antibodies	4
Toxocara canis and Toxocara cati	4
farmers	4
One goat	4
macrophages and fibroblasts	4
Onchocerca spp.	4
A. marginale	4
bovine anaplasmosis	4
one strain	4
COWP	4
six animals	4
2-g COWP bolus	4
six goats	4
indigenous South African goats	4
diagnostic tools	4
columnar epithelium	4
Barrett's metaplasia	4
acinar cells	4
acinar cell precursors	4
ductal cells	4
CMG helicase	4
organic solvents	4
surfactant proteins	4
DIO mice	4
zinc-bound ISCU	4
recombinant ISCU	4
sterol side-chain	4
affinity ligands	4
affinity chromatography	4
classical brown adipose tissue depots	4
enzyme active site	4
one-carbon donor	4
5-methyl THF	4
curly tail strain	4
website	4
constituent domains	4
N. benthamiana	4
ones	4
lysosomal alpha-galactosidase	4
ribosomal components	4
calcium ions	4
phylogenetic trees	4
respiratory chain	4
SCS	4
injured tissues	4
injured brain	4
11β-HSD1−/− mice	4
aortic rings	4
vascular smooth muscle cells	4
assumptions	4
cholesterol biosynthesis pathway	4
DNA structures	4
tyrosine residue	4
OPPh3 complexes	4
X-ray crystal structure	4
Bis-tris propane	4
BEDT-TTF	4
L–L	4
simulants	4
t-butylacetylide compound	4
oxygen atoms	4
H-bonds	4
peripheral circulation	4
cross-linker	4
CEN1HC-	4
human monocytes	4
ileum	4
encapsulated glutamine	4
gastrointestinal and pancreatic peptides	4
primary cultures	4
colonic L-cells	4
dietary fat	4
gut hormones	4
anterior pituitary	4
Aea-HP-1	4
broad-spectrum antibiotics	4
qualitative research	4
P. aeruginosa	4
closed beds	4
throat swabs	4
Surface contacts	4
geo-temporal clusters	4
Netherlands	4
health systems	4
viable virus	4
11 patients	4
low-income settings	4
M-CSF and GM-CSF	4
macrophages and dendritic cells (DCs)	4
IA1-activated PBMC	4
resting PBMC	4
Lyme borreliosis	4
206-2-4	4
206-2-4 and 201-6-8	4
Influenza virus	4
influenza A virus	4
Respiratory syncytial virus (RSV)	4
Peyer’s patches	4
c-Rel-deficient mice	4
bacterial membrane	4
hospitals worldwide	4
healthy mice	4
Heligmosomoides polygyrus	4
old DCs	4
many cells	4
transforming growth factor-β (TGF-β)	4
cases and controls	4
complement regulators	4
human DCs	4
important modulators	4
extracellular pathogens	4
cell surfaces	4
lectin pathway of complement	4
spatial networks	4
new mechanisms	4
topics	4
rapidly growing field	4
rare ones	4
global conservation community	4
emerging issues	4
unified framework	4
projects	4
cognitive theory	4
biological diversity	4
non-human animals	4
class-switched antibodies	4
Glioblastoma multiforme (GBM)	4
EU	4
various research areas	4
human induced pluripotent stem cells (hiPSC)	4
Experimental models	4
glial scar	4
fundamental principles	4
laboratory studies	4
paediatric patients	4
metallic nanoparticles	4
sample preparation	4
cells, tissues or biofluids	4
dosage forms	4
variety of tissues	4
messenger RNA	4
distantly related species	4
developing CNS	4
MCPH proteins	4
human intestinal epithelial cells	4
R. solanacearum	4
developmental regulators	4
grain yield	4
central metabolism	4
ions	4
crop plants	4
marginal environments	4
Golden Gate array	4
QTL	4
recombinant inbred lines	4
palmitic acid	4
nodosity	4
soluble sugars	4
promoter sequences	4
purified enzymes	4
phosphate buffer	4
enzyme preparations	4
valuable resource	4
terminology services	4
TC	4
EDGAR platform	4
complex microbial communities	4
kind of data	4
software package	4
RNA workbench	4
NBI)	4
mass spectrometry	4
graphical user interface	4
host cell proteins	4
3′ overhangs	4
multiple locations	4
three biological samples	4
Innate immunity	4
novel Innate Defense Regulator	4
ligninolytic fungi	4
3D cell culture	4
cell-lines	4
CRISPR/Cas9 technologies	4
DSB site	4
I-SceI	4
versatile puromycin-linker	4
functional peptides and proteins	4
CellTank	4
whole system	4
nanofiber adsorbents	4
normal and tumour tissue	4
liquid nitrogen	4
extracellular metabolites	4
chromatography resins	4
CTV-RNAi vector	4
D. citri	4
kinetic model	4
single IEMRs	4
complex molecules	4
co-evolved residues	4
respiratory motion phantom	4
breast/chest wall	4
mediastinal HL	4
curative setting	4
accumulated EUD	4
left ventricular segments	4
target areas	4
tumour	4
1 patient	4
intermediate and high doses	4
spine patients	4
spine fixation device	4
MR-linac	4
evaluable patients	4
whole breast radiotherapy	4
46 patients	4
HT3+	4
bone metastases	4
oral mucositis	4
various biotechnological applications	4
diverse applications	4
Imaging flow cytometry (IFC)	4
tumour microenvironment	4
large numbers of cells	4
computer science	4
biological components	4
antigen-presenting cells (APCs)	4
Escherichia coli or Saccharomyces cerevisiae	4
Nucleic acids	4
microbial organisms	4
hydrolytic enzymes	4
fluorescent dyes	4
β-galactosidase expression	4
bacterial infections	4
antibiotic-resistant bacteria	4
tests	4
positive samples	4
CT IgG antibodies	4
Ct DNA	4
M. furfur	4
E. coli chromosome	4
fluorescent chemical probes	4
bioreactor cultivation	4
DNA fragment	4
distinct subclades	4
single clade	4
Mhf, CMhm and CMt sequences	4
three systems	4
Mycobacterium leprae	4
overnight growth	4
single PCR fragments	4
viable cells	4
PCR assays	4
livestock industry	4
Fecal DNA	4
majority of genes	4
I942-regulated genes	4
TRP channels	4
implanting embryo	4
small interfering RNA	4
glioma cells	4
autophagy inhibitors	4
Two-pore channels (TPCs)	4
multiple human cancers	4
Cks proteins	4
mechanisms	4
dietary calcium	4
mitochondrial intermembrane space (IMS)	4
ubiquitously expressed	4
individual cardiomyocytes	4
Ralf Erdmann	4
subpopulation	4
drug transporters	4
three cell lines	4
cytoplasmic Ca2+	4
primary cortical neurons	4
binding proteins	4
Ulk3 kinase	4
signaling cascade	4
sumoylated proteins	4
wide range of proteins	4
functional unit	4
Molecular chaperones	4
human normal dermal fibroblasts	4
Wnt/β-catenin signaling pathway	4
TatA complex	4
(SOCE)	4
BBSome	4
anchor	4
Hsp90 complexes	4
cancerous tissue	4
cell survival	4
193gly-M-LDH	4
H9C2 cells	4
calcineurin/NFAT pathway	4
regulator of calcineurin 1 isoform 4 (RCAN1-4)	4
AIRE protein	4
catalytic domain	4
mutant parasites	4
bloodstream forms	4
encode proteins	4
remnant chloroplast	4
tetracycline inducible system	4
procyclic forms	4
nuclear exosome	4
enzymatic assay	4
subdomain 2	4
human malaria parasite Plasmodium falciparum	4
female and male gametocytes	4
bloodstage parasites	4
therapeutic drug target	4
Pf aldolase	4
type 1 membrane proteins	4
extended PRESAN domain	4
PHIST proteins	4
numerous proteins	4
single population	4
one clone	4
PbLAP4, PbLAP5 and PbLAP6	4
mammalian equivalent	4
several protozoan parasites	4
Malaria parasites	4
trypanosomal γH2A	4
T. b. brucei	4
pathway components	4
Apicomplexan parasites	4
Leishmania spp	4
known proteins	4
resulting peptides	4
Trypanosoma congolense	4
therapeutic compounds	4
host antibodies	4
single protein	4
mammalian host	4
RNAi pathway	4
Tudor-SN	4
trypanosomatid protein phosphatases	4
acetylated α-tubulin	4
asexual blood stage parasites	4
antimalarial drugs	4
B. bovis	4
multiple genotypes	4
orthologous enzymes	4
pathogenic species	4
infected red blood cells	4
T. brucei bloodstream form cells	4
T. brucei enzyme	4
trypanothione disulphide	4
hexose transporters	4
bloodstream-form Trypanosoma brucei	4
bloodstream form T. brucei	4
insect vector	4
individual flukes	4
phenylalanine	4
isotypes	4
RNA interference	4
model eukaryotes	4
female gametocytes	4
parasite life cycle stages	4
DBLα0-like domains	4
spotlight	4
patient’s immune system	4
certain other PKC isoforms	4
PKC-α	4
patients with RRTI	4
Lantigen B	4
transcription factor NF-κB	4
lung tissues	4
blood monocytes	4
soluble protein	4
C-type lectin receptors	4
draining lymph nodes	4
helminth parasites	4
ideal model system	4
asymptomatic pregnant women	4
nulligravid women	4
parous women	4
classical monocytes	4
subpopulations	4
HLA-C antibodies	4
cervical macrophages	4
human placenta	4
women with ectopic pregnancy	4
non-pregnant Fallopian tube	4
human endometrium	4
developing fetus	4
P. tricornutum	4
sufficient DHA	4
HDL particles	4
phosphatidylinositol 4-kinases	4
catalytic domains	4
3-hydroxydodecanoic acid	4
2-hydroxydodecanoic acid	4
dodecanoic acid	4
heme iron	4
side chain	4
metal site	4
caspase 9	4
DPP-IV	4
X-ray crystallographic structures	4
di-Fe(II)	4
ferrous iron	4
MCT formulations	4
different allergoids	4
type three secretion system	4
antivirulence drugs	4
metal complexes	4
two complexes	4
Cu(bpy)2 complex	4
solid Mg5(H2L)·22H2O	4
divalent cations	4
CD-1 mice	4
chip	4
single epitope	4
many antibiotics	4
gene of interest	4
different strains	4
genetic constructs	4
ArgR	4
inositol 1,4,5-trisphosphate receptors (IP3Rs)	4
meniscal hoop structure	4
biomimetic materials	4
rhBMP-2 alone	4
bone-like material	4
VCP/p97	4
films	4
collagen films	4
crosslinked collagen films	4
quiescent cells	4
fibroblast growth factors (FGFs)	4
platform technology	4
epicardium	4
research models	4
covalently attached molecular rotors	4
molecular rotors	4
FB-VEGF-C	4
new tissue	4
FN fibrils	4
fibronectin (FN)	4
ZHER2-ΔHBc particles	4
proliferative cells	4
retinal ganglion cells (RGCs)	4
target tRNAPhe	4
extracts	4
human mesenchymal stem cells (hMSCs)	4
macrophage cells	4
implanted cells	4
parallel microgrooves	4
extracellular matrix protein	4
human embryonic stem cells (hESC-CMs)	4
THP-1 cells	4
hAD	4
f-MWNT	4
astrocytes	4
Human mesenchymal stem cells (hMSCs)	4
biodegradable hydrogels	4
single units	4
neural interfacing	4
electrode material	4
neurite extension	4
ICDD-VEGF	4
anionic nanoparticles	4
presence of serum	4
unfolded α-synuclein	4
Al(OH)3 layer	4
NFC and HG hydrogels	4
spheroids	4
HepaRG liver progenitor cells	4
anionic formulations	4
rat brains	4
wear surface	4
myoblasts and myotubes	4
anisotropic myoblast sheets	4
complex tissue	4
gap	4
co-culture model	4
neuronal growth	4
engineered neural tissue	4
cell adhesion	4
neuroblastoma tumours	4
suitable scaffolds	4
self-supporting hydrogel	4
natural extracellular matrix	4
coatings	4
collagen	4
fibroblasts	4
mature human tendon fibroblasts	4
GADD45β/MKK7 complex	4
fibronectin and heparin	4
different sources	4
PREC fraction	4
l-gluco-heptulose	4
Deinococcus geothermalis	4
genome sequences	4
one-pot system	4
sphingolipids, antibiotics, and antiviral glycosidase inhibitors	4
Chiral amino alcohols	4
controlled environment	4
recombinant microorganisms	4
depressed patients	4
Docosahexaenoic acid (DHA)	4
novel mediators	4
septic patients	4
transmissible “stumpy forms	4
Sec61 translocon	4
flanking regions	4
dynamic microtubules	4
spindle poles	4
BLA-silenced rats	4
colonic mesenchyme	4
novel ligands	4
heparan sulfate (HS)	4
repressive RBPs	4
druggable target	4
popular drug targets	4
mammalian nervous system	4
reconstructions	4
main site	4
two cases	4
high-resolution structures	4
prostaglandin E2 (PGE2)	4
DNA-bound cohesin	4
dysfunctional telomeres	4
functional regions	4
Unfolded proteins	4
unfolded proteins	4
cellular protein degradation machinery	4
external stimuli	4
mosquito vector	4
metastatic sites	4
branched organs	4
innate macrophages	4
myelinating glia	4
epithelial progenitors	4
adult lung	4
mesenchymal cell types	4
metastatic lesions	4
P. berghei	4
cell wall of Mycobacterium tuberculosis	4
infected neurons	4
Cnn molecules	4
BRCA2 mutation carriers	4
nematode C. elegans	4
LTMR-RZ	4
paternal DNA lesions	4
paternal genome	4
DNA and histone modifications	4
decoding center	4
viral lineages	4
Aurora B kinase	4
active promoters	4
interacting regions	4
nearby genes	4
target locus	4
P site	4
originating breast cancers	4
pre-clinical models	4
VRC01-class bnAbs	4
broadly neutralizing antibodies (bnAbs)	4
specific cytokines	4
autoimmune regulator (AIRE)	4
mRNA 3′ ends	4
different data types	4
ER membrane	4
endosomal system	4
influenza	4
SummaryInfluenza virus	4
mammalian CNS axons	4
extrinsic signals	4
biased agonists	4
molecular memory	4
filter	4
major regulators	4
surrounding cells	4
PSM cells	4
presomitic mesoderm (PSM)	4
vertebrate embryos	4
motor proteins	4
DRN DA neurons	4
two parts	4
cohesin loader	4
kleisin subunit	4
NEC	4
outer nuclear membrane	4
inner nuclear membrane (INM)	4
Drosophila circadian clock	4
calcium and SOL protease	4
nuclear transport receptors (NTRs)	4
IFN-β	4
multisubunit complexes	4
lid	4
polyunsaturated fatty acids (PUFAs)	4
upstream regulators	4
nuclear FAK	4
regulatory T cells (Tregs)	4
distant regions	4
phosphorylation motifs	4
prostaglandin E2	4
regrowing axons	4
Ras-Erk-ETS signaling	4
ssDNA	4
RAD-51-ssDNA filaments	4
homologous duplex DNA	4
EVs	4
less malignant tumor cells	4
EVs in vivo	4
proteins, lipids, and nucleic acids	4
Pol II CTD	4
stable-bleb cells	4
genomic sequences	4
recently evolved enhancers	4
promoters and enhancers	4
whole organism	4
early human germline	4
primordial germ cells (PGCs)	4
culture systems	4
human liver	4
mammalian neocortex	4
mouse neocortex	4
40S subunit	4
initiator tRNA	4
eIF3 components	4
c-di-GMP	4
mammalian ribosome-Sec61 complex	4
viral proteins	4
CrPV-IRES	4
developmental signals	4
RNA polymerase II (RNAPII)	4
conventional kinetochore proteins	4
embryoid bodies	4
lipid biosynthetic enzymes	4
cues	4
target tissues	4
phenotypes	4
distinct signaling pathways	4
proteolytic sites	4
healthy flies	4
conserved site	4
contents	4
cell-cycle machinery	4
circadian system	4
small space	4
Drosophila species	4
closely related mammals	4
purified components	4
substrate-ligase interactions	4
yeast cell	4
Met1 linkages	4
SummaryThe linear ubiquitin (Ub) chain assembly complex (LUBAC)	4
interaction sites	4
3′ end	4
cellular debris	4
monocytes	4
intestinal microbiome	4
ubiquitin conjugates	4
polyubiquitin conjugates	4
interferon-γ	4
antigenic peptides	4
hnRNP C	4
human transcriptome	4
acetylated histone H4	4
replicating cells	4
unicellular organisms	4
Bone morphogenetic proteins (BMPs)	4
serum- and 2i-grown ES cells	4
growing microtubule ends	4
adult neurogenesis	4
hydrophobic insertions	4
clone	4
whole-genome sequences	4
distal neuronal compartments	4
RYBP-PRC1	4
vertebrate neural tube	4
many developing tissues	4
LC3-positive autophagosomes	4
preautophagosomal structures	4
double-membraned autophagosomes	4
intracytoplasmic contents	4
intramembrane proteases	4
female germline	4
oligomerization	4
insulin/IGF-like peptides	4
PG synthases	4
PtdIns4,5P2-containing membranes	4
repeat elements	4
oncogenic Ras	4
BRAF-selective drugs	4
oncogenic RAS	4
duplicated region	4
N- and C-terminal regions	4
SummaryDynein ATPases	4
p38δ null mice	4
cytoplasmic tyrosine kinases	4
cis-SNARE complex	4
VAMP7 longin domain	4
posterior	4
ER membranes	4
physical platforms	4
Eight genes	4
parasite-infected erythrocytes	4
human cancer cell lines	4
distinct clusters	4
N- and C-terminal domains	4
Hsp104 hexamers	4
cohort studies	4
environmental exposures	4
female patients	4
pustular psoriasis	4
skin inflammation	4
IL-23–induced psoriasis mouse model	4
animal studies	4
Animal models	4
IL-1β/IL-18	4
27 patients	4
identified clusters	4
Sap-deficient mice	4
epithelial IFN-α	4
type I interferon	4
pattern recognition receptors (PRRs)	4
robust tool	4
asymptomatic carriers	4
one of the genes	4
Signaling pathways	4
tumor model	4
gene-corrected Prf−/−	4
in vivo models	4
large granules	4
several cell types	4
stable COPD	4
patients with stable COPD	4
airway samples	4
reporter assays	4
birth cohort	4
breast-fed infants	4
16S rRNA gene sequencing	4
nondigestible oligosaccharides	4
antioxidant N-acetyl cysteine	4
unique model	4
healthy control neutrophils	4
T-cell receptor excision circles	4
normal skin	4
patients with AE	4
circulating basophils	4
2 innate lymphoid cells (ILC2s)	4
environmental stressors	4
skin barrier	4
serine/threonine kinase	4
children with STRA	4
IPF lung fibroblasts	4
microRNA (miR)-155	4
conventional antibodies	4
Recombinant antibodies	4
3 patients	4
potent inducer	4
commensal staphylococci	4
skin microbiome	4
Five patients	4
5 patients	4
airborne dust	4
lung DCs	4
patient groups	4
Long noncoding RNAs (lncRNAs)	4
induced Treg cells	4
phosphoinositide	4
ILC2-deficient mice	4
environmental pollutants	4
TSLPR KO mice	4
IL-13–producing ILC2s	4
group 2 innate lymphoid cells (ILC2s)	4
syncytial virus (RSV)	4
3 clusters	4
EIG	4
6 foods	4
standard introduction group	4
multiple allergenic foods	4
cis-UCA	4
FLG-null subjects	4
Western countries	4
year-of-birth cohorts	4
maternal geohelminths	4
hypotheses	4
3 families	4
component-specific IgE responses	4
HDM allergy	4
treated patients	4
healthy donors	4
4 patients	4
patients with WAS	4
SR asthma	4
induced sputum	4
mucosal-associated invariant T (MAIT) cells	4
regulatory T cells	4
TH17 cells	4
PS children	4
egg allergy	4
children with egg allergy	4
SOCS1-deficient mice	4
reporter genes	4
Cork Babies	4
respiratory allergies	4
wide range of genes	4
PCR array	4
peanut protein	4
specific IgE	4
Munc13-4	4
primary epithelial cells	4
peanut antigen in dust	4
biopsy specimens	4
IgE repertoires	4
3 subgroups	4
COPD predominant	4
sputum mediators	4
atopic subjects	4
IgG anti-IgE autoantibodies	4
peanut-sensitized but tolerant	4
large data set	4
gene encoding filaggrin (FLG)	4
multifunctional protein	4
intestinal cells	4
food allergens	4
preschool wheezing	4
rApi g 1.0101	4
cell-based assays	4
pulmonary eosinophilia	4
airways of mice	4
Cluster 1	4
additional tools	4
defective skin barrier	4
human gene	4
flaky tail mice	4
Type I interferon (IFN-I)	4
lymphocytic choriomeningitis virus (LCMV)	4
mTOR inhibitor rapamycin	4
allergic patients	4
human fibrocytes	4
positive cells	4
filaggrin mutations	4
filaggrin gene	4
filaggrin breakdown products	4
FLG-associated AD	4
pediatric eczema	4
early childhood	4
VA opsin	4
photopigment	4
GABAA receptors (GABAARs)	4
oscillator	4
adult CNS	4
comprehensive resource	4
DNA double helix	4
CG base pair	4
DNA duplexes	4
right ventricle	4
left ventricle	4
cognate antigen	4
sub-cellular domain	4
imaging technology	4
model species	4
Computational models	4
repolarization reserve	4
ischemic border zone	4
ischemic region	4
Macro-reentry	4
second messenger cAMP	4
Popdc proteins	4
S4–S5 linker	4
BRCA1 BRCT domains	4
protein–protein interaction interfaces	4
right-handed fibres	4
left-handed fibres	4
isolated hearts	4
Sprague–Dawley rats	4
WT hearts	4
Scn5a mRNA	4
embryonic stem (ES) cells	4
PHO-inhibited AChE	4
effective reactivator tested	4
Obidoxime Cl2	4
battery	4
carbonyl carbon	4
trifluoromethylphenyl amides	4
metazoan	4
osteoporotic patients	4
experimental groups	4
damaging agents	4
arrhythmic substrate	4
aged WT	4
ROS-NF-κB axis	4
bystander cells	4
mice models	4
murine genome	4
specific genomic loci	4
older participants	4
Older people	4
multiple models	4
guinea pigs	4
medications	4
various brain regions	4
Tg-ArcSwe mice	4
Fe(III)	4
> 	4
cord blood	4
school-aged children	4
glucocorticoid receptor	4
blood brain barrier	4
aromatase inhibitors	4
ouabain-like steroids	4
plant roots	4
lignin, chitin, and protein	4
gram-positive bacteria	4
atmospheric CO2	4
biomolecules	4
drought-exposed soils	4
mixed planting	4
rice paddy soils	4
microbial population	4
14C-glucose	4
aggregate fractions	4
soil aggregates	4
carbon dioxide (CO2) and methane (CH4)	4
Root exudate analogues	4
cropping systems	4
grassland soil	4
forest soil	4
15N tracer	4
air-dried soil	4
complex C	4
aggregate fraction	4
CO2	4
dry soils	4
labile C.	4
ectomycorrhizal fungi	4
certain sites	4
accurate modelling	4
urine patches	4
urine patch diffusional area	4
N2O emissions	4
diffusional area	4
forages	4
semi-arid soils	4
long-term additional crop residues	4
tilled soil	4
conceptual model	4
labile inputs	4
dry soil	4
girdled plots	4
roots	4
canopy	4
different components	4
service	4
alpine areas	4
mineral subsoil horizons	4
organic topsoil horizons	4
soil samples	4
horizons	4
SOM decomposition	4
EPS-polysaccharide	4
Pseudomonas spp.	4
soil-extracts	4
organic N mineralized	4
healthy community	4
diseased one	4
healthy network	4
healthy and diseased networks	4
soil microbial communities	4
bacterial ammonia oxidisers	4
Nitrosotalea devanaterra	4
dead mycelium	4
patients with SSc	4
fingertip and extensor DUs	4
DUPeriphery	4
DUCore	4
hand	4
small nerve fibers	4
vasomotor response model	4
infrared lamp	4
Small nerve fibers	4
vehicle and ZD6126-treated cohorts	4
vascular disrupting agent ZD6126	4
beige adipocytes	4
infrared thermography	4
healthy male volunteers	4
PCR products	4
saturated fatty acids	4
chylomicron remnants	4
dietary fats	4
different model systems	4
rectum cancer patients	4
Raman microspectroscopy	4
ABCFs	4
long mitochondria	4
AD fibroblasts	4
Ursodeoxycholic acid (UDCA)	4
citric acid cycle	4
multiple mutants	4
unspliced gRNA	4
major enzyme	4
ribonucleotides (rNMPs)	4
viral envelope protein	4
mRNA species	4
vertebrate sHsps	4
phase separation assays	4
two strains	4
protein tags	4
native ensemble	4
binding partner	4
biofilm matrix	4
C-terminal residues	4
isolated domains	4
Fibrillin microfibrils	4
stable complex	4
S-adenosyl-l-homocysteine	4
sterile alpha motif domain	4
peroxisomal membrane	4
specific areas	4
pre-initiation complex	4
helical filaments	4
tight dimers	4
YbAnbu subunits	4
HslV and 20S proteasomes	4
interactions	4
Functional assays	4
BamA barrel	4
thicker bilayers	4
gram-negative bacteria	4
truncated tau	4
additives	4
paired helical filaments (PHFs)	4
DiY-modified monomers and dimers	4
moderate inhibitors	4
3Q fibrils	4
Aβ40 fibrils	4
glycosaminoglycans (GAGs)	4
first high-resolution structures	4
conserved terminal loop of pri-miR-7	4
aggregation-prone regions	4
Cvt pathway	4
novel proteins	4
IL-13Rα1 and IL-13Rα2	4
tryptophan residues	4
web portals	4
eukaryotic genes	4
script	4
key interacting residues	4
form	4
human RAD51	4
constriction zone	4
H4K20me1-mintbody	4
classes	4
complex set	4
cysteines	4
bacterial pathogen	4
recycling cargo	4
bacterial effector proteins	4
Atg1/ULK1 kinase	4
protein aggregates	4
autophagic cargo	4
rest of the protein	4
repeat protein	4
hemichannel	4
intervening loops	4
variety of bacterial species	4
amyloid-like fibrils	4
circuits	4
new riboregulator	4
portions	4
catalytic machinery	4
FASII enzymes	4
facility	4
Protein Data Bank (PDB)	4
query protein	4
cytokine IL-22	4
adjoining sarcomeres	4
telomere	4
protein–protein interfaces	4
stop codons	4
kingdoms	4
C4 scFv	4
all-β Greek key proteins	4
7-oxo-SD8	4
central pore	4
unstructured C-terminal tail	4
PIDDosome core	4
RAIDD-DDs	4
intein	4
flanking sequences	4
adjoining cells	4
TJ strands	4
parts	4
intercellular spaces	4
baculovirus expression system	4
junction-resolving enzyme GEN1	4
Holliday junctions	4
helicases	4
protein-bound DNA	4
accessory replicative helicases	4
Replicative helicases	4
transcription complexes	4
template DNA	4
active chromatin	4
FLC loci	4
multiple layers	4
motor domain	4
Serine integrases	4
Web site	4
domain superfamilies	4
sequence similarity networks	4
DNA gyrase	4
Simocyclinone D8 (SD8)	4
CH2 domain	4
V-ATPase	4
key hub	4
trans-divalent streptavidin	4
tetramer domain	4
two states	4
substrate protein	4
integrin tails	4
adaptor proteins	4
muscle sarcomeres	4
amino-terminal domain	4
clamp loader–	4
holoenzyme	4
ClC chloride channels	4
usher	4
pore-forming toxin	4
actin polymerisation	4
heavy water	4
Solution structures	4
15 genes	4
several sources	4
linker sequences	4
arc	4
membrane vesicles	4
conserved architecture	4
p53-deficient cancer cells	4
pore-lining helices	4
α subunits	4
expressed protein	4
spikes	4
modified protein	4
immunodominant region	4
foreign epitopes	4
key intermediates	4
Serum IgG	4
Vibrio cholerae	4
two nucleases	4
sequence-directed nucleosome positioning	4
machineries	4
double-stranded DNA breaks	4
liposomes	4
diC12:0PC liposomes	4
multiple domains	4
chaperone proteins	4
periplasmic proteins	4
domain-swapped dimer	4
p53 family members	4
VapC toxins	4
toxins	4
antitoxins	4
range of specimens	4
non-natural substrates	4
various mutants	4
α-helices	4
A2AR-GL26	4
diffraction-quality crystals	4
p53 tetramer	4
DBD	4
protein structure	4
bioavailable zinc	4
protein–protein interface	4
drusen deposits	4
novel model	4
bottom sheet	4
fingers	4
acceptor proteins	4
annulus	4
rhomboid protease	4
hydrophilic cavity	4
different promoters	4
different locations	4
reading frame	4
new inhibitors	4
Ca2+ site	4
Langerhans cells	4
myosin filaments	4
site-directed mutants	4
membrane attack complex (MAC)	4
secondary structural elements	4
E192N variant	4
range of substrates	4
co-factors	4
β2-adrenergic receptor	4
two residues	4
Mn2+	4
α-ketoglutarate	4
consensus motif	4
nucleation sites	4
Collagen fibrils	4
rE2/E3BP	4
unfolded state ensemble	4
disulfide bond	4
small protein domains	4
ensemble of conformations	4
full-length PfEMP1	4
folding intermediate	4
polar groups	4
mRNA entry channel	4
small ribosomal subunit	4
eIF3j/HCR1	4
N-terminal half	4
eIF3 subunits	4
purified protein	4
surface of the protein	4
simple sugars	4
glycoprotein ligands	4
flexible tether	4
multiple repeats	4
insert	4
ligand-binding site	4
various environments	4
α-LA	4
C-helix	4
individual residues	4
DNA-binding domain	4
RelB dimers	4
intact VAR2CSA	4
DBL6ɛ	4
two mechanical sub-domains	4
external signals	4
Gram-positive bacterium	4
novel enzyme	4
capsular polysaccharides	4
capsule	4
R15 folds	4
NTS1-7m	4
receptor mutants	4
G-protein-coupled receptors	4
key regions	4
cryo-electron microscopy maps	4
modified RNA	4
RNA degradosome	4
DC-SIGN	4
CRDs	4
cell models	4
Z α1-antitrypsin	4
aromatic side chains	4
model substrate	4
tumour suppressor p53	4
helicase domain	4
HsdR subunits	4
trimeric autotransporters	4
respiratory epithelium	4
epitope peptide	4
feedback loops	4
β-sheet	4
C-terminal segment	4
present-day ribonucleases	4
Schiff base	4
extracellular loop 2	4
wildtype rhodopsin	4
deprotonated Schiff base	4
mixed disulfides	4
nearly all organisms	4
larger proteins	4
single domains	4
face	4
secretion apparatus	4
basal body	4
virulence proteins	4
drug binding site	4
structural basis	4
secretion systems	4
Helicobacter pylori	4
fibroblast growth factor receptor (FGFR)	4
rare examples	4
native and early-locked pathways	4
inner membrane	4
FliI ATPase	4
unchaperoned early and chaperoned late subunits	4
neighbouring genes	4
one site	4
DNA-binding cleft	4
bovine MHC-II-1	4
homologues	4
Q-loop	4
RNA binding protein	4
host plasma	4
regulatory systems	4
bound DNA	4
M subunits	4
multisubunit enzyme	4
salt bridges	4
recognition sites	4
two recognition sites	4
recognition sequence	4
three-helix bundle	4
helix II	4
developing hydrophobic core	4
resulting proteins	4
tight dimer	4
hemopexin domain	4
dynamic environment	4
RV	4
MCT + BB	4
cell monolayers	4
trigger	4
phosphoproteome	4
cell lysates	4
ARVM expressing GFP-B56δ-WT	4
serine/threonine phosphatases	4
human VSMCs	4
ER and mitochondria	4
FKBP8 knockdown H9c2 myocytes	4
TAC-operated Fkbp8−/− hearts	4
Fkbp8−/− mice	4
Brugada syndrome patient	4
neonatal rat cardiomyocytes	4
human atria	4
potassium channels	4
inner and outer membranes	4
altered haemodynamics	4
vitro cardiomyocyte model	4
thin filament	4
failing heart	4
adult mouse	4
damaged myocardium	4
zebrafish (Danio rerio)	4
fibrillar collagen	4
young animals	4
HCM models	4
aromatic residues	4
cell interior	4
failing myocytes	4
CAL myocytes	4
ICa-L	4
SR Ca2	4
HF atrial myocytes	4
CCN1 expression	4
wild-type littermates	4
tricarboxylic acid cycle	4
ventricles	4
functional dystrophin	4
SLIT3/ROBO4 pathway	4
Cardiac Myocytes	4
rat hearts	4
exogenous NO	4
Na/K-ATPase	4
sST2 protein	4
human heart	4
human myocardial tissue	4
IL-33 mRNA	4
ST2 receptor	4
IL-1 family of cytokines	4
Monte Carlo simulations	4
M2 receptors	4
individual receptors	4
Rrm1+Rrm2 overexpression	4
non-transduced cardiomyocytes	4
demembranated cardiac muscle	4
caveolar lipid rafts	4
intact cells	4
L-type Ca2+ current	4
genetic model	4
SAN cells	4
WKY control	4
grooming reflex	4
stressors	4
setal tracheal gills	4
haemolymph glucose	4
tasks	4
ls-tim	4
continents	4
stressful environments	4
Aedes aegypti	4
P. papatasi pk/pban gene	4
long and short forms	4
C-termini	4
essential amino acids	4
single amino acids	4
sucrose solutions	4
individual nutrients	4
solitarious locusts	4
stimuli	4
locusts	4
haemolymph	4
systemic hormone	4
neurotransmitter	4
invertebrates	4
chill coma	4
larval groups	4
them	4
tracheal system	4
MIA	4
ICT-EIAs	4
on-site	4
primary center	4
complex biological samples	4
Bcl2 transgene	4
players	4
developing lymphocytes	4
Fc Array	4
oral vaccine	4
promising adjuvant	4
MSD platform	4
regulatory agencies	4
32 countries	4
chemokine receptor CX3CR1	4
antigen-specific antibodies	4
NHP species	4
mononuclear leukocytes	4
extracellular vesicles (EVs)	4
infectious diseases	4
sero-diagnostic assays	4
bead	4
cell surface molecules	4
IgG antibodies	4
B-cell FluoroSpot assay	4
multiple analytes	4
peptide-specific T-cell clones	4
TCR complex	4
NF-κB, NFAT and AP-1 activity	4
NF-κB, NFAT and AP-1	4
multiple samples	4
purified antibodies	4
single animal	4
intrahepatic lymphocytes	4
global HIV-1 peptide microarray	4
human immunodeficiency virus type 1 (HIV-1)	4
motile cells	4
Foxp3+ iTreg cells	4
human sera	4
plastic surfaces	4
IMC LucR VIA	4
Stromal cells	4
heterogeneous populations	4
Escherichia coli periplasm	4
MILLIPLEX kit	4
kit	4
tissue samples	4
SFU counts	4
retrospective cohort	4
sera	4
mononuclear cells	4
anti-CD3	4
IL-2, IL-7 and IL-15	4
anti-CD28	4
lung tissue	4
sensitive assay	4
malaria vaccines	4
body region	4
hypothalamic-pituitary-adrenal axis	4
different fields	4
one sample	4
snowstorm	4
thyroid hormones	4
pre-nuptial molt	4
lean animals	4
control pigs	4
research facility	4
GnRH signaling system	4
number of animals	4
gonadal hormones	4
glucocorticoid hormones	4
neuroimmune system	4
physiological systems	4
reproductive hormones	4
LET and HET females	4
tammar wallaby	4
newborn	4
snow cover	4
pituitary gland	4
Oleic acid	4
reproductive system	4
institution	4
presumed unexposed controls	4
probe	4
EOMA conditioned media	4
filarial worms	4
long-term in vitro culture	4
filarial nematodes	4
province	4
cutaneous leishmaniasis	4
wastewater samples	4
ears	4
active moiety	4
procyclic form cells	4
bloodstream form Trypanosoma brucei	4
nascent protein	4
endemic regions	4
field samples	4
parasite DNA	4
tropical and sub-tropical regions	4
bovine babesiosis	4
reporter protein	4
apicoplast targeted proteins	4
bipartite signal	4
nuclear genome	4
mouse IgG1	4
major targets	4
IgG subclasses	4
vitro culture	4
endocytic system	4
resistant line	4
cDNA	4
short hairpin	4
hepatocellular carcinoma tissues	4
rare populations of cells	4
Ct cells	4
monolayer culture	4
3D sandwich	4
respective proteins	4
buccal epithelial cells	4
actin and microtubule cytoskeleton	4
cell-cell contacts	4
U2OS cells	4
bone formation	4
all-trans retinoic acid (ATRA)	4
adhesions	4
yeast Rfa2	4
plectin-deficient	4
nematode	4
endogenous and exogenous sources	4
Transcription factors (TFs)	4
ECs	4
Bcl-2 family proteins	4
intracellular signaling pathways	4
32D cells	4
NIH 3T3 fibroblasts	4
junctional actin	4
adhesion molecule	4
Desmoglein 3 (Dsg3)	4
proteasome inhibitors	4
chromosome arms	4
AO herbal extract	4
Low-Ki67 Low-HER2 subgroup	4
High-Ki67 Low-HER2 subgroup	4
AmRFamide-expressing cells	4
mesoglea	4
planula	4
myocardial growth	4
embryonic structures	4
tissue culture	4
eggs	4
sclerotome	4
vertebral column	4
sub-epidermal collagen	4
Pt-hh stripes	4
surface cells	4
embryonic field	4
cell-based field	4
neural crest-derived	4
neural stem cells (neuroblasts)	4
Grhl3 null embryos	4
excitatory neurons	4
epithelia	4
interommatidial cells	4
number of neurons	4
cross-reactive antibodies	4
muscle bulk	4
afferent neurons	4
intercellular junctions	4
resources	4
online database	4
several candidates	4
node	4
cortical plate	4
amyloid precursor protein (APP)	4
Model systems	4
new neurons	4
gene models	4
underlying regulatory networks	4
multiple gRNAs	4
different signalling pathways	4
many different cell types	4
normal intestine	4
early leaf and flower organogenesis	4
stores of glycogen	4
glycogen cells	4
transgenic model	4
single species	4
known regulators	4
seed yield	4
primitive erythrocytes	4
GFP reporter	4
neighboring genes	4
lncRNA transcripts	4
biological setting	4
critical effectors	4
GRNs	4
social amoeba Dictyostelium discoideum	4
classical models	4
cartilaginous fishes	4
oral teeth	4
chick embryo	4
marker	4
cartilage and bone	4
neural crest mesenchyme (NCM)	4
Z-disc	4
Imprinted genes	4
different mouse models	4
human ortholog	4
different studies	4
neuroepithelium	4
ventromedial neural plate	4
non-model organisms	4
fetal liver	4
Xenopus larvae	4
Xenopus system	4
exogenous RA	4
PCT	4
retinoic acid (RA) signaling	4
intermediate mesoderm (IM)	4
transcription factor Cdx2	4
pluripotent epiblast	4
groups of cells	4
whole cells	4
many labs	4
gene set	4
evolutionarily conserved genes	4
developing zebrafish embryo	4
early zebrafish embryos	4
Activin signaling	4
UGS mesenchyme	4
Staufen dsRNA-binding domain 5	4
oskar mRNA	4
embryonic gonad	4
hindgut	4
embryo proper	4
trophectoderm	4
non-coding DNA	4
paracrine signals	4
growth factor	4
flight apparatus	4
distal tubule	4
renal progenitor field	4
osteogenic genes	4
vascular network	4
enteric nervous system (ENS)	4
cerebellar primordium	4
two separate domains	4
5-methylcytosine (5mC)	4
Myf5 expression	4
Myf5 promoter	4
epaxial somite	4
guard hairs	4
touch domes	4
Xenopus chordamesoderm cells	4
mdx mouse model	4
S1PR3-null mice	4
Dermal fibroblasts	4
wounded skin	4
mouse epidermis	4
signalling pathway	4
nasal retina	4
Wnt genes	4
MII oocytes	4
F-actin-rich protrusions	4
mammalian oocytes	4
junctional complexes	4
lung epithelia	4
mammalian lung	4
tube	4
CRM	4
Notch pathway components	4
glutamatergic neurons	4
vertebrate head	4
E7.5 embryos	4
cellular and in vivo studies	4
new hair follicles	4
adult skin	4
chimeric mice	4
DP cells	4
cortical hem	4
Neural crest	4
cis-regulatory modules	4
LECs	4
tissues and organs	4
human blastocyst	4
rodent embryos	4
human blastocysts	4
human embryo	4
facial nerve	4
X. tropicalis genome	4
posterior segments	4
midbrain cells	4
midbrain–hindbrain boundary (MHB)	4
non-canonical Calcium/NFAT Wnt signalling pathway	4
PTC proteins	4
hindbrain boundaries	4
adhesion molecules	4
inner cells	4
hair follicles	4
important transcription factor	4
STAT92E regulated enhancers	4
tracheal primordia	4
sensory precursor population	4
antisense morpholino oligonucleotides	4
hybrid proteins	4
prespore cells	4
two transcription factors	4
Adriamycin-treated embryos	4
trachea	4
lens fulcrum	4
elongating epithelial cells	4
major structural protein	4
thick filaments	4
X. tropicalis	4
cleft palate	4
presomitic mesoderm	4
Cwe/Cwe animals	4
chromosome 12	4
tractable system	4
specific functions	4
hepatic endoderm	4
basal disc	4
dM-DIF-1	4
substratum	4
outer basal disc	4
polyketide DIF-1	4
atlas	4
vegetative cells	4
core complex	4
Drosophila wing	4
enhancers	4
control elements	4
specific tissues	4
exon 4	4
medial ganglionic eminence	4
transcription factor Tbr2	4
available assays	4
HDL2 and HDL3	4
homogeneous assay	4
acute phase proteins	4
Groningen cohort	4
T2DM subjects	4
2 independent cohorts	4
urinary tract	4
high-risk groups	4
BNP immunoassays	4
common calibrator	4
Cobas e411 assay	4
reference laboratory	4
C-peptide and insulin	4
three institutions	4
Abbott ARCHITECT assay	4
Roche ELECSYS assay	4
DiaSorin LIAISON assay	4
Serum samples	4
novel biomarkers	4
blood's DNase	4
nonanticoagulated plasma and serum	4
extracellular DNA	4
two NMR platforms	4
clinical laboratory setting	4
Elecsys Tacrolimus assay	4
CAD and control participants	4
Uygur population	4
embryonic origin	4
DR3ko mice	4
gut immune system	4
key players	4
capsular polysaccharide	4
Burkholderia pseudomallei	4
bovine serum albumin (BSA)	4
glycosidic bonds	4
Lytic polysaccharide monooxygenases (LPMOs)	4
efficient biocatalyst	4
non-reducing end	4
key molecules	4
main product	4
conversion tools	4
international glycan structure repository	4
membrane preparations	4
acceptor substrates	4
acceptor substrate	4
neutral oligosaccharides	4
non-reducing terminals	4
UDP-glucose pyrophosphorylase	4
conformational ensembles	4
competitive inhibitors	4
complex carbohydrates	4
CXC chemokine receptor 4 and sphingosine-1-phosphate receptors	4
biomolecular motors	4
in vivo system	4
ICM	4
ICM organoids	4
salt-and-pepper pattern	4
endocardial ridges	4
cardiac tissue	4
solid substrates	4
space	4
detergent micelles	4
Salmonella typhimurium	4
copolymers	4
coarse-grained molecular dynamics simulations	4
nonmuscle cells	4
regions of the protein	4
cSH2-SH3 linker	4
nSH2-cSH2 junction	4
tyrosine kinases	4
bond	4
vertebrate tissues	4
LH proteins	4
chromatosome	4
thin hydrogels	4
glass substrates	4
vascular networks	4
computational fluid dynamics	4
single living cells	4
intracellular calcium	4
outer leaflets	4
asymmetric vesicles	4
α-helical structure	4
new system	4
Wnt proteins	4
key protein	4
residue contacts	4
Photosystem II complex	4
thylakoid membrane	4
interaction interface	4
detergent	4
kinesin-5 subfamily	4
multiple subunits	4
-T	4
sub-sarcolemmal mitochondria	4
isolated cardiomyocytes	4
short-chain n-alcohols	4
stop codon	4
conformational ensemble	4
molecular environment	4
transcription factor Nanog	4
sensor	4
Mg2+ ions	4
β-hairpin	4
rProtein uL23	4
mechanical and chemical stimuli	4
custom software	4
many researchers	4
vascularized tissues	4
ParA-depletion zone	4
ParA ATPase	4
living bacteria	4
DNA-binding proteins	4
human T cells	4
several targets	4
similar systems	4
three phases	4
aggregated protein	4
human lysozyme	4
TOPP label	4
viral genomes	4
large RNAs	4
toolkit	4
outer leaflet	4
lipopolysaccharide molecules	4
astral microtubules	4
anterior-posterior axis	4
dimeric assembly	4
range of contexts	4
myelin sheets	4
actin-based cytocortex	4
vertebrate nervous system	4
human chromosomes	4
chromatin loops	4
multiple ITAMs	4
TCR ζ-chain	4
G-actin	4
membrane surfaces	4
MARCKS peptide	4
free PIP2	4
signaling lipid phosphatidylinositol-3,4,5-trisphosphate (PIP3)	4
thick fibers	4
Thin fibers	4
major structural component	4
freeze-dried samples	4
differentiated cell types	4
cytoskeletal network	4
experimental scenarios	4
electrophysiological cell models	4
online resource	4
particular model	4
many models	4
marker molecules	4
dye molecules	4
(KATP) channels	4
layer	4
distinct proteins	4
quiescent keratocytes	4
outer leaflet of cancer cells	4
convenient platform	4
magnetic fields	4
IDR	4
myosin heads	4
minority	4
four sites	4
SR	4
individual molecules	4
phenomenological model	4
cell nuclei	4
gray matter	4
aqueous phase	4
intracellular leaflet	4
extracellular	4
ryanodine receptor	4
ligand-bound receptors	4
macromolecules	4
FG Nups	4
coexisting liquid-ordered (Lo) and liquid-disordered (Ld) domains	4
inhomogeneous fluid solvation theory	4
RLC regions	4
light chain domains	4
isolated thick filaments	4
N-lobe	4
internal cavity	4
Bet v 1	4
northern hemisphere	4
ACTC E361G myofibrils	4
nontransgenic mouse myofibrils	4
myofibrils	4
protein kinase A (PKA)	4
deubiquitinating enzymes	4
charge transfer center	4
thioether linkage	4
deep tissues	4
excitable cells	4
molecular probes	4
erythrocyte	4
stator	4
stator cylinder	4
motor protein	4
object	4
yeast colonies	4
disulfide bridges	4
living cells and tissues	4
plugin	4
Ca2+ sparks	4
new structure	4
permeability barrier	4
cytoplasm and the nucleus	4
fibrillation modulators	4
clathrin-coated vesicles	4
membrane-bound compartments	4
minimal biophysical model	4
gene families	4
optimized binomial filter	4
negatively charged lipid headgroups	4
C2 domain	4
phosphatase domain	4
phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3)	4
3′ phosphate	4
camera	4
free solution	4
duplex RNA	4
-bound TnC	4
TM domain	4
SNARE complex	4
vesicle membrane	4
rat cardiomyocytes	4
normal hepatocytes	4
liver cancer cells	4
tumor-initiating cells	4
stem cells (CSCs)	4
BST2-deficient cells	4
C-terminal	4
RNA-seq data	4
certain RNAs	4
Colorectal cancer (CRC)	4
endocrine organ	4
(KO) mice	4
NAFL rats	4
chemical reagents	4
Drosophila Toll-1 receptor	4
efflux transporter	4
bone tissue	4
graphene-based materials	4
p21 and cyclin B1	4
molecular signaling pathways	4
tracer	4
standard model	4
YFP-tagged p62	4
PDAC cells	4
surrounding tissue	4
cleaved caspase 3	4
PBMC assay	4
donor samples	4
key cytokine	4
total N-glycoproteins	4
hexosamine biosynthesis pathway (HBP)	4
two components	4
reporters	4
undifferentiated NSCs	4
self-renewing multipotent stem cells	4
soft YRGDS fibers	4
chow diet group	4
SSB biosensor	4
TLR2 and TLR4 signaling	4
pattern recognition receptors	4
every sheet	4
chondrocyte sheets	4
Pex22p binding	4
cycling receptor protein	4
conserved cysteine residue	4
plant actin	4
Myosin XI	4
α5-containing laminins	4
peritrophic matrix	4
mutant proteins	4
resting cells	4
constitutively active GPCRs	4
HCN2 channels	4
membrane-bound proteins	4
PRM1 promoter	4
Euglena gracilis Z	4
ADAM9 ectodomain	4
selection medium	4
P29H(sp)B6 cybrids	4
tumors in B6 mice	4
mucus bundles	4
CLN025 and Trp-cage	4
SE-ADM system	4
CML patients	4
leukotriene pathway	4
different enzymes	4
target enzyme	4
human NPCs	4
cytoplasmic calcium	4
reactive oxygen species (ROS) generation	4
Human pluripotent stem cells (hPSCs)	4
stalk and clamp orientations	4
K. pastoris Pol II	4
macrophage	4
mucosal surface	4
S. oralis	4
Oral streptococci	4
B6 group	4
lethally irradiated recipients	4
Osteopontin (OPN)	4
gastrointestinal (GI) tract	4
ibuprofen arginate	4
lung epithelial cells	4
member	4
F344 rats	4
aortic aneurysm	4
appropriate experimental models	4
immunofluorescence staining	4
α-SMA	4
nucleophile	4
conserved tyrosine residue	4
apo-state	4
phage Ab libraries	4
pharmaceutical drugs	4
novel regulator	4
heart failure patients	4
HFD	4
high-fat diet (HFD)	4
hepatokine	4
intestinal lumen	4
Siglec-F	4
functional components	4
A549 cells	4
Mstn knockout rat model	4
epidermal keratinocytes	4
androgen receptor (AR)	4
Lys63/Met1-Ub hybrids	4
pregnant mice	4
human neuronal cells	4
psychoactive pharmaceuticals	4
pharmaceuticals	4
CHO cell line	4
core-6 fucose	4
inactive form	4
L443C/R905C	4
/S909C	4
first transmission interface	4
NBDs	4
wings	4
DRG cultures	4
repeat units	4
PP peptides	4
polypro helix	4
amphipathic peptides	4
short synthetic peptides	4
UC crypts	4
normal crypts	4
normal and UC crypts	4
Small molecule inhibitors	4
Aβ1-42 fibrils	4
unfolded monomer	4
Aβ1-42 oligomers	4
S2 cells	4
autolysosome	4
mitotic centrosome	4
PPAR-γ2	4
IPFP	4
potential regulator	4
IκB-ζ	4
T-cell subsets	4
5′ ends	4
mature mRNA	4
sEH inhibitors	4
brain microvasculature	4
Clostridium cluster XI	4
Starch and HFD groups	4
Starch group	4
contrast agent	4
small animal models	4
high serum	4
low serum	4
cells cultured	4
outer leaflet of the plasma membrane	4
membrane rafts	4
wild-type sequence	4
arginine residues	4
various biological specimens	4
high-resolution FTE system	4
unstained biological specimens	4
biological specimens	4
PIMT KO mice	4
ethanol-fed rats	4
isoaspartate-damaged proteins	4
cryogenic protein structures	4
Oct4 proteins	4
recombinant antibodies	4
zebrafish embryo	4
antisense RNAs	4
protein scaffold	4
nephron	4
methyl groups	4
precursor	4
mreB homologs	4
wall-less bacteria	4
retinal cells	4
Cyp46a1−/− mouse	4
oxysterol	4
24S-hydroxycholesterol	4
adult human serum	4
Girard P reagent	4
internal standard	4
vitamins D metabolites	4
25-hydroxyvitamins D	4
absence	4
extracellular region	4
short interfering RNA	4
CD9-HT1080 cells	4
autophagy/lysosomal pathway	4
atpgp1-2	4
INS-1E β-cells	4
target molecules	4
thromboxane mimetic	4
osteoclast precursors	4
population of cells	4
bone marrow cells	4
healthy muscle	4
wild-type counterpart	4
endogenous loci	4
genomic regions of interest	4
CRISPR system	4
possible signaling pathways	4
[8]-gingerol	4
class III PI3 K/beclin-1/Bcl-2 signaling pathways	4
subset of tissues	4
poly(I:C)	4
beta cells	4
junctional membranes	4
pancreatic islet cells	4
neo-glycoproteins	4
Entamoeba histolytica	4
intestinal mucins	4
nonphosphorylatable forms of Drok	4
insect ORs	4
molecular targets	4
310 helix	4
peptide-binding site	4
design	4
Bile acids	4
Tln2cd/cd mice	4
mannose residues	4
chromatin fibres	4
HCT116 cells	4
transcriptional corepressor	4
human endothelial cells	4
new variant	4
β-cells	4
serine residue	4
fusion	4
enhanced green fluorescent protein	4
three subtypes	4
human placental trophoblast	4
secretory and endocytic pathways	4
several small GTPases	4
prenylated proteins	4
conserved cysteine residues	4
obese dams	4
lean dams	4
pancreas and liver	4
PML bodies	4
tested miRNAs	4
mineralocorticoid receptor gene NR3C2	4
excellent model system	4
30S ribosome	4
stem region	4
lean subjects	4
activin B	4
Male Wistar rats	4
trans-Golgi network (TGN)	4
CaBPs	4
GTPases	4
E. coli HflX	4
zebrafish heart	4
single myocytes	4
human monocytic cells	4
minus end of actin filaments	4
human NAT1	4
adenovirus	4
cultured endothelial cells	4
endothelial NO synthase (eNOS)	4
selectivity filter	4
ion	4
two binding sites	4
charged rings	4
PEG linkers	4
lipid analogs	4
SC lipid matrix	4
cardiolipin binding sites	4
mitochondrial inner membrane	4
helical bundle	4
transient pores	4
larger pores	4
Pablo V. Escribá	4
individual ceramide species	4
50μM)	4
epidermis and dermis	4
bioactive lipids	4
sphingoid bases	4
dermis and epidermis	4
lipase	4
related enzymes	4
triglyceride surfaces	4
folded protein	4
placental syncytiotrophoblast	4
Membrane Proteins	4
capsid	4
Enveloped viruses	4
plasma membranes of living cells	4
spectra	4
cytoplasmic domain	4
pentameric channel	4
magnesium ions	4
negatively charged lipids	4
Hepatitis C virus (HCV)	4
solid substrate	4
extracellular polymeric substances (EPS)	4
silicon oxide surface	4
well-ordered crystals	4
damaged membrane lipids	4
intracellular membranes	4
original model	4
specialized membrane domains	4
basic model	4
N-terminus of TMEM16A	4
wounds	4
healthcare services	4
zfP2X4.1 crystal structure	4
extracellular domains	4
PAT2-expressing oocytes	4
transported substrates	4
β-alanine	4
H+-electrochemical gradient	4
porcine milk	4
stable isotopes	4
healthy young adults	4
endogenous Apaf-1	4
apoplast	4
cysteine sensors of Keap1	4
sulfhydryl groups	4
NF-E2 p45-related factor 2 (Nrf2)	4
Zn(II)	4
zinc ions	4
Ca2+-sensitivity	4
transgenic mouse	4
troponin	4
hardware and software	4
mouse skeletal muscle	4
L. monocytogenes	4
chlorite dismutase-like protein	4
Chlorite dismutase-like proteins	4
young healthy subjects	4
visual stimulus	4
native structures	4
non-native species	4
research tool	4
DUP4 variant	4
cilium	4
candidate locus	4
bi-allelic variants	4
tRNA synthetases	4
40 individuals	4
conditional eQTL	4
fibroblasts and skeletal muscle	4
one affected individual	4
nuclear foci	4
COUP-TF2	4
genetic models	4
cell-cycle genes	4
spectrum	4
important pathways	4
connective tissue	4
mammalian central nervous system	4
Levant	4
Canaanites	4
Bayesian framework	4
low-frequency variants	4
endolysosomal pathway	4
synaptic membrane proteins	4
synaptic proteins	4
fibroblast growth factor	4
cytoplasmic vacuoles	4
swollen mitochondria	4
gene(s)	4
Krebs cycle	4
immediate precursor	4
Eurasian ancestry	4
humans	4
homozygous knock-in mice	4
exon 1	4
affected tissues	4
developing enamel matrix	4
heterotetramer	4
classical complement pathway	4
mapped locus	4
families)	4
carrier	4
respiratory chain complexes	4
human breast cancers	4
normal breast tissues	4
relevant tissues	4
20 loci	4
one variant	4
inorganic pyrophosphatase	4
many individuals	4
structural subunits	4
endometrial tumors	4
Hh signaling	4
several tumors	4
metabolic centers	4
Streptococcus pneumoniae	4
de novo	4
subject 1	4
mt-tRNAs	4
Neandertal and modern human Y chromosomes	4
three unrelated individuals	4
direct transcriptional repressor	4
unrelated affected individuals	4
killer cell immunoglobulin-like receptors (KIRs)	4
Cys282Tyr homozygotes	4
two real datasets	4
test SNP	4
parent	4
risk alleles	4
common diseases	4
PubMed abstracts	4
annotations	4
genetic and epigenetic information	4
five families	4
multivariate model	4
HLA region	4
particular gene	4
E2 ubiquitin-conjugating enzyme	4
ExSpe U1s	4
different cellular models	4
shared pathways	4
shared loci	4
one individual	4
Greenlanders	4
modification	4
affected siblings	4
p.Ile482Lys)	4
three individuals	4
European descent	4
Gln67del variant forms	4
genetics centers	4
luciferase assays	4
condition	4
two unrelated individuals	4
admixed individuals	4
dynein intermediate chain	4
9 families	4
IFT proteins	4
specific molecules	4
nephronophthisis-related ciliopathy	4
two subjects	4
Drosophila model	4
LCT enhancer region	4
unaffected parents	4
GDP-mannose	4
14 genes	4
whole human genome	4
founder haplotypes	4
target tissue	4
Next-generation sequencing (NGS)	4
ion channel	4
179 individuals	4
ubiquitin/proteasome system	4
genome-wide SNPs	4
disorder	4
three loci	4
six loci	4
respiratory cilia	4
enamel organ	4
tooth enamel	4
single variants	4
European ancestry	4
acetylcholine receptors	4
five individuals	4
HapMap Project	4
trait-associated loci	4
either cohort	4
brain function	4
anterior chamber of the eye	4
OA cases	4
syndrome	4
rod opsin	4
exon 3	4
RPGR gene	4
large deletions	4
deletion	4
23 patients	4
human growth	4
ALSPAC cohort	4
Avon Longitudinal Study of Parents and Children (ALSPAC)	4
Norrin-β-catenin signaling pathway	4
signaling complex	4
FEVR genes	4
extracellular ligands	4
plasma membrane receptors	4
hundreds of genes	4
maturation-stage ameloblasts	4
POS-RPE junction	4
cone and rod photoreceptors	4
healthy humans	4
Lebanese Muslims	4
detectable DNA	4
S. stercoralis	4
places	4
VL cases	4
study areas	4
quintuple mutant	4
uncomplicated malaria	4
index patient	4
new leprosy patients	4
T. solium cysticerci	4
T. solium cysts	4
prevalent species	4
species complex	4
Female mosquitoes	4
malaria vectors	4
treated nets	4
net	4
particulate matter	4
field-caught DENV-infected Ae.	4
field-caught Ae	4
main vector	4
vector species	4
Leishmania DNA	4
Indian sub-continent	4
endemic area	4
human and pig infections	4
taeniasis and porcine cysticercosis	4
porcine cysticercosis	4
insect pests	4
surveillance systems	4
rare diseases	4
domestic dogs	4
heterozygous SNPs	4
government support	4
Mesocyclops program	4
Ethiopian vvIBDVs	4
commercial and breeding poultry farms	4
trematodes	4
newly excysted juveniles	4
salivary glands	4
NGC antigen	4
diagnostic tests	4
endemic region	4
haplotypes	4
P. vivax populations	4
Lutzomyia longipalpis	4
tsetse species	4
Glossina morsitans morsitans	4
enzyme loci	4
established biomarker	3
baby	3
DNA repair machinery	3
20 patients	3
land plants	3
enzyme hyaluronidase	2
large epidemiological cohorts	2
human breast milk	2
livestock science and related fields	2
YAL group	2
Subdividing articles	2
largest group	2
surveyed group	2
quantitative scale	2
six most prominent livestock journals	2
(225) RT-qPCR articles	2
Livestock science	2
experimental condition/sample set	2
set of stably expressed internal control genes (ICG)	2
Reverse-Transcription quantitative PCR (RT-qPCR)	2
CASP9 Ex5 +32G	2
>G	2
_G	2
two haplotypes G_C_del (+)	2
promoter and exonic polymorphisms	2
age and gender-matched healthy individuals	2
Nizams Institute	2
999 individuals	2
Ex5 +32G>A) regions of CASP9 gene	2
T, -293 del)	2
mitochondrial-mediated apoptotic pathway	2
initiator caspase	2
Caspase 9	2
downstream pathways	2
catalytic copper center of pMMO	2
pMMO monomer	2
metal-deficient membrane fraction	2
divalent metal cations	2
exogenous copper ions	2
two different reductants, nicotinamide adenine dinucleotide (NADH) and 2,3,5,6-tetramethyl hydroquinone (duroquinol)	2
bacterial cell membrane components	2
membrane fraction	2
Methylosinus trichosporium OB3b	2
particulate methane monooxygenase (pMMO)	2
chelating reagent, ethylenediaminetetraacetic acid (EDTA)	2
IL2 field	2
presently expanding repertoire of immuno-oncological targets	2
novel, engineered IL2 formats	2
certain patient subpopulations	2
patients with metastatic renal cell carcinoma and metastatic melanoma	2
promising cancer therapeutic	2
labeled extracellular elements	2
cell microenvironment	2
Collagen VI and fibronectin	2
cells remodel ECM	2
ECM networks	2
thick cell regions	2
collagen VI fibril organization	2
native-like context	2
major fibroblast ECM components	2
matrix microenvironment	2
resulting ECM architecture	2
ECM precursors	2
Cells and extracellular matrix (ECM)	2
P-Rex selective compounds	2
PH domain	2
1.9 Å crystal structure	2
P-Rex2 pleckstrin homology (PH) domain structure	2
breast cancer and melanoma	2
P-Rex1 and P-Rex2	2
subset of small GTPases	2
Rho guanine-nucleotide exchange factors	2
P-Rex family	2
smaller phenylalkylamines	2
stationary phase surface	2
water solvated binding sites	2
open ligand structure	2
phenylalkanols and phenylalkylamines	2
DFT simulation	2
BDC8 ligands	2
less hydrophobic surface	2
open brush-like state	2
perfluoroC8 ligands	2
individual perfluoroC8 ligand chains	2
BDC8 stationary phase surface	2
potential ANP binding sites	2
bidentate-anchored C8 ligands	2
hydrophobic surface	2
adjacent BDC8 ligands	2
two stationary phases	2
immobilised ligands	2
linear solvation energy concepts	2
mobile phase	2
aqueous normal phase (ANP) mode (i.e.	2
BDC8, stationary phase	2
PerfluoroC8	2
BDC8 stationary phase	2
aqueous-acetonitrile (ACN) mobile phases	2
n-alkyl chain length	2
homologous phenylalkanols and phenylalkylamines	2
Perfluorinated C8-(PerfluoroC8) and bidentate anchored C8-(BDC8)-modified silica hydride stationary phases	2
onsite biodefense screening tool	2
BoNT-A and BoNT-B in PBS	2
spiked human serum	2
two neurotoxins	2
powdered matrix	2
biocompatible solvent	2
neurotoxins in phosphate-buffered saline (PBS)	2
“white powder” threat	2
gold nanoparticle labels	2
(BoNT-A) and serotype B (BoNT-B)	2
inactivated Clostridium botulinum neurotoxin serotype	2
Botulinum neurotoxins (BoNTs)	2
diabetes medicines	2
multivariate logistic regression model	2
Glycated hemoglobin	2
sources of diabetes treatment medications	2
Additional questionnaires	2
2 tertiary, 2 district and 1 rural hospital	2
five health facilities	2
1226 participants with T2DM enrolled	2
Ghanaians with T2DM.MethodsA cross-sectional study	2
myriad cellular systems	2
‘clock gene’ transcriptional circuits	2
‘Biological clocks’	2
male and female patients	2
circadian biology	2
BCL-2-regulated apoptotic pathway	2
interconnected hierarchical network of interactions	2
BCL-2, BCL-XL, and MCL-1	2
BAX and BAK	2
BH3-only molecules	2
third BCL-2 subfamily of proteins	2
anti-apoptotic BCL-2, BCL-XL, and MCL-1	2
essential effectors	2
Multidomain pro-apoptotic BAX and BAK	2
mitochondrial outer membrane permeabilization (MOMP)	2
Theoretical models	2
available channels	2
ion channel gene	2
nervous systems	2
one set of channels	2
Coexpressed channel types	2
rich toolbox	2
wide variety of ion channels	2
stored Ca2+	2
ligand-regulated pathway	2
RyR	2
largest intracellular ion channels	2
Ryanodine receptor Ca2+ release channels (RyR)	2
non-myocyte resident cells	2
collagen scar	2
neonatal heart	2
Multiple resident cell types	2
mariculture of sea cucumbers	2
immune enhancer	2
A. japonicus	2
intestine, tentacles, peristome and coelomic fluid	2
lysozyme activity	2
acid phosphatase	2
1.5% and 3% HCT addition groups	2
A. japonicus coelomocytes	2
intestine, tentacles, peristome, and coelomic fluid	2
HCT powder	2
sea cucumber, Apostichopus japonicus	2
feed additive	2
aquaculture systems	2
Chinese herb Houttuynia cordata Thunb (abbreviated as HCT hereafter)	2
354 caught	2
1 fish	2
released fish	2
release location	2
temporary net cages	2
low tide area	2
recaptured individuals	2
release point	2
recaptured fry	2
plastic tags	2
Released fish	2
released fry	2
high flow area	2
released fishes	2
test species	2
Sparus microcephalus	2
species’ local populations	2
plentiful food and rocky reefs	2
sea area	2
fish-conditioned water	2
first four fractions	2
male-specific activity	2
samples some fractions	2
males and females	2
potent extract	2
potent odorants than females	2
electro-olfactogram	2
male- and female-conditioned water	2
males attracted females	2
Male-released odorants attracted females	2
isolated females	2
males ovulated	2
females ovulated	2
chemical contact	2
steroids and their metabolites	2
reproductive context	2
male-released odorants	2
reproductive pheromones	2
polar lipids)	2
essential fatty acids from diets in larval tissues	2
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)	2
Copepod nauplii	2
Eurytemora herdmani	2
St. Lawrence estuary	2
two of the main species of copepods	2
Nauplii of Eurytemora spp. and Acartia sp.	2
two live prey	2
copepods and rotifers	2
winter flounder larvae	2
larval rearing	2
live prey	2
many marine fish larvae	2
main natural food	2
estuarine and coastal areas	2
wide range of salinities	2
S. ommaturus	2
freshwater group	2
Serum osmolality	2
gill Na+/K+-ATPase activity	2
528 	2
juveniles in each tank	2
L tanks	2
juvenile fish	2
spottedtail goby Synechogobius ommaturus	2
wastes in different culture systems	2
fish culture	2
sources of wastes	2
feed, chemicals, and pathogens	2
different culture systems	2
sources, components	2
aquaculture wastes	2
aquaculture products	2
waste products	2
aquaculture production systems	2
fish and feed per unit culture area	2
increased inputs	2
production and developmental sectors	2
land and water	2
natural resources	2
different stocks of D. gigas	2
gladius microstructures	2
equatorial waters	2
statoliths	2
stem and lateral plate	2
Gladius increments	2
sex-specific energetic allocations	2
gladius parts	2
power model	2
gladius growth increments	2
tropical Pacific Ocean	2
geographic stocks of the jumbo squid (Dosidicus gigas)	2
somatic growth	2
pelagic squid	2
accepted hard tissue	2
small-scale fisheries sector	2
adequate infrastructural facilities	2
Arius heudeloti and Shrimp: Nematopalaemon hastatus)	2
fish losses (Croaker: Pseudotolithus elongatus, Catfish:	2
storage and transportation facilities	2
Regression model	2
storage facilities	2
covering facilities	2
fishermen	2
5 viable fishing communities	2
three (3) dominant marine fish species	2
wt1a homozygous mutants	2
wt1a-mutated embryos	2
wt1a mutants	2
P62 and LC3A/B	2
wt1b morpholino knockdown embryos	2
homozygous wt1b mutants	2
podocyte differentiation	2
yolk sac edema	2
pericardial edema	2
homozygous wt1a mutants	2
wt1 genes	2
wt1b	2
two wt1 genes	2
Wilms tumor protein (WT1)	2
glomerular filtration barrier	2
essential elements	2
cell membrane of S. putrefaciens	2
structure of bacterial cells	2
scanning electron microscope (SEM)	2
bacteria, alkaline phosphates activity (AKP)	2
growth of bacteria	2
sterile distilled water	2
tryptic soy broth (TSB) medium	2
2MIC	2
refrigerated pomfret	2
spoilage bacteria (Shewanella putrefaciens and Saprophytic staphylococcus)	2
Ginkgo biloba leaf extracts (GBLE)	2
QTL regions	2
124,419 SNP markers	2
significant SNPs	2
important maricultured fish species	2
large yellow croaker (Larimichthys crocea)	2
kidney, gill, and liver tissues	2
dietary EU	2
kidney, gill, liver, spleen, and blood tissues	2
Nrf2 gene	2
Grass carp	2
hydrophilic and non-secretory protein	2
predicted Nrf2 protein	2
593 amino acids	2
full-length of Nrf2 gene of grass carp	2
Nrf2 gene in tissues	2
Eucommia ulmoides (EU)	2
Nrf2 proteins	2
Nrf2 gene of grass carp	2
complete cDNA sequence	2
mollusc taxa	2
bivalve species	2
R. decussatus TLRs	2
protein domain organization	2
membrane receptors	2
genes of the C1q domain-containing protein family	2
146 immune-related genes	2
tumor necrosis factors (15) and toll-like receptors (TLRs, 10)	2
C1q domain-containing proteins (63)	2
contigs	2
132 contigs	2
Illumina platform	2
eight R. decussatus individuals	2
Pooled mantle samples	2
immunological repertoire of R. decussatus	2
one of the main native bivalve species	2
grooved carpet-shell clam Ruditapes decussatus	2
different sediments/organism scenarios	2
benthic organisms in sediments	2
V. philippinaram	2
DGT film	2
zeolite-amended sediments	2
Cu, Pb, Cd, Cr and As in V. philippinaram	2
sediment pore water	2
Cu, Pb, Cd, Cr and As	2
Venerupis philippinaram	2
restorative material	2
natural zeolite amendment of sediments	2
sea bass	2
growth, metabolic and the stress axis	2
endocrine regulatory pathways	2
liver, muscle and brain	2
sea bass genome	2
brain, liver and muscle	2
47.071 unique transcripts	2
SAGE library	2
11 million edited tags	2
6 individuals of the first and last quartile	2
divergent sustained SGR	2
brain, liver and white muscle	2
group of hatchery bred sea bass individuals	2
European sea bass (Dicentrarchus labrax)	2
application C. quadricarinatus	2
decapod Crustacea	2
Differentially and uniquely transcribed genes of the retina	2
C. quadricarinatus ocular transcriptome	2
X-organ Sinus Gland complex, hemiellipsoid body and optic nerve)	2
basal, non-pigmented neuroendocrine ocular tissue	2
ommatidia and lamina ganglionaris)	2
outer, pigmented retinal tissue	2
retinal section of the Cherax quadricarinatus (red-claw crayfish) eye	2
adult arthropod eye	2
exoskeleton	2
fruit fly Drosophila melanogaster	2
arthropod species	2
ARA, DHA and EPA	2
stinger gonad high-unsaturated fatty acids (HUFA)	2
lipid class-specific	2
stinger broodstocks	2
gonad and muscle of both male and female stinger	2
polar lipids (PL)	2
stinger liver	2
neutral lipids (NL)	2
female stinger liver	2
tissues (ovary, testis and muscle) in both male and female stinger	2
Wild-caught devil stinger	2
different tissues (gonad, liver and muscle) of the wild-caught devil stinger	2
S. constricta	2
dsRNA	2
clams	2
Sc-EGFRs	2
EGFP-N1 control	2
intracellular region	2
typical extracellular region, transmembrane region	2
siphon	2
Sc-EGFR isoforms	2
one form	2
common gene	2
2 isoforms	2
coding region of Sc-EGFRs	2
Sinonovacula constricta	2
two EGFR isoforms (Sc-EGFR-1a and Sc-EGFR-1b)	2
saprolegniasis pathogens	2
CP and S. hypogyna (96%); and S2, L5, ATCC200013 and S. salmonis	2
isolates S1 and S. australis	2
S. bulbosa and S. oliviae	2
S. diclina, S. longicaulis, S. ferax, S. mixta, and S. anomalies	2
Isolates 02 and LP	2
CLADE2 (S1), and CLADE3 (CP, S2, L5 and the reference ATCC200013)	2
eight isolated strains	2
neighbor-joining (NJ) and maximum parsimony (MP) phylogenetic trees	2
internal transcribed spacer (ITS) ribosomal DNA (rDNA)	2
Chinese regions	2
Saprolegnia infection	2
otter-boards	2
single-slotted otter-board	2
otter-board model	2
three otter-board models	2
coefficients	2
engineering models	2
single-slotted cambered otter-board	2
main-panel angle	2
Hsp proteins	2
mantle, adductor muscle, gills and hemocytes	2
mantle, adductor muscle and hemocytes	2
digest gland, gills and heart	2
Hsp90	2
clam Paphia undulata	2
full-length cDNA of the heat shock protein 90 (PuHsp90)	2
group of molecular chaperones	2
natural habitats	2
fish assemblages	2
SIS	2
individual fish (y)	2
small sized species	2
individual fish species	2
different fish species	2
fish markets	2
abundance and biomass of fish species	2
ensemble of different fish species	2
small indigenous fish species (SIS)	2
immunity genes	2
poly(I:C)-challenged RBCs	2
C)-challenged WBCs and irf (1, 3, 4, and 9) and tlr3	2
poly(I:	2
WBCs and RBCs	2
immune genes (interferon regulatory factors (irf) 1–5 and 9 and tlr3)	2
RBCs and WBCs	2
immune system pathways	2
809 transcripts	2
3251 transcripts	2
20.876 transcripts	2
numerous mitochondria and lysosomes in tilapia RBCs	2
Fluorescent staining	2
teleost fish, Nile tilapia (Oreochromis niloticus)	2
immune-related genes and responses	2
RBCs	2
circulatory system of vertebrates	2
abundant cell types	2
erythrocytes or red blood cells (RBCs) and leucocytes or white blood cells (WBCs)	2
diets with cork supplementation	2
microball and vermiculite (3%–5%)	2
dietary cork	2
5% microball group	2
increasing buoyant materials	2
intestinal walls	2
buoyant materials supplemented groups	2
P 	2
diets and feces	2
Dietary cork	2
microball- and vermiculite-fed groups	2
cork-fed groups	2
3% vermiculite	2
tilapia juveniles	2
450–830 μm)	2
three buoyant materials with coarse particles	2
tilapia fry	2
250–450 μm)	2
expanded vermiculilite fine particles	2
expanded and vitrified microball	2
ten diets	2
positively buoyant dietary materials	2
lower vertebrates	2
aforementioned viruses	2
frogs, giant salamanders, fish, and so on	2
aquaculture animals and wild lower vertebrates	2
ranavirus (e.g., Rana grylio virus, RGV and Andriasd avidianus ranavirus, ADRV), herpesvirus (e.g., Carassius carassius herpesvirus, CaHV), reovirus (e.g., grass carp reovirus 109, GCRV-109, Scophthal musmaximus reovirus, SMReV and Micropterus salmoides reovirus, MsReV), and rhabdovirus (e.g., Siniper cachuatsi rhabdovirus, SCRV and Scophthal musmaximus rhabdovirus, SMRV)	2
emergent and resurgent viruses	2
Aquatic vertebrates	2
two animal groups	2
fish kidney cells	2
GSK cells	2
vacuoles and swollen mitochondria	2
pale or lightly stained cytoplasm	2
shrunken CIK cells	2
cytoplasmic vacuole	2
CIK and GSK cells	2
fish and amphibian cells	2
different mediums	2
freshwater grass carp (CIK) and Chinese giant salamander (GSK)	2
kidney cell line	2
aquatic and terrestrial environments	2
dried fish vendors from D. maculatus and other pestiferous species	2
C. nigrodigitatus	2
D. maculatus infestations (larval, adult) was H. bidorsalis	2
fish vendors	2
dried fish vendors	2
Ipata market	2
D. maculatus larvae and adults	2
dried fish species	2
Dermestes maculatus Degeer-infested specimens of dried Chrysichthys nigrodigitatus, Heterobranchus bidorsalis and Oreochromis niloticus	2
Dried fish vendors	2
polyculture systems	2
traditional carp	2
alternative species	2
Gross margin	2
a) C and b) C + T + S. Combined net fish yield	2
farmer-managed earthen ponds	2
Combined net fish yield	2
T + S	2
C + 	2
tilapia + sahar (	2
three separate treatments: a) carp only (C); b) carp + tilapia (C + T); and c) carp + 	2
on-station trial stocked ponds	2
earthen ponds	2
carp polyculture ponds	2
Nile tilapia and sahar	2
fish yields	2
south Asia	2
Carp polyculture	2
rotifers	2
rotifer distribution	2
total phosphorus (TP)	2
nitrite nitrogen (NO2-N)	2
1346 ind./L	2
autumn and winter	2
winter and summer	2
Cephalodella exigua and Keratella cochlearis	2
spring and autumn	2
four seasons	2
common species	2
Polyarthra trigla	2
rotifer species	2
Backshore Wetland of the Expo Garden	2
multiple GCRV genotypes	2
GCRV genotypes	2
GCRV strains	2
protein VP6 and VP6 antiserum	2
GCRV GD108 (genotype Ш)	2
purified VP6 protein	2
antiserum against	2
VP6 protein	2
predicted protein-protein interaction domains	2
GD108 (genotype Ш)	2
VP6 protein of GCRV 096 (genotype Ι)	2
genotype GCRV 096	2
different GCRV stains	2
strains of different GCRV genotypes	2
four known genotypes of GCRV	2
grass carp aquaculture industry	2
Grass carp reovirus (GCRV)	2
artisanal fishers' livelihoods	2
SMF resources	2
artisanal fishermen's livelihoods	2
SES	2
money lenders or middle man roles	2
ecological component (mangrove resources	2
social component (human)	2
artisanal fishers of the SMF	2
corrupt officials	2
illness, natural disasters	2
local bandits	2
wild animals (especially tigers)	2
fishers' livelihood	2
whose livelihood	2
destroyed fish stocks	2
mangroves	2
local people	2
mangrove wood	2
forest	2
artisanal fishers in the SMF	2
small-scale or artisanal fisheries	2
social-ecological system (SES)	2
empirical research	2
varied and profuse natural resources	2
intricate ecosystem	2
Sundarban Mangrove Forest (SMF)	2
background counterstaining	2
transgenic reporter double staining	2
zebrafish samples	2
labeled antibodies	2
specific antigen-antibody interactions	2
razor clam	2
Sc-igf2bp	2
Glutathione Sepharose 4B resin	2
pLysS cells	2
Escherichia coli Rosetta (DE3)	2
95 kDa recombinant pEGX-4T-1-Sc-igf2bp protein	2
Sc-igf2bp transcripts	2
single RNA recognition motif (RRM) and four K homology (KH) domains	2
deduced protein	2
610 amino acid (aa) residues	2
complete 2254 bp Sc-igf2bp cDNA	2
razor clam Sinonovacula constricta	2
novel igf2bp gene	2
multiple transcripts	2
mRNA binding protein	2
Insulin-like growth factor-II mRNA binding protein (igf2bp)	2
organisations	2
large yellow croaker farming industry	2
closely-knit industry organisation	2
labour input	2
capital input	2
different forms of organisation	2
basic production unit	2
farming household	2
different forms of industry organisation	2
transcendental logarithmic stochastic frontier production function model	2
nine breeding regions of three counties (cities)	2
405 households	2
yellow croaker farming households	2
duck heart	2
S. haraldi culture	2
moist feed	2
shrimp meat	2
S. haraldi	2
F9 group	2
F1 and F9 diets	2
S. haraldi these diets	2
F7 and F9 diets	2
F9 groups	2
F3, F8, and	2
Dietary fatty acids (FA)	2
beef heart and/or shrimp meat	2
F1 and F6 groups	2
S. haraldi first	2
beef heart within the diet	2
i.e., 10:0:0 (F1), 9:0:1 (F2), 8:0:2 (F3), 6:2:2 (F4), 4:4:2 (F5), 2:6:2 (F6), 0:8:2 (F7), 0:9:1 (F8) and 0:10:0 (F9)	2
three main ingredients (beef heart, duck heart, and shrimp meat	2
Nine different types of diets	2
discus fish Symphysodon haraldi tissues	2
different diets	2
Edwardsiella ictaluri in aquaculture production units	2
spontaneous diseased Pelteobagrus fulvidraco)	2
artificial infected fish	2
fluorescein isothiocyanate	2
working dilutions of 5D11 and goat-anti-mouse Ig	2
secondary antisera (enzyme-labeled goat anti-mouse Ig)	2
monoclonal antibody, 5D11	2
yellow catfish (Pelteobagrus fulvidraco)	2
pallial region of the mantle	2
mantle	2
ala/gly-rich regions	2
poly-ala forms	2
alanine (ala, 30.8%), glycine (gly, 25.8%) and serine (ser, 10.6%)	2
850 amino acid protein	2
hic74 gene	2
mantle of the freshwater mussel Hyriopsis cumingii	2
novel matrix protein	2
mollusc shells	2
Organic matrix proteins	2
male follicular wall	2
female oocyte cell membrane	2
strong and specific signal	2
Hcfem-1c transcripts	2
gonads Hcfem-1c	2
two years old)	2
adductor muscle, foot, liver, gill, kidney, mantle, and gonads of male and female adult mussels	2
invertebrates homologues	2
deduced HcFEM-1C protein	2
ANK domains	2
putative protein	2
isolated Hcfem-1c cDNA	2
freshwater mussel (Hypriopsis cumingii)	2
full-length cDNA of the fem-1c (Hcfem-1c) gene	2
ANK superfamily	2
fem-1 family	2
many metazoan species	2
feminization-1c (fem-1c) gene	2
Dabry's sturgeon	2
primary organs	2
trunk kidney	2
orthochromatic erythroblasts	2
spleen or liver	2
thrombocyte	2
monoblast and macrophage	2
primitive, young to mature blood cells	2
three developmental stages	2
erythroid, granuloid, monocytoid, lymphoid and other cells	2
Dabry's sturgeon's blood cells	2
imprints of four tissues	2
Glutamic-pyruvic transaminase (ALT) and glutamic-oxalacetic transaminase (AST)	2
Red blood cell (RBC)	2
Dabry's sturgeon (Acipenser dabryanus)	2
freshwater species	2
spotted barbell genetic resources	2
cultured populations	2
populations SH and YS	2
populations XJ	2
aquaculture populations Shanghai (SH), Hangzhou (HZ), Kaihua (KH) and Xianju (XJ) and one wild population Yingshan (YS) of spotted barbell (Hemibarbus maculates)	2
survey program	2
fish community	2
simulated sampling	2
seasonal and rare species	2
total number of species	2
fish populations and community	2
good resources	2
chloroplast genomes	2
S. subgen	2
S. vachellianum	2
species of S. subgenus Bactrophycus	2
plastid-encoded proteins	2
Sargassum species	2
S. vachellianum cpDNA	2
highly variable regions	2
whole genome	2
24 tRNA genes	2
four ribosomal RNA genes	2
160 genes	2
small single copy (SSC) region	2
large single copy (LSC) region of 73,721 bp	2
pair of inverted repeats (IRs)	2
complete S. vachellianum	2
S. vachellianum, S. horneri and S. thunbergii	2
circular complete chloroplast genome (cpDNA)	2
rocky intertidal zones	2
China-specific	2
ecologically important brown alga	2
Sargassum vachellianum	2
bacteria of the three BFTs	2
top three	2
three BFT systems	2
aspartate aminotransferase	2
back muscle from tilapia of the three experimental groups	2
S-0 (1.40) and S-10 (1.39) tilapia	2
tilapia in S-20	2
S-10 group	2
total ammonium nitrogen (NH4+-N) and nitrite nitrogen (NO2−-N)	2
S-0, S-10 and S-20 groups	2
genetically improved farmed tilapia (Oreochromis niloticus)	2
bacteria community of indoor biofloc technology (BFT) systems	2
inorganic nitrogen syndrome	2
2n and 3n hybrids	2
grass carp control	2
2n gynogens, 2n hybrids, 3n hybrids	2
UV-irradiated blunt snout bream (Megalobrama amblycephala) sperm	2
meiotic gynogenetic offsprings of grass carp (Ctenopharyngodon idella)	2
2n hybrids fish	2
(3n) hybrids	2
Diploid (2n) gynogens	2
free-floating plants	2
smallest, shortest burrows	2
flat bottom	2
water lettuce treatment	2
hyacinth treatment	2
V-shaped, Y-shaped, inverted L-shaped, or complicated dendritic networks	2
burrow structures	2
loach feeding, living and burrowing	2
suitable habitat	2
Water hyacinth purified water	2
TOC and EC	2
water turbidity	2
water TP and NH4-N. Water hyacinth and water lettuce	2
water TN, COD, NO3-N and NH4-N	2
Water hyacinth	2
water lettuce Pistia stratiotes	2
tanks without plants, tanks with the free-floating plant water hyacinth Eichhornia crassipes	2
pond loach Misgurnus anguillicaudatus	2
mud of shallow waters	2
HcHSP90 expression	2
Aeromonas hydrophila	2
haemolymph and gill	2
different concentrations of cadmium	2
various tissues of H. cumingii	2
HSP90 proteins	2
HcHSP90 protein	2
728 amino acid protein	2
3′ and 5′-untranslated regions	2
HcHSP90 cDNA	2
Hyriopsis cumingii	2
full-length complementary DNA (cDNA) of HSP90 (HcHSP90)	2
highly conserved and multi-functional molecular chaperone proteins	2
Heat shock protein 90 (HSP90)	2
tilapia, Oreochromis niloticus	2
best feed formulation	2
dietary palm oil	2
whole body docosahexaenoic acid (DHA)	2
palm oil	2
DHA/EPA in muscle	2
total n-6 PUFA	2
total n-3 poly unsaturated fatty acids (PUFA)	2
total saturates	2
muscle and whole body	2
major lipid source	2
crude protein	2
isonitrogenous diets	2
Oreochromis niloticus	2
serum metabolites	2
important aquaculture species	2
pure natural resources of E. sinensis	2
genetically differentiated species	2
E. sinensis and E. hepuensis	2
E. japonica	2
mitogenome and 5S rDNA sequences	2
mitten crabs species	2
non-transcribed spacer (NTS) region	2
5S gene (5S rDNA) sequence	2
mitochondrial D-loop region	2
three mitten crabs distinct tandem repeats	2
mitogenomes	2
nuclear 5S	2
complete mitogenomes	2
three mitten crabs (Eriocheir sinensis, E. hepuensis, and E. japonica)	2
artificial polyploids	2
natural polyploid species	2
polyploidy advantages	2
natural polyploid species in cyprinid fishes	2
synthetized autopolyploids or allopolyploids	2
natural polyploid fishes of the Cyprinidae and Salmonidae	2
Many artificial polyploids	2
important target species	2
common carp, gibel carp, crucian carp, salmon, and sturgeon	2
numerous species of natural polyploid fishes	2
polyploid aquatic animals	2
fish health	2
closely-related orange-spotted grouper (E. coioides)	2
hardier species	2
suitable alternative ingredients	2
fish immunity	2
immunostimulant compounds	2
fish immune system	2
aspects of immunity, feed, and husbandry	2
healthy fish growth	2
aquaculture species	2
brown-marbled grouper (Epinephelus fuscoguttatus)	2
Asian-Pacific region	2
live reef fish trade	2
tropical and subtropical waters	2
dispersed worldwide	2
pth1, pth2, pthrp1, pthrp2, pth1r, pth2r and pth3r	2
pth1, pth2, pthrp1, pthrp2, pth1r, pth2r and pth3r genes	2
pth receptors	2
pth1, pth2, pthrp1, pthrp2 and pth3r	2
embryos and larvae	2
pthrp2 mRNA	2
zebrafish embryos and larvae	2
pth2 and pth3r mRNA	2
pth1, pthrp1, pth1r, pth2r mRNA	2
pthrp1, pthrp2, pth1r, pth2r, pth3r	2
zebrafish, Danio rerio	2
pth1, pth2, pthrp1, pthrp2, and their receptors pth1r, pth2r, pth3r	2
Parathyroid hormone (pth), parathyroid hormone-related peptide (pthrp)	2
sea urchin species	2
protein diet	2
HSP70 in the intestine	2
coelomic fluid of sea urchins	2
juvenile sea urchins	2
coelomic fluid and intestine	2
sea urchins	2
sea urchin (Strongylocentrotus intermedius)	2
anti-oxidative enzymes and heat shock protein 70 (HSP70) transcription	2
pure PE fiber ropes	2
nanocomposite fiber ropes	2
VTMS-g-PE/SiO2 nanocomposite fibers	2
polymeric matrix	2
SiO2 nanoparticles	2
nanocomposite fibers	2
silane-grafted-polyethylene/SiO2 (VTMS-g-PE/SiO2) nanocomposite fibers and ropes	2
vinyltrimethoxysilane (VTMS) graft	2
data-poor species	2
neighboring Scotian Shelf	2
female and male halibut	2
young halibut	2
waters	2
data-poor stock	2
Atlantic halibut (Hippoglossus hippoglossus, Linnaeus, 1758)	2
visceral mass of S. constricta	2
+-ATPase	2
Na+ K+-ATPase, Mg+ 	2
superoxide anion free radicals and H2O2	2
molluscan bivalve Sinonovacula constricta exposed	2
gills and visceral mass tissues	2
Ca+ +-ATPase) and H+ K+-ATPase	2
adenosine triphosphates (including Na+ K+-ATPase, Mg+ 	2
antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT)	2
China's coastal waters	2
living environment	2
Aquatic animals	2
bait replacement	2
traps	2
fishing enterprises	2
traditional baited traps	2
LED lights (no bait)	2
unbaited traps	2
baited traps	2
white and purple LED lights	2
first field experiment	2
commercial traps	2
green and red lights	2
purple lights	2
blue and white lights	2
coloured LED lights	2
laboratory setting	2
different low-powered LED lights	2
snow crab (Chionoecetes opilio)	2
TNF-α and IL-6 expression	2
tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) transcripts (	2
LcRab5 in L. crocea kidney (LCK) cells	2
mitochondria of liver and fibrous tissue of spleen	2
LcRab5 protein	2
Recombinant LcRab5 protein	2
V. parahaemolyticus	2
LcRab5 transcripts	2
polyinosinic polycytidynic acid and Vibrio parahaemolyticus	2
liver, spleen, and head-kidney	2
blood and gill	2
LcRab5 mRNA	2
mammals and other fish	2
215 amino-acid protein	2
648 bp	2
Larimichthys crocea	2
full-length cDNA of Rab5 (LcRab5)	2
active food packaging	2
gelatin film	2
natural antimicrobial agent	2
CEO release	2
tested microorganisms (Escherichia coli, Staphylococcus aureus, Aspergillus niger, Rhizopus oryzae, and Paecilomyces varioti)	2
(FTIR-ATR) spectra	2
porous formation	2
heterogeneous surface	2
gelatin based film	2
various concentrations of cinnamon essential oil (CEO)	2
Fish skin gelatin films	2
processed seafood products	2
dry-cured products	2
surimi-based products	2
frozen aquatic products	2
processed aquatic products	2
country's marine catches	2
four provinces	2
Marine capture production	2
total freshwater catches	2
four provinces including Jiangsu	2
freshwater catches	2
wild fish	2
shellfish production	2
bottom sowing and raft culturing products	2
pond aquaculture	2
freshwater aquaculture	2
China's aquaculture products	2
China's aquatic products	2
China Statistical Yearbooks and other sources	2
China Fishery Statistics Yearbooks	2
microbial molecular resources	2
12 strains	2
12 strains of V. parahaemolyticus	2
pir gene	2
16S rRNA sequence alignment	2
Vibrio parahaemolyticus	2
strain diversity	2
16S rRNA gene and pir gene	2
3 pairs of primer	2
Suspected isolates	2
shrimp farm	2
81 isolates	2
Two insecticidal Photorhabdus insect-related (pir) genes	2
large plasmid	2
novel type of Vibrio parahaemolyticus	2
Asian seabass	2
F2 fish	2
F1 generation	2
BW, TL, SL, Ktl and Ksl	2
F1 fish	2
2136 individuals	2
3530 individuals	2
12,117 individuals	2
F2 generation	2
mass-cross	2
brood stock	2
10 microsatellites	2
F1 brooders	2
mass crosses	2
F2 fish generation	2
Asian seabass (Lates calcarifer)	2
major protective antigens	2
GldJ, Lip and Omep	2
sera of immunized fish	2
immunized fish	2
immuno-related genes	2
recombinant GldJ, Lip and Omep	2
Escherichia coli DE3	2
hypothetical protein FCOL_13420 (Fco1), lipoprotein (Lip), F0F1 ATP synthase subunit beta (F0f1) and outer membrane efflux protein precursor (Omep)	2
gliding motility lipoprotein GldJ (GldJ)	2
Five unique immunogenic proteins	2
grass carp (Ctenopharyngodon idella), and anti-grass carp-recombinant Ig (rIg) monoclonal antibodies	2
antibacterial sera	2
two-dimensional electrophoresis (2-DE) map gels	2
immunogenic outer membrane proteins (OMPs)	2
protective antigens	2
Flavobacterium columnare	2
sub-models	2
multiple stocks	2
different species and fisheries	2
simulation model	2
populations and their associated fisheries	2
individual-based probabilistic model	2
assessment model	2
target species	2
stock assessment models	2
economy of the resource users	2
fish populations	2
Vibrio alginolyticus, V. carchariae, V. parahaemolyticus, and V. vulnificus	2
species of pathogenic bacteria	2
Seventeen species of non-indigenous zooplankton	2
noxious algae	2
red-tide causing species	2
diatoms and dinoflagellates	2
five phyla	2
species of non-indigenous phytoplankton	2
major Chinese ports	2
ports	2
ballast water of ships	2
exotic species	2
one of the top trading countries	2
aquaculture sector	2
fishery exports	2
inland aquaculture sector	2
Bangladeshi inland fisheries	2
related un-published grey literatures	2
Bangladesh Department of Fisheries	2
third largest aquatic biodiversity	2
world's largest flooded wetland	2
fisheries in the world	2
juvenile carp	2
diphosphomevalonate decarboxylase and selenide & water dikinase-1	2
rho guanine nucleotide exchange factor 17-like	2
ferritin heavy chain	2
pyknotic nuclei	2
secondary lamellae of gills	2
kidney, liver and gills of the treated groups	2
glutathione-S-transferase	2
activity oxidative stress enzymes catalase, superoxide dismutase	2
certain water resources	2
juvenile carps (Cyprinus carpio), a freshwater teleost edible	2
teleosts performance	2
serious water pollutants	2
Copper nanoparticles (Cu-NPs)	2
trypsin family	2
skins of juveniles	2
fish skins	2
genetically closely related offspring in the same tanks	2
fish cannibalism	2
cannibalizing their siblings	2
group without feeding	2
three mass crosses	2
polymorphic microsatellites	2
juveniles of Asian seabass	2
organisms in natural populations	2
novel immune genes	2
L. morii	2
protein disulfide isomerase family A (member 4), cystathionase, and serum lectin	2
polyl 4-hydroxylase,	2
gill, kidney, heart, intestine, liver, and supraneural body	2
cofilin 1 mRNA expression	2
serum lectin	2
Polyl 4-hydroxylase	2
cystathionase and Zgc:112210-201	2
corresponding differentially expressed proteins	2
Quantitative real-time PCR (qPCR)	2
Lampetra morii	2
lipopolysaccharide (LPS) induced liver proteome	2
up-regulated and ten down-regulated proteins	2
preservative	2
microorganism growth	2
GBLE1 (2.5 mg/mL) treated group	2
untreated (0.0 mg/mL) pomfret samples	2
Polyethylene bag	2
water-ice mixture	2
local fish market	2
Fresh pomfret samples	2
silver pomfret (Pampus argenteus)	2
Gingko biloba leaf extract (GBLE)	2
microbiological, amino acid content, and flavor effects	2
chemical (TVB-N, K value and TBA)	2
P. yezoensis	2
YZ-4 blades	2
15th day WT blades	2
50-day-aged F1 gametophytic blades of YZ-4	2
WT conchospores	2
surviving conchospores	2
regenerated blades of single somatic cells of the wild-type (WT) blades	2
heat-resistant Pyropia yezoensis strain YZ-4	2
glucose, galactose and mannitose	2
monosaccharides	2
small, long and fiber-like shapes	2
solid substances	2
supernatant of the fermentation liquid	2
highly efficient bio-flocculants	2
biofloc in aquaculture waters a strain of Bacillus thuringiensis	2
PepT1 protein	2
PepT1 transcripts	2
free amino acids	2
gastrointestinal track	2
intestines of vertebrates	2
di- and tripeptide forms	2
fraction of dietary amino acids	2
low-affinity/high-capacity, stereoselective transmembrane transporter	2
Peptide Transporter 1 (PepT1)	2
spawning population of Japanese Eels in the Yangtze River	2
Japanese Eel	2
females and males	2
Pearl River Estuary	2
samples caught	2
ovaries	2
females the ovaries of most of the out-migrating population	2
Jingjiang Reach of the Yangtze River	2
121 Japanese eels	2
Japanese Eel (Anguilla japonica)	2
important habitats	2
branches	2
fisheries	2
better BRPs	2
“knife-edge” HCR	2
bigeye and yellowfin tuna fisheries	2
current maximum sustainable yield (MSY)-based BRP combinations	2
bigeye tuna (Thunnus obesus) and yellowfin tuna (Thunnus albacares) fisheries	2
alternative BRPs	2
different BRPs	2
many different BRPs	2
fishery stock	2
Biological reference point (BRP)	2
pre-treated fish fillet	2
untreated and osmotically pre-treated with HDM, HDM + treh and HDM + gluc fish slices	2
osmotically treated fillets	2
HDM + treh and HDM + gluc	2
, H2S-producing bacteria, lactic acid bacteria, yeasts and moulds), total volatile nitrogen (TVB-N), lipid oxidation (TBARs) and sensory scoring	2
, Brochothrix thermosphacta, Enterobacteriaceae spp.	2
HDM:glucosamine:NaCl/100 g (HDM + gluc)	2
dextrose equivalent maltodextrin:NaCl/100 g (HDM), 40:10:5 HDM:trehalose:NaCl/100 g (HDM + treh)	2
osmotic solutions	2
) fillets	2
Fresh gilthead seabream (Sparus aurata	2
osmotically pre-treated fish	2
fungal cell wall	2
given CS	2
nascent chitin chain	2
CS’s active site	2
hydrolyzing UDP-GlcNAc	2
chitin oligosaccharides	2
2-acylamido GlcN analogues	2
chain-extending, UDP-GlcNAc-derived GlcNAc	2
priming GlcNAc	2
insoluble chitin chains	2
insoluble chitin	2
di-N-acetylchitobiose	2
free GlcNAc	2
synthase	2
transmembrane channel	2
non-reducing end of a growing chitin chain	2
cytoplasmic face of the plasma membrane	2
different sites on the cell surface	2
multiple chitin synthases (CSs)	2
oocyst wall structure and molecules	2
terrestrial and aquatic environments	2
infective T. gondii parasites	2
oocyst and sporocyst walls	2
contaminated water or food	2
infected meat of intermediate hosts	2
tissue cysts	2
warm-blooded animal	2
cat	2
coccidian parasite	2
arabinan core	2
α(1 → 5)	2
C5 of the Araf positioned on the synthetic acceptor(s)	2
Araf residue	2
arabinofuranose (Araf) “primed” galactan chain	2
C. glutamicumΔaftA, C. glutamicumΔemb, C. glutamicumΔaftAΔemb and C. glutamicumΔaftBΔaftD and two synthetic acceptors	2
vitro cell-free assays	2
cell wall bound mycolates	2
galactan backbone	2
truncated cell wall	2
substrate for Cg-Emb	2
priming Cg-AftA protein	2
double ΔaftAΔemb mutant	2
singular Emb protein	2
characteristic terminal hexa-arabinosuranosyl motif	2
front-line anti-tubercular drug ethambutol	2
arabinosyltransferases (ArafTs)	2
Emb proteins	2
Mycobacterial EmbA	2
distinct structural motifs	2
elaborate arabinan domains	2
AG and LAM	2
Corynebacteria, Norcadia and Mycobacteria	2
Corynebacterineae	2
arabinan-containing polysaccharides, arabinogalactan (AG) and lipoarabinomannan (LAM)	2
drug-free and -bound forms of the enzyme	2
amphipathic cationicα-helical antimicrobial peptides	2
membrane-interacting surface of the jaw subdomain	2
two drug-binding sites	2
PGT donor site	2
jaw subdomain	2
second MoeA	2
MoeA-bound Staphylococcus aureus monofunctional PGT enzyme	2
antibiotic moenomycin A (MoeA)	2
smaller jaw subdomain	2
large head subdomain	2
PGT domain	2
linear glycan chains	2
lipid II	2
Bacterial peptidoglycan glycosyltransferases (PGT)	2
carrier lipid	2
C55-PP phosphatases	2
PBP1B. C55-PP	2
another C55-PP pyrophosphatase, BacA and both,	2
PgpB. Purified PBP1B	2
cefsulodin, a β-lactam specific for PBP1A	2
C55-PP pyrophosphatase gene pgpB	2
membrane-embedded pyrophosphatases	2
diphosphate form of the carrier lipid, undecaprenyl pyrophosphate (C55-PP)	2
Penicillin-binding proteins (PBPs)	2
membrane anchored PG synthases	2
glycan chains	2
periplasmic side	2
inner leaflet of the cytoplasmic membrane	2
PG precursor lipid II	2
bacterial cell wall	2
Peptidoglycan (PG)	2
PA or PA analogues	2
C. albicans, C. dubliniensis, C. tropicalis, and C. glabrata	2
C. guilliermondii, C. orthopsilosis, and C. parapsilosis	2
hotspot1 region of the β-1,3-glucan synthase subunit Fks1	2
cell wall β-glucan content	2
Candida species	2
calcineurin pathway	2
human pathogenic Candida species	2
medically important fungi	2
cell wall β-1,3-glucan	2
range of plant pathogens	2
β-1,3-glucan synthesis	2
plant natural product poacic acid (PA)	2
potential novel inhibitors	2
new classes of inhibitory molecules	2
α(1 → 5) AraT	2
single (ΔaftD) and double deletion (ΔaftB ΔaftD) mutants of C. glutamicum	2
fourth AraT	2
variety of arabinofuranosyltransferases (AraT)	2
highly branched component of AG	2
D-arabinan segment	2
outer mycolic acid layer	2
essential structural macromolecule	2
Arabinogalactan (AG)	2
Small molecule activators of Nrf2	2
isolated mitochondria and cultured cells	2
several of the downstream target genes of Nrf2	2
principal small molecule antioxidant	2
Reduced glutathione	2
mitochondrial toxins	2
large network of antioxidant enzymes	2
Nrf2 target genes	2
transcription factor nuclear factor erythroid 2 p45-related factor 2 (Nrf2)	2
high-resolution quantitative imaging	2
C. elegans research	2
dynamic modeling	2
-omics technologies	2
cell lines to mouse models	2
different biological models	2
deep neural networks	2
advanced learning technologies	2
streamlining image-based profiling assays	2
high-dimensional profiling data	2
single-cell phenotypes	2
high-performance computational resources	2
new analytical frameworks	2
proto-metabolic networks	2
inanimate one	2
living matter	2
biotechnology and biomedicine	2
constituent microbial populations	2
keystone genes, functions and species	2
high-throughput molecular data (multi-omics)	2
cells overproduce and release metabolites	2
emerging biochemical concepts	2
sharing of metabolites	2
colonies, biofilms or tissues	2
extracellular nutrients	2
biosynthetically active cells release metabolites	2
almost any organism	2
different chemicals	2
every gene	2
multi-omic datasets	2
single-omic datasets	2
genome, transcriptome, proteome, metabolome or ionome	2
tractable therapeutic targets	2
clinical and in vitro sources	2
subgroups of patients	2
Subgroups of patients	2
life-threatening infection	2
undiscovered sub-groups	2
susceptible host	2
important and tractable targets	2
many medical applications	2
single cell transcriptomics	2
Big single cell RNA sequencing data	2
ever growing datasets	2
single-cell RNA sequencing data	2
scalable solutions	2
resulting data	2
thousands of single cells	2
Single cell transcriptomics	2
systemic phenotyping	2
valuable open access data resource	2
encoding proteins	2
Long non-coding RNAs	2
American College of Medical Genetics and Genomics	2
Council for International Organizations of Medical Sciences	2
Genomics and Health-Related Data	2
Framework	2
Global Alliance	2
intensive science	2
health data (and especially genetic data	2
fast-paced field	2
three-dimensional chromatin organisation	2
eukaryotic nucleus	2
highly ordered structure	2
high-precision multi-faceted biological data	2
governing mechanistic system equations	2
visionary review	2
precise causative drug targets	2
different systems	2
Systems Biology	2
1-dose vaccine schedule	2
LMIC immunisation managers and advisors	2
anti-vaccine groups or the media	2
re-train health workers	2
health worker hesitancy	2
routine immunisation services	2
logistical and financial resources	2
18 countries	2
national immunisation technical advisory group members (key informants; KIs)	2
LMIC immunisation programme managers	2
HPV vaccine schedule	2
immunisation programme managers and advisors in low and middle-income countries (LMIC)	2
girls aged 9–14 years	2
2-dose HPV vaccine schedule	2
laryngeal and oropharyngeal carcinomas	2
hypopharyngeal carcinomas	2
p16 immunohistochemical staining	2
L1 and E6 regions of HPV and p16 immunohistochemical staining	2
112 South African patients	2
squamous cell carcinomas of the oropharynx, nasopharynx, larynx and hypopharynx	2
p16 immunohistochemistry staining	2
patients with histologically confirmed head and neck squamous cell carcinomas	2
house molecular assays	2
human papillomaviruses (HPVs)	2
head and neck tumours	2
present HPV 16, 18 vaccines	2
ICC cases	2
HR types	2
HPV 18, 45, 39 and 59 (alpha-7)	2
HPV HPV52, 31 and 58 (alpha-9)	2
SCC and adenocarcinoma (ADC)	2
probably HR HPV 53, 67, 69, and 70	2
HPV 35	2
13 internationally recognized high-risk (13HR) types	2
single-type infections	2
novel Genosearch-31+5 HPV test	2
1526 cervical intraepithelial neoplasia (CIN) and 371 invasive cervical cancer (ICC) patients	2
oncogenic human papilloma virus (HPV) types	2
national HPV vaccine registry	2
self-reported information	2
1230 eligible registrants	2
Niigata city	2
(HPV) vaccine	2
human papillomavirus	2
proactive recommendations	2
national vaccine registry	2
HPV demonstration districts	2
girls	2
Sub-Saharan Africa	2
29,846 residents	2
71,177 female residents	2
Ministry	2
HPV negative cervical cancers	2
Truly HPV negative	2
non-HR-HPV types	2
HPV-DNA	2
primary undifferentiated carcinoma of the uterine cervix	2
HPV 16 and two HPV-18)	2
four patients with HC2-negative cervical cancer	2
high-risk subtypes	2
HPV-73)	2
Non-high-risk HPV subtypes	2
340/350 cases	2
smears and paraffin embedded tissue blocks	2
high-risk HPV (HR-HPV)	2
371 patients	2
prospectively collected smears	2
Caucasian population	2
HPV-negative cervical cancers	2
biopsy-proven invasive cervical cancers	2
HPV-induced hyperplastic epithelium	2
soluble regulatory factors	2
epidermal DCs	2
HPV E6 and E7 oncoproteins	2
HR-HPV	2
antiviral and antitumor cytotoxic CD8+ T cells	2
/cross-priming antigen-specific T cells	2
infect basal keratinocytes	2
High-risk human papillomaviruses (HR-HPV)	2
state	2
public and providers	2
HPV vaccine funding	2
HEDIS measures	2
state immunization registry	2
school-entry Tdap requirement	2
four interviews	2
Digital interview files	2
public health agencies, medical associations, K-12 schools, universities, insurers, and cancer advocacy organizations	2
relevant organizations	2
Young adults	2
young adult college students	2
unvaccinated self	2
partner vaccination	2
HPV vaccinated	2
respondent's partner	2
HPV associated cancers	2
sexual partners	2
potential respondents	2
self-selected cross-sectional sample of college students	2
HPV associated diseases and vaccines	2
male and female college students	2
stocks
T7	Data	284 295	model rates
T8	Data	297 318	Initial anal cytology
T9	Material	322 350	new cervical cancer patients
T10	Process	352 388	dysplasia progression and regression
T11	Material	407 457	high-grade squamous intraepithelial lesions (HSIL)
T12	Data	463 477	lifetime costs
T13	Process	482 498	anal cancer care
T14	Material	526 536	literature
T15	Data	538 549	Local costs
T16	Material	553 569	anal HPV testing
T17	Data	616 633	anal cancer rates
T18	Data	635 653	anal cancer deaths
T19	Data	655 670	screening costs
T20	Data	675 686	cancer care
T21	Material	710 724	screened group
T22	Material	747 759	anal cancers
T23	Material	782 800	anal cancer deaths
T24	Data	835 899	predicted costs per anal cancer prevented and anal cancer deaths
T25	Data	905 926	$168,796 and $210,057
T26	Data	936 968	$98,631 and $210,057 at 20 years
T27	Data	970 1016	Predicted costs per quality of life year saved
T28	Data	1020 1035	10 and 20 years
T29	Data	1041 1056	$9785 and $1687
T30	Method	1058 1078	Sensitivity analysis
T31	Data	1092 1110	cost-effectiveness
T32	Data	1130 1151	variety of cure rates
T33	Material	1201 1209	anal HPV
T34	Material	1227 1236	anal HSIL
T35	Material	1240 1269	patients with cervical cancer
T36	Process	1273 1287	cost-effective
T37	Data	1298 1309	anal cancer
T38	Data	1322 1340	anal cancer deaths
	2
MethodsA dynamic model	2
out-of-school girls	2
vaccination venue	2
13 countries	2
solicited unpublished documents	2
5 databases	2
HPV vaccine demonstration projects	2
low and middle income countries (LAMIC)	2
demonstration projects	2
56 interviews	2
conference abstracts	2
45 LMICs	2
low and middle-income countries (LMICs)	2
Realtime HPV assay	2
Cell line samples	2
pre-treated NHQ	2
best performing LBC	2
CE marked liquid based cytology preservatives	2
assay manufacturers media	2
automated HPV assay (Abbott RealTime HR HPV)	2
certain HPV assays	2
cervical cells in Novaprep media (NHQ)	2
spray-dried MS2-16L2 VLPs	2
group of mice	2
high titer anti-HPV antibodies	2
two doses of MS2-16L2 VLPs	2
high dose of HPV16	2
single dose of spray-dried MS2-16L2 VLPs	2
spray-dried VLPs	2
dry powder	2
MS2-16L2 VLPs	2
diverse HPV types	2
broadly protective antibodies	2
bacteriophage L2 virus-like particle (VLP)-based candidate vaccine	2
third world countries	2
three prophylactic vaccines	2
providers, parents, patients, professional organizations, public health agencies, policymakers, researchers, and community-based organizations	2
multiple stakeholders	2
genders	2
related illnesses	2
HPV and HPV vaccines	2
female-specific disease	2
number of anogenital cancers (i.e., cervical, penile, anal, vaginal, vulvar) and genital warts	2
Human papillomavirus (HPV)	2
French population	2
girls with quadrivalent HPV vaccine	2
sub-optimal VCR.MethodsA dynamic transmission model	2
Involvement front line physicians	2
male child	2
receiving HPV vaccine	2
school-based vaccines	2
first dose of the vaccine	2
eligible boys	2
vaccine eligible girls	2
HPV infection and HPV vaccine	2
questionnaires	2
20 randomly selected primary schools	2
4th grade school children	2
newly implemented gender-neutral, school-based HPV Immunization program	2
school-based gender-neutral human papillomavirus (HPV) immunization program	2
substantial vaccine-preventable HPV	2
Three-dose vaccine coverage	2
bivalent, quadrivalent or 9-valent vaccine type	2
16–20 year olds	2
women in Natsal-2	2
2569 sexually-experienced women	2
bivalent (HPV-16/18), quadrivalent (HPV-6/11/16/18) and 9-valent (HPV-6/11/16/18/31/33/45/52/58) vaccine types	2
HPV-induced (pre) cancerous lesions	2
mitotic checkpoints	2
DNA methylation machinery	2
viral oncogenes	2
viral oncogenes E6 and E7	2
High-grade CIN lesions	2
high-risk types of the human papillomavirus (hrHPV)	2
Cervical cancer	2
men with HSIL-AIN2.ConclusionsGrouping HSIL-AIN2	2
HIV-negative (61.1%) and HIV-positive (54.9%)	2
common HR-HPV type	2
Lifetime receptive partners	2
Recent receptive anal partners	2
HIV-positive men	2
HSIL-AIN2	2
HIV-positive and 396 HIV-negative men	2
anal swabbing	2
men	2
cohort of homosexual men	2
HSIL-AIN2 and HSIL-AIN3	2
high grade squamous intraepithelial lesions (HSIL)	2
intraepithelial neoplasia grade 2 (AIN2)	2
laryngeal cancers	2
p16 and/or HPV DNA	2
genotypes 18	2
papillary SCC tumors	2
non-keratinizing SCC	2
p16 and HPV DNA	2
laryngeal tissue	2
HPV DNA.Overall	2
U.S. Samples	2
laryngeal cancer cases	2
population-based sample	2
second generation vaccines	2
first generation HPV vaccines	2
new genital warts	2
second and first generation vaccine types	2
new HPV-attributable anogenital precancerous lesions	2
284,373	2
first generation vaccine types	2
new anogenital HPV-attributable cancers	2
respective HPV types	2
cancer registries	2
IARC database	2
women and men	2
first generation vaccines	2
nine HPV types	2
cervix, vulva, vagina, anus and of genital warts	2
anogenital cancers	2
second generation HPV vaccine	2
novel SNPs	2
HPV16-positive exfoliated cervical cell specimens	2
89 specimens	2
Ion Torrent Proton platform	2
overlapping amplicons	2
AmpliSeq™ panel	2
custom HPV16	2
HPV16 and cervical cancer	2
HPV-related cancers	2
uniquely powerful carcinogenic type	2
type	2
closely related variant lineages	2
different HPV types	2
established HPV tests	2
general screening population	2
One case of CIN2	2
CIN3+	2
172 participants	2
Qiagen hc2 third	2
Roche cobas4800 and Cepheid Xpert assays	2
residual Preservcyt cytology samples	2
women attending screening	2
various cell types and reconstituted forms	2
Cell-free protein synthesis (CFPS) or in vitro translation (IVT) systems	2
cell-free protein or peptide synthesis	2
cellular protein expression	2
stable isotope-labeled peptide internal standards	2
low-abundance proteins	2
specific biological systems	2
homeostatic pathways	2
alternative non-transcriptional pathways	2
constant internal environment	2
secrete cytokines	2
tumor-draining lymph nodes	2
immunogenic cancers	2
specific DC subset, conventional type 1 DCs (cDC1s)	2
breast cancer candidate genes	2
modifier alleles	2
Multiple nonmalignant cell types in the tumor microenvironment (TME)	2
antimetastatic agents	2
candidate migrastatic drugs	2
conventional cytostatic drugs	2
specific category of anti-invasion and antimetastatic drugs	2
mutated cells	2
integrated heterocellular systems	2
heterotypic cells	2
colorectal cancer (CRC)	2
heterocellular systems	2
multiple different cell types	2
stochastic and deterministic processes	2
tumor spatial structures	2
individual cancer	2
control area	2
potentially infected people and pigs	2
newly developed electronic educational tools	2
South Asian and Peruvian context	2
rapidly evolving field	2
English scientific literature	2
neglected parasitic zoonosis	2
T. gondii DNA in fresh meats	2
T. gondii type II (66.7%) and type III (33.3%)	2
provinces sampled	2
three meat types	2
chicken breasts and ground pork	2
packages of fresh ground beef	2
T. gondii DNA	2
T. gondii in retail meats	2
oocysts in food, water or soil	2
tissue cysts in raw or poorly cooked meat and organs of infected animals	2
Human toxoplasmosis	2
wide variety of mammals and birds	2
horse meat	2
previously reported cases	2
Trichinella spiralis-infected horses	2
Trichinella-infected horse	2
naturally acquired T. murrelli infection	2
T. murrelli by PCR	2
digested tongue and diaphragm samples	2
USA	2
T. murrelli in a horse	2
infected wild game	2
human trichinellosis	2
wild carnivores	2
Trichinella murrelli	2
domestic swine, wild boar and occasionally horses	2
particular matrix	2
parasite transmission stages	2
contaminated berries	2
Cyclospora and Trypanosoma cruzi	2
various stages of harvesting, packaging, and sale	2
Parasite transmission stages	2
berry pickers in the production field	2
contaminated harvesting equipment	2
animal and human faeces	2
contaminated water	2
farm-to-fork pathway	2
fresh berries	2
healthy diet	2
Fresh fruits and vegetables	2
housing type	2
trichinellosis cases	2
Trichinella testing	2
Trichinella (QMRA-T)	2
controlled and non-controlled housing	2
bacterial foodborne outbreaks	2
meeting	2
different foods	2
Euro-FBP consortium	2
one or more FBP	2
common topic	2
COST Action FA1408, A European Network for Foodborne Parasites (Euro-FBP)	2
infection vehicle	2
standardized detection methods	2
many FBP	2
Foodborne parasites (FBP)	2
World Organization for Animal Health (OIE), European Union (EU) and International Commission on Trichinellosis (ICT)	2
meat samples	2
Trichinella spiralis L1	2
diaphragm, tongue, masseter, and loin of 3–4month old pigs	2
Multiple muscle samples	2
encapsulated first stage Trichinella larvae (L1)	2
samples from different muscle sites	2
various muscles from domestic and wild animals	2
new assay	2
hazardous substances	2
muscle of infected animals	2
Trichinella larvae	2
Trichinella AAD)	2
pepsin enzyme and hydrochloric acid (HCl)	2
Trichinella muscle larvae	2
pork and horse meat	2
susceptible food animals	2
raw or under-cooked meat	2
zoonotic nematode parasite	2
human consumers	2
RTE meats	2
dry curing components	2
curing components in the formulated batter	2
T. gondii encysted bradyzoites	2
encysted T. gondii bradyzoites	2
T. gondii bradyzoites	2
T. gondii bradyzoites in tissue cysts	2
(RTE) products	2
ready-to-eat	2
T. gondii in pork meat	2
Trichinella spiralis, a nematode parasite	2
pork meat	2
target audience	2
common quantitative methods	2
important foodborne hazards	2
possible foodborne hazards	2
financial resources	2
fishborne zoonotic heterophyid infections	2
heterophyid species	2
heterophyid flukes	2
eggs in feces	2
species infection	2
raw or improperly cooked fish	2
major endemic areas	2
Human infections	2
Metagonimus (M. yokogawai, M. takahashii, M. miyatai, M. minutus, and M. katsuradai), Heterophyes (H. heterophyes, H. nocens, H. dispar, and H. aequalis), Haplorchis (H. taichui, H. pumilio, H. yokogawai, and H. vanissimus), Pygidiopsis (P. summa and P. genata), Heterophyopsis (H. continua), Stellantchasmus (S. falcatus), Centrocestus (C. formosanus, C. armatus, C. cuspidatus, and C. kurokawai), Stictodora (S. fuscata and S. lari), Procerovum (P. varium and P. calderoni), Acanthotrema (A. felis), Apophallus (A. donicus), Ascocotyle (A. longa), and Cryptocotyle (C. lingua)	2
infected people	2
species worldwide	2
Fishborne heterophyid trematodes infecting humans	2
developing and developed countries	2
waterborne protozoan parasites	2
virulent C. hominis subtypes	2
Cryptosporidium species and subtypes	2
developing and industrialized countries	2
G. duodenalis	2
virulent subtypes	2
multilocus typing tools	2
infections sources	2
subtyping tools	2
animals and the environment	2
humans and public health potential of parasites	2
infection sources	2
host-adapted Cryptosporidium species and G. duodenalis assemblages	2
two of the most important waterborne parasites	2
Giardia duodenalis	2
Molecular diagnostic tools	2
health-based targets	2
water utilities	2
source waters	2
microbiologically safe drinking water	2
Health-Based Targets (HBTs)	2
ADWG	2
hazards	2
Australian Drinking Water Guidelines (ADWG)	2
risk management framework	2
ten member states (i.e., Brunei Darussalam, Cambodia, Indonesia, Lao People's Democratic Republic (PDR), Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam)	2
Association of Southeast Asian Nations (ASEAN)	2
waterborne parasite occurrences	2
parasitic infections or waterborne outbreaks	2
surveillance and reporting systems	2
waterborne parasitic protozoa	2
Trichinella ML in stuffed sausages	2
Trichinella in pork	2
lower salt	2
new RTE products	2
Trichinella muscle larvae (ML)	2
pork products	2
associated waters	2
positive samples (seawater and oysters)	2
seawater samples	2
oocyst counts	2
20L of seawater	2
Approved, Restricted, and Prohibited)	2
three commercial shellfish zones	2
seawater and oyster samples	2
2014 spring eastern oyster harvesting season	2
Arctic regions	2
scientists, veterinarians, and physicians	2
several food and waterborne parasites or groups of parasites	2
Arctic peoples	2
climate	2
protozoan pathogen	2
environmental pathogen	2
gregarine protozoa	2
coccidian to a gregarine	2
host cell-free environment	2
facultatively epicellular apicomplexan	2
close relatives	2
humans and domestic animals	2
ubiquitous enteric protozoan pathogen of vertebrates	2
Echinococcus genotypes within definitive and intermediate hosts	2
livestock genotypes of E granulosus sensu stricto	2
European and Asian strains of E. multilocularis	2
human AE and CE	2
E. canadensis genotypes	2
E. multilocularis N1 strain	2
multiple cases	2
N2 and European-type strains	2
Individual human cases	2
Central North American (N2) strain and European-type strains of E. multilocularis	2
western Alaska	2
N1 strain	2
North American N1 strain	2
Asian, Mongolian, European and North American strains of E. multilocularis	2
sylvatic arvicoline rodent-canine lifecycle	2
Echinococcus multilocularis	2
G6, G8, G10; and Fennoscandia - G10	2
G8 and G10	2
following northern regions	2
sylvatic (wild animal) and synanthropic (ecological association with humans) cervid-canine life cycles	2
Echinococcus canadensis	2
Genotypes G6	2
zoonotic Echinococcus spp.	2
eight circumpolar countries	2
Echinococcus spp	2
endemic Asian and central European countries	2
human AE	2
canids in some geographic locations	2
accidental hosts	2
animal intermediate hosts	2
definitive canid hosts	2
Russia, Fennoscandia, Iceland, Greenland, Canada and Alaska	2
circumpolar region	2
alveolar (AE) and cystic (CE) echinococcosis	2
indigenous as well as other northern residents	2
almost all circumpolar nations	2
Zoonotic Echinococcus spp.	2
T. britovi	2
distribution area	2
Trichinella T6	2
distribution area of T. nativa	2
Trichinella taxa	2
humans consuming game meat	2
host muscles	2
three Trichinella taxa	2
Trichinella spp.	2
subnivean climate	2
snow	2
frozen muscles of carrions	2
Trichinella britovi	2
muscle larvae of Trichinella nativa, Trichinella T6	2
egg stage of most of other nematode species	2
“free-living” stage	2
larvae in putrefying flesh	2
decaying tissues	2
scavenging host	2
decaying carcasses	2
muscle larvae	2
one host	2
entozoic parasites	2
mammals, birds and reptiles	2
broad host spectrum	2
Africa, the Americas, Asia, Australasia and Europe	2
complex of at least 12 taxa	2
genus Trichinella	2
hardly accessible papers	2
rare or uncommon species	2
human-infecting broad fish tapeworms	2
species in distantly related lineages	2
genus Diphyllobothrium	2
Diphyllobothrium latum, D. dendriticum and D. nihonkaiense	2
important broad tapeworm species	2
man (Diphyllobothrium alascense, D. dalliae, D. ursi)	2
validity of species	2
Dozens of nominal species	2
raw food	2
human societies	2
new geographical regions	2
subarctic and arctic areas	2
colder climates	2
cestode	2
important fish-borne zoonosis	2
diphyllobothriosis itself	2
individual genera	2
broad fish tapeworms (genera Adenocephalus, Diphyllobothrium and Diplogonoporus)	2
second intermediate hosts	2
case of Spirometra)	2
teleost fishes	2
large-sized human tapeworms	2
i.e. members of the order Diphyllobothriidea	2
called broad tapeworms	2
Fish-borne cestodes	2
raw or undercooked fish dishes	2
human fish-borne nematodiosis	2
fish-borne nematodes	2
raw or undercooked fish	2
humans in Brazil	2
fish-borne zoonotic nematodioses	2
marine and freshwater hosts	2
variety of potentially zoonotic fish-borne nematode species	2
fish stocks	2
infected fish	2
stomach of marine mammals	2
additional moults	2
infected invertebrates	2
transport hosts	2
range of fish species	2
euphausiids, copepods and amphipods	2
Various invertebrates	2
free-living third-stage larvae	2
adult stage in pinnipeds (seals)	2
P. decipiens and C. osculatum	2
final hosts	2
A. simplex nematodes use cetaceans (whales)	2
several hosts	2
liver, body cavity, mesenteries and pyloric caeca	2
fish musculature (fillet) and C. osculatum larvae	2
P. decipiens	2
musculature and various organs	2
Third-stage larvae of A. simplex	2
oesophagus and stomach	2
raw or under-cooked fish products	2
marine fish products	2
third-stage larvae	2
anisakid nematodes Anisakis simplex (Rudolphi, 1809), Pseudoterranova decipiens (Krabbe, 1878) and Contracaecum osculatum (Rudolphi, 1802)	2
molecular typing tools	2
different Giardia and Cryptosporidium species/subspecies	2
Cryptosporidium and Giardia in environmental samples	2
potentially zoonotic	2
B	2
humans, G. duodenalis assemblages	2
Cryptosporidium suis	2
Giardia duodenalis assemblages A and B	2
Cryptosporidium-positive samples	2
Giardia-positive samples	2
Giardia and Cryptosporidium and the β-giardin gene	2
SSUrDNA gene	2
Microscopy positive samples	2
Giardia cysts	2
vegetable/composted waste sample	2
Cryptosporidium in samples	2
contaminating vegetables	2
Giardia spp. and Cryptosporidium spp.	2
Giardia spp	2
composted waste samples	2
canal water	2
fishpond water	2
molecular epidemiological tools	2
potential contamination sources	2
protozoa	2
Cryptosporidium and Giardia	2
optimized isolation methods and qPCR MCA	2
herbs or green onions	2
herbs and green onions	2
green onions	2
PCR inhibitors	2
orbital shaking	2
aromatic woody-stemmed herbs	2
soft stems	2
leafy herbs	2
Blackberries, cranberries, raspberries and strawberries	2
five types of berries (blackberries, blueberries, cranberries, raspberries and strawberries), five types of herb (cilantro, dill, mint, parsley, thyme) and green onions	2
wash buffers	2
artificial stomacher or orbital shaker	2
produce samples	2
coccidia of public health concern	2
Eimeria papillata oocysts	2
several types of leafy greens	2
protozoan oocysts	2
leafy green and berry type	2
Cryptosporidium, Cyclospora and Toxoplasma	2
transmission vehicles	2
Leafy green vegetables and berry fruits	2
permeable or impermeable eggshells	2
viable hookworm eggs	2
Vital stains	2
permeable eggshells	2
heat-inactivated eggs	2
vital stains (eosin Y, methyl red, and methylene blue)	2
heat-inactivated eggs of hookworm (Ancylostoma caninum)	2
viable eggs	2
eggshells	2
hookworm eggs	2
vital stains	2
foodborne parasites on ready-to-eat leafy greens	2
T. gondii in leafy greens	2
1 sample of arugula (USA) and 1 sample of baby spinach	2
3 samples of baby spinach	2
1 sample of spring mix (USA)	2
1 sample of baby arugula (USA and Mexico), 1 sample of baby spinach (USA)	2
3 samples of arugula (USA origin)	2
Cyclospora cayetanensis	2
presence of target DNA	2
C. cayetanensis, C. parvum, C. hominis, or T. gondii controls	2
Test samples	2
universal coccidia primer cocktail	2
previously developed and validated 18S rDNA qPCR assay	2
C. cayetanensis, Cryptosporidium spp., and T. gondii	2
wash concentrates	2
elution buffer	2
Canadian cities	2
retail outlets	2
domestic (24.25%) and imported	2
pre-packaged or bulk leafy greens	2
leafy greens)	2
Cyclospora cayetanensis, Cryptosporidium spp., and Toxoplasma gondii in leafy green vegetables	2
variety of terrestrial and aquatic domestic or wild host species	2
new MAT	2
commercial MAT kit	2
naturally infected cats, sheep, and 20 wildlife host species	2
Serum and/or blood samples	2
commercial MAT	2
serum and meat juice samples	2
commercially available MAT kit	2
pigs and cats	2
samples of serum and/or meat juice	2
murine peritoneal cavity	2
in-house MAT	2
livestock and wild animals	2
Toxoplasma IgG antibodies	2
broad range of host populations	2
Serological tests	2
warm-blooded animals	2
zoonotic protozoan parasite	2
parasite in clinical samples	2
Cryptosporidium genotyping	2
GP60 sequencing	2
C. parvum subtyping	2
SSU rDNA sequencing	2
nested PCR	2
Cryptosporidium SSU rDNA gene sequence	2
similar number of oocysts	2
C. parvum oocysts	2
sqRT-PCR and qRT-PCR product	2
DNA extracts of the same C. parvum fecal samples	2
C. parvum-containing calf feces	2
Cryspovirus sequences	2
C. parvum in clinical samples	2
Cryptosporidium parvum	2
C. parvum oocysts and other protozoan parasites	2
safe irrigation water	2
oocysts present	2
oocyst	2
low quality water	2
different types of surface water	2
many tropical countries	2
M. oleifera seeds	2
untreated wastewater and stream water	2
untreated stream water	2
supernatant of MO treated stream water	2
oocysts L−1	2
C. parvum oocyst load	2
MO seed extracts	2
three (stream water) or six (wastewater) replicate glass jars	2
remaining water	2
5% w/v MO seed extract	2
wastewater and stream water	2
glass jars	2
Danish sewage treatment plant	2
primary settling tanks	2
500mL wastewater	2
Glass jars (n=60)	2
turbidity in wastewater and stream water	2
Cryptosporidium parvum oocysts	2
seeds of the Moringa oleifera tree (MO)	2
coagulant	2
feces contaminated water	2
fruit and vegetables	2
limited freshwater resources	2
different types of low quality water	2
human outbreaks	2
S. nesbitti	2
unknown species of snakes	2
Maccaque monkeys	2
“Sarcocystis nesbitti”	2
new type of zoonosis	2
biopsy of muscles	2
humans on vacation/travel	2
muscular sarcocystosis	2
isolated human cases	2
Sarcocystis heydorni	2
Sarcocystis hominis	2
zoonotic species	2
domestic and wild pigs	2
pork, Sarcocystis suihominis	2
Sarcocystis species	2
infected beef	2
infected pork	2
infected meal	2
sporulated sporocysts in human feces	2
raw meat	2
toxic substances	2
raw beef or pork	2
advanced analysis models	2
head and neck, rectum, cervix, prostate, and brain	2
different tumor sites	2
potential RT biomarkers	2
mono- and bi-exponential models	2
RT purposes	2
Younger patients	2
122 head and neck cancer patients	2
main trial	2
prospective consent	2
central study-specific uropathologist	2
recruiting centre pathologist	2
Gleason grade group	2
central Trans-CHHiP group	2
highly motivated Clinical Trials Unit chasing samples	2
pathology departments	2
patients provided tissue	2
centrally-assigned Gleason grade group	2
study-specific specialist uropathologist	2
localised prostate cancer	2
Prostate cancer, ISRCTN 97182923) trial	2
newly diagnosed glioblastoma	2
 temozolomide	2
molecular targeted agents	2
sonic hedgehog and LXRα pathways	2
ATP-binding cassette transporters, ABCA1 and ABCG1	2
sonic hedgehog expression	2
sonic hedgehog pathway mediator, smoothened	2
human breast cancer cell line (MDA-MB-231)	2
mixture of 5α-cholestane-3β,6β-diol and 5α-cholestane-3β,6α-diol (diol)	2
7-ketocholesterol (7-KC), cholestane-3β-5α-6β-triol (triol)	2
oxidation products	2
TSG-6 and HC-HA	2
Cultured human lung microvascular endothelial cells	2
intravascular HC-HA formation	2
systemically-induced endotoxemia	2
intraperitoneal and intratracheal LPS	2
plasma and lung tissue	2
littermate controls	2
TSG-6 knockout mice	2
intraperitoneal lipopolysaccharide (LPS)-induced endotoxemia	2
HC-HA	2
HC-modified HA (HC-HA)	2
enzyme tumor necrosis factor α (TNFα)-stimulated-gene-6 (TSG-6)	2
heavy chains (HC) of the serum protein inter alpha inhibitor (IαI)	2
ubiquitous extracellular polysaccharide hyaluronan (HA)	2
several solute carrier transporter and megalin genes	2
megalin gene	2
HNF4α binding site	2
megalin promoter	2
endocytic receptor of various molecules	2
megalin (LRP2)	2
human PTEC-derived HK-2 cells	2
many solute carrier transporter genes	2
novel HNF4α target genes	2
transporters, ion channels	2
various substances	2
proximal tubular epithelial cells (PTECs)	2
many genes in the liver, pancreas, small intestine, and colon	2
nuclear receptor superfamily	2
Hepatocyte nuclear factor 4α (HNF4α)	2
dPDPN-expressing canine SCCs and melanomas	2
CHO/dPDPN	2
canine mononuclear cells	2
(CHO)/dPDPN cells	2
Chinese hamster ovary	2
mouse–canine mAb of subclass B, P38B	2
canine squamous cell carcinomas (SCCs) and melanomas	2
mouse monoclonal antibody (mAb), PMab-38 (IgG1, kappa) against dog PDPN (dPDPN)	2
C-type lectin-like receptor 2 (CLEC-2)	2
renal podocytes	2
alveolar cells	2
pulmonary type	2
type I transmembrane heavily glycosylated sialoglycoprotein	2
Podoplanin (PDPN)	2
diethylene glycol	2
zinc acetate dihydrate	2
prepared particles	2
Gram-positive Staphylococcus aureus (NCIM 2654)and Gram-negative Proteus vulgaris (NCIM 2613)	2
presence and in the absence of sodium acetate	2
refluxing zinc acetate precursor in diethylene glycol(DEG) and triethylene glycol(TEG)	2
trehalose and BSA	2
native G3LEA protein	2
active site of mKate2	2
red fluorescent protein, mKate2	2
group 3 late embryogenesis abundant (G3LEA) protein	2
short model peptide	2
gradient of proteins	2
gradient of protein	2
caudal mesenchyme	2
proximal, middle and caudal MDs	2
Aldh1a2 promoter	2
proximal and middle regions of the MDs	2
C/EBPδ protein	2
uterine mesenchymal cell line	2
RA synthesis enzyme	2
transcription factors regulating Aldh1a2	2
epithelium of caudal MD	2
RA metabolizing enzyme, CYP26A1	2
uterine or vaginal mesenchyme	2
mesenchymal fate determination system	2
female reproductive tract epithelia	2
oviduct, uterus and vagina	2
proximal, middle and caudal Müllerian ducts (MDs)	2
secondary DSBs	2
PARP inhibitor	2
delayed DSBs	2
uracil-DNA glycosylase 2 (UNG2)	2
major deamination product	2
long-lasting DSBs	2
inflammation-associated cancers	2
5-methyl cytosine	2
begin adenomas	2
colon cancers	2
miRNA34a gene expression	2
patients groups	2
microRNA 34a	2
apparently healthy persons	2
benign colon polyp	2
colon adenocarcinoma	2
vaccine adjuvant	2
oldest known nanomedicine	2
traditional herbal medicine	2
cytochalasin D.	2
phagocytosis inhibitor	2
genes and proteins of inflammatory cytokines	2
polysaccharide	2
immunostimulant	2
novel immunostimulant component	2
immunostimulants	2
boiling water extract	2
herbal secondary metabolites	2
glycyrrhizic acid (old example) and FTY720 (current example)	2
Many epoch-making immunosuppressant drugs	2
Herbal medicine	2
HSC-2/PODXL-KO	2
HSC-2/PODXL-KO cells	2
OSCC cell lines	2
HSC-2 cells	2
PODXL-KO OSCC cell lines	2
parental SAS cells	2
SAS/PODXL-KO cell lines	2
SAS OSCC cell lines	2
PODXL-knock out (PODXL-KO) cell lines	2
mouse IgG2a-type, 47-mG2a	2
previously established anti-PODXL monoclonal antibody (mAb), PcMab-47	2
PODXL overexpression	2
lung, renal, breast, colorectal, and oral cancers	2
heart, breast, and pancreas	2
highly glycosylated type I transmembrane protein	2
Oral cancers	2
hepatoprotective agent	2
extracts of Radix Fici Hirtae	2
ethyl acetate groups	2
AST, ALT, AKP and LDH in chloroform groups	2
model group	2
hepatic lipid	2
rest of the groups	2
group with saturated n-butyl alcohol	2
mice in alcohol-induced liver injury model	2
aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (AKP), and lactate dehydrogenase (LDH)	2
mouse lavage	2
g crude drug/d	2
three dose groups	2
petroleum ether, chloroform, ethyl acetate and n-butanol	2
component of Radix Fici Hirtae	2
ASM tissue-like construct	2
stretched ASM cells	2
α-smooth muscle actin, calponin, myosin heavy chain 11, and transgelin	2
nuclei and actin stress fibers	2
tissue-like structure	2
type-I collagen	2
3-D gel	2
type-I collagen gel	2
human ASM cells	2
bioengineered ASM models	2
airway smooth muscle (ASM) cells	2
functional anti-mPDPN monoclonal antibodies	2
Asp39 and Met41 of mPDPN	2
critical epitope of PMab-1	2
normal cells and cancers	2
PLAG2 and PLAG3 domains of mPDPN	2
rat anti-mPDPN monoclonal antibody clone PMab-1	2
C-type lectin-like receptor 2 of platelets	2
PLAG4 in the middle of the mPDPN protein	2
PLAG1, PLAG2, and PLAG3 in the N-terminus	2
platelet aggregation-stimulating (PLAG) domains	2
platelet aggregation-inducing factor	2
type I alveolar cells of the lung	2
lymphatic endothelial cells, podocytes of the kidney	2
transmembrane sialoglycoprotein	2
Mouse podoplanin (mPDPN)	2
functional anti-ATRX mAbs	2
Gln2368 of ATRX	2
binding epitope of AMab-6	2
recombinant human ATRX	2
immunizing mice	2
sensitive monoclonal antibody (mAb) AMab-6	2
subtypes of diffuse gliomas	2
codeletion of chromosomes 1p/19q	2
transcriptase (TERT) promoter	2
isocitrate dehydrogenase (IDH), telomerase reverse	2
cancer subtypes	2
pancreatic neuroendocrine tumors	2
q arm of the X chromosome	2
alpha-thalassemia/mental-retardation-syndrome-X-linked (ATRX) gene	2
SUR2A expression	2
high glucose	2
upregulating Kir6.1 and Kir6.2	2
inhibitor of oxidative phosphorylation	2
50 mM)	2
glucose and 2-deoxyglucose	2
Kir6.2 mRNA	2
IES SUR2A and IES SUR2B mRNAs	2
SUR1	2
mRNAs of Kir6.2, Kir6.1, SUR1 and IES SUR2B	2
heart H9c2 cells	2
SUR2A/KATP channel subunits	2
KATP channel subunit	2
SUR2A,	2
ER-positive breast cancers	2
HER3 and Nedd4-1	2
si-RNA	2
ER-positive breast cancer, MCF-7	2
proteasome pathway	2
receptor tyrosine kinase super family	2
soyasapogenol B	2
soyasapogenol B-treated cell media	2
soyasapogenol A-, soyasapogenol B-, and vehicle-treated cells	2
adipose triglyceride lipase	2
vehicle cells	2
soyasapogenol B-treated cells	2
presence of soyasapogenol A or B (6.25 or 12.5 µM	2
mouse 3T3-L1 adipocyte cells	2
soyasapogenol A and B	2
glycoside form	2
soyasaponin aglycone	2
AhR receptor	2
2-fold dilutions of LMWF5A or synthetic NAK with or without an AhR antagonist (CH223191)	2
phorbol 12-myristate 13-acetate (PMA)	2
LMWF5A. THP-1 monocytes	2
major degradation product	2
known AhR agonist	2
AhR	2
N-acetyl kynurenine (NAK), an N-acetyl tryptophan (NAT) breakdown product in LMWF5A	2
low molecular weight fraction of 5% human serum albumin (LMWF5A) and	2
immuno-modulatory mediators	2
Activated macrophages	2
multi-domain histidine kinase	2
crystal model	2
3.25-Å resolution dataset	2
improved LOV-HK crystals	2
almost the whole protein	2
search models	2
dimer in the asymmetric unit	2
complete X-ray diffraction data set	2
single crystal	2
individual native data sets	2
controlled illumination environment	2
full-length LOV-HK	2
key blue light-activated virulence factor	2
multi-domain dimeric cytoplasmic histidine kinase called LOV-HK	2
pathogenic bacterium Brucella abortus	2
neither β-catenin nor γ-catenin expression	2
β-catenin and γ-catenin genes	2
role of β-catenin	2
γ-catenin	2
β-catenin gene	2
middle part of the molecule	2
amino-terminal β-catenin–binding region	2
wild-type LEF-1	2
one of the Wnt/β-catenin target genes	2
Transcription factor lymphoid-enhancer–binding factor 1 (LEF-1)	2
MSCs conditioned media (CM)	2
Human Dermal Fibroblasts (HDFs)	2
vitro	2
one of the rejuvenation factors, the growth differentiation factor-11 (GDF-11)	2
Epithelial Growth Factor (EGF), basic Fibroblast Growth Factor (bFGF), Platelet Derived Growth Factor (PDGF), Hepatocyte Growth Factor (HGF), Collagen type 1	2
human umbilical cord blood-derived mesenchymal stem cells conditioned media (USC-CM)	2
many cytokines	2
plasma and liver	2
interleukin-1β (IL-1β) and interferon-γ (IFN-γ)	2
LPS-induced inflammatory cytokines	2
administered a nonlethal dose	2
lung, and liver samples	2
lethal (30 mg/kg) or nonlethal (15 mg/kg) dose of lipopolysaccharide (LPS)	2
normal chow	2
dams and offspring	2
Female C57BL/6 mice	2
functional anti-EGFR mAbs	2
377-RGDSFTHTPP−386 sequence	2
minimum epitope of EMab-134	2
blocking peptide (375–394 amino acids of EGFR)	2
epitope of EMab-134	2
endogenous EGFR-expressing cancer cell lines and normal cells	2
EMab-134, a novel anti-EGFR monoclonal antibody (mAb)	2
oral and lung cancers	2
downstream signaling cascades	2
type-1 transmembrane receptor tyrosine kinase	2
excellent fungicidal agent	2
CD3 counting	2
candida yeast	2
Haematoxylin & Eosin and CD3 immunohistochemical staining	2
tongue specimens	2
ozone oxygen gas mixture	2
group IV rats	2
daily mycostatin drops local applicator	2
Group III rats	2
oral inoculums of C. albicans on the dorsal surface of the tongue	2
Rats of group 1	2
four equal groups	2
Sixty male healthy rats	2
oral candidiasis	2
local or general defense mechanisms	2
Immunosuppressive drugs	2
C44Mab-5 antibody	2
Ca9-22, HO-1-u-1, SAS, HSC-2, HSC-3, and HSC-4	2
CD44s and CD44v3-10	2
One of the clones, C44Mab-5 (IgG1, kappa)	2
novel anti-CD44 mAbs	2
CHO-K1 cell lines overexpressing CD44v3-10	2
CD44 variant isoforms	2
surface of most tissues and all hematopoietic cells	2
variant exons	2
CD44 standard (CD44s)	2
various combinations of alternative exons	2
alternative splicing isoforms of CD44	2
variety of genes	2
functional anti-PODXL mAbs	2
minimum epitope	2
blocking peptide	2
Asp207, His208, Leu209, and Met210	2
minimum epitope of PcMab-47	2
epitope of PcMab-47	2
endogenous PODXL-expressing cancer cell lines and normal cells	2
PcMab-47, a novel anti-PODXL monoclonal antibody (mAb)	2
oral, breast, and lung cancer tissues	2
types of human cancer tissues	2
intact cardiac troponin complex	2
structured core	2
cCTnC domain	2
residues 39–60 of cTnI	2
cTnC-cTnI135–209 complex	2
cTnC-cTnI1–77 complex	2
segments of cTnI	2
two soluble constructs	2
cardiac troponin I (cTnI)	2
regulatory N-terminal domain (cNTnC)	2
structural C-terminal domain of cTnC (cCTnC)	2
calcium-sensing subunit of the cardiac troponin complex, cardiac troponin C (cTnC)	2
compound MCI-154	2
native β-enolase	2
epitope 2 peptidic homolog	2
A198 with E in peptide representing β-enolase epitope 2	2
E197 with A in α-enolase epitope 2 peptide	2
epitope 2 in β-enolase (G194VIKAKYGKDATN206)	2
anti-α- nor anti-β-antibody	2
anti-β-enolase antibodies	2
α-enolase sequence (epitope 2 - N193VIKEKYGKDATN205)	2
anti-α-enolase	2
C-terminal portion of the epitope 3 - S262PDDPSRYISPDQ273)	2
α-enolase epitope	2
pin-attached peptides	2
α- and β-enolase	2
antibodies selective bioinformatic tools	2
pig and rat β-enolase	2
human α-isoenzyme	2
human β-enolase	2
either α- or β-enolase-Sepharose columns	2
Selective anti-α- and anti-β-enolase antibodies	2
human kidney (α-enolase) and skeletal muscle (β-enolase)	2
anti-α- and anti-β-enolase polyclonal antibodies	2
highly homologous enzymes	2
β-enolases	2
Human α-	2
different QCC ligands	2
epitope tagged EmrE	2
range of structurally different QCC ligands	2
DDM environment	2
EmrE protein	2
detergent n-dodecyl-β-D-maltopyranoside (DDM)	2
hexahistidinyl (His6) – myc epitope tagged EmrE	2
wide variety of quaternary cation compounds (QCCs)	2
small multidrug resistance (SMR) protein family	2
future road map	2
complex gut samples	2
cell surface proteins	2
low pH and bile acid	2
harsh gut environment	2
proteome map	2
proteomics of probiotics	2
Lactobacillus and Bifidobacterium	2
gastro-intestinal tract of humans and other animals	2
heart cells	2
high-functioning cells	2
3D tissues	2
denser prevascular networks	2
Cardiac tissue	2
skin of nude rats	2
dense myocardial tissue	2
myocardial tissue	2
thicker 3D tissues	2
low-temperature environments	2
cell sheet technology	2
supplied nutrients	2
sufficient oxygen and nutrients	2
complex capillary structures	2
higher-density tissues	2
Assembling three-dimensional (3D) tissues	2
healthy individuals biofluids	2
neurofilament-containing aggregates	2
UC aggregates	2
lesser extent extra-cellular matrix proteins	2
cell structural	2
Shotgun proteomics	2
SDS-stable high molecular weight aggregates	2
neurofilament heavy chain (NfH)	2
Nf isoforms	2
plasma of healthy individuals	2
commercially available protein aggregate binder, Seprion PAD-Beads (SEP)	2
ultracentrifugation (UC)	2
novel disease biomarkers	2
Nf-containing hetero-aggregates (NCH)	2
high molecular weight complexes	2
building blocks of neurons	2
neurofilaments (Nf)	2
plasma or cell proteins	2
fluid-borne aggregates	2
hPD-L1	2
L1Mab-4 stained 106/150	2
membrane-staining pattern	2
oral cancer cell lines (Ca9-22, HO-1-u-1, SAS, HSC-2, HSC-3, and HSC-4) in flow cytometry	2
L1Mab-4 (IgG2b, kappa)	2
novel anti-hPD-L1 monoclonal antibody (mAb),	2
human PD-L1 (hPD-L1) expression	2
melanoma and lung cancer cells	2
several tumor cells	2
ligand of programmed cell death-1 (PD-1)	2
Programmed cell death-ligand 1 (PD-L1)	2
Fab	2
K5- and R5-mutants	2
encounter complex	2
two mutant antigen-binding fragments (Fabs)	2
basic amino acid residues	2
introduced charged residues	2
framework region of an antibody	2
research tools and diagnostic agents	2
infectious form	2
base sequences	2
pseudoknots	2
prion protein mRNA pseudoknots of the same species	2
larger complexes	2
particular species	2
Prion protein	2
structured region of the prion protein	2
incipient nonpolar groups	2
protein and nucleic acids	2
larger nucleoprotein complexes	2
reactants	2
number of sites	2
intrinsic tryptophan groups of the protein	2
tRNA and polyA	2
prokaryotic and eukaryotic prion protein mRNA pseudoknots	2
small highly structured RNAs	2
recombinant prion protein	2
toxic species	2
protofibrillar aggregates	2
Aβ-42 nuclei	2
amyloid beta (Aβ-42)	2
7-ketocholesterol (7keto)	2
Oxidized cholesterol	2
antioxidants	2
P.sapota leaf	2
MCF-7 cell lines	2
aqueous extract of the P.sapota leaf	2
breast cancer cell lines (MCF-7)	2
aqueous leaf extract	2
leaf extract	2
aqueous leaf extract of Pouteria sapota (P.sapota)	2
Natural products	2
IRS-1 at serine residue	2
JNK and NF-kB pathways	2
2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]−2-deoxy-D-glucose (2-NBDG)	2
C2C12 differentiated myoblasts	2
blueberry leaf extract (BLEx)	2
anti-obesity food component	2
Blueberry (Vaccinium ashei) leaf	2
polyphosphate in mammalian systems	2
established ATP-dependent glucokinase	2
polyphosphate-dependent enzyme system	2
several nucleotide phosphates	2
new enzyme	2
mammalian ATP-glucokinases	2
phosphoryl donors	2
mammalian ATP-glucokinase	2
liver enzyme	2
nuclei of mammalian hepatocytes	2
phosphoryl donor	2
hexametaphosphate (HMP)	2
novel mammalian glucokinase	2
NMR and NAD-linked assay systems	2
polyphosphate exclusively	2
micro-organisms	2
polyphosphate in mammalian cells	2
microbial systems	2
Polyphosphate synthesising or utilizing enzymes	2
eukaryotic and microbial systems	2
variety of polyphosphate substrates	2
substrates in mammalian systems	2
glucokinase enzymes	2
good source	2
biofilm producing pathogens	2
bacterial strain S. aureus	2
EPS of S. aureus	2
pathogenic strain of S. aureus	2
herbal extract S. grandiflora	2
Extracellular polymeric substance (EPS)	2
congo-red assay	2
Biofilm forming pathogens	2
Sesbania grandiflora (S. grandiflora)	2
microglia homeostasis	2
LPS-challenged BV-2 cells	2
pro-inflammatory markers IL6, CCL2, and iNOS	2
lipopolysaccharide (LPS)-activated BV-2 microglia	2
key functions	2
plant-derived carotenoid	2
biodegradable plastics	2
PHAs	2
cheap substrates	2
abundance	2
hand Bacillus species	2
PHAs by Bacillus species	2
conventional non-degradable, petrochemical-based polymer	2
microbially derived polyhydroxyalkanoates biopolymers	2
homo-hexadecameric archaeal chaperonin	2
wild type complex	2
mutant subunit	2
archaeal chaperonin	2
eight similar but non-identical subunits	2
~ 1MDa nanomachine	2
human chaperonin complex	2
STAT3 and NF-κB.	2
paw tissues	2
carrageenan-induced mouse paw edema model	2
two major transcription factors STAT3 and NF-κB	2
Kaempferol deactivated	2
human monocytic THP-1 cells	2
plant polyphenol, kaempferol	2
anti-inflammatory drugs	2
prostanoids and prostaglandins	2
inducible isoform of cycloxygenase enzyme family	2
Cycloxygenase-2 (COX-2)	2
peroxisome proliferator-activated receptor α	2
Extramitochondrial Acot11 and acyl-CoA oxidase	2
unilocular, large lipid droplets	2
ddY, ICR and KK-Ay	2
baseline and control low-fat diet (LFD)-fed mice	2
(Acot) 2	2
carnitine palmitoyltransferase 2 (Cpt2), acyl-CoA thioesterase	2
C57BL/6J mice fed a high-fat diet (HFD)	2
diet-induced obesity C57BL/6J mouse model	2
fatty acid oxidation-associated enzymes and uncoupling protein 1 (Ucp1)	2
fuel	2
powerful analytical tools of Multi-PK antibodies	2
recently developed technologies	2
various biological species	2
518 protein kinase genes	2
coral calcification	2
pockets of SCM	2
calcein-stained SCM	2
live primary polyp tissues	2
calicoblastic cells	2
skeletal growth	2
calcein-containing seawater	2
primary polyp tissues	2
tissue-skeleton interface (subcalicoblastic medium, SCM)	2
calcium deposition marker	2
fluorophore calcein	2
coral species Acropora digitifera	2
aposymbiotic primary polyps	2
scleractinian corals	2
50S subunit	2
E. coli 30S subunits	2
highly purified E. coli translation system	2
Escherichia coli and Bacillus subtilis or E. coli and Geobacillus stearothermophilus subunits	2
broad range of organisms	2
rRNA and ribosomal proteins	2
osteoblastic mechanoresponses	2
soluble factor(s)	2
RAF activity	2
+, PI3-kinase, and Rho kinase	2
mechanoresponses	2
“mechanoresponse”	2
differentiating myoblasts	2
miR-23a/b	2
muscle-enriched miR-486	2
exception of miR-206	2
Smad2 signaling	2
potent ALK4/5/7 inhibitor	2
myomiRs (miR-1, 133a/b and 206)	2
recombinant myostatin	2
myomiRs miR-1	2
3′ UTR of target mRNA	2
22 base pair nucleotides	2
activin receptor IIB, activin receptor-like kinase (ALK)	2
muscle growth	2
small glycopeptide	2
Several of the proteins	2
Calmodulin, cystatin-B, histone H2B, peroxiredoxin1, apolipoprotein A1, natterin-2, 14-3-3 protein, alfa enolase, pentraxin	2
PANTHER (www.patherdb.org)	2
databases SwissProt, NCBInr and vertebrate EST	2
Mucosal proteins	2
2D gels	2
lumpsucker skin mucus	2
pathogens and external stressors	2
Fish skin mucus	2
glycine and L-α-alanine	2
small osmolytes	2
PB2 627	2
amide peaks	2
L-arginine L-glutamate salt, (L-arginine)2SO4, glycerol, β-octylglucoside, 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate, Na2SO4, 1,5-diaminopentane, 1,4-diaminobutane, trehalose, sucrose, glycine, trimethylamine N-oxide, β-alanine, L-α-alanine, hydroxyectoine, betaine, L-proline, and non-detergent sulfobetaine 195, 201, and 256	2
different additives	2
backbone amide proton signals	2
lysine 627 (PB2 627)	2
C-terminal RNA-binding domain in PB2	2
subunits PA, PB1, and PB2	2
RNA-dependent RNA polymerase	2
RNA genome	2
dynamic enzyme	2
two cofactors	2
donor-acceptor distance	2
two identical monomers	2
valine, alanine and glycine	2
conserved I135 residue of Fno	2
donor-acceptor distance between NADP+ and the F420 precursor, FO.	2
Fno variants	2
wtFno and isoleucine 135 (I135)	2
reduced F420 cofactor	2
Oxidoreductase (Fno)	2
MOMP channel	2
outer membrane of Campylobacter	2
mono and trimers	2
two main distinct populations of protein channels	2
pathogenic strain of C. jejuni	2
cell wall of Campylobacter jejuni	2
major outer membrane protein	2
MOMP porin	2
short poly-arginines	2
several known and novel modulators	2
small molecule library	2
small molecule libraries	2
luciferase cargo	2
fatty acid medium	2
POT-1 promoter	2
Renilla luciferase reporter genes	2
yeast S. cerevisiae	2
dual luciferase based assay	2
new candidate molecules	2
novel sensitive assays	2
high throughput format	2
conventional autophagy assays	2
small molecule effectors	2
potential drugs	2
potential pharmacological target	2
superfluous and damaged cytoplasmic constituents	2
caspase 3	2
Hela cells	2
anthracycline antibiotics, doxorubicin	2
human RCC cell line	2
many cancerous cells	2
Peroxisome proliferator-activated receptor-γ (PPARγ)	2
chemoresistant renal cell carcinoma (RCC)	2
endogenous anticancer agent, 15-deoxy -Δ12,14-prostaglandin J2 (15d-PGJ2)	2
different types of yeast strains	2
type of feedstocks	2
hybrid, recombinant and wild-type yeasts	2
Various types of yeast strains	2
pentose sugars	2
wide range of sugars	2
types of microoganisms, yeasts	2
sucrose, starch, lignocellulosic and algal biomass	2
various types of feedstocks	2
mostly used biofuel worldwide	2
complementary ssDNA or dsDNA	2
circular dichroism spectra	2
secondary structure of Thermus thermophilus HU (TtHU)	2
HU binds double-stranded DNA (dsDNA)	2
various nucleoid-associated proteins (NAPs)	2
aggregated structure	2
prokaryotic cells	2
MC degranulation	2
resulting super agonist, 2-deoxy-LysoPT with C3-pH-p-O-C11	2
aromatic fatty acid surrogate (C3-pH-p-O-C11)	2
fatty acid surrogates	2
potent LysoPS analogs	2
methyl group at the carbon of the serine residue, i.e., lysophosphatidylthreonine (LysoPT)	2
kind of lysophospholipid	2
Lysophosphatidylserine (LysoPS)	2
cytoplasmic granules	2
wide variety of chemical mediators	2
mast cells (MCs)	2
Alzet osmotic pump	2
actinomycin D	2
PER2::LUC protein	2
Per1 and Per2 in neuronal cells	2
PER2::LUC mouse embryos	2
neuronal progenitor cells	2
cell-autonomous endogenous system	2
cinnamic acid	2
Cinnamic acid (CA) derivatives	2
hepatic capsule	2
tissues from NASH model mice	2
second harmonic generation (SHG) and auto-fluorescence (AF)	2
ubiquitination machinery	2
replication inhibitor hydroxyurea	2
overexpressed protein	2
additional lysines	2
primary attachment site for ubiquitin on S. cerevisiae Mcm10	2
replication clamp	2
multivalent DNA scaffold, Mcm10	2
eukaryotic replication machinery	2
Minichromosome maintenance protein (Mcm) 10	2
Dmrt3 gene	2
single and double KO mice	2
adult and neonatal testes	2
double KO mice	2
multiple DM domain genes in mice	2
DMRT genes	2
Dmrt1 knockout	2
seven mammalian family members of DM domain transcription factors	2
DM domain transcription factors	2
8-bromo-cAMP	2
cells expressing AC3	2
cells expressing AC7	2
cAMP inducing artificial promoter	2
AC7 or AC3	2
NIH 3T3 cells	2
specific AC isoform	2
AC isoform-specific; type 7 AC (AC7)	2
cyclic AMP (cAMP) signal transduction system	2
hepatic breast cancer	2
peritoneal seeding	2
hepatic breast cancer tumor foci	2
experimental (preclinical) model	2
MDA-MB-231 cell line	2
liver breast cancer	2
several distant organs	2
cancer-related deaths	2
protein polymers	2
peptidic cross-linker	2
synthesized PLCys	2
free cysteine	2
protein polymer	2
PLCys peptides	2
PLCys-independent, β-elimination-mediated cross-linkings	2
free SH group	2
four disulfide bonds	2
protein materials	2
synthetic multi-thiol additives	2
multi-thiol peptide	2
free forms	2
SH groups	2
poly-l-cysteine (PLCys)	2
l-cysteine ethyl ester in a frozen buffer	2
ShcKO mice	2
gluconeogenesis and lipid catabolism	2
glycolytic and gluconeogenic enzymes	2
key regulatory metabolites	2
gluconeogenic and transamination enzyme activities	2
Fourier terms	2
canine kidney epithelial cells	2
human cerebral endothelial cells	2
cell barrier models (e.g. blood-brain barrier	2
eicosapentaenoic acid	2
eicosapentaenoic acid-containing phosphatidylcholine	2
testicular interstitium	2
relevant lipids in testes	2
serum testosterone	2
AQP4 arrays	2
two or more tetramers	2
large cluster of AQP4	2
anti-AQP4-ECDs antibody	2
bound mAbs	2
AQP4 on the cell surface	2
lysate of cells	2
fluorescence-labeled antibodies	2
cells expressing AQP4	2
M1 and M23	2
square-array-formable M23 isoform	2
(E5415B)	2
M1 and M23 isoforms	2
Two types of mAb	2
ECDs of mouse AQP4	2
extracellular domains (ECDs) of aquaporin-4 (AQP4)	2
autoantibody called NMO-IgG	2
Neuromyelitis optica (NMO)	2
transcription elongation factor Brd4	2
small intestine of mice	2
intestinal Caco-2 cells	2
SLC2A5 gene	2
-TEFb	2
another intestinal gene sucrase-isomaltase	2
small-intestine Slc2a5	2
acetylated histones	2
bromodomain-containing protein-4 (Brd4)–positive transcriptional elongation factor-b (P-TEFb)–RNA polymerase II complex	2
small intestine of wild-type mice	2
(sh) RNA expression vector	2
Caco-2 cells with or without Brd4 small hairpin	2
p44/42 MAPK inhibitor PD98059 (PD)	2
glucocorticoid receptor agonist dexamethasone (Dex)	2
small intestinal Caco-2 cells	2
glucocorticoids and p44/42 mitogen-activated protein kinase	2
histone acetylation	2
fructose transporter gene SLC2A5	2
high salt extracellular environment	2
inducible nitric oxide synthetase expression	2
MΦ2-like phenotype specific anti-inflammatory cytokine, IL-10, TGFβ, CCL-17 (3.7 fold) and CCR-2 (4.3 fold)	2
MΦ1 phenotype specific pro-inflammatory cytokine, TNFα (3.3 fold), IL-12 (2.3 fold), CCL-10 (2 fold) and CCL-5 (3.8 fold)	2
peripheral circulating monocyte/macrophages	2
extracellular sodium chloride	2
high salt tissue micro-environment	2
RHN and NG108 cells	2
1-kHz burst	2
psEP-treated cells	2
brief psEP bursts	2
depolarized cells	2
rat hippocampal neurons (RHN), NG108, and CHO cells	2
500ps stimuli	2
micro- and nanosecond-duration stimuli	2
multicomponent recombinant protein expression systems	2
relevant proteins	2
S100 protein complexes	2
S100A9	2
Semi-stable homodimers of S100A8	2
biologically active samples	2
stable S100A8/A9 heterodimer complex	2
single-vector system	2
S100A8 and S100A9 proteins	2
S100 protein family	2
multicomponent protein assemblies	2
nanoparticles based drugs delivery system	2
high and low-affinity binding sites	2
CuO and TiO2 nanoparticles	2
structural information	2
HSA protein	2
i.e subdomain IIA	2
suldow site	2
suldow site II i.e subdomain III A of HSA protein	2
TiO2 nanoparticle-HSA interaction	2
hydrophopobic grove	2
hydrogen bond with nanoparticle and Leu 283, Leu 284	2
TiO2-HSA, Ser-287 at the centre region	2
aliphatic grove	2
Glu 285, Lys 286	2
neighbouring residue	2
Arg 257, Ala 258, Ser 287, His 288, Leu 283, Ala 254, Tyr 150 (subdomain II A)	2
binding region	2
aliphatic region	2
Lys 475, Glu 492	2
bound neighbouring residues	2
2.113Å and Lys 475, Glu 492, Ala 490, Cys 487, Ala 490	2
centre of Subdomain IIIA	2
specific binding site of protein with CuO nanoparticles	2
human serum albumin (HSA) protein-CuO nanoparticle interaction	2
frameshifting pathways	2
shunt	2
(2014) [29]	2
dnaX −1 frameshift mRNA	2
, internal Shine–Dalgarno (SD) sequence	2
upstream	2
additional stimulatory signal	2
dnaX gene of Escherichia coli	2
prokaryotic cases	2
downstream mRNA pseudoknot	2
CD86 and HLA-DR expression	2
HLA-DR (+30%, P=0.015) and CD86 (+204%, P=0.004) positive cells	2
PTX3 in apoptotic cells	2
nuclear factor-kappa B (NF-κB) activation	2
activated transforming growth factor-β (TGF−β)	2
macrophage interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α)	2
apoptotic macrophages (THP-1 cell line)	2
Raw 264.7 cell culture medium	2
THP-1 culture medium	2
MethodsPMA-treated THP-1 cell line (THP-1 macrophage) and monocyte-derived human primary macrophages	2
aimsPentraxin-3 (PTX3)	2
tissue source	2
potential xenotransplant	2
bovine pancreas	2
bovine genome	2
bovine pancreatic acini	2
protease>lipase>amylase	2
surface of cells	2
heterogenous enzyme granules	2
porosome	2
bovine pancreatic acinar cell culture model	2
mevalonate-derived intermediates	2
[3H]sphingomyelin	2
Exogenous mevalonic acid or cholesterol	2
lovastatin	2
sphingomyelin synthase and neutral sphingomyelinase	2
[3H]choline into phosphatidylcholine and sphingomyelin, inhibited CTP: phosphocholine cytidylyltransferase (CT) activity	2
oxysterol, 27-hydroxycholesterol	2
phosphatidylcholine and sphingomyelin	2
two phospholipids	2
uncontrolled and serious itching	2
advanced konjac ceramide material	2
neurite growth cones	2
Sema 3A	2
NGF-induced neurite outgrowth	2
Sema 3A.	2
epidermal nerve fibers	2
Semaphorin 3A (Sema 3A)	2
stratum corneum of the skin	2
itch factors	2
Nerve growth factor (NGF)	2
dry skin	2
enriched source of GlcCer (kGlcCer)	2
Konjac, a plant tuber	2
successfully prepared konjac ceramide (kCer) using endoglycoceramidase I (EGCase I)	2
health supplement	2
dietary GlcCer	2
glucosylceramide (GlcCer)	2
Dietary sphingolipids	2
cerebellar Purkinje cells in Dgcr2-KO mice	2
Dgcr2-knock-out/EGFP-knock-in mice (Dgcr2-KO mice	2
DGCR2 gene	2
non-canonical NF-κB pathway	2
TNF treated cells	2
non-canonical NF-κB signalling pathway	2
cold-inducible RNA binding protein (CIRBP)	2
plethora of genes	2
phenyl moiety structure of the curcuminoids	2
healthy bronchial epithelia	2
apically and basolaterally	2
F-actin structures	2
hydroxypropyl-γ–cyclodextrin	2
curcuminoids	2
bronchial epithelial cell line VA10	2
epithelial tight junction complex	2
bisdemethoxycurcumin and dimethoxycurcumin	2
investigated cells	2
combination of curcumin, demethoxycurcumin and bisdemethoxycurcumin	2
commercial curcumin	2
cystic fibrosis transmembrane regulatory (CFTR) protein in lung epithelium	2
phytochemical curcumin	2
IL-38 (−/−) mice	2
autoantibody-induced rheumatoid arthritis (RA) mouse model	2
C57BL/6 IL-38 gene-deficient (−/−) mice	2
IL-38 protein	2
soluble form of IL-38 protein	2
IL-38 cDNA	2
recombinant caspase-1, chymase, or PR3	2
human recombinant IL-38 protein	2
enzyme-linked immunosorbent assay	2
anti-human IL-38 monoclonal antibodies	2
inflammatory or an anti-inflammatory cytokine	2
newly characterized cytokine IL-38 (IL-1F10)	2
free maltase	2
substrate (maltose)	2
free counterpart	2
calcium chloride	2
immobilization yield	2
Immobilized maltase	2
calcium alginate beads	2
Bacillus licheniformis KIBGE-IB4	2
murine undifferentiated neural progenitor cells	2
mTOR signaling pathway	2
neuronal marker protein	2
murine embryonic neocortex and adult hippocampus	2
stable transfectants	2
undifferentiated P19 cells	2
mTOR-relevant proteins	2
embryonic mouse neocortex	2
mTOR and downstream proteins	2
murine neural progenitor cells	2
mTOR) kinase pathway	2
mammalian target of rapamycin (	2
good substrate	2
green tea amino acid theanine	2
pluripotent P19 cells	2
critical chemical substance	2
single-year birth cohorts	2
derived equations	2
new mortality function	2
closed-form analytical expression	2
temperature-dependent mortality function	2
reaction kinetics model	2
almost all multicellular animals	2
cells co-expressing Hsp70 and Hsp90	2
ischemia- and reperfusion-induced murine cardiomyocyte cultures	2
primary cardiomyocyte cultures	2
heat shock proteins (Hsp70 and Hsp90)	2
specific Calpn inhibitor	2
Calpastatin (Calp)	2
calpains (Calpn)	2
ObjectiveCalcineurin (CaN)	2
two-pore domain K+ channel (K2P)	2
20μM)	2
Internal arachidonic acid	2
bell-shaped outward Cs+ current	2
Internal Na+	2
wing cells	2
Cs+ external and internal solutions	2
current	2
Cs+ internal solution	2
internal K+	2
rod cells in frog taste discs	2
General significanceThe AQP8-knocked down cells	2
complex IV and ATP synthase	2
shAQP8	2
shAQP8 cells	2
short hairpin RNA	2
MethodsAQP8-knocked down (shAQP8) cells	2
mouse adipose tissues	2
tissues and cells including liver and kidney	2
various cells	2
Mitochondrial AQP8	2
liver, testis, and pancreas	2
various tissue and cells	2
member of the aquaporin water channel family	2
(AQP8)	2
two β-hairpins	2
folding simulations	2
classical, isothermal–isobaric molecular dynamics (NTP MD) simulations	2
xanthophyll-regulated genes	2
hyaluronic acid, a non-sulfated glycan	2
sulfated glycosaminoglycans	2
peptidase inhibitors	2
176 genes	2
qPCR validation	2
Affymetrix Human Genome Array U113	2
EpiDerm tissue model	2
gene expression and biochemical pathways	2
keratinocyte culture	2
skin health	2
xanthophylls lutein and zeaxanthin	2
multiple-turnover enzyme	2
unmodified Ensifer (Sinorhizobium) meliloti choline-O-sulfatase	2
active-site cysteine 54	2
recombinant sulfatase	2
synthetic substrates p-nitrophenyl sulfate and methylumbelliferyl sulfate	2
natural substrate, choline-O-sulfate	2
dimer in solution	2
 Escherichia coli	2
Ensifer (Sinorhizobium) meliloti choline-O-sulfatase	2
crude extracts	2
enzyme choline-O-sulfatase	2
choline sulfate	2
osmoprotectant glycine betaine	2
nitrogen-fixing α-proteobacterium	2
Ensifer (Sinorhizobium) meliloti	2
Aβ–Cu(II) complex	2
peptide molecule	2
oxidized Met35	2
Aβ	2
one oxygen atom	2
fibrillization	2
fibrils of regular and oxidized peptides	2
regular peptide	2
bound copper ions	2
insoluble Aβ aggregates	2
64 glutamines	2
expanded AR	2
mouse mammary tumor virus (MMTV) promoter	2
hormone response element	2
corresponding mRNAs	2
polyglutamine tracts	2
AR variants	2
X-linked neuromuscular disease spinal and bulbar muscular atrophy (SBMA)	2
polyglutamine-encoding trinucleotide CAG repeat	2
General significanceTranscriptional control	2
procollagen molecule	2
Major conclusionsIn high collagen producing cells	2
coherent model	2
many different labs	2
collagen pathway	2
procollagen (type I)	2
average protein	2
embryonic tendon fibroblasts	2
C-terminal regions of the two subunits	2
two cysteine residues (C303)	2
0.8mM dithiothreitol	2
Sulfolobus tokodaii	2
aspartate pathway	2
l-homoserine and aspartate 4-semialdehyde	2
Homoserine dehydrogenase (HSD; 305 amino acid residues)	2
certain amino acid sequences	2
14-amino-acid, but not an 11-amino-acid, cytoplasmic tail	2
residues 61–115	2
residues 47–48, 67–69, 73–75 and 79–87 stabilize CM2	2
expressed CM2 mutants	2
cytoplasmic tail of CM2	2
influenza C virus M gene	2
KKAy mice	2
PACAP-Tg:KKAy mice	2
ribonucleoprotein complex, mitochondrion, and chromosome organization	2
terms ribosome and intracellular organelles	2
five clusters	2
1371 probes	2
four F1 offspring genotypes (wild-type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy)	2
laser capture microdissected pancreatic islets	2
lethal yellow agouti (KKAy) diabetic mice	2
PACAP-Tg mice	2
type 2 diabetic models	2
PACAP in pancreatic β-cells (PACAP-Tg)	2
pituitary adenylate cyclase-activating polypeptide (PACAP)	2
atenolol transporter	2
flavonoids	2
various flavonoids	2
Madin-Darby canine kidney II cells	2
brush border membrane of enterocytes	2
human organic cation transporter 1 (OCT1/SLC22A1)	2
interacting components	2
responsible transporter	2
components of fruit juices	2
apple and orange juices	2
carrier protein	2
β1-adrenergic receptor blocker	2
OCT technology	2
tight adhesions	2
functional thicker 3-D tissues	2
cardiac cell sheet-tissues	2
Cell sheets	2
regenerating damaged tissues	2
fabricated tissues	2
cell-dense three-dimensional (3-D) tissues	2
investigators/clinicians	2
structural probe	2
protein׳s zinc ion	2
chelator	2
denaturants	2
chelator-inaccessible form	2
LF with 4-(2-pyridylazoresorcinol) (PAR)	2
demetallated LF (apoLF) in urea	2
latter denaturant	2
urea and GdnHCl	2
urea and guanidine hydrochloride (GdnHCl)	2
host cell cytosol	2
protective antigen	2
zinc-dependent endopeptidase	2
Anthrax lethal factor (LF)	2
disordered nuclear proteins	2
various compartments and sub-nuclear bodies of the nucleus of the human cells	2
Intrinsically disordered proteins	2
developmentally regulated genes	2
anchors of loops	2
lineage-committed cells	2
structural loops	2
mouse ESC and neural stem cell (NSC) derivatives	2
structural loops and contact domains	2
nucleosome-free regions	2
weakly condensed heterochromatin	2
unique three-dimensional architecture	2
diverse neuronal cell types	2
previously uncharacterized zinc finger transcription factors	2
high-confidence miR-124 targets	2
RNA-induced-silencing-complex precipitation	2
neurotransmitter specification	2
miR-124-deleted cells	2
six miR-124 alleles	2
thousands of annotated targets	2
key player	2
brain-enriched miR-124	2
-coding RNAs	2
functional architecture	2
allosteric kinase inhibitors	2
regulatory sector	2
catalytic sector	2
three quasi-independent “sectors”—groups of evolutionarily coupled residues	2
substrate outputs	2
hierarchical organization of the kinase domain	2
appropriate substrates	2
specialized spectral libraries	2
430 proteins	2
19,610 proteins	2
MassIVE-KB	2
mass spectrometry interactive virtual environment (MassIVE)	2
public human data	2
community-wide, continuously updating knowledge base	2
discoveries	2
public mass spectrometry runs	2
growth-modulating interactions	2
co-culture	2
model mouse microbiota	2
co-cultures of strains	2
diversity and number of species	2
corresponding metabolomes	2
97 Saccharomyces cerevisiae kinase deletion strains	2
cell’s metabolome	2
development, reprogramming, and other contexts	2
incorrect branches	2
Reprogrammed cells	2
well-characterized model system	2
reprogramming systems	2
single-cell sequencing and quantitative biophysical modeling	2
somatic lineages	2
naïve pluripotent cells	2
parental epigenetic memory	2
immune-related and lineage-defining genes	2
the biosynthetic machinery	2
biosynthetic machinery components	2
technical spike-in molecules	2
BASiCS statistical framework	2
otherwise homogeneous cell populations	2
distinct membrane systems	2
PTPs	2
monomeric EGFR	2
tumor suppressor PTPRG	2
autocatalytically activated monomeric EGFR	2
ER-associated PTPN2	2
receptor-like PTPRG/J	2
spatially organized protein tyrosine phosphatases (PTPs)	2
tyrosine kinase	2
proto-oncogenic epidermal growth factor receptor (EGFR)	2
Python library and command line interfaces	2
NetMHCpan 4.0	2
standard tools	2
mass spectrometry datasets	2
MHCflurry 1.2.0	2
benchmark of ligands	2
non-9-mer peptides	2
allele-specific neural networks	2
peptide ligands	2
major histocompatibility complex I (MHC I) proteins	2
nuclear-constrained YAP1	2
migrating fibroblasts	2
EYFP-YAP1	2
normal and activated fibroblasts	2
activated cancer-associated fibroblasts	2
normal fibroblasts	2
transcriptional regulator YAP1	2
recently evolved genes	2
novel protein complexes	2
large protein-protein interaction networks	2
mammalian SWI/SNF complex	2
novel functional modules	2
well-studied protein complexes	2
functional similarity networks	2
hundreds of human cancer cell lines	2
genome-scale RNAi- and CRISPR-Cas9-based fitness screens	2
assemblies of subunits	2
re-designed oscillators	2
oscillator's transcription factors	2
sink module	2
orthogonal “sink module	2
input “dials	2
dual-feedback oscillator	2
two classic genetic oscillators	2
MYC or the PMN	2
pan-cancer	2
tumor subtypes	2
MYC-associated pathways	2
distinct oncogenic driver	2
APC, or BRAF alterations	2
 tumor suppressors	2
frequently mutated or deleted members	2
MYC antagonists MGA	2
MYC paralogs	2
Pan-cancer	2
PMN	2
proximal MYC network (PMN)	2
co-regulatory proteins	2
related transcription factors	2
team science	2
number of institutes	2
PanCan Atlas papers	2
DNA extraction, hybridization-capture, sequencing, and analysis methods	2
Multiple Cancers project	2
raw data files	2
10,000 tumor-normal exome pairs	2
(TCGA) cancer genomics dataset	2
combinations of simple motifs	2
excitable system	2
ensembles of oscillators	2
genetically encoded regulatory circuit	2
allosteric repressors	2
ubiquitous simple repression motif	2
Monod-Wyman-Changeux model	2
simple, predictive theories	2
L-HER2+ cells	2
HER2E and HER2-HER3 heterodimerization	2
MET signaling	2
HER2+ subtype	2
3D cultures and murine xenografts	2
inhibitor of HER2-HER3 heterodimerization	2
ligand for HER3	2
L-HER2+ cells, neuregulin1-β1 (NRG1β)	2
inhibitor of MET	2
HER2E cells	2
TKIs lapatinib or neratinib	2
(L-HER2+) cells	2
basal-like HER2+ (HER2E) or luminal-like HER2	2
soluble and 46 matrix microenvironmental proteins	2
∼2,500 combinations	2
printed extracellular matrix proteins	2
microenvironment microarrays	2
TKI-treated breast cancer cell lines	2
HER2-targeted tyrosine kinase inhibitors (TKIs)	2
simple cell-to-cell communication circuit motifs	2
complex intracellular signaling networks	2
cell-to-cell communication networks	2
-to-cell communication networks	2
an excellent novel reference gene	2
“housekeeping” genes	2
non-transporter gene classes	2
Transporter genes	2
SLC transporters	2
common substrates	2
Many transporters	2
different human tissues and cell lines	2
SLC or ABC membrane transporter transcripts	2
raw reads	2
web app	2
new Hi-C dataset	2
public browser	2
shareable URL	2
browser	2
Juicebox.js also	2
Google Earth	2
original Juicebox application	2
genomes fold	2
Hi-C	2
cell-line-specific models	2
panel of cell lines	2
histone deacetylase inhibitor	2
pituitary cell line	2
human growth hormone or human prolactin promoters	2
luciferase reporters	2
gene-specific bursts or pulses	2
internal, experimentally observed reference	2
NF-κB dynamics	2
non-responsive cell subpopulations	2
exemplar applications	2
given application	2
software tool	2
complex data streams	2
time series	2
reservoirs of molecules	2
E-cadherin loss	2
adherens junction complex	2
tumor suppressor E-cadherin (CDH1)	2
additional complex members	2
one subunit of a co-regulated complex	2
specific breast cancer subtypes	2
high-confidence protein complexes	2
large-scale protein-protein interaction network	2
L. lactis in a medium	2
L. plantarum in grape juice	2
nitrogen catabolite repression pathways	2
available nitrogen sources	2
Lactobacillus plantarum and Lactococcus lactis	2
pool of metabolites	2
metabolism	2
nitrogen-rich environments	2
readily established community	2
fellow community members	2
mechanistic hypotheses	2
PIDC tutorials	2
three experimental single-cell datasets	2
single-cell gene expression datasets	2
triplets of genes	2
single-cell gene expression experiments	2
altered genomes	2
complex members	2
complex subunits	2
protein complex members	2
breast, ovarian, and colorectal tumor samples	2
CPTAC and TCGA consortia	2
recently published genomics, transcriptomics, and proteomics datasets	2
proteome of tumors	2
-number variations (CNVs)	2
functionally similar molecular “microstates”	2
functionally distinct cellular “macrostates”	2
hidden Markov model	2
intermediate epiblast-like state	2
neuronal lineage	2
individual mouse embryonic stem cells	2
somatic lineages in vivo	2
transomics datasets	2
orthogonal genomics platforms	2
quantitative high-resolution datasets	2
user-friendly graphical interface	2
standalone tool	2
established frameworks	2
extended functionality	2
large-scale human tissue and cancer phosphoproteome datasets	2
mapping peptides	2
reference genomes	2
omics datasets	2
sensor kinase, KinB	2
moderate phosphate	2
PhoB in media	2
78 media	2
different ADAGE models	2
many neural networks	2
ADAGE models	2
denoising autoencoder neural networks	2
public data compendia	2
new datasets	2
CancerGD includes different screen types (siRNA, shRNA, CRISPR)	2
tumor cell lines	2
FLC transcription	2
COOLAIR-expressing cells	2
large transcriptional bursts	2
heterogeneously sized cells	2
several different human cancer cell lines and patient tissue samples	2
∼10,000 phosphorylation sites	2
∼7,000 N-acetylation sites	2
unique peptide sequences	2
HeLa proteome	2
deepest proteome of a human single-cell type	2
modern MS instruments	2
complete human proteome	2
wild-type spindles	2
amphitelic, but not syntelic, attachments	2
IPBO	2
high-tension amphitelic attachments	2
bioriented attachments	2
low-tension kinetochore-microtubule attachments	2
kinetochore proteins	2
erroneous, syntelic attachments	2
opposite spindle poles	2
bioriented, amphitelic attachments	2
replicated genome	2
gene expression model	2
bortezomib, a first-line chemotherapy and proteasome inhibitor	2
multiple myeloma cells	2
cis- and trans-regulatory inputs	2
diffusible regulators	2
versatile resources	2
amino acid biosynthesis	2
specific carbon and nitrogen sources	2
B. subtilis auxotrophic genes	2
set of essential genes	2
Gram-positive model organism	2
two ordered, barcoded, erythromycin-resistance- and kanamycin-resistance-marked single-gene deletion libraries	2
, validated genomic resources	2
diverse neurodegenerative genes	2
cross-species platform	2
patient induced pluripotent stem cell (iPSC)-derived neurons	2
specific genes (LRRK2/PARK8, ATXN2, and EIF4G1/PARK18)	2
network (ATP13A2/PARK9 and VPS35/PARK17)	2
calcium signaling hub	2
multiple parkinsonism genes	2
molecular network	2
α-syn toxicity	2
332 genes	2
alpha-synuclein (α-syn)	2
neurodegenerative proteinopathies	2
mechano-timer	2
adhesion dynamics	2
Rac1/Cdc42 effector	2
β-PIX, a Rac1/Ccd42 GEF	2
human kinases, Rho family GTPases, GEFs, and GTPase activating proteins (GAPs)	2
cellular populations	2
statistical models	2
direct regulators	2
mechanosensitive proteins	2
physical signals	2
Yes-associated protein (YAP)	2
different NF-κB-dependent genes	2
 experiments	2
deterministic system	2
deterministic simulations	2
frequency modes	2
periodic tumor necrosis factor (TNF) inputs	2
transcription factor nuclear factor κB (NF-κB)	2
complex, mammalian setting	2
context-specific hypotheses	2
four breast cancer cell lines (MCF7, UACC812, BT20, and BT549)	2
five kinase inhibitors	2
well-defined set of signaling proteins	2
extensively studied biological networks	2
SummarySignaling networks	2
additional BMD GWAS associations	2
chromosomes 2p16.2	2
functionally related genes	2
(sc)RNA-seq libraries	2
existing samples	2
RNA-seq and single-cell (sc) RNA-seq libraries	2
oleic acid controller	2
hydroxycinnamic acid	2
One controller	2
substrate-sensing modules	2
glucose nutrient sensors	2
two versions of controller	2
metabolic resources	2
mixed pool	2
target substrates	2
two-layer circuit	2
nutrient and substrate	2
integrated modules	2
enzymatic pathways	2
synthetic gene circuit	2
low-abundance motifs	2
two aptamers	2
motifs in C-C chemokine receptor type 7	2
sequence-structure motifs	2
many secondary motifs	2
scalable analytic tools	2
short RNA or DNA molecules	2
compressed contact matrices	2
hic file	2
normalized contact maps	2
computational background	2
terabase-scale Hi-C datasets	2
high-resolution contact maps	2
modeling	2
E2F and MADS-domain TF families	2
TF flexible models	2
TFBS predictions	2
400 human ChIP-seq datasets	2
TF binding sites (TFBSs)	2
various DNA sequence-based models	2
in vivo datasets	2
base-specific amino acid contacts	2
transcription factors (TFs) with DNA	2
bacterial networks	2
adipose- and muscle-specific association	2
liver-derived housekeeping module	2
multi-tissue preservation	2
murine brain, liver, adipose, and muscle tissues	2
gene coexpression modules	2
organisms, tissues, cell types, and molecules	2
topologically distinct groups of edges and nodes	2
SummaryNetwork modules	2
long-lived mutants	2
many of these age-variant proteins	2
chronologically age-matched, long-lived daf-2 insulin/IGF-1-pathway mutants	2
set of age-variant proteins	2
peroxisome	2
PRX-5/PEX5 import protein	2
three biological replicates	2
C. elegans adult proteome	2
proteomic datasets	2
interconnectivity of networks	2
feedforward motif model	2
cell-cycle inhibitor Far1	2
feedforward motif	2
complex larger networks	2
network motifs	2
smaller sub-networks	2
complex networks	2
MHC class I antigen processing and presentation genes	2
NF1 and	2
gbmSYGNAL network	2
Two pairwise combinations (ETV6-NFKB1 and romidepsin-miR-486-3p)	2
distinct co-regulated gene modules	2
somatically mutated genes or pathways	2
resulting gbmSYGNAL network	2
patients with glioblastoma multiforme (GBM)	2
multi-omic and clinical patient data	2
transcriptional regulatory networks	2
transcription factor (TF)-target gene database	2
Software packages	2
zebrafish and Drosophila in vivo immune cell trajectory datasets	2
fiducial marks	2
3D imaging data	2
conventional Mercator maps	2
unseen and irregularly curved surfaces	2
particle-tracking data	2
cells or particles in vivo	2
dynamic environments	2
different leaves	2
examples in mutants of Arabidopsis	2
large numbers of plants	2
parallel imagers	2
dynamic environmental photosynthesis imager (DEPI)	2
valuable datasets	2
private genomic datasets	2
simulated and real GWAS datasets	2
large genomic databases	2
1,000-protein, quantitative plasma proteome	2
FDA-approved biomarkers	2
C-reactive protein, gender-related proteins	2
inflammatory markers	2
apolipoprotein family	2
single finger pricks	2
plasma proteomes	2
rapid and robust “plasma proteome profiling” pipeline	2
blood, plasma, and serum	2
circulatory system	2
vertebrate model	2
small molecule rotenone	2
module of genes	2
mitochondrial respiratory chain complex I	2
longer-lived individuals	2
Nothobranchius furzeri	2
short-lived killifish	2
downstream signaling	2
small chemical inhibitor of PAK	2
network containing Rac1, RhoA, and PAK family kinases	2
MDA-MB-231 mesenchymal breast cancer cells	2
members of the Rho small GTPase family	2
G1/S reporters	2
Cdk inhibitor p27Kip1	2
G1/S regulators	2
single human cells	2
cyclin-dependent kinases (Cdks), Cdk inhibitors (CKIs), and the anaphase-promoting complex/cyclosome (APC/C)	2
2D feature sets	2
geographic map	2
user of Google Earth	2
Hi-C maps	2
Hi-C and other contact map data	2
contact maps	2
built environment	2
baseline metagenomic map of NYC	2
hurricane-flooded station	2
marine-associated bacteria	2
 subway surfaces	2
human DNA	2
skin (e.g., Acinetobacter)	2
bacterial, viral, archaeal, and eukaryotic taxa	2
identified organisms	2
known organism	2
public parks	2
Gowanus Canal	2
entire New York City (NYC) subway system	2
panoply of microorganisms and other species	2
weakly immunogenic self-antigens	2
immunostimulatory adjuvant	2
expressing CEA	2
parental MC38 cells	2
CEA-vaccinated mice	2
recombinant adeno-associated virus vector encoding CEA (rAAV-CEA)	2
CEA-expressing tumors	2
syngeneic mouse colon cancer cell line, MC38-CEA, overexpressing CEA	2
self-protein	2
human CEA	2
immunotherapeutic target	2
colorectal, gastric, squamous esophageal, and breast carcinomas	2
several human epithelial cancers	2
human glycoprotein	2
Carcinoembryonic antigen (CEA)	2
CAR-redirected cytotoxic T lymphocytes	2
CD19-positive, but not CD19-negative, tumor cells	2
CAR-T/iReporter cells	2
CD19-positive target cells	2
inducible reporter genes (CAR-T/iReporter)	2
CD19-targeted CAR	2
tumor locality	2
anticancer molecules	2
antitumor cytokine	2
T cells expressing a chimeric antigen receptor (CAR)	2
metastasized model mice	2
delta-like ligand 4 (DLL4)	2
RGD-LNP encapsulating siRNA	2
normal lung	2
metastasized vasculature	2
metastasis tumors	2
metastasized lung	2
PEG-LNP	2
malformed structure of vasculature in the metastasized lung	2
lung-metastasized model	2
polyethylene glycol (PEG)ylated LNP (PEG-LNP)	2
RGD peptide-modified lipid nanoparticle (RGD-LNP)	2
anti-angiogenic small interfering RNA (siRNA)	2
metastatic cancer	2
target genes TGFBR2, ITGB8, and LATS2	2
target genes TGFΒR2, ITGB8, and LATS2	2
PC tissues	2
target genes of miR-93	2
miR-93 antisense oligonucleotide (ASO)	2
methyl thiazolyl tetrazolium	2
PC tissues and cell lines	2
prostate cancer (PC) cells (PCCs)	2
virus-induced anti-tumoral immune response	2
polymorphonuclear and CD8+ T cell infiltrate	2
immunodeficient setting	2
immunodeficient or immunocompetent mice	2
tumor isograft mouse model CMT64.6	2
non-iRGD counterpart	2
xenografted A549 tumors in nude mice	2
new oncolytic adenovirus ICOVIR17K-iRGD	2
secreted hyaluronidase	2
C terminus of the fiber	2
internalizing Arginine-Glycine-Aspartic (iRGD) tumor-penetrating peptide	2
oncolytic adenoviruses	2
IL-12-secreting CAR T cells	2
target CD19+ cells	2
IL-12-expressing CAR T cells	2
truly lymphoreplete model	2
established B cell lymphoma	2
Murine second generation CAR T cells expressing IL-12	2
CARs	2
fully mouse first and second generation anti-murine CD19 CARs with or without interleukin-12 (IL-12) secretion	2
lymphodepleting preconditioning	2
chemoresistant and/or refractory CD19+ leukemia or lymphoma	2
Chimeric antigen receptor (CAR)	2
liver-specific DNIκBα expression cassette	2
human non-hepatic tumor cells	2
normal human hepatocyte cell line	2
liver-specific promoter-driven dominant-negative IκBα (DNIκBα) expression cassette (TRAD-DNIκBα)	2
nuclear factor-κB (NF-κB)	2
Ad genes in liver	2
intratumorally administered	2
human telomerase reverse transcriptase promoter	2
E1 gene expression cassette	2
Telomerase-specific replication-competent adenoviruses (Ads), i.e., TRADs	2
viral HA	2
attenuation marker “elastase cleavage site”	2
heterologous human PANC-1-derived tumors	2
syngeneic B16f1 melanoma-derived tumors in mice	2
AE viruses	2
trypsin-activated counterparts (AT viruses)	2
Newly generated elastase-activated influenza viruses (AE viruses)	2
elastase cleavage site	2
trypsin cleavage site	2
IAV	2
virus in normal tissue	2
deletions	2
viral interferon antagonist	2
viruses (IAVs)	2
tumoricidal proteins	2
bacterial carrier	2
treated non-responders	2
treated responders	2
restored neural environment	2
control untreated animals	2
human glioblastoma in rats	2
pro-apoptotic drug, Azurin	2
tumor suppressor protein p53	2
tumor zones	2
bacterial carriers	2
diffusion barriers	2
aggressive glioblastoma brain tumors	2
multiple classes of allotransplant leukocytes	2
MYXV-preloaded cells	2
virus-armed carrier cells	2
neutrophils and activated T cells	2
pre-seeded residual MM	2
MYXV-armed allogeneic bone marrow (BM) transplantation	2
in vitro resistance	2
murine MM cell line	2
human MM cell lines	2
allogeneic mouse-mouse model	2
residual murine MM	2
MYXV virotherapy	2
immunodeficient xenotransplant murine model	2
effective cancer killers	2
transplant-derived T cells	2
Oncolytic myxoma virus (MYXV)	2
Allogeneic stem cell transplant-derived T cells	2
dendritic cells and CD4+ T cells	2
EnAd-infected tumor cells	2
TNF-α, IL-6, and HMGB1	2
ex vivo culture	2
human tumor biopsies	2
ATP, HSP70, and HMGB1	2
 calreticulin	2
Infected cells	2
cellular ATP	2
EnAd death pathway	2
type 5 adenovirus	2
preclinical systems	2
diverse range of carcinoma cells	2
library of adenovirus serotypes	2
chimeric group B adenovirus	2
Enadenotucirev (EnAd)	2
intratumoral virus spread	2
tumors in animals	2
oncolytic vesicular stomatitis virus in tumor-bearing mice	2
imaging system	2
iodide symporter (NIS)	2
thyroidal sodium–	2
oncolytic virus	2
thyroid radiotracers	2
numerous sequential stained tumor sections	2
Systemically administered oncolytic viruses	2
tumor pVHL	2
transglutaminase 2	2
NF-κB expression	2
hypoxia-inducible factor (HIF)-1, 2α protein	2
hepatoma mouse model	2
HCC-implanted mice	2
HCC samples	2
VHL gene	2
sulfoquinovosyl-acylpropanediol (SQAP), a novel synthetic sulfoglycolipid	2
von Hippel-Lindau protein (pVHL)	2
cellular innate immunity	2
IFN-stimulated genes	2
exogenous human interferon (IFN)-β	2
(iv) resminostat	2
epi-virotherapeutic combination (Res + MeV)	2
oncolytic MeV	2
panel of human hepatoma cell lines	2
two corresponding monotherapies	2
patients with hepatocellular carcinoma (HCC)	2
novel oral HDACi resminostat (Res)	2
oncolytic measles vaccine virus (MeV)	2
antiviral response genes	2
histone deacetylase inhibitors (HDACi)	2
every tumor entity	2
virus dosages	2
systemic versus intratumoral)	2
types of cancer	2
identical routes	2
two distinct virus families	2
two different virotherapeutics	2
oncolytic vector families	2
efficient syncytium-mediated lyses	2
malignant cell	2
MV, MuV, NDV, and SeV.	2
surface some molecules	2
Metastatic cancer cells	2
attenuated measles virus (MV), mumps virus (MuV), low pathogenic Newcastle disease (NDV), and Sendai (SeV) viruses	2
list of oncolytic paramyxovirus representatives	2
retroviruses or some DNA viruses	2
representatives of other viral families	2
oncolytic agents	2
intratumoral, intravenous, intradermal, intraperitoneal, or intrapleural)	2
established metastases	2
cells of ecto-, endo-, and mesodermal origin	2
broad spectrum of human malignant cells	2
cancer antigens	2
sialic acids on the surface of malignant cells	2
viral envelope of Newcastle Disease, Mumps, and Sendai viruses	2
neuraminidase (sialidase)	2
natural killer cells, dendritic cells	2
IFN and other immuno-stimulating cytokines	2
powerful inducers	2
multiple danger signals	2
host neutralizing antibodies	2
polykaryonic structure	2
syncytium formation	2
interferon (IFN) and apoptotic pathways	2
natural receptors	2
strains of Measles, Mumps, Newcastle disease, and Sendai viruses	2
Oncolytic paramyxoviruses	2
microenvironment of cancer tissue	2
L-ASNase	2
cancer-starving proteins	2
cancer drug delivery vehicles	2
solid malignancies	2
engineered bacteria	2
inducible araBAD promoter system of Escherichia coli	2
L-ASNase selectively	2
anticancer protein	2
L-asparaginase (L-ASNase)	2
controlled expression system	2
anticancer proteins	2
local parklands	2
closed- and open-ended questions	2
station	2
animals, humans and the environment	2
various professionals	2
human-animal and animal-animal interactions	2
veterinarians in society	2
environmentally-acquired zoonoses (botulism)	2
dangerous dogs	2
cultures and belief systems	2
humans, dogs, horses, and wildlife	2
local parklands area	2
medical students	2
plant, animal and human communities	2
Field trips	2
related areas	2
camelids	2
MERS-CoV RNA	2
661 camels, alpacas and lamas	2
naturally infected llamas	2
surrounding countries	2
Israeli dromedaries	2
MERS-	2
llamas' sera	2
102 alpacas	2
Israeli camelids	2
almost all the countries	2
MERS-CoV	2
human MERS-CoV infections	2
One Health sectors	2
Rift Valley fever virus	2
country-, local- and project-level implementation	2
international institutions	2
ethno- and bio-veterinary knowledge	2
incorrect veterinary drugs	2
bovine veterinary knowledge	2
bloody diarrhoea	2
two previously undescribed Fulfulde disease names	2
Gortowel and dauda	2
hanta is the Hausa word for liver)	2
liver-fluke	2
“hanta”	2
hanta (CBPP); sammore (trypanosomiasis); boro (foot and mouth disease), gortowel (liver fluke), dauda (parasitic gastro-enteritis with bloody diarrhoea) and susa (parasitic gastro-enteritis)	2
Fulani pastoralists	2
soil-transmitted parasites, trypanosomiasis and tick-borne diseases	2
veterinary diseases	2
Fulani disease	2
participant and non-participant observations	2
Fulani communities	2
pastoralists and veterinary services	2
veterinary drugs	2
veterinary services	2
Fulani pastoralists in Nigeria	2
similar locations	2
Indigenous and other Australians	2
Dog health	2
Indigenous communities and tourists in the Wet Tropics	2
popular tourist locations	2
Indigenous community	2
A. caninum	2
necropsy and faecal samples	2
hookworm in Indigenous community dogs	2
hookworm species identification	2
Wet Tropics World Heritage Area	2
tourist attractions	2
six rainforest locations	2
soil and free-ranging domestic dogs	2
common hookworm of domestic dogs and cats	2
Ancylostoma ceylanicum	2
Thamnophis sirtalis sirtalis	2
Eastern Garter Snakes	2
WNV viral RNA	2
Six species of snakes	2
Pennsylvania harbored WNV	2
wild population of snakes	2
reservoirs and hosts	2
West Nile virus (WNV)	2
prioritized zoonotic diseases	2
public health and veterinary laboratories	2
One Health-focused Zoonotic Disease Unit	2
rabies, anthrax, brucellosis, leptospirosis, and echinococcosis	2
following five priority zoonotic diseases	2
-three zoonotic diseases	2
criterion	2
Committee members	2
Ethiopia or the East Africa region	2
core decision-making participants	2
human, animal, and environmental health ministries	2
Workshop participants	2
animal and human health agencies	2
significant zoonotic diseases	2
Global Health Security Agenda	2
livestock or other domestic animals	2
largest livestock population	2
second largest human population in Africa	2
another tick borne pathogen	2
Borrelia species	2
Borrelia in Australian ticks	2
Australian Lyme-like cases	2
Haemaphysalis spp.	2
Australian Ixodes spp	2
Lyme-endemic countries	2
B. burgdorferi s. l. reservoirs	2
arthritic, cardiac, neurological and dermatological manifestations	2
spirochaetes of the Borrelia burgdorferi sensu lato (B. burgdorferi s. l.) complex	2
Livestock officers	2
Brucella antibody	2
positive goat farm	2
dogs and/or rats on the farm	2
≥51 goats)	2
breeder goats	2
public pasture	2
community enterprise farms	2
standard farms	2
Venous blood samples	2
random sample of farms	2
goat keepers of the selected farms	2
Field researchers	2
Brucella sero-positivity goats	2
private goat farms	2
community enterprise	2
three types of goat farms	2
human Brucella sero-positivity	2
types of goat farms	2
farm animals	2
zoonotic disease	2
One Health stakeholders	2
structural components	2
Caribbean	2
interface of wildlife, domestic animals, and humans	2
diverse topics	2
many countries of the Caribbean	2
St. Kitts and Nevis	2
Caribbean island of St. Kitts	2
Veterinary Medicine	2
emerging”	2
emerging infectious diseases and pathogens	2
riskiest potential pathogens	2
threatening diseases	2
existing pathogen	2
human hosts	2
term and the phenomena	2
Microbial infections	2
viruses in humans	2
influenza A viruses	2
immunologically naïve population	2
novel influenza virus strain	2
waterfowl (the original reservoir), terrestrial and aquatic poultry, swine, humans, horses, dog, cats, whales, seals and several other mammalian species	2
diversity of host species	2
challenging viruses	2
novel therapeutic target and biomarker	2
bladder cancer, breast cancer, colorectal cancer and Lung cancer	2
various kinds of cancers	2
several piRNA	2
identified small noncoding RNA (ncRNA)	2
death globally	2
normal subjects and patients	2
Roche Diagnostics Cobas 6000® analyzer	2
Tubes stored	2
One tube	2
normal volunteers	2
QC samples	2
quality control (QC) samples	2
five laboratories	2
lenvatinib, a novel multi-targeted tyrosine kinase inhibitor	2
bioanalytical methods	2
automatic blood cell analyzer	2
mixed phenotype lineage acute leukemia	2
B lymphoid lineage markers	2
blasts positive	2
hematology department	2
Acute leukemia	2
48/100 WBCs)	2
many orthochromatic erythroblasts	2
peripheral blood smear	2
nucleated red blood cells	2
abnormal cells	2
giant PLTs	2
emergency department	2
back, right arm, and ankle joint pain	2
38-year-old woman	2
underlying malignancy	2
cold reactive anti-A1	2
newly developed anti-A1 alloantibody	2
hemolytic anemia	2
alloantibody	2
group A1 RBCs	2
blood type A	2
metastatic carcinoma	2
76 year old male patient (A2)	2
group A1 RBC units	2
cold-reactive anti-A1 alloantibody	2
ABO antigens	2
various malignancies	2
autoantibody	2
donor A1 red blood cell (RBC) transfusion	2
warm-reactive anti-A1	2
A-subgroup patients	2
usually clinically insignificant naturally occurring cold IgM antibody	2
Anti-A1 antibodies	2
second-generation tyrosine kinase inhibitors	2
adenosine diphosphate (ADP)	2
observational study	2
19 patients	2
P2Y12 antagonists (PLT VASP/P2Y12)	2
vasodilator-stimulated phosphoprotein (VASP) phosphorylation	2
recently released kit (PerFix EXPOSE)	2
variant combination	2
previous guidelines	2
sweat tests	2
sweat chloride guidelines	2
services of academic medical centers	2
12 analyzers	2
30–50 samples	2
Na+, K+, Cl-,	2
central laboratory	2
pO2, Na+, K+, Cl-,	2
care sites	2
Clermont-Ferrand Hospital	2
Ca2+, lactate, hemoglobin and oxyhemoglobin (O2Hb)	2
pH, pCO2, pO2, Na+, K+, Cl-,	2
GEM PREMIER 4000 analyzers	2
International standards	2
point-of-care testing provisions	2
gas analyzers	2
invasive venipunctures	2
venipuncture and central line blood collections	2
™ collections	2
venipuncture and central line blood collection methods	2
PIVO™-flagged samples	2
flagged collections	2
7600 PIVO™ blood draws	2
collection methods	2
PIVO™ blood collections	2
high-quality blood specimens	2
needle-less blood collection device	2
blood specimens	2
peripheral intravenous catheters	2
non identical epitope	2
similar serpins	2
recombinant kallistatin	2
significant band	2
(cirrhotic liver and healthy) PVDF (polyvinylidene diflouride) membranes	2
healthy subject's serum	2
R.L. Jalappa Hospital and Research Centre	2
healthy)	2
serpins	2
concentration in serum	2
multifunctional serpin clade	2
(Kallistatin)	2
class of plasma proteins	2
Serpins (Serine protease inhibitors)	2
functions of liver	2
point of care testing system	2
large population of patients with malignancies	2
large oncology unit	2
laboratory reference analyser	2
life-threatening neutropenia	2
neutrophils, eosinophils and basophils	2
many haematology analysers	2
single pretreatment	2
−0.197,	2
r=0.994,	2
−1.175, n=200 (CsA)	2
r=0.995, y=0.924x	2
ACMIA and ECLIA	2
hematocrit	2
chyle, and rheumatoid factor	2
unconjugated bilirubin	2
conjugated bilirubin	2
CsA and TAC calibrations	2
interference substances	2
chemiluminescence immunoassay (CLIA)	2
CsA or TAC	2
autoimmune disease and transplantation patients	2
residual whole blood samples	2
Tacrolimus assay kits	2
immunosuppressant drugs	2
(CsA) and tacrolimus (TAC)	2
Quo-Test POCT device	2
Quo-Test	2
HbA1c samples	2
subjects (n=100)	2
blood EDTA samples	2
automated Quo-Test POCT device (EKF Diagnostics)	2
glycated haemoglobin (HbA1c)	2
Point of Care Testing (POCT) devices	2
healthy population	2
new generation of the assay	2
total 25OHD	2
healthy Irish subjects	2
patients’ samples	2
old and the new generations of reagent	2
generations of the Abbott reagents	2
healthy Irish population	2
old and new generations of the reagents	2
Abbott Architect, DiaSorin Liaison and AB SCIEX API 4000 (LC-MS/MS)	2
old and new generations of the Abbott total 25-hydroxyvitamin D (25OHD) assays	2
residual cytoplasm and nucleic acids	2
NRBCs that	2
reticulocytes and erythrocytes	2
FSC and SFL areas	2
flow cytometer (FCM)	2
leukocyte type	2
isolated peripheral WBCs and NRBCs with specific reagents	2
forward scattered light (FSC) and side fluorescence light (SFL).MethodWe	2
acidic detergent	2
WNR-specific reagents	2
basophils and nucleated red blood cells (NRBCs)	2
white blood cells (WBCs)	2
XN-Series automated hematology analyzer (Sysmex)	2
ABX Pentra 400 analyzer	2
; rho=0.996.ConclusionThe Roche Total Mycophenolic Acid® assay	2
[Roche MPA	2
Roche MPA assay package insert	2
open-channel on the ABX Pentra 400	2
mycophenolate mofetil (	2
samples from children	2
ABX Pentra 400	2
recombinant inosine monophosphate dehydrogenase (IMPDH)	2
mycophenolate acid (MPA)	2
coagulation laboratories	2
robust high-throughput analyzer	2
two Sysmex analyzers	2
CS systems	2
patients’	2
CS-5100 and the ACL TOP	2
Sysmex CS-5100 and Sysmex CS-2000i systems	2
routine coagulation, chromogenic and immunological assays	2
ACL TOP analyzer	2
Sysmex CS-2000i	2
Sysmex CS-5100	2
(Instrumentation Laboratory, Werfen Group,	2
Sysmex CS-5100 System	2
(Siemens)	2
mid-volume blood coagulation analyzer Sysmex CS-2000i System	2
new high-volume blood coagulation analyzer Sysmex CS-5100 System™ (Siemens Healthcare Diagnostics, Erlangen, Germany)	2
II GEN	2
fully automated LIAISON® BRAHMS PCT®	2
healthy children population	2
LIAISON® BRAHMS PCT® II GEN	2
blood bank	2
apparently healthy specimens	2
patients with suspected infection	2
Thermo Fisher Scientific Clinical Diagnostics, Hennigsdorf, Germany)	2
assay reference method B·R·A·H·M·S PCT KRYPTOR	2
LIAISON® BRAHMS PCT® II GEN (DiaSorin, Saluggia, Italy)	2
compromised immune system	2
PCP IgA and PCP IgM	2
four phenotypes	2
51–90 years group	2
61–90 years group	2
PCP IgM	2
isotype	2
adult blood donors	2
-pneumococcal capsular polysaccharide (PCP) IgM, IgG and IgA ELISAs	2
common allergens	2
PROTIA Allergy-Q	2
Allostation Smart II	2
class 2	2
different analyzers	2
common allergens (Dermatophagoides farina and Dermatophagoides pteronyssinus)	2
two new analyzers	2
AdvanSure Allostation Smart II or PROTIA Allergy-Q	2
food and inhalant panel	2
AdvanSure AlloScreen	2
AdvanSure Allostation Smart II	2
four analyzers	2
four analyzers including AdvanSure AlloScreen (LG Life Science, Korea), AdvanSure Allostation Smart II (LG Life Science), PROTIA Allergy-Q (ProteomeTech, Korea), and RIDA Allergy Screen (R-Biopharm, Germany)	2
food panels and inhalant panels	2
conventional MAST assays	2
two newly introduced fully automated multiple allergen simultaneous tests (MAST) analyzers	2
1 μl blood	2
StatStrip	2
iSTAT-1.ConclusionBoth POCT devices	2
ABL-735	2
iSTAT-1	2
ED samples	2
umbilical cord blood	2
analyzers	2
routine laboratory analyzer (ABL-735, Radiometer)	2
(CG4+ cassettes, Abbott)	2
StatStrip-Lactate (Nova Biomedical) and the iSTAT-1	2
two POCT devices	2
ED	2
first time-two point-of-care testing (POCT) lactate devices	2
lactate/blood gas	2
Emergency Department (ED)	2
whole blood lactate	2
YSI 2300 analyzer	2
whole blood and plasma lactate	2
6 individuals	2
venous samples	2
muscle lactate	2
extracellular and intramyocellular space	2
immunometric assays	2
polyethylene glycol (PEG) precipitation	2
serial sample dilutions	2
in-house ‘nonsense’ sandwich assay	2
antibody blocking tubes	2
alternative platform	2
analytical interference	2
pituitary origin	2
30-year-old man	2
patient whose serum sample	2
different immunoassays	2
single type of EA	2
different manufacturers	2
antibodies (EA)	2
patients with bacterial infections	2
four clinical chemistry analyzers	2
Diazyme PCT	2
Vidas, Advia Centaur, Architect, Cobas C501 and AU5800	2
BRAHMS PCT Kryptor results	2
nine different reagents and analyzers	2
Abbott Architect c16000, Siemens Advia 2400, Roche Cobas C501 and Beckman Coulter AU5800).Design	2
four clinical chemistry platforms	2
Diazyme immunotubidimetric assay	2
four BRAHMS-partnered procalcitonin (PCT) automated immunoassays (DiaSorin Liaison, BioMérieux Vidas, Roche Cobas E601 and Siemens Advia Centaur)	2
BRAHMS Kryptor PCT	2
responsIQ system	2
reference methods	2
patient samples.c	2
laboratory analyzer	2
POC reference device	2
separate experiments	2
POC test.b	2
reference systems	2
B-type natriuretic peptide (BNP) assay	2
optical sensors	2
active microfluidics	2
new point-of-care (POC) immunoassay platform	2
respons®	2
general neuropil	2
microglial proliferation	2
larger plaques	2
elevated plus maze	2
light/dark box	2
open field	2
forced-alternation T-maze	2
upregulated microglial genes	2
Transgenic mice (TASTPM; APPSwe/PSEN1M146V)	2
synaptic interactions	2
rising amyloidβ	2
Foxm1 pathway	2
human ESC derived CM hypoxia/reperfusion system	2
Foxm1 upregulation	2
potential key target of VPA	2
gene and signaling pathways	2
over-expression	2
serum biology assays	2
MI rats	2
cell functions	2
multiplex methylation marker panel	2
distant non-neoplastic colonic mucosa	2
non-neoplastic mucosa a four marker panel (APC1A, SFRP4, SFRP5, SOX7)	2
pre-cancerous and invasive neoplasia	2
neoplastic mucosa a five marker panel (SFRP2, SFRP4, WIF1, APC1A, APC2)	2
neoplastic and non-neoplastic mucosa	2
Predictive models	2
medical centres	2
11 marker panel (SFRP1, SFRP2, SRP4, SRP5, WIF1, TUBB6, SOX7, APC1A, APC2, MINT1, RUNX3)	2
bisulphite pyrosequencing	2
prospective cohort	2
previously identified biomarkers	2
inflamed colon	2
former high–dose smokers	2
Low–dose former smokers	2
lighter smokers	2
heavier smokers	2
smoker–enriched cluster	2
Generation Scotland cohort	2
4900 individuals	2
previously identified smoking–associated CpG sites	2
peripheral blood samples	2
high incidence setting	2
relevant transmission chains	2
24-loci-MIRU-VNTR	2
Spoligotyping, 24-loci MIRU-VNTR typing, WGS based SNP (Single Nucleotide Polymorphism) and core genome multi locus sequence typing (cgMLST)	2
high endemic setting	2
324 isolates	2
recent transmission chains	2
widespread pathogens	2
potential genetic-brain-cognition mediation pathway	2
discovery cohort	2
166 subjects)	2
independent cohort	2
CSMD1, CNTNAP2, DCC, GABBR2 etc	2
axon pathways	2
synapse organization	2
thalamus, putamen and bilateral temporal gyrus	2
Chinese subjects	2
4522 schizophrenia-susceptible single nucleotide polymorphisms (SNP)	2
large Chinese dataset	2
InterpretationThese inducible RNA assays	2
inducible cf-RNA assay	2
latently infected cells	2
QVOA	2
3-day inducible cf-RNA assay	2
infected CD4+ T-cells	2
defective proviruses	2
complete virions (cf-RNA)	2
large proportion of transcription-competent proviruses (ca-RNA)	2
ca-RNA gag and tat-rev, and cf-RNA	2
anti-CD3/CD28 stimulation	2
(gag and tat-rev) and cell-free [cf-]	2
new inducible RNA assays	2
replication-competent HIV	2
optimized quantitative viral outgrowth assay (QVOA)	2
FundCNPq, FAPES, GCRF MRC and Wellcome Trust	2
Old World	2
L. infantum and L. donovani sequenced isolates	2
cline	2
n = 157)	2
genetically stable L. infantumMiltefosine Sensitivity Locus (MSL)	2
cured and relapsed patients	2
L. infantum isolates	2
FundNational Institute of Allergy and Infectious Diseases	2
sleep disturbance and HIV- groups	2
HIV- MSM	2
HIV+ MSM	2
HIV+ vs. HIV- MSM	2
N = 1217; 12,680 person-visits	2
non-depressed HIV+(N = 1054; 9556 person-visits) and non-depressed HIV-	2
uninfected with HIV (HIV-).MethodsUsing data	2
infected with human immunodeficiency virus (HIV+)	2
FundMarie Curie Intra-European Fellowships	2
disrupted ferredoxin system	2
detailed map	2
primary adrenal insufficiency patients	2
glutamine-dependent pathways	2
disrupted ferredoxin (fdx1b) system	2
cortisol-deficient zebrafish mutant	2
A.P. Møller Foundation	2
NIH Grants, Aase and Ejnar Danielsen's Foundation	2
Vanderbilt Digestive Disease Research Center	2
Lundbeck Foundation	2
Novo Nordisk Foundation	2
COX-2–PGE2 signaling	2
COX-2-PGE2 signaling	2
flaring UC	2
responders (Rs)	2
mini-guts”).FindingsWe	2
primary human intestinal organoids	2
down-stream effector, PGE2	2
patient-derived monocytes	2
human intestinal biopsies	2
cyclooxygenase-2 (COX-2)	2
prostaglandins (PGs) and thromboxanes	2
tumor necrosis factor-α (TNF) signaling	2
worst 4 mm segment	2
necrotic core	2
143 patients	2
10,881 NORDIL patients	2
non-culprit coronary artery	2
IBIS-3 analyzed lesions	2
prospective study	2
IgG and IgM autoantibodies against malondialdehyde low density lipoprotein (MDA-LDL)	2
immunoglobulins (Ig)	2
complex genetic architecture	2
low RA	2
locus within Meis Homeobox 1 (MEIS1)	2
Solute Carrier Family 25 Member 17 (SLC25A17)	2
Neurofascin (NFASC) and	2
independent genetic loci	2
71,500 UK Biobank participants	2
NIHR Oxford Biomedical Research Centre	2
NIHR Health Protection Research Unit Oxford	2
Health England	2
lineage 1	2
MIRU-VNTR linked pairs	2
co-resident individuals	2
MIRU-VNTR typed	2
least one M. tuberculosis isolate	2
Closely related samples	2
Enhanced Tuberculosis Surveillance system	2
relevant patients	2
Illumina technology	2
English Midlands	2
Whole-genome sequencing (WGS)	2
Interspersed Repetitive Unit-Variable Number Tandem Repeat (MIRU-VNTR) typing	2
Therapeutics LP	2
FundingHealth Innovation Challenge Fund (Wellcome Trust and Department of Health)	2
mg adalimumab	2
α-SMA and type I procollagen proteins	2
adalimumab in 0.4 ml	2
sub group	2
procollagen type I protein expression	2
placebo treated patients	2
ACTA2, COL1A1, COL3A1 and CDH11	2
adalimumab cohorts	2
α-SMA and collagen proteins	2
α-smooth muscle actin (ACTA2)	2
injected tissue	2
dose cohorts	2
TNF inhibitor	2
Dupuytren's disease	2
surgically-excised tissue	2
approved therapy	2
's disease	2
stable ectopic pregnancies	2
ectopic pregnancies	2
tubal ectopic pregnancies	2
ACTRN12611001056987).Findings30 participants	2
oral gefitinib	2
intramuscular methotrexate	2
four hospitals	2
larger ectopic pregnancies	2
oral gefitinib (epidermal growth factor receptor inhibitor)	2
patients with HF	2
either inotropic agents	2
inotropic agents	2
145 combinations	2
213 patients	2
patients with heart failure (HF)	2
retrospective studies	2
ATP gliotransmission	2
brain-derived neurotrophic factor	2
A2b receptors	2
P2Y11 and adenosine	2
metabolite adenosine	2
Released ATP	2
VNUT-dependent astrocytic ATP exocytosis	2
astrocyte-selective VNUT	2
astrocyte-selective VNUT-knockout mice	2
vesicular nucleotide transporter (VNUT)	2
FLX increased ATP exocytosis	2
gliotransmission of ATP	2
anti-depressant	2
fluoxetine (FLX)	2
psychotropic drugs	2
numerous oxysterols in human peripheral blood mononuclear cells and plasma	2
diverse cellular pathways	2
aged murine macrophages	2
age-related macular degeneration (AMD)	2
CLL patients	2
score	2
primary CLL samples	2
key enzymes of glycolysis	2
pyruvate kinase and lactate dehydrogenase	2
TP53 wild-type	2
skin melanoma	2
368 patients	2
patients with metastatic melanoma	2
one public cohort	2
metastatic melanoma	2
diet and commercially available drugs	2
serum, skeletal muscle and metabolic tissues of SMA mice	2
Taiwanese Smn−/−;SMN2 and Smn2B/−mouse models	2
circadian regulatory networks	2
key regulatory axis	2
circadian glucocorticoid-Krüppel-like factor 15-branched-chain amino acid (GC-KLF15-BCAA) signaling pathway	2
mouse RTECs	2
PI3K subunit p110δ	2
renal tubular epithelial cells	2
renal tubular epithelial cells (RTECs)	2
Endothelial-to-Hematopoietic Transition (EHT)	2
Runt-related transcription factor 1(RUNX1)	2
quantitative platform	2
individual SC divisions	2
limited niche access	2
colonic epithelial crypt	2
OXPHOS-deficient clones	2
human colorectal crypts	2
human colorectal crypt SC niche	2
omega-3 supplements	2
NOS3 and PPARG	2
fish oil supplements	2
PPARG-G allele and NOS3-A allele	2
CD36-G allele	2
NOS3 genotype	2
CD36, NOS3 or PPARG variants	2
CD36 (rs1527483), NOS3 (rs1799983) and PPARG (rs1801282)	2
50)	2
fish oil and 44 for flaxseed oil)	2
patients with type 2 diabetes (T2D)	2
Trial RegistrationSRCTN registry	2
selected cytokines	2
high-dose vitamin D	2
mostly Caucasian individuals	2
31,568 cis-eQTLs (unique SNP-probe pairs	2
placebo or high dose vitamin D regimen	2
rs7041 (intron variant, GC)	2
25-hydroxy-vitamin D (25[OH]D, 4000 IU regimen)	2
(IFN-γ, IL-10, IL-8, IL-6 and TNF-α)	2
placebo daily	2
2000 IU	2
vitamin D3 4000 IU	2
community-dwelling individuals	2
allergen-specific T effector and Treg cells	2
weed mugwort	2
major pollen allergen	2
Tregs with IL-2-αIL-2 mAb complexes	2
TCR-DR1 mice	2
single DR1 transgenic mice	2
TCR-DR1, but not DR1, TCR or wildtype (WT) control mice	2
systemic priming and adjuvants	2
human-relevant major mugwort (Artemisia vulgaris) pollen allergen Art v 1	2
novel human T cell receptor(TCR) and human leucocyte antigen (HLA)-DR1 (TCR-DR1) transgenic mouse model	2
innocuous antigens	2
-associated allergies	2
entire spectrum of repeats	2
CAG repeat	2
higher repeats	2
CAG repeats	2
HTT gene	2
tubal ITGB1 expression	2
anti-ITGB1-antibody	2
OE-E6/E7 cells	2
OE-E6/E7 cell ITGB1 expression	2
women and mice	2
C. trachomatis increased Fallopian tube/oviduct integrin-subunit beta-1 (ITGB1)	2
trophoblast spheroid-OE-E6/7 cell co-culture	2
human embryo attachment	2
immortalised human oviductal epithelial cells (OE-E6/E7)	2
Fallopian tubes of women	2
cell adhesion molecules)	2
endometrial “receptivity” integrins	2
Tubal ectopic pregnancies	2
primary lung cancer cells	2
tumor-associated MSCs	2
primary human lung carcinoma cells	2
paired tumor-associated and normal lung tissue mesenchymal stem cells (MSCs)	2
influenza A.Funding SourceMedical Research Council UK, NIHR BMRC Oxford	2
MVA/ChAdOx1 NP+M1	2
MVA/ChAdOx1	2
ChAdOx1 NP+M1	2
49 subjects	2
conserved influenza virus antigens, nucleoprotein (NP) and matrix protein-1 (M1)	2
chimpanzee adenovirus ChAdOx1	2
two viral vectored vaccines, modified vaccinia virus Ankara (MVA)	2
inactivated influenza vaccines	2
highly conserved influenza antigens	2
m.13094T>C.	2
basal ganglia involvement	2
brainstem and cerebellum	2
six families	2
Nine patients	2
clinically affected individuals	2
international cohort study	2
m.13094T>C MT-ND5 gene	2
brain aging (Wendt et al., 2008)	2
known harmful substance	2
cathepsin S	2
lifespan	2
offending antigen	2
volumes	2
*13:02 allele (N=11)	2
DRB1*13:02 group, N=60)	2
*13:02 allele	2
2017).MethodsSeventy-one cognitively healthy women	2
James et al.,	2
Human Leukocyte Antigen (HLA) allele DRB1*13:02	2
autologous or heterologous MVs	2
fibroblast-like synoviocytes -	2
synovia	2
specific MV determinants	2
joint macrophages	2
arthritic mice	2
subsequent co-culture settings	2
activated fibroblast-like synoviocytes	2
Classically-activated macrophages	2
transforming growth factor-β	2
MVs	2
phosphatidylserine and annexin-A1	2
macrophage/fibroblast-like synoviocyte co-culture system	2
K/BxN mouse model	2
administered intra-articularly	2
neutrophil-derived MVs	2
Microvesicles (MVs)	2
broadly-defined headache	2
multiple brain tissues	2
LINC02210-CRHR1 gene	2
14 new loci	2
LRP1 gene	2
3343 SNPs	2
149,312 controls	2
74,461 cases	2
single entity	2
UK Biobank participants	2
specific question	2
UK Biobank cohort	2
223,773 subjects	2
common neurological symptom	2
emerging immunotherapies	2
immune cell infiltrates	2
: p<0.001)	2
p<0.001, CTLA4	2
TERT mutations	2
ATRX mutations (PD-L2: p<0.001, PD-1: p=0.001)	2
p<0.001; PD-L2:	2
PD-L1: p=0.005; PD-L2: p<0.001; CTLA-4: p<0.001)	2
IDH-mutated LGG	2
CTLA4, PD-L1, PD-L2, and PD-1 in diffuse lower-grade gliomas (LGG) harboring isocitrate dehydrogenase (IDH) mutations	2
Immune checkpoints	2
scarlet fever emm12 clones	2
toxin encoded prophage	2
scarlet fever lineages	2
mainland China multi-clonal emm12 isolates	2
macrolide and tetracycline resistant ICE-emm12 and ICE-HKU397 elements	2
Streptococcal toxin encoding prophage φHKU.vir	2
scarlet fever outbreaks	2
published emm12 S. pyogenes genomes	2
different geographic regions of China	2
emm12 non-scarlet fever isolates	2
emm12 scarlet fever isolates	2
Chinese Nationwide Notifiable Infectious Diseases Reporting Information System	2
mainland China	2
predominantly serotype M12 Streptococcus pyogenes scarlet fever isolates	2
reported cases	2
Rv0678 RAVs	2
active drug classes	2
non-susceptible BDQ MIC	2
BDQ exposed patients	2
Susceptible and intermediate categories	2
total of 391 isolates	2
CFZ MICs	2
BDQ ECVs	2
multi-drug resistant tuberculosis (MDR-TB)	2
novel agent	2
(BDQ)	2
high-performing NAAT	2
io® CT assay	2
additional-to-routine self-collected vulvovaginal swabs	2
(GUM)/RSH clinics	2
four UK Genito-Urinary Medicine	2
io® CT-assay	2
nucleic acid amplification test (NAAT)-based CT cartridge	2
io® single module system (Atlas Genetics Ltd.)	2
Chlamydia trachomatis (CT)	2
Point-Of-Care Tests	2
children with cerebral palsy	2
polygenic dopamine score	2
dopamine system	2
endogenous dopaminergic neurotransmission	2
five dopamine genes (COMT, DAT, DRD1, DRD2, and DRD3)	2
dopamine genes	2
COMT, DAT, DRD1, DRD2, DRD3, and BDNF	2
involved hand	2
-three children	2
dopamine and BDNF genes	2
dopamine neurotransmission and brain-derived neurotrophic factor (BDNF) signalling	2
number of microtubules	2
polarized functional monolayer	2
hfRPE (human fetal retinal pigment epithelial) cell culture model	2
AMD patients	2
retinal pigment epithelial (RPE) cells	2
protein HtrA1	2
heart and muscles	2
human adipose tissue-derived endothelial cells	2
HUVEC and human cardiac endothelial cells	2
plasma BCAA	2
around 10,000 extensively phenotyped individuals	2
secreted mediator	2
Branched-chain amino acids (BCAAs) metabolite, 3-Hydroxyisobutyric acid (3-HIB)	2
enzyme pathways	2
Maori and European populations	2
Maori and European patients	2
Maori and European subjects	2
once-daily clozapine doses	2
12 Maori and 16 European patients	2
New Zealand Maori and European patients	2
effective drug	2
GWI and other immune-related diseases (Georgopoulos et al., 2017)	2
brain atrophy	2
DRB1*13:01	2
cerebellar gray matter	2
P=0.007)	2
*13:02.FindingsWe	2
HLA class II allele DRB1	2
subcortical brain regions	2
55 with GWI	2
-six Gulf War veterans	2
broad range of autoimmune diseases (Furukawa et al., 2017)	2
one of the six HLA GWI-protective HLA alleles	2
GWI (Christova et al., 2017)	2
James et al., 2016)	2
GWI (Georgopoulos et al., 2016)	2
six Human Leukocyte Antigen (HLA) alleles	2
fully differentiated CECs	2
CEC-specific promoters	2
transcription factor POU class 6 homeobox 2 (POU6F2)	2
gene loci	2
45 promoters	2
various human tissues and cells	2
FANTOM5 promoter-level expression atlas	2
single molecule sequencer	2
human CECs	2
Corneal endothelial cells (CECs)	2
several previously reported putative biomarkers	2
geographically diverse and large population of tuberculosis patients	2
Several previously reported putative tuberculosis-associated biomarkers (HOMX1, neopterin, and cathelicidin)	2
IL-1β, IL-6, CRP, PTX-3 and MMP-8	2
novel, multiplexed electrochemiluminescence assay	2
Biomarker assays	2
319 protocol-correct, culture-confirmed pulmonary tuberculosis patients	2
tuberculosis clinical trial	2
host biomarkers	2
efficacious treatment regimens	2
Aurora A SNP	2
codon 31 SNP	2
poor prognostic biomarker	2
modified intent-to-treat (mITT) patients	2
paclitaxel alone arm	2
alisertib plus paclitaxel	2
patients carrying IV or II alleles	2
II alleles	2
solid tumor patients with VV and VI alleles	2
codon 57 SNP	2
Whole blood	2
paclitaxel alone	2
alisertib plus weekly paclitaxel (n=62)	2
single-agent alisertib	2
advanced solid tumors	2
85 patients	2
Genome Atlas (TCGA) database	2
investigational, oral, selective Aurora A kinase inhibitor	2
(MLN8237)	2
pylori gastritis	2
23 endoscopists	2
397 patients	2
separate test data set	2
anatomical locations	2
Another CNN	2
, deep CNN	2
Helicobacter pylori gastritis	2
rare heterozygous missense/frameshift IRX3 variants	2
UCP1 promoter	2
induced mouse and human beige adipocytes	2
young obese subjects	2
primary preadipocytes	2
induced beige adipocytes	2
human and mouse models	2
FTO variants	2
cytoplasmic FUS aggregates	2
wild-type FUS	2
mutant but	2
Mutant FUS transgenic mice	2
ALS mouse model	2
ALS-FTD-associated FUS	2
FUS proteinopathy	2
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)	2
fused in sarcoma (FUS)	2
EPCs' paracrine effects	2
transplanted EPCs	2
recipient ischemic brain	2
donor animals	2
chronic antibiotic-treated mice	2
transplantated EPCs	2
US Food and Drug Administration (FDA)	2
subtherapeutic chlortetracycline, penicillin or vancomycin	2
Subtherapeutic antibiotics	2
complex parasite	2
Signaling Lymphocyte Activation Molecule (SLAM)-Associated Protein (SAP)-deficient mice	2
immunization and viral infection models	2
Plasmodium chabaudi in C57BL/6 mice	2
Tfh program	2
gene that encodes Bcl6	2
CD4+ follicular helper T (Tfh) cells	2
internal RBC ascorbate	2
bromo-dehydroascorbic acid	2
RBCs in vitro	2
red blood cell (RBC) ascorbate/6-bromo-ascorbate	2
6-bromo-ascorbate	2
ascorbate (vitamin C)	2
Mice (gulo−/−)	2
oxidized form, 6-bromo-dehydroascorbic acid	2
sodium-dependent vitamin C transporters	2
analog	2
vitamin C analog 6-bromo-ascorbate	2
chemical transport knockout model	2
dehydroascorbic acid (oxidized vitamin C, DHA)	2
glucose transporters (GLUTs)	2
T1D cases	2
Subtype 2	2
Subtype 2, anti-GAD Ab negative and non-elevated IgE	2
Subtype 1, anti-GAD Ab positive and non-elevated IgE	2
anti-GAD Ab and IgE profile	2
YH controls	2
putative virus-induced diabetes susceptibility gene	2
α-synuclein and CHOP (an ER stress-mediated cell death executor)	2
surviving neurons	2
Parkinson's disease models	2
KUSs, esculetin, and GSK4716 (an ERRγ agonist)	2
ERR agonist	2
ERRs (estrogen receptor-related receptors)	2
agonistic ligands	2
small chemicals, KUSs (Kyoto University Substances)	2
affected dopaminergic neurons	2
neuromarkers	2
orbitofronto-striato-thalamic and premotor circuits	2
premotor and ventral striatum	2
medicated patients	2
thalamus and medial orbitofrontal cortex	2
d=−0.83, −0.71	2
left premotor/presupplementary motor areas	2
left ventral striatum (d=0.88, 0.67), bilateral medial orbitofrontal cortex (d=0.86, 0.71; 0.90, 0.73), and left inferior temporal gyrus (d=0.83, 0.66)	2
left thalamus	2
drug-naïve and medication-free patients	2
medication-free patients	2
65 medicated (age: 18–57)	2
95 drug-naïve patients	2
obsessive-compulsive disorder (OCD)	2
Malnutrition enteropathy	2
Anti-Deamidated Gliadin Peptide IgG concentrations	2
malnourished children	2
Circulating lipopolysaccharide	2
claudin-4 and E-cadherin	2
Histological lesions	2
muscularis mucosae	2
adult controls	2
blood and intestinal secretions	2
protective proteins	2
many thousands of children globally	2
cathepsin independent, TAP and proteosome dependent cytosolic antigen processing pathway	2
IFN (and not TNF-α)	2
influenza virus challenge	2
IFN-γ-secreting CD8+ cytotoxic T lymphocytes (CTL)	2
Cyclic di-AMP (CDA)	2
Cyclic di-nucleotides (CDN)	2
PE(36:3)	2
HexCerd(d18:1/22:0)	2
GM3 ganglioside, GM3(d18:1/18:0)	2
phosphatidylethanolamine PE(36:3)	2
total monocytes	2
HIV+ men	2
lipidomic profiling	2
Australian men	2
older HIV+	2
HIV+ individuals	2
intramuscular multivalent Shigella vaccines	2
administered Shigella sonnei GMMA vaccine	2
median convalescent antibody	2
median antibody	2
vaccine group	2
first dose	2
convalescent subjects	2
serum IgG median antibody	2
doses ≥1.5/25μg	2
anti-LPS antibody	2
Shigella sonnei	2
intramuscular route (0.059/1, 0.29/5, 1.5/25, 2.9/50, 5.9/100μg of OAg/μg of protein; study 1)	2
O Antigen (OAg)	2
Alhydrogel adsorbed 1790	2
18–45years old subjects	2
healthy European adults	2
Generalized Modules for Membrane Antigens (GMMA) technology	2
candidate Shigella sonnei vaccine (1790GAHB)	2
GSK Vaccines Institute for Global Health (GVGH)	2
safe and affordable Shigella vaccine	2
deaths yearly	2
ICAM-1 or VCAM-1 in non-phagocytic NIH3T3 cells	2
Icam-1-deficient mice	2
live T cells, myeloid cells, and B cells	2
ICAM-1, VCAM-1	2
various cell surface receptors	2
CpG DNA, interferon-γ, and anti-interleukin-10 receptor antibody	2
LTNP patients	2
W614A-3S neutralizing Abs	2
primary monocyte-derived macrophages	2
Fc-mediated inhibitory functions	2
transmitted founder primary viruses	2
HIV-1 progressor patients	2
untreated LTNP patients	2
untreated long-term non-progressor (LTNP)	2
highly conserved motif of the gp41 envelope protein	2
Antibodies (Abs)	2
HIV patients and renal transplant recipients	2
local clusters of patients	2
renal transplant patient	2
patients)	2
given country	2
Nine genotypes	2
201 combinations	2
analysable samples	2
i.e., ≥2 alleles	2
Mixtures of STR markers	2
European centres	2
PCP patients	2
249 samples	2
six already validated short tandem repeat (STR) markers	2
European hospitals	2
standardised culture	2
epidemiology	2
immunocompromised patients	2
airborne human-specific ascomycetous fungus	2
Pneumocystis jirovecii	2
people of other ethnicities	2
European and North American populations	2
healthy non-obese Chinese	2
fat, relatively higher carbohydrate diet	2
two diet groups	2
low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol	2
higher fat, lower carbohydrate group	2
moderate fat, moderate carbohydrate group	2
two other groups	2
diet group	2
lower fat diet	2
written informed consent	2
Ethics Committee	2
Laboratory personnel	2
food and beverages	2
moderate fat, moderate carbohydrate diet	2
one of the three isocaloric diets (1:1:1)	2
computer-generated number	2
hospital dormitory	2
university campus	2
People's Liberation Army General Hospital	2
non-obese healthy population	2
Western societies	2
fat and lower carbohydrate	2
traditional Chinese diet	2
traditional low fat, high carbohydrate diet	2
ultra-rare pretreatment mutation (T790M)	2
multiplex ultrasensitive genotyping platform	2
duplex assay and multiplex assay	2
formalin-fixed paraffin-embedded (FFPE) tissue samples	2
common EGFR mutations (L858R, exon 19 deletion	2
EGFR tyrosine kinase inhibitors (TKIs)	2
Epidermal growth factor receptor	2
LPS-induced endotoxin shock model	2
excessive IL-6 via ATF4 pathways	2
p32 deficient MEFs	2
NF-κB independent but activating transcription factor (ATF) 4 dependent pathways	2
p32 deficient mouse embryonic fibroblasts (MEFs)	2
seriously ill patients	2
somato-dendritic region of neurons	2
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-methyl-d-aspartate (NMDA) stimulation	2
gluatamatergic antagonists MK801	2
somato-dendritic component of primary hippocampal cells	2
postsynaptic motor protein	2
Myosin Va	2
mRNP granules	2
Tau mRNA	2
Ca2+-calmodulin dependent protein kinase (CaMK)IIα mRNA	2
dendritic ribonucleoprotein (RNP) complex	2
somato-dendritic compartment of degenerating neurons	2
axonal protein	2
neurofibrillary tangles (NFT)	2
CRUSADE score	2
real life	2
VerifyNow Analyzer	2
BARC scale	2
Unstable Angina Patients	2
Multiple scores	2
core clock gene	2
LDLR-deficient mice	2
constant darkness	2
mice lacking functional LDLR (low density lipoprotein receptor)	2
conservative mobile elements carrying blaNDM or blaKPC-2 on conjugative and non-conjugative plasmids	2
blaKPC-2 gene	2
common core structure, blaNDM-blaMBL-trpF.	2
test strains	2
blaNDM-bearing plasmids	2
colistin resistance determinant mcr-1	2
fosA3 gene	2
new CRE strains	2
specific resistant clones	2
ST131/ST167 of E. coli	2
ST11 of K. pneumoniae	2
several major strain types	2
two carbapenemase genes, blaKPC-2 and blaNDM	2
geographical locales	2
carbapenem-resistant Enterobacteriaceae (CRE) - mediated hospital infections	2
anti-bacterial genes	2
Smed-sted8-1-dependent expression	2
Smed-morn2	2
Smed-p38 MAPK	2
Smed-PGRP-2 and Smed-setd8-1	2
Smed-PGRP-2 and Smed-setd8-1 expression	2
Smed-setd8-1 histone methyltransferase expression	2
peptidoglycan receptor Smed-PGRP-2	2
stem cell-like neoblasts	2
ZIKV-related congenital brain malformations	2
different mice	2
ZIKV-infected mice	2
retina and cerebellar cortex	2
congenitally ZIKV-infected mice	2
macular atrophy	2
intracranial calcifications	2
Human infants	2
specific inhibitor, RO-3306	2
independent case cohort	2
core genes in the network	2
tissue microarrays	2
functional protein-protein interaction (PPI) network	2
random survival forest models	2
postoperative HCC patients	2
two independent HCC datasets	2
(HCC) patients	2
P2X7R inhibitor (AZ11657312)	2
human mesangial cells	2
P2X7 receptors (P2X7R)	2
Monocyte chemoattractant protein-1 (MCP-1)	2
circulating macrophages	2
ANRIL promoter	2
Estrogen Response Element	2
peripheral blood from adolescents	2
ethnically diverse neonates	2
birth tissues	2
three additional populations	2
childhood adiposity	2
promoter of the long non-coding RNA ANRIL (encoded at CDKN2A)	2
child's adiposity	2
human birth tissues	2
high risk patient cohorts	2
large independent cohort	2
Go-DARTS cohort	2
without LVH	2
KLF15 SNP rs9838915	2
Tayside Scotland (Go-DARTS) type 2 diabetes cohort	2
KLF15 SNPs	2
two KLF15 single nucleotide polymorphisms (SNPs) (rs9838915, rs6796325)	2
transthoracic echocardiographic assessment (Melbourne Diabetes Heart Cohort)	2
transcriptional factor Kruppel like factor 15 (KLF15)	2
lipid species, amino acids and glycoproteins	2
patients with pneumonia	2
VAP	2
pneumonia	2
OPLS-DA).We	2
Metabolic data	2
1D 1H NMR spectra	2
intensive care unit	2
prospective observational study	2
critical care	2
New tools	2
asthma endotypes	2
Nasosorption and bronchosorption	2
upper and lower airways	2
bronchial lining fluid	2
asthmatics IFN-γ, CXCL10/IP10, CXCL11/ITAC, IL-15 and IL-5	2
distinct interferon-related and type 2 pathways	2
Nasal IL-5 and IL-13	2
type 2 inflammatory pathway (IL-4, IL-5, IL-13, CCL17/TARC, CCL11/eotaxin, CCL26/eotaxin-3)	2
anti-viral pathway (including IFN-γ, IFN-λ/IL-29, CXCL11/ITAC, CXCL10/IP10 and IL-15)	2
rhinovirus infection asthmatics	2
sensitive multiplex assay	2
cytokines and chemokines	2
synthetic absorptive matrix	2
patients with allergic asthma (n=28) and healthy non-atopic controls (n=11)	2
related terms	2
“(autophagy OR mitophagy)	2
relevant articles	2
major senescence-associated phenotypes	2
Senescent cells	2
AMPKα2 knockout mice	2
cAMP effector protein Epac	2
cAMP degrading phosphodiesterase (PDE)	2
important metabolic regulator	2
specific Sirt1 activator SRT1720	2
vaccine encoding subdominant antigens	2
SIV accessory antigens vaccine	2
rectal CD4+ T cell population	2
detectable viremia	2
5/6 animals	2
vaccinees	2
MHC class II associated invariant chain	2
normally weakly immunogenic tat, vif, rev and vpr antigens	2
heterologous adenovirus vectored SIV vaccine regimen	2
acute peak viremia	2
FundingBill & Melinda Gates Foundation	2
linear growth	2
multiple mechanistic pathways	2
non-diarrheal stools	2
proposed mechanistic pathways	2
directed acyclic graph	2
(N=6363) and plasma alpha-1-acid glycoprotein (AGP) (N=2797)	2
urinary lactulose:mannitol (L:M)	2
alpha-1-antitrypsin, and neopterin	2
1253 children	2
MethodsNon-diarrheal stool samples	2
eight countries	2
intestinal and systemic inflammation	2
theory-driven systems model	2
low- and middle-income populations	2
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)	2
patients with AIF mutation	2
cultured astrocytes	2
mouse Harlequin (Hq) subgroup	2
antidiabetic drug pioglitazone (PIO)	2
respiratory chain complex I	2
highly heterogeneous mitochondriopathy	2
Depressed adolescents	2
left supragenual ACC	2
right insula	2
bilateral supragenual ACC	2
left amygdala	2
Longitudinal Cohort	2
amygdala, anterior cingulate cortex (ACC), and pre-frontal cortex (PFC)	2
34 controls	2
82 patients	2
Cross-sectional Cohort	2
control participants	2
emotional (‘hot’) and cognitive control (‘cold’) neural systems	2
adults with major depressive disorder (MDD)	2
PD-1 pathway	2
PD-1 Ig fusion protein	2
high-affinity chimeric	2
local and metastatic tumor burden	2
murine Lewis lung carcinoma	2
mixed lymphocyte reaction (MLR) assay	2
cell-based and in vivo studies	2
soluble chimeric Ig fusion protein	2
mutant (A132L)	2
PD-L1 and PD-L2	2
high-affinity mutant PD-1 (HA PD-1)	2
mutant PD-1 receptors	2
crystallographic interface	2
PD-1 binding interface	2
human PD-1 ectodomain	2
ligands PD-L1 and PD-L2	2
inhibitory immune receptor	2
Programmed Cell Death-1 (PD-1)	2
normal kidney	2
subendothelium	2
Neutrophil proteases	2
human kidney	2
elastase inhibitor	2
elastase and the GBM	2
perfusion system	2
surface of primary glomerular endothelial cells	2
VWF-platelet strings	2
GBM-mediated VWF-cleaving activity	2
neutrophil serine proteases	2
serine protease or metalloprotease category	2
potent components	2
neutrophil proteases, elastase, proteinase 3 (PR3), cathepsin-G and matrix-metalloproteinase 9	2
smallest multimers	2
human GBMs	2
subendothelial glomerular space	2
glomerular basement membrane (GBM)	2
ADAMTS13 other proteases	2
thrombotic microangiopathy	2
main VWF-cleaving protease	2
von Willebrand factor (VWF)	2
MITF expression	2
polycomb group protein EZH2	2
novel downstream effector	2
NFIB transcription factor	2
two transcription factors, BRN2 and MITF	2
sub-populations of tumour cells	2
serologic assay	2
NS1 and NS5 in the MIA	2
NS1 and NS5 proteins	2
(DENV; a closely related flavivirus) infections	2
known ZIKV and/or dengue virus	2
153 patient specimens	2
virus-type specific antibodies	2
viral nonstructural proteins NS1 and NS5	2
flaviviruses)	2
robust, yet cross-reactive antibodies	2
different flaviviruses	2
IgM-capture ELISA	2
pathology	2
blunting inflammation	2
male births	2
sequela	2
55 articles	2
cases of campylobacteriosis and salmonellosis	2
irritable bowel syndrome (IBS) and Guillain-Barré syndrome (GBS)	2
Reiter's syndrome (RS)	2
four databases	2
campylobacteriosis and salmonellosis	2
antibiotics, proton pump inhibitors (PPI)	2
mice with insulin-deficient diabetes	2
corresponding miRNA mimics	2
corresponding anti-miRNAs	2
BM cells	2
miRNAs (miR-106b-5p and miR-222-3p)	2
42 miRNAs	2
murine miRNAs	2
two microRNAs (miRNAs)	2
bone marrow (BM) transplantation (BMT)	2
hemoglobin or non-mass spectromietry-derived metabolites	2
postnatal gestational age prediction tools	2
small for gestational age infants	2
developed models	2
159,215 infants	2
newborn blood spot samples	2
many parts of the developing	2
patients with indolent disease	2
subgroup of patients	2
circulating CLL cells	2
LDLs in lysosomes	2
nuclear receptor PPARδ	2
normal lymphocytes or glycolytic lymphoma cell-lines	2
tyrosine-phosphorylated STAT3	2
pseudofollicles	2
kinds of patients	2
cholesterol-lowering statin drugs	2
Chronic Lymphocytic Leukemia (CLL) patients	2
entorhinal principal neurons	2
glutamatergic-GABAergic neuronal circuit	2
entorhinal LFES	2
focal hippocampal GABAergic neurons	2
activating entorhinal CaMKIIα-positive neurons	2
channelrhodopsin-2-eYFP labeled entorhinal CaMKIIα-positive neurons	2
entorhinal CaMKIIα-positive neurons	2
entorhinal low-frequency electrical stimulation (LFES)	2
entorhinal calcium/calmodulin-dependent protein kinase II α (CaMKIIα)-positive neurons, but not GABAergic neurons	2
IgG1 variants	2
IgA2 isotypes	2
IgG1 isotype bnAbs	2
mucosal models	2
CH54 IgG1 and CH38 mIgA2)	2
CH31 IgG1 and IgA2 isoforms	2
FcR-expressing effector cells	2
IgG1 and IgA nnAbs	2
CD4 binding site bnAbs b12 IgG1 and CH31 IgG1 and IgA2 isoforms	2
replication-competent, secreted NanoLuc reporter virus system	2
human vaginal explants	2
monoclonal broadly-neutralizing (bnAb) and non-neutralizing Abs (nnAbs)	2
rhesus macaque in vivo intrarectal SHIV challenge model	2
human ex vivo vaginal HIV-1 infection model	2
biologically relevant mucosal models	2
standard FFPE tissue sections	2
high- and low-risk PBC	2
biliary epithelial cells	2
senescence marker p21WAF1/Cip	2
gene product	2
high-risk PBC	2
complement pathway	2
High-risk PBC	2
controls and high- and low-risk PBC	2
Immunity 770-gene panel	2
nCounter PanCancer	2
NanoString®	2
Formalin-fixed paraffin-embedded (FFPE) liver biopsies	2
low-risk patients	2
high-risk PBC patients	2
Stratifying high-risk patients	2
MRC/DFID Concordat	2
International Development (DFID)	2
populations of African descent	2
erythrocytic stage malaria	2
laboratory and field strains of P. falciparum	2
subject RBCs	2
vitro parasite growth	2
P. falciparum laboratory and field strains	2
flow cytometry-based in vitro growth and invasion assays	2
Children donated RBCs	2
micronutrient powder	2
ISRCTN registry, number ISRCTN07210906)	2
135 children	2
anemic children	2
fresh RBCs	2
malaria-endemic region	2
observational cohort study	2
Rarer variants	2
common risk variants	2
common environments	2
genetic and environmental variance components	2
large Scottish family-based cohort (GS:SFHS, N=19,994)	2
clinically-assessed major depressive disorder (MDD)	2
dietary fiber	2
probiotic product	2
clinical trial	2
LU+B420 group	2
abdominal region	2
Placebo group	2
PP population	2
ITT population	2
three participants	2
antibiotic use	2
blood and fecal biomarkers	2
dietary fiber Litesse® Ultra polydextrose (LU)	2
(B420)	2
lactis 420	2
Bifidobacterium animalisssp.	2
asymptomatic population	2
malaria-infected asymptomatic, G6PD-normal individuals	2
PQ arms	2
DHAP alone	2
asymptomatic, malaria-infected individuals	2
P. falciparum gametocytemia	2
sequentially numbered opaque envelopes	2
computer-generated sequence	2
asymptomatic, malaria-infected, glucose-6-phosphate dehydrogenase (G6PD) normal individuals	2
Plasmodium falciparum gametocytaemia	2
single dose of primaquine (PQ)	2
dihydroartemisinin-piperaquine (DHAP)	2
artemisinin-based combination therapy	2
single low dose of primaquine	2
malaria-infected individuals	2
low-density gametocyte carriers	2
B2-cell autoantibody-production axis	2
Toll-Like Receptor Signaling Pathway RT2 Profiler PCR Array	2
activated B2 cell subsets	2
TLR-signaling-related genes	2
anti-B2-cell surface CD23 antibody	2
broad-spectrum antibiotic cocktail (AVNM)	2
circulating IgG	2
B2 cells in perivascular adipose tissue	2
7 studies	2
people from Chinese Jiangsu province (rs1550117, OR 1.77, 95%CI 1.25–2.51; rs1569686, OR 0.48, 95%CI 0.36–0.64)	2
remaining SNPs	2
rs1569686 (dominant model: OR 0.74, 95%CI 0.61–0.90	2
heterozygote model	2
GC cases	2
Findings20 studies	2
heterogeneity source	2
Four genetic models (homozygote, heterozygote, dominant and recessive model	2
rs13420827 in DNMT3A, rs1569686, rs2424913 in DNMT3B)	2
rs16999593, rs2228611, rs8101866 in DNMT1	2
DNMTs polymorphisms	2
single nucleotide polymorphisms (SNPs) of DNMTs (DNMT1, DNMT3A and DNMT3B)	2
substantial, widespread, distinct and orderly HLA- and non-HLA-related neural influences	2
multidimensional plot	2
widespread but distinct distributions in sensor space	2
sensor space	2
prewhitened MEG time series	2
65 with GWI	2
-one Gulf War veterans	2
protective alleles	2
Neurological-Cognitive-Mood (NCM)	2
Georgopoulos et al., 2015)	2
alleles from class II genes of the Human Leukocyte Antigen (HLA)	2
inoculated animals	2
ZIKV-specific immune responses	2
spleen and lymph nodes	2
intestinal tracts, spleen, and parotid glands	2
ZIKV initially	2
central nervous system and visceral organs	2
ZIKV RNA in urine, saliva, and lacrimal fluid	2
2016 contemporary clinical isolate of ZIKV	2
left transverse temporal gyrus	2
auditory cortex	2
AESZ participants	2
HC and NASZ groups	2
AESZ group	2
healthy controls (HC)	2
symptom-severity-matched patients with non-acute episode schizophrenia (NASZ)	2
patients with acute episode schizophrenia (AESZ)	2
click trains	2
BOLD responses	2
BOLD signals	2
schizophrenia patients	2
gamma oscillations	2
memory B cell repertoire	2
small subset of memory B cells	2
classical memory cells	2
plasmablasts	2
one serotype	2
four dengue virus serotypes	2
novel classification model	2
Kyorin University Hospital	2
external data set	2
NMIBC patients	2
novel risk classification system	2
856 patients	2
recurrent cases	2
six hospitals	2
1085 patients	2
patients with non-muscle invasive bladder cancer (NMIBC)	2
Sepsis patients	2
sepsis courses	2
rare SNVs	2
trained model	2
Greek patients	2
rare deleterious single nucleotide variants (SNVs).We	2
bacterial sepsis	2
exomes	2
inadequate responders	2
103 patients	2
219 patients	2
3576 patients	2
groups of patients	2
growth mixture models	2
national registries of patients with diagnosis of RA	2
disease modifying antirheumatic drugs (DMARDs)	2
MS subjects	2
0.97.ConclusionsExogenous C-peptide	2
non-MS subjects	2
erythrocytes in MS samples	2
average C-peptide	2
n=39)	2
subjects with MS (n=86), other non-MS neurologic diseases (OND n=75)	2
enzyme linked immunosorbent assay (ELISA).ResultsThe cohort	2
remaining C-peptide	2
supernatant	2
exogenous C-peptide	2
subjects with MS, non-MS neurologic diseases	2
patients with Multiple Sclerosis (MS).MethodsWhole blood	2
developing world	2
existing literature	2
apparently healthy individuals	2
fecally contaminated food, water and fomites	2
enough variants	2
heterogeneous radiotherapy cohorts	2
bladder, kidney, rectum and small intestine	2
single nucleotide polymorphism (SNP) associations	2
1564 men	2
prostate cancer radiotherapy cohorts	2
many cancer patients	2
minority limits doses	2
long-term cancer survivors	2
anti-inflammatory molecules	2
deubiquitinating enzyme	2
preclinical murine models	2
LPA1-CD14 interaction complex	2
Nedd4L. Knockdown	2
USP11 in quiescent cells	2
deubiquitinates LPA1	2
ubiquitin-specific protease 11 (USP11)	2
LPA-LPA1-mediated cytokine release	2
Ubiquitin E3 ligase Nedd4L targets LPA1	2
Lysophosphatidic acid receptor 1 (LPA1)	2
strongest identified signal IRAK4	2
exons and flanking regions	2
/A genotype	2
IRAK4 rs4251552 G risk allele	2
IRAK4 rs4251552	2
haplotype block	2
rs4251552 of IRAK4	2
rs2067085 in NOD2	2
rs2008521 in CARD8 (p=6.1e−04)	2
416 controls	2
pneumococcal meningitis patients	2
Pneumococcal meningitis	2
promising biomarkers	2
broad range of relevant biomarkers	2
blood biomarkers	2
final list of 788 biomarkers	2
miss-classified and duplicate markers	2
Clinical experts	2
potential blood-based biomarkers	2
CRD42014010827).FindingsThe searches	2
Consortium	2
inclusive database	2
blood based biomarkers	2
retrieved titles and abstracts	2
relevant literature	2
Cochrane library and Biosis	2
Early Cancer Detection Consortium	2
BRCA1-BRCA2 mutation carriers (n=71)	2
patients with HGSOCs	2
apparently normal FTE	2
key stem cell differentiation gene SOX2	2
40kb distal repressor region	2
(FTE) cells	2
primary cultured fallopian tube epithelial	2
in-vivo reporter assay and mammalian models	2
protein expression	2
high-grade serous ovarian cancer (HGSOC)	2
single patient	2
microscopic residual disease	2
molecular precursors	2
calcium signaling	2
pSS SGs	2
primary regulator of the store-operated Ca2+ entry (SOCE) pathway	2
stromal interacting molecule 1 (STIM1)	2
salivary glands (SGs) of pSS patients	2
EBV-specific microRNA (ebv-miR-BART13-3p)	2
Epstein Barr Virus (EBV)	2
salivary and lacrimal glands	2
blood of MS patients	2
patients with inactive disease	2
Collected sera	2
ODC derived demethylated MOG cfDNA	2
cuprizone-fed mouse model	2
DNA from human oligodendrocyte precursor cells (OPCs)	2
O4+ ODCs	2
MOG-DNA	2
myelin-producing oligodendrocytes (ODCs)	2
myelin oligodendrocyte glycoprotein (MOG) gene	2
methylation-specific primers	2
useful biomarker	2
Differentially methylated circulating-free DNA (cfDNA)	2
Minimally invasive biomarkers	2
pannexin channels	2
human lung	2
calcium channel variants	2
another calcium channel inhibitor	2
vascular smooth muscle	2
high-affinity splice variant of CaV1.2	2
CaV1.2 splice variant	2
specific combination of variable exons	2
CACNA1C mRNA	2
Human lung tissue	2
human lungs	2
CACNA1C transcripts	2
different DHPs	2
peripheral arteries	2
vascular smooth muscle (VSM)	2
l-type calcium channels (CaV1.2; gene CACNA1C)	2
Clevidipine, a dihydropyridine (DHP) analogue	2
line-probe assay	2
NTM PCR-based detection and culture	2
drug susceptible MTB.MTB molecular-based detection and culture	2
nontuberculous mycobacteria (NTM)	2
Mycobacterium tuberculosis complex (MTB),	2
PCR-based assays	2
6875 clinical samples	2
clinical mycobacteriology	2
Molecular assays	2
NSCLC, breast and prostate cancer cells	2
sensitized NSCLC cells	2
loratadine, astemizole and ebastine	2
ebastine use	2
patients with any non-localized cancer	2
non-CAD antihistamines	2
non-localized cancer	2
patients with non-localized NSCLC	2
commonly prescribed CAD antihistamine	2
patients diagnosed with non-localized cancer	2
several CAD antihistamines	2
NSCLC cells	2
cationic amphiphilic drug (CAD) library	2
one of the deadliest cancers	2
Non-small cell lung cancer (NSCLC)	2
patients with hypertension	2
total serum IgG	2
basic risk model	2
total serum IgG and IgM respectively	2
MDA-LDL	2
IgG and IgM antibodies	2
C-reactive protein (CRP) and N-terminal pro-B-type natriuretic peptide (NtProBNP)	2
baseline total serum IgG	2
485 patients	2
Blood Pressure-Lowering Arm	2
specific antibodies against malondialdehyde-conjugated low-density lipoprotein (MDA-LDL)	2
total serum IgM and IgG	2
activation marker sCD30	2
recipients	2
strong DSA	2
sCD30 and DSA positive	2
patients who	2
patients with or without DSA	2
immune activation marker sCD30	2
pretransplant DSA	2
presensitized kidney transplant recipients	2
pretransplant DSA and immune activation marker soluble CD30 (sCD30)	2
preactivated T-cells	2
patients DSA	2
pretransplant donor-specific HLA antibodies (DSA)	2
kidney transplant recipients	2
tumor multisampling	2
bilateral WT	2
separate tumor origins	2
majority of tumors	2
Illumina CytoSNP12v2.1 arrays	2
WT cases	2
sample per tumor	2
1q+ in Wilms tumor (WT)	2
Wnt/β-catenin and Rho-GTPase pathway-related genes	2
specific promoter regions of Wnt/β-catenin and Rho-GTPase pathway-related genes	2
NKX6 transcription factor, locus 3 (NKX6.3)	2
Wnt/β-catenin and Rho-GTPase signaling pathways	2
advanced gastric cancer	2
e-learning and non-e-learning groups	2
non-e-learning group	2
35 countries	2
either an e-learning or non-e-learning group	2
Internet-based e-learning system	2
specific SCRIB exons	2
underused exons	2
Conserved exons	2
polarity regulator	2
tissue microenvironment	2
parasitic infections	2
bile duct	2
unique microbial communities	2
altered microbiota	2
ammonia in OVa tissues	2
CCA microbiomes	2
O. viverrini microbiome	2
enriched families, Bifidobacteriaceae	2
specific enteric bacteria (Bifidobacteriaceae, Enterobacteriaceae and Enterococcaceae)	2
parasite associated (OVa) vs non-associated (non-OVa) groups	2
paired normals	2
Stenotrophomonas species	2
several bacterial families	2
non-cancer normals	2
tumor and paired normal samples	2
bile duct tissues	2
bacterial families Dietziaceae, Pseudomonadaceae and Oxalobacteraceae	2
distinct, tissue-specific microbiome	2
non-O. viverrini associated (non-OVa, n=32) cancers	2
liver fluke (Opisthorchis viverrini) associated (OVa, n=28) and	2
matched normals	2
primary CCA tumors	2
bile duct tissue microbiomes	2
bile duct system	2
unmeasured confounders	2
either humans or Drosophila	2
reduced Ca2+-Calmodulin-dependent adenylyl cyclase	2
Drosophila rutabaga mutants	2
cyclic adenylate monophosphate (cAMP) pathway	2
offspring of standard diet parents	2
Drosophila offspring	2
fruit juice	2
maternal daily serving of fruit	2
808 eligible CHILD-Edmonton sub-cohort subjects	2
early hominins and humans	2
important dietary constituent	2
In-utero nutrition	2
specific glycosylation enzymes	2
global target	2
core set of enzymes	2
(SLeX), O-GlcNAc and chondroitin sulphate	2
sialyl LewisX	2
core set of regulated enzymes including sialyl-Tn (sTn)	2
clinical prostate carcinoma	2
set of 8 (GALNT7, ST6GalNAc1, GCNT1, UAP1, PGM3, CSGALNACT1, ST6GAL1 and EDEM3)	2
reciprocally-regulated glycosylation enzymes	2
700 genes	2
patients with prostate cancer	2
RNASeq data	2
androgen-regulated cellular pathways	2
Steroid androgen hormones	2
human drug target	2
target of one of the small molecules	2
negligible cytotoxicity	2
cells of multiple species (including human)	2
three structurally diverse and potent compound classes	2
primary screen	2
several hundred lipid storage inhibitors	2
active small molecules	2
multifarious tools	2
fly cells	2
FundingAeras, FDA, Bill and Melinda Gates Foundation	2
healthy adult vaccine recipients	2
two volunteers	2
one key macrophage marker (F4/80)	2
post-vaccination monocyte expression modules	2
post-vaccination T cell expression modules	2
latent VZV	2
BCG-specific IFN-γ responses	2
two vaccinees	2
whole blood bactericidal activity culture assay (WBA)	2
Ag85A- and Ag85B-specific lymphoproliferative responses	2
independently prepared randomly generated sequence	2
1–8×105CFU)	2
non-recombinant Tice BCG	2
single intradermal dose of AERAS-422	2
one US clinical site	2
HIV-negative, healthy adult, BCG-naïve volunteers	2
mutant perfringolysin	2
recombinant BCG, AERAS-422, over-expressing TB antigens Ag85A, Ag85B, and Rv3407	2
major cities	2
albopictus)	2
sufficient vector populations (either Ae. aegypti and Ae.	2
three non-European reference cities	2
European cities	2
temperate areas	2
quantitative gene expression scoring system	2
alopecia totalis or universalis	2
AA or normal control subjects	2
human scalp skin biopsy specimens	2
Alopecia areata (AA)	2
neurocognitive architecture	2
CPAP plus BSC group	2
BSC group	2
right thalamus	2
BSC alone	2
CPAP with best supportive care (BSC)	2
parallel groups	2
matched healthy volunteers	2
patients with OSA.Methods55 patients	2
FundingGeneuro-Innovation	2
MSRV-Env expression	2
patients with CIDP	2
critical immune mediators	2
highly specific and neutralizing humanized monoclonal antibody targeting MSRV-Env	2
IL6 and CXCL10 transcripts	2
MSRV-env	2
5/7 CIDP biopsies	2
MSRV-Env protein	2
cultured primary human Schwann cells (HSCs).FindingsIn both cohorts	2
CIDP and neurological controls biopsies	2
distal sensory nerves	2
MSRV-Env immunohistology	2
two different countries	2
healthy blood donors (HBDs)	2
19 other neurological controls (ONDs)	2
patients with chronic inflammatory demyelinating polyradiculoneuropathies (CIDPs)	2
various neurological controls	2
pro-inflammatory protein	2
endogenous retroviruses HERV-W	2
49,711 patients	2
stroke patients	2
Danish Registries	2
hospitalized	2
citizens	2
sphingolipids and glycerophospholipids	2
essential nutrient	2
essential amino acids and choline	2
six different sphingolipids	2
conditionally essential amino acids (arginine, glycine, glutamine), non-essential amino acids (asparagine, glutamate, serine)	2
stunted children	2
p<0.01)	2
nine essential amino acids (tryptophan, isoleucine, leucine, valine, methionine, threonine, histidine, phenylalanine, lysine)	2
rural Malawi	2
313 children	2
glycerophospholipids, sphingolipids, and other metabolites	2
serum amino acids	2
metabolic machinery	2
Epstein–Barr and Flu virus	2
HIV- infected persons	2
antiretroviral therapy	2
foreign antigens	2
non-MSM individuals	2
significantly richer and more diverse fecal microbiota	2
non-MSM subjects	2
Prevotella-rich enterotype	2
HIV-1-negative controls	2
HIV-1-infected subjects	2
two independent cohorts	2
HIV-1 transmission groups	2
Bacteroides to Prevotella predominance	2
Flemish and white and black Africans	2
inactive desphospho-uncarboxylated MGP (dp-ucMGP)	2
South Africans	2
1166 white Flemish	2
vitamin K (VK), matrix Gla protein (MGP)	2
highly resistant CSC sub-population	2
endoplasmic reticulum (ER) stressor and autophagy inhibitor Thapsigargin	2
sub-population	2
TGFβ and retinoic acid (RA)	2
post-EMT CSCs	2
epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET)	2
Cancer stem cells (CSCs)	2
first-line diagnostic assay	2
filipin test	2
rapid and reliable biomarker	2
many NP-C patients	2
Niemann Pick type C1, type C2, type A/B	2
Cholestane-3β,5α,6β-triol	2
SMPD1 gene	2
12 Niemann Pick type A/B patients	2
69 NP-C1 and two NP-C2)	2
new NP-C patients	2
elevated oxysterols	2
, c-triol	2
potential biomarker	2
oxysterol cholestane-3β,5α,6β-triol (c-triol)	2
accumulating cholesterol	2
reliable blood test	2
Niemann Pick type C (NP-C)	2
veterans with GWI.FundingUniversity of Minnesota and U.S. Department of Veterans Affairs	2
6 alleles	2
Class II alleles	2
6 domains	2
respective group	2
subset of HLA alleles	2
66 with and 16 without GWI	2
unique alleles of Class I and II HLA genes	2
antigen-specific sequences	2
total repertoire	2
vaccine-specific sequences	2
vaccine-specific memory cells	2
vaccine-specific sorted cells	2
hepatitis B vaccination	2
diverse B cell immunoglobulin repertoire	2
R213G heterozygotes	2
93,521 R213G non-carriers	2
national hospitalization and death registers	2
SOD3 gene	2
R213G	2
extracellular superoxide dismutase (SOD3	2
osteoblastic differentiation	2
potential therapeutic agent	2
C-terminal tail of ubiquitin	2
pocket of CYLD	2
lansoprazole tightly	2
deubiquitination enzyme, cylindromatosis (CYLD)	2
TNF receptor-associated factor 6 (TRAF6)	2
noncanonical bone morphogenic protein (BMP)-transforming growth factor-beta (TGF-β) activated kinase-1 (TAK1)–p38 mitogen-activated protein kinase (MAPK) pathway	2
rat femoral fracture model	2
human mesenchymal stromal cells	2
proton pump inhibitor	2
osteochondroblast lineages	2
transcription factor, runt-related transcription factor 2 (Runx2)	2
– New England Division – Ellison Foundation Research Scholar Grant (RSG-15-129-01-CPHPS	2
Cancer Society	2
≥3 FDRs	2
1 FDR	2
BRCA2 carriers	2
BRCA2 and one FDR	2
primary BRCA2 cohort	2
first-degree relatives (FDRs)	2
Additional higher risk BRCA2 cohorts	2
previously published Markov model	2
pancreatic adenocarcinoma (PAC)	2
Principado de Asturias, FICYT, and Hackensack University Medical Center Foundation	2
European Union FEDER Funds	2
Red de Investigación Renal	2
Instituto de Salud Carlos III	2
Social “La Caixa”	2
Caucasian subjects	2
autoimmune memory	2
naïve T, TCM, and TEM cells	2
C–C chemokine receptor 7 (CCR7) expressions	2
CD4+ effector memory T cells (TEM) and CD8+ TEM cells	2
CD4+ central memory T cells (TCM)	2
naïve CD4+ T cells	2
patient's blood circulation	2
“educated” lymphocytes (but not the CB-SCs)	2
CB-SCs	2
patient's lymphocytes	2
closed-loop system	2
human multipotent cord blood-derived multipotent stem cells (CB-SCs)	2
Caucasian T1D patients	2
autoimmune T cell memory	2
pancreatic islet β cells	2
mammography setting	2
mammogram populations	2
HBOC syndrome	2
insured reference population	2
prophylactic mastectomies	2
underserved population	2
expected BRCA1/2 mutation carriers	2
two safety net hospitals	2
61,924 underserved women	2
mammogram population	2
high-risk underserved women	2
[3H]-progesterone	2
wild-type control cells	2
DTG-protectable [125I]-IAF photolabeling	2
S2R (Bmax)	2
overexpressing PGRMC1	2
PGRMC1 knockout NSC34 cell lines	2
S2R (Nature Communications, 2011, 2:380)	2
25kDa protein	2
progesterone receptor membrane component 1 (PGRMC1)	2
[125I]-iodoazido-fenpropimorph ([125I]-IAF)	2
[3H]-Azido-DTG and	2
selective sigma-1 receptor ligand (+)-pentazocine	2
1,3-di-o-tolylguanidine (DTG) and haloperidol	2
sigma-2 receptor (S2R)	2
human experimentation	2
mouse versus human RBCs	2
microvascular angiopathy	2
Human RBC β-spectrin	2
normal and diabetic mice	2
facilitated glucose transporters	2
ascorbate's oxidation product dehydroascorbic acid (DHA)	2
decreased β-spectrin	2
ascorbate deficient mice	2
human and mouse RBCs and plasma	2
neointima formation	2
BET bromodomains	2
vehicle control	2
JQ1(+)-treated arteries	2
PDGF receptor-α	2
JQ1(−)	2
BRD4 siRNA	2
human aortic endothelial cells	2
primary human aortic smooth muscle cells	2
primary rat aortic smooth muscle cells	2
platelet-derived growth factor (PDGF-BB)-stimulated proliferation	2
inactive enantiomer JQ1(−)	2
BET bromodomains with JQ1(+)	2
rat and human hyperplastic neointima	2
rat balloon angioplasty model	2
BET family	2
seemingly undruggable BET bromodomains	2
bromo and extra-terminal (BET) epigenetic “readers	2
ML-ratio-associated gene set	2
IRF1, IRF2, RUNX1, RELA and ESRRB	2
-I and -II interferon signalling (p=1.2×10−8)	2
ML-ratio associated genes	2
906 genes	2
sorted monocytes	2
unstimulated CD14+ monocytes	2
liquid culture	2
whole or sorted blood	2
HbSC red cells	2
two genotypes	2
Gardos channel	2
conductive channels Psickle	2
Two transporters	2
homozygous HbSS individuals	2
patients of HbSC genotype	2
W ST-11 cases	2
meningococcal virulence genes	2
virulence genes encoding factor H binding protein, nitric oxide reductase, and nitrite reductase	2
descendants	2
whole genome phylogenetic and major antigen-encoding gene sequence analyses	2
patients with invasive meningococcal disease	2
270 meningococcal strains	2
recent W ST-11 disease clusters	2
Hajj outbreak strain (Hajj clone	2
sporadic W ST-11 strains	2
endemic cases	2
meningitis belt’	2
African ‘	2
serogroup W (W) sequence type (ST) 11	2
Hajj pilgrims	2
Alcohol-dependent subjects	2
subjects without alcohol use disorders (AUDs)	2
comparator population	2
, MEDLINE	2
anti-RANKL antibody	2
BRCA-mutation carriers	2
P–RANKL/OPG system	2
BRCA-mutation carriers (rho=−0.216; p=0.002)	2
BRCA1-mutation carriers	2
free serum OPG	2
n=150).BRCA-mutation carriers	2
serum RANKL and OPG in postmenopausal women	2
serum and mammary tissues of female cynomolgus macaques (n=88)	2
782 noncarriers	2
BRCA1/2-mutation carriers	2
RANKL, OPG, RANKL/OPG complex, oestradiol (E2), and progesterone (P)	2
RANKL/osteoprotegerin (OPG) signalling	2
excellent targets	2
cellular reservoirs of HIV	2
HIV-1-infected patients	2
asymptomatic malaria	2
youngest, and female infants	2
malaria and other febrile illnesses	2
≤8years old	2
Kenyan children	2
malaria antigens	2
iron-regulatory hormone hepcidin	2
Hiroshima University	2
FundingThis study	2
stroke subtypes	2
pravastatin group	2
pravastatin group or control group	2
1578 patients	2
control group patients	2
pravastatin group patients	2
ischemic stroke patients	2
low-dose pravastatin	2
premanifest-HD	2
motor tasks	2
left hemisphere network	2
right dorsolateral prefrontal cortex	2
working memory task	2
right parietal cortex	2
premanifest-HD gene-carriers	2
premanifest Huntington's disease (HD) gene-carriers	2
Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46)	2
GWAS	2
Chr8p23.1	2
Chr1p35.1 (ZSCAN20-TLR12P)	2
(GoDARTS) cohort	2
diabetic controls	2
diabetic neuropathic pain cases	2
diabetic individuals	2
genetic contributors	2
somatosensory system	2
IntFam proteins	2
different lineages (births and deaths	2
10,772 predicted nematode intestinal protein families (IntFams)	2
2 outgroup species	2
3 host species	2
9 pathogens of humans or animals)	2
whole proteomes	2
three parasitic nematodes	2
dissected intestines	2
comprehensive nematode intestinal functional database	2
outside environment	2
nematode intestine	2
centenarians and semi-supercentenarians	2
long telomeres	2
centenarian offspring	2
(semi-)supercentenarians	2
linear forward stepwise models	2
old and (semi-)supercentenarians	2
Cox proportional hazard models	2
cellular senescence domains	2
liver function	2
lipid and glucose metabolism	2
536 community-living very old	2
167 pairs of centenarian offspring	2
centenarians and (semi-)supercentenarians,	2
1554 individuals	2
community-based prospective cohorts	2
important drivers	2
volatiles	2
methanol, 2-pentanone and limonene	2
individual basis limonene	2
limonene, methanol, 2-pentanone, 2-butanone and carbon disulfide	2
breath of patients	2
post-transplant period	2
patients with cirrhosis	2
Alveolar breath samples	2
breath volatiles	2
CD8+DR/DP/DQ+ cells	2
CD4+CD38+ and CD8+CD38+ cells	2
2-LTR circular HIV-1 DNA	2
−0.2, 0.6; p=0.28	2
HIV-1 DNA load (per 106 peripheral blood mononuclear cells)	2
50 patients	2
soluble CD14 (sCD14)	2
T-cell activation markers	2
consistently suppressive first-line antiretroviral therapy (ART).MethodTotal, integrated, and 2-long terminal repeats (LTR) circular HIV-1 DNA	2
independent patient cohorts	2
robust gene sets	2
aggressive cases	2
subset of the 100 genes	2
tumour tissue	2
RB1 and PTEN deletions	2
NKX3-1	2
MAP3K7, MELK, RCBTB2, ELAC2, TPD52, ZBTB4)	2
six genes	2
third cohort	2
separate discovery and validation sets	2
discriminating genes	2
separate patient subgroups	2
array transcriptomics	2
tumour, benign and germline samples	2
integrated genomics	2
prostate cancer subgroups	2
heterogeneous genotypes	2
given individual	2
highly polygenic background	2
SUDEP cases	2
one single gene	2
possible candidate genes	2
SUDEP cohort	2
epilepsy (P=5.7×10−3) and non-epilepsy disease controls	2
individual in the SUDEP cohort	2
non-epilepsy disease controls	2
living people	2
18 people	2
whole-exome sequences	2
rare, protein-changing variants	2
original antibody	2
identified peptides	2
specific protein sequences	2
randomly produced small proteins (“peptides”)	2
potent neutralizing mAbs	2
functional peptide antigens	2
specific epitopes	2
commonly selected peptides	2
original mAb	2
selected peptides	2
hepatitis C virus neutralizing mAb	2
affinity binding peptides	2
mAb-specific epitopes	2
conformationally optimized mimotope antigens	2
high complexity peptide library	2
antibody antigen-binding sites	2
unknown antigen structures	2
neutralizing monoclonal antibodies (mAbs) and antigens	2
LRG1 combined	2
separate patient cohort	2
650 proteins	2
8 channel isobaric tagging tandem mass spectrometry discovery proteomics platform	2
patients pre-	2
patients with non-small cell lung cancer	2
appropriate protein biomarkers	2
NSCLC patients	2
predictive marker	2
locally advanced non-small cell lung cancer (NSCLC)	2
hybridization protection assay	2
telomeric 3′-overhang	2
AZM monotherapy	2
last line antibiotic colistin	2
host cathelicidin antimicrobial peptide LL-37	2
eukaryotic tissue culture media	2
MDR carbapenem-resistant isolates of Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii	2
azithromycin (AZM)	2
bacteriologic media	2
carbapenem-resistance among multidrug-resistant (MDR) Gram-negative rods (GNR)	2
research data	2
ER positive tumors	2
tissue microarray cores	2
Cell Slider web page	2
98,293 Citizen Scientists	2
citizen science project	2
Cell Slider	2
non-specialists	2
Education, Culture, Sports, Science and Technology	2
virus-induced diabetes susceptibility gene	2
anti-glutamic acid decarboxylase autoantibody	2
multiple genetic polymorphisms	2
TYK2 promoter haplotype	2
302 patients with T1D and 314 with type 2 diabetes (T2D)	2
TYK2 gene	2
human TYK2 gene	2
susceptibility region	2
(Tyk2) gene	2
Tyrosine kinase 2	2
key signaling node	2
GLI3 repressor protein	2
arsenic-exposed NIH3T3 cells	2
fetal tissues	2
fetal placenta	2
female placentae	2
HEDGEHOG pathway component, GLI3	2
groundwater arsenic	2
US region	2
unregulated water supplies	2
birth cohort of women	2
key developmental genes in fetal placenta	2
areas of the world	2
critical genetic factors	2
downstream effector Grhl3	2
canonical Wnt signaling	2
uncommitted progenitors in the neural plate	2
grainyhead-like 3 (Grhl3) transcription factor	2
neural plate border	2
canonical Wnt and its antagonists, DKK1/KREMEN1	2
stem cell markers	2
uncommitted progenitor cells	2
SE and NE lineages	2
SE and neural ectoderm (NE) cell fates	2
surface ectoderm (SE) and neural tube	2
single-layered ectodermal sheet	2
TBI alone or C61-LNP alone	2
advanced stage, radiation-resistant BPL	2
ABL double transgenic mice	2
CD22ΔE12×BCR–	2
relapsed BPL patients	2
human ALL xenograft cells	2
otherwise invariably fatal dose	2
C61-LNP alone	2
“C61-LNP	2
liposomal nanoparticle (LNP) formulation of the SYK-P-site inhibitor C61 (	2
B-precursor acute lymphoblastic leukemia (BPL)	2
radiation-resistant leukemia	2
novel arm of neurocryobiology	2
upregulating adaptive chaperone-driven pathways of the UPR	2
ER stressor tunicamycin	2
pre-cooling neurons	2
principal UPR pathway	2
human pluripotent stem cells (hCNs)	2
AKT inhibitors	2
non-wild-type subcellular distribution	2
duplications	2
somatic lesions	2
highly conserved residues	2
JGCTs	2
peritumoral DNA	2
pleckstrin-homology domain of AKT1	2
Western-blot and luciferase assays	2
PI3K–AKT axis	2
analyzed JGCTs	2
juvenile (JGCTs) and adult forms	2
common sex-cord stromal tumors	2
granulosa cell tumors	2
C3H/HeJ mouse model	2
C3H/HeJ AA mouse model	2
JAK1/2 inhibitor	2
patient with AA	2
JAK molecules	2
areata (AA)	2
dystrophic muscle environment	2
endogenous Il6r	2
interleukin-6 receptor (Il6r) neutralizing antibody	2
muscle of mdx	2
patients with DMD	2
pro-inflammatory cytokine interleukin (IL) 6	2
anti-inflammatory agents glucocorticoids (GC)	2
FGFR1 and FGFR3 kinase activity	2
Fibroblast growth factor receptors (FGFRs)	2
formation of the cerebral cortex	2
cortical neural stem cells	2
triplicated gene	2
Ts65Dn mouse model	2
radial glial progenitors	2
neurogenic divisions	2
DYRK1A protein	2
embryonic cortical stem (radial glia) cells	2
human DYRK1A kinase on chromosome 21	2
HER2-enriched, basal-like, and TP53 mutant breast cancers	2
autophagy gene BECN1	2
TP53 mutations	2
HER2-enriched or basal-like subtypes	2
luminal A/B intrinsic tumor subtypes	2
like (mostly triple-negative) breast cancers	2
HER2-enriched and basal-	2
Cancer Genome Atlas (TCGA) (n=1067)	2
two large datasets	2
human chromosome 17q21 breast cancer tumor susceptibility locus	2
BRCA1 and Beclin 1 (BECN1)	2
multiple distinct strains	2
sub-lineages	2
related gonococcus	2
Several isolates	2
Asian isolates	2
third, genetically more diverse sub-lineage	2
one of two closely related sub-lineages	2
European and American isolates	2
number of sub-lineages	2
star phylogeny	2
antigen encoding genes	2
diverse and conserved core genes, accessory genes	2
1940 genes	2
‘Lineage 5 pan genome’	2
Neisseria meningitidis isolates	2
global collection	2
hyper-invasive ET-5/ST-32 complex	2
virulent variant	2
bacterial pandemics	2
predominant model	2
white blood cells in the vicinity	2
highly sensitive cell type	2
unconventional TLR signalling pathway	2
ligands of TLR2	2
InterpretationmetHb and metHb+LTA complex	2
types of white blood cells	2
expressions of IL-8, TNFα, and CD11b	2
isolated neutrophils	2
normal or TLR9-expressing HEK293 cells	2
TLR2-expressing HEK293 cells	2
signalling mediators (ERK and p38)	2
metHb and lipoteichoic acid (LTA)	2
human white blood cells	2
primary whole blood cells	2
single cell lines	2
pathogen-associated molecular patterns (PAMPs)	2
redox-active cytotoxic extracellular Hb (metHb)	2
haemoglobin (Hb)	2
various epitopes and HLA molecules	2
potent cytotoxicity	2
predicted HLA	2
B*27/57posLTNP/EC	2
highly conserved epitopes	2
B*27/57negLTNP/EC	2
previously unreported immunodominant responses	2
B*27/57negLTNP/EC (n=23), B*27/57posLTNP/EC (n=23) and B*27/57negprogressors (n=13)	2
most, but not all LTNP/EC	2
Protective Human Leukocyte Antigen (HLA) class	2
highly functional virus-specific CD8+ T-cells	2
rare long-term nonprogressors/elite controllers (LTNP/EC)	2
Human Immunodeficiency Virus	2
distinctive profile of adhesion molecules	2
stress reticulocytes	2
SCA asymptomatic infants	2
mature red cells	2
adhesion molecules Lu/BCAM, ICAM-4 and LFA-3	2
reticulocytes of SCA infants	2
non-SCA infants	2
non-SCA very young infants	2
β globin gene	2
A561E-CFTR	2
Compound C18	2
F508del-homozygous cells	2
F508del in primary HBE cells	2
alleles)	2
A561E/A561E and F508del/F508del cells	2
corrector C18	2
perfused open-circuit Ussing chambers	2
Forskolin plus Genistein-inducible equivalent short-circuit current (Ieq-SC-Fsk+Gen)	2
non-CF and CF patients with F508del/F508del, A561E/A561E, N1303K/G542X, F508del/G542X and F508del/Y1092X genotypes	2
primary HBE cells	2
primary human bronchial epithelial (HBE) cells	2
Class II mutants	2
Class II CFTR mutants	2
corrector	2
VX-809 (lumacaftor)	2
common CF-causing mutation (F508del)	2
cystic fibrosis (CF) patients	2
best investigational drug	2
Immunohistochemistry staining	2
regular aspirin users	2
familial adenomatous polyposis (FAP) patients	2
reliable biomarkers	2
cancer (CRC)	2
ClinVar genes	2
non-BRCA cancer genetics patients	2
163 clinically-relevant genes	2
nonsynonymous variants	2
members of two cohorts of cancer genetics patients	2
cancer genetics clinic	2
FundingBrain Resource Ltd	2
neuroanatomical basis	2
commonly used medications	2
left cingulum bundle<0·63, right superior fronto-occipital fasciculus<0·54 and right superior longitudinal fasciculus<0·50	2
Left middle frontal volume<14·8mL & right angular gyrus volume>6·3mL	2
two decision trees	2
remaining participants	2
first 50% participants	2
escitalopram, sertraline or venlafaxine-ER	2
high risk population	2
type I IFN related signaling genes	2
Cases expressing IL13	2
HIV-infected drug users	2
causative RV groups	2
VP1 N-terminus	2
capsid and non-structural proteins	2
N-terminal VP1 fragment	2
IgG1 antibodies	2
non-asthmatic subjects	2
asthmatic group	2
three RV groups	2
representative VP1 proteins	2
N-terminal fragments	2
RV16.FindingsBefore infection subjects	2
three known RV groups (RV-A, RV-B and RV-C)	2
four RV strains (RV14, 16, 89, C)	2
N-terminal fragments of VP1	2
non-structural proteins	2
recombinant RV coat proteins VP1-4	2
common colds	2
(RVs)	2
6 patients in the placebo group	2
artesunate	2
artesunate and placebo groups	2
Randomization groups	2
artesunate=9, placebo=11)	2
Findings20 patients	2
c-MYC, CD31, Ki67 and p53	2
daily doses of oral artesunate (200mg; n=12)	2
opaque envelopes	2
computer-generated code	2
biopsy confirmed single primary site CRC	2
oral artesunate	2
case reports	2
antimalarial agent	2
disease-associated diaphanous inhibitory domain (DID) mutants	2
either RhoA	2
INF2 mutants	2
wild-type human INF2	2
defective slit-diaphragm signaling	2
glomerular slit diaphragm proteins	2
wild type INF2	2
vivo model	2
diaphanous formin family protein	2
Inverted Formin 2 (INF2)	2
MM patients	2
bone marrow and extramedullary plasmacytomas	2
panel of known oncogenes	2
Clinical Laboratory Improvement Amendments (CLIA)-approved, high-throughput, genotyping platform	2
Massachusetts General Hospital (MGH)	2
EBV subverts macroautophagy	2
Atg8/LC3 coupled membranes	2
substrate anchor on autophagic membranes	2
essential macroautophagy protein	2
viral DNA	2
infected epithelial and B cells	2
adult human population	2
Epstein Barr virus (EBV)	2
patients with hypertensive nephrosclerosis	2
circulating methylated RASAL1 promoter DNA fragments	2
kidney biopsies	2
circulating methylated RASAL1 promoter DNA fragments in peripheral blood	2
Ras-GTP suppressor RASAL1	2
novel therapeutics and biomarkers	2
clinical nephrology	2
fecal microbial population	2
22 taxa	2
cesarean birth	2
17 taxa	2
individual microbial taxa	2
1097 adult volunteers	2
altered adult microbiota	2
neonate's microbiota	2
Scientific Research from Ministry of Education, Culture, Sports, Science and Technology, Japan)	2
research	2
subjects with MS	2
meal tolerance test	2
isolated monocytes	2
C-reactive protein, adiponectin, and tumor necrosis factor-α	2
inflammatory cytokines or adipokines	2
MES+HS-treated T2DM patients	2
therapeutic MES+HS	2
heat shock protein (HSP) 72	2
HIV vaccine	2
RV144-induced V3-specific Abs	2
V3 hydrophobic core	2
vaccinees' breakthrough viruses	2
vaccinees' plasma Abs	2
V3 site 307	2
V3 site 317 (p=0.004)	2
amino acids mismatching the vaccine	2
placebo-recipients	2
43 vaccine-	2
CRF01_AE breakthrough viruses	2
diverse virus subtypes	2
cyclic V3 peptides (cV3s)	2
Vaccinees' V3 Abs	2
V3-specific IgG antibodies (Abs)	2
ciliary body	2
systemic organs of human fetuses	2
ciliary body of the eye	2
circulating hematopoietic stem cells	2
SYK ATP binding site	2
cell cycle checkpoint regulator	2
non-lymphohematopoietic and B-lineage lymphoid cells	2
spleen tyrosine kinase (SYK)	2
genetic and biochemical evidence	2
CDC25C S216-phosphorylation	2
nocodazole-treated human cell lines	2
chemical SYK inhibitor	2
S216 residue	2
dual-specificity phosphatase CDC25C	2
cell cycle regulatory checkpoint genes	2
new class of anti-cancer drug candidates	2
SYK inhibitors	2
/lymphoma cells	2
B-lineage leukemia	2
genotype D8 variant group	2
Southern Vietnam	2
R442,	2
D8-VNM variant strains	2
D8 reference strain	2
branch	2
genotype D8 group (D8-VNM)	2
genotype D8	2
Vietnamese strains	2
measles reference sequences	2
One hundred and eighteen strains	2
31 cases	2
intermediate replicative form of MV	2
Positive-strand viral RNA	2
ResultsMV RNA	2
N and H genes	2
Measles virus (MV) RNA	2
designThroat swab samples	2
genes of virus	2
aggressive or chemotherapy-resistant B-lineage lymphoid malignancies	2
nanoparticle or other nanoformulation platforms	2
cytoplasm of leukemia cells	2
siRNA cargo	2
RNAi therapeutic candidate	2
unique polypeptide-based nanoparticle formulation	2
high-risk and relapsed BPL patients	2
CD22ΔE12 in primary BPL cells	2
BPL cells	2
pediatric and adult B-lineage lymphoid malignancies	2
CD22ΔE12 molecular lesion	2
five different countries	2
three risk groups	2
gene signatures	2
testing cohort	2
training cohort	2
largest training and testing cohorts	2
gene expression datasets	2
many current predictive models	2
genetic predictive models	2
commonly diagnosed cancer	2
critical molecular trigger	2
cyclooxygenase-2 expression	2
sera of young women	2
soluble biomarkers	2
chronic cystitis	2
urinary tract infections (UTIs)	2
multidrug-resistant microorganisms globally	2
α+thalassemia on its own	2
α+thalassemia alone	2
normal pRBCs	2
mixed genotype	2
normal pRBC controls	2
HbAS pRBCs	2
parasite-derived adhesion molecule P. falciparum erythrocyte membrane protein-1 (	2
pRBCs with uninfected RBCs	2
endothelial receptors CD36 and ICAM1	2
parasitized RBCs (pRBCs)	2
four well-characterized P. falciparum laboratory strains	2
various HbAS and α+thalassemia genotype combinations	2
>300 donors	2
red blood cell (RBC) polymorphisms sickle cell trait (HbAS) and α+thalassemia	2
advanced breast cancer	2
people in Region II.InterpretationWe	2
human breast cancer cell lines	2
Region V	2
women in Region II	2
arsenic removal plant	2
main city Antofagasta	2
northern Chile	2
arsenic trioxide	2
suspected sepsis patients	2
signature	2
sepsis patients	2
unique cohort of possible sepsis patients	2
11 cohorts	2
593 patients	2
Bacterial endotoxins like lipopolysaccharide (LPS)	2
macrophage-tropic strain	2
Vpr-dependent nuclear localization of virus	2
MRJ-L expression	2
male homosexual subjects	2
uninfected counterparts	2
n=31)	2
large isoform of Mammalian DnaJ (MRJ-L), a HIV-1 Vpr-interacting cellular protein	2
simple autologous blood sample	2
two pediatric patients	2
two autologous PWB tissue-engineered vein conduits	2
luminal surface of the grafts	2
flat cells	2
VEGFR-2+/CD14+ cells	2
Circulating, VEGFR-2+/CD45	2
peripheral whole blood (PWB)	2
decellularized allogeneic vascular scaffolds	2
ex vivo expanded stem cells	2
autologous cells	2
tissue-engineered vascular grafts	2
branched-chain amino acids	2
plasma essential amino acids	2
group fed the WPH supplement	2
extensor digitorum longus	2
Wistar rats fed a protein-free (PF) diet	2
muscle protein synthesis	2
hydrolysates (WPH)	2
ovariectomized group	2
femur and tibia	2
animals in the OVX group	2
bones i.e. femur and tibia	2
Control, Zinc, Ovariectomized (OVX) and OVX + Zinc	2
two batches of twenty four animals	2
eight animals	2
nutritional supplement	2
long chain n-3 PUFA	2
infant formula	2
supplemented breastfed and fortified formula fed/directly supplemented infants	2
maternally or in formula/directly	2
n-3 PUFA supplementation	2
without AA	2
milk based formula or directly	2
taken maternally	2
randomized and semi-randomized controlled trials on term infants	2
arachidonic acid (AA)	2
fortified formula/taken directly	2
long chain n-3 PUFA supplementation	2
docosahexaenoic acid (DHA)	2
AimsLong chain omega-3 polyunsaturated fatty acids (n-3 PUFA)	2
strong empirical foundation	2
LCn-3 fatty acid biostatus	2
antidepressant medications	2
EPA + DHA composition	2
patients with MDD	2
habitual fish or fish oil intake	2
preformed EPA + DHA	2
long-chain omega-3 (LCn-3) fatty acids, including eicosapenaenoic acid (EPA) and docosahexaenoic acid (DHA)	2
regular endogenous ligands like CRP	2
synovial TLR-2 expression	2
A. vasica	2
CIA mice	2
liver, spleen and synovial tissues	2
Reduced chemokines	2
serum and synovial tissues	2
male Swiss albino mice	2
methanolic extract of Adhatoda vasica leaf (AVE)	2
constituent's toxicity	2
crocin, crocetin and safranal	2
saffron	2
crocin and crocetin	2
histone H1 and H1-DNA structures	2
DNA, RNA and protein in neoplastic cells	2
cancer cells growth	2
important anticancer agent of saffron	2
RNA and DNA synthesis	2
English and 5 Persian articles	2
following key words: toxicity, saffron, crocin, crocetin, safranal, cancer	2
PubMed, Science direct, SID and Magiran databases	2
spice	2
farmers with wastewater	2
zoonotic pathogen causing gastroenteritis	2
consumers of wastewater irrigated produce	2
farm produce	2
food chain	2
100- to 1,000-person systems	2
small cohort groups	2
local wastewaters	2
various waters	2
Simulated daily infections	2
combined greywater and local combined wastewater (i.e., including toilets)	2
showers/baths	2
bathroom sinks	2
fresh greywaters	2
10,000 possible years	2
reference pathogens (viruses: adenoviruses, Norovirus, and Rotavirus; bacteria: Campylobacter and Salmonella spp.; and protozoa: Cryptosporidium and Giardia spp.)	2
various residential wastewater sources	2
fecal loadings	2
variously sized greywater and combined wastewater collection systems	2
e.g., sink, shower/bath, and laundry waters	2
many source streams	2
smaller systems	2
active infected excreter	2
decentralized collection systems	2
locally-collected wastewaters	2
major wastewater and reuse system	2
children and adults living	2
children in slum communities	2
sanitation workers	2
exposed groups	2
8.3)	2
slum communities	2
18,204 exposed people	2
, pathogenic E. coli, pathogenic Salmonella spp., Cryptosporidium spp.	2
measured organism and pathogenic strains of norovirus, rotavirus, Campylobacter spp.	2
eggs in wastewater samples	2
Ascaris spp.	2
Escherichia coli, Salmonella spp.	2
faecal sludge (sanitation workers)	2
drainage system	2
slum settlements	2
slum dwellers	2
wastewater in the Nakivubo area	2
population groups	2
shores of Lake Victoria	2
recreational areas	2
Nakivubo channel and wetland	2
wastewater systems	2
NCBI's Gene Expression Omnibus	2
TGF-β–treated HSCs	2
PDGF signaling pathway	2
EZH2 histone methyltransferase	2
redundant and distinct transcriptomic targets	2
-β	2
Trichrome and Sirius red stains, hydroxyproline, and α-smooth muscle actin/collagen protein assays	2
carbon tetrachloride or bile duct ligation	2
TGF-β–treated cells	2
EZH2 in HSCs	2
TGF-β–induced fibronectin, collagen 1α1, and α-smooth muscle actin	2
PDGF-BB	2
zeste homolog 2 (EZH2)	2
histone methyltransferase class of epigenetic modulators	2
2 pathways	2
TGF-β or PDGF-BB	2
TGF-β and PDGF signaling pathways	2
epigenetic modulators	2
HSC activators	2
Transforming growth factor β (TGF-β) and platelet-derived growth factor (PDGF)	2
NCBI’s Gene Expression Omnibus	2
granulocyte-macrophage colony-stimulating factor and interleukin-15	2
activated HSCs	2
neutrophil apoptotic bodies	2
reactive oxygen species producing nicotinamide adenine dinucleotide phosphate-oxidase	2
p47phoxgene (also called neutrophil cytosolic factor 1)	2
intercellular adhesion molecule-1 expression	2
chemokine (C-X-C motif) ligand 1	2
HFD+1B model	2
highly activated signaling pathway	2
HFD plus multiple binges of ethanol (HFD+mB)	2
In vitro cell culture	2
clinically relevant mouse model	2
livers of HFFr-fed Nrf2-null mice	2
livers of HFFr-fed wild-type mice	2
inflammation genes	2
fatty acid oxidation and lipoprotein assembly genes	2
lipid synthesis genes	2
HFFr-fed Nrf2-null mice	2
oxidative stress	2
dimethyl sulfoxide vehicle control	2
either TBE-31	2
HFFr or regular chow diets	2
regular chow diet	2
high-fat plus fructose (HFFr)	2
Nrf2-/-C57BL/6 mice	2
acetylenic tricyclic bis(cyano enone)	2
hepatic context	2
uncoordinated phenotype-5/death-associated protein kinase	2
ConclusionsUPR-resistant, internal ribosome entry site–	2
netrin transgenic mice	2
death-associated protein kinase 1	2
protein phosphatase 2A	2
mice livers	2
netrin-1 messenger RNA	2
several structurally related oncogenic transcripts (l-myc, c-myc, c-myb)	2
netrin 5' untranslated region–driven luciferase	2
related internal ribosome entry site regions	2
E-loop motifs	2
complex double pseudoknot	2
netrin-1 messenger RNA 5'-end	2
3 sensors of the UPR (protein kinase RNA–like endoplasmic reticulum kinase (PERK)), inositol requiring enzyme 1α (IRE1α), and activated transcription factor 6 (ATF6)	2
bona fide model	2
in vitro–grown hepatocytic cells, wild-type, and netrin-1 transgenic mice	2
bicistronic constructs	2
selective 2’-hydroxyl acylation and primer extension/dimethyl sulfate	2
translational complexes	2
Netrin-1's	2
colorectal carcinoma	2
prototypical dependence receptors	2
multifunctional secreted protein	2
appropriately enumerated	2
Differentially expressed transcripts	2
diverse elements of the immune system	2
normal children	2
mucous layer	2
Several mucins	2
broad spectrum of viral, bacterial, and parasitic microbes	2
EED-associated transcripts	2
activators of neutrophils and B cells	2
interferon-induced proteins	2
multiple immunoglobulin families	2
Fc fragments	2
12 transcripts	2
host messenger RNA	2
feces in Malawian children	2
children in the developing world	2
T-cell mediated GI tract inflammation	2
distal colon	2
colonic DC subsets	2
transwell assays	2
colonic culture supernatants	2
CD141+ mDC	2
circulating CD1c+	2
proximal DC	2
mucosal homing markers (β7, CCR9)	2
DC and DC-invoked T-cell expression	2
CD4+CD45RA+ T-cells	2
distal DC	2
fewer CD103+SIRPα+ cells	2
CD141+ILT3−CCR2−. Proximal colon samples	2
minor subset	2
CD103+SIRPα- DC	2
major population	2
CD103 and SIRPα (human analog of murine CD11b) expression	2
myeloid (mDC, CD11c+CD123−)	2
proximal (right/ascending) and distal (left/descending) human colonic biopsies	2
human GI-DC	2
CD11b+/− subsets	2
CD103+ DC	2
gastrointestinal (GI)-tract dendritic cells (DC)	2
new cells	2
Oxidized LDL	2
full-length and subgenomic HCV genomes	2
INDIV-2 study	2
379 participants	2
chronic hepatitis C.MethodsBaseline oxLDL	2
SR-BI	2
Oxidized low density lipoprotein (oxLDL)	2
(SR-BI)	2
scavenger receptor class B type	2
several cell surface receptors	2
hepatotropic viruses	2
viral antigen	2
LCMV-specific CD4+ and CD8+ T cell responses	2
chronically infected TTR-NP mice	2
otherwise immunocompetent host	2
single viral protein	2
peripheral tolerance	2
virus-specific T cells	2
interleukin-10-secreting CD4+ regulatory T cells	2
TTR-NP mice	2
Armstrong (Arm) or WE acute strains	2
hepatocytes under control of a modified transthyretin (TTR) promoter	2
nucleoprotein (NP) of lymphocytic choriomeningitis virus (LCMV)	2
MethodsTTR-NP mice	2
liver’s tolerogenic nature	2
food and bacterial antigens	2
IL33 expression	2
helper 2–cytokine–expressing cells	2
mature lymphocytes	2
Rag-1-/- mice	2
mucous metaplasia	2
IL33-treated mice	2
innate lymphoid cell 2	2
human biopsy specimens	2
IL33 and its receptor Interleukin 1 receptor-like 1 (ST2)	2
IL33-positive epithelial cells	2
surface mucus cell markers Ulex Europaeus 1 (UEA1), and Mucin 5AC (Muc5AC)	2
subpopulation of surface mucus cells	2
IL33 protein	2
recombinant IL33	2
mice and human biopsy specimens	2
recently described alarmin	2
AimsInterleukin (IL)33	2
important microbes	2
one of the substrates (Fluted pumpkin)	2
combined heat and power (CHP) system	2
localities	2
Telfairia occidentalis (Fluted pumpkin) fruit rind and poultry manure	2
flexible timber diaphragms” (Kallioras et al., 2018)	2
full-scale unreinforced clay-masonry building	2
building specimen	2
EUC-BUILD-2	2
EUCENTRE repository	2
unreinforced masonry buildings	2
analytical and numerical models	2
complete building	2
flexible diaphragms	2
unreinforced masonry walls	2
unique data set	2
EUCENTRE facilities	2
unreinforced masonry building	2
patient's general ward stay	2
second set of graphs	2
first set of graphs	2
2 sets of graphs	2
general ward in a community hospital	2
many units	2
nurses in typical general wards	2
(Chuang et al., 2017)	2
shell of shrimp, Litopenaeus vannamei	2
novel red color-related pigment-binding protein	2
crude water-soluble proteins	2
different soluble proteins	2
shrimp shell	2
red color-related pigment-binding protein	2
water-soluble oligosaccharide 2-hydroxypropyl−β−cyclodextrin (HP-β-CD)	2
local anesthetics (LAs) bupivacaine (BVC, C18H28N2O) and ropivacaine (RVC, C17H26N2O)	2
complexed local anesthetics	2
supplementary file	2
long, intermediate to short-stumpy forms	2
challenge of quantity, strain and species of T. brucei	2
A–E	2
controlled experimental system	2
fifteen, 180–220g) and New Zealand white and chinchilla rabbits (fifteen, 2.8–3.0kg)	2
wistar rats	2
forty-five, 18–23g)	2
Trypanosoma brucei (NITR201 strain)	2
trypanosomes in laboratory animals	2
Scientist in developing countries	2
M. Zychowska, E. Rojewska, W. Makuch, S. Luvisetto, F. Pavone, S. Marinelli, B. Przewlocka, J. Mika, 2016)	2
CCI-exposed rats	2
pronociceptive factors (IL-1beta and IL-18)	2
spinal Iba-1 positive cells activation	2
naïve and CCI-exposed rats	2
botulinum toxin A (BoNT/A)	2
various datasets of membrane protein families (Sodium/Calcium exchanger and Heme Copper Oxidase)	2
Bilayer’ (A. Shelar, M. Bansal, 2016)	2
Inter-helical Interactions	2
curved and kinked geometries	2
310- and π-helices	2
predominantly observed linear α-helical conformation	2
TM helices of membrane proteins	2
hypoxic adipose tissue” (Zhao et al.,)	2
part	2
saline, metformin, resveratrol, or injected intraperitoneally (ip)	2
human endometriosis	2
serum from women with endometriosis	2
PMTMCTs	2
single pass transmembrane protein	2
left parotid gland of a patient	2
PMTMCT	2
phosphaturic mesenchymal tumor, mixed connective tissue variant (PMTMCT)	2
FGF23-producing tumors	2
patients with TIO	2
causative tumors	2
multiple fractures/pseudofractures	2
FGF23 excess	2
bone-derived hormone	2
fibroblast growth factor 23 (FGF23)	2
brown tumors	2
bone tumor-like lesions	2
brown tumor	2
majority of the giant cells in the lesion	2
tartrate-resistant acid phosphatase	2
multinucleated giant cells near areas of bone matrix	2
fibrous tissue background	2
multinucleated giant cells	2
brown mass	2
resected specimen	2
bone tumor-like lesion	2
right distal tibia	2
nail-patella syndrome	2
brown tumor of the right distal tibia	2
48-year-old Japanese man	2
combination of OVX and glucocorticoids	2
Total and trabecular vBMD	2
experimentally treated groups	2
Femur and lumbar spine bone density	2
OVXG group	2
OVX group	2
bone resorption marker C-terminal telopeptides of type 1 collagen (CTx-1) and	2
two OVX groups receiving glucocorticoids	2
control, ovariectomy (OVX)	2
Aged Merino ewes	2
specific biomarkers in the blood of the sheep	2
CatKi-L	2
Sham sample	2
ALN-treated animals	2
control Sham surgery group	2
CatKi MK-0674 (0.6 or 2.5 mg/kg daily, CatKi-L and H	2
vehicle (VEH), ALN	2
ovariectomized (OVX) cynomolgus monkeys	2
bisphosphonate (alendronate, ALN) and cathepsin K inhibitor (MK-0674, CatKi)	2
osteoclast activity	2
Anti-resorptive drugs	2
CYP26B1 deficient human bone	2
Vegfa overexpression	2
hypervitaminosis A rats	2
bone marrow microhemorrhage	2
Normal human endothelial cells	2
abundant blood vessels	2
marrow cavity	2
human angulated fetal femur	2
piles within deep resorption pits	2
periosteal osteoclasts	2
human with	2
CYP26B1 deficient human and rats with hypervitaminosis A	2
retinoic acid (RA, the active metabolite of vitamin A), and mice overexpressing vascular endothelial growth factor a (Vegfa)	2
CYP26B1 deficient humans	2
Angulated femurs	2
sera of the three groups	2
healthy volunteer and osteoporosis patient female subjects	2
post-menopausal	2
LN)	2
pre-menopausal	2
antenatal insults	2
teratogen-exposed C57 and C3H mice	2
5-AZA-exposed C57 males	2
axial skeleton	2
3rd lumbar vertebra	2
12-mo-old C57 and C3H males	2
mother's pregnancy	2
single injection of 5-AZA	2
12 mo-old mice	2
3- and 6-mo-old C3H offspring	2
two inbred strains, C3H/HeJ (C3H, with inherently stronger bones) and C57Bl/6J (C57, with weaker bones	2
teratogen 5-deoxy-2′-cytidine (5-AZA)	2
Mayo Medical Laboratories	2
~5,000,000 patients	2
US population	2
immunoassays and liquid chromatography mass spectrometry (LC-MS/MS) assays	2
vitamin-D metabolites including 25-hydroxyvitamin-D (25(OH)D), 1,25-dihydroxyvitamin-D and 24,25-dihydroxyvitamin-D	2
diverse disease pathways	2
normal animals	2
normal littermates	2
NL littermates	2
normal (NL) and Cy/+ (CKD) animals	2
skeletal perfusion	2
national expert center	2
large group of adults	2
expert center	2
bisphosphonate use	2
patient history	2
adults with OI	2
Isala Hospital	2
expert center for adults with Osteogenesis Imperfecta (OI)	2
custom code and Guassian filters	2
bones	2
consistent transverse fractures	2
custom-built rig	2
porcine femora	2
long bones in-vitro	2
repeatable transverse fractures	2
accurate fracture representation	2
computer and experimental models	2
open and periprosthetic fractures	2
Long bone fractures	2
clinical and educational provision	2
maternally inherited PLS3 variant	2
variant in NRX1	2
trio whole exome sequencing (WES).Resultsone patient	2
Exome sequencingIn patients	2
socialisation, communication and play/imagination	2
Clinical Psychologist	2
ADI& ADOSStandardised tools	2
ADI/ADOS confirmed ASD and bone fragility	2
prevalence study	2
complex/severe OI clinic	2
sub-set of patients	2
severe/complex OI	2
7 children	2
minority of children	2
aBMD and bone strain	2
Hierarchical linear regression models	2
nonlinear regression model	2
Areal BMD	2
forearm	2
continuum finite element models	2
macro- and micro-structure	2
Seventy-two women	2
voluntary upper-extremity loading model	2
inducible Col2-Cre (Col2-CreERt)	2
postnatal chondrocytes	2
mouse phenotypes	2
non-cartilaginous expression of collagen alpha(1) II	2
non-cartilaginous tissues	2
collagen type 2-driven Cre (Col2-Cre)	2
TSC1-floxed mice	2
Nature Communications 2016, 7:11151)	2
bone mass	2
bone periosteally	2
periosteal and endosteal surface	2
entire cortical surface	2
tibial endosteal and periosteal surface	2
peak mechanical stimulus	2
2D maps	2
finite element model	2
entire bone	2
murine tibia axial loading model (C57BL/6)	2
local mechanical environment	2
tweaking Treg-Th17 cell balance	2
osteo-protective agent	2
anti-osteoclastogenic factors (IL-10, IFN-γ)	2
osteoclastogenic factors (IL-6, IL-17, TNF-α and RANKL)	2
ovx mice	2
anti-osteoclastogenic Treg cells	2
osteoclastogenic Th17 cells	2
trabecular and cortical bone microarchitecture	2
LA in ovariectomized (ovx) mice	2
Lactobacillus acidophilus (LA)	2
former preterm born children	2
DXA and pQUS measurements	2
total body and lumbar spine	2
boys; 29 girls)	2
former preterm infants	2
Phalangeal quantitative ultrasound (pQUS)	2
bone mineralization	2
sedentary controls	2
Adult mice	2
tibia	2
osteocytes expressing sclerostin	2
SOST expression	2
PTHrP and SOST gene expression	2
narrow neck, intertrochanter and femoral shaft	2
three analyzed areas	2
Japanese bone architecture	2
Japanese osteoporosis patients	2
human monoclonal antibody against RANK ligand	2
middle-aged women	2
IgG-OPG	2
women and IgG-OPG negative	2
healthy blood donors	2
non-dominant wrist	2
50.4–60.6)	2
698 women	2
women general population	2
osteoprotegerin (OPG)	2
osteoporosis patients	2
lumbar spine and femur of OVX rats	2
urinary CTX	2
femoral diaphysis	2
lumbar vertebral body	2
ZOL.The group	2
Serum osteocalcin	2
group treated with ZOL	2
lumbar vertebral body, femoral diaphysis, and proximal femur	2
second treatment period).The group	2
osteopenic rats	2
ovariectomized (OVX) rats	2
zoledronic acid (ZOL) and TPTD (or vice versa)	2
Bisphosphonates (BPs) and teriparatide (TPTD)	2
ex vivo loading system	2
natural, in vivo maturation	2
calcified area	2
deactivated, cell-free samples	2
3-day culture	2
bone slices	2
tissue calcification	2
β-glycerol phosphate and dexamethasone in culture medium	2
immature bone specimen	2
custom-made, bioreactor system	2
ex vivo culture experiment	2
0-day-old chick	2
slice of the tibia	2
ex vivo culture system	2
cell adhesion molecule	2
novel isoform of neurexin-2 (NRXN2) gene	2
histone modification	2
novel osteoblast-relevant genes	2
significant DMRs	2
gene body and intergenic regions	2
CGI shores/shelves	2
CpG islands (CGIs) and promoters	2
Significant DMCs/DMRs	2
significant differentially methylated regions (DMRs)	2
significant osteoblast-specific differentially methylated CpGs (DMCs)	2
DNA methylation datasets	2
two isogenic replicates	2
cell strains	2
types of human cells	2
human osteoblast	2
ALP	2
calcium, collagen type	2
treating cells	2
implant surface	2
bone osseointegration	2
hMSCs on Ti surfaces	2
bisphosphonate (BP)	2
implant surfaces	2
hydroxyapatite (HA) and calcium phosphate	2
missing teeth	2
titanium (Ti) implants	2
T6-L1 internal rods	2
26-year-old medical doctor	2
spine surgeons	2
2D images	2
mouse vertebral body trabecular bone	2
trabecular bone outcomes	2
μCT scans	2
Micro-computed tomography (μCT)	2
easily accessible stimulus	2
p=0.015)	2
aBMD of Ward's region of the femoral neck	2
lumbar spine, femoral neck, and total body	2
ibuprofen supplementation	2
lumbar spine, femoral neck, and total body areal bone mineral density (aBMD)	2
400mg, post-exercise) or placebo (i.e. 4 groups)	2
females:	2
bone and muscle in postmenopausal women	2
Col1al, Runx2, Bglap, Alpl and Spp1	2
low sulfur amino acid growth media	2
Mouse preosteoblast cell line	2
MR mice	2
Plasma biomarkers	2
CF and MR mice	2
smaller bones in MR mice	2
control-fed (CF) mice	2
young and aged male and female C57BL/6J mice	2
rodents, drosophila, nematodes, and yeasts	2
Hamamy syndrome patients	2
specific cranial bones	2
Irx3flox/flox/Irx5−/−/Osx-Cre+ mice	2
Newborn endochondral long bones	2
enlarged sutures	2
parietal, interparietal, and frontal bones	2
newborn Irx3flox/flox/Irx5−/−/Osx-Cre+ mice	2
Osx-Cre transgene	2
Irx3 in Irx5−/− mice	2
Osx-Cre	2
Irx3 and Irx5 in mice	2
Iroquois family	2
Iroquois homeobox transcription factors (IRX)	2
Cranial malformations	2
human peripheral blood mononuclear cells	2
osteoclastogenesis of RAW264 cells	2
amino N-phenylcarbamate (PUGNAc)	2
inhibitor of N-acetyl-β-D-glucosaminidase, O-(2-acetamido-2-deoxy-D-glucopyranosylidene)	2
GlcNAc and GalNAc	2
murine RAW264 cells	2
monomeric sugars (glucose, galactose, N-acetylglucosamine (GlcNAc), and N-acetylgalactosamine (GalNAc))	2
reactive oxygen species generation	2
receptor activator of NF-κB ligand (RANKL)	2
monocyte/macrophage lineage cells	2
new source of cells	2
osteogenic adult ‘stem cells’	2
one surface	2
modified Ti surfaces	2
Human bone marrow derived stromal cells (hBMSCs)	2
rough, hydrophilic Ti	2
Ti implant surfaces	2
subset of cells	2
mixture of cells	2
multipotent stromal cells (MSCs)	2
titanium (Ti) implant	2
osteoporotic fractures	2
Thirty-five patients	2
494 patients	2
Trained study investigators	2
Mayo Clinic	2
total hip or lumbar spine)	2
skeletal anabolic agent	2
less and smaller resorption pits	2
Cstb−/− osteoclasts	2
Cstb−/− group	2
Bone marrow-derived osteoclast cultures	2
thinner growth plates	2
Cstb−/− mouse bones	2
thicker trabeculae	2
hind limbs	2
CSTB-deficient mouse (Cstb−/−) model	2
cysteine cathepsins	2
gene encoding cystatin B (CSTB)	2
arachnodactyly and scoliosis	2
thickened frontal cranial bone	2
fracture model	2
osteoporotic cancellous tissue	2
cancellous bone tissue	2
crack growth	2
well defined cohort	2
patients (n=37)	2
diseased bone	2
animal proxies	2
human osteoporotic specimens	2
whole body	2
controller	2
hypophosphatemic rickets	2
genu valgum	2
major arteries	2
antihypertensive drugs	2
etidronate disodium (EHDP)	2
boy	2
coronary arteries	2
GACI patients	2
responsible gene	2
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1)	2
LGEA patients	2
symptomatic fractures	2
patients with LGEA who	2
cumulative loop diuretic over days exposed	2
non-loop diuretics (P=0.006)	2
entire cohort	2
non-loop diuretics	2
loop diuretics	2
(PN)	2
parenteral nutrition	2
I, days	2
Symptomatic fractures	2
LGEA-patients	2
potentially high-risk population	2
Long-Gap Esophageal Atresia (LGEA) patients	2
dominantly inherited HVDRR	2
dominant-negative mutant of VDR	2
R370H-VDR	2
corepressor NCoR	2
healthy mother	2
heterozygous R370H	2
Heterozygous Q400LfsX7	2
reported variant (R370H)	2
retinoid X receptor, cofactors, and the vitamin D response element (VDRE)	2
paternal grandfather	2
18-month-old Japanese boy	2
Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR)	2
C3H/HeN mice	2
C57BL/6J and DBA/2J mice	2
cortical and trabecular bone	2
aBMD in DBA/2J and C3H/HeN mice	2
mouse strain	2
contralateral limb	2
(−1%) mice	2
C3H/HeN	2
C3H (−25%) mice	2
BALB/cJ (−45%) and C3H/HeN (−34%) mice	2
BV/TV	2
bone histomorphometry	2
n=10/group)	2
unilaterally with saline	2
BTX (n=10/group)	2
four inbred mouse strains (BALB/cJ, C57BL/6J, DBA/2J, and C3H/HeN)	2
Female mice	2
estrogen ablation model	2
cortical femur diaphysis	2
OVX+S group	2
OVX+S+E group	2
Sham group	2
bone formation marker osteocalcin	2
whole body and femoral BMDs	2
non-exercised control groups	2
femur mid-shaft	2
Bone microarchitecture	2
OVX rats+5mg/kg Scl-Ab	2
(OVX+S)	2
/kg Scl-Ab	2
OVX rats+treadmill	2
OVX+E+S)	2
OVX rats+saline+treadmill training	2
ovariectomized rats+saline, (3) (OVX+E)	2
OVX)	2
sedentary rats+saline	2
five groups	2
aged 8months	2
Sixty female Wistar rats	2
combination of both	2
patients with osteoporosis	2
Sclerostin antibody (Scl-Ab)	2
larger SCI cohort	2
vitamin D or other bone nutrients	2
non-SCI controls	2
FN BMD	2
SCI and non-SCI groups	2
vitamin D and/or multivitamin supplements	2
vitamins D & K, and protein	2
LS BMD	2
FN	2
n=12 paraplegic	2
serum leptin, adiponectin and insulin	2
plasma 25-hydroxyvitamin D (25(OH)D)	2
calcium, vitamins D & K	2
lumbar vertebrae	2
visceral adipose tissue (VAT)	2
BMD at the femoral neck (FN) and lumbar spine (LS)	2
non-SCI individuals	2
American Spinal Injury Association Impairment Scale	2
–D	2
non-SCI control cohort	2
chronic spinal cord injury (SCI) population	2
TRIM21-expressing cells	2
targeted proteins	2
cytosolic antibodies	2
charges of proteins	2
HEPES-protein mixtures	2
cells internalize HEPES-protein mixtures	2
endosomal markers	2
endocytotic inhibitors	2
commercially available systems	2
antibodies, recombinant proteins, and peptides)	2
pure HEPES solution	2
readily available, inexpensive organic agent	2
biological purposes	2
protein transfection	2
active proteins	2
adult β-globin	2
γ-globin proteins	2
fetal γ-globin genes in adult erythroid cells	2
genetically modifying hematopoietic stem and progenitor cells	2
II molecules	2
individuals expressing different major histocompatibility complex (MHC)	2
ppins-specific therapeutic immunity	2
PD-L1−/− mice	2
RIP-B7.1 tg mice	2
ppins antigens	2
ppins variants	2
diabetes-susceptible H-2g7 haplotype	2
Female NOD mice	2
autoreactive ppins-specific (Kb/A12-21 and/or Kb/B22-29	2
co-stimulator molecule B7.1 in beta cells	2
H-2b RIP-B7.1 tg mice	2
ppins designer antigens	2
preproinsulin (ppins) variants	2
autoimmune type 1 diabetes (T1D)	2
similar institutions	2
academic institutions	2
medium-sized academic institution	2
lentiviral vector and CliniMACS Prodigy	2
CAR T cell production system	2
CAR19s	2
CART19	2
NOD.Cg-PrkdcscidIl2rdtm1Wjl/SzJ (NSG) xenograph B-ALL mouse model	2
CD8 hinge and transmembrane region, 4-1BB- and CD3z-signaling domains	2
anti-CD19 antibody (A3B1)	2
novel CART19	2
CD19+ B cell malignancies	2
anti-CD19 chimeric antigen receptor (CAR)	2
autologous T cells	2
suspension HEKExpress cells	2
striatum of adult mice	2
nuclear localization signal (AAV2/9-CBA-nlsGFP)	2
corresponding HEK293 cell line	2
bioequivalence in vitro and in vivo	2
suspension cell line	2
HEKExpress cells	2
AAV2/8 and AAV2/9 vectors	2
fully characterized suspension-adapted cell line	2
orbitally shaken bioreactors	2
highly pure and potent vectors	2
pure rAAV9	2
varied AAV genome constructs	2
HEK293EB cells	2
final rAAV9 titer	2
impurities and empty capsids	2
EGFP transgene	2
rAAV9 particles	2
three capsid proteins	2
final purified rAAV9	2
quaternary ammonium anion exchangers	2
rAAV9 preparations	2
challenging rAAV serotype	2
muscle and neuronal tissues	2
Recombinant adeno-associated virus serotype 9 (rAAV9)	2
vector transduction site	2
tissue-resident T cells	2
CD107a+, granzyme B+, CD4+, and CD8+ transgene-specific cellular responses	2
human UGT1A1 sequence	2
AAV capsid and/or transgene	2
either vector dose	2
vector biodistribution	2
liver-specific promoter	2
codon-optimized version of human uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1)	2
AAV serotype 8 vector	2
1.0 	2
wild-type rhesus macaques	2
Crigler-Najjar syndrome	2
eluted LVs	2
captured LVs	2
streptavidin magnetic beads	2
infectious particles	2
viral surfaces	2
CD8α stalk	2
cyclical biotin-mimicking peptide	2
packaging HEK293T cells	2
biotin-streptavidin system	2
specifically purify LVs	2
Lentiviral vectors (LVs)	2
transgene product (hAAT)	2
rAAV8-CB-hAAT	2
spontaneous lupus mouse model	2
recombinant adeno-associated virus 8 (rAAV8-CB-hAAT)	2
hAAT protein	2
DC help	2
bone marrow-derived conventional and plasmacytoid DCs	2
CpG- (TLR9 agonist)	2
DCs from lupus-prone mice	2
serine proteinase inhibitor	2
Human alpha 1 antitrypsin (hAAT)	2
DMD patients	2
D2/mdx mice	2
skeletal and cardiac muscle	2
severely affected D2/mdx mice	2
AAV9-mediated micro-utrophin transgene delivery	2
mildly affected BL10/mdx mouse	2
dystrophin-related protein utrophin	2
DMD boys	2
FKRPP448L mice	2
recombinant adeno-associated virus (AAV) serotype 9 vector expressing human FKRP (AAV9-FKRP)	2
P448L (FKRPP448L) mouse model	2
p.	2
Muscular dystrophy-dystroglycanopathies (MDDGs)	2
pAdHelper	2
pABHelper	2
conventional three-plasmid transfection system	2
novel dual helper plasmid (pABHelper)	2
Ad helper genes	2
HBoV1 NP1 and NS2 genes	2
HBoV1 helper system	2
Ad E2A gene	2
pAdHelper in a five-plasmid transfection system	2
strong promoters	2
AAV capsid proteins	2
AAV Rep52 and capsid proteins	2
pBocaHelper transduced cells	2
pAdHelper (expressing Ad genes E2A, E4, and VA), rAAV vector	2
HBoV1 genes NP1, NS2, and BocaSR, (2) pAAV transfer plasmid	2
cloned HBoV1 helper minigenome (pBocaHelper)	2
triple plasmids	2
recombinant AAV (rAAV) vector in HEK293 cells	2
wild-type adeno-associated virus 2 (AAV2)	2
helper virus	2
autonomous parvovirus	2
Human bocavirus 1 (HBoV1)	2
AR model	2
promising vaccine	2
P-FN12 +	2
tissue eosinophilia	2
 Th2 immunity	2
OVA-specific IgE	2
P-FN12-based vaccine	2
peripheral blood mononuclear cell cultures	2
interferon (IFN)-γ and interleukin-2 (IL-2)	2
ovalbumin (OVA)-specific immunoglobulin E (IgE)	2
nasal rubbing	2
nasal drops	2
P-FN12 + CTB@Lipo-formulated vaccine	2
H4R monoclonal antibody (mcAb)	2
P-FN12	2
peptide FNKWMDCLSVTH	2
corresponding peptide	2
phage clone	2
specific epitope of the H4R.	2
12-mer random peptide library	2
almost all immune-related cells	2
Histamine H4 receptor (H4R)	2
e.g., histamine receptor blockers	2
histamine pathway	2
nasal mucosa	2
well known sites	2
cancer-related genes	2
new blood cell progeny	2
murine and human transduced HSCs	2
GLOBE LV-transduced cells	2
GLOBE lentiviral vector (LV)	2
surrounding genes	2
newly GLOBE-derived vectors	2
in vitro and in vivo studies	2
sensitive, specific, and selective immunoassay	2
specific anti-thymidine phosphorylase antibodies	2
human autologous erythrocytes	2
Erythrocyte encapsulated thymidine phosphorylase is recombinant Escherichia coli thymidine phosphorylase	2
muscle directed rAAV-mediated TNALP-D10 transduction	2
mandibular bones and teeth of hypophosphatasia	2
alveolar bone	2
treated Akp2−/−mice	2
molar root	2
mandibular growth	2
scAAV8-MCK-TNALP-D10 injection	2
mandibular bone and teeth in neonatal Akp2−/−mice	2
scAAV8-MCK-TNALP-D10 treatment	2
muscle creatine kinase (MCK) promoter	2
self-complementary (sc) type 8 recombinant adeno-associated virus (rAAV8) vector expressing bone-targeted TNALP with deca-aspartates at the C terminus (TNALP-D10)	2
TNALP-deficient (Akp2−/−) mice	2
bones and teeth	2
gene encoding tissue-nonspecific alkaline phosphatase (TNALP)	2
PF4-knockout mice	2
 platelet factor 4 (PF4)	2
sera proteins	2
vector serotypes	2
rAAV-8 and rAAV-9, two vectors	2
rAAV-1 and rAAV-6 transduction effectiveness	2
mouse C-reactive protein	2
human galectin 3 binding protein	2
blood-borne components	2
recombinant adeno-associated vectors (rAAVs)	2
in vivo studies	2
gene therapy vectors and oncolytic viruses	2
ex vivo lung slices	2
gene therapy vectors	2
range of applications	2
precision-cut lung slices	2
agarose-perfused normal and murine melanoma tumor-bearing lungs	2
precision-cut ovine and murine tissue slices	2
viruses and viral vectors	2
Organotypic slice cultures	2
peri-infarct areas	2
microglial activation	2
unmodified DPSCs	2
DPSCs overexpressing	2
DPSCs that overexpress HGF	2
brain of rats	2
Dental pulp stem cell (DPSC) transplantation	2
vector doses	2
control and vector-administered male mice	2
highest vector dose	2
liver transaminases	2
vehicle-only control mice	2
genome copies (GC)/kg of a clinical candidate vector, AAV8.TBG.hUGT1A1co	2
phototherapy-rescued adult UGT1 knockout mice	2
uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1) activity	2
toxic metabolites	2
two-dimensional plot	2
clustering and visualization algorithms	2
input cells	2
single-cell RNA sequencing experiments	2
bulk cell populations	2
new populations of cells	2
anti-SaCas9 and anti-SpCas9 antibodies	2
200 human serum samples	2
Cas9 from Staphylococcus aureus (SaCas9) and Streptococcs pyogenes (SpCas9) in human sera	2
ELISA-based assays	2
robust and reliable assays	2
anti-Cas9 antibodies	2
different immunological pathways	2
protein of microbial origin	2
CRISPR/Cas microbial adaptive immune system	2
MPS IIIB	2
genetically engineered iNSCs	2
iNSCs in the brain	2
neighboring regions	2
area of engrafted cells	2
storage material	2
Successfully transplanted Naglu−/−mice	2
majority of engrafted animals	2
corrected iNSCs	2
deficient cells	2
functional NAGLU enzyme	2
Naglu−/−mice (iNSCs)	2
Naglu−/−neural stem cells	2
enzyme α-N-acetylglucosaminidase (NAGLU)	2
Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB [MPS IIIB])	2
suboccipital AAV delivery	2
dorsal root ganglia neurons and associated axons	2
vector-treated animals	2
vehicle or one of two doses of vector	2
three immunosuppressed animals	2
human α-L-iduronidase	2
large animals	2
cisterna magna	2
suboccipital puncture	2
adeno-associated virus serotype 9 (AAV9)	2
lysosomal enzyme α-L-iduronidase	2
highly active enzymes	2
variant-specific activity assays	2
transgene-product-specific assays	2
isolated FIX Padua-specific mini-antibody	2
human and mouse plasma	2
chromogenic FIX Padua-specific activity assay	2
mini-antibody	2
human plasma samples	2
FIX Padua protein	2
human and monkey plasma samples	2
FIX Padua-specific ELISA	2
Fab2 mini-antibody	2
Ag ELISA	2
inactive FIX protein	2
viral vector	2
FIX Padua variant	2
AAV8-based hemophilia B gene therapy vector	2
BAX 335	2
hyper-functional factor IX (FIX) Padua	2
HS in MPSs	2
competitive binding molecule	2
MPS fibroblasts	2
extracellular accumulated HS	2
primary fibroblasts from MPS I and MPS IIIB patients	2
excess of extracellular accumulated heparan sulfate (HS)	2
Mucopolysaccharidoses (MPSs)	2
’s time	2
week	2
laboratory grade AAV particles	2
AAV preps	2
mammalian AAV production system	2
helper-free HEK293 cell system	2
laboratory grade recombinant AAV	2
gene delivery vehicle	2
one of the most promising gene therapy vectors	2
Adeno-associated virus (AAV)	2
CRISPR/Cas9 complex	2
HDAd-Acr vector	2
γ-globin expression	2
transplanted mice	2
In vitro differentiated HSCs	2
genome-edited primitive HSCs	2
pre-transplantation CD34+ cells	2
engrafted human cells	2
HDAd-CRISPR and HDAd-Acr	2
CRISPR/Cas9 complex (HDAd-Acr)	2
two anti-CRISPR (Acr) peptides (AcrII4 and AcrII2)	2
HDAd5/35++ vector	2
HDAd-globin-CRISPR vectors	2
irradiated NOD/Shi-scid/interleukin-2 receptor γ (IL-2Rγ) null (NSG) mice	2
multi-lineage progenitor colony formation	2
primitive HSCs	2
fetal γ-globin expression (HDAd-globin-CRISPR)	2
helper-dependent HDAd5/35++ adenovirus vectors	2
one fully enclosed bioreactor	2
cells in planar culture dishes	2
continuous stirred-suspension bioreactor	2
primary human fibroblast	2
engineered cell therapy products	2
patients or compatible donors	2
thousands of patients	2
clinically relevant quantities of cells	2
scalable manufacturing platforms	2
best choice of TAs	2
the trichosanthin gene encoding a type I ribosome-inactivating protein	2
adenoviral helper genes	2
lipid-based liposomes	2
rAAV transduction	2
various TAs	2
plasmid DNA or RNA	2
rAAV vector	2
genetic materials	2
transfection agents (TAs)	2
non-viral strategies	2
ideal vehicles	2
Recombinant adeno-associated virus (rAAV) vectors	2
gene therapy drug products	2
short-term HSPCs	2
Prostaglandin E2 (PGE2)	2
engrafted human cells in mouse bone marrow	2
mPB) CD34+ cells	2
mobilized peripheral blood	2
LVV entry barrier	2
genetically modified HSPCs	2
staurosporine, a serine/threonine kinase inhibitor	2
human CD34+ hematopoietic stem and progenitor cells (HSPCs)	2
recombinant AAV (rAAV)2/2-REP1	2
two Rab proteins	2
Rab escort protein 1 (REP1)	2
CHM gene	2
bacterial plasmid backbone	2
production system	2
SV40 vectors	2
recombinant SV40 (rSV40) vector	2
(SV40)-derived vectors	2
Simian virus 40	2
additional viral vectors	2
non-integrating AAV vectors	2
currently used viral vector systems	2
currently used lentivirus vectors	2
HDAd5/35++ vectors	2
long-term repopulating HSCs	2
HDAd35++ vectors	2
adult α-globin	2
γ-globin	2
Erythroid cells	2
mobilized donors	2
peripheral blood CD34+ cells	2
SB100x transposase	2
hyperactive Sleeping Beauty	2
adult mouse globin	2
primary and secondary transplant recipients	2
γ-globin-positive cells in peripheral blood erythrocytes	2
human CD46-transgenic mice	2
bone marrow lineage-depleted cells	2
γ-globin-expressing erythrocytes	2
β-globin locus control region (LCR)/promoter driven human γ-globin gene and an elongation factor alpha-1 (EF1α)-mgmtP140K expression cassette	2
∼12-kb transgene cassette	2
integrating, CD46-targeted, helper-dependent adenovirus HDAd5/35++ vector system	2
CD4+CD25+FOXP3+ cells	2
pure Treg population	2
clinical grade Tregs	2
liver-directed gene therapy vector designs	2
first two technologies	2
AAV-fVIII vector	2
ancient and orthologous fVIII sequence elements	2
target cell types, e.g., hepatocytes	2
smallest AAV-fVIII vector genome	2
minimal synthetic promoter	2
high-expression bioengineered fVIII variant	2
liver-directed 146-nt transcription regulatory module	2
three unique elements	2
minimally sized, highly potent AAV-fVIII vector	2
hemophilia A gene therapy product candidates	2
flash electroretinography	2
AAV2 alone	2
this optimized AAV2-enzyme combination	2
hyaluronan lyase	2
heparinase III	2
singly or in combination	2
glycosaminoglycan-degrading enzymes	2
Viral gene delivery	2
 G-CSF/AMD3100-mobilized, in vivo-transduced mice	2
progeny cells	2
proliferation stimulus	2
stably transduced HSCs	2
O6-BG/BCNU	2
mutant of the O6-methylguanine-DNA methyltransferase (mgmtP140K) gene	2
 the peripheral blood cells	2
bone marrow HSCs	2
primitive bone marrow HSCs	2
integrating helper-dependent adenovirus vector system	2
peripheral blood stream	2
mobilize HSCs	2
G-CSF/AMD3100	2
in vivo hematopoietic stem cell (HSC) gene therapy approach	2
optimized medium	2
B cell tumors	2
patient-derived T cells	2
multiple myeloma patients	2
differentiated T cells	2
new medium	2
humanized mouse model	2
chemically defined cell culture medium	2
adoptively transferred T cells	2
T cell culture systems	2
high-titer in vivo-grade NDV	2
NDV preparations	2
oncolytic agent	2
oncolytic NDV	2
large quantities of virus	2
immunogenic chicken host cell proteins	2
relatively low-titer preparations	2
purifying virus	2
embryonated chicken eggs	2
oncolytic trials	2
potent oncolytic virus	2
avian pathogen	2
Paramyxoviridae family	2
single-stranded, negative-sense RNA virus	2
Newcastle disease virus (NDV)	2
single virus	2
two genetic loci	2
vvDD-A34R-hCCL5	2
oncolytic poxvirus expressing human chemokine CCL5	2
therapeutic viruses	2
inserted DNA sequences	2
different cytokines and other therapeutic genes	2
multiple marker-free oncolytic poxviruses	2
SEM system	2
recombinant poxviruses	2
recombinant vaccinia virus	2
selectable and excisable marker (SEM) system	2
multiple genetic loci	2
vaccine vectors and oncolytic viruses	2
Recombinant poxviruses	2
effective mAb therapeutics	2
DNA gene transfer platform technology	2
lethal influenza or Ebola virus challenges	2
expressed mAbs	2
multiple mAbs	2
functional mAbs in vivo	2
optimized electroporation-based DNA gene transfer platform technology	2
global access	2
Monoclonal antibodies (mAbs)	2
VSV-G sequences	2
envelope gene sequences (vesicular stomatitis virus G glycoprotein [VSV-G])	2
qPCR assay	2
fresh infusion	2
qPCR-based assays	2
cell-based products	2
non-target cells	2
replication competent lentivirus (RCL)	2
new and corrected genes	2
MΦ-based therapeutics	2
HDP-on and liposomal clodronate	2
peritoneal cavity, spleen, and liver	2
HDPs and HDP-on cells	2
liposomal clodronate	2
peritoneal cavity	2
HDP-on cells	2
immunocompetent BALB/c mice	2
peritoneal cavity, liver, spleen, kidney, bone marrow, brain, lung, heart, and blood	2
luciferase reporter	2
immunodeficient NCG mice	2
JAK1/2 blockade	2
tamoxifen and ruxolitinib (GMCSF inhibitor	2
MΦ	2
HDP-on	2
“HDP-on.	2
tamoxifen-induced transcription factor IRF8	2
constitutively active GMCSF receptor	2
tamoxifen-inducible Cre	2
loxP. HDPs	2
constitutively expressed Hoxb8	2
lineage-negative bone marrow cells	2
Hoxb8-dependent myeloid progenitors (HDPs)	2
large numbers of myeloid progenitor cells, precursors to macrophages (MΦs)	2
conformation-dependent and highly specific antibodies	2
Liposome-formulated DNA vaccines	2
P. falciparum growth-inhibition assays	2
P. falciparum Rhoptry antigen 5	2
C terminus of merozoite surface protein 1 from Plasmodium vivax	2
Circumsporozoite protein	2
three malarial antigens	2
in vitro cell cultures	2
different antigens in cationic particles	2
naked DNA vaccine	2
combination of liposome application	2
sophisticated ballistic devices	2
vaccine regimen	2
69 antigens	2
live sporozoite vaccine regimen	2
adenovirus vectors	2
highly expressed pre-erythrocytic Plasmodium yoelii antigens	2
adenovirus array	2
specific antigen targets	2
live sporozoite vaccines	2
antigen discovery platform	2
large numbers of antigens	2
protective T cells	2
many of the antigens	2
causative agents of HIV, tuberculosis, and malaria	2
intravascular infusions of AAV8 in patients with MPS VI	2
MPS VI mice	2
alanine aminotransferase	2
AAV-treated mice	2
mucopolysaccharidosis type VI (MPS VI)	2
hemophilia B.	2
Ad-E4-122aT-AHAFIX administration	2
hemophilia B mice	2
Ad-E4-122aT-AHAFIX	2
Ad-E4-122aT expressing human FIX (hFIX) (Ad-E4-122aT-AHAFIX)	2
conventional Ad vector	2
 Ad genes in liver	2
novel Ad vector, Ad-E4-122aT	2
adenovirus (Ad) vector	2
deficiency of blood coagulation factor IX (FIX)	2
neonatal and infant stages	2
disease-specific HS	2
BMN 250	2
ICV doses	2
regional, cell type-specific, and dose-dependent biodistribution of NAGLU-IGF2 (BMN 250)	2
the Naglu−/−mouse brain	2
HS storage	2
insulin-like growth factor 2 (IGF2)	2
human NAGLU	2
modified recombinant NAGLU	2
inherited deficiency of α-N-acetylglucosaminidase (NAGLU)	2
Sanfilippo syndrome type B (mucopolysaccharidosis IIIB)	2
nuclei in the kidney	2
isotype control	2
cervical and axillary lymph nodes	2
[18F]FAC-PET/CT	2
1-(2′-deoxy-2′-[18F]fluoro-β-D-arabinofuranosyl)cytosine ([18F]FAC) positron emission tomography/computed tomography (PET/CT)	2
Urine albumin	2
(IgG2a)	2
class-matched control immunoglobulin	2
5 mg/kg weight)	2
MRL/lpr lupus-prone mice	2
neutralizing anti-high mobility group box 1 (HMGB1) monoclonal antibody	2
new shRNA vector	2
endogenous silencing machinery	2
shRNA vector in vitro	2
striatum of an in vivo rodent HD model	2
induced pluripotent stem cells (iPSCs) of HD patients	2
striatal neurons	2
novel vector	2
original reporter genes	2
a tat-independent third-generation LV (pCCL) backbone	2
HD rodent model	2
HIV-1-derived lentiviral vector (LV)	2
small hairpin RNA (shRNA)	2
normal and mutant HTT	2
huntingtin (HTT) protein	2
neonatal Mecp2-null mice	2
additional regulatory 3′ UTR elements	2
extended Mecp2 promoter	2
mutant T158M allele	2
mice lacking MeCP2	2
minimal endogenous promoter	2
Mecp2 null mice	2
 the MECP2 gene	2
age-matched untreated cohorts	2
muscle function	2
mouse model of LGMD2I	2
single dose of recombinant adeno-associated virus serotype 9 (AAV9) vector expressing human FKRP	2
α-dystroglycan (α-DG) protein	2
Fukutin-related protein (FKRP) gene cause limb-girdle muscular dystrophy type 2I (LGMD2I)	2
bone marrow plasma cell survival	2
helper type 2 support	2
activated CD4+ T cells expressing PD1 and GL7	2
IgD−IgG+ class-switched/FAS+CL7+ germinal center B cells	2
IgG-secreting and AAV9-specific Ab-producing plasma cells	2
B cells, plasma cells	2
serum AAV9 Abs	2
bortezomib, rapamycin, and prednisolone, individually or in combination	2
pre-existing AAV9 Abs	2
Pre-existing antibodies (Abs)	2
related uterine disorders	2
CXCL12 or other CXCR4 receptor agonists	2
CXCL12 receptor (CXCR4) antagonist, ADM3100	2
BMDSC engraftment	2
 bone marrow-derived mesenchymal stem cells (BMDSCs)	2
uterine fibrosis and adhesions	2
iPSCs of ALS patients and model mice	2
separate Sendai virus vectors	2
HB9-positive cells	2
three transcription factors, LIM/homeobox protein 3, neurogenin 2, and islet-1	2
single Sendai virus vector	2
human and mouse ESCs/iPSCs	2
vector genes	2
ESCs/iPSCs	2
Embryonic stem cells (ESCs)/induced pluripotent stem cells (iPSCs)	2
syngeneic AAV pseudo-vectors	2
residual “empty” particles	2
pseudo-vectors	2
corresponding full AAV particles	2
syngeneic pseudo-vector DNA	2
pseudo-AAV particles	2
null or allogeneic particles	2
syngeneic particles	2
capsids	2
null pseudo-vectors	2
corresponding full particles	2
allogeneic pseudo-vectors	2
DNA of the corresponding full particles	2
partial AAV genomes	2
syngeneic pseudo-vectors	2
three types of “empty” AAV particles	2
safe and efficient gene therapy platform	2
low-dose anti-CD163-IgG-dexamethasone conjugate	2
control IgG	2
Non-conjugated dexamethasone or dexamethasone	2
glycogen deposition	2
antibody-drug conjugate	2
hemoglobin scavenger receptor CD163 in Kupffer cells and other M2-type macrophages	2
low dose of an anti-CD163-IgG-dexamethasone conjugate	2
liver macrophages	2
high-caloric carbohydrates	2
known protein interaction pathways	2
218 gel spots	2
minicircle	2
adeno-associated virus	2
plasmid vector	2
gene transfer vector	2
sonoporation alone	2
salivary gland	2
plasmid and minicircle vectors	2
submandibular salivary glands of mice	2
conventional plasmid and a minicircle vector	2
multilineage polyclonal hematopoiesis	2
abundantly marked clones	2
300 kb region of RIS	2
different gene-modified HSC clones	2
hematopoietic contribution	2
stable gene-modified cells	2
pigtailed macaque HSC transplantation model	2
therapeutic transgene expression	2
genetically modified hematopoietic stem cells (HSCs)	2
/B	2
serotypes /A	2
three serotypes	2
combination of these vectors	2
β-propiolactone-inactivated rabies virus particles	2
botulinum neurotoxin receptor binding domains from serotypes /A, /B, and /E.	2
recombinant rabies virus particles	2
heterologous antigens	2
–based particles	2
recombinant rabies virus	2
receptor-binding domain of the neurotoxin	2
eight distinct botulinum neurotoxin serotypes	2
Category A-Tier 1 agents	2
various neuropathies	2
one of the most potent toxins	2
Botulinum neurotoxins	2
buried fibrous layers	2
brachiocephalic artery plaques	2
male apolipoprotein E–deficient mice	2
smooth muscle cell, macrophage, and endothelial cell apoptosis	2
EC4 domain	2
extracellular (EC) 4 domain of SNC	2
N-cadherin or fibroblast growth factor receptor (FGFR)	2
active site of SNC	2
soluble N-cadherin (SNC)	2
fibrous cap	2
similarly oversized AAV-fVIII vectors	2
immune-competent hemophilia	2
AAV-ET3	2
partial genome fragments	2
AAV-ET3 genomes	2
novel fVIII molecule, designated ET3	2
human fVIII	2
VIII (fVIII) transgene	2
novel cell-based medicinal products	2
related cell products	2
future recipients	2
regulatory macrophages	2
similar novel cell-based medicinal products	2
therapeutic drug	2
human regulatory macrophages	2
new cell-based medicinal product	2
recurrent solid tumors	2
antiadenovirus antibodies	2
nuclear membranes	2
oncolytic adenovirus particles	2
oncolytic adenovirus AdE3-IAI.3B	2
rAAV preparations	2
fixed doses of rAAV8 preparations	2
two different mouse strains	2
either cellular (EGFP (enhanced green fluorescent protein) or nuclear-targeted (n) LacZ) or secreted (human α1-antitrypsin (hA1AT)) reporter genes	2
aforementioned dosing formulations of rAAV8	2
mixtures of empty and fully packaged virions	2
fully packaged rAAV8 lots	2
partially and completely empty AAV8 virions	2
mixtures of full and empty virions	2
vector lots	2
Empty virions	2
AAV serotypes	2
cell-permeable peptides (CPPs)	2
various cells and tissues	2
several disease models	2
Adeno-associated virus type 2 (AAV2)	2
different disease models	2
gene delivery vehicles and target tissues	2
immature dendritic cells and B cells	2
protolerogenic antigen-presenting cells	2
“self	2
hematopoietic stem cells or immunological precursor cells	2
liver or thymus	2
tolerogenic microenvironment	2
humoral and/or effector T-cell immune responses	2
organ and cell transplantation	2
vaccine-draining right inguinal lymph node (VRILN) in DPX mice	2
DPX-vaccinated animals	2
C3 (HPV) tumor cells	2
injection site	2
novel adjuvant lipid-in-oil–based formulation	2
DepoVax (DPX)	2
immunotherapy candidates	2
insulated γ-globin lentiviral vector	2
liver, spleen, and kidneys	2
SCD mice	2
immunofluorescence (F-cells)	2
circulating red blood cells	2
total hemoglobin	2
transduced hematopoietic stem cells	2
Berkeley mouse model	2
γ-globin gene-corrected cells	2
adult SCD patients	2
autologous hematopoietic stem cells (HSCs)	2
novel chimeric MS2-lentiviral particles	2
primary human bone-marrow mesenchymal-stem cells	2
Cre-recombinase mRNA	2
high-titer particles	2
human CD34+ and iPS cells	2
biologically active RNAs	2
several types of RNAs	2
engineered chimeric particles	2
MS2-Coat-retrovirus chimeras	2
dimerization-independent MS2-driven RNA packaging system	2
genome-molecules per viral particle	2
Retroviral platforms	2
research projects	2
naturally occurring FVIII	2
host-cells	2
HEK293T lines	2
BDD product	2
CO-N6 transgene	2
two canine cell lines	2
sixfold more protein	2
transgene in HEK293T cells	2
CO-N6 cFVIII transgene	2
cBOECs, HEK293T, and MDCK cells	2
B-domain-deleted (BDD) and modified codon-optimized (CO-N6) transgenes	2
different host cells	2
Recombinant FVIII manufacturing	2
Surv.m-CRAs	2
vivo teratoma formation	2
Tert.m-CRA	2
Surv.m-CRA	2
cocultured differentiated normal cells	2
TERT-responsive m-CRAs (Tert.m-CRA)	2
survivin-responsive m-CRA (Surv.m-CRA)	2
differentiated normal cells	2
telomerase reverse transcriptase (TERT) promoter	2
survivin promoter	2
multiple factors (m-CRAs)	2
conditionally replicating adenoviruses	2
large panel of methods	2
iodixanol-based isopycnic density gradient	2
whole transfected cell culture	2
small quantity of detergent	2
cell pellets	2
adherent human embryonic kidney 293 cells	2
type of gene transfer vectors	2
Recombinant adeno-associated viruses (rAAV)	2
anticancer peptide drug	2
nonmuscle myosin IIA filaments	2
human prostate cancer xenografts	2
new blood vessel formation	2
capillary formation	2
corresponding synthetic peptide (named NBD)	2
DNA synthesis	2
mouse endothelial MSS31 cells	2
effector protein	2
S100A4-binding domain of methionine aminopeptidase 2	2
novel antiangiogenic agent	2
synthetic peptide	2
endothelial S100A4	2
xenograft cancer model	2
prometastatic calcium-binding protein,	2
PB and CB-HSCT	2
CD4+/CD8+ T cell precursors	2
CB-HSCT	2
polyclonal effector memory CD8+ T cells in blood, spleen and bone marrow, and pp65-reactive CTL and IgG responses	2
PB-HSCT	2
irradiated NOD.Rag1−/−.IL2γc−/− mice	2
functional pp65-specific memory cytotoxic T lymphocytes (CTLs)	2
activated CD4+ and CD8+ T cells	2
(“SmyleDCpp65”	2
PB and CB monocytes	2
tricistronic integrase-defective lentiviral vector (coexpressing GM-CSF, IFN-α, and HCMV pp65 antigen)	2
(CB)-HSCT	2
peripheral blood hematopoietic stem cell transplantation (PB-HSCT)	2
Human cytomegalovirus (HCMV) harmfully	2
enzyme, acid and alkaline pretreatments	2
NL media	2
total sugars	2
starch and lipids	2
BG-11 medium	2
Chlorococcum sp.	2
lipids and starch in Chlorococcum sp.	2
biomass constituents	2
Algal biomass growth	2
fed batch reactor	2
mixed microalgae consortia cultivation	2
polyketides and nonribosomal peptides	2
bioactive secondary metabolites	2
least five gene clusters	2
Red Sea sediments	2
Zooshikella ganghwensis strain VG4	2
draft genome sequence	2
novel structural scaffolds	2
Multidrug resistant bacteria	2
extract of the Aequorivita sp.	2
biosynthetic gene clusters	2
Aequorivita sp.	2
Gram-negative Antarctic bacterium	2
Antarctic shallow water sediments	2
several bacterial strains	2
Miniaturized Culture Chip	2
extreme environments	2
as-yet-unknown or atypical microorganisms	2
Novel secondary metabolites	2
microbial diversity	2
treated mice	2
Wild type and mutant Weissella confusa EPS	2
highest IgG and IgM	2
mutant Weissella confusa EPS	2
highest 1,1-Diphemy 1-2-picryl-hydrazyl (DPPH) capacity	2
antioxidant capacity	2
Wild type Weissella confusa and mutant Weissella confusa EPS	2
Wild type Weissella confusa EPS (WWCEPS) and mutant Weissella confusa EPS (MWCEPS)	2
g EPS	2
Eight (8) sugar moieties	2
Wild type Weissella confusa (WWCEPS)	2
EPS production	2
wild type and mutant Weissella confusa	2
exopolysaccharide (EPS)	2
bio-synthesized Au NPs	2
colloidal Au NPs	2
green synthesized Au NPs on Danio rerio (Zebra fish) embryo	2
A549 human lung cancer cell lines	2
biogenic synthesized Au NPs	2
Bacillu subtilis, Staphylococcus aureus, Salmonella typhi, Pseudomonas aeroginosa, Micrococcus luteus, and Enterobacter aerogenes	2
spherical shaped structures	2
biosynthesized Au NPs	2
leaf extract of Alternanthera bettzickiana (A. bettzickiana)	2
gold nanoparticles (Au NPs)	2
concentrated H2O2	2
large-scale MECs	2
bulk liquid	2
cathode	2
CEM-MEC	2
anion exchange membrane (AEM) and a cation exchange membrane (CEM)	2
H2O2 yield	2
electron donor	2
acetate medium	2
carbon gas-diffusion cathode	2
pilot-scale dual-chamber microbial electrolysis cell (MEC)	2
grease trap waste	2
effluent	2
methane gas	2
siphon-driven self-agitated anaerobic reactor	2
proteins of the hemostasis system	2
chromogenic peptide substrates	2
hemostasis system proteins	2
micromycetes - producers of proteases	2
biologically active	2
rhBMP-4 dimer	2
remaining monomer, aggregates and host cell contaminants	2
aggregation suppressors	2
rhBMP-4 monomer	2
non-active aggregated form	2
Escherichia coli (E. coli)	2
hBMP-4 cDNA	2
prokaryotic host	2
Biologically active human bone morphogenetic protein-4 (hBMP-4)	2
immunohistochemical and immunofluorescent stainings	2
paraffin embedded sections	2
different cellular markers	2
additional stainings	2
particular miRNA	2
tissues or cells	2
wide variety of different tissue types	2
routinely used ELISA-methods	2
soluble RTK sAxl	2
new antibodies	2
Olink Bioscience	2
innovative Proseek Single-Plex Protein Assay Kit System	2
sAxl and Gas6 in human blood samples	2
human glioma tissue	2
blood of animals	2
peri-tumoral edema	2
extracellular domain of Axl (sAxl) and Gas6	2
high-grade glioma (HGG)	2
•The receptor tyrosine kinase (RTK)	2
diluted organosolv hydrolysate	2
consumed carbohydrates	2
Two other strains	2
DSM No. 2314	2
Three of the Bacillus coagulans strains	2
Monod-type model	2
ethanol/water-pulped beechwood	2
lignocellulose organosolv hydrolysate	2
five Bacillus coagulans strains	2
lignocellulosic feedstock hydrolysates	2
interesting facultative anaerobic microorganism	2
Bacillus coagulans	2
lead contaminated wastewater	2
extremophilic isolate	2
presence of ligands	2
uranium rich soil	2
P. ficuserectae PKRS11	2
P. alcaligenes MJ7	2
P. aeruginosa MTCC2474	2
batch culture and column study	2
Synthetic Bangladesh Ground Water medium	2
solid and liquid minimal media	2
1.0mM lead	2
Lead biosorption property	2
extreme habitat of hot water spring of North–East India	2
Pseudomonas sp.	2
efficient bioremediating agent	2
landfill leachate	2
automobile company	2
manufacturing factories, recycling plants	2
bacteria in water samples	2
mM bicarbonate	2
non-autoclaved water	2
autoclaved water samples	2
water sample	2
four different bacterial species in tap water	2
sought-after agents	2
drinking and natural water	2
transformed leaves	2
recombinant CCL21 protein	2
S. lycopersicum leaves	2
resulting CCL21 plasmid	2
construct of ccl21	2
S. lycopersicum	2
CCL21 protein	2
recombinant protein of C-C chemokine ligand 21 (CCL21)	2
pretreatment	2
standard substrates	2
B. licheniformis	2
biogas yield	2
pulp mill biosludge	2
enzyme solutions	2
pulp mills	2
tracheal smooth muscle of rats	2
main component citral	2
EOLa	2
Acetylcholine (Ach	2
potassium (60 mM K+)	2
EOLa, citral and limonene	2
main constituents, citral and limonene	2
essential oil of L. alba (EOLa) effect	2
N.E. Brown (Verbenaceae) species	2
Lippia alba (Mill.)	2
Vermicomposting and anaerobic digestion	2
Ageratum conyzoides	2
Saccharum spontaneum	2
Parthenium hysterophorous, Lantana camara	2
forest, agriculture and urban	2
different ecosystems	2
terrestrial weed	2
ELS resistant genotypes in groundnut breeding	2
GM1911, GM1883, GM1000 and Seq13E09)	2
Four markers	2
SMA	2
susceptible genotypes	2
F2 population	2
polymorphic markers	2
simple sequence repeat (SSR) markers	2
ELS resistant genotype NAMA	2
ELS susceptible genotype QH243C	2
improved varieties	2
groundnut breeding	2
important oilseed and food crop of the world	2
Groundnut (Arachis hypogaea L.)	2
dusquetide therapy	2
(HNC) patients	2
dissolved phase	2
size exclusion chromatograms	2
eleven proteases	2
Deproteinisation yield	2
mild dried shell	2
formic acid	2
shrimp shells proteins	2
commercial proteases	2
shrimp shells bio-refining process	2
planted trees	2
soil amendment	2
sludge/soil mixture	2
sludge mixtures	2
control and sludge-treated plants	2
number of leaves	2
sludge/soil mixtures	2
One-year-old saplings of Eucalyptus camaldulensis	2
wastewater treatment plant of Tiaret (Algeria)	2
sludge	2
forest plantations	2
landfills or incineration	2
eliminations sludge	2
large amount of sludge	2
induced-hepatocyte-like cells (iHep)	2
mouse embryo fibroblast (MEF)	2
Recombinant adenovirus	2
adenovirus that expresses Cre-recombinase (AxCANCre)	2
inserted gene	2
red fluorescent protein (RFP)	2
recombinant adenoviruses	2
Cre-loxP-regulated fluorescent universal vector (termed pAxCALRL)	2
host HEK293 cells	2
expressed gene	2
recombinant adenoviral gene expression system	2
high-quality RNA	2
isolated RNA	2
EDTA, SDS and NaCl)	2
different prokaryotic and eukaryotic sources	2
isolated enzymes and biosurfactants	2
organic solvents, ionic and commercial detergent and oxidizing agents	2
protease, amylase and biosurfactant production	2
design expert software	2
detergent additive	2
feather meal, potato peel and rape seed cake in a single media	2
keratinolytic protease, amylase and biosurfactant	2
insoluble ones	2
unfolded BSA structure	2
BSA structure	2
foam fractionation	2
electron-confurcating enzyme	2
Ca.subterranus [FeFe]-hydrogenase	2
pyruvate::ferredoxin oxidoreductase and ferredoxin from Thermotoga maritima	2
active hydrogenase	2
Caldanaerobacter subterranus	2
apparently NADH-dependent, hydrogen-evolving [FeFe]-hydrogenase	2
E. coli host	2
NAD+/NADH-linked hydrogenase	2
NAD+/NADH cofactors	2
diaphorase enzymes	2
hydrogenase enzymes	2
non-native hydrogenase activity	2
different self-assembled monolayers	2
gold surface	2
thioctic acid	2
SAM	2
immune-capacitive biosensor	2
self-assembled monolayers (SAM)	2
Anti-aflatoxin B1	2
plasma cleaner	2
Piranha solution	2
redox couple	2
cleaning gold electrodes	2
aflatoxin B1	2
capacitive biosensor	2
resource settings	2
SP-SDS	2
composite samples	2
diverse bacteria	2
101–106 dilutions	2
solid samples	2
colloidal suspensions	2
liquid samples	2
9-cm plates	2
agar-gelled medium	2
micro-drops	2
0.1OD (100) stock	2
serial dilutions	2
pure cultures	2
viable counts	2
diverse samples	2
bacterial and yeast cfu estimations	2
omega 6 Kennedy pathway	2
mutant cultures	2
highest lipid containing cells	2
Nannochloropsis salina	2
chemical feed stock	2
Adding water	2
enzyme molecules	2
organic solvents enzymes	2
Biotechnologists prefer stable enzymes	2
RAPD markers	2
micropropagated clones	2
1/2 MS medium	2
Cell suspension cultures	2
0.3mgl−1)	2
MS media	2
various phytohormones	2
tips explants	2
Swertia chirayita	2
important herb	2
Swertia lawii Burkill	2
Highly efficient in vitro regeneration system	2
structures and sources	2
natural components	2
Many components	2
improved and potent compound	2
parent compounds	2
carcinogenic agents	2
inhibitor’s nature	2
many medicines	2
plants extracts	2
many efficient components	2
ayurvedic roots	2
drugs or therapies	2
radiation therapies	2
enclosed materials	2
capsid-like surface	2
natural capsid	2
artificial beads	2
cubic magnetite beads	2
spherical beads	2
silica beads	2
polystyrene beads	2
purified recombinant VP1 pentamers	2
five VP1 molecules	2
pentameric subunits	2
icosahedral capsid structure of simian virus 40 (diameter, 45nm)	2
different functional foods	2
unfermented sample	2
freeze-dried water extract of fermented wheat	2
Improved ABTS+ [2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)] and DPPH (2,2-diphenyl-1-picrylhydrazyl)	2
R. oryzae fermented wheat	2
water, methanol, 70% methanol, ethanol, 70% ethanol, acetone and 70% acetone	2
bound compounds from matrix	2
Rhizopus oryzae RCK2012	2
natural antioxidant PCs	2
Antioxidant phenolic compounds (PCs)	2
higher FI-CD34+	2
FI-CD34+ of 17±2.5	2
expansion stage (FI-CD34+)	2
platelet-like particles	2
culture-derived Mks	2
100ng/mL) and IL-3 (10ng/mL)	2
human bone marrow mesenchymal stem cells (MSC) feeder layer	2
-enriched cells	2
human UCB CD34+	2
umbilical cord blood (UCB) transplantation	2
hematopoietic stem/progenitor cells (HSC/HPC)	2
ex-vivo generated megakaryocytic progenitors	2
ethanolic extract of L. sativum L. plant parts	2
vitamin C.	2
shoot extract	2
vitamin C	2
Fe3+–Fe2+	2
ethanolic extracts	2
ethanolic extracts of L. sativum	2
total glutathione S-transferase enzyme	2
different ethanolic extracts of L. sativum	2
reducing power (Fe3+–Fe2+ Transformation Ability)	2
reduced glutathione activity	2
total glutathione S-transferase assay	2
1,1-diphenyl-2-picrylhydrazyl (DPPH)	2
ethanolic extract of cress (L. sativum L.) shoot, leaf, stem and seed	2
diabetes, local and rheumatic pain	2
Lepidium sativum Linn.	2
secreted resveratrol	2
Amberlite XAD-7 resin	2
intracellular resveratrol	2
jasmonic acid (JA), salicylic acid, β-glucan (GLU), and chitosan	2
seven investigated elicitors	2
Vitis vinifera L. cell suspension cultures	2
large scales of resveratrol	2
C. botulinum genome sequences	2
Clostridium botulinum	2
deadly botulinum neurotoxin	2
food systems	2
energy use	2
scientific areas	2
related techniques, approaches, and bioanalytical platforms	2
wide-ranging economic, social, health and environmental impacts	2
public health experts	2
food and water-borne diseases (FWDs)	2
Composite health measures	2
well-established assay	2
tested polymerases	2
substituted polymerases	2
published assays	2
gold standard Platinum Taq polymerase	2
different polymerases (or ready-to-use mastermixes)	2
suitable test platform	2
Listeria monocytogenes prfA qPCR assay	2
numerous assays	2
quantitative real-time polymerase chain reaction (qPCR)	2
detection chemistries	2
hydrolysis probe assays	2
quantitative Real-Time PCR experiments	2
rat RNA samples	2
qPCR-based assay	2
RNA samples	2
large comparison dataset	2
intact to heavily degraded samples	2
cultured cell lines and rat strains	2
wide range of RNA samples	2
3′ and 5′ regions of a rat housekeeping gene	2
Two PCR primer sets	2
microfluidic capillary electrophoresis systems	2
patients diagnosed with cancer	2
hematologic malignancies)	2
target and reference	2
cancer diagnostic center	2
suspected cancer patients	2
mtDNA and nDNA gene	2
external calibrator	2
reference nuclear gene (mtDNA/nDNA)	2
target mitochondrial gene	2
useful clinical biomarker	2
source of template material	2
unpurified industrial samples	2
synthetic biology qPCR standard	2
CAL1 standard	2
T7 target sequence	2
SC qPCR	2
cell sonicates	2
plasmid-encoded T7 bacteriophage sequence	2
equivalent bioreactor-derived sample	2
97–9.7×105 copies	2
shake flask-derived cell sonicates sample	2
BirA target sequence	2
shake flask cultivation	2
reaction	2
lone genomic BirA locus	2
putatively universal CAL1 calibration reaction	2
total Escherichia coli (E. coli) cellular material	2
new pharmaceutical targets	2
potential new biomarkers	2
applied global microRNA–mRNA interaction network	2
microRNA 96	2
microRNA 27a	2
pre-selected, significantly regulated microRNAs	2
TargetScan Mouse 5.2	2
integrative microRNA-mRNA network	2
vitro adipogenesis	2
expression data sets	2
developing 3T3-L1 pre-adipocytes	2
certified reference materials	2
calibrants	2
RNA calibration materials	2
viral RNA pathogens	2
sophisticated primer and probe chemistry	2
different PCR target choice	2
vitro transcribed RNA).While	2
synthetically prepared RNA transcript	2
cell cultured influenza A	2
total genomic RNA	2
two RNA template types	2
Zip Nucleic Acids (ZNAs), Locked Nucleic Acids (LNAs), and Scorpions®	2
alternative primer and probe chemistries	2
conventional dual labelled probes (DLP)	2
reverse transcription digital PCR (RT-dPCR)	2
PCR amplification target	2
nucleic acid fragments	2
PCR technologies	2
digital PCR method	2
nucleic acid background	2
purified linearized plasmid in solution	2
biobanking of samples	2
snap frozen tissue	2
heat stabilized brain tissue samples	2
DNA yield	2
snap frozen and heat inactivated samples	2
stabilized samples	2
heat stabilized samples	2
snap frozen samples	2
heat stabilized brain samples	2
Agilent Bioanalyzer	2
gene expression data	2
Illumina MiSeq data	2
MinION sequence reads	2
existing sequencing technologies	2
first nanopore-based single molecule sequencer	2
single read	2
5kb rRNA operon	2
longest single read	2
G+C strain	2
three bacterial genomes	2
repeat-rich regions	2
genome sequence assemblies	2
portable DNA sequencer	2
new sequencing technology	2
serial dilution series	2
one platform	2
qPCR replicates	2
different plates	2
qPCR replicate	2
standard curve	2
analyte transferred	2
six different qPCR instruments	2
multiple sequencing technologies	2
multiple laboratories	2
likely variant combination set	2
likely set	2
set of biologically conserved positions	2
identified variants	2
Ion Torrent PGM®	2
Roche 454 pyrosequencing®	2
Escherichia coli O157:H7 strain EDL933 and Listeria monocytogenes serovar 4b strain NCTC11994	2
six laboratories	2
16S ribosomal RNA gene (16S rRNA) sequencing	2
multi-copy, paralogous gene	2
different sequencing platforms	2
mineral nutrition	2
nutrient ions	2
Arabidopsis roots	2
gene microarray	2
several cation and anion channel- and transporter-related genes	2
Ca2+ and Mg2+) and anions (Cl−, SO4=, NO3− and PO4=)	2
+, K+,	2
cations	2
near null magnetic field	2
still uncharacterized magnetoreceptor	2
Earth magnetic field (or geomagnetic field, GMF)	2
cornu Ammon 1	2
Nr1 and GluR1 in the hippocampus	2
3 arms	2
novel arm	2
Gy radiation	2
Y-maze	2
glutamate receptor gene expression	2
Dendritic spines	2
synapses in the hippocampus	2
postsynaptic membrane	2
ionotropic and metabotropic glutamate receptors	2
major excitatory neurotransmitter	2
glutamate receptors	2
high linear energy transfer radiation	2
spaceflight experiments	2
differentially expressed transcripts and proteins	2
membrane and soluble fractions	2
RNAlater®	2
closed containers	2
BRIC-PDFU hardware	2
forty-four 60 mm Petri plates	2
bulk plated	2
wild-type Columbia (Col-0) seeds	2
without hardware	2
transcriptome and proteome of Arabidopsis seedlings	2
BRIC-Petri Dish Fixation Units (BRIC-PDFU) hardware	2
hardware	2
Space Transport System (STS, commonly known as the space shuttle) and the International Space Station (ISS)	2
Biological Research in Canisters (BRIC) hardware	2
aluminum shields	2
primary and secondary particles	2
free space	2
extensive simulations	2
particle spectrometers	2
existing dosimetry systems	2
space missions	2
new risk cross sections	2
leukemia and solid tumors	2
investigated 55 SNPs	2
ERBB3-rs2292239	2
major G allele	2
ERBB3 gene	2
16 non-HLA genes (VTCN1, PTPN22, CTLA4, SUMO4, CD274, IL2RA, INS, DHCR7, ERBB3, VDR, CYP27B1, CD69, CD276, PTPN2, UBASH3A, and IL2RB)	2
single nucleotide polymorphisms (SNP) markers	2
unrelated healthy children	2
multiple centers	2
Chinese case-control cohort	2
HLA-DPA1	2
individuals of European ancestry	2
Lebanese people	2
different communities and religious sects of the country	2
different Lebanese geographical areas	2
Luminex reverse SSO DNA typing system	2
HLA DPA1 alleles	2
Arab population	2
histocompatibility laboratories	2
bone marrow and organ transplantation	2
AimsHLA-DPA1	2
aberrant sodium ion channel	2
genetic compounds	2
SCN5A. The ‘G’ allele	2
DIIS6–DIIIS1 domain of the SCN5A transmembrane protein	2
exon-17 of SCN5A	2
novel C3417A (S1074R)	2
polymorphisms A3378G (E1061E)	2
LQTS patients	2
rs1805124) and	2
A1868G polymorphism (H558R	2
N-terminus of SCN5A protein	2
Exon-2 of SCN5A gene	2
polymorphisms	2
E1061E and S1074R (exon-17) and IVS25+65G>A (exon-25)	2
five polymorphisms — A29A (exon-2), H558R (exon-12),	2
SCN5A in South Indian cohort	2
long QT syndrome type-3 (LQTS-type-3)	2
INa channel	2
SCN5A gene	2
NAD(P)H oxidase p22 phox gene 242T allele	2
allelic model	2
recessive model	2
additive model	2
identified articles	2
MEDLINE, PubMed, EMBASE, and China National Knowledge Infrastructure	2
rare homozygous genotype (TT)	2
carriers of heterozygous genotype (GT)	2
population sample	2
ADIPOQ 276G>	2
many subject-level models	2
dominant, multiplicative, recessive, and over-dominant models	2
minor allele homozygote	2
persons with variant alleles	2
persons with normal alleles	2
patient derived data sets	2
common promoter motifs	2
large sample size breast cancer cohorts	2
ideal drug target	2
HER2− samples	2
TN and ER+	2
germ cells of gonads	2
NR6A1 an orphan nuclear receptor	2
SOX9, E2F1, HIF1A, HMGA1, MYC BACH2, CEBPB, and GCNF/NR6A1	2
TN samples	2
three different genome expression platforms (Affymetrix, Illumina and RNAseq)	2
seven cohorts	2
common promoter motif	2
consistently enriched genes	2
TN vs. ER+ HER2−	2
different breast cancer whole genome gene expression cohorts	2
viable targets	2
estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) receptors	2
PurposeTriple negative (TN) breast cancers	2
defective tafazzin	2
exon 7	2
putative substrate-binding cleft	2
another alternatively spliced exon	2
Exon 7	2
primate-specific molecular interactions	2
intrinsically unstructured region	2
Primate specific exon 5	2
candidate amino acid residues	2
distinct alternatively spliced transcripts	2
Human tafazzin gene	2
mitochondrial phospholipid transacylase	2
dairy livestock breeds	2
exotic sheep	2
malpura sheep	2
κ-casein gene	2
exotic goat (X60763)	2
Indian domestic Gaddi goat (Capra hircus)	2
κ-casein (CSN3) locus	2
corresponding amino acids	2
Capra hircus	2
Ovis aries	2
Bos grunniens	2
Bos indicus	2
SNP variants	2
exon 7 of β-casein and exon 4 of κ-casein genes in Arunachali yaks (Bos grunniens), Sahiwal (Bos indicus) cattle, malpura sheep (Ovis aries) and Gaddi goat (Capra hircus)	2
milk protein	2
Milk protein genetic polymorphism	2
β-casein	2
AbstractsThe most polymorphic milk protein gene	2
rs109019599 and rs109163366 in ADIPOQ, OLR1 and PPARGC1A gene	2
Nelore cattle	2
ADIPOQ, OLR1 and PPARGC1A genes	2
beef cattle	2
cross pollinated heterozygous species	2
introduced and domesticated genotypes	2
domesticated population	2
Indian ramie populations	2
five populations	2
indigenous, introduced and domesticated ramie (Boehmeria nivea L. Gaudich.)	2
Twenty-four start codon targeted (SCoT)	2
Y chromosome	2
pregnant cows	2
Australian Brahman population	2
“pregnant” cows	2
“non-pregnant” and	2
Pooled DNA	2
HD SNP chip	2
pseudoautosomal boundary region of the Y chromosome	2
crossbred population	2
Y chromosome specific region	2
Brahman cows (n=929)	2
presence Y markers	2
Indicine cattle	2
potent regulators	2
pseudogenes and microRNAs	2
19q13.33→qter region	2
breakpoint	2
nucleolar organization region (	2
small acrocentrics	2
short arm of chromosome 21	2
Fluorescent in situ hybridization (FISH)	2
chromosome 19q13	2
genomic array	2
female patient	2
hOSCP1 variants	2
non-viral LC patients	2
rs2275477 (Gly307→Arg)	2
synonymous SNP	2
(Thr131→Ala)	2
2 non-synonymous SNPs	2
normal portion of LC	2
hOSCP1 gene in Japanese patients with non-viral liver carcinoma (LC)	2
Na+-independent multispecific organic solute transporter	2
Human organic solute carrier protein 1 (hOSCP1)	2
populations worldwide	2
Syrian population	2
VDR polymorphisms	2
vs t and A vs a alleles	2
unrelated normal healthy individuals of Syrian population	2
Taq-I and Apa-I) polymorphisms	2
VDR gene (	2
Vitamin D receptor (VDR)	2
vitamin D endocrine system	2
bioactive food/food constituents	2
Nrf2/ARE pathway	2
[TA]6/6 and [TA]7/7 polymorphisms	2
study coffee	2
−651 SNP	2
Nrf2, GST1A1 and UGT1A1 gene transcription	2
−653 SNP	2
Nrf2 and subsequent ARE-dependent GST1A1 and UGT1A1 transcription	2
specific Nrf2 genotypes	2
dark roast products	2
natural green coffee bean constituents	2
D. nobile	2
various secondary metabolite compounds	2
mother and the micropropagated plants	2
micropropagated plants	2
mother plant	2
RAPD and SCoT primers	2
regenerants	2
randomly amplified polymorphic DNA (RAPD) and start codon targeted (SCoT) polymorphism markers	2
greenhouse	2
activated charcoal	2
best rooting (5.41 roots/shoot)	2
PLBs	2
plantlet regeneration	2
thidiazuron (TDZ; 1.5mg/l)	2
pseudostem segments	2
Protocorm like bodies (PLBs)	2
highly prized orchid	2
Dendrobium nobile	2
phytochemical production	2
FABP2 Ala54Ala, Ala54Thr genotype (p<0.05) and PPARG2 CC, CG, GG genotype (p<0.05)	2
Ala54Ala, Ala54Thr and Thr54Thr genotypes in FABP2 gene	2
cataract cases and controls	2
North Indian population	2
bilaterally blind	2
basic database	2
India	2
four alleles	2
Ile105 and Val105 allele	2
GSTP1*A, GSTP1*B, GSTP1*C, and GSTP1*D	2
four alleles: GSTP1*A (wild-type Ile105; Ala114), GSTP1*B (Val105; Ala114), GSTP1*C (Val105; Val114) and GSTP1*D (Ile105; Val114)	2
(Ile105→Val105; Ala114→Val114)	2
500 normal individuals	2
exon 5 and exon 6 of GSTP1 gene	2
less reactive water-soluble compounds	2
endogenous and exogenous compounds	2
super family of phase II detoxification enzymes	2
Glutathione S-transferases (GSTs)	2
AR protein	2
ligand-binding domain (LBD) of the AR gene	2
exon 4 region of the AR gene	2
(GenBank Protein_id ADF47187).ConclusionsWe	2
exon 4 [Cys669Trp]	2
codon 669	2
amino acid interchange cysteine	2
position 2369 (GenBank accession number HM010955)	2
nucleotide G	2
(AR) gene	2
sex-determining region Y (SRY) gene and androgen receptor	2
corresponding exon–intron boundaries	2
peripheral blood sample	2
G gene loci of apoCIII3206	2
apoCIII3175 GG genotype carriers	2
G gene loci of apoCIIIT3206G polymorphism	2
TG unconditional logistic regression	2
G gene loci of apoCIIIC3175G	2
TG group	2
total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C)	2
content	2
apoCIIIT3206G	2
G gene loci	2
triacylglycerol (TG)	2
apoCIII3175 GG genotypes	2
T3206G polymorphisms	2
apoCIII gene C3175G	2
two hospitals	2
healthy male participants	2
apoCIII gene	2
Han Chinese subjects	2
apoCIII	2
foreign studies	2
apolipoprotein (apo	2
Plasma lactate	2
adults with MELAS syndrome	2
lactic acidemia	2
precursors arginine and citrulline	2
Mitochondrial encephalomyopathy	2
11 LSD enzymes	2
filter paper blank sample	2
DBS	2
enzyme reaction products	2
dried blood spot (DBS) samples	2
11 enzymes	2
lipids, glycolipids, oligosaccharides, mucopolysaccharides, and other biological substances	2
AA formula	2
amino-acid supplements	2
natural protein sources	2
PKU diet	2
structured questionnaire	2
low- phenylalanine diet	2
Gln46Pro and p.Glu609Lys)	2
periodic acid-Schiff-positive materials	2
Japanese boy	2
GSD IV.Case	2
non-progressive form (NP-GSD IV)	2
psychometric tests	2
accurate and objective measure	2
Several psychometric tests	2
38-year old man	2
2-methyl-3-hydroxybutyric acid	2
Background2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (MHBDD)	2
four GCS genes	2
Fifty-two variants tagging (r2 	2
young, healthy individuals	2
GCS genes	2
dimethylglycine, formate, and serine in blood	2
source of one-carbon units	2
complex of four enzymes	2
glycine cleavage system (GCS)	2
similar cases	2
orthopedic surgeons	2
favored system	2
toxic agents	2
right hip prosthesis removal	2
toxicology screen	2
metallic content	2
right ilium	2
right proximal part of the femur	2
tricarboxylic acid cycle intermediates and 2-ethylhydracryllate	2
Urine organic acid screen	2
58-year old man	2
resultant multisystemic clinical presentation	2
3 month old	2
U.S. Food and Drug Administration approved alglucoside alfa	2
patients with Infantile Onset Pompe Disease (IOPD)	2
alglucoside alfa	2
urinary bile acid metabolite	2
SPC and/or lysophingomyelin-509	2
novel combination of plasma biomarkers	2
3β-sulfooxy-7β-N-acetylglucosaminyl-5-cholen-24-oic acid	2
plasma SPC and lysosphingomyelin-509	2
newly reported biomarker	2
NPC-affected and control individuals	2
potential precursor	2
Sphingosylphosphorylcholine (SPC)	2
multiple lipid biomarkers	2
numerous novel biomarkers	2
cholestane-3β,5α,6β-triol and 7-ketocholesterol	2
oxidation products of cholesterol	2
membraneous and soluble fractions	2
lysosomal proteins	2
either NPC1 or NPC2	2
cholesterol and sphingolipids	2
Niemann-Pick disease type C (NPC)	2
skilled specialists	2
lysosomal storage disorders (LSDs)	2
Totally implantable vascular access devices (TIVADs)	2
patients with VLCAD deficiency	2
l-carnitine	2
common cold	2
elder brother of case 1	2
8-year-old boy	2
Case 2	2
6-year-old boy	2
long-chain acyl-CoA dehydrogenase (VLCAD) deficiency	2
small trial population	2
bezafibrate administration	2
serum acylcarnitines (ACs, C14:1 or C16 + C18:1)	2
2 patients with carnitine palmitoyltransferase-II (CPT-2) deficiency	2
6 patients with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency	2
vitro FAO capacity	2
peroxisome proliferator-activated receptor agonist	2
mitochondrial fatty acid oxidation (FAO) enzymes	2
real-world setting	2
heterogeneous subset of MPS IVA patients	2
EQ-VAS score	2
Three patients	2
3-MSCT	2
wheelchair	2
Spanish Morquio-A Early Access Program	2
pediatric MPS-IVA patients	2
patients with mucopolysaccharidosis type IVA (MPS-IVA)	2
Male participants	2
renal net acid, magnesium and sulfate	2
Males and females	2
male participants	2
female participants	2
consuming AA-MF or GMP-MF	2
4 males, 4 females, aged 16–35y)	2
amino acid medical foods (AA-MF) or glycomacropeptide medical foods (GMP-MF)	2
low-phenylalanine (Phe) diet	2
participants with early-treated PKU	2
male and female participants	2
severely deficient FAH allele	2
heterozygotes for c.1021C>T (p.Arg341Trp)	2
maleylacetoacetate isomerase	2
newborns	2
prevalent “pseudodeficient” FAH allele, c.1021C>T (p.Arg341Trp)	2
Neither individual	2
typical HT1	2
HT1ObservationsTwo newborns	2
tyrosine and phenylalanine	2
nitisinone (NTBC)	2
HT1 newborns	2
fumarylacetoacetate hydrolase	2
FAH gene	2
hepatorenal tyrosinemia (HT1, MIM 276700)	2
succinylacetone (SA) in blood	2
PKU adolescents	2
PKU teenagers	2
selected group	2
adolescents with phenylketonuria (PKU)	2
individuals with GLA mutations	2
one first degree relative	2
81 families	2
Fabry disease patients	2
Icahn School of Medicine at Mount Sinai (ISMMS)	2
Fabry patients	2
Fabry disease patients and family members with likely pathogenic alpha-galactosidase A (GLA) mutations	2
ID2S, GALN, and ARSB in disease-affected individuals	2
ID2S, GALN, and ARSB in random neonates	2
interday assay of ID2S, GALN, and ARSB	2
Kumar et al., Clin Chem 2015 61(11):1363-1371)	2
three disorders in a 96-well plate	2
combined assay	2
N-acetylgalactosamine-6-sulfatase (GALN) and	2
iduronate-2-sulfatase (ID2S)	2
multiple MPS disease subtypes	2
Mucopolysaccharidosis (MPS)	2
trachea, humerus, knee cartilage, and lung bronchus	2
severely ballooned and vacuolated chondrocytes	2
systemic storage materials	2
thyroid, lung, lung bronchus, trachea, heart, aorta, liver, spleen, kidney, testes, humerus, knee cartilage, and knee ligament	2
postmortem tissues pathohistologically	2
autopsied case of a 23-year-old male	2
autopsied cases	2
coxa valga, genu valgum	2
tracheal obstruction	2
kyphoscoliosis, pectus carinatum	2
short neck	2
partially degraded glycosaminoglycans (GAGs), keratan sulfate and chondroitin-6-sulfate	2
N-acetylgalactosamine-6-sulfate sulfatase	2
Morquio A syndrome (mucopolysaccharidosis IVA, MPS IVA)	2
appropriate venous access	2
infusion related reactions (IRR)	2
appropriately trained members of homecare staff	2
safe and effective homecare service	2
Mucopolysaccharidosis type IVA (MPS IVA, Morquio syndrome)	2
hearing aid	2
legs	2
arms	2
abdominal bloating	2
case report	2
severely affected, non-ambulatory, 47-year-old patient	2
severely affected, non-ambulatory patients	2
bone-targeting treatments	2
early ERT	2
younger sibling	2
older sibling	2
galsulfase 1mg/kg	2
two Japanese siblings with MPS VI	2
recombinant human ASB (galsulfase)	2
patients with mucopolysaccharidosis type VI (MPS VI)	2
population of GAA	2
n=83)	2
LSD enzymes	2
substrate-derived in-source decomposition products	2
two populations in Japanese neonates	2
Clin Chem (2017)	2
pseudodeficiency alleles of the GAA enzyme [Liao HC et al.	2
population of IOPD	2
GAA enzyme activity	2
sphingolipids, glycolipids, oligosaccharides, mucopolysaccharides, the oxidation products of cholesterol, and other biological substances	2
McArdle patients	2
Eight-isoprostanes	2
N=12)	2
skeletal muscle of MCD patients	2
NAD(P)H-oxidase, xanthine oxidase and antioxidant enzyme (superoxide dismutase, catalase and glutathione peroxidase) activity	2
xanthine oxidase pathway	2
patients with Pompe disease	2
empty NP or MTX	2
anti-rhGAA antibody responses	2
Empty nanoparticles (NP)	2
methotrexate (MTX)	2
GAA-KO mice	2
synthetic vaccine particles carrying rapamycin (SVP-Rapa)	2
anti-rhGAA antibodies	2
enzyme replacement therapy (ERT) with recombinant human acid-α-glucosidase (rhGAA)	2
case of a 13-year-old Malaysian patient	2
anti-IDS antibodies	2
patients with MPS II	2
idursulfase (Elaprase, Shire Pharmaceuticals) and idursulfase beta (Hunterase, Green Cross Corp)	2
severely affected individuals	2
male individual	2
bilateral Tessier IV facial clefts	2
dysplastic clavicles	2
one of the siblings	2
two male siblings	2
surviving male	2
currently reported male patients	2
non-mosaic males	2
skin, ocular and skeletal malformations	2
idursulfase antibodies	2
study patients	2
seropositive patients	2
planned patients	2
enrolled patients	2
anti-idursulfase antibody testing	2
Blood/urine samples	2
urinary glycosaminoglycans [uGAGs]).MethodsMale patients	2
idursulfase-specific antibody generation	2
(MPS II) patients	2
various mechanisms and pathways in the central nervous system	2
new algorithms and programs	2
neurological development and immunological function pathways	2
knockout animals	2
significant up- and down-regulated genes	2
Wildtype pups	2
unconjugated biotin	2
knockout pups	2
wildtype mice	2
brains of biotinidase-deficient, transgenic, knock-out mice	2
protein-bound biotin	2
proteolytic digestion product	2
biocytin (N-biotinyl-ϵ-lysine)	2
Untreated individuals	2
blood brain barrier (BBB)	2
low anti-rhGAA immunoglobulin G (IgG)	2
Patient 1	2
younger sister (Patient 2)	2
female proband (Patient 1)	2
patients with IOPD	2
recombinant human acid alpha glucosidase (rhGAA)	2
Infantile-onset Pompe disease (IOPD)	2
acid α-glucosidase deficiency	2
Mol Genet Metab 118 (2016) 304–309]	2
LSDs in a Japanese population	2
LSD-confirmed individuals	2
Dried blood spots (DBSs)	2
enzyme products	2
individual LSDs	2
fluorescent substrates	2
individuals with LSDs	2
glycolipids, oligosaccharides, mucopolysaccharides, sphingolipids, and other biological substances	2
microelements and vitamins in A-1 and MP-11 preparations	2
natural foods	2
low-protein food	2
protein and fat	2
microelements and vitamins	2
3-hydroxyisovaleric acid	2
urinary biotin	2
serum selenium	2
Phe-free milk and amino acid substitutes	2
phenylalanine-free (Phe-free) milk and Phe-free amino acid substitutes	2
14 patients	2
energy, carbohydrates, fat, vitamins, and microelements	2
lifetime low-phenylalanine diet	2
phenylalanine-restricted diet	2
diet-off adult patients	2
DGUOK, POLG1, and MPV17 genes	2
hepatocerebral MDS	2
four Korean children	2
East Asian countries	2
total GAG	2
urine of patients	2
MPS II-affected patients	2
urine of MPS II patients	2
49–56.]	2
Molecular Genetics and Metabolism 102 (2011)	2
disease-specific one	2
Heparan sulfate (HS), Dermatan sulfate (DS) and chondroitin sulfate	2
mucopolysaccharidoses (MPSs)	2
total GAGs	2
Glycosaminoglycans (GAGs)	2
post-translational modifications of proteins	2
monitoring patients	2
global glycoproteome	2
2D DIGE	2
complex cases	2
CDG patients	2
LARGE and B3GALNT2-deficient muscular dystrophies	2
lower molecular weight glycoform of C1-esterase inhibitor	2
α1-antitrypsin, α1-antichymotrypsin, α2-HS-glycoprotein, ceruloplasmin, and α1-acid glycoproteins 1&2	2
CDG-II	2
PMM2-CDG (n=5), CDG-II (n=7), MD and known complex N- & O-linked glycosylation defects (n=3)	2
Patient samples	2
serum glycoproteome	2
additional glycoproteins	2
glycoproteins transferrin, and/or apolipoprotein CIII	2
N- & O-linked defects	2
protein and lipids	2
asymptomatic carriers and X-ALD-affected subjects	2
controls and ALD-affected individuals	2
QC DBSs	2
QC DBS	2
X-ALD-affected individuals	2
1-hexacosanoyl-2-hydroxy-sn-glycero-3-phosphocholine (Lyso-PC 26:0)	2
peroxisomes	2
long chain fatty acids	2
MELAS, MERRF (Myoclonic epilepsy and ragged-red fiber syndrome), MNGIE (Mitochondrial neurogastrointestinal encephalopathy), KSS (Kearns-Sayre Syndrome)	2
proposita	2
m.3291T	2
Caucasian family	2
MT-TL1 gene	2
adolescents and adults with PKU	2
p=0.19 and p=0.24	2
preadolescents or adolescents/adults	2
online questionnaires	2
individuals with phenylketonuria (PKU)	2
new therapies and treatments	2
Payers, government agencies, clinicians, and industry partners	2
disliked therapeutic injections	2
newly developed therapies	2
medical formula and foods	2
medical foods	2
natural protein	2
Individuals with PKU	2
Phe-restricted diet	2
≤18year old individuals	2
Blood Phe	2
younger (≤18years) individuals	2
625 survey respondents	2
membership	2
National PKU Alliance (NPKUA)	2
phenylalanine (Phe)	2
cognitively affected patients	2
CSF GAG	2
MPS II patients	2
GAG in cerebrospinal fluid (CSF)	2
MPS II	2
mucopolysaccharidoses (MPS), glycosaminoglycans (GAG)	2
trimethylamine N-oxygenation	2
p.(Cys197Ter)	2
novel missense or duplicationFMO3 variants	2
seven variants	2
Escherichia coli membranes	2
variant FMO3 proteins recombinantly	2
c.929 C>T p.(Glu158Lys)	2
p.(Ser310Leu) FMO3 allele	2
single-nucleotide polymorphism c.929 C>T p.(Ser310Leu)	2
novel duplication c.850_860dupTTTAACGATGA p.(Glu287AspfsTer17)	2
p.(Gly376Glu)	2
c.1127G>	2
>A p.(Phe43Ile), c.488 T>C p.(Leu163Pro)	2
, c.122 G>A p.(Trp41Ter)	2
T>C p.(Ile7Thr)	2
novel single-nucleotide polymorphisms	2
FMO3 genes	2
urinary trimethylamine and trimethylamine N-oxide concentrationsin171 Japanese volunteers	2
novel FMO3 variants	2
another self-reported Japanese trimethylaminuria cohort	2
Japanese cohort	2
variety of ethnic groups	2
Several FMO3 variants	2
Polymorphic human flavin-containing monooxygenase 3 (FMO3)	2
siblings)	2
phenylketonuria group vs sibling controls	2
therapeutic inventions	2
peritoneal dialysis	2
medical literature	2
isolated splenomegaly	2
SynopsisAn elderly female patient	2
first reported NP-C patient	2
[V664M]	2
exon 13	2
one in exon 8 (c.1133T>C [V378A])	2
NPC1 gene	2
compound heterozygous mutant NP-C genotype	2
NP-C positive control	2
cells from normal controls	2
cholesterol-filled vesicles	2
LDL-enriched medium	2
massive splenomegaly	2
Pick disease type C (NP-C)	2
Niemann–	2
oldest known living patient	2
66year-old female	2
foster care	2
12-year-old child	2
grandparents	2
kinship home	2
3-year-old girl	2
foster care or kinship homes	2
two case studies	2
patients and their caregivers	2
phenylketonuria (PKU)	2
mild PKU patients	2
BH4 responders	2
4 different categories	2
phenylalanine 360–2420μmol/L)	2
children's medical center	2
BH4 deficient type	2
cases of patients	2
6R-Tetrahydrobiopterin (BH4) responsive phenylketonuria (PKU)	2
specific tissue	2
transgenic Cre strain of choice	2
FLP recombinase	2
Agps-KOMP mice	2
surviving adult Agps knock-out mice	2
Knockout Mouse Project (KOMP) resource	2
Agps knockout mice	2
bs2 locus	2
multicellular cellular clusters	2
first opacities	2
bs2 lenses	2
significant humeral	2
adult bs2 mice	2
surviving bs2 mice	2
~50% bs2 mice	2
RCDP3 patients	2
blind sterile 2 (bs2) mice	2
alkylglycerone phosphate synthase (AGPS)	2
RCDP children	2
proximal limbs	2
carnitine, biotin, and thiamine	2
PCCB gene	2
propionic acidemia	2
A; p.G607S)	2
c.1819G>	2
maternal allele:	2
GLDC gene (paternal allele: c.1576_1577insC delT and c.1580delGinsCAA; p.S527Tfs*13	2
non-ketotic hyperglycinemia and propionic acidemia	2
BCKDHB gene	2
c.488_1167+3del)	2
BCKDHA gene	2
identified mutations	2
resultant amplified products	2
genes implicated in MSUD (BCKDHA, BCKDHB, and DBT)	2
exonic and flanking intronic regions	2
extracted DNA	2
MSUD patients	2
oxidative stress axis	2
dicarboxylic acids in urine	2
blood reduced glutathione (GSH)	2
identified OPA3 variants	2
patient's cells	2
brother	2
older female sibling	2
IVS1+5 splice site variant	2
c.1A>G variant	2
c.1A>G	2
+5G>C	2
second variant, c.142	2
translation initiation codon	2
OPA3 gene	2
3-methylglutaconic aciduria	2
OPA3-related 3-methylglutaconic aciduria	2
soaps, body sprays, and air fresheners	2
synthetics fragrances	2
natural antimicrobial fragrance option	2
S. aureus, Str. pneumoniae, P. aeruginosa, and A. brasiliensis	2
EO of orange, patchouli, peppermint, and clary sage	2
(−)-menthol	2
(+)-menthol	2
(−) and (+)-limonene	2
EOs	2
A. brasiliensis	2
S. aureus and Str. pneumoniae	2
single oils	2
inhibitory zone	2
body spray	2
Str. pneumoniae	2
liquid soap and body spray	2
air freshener	2
four microorganisms	2
disc-diffusion assay	2
Staphylococcus aureus, Streptococcus pneumoniae, Pseudonomas aeruginosa, and Aspergillus brasiliensis	2
air freshener, liquid soap, and body spray	2
three household products	2
individual single oils	2
new EO blend containing orange, patchouli, peppermint, and clary sage	2
blending EOs	2
synthetic household products	2
Plant essential oils (EOs)	2
tissue remodeling-related proteins	2
Helichrysum and ylang ylang essential oils	2
bergamot, cilantro, and spikenard essential oils	2
oils from frankincense, Hawaiian sandalwood, lavender, myrrh, helichrysum, and rose	2
essential oil blend (commercial name Immortelle)	2
Citrus bergamia (bergamot), Coriandrum sativum (cilantro), Pelargonium graveolens (geranium), Helichrysum italicum (helichrysum), Pogostemon cablin (patchouli), Citrus aurantium (petitgrain), Santalum album (sandalwood), Nardostachys jatamansi (spikenard), and Cananga odorata (ylang ylang)	2
nine single oils	2
pre-inflamed human dermal fibroblast system	2
nine single and one blend)	2
good therapeutic candidate	2
LEO in human skin cells	2
immunomodulatory biomarker macrophage colony-stimulating factor (M-CSF)	2
tissue remodeling biomarkers collagen-I and III, epidermal growth factor receptor (EGFR), and plasminogen activator inhibitor (PAI-1)	2
inflammatory biomarkers vascular cell adhesion molecule 1 (VCAM-1), interferon gamma-induced protein 10 (IP-10), interferon-inducible T-cell alpha chemoattractant (I-TAC), and monokine	2
17 protein biomarkers	2
pre-inflamed human dermal fibroblasts	2
commercially available LEO	2
main component	2
Lemongrass (Cymbopogon flexuosus) essential oil (LEO)	2
major active component	2
altered signaling pathways	2
macrophage colony-stimulating factor (M-CSF)	2
immunomodulatory biomarker	2
namely collagen I, collagen III, epidermal growth factor receptor (EGFR), matrix metalloproteinase 1 (MMP-1), plasminogen activator inhibitor 1 (PAI-1), tissue inhibitor of metalloproteinase (TIMP) 1 and 2	2
tissue remodeling biomarkers	2
vascular cell adhesion molecule 1 (VCAM-1), intracellular cell adhesion molecule 1 (ICAM-1), interferon gamma-induced protein 10 (IP-10), interferon-inducible T-cell alpha chemoattractant (I-TAC), and monokine	2
monocyte chemoattractant protein 1 (MCP-1)	2
several inflammatory biomarkers	2
human skin cell disease model	2
carvacrol content	2
commercially available OEO	2
oregano (Origanum vulgare) essential oil (OEO)	2
AEO in human skin cells	2
numerous critical genes and signaling pathways	2
21,224 genes	2
collagen-I, collagen-III, plasminogen activator inhibitor-1 (PAI-1), and tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2)	2
interferon gamma (MIG), and macrophage colony-stimulating factor (M-CSF)	2
intracellular cell adhesion molecule 1 (ICAM-1), interferon gamma-induced protein 10 (IP-10), interferon-inducible T-cell chemoattractant (I-TAC), monokine	2
vascular cell adhesion molecule 1 (VCAM-1)	2
pre-inflamed human dermal fibroblast culture model	2
Arborvitae (Thuja plicata) essential oil (AEO)	2
major active components	2
many important signaling pathways	2
intracellular cell adhesion molecule 1	2
interferon gamma-induced protein 10	2
FREO in pre-inflamed human dermal fibroblasts	2
frankincense essential oil (FREO)	2
associated cytokines	2
attractive targets	2
Tumor-associated macrophages (TAMs)	2
rhTSH.FundingCancer Research UK	2
patients with low-risk differentiated thyroid cancer	2
low-dose radioactive iodine	2
low-dose and high-dose radioactive iodine groups	2
two in each group	2
21 patients	2
Confirmed recurrences	2
high-dose group	2
low-dose group	2
434 patients	2
438 patients	2
either recombinant human thyroid-stimulating hormone (rhTSH) or thyroid hormone withdrawal	2
differentiated thyroid cancer	2
radioactive iodine doses	2
low administered radioactive iodine (131I) dose (1·1 GBq)	2
well-differentiated thyroid cancer	2
mental and behavioural, neurological, and external causes	2
individuals of healthy weight	2
mental and behavioural, neurological, and accidental (non-transport-related) causes	2
respiratory diseases	2
cardiovascular diseases	2
transport-related accidents	2
648 people	2
674 people	2
Poisson model	2
Fully adjusted models	2
1·06–1·41).InterpretationIn men	2
women	2
corresponding lower risk groups	2
physical inactivity	2
102 633 individuals	2
national death registries	2
IPD-Work consortium	2
men and women with and without	2
European Regional Development Fund	2
Italian Ministry of Health, Aide aux Jeunes Diabetiques, Societe Francophone du Diabete, Ipsen, Slovak Research and Development Agency	2
Kristian Gerhard Jebsen Foundation, Western Norway Regional Health Authority, Southern and Eastern Norway Regional Health Authority	2
Norwegian Research Council	2
European Research Council	2
Royal Society	2
Diabetes UK	2
-dose sulfonylurea therapy	2
; p=0·0005	2
sulfonylurea therapy	2
ClinicalTrials.gov, number NCT02624817.Findings90 patients	2
large international cohort of patients	2
type 2 diabetes	2
Aging (US National Institutes of Health)	2
women with diabetes	2
men and women with diabetes	2
statins and antihypertensive drugs	2
cost-effective drugs	2
age and sex groups	2
Cox regression models	2
medical death certificates	2
tobacco use	2
treatments	2
42 patients	2
daily	2
haemodynamic monitoring facilities	2
seven sites	2
doxazosin 4–8 mg	2
bisoprolol 5–10 mg	2
314 patients	2
UK primary and secondary care sites	2
three substudies	2
conventional antihypertensive drugs	2
UK Medical Research Council Population Health Research Unit	2
Mexican Health Ministry	2
4185 participants	2
5042 participants	2
combination of vascular, renal, or infectious causes	2
662 participants	2
participants without diabetes	2
Cox models	2
000 women	2
100 	2
Mexican adults	2
indication	2
non-centre-involving diabetic macular oedema	2
painful, sticky, or watery eyes	2
either mask	2
277 patients	2
randomised patients	2
masked technicians	2
Outcome assessors	2
central web-based computer system	2
sleep (Noctura 400 Sleep Mask, PolyPhotonix Medical, Sedgefield, UK) or a sham (non-light) mask	2
Adults with non-centre-involving diabetic macular oedema	2
ophthalmic centres	2
organic light-emitting sleep mask	2
many patients	2
urban and rural Malawi	2
566 participants	2
rural women	2
rural men	2
urban men	2
rural, the poorest, and least educated participants	2
urban residents	2
Karonga District	2
rural adults	2
eligible urban adults	2
location-specific (urban vs rural), age-specific, and sex-specific groups	2
current antihypertensive medication	2
fasting blood samples	2
Lilongwe city	2
two defined geographical areas	2
≥18 years)	2
urban—population	2
predominantly rural	2
non-communicable diseases	2
-Saharan Africa	2
FundingWellcome Trust and Diabetes UK	2
diabetes cases	2
genetically defined cases	2
white European individuals	2
remaining cases	2
low genetic susceptibility group	2
high genetic susceptibility group	2
half of the population	2
individuals of white European descent	2
children and young adults	2
Wellcome Strategic Award	2
Health Research Cambridge Biomedical Research Centre	2
Larger and longer studies	2
adults with type 1 diabetes	2
One participant	2
day-and-night hybrid closed-loop system	2
web-based randomly permuted blocks	2
Addenbrooke's Hospital	2
adults (aged ≥18 years)	2
population settings	2
consumers of diets	2
groups of free-living people	2
highly controlled environment	2
p<0·0001).InterpretationUrinary metabolite models	2
Danish cohort	2
derived metabolite models	2
four diets	2
eligible participants	2
healthy-eating Danish cohort	2
data and samples	2
urinary metabolite models	2
diet-discriminatory metabolites	2
Urine samples	2
opaque, sealed, sequentially numbered envelopes	2
inpatient stays	2
fats, sugars, and salt)	2
fruits, vegetables, whole grains, and dietary fibre	2
clinical research unit	2
free-living populations	2
hundreds of metabolites in urine	2
Metabolic profiling	2
FundingBritish Heart Foundation, and University College London Hospitals NHS Foundation Trust (UCLH)	2
PCSK9 inhibitor drugs	2
independent PCSK9 variants (rs11583680, rs11591147, rs2479409, and rs11206510)	2
000 individuals	2
PCSK9 genetic variants	2
genetic consortia	2
PCSK9 inhibitors	2
LDL cholesterol-lowering PCSK9 variants	2
gene encoding HMG-CoA reductase	2
Wellcome Trust	2
European Foundation	2
insulin-treated adults with type 2 diabetes	2
meal-time boluses	2
closed-loop intervention group	2
meal-time insulin boluses	2
rapid-acting insulin analogue	2
general wards	2
insulin therapy	2
so-called artificial pancreas)	2
Austrian Science Fund	2
617 participants	2
natriuretic peptide family members	2
literature (PubMed, Scientific Citation Index Expanded, and Embase)	2
NT-proBNP) concentration	2
N-terminal-pro-B-type natriuretic peptide (	2
Australian National Heart Foundation	2
Australian National Health and Medical Research Council	2
dialysis trials	2
LDL cholesterol	2
28 trials	2
novel written material	2
p=0·070)	2
1·56, 0·96–2·51	2
POWeR+F group	2
patients in the POWeR+F group	2
nurse contacts	2
fruit and vegetable intake	2
similar, but healthier, choices	2
patients (1:1:1)	2
Eligible adults	2
primary care practices	2
Bupa Foundation	2
cholecalciferol daily	2
569 mothers	2
women in the placebo group	2
Neonatal whole-body BMC of infants	2
randomly assigned participants	2
usable DXA scan	2
randomly assigned neonates	2
neonatal whole-body BMC	2
Participants and the research team	2
taken orally	2
Eligible participants	2
three study sites	2
plasma urate	2
198 598 individuals	2
prospective observational studies	2
certain SNPs	2
urate-associated single nucleotide polymorphisms (SNPs)	2
genetic instrument	2
diuretic	2
amiloride plus hydrochlorothiazide	2
either drug	2
amiloride and hydrochlorothiazide groups	2
participants in the amiloride group	2
145 patients	2
MHRA	2
hydrochlorothiazide and combination groups	2
hydrochlorothiazide and amiloride groups	2
participants and investigators	2
central computer system	2
previously untreated patients	2
direct renin inhibitors	2
angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, β blockers, calcium-channel blockers	2
permitted background drugs	2
secondary and two primary care sites	2
thiazide	2
potassium-sparing diuretic, amiloride	2
thiazide diuretics	2
International Association of Diabetes and Pregnancy Study Groups	2
UK NICE	2
diagnostic criteria	2
south Asian	2
white British	2
4088 women	2
eligible pregnancies	2
group of women	2
antenatal clinic	2
Born in Bradford study	2
south Asian and white British women	2
groups of women	2
white European women	2
South Asian women	2
mothers in the EMPOWaR study	2
either placebo (n=223) or metformin	2
liveborn babies	2
Participants, caregivers, and study personnel	2
oral metformin	2
Pregnant women	2
antenatal clinics	2
previously undiagnosed people	2
health surveys	2
previously undiagnosed participants	2
specific communities	2
survey population	2
gross domestic product	2
glucose-based and HbA1c-based prevalences	2
age–sex–survey groups	2
history of diabetes or using insulin or oral hypoglycaemic drugs	2
different biomarkers	2
obese participants	2
gestational diabetes	2
antihypertensive and lipid-lowering drugs	2
sleeve gastrectomy (317)	2
gastric bypass	2
laparoscopic gastric banding (n=1053)	2
2167 controls	2
2167 patients	2
family practices	2
UK-wide database	2
large population of obese individuals	2
obese people	2
CYP2R1 (hepatic 25-hydroxylation), DBP (also known as GC; transport), and CYP24A1 (catabolism)	2
near four genes	2
non-cases	2
type 2 diabetes cases	2
populations of European descent	2
several data sources	2
25-hydroxyvitamin D (25[OH]D)	2
Economic and Social Research Council	2
Ministry of Social Affairs and Employment (Netherlands)	2
Working Environment	2
Danish National Research Centre	2
German Social Accident Insurance	2
Working Life and Social Research	2
Swedish Research Council	2
Finnish Work Environment Fund	2
individuals in the low socioeconomic status groups	2
shift workers	2
high socioeconomic status group	2
CI 0·89–1·27	2
international open-access data archives	2
Working-Populations Consortium	2
English-language publication	2
published studies	2
socioeconomic status groups	2
individual SFAs	2
individual plasma phospholipid SFAs	2
longer-chain SFAs (20:0 [arachidic acid], 22:0 [behenic acid], 23:0 [tricosanoic acid], and 24:0 [lignoceric acid])	2
heptadecanoic acid)	2
[0·63–0·71]	2
pentadecanoic acid	2
measured odd-chain SFAs (15:0 [pentadecanoic acid] and 17:0 [heptadecanoic acid]	2
Even-chain SFAs	2
different individual SFAs	2
total plasma phospholipid fatty acids	2
laboratory staff	2
subcohort participants	2
samples from people with type 2 diabetes	2
fatty acids in plasma phospholipids (mol%)	2
234 European participants	2
154 individuals	2
representative subcohort	2
EPIC-InterAct participants	2
Closed loop	2
either the closed-loop group or the control group	2
initial treatment group	2
real-time display	2
three centres	2
-loop insulin delivery	2
Marie Curie Actions	2
NIHR Cambridge Biomedical Research Centre	2
THRA.FundingWellcome Trust	2
THRA gene	2
patient-derived blood cells	2
thyroid hormone-responsive target genes	2
Ala263Val mutant TRα2	2
normal receptor	2
TRα1 and TRα2 proteins	2
heterozygous mis-sense mutation (Ala263Val)	2
total reverse T3	2
free tri-iodothyronine [T3]	2
free thyroxine:	2
circulating thyroid hormones	2
index case	2
TRα1 and TRα2	2
first patients	2
either thyroid hormone receptor (TR)α1 or a non-hormone-binding variant protein, TRα2	2
(THRA) transcript	2
thyroid hormone receptor α gene	2
Research Council	2
reduced adiponectin	2
married parents	2
singleton births	2
nationally representative sample	2
low-income and middle-income countries	2
every region	2
2010 Study	2
attributable deaths	2
large prospective studies	2
country, age group	2
countries and regions	2
individual variants	2
final dataset	2
Findings5386 individuals	2
Research in Tayside Scotland (GoDARTS) study	2
first-line oral agent	2
152 families	2
156 family clusters	2
1319 people	2
linear regression models	2
dietitian	2
Participants in the same family	2
participants in the family	2
permuted blocks	2
men and women of Indian and Pakistani origin	2
south Asian individuals	2
people of south Asian descent	2
middle-aged patients	2
known diabetes	2
normoglycaemic participants	2
Mean HbA1c	2
cognitive tests	2
2 diabetes	2
non-diabetic patients	2
64 patients	2
non-HDL-cholesterol	2
HDL-cholesterol	2
taking placebo	2
Patients taking metformin	2
trial staff	2
European Union	2
diabetes prediction models	2
waist-circumference subgroups	2
prediction models	2
EPIC-InterAct case-cohort sample	2
populations of European ancestry	2
selected non-invasive prediction models	2
existing non-laboratory-based models	2
existing models	2
p=0·011).Interpretation111In-DTPA-exendin-4 SPECT/CT	2
assessable patients	2
111In-DTPA-exendin-4 imaging	2
Seven patients	2
separate patients	2
islet-cell hyperplasia and two uncharacterised lesions	2
additional positive lesions	2
Consenting patients	2
111In-[Lys40(Ahx-DTPA-111In)NH2]-exendin-4 (111In-DTPA-exendin-4)	2
abdomen	2
three tertiary nuclear medicine centres	2
referring centres	2
conventional imaging	2
metastatic disease	2
glucagon-like peptide-1 receptor avid radiotracer	2
benign insulinomas	2
Victorian Government	2
Australian Research Council	2
National Health and Medical Research Council	2
Baker IDI Bright Sparks Foundation	2
people in nursing homes	2
Cumulative Index to Nursing and Allied Health Literature	2
neighbouring countries	2
penicillin (by β-lactamase production), tetracycline and ciprofloxacin	2
five antibiotics	2
281 genital samples	2
gonococcal isolates	2
Lao People’s Democratic Republic	2
Neisseria gonorrhoeae isolates	2
globally distributed clones PMEN3	2
13 multidrug-resistant isolates	2
PI-2+	2
PI-2 type pili	2
Thirty-nine isolates	2
antimicrobial class	2
discussionForty-one isolates	2
β-lactam non-susceptibility	2
core genomic and accessory elements	2
pneumococcal conjugate vaccines (PCVs)	2
invasive and 15 non-invasive strains	2
several regional hospitals	2
98 pneumococcal isolates	2
-genome sequences	2
associated genetic determinants	2
pneumococcal isolates	2
pneumococcal infections	2
effective regimens	2
new classes of TB drugs	2
second-line DST	2
phenotypic DST	2
MDR-TB	2
14 isolates	2
drug-susceptible and multidrug-resistant TB (MDR-TB)	2
total of nine antibiotics	2
Known resistance genes	2
multidrug-resistant Mycobacterium tuberculosis isolates	2
whole-genome sequencing (WGS)	2
Drug-resistant tuberculosis (TB)	2
A. baumannii	2
PFGE types	2
A. baumannii antibiotic resistance	2
three or more isolates	2
cluster(s)	2
Every PFGE type, except D	2
66 isolates	2
tested β-lactams, quinolones and aminoglycosides	2
tested β-lactamase/β-lactamase inhibitors, cephalosporins, carbapenems, fluoroquinolones and trimethoprim/sulfamethoxazole	2
intensive care unit (ICU) patients	2
lower respiratory tract specimens	2
National Hospital of Tropical Diseases (NHTD)	2
clinical A. baumannii complex isolates	2
A. baumannii in Vietnam	2
hospital-acquired infections (HAIs)	2
Acinetobacter calcoaceticus–baumannii complex	2
endoderm lineage	2
functional cell types	2
efficient small molecule	2
large quantities of cells	2
HCM patients	2
cardiac microtissue assays	2
β-myosin heavy chain and myosin-binding protein C3 mutations	2
four isogenic induced pluripotent stem cell (iPSC) models	2
subset of these NCEs	2
ex vivo and in vivo models	2
internal NCEs	2
weighted scoring matrix	2
different classes of cardio-active drugs	2
hazard score system	2
calcium transient screening assay in hiPSC-CMs	2
new chemical entities (NCEs)	2
promising cardiac safety platform	2
induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)	2
RNA-seq of axons	2
Nrp1, Dbn1, and Nek1, a known ALS-causing gene	2
121 ALS-dysregulated transcripts	2
SOD1G93Amutation	2
motor axons	2
e.g., Ybx1	2
transcription factor mRNAs	2
mouse and human stem cell-derived spinal motor axons	2
3,500–5,000 transcripts	2
fewer genes	2
axonal transcriptome	2
microfluidics, RNA sequencing (RNA-seq)	2
axon-specific processes	2
SummarySpinal motor axons	2
thrombopoietin or erythropoietin	2
megakaryocytes or erythroblasts	2
committed progenitors	2
programmed cells	2
erythroblast or megakaryocyte	2
“rainbow” lentiviral vectors	2
megakaryocyte or erythroblasts	2
population of progenitors	2
GATA1, FLI1, and TAL1	2
human pluripotent stem cells (hPSCs) in vitro	2
host neural circuitry	2
GSI-treated hiPSC-NS/PC transplantation	2
human induced pluripotent stem cell-derived neural stem/progenitor cell (hiPSC-NS/PC) transplantation	2
gamma-secretase inhibitor (GSI)	2
intraspinal environment	2
chronic spinal cord injury (SCI)	2
chronically injured spinal cord	2
anterior horn cells	2
engrafted oNPCs	2
spared axons	2
lesion epicenter	2
immunodeficient rat model	2
crosslinked methylcellulose biomaterial	2
oligodendrogenic fate (oNPCs)	2
directly reprogrammed human NPCs	2
NPCs and delivery system	2
cellular signaling	2
photoperiod	2
Drosophila intestinal cells	2
intestinal stem cells and enterocytes	2
circadian clocks	2
molecular pacemaker	2
model of human atrium	2
human atrial and ventricular muscle preparations	2
atrial-selective potassium currents	2
RA-EHTs	2
atrial-selective markers	2
standard protocol-derived hiPSC-CMs (Ctrl-EHT) and intact human muscle strips	2
3D model of human atrium	2
right atrial engineered heart tissue (RA-EHT)	2
atrial CMs	2
atrial fibrillation	2
atrial biology	2
SummaryCardiomyocytes (CMs)	2
hit compounds	2
mTOR signaling modulator	2
one of the hit compounds	2
FOP-iPSCs	2
HO model mice	2
FOP-ACVR1 transgenic mice	2
multiple model mice	2
FOP patient-derived induced pluripotent stem cells (FOP-iPSCs)	2
two hit compounds	2
5,000 small-molecule compounds	2
chondrogenic ATDC5 cell line	2
high-throughput screening (HTS) system	2
bone morphogenetic proteins	2
type I receptor	2
(FOP-ACVR1)	2
FOP patients	2
isogenic hiPSC-CMs	2
E99K mutant protein	2
E99K-expressing hiPSC-CMs	2
heterozygote father	2
E99K-ACTC1	2
2D monolayers	2
3D engineered heart tissues	2
isogenic pairs of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)	2
heart muscle	2
friends and colleagues	2
award	2
numerous students, postdocs, technicians and valuable collaborators, clinicians, regulators, and, lately, industrial partners	2
squamous epithelia	2
equally fascinating stem cells	2
human hematopoietic and epithelial stem cells	2
triggering stimulus	2
reactive astrocytes	2
IL-1β, TNF-α, and IL-6,	2
resting astrocytes	2
astrocyte culture	2
serum-free media	2
13 hiPSC lines	2
highly enriched population of resting mature astrocytes	2
Gene expression and functional assays	2
CNS cells	2
differentiating hESCs	2
hemogenic endothelium populations	2
earliest specified hemogenic endothelium	2
primitive and definitive subsets	2
three populations of hematopoietic progenitors	2
endothelium populations	2
transient specialized endothelial precursor	2
PD patients	2
T-type calcium channel knockdown or antagonists	2
one voltage-gated calcium channel antagonist, benidipine	2
FDA-approved drug library	2
PARK2 patient-specific, isogenic PARK2 null and PARK6 patient-specific induced pluripotent stem cells	2
versatile research model	2
sporadic cases	2
dopaminergic (DA) neurons	2
human organs in animals	2
animal embryos	2
Stem Cell Reports	2
FGF8 in vitro	2
COUP-TFI translation	2
mouse embryonic stem cell corticogenesis	2
COUP-TFI/Nr2f1 anterior expression	2
morphogen FGF8	2
human PMD oligocortical spheroids	2
jimpy, in vitro and in vivo	2
compound, Ro 25–6981	2
severe mouse model	2
pure, scalable quantities of induced pluripotent stem cell-derived oligodendrocyte progenitor cells (OPCs)	2
oligodendrocyte survival	2
myelinating oligodendrocytes	2
C57BL/6N, mice	2
(Nnt)—that	2
Nicotinamide Nucleotide Transhydrogenase	2
substrains	2
C57BL/6J and C57BL/6N inbred mice	2
non-canonical BMP signaling	2
Drosophila BMP homolog, Dpp	2
BMP signals	2
Somatic Tkv	2
Drosophila developing ovarian soma	2
Thickveins (Tkv), a type I bone morphogenetic protein (BMP) receptor	2
developing organisms	2
series of iPSCs	2
tau oligomerization	2
/SHH signaling	2
MAPT IVS10+16 neurons	2
healthy donor induced pluripotent stem cells (iPSCs)	2
translational in vitro disease models	2
frontotemporal dementia (FTD)	2
nearly homogeneous and fully functional MSCs	2
MSX2 ectopic expression	2
cocktail of soluble molecules	2
muscle segment homeobox 2 (MSX2)	2
mesenchymal cell lineages	2
mesenchyme and endothelium	2
TGFB1 expression	2
hiPSC-LB	2
Stromal cell-specific RNA interferences	2
hiPSC-LBs	2
human liver mesenchyme	2
TGFBs and cholangiocyte marker expression	2
O2-non-permeable plate	2
extensive hypoxia	2
O2-permeable plate	2
human induced pluripotent stem cell-derived liver bud (hiPSC-LB) model	2
developing liver	2
Sox9 RNA	2
mammalian skeletogenesis	2
Sox9 transgene	2
4E-BP1/2	2
4E-BPs	2
5′ terminal oligopyrimidine tract motif	2
mesenchymal condensations	2
component of mTORC1	2
mTORC1/4E-BPs/SOX9 axis	2
mechanistic/mammalian target of rapamycin complex 1 (mTORC1)	2
patients with GRIN2B mutations	2
non-synaptic NMDA receptors	2
NMDA receptors	2
electrophysiology and calcium imaging	2
glutamate binding domain	2
clonal models	2
subunit of the NMDA receptor	2
specific phosphorylated forms of tau	2
neuronal gene expression	2
pyroglutamate (E3)-containing amyloid aggregates	2
euploid human pluripotent stem cells	2
trisomic Down syndrome induced pluripotent stem cells	2
supernumerary copy of the APP gene	2
isogenic human model	2
amyloid precursor protein (APP) gene	2
two distinct endothelial lineages	2
GATA2-independent pathways	2
DLL4+ arterial and DLL4– non-arterial lineages	2
VE-cadherin+CD43−CD73+ non-HE or VE-cadherin+CD43−CD73–	2
conditional GATA2 expression (iG2−/− hESCs)	2
GATA2 knockout human embryonic stem cell (hESC) lines	2
unique system	2
endothelial-to-hematopoietic transition (EHT)	2
GATA2 controls	2
transcriptional factor GATA2	2
liver transcriptional factors, e.g., HNF4	2
in vitro cultured primary hepatocytes	2
several potential genetic regulators	2
reporter readout	2
high-throughput hPSC screening platform	2
differentiated HLCs	2
promising cell resource	2
SummaryHepatocyte-like cells (HLCs)	2
normal luminal cells	2
defined populations of normal mouse mammary cells	2
patients' samples	2
basal-like tumors	2
subset of normal luminal cells	2
normal adult human mammary gland	2
Human breast cancers	2
GATA6-negative cells	2
similar colonies	2
spontaneously differentiated endoderm cells	2
GATA6-positive cells	2
GATA6-positive and GATA6-negative cells	2
clonal stem cell colonies	2
endoderm transcription factor, GATA6	2
putative undifferentiated cells	2
GFP reporter line	2
stem cell compartment	2
discrete substates	2
late corticogenesis	2
neocortical and hippocampal development	2
neuroepithelial cell-like NSCs	2
proliferation-associated genes	2
neuronal differentiation-related genes	2
BAF (mSWI/SNF) complexes	2
patient-derived, gene-corrected cells	2
human myofibers	2
murine muscle	2
myogenic progenitors	2
human-specific nuclear and sarcolemmar antigens	2
AAVS1 locus	2
acid α-glucosidase cDNA	2
striated and contractile myofibers	2
Pompe disease iPSCs	2
fluorescence-activated cell sorting-purified myogenic progenitors	2
IR-induced p16INK4a expression	2
p16INK4a-expressing cells	2
superoxide dismutase mimetic	2
Ink4a/arf-null mice	2
bromodeoxyuridine incorporation	2
doublecortin expression	2
hippocampus and subventricular zone regions	2
irradiated brain	2
 the tumor suppressor gene p16INK4a	2
highly cardiogenic hPSC lines	2
cyclin D1	2
GSK3β inhibitors	2
multiple human pluripotent stem cell (hPSC) lines	2
primary ECs and hiPSC-ECs	2
hiPSC-derived and primary ECs	2
in vitro and in vivo assays	2
endothelia-leukocyte interaction	2
various functional assays	2
primary ECs	2
hiPSC lines	2
multiple (non-integrating)	2
hiPSC-derived ECs (hiPSC-ECs)	2
HDAC2	2
HDAC1 and HDAC2	2
epigenetic silencers	2
first blood cells in vitro and in vivo	2
epigenetic regulators HDAC1 and HDAC2	2
(HE)	2
first hematopoietic stem and progenitor cells	2
MSI2 and HSPC-specific transcriptional circuitry	2
promoter of MSI2	2
CD34+ cells in vitro	2
PLAG1 in primitive cord blood cells	2
endogenous MSI2	2
promoter binding	2
blood system	2
plasma membrane TREM2	2
immature form	2
mutant TREM2	2
myeloid cells 2 (TREM2)	2
microglial-expressed protein triggering receptor	2
stem cell-derived microglia	2
primary microglia	2
human microglia	2
marker-enriched populations	2
single ALDH+ cells	2
ID1, SOX2,	2
stemness and epithelial-to-mesenchymal transition-associated genes	2
co-expressing ALDH+	2
ALDH+ and ALDH−CD44+CD24− human mammary cells	2
non-cancerous mammary glands	2
mesenchymal and epithelial populations	2
CD44+CD24low/− or aldehyde dehydrogenase (ALDH) expression	2
Breast cancers	2
TET proteins	2
polyploid trophoblast giant cells	2
Tet1/2 mutant TSCs	2
mutant TSCs	2
critical epithelial genes	2
abundantly expressed TET1	2
trophoblast stem cells (TSCs)	2
ten-eleven translocation (TET) proteins	2
RGC subtypes	2
defined subtypes	2
numerous RGC subtypes	2
class of cell	2
nearly all RGCs	2
postsynaptic targets	2
projection neurons of the retina	2
SummaryRetinal ganglion cells (RGCs)	2
dish	2
patient-specific organoids	2
observed ciliopathy	2
three-dimensional retinal organoids	2
patient iPSCs, RPE cells	2
shorted cilium	2
well-structured retinal organoids	2
retinal pigment epithelium (RPE) cells	2
three RP patients	2
iPSC applications	2
soluble factors, and HCA	2
key niche protein	2
additional induced pluripotent stem cell (iPSC) lines, primary tissue	2
top hit	2
i-	2
HLI	2
human donors	2
freshly isolated hepatocytes	2
induced pluripotent stem cells (i-Heps)	2
“stemness” gene-expression programs	2
chromatin remodeler BPTF and NURF	2
key HSC “stemness” genes	2
several master transcription factors (Meis1, Pbx1, Mn1, and Lmo2)	2
HSC-specific gene-expression programs	2
hematopoietic-specific knockout of Bptf	2
Bptf-deficient HSCs	2
long-term hematopoietic stem cells (HSCs)	2
component of the nucleosome remodeling factor (NURF) chromatin-remodeling complex	2
bromodomain PHD finger transcription factor (BPTF)	2
hiPSC-CMs/EHT	2
commercial line	2
EHT-CMs	2
ML- and EHT-CMs	2
intact tissues	2
human right atrial (RA) and left ventricular (LV) tissue	2
monolayer (ML) or 3D engineered heart tissue (EHT)	2
hiPSC-CMs (proprietary and commercial cell line)	2
induced pluripotent stem cell (hiPSC) cardiomyocytes (CMs)	2
in vitro culture	2
functioning nephrons	2
hPSC-derived kidney precursors	2
glomerular filtrate	2
fluorescent low-molecular-weight dextran	2
mesangial cells	2
podocytes with regions of mature basement membrane	2
human capillaries	2
perfused glomeruli	2
organ-like masses	2
Kidney progenitors	2
Lentiviral-transduced hPSCs expressing reporter genes	2
nephron and collecting duct lineage marker genes	2
kidney precursors	2
three genetically distinct wild-type hPSC lines	2
reserve cell assay	2
subpopulation of myoblasts	2
myoblast quiescence	2
satellite cell niche	2
satellite cell-derived myoblasts	2
niche-generated signals	2
specialized niche	2
adult muscle stem cells	2
rodent myocardial infarction model	2
cells and media	2
cultured NHP and human iPSC-CMs	2
ischemic environment	2
iPSC-CM-treated groups	2
PBS control	2
number of respective fibroblasts	2
NHP or human iPSC-CMs	2
RNU rats	2
induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)	2
human-like model	2
SummaryNon-human primates (NHPs)	2
certain models	2
Nrl−/−;RPE65R91W/R91W, murine models	2
Nrl−/−and Prph2rd2/rd2	2
substantial numbers of cones	2
non-degenerative hosts	2
rescued cells	2
stem cell- and donor-derived cones	2
host photoreceptors	2
donor rod photoreceptors	2
host retina	2
healthy photoreceptors	2
self-renewing human pluripotent cells	2
maternal ICRs	2
primed to naive pluripotency	2
disease-causing miR-184C57U mutant	2
cytokeratin 15 (K15)	2
human epidermal cells	2
miR-184 knockout mouse model	2
miR-184 gene	2
highly evolutionary conserved microRNA (miRNA)	2
wide range of patients	2
abundant “universal” NK cells	2
less (less KIRs)	2
blood cell	2
recipients' human leukocyte antigen genotypes	2
high-purity functional and expandable NK cells	2
good manufacturing practice-compatible iPSC source, PBC-derived iPSCs (PBC-iPSCs)	2
peripheral blood cells (PBCs)	2
highly accessible human cell source	2
many recipients	2
unlimited “off-the-shelf” NK cells	2
limited patients	2
limited “made-to-order” therapeutic natural killer (NK) cells	2
human stem cell-derived cones	2
fetal retina and stem cell-derived retinal organoids	2
cluster of differentiation marker combination	2
cone-enriched gene signature	2
AAV2/9.pR2.1:GFP reporter	2
human L/M-opsin cone photoreceptor transcriptome	2
human cone population	2
stem cell-derived L/M-opsin cones	2
Dlk1-Dio3 locus (miR-541-5p, miR-410-3p, and miR-381-3p)	2
ground-state miRNAs	2
Dlk1-Dio3 locus	2
imprinted region on chromosome 12	2
“ground-state miRNAs”	2
distinct set of miRNAs	2
ground-state ESCs	2
ESC-associated microRNAs (miRNAs)	2
endogenous differentiation pathways	2
-state pluripotency	2
conventional hiPSCs	2
naive-state hiPSCs	2
core transcriptional network of mESCs	2
naive-like human induced pluripotent stem cells (hiPSCs)	2
nuclear receptor ESRRB	2
differentiation-specific genes	2
activated AHR/NuRD complex	2
chromatin remodeling complex NuRD (nucleosome remodeling and deacetylation)	2
AHR interactome	2
widely expressed nuclear receptor	2
aryl hydrocarbon receptor (AHR)	2
chemical pollutants	2
differentiation genes	2
well-defined transcription factors	2
unfavorably differentiated hPSCs)	2
chemically transitional embryoid-body-like state (CTraS)	2
SB431542, dorsomorphine, and CHIR99021—that	2
three small molecules	2
purified terminally differentiated cells	2
islet-lineage commitment	2
pancreatic progenitor cells	2
BiPSC-derived definitive endoderm	2
monogenic diabetes (PDX1, NKX2-2, HNF1A	2
FOXA2 binding sites	2
bivalent and weak enhancers	2
(Bi-DOCS)	2
two iPSC subtypes	2
∼8.3k significant, differential open chromatin sites (DOCS)	2
BiPSCs and FiPSCs	2
genome-wide open chromatin	2
fibroblasts (FiPSCs)	2
endocrine pancreas-like cells	2
pancreatic beta cells (BiPSCs)	2
transcriptional codes	2
EP300, HNF4A, and FOXA family members	2
unexplored transcription factors	2
almost all genes	2
Notch, Wnt, BMP, and FGF signaling	2
dorsal pancreatic bud	2
Pancreas-enriched gene expression	2
earliest stages of human organogenesis	2
MET	2
strong activator	2
oocyte-specific factor Obox1	2
cell-cycle-related gene expression	2
THY1-negative cells and Oct4-GFP-positive cells	2
THY1-positive cells	2
oocyte-specific factor	2
oocyte-specific homeobox 1 (Obox1)	2
totipotent embryos	2
terminally differentiated germ cells or somatic cells	2
fascinating unknown factors	2
genetically modified rats	2
germline-competent rat ESCs	2
oligodendrocyte lineage cells	2
dsRed in neonatal brain slices	2
germline chimeras	2
Sox10 locus	2
non-disruptive knockin of dsRed	2
Mutant cells	2
valuable biomedical model species	2
iPSC-CM-encapsulating bioactive hydrogel therapy	2
grafted cells	2
regions of muscle	2
gel-EPO, cell, and gel-cell-EPO groups	2
PEG injections	2
almost any combination of the therapeutics	2
infarcted hearts	2
saline alone	2
/out iPSC-CMs	2
combined polyethylene glycol hydrogel (PEG), human induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM), and erythropoietin (EPO) therapy	2
synthetic matrices	2
neurogenic clones	2
bifunctionalized gels	2
adult neural stem cell culture	2
embryonic cortical neurons	2
bifunctional gels	2
embryonic and adult neural progenitors	2
19-mer peptide containing the laminin motif IKVAV (IKVAV) on embryonic and adult neuronal progenitor cells	2
polylysine (PL)	2
bifunctionalized hydrogels	2
A-iPSC	2
Excess GPX2	2
glutathione peroxidase 2 (Gpx2)	2
ARE-containing RNAs	2
aged tissue donors (A-iPSC)	2
induced pluripotent stem cell clones	2
multiple RNA exosome complex subunits	2
transcription factor, ZSCAN10	2
AU-rich element (ARE)-containing mRNAs	2
several keratins	2
denser basal layer	2
organotypic cultures	2
generated keratinocytes	2
generated skin epithelial precursors	2
silencing	2
important inhibitor	2
candidate kinases	2
early epithelial cells	2
pure skin epithelial cell population	2
human skin epithelial cells	2
neutrophils and endothelial cells	2
types of murine phagocytic cells	2
human CD34+ cell-grafted mice	2
clodronate-liposomes	2
phagocytic macrophages	2
cobra venom factor (CVF)	2
professional phagocytic macrophages and neutrophils and non-professional phagocytic endothelial cells	2
mouse serum	2
macrophages in immunodeficient mice	2
human red blood cells (hRBCs)	2
phenomenon	2
fully defined culture system	2
in vitro counterparts	2
time course transcriptional resource	2
ESC self-renewal program	2
epithelial-to-mesenchymal transition blockage	2
preimplantation epiblast cell-related genes	2
MEK and TGF-β pathways	2
inner cell mass (ICM) of the blastocyst	2
SummaryPluripotent cells	2
human dystrophic MuSCs	2
young dystrophic mice	2
uninjured wild-type mice	2
young and aged MuSCs	2
either mice or humans	2
stem cells (MuSCs)	2
accessible and tractable in vitro modeling system	2
fluorescence cell-cycle reporter	2
signaling cues	2
mature brush border cells	2
simple uniform structure	2
cystic spheroids	2
hPSC-derived gastrointestinal epithelial precursors	2
enterospheres (hEnS)	2
human gastrointestinal tissues	2
in vitro research models	2
SummaryIntestinal organoids	2
adult mouse retina	2
Purified human long/medium cones	2
pure population of stage-matched cones	2
differentiation system	2
presynaptic structures	2
nascent outer segments	2
connecting cilia	2
cones and rods bearing inner segments	2
well-formed ONL-like structures	2
hPSC-derived neural retinal vesicles	2
transplantable human cones	2
macular retinopathies	2
daylight, color, and high-acuity vision	2
neonatal retinae	2
rod photoreceptors	2
NM IIs	2
NM II inhibitors	2
PDX1+NKX6.1+ cells	2
aggregation culture	2
phosphorylated myosin light chain 2 and NM IIA	2
Rho-associated kinase (ROCK) or non-muscle myosin II (NM II) inhibitors	2
PDX1+ posterior foregut cells	2
pancreatic committed progenitor cells	2
PDX1+NKX6.1+ pancreatic endoderm cells	2
ischemic tissue	2
generation aECs	2
Etv2 in ESCs	2
ischemic myocardium	2
aECs in mice	2
mouse hindlimb ischemia model	2
EC progenitors	2
transcription factor Etv2	2
revascularizing ischemic tissue	2
functional arterial endothelial cells (aECs)	2
Pou3f1-miR-29b-Dnmt3a regulatory axis	2
critical neural transcription factor	2
miR-29b targets DNA methyltransferase 3a (Dnmt3a)	2
embryonic stem cell (ESC) neural differentiation systems	2
neural tube epithelial (NTE) cells and neural crest cells (NCCs)	2
neuroectodermal cells	2
neural tube and neural crest	2
neuroectoderm cells	2
SCA-1+ cells	2
ApoE-deficient mice	2
Adventitial progenitors	2
wild-type and atherosclerotic-prone (ApoE-deficient) mice	2
primary adventitial mouse	2
vein grafts	2
SCA-1+ progenitor cells	2
SCA-1+ and mesenchymal stem cells	2
mouse models and human cells	2
severe dystrophic mouse model	2
BMI1 overexpression	2
human myoblasts	2
adult skeletal muscle satellite cells	2
Polycomb group gene BMI1	2
haplotype-specific MAPT expression	2
mature iPSC-derived dopaminergic neuronal cultures	2
adult tau protein variants	2
exon 3+ transcripts	2
MAPT transcripts	2
Mature dopaminergic neuronal cultures	2
exon 3+ and exon 10+ transcripts	2
six adult tau protein isoforms	2
mature dopaminergic neuronal cultures	2
H1 haplotype of the microtubule-associated protein tau (MAPT) locus	2
Downregulating STRA6	2
STRA6 expression	2
xenograft mouse model	2
JAK2-STAT3 signaling cascade	2
vitamin A-bound serum retinol binding protein 4 (RBP4)	2
vitamin A transporter	2
transmembrane protein, STRA6	2
different somatic lineages	2
defined culture	2
multiple fates	2
NF-E2-silenced HSPCs	2
in vitro studies	2
Notch1 protein expression	2
immunodeficient (NSG) mice	2
normal human hematopoiesis	2
myeloproliferative neoplasms	2
SummaryNuclear factor erythroid-derived 2 (NF-E2)	2
HNF4A expression	2
FOXA2 and TETs	2
P1 locus	2
liver pioneer factor FOXA2	2
ten-eleven translocation (TET) dioxygenases	2
promoter 1 (P1)-dependent isoforms of HNF4A	2
different mammals	2
naive pluripotent stem cells	2
two types of pluripotent stem cell, naive ESCs and primed post-implantation epiblast stem cells (EpiSCs)	2
signaling environment	2
recalcitrant mouse strains	2
germline-competent ESCs	2
corresponding monocultures	2
homeostatic function pathways	2
pathogen-response pathways	2
co-culture microglia	2
multiple microglia-relevant cytokines	2
ameboid	2
key microglia-specific markers and neurodegenerative disease-relevant genes	2
Co-culture microglia	2
Co-cultures	2
iPSC-derived cortical neurons	2
embryonic MYB-independent iPSC-derived macrophages	2
microglial ontogeny	2
MYB-independent macrophages	2
authentic, efficient in vitro models	2
extrinsic cues	2
LIF/STAT3 signaling	2
Sox1, Gata4, or Blimp1	2
master lineage regulators	2
chimeric transcripts	2
distinct classes of transposable elements (TEs)	2
embryonic lineages	2
MMC defect sites	2
AF-T21-iPSCs and AF-TTTS-iPSCs and dermis of human fibroblasts and collagen type I.	2
three-dimensional skin	2
patient with Down syndrome (AF-T21-iPSCs) and twin-twin transfusion syndrome (AF-TTTS-iPSCs)	2
surgical repairs	2
self-renewing hESCs	2
regulator of RHO family small GTPases	2
robust, renewable cell source	2
subretinal space of Aipl1−/−mice, a model	2
adult mouse eyes	2
MESC-derived cones	2
cone-specific phototransduction-related proteins	2
early thyroid hormone receptor β2-positive precursors	2
in vivo development	2
mesenchymal or epithelial renal lineages	2
full repertoire of developing kidney cells	2
nephron stem cell cultures	2
early human nephrogenesis	2
discrete stages	2
differentiating and differentiated epithelial lineages	2
uninduced and induced cap mesenchyme	2
EpCAM expression	2
NCAM+/CD133− progenitor cells	2
mouse nephron progenitors	2
modified medium	2
culturing hFK	2
culture nephron progenitors	2
human fetal kidney (hFK)	2
isolated progenitors	2
proximal and distal nephron cell types	2
early nephron structures	2
direct targets of POLR3G	2
POLR3G-regulated transcripts	2
POLR3G polyA+ transcriptome	2
 long intervening non-coding RNAs, microRNAs and small nucleolar RNAs	2
multiple transcript types	2
specific subset of the hPSC transcriptome	2
 POLR3G	2
POLR3G-dependent manner	2
polyA+ and smallRNA transcriptomes	2
POLR3G	2
media containing BMP9	2
endoglin expression	2
endoglin-depleted CDCs	2
endoglin dependent	2
CDC secretome	2
endothelial cells endoglin	2
bone morphogenetic protein 9 (BMP9)	2
specific transforming growth factor β (TGFβ) family ligands	2
Cardiosphere-derived-cells (CDCs)	2
paracrine mechanisms	2
Small benefits	2
apical part of the cluster	2
actively proliferating cells	2
slowly cycling cells	2
intra-aortic hematopoietic clusters	2
fetal liver HSCs	2
Fucci reporter mice	2
AGM region	2
nascent HSCs	2
aorta-gonad-mesonephros (AGM) region	2
critical interface	2
single phosphorylation site	2
N-terminal domain of NANOG	2
NANOG S65A	2
pluripotency regulators (ESRRB, OCT4, SALL4, DAX1, and TET1)	2
alanine (S65A)	2
core pluripotency transcription factor NANOG	2
key cell therapy resource	2
donor-specific FOXP3+ Tregs	2
donor-antigen peptides	2
donor-type iPS-DCregs	2
B6 cardiac grafts	2
immunized CBA recipients	2
CBA splenocytes	2
Tregs (CD4+CD25+FOXP3+)	2
naive CBA (H-2Kk) mice with B6 (H-2Kb) iPS-DCregs	2
negative vaccine	2
murine induced pluripotent stem cells (iPSCs)	2
(DCregs)-based immunotherapy	2
dendritic cell	2
Reporting guidelines	2
stem cell therapies	2
industry trials	2
industry-sponsored trials	2
known stem cell tourism clinics	2
48 trials	2
reported trials	2
derived cell lines	2
risk and non-risk alleles	2
representative individuals	2
iPSCORE collection	2
family of individuals	2
high-throughput RNA-sequencing and genotyping arrays	2
somatic copy-number variants	2
ethnically diverse individuals	2
systematically derived and characterized iPSC lines	2
iPSCORE resource	2
powerful model systems	2
-scale collections of induced pluripotent stem cells (iPSCs)	2
patient-specific iPSC lines and controls	2
small panels of iPSC-derived cell lines	2
living patients	2
MNs and non-MNs	2
sALS iPSC-derived astrocytes	2
aggregated ubiquitin	2
disorganized neurofilaments	2
surviving MNs	2
host spinal cord	2
contacted neurons	2
endogenous astrocytes	2
large areas	2
differentiated human astrocytes	2
cervical spinal cord of adult SCID mice	2
sALS and healthy induced pluripotent stem cells (iPSCs)	2
spinal neural progenitors	2
sporadic ALS (sALS) patients	2
familial amyotrophic lateral sclerosis (ALS) patients	2
activated p38 and ERK	2
mutant FUS MNs	2
non-MNs	2
AP1 complex member JUN, an ERK/JNK downstream target	2
mutant SOD1 MNs	2
activated ERK and JNK signaling	2
human MNs	2
common pathways	2
human oligodendrocytes	2
neurons and functional skeletal myocytes	2
human cell types	2
many human cell types	2
human stem cell models	2
core γ-secretase	2
longer, potentially more toxic peptides	2
short Aβ peptides	2
avermectins	2
complex genetic model	2
trisomy 21/Down syndrome neurons	2
APP-derived amyloid β (Aβ) peptides	2
stem cell models	2
important countermeasure	2
injured spinal cord of NOD/SCID mice	2
iPSC-NS/PCs	2
iPSCs and iPSC-derived neural stem/progenitor cells (iPSC-NS/PCs)	2
two iPSC lines	2
iPSC-derived somatic cells	2
inducible caspase-9 (iCaspase9) gene	2
neurotrophic factor HGF	2
neural stem cell (NSC) transplantation	2
GCase chaperones	2
intact host genome	2
neural crest stem cell-derived dopaminergic neuronal model	2
idiopathic PD brain	2
In vitro and in vivo	2
glucocerebrosidase GBA1 gene	2
mature myelinating oligodendrocytes	2
“fast-response element	2
aged CC	2
SEZ	2
neuroblasts of the neurogenic output	2
“oligodendroblasts	2
bona fide OPCs	2
SEZ-derived oligodendroglial progenitors	2
young-adult and aging brain	2
homeostatic and regenerating CC	2
CreErt2 mice	2
hGFAP:	2
committed perinatally	2
subependymal zone (SEZ) cytogenic niche	2
Local, parenchymal oligodendrocyte progenitor cells (pOPCs) and progenitors	2
corpus callosum (CC) of the adult mouse	2
populations of oligodendrogenic progenitors	2
alveolar and kidney macrophages, microglia, Kupffer cells, and Langerhans cells	2
MYB-independent tissue-resident macrophages	2
human iPSC-derived macrophages	2
MYB-independent, RUNX1-, and SPI1 (PU.1)-dependent fashion	2
human iPSC-derived monocytes/macrophages	2
human induced pluripotent stem cells (iPSCs)	2
Myb-dependent HSCs	2
infiltrating, gut, and dermal macrophages	2
adult blood monocytes	2
circulating monocytes and HSCs	2
Myb-independent YS-derived resident macrophages self-renew locally	2
(YS) progenitors	2
Myb-independent yolk sac	2
microglia, Kupffer cells, and Langerhans cells	2
SummaryTissue-resident macrophages	2
effective and specific target	2
SOX2 expression	2
small-molecule RAD51 inhibitors RI-1 and B02	2
DSB repair protein RAD51	2
patient-derived glioblastoma stem cells (GSCs)	2
stem-like cells	2
chemoattractant fibroblast growth factor 2	2
NES cells	2
Nsun2−/− brains	2
5′ tRNA fragments	2
upper-layer neurons	2
intermediate progenitors	2
developing Nsun2−/− mouse cerebral cortex	2
human neuroepithelial stem (NES) cells	2
early neuroepithelial progenitors of the developing human brain	2
cytosine-5 RNA methylase NSUN2	2
multilineage hematopoiesis	2
USP10-competent bone marrow cells	2
lineage-committed progenitor cells	2
USP10-KO fetal liver	2
bone marrow and fetal liver	2
long-term HSCs (LT-HSCs)	2
USP10 knockout (KO) mice	2
mouse hematopoiesis	2
ubiquitin-specific peptidase 10 (USP10)	2
niche cells in fetal liver and bone marrow	2
naive pluripotency genes	2
Kruppel-like factor 2 and ten-eleven translocation (TET) proteins	2
leukemia inhibitory factor in adherent culture	2
ESC-like cells	2
PR domain-containing 14 (PRDM14)	2
 ESCs	2
functional ECs	2
inactive unligated state	2
PAR1-deficient mESCs	2
active complex	2
mouse embryonic stem cell (mESC)	2
G-protein-coupled receptor PAR1	2
hPSC cultures	2
undifferentiated and differentiating cultures	2
Five compounds	2
undifferentiated and differentiating NPCs	2
24 compounds	2
human neural progenitor cell line	2
3D cell culture chip	2
several epithelial genes	2
mesendodermal lineages	2
signaling regulators	2
Wnts, STAT3, and p38 pathways (3i)	2
AD and EB cells	2
AD-FP	2
GABA and cholinergic neurons	2
EB-MGE	2
AD cells	2
medial ganglionic eminence (MGE)	2
sonic hedgehog-induced ventral neuroprogenitors	2
SummaryEmbryoid body (EB) formation and adherent culture (AD) paradigms	2
hepatocyte growth factor (HGF)	2
in vivo mouse model	2
corneal transparency	2
corneal opacity	2
Ocular trauma	2
pretreating hiPSC-NS/PCs	2
γ-secretase inhibitor (GSI)	2
NS/PCs	2
hiPSC-NS/PC transplantation	2
mature cell types	2
Remnant immature cells	2
certain hiPSC-NS/PCs	2
promising cell source	2
stem/progenitor cells (NS/PCs)	2
individual Wnt signal and Wnt receptor genes	2
vertebrate cardiomyogenesis	2
FZD4 and FZD6	2
MESP1 expression	2
ROR2 and noncanonical signaling	2
FZD7 and canonical signaling	2
endogenous Wnt signaling components	2
in vivo Lewis lung carcinoma mouse model	2
embryoid bodies and human umbilical vein endothelial cells	2
angiogenic modulators	2
robust embryonic stem cell-based vascular differentiation assay	2
alternative targets	2
vascular endothelial growth factor pathway	2
adult neoangiogenesis	2
endothelial network	2
SummaryBlood vessels	2
homogeneous populations of iPSC-derived hepatocyte-like cells	2
cell-surface N-linked glycoproteins	2
extensive catalog	2
pluripotent stem cell network	2
liver gene regulatory network	2
hepatocyte-like cells expressing SLC10A1, CLRN3, or AADAC	2
homogeneous cell populations	2
different liver disease patients	2
iPSC-derived hepatocyte-like cells	2
differentiated derivatives	2
robust and straightforward tagging system	2
GAPTrap vectors	2
derivatives of the three germ layers	2
spectrum of cell types	2
GT-lacZ hPSCs	2
definitive endoderm, and ventral midbrain dopaminergic neurons	2
cardiac mesoderm	2
reporter expression	2
GT vectors	2
Independent clones	2
GAPDH locus	2
GFP, mCherry, mTagBFP2, luc2, Gluc, and lacZ	2
GAPTrap (GT)	2
simple expression system	2
integrin signaling cascade	2
hESC regulatory networks	2
FAK downstream targets, AKT and MDM2	2
FAK kinase activity	2
substrate adhesion	2
extracellular matrix substrates	2
fully defined niche	2
proliferating progenitor cells	2
differential G9a-ZNF644 associations	2
ZNF644 orthologs	2
G9a/GLP-interacting protein	2
uncharacterized C2H2-like zinc finger protein ZNF644	2
histone methyltransferase (HMT) complexes	2
post-mitotic progeny	2
specific stem cell niches	2
3D systems	2
adult and embryonic stem cells	2
basal surface	2
WNT3A proteins	2
defined and directed source of WNT proteins	2
patients with hypopituitarism	2
murine model of hypopituitarism	2
hPSC-derived pituitary cells	2
defined signals	2
purified placode cells	2
human pituitary lineages	2
unknown cellular signals	2
3D organoid cultures	2
mouse and human ESCs	2
pituitary lineages	2
Hormone-producing cells	2
unlimited cell source	2
broadly applicable bioengineering solution	2
untreated or TPCA-1-preconditioned hMSCs	2
human cardiac fibroblasts	2
TPCA-1-loaded hMSCs	2
Conditioned medium (CM)	2
TPCA-1, a small-molecule NF-κB inhibitor	2
pro-inflammatory pathways	2
potent immunomodulatory and anti-inflammatory secretome	2
stromal cells (MSCs)	2
episomal vectors	2
generated iPSCs	2
OS + M + K + B)	2
combination of EV plasmids	2
two individual vectors	2
2A linker	2
OCT4 (O) and SOX2 (S)	2
two most critical factors	2
vector combination	2
extra factor BCL-XL (B)	2
spleen focus-forming virus U3 promoter	2
improved episomal vector (EV) system	2
adult peripheral blood (PB)	2
integration-free induced pluripotent stem cells	2
Notch signaling cascade	2
polyploid giant-cell, cancer stem cell-like, phenotype	2
HIF1α protein	2
xenografted tumors	2
CSL in breast tumor cells	2
DNA-binding protein CSL	2
iPSC-derived motor neurons	2
FALS MPCs	2
CLIP-seq datasets	2
motor neuron precursor cells (MPCs)	2
cytosolic and stress granules	2
cell-derived motor neurons	2
isogenic iPSCs	2
fused-in sarcoma (FUS) gene	2
two familial ALS (FALS) patients	2
induced pluripotent stem cells (iPSC)	2
shorter telomeres	2
pluripotency marker Rex1	2
canonical mouse embryonic stem cells	2
Human counterparts	2
human naive embryonic stem cells	2
primed cells	2
specific conditions individual inner cell mass cells	2
naive epiblast cells	2
elevated extracellular α-synuclein	2
extracellular α-synuclein in patient-derived neuronal culture medium	2
lysosomal compartment	2
mutant glucocerebrosidase protein	2
three controls and three unrelated PD patients	2
ten independent induced pluripotent stem cell (iPSC) lines	2
glucocerebrosidase gene (GBA)	2
juvenile patient	2
adult human dermal fibroblast-derived iPSCs	2
T cell-derived iPSCs (TiPSCs)	2
embryoid body formation	2
patient-specific iPSCs	2
somatic cells of patients	2
neurological diseases	2
early trophoblast	2
protein and non-protein-coding markers	2
robust panel	2
BMP-treated human ESC	2
2102Ep, an embryonal carcinoma cell line	2
bone morphogenetic protein (BMP)-treated human ESC	2
chromosome 19 miRNA cluster (C19MC)	2
primary first-trimester trophoblast	2
selected criteria	2
placentas and embryonic stem cells (ESC)	2
human trophoblast cells	2
MSC cultures	2
individual subclones of MSCs	2
primary cell preparations	2
MSCs from bone marrow and adipose tissue	2
two CpG sites	2
serum supplements	2
NHP model	2
blood and immune system diseases	2
NHP-iPSCs	2
GSK3β inhibitor	2
mesoderm, myeloid, and lymphoid cells	2
different NHP species	2
transgene-free iPSCs	2
NHP-iPSC differentiation cultures	2
non-human primate (NHP) models	2
large animal models	2
de novo generated blood products	2
combination of serum biomarkers	2
combination of three plasma biomarkers (CEA, AFP, and HCG)	2
serum biomarkers	2
immunocompromised rat hearts	2
selected clones	2
human-induced pluripotent stem cells (iPSCs)	2
preclinical platform	2
pluripotent stem cells and differentiated cells	2
Edited genes	2
edited human embryonic stem cells	2
thousands of edited cell populations	2
one-pot transcribed single-guide RNAs	2
surface-modified multiwell plates	2
initial edited samples	2
human cells and tissues	2
spinal cord injury (SCI) model	2
human-induced pluripotent stem cell-derived oligodendrocyte precursor cell-enriched neural stem/progenitor cells	2
human iPSC-NS/PCs	2
spared demyelinated axons	2
human-induced pluripotent stem cell-derived neural stem/progenitor cells (iPSC-NS/PCs)	2
dynein arms	2
“9 + 2” microtubule arrangement	2
induced MCACs	2
Notch pathway inhibitor	2
pulmonary neuroendocrine lineage cells	2
alveolar epithelial cells	2
airway lineage cells	2
CPM+ VAFECs	2
proximal airway epithelial progenitor cell spheroids	2
NKX2-1+-ventralized anterior foregut endoderm cells (VAFECs)	2
functional MCACs	2
-ciliated airway cells (MCACs)	2
canonical miRNA	2
DGCR8 cDNA	2
Dgcr8−/− embryonic stem cells	2
mature somatic tissues	2
pluripotency-associated markers	2
Dgcr8-deficient mouse fibroblasts or NSCs	2
canonical miRNAs	2
mouse fibroblasts and neural stem cells (NSCs) lacking Dgcr8	2
biomedical application	2
stem cell-based hepatocytes	2
unfavorable gene regulatory networks	2
recombinant laminin substrates	2
undefined components	2
variable populations of hepatocytes	2
hepatocyte	2
major cell type of the human liver	2
basic and translational science	2
unlimited resource	2
cell-derived somatic cells	2
chicken genetic resources	2
constitutively active MEK1, AKT, and SMAD3 proteins	2
germline-competent PGCs	2
cognate-signaling pathways	2
growth factors FGF2, insulin	2
feeder cells	2
embryonic germ cell environment	2
migratory PGCs in vivo	2
active signaling pathways	2
several embryonic locations	2
germ lineage, primordial germ cells (PGCs)	2
early precursors	2
germ cell lineage	2
ICM growth	2
epiblast and primitive endoderm	2
two ICM	2
single blastocyst	2
two morphologically distinct ICMs	2
two ICMs	2
single “parental” ICM	2
inner cell masses (ICMs)	2
gene-edited PKDiPSCs	2
single-nucleotide polymorphism	2
second intron of the PKLR gene	2
partial codon-optimized R-type pyruvate kinase cDNA	2
non-integrative Sendai viral vectors	2
peripheral blood mononuclear cells (PB-MNCs) of PKD patients	2
PKD induced pluripotent stem cells (PKDiPSCs)	2
PKD patients	2
PKLR gene	2
human cord blood stem cells	2
Equivalent progenitors	2
virtually all cells	2
long-term cultured cells	2
murine hematopoietic progenitor cells	2
transcriptional inhibitor ID3	2
human vessels	2
larger grafts	2
host vascularization	2
rare human vessels	2
comparable grafts	2
hESC-CMs and hESC-CVPs	2
nude rat model	2
commonly used clinical cell type, human bone marrow mononuclear cells (hBM-MNCs)	2
multiple components of myocardium	2
mesodermal cardiovascular progenitors (hESC-CVPs)	2
injured hearts	2
HSC	2
bone marrow stem cells	2
hematopoietic progenitor cell (HPC) counterparts	2
xenotransplantation model	2
mouse hematopoietic stem cells (HSCs)	2
system dependent	2
reprogramming roadblocks	2
N terminus of KLF4	2
less efficient reprogramming systems	2
wild-type and Nanog−/− fibroblasts	2
efficient cassettes	2
roadblock	2
less efficient polycistronic reprogramming cassettes	2
several reprogramming systems	2
endogenous retinoic acid	2
GSK3s inhibitor	2
regenerated podocytes	2
pre-B cells	2
macrophage enhancer pathways	2
C/EBP factors	2
hematopoietic lineage tree	2
Pre-existing enhancers	2
incoming C/EBPα	2
pre-existing enhancers	2
two types of myeloid enhancers	2
3D bone marrow components	2
surrounding osteoblast cells and bone collagen	2
ready-made software	2
HSC-niche interactions	2
research theme	2
BMSC subpopulations	2
non-differentiating BMSC clones	2
heterogeneous human BMSC fractions	2
IL-7hi cells	2
Colony-forming CD317+	2
Cxcl12-DsRed+ perivascular stromal cells	2
rare non-differentiating BMSC subtype	2
CD317 immunolocalization	2
immunomodulatory transcriptional networks	2
CD317 positive	2
non-differentiating clones	2
enhanced vascular interaction gene sets	2
BMSC cell-surface antigens	2
BMSC subsets	2
immortalized human BMSC clonal lines	2
stem cell fraction	2
marrow stromal cells (BMSCs, also called bone-marrow-derived mesenchymal stromal cells)	2
flexible and expandable platform	2
multiple cell and tissue samples	2
human fetal atlas	2
human fetus	2
specific cell or tissue types	2
next-generation sequencing or microarray data	2
either human adult tissue or model organisms	2
Cellular identity and signaling pathways	2
human fetal equivalents in vivo	2
human pluripotent stem cells in culture	2
extreme hypomethylated environment	2
non-rodent models	2
early hPGCs	2
hESC-derived cells	2
four Asian patients	2
human embryonic-stem-cell (hESC)-derived retinal pigment epithelium	2
pluripotent stem cell progeny	2
cell type in the body	2
SummaryEmbryonic stem cells	2
known hepatotoxic drugs	2
drug carbamazepine	2
mutant AAT protein	2
disease-specific cells	2
PiZZ iPSC-hepatic cells	2
135 genes	2
PiZZ iPSCs	2
diseased versus normal human cohorts	2
disease and testing drugs	2
PD-related genes	2
PARK2 null line	2
non-midbrain neurons	2
isogenic PARK2 null lines	2
age-matched control subject	2
Parkinson’s disease (PD) patient-derived neurons	2
TH+ neurons	2
patient-specific and isogenic PARK2-induced pluripotent stem cells (iPSCs)	2
cargo of cytotoxic protein	2
cytoplasm of Escherichia coli	2
catalytic domain of Pseudomonas aeruginosa exotoxin A	2
recombinant lectin-toxin fusion protein of rBC2LCN	2
high-density lectin microarrays	2
human pluripotent stem-cell-specific lectin probe	2
residual human pluripotent stem cells	2
SMA patient-derived iPSCs	2
current in vitro model	2
full-length SMN transcripts	2
SMA patient-specific induced pluripotent stem cells (iPSCs)	2
NMJ-like structures	2
SMA patients’ motor neurons (MNs)	2
survival of motor neuron 1 (SMN1) gene	2
Med14 (and Mediator)	2
zebrafish med14 mutant embryos	2
Multiple stem/progenitor cell populations	2
many other Mediator components	2
log cells	2
log mutants	2
zebrafish logelei (log) mutant	2
many Mediator subunits	2
Mediator complex	2
nephron progenitors	2
PI3K and other pathways	2
β-catenin pathway	2
PI3K signaling	2
SummaryNephron progenitor cells	2
human mesenchymal progenitor populations	2
cell-surface proteome repository	2
mesenchymal progenitor populations	2
upregulated mesenchymal progenitor biomarkers	2
>6,000 proteins	2
adult mesenchymal fibroblasts	2
MSCs and HUCPVCs (three donors each	2
cell-surface-enriched fractions	2
human bone marrow mesenchymal stromal/stem cells (MSCs) and human umbilical cord perivascular cells (HUCPVCs)	2
cell-surface interface proteome	2
cell-surface interface	2
vascular barriers	2
blood-to-BM	2
BM niches	2
BM space	2
vessel walls	2
guidance molecule ROBO4	2
bone marrow (BM) niches	2
microenvironmental and structural cues	2
heterogeneous offspring	2
proteasome-targeting degron	2
core stem cell transcription factors OCT4 and SOX2	2
flexible lentiviral-based reporter system	2
complex combinations	2
minority cell population	2
functional hair cells and neurons	2
iMOP cells	2
C-MYC and SOX2 target genes	2
existing SOX2-dependent transcripts	2
endogenous C-MYC	2
SOX2-expressing otic progenitor cells	2
fate-restricted cell type	2
immortalized multipotent otic progenitor (iMOP) cells	2
developing inner ear	2
Two genes	2
sensory hair cells and neurons of the inner ear	2
programmable nucleases	2
important framework	2
full-length dystrophin protein	2
corrected iPSCs	2
DMD-patient-derived iPSCs	2
dystrophin protein	2
off-target sites	2
unique target region	2
unique k-mer database	2
TALENs or CRISPR-Cas9	2
predominantly ventricular-like cardiomyocytes	2
100 ml bioreactors	2
BMP agonists/antagonists	2
tank bioreactors	2
stirred Erlenmeyer flasks	2
multiwell screen	2
chemical Wnt pathway modulators	2
matrix-independent aggregates in suspension culture	2
progenies	2
myeloid and T lymphoid potential	2
VE-Cadherin+CD73−CD235a/CD43− HE	2
OP9 feeders	2
hPSCs cocultured	2
Tenascin C (TenC)	2
Essential 8 (E8) medium	2
clinical-grade therapeutic blood cells	2
current differentiation systems	2
poorly defined human or animal components	2
exploratory platform	2
human pluripotent stem cell (hPSC) cultures	2
universal platelets	2
renewable cell source	2
HLA-ABC-negative platelets	2
major histocompatibility antigens	2
β2-microglobulin gene	2
developing mouse thrombi	2
macrophage-depleted animals	2
human blood platelets	2
MK progenitors	2
functional platelets	2
megakaryocytes (MKs)	2
transfusable platelets	2
EMT factor SNAI1	2
let-7 microRNAs	2
let-7 promoter	2
cells expressing SNAI1	2
knockin SNAI1-YFP reporter	2
epithelial-to-mesenchymal transition (EMT) factor SNAI1 (SNAIL)	2
true HSCs	2
CD11A−Lin−KIT+SCA-1+CD150+CD34− cells	2
CD11A+Lin−KIT+SCA-1+CD150+CD34− cells	2
Lin−KIT+SCA-1+CD150+CD34−)	2
phenotypic HSCs	2
CD11A on HSCs	2
in vivo transplantations	2
marker, CD11A	2
downstream progenitors	2
transiently proliferating progenitor cells	2
mature effector cells	2
multiple epidermal compartments	2
sebocyte progenitor population	2
BLIMP1-expressing cells	2
BLIMP1− sebocytes	2
BLIMP1+ sebocytes	2
SG, interfollicular epidermis, and hair follicle	2
postmitotic, terminally differentiated epidermal cells	2
multiple stem cell populations	2
sebaceous gland (SG) progenitor population	2
SummaryB-lymphocyte-induced nuclear maturation protein 1 (BLIMP1)	2
cTnI:	2
single marker	2
Rodent stem cell-derived and primary myocytes	2
human induced pluripotent stem cell (iPSC) cardiac myocytes (hiPSC-CMs)	2
adult TNNI gene product, TNNI3 (cTnI)	2
“fetal” TNNI gene, TNNI1 (ssTnI)	2
stem cell field	2
alveolar epithelial spheroids	2
lamellar-body-like structures	2
CPM	2
fetal human lung fibroblasts	2
3D coculture system	2
SFTPC-GFP reporter hPSCs	2
fetal human and murine lungs	2
NKX2-1+ “ventralized” anterior foregut endoderm cells (VAFECs)	2
alveolar epithelial cells (AECs)	2
human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs)	2
induced alveolar epithelial progenitor cells (AEPCs)	2
age-related DNAm	2
senescence-associated DNAm	2
primary MSCs	2
standardized cell preparations	2
Starting material	2
conditional LacZ reporter	2
stem cells in the small intestine	2
eGFPCreERT2 fusion protein	2
Olfm4-IRES-eGFPCreERT2 knockin mouse model	2
murine small intestinal stem cells	2
Lgr5 stem cells	2
(Olfm4)	2
patches of adjacent crypts	2
Lgr5-eGFP-IRES-CreERT2 knockin allele	2
bottom of intestinal crypts	2
long-lived pool of cycling stem cells	2
rapidly self-renewing tissue	2
AKT signal	2
treated mouse group	2
lumbar spinal cord of ALS mouse models	2
renewable human cell source	2
rodent models of mutant superoxide dismutase 1 (SOD1)-mediated amyotrophic lateral sclerosis (ALS)	2
salamander myotubes	2
postmitotic salamander muscle cells	2
extracellular signal-regulated kinase (ERK) activation	2
regeneration-incompetent species	2
various differentiated adult cell types	2
regeneration-competent vertebrates	2
MethylRO mouse	2
MethylRO (methylation probe in ROSA26 locus)	2
red fluorescent protein (RFP)-fused methyl-CpG-binding domain (MBD) protein	2
knockin mouse	2
healthy progeny	2
karyotypically abnormal cells	2
normal hESCs	2
long-term proliferating colonies	2
karyotypically normal cells	2
karyotypically abnormal variants	2
early-passage human embryonic stem cells (hESCs)	2
+ TEC progenitors	2
Human FOXN1	2
unmanipulated PSCs	2
differentiating cultures	2
FOXN1+ TEC progenitors	2
integrin-β4 (ITGB4, CD104) and HLA-DR	2
FOXN1-GFP+ thymic endoderm cells	2
readout	2
FOXN1GFP/wline	2
sequences encoding GFP	2
hESC reporter lines	2
PSC-derived TECs	2
human pluripotent stem cells (PSCs)	2
SummaryThymic epithelial cells (TECs)	2
rare population of pNSCs	2
subependyma	2
definitive GFAP+ NSCs	2
self-renewing, multipotent colonies	2
inner cell mass of blastocysts	2
Oct4 expression	2
GFAP−, LIF-responsive stem cells	2
Adult-derived pNSCs (AdpNSCs)	2
periventricular region of the adult forebrain	2
rare population of pNCSs	2
leukemia inhibitory factor (LIF)-responsive, Oct4-expressing primitive NSCs (pNSCs)	2
Embryonic FGF-dependent NSCs	2
embryonic fibroblast growth factor (FGF)-dependent NSCs	2
subpopulation of GFAP-expressing subependymal cells	2
forebrain definitive neural stem cells (NSCs)	2
Hypermethylated genes	2
in vivo counterparts	2
mouse iPSCs and primary mdDA (Pitx3Gfp/+) neurons	2
mdDA (Pitx3Gfp/+) neurons	2
iPSC-derived midbrain DA neurons	2
mesodiencephalic dopaminergic (mdDA) neurons	2
YS-derived progenitors	2
YS and AGM	2
aorta-gonad-mesonephros (AGM) or fetal liver	2
yolk sac (YS)	2
defined population of multipotent, engraftable progenitors	2
single-cell multipotency assay	2
well-defined populations	2
definitive waves	2
primitive erythroid-biased waves	2
human muscle	2
functionally distinct progenitor cells	2
fetal counterparts	2
CD45−CD11b−GlyA−CD31−CD34−CD56intITGA7hi hMFA cells	2
PAX7+	2
Adult muscle	2
stromal constituents of muscle	2
CD45−CD11b−GlyA−CD31−CD34+ fetal hMFA cells	2
mouse muscle	2
robust, bipotent myogenic and osteogenic activity	2
CD45−CD11b−GlyA−CD31−CD34−CD56intITGA7hi cells	2
subset of CD45−CD11b−GlyA−CD31−CD34−CD56intITGA7hi hMFA cells	2
satellite cell marker PAX7	2
pool of fetal human myofiber-associated (hMFA) cells	2
subretinal space	2
xeno-RPE	2
continuous polarized human RPE monolayer	2
fetal or adult transplant	2
retinal edema	2
rabbit, a large-eyed animal model	2
Trephined pieces of RPE monolayers	2
(PET) membranes	2
Polarized monolayers	2
alternative RPE source	2
adult human RPE stem cell (hRPESC)	2
(iPSC)-derived RPE	2
pluripotent stem cell	2
Human embryonic stem cell (hESC)	2
signature gene,	2
single TFs	2
potent TFs	2
appropriate target cells	2
synthetic mRNAs of TFs	2
myocytes, hepatocytes, blood cells, and neurons	2
Myod1, Mef2c, Esx1, Foxa1, Hnf4a, Gata2, Gata3, Myc, Elf5, Irf2, Elf1, Sfpi1, Ets1, Smad7, Nr2f1, Sox11, Dmrt1, Sox9, Foxg1, Sox2, or Ascl1—can	2
identified TFs	2
possible combinations	2
combinations of TFs	2
combination of TFs	2
SummaryA network of transcription factors (TFs)	2
hPSC-derived cell population	2
undifferentiated hESCs	2
undifferentiated human pluripotent stem cells (hPSCs), neural progenitor cells (NPCs), and anterior foregut endoderm (AFE)	2
SOX2 gene	2
SOX2 reporter line	2
SOX2 locus	2
reporter gene encoding GFP	2
human embryonic stem cell (hESC) line	2
gut endoderm	2
stem cell marker Sca1	2
descendants of cells	2
tet-cre system	2
triple-transgenic mice	2
putative adult cardiac precursor cells	2
one of the least regenerative organs in the body	2
diversity of endodermal derivatives	2
sustainable source of multipotent endoderm stem cells	2
pluripotent lines	2
near-homogenous populations of hFSCs	2
pancreatic and hepatic cells	2
human foregut stem cells (hFSCs)	2
defined culture system	2
endodermal lineage	2
tissue-specific cells	2
specialized cells	2
clinically relevant cells	2
SMC loading factor NIPBL	2
two SMC complexes	2
transcriptional regulatory elements	2
second SMC complex, condensin II	2
structural maintenance of chromosomes (SMC) complex	2
initiation sites	2
transcription apparatus	2
allogeneic grafts	2
iPSC-derived neural cells	2
autografts	2
leukocytes (CD45+/CD3+)	2
microglia (IBA-1+/MHC class II+)	2
allografts	2
brains of humans or nonhuman primates	2
patient’s own cells	2
isogenic TAU-iPSC lines	2
TAU-A152T.	2
two isogenic iPSC lines	2
human neuronal model	2
pathological TAU protein	2
canonical Wnt pathway effector LEF1	2
differentiation-associated genes	2
core pluripotency genes	2
inhibitor of glycogen synthase kinase 3 (GSK3)	2
mice and rats	2
SummaryGermline-competent embryonic stem cells (ESCs)	2
glioblastoma assays	2
cell-lineage tracing	2
SOX2-Cre reporter mouse model	2
noncanonical signaling pathway engaging JAK-STAT	2
irradiated NSCs	2
astrocyte marker GFAP	2
mammalian somatic stem cells	2
specific enhancers	2
dTF repressors	2
epiblast stem cells (EpiSCs)	2
Nanog enhancer	2
mouse embryonic fibroblast cells (MEFs)	2
exogenous OCT4	2
distal enhancer of the Pou5f1 (Oct4) locus	2
designer transcription factors (dTFs)	2
plant pathogenic bacterial genus	2
transcription-activator-like effectors (TALEs)	2
modular DNA recognition code	2
potent and genetically stable MSCs	2
combination marker LNGFR+THY-1+VCAM-1hi+ (LTV)	2
Rapidly expanding clones (RECs)	2
LNGFR+THY-1+ cells	2
highly enriched clonogenic cells	2
cell-surface markers (LNGFR, THY-1, and VCAM-1)	2
mesenchymal stem cells (hMSCs)	2
chronically dysfunctional telomeres	2
different subsets of primitive normal human mammary cells	2
multiple DNA damage response proteins	2
luminal progenitors (LPs)	2
phenotypically defined cell population	2
normal human mammary gland	2
epidermal and dermal signals	2
distinct stem cell populations	2
different IFE differentiation compartments	2
interscale	2
wild-type skin	2
scale-interscale boundaries	2
Epidermal Wnt signaling	2
melanocytes and follicles	2
interscale progenitors	2
scale progenitors	2
underlying basal layer	2
unipotent cells	2
scale and interscale	2
parakeratotic (scale) and orthokeratotic (interscale)	2
distinct terminal differentiation programs	2
mouse tail interfollicular epidermis (IFE)	2
alternative safe drug	2
c-Jun N-terminal kinase (JNK) and mitogen activated protein kinase (MAPK)/P38 kinase in vitro and in vivo	2
extracellular regulated protein kinases (ERK) and cAMP response element binding protein (CREB)	2
downstream protein	2
brain-derived neurotrophic factor (BDNF), hypoxia-inducible factor 1α (HIF-1α)	2
neuroprotection	2
several antioxidant enzymes	2
main intracellular iron regulation protein	2
divalent metal transporter (DMT1) and transferrin receptor (TFR)	2
subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model	2
classical iron chelators, lactoferrin (Lf), a multifunctional iron-binding globular glycoprotein	2
Iron chelators	2
Δsco2Δsod1 strain	2
complementation-based system	2
Arabidopsis thaliana HCC1	2
Kluyveromyces lactis K07152	2
double deletion mutant	2
Drosophila, Arabidopsis, human and two other yeast species	2
Sco homologs	2
respiratory competent double deletion strain Δsco2Δsod1	2
SCO1 or SCO2 and SOD1	2
double deletion strains	2
superoxide dismutase 1	2
two SCO homologs (SCO1 and SCO2)	2
thioredoxin-like fold	2
mitochondrial cytochrome c oxidase	2
evolutionary conserved Sco protein family	2
XO-derived oxidants	2
hemolysis (free heme	2
sickle cell, malaria and sepsis	2
circulating XO	2
principle compound	2
endothelial-bound XO	2
glycocalyx on the endothelium	2
distal vascular beds	2
tissue-specific XO knockout models	2
xanthine to uric acid generates superoxide (O2•-) and hydrogen peroxide (H2O2)	2
purine catabolizing enzyme, xanthine oxidase (XO)	2
enzymatic sources of reactive species	2
circulating free heme	2
8-oxodGuo, and 8-oxoGuo	2
MV and COPD patients	2
patients with chronic obstructive pulmonary disease (COPD), and patients on mechanical ventilation (MV)	2
malondialdehyde (MDA, a product of lipid peroxidation)	2
three oxidized nucleic acid products	2
8-oxodGuo and 8-oxoGuo).With	2
deionized water	2
frozen urine samples	2
urine, 8-oxoguanine (8-oxoGua), 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodGuo) and 8-oxo-7,8-dihydroguanosine (8-oxoGuo)	2
oxidized nucleic acid damage products	2
molecules, cells and tissues	2
sarcomeric proteins	2
gastrointestinal tumours	2
redox regulatory enzymes	2
gastrointestinal cancer data sets (oesophageal, stomach and colorectal carcinomas)	2
various gastrointestinal tumours	2
agents modulating ROS	2
Double Strand Breaks (DSBs)	2
group of short-lived, highly reactive, oxygen-containing molecules	2
UPR sensors/transducers	2
autophagy, apoptosis, ferroptosis, inflammation, senescence, stemness, and cell cycle, etc.)	2
variety of cellular signaling pathways	2
activated UPR	2
protein folding and antioxidative machinery	2
protein disulfide isomerase (PDI) family and other oxidoreductases	2
disulfide bridge	2
specific three-dimensional structures	2
almost all membrane proteins	2
dynamic organelle	2
Endoplasmic reticulum (ER)	2
biomaterials or stem cells	2
Citrate-regulated global PPARγ expression	2
diverse components	2
various free radical scavenging proteins	2
rat air pouch model	2
stable molecular structure	2
chemical, cellular and animal assays	2
different cells and tissues	2
anti-oxidant and anti-inflammatory properties	2
calcium citrate, citrate esters	2
Chemical substances containing citrate	2
high fructose-fed mice	2
hepatic SELENBP1	2
pro-inflammatory cytokine tumour necrosis factor alpha (TNF-α)	2
differentiating 3T3-L1 cells	2
key lipogenic enzyme, acetyl-CoA-carboxylase (ACC)	2
SELENBP1 in 3T3-L1 adipocytes	2
known marker proteins of white adipocytes	2
hydrogen sulphide	2
organosulfur compound	2
Selenium-binding protein 1 (SELENBP1)	2
phagocytized bacteria	2
bacterial cysteine proteome	2
major metabolic pathways	2
phagocytized E. coli	2
complex mixture of oxidants	2
number of oxidants	2
thiol groups	2
thiol group of the amino acid cysteine	2
oxidants	2
microbial intruders	2
complex mixture of different oxidants	2
CHOP/ERO1 branch	2
SelenoN KO mice	2
oxidised poise	2
ER redox	2
SELENON-devoid models	2
maladaptive CHOP-induced ERO1	2
hind limb muscles	2
highly active diaphragm muscle	2
SelenoN knockout (KO) mouse limb muscles	2
endoplasmic reticulum (ER) protein	2
Selenoprotein N (SELENON)	2
OxyR and KatA	2
different mutants	2
stably expressed Mrx1-roGFP2 biosensor	2
peroxiredoxins Mpx and Tpx	2
major H2O2 detoxification enzyme	2
catalase KatA	2
sigH mutant	2
basal EMSH	2
mshC and mtr mutants	2
antioxidant defense (MSH, Mtr, KatA, Mpx, Tpx)	2
ROS (OxyR, SigH)	2
highly reducing intrabacterial EMSH	2
Mrx1-roGFP2 biosensor in C. glutamicum	2
industrially important Corynebacterium glutamicum	2
major low molecular weight (LMW) thiol	2
Mycothiol (MSH)	2
cytotoxic agents	2
HTS platforms	2
mt-roGFP probe	2
known plant-derived antioxidants	2
H2B-mCherry	2
quantitative methods	2
mt-roGFP and H2B-mCherry	2
known toxic and cancer drugs	2
Diverse imaging platforms	2
mitochondrial damage sensor	2
genetically encoded mitochondrial-targeted redox-GFP2 (mt-roGFP)	2
Cancer cell lines	2
end-stage assays	2
permeabilization	2
antioxidant and lipid detoxification genes	2
UVA - oxidized phospholipids	2
selected reactive lipids	2
known bioactive and also potentially reactive carbonyl containing species	2
known and novel lipid species	2
light (UVA)	2
primary human keratinocytes (KC)	2
oxidized phospholipid (OxPL) mediators	2
major skin aging factor	2
Ultraviolet light	2
glutathione-dependent antioxidant system	2
inhibitor of GPx	2
mercaptosuccinic acid	2
antioxidant enzymes Gpx1 (3.9-fold) and Gclc	2
cellular glutathione-dependent antioxidant system	2
tert-BuOOH	2
tert-BuOOH (in vitro model of oxidative stress)	2
mouse hippocampal cell line (HT22)	2
two stress-responsive transcription factors, Nrf2 and FOXO1	2
Nrf2 target gene mRNAs	2
FOXO-dependent expression of genes	2
arsenite or copper ions	2
insulin or xenobiotics	2
FOXO target gene expression	2
FOXO1 DNA binding	2
cysteine-deficient FOXO1 mutant	2
GFP-coupled wild-type human FOXO1	2
FOXO in cultured human cells (HepG2, HEK293)	2
FOXO signaling	2
Nrf2 ortholog, SKN-1, and the forkhead box O (FOXO) family transcription factor DAF-16	2
glutathione (GSH) in exposed cells	2
Diethyl maleate (DEM), a thiol-reactive α,β-unsaturated carbonyl compound	2
various antioxidant candidates	2
valuable animal model	2
Idh2−/−hair cells	2
H2O2-induced ototoxicity	2
Idh2-deficient mouse cochlea	2
mitochondria-targeted antioxidants	2
hair cells and spiral ganglion neurons (SGNs) in the cochlea	2
Idh2 knockout (Idh2−/−) mice	2
antioxidant agent	2
major NADPH-producing enzyme	2
Mitochondrial NADP+-dependent isocitrate dehydrogenase 2 (IDH2)	2
ascorbate compounds	2
circulating Vitamin C metabolite	2
O-methylascorbate	2
Mendelian Randomization models	2
circulating metabolites	2
hepatic I/R.	2
mitochondrial biogenesis related peroxisome proliferative activated receptor-γ (PPARγ) co-activator 1α (PGC-1α) and mitochondrial transcription factor (TFAM) expression	2
mitochondrial fission related protein dynamin related protein 1 (drp-1) and fission 1 (Fis-1) expression	2
recently identified hormone	2
specific treatment	2
sulfones and sulfoxides of DSF	2
DDC + HOCbl	2
oxidized forms	2
copper chelator bathocuproine disulfonate (BCS)	2
nominally Cu-free solutions	2
Cu2+ in culture medium	2
oxidized forms, sulfones and sulfoxides	2
DDC with HOCbl are disulfiram (DSF)	2
main products	2
crystalline precipitate	2
DDC solutions	2
ascorbate, pyruvate, and tiron, a scavenger of superoxide anion	2
+ 	2
antioxidants N-acetylcysteine (NAC) and glutathione (GSH)	2
+ HOCbl solutions	2
aqueous DDC solutions	2
diethyldithiocarbamate (DDC)	2
hydroxycobalamin (a form of vitamin B12, HOCbl)	2
metals (Cu, Zn, Cd, Au)	2
suitable locations	2
Hb subunits	2
accessible site	2
alternative oxidative site	2
cysteine residue at α19 on the exposed surface of the α-chain	2
recombinant mutants	2
heme pocket	2
redox active γCys93	2
adult hemoglobin (HbA)	2
Human fetal hemoglobin (HbF)	2
hemoglobin structure	2
hemoglobin's “oxidation hotspot	2
Redox active cysteine residues	2
NAA10 acetylates HIF-1α	2
lysine residue	2
new hydrogen-bond	2
hydroxylated W38	2
lysyl-acetyltransferase activity	2
W38 oxygen-dependently	2
human FIH (factor inhibiting HIF) hydroxylates human NAA10	2
NAA10 acetylates lysine residues	2
hypoxia-inducible factor 1α (HIF-1α)	2
internal lysine residues of several substrates	2
monomeric NAA10	2
internal lysine residue	2
catalytic subunit NAA10	2
N-terminal acetyltransferase A (NatA) complex	2
oxidative equivalents	2
neuroblastoma tumor cells	2
reactive oxygen species generating NOX	2
redox-switch	2
integral components	2
Cysteines 102	2
characteristic disulfide bond	2
reducing agents	2
HDAC8 preparations	2
redox-sensitive cysteinyl thiol	2
HDAC class I enzymes	2
established target	2
(HDAC) family	2
BDNF dependent TrkB pathway, and NFkB pathway	2
MAPK/ERK and PI3K/Akt pathways	2
hepatocyte-specific recombinant adeno-associated viral (AAV) serotype 8-mediated DYRK1A gene therapy (AAV2/8-DYRK1A)	2
adenovirus expressing Dyrk1A	2
brain of heterozygous CBS deficient mice	2
serine/threonine kinase DYRK1A	2
vasoconstrictor prostaglandin	2
cyclooxygenase 2 proteins	2
cytoplasm and activated AMP-activated protein kinase-α (AMPKα)	2
liver kinase B1 (LKB1)	2
PPARα or AMPKα inhibitors	2
vehicle-treated DM	2
superoxide dismutase and catalase	2
macro- and microvessels	2
streptozotocin-induced diabetic mice	2
α (PPARα) agonist	2
peroxisome proliferator-activated receptors	2
CORM-3 and related CORMs	2
surface-exposed amino acids	2
GSH, free Cys, His and Met residues	2
Intracellular targets	2
histidine, GSSG and methionine	2
pertinently cysteine and reduced glutathione (GSH)	2
histidine, methionine and oxidised glutathione	2
thiols and amino acids in complex growth media	2
active antimicrobial agent	2
CO in buffers and cell culture media	2
CORM-3 (Ru(CO)3Cl(glycinate))	2
Ru-carbonyl CORMs	2
bacteria in vitro and in animal models	2
potential novel antimicrobial drugs	2
biological ‘gasotransmitter’	2
metal carbonyl compounds	2
Carbon monoxide (CO)-releasing molecules (CORMs)	2
RPE maintenance	2
RPE cells and zebrafish retina	2
light damaged adult zebrafish retina	2
lysosomal acidification inhibitor	2
zinc protoporphyrin, an HO-1 inhibitor	2
RS9 protected ARPE-19 cells	2
novel Nrf2 activator, RS9	2
certain anti-oxidative enzymes [e.g. Heme oxygenase-1 (HO-1)]	2
NF-E2-Related Factor 2 (Nrf2)-kelch like ECH associated protein 1 (Keap1) axis	2
lipofuscin and drusen on the retinal pigment epithelium (RPE)	2
Non-exudative age-related macular degeneration (AMD)	2
Nrf2 activator	2
PC12 cells and mice	2
Nrf2/HO-1 signaling pathway	2
6-OHDA-induced mouse model	2
critical cysteine thiols	2
Kelch-like ECH-associated protein 1 (Keap1)	2
non-thiol reducing antioxidant, Trolox	2
thiol reducing agents, N-acetylcysteine (NAC) or dithiothreitol (DTT)	2
small, interfering RNA (siRNA)	2
Nrf2 and antioxidant enzyme heme oxygenase-1 (HO-1)	2
6-hydroxydopamine (6-OHDA)-induced cytotoxicity	2
hydrogen peroxide (	2
one of the sesquiterpenoids in Farfarae Flos	2
7β-(3-ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone (ECN)	2
nuclear factor-E2-related factor 2 (Nrf2)	2
mitochondrial RPL10	2
specific binding motif	2
tumor suppressor or transcription co-regulator	2
ribosomal protein L10 (RPL10)	2
Heph/Cp knockout mice	2
plasma lipase	2
Perls’ Prussian blue staining	2
MCFs	2
either MCF	2
HEPH and CP	2
Heph/Cp double-knockout mice	2
hephaestin (Heph) and ceruloplasmin (Cp) single-knockout mice	2
multicopper ferroxidases (MCFs)	2
antioxidant glutathione	2
receptor 2 (VEGFR2)	2
class of aldehydes	2
secosterol aldehydes	2
dimer interface (Lys 3 and 9)	2
electrostatic loop (Lys 122, 128 and 136)	2
Lys residues	2
SOD1 aggregates	2
secosterol molecules	2
SOD1-secosterol adducts	2
secosterol adduction	2
HMW region	2
modified proteins	2
ω-alkynyl-secosterols	2
HMW) SOD1 aggregates	2
Seco A and Seco B	2
pre-symptomatic animals	2
Seco B	2
blood plasma, spinal cord and motor cortex of ALS rats	2
Secosterol aldehydes	2
secosterol aldehydes in ALS SOD1-G93A rats	2
Cholesterol 5,6-secosterol aldehydes (Seco A and Seco B)	2
Cu,Zn-superoxide dismutase (SOD1) immunoreactive aggregates	2
upper and lower motor neurons	2
gustatory system	2
gustatory neuron ASER	2
receptor NPR-1	2
GCY-22 and neuropeptide	2
guanylyl cyclases GCY-5 and	2
P. aeruginosa diet	2
primary superoxide dismutase	2
five superoxide dismutases	2
less-toxic hydrogen peroxide and oxygen	2
Superoxide dismutase	2
previously unknown glutathionylation sites	2
proteins like SERCA1, and NDUV2 of mitochondrial complex	2
14-3-3 protein gamma and MAP2K4	2
S-glutathionylated proteome	2
RYR1, SERCA1, titin, and troponin I2	2
mitochondrial complex I and II, GAPDH, MDH1, ACO2, and mitochondrial complex V	2
significantly S-glutathionylated	2
Regulatory cysteines	2
site-specific protein S-glutathionylation	2
glutaredoxin enzyme cocktail	2
S-glutathionylation	2
right (stimulated) and left (unstimulated) gastrocnemius muscleswere	2
Anesthetized adult male CB6F1 (BALB/cBy × C57BL/6) mice	2
redox sensitive thiols	2
transcription factors, kinases, phosphatases	2
Neither heme proteins hemoglobin and cytochrome c nor DNA	2
fluorescein-5-thiosemicarbazide (FTC)-based fluorometric assay	2
guanidine-HCl	2
protein carbonyl-RBH hydrazone	2
rhodamine B hydrazide (RBH)	2
total protein carbonyls	2
new fluorometric assay	2
master athletes	2
muscles of age-matched controls	2
Master athletes	2
anti-oxidant and metabolic proteins	2
enzyme SIRT1	2
24-OH in the brain	2
amyloid β monomers	2
spontaneously developing tau pathology (hTau mice	2
mice that express human tau	2
SIRT1-dependent neuroprotective pathway	2
7-ketocholesterol (7-K)	2
deacetylase sirtuin 1 (SIRT1)	2
SK-N-BE neuroblastoma cells	2
24-hydroxycholesterol (24-OH)	2
certain oxysterols	2
cholesterol oxidation products (oxysterols)	2
extra virgin olive oil polyphenols	2
NF-kB	2
MAPK-NF-kB pathway	2
enterocyte-like cells	2
human colon adenocarcinoma cell line (Caco-2)	2
representative mixture of dietary oxysterols	2
extra virgin olive oil phenolic extract	2
Extra virgin olive oil polyphenols	2
intestinal epithelial layer	2
cholesterol-containing foodstuffs	2
oxidized products of cholesterol	2
platelet metabolome	2
platelet activation genes	2
transcriptomics and metabolomics	2
semi-immune group	2
lipoxygenase, cyclooxygenase and non-specific lipid peroxidation products	2
urea cycle	2
Top pathways	2
amino acid pathways	2
Metabolomics data	2
interferon related genes	2
naïve and semi-immune subjects	2
P. vivax controlled human malaria infection trial	2
asymptomatic infections	2
NADH and other possible reductant(s)	2
Amplex Red assays	2
oxidized and reduced resorufin	2
resorufin accumulated	2
Combined NADH	2
reduced resorufin	2
colorless reduced resorufin	2
succinate by intact mitochondria	2
succinate-supported complex I-mediated ROS	2
respiratory complexes II and III and by the reverse electron transfer (RET)-mediated by complex I)	2
ammonium-stimulated dihydrolipoamide dehydrogenase	2
respiratory complexes	2
significant mitochondrial generators	2
Amplex Red assay	2
coupled inside-out bovine heart submitochondrial particles (SMP) oxidizing NAD-dependent substrates, NADH, and succinate	2
intact or permeabilized rat heart mitochondria	2
PARP1-deficient tumor xenografts	2
NADPH oxidases 1 and 4	2
high grade serous ovarian carcinoma	2
breast cancer and ovarian cancer	2
cytoprotective mitophagy	2
ART-treated cells	2
ART-induced mitophagy	2
1A/1B light chain 3 (LC3)	2
Parkin, sequestosome 1 (SQSTM1), ubiquitin and microtubule-associated proteins	2
full-length form of PTEN induced putative kinase 1 (PINK1)	2
large number of mitochondrial proteins	2
important cellular pathway	2
prominent anti-malarial	2
Artesunate (ART)	2
NOX enzymes	2
two NOXs	2
neuroprotective agents	2
GL-V9	2
TNBCs in vitro	2
anchorage independent growth	2
synthesized flavonoid derivative GL-V9	2
Amount of glucose	2
fatty acid oxidation (FAO)	2
detached-growth	2
anchorage independent growth model	2
triple-negative breast cancers (TNBCs)	2
one of the most lethal tumors	2
Plasma oxysterols	2
hypercholesterolaemic midlife men	2
plasma cholesterol	2
specific plasma free oxysterols	2
oxysterols in human plasma	2
free oxysterols	2
plasma free oxysterols	2
lipoprotein core	2
Esterified oxysterols	2
e.g. 7-ketocholesterol, 7β-OHC and 25-OHC)	2
enzymatically (e.g. 24S-OHC, 25-OHC and 27-OHC)	2
biologically active cholesterol metabolites	2
Oxysterols (OHC)	2
redox active biomolecules	2
N-acetyl-cysteine	2
HyPer-expressing cells	2
oxidized biosensor	2
human cell lines	2
pH-clamped cells	2
close environment	2
cytosol, mitochondrion and endoplasmic reticulum	2
H2O2-sensitive fluorescent biosensor	2
redox biosensor advent	2
intracellular hydrogen peroxide	2
intrinsic antioxidant machinery	2
novel prognostic/diagnostic platform	2
human blood cells, urine and saliva	2
acid-labile sulfide/thiols	2
free reduced/oxidized as well as bound thiols and sulfide	2
reduced/oxidized glutathione	2
healthy human volunteers	2
aminothiols and sulfide	2
mixed disulfides (S-thiolation	2
alkylating agent	2
methanethiol, N-acetylcysteine, and coenzyme A.	2
additional analytes	2
stable isotope labelled standards	2
sulfhydryl groups with N-ethylmaleimide	2
blood, saliva and urine	2
disulfides and sulfide	2
total and free thiols	2
12 analytes	2
specific and sensitive platform	2
cells/biofluids	2
sulfur-containing species	2
Calu-3 cells	2
specific reagent	2
mitochondrial NADH-cytochrome c oxidoreductase (mCx I-III) activity	2
NF-kB inhibitor, IKK-2 (10 µM)	2
N-acetyl cysteine (NAC, 5 mM)	2
Calu-3 airway epithelial cells	2
Cigarette Smoke Extract (CSE)	2
brain endothelial cells	2
(PERK) inhibitor GSK2606414	2
protein kinase R-like ER kinase	2
interleukin (IL)−6 as well as IL-8	2
protein palmitoylation	2
2-ClHA and its alkyne analogue	2
2-ClHyA in the endoplasmic reticulum (ER) and mitochondria of human BMVEC (hCMEC/D3 cell line)	2
parent compound	2
‘clickable’ alkyne derivative (2-ClHyA)	2
brain microvascular endothelial cells (BMVEC)	2
cerebrovasculature these compounds	2
2-chlorohexadecanal and its conversion product 2-chlorohexadecanoic acid (2-ClHA)	2
chlorinated inflammatory mediators	2
endogenous pool of ether phospholipids (plasmalogens)	2
activated phagocytes	2
myeloperoxidase-H2O2-chloride system	2
hypochlorous acid (HOCl)	2
cytotoxic mediators	2
Peripheral leukocytes	2
cellular protein thiols	2
peroxiredoxin overoxidation	2
cytosolic peroxiredoxin 2	2
mitochondrial peroxiredoxin 3	2
free 20S proteasome	2
polyubiquitinated proteins	2
20S and 19S subunits	2
26S proteasomes	2
oxidatively stressed cells	2
regulatory pathway	2
PARP1 or OGG1 in PARP1 overexpressing cells	2
immunoprecipitable complex	2
PARP1 overexpressing cells	2
8-oxoguanine glycosylase (OGG1)-dependent base excision DNA repair pathway	2
poly(ADP-ribosyl)ation	2
anticancer drugs (WP631 and etoposide)	2
PARP1 promoter	2
RB1-E2F1-HDAC1-EZH2 repressive complex	2
CDK4/6 inhibitors, ribociclib (LEE011) and palbociclib (PD0332991)	2
non-small lung cancer cells	2
graphene-based theranostic platforms	2
role of ROS	2
graphene-cell interactions	2
surface containing functional groups	2
graphene and target tissues and cells	2
living organs	2
carbon nanotubes, gold nanostructures or polymeric nanoparticles	2
currently available theranostic agents	2
reactive oxygen species (ROS) production	2
erythrocytic 7KCh	2
ATF4-dependent pathway	2
subjects of control subjects	2
oxidized cholesterol 7-ketocholesterol (7KCh)	2
lysoPCs, lysoPEs, and ceramides	2
phosphatidylcholines (PCs), phosphatidylethanolamines (PEs)	2
HF patients	2
lipidomes of erythrocytes	2
erythrocytes from heart failure (HF) patients	2
adipogenic molecular network	2
two key genes	2
PPARγ and FABP4 expression	2
major cellular antioxidant GSH	2
bone marrow of patients with PSP	2
tauopathy	2
Atypical Parkinsonism	2
Sporadic cases	2
microglia in the spinal cord	2
spinal microglia	2
Naive rats	2
N-tert-Butyl-α-phenylnitrone (PBN, 50 and 100mg/kg) and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol, 100 and 200mg/kg)	2
well-established CIBP model	2
spinal ROS	2
p62–Keap1/Nrf2 pathway	2
novel activator	2
downstream antioxidant factors, heme oxygenase-1 (Ho-1) and nicotinamide adenine dinucleotide phosphate quinone dehydrogenase 1 (Nqo1)	2
nuclear factor (erythroid-derived 2)-like 2 (Nrf2)	2
mechanistic target of the rapamycin (mTOR)-independent inducer	2
plants, insects, microorganisms and invertebrates	2
naturally occurring nontoxic disaccharide	2
organelles and proteins	2
aconitase, complex I, and complex II	2
ARB treated animals	2
Nrf2 binding	2
10mg olmesartan	2
Evans Tokushima Fatty (OLETF), and 3) OLETF + angiotensin receptor blocker (ARB	2
insulin resistant, obese Otsuka Long	2
1) Long Evans Tokushima Otsuka (LETO; lean strain-control)	2
adult male rats	2
many antioxidant genes	2
transcription factor, nuclear factor erythriod-2- related factor 2 (Nrf2)	2
renin-angiotensin system (RAS)	2
mitochondrial enzymes	2
multitude of pathways	2
redox and proton transfer domains	2
state in complex I	2
mitochondrial NADH/NAD+ couple	2
NADH/NAD+ couple	2
isolated mitochondria	2
submitochondrial particles	2
diguanides and phenformin	2
biguanide phenformin	2
antihyperglycaemic diguanides	2
primary hepatocytes and H4IIE hepatoma cells	2
biguanide metformin	2
Many guanide-containing drugs	2
H26A-Prdx6 lungs	2
Control lungs and cells	2
wild type control and mutant lungs	2
Isolated lungs	2
Prdx6 null cells	2
-Prdx6 expressing pulmonary microvascular endothelial cells (PMVEC)	2
-Prdx6 expressing mice	2
His26 residue	2
peroxidized cell membranes	2
phospholipid hydroperoxides	2
peroxiredoxins	2
peroxiredoxin 6 (Prdx6)	2
lungs or cells	2
xenosensors, ROS and FOXO transcription factors	2
Constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome proliferator-activated receptors (PPARs), arylhydrocarbon receptor (AhR) and nuclear factor erythroid 2-related factor 2 (Nrf2)	2
encode antioxidant proteins	2
FOXO target genes	2
class O) transcription factors	2
FOXO (forkhead box,	2
cellular xenosensors	2
biosynthesis of proteins	2
subset of the population	2
cytoprotective CNC regulatory network	2
gene MS4A6A.	2
strong CNC binding sequence	2
risk allele of rs667897	2
stress responsive Cap-n-Collar (CNC) transcription factors NRF1 (encoded by NFE2L1) and NRF2 (encoded by NFE2L2)	2
antioxidant response element	2
MS4A locus	2
one of the most significant loci	2
MS4A (membrane-spanning 4-domains subfamily A) gene cluster	2
BNIP3 silencing	2
UCB-hMSC	2
cofilin-1-mediated F-actin	2
SREBP1/FASN pathway	2
BNIP3 suppressed free fatty acid (FFA) synthesis	2
BNIP3 expression	2
19kDa protein-interacting protein 3 (BNIP3)-dependent mitophagy	2
Bcl2/adenovirus E1B	2
major mitophagy regulator	2
umbilical cord blood-derived human mesenchymal stem cells (UCB-hMSCs)	2
fatty acid synthase (FASN)	2
8-oxoGuo	2
morning urine	2
1381 newly diagnosed diabetes patients	2
8-oxo-7,8-dihydroguanosine (8-oxoGuo)	2
One promising biomarker	2
high risk patients	2
important biomarker	2
Urinary albumin	2
well-defined, and specific group of human carcinomas	2
perinuclear membranes	2
new probe	2
histologically-uninvolved specimens	2
7/15 patients	2
malignant melanoma	2
carcinomas of the head and neck (15/19 patients), esophagus (12/18 patients), bladder (10/19 patients), ovary (6/17 patients), and prostate (7/19 patients)	2
20 sets of epithelial tumors	2
six members of the NOX gene family	2
specific extracellular region of the human NOX4 protein	2
immunological tools	2
human tumor specimens	2
small number of tumor cell lines	2
H2O2 constitutively	2
redox active, membrane-associated protein	2
NADPH oxidase 4 (NOX4)	2
adipocyte oxidative phosphorylation system	2
human adipose tissue-derived stem cells	2
several adipokines and proteins	2
adipocyte secretome	2
adipokine production	2
ribosomal antibiotic linezolid	2
off-target	2
mitochondrial translation system	2
bacterial one	2
ribosomal antibiotics	2
widely used therapeutic drugs	2
xenobiotics inhibitors	2
L6 galactose media model	2
L6 skeletal muscle models	2
sulfonyl isoxazoline compounds	2
vitro L6 metabolic models	2
skeletal muscle tissues	2
Novel sulfonyl isoxazoline herbicides	2
vitro rat skeletal muscle model (L6)	2
robust in vitro models	2
NRF2 gene in wild type NSPCs	2
astrocytes and oligodendrocytes vs. neurons	2
neurosphere differentiation assays	2
neurosphere cultures	2
newborn and 3-month-old Nrf2-/-mice	2
SGZ-derived NSPCs	2
Nrf2-/- vs. Nrf2+/+ mice	2
NRF2-knockout (Nrf2-/-) mice	2
NSPCs destinies	2
transcription factor Nuclear Factor-Erythroid 2-Related Factor 2 (NRF2)	2
neurogenic niche	2
synaptic networks	2
subgranular zone (SGZ) of the hippocampus	2
Neural stem/progenitor cells (NSPCs)	2
cell-type and context specific routes of PDI externalization	2
VSMC pecPDI	2
PDI-overexpressing mice	2
ex vivo wild-type mice aortas	2
Secreted PDI	2
cytoskeleton or lysosomes	2
VSMC csPDI	2
Calcium ionophore A23187	2
soluble secreted PDI pool	2
robust cell-surface(cs) PDI pool	2
vascular smooth muscle cells(VSMC)	2
platelets PDI	2
classical and unconventional pathways	2
peri/epicellular(pec) pool of the endoplasmic reticulum redox chaperone protein disulfide isomerase-A1(PDI)	2
intracellular molecular chaperones	2
Extracellular pools	2
new class of neuroprotective drugs	2
APP/Psen1 mice	2
/Psen1 mice	2
pro-inflammatory cytokines TNF-α and IL-17A.	2
brains of methysticin-treated APP/Psen1 mice	2
hippocampus and cortex of mice	2
Morris water maze	2
Luminex multi-plex assays	2
Pro-inflammatory cytokines	2
microglia and astrocytes	2
immunohistochemical stainings	2
Nrf2-target genes	2
ARE-luciferase mice	2
6 month old transgenic APP/Psen1 mice	2
AD.MethodsThe kavalactone methysticin	2
anti-inflammatory transcription factor	2
subcutaneous white adipocytes	2
pink adipocytes	2
mammalian model organisms	2
so-called pink adipocytes	2
white and brown adipocytes	2
common functional subunits of adipose tissue	2
internal and external stimuli	2
complex and multi-faceted organ	2
Adipose tissue	2
GLP-1 (r=−0.45, p<0.001) and nitrite (r=−0.29,	2
FM and FFM	2
total body water, intra- and extra-cellular water	2
summit	2
Everest base camp (EBC 5300m)	2
24 investigators	2
Caudwell Xtreme Everest expedition	2
adipokines and inflammatory mediators	2
localized H2O2 pools	2
simple molecule	2
final regulatory redox target	2
H2O2-dependent oxidability	2
endothelial cells and brain tissue	2
active to ‘deactive’ form	2
PTEN-induced putative kinase 1 (PINK1)	2
superoxide burst	2
final acceptor of the respiratory chain	2
CA3 and dentate gyrus in the hippocampus	2
anti-oxidant system	2
superoxide dismutase (SOD), reduced glutathione (GSH) and glutathione peroxidase (GPx)	2
Antioxidant defence systems	2
brain extracts	2
rats exposed	2
hypoxic organ	2
antioxidant agents	2
H2O2, (100–1000µM)	2
H2O2 (1–1000µM)	2
Human neuroblastoma SH-SY5Y cells	2
cholinergic system	2
monocyte adhesion	2
AKT/eNOS pathway	2
VCAM1 and SELE	2
Pro-inflammatory adhesion molecules intercellular adhesion molecule-1 (ICAM1), vascular cell adhesion molecule-1 (VCAM1), selectin E (SELE) and chemokine (C-C motif) ligand 2 (CCL2/MCP-1)	2
1 (HMOX1) or NAD(P)H quinone dehydrogenase 1 (NQO1)	2
target genes heme oxygenase (decycling)	2
nuclear factor erythroid 2-related factor 2 (NRF2)	2
aqueous cigarette smoke extract (CSEaq)	2
Primary human endothelial cells	2
mitochondrial antioxidants	2
F1Fo ATPase	2
neurons of the patients	2
patients of FTDP-17	2
4R tau isoforms	2
encoding tau	2
Tau protein inclusions	2
GSTP substrate	2
potential	2
MDA-MB-231, cells	2
L-cysteine source NAC	2
GSTP-lacking MCF7	2
GSTP substrate CDNB	2
carmustine (BCNU)	2
GSTP1 expressing MDA-MB-231 cells	2
intracellular glutathione (GSH) by buthionine sulfoximine (BSO)	2
MDA-MB-231 differentially expressed glutathione-S-transferase (GSTP1)	2
MDA-MB-231	2
glutathione peroxidase (GPX4)	2
two phenotypically and genotypically different breast adenocarcinoma cell lines, MCF7 and MDA-MB-231, to hypericin PDT (HYP-PDT)	2
different cancers	2
stem cell population	2
mitochondrial uncoupling protein 3	2
MnSOD and catalase	2
C57B/L6 mice	2
mouse primary bone marrow cells	2
redox- active MnSOD mimetic	2
MnTnBuOE-2-PyP5+(MnP)	2
mouse hematopoietic stem/progenitor cells (HSPC)	2
scavenger of ROS in mitochondria	2
human manganese superoxide dismutase (MnSOD) gene	2
family of leukocyte-activating platelet phospholipids	2
structures and cellular synthetic pathway	2
free eicosanoid	2
Purified platelet DXA3-PE	2
human clots	2
four DXA3-PEs	2
newly formed DXA3	2
cytosolic phospholipase A2 (cPLA2), phospholipase C and intracellular calcium	2
cyclooxygenase-1 (COX), protease-activated receptors (PAR) 1 and 4	2
/DXA3-PEs	2
four esterified eicosanoids, 16:0p, 18:0p, 18:1p and 18:0a	2
8-hydroxy-9,10-dioxolane A3 (DXA3)	2
eicosanoid	2
Activated platelets	2
human liver cancer	2
primary malignancies	2
vicinity of cancer	2
non-malignant lung tissue	2
malignant tissue	2
cancer or stromal cells	2
non-malignant surrounding tissue	2
metastatic	2
surrounding lung tissue	2
HNE-immunohistochemistry	2
primary lung carcinomas	2
HNE-histidine adducts	2
genuine monoclonal antibody	2
malignant and surrounding non-malignant lung tissue	2
4-hydroxynonenal (HNE)	2
major bioactive marker of lipid peroxidation	2
pulmonary metastasis	2
seventeen patients	2
primary lung cancer	2
surrounding non-malignant lung tissue	2
lymphocyte GSH	2
non-toxic form of cysteine	2
0.7 (2g γ-GC) and 1.8 (4g γ-GC) nmol.h/106 lymphocytes	2
106 lymphocytes	2
single oral doses	2
lymphocytes of healthy, non-fasting participants	2
cellular GSH	2
γ-GC supply	2
glutamate cysteine ligase (GCL)	2
orally dosed γ-glutamylcysteine (γ-GC)	2
H2O2 supply sites	2
sulfenate and disulfide forms	2
sulfenic and disulfide forms	2
signaling localized	2
H2O2 sites	2
peroxiredoxin forms	2
Redox targets	2
peroxiredoxin sulfenate and disulfide forms	2
peroxiredoxins I and II	2
H2O2 supply	2
peroxiredoxin	2
early mitogenic signaling time frame	2
typical targets	2
computational reaction-diffusion models	2
cytoplasmic peroxiredoxins	2
cytoplasmic phosphatases, kinases and transcription factors	2
key signaling agent	2
RAGE-ligand interaction	2
new RAGE ligands	2
plasma and milk	2
AGE-albumins	2
specific modified residues and amino acids of the V domain	2
vitro generated AGE-albumins	2
specific VC1 binding partners	2
VC1 interaction assay	2
insoluble affinity matrix (VC1-resin)	2
magnetic beads	2
yeast Pichia pastoris	2
glycosylated form of VC1	2
VC1 domain	2
extremely specific biological interaction AGEs ligands	2
affinity assay	2
adjacent C1 domain	2
N-terminal domain of RAGE, the V domain	2
pattern recognition receptor (PRR)	2
receptor for AGEs (RAGE)	2
lipoxidation break-down products	2
heterogeneous class of compounds	2
Advanced Glycation and Lipoxidation End products (AGEs and ALEs)	2
Nrf2/Keap1 or NF-κB.	2
master switches	2
H2O2 in biological settings	2
major redox metabolite	2
PAMP-triggered immunity	2
MAPK cascades	2
yeast, plants, flies to mammals	2
evolutionarily conserved modules	2
(MAPK) cascades	2
Mitogen-activated protein kinase	2
freshly hatched and developing worms	2
gcs-1 knockdown	2
γ-glutamylcysteine synthetase (gcs-1) expression	2
p53-orthologue, CEP-1	2
100µM DEM	2
Cytoprotective target genes of DAF-16 and SKN-1	2
Nrf2 orthologue, SKN-1	2
FoxO orthologue, DAF-16	2
low and moderate doses of DEM (10–100µM)	2
GSH and other thiols	2
α,β-unsaturated carbonyl compound	2
Diethyl maleate (DEM)	2
model organism Caenorhabditis elegans	2
major intracellular redox buffer	2
glutathione (GSH)	2
low-molecular mass and protein-bound thiols	2
diabetic kidney	2
tubular cells	2
seahorse bio-analyzer	2
human primary mesangial (HMCs) and proximal tubular cells (HK-2)	2
renal mitochondria	2
renal tubular and mesangial cells	2
noxious stimuli	2
TSPO expression	2
many pathological states of the CNS	2
mitochondrial Translocator Protein 18kDa (TSPO)	2
pro-inflammatory cytokines and reactive oxygen species (ROS)	2
brains innate immune effector cells, microglia	2
exogenous and endogenous sulfide bioavailability	2
claudin 5 protein expression	2
endothelial junction structures	2
reduced endogenous bound sulfane sulfur	2
CSE deficient MAECs	2
sulfide donors	2
endothelial junction proteins claudin 5 and VE-cadherin	2
free sulfide donors	2
polysulfide donors	2
Miles assay	2
predominant source of H2S	2
mice lacking cystathionine γ-lyase (CSE)	2
endogenous H2S, mouse aortic endothelial cells (MAECs)	2
exogenous H2S.	2
Different H2S donors	2
various metabolites	2
free H2S	2
important gaseous signaling molecule	2
Hydrogen sulfide (H2S)	2
NOX enzyme	2
bioactivation of nitrite	2
p47phox and p67phox subunits	2
cell culture medium	2
Biotin Switch assay	2
p22phox	2
NOX2 subunits	2
nitrite-derived nitric oxide (NO) production	2
NOX subunits	2
lipid and cholesterol metabolites	2
different lipid dietary model	2
lipids and oxysterols profile	2
combination model	2
HFA or HCh diets	2
fatty acids and oxysterols	2
high fat and high cholesterol (HFA+FCh) diets	2
high fatty acids (HFA), high cholesterol (HCh)	2
nutritional model	2
samples of diabetic patients	2
Vitreal fluids	2
epiretinal membranes	2
control (non-diabetic) patients	2
PDR patients	2
] content	2
advanced glycation endproducts (AGE); protein carbonyl and glutathione (GSH)	2
various target organs	2
downstream antioxidant gene targets	2
Nrf2 paralogs	2
zebrafish gstp	2
standard mammalian-derived canonical sequence	2
functional elements	2
except gstr	2
heme oxygenase 1, peroxiredoxin 1, glutamate-cysteine ligase, and the glutathione S-transferases pi and rho (hmox1, prdx1, gclc, gstp, and gstr)	2
promoter flanking sequences	2
functional target AREs	2
strong activating factor	2
one of the zebrafish forms	2
nearest non-salmonid outgroup	2
singleton ortholog of the esocid Esox lucius	2
Nrf2A and -2B	2
salmon paralogs	2
ecologically important salmonid, Oncorhnychus kisutch (coho salmon)	2
non-model teleost	2
zebrafish paralogs	2
non-model aquatic organisms	2
mechanistic pathway	2
one ARE target	2
(Nuclear Factor, Erythroid 2-Like 2, or NRF2)	2
transcription factor NFE2L2	2
role of free radicals	2
Anti-DMPO antibodies	2
macromolecule-derived radicals	2
free radicals in biological systems	2
spin trap	2
macromolecule-DMPO-nitrone adducts	2
anti-DMPO nitrone antibodies	2
stable product	2
stable macromolecule-DMPO-nitrone product	2
nitroxide radical adducts	2
protein- and DNA-DMPO	2
spin trap 5, 5-dimethyl-1-pyrroline N-oxide (DMPO)	2
amino acid- and DNA base-derived radicals	2
human lenses	2
matched pair controls	2
whole human lenses	2
FHL124 cells	2
FHL124 cell line and whole human lenses	2
targeted siRNA	2
human lens epithelial cell line FHL124 and whole human lens cultures	2
non-cirrhotic and cirrhotic non-malignant liver tissues	2
tumoural tissues	2
p=0.7722)	2
tumors of Australian hepatocellular carcinoma patients	2
Southern African patients	2
non-malignant liver tissue	2
hepatocellular carcinoma tissue	2
Royal Brisbane and Women's Hospitals	2
Princess Alexandra Hospital	2
hepatocellular carcinoma patients	2
tumors of hepatocellular carcinoma patients	2
8-oxy-2′-deoxy-guanosine (8-oxodG)	2
mouse depleted of GSH	2
permeabilized liver mitochondria	2
enzymatically active glutaredoxin-2 (Grx2) in reaction mixtures	2
2.5mM GSH	2
purified Ogdh	2
reduced (GSH) and oxidized (GSSG)	2
important mitochondria redox sensor	2
2-Oxoglutarate dehydrogenase (Ogdh)	2
catalase and MnSOD contents	2
6% O2	2
myoblasts grown	2
DCF fluorescence	2
diacetate (CM-DCFH-DA).Data	2
different specificities i.e. dihydroethidium (DHE), 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM DA) and 5-(and-6)-chloromethyl-2′,7′ -dichlorodihydrofluorescein	2
Primary mouse satellite cells	2
RONS in cultured skeletal muscle cells	2
number of cell types	2
Cultured cells	2
intracellular ROS signaling	2
FOXO- and sirtuin-dependent regulatory mechanisms	2
Nrf2-, FOXO-, and sirtuin-dependent mechanisms	2
oxidative stressors	2
lipids and phospholipids	2
crucial downstream signaling molecule	2
target molecules of ROS	2
TRAF6, Rac1, and then Nox	2
current assumed signaling cascade	2
intra-cellular signaling molecules	2
breast cancer cell model	2
aconitase and GAC	2
Krebs cycle enzyme, aconitase,	2
Krebs cycle and glutaminolysis intermediates	2
tumorigenic versus non-tumorigenic cells	2
non-tumorigenic MCF-10A cells	2
non-thiol modifying analog	2
MDA-MB 231 (MB231) breast adenocarcinoma cells	2
model compound, iodobutyl triphenylphosphonium (IBTP)	2
mitochondrial protein thiols	2
certain oxidants	2
reactive thiolate group	2
Critical enzymes	2
electron transport chain and amino acids	2
Many cancer cells	2
outside mitochondria	2
GSH redox buffering network	2
glutathione pool	2
GSH and oxidized glutathione (GSSG)	2
modifiable cysteine residues	2
glutathione moieties	2
variety of molecules	2
protein thiols (SH) forming sulfenic acid (SOH)	2
protein cysteine thiols	2
antioxidant networks	2
reduced glutathione (GSH) and peroxiredoxins (Prx)	2
redox buffering network	2
reactive oxygen species (ROS), superoxide (O2·-) and hydrogen peroxide (H2O2)	2
NADH and NADPH, electron carriers	2
ClearView software	2
hundred and ninety-five out of the three hundred and fifty-three human subjects	2
biophotonic emission	2
ClearViewTM system (ClearView)	2
biophoton emissions	2
dietary phytochemical morin	2
active site of PHLPP2 enzyme	2
morin-conjugated beads	2
Fyn kinase	2
Nrf2 silenced hepatocytes	2
redox enzyme	2
Nrf2-regulated antioxidant defenses	2
tert-butyl hydroperoxide (tBHP) and acetaminophen	2
/Fyn kinase axis	2
PHLPP2-regulated Akt/GSK3β	2
flavonol	2
significant chemo-immunosensitizing agent	2
subtoxic cytotoxic drugs	2
donors/iNOS inducers	2
donor, DETANONOate, and PDT	2
inhibitor, l-NAME	2
NF-kB, Snail, and YY1	2
anti-survival/pro-apoptotic and metastasis suppressor RKIP	2
pro-survival/anti-apoptotic NF-κB, Snail, and YY1	2
PDT-induced NO	2
dysregulated pro-survival/anti-apoptotic NF-κB/Snail/YY1/RKIP loop	2
tumor and the microenvironment	2
/NO	2
deep cancers	2
oral GSH form	2
oral GSH group	2
two commonly used dietary supplements, N-acetylcysteine (NAC) and oral GSH	2
Glutathione (GSH)	2
control and Sorafenib-treated cells	2
Sorafenib-treated cells	2
cell death signaling pathway	2
10µM)	2
cell death receptor expression	2
Sorafenib-treated HepG2 cells	2
advanced hepatocellular carcinoma	2
unique recommended molecular-targeted drug	2
cell death receptor	2
nitric oxide synthase type III (NOS-3)	2
FAS receptor and caspase-8	2
perhydroxyl radicals (HO2.)	2
peroxynitrous acid	2
cell-derived extracellular singlet oxygen	2
extracellular photofrin alone	2
HOCl and the NO/peroxynitrite	2
tumor cell protective catalase	2
nonmalignant and malignant cells	2
photofrin-loaded cells	2
ubiquitin-proteasome system (UPS), autophagy	2
altered proteins	2
antimycin A.	2
mitochondrial DNA double strand breaks	2
A549 lung epithelial cells	2
downstream targets p53	2
nuclear DNA double strand breaks	2
Ataxia telangiectasia mutated (ATM) kinase	2
excessive reactive oxygen species (ROS)	2
prolonged hyperoxia	2
oxygen (hyperoxia)	2
mitochondria targeted antioxidants	2
Administering MitoQ	2
renal vessels	2
kidneys in mice	2
mitochondria targeted antioxidant MitoQ	2
totally inactive molecules	2
population of that specific protein	2
old cells and tissues	2
inactive and abnormal proteins	2
non-enzymatic PTM (nePTM)	2
various enzymatic pathways	2
PTM	2
immune cells of Lyme borreliosis patients	2
Lyme borreliosis patients (n=11)	2
Lyme borreliosis patients (n=32)	2
peripheral blood mononuclear cells (PBMCs) of Lyme borreliosis patients	2
Mitochondrial superoxide	2
bacterial spirochete Borrelia burgdorferi	2
tick	2
cultured ECs	2
bt-15d-PGJ2	2
tryptic peptide	2
additional adduct	2
C157 residue	2
biotin-tagged analog of 15d-PGJ2 (bt-15d-PGJ2)	2
specific cysteine residues	2
covalent adducts	2
electrophilic lipid, 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2)	2
important redox signaling mediator	2
redox signaling compounds	2
active site cysteine residue	2
GTPase Rac1	2
Vascular endothelial cells (ECs)	2
female versus male carotid arteries	2
male VSMC	2
Sprague-Dawley rats	2
rat carotid artery injury model	2
colorimetric assay	2
aortae of Sprague-Dawley rats	2
female vascular smooth muscle cells (VSMC)	2
superoxide dismutase-1 (SOD-1)	2
superoxide (O2•−)	2
etiology	2
neointimal hyperplasia	2
oxide (•NO)	2
selective autophagy subtypes	2
impaired autophagy	2
cilia components	2
bacteria (xenophagy)	2
Selective pathways	2
metabolic precursors	2
cytosolic cargos	2
damaged organelles and proteins	2
cellular pathway	2
elastin homeostasis	2
aged vessels	2
elastin fiber	2
intima, media and adventitia layers of human aortas	2
4-HNE-histidine-adducts	2
elastin fibers	2
intima and media in human aorta	2
aldehyde-adducts	2
aldehydes	2
polyunsaturated fatty acids (PUFA), (4-hydroxynonenal, malondialdehyde, acrolein)	2
extracellular matrix (ECM) components	2
intima and the media	2
Trx metabolism	2
cancer cell counterparts (MDA-MB-231)	2
2DG, DHEA, and Au combinations	2
normal human mammary epithelial cells (HMEC)	2
thiol antioxidant, N-acetylcysteine (NAC, 20mM)	2
three human cancer cell lines	2
2DG+DHEA or DHEA-alone	2
inhibitor of thioredoxin reductase (TrxR) activity (Auranofin; Au, 1µM)	2
inhibitor of glutathione (GSH) synthesis (l-buthionine sulfoximine; BSO, 1mM)	2
(MDA-MB231) cancer cells	2
human prostate (PC-3 and DU145) and human breast	2
pentose cycle using dehydroepiandrosterone (DHEA, 300µM,	2
2-deoxy-d-glucose (2DG, 20mM, 24–48h)	2
catechol group	2
nucleophilic moiety (the catechol/quinone moiety)	2
Keap1 protein	2
electrophilic moiety	2
Nrf2 and phase II enzymes	2
nucleophilic and electrophilic moieties	2
double bond in CA (Michael acceptor)	2
generated hydrogen peroxide	2
coffee polyphenol	2
caffeic acid (CA)	2
Nrf2 in cancer cells	2
Nrf2/Keap1 pathway	2
many polyphenols	2
polyphenols in western diet	2
cells ±UCP2	2
INS-1E cells ±UCP2	2
mitochondrial uncoupling protein-2 (UCP2)	2
equivalent non-targeted probe	2
MitoSOX, a mitochondria-targeted superoxide probe	2
INS-1E insulinoma cells	2
CNP in human dermal fibroblasts (HDF)	2
Redox-active CNP	2
cerium (Ce) oxide nanoparticles (CNP; nanoceria)	2
several phospholipid classes	2
LC3 lipidation	2
effective substrates	2
native and oxidized PE	2
native PE	2
yeast Atg8 lipidation	2
LOX-derived oxidized phospholipid, 12-hydroxyeicosatetraenoic acid-phosphatidylethanolamine (12-HETE-PE)	2
electron dense material	2
numerous cytoplasmic vacuoles	2
defective mitochondria	2
monocytes and macrophages	2
12/15-Lipoxygenase (LOX) enzymatically	2
either catalase or mitochondrial-targeted catalase	2
DRP1 inhibitor mdivi-1	2
wild type controls	2
expressing shRNAs	2
malignant mesothelioma (MM) cells	2
PRX3 a credible therapeutic target	2
FOXM1 and other redox-responsive factors	2
Mitochondrial oxidants	2
principal peroxidase	2
typical 2-Cys peroxiredoxin	2
Peroxiredoxin 3 (PRX3)	2
SOD2 in endothelial cells	2
E2-induced SOD2 expression	2
presence of E2	2
(HFT) mice	2
GC-box on the SOD2 promoter	2
human aorta endothelial cells	2
mitochondrial superoxide dismutase (SOD2)	2
method	2
whole aorta tissue	2
younger and older cells	2
corresponding wild type cells (P=0.0012)	2
MRC5/hTERT (human lung fibroblasts transfected with telomerase) cells	2
RC enzymes	2
liver (P<0.001)	2
skin cell types	2
complex II enzyme	2
human skin complex II	2
skin cell types (P<0.05)	2
RC inhibitor	2
complex II inhibitor, TTFA	2
compromised mitochondrial status (Rho-zero A549	2
tissue cell types	2
epidermal and dermal derived skin cells	2
2 types of human skin cells	2
mitochondrial RC complexes	2
DHR123 fluorescence	2
array of established specific metabolic inhibitors	2
potent generator	2
rat tissues	2
respiratory chain (RC) complexes I, II and III	2
many tissues including skin	2
intense PARylation	2
several NAD-derived ADP-ribose units forming poly(ADP-ribose) (PAR) polymers	2
17 member PARP enzyme family	2
DNA nick sensor enzyme poly(ADP-ribose)	2
signaling nSMase	2
internal and sarcolemmal membranes	2
neither variant	2
detergent soluble membrane proteins	2
85kD isoform lacking exon 11 (nSMase3b)	2
full-length 88kD isoform (nSMase3a)	2
nSMase3 protein doublet	2
nSMase3 (Smpd4 gene)	2
differentiated C2C12 myotubes	2
skeletal muscles of healthy mice and humans	2
nSMase3 protein	2
striated muscle-specific nSMase	2
family of agonist-activated effector enzymes	2
neutral sphingomyelinase (nSMase)	2
connection between systems	2
reduced Flt-1 protein	2
placental angiodysplasia	2
non-pregnant and pregnant mice	2
Female Tet-mev-1 mice	2
doxycycline-induced mutant SDHCV69E transgene	2
Tet-mev-1 conditional transgenic mice	2
infertile couples	2
ATM activator doxorubicin	2
(GLUT1-S490A)	2
ATM target site	2
Ataxia telangiectasia mutated (ATM) inhibitors and activators	2
superoxide generator pyrogallol	2
GLUT1 inhibitors fasentin and phloretin	2
L6 myoblasts	2
glucose and dehydroascorbic acid	2
multitude of H2O2 targets	2
unknown target	2
diverse thiol protein sensors	2
specific regions of chromatin	2
DNA, co-activators or repressors	2
membrane anchors	2
ubiquitin E3 ligase complex	2
Multiple H2O2 sensors and pathways	2
bacteria (OxyR and PerR), lower eukaryotes (Yap1, Maf1, Hsf1 and Msn2/4) and mammalian cells (AP-1, NRF2, CREB, HSF1, HIF-1, TP53, NF-κB, NOTCH, SP1 and SCREB-1)	2
antioxidant or an anti-inflammatory agent	2
potential therapeutic candidate	2
p65 expression	2
Nrf2 and HO-1 expression	2
LPS-induced in vivo lung inflammation model	2
HO-1 expression	2
phosphatidylinositol 3-kinase (PI3K)/Akt pathway	2
p38, JNK and ERK	2
antioxidant proteins and enzymes	2
intracellular reactive oxygen species (ROS) and peroxynitrite	2
potent component	2
tert-butylhydroperoxide (t-BHP)-induced RAW 264.7 macrophage cell line	2
Rheum undulatum L.	2
six stilbene derivatives	2
major transcription factor, nuclear factor (erythroid-derived 2)-like 2 (Nrf2)	2
important anti-inflammatory, antioxidative and cytoprotective enzyme	2
Heme oxygenase-1 (HO-1)	2
chemo-drugs	2
DGLA׳s radical pathway and metabolites	2
widely used chemo-drug	2
5-Fluorouracil (5-FU)	2
exclusive radical derivatives	2
cell cycle inhibitor p27	2
cancer suppressor p53	2
human colon cancer cell line HCA-7 colony 29	2
C-8 oxygenation	2
exclusive DGLA׳s free radical derivatives	2
DGLA׳s free radical derivatives	2
distinct DGLA׳s free radical derivatives	2
DGLA and AA	2
contrasting bioactivities	2
AA and its metabolites (2-series prostaglandins)	2
metabolites (1-series prostaglandins)	2
nutritionally important ω–6 polyunsaturated fatty acids (ω–6s)	2
downstream fatty acid arachidonic acid (AA)	2
Dihomo-γ-linolenic acid (DGLA)	2
mitochondrially produced reactive oxygen species	2
exogenously added lithocholic bile acid enters yeast cells	2
nematode and in human cells	2
UPS-related genes	2
major players	2
UPS	2
nematode, Caenorhabditis elegans	2
simple model organisms	2
proteasome genes	2
UPS system	2
main proteolytic systems	2
Proteasome System (UPS)1	2
Ubiquitin–	2
normal proteins	2
UA and related compounds	2
dysfunctional blood monocytes	2
metabolic stress-induced Nox4 expression	2
THP-1 monocytes	2
glutathione and protein thiols	2
principal enzyme	2
actin-S-glutathionylation	2
global protein-S-glutathionylation	2
chemoattractant MCP-1	2
murine peritoneal macrophages	2
human THP-1 monocytes	2
ursolic acid (UA)	2
multiple bioactive products	2
polysulfides	2
short-lived NO-donor, thionitrite (SNO−)	2
nitrosopersulfide (perthionitrite, SSNO−; λmax 412nm in aqueous buffers, pH 7.4; 448nm in DMF	2
either hydrosulfide or hydrodisulfide	2
‘yellow compound’	2
sulfide donor, GYY4137	2
S-nitrosopenicillamine (SNAP)	2
reporter system	2
RFL-6 cells	2
cell regulatory elements	2
hydrogen sulfide	2
Sulfide salts	2
unfavorable redox environment	2
hematological tissues	2
classical tumor suppressor	2
p53 knock-out model	2
p53 knock-out	2
conditional pan-hematopoietic cell p53 knock-out	2
two well established models	2
MnSOD knock-out	2
pan-hematopoietic cell MnSOD knock-out mice	2
hematopoietic stem cell specific Cre-recombinase mouse model	2
conditional tissue-specific MnSOD knock-out mouse	2
MnSOD constitutive knock-out mouse	2
postulate	2
mitochondrial antioxidant enzyme	2
superoxide dismutase (MnSOD)	2
brain Trx1 mimetic peptides	2
activated AMPK	2
plasma glucose	2
SH-SY5Y cells	2
CB3 and CB4	2
p70S6K kinase	2
AMP-ribose activating kinase (AMPK)	2
thioredoxin-interacting-protein (TXNIP/TBP-2)	2
ZDF rats	2
Daily i.p.	2
thioredoxin mimetic (TxM) peptides, Ac-Cys-Pro-Cys-amide (CB3) and Ac-Cys-Gly-Pro-Cys-amide (CB4) in the brain of male leptin-receptor-deficient Zucker diabetic fatty (ZDF) rats and human neuroblastoma SH-SY5Y cells	2
mitogen-activated kinsase (MAPKs), c-jun NH2-terminal kinase (JNK), p38 MAP kinases (p38MAPK), and extracellular activating kinsae1/2 (ERK1/2)	2
persons without diabetes	2
aged-matched sedentary subjects	2
healthy elderly trained subjects	2
untrained group	2
Hsp70 and Hsp27 proteins	2
stress–protein response (Hsp70 and Hsp27 expression	2
Blood glutathione (GSH, GSSG, GSH/GSSG)	2
control, not exercising group (n=8)	2
Sixteen subjects	2
old people	2
anti-oxidant and stress-induced markers	2
known contributors of ROS	2
diabetic or normal rat aorta	2
ROS in diabetic rats	2
U46619 induced tone	2
control rat aorta	2
Diabetic rat aortas	2
organ bath	2
thoracic aorta	2
CO2 asphyxiation	2
apocynin, SOD, and allopurinol on phenylephrine and U46619 induced contraction	2
highly selective NOX inhibitor VAS2870	2
diabetic (streptozotocin treated; STZ) rat arteries	2
contractile pathways	2
Mdivi-1—an inhibitor	2
permeabilized cells	2
Synthetic VSMCs	2
mitofusin 2	2
platelet-derived growth factor-BB (PDGF)	2
Vascular smooth muscle cells (VSMCs)	2
arterial tissue	2
NAD(P)H oxidases, 12-lipoxygenase, MCP-1, and angiotensin II receptors	2
cytoprotective target genes	2
2mg/kg/day) or vehicle	2
Subgroups of CKD rats	2
Sham-operated rats	2
aorta of rats with CKD	2
Nrf2-mediated antioxidative system	2
pro-inflammatory transcription factor NF-κB.	2
synthetic oleanane triterpenoid compound	2
cytoprotective transcription factor Nrf2	2
disused human skeletal muscle	2
functional SNO-proteins	2
human skeletal muscle	2
novel NO target	2
chronically disused skeletal muscle	2
contractile myosin heavy chains	2
specific calcium release/uptake proteins (SNO-RyR1, –SERCA1 and –PMCA)	2
control muscle fibers	2
superimposed vibration stimuli (RVE, n=7)	2
two bed rest resistive exercise groups	2
bed rest disuse control group (CTR, n=9)	2
calf soleus and hip vastus lateralis	2
Muscle biopsies	2
new NO target proteins	2
healthy male subjects	2
S-nitrosylated (SNO) functional muscle proteins	2
atrophic skeletal muscle	2
Activity-induced nitric oxide	2
mutant brain	2
Nitric oxide	2
NPY/AgRP and pro-opiomelanocortin (POMC) neurons	2
Reactive oxygen species	2
cell culture studies	2
young MPCs	2
young versus old MPCs	2
young (3–4m) and old	2
myoblast precursor cells (MPCs)	2
proteins (protein disulfides, carbonyls and aggregates)	2
young versus old animals	2
physiological O2	2
primary cultures of myoblasts	2
promising renoprotective molecule	2
master regulator of antioxidant response nuclear factor erythroid-derived 2 (Nrf2)	2
compounds such as gentamicin, adriamycin, chloroquine, iron nitrilotriacetate, sodium fluoride, hexavalent chromium	2
several experimental models	2
bifunctional antioxidant	2
several foods	2
spice, pigment and additive	2
Curcuma longa rhizome	2
phenolic compound	2
natural compounds plant-derived	2
current redox-sensitive probes	2
unique environments	2
fluorescent probe technologies	2
many sub-cellular compartments	2
phagosomal redox chemistries	2
phagosomes of macrophages and dendritic cells	2
promising oxidative biomarkers	2
research and clinical settings	2
selected biomarkers	2
stable by-products	2
cardiovascular cells	2
signalling microdomains	2
Redox-sensitive proteins	2
emerging, less well-defined variables	2
Nrf2–NF-κB axis	2
various pharmacological modulators	2
Nrf2 and NF-κB	2
Nuclear factor-kappa light chain enhancer of B cells (NF-κB)	2
endogenous antioxidant defences and detoxifying enzymes	2
antioxidant defence systems	2
redox regulated transcription factor	2
Nuclear factor-2 erythroid related factor-2 (Nrf2)	2
mitochondria targeted HO-1	2
ER associated HO-1	2
mitochondrial HO-1	2
truncated protein	2
heme aa-3 and cytochrome c oxidase (CcO) activity	2
HO-1 and N-terminal truncated HO-1	2
intact	2
N-terminal ER targeting domain	2
cloned cDNA	2
HO-1 protein	2
macrophage RAW-264.7 cells	2
degradation of heme proteins	2
free heme	2
major endoplasmic reticulum (ER) associated heme protein	2
inducible form of Heme Oxygenase-1 (HO-1)	2
cullin 3 (Cul3)	2
members of the cullin family of proteins	2
multimeric complex of E3 ligases	2
essential components of the UPS	2
malfunctioning disposal system of cell protein called ubiquitin–proteasome system (UPS)	2
common marmosets	2
MARS model	2
nonhuman primate model	2
marmoset	2
plasma redox nodes	2
cysteine (Cys), cystine (CySS), glutathione (GSH) and glutathione disulfide (GSSG)	2
two major thiol-dependent redox nodes	2
Blood and extracellular fluid	2
common marmoset (Callithrix jacchus)	2
reactive species (oxidants vs. •NO)	2
XOR-catalyzed reactive species generation	2
nitric oxide synthase	2
beneficial •NO	2
nitrate/nitrite reductase capacity	2
endothelium-independent dilator sodium nitroprusside	2
xanthine oxidase	2
Kreb's buffer	2
endothelium and adventitia	2
aorta 24h	2
SOD3 and SOD1 isoforms	2
gene for Escherichia coli β-galactosidase, SOD1, or SOD3	2
New Zealand rabbits	2
Aortic ring segments	2
extracellular SOD (SOD3)	2
cytosolic superoxide dismutase (SOD1)	2
intracellular and extracellular compartments	2
Superoxide (O2•−)	2
gpx in brain tissue	2
NAD(P)H:quinone oxidoreductase 1 (noq1), Sulfiredoxin 1 (srnx1) and Glutathione Peroxidase 1 (gpx)	2
newborn lung and brain tissue 1 (P1) and 7 (P7) days	2
several redox-sensitive genes	2
(γ-GC) and L-cysteine (CySH)] content	2
Reduced (GSH) and oxidized (GSSG) glutathione and its precursors [γ-glutamyl cysteine	2
mice pups	2
lung and brain	2
preterm infants	2
histone acetyl transferase (HAT) p300	2
processing enzyme calpain	2
N terminal domain	2
Sub-lethal doses of H2O2	2
Alzheimer's, arthritis, atherosclerosis, diabetes and cancer	2
pro-inflammatory cytokine Interleukin-1α (IL-1α)	2
emerging subcellular target	2
blood and tissue	2
bioactive NO	2
physiological storage pool of NO	2
biologically inert metabolite	2
HS saccharide sequences	2
extremely rich tandem mass spectra	2
heparan sulfate-protein binding	2
highly sulfated polysaccharides	2
growth factor receptors	2
surface heparan sulfates	2
philosophical and technical underpinnings of GLYDE-II	2
several glycoinformatics tools	2
GLYDE-II	2
data processing software	2
consistent structural representations	2
human language	2
partonomy model	2
diverse computational tools	2
monosaccharides, glycans and glycoconjugates	2
different origin	2
fundamental information well-defined starting material	2
glycans in biological systems	2
synthetic glycans	2
mammalian glycobiology	2
glycan microarrays, glycan nanoparticles and anti-glycan antibodies	2
defined oligosaccharides	2
building blocks and all reagents	2
Glyconeer 2.1™ synthesizer	2
many biological systems	2
building material	2
dominant biopolymer on earth	2
set of software tools	2
informatics tool	2
large sample sets	2
plate format	2
glycans in a given sample	2
pathological situation	2
protein–GAG complexes	2
corresponding protein–heparan sulfate interaction networks	2
pericellular matrix	2
protein–heparan sulfate interactions	2
multimolecular complexes	2
SummarySulfated glycosaminoglycans (GAGs) are complex polysaccharides	2
2-C-substituents	2
target cavity	2
2-C-branched antagonists	2
selected antagonists	2
2-C-branched mannosides	2
equatorial 2-position of the mannose	2
Ile13, Phe142 and Asp140	2
previously unexplored cavity	2
crystal structure of FimH	2
mannose core	2
wide range of lipophilic aglycones	2
mannose moiety	2
FimH antagonists	2
human bladder cells	2
mannose-specific bacterial lectin FimH	2
uropathogenic Escherichia coli (UPEC)	2
SummaryUrinary tract infections (UTIs)	2
flexible glycans of bacterial origin	2
respective glycan	2
glycan interaction sites	2
TSP-oligosaccharide complexes	2
bacterial cell surfaces oligosaccharides	2
Bacteriophage tailspike proteins (TSP)	2
standardized ontologies and formats	2
disparate sets of data	2
carbohydrate epitopes and antibodies	2
comprehensive database	2
Another database	2
GlycoProtDB database	2
several glycoscience-related databases	2
Glycobiology and Glycotechnology Database (JCGGDB)	2
Japan Consortium	2
glycoscience databases	2
group of glycoscientists	2
hydratase-aldolases	2
two of the enzymes (NahE and PhdJ)	2
two hydratase-aldolases in the phenanthrene pathway (PhdG and PhdJ)	2
hydratase-aldolase in the naphthalene pathway (designated NahE)	2
double bond of an α,β-unsaturated ketone	2
hydratase-aldolase	2
isomerase opens the ring	2
ring fission	2
high molecular weight PAHs (e.g., phenanthrene, fluoranthene, and pyrene)	2
many of the enzymes	2
substrates and products	2
pervasive environmental pollutants	2
aromatic hydrocarbons (PAHs)	2
sophisticated enzymes	2
ancestral enzymes	2
root of the tree	2
internal nodes	2
ancestral proteins	2
extant homologous enzymes	2
multiple sequence alignment (MSA)	2
ASR	2
primordial enzymes	2
thioredoxin and peroxiredoxin redox cycles	2
Escherichia coli thioredoxin system	2
realistic computational model	2
common reaction intermediates	2
redoxins)	2
, glutaredoxin, and peroxiredoxin systems	2
amidohydrolase superfamily	2
newly sequenced genes	2
highly divergent sequences	2
experimentally characterized proteins	2
(EA)2 assay	2
Briggs–Haldane reaction scheme	2
7th Beilstein ESCEC Symposium	2
2015 Beilstein ESCEC Symposium	2
dihydrofolate reductase (DHFR)	2
synthetic community	2
illustrative examples	2
diverse range of active pharmaceutical ingredients and alkaloid natural products	2
engineered variants of monoamine oxidase	2
novel ‘smart’ amine donors	2
active pharmaceutical ingredients or key chiral intermediates	2
two enzyme classes	2
ω-transaminases and monoamine oxidases	2
high-value chemicals	2
range of enzymes	2
ethanolamine catabolism	2
novel pathway	2
EFI-EST and EFI-GNT web tools	2
SBP ligand	2
transported solutes	2
physical ligand library	2
ABC, TRAP, and TCT transport systems	2
solute binding proteins (SBPs)	2
EFI	2
microbial and fungal genomes (EFI-GNT)	2
genome neighbourhoods	2
protein families (EFI-EST)	2
sequence and function space	2
web tools	2
National Institutes of Health	2
UniProt database	2
sequence databases	2
Symposium	2
diversity of topics	2
chemical system	2
Beilstein Bozen Symposium	2
soft and dynamic nanomaterials	2
liquid water	2
synthetic nanoparticles	2
organic nanomaterials	2
resulting nanoparticles	2
novel chemotherapeutic delivery systems	2
oxaliplatin analogue	2
soft, synthetic nanoparticles	2
multi-copper containing enzymes	2
disulfide radical ion and the Cu(II)	2
bacterial electron mediating protein azurin	2
two types of proteins	2
carbohydrate and natural products biochemistry	2
Many genes	2
intriguing organism	2
endosymbiotic genomes	2
eukaryotic microalgae	2
phenotypic assays	2
intact biomembrane Phospholipid Bilayer diffusion	2
cells such drugs	2
successful (marketed) drugs	2
real systems	2
several different mechanisms (and theoretical models	2
molecular electronics	2
organic electronic components with flexible molecules	2
two significantly different time domains	2
TET family of proteins	2
histone code	2
O-GlcNAc	2
specific O-GlcNAc site	2
O-GlcNAcylated	2
RNA polymerase II transcription factors	2
polycomb gene	2
glucose, amino acid, fatty acid, energy and nucleotide metabolism	2
major metabolic pathways of the cell	2
nucleotide sugar	2
donor for the O-GlcNAc transferase (OGT)	2
nutrient sensor	2
O-linked N-acetylglucosamine (O-GlcNAc) on serine or threonine residues of nuclear and cytoplasmic proteins	2
well-tuned transport system	2
first of the involved transporters	2
defensive system	2
larval body	2
functional network of transporters	2
complex transport system	2
plant-derived or de novo synthesised glucosides	2
“bioreactors”	2
back	2
glandular reservoirs	2
small droplets	2
impressive repertoire of toxins	2
network of core ‘clock genes’	2
chemists	2
retort	2
variety of reactive molecules	2
ultimate energy quantum and currency	2
orientating pathways	2
bathing medium of life	2
l-enantiomer type	2
Proteinogenic amino acids	2
stable covalent bonds	2
atoms of life	2
arcanes	2
organisation	2
fairly haphazard intertwined collection of chemical compounds	2
polluted environment	2
detoxication enzyme	2
main isoform	2
electrophilic model substrate, 1-chloro-2,4-dinitrobenzene (CDNB)	2
lindane, an organochlorine insecticide	2
glutathione transferase (GST) in 10-week-old juvenile catfish (Clarias gariepinus)	2
efficient detoxication enzymes	2
range of chiral amines employing ω-transaminases and monoamine oxidase variants	2
Highly regio- and stereoselective chemoenzymatic cascades	2
functionalised, chiral building blocks	2
‘toolbox’ of biocatalysts	2
C–C bonds	2
commercially available biocatalysts	2
active pharmaceutical ingredients (APIs) and other medicinally relevant compounds	2
X-ray crystallography, NMR and theoretical calculations	2
isotopes and mutated DADHs	2
alternative substrates, dead end and product inhibitors	2
important amino acids and water molecules	2
member of the short chain dehydrogenase/reductase (SDR) superfamily	2
drosophilid alcohol dehydrogenases (DADH)	2
tautomerase superfamily	2
dehalogenase and decarboxylase activities	2
unknown acetylene compound	2
best substrate	2
Cg10062 mutants	2
hydration and decarboxylation products	2
Pro-1)	2
hydratase/decarboxylase	2
cis-CaaD	2
initial substrate	2
product of hydration	2
malonate semialdehyde	2
hydratase/decarboxylase using propiolate and cis-3-chloro- and 3-bromoacrylates	2
Two acetylene compounds (propiolate and 2-butynoate) and an allene (2,3-butadienote)	2
poor cis-CaaD	2
six critical active site residues (Pro-1, His-28, Arg-70, Arg-73, Tyr-103, and Glu-114)	2
cis-3-chloroacrylic acid dehalogenase (cis-CaaD) homologue	2
characteristic β−α−β fold	2
tautomerase superfamily member	2
[4Fe–4S]-cluster	2
another molecule of SAM	2
another substrate molecule	2
free thiol group of Cys-272	2
transient thiophosphate intermediate	2
C2-hydroxyl	2
final product, PRcP	2
radical intermediate	2
thiophosphate intermediate, methane	2
proS hydrogen of Gly-32	2
transient thiophosphonate radical intermediate	2
phosphorus center of the substrate, PRPn	2
Ado-CH3 and a glycyl radical	2
proR hydrogen from Gly-32 of PhnJ	2
Ado-CH2∙ radical intermediate	2
reduced [4Fe–4S]1+-cluster	2
S-adenosylmethionine (SAM)	2
glycyl and thiyl radicals	2
novel radical SAM enzyme	2
methane and ribose-1,2-cyclic-phosphate-5-phosphate (PRcP)	2
(PRPn)	2
carbon–phosphorus bond	2
C–P lyase complex	2
structural bases	2
single DNA adduct	2
mispairs	2
several DNA polymerases	2
isomeric etheno guanine adducts	2
DNA adduct/DNA polymerase pairs	2
single-tryptophan mutants of Sulfolobus solfataricus Dpo4 and human (h) pol κ	2
minimum kinetic models	2
damaged DNA.Pre-steady-state kinetic analysis	2
forms of life	2
Translesion DNA polymerases	2
replicative DNA polymerases	2
exogenous and endogenous factors	2
pose	2
ternary structure of the FosB·Zn(II)·fosfomycin·l-Cys complex	2
preferred divalent cation and thiol substrate	2
Mn(II)	2
Staphylococcus aureus and Bacillus cereus	2
high-resolution X-ray diffraction structures	2
pathogenic strains of Staphylococcus and Bacillus	2
fosfomycin resistance proteins	2
many Gram-positive organisms	2
FosB-type fosfomycin resistance proteins	2
oxirane ring of the molecule	2
nucleophiles such as water, glutathione (GSH), l-cysteine and bacillithiol (BSH)	2
Fosfomycin resistance proteins	2
Gram-positive and Gram-negative pathogens	2
antibiotic, fosfomycin [(1 R,2 S)-epoxypropylphosphonic acid]	2
Certain strains of the soil microorganism Streptomyces	2
“glucokinase” (hexokinase D or hexokinase IV)	2
natural substrate	2
enzyme conformations	2
oligomer	2
substrate binding site per enzyme molecule	2
Two main models	2
threonine deaminase and aspartate transcarbamoylase	2
glucose	2
groundwork	2
doctoral thesis of Victor Henri (Henri, 1903)	2
Leonor Michaelis and Maud Menten (Michaelis and Menten, 1913)	2
enzyme-kinetic assays	2
model simulations	2
Realistic mathematical models	2
experimental design	2
moonlighting proteins	2
low-water systems	2
enzyme preparation	2
aqueous buffers	2
solid or protein	2
activity units	2
interfering substances	2
commercial preparations of the enzymes	2
commercial preparations	2
vendors	2
various sectors of industry	2
IUBMB	2
International Union of Biochemistry (IUB, now IUBMB)	2
defined enzyme units	2
complex enzyme assays	2
assay mixtures	2
enzyme assay	2
substrates and enzymes	2
assay components	2
individual enzyme	2
mammalian sources	2
essential components like substrates and enzymes	2
assaying enzymes	2
SABIO-RK	2
different publications	2
controlled vocabularies, ontologies and external databases	2
biological experts	2
whole publication	2
biochemical reaction networks	2
web-accessible, manually curated database	2
SABIO-RK (http://sabio.h-its.org/)	2
experimentally identified and theoretically predicted enzymes	2
concrete example cases	2
ortholog groups	2
specific organisms	2
enzyme genes	2
reactions, reactant pairs	2
orthologous groups	2
enzyme genes (KEGG Orthology; KO	2
similarity groups	2
enzyme reactions	2
similarity group	2
many different viewpoints	2
KEGG (Kyoto Encyclopedia of Genes and Genomes) database	2
possible enzymes, reactions and metabolites	2
public literatures and databases	2
enzyme protein sequences (or structures	2
nomenclature of enzymes	2
valuable library	2
IUBMB׳s Enzyme List	2
enzyme ligands chemical structures	2
ontologies and controlled vocabularies	2
biological enzyme sources	2
classified enzymes	2
enzyme nomenclature part of BRENDA	2
world׳s main information system	2
addenda (AMENDA, FRENDA, DRENDA)	2
BRENDA enzyme database	2
IUBMB biological nomenclature committee	2
accepted or recommended names	2
enzymes and ligands	2
relevant data	2
huge datasets	2
modern life sciences	2
biochemical substances	2
standards documents	2
biochemical and biological systems	2
reporting format	2
common enzyme classes	2
robust and sensitive enzyme assays	2
bench top assays	2
HTS enzyme assays	2
key steps and methods	2
actively translating pool of ribosomes	2
fascinating disorder	2
nascent particle	2
SBDS protein	2
human ribosomopathies	2
large 60S and small 40S ribosomal subunits	2
essential macromolecular machines	2
diverse tissue-specific disorders (ribosomopathies)	2
inositol lipid kinases	2
non-ATP binding sites	2
altered ATP- or PI5P-binding sites	2
two PI5P4Kγ mutants	2
three mammalian PI5P4Ks	2
ATP-competitive inhibitor I-OMe Tyrphostin AG-538	2
γ (PI5P4Kγ)	2
Phosphatidylinositol-5-phosphate 4-kinase	2
important family of enzymes	2
phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks)	2
Ras and Gβγs	2
up-gradient leading edge	2
eGFP-PH reporters	2
Class	2
authentic mouse neutrophils	2
eGFP-PH reportersand electron microscopy (EM).We	2
mouse neutrophils	2
important cue	2
leading edge of migrating cells	2
primary lipid products PtdIns(3,4,5)P3 and PtdIns(3,4)P2 preferentially	2
phosphoinositide 3-kinases (PI3Ks)	2
different acyl species of PIP3	2
PI3Ks and PIP3-phosphatases)	2
several different molecular species	2
interconvert phosphoinositides	2
polyunsaturated C38:4 and C38:3 species	2
PIP2 species	2
arachidonate supplementation	2
combined PIP3 species	2
C38:4 PIP3	2
Class I PI3K	2
either normal or arachidonate-enriched conditions	2
combined species	2
total species	2
phosphoinositide classes	2
C38:4 species	2
BSA-loaded arachidonic acid	2
phosphoinositide class (approx.	2
C36:2, C38:4, C38:3, C38:2 and C36:1 diacylglycerol backbones	2
abundant species of PI, PIP, PIP2 and PIP3	2
either serum or serum starved	2
MCF10a cells	2
phosphoinositide species	2
sn-2 position	2
diverse molecular species of phosphoinositides	2
stearoyl/arachidonyl (C38:4) diacylgycerol backbone	2
primary mammalian tissue	2
FGFR and other tyrosine kinases	2
GyrB.FGFR1KD.TC homodimer	2
phosphorylation-dependent TR-FRET readout	2
mTurquoise fluorescent protein (mTFP)	2
downstream effector of FGFR1	2
Src homology 2 (nSH2) domain of phospholipase Cγ (PLCγ)	2
FlAsH-tagged GyrB.FGFR1KD.TC and N-terminal	2
bimolecular system	2
biarsenical dyes FlAsH-EDT2 and ReAsH-EDT2	2
coumermycin-induced artificial dimerizer (GyrB), FGFR1 kinase domain (KD) and a tetracysteine (TC) motif	2
exogenous fluorogenic probes	2
genetically encoded, site-specifically incorporated, bioorthogonal reporter	2
minimally invasive, molecularly precise optical probes	2
protein tyrosine kinase activity	2
In vitro and in vivo imaging	2
PI5P4Ks	2
substrate, phosphatidylinositol 5-phosphate (PI5P)	2
mainstream	2
family of phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks)	2
classical mammalian PLD's, PLD1 and PLD2	2
survival signals	2
gastric, colorectal, renal, stomach, esophagus, lung and breast	2
PLD1 or PLD2 (the two mammalian isoforms of PLD)	2
cancer regulators (Ras, PDGF, TGF and kinases)	2
variety of partners	2
cellular or intracellular membranes	2
Phospholipase D (PLD)	2
PI3Ks	2
different p110 isozymes	2
C2/iSH2 inhibitory contact	2
class IA isoforms	2
cSH2 contact	2
C-lobe of the kinase domains of p110β and p110δ	2
nSH2 contact	2
class IA enzymes	2
p110 helical domains	2
RTK-pY binding	2
subset of these inhibitory contacts	2
phosphotyrosine-containing peptides (RTK-pY)	2
inhibitory contacts	2
p110 catalytic subunits	2
PIP2 yielding PIP3	2
identical p85-related subunits	2
catalytic subunits of all class IA phosphoinositide 3-kinases (PI3Ks)	2
fascinating area	2
ATP and inositol pyrophosphate	2
known functions	2
polymer polyP	2
inorganic polyphosphates (polyP)	2
Inositol pyrophosphates	2
protein kinases and phosphatases	2
phosphate monoester	2
nucleic acid structure	2
Phosphate diesters	2
life forms	2
phosphate PO43− configuration	2
additional patients	2
BMD+ FRAX®	2
additional 1 patient	2
degraded microstructure	2
serial DXAs	2
prior BMAs	2
postmenopausal breast cancer patients	2
TBS and FRAX®	2
bone microarchitecture	2
bone-modifying agent (BMA)	2
additional osteopenic patients	2
current standard-of-care screening tool	2
hormone-receptor positive breast carcinoma	2
IntroductionAromatase-inhibitors (AIs)	2
premenopausal women	2
osteoblastic niche	2
bone microenvironment	2
primary tumour and bone microenvironment	2
paracrine factors activin and follistatin	2
ovarian endocrine hormone, inhibin	2
bone metastatic niche	2
similar paracrine factors	2
reproductive endocrine hormones	2
bone targeted agents bisphosphonates and denosumab	2
endocrine)	2
locally (paracrine)	2
multiple host cells	2
new metastatic environment	2
marrow adipose tissue	2
local regulators	2
Bone marrow adipocytes	2
osteolytic bone metastasis	2
osteoclasts and breast cancer cells	2
tumour growth	2
bone-derived factors	2
normal bone-resorbing cells	2
parasite's genome	2
druggable (epigenetic) target	2
novel/repositioned anti-schistosomals	2
potent and selective SmLSD1 compounds	2
attractive new target	2
L10 and L8	2
schistosomes co-cultivated	2
schistosomula, 9 for juveniles, 1.5 for adults)	2
active compound L10	2
surrogate human cell line (HepG2)	2
tegumental surfaces	2
juvenile (3 wk old) and mature (7 wk old) schistosome stages	2
active compounds (L10 - pirarubicin > L8 – danunorubicin hydrochloride)	2
Roboworm anthelmintic discovery platform	2
three structural analogues of L7 (L8 – L10)	2
six of these seven (L1 – L6)	2
target pocket of SmLSD1 vs Homo sapiens HsLSD1	2
putative inhibitors	2
S. mansoni Lysine Specific Demethylase 1 (SmLSD1, Smp_150560) homolog	2
histone methyltransferases (HMTs) and the histone demethylases (HDMs)	2
two families of druggable epigenetic targets	2
PZQ-insensitive juvenile schistosomes	2
single class chemotherapy, praziquantel (PZQ)	2
fasciolosis and schistosomiasis	2
potent analogues	2
novel broad acting anthelmintic triterpenoid	2
liver and blood flukes	2
surface membranes	2
3 for adult females	2
4 for adult males	2
S. mansoni	2
mature flukes	2
potent triterpenoid (700015; anthelmintic EC50s range	2
representative mammalian cell lines (MDBK and HepG2)	2
tetracyclic steroid-like nucleus core and a lactone side chain	2
two most active triterpenoids	2
F. hepatica and S. mansoni larval and adult lifecycle stages	2
mature bark of Abies species	2
ten triterpenoids	2
animal and human populations	2
new anthelmintics	2
endemic communities	2
laboratory settings	2
single class chemotherapies triclabendazole (F. hepatica) and praziquantel (S. mansoni)	2
Two economically and biomedically important platyhelminth species, Fasciola hepatica (liver fluke) and Schistosoma mansoni (blood fluke)	2
useful framework	2
bus-8 mutant	2
extra-pharyngeal sites	2
control (N2) and drug-resistant worms (avr-14; avr-15; glc-1, unc-38 and unc-49)	2
different ICs/NTRs	2
ivermectin, levamisole and piperazine	2
panel of anthelmintics	2
head-first vs. tail-first)	2
neuromodulator serotonin, or with E. coli bacteria (C. elegans’ food in the laboratory)	2
perfusing 8-channel microfluidic devices (chips)	2
drugs, compounds or natural products	2
anthelmintic bioactivity	2
pharyngeal pumping (feeding)—in Caenorhabditis elegans and parasitic nematodes	2
muscles and neurons of the pharynx	2
electropharyngeograms (EPGs)—the electrical signals	2
medium-throughput platform	2
valuable anthelmintic targets	2
current anthelmintics	2
neurons and muscles: ion channels (ICs) and neurotransmitter receptors (NTRs)	2
Many anthelmintic drugs	2
improved formulations of buparvaquone	2
secondary alveolar echinococcosis	2
cytochrome bc1 complex	2
Seahorse XFp Analyzer	2
isolated E. multilocularis cells	2
parasite mitochondria	2
vitro cultured E. multilocularis metacestodes	2
anti-theilerial drug MMV689480 (buparvaquone) and MMV671636 (ELQ-400)	2
400 compounds of the Medicines for Malaria Venture (MMV) Pathogen Box	2
alternative drugs	2
benzimidazoles (albendazole and mebendazole)	2
fox tapeworm Echinococcus multilocularis	2
effective chloroquine analogs	2
active in vitro and in vivo	2
linear side chain	2
chloroquine analog	2
P. berghei infected mice	2
sensitive and chloroquine-resistant P. falciparum blood parasites	2
chloroquine analogs	2
powerful mutation detection and quantification assay	2
resistance-determining mutant allele	2
faecal larval cultures	2
Sequencing (NGS) platform	2
single-worm samples	2
newly developed ddPCR assay	2
common resistance-conferring mutation F200Y (TAC) in the β tubulin isotype 1 gene	2
benzimidazole drugs	2
H. contortus strains	2
resistance-predicting alleles	2
resistant worms	2
resistant strains of this parasite	2
blood-sucking abomasal nematode	2
one of most frequently encountered drug-resistant GINs	2
gastrointestinal nematode (GIN) parasites of grazing ruminants	2
public-private partnerships	2
drug discovery pipelines	2
existing therapeutics	2
Drug-resistant parasite strains	2
first-choice drugs	2
cutaneous lesions	2
complex group of diseases	2
, Trypanosoma cruzi and Trypanosoma brucei subspecies	2
Tritryps diseases	2
clinical and epidemiological contexts	2
ML-resistant heartworms	2
2-SNP model	2
predictive SNP combination models	2
SNP sites	2
genomic DNA extraction	2
single standard dose of Advantage Multi®	2
blood collection, dosing and prepaid shipping	2
participating veterinary clinics	2
surrogate clinical assay	2
microfilaraemia in infected dogs	2
L3 or microfilarial stages	2
reliable in vitro assays	2
wild-type populations	2
genomes of ML-resistant isolates	2
ML-resistant Dirofilaria immitis isolates	2
(ML) endectocides	2
macrocyclic lactone	2
E. multilocularis	2
trifluoromethyl residue on position 8 of the quinoline structure	2
amino group-containing residue	2
2-piperidylmethanol group of mefloquine	2
mefloquine and ten derivatives	2
mg/L	2
mefloquine-treated animals	2
liver squeeze chamber	2
parasite lesions	2
intraperitoneal inoculation of metacestodes	2
anti-malarial mefloquine	2
novel drugs	2
tumor-like growth	2
continuously proliferating metacestode (larval stage) of the parasite	2
disease alveolar echinococcosis (AE)	2
cestode E. multilocularis	2
schools	2
three other schools	2
schoolchildren in Rwanda	2
J. Parasitol, 7, 262–271)	2
(Int. J. Parasitol, 2018, 8, 67–69)	2
piperaquine survival assay	2
artemisinin, chloroquine and piperaquine	2
3D7 genetic background	2
plasmepsin II and plasmepsin III	2
haemoglobinases Plasmepsin II and Plasmepsin III	2
Cambodia and adjacent countries	2
population of Plasmodium falciparum parasites	2
remaining parasites	2
emerging artemisinin resistance	2
Dihydroartemisinin-piperaquine	2
evolving drug-resistant parasites	2
artemisinin efficacy	2
partner drugs	2
Artemisinin derivatives	2
FAD-dependent oxidoreductases	2
nitro compounds	2
wildtype trophozoites	2
ornithine-carbamyl-transferase activity	2
nitro compound-resistant C4 trophozoites	2
FAD contents	2
oxygen consumption and resazurin reduction assays	2
trophozoites of both strains	2
corresponding wild-type strain WBC6	2
strain C4	2
stable metronidazole- and nitazoxanide-resistant Giardia lamblia WBC6 clone	2
metronidazole and other nitro compounds	2
adult females	2
iron transporter	2
DMT1 in B. malayi	2
lateral chords, and reproductive tissues of males and females	2
intestinal brush border	2
adult female and male B. malayi and Onchocerca volvulus	2
low-iron medium	2
iron transport-deficient yeast strain	2
functional iron uptake assays	2
iron-deficient fet3fet4 strain of Saccharomyces cerevisiae	2
B. malayi NRAMP ortholog	2
highly conserved family of NRAMP proteins	2
filarial ortholog of Divalent Metal Transporter 1 (DMT1)	2
neglected parasitic diseases	2
Lymphatic filariasis	2
bovine babesiosis and equine piroplasmosis	2
Babesia/Theileria parasites	2
IC50	2
highly effective anti-Babesia/Theileria drug	2
three species tested, B. bovis, B. bigemina and T. equi	2
vitro cultures	2
cultured B. bovis, B. bigemina and T. equi	2
Draxxin® (tulathromycin)	2
vast range of bacteria and Plasmodium yoelli, a Babesia and Theileria related intra-erythrocytic apicomplexan	2
macrolide antibiotic	2
safe and effective alternative drugs	2
T. equi	2
pathogen contamination	2
potential erythrocyte antigen	2
B. bovis and B. bigemina	2
live-attenuated vaccines	2
worldwide tick-borne hemoprotozoan	2
Babesia bovis, Babesia bigemina and Theileria equi	2
ovine Eimeria spp	2
CI 	2
20 farms	2
controls from the 20 farms	2
treated lambs	2
untreated lambs	2
second faecal sample	2
One twin of each pair	2
Norwegian sheep farms	2
8 pairs of twin lambs	2
Ovine Eimeria spp.	2
schistosome parasites	2
DNA transposon classes	2
5-AzaC-treated and control females with long terminal repeat (LTR) and	2
46 repeats	2
protein coding genes	2
5-ethynyl-2′-deoxyuridine (EdU) positive cells	2
proliferating schistosome cells	2
adult female stem cells	2
female-schistosomes	2
adult schistosomes	2
amino acid metabolism	2
5-AzaC treated females	2
amino acid-, carbohydrate-, fatty acid-, nucleotide- and tricarboxylic acid (TCA)- homeostasis	2
S. mansoni gene products	2
ribonucleoside analogue	2
ribonucleoside analogue 5-azacytidine (5-AzaC)	2
endemic or emerging areas	2
schistosome egg production	2
tissue-trapped eggs	2
human babesiosis	2
antibabesial drug	2
potent drug	2
B. microti	2
vitro cultures of Babesia and Theileria parasites	2
two-drug combination of 17-DMAG with diminazene aceturate (DA) and atovaquone (AV)	2
tested species	2
host cell lines	2
IC50s	2
MDBK and NIH/3T3 cell lines	2
17-DMAG on B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi	2
species tested	2
B. microti–infected mouse model	2
vitro cultures of Babesia and Theileria species, including B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi	2
Hsp90 inhibitor	2
17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG)	2
chaperone protein	2
Heat shock protein 90 (Hsp90)	2
liver fluke GPCRs	2
frizzled and adhesion/secretin families	2
broad complement of GPCRs in F. hepatica	2
pathogenic intra-mammalian juvenile parasites	2
various developmental stages	2
acetylcholine, neuropeptide F/Y, octopamine or serotonin	2
seventeen receptors	2
deorphanised rhodopsins	2
exquisitely selective anthelmintics	2
unique flatworm ligands	2
new members of existing groups (PROF1/Srfb, Rho-L, Rho-R, Srfa, Srfc) of flatworm-specific rhodopsins	2
available flatworm genomes	2
larger cohort	2
new sub-group of potential flukicide targets	2
non-flatworm sequences	2
highly diverged rhodopsins in F. hepatica	2
five frizzled, one smoothened, and one secretin GPCR	2
glutamate, 135 rhodopsin, two adhesion	2
parasitic helminth	2
silico ligand-receptor predictions	2
largest set	2
largest cohort of GPCRs	2
high confidence GPCRs	2
F. hepatica genome	2
GPCR-targeted anti-parasite drugs	2
anti-Toxoplasma molecules	2
compound 363	2
different human cell lines	2
range of known anti-Toxoplasma compounds	2
best-performing compound (named 363)	2
synthetized compounds	2
anti-histone deacetylase (HDAC)	2
Leishmania, Trypanosoma, and Toxoplasma	2
series of aminophenylhydroxamates and aminobenzylhydroxamates	2
multiple nAChR subtypes	2
heterologously expressed receptors	2
adult A. suum	2
monepantel on muscle flaps	2
A. suum	2
expressed receptors	2
non-competitive antagonist	2
acetylcholine induced currents	2
UNC-29, UNC-38, UNC-63 and ACR-8 subunits	2
UNC-29, UNC-38 and UNC-63 subunits; and a levamisole preferring subtype (O. dentatum)	2
ACR-16; a pyrantel/tribendimidine preferring heteromeric subtype from O. dentatum	2
nicotine preferring homomeric nAChR subtype from A. suum	2
Ascaris suum and Oesophagostomum dentatum heterologously	2
Caenorhabditis elegans and Haemonchus contortus somatic muscle	2
several nematode species	2
DEG-3/DES-2 type nicotinic acetylcholine receptors (nAChRs)	2
active ingredient	2
anthelmintic drench	2
Zolvix®	2
E. histolytica and human cells	2
PanK activity	2
One compound	2
recombinant EhPanK	2
Kitasato Natural Products Library	2
E. histolytica PanK (EhPanK)	2
Cytosolic enzyme PanK	2
pantothenate kinase (PanK, EC 2.7.1.33), bifunctional phosphopantothenate-cysteine ligase/decarboxylase (PPCS-PPCDC), phosphopantetheine adenylyltransferase (PPAT) and dephospho-CoA kinase (DPCK)	2
CoA pathway	2
four key enzymes	2
human amebiasis	2
enteric protozoan parasite	2
CoA biosynthetic pathway of Entamoeba histolytica (E. histolytica)	2
Coenzyme A (CoA)	2
candidate lead compound	2
concentration-dependent manner (pEC50 5.43 ± 0.43)	2
activated IscaGluCl1	2
fermentation products of Penicillium simplicissimum (strain AK40) grown on okara pulp	2
indole alkaloid okaramine B	2
L-glutamate response	2
pIC50 6.20 ± 0.04) and the phenylpyrazole fipronil (pIC50 6.90 ± 0.04)	2
quisqualate, kainate, AMPA or NMDA	2
mRNA encoding IscaGluCl1	2
agents of Lyme disease	2
black-legged tick, Ixodes scapularis	2
novel L-glutamate-gated anion channel (IscaGluCl1)	2
novel anthelmintics	2
high-throughput system	2
benzoxaborole and isoxazole chemotypes	2
14 compounds	2
tolfenpyrad, auranofin, and mebendazole	2
Pathogen Box chemical library	2
Caenorhabditis elegans, Haemonchus contortus, Teladorsagia circumcincta, and Trichuris muris	2
model and parasitic nematodes	2
panel of known anthelmintics	2
parasitic worms	2
INVertebrate Automated Phenotyping Platform (INVAPP)	2
existing anthelmintic compounds	2
people and farmed livestock	2
Parasitic nematodes	2
cyathostomins in Equidae	2
LMIT	2
IVM resistant larvae	2
IVM sensitive L3	2
IVM resistant	2
populations of L3	2
range of P-gp inhibitors	2
pgp-9 in IVM resistant versus IVM sensitive third stage larvae (L3)	2
ML ivermectin (IVM) in cyathostomins	2
ABC transporters, P-glycoproteins (P-gps)	2
widely used anthelmintics, the macrocyclic lactones (ML)	2
licenced anthelmintics	2
three novel anthelmintic classes	2
equine gastrointestinal cyathostomins (Phylum Nematoda; Superfamily Strongyloidea)	2
particular isolate	2
investigated CYPs	2
CYP HCOI01579500	2
susceptible HcH isolate	2
intermediately resistant IRE isolate	2
β-tubulin SNP	2
susceptible and intermediate-level BZ-resistant isolates	2
multi-drug resistant WR isolate	2
CYP34/35 family member HCOI100383400	2
TBZ inducible	2
resistance-associated β-tubulin SNPs	2
fourth-stage larvae of two susceptible and three BZ-resistant Haemonchus contortus isolates	2
CYP34/35 and CYP31 families	2
5 CYPs	2
BZ and/or xenobiotic inducible and thiabendazole (TBZ)	2
several members of the CYP34/35 and CYP31 families	2
Cytochrome P450 monooxygenases (CYPs)	2
egg hatch assay (EHA)	2
multi-genic	2
substitutions F167Y, E198A or F200Y.	2
isotype 1 β-tubulin gene	2
single-nucleotide polymorphisms (SNPs)	2
gastro-intestinal nematode infections	2
anthelmintic drug classes	2
Benzimidazoles (BZs)	2
potential compounds	2
different drug-resistant backgrounds	2
N093 clinical isolate	2
Dd2 strain	2
P. falciparum clinical isolates	2
optimized in vitro growth inhibitory assays	2
four clinical isolates	2
twenty compounds	2
laboratory strains of P. falciparum	2
active antimalarial compounds	2
new, affordable and easily accessible antimalarial drugs	2
new antimalarial drugs	2
potential resistant alleles	2
malaria endemic regions	2
promising antimalarial compounds	2
gene-targets	2
∼2000 Plasmodium falciparum genome sequences	2
New antimalarial compounds	2
antimalarial resistant parasite alleles	2
pyrimidine salvage system	2
deoxynucleotide metabolism	2
5F-2′dUrd	2
inducing drug	2
analogs	2
effective antileishmanials	2
pyrimidine antimetabolites	2
NT2-like genes	2
NT1-like genes of either species	2
L. donovani reports	2
corresponding L. major and L. mexicana genes	2
NT2 gene encoding an inosine transporter	2
two NT1-like genes encoding uridine/adenosine transporters	2
reported L. donovani model	2
adenosine, uridine, 5F,2′dUrd and thymidine and was designated Nucleoside Transporter 1 (NT1)	2
uridine-uracil transporter 1 (UUT1)	2
uracil and the antimetabolites 5-fluoruracil (5-FU) and 5F,2′deoxyuridine (5F,2′dUrd)	2
uridine/adenosine	2
two transporters	2
similar pyrimidine transporters	2
various Leishmania species	2
specific transporters	2
enzyme inhibitors	2
medical and veterinary importance	2
extremely diverse life-cycles of vectors and vector-borne pathogens	2
Chemical entities	2
insects	2
systemic isoxazolines	2
ectoparasitic drugs	2
companion and farm animals	2
calf populations	2
developed model	2
fixed percentage of the population	2
Ostertagia ostertagi, i.e.	2
‘beneficial’ indicator	2
pasture or in untreated hosts	2
efficacious FLBZ regimens	2
rapidly dividing cells	2
adult worm cuticle	2
genes encoding cuticle components	2
treated adult female Brugia malayi	2
experimental rodent models	2
onchocerciasis and lymphatic filariasis (LF)	2
microfilaricidal drugs	2
anthelmintic candidates	2
A. ceylanicum L4s and A. suum L3s	2
1 mM 5HT	2
pig lungs	2
A. suum L3s	2
EPG activity	2
anthelmintic drug ivermectin (IVM)	2
neuromodulator serotonin (5-hydroxytryptamine; 5HT)	2
custom-designed software	2
esophogeal-intestinal valve	2
esophagus	2
conventional pumps	2
infective L3s (iL3s)	2
Ancylostoma ceylanicum and A. caninum	2
hookworm and Ascaris suum host-stage larvae	2
Microfluidic technologies	2
neurotransmitter receptors and ion channels	2
multiple worms per chip	2
worm's pharynx	2
tiny electrophysiological signals	2
Caenorhabditis elegans a microfluidic device (‘chip’)	2
human and animal parasites	2
candidate compounds and natural products	2
egg count methods	2
52 farms	2
2175 cattle	2
transformed versions	2
presence of anthelmintic resistant nematodes in cattle	2
sheep flock B	2
farm A.	2
ovine farm B isolate	2
juvenile flukes	2
farms and one additional bovine isolate	2
Fasciola eggs in isolates	2
adult F. hepatica on farm A.	2
two sheep farms	2
ABZ and triclabendazole (TCBZ)	2
adulticide compound albendazole (ABZ)	2
Fasciola hepatica	2
dhps-VAGKGS mutant haplotype	2
2nd β-strand	2
S436A/F and A437G	2
Isoleucine to Valine (dhps-431V)	2
P. falciparum DHPS crystal structure modelling	2
436A + 	2
combination 431V + 	2
codons 431, 436, 437, 540, 581 and 613 of the dhps gene	2
dhfr gene	2
placental impressions	2
uncomplicated falciparum malaria	2
surveys of pregnant women and children	2
parasites in different parts of the country	2
P. falciparum populations	2
dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes	2
anthelmintic hits	2
negative allosteric modulators	2
-butaclamol Cl	2
four ligands were acetylcholine inhibitors (SB-277011-A, IC50,	2
Asu-ACR-16 receptors	2
sites on Asu-ACR-16	2
four ligands	2
Asu-ACR-16 receptor	2
orthosteric and allosteric binding sites	2
homology modeling	2
Torpedo marmorata nAChR	2
human α7 nAChR chimeras	2
new bioactive compounds	2
transmembrane protein receptor	2
ACR-16 nicotinic acetylcholine receptor of Ascaris suum (Asu-ACR-16)	2
novel therapeutic drugs	2
effective anthelmintic drugs	2
sheep blowfly	2
new class of prospective insecticides	2
human and other mammalian HDACs	2
blowfly HDACs	2
larval growth	2
commercial insecticide cyromazine	2
Trichostatin A	2
early instar blowfly larvae	2
suberoylanilide hydroxamic acid	2
possible new insecticide targets	2
different vulnerabilities	2
sexes of adult flies	2
different blowfly HDACs	2
commercial insecticide	2
HDAC inhibitors	2
corresponding human sequences	2
catalytic domain amino acids	2
blowfly and the other Dipteran species	2
HDACs 4, 6 and 11	2
corresponding human and other Dipteran insect HDACs (Musca domestica and Drosophila melanogaster)	2
blowfly HDACs 1 and 3	2
human HDACs 1, 3, 4, 6 and 11	2
HDAC genes	2
blowfly genome	2
new insecticides	2
histone deacetylases (HDACs), enzymes	2
sheep industry	2
ecto-parasite	2
Australian sheep blowfly, Lucilia cuprina	2
European cattle farms	2
Cooperia spp.	2
remaining farms	2
8 farms)	2
40 farms	2
naturally acquired gastro-intestinal nematodes	2
injectable formulations of ivermectin and moxidectin	2
damage to tissues	2
hypodermis and developing embryos	2
varying concentrations of FLBZ or FLBZ-R (100 nM–10 μM)	2
Adult female Brugia malayi	2
reduced metabolite (FLBZ-R)	2
number of experimental filarial rodent models	2
microfilaricidal drug	2
optimal feed mixtures	2
condensed tannins	2
tannins and flavonoid monomers	2
combinations of tannins and quercetin or luteolin	2
prodelphinidin tannins (PD)	2
Procyanidin (PC) tannins	2
naringenin, quercetin and luteolin	2
Arbutin, vanillic acid, and taxifolin	2
Haemonchus contortus third stage larvae	2
major tannin types (procyanidins and prodelphinidins) and flavonoid types (flavonols, flavones and flavanones)	2
red currant leaves	2
black currant leaves	2
goat willow leaves	2
tilia flowers	2
willow tannins	2
range of contrasting model tannins	2
potentially valuable dry season feed	2
willow leaves	2
condensed tannins and flavonoids	2
different phenolic compounds	2
T. b. gambiense isolates	2
AQP2–AQP3 chimerization	2
T. b.	2
chimeric AQP2/3 gene in aqp2–aqp3 null	2
one of these isolates	2
wild-type AQP2	2
melarsoprol–pentamidine cross-resistant Trypanosoma brucei gambiense isolates	2
AQP2–AQP3 tandem locus	2
Trypanosoma brucei brucei laboratory strains	2
melarsoprol–pentamidine cross-resistance	2
model organism C. elegans	2
parasitic nematode Pgp	2
transgenic control strain	2
two lines	2
motility (thrashing) assay	2
two transgenic lines	2
Parascaris pgp-11	2
pgp-11-deficient Caenorhabditis elegans strain	2
Parascaris Pgp-11	2
P-glycoproteins (Pgps)	2
different targets in other apicomplexan parasites	2
series of compounds	2
TaSP and Tap104 proteins	2
host cell actin	2
T. annulata infected bovine monocytes	2
tasp and tap104	2
two Theileria genes	2
active compounds	2
read-out	2
infected host cell	2
Current drug assays	2
hydroxynaphthoquinone related to parvaquone	2
Theileria annulata and Theileria parva immortalize bovine leucocytes	2
apicomplexans	2
Intracellular schizonts	2
avermectin/milbemycin anthelmintics	2
B. malayi developing embryos and reproductive tissues	2
mature sperm	2
terminal end of the vas deferens	2
somatic muscles	2
mature spermatozoa	2
lateral chords	2
wall of the vas deferens	2
adult male worms	2
stretched microfilariae	2
uterus wall	2
lateral hypodermal chords	2
subunits of BmAVR-14	2
adult filarial worms	2
avr-14 (BmAVR-14)	2
Brugia malayi GluCl gene	2
subunit-specific RNA probes	2
gastrointestinal nematodes	2
somatic and pharyngeal muscles	2
A/M) anthelmintics	2
Glutamate-gated chloride channels (GluCl)	2
human FECRTs	2
low FEC subjects	2
FEC <150 individuals	2
extreme negative drug efficacy cases	2
eggs in stools	2
single random distribution of eggs	2
pre-treatment sample	2
single randomly distributed sample	2
negative drug efficacy cases	2
pre-treatment FEC subjects	2
hookworm-infected humans	2
pyrimethamine and sulfa drugs	2
areas where IPTp-SP	2
codons 436 and 437	2
N51I/C59R/S108N and dhps	2
Thies region	2
parasite samples	2
dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes	2
sulfadoxine–pyrimethamine (SP)	2
nitroimidazole drugs	2
nitroimidazoles	2
G. lamblia proteins	2
2-Nitroimidazole (azomycin) and the 5-nitroimidazole ronidazole	2
essential factor	2
Translation elongation factor EF-1γ	2
subset of proteins	2
5-nitroimidazoles metronidazole	2
G. lamblia physiology	2
5-nitroimidazole drugs	2
Entamoeba histolytica and Trichomonas vaginalis	2
two other micro-aerophilic parasites	2
5-nitroimidazole drugs metronidazole and tinidazole	2
G. lamblia infections	2
globally occurring micro-aerophilic human parasite	2
duodenalis, intestinalis)	2
Giardia lamblia (syn.	2
infection and disease models	2
non-immunogenic IRMs	2
potentially novel and effective immune regulatory molecules (IRMs)	2
secretions	2
investigational medicinal products (IMPs)	2
stromal components	2
ex vivo immunocompetent tumor microenvironments	2
powerful platforms	2
 tumors-on-chip	2
Cancer-associated fibroblasts (CAFs)	2
drug trastuzumab	2
HER2 receptor	2
absence or in the presence of the drug trastuzumab (Herceptin), a targeted antibody therapy	2
tumor-on-chip	2
human tumor ecosystem (HER2+ breast cancer)	2
ex vivo	2
four cell populations: cancer, immune, endothelial, and fibroblasts)	2
3D co-cultures in microfluidic devices	2
organ-on-chip	2
Treg cell-deficient mice	2
lesioned skin	2
granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing CD4+ T cells	2
psoriasis-associated cytokines IL-17A, IL-17F, and IL-22	2
Foxp3+ Treg cells	2
Aldara-skin inflammation model	2
regulatory Foxp3+ T cells (Treg cells)	2
T cells and polymorphonuclear granulocytes	2
activator of the zygotic genome	2
class of maternal mRNAs	2
pgc mRNA	2
undifferentiated and early-differentiating oocytes	2
3′ UTR of pgc mRNA	2
10-nt sequence	2
different conserved RNA-binding proteins	2
germline determinant	2
maternal transcripts	2
Drosophila maternal mRNA	2
polar granule component (pgc)	2
translational repressors	2
somatic or germline determinants	2
future generations	2
adult KO mice	2
young KO mice	2
(KI) mice	2
knockout (KO) or Kcnh6 p.	2
p.P235L	2
non-KATP K+ channel, KCNH6	2
non-KATP K+ channels	2
islet β cells	2
RAS oncogenes	2
EGFR-mutant lung cancer	2
important signaling node	2
EGFR-mutant-induced lung adenocarcinoma	2
autochthonous mouse model	2
AKT and RAC1 in EGFR-mutant lung cancer cells	2
RAS-mutant-oncogene-driven tumor formation	2
PI3K catalytic p110 subunits	2
RAS-binding domains	2
type I phosphoinositide 3-kinases (PI3Ks)	2
family GTPases	2
tumor stimuli	2
LN LECs	2
integrin αIIb	2
LNs in vivo	2
LEC-associated fibrinogen	2
fibrinogen in vitro	2
LECs of tumor-draining LNs	2
Integrin αIIb	2
tumor models	2
naive LNs	2
tumor-draining	2
4T1 breast cancer and B16F10 melanoma models	2
lymphovascular niche	2
tumor-draining lymph nodes (LNs)	2
lymphatic vascular network	2
immunotherapeutics and vaccines	2
virion surface	2
region of the RVFV Gn-Gc assembly	2
Gn-Gc lattice	2
membrane-distal domain of RVFV Gn	2
nAbs	2
mouse infection model	2
RVFV Gn	2
class of neutralizing monoclonal antibodies (nAbs)	2
primary target	2
human and animal pathogen, Rift Valley fever virus (RVFV),	2
Gn subcomponent of the Gn-Gc assembly	2
aggressive TNBC cells	2
Δaa25–45 variant)	2
full-length LYN splice isoform	2
c-KIT	2
BRCA1 mutant TNBC PIN1	2
prolyl isomerase	2
c-KIT in normal mammary cells	2
c-KIT-positive luminal progenitors	2
triple-negative/basal-like breast cancer (TNBC)	2
SRC-family kinase LYN	2
Plk1/Polo sites	2
bona fide PCM proteins	2
Plk1/Polo kinase site of Sas-4	2
meiotic and mitotic centrosomes	2
conserved centrosomal protein Sas-4	2
Centrosomal PCM	2
major microtubule-organizing centers	2
LXR targets	2
canonical nuclear receptor binding sites	2
liganded LXR	2
sterile peritonitis	2
LXR binding sites	2
inflammatory gene enhancers	2
 transposase-accessible chromatin	2
inflammatory genes	2
liver X receptor (LXR)	2
less fit neurons	2
impaired neurons	2
secreted form of human amyloid-β42 peptide	2
Drosophila AD model	2
STING-specific small-molecular inhibitor	2
STING signalosome	2
Trex1−/− mouse autoimmune disease model	2
Trex1−/− BMDM cells	2
cytosolic DNAs	2
the medicinal plant Aster tataricus	2
cyclopeptide	2
effective lead compounds	2
autoimmune and autoinflammatory diseases	2
-STING signaling	2
C-terminal of APP	2
healthy neurons	2
APP and PSEN1 mutant neurons	2
C-terminal APP	2
lysosome-autophagy system	2
human neuronal models	2
endolysosomal and autophagy systems	2
expandable intermediary population of mesenchymal progenitor cells	2
human beige adipocytes	2
Beige fat cells	2
un-budded (G1) and budded (S-G2-M) phase	2
abundant structural information	2
possible endogenous ligand	2
guanosine 2′,3′-cyclic phosphate (2′,3′-cGMP)	2
TLR7-specific ligands	2
engineered TLR8 mutant	2
chemical structures of ligands	2
single uridine-containing ssRNAs	2
successive uridine-containing ssRNAs fully or moderately bind TLR7	2
single-stranded RNA (ssRNA)	2
innate immune receptor	2
SummaryToll-like receptor 7 (TLR7)	2
ISR	2
fibroblast growth factor 21 (FGF21)	2
hypomorphic allele	2
mitochondrial-localized WARS2 protein	2
tryptophanyl-tRNA synthetase 2 (Wars2) gene	2
MOG GC	2
memory-phenotype B cells	2
cognate T cell partner	2
memory B cells	2
circulating antigen-specific antibodies	2
standard model foreign antigen	2
oligodendrocyte glycoprotein (MOG)	2
autoantigen myelin	2
given antigen	2
germinal center (GC)	2
protective epitopes	2
five Fab-EEEV complexes	2
ribosome binding site	2
viral RNA genome binding site	2
EEEV capsid structure	2
lectin-expressing myeloid lineage cells	2
cryptic E2 glycan	2
cellular attachment factor heparan sulfate	2
envelope protein E2	2
alphavirus	2
eastern equine encephalitis virus (EEEV)	2
4.4-Å cryoelectron microscopy (cryo-EM) structure	2
enveloped pathogens	2
ER and lysosomes	2
low-affinity lysosomal uptake system	2
large-conductance IP3Rs	2
ER-lysosome contacts	2
IP3R clusters	2
[Ca2+]	2
low-affinity Ca2+ sensor	2
store-operated Ca2+ entry (SOCE)	2
Ca2+ entering cells	2
IP3R subtypes	2
 small interfering RNA (siRNA) and vacuolar H+-ATPase (V-ATPase) inhibitors	2
cytosol or other organelles	2
SummaryInositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs)	2
fixed set	2
location and/or object	2
the reach location	2
neural population in the primary motor cortex (M1)	2
LT-HSC subset	2
mLT-HSCs gene program	2
CD61-high LT-HSCs	2
mLT-HSCs	2
LT-HSC population (mLT-HSCs)	2
myeloid-biased subset	2
single-cell RNA sequencing (scRNA-seq)	2
cell-intrinsic, myeloid-biased expression program	2
young and aged LT-HSCs	2
myeloid-biased output	2
SummaryLong-term hematopoietic stem cells (LT-HSCs)	2
mSCs	2
histone deacetylases histone deacetylase 1 (HDAC1) and HDAC2	2
mSC	2
myelinating Schwann cells (mSCs)	2
NAD precursor nicotinamide mononucleotide (NMN), or vitamin K2	2
exogenously provided NAD+	2
mitochondrial NADH dehydrogenase or lactate dehydrogenase	2
inhibitor of mitochondrial NADH dehydrogenase	2
lactate and H+ efflux	2
MCT4)	2
dual MCT1 and MCT4 inhibitor	2
anti-hypertensive drug	2
monocarboxylate transporters 1 (MCT1) and 4 (MCT4)	2
glycolytic end-products lactate and H+	2
glycolytic cancer cells	2
adult-born neurons	2
diverse and transcriptionally distinct neuronal and nonneuronal cell types	2
subtypes of inhibitory interneurons	2
odor information	2
reprogrammed HSCs	2
fibroblast genes	2
open enhancers and promoters	2
cohort of targets	2
repopulate immunodeficient mice	2
hematopoietic progeny	2
Induced cells	2
hemogenic cells	2
hemogenic precursor cells	2
specialized endothelial cells	2
LTM engram cells	2
c-Fos/CREB cycling	2
c-fos-positive engram neurons	2
c-Fos	2
Preexisting CREB	2
olfactory associations	2
subset of KCs in the mushroom bodies	2
c-Fos and CREB	2
aversive olfactory association	2
memory engrams	2
phosphorylated ERK (pERK)	2
activating kinases	2
CREB and c-Fos	2
engram cells encoding long-term memories (LTMs)	2
perforant path inputs	2
SuM inputs	2
synapses	2
co-release glutamate and γ-aminobutyric acid (GABA)	2
DG	2
hilar mossy cells	2
granule cells (GCs) and GABAergic interneurons	2
axons of SuM neurons	2
SuM and hippocampus	2
precise neural connections	2
SuM-to-hippocampus circuits	2
CA2 region of the hippocampus	2
dentate gyrus (DG)	2
supramammillary nucleus (SuM) of the hypothalamus	2
melanopsin photoresponses	2
melanopsin function	2
either β-arrestin	2
β-arrestin 1	2
light pulse	2
β-arrestin 2	2
binding site for β-arrestin 1 (βARR1) and β-arrestin 2	2
C-terminal region of mammalian melanopsin	2
cluster of Ser/Thr sites	2
melanopsin photopigment	2
SummaryMelanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs)	2
autocrine-like signaling	2
common pool	2
chained cells	2
ATM or CLA presence	2
membrane-anchored receptor (ComD)	2
small extracellular peptide (CSP)	2
autolysin mutant (ΔlytB)	2
d,d-carboxypeptidase PBP3	2
aztreonam (ATM) and clavulanic acid (CLA)	2
embryonic-like cells	2
host embryonic microenvironment	2
epiblast ontogenic genes	2
chimeric monkeys	2
germ cell progenitors	2
embryonic and placental tissues	2
chimeric contributions	2
somatic cell nuclear transfer-derived ESCs	2
induced PSCs	2
cynomolgus monkey primed ESCs	2
injected morulae	2
conventional primed pluripotent stem cells (pPSCs)	2
dome-shaped embryonic stem cells (dESCs)	2
chimeric cynomolgus monkey fetuses	2
optimal model species	2
key target	2
HSV-1 ocular infection murine model	2
host immune-suppressive factor regulatory T cells (Treg cells)	2
SummaryHerpes simplex virus 1 (HSV-1)	2
ΔAPC7ΔMAD2 cells	2
two subunits	2
APC7 and APC16	2
APC/C subunits APC7 and APC16	2
multisubunit ubiquitin ligase APC/C (anaphase-promoting complex/cyclosome)	2
gasdermin E	2
pyroptotic cell death effectors gasdermin D	2
apoptotic executioner caspases, caspase-3 and -7	2
Computational simulations	2
F-actin and adhesions	2
microtubule-dependent signaling-based model	2
compliant hydrogels	2
human glioma cells	2
two clinically approved MTAs	2
microtubule-dependent cellular functions	2
SummaryMicrotubule-targeting agents (MTAs)	2
submental region of immunodeficient mice	2
surgical model of barcoded HNSCC	2
cancer cell populations	2
class of experimental cancer drugs	2
transcription and recombination machineries	2
HEXIM1 and RAD51	2
homologous recombination factor RAD51	2
transcription-replication conflicts	2
inhibitor HEXIM1	2
bromodomain proteins	2
endogenous Tau	2
Cell surface heparan sulfate proteoglycans	2
vesicle-free form	2
N2A cells	2
phosphorylated, oligomeric Tau clusters	2
normal Tau	2
pathological Tau	2
Tau protein aggregates	2
HO-1 in myeloid cells	2
whole-body or myeloid-specific HO-1-deficient mice	2
granulocytic karyorrhexis	2
reactive oxygen and/or nitrogen intermediates	2
human TB lung tissues	2
freshly resected human TB lung tissue	2
cytoprotective enzyme	2
SummaryHeme oxygenase-1 (HO-1)	2
lrrc10 in zebrafish	2
cavefish cardiomyocytes	2
permanent fibrotic scar	2
Pachón cave-dwelling counterparts	2
Astyanax mexicanus surface fish	2
cilia of ASIs	2
ion channel OCR-2	2
SER-1 receptor	2
ADFs release 5-HT	2
SER-3 and SER-6 receptors	2
octopamine (OA)	2
ASER activates RIC interneurons	2
sensory neurons ASER, ADFs, and ASHs	2
off-response ASI neurons	2
off-response neurons	2
PIF4-dependent genes	2
B-box proteins	2
PIF4 mutant and a BBX18/BBX23 double mutant	2
multiple thermoresponsive genes	2
ELF3 abundance	2
PIF4 or constitutive photomorphogenic 1 (COP1)	2
hypocotyl growth	2
BBX18 overexpression	2
BBX18 and	2
important thermomorphogenesis regulators	2
B-box 18 (BBX18)	2
early flowering 3 (ELF3)	2
Phytochrome interacting factor 4 (PIF4)	2
ovalbumin-specific IgG production	2
PDH inhibitor	2
p32-null mice	2
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase [PDH] complex)	2
p32-deficient DCs	2
multifunctional chaperone protein	2
endogenous metabolite citrate	2
Toll-like receptor agonists	2
ESCRT components	2
ESCRT (endosomal sorting complex required for transport) machinery	2
whole genome small interfering RNA (siRNA) screens	2
receptors recognizing ligands of the transforming growth factor β (TGF-β) family	2
transduction pathways	2
cholinergic motor neurons	2
protein, HIC-1	2
actin-binding protein NAB-1	2
secreted Wnt	2
hic-1 mutants	2
presynaptic neurons	2
acetylcholine receptor AChR/ACR-16	2
mutants in hic-1	2
cholinergic synapses	2
C. elegans tetraspan protein, HIC-1	2
least IFT-A, IFT-B, IFT-dynein, and OSM-3 complexes	2
OSM-6 pauses	2
IFT-B particle component	2
motor proteins and IFT-A particle component CHE-11	2
tips of phasmid cilia of living C. elegans	2
IFT components	2
IFT dynein	2
ciliary base	2
Kinesin-2 motors	2
intraflagellar transport (IFT)	2
microtubule-based sensing hubs	2
single visual projection neuron type	2
integrated system, FlyPEZ	2
single projector	2
fly’s visual receptive field	2
spherical projection system	2
FlyDetect tracks	2
three assay components	2
behavioral tools	2
Genetic tools	2
certain mutational contexts	2
low-mappability regions	2
discordant somatic variants	2
technical replicate pairs	2
matched normal DNA	2
identified somatic variants	2
cancer-only pipeline	2
different WES pipelines	2
Somatic variants	2
three anatomically distinct regions of the same tumor	2
user-friendly, interactive web portal	2
broad biological community	2
automated literature and data mining	2
small set of essential regulators	2
recently published mouse cell atlas data	2
major cell types	2
single-cell technologies	2
self-propagating wave	2
neighboring cell	2
Dishevelled in one cell	2
other members of the core planar polarity complex	2
core planar polarity protein Dishevelled	2
cell neighbors	2
core planar polarity pathway	2
cells in the plane of a tissue	2
MTDPS3 in culture	2
DGUOK-deficient iPSC-derived hepatocytes	2
deficient in ribonucleoside-diphosphate reductase subunit M2B (RRM2B)	2
hepatocyte-like cells	2
MTDPS3-null rats	2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α)	2
Nicotinamide adenine dinucleotide (NAD)	2
MTDPS3 primary hepatocytes	2
VWA domain	2
Asp122 in CaV2.2 domain-I	2
disrupted MIDAS motif	2
additional Cache domain interactions	2
(MIDAS) motif	2
first loop in CaV1.1 domain-I	2
α2δ-1 VWA domain	2
α2δ-1 and an α2δ-like protein called Cachd1 on neuronal N-type (CaV2.2) channels	2
α2δ subunits	2
SummaryVoltage-gated calcium channel auxiliary	2
two pivotal regulators	2
CAV1-YAP mechanotransduction system	2
model of pancreatitis-driven acinar-to-ductal metaplasia	2
14-3-3 protein YWHAH	2
image-based small interfering RNA (siRNA) screens	2
YAP mechanoresponse	2
CAV1 positively	2
Mechanical stimuli	2
transcriptional regulator YAP	2
salt-stress-responsive transcriptome	2
plant transcriptomes	2
m6A generally	2
unmodified m6A sites	2
many m6A-modified mRNAs	2
least one m6A site	2
3′ ends of eukaryotic mRNAs	2
dynamic, reversible, covalently modified ribonucleotide	2
(m6A)	2
RNASEH2 genes	2
active and inactive enzymes	2
RER substrates	2
defective enzymes	2
Compound heterozygous cells	2
rNMPs in DNA	2
RNase H2 AGS-related mutant	2
RNase H2 mutant	2
RNA portion of an R-loop	2
the ribonucleotide excision repair (RER) pathway	2
pre-spliceosome	2
epigenetic modifiers ING5, SMARCA5, BRD1, UHRF1, BPTF, and SMARCC2	2
matrin-type 2 zinc-finger protein ZMAT2	2
DNA and/or RNA binding regulators	2
epidermal surface	2
possible preventive or therapeutic target	2
transforming growth factor-β or activin type I receptors	2
in vitro experiments	2
Hepatic activin E-transgenic mice	2
mesenteric WAT	2
ingWAT and other adipose tissues	2
inguinal WAT (ingWAT)	2
white adipose tissue (WAT)	2
valuable models	2
HNSCC lines	2
HPV(–) cell lines	2
aggressive HNSCCs	2
important signaling pathways	2
cell lines and tumors	2
11q13/22, and 8p11	2
chromosomes 3q22–29	2
279 tumors	2
(HNSCC) lines	2
human papillomavirus (HPV)-negative and 11 HPV-positive head and neck	2
natural DENV4 infections	2
pre-existing neutralizing antibodies	2
changing or emerging DENV genotypes	2
DENV4s	2
vaccine sera	2
immune sera	2
DENV4 antibodies	2
isogenic panel of viruses	2
one DENV4 genotype	2
distinct genotypes	2
distinct DENV serotypes	2
ANDY mouse	2
mammalian dietary niacin requirements	2
(ANDY) mice	2
acquired niacin dependency	2
niacin-free diets	2
ACMSD expression	2
human alpha-amino-beta-carboxy-muconate-semialdehyde decarboxylase (ACMSD)	2
sufficient NAD+	2
dietary niacin (nicotinic acid, nicotinamide, and nicotinamide riboside)	2
GluN2A CTD	2
endogenous GluN2B CaMKII site	2
endogenous NMDARs	2
unique CaMKII interaction site	2
GluN2 cytoplasmic C-terminal domains (CTDs)	2
previously GluN2B-dominated NMDARs	2
forebrain NMDA receptors (NMDARs)	2
SummaryThe GluN2 subtype (2A versus 2B)	2
AIDS vaccines	2
completely glycan-shielded viruses	2
hole-targeting neutralizing antibodies	2
glycan acquisition	2
transmitted viruses	2
longitudinally followed individuals	2
M-group viruses	2
individual Env sequences	2
vaccine-induced neutralizing antibodies	2
shield (glycan holes)	2
Strain-specific breaches	2
HIV-1 envelope (Env) trimer	2
arranged N-linked glycans	2
 endoplasmic reticulum and lysosomes	2
GFAP aggregates	2
two AxD patients	2
glial fibrillary acidic protein (GFAP)	2
Cdkn1aSUPER allele	2
chemically induced fibrosarcoma model	2
Tp53SUPER animals	2
Cdkn1aSUPER mice	2
autochthonous Kras-driven lung adenocarcinoma model	2
chemically induced skin cancer model	2
natural genomic context	2
additional Cdkn1a allele	2
Cdkn1aSUPER mouse	2
BAC transgenesis	2
divergent regulatory circuit	2
SsrB-binding region	2
STM and S. bongori (SBG)	2
TCS	2
SsrA-SsrB TCS	2
Salmonella Typhimurium (STM)	2
niche-specific cues	2
SummaryBacterial two-component regulatory systems (TCS)	2
resulting neurons	2
HD patient iPSCs	2
HD and non-diseased iPSCs	2
human corticogenesis	2
mutant Hungtintin (mtHTT)	2
disease-relevant patient tissues	2
Induced pluripotent stem cell (iPSC) models	2
Huntingtin (HTT) gene	2
growth cone	2
clutch molecule	2
adhesive substrate	2
cortactin and L1-CAM,	2
leading process growth cone	2
migrating mouse olfactory interneurons	2
Grxcr2-deficient mice	2
Stereocilia lacking GRXCR2	2
Grxcr2-deficient hair cells	2
another protein	2
sound-induced vibrations	2
cochlear hair cells	2
actin-based mechanosensing organelles	2
base of the stereocilia	2
mouse GRXCR2	2
human GRXCR2	2
proposed models	2
available data and models	2
single E. coli cells	2
p38-deficent cells	2
hypoxia-inducible transcription factor Hif-1α	2
aneuploid subclones	2
p38-deficient cells	2
p38 stress response kinase	2
karyotype heterogeneity	2
normal somatic cells	2
normal karyotype	2
Tafazzin-deficient mice hearts	2
tafazzin-deficient cells	2
tafazzin mutant cells	2
Barth syndrome patients	2
cardiolipin acyl transferase tafazzin	2
crucial cellular signaling hubs	2
key human immune regulators	2
latrophilin family member ADGRL2	2
interferon-lambda locus	2
Th2 and Th17	2
disease-relevant T helper cell subsets	2
genome-wide significant associations	2
489 healthy individuals	2
functionally relevant phenotypes	2
enhancers of axonal guidance genes	2
neural ENB methylome	2
basal ENB methylome	2
IDH2 mutant gliomas	2
IDH2 R172 mutant-enriched subgroup	2
basal subtype	2
basal or neural	2
olfactory mucosa	2
(ENB)	2
peripheral nerve system	2
LXR and lipid-sensor pathways	2
sensory neurons of the DRG	2
lipid-binding nuclear receptors	2
WD-fed mice	2
sensory neurons of the dorsal root ganglia (DRG)	2
western diet (WD)-fed mice	2
neurobiology	2
complex adipose tissue samples	2
online available tool	2
complex human and mouse biopsies	2
brown and white adipocytes	2
pure brown, brite, and white adipocyte transcriptomes	2
adipose tissue biopsies	2
brown and brite adipocytes	2
Tnks substrates	2
two lysine residues of JNK	2
Tnks-dependent poly-ADP-ribosylation	2
direct substrate of Tnks	2
JNK signaling pathway	2
muscle-specific knockdown	2
physiological contexts	2
viral infection	2
SummaryTankyrase (Tnks) transfers poly(ADP-ribose)	2
microtubule-dependent protrusions	2
Arp2/3- and Formins-dependent actin architectures	2
aligned protrusions	2
microtubules and actomyosin-microtubule interactions	2
flat and nanotextured substrates	2
set of CG platforms	2
aligned extracellular matrix	2
immature or nascent synapses	2
GluA1-containing AMPARs	2
hippocampal Schaffer collateral synapses	2
exogenous netrin-1	2
chemotropic guidance cue netrin-1	2
N-methyl-D-aspartate receptor (NMDAR)	2
key molecular effectors	2
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors (AMPARs)	2
cellular bioenergetics	2
MEFs lacking mitofusin 2	2
senescent MEFs	2
young mouse embryonic fibroblasts (MEFs)	2
mitochondria in cancer cells	2
 glucose or other hexose sugars	2
variety of cancer cell types	2
organelle-targeted ATP biosensors	2
Cacna1e function	2
hypothalamic POMC neurons	2
pore-forming subunit of the R-type (CaV2.3 or Cacna1e) conductance	2
“R-type” channel	2
voltage-gated calcium (CaV) conductance	2
hypothalamic pro-opiomelanocortin (POMC) neurons	2
baseline cell-cytokine network	2
serum cytokines	2
presently deposited ImmPort database	2
publicly available resource	2
diverse human immunology reference	2
sufficiently large and diverse healthy human cohort	2
immune assays	2
ciliary ultrastructure	2
axonemal microtubules	2
IFT motor kinesin-II	2
ciliary base and tip	2
frequent pauses	2
ciliary subdomains	2
IFT components in living C. elegans	2
H3K4me2 marks	2
H3K4 demethylases KDM1A and KDM5B	2
piRNA-dependent methylated regions	2
retrotransposon genes	2
capacitor	2
yeast prion [PSI+]	2
fluctuating environment	2
benign (instead of deleterious) mutational neighborhood	2
biological populations	2
Pol II C-terminal domain	2
Pol II heptad repeated C-terminal domain	2
threonine 4	2
conserved PP1 phosphatase Dis2	2
elongation factor Spt5	2
Seb1 interaction surface	2
Rpb4/7 stalk	2
end of the RNA exit channel	2
conserved and essential termination factor Seb1	2
 foreskin	2
IL1βhiCCL3hiCD14+ monocyte-derived macrophages	2
psoriatic epidermis	2
CD1C+CD301A+ myeloid dendritic cell population	2
the interfollicular epidermis of normal scalp	2
Transcriptomics-derived keratinocyte subpopulations	2
normal and 3 inflamed skin samples	2
92,889 human epidermal cells	2
complex cellular program	2
peptidoglycan precursors	2
phosphorylated and non-phosphorylated forms of CwlM are FhaA, a fork head-associated domain protein, and MurJ, a proposed lipid II flippase	2
PknB-phosphorylated cytoplasmic form	2
non-phosphorylated membrane-associated form	2
two forms of CwlM	2
growing mycobacteria	2
cwlM mutant of M. tuberculosis	2
major PknB substrate	2
essential regulator of peptidoglycan synthesis	2
PknB-producing and PknB-depleted mycobacteria	2
osmoprotective medium	2
PknB-depleted M. tuberculosis	2
Protein kinase B (PknB)	2
 a highly successful pathogen	2
its causative agent Mycobacterium tuberculosis	2
neurons, astrocytes, and microglia	2
infected CNS	2
type I IFN receptor signaling of neurons	2
monocytes in the OB	2
 activated microglia	2
intranasal vesicular stomatitis virus instillation	2
odorant system	2
Many viruses	2
viral encephalitis	2
sterile neuroinflammation	2
regulatory framework	2
DET1/COP1-PIF4 module	2
transcription factor Phytochrome Interacting Factor 4 (PIF4)	2
Key light-signaling components De-Etiolated 1 (DET1)	2
common signaling module	2
ventral V3 interneurons	2
V3 INs	2
recurrent excitatory, glutamatergic input	2
ipsilateral motoneurons	2
ventrolateral V3 INs	2
ventromedial V3 INs	2
focal, layered modules	2
spinal V3 interneurons (INs)	2
anatomical layers	2
subsequent Trm cell cohorts	2
large niche	2
Trm cells	2
in vitro-activated but not naive CD8+ T cells	2
Liver Trm cells	2
naive mice	2
sinusoids	2
tissue-resident memory T (Trm) cells	2
posttranslationally modified peptides	2
tyrosine ADPr on HPF1 and other proteins	2
O-linked ADPr spectrum	2
H3S10 in vitro and in vivo	2
neighboring residues	2
core histone tails	2
eponymous histone PARylation factor 1 (HPF1)	2
PARP1 and PARP2	2
SummarySerine ADP-ribosylation (Ser-ADPr)	2
lung microbiota	2
advanced B16 metastases	2
probiotics or antibiotics	2
B16 lung metastases	2
Aerosolized Lactobacillus rhamnosus	2
antibiotic-treated lungs	2
bacterial isolates	2
melanoma B16 lung metastases	2
lungs of vancomycin/neomycin-aerosolized mice	2
melanoma metastasis	2
pulmonary tolerance	2
Lung microbiota	2
permissive milieu	2
inhaled particulates	2
TPS osmotic stress pathway	2
predicted substrates	2
known pathways	2
pathway members	2
dynamic phosphosites	2
time-resolved phosphoproteomic data	2
shorter poly(A) tails	2
stress-induced RNA granules	2
known ER stress regulators, XBP1, DDIT3, and HSPA5	2
casein kinase II	2
non-canonical degron site (TSGXXS)	2
Cyclin F	2
cyclin proteins	2
Checkpoint systems	2
long-lasting Trm precursor pool	2
long-lasting circulating effector memory (Tem) populations	2
lung Trm	2
primary lung Trm	2
repeatedly stimulated circulating memory CD8+ T cells	2
Lung Trm	2
influenza-specific lung Trm populations	2
SummaryLung-resident primary memory CD8+ T cell populations (Trm)	2
male genome	2
first bromodomain of Brdt, the testis-specific member of the BET family	2
K5 and K8	2
post-meiotic spermatogenic cells	2
highly aggressive NUT midline carcinoma	2
universal oncogenic driver	2
SummaryNuclear protein in testis (Nut)	2
transsynaptic assembly	2
pre-synaptic dystroglycan glycoprotein complex	2
downstream ON-bipolar neurons	2
key post-synaptic signaling complex	2
HSPG member Pikachurin	2
GPR158/179 group of orphan receptors	2
members of the heparan sulfate proteoglycan (HSPG) family	2
individual synaptic connections	2
host of cell adhesion molecules	2
amino-acid-sensitive and Dilp-independent function of glia	2
third instar	2
SLC7 amino acid transporter, Sobremesa (Sbm)	2
amino acids)	2
 lesions	2
inhibitory lipid debris	2
transiently expressed factor	2
peroxisome proliferator-activated receptor gamma co-activator 1-alpha (PGC1α) activation	2
 pro-remyelination pathways	2
remyelinated axons	2
running wheel	2
critical therapeutic target	2
myelin sheaths	2
presence of sugar	2
Scaf and Scaf neurons	2
sated flies	2
 these neurons	2
nutritious sugars	2
neurons expressing one of these SPHs, Scarface (Scaf)	2
serine protease homologs (SPHs)	2
balanced diet of macronutrients	2
SDF1 promoter	2
histone H3 lysine 27 trimethylation	2
enhancer of zeste homolog 2 (EZH2)	2
young skin	2
secreted factor, stromal-derived factor 1 (SDF1)	2
blood from young mice	2
aged animals	2
aged but not young mice	2
full-thickness skin wounds	2
wounds in young patients	2
thinner scars	2
surgical wounds in the elderly	2
stabilized native-like Env trimer	2
ConSOSL.UFO.664	2
soluble ConSOSL.UFO.664 trimer	2
soluble counterpart	2
quaternary and MPER-specific bNAb binding	2
stabilized HIV-1 trimer, ConSOSL.UFO.750	2
series of membrane-bound Envs	2
non-neutralizing antibody (nNAb) epitopes	2
stabilized trimers	2
broadly neutralizing antibodies (bNAb)	2
antibody-based prophylactic vaccines	2
SummaryThe HIV-1-envelope glycoprotein (Env)	2
iMSN-D2Rs	2
Chl D2Rs	2
direct pathway and iMSNs	2
iMSN-D2Rs (iMSN-Drd2KO)	2
M1-selective muscarinic acetylcholine receptor antagonist	2
Chl-Drd2KO mice	2
subtypes of MSNs	2
(Chl-Drd2KO)	2
Chl-D2Rs	2
striatal cholinergic interneurons (Chls) and indirect pathway medium spiny neurons (iMSNs)	2
D2Rs	2
(DA) D2 receptors (D2Rs)	2
CCM3 patients	2
apical membranes	2
MO25 ortholog mop-25.2	2
human CCM signaling network	2
CCM-3 pathway genes	2
mammalian vasculature	2
biological tubes	2
C. elegans ccm-3 gene	2
one of three genes (CCM1–3)	2
neurovascular lesions	2
main regulatory cytokine	2
CD4 adhesion	2
lymphocytes (CD4)	2
acoustic waves	2
mutant Ras	2
altered TGF-β signaling	2
hyperactive PI-3′ kinase signaling	2
elongating tubes	2
tip and stalk genes	2
Organoid morphogenesis models	2
intracerebral hemorrhage	2
dilated, proliferative blood vessels	2
endothelial-specific, inducible HRASV12 mouse model	2
majority of brain arterio-venous malformations	2
SummaryCerebrovascular malformations (CVMs)	2
dynamic and stable environments	2
coupled feedbacks	2
accurate modeling	2
E. coli PhoB-PhoR two-component system	2
positively autoregulated systems	2
many signaling circuits	2
e.g., 22q11.2, 3q29	2
 well-known ASD/SCZ-associated CNV loci	2
multiple disease-relevant genes	2
ASD and SCZ cases	2
2,458 SCZ cases	2
1,108 ASD cases	2
autism spectrum disorder (ASD) and schizophrenia (SCZ)	2
copy-number variations (CNVs)	2
flagellar nanodomains	2
bilateral longitudinal lines	2
Hv1, CatSper, and its regulatory protein ABHD2	2
flagellar regulatory nanodomains	2
voltage-gated proton channel Hv1	2
human sperm	2
either proton transporters	2
flagellar calcium channel CatSper	2
SummaryIon channels	2
specific fatty acids	2
NF-κB transcription factor	2
toxic saturated ceramides and acyl-carnitines	2
phospholipid pools	2
unsaturated fatty acid oleate	2
saturated lipids	2
oxygen-dependent stearoyl-CoA desaturase (SCD) enzyme	2
ccRCC tumors and ccRCC cells	2
triglycerides and cholesterol esters	2
SummaryLipid droplets	2
Ral-dependent developmental signaling cascade in vivo	2
PMK-1/p38 MAP kinase cascade	2
GCK-2, a citron-N-terminal-homology-domain-containing MAP4 kinase	2
exocyst complex	2
established Ral binding partner, Exo84	2
C. elegans RAL-1/Ral	2
RalGEF-Ral	2
oncogenic Ras effectors	2
non-canonical RalGEF-Ral	2
canonical Raf-MEK-ERK mitogen-activated protein (MAP) kinase cascade	2
LET-60/Ras switching effectors	2
LIN-12/Notch.	2
epidermal growth factor (EGF) gradient	2
SummaryC. elegans vulval precursor cell (VPC) fates	2
self-motion feedback	2
population of V1 neurons	2
visual cues	2
subset of neurons	2
linear corridor	2
reward	2
virtual environment	2
V1 neurons	2
behaviorally relevant locations	2
visual, reward, and self-motion-related inputs	2
primary visual cortex (V1)	2
motor feedback	2
visual stimuli	2
conserved filoviral fusion machinery	2
rare but potent antibodies	2
ebolavirus immunogenic landscape	2
heptad repeat 1 (HR1) region	2
GP protomers	2
highly conserved residues in the internal fusion loop (IFL)	2
EBOV/Mak and Bundibugyo virus (BDBV) glycoproteins (GPs)	2
cryo-EM structures of ADI-15878 in complex	2
unliganded crystal structure of ADI-15878	2
three ebolavirus species	2
rodent and ferret models	2
known ebolaviruses	2
mAb	2
human survivor of Ebola virus Makona variant (EBOV/Mak) infection	2
antibody ADI-15878	2
cross-reactive epitopes	2
antibodies (mAbs)	2
mitochondrial RNA trafficking pathway	2
mitochondrion-localized RNASET2	2
shorter form TERC-53	2
RNA component of mammalian telomerase TERC	2
purinergic receptors	2
specific brain areas	2
male microglia	2
male and female mouse brains	2
microglia freshly	2
brain’s immunocompetent cells	2
PGC-like cells in culture	2
HDAC3/BLIMP1-targeted somatic gene products	2
H3 and H4 histones	2
decreased nascent PGCs in vitro	2
pluripotent epiblasts	2
nucleocytoplasmic transport machinery	2
STK25-GM130 pathway	2
nuclear export machinery	2
polarity protein LKB1/Par4	2
cultured neurons	2
dendritic arborization	2
Ran-binding protein 1 (RanBP1)	2
Ran-dependent nucleocytoplasmic transport machinery	2
axon and dendrites	2
unlabeled RNA samples	2
newly synthesized RNA	2
local RNA polymerase stalling and termination sites	2
RNA sample	2
S. cerevisiae poly(A)+ and poly(A)− RNA 3′ ends	2
functional domains of MeCP2	2
NLS of MeCP2	2
intact methyl-CpG binding domain (MBD)	2
nuclear import factors KPNA3 and KPNA4	2
conserved nuclear localization signal (NLS)	2
nuclear protein	2
Escherichia coli or zymosan substrates	2
apoptotic bodies	2
control and TREM2 variant iPSC-MGLCs	2
variant lines	2
TREM2 expression	2
primary macrophages	2
patients with NHD	2
induced pluripotent stem cell-derived microglia-like cells (iPSC-MGLCs)	2
TREM2 cause Nasu-Hakola disease (NHD)	2
brain’s immune cells	2
protocadherin, olfactory, and other monoallelically expressed genes	2
Cyclin D3	2
Vκ gene containing TADs	2
cyclin D3	2
Vκ loci	2
topological associating domains (TADs)	2
E2A-loaded Vκ promotors	2
CTCF-bound sites	2
nuclear matrix	2
Vκ genes	2
stochastic repertoires	2
individual pre-B cells monoallelically transcribe divergent arrays of Vκ genes	2
individual variable (V) genes	2
single receptor	2
vast repertoires of antigen receptors	2
pericentriolar scaffold	2
sensory apparatus	2
actin nucleator Cobl	2
fully differentiated and post-mitotic Paneth cells	2
c-Kit receptor	2
inflammatory cues	2
differentiated lineages	2
intestinal progenitor and stem cells	2
specific intestinal segments	2
recombinant SOSIP and virion-derived Env proteins	2
key bnAb epitopes	2
CHO-derived clinical grade material	2
recombinant BG505 SOSIP trimers	2
lymphoid cell line	2
BG505 (clade A) virions	2
gp120 and gp41 subunits	2
infectious viruses	2
virion Env	2
close structural and antigenic mimics	2
SOSIP trimers	2
SOSIP design	2
recombinant, soluble trimeric immunogens	2
bnAbs	2
Env) spikes	2
native, virion-associated envelope glycoprotein (	2
broadly neutralizing antibodies (bnAbs) against HIV-1	2
 extra-embryonic gene expression	2
Oct4-bound distal regulatory elements	2
Smad2/3 double-knockout ESCs	2
Smad2/3-deficient embryonic stem cells (ESCs)	2
Smad2/3 double-mutant mouse embryos	2
early post-implantation stage mammalian embryo	2
MidA/NDUFAF7	2
MidA methyltransferase activity	2
NDUFAF7	2
regulatory domain	2
large core loops	2
eukaryotic methyltransferases	2
MidA catalytic core domain	2
Dictyostelium ortholog of NDUFAF7	2
subunit NDUFS2	2
∼1-MDa mitochondrial complex I (CI; the NADH ubiquinone oxidoreductase)	2
human protein arginine methyltransferase NDUFAF7	2
synaptic clustering	2
proBDNF and mature BDNF	2
proBDNF signaling	2
proBDNF-to-BDNF converting enzyme	2
matrix-metalloproteinase-9 activity	2
proBDNF downregulates out-of-sync synapses	2
clustered synapses	2
proBDNF/p75NTR signaling	2
locally synchronized synapses	2
developing hippocampal neurons	2
postsynaptic brain-derived neurotrophic factor (BDNF)	2
mature brain	2
activity-dependent synaptic plasticity	2
several human tauopathies	2
tau inclusion-rich brain regions	2
transgenic P301S-tau mouse brains	2
neurons with tau inclusions	2
(NO)	2
opsonin milk-fat-globule EGF-factor-8 (MFGE8)	2
contacting microglia	2
insoluble tau inclusions	2
co-cultured phagocytes (BV2 cells or primary microglia)	2
P301S-tau mice	2
tauopathies	2
insoluble filamentous inclusions	2
1-year-old PPARγ2-KO mice	2
acutely overfeeding PPARγ2-KO mice	2
adipose tissue-specific transcription factor peroxisome proliferator-activated receptor γ2 (PPARγ2)	2
white adipose tissue (AT)	2
repository of OCSCC-specific PDXs	2
clinical trial framework	2
previously described basal, mesenchymal, and classical molecular subtypes	2
matched PDX	2
12 models	2
n = 	2
larger OCSCC PDX repository	2
representative subset	2
pairs	2
additional whole-genome sequencing (WGS)	2
tumors and matched PDXs	2
whole-exome sequencing (WES) and transcriptome sequencing (RNA-seq)	2
oral cavity squamous cell carcinoma (OCSCC) patient-derived xenograft (PDX) platform	2
right primary motor cortex	2
hundreds of calcium indicator-expressing cortical neurons	2
miniature fluorescence microscope	2
climbed ladders	2
food pellets	2
naturally behaving common marmoset	2
deep layer cortex	2
large neuronal populations	2
large tissues	2
hydrophilic clearing cocktails	2
mammalian body and large primate and human tissues	2
large primate and human tissues	2
mouse body including bone	2
mouse organs	2
CUBIC (clear, unobstructed brain/body imaging cocktails and computational analysis) protocols	2
optimal chemical cocktails	2
phosphate ion	2
aromatic amide	2
N-alkylimidazole	2
salt-free amine	2
high-throughput evaluation system	2
1,600 chemicals	2
hydrophilic chemical cocktails	2
intracellular whole-cell recordings	2
mouse V1	2
two-dimensional frequency domain	2
intricate receptive fields	2
mouse V1 neurons	2
rodents and lagomorphs)	2
orientation map	2
primary visual cortex (V1) of mammals	2
connectivity principles	2
Pvalb-expressing cells of the striatum	2
Pthlh cells	2
larger group of cells expressing Pthlh	2
discrete cluster	2
Pvalb-expressing cells	2
two small populations of cells expressing Cck with or without Vip	2
Sst/Npy, Th, Npy without Sst, and Chat	2
discrete interneuron types	2
striatal cells	2
rest of the basal ganglia	2
nearby circuits	2
SummaryStriatal locally projecting neurons, or interneurons	2
glutathione synthesis	2
glia cells	2
genetically encoded redox sensors	2
one of the two major NADPH-dependent reducing systems	2
major low-molecular weight thiol of eukaryotic cells	2
separate processing streams	2
different connector hubs	2
brain’s network structure	2
three hub categories	2
specific brain networks	2
three separable sets of connector hubs	2
two independent datasets	2
individual-specific hub regions	2
individual brains	2
single category of brain regions	2
discrete networks	2
specialized “connector hub” regions	2
lower-level sensory motor and default networks	2
brain’s control networks	2
pro-apoptotic LIF pseudogene	2
proboscidean stem lineage	2
TP53 response element	2
living and extinct proboscidean LIF6 genes	2
leukemia inhibitory factor pseudogene (LIF6)	2
extinct relatives (proboscideans)	2
“Peto’s paradox”	2
small-bodied organisms	2
SummaryLarge-bodied organisms	2
endometrial cells	2
cancer-associated genes in endometriotic epithelium	2
endometrial epithelium	2
single endometrial glands	2
 the endometriosis and uterine endometrium genomes	2
endometriotic epithelium	2
endometriosis-associated ovarian cancers	2
endometriotic and normal epithelium samples	2
normal uterine endometrial epithelium samples	2
ovarian endometriotic	2
ectopic endometrial-like epithelium and stroma	2
monkey, the human agent	2
previously chosen target	2
monkey or the human	2
right and left parts of a screen	2
four potential targets	2
monkey-human paradigm	2
two male rhesus monkeys	2
dorsal premotor cortex (PMd)	2
others’ intentions	2
polybasic motif	2
PIP2-enriched plasma membrane ruffles	2
resting, non-pyroptotic macrophages	2
ectopic IL-1β	2
primary non-pyroptotic myeloid cells in vitro	2
endogenous IL-1β	2
caspase-1 and GSDMD therein	2
pyroptotic and non-pyroptotic cells	2
inflammasome-activated macrophages	2
active, pro-inflammatory cytokine	2
gatekeeper	2
reprogramming blockers	2
early immediate response genes	2
pioneer factors	2
network of pluripotency factors	2
Yamanaka’s pioneer factors	2
CCDD etiology	2
abducens nucleus	2
soma clumping	2
Mafba/MAFB	2
Duane retraction syndrome-associated transcription factors	2
single muscle	2
pools of abducens motor neurons	2
ocular motor system	2
neuromuscular connection	2
cranial motor nuclei	2
neuromuscular connections	2
diverse types of head and neck muscles	2
motor nuclei	2
downstream wake-promoting circuits	2
neuro-modulatory IGF	2
Pitpnc1a-expressing neurons	2
pitpnc1a mutants	2
IGF pathways	2
Pitpnc1a increases insulin-like growth factor (IGF) signaling	2
Zebrafish pitpnc1a mutants	2
brain-specific, conserved class II PITP member, pitpnc1a	2
Cas9-generated zebrafish mutant	2
neuronal signaling pathways	2
specific phosphoinositides	2
phosphoinositide compartmentalization	2
phosphatidylinositol transfer protein (PITP) family	2
lipid transporters	2
Transcriptionally active ESR1 fusions	2
ESR1-e6>YAP1 fusion	2
patient-derived xenograft (PDX)	2
CDK4/6 inhibitor	2
ESR1-e6>YAP1- and ESR1-e6>PCDH11X-induced growth	2
estrogen-independent growth	2
partner gene	2
C-terminal sequences	2
ESR1 exons 1–6	2
stable and functional fusion proteins	2
multiple ESR1 fusions	2
estrogen receptor-positive (ER+) breast cancer	2
estrogen receptor alpha gene (ESR1) fusion transcripts	2
Nr4a factors	2
Treg-fated thymocytes	2
developing Treg precursors	2
Nr4a-deficient Treg-fated thymocytes	2
Treg cell developmental machineries	2
Nr4a family of nuclear receptors	2
Treg-fated developing thymocytes	2
self-reactive, CD4-single positive (CD4SP) precursor cell pool	2
cytosolic pairs of proximal cysteine and N-acetylated lysines	2
N-acetylated lysines	2
pairs of proximal cysteine	2
mammalian and bird species	2
cysteine	2
619 proteins	2
adjacent cysteine	2
protein lysines	2
abundant metabolite	2
SummaryAcetyl-coenzyme A (CoA)	2
cell types of the NSC lineage	2
nanoscale scaffold and ruler	2
conserved 1D periodic membrane cytoskeletal motif	2
two adhesion molecules, neurofascin and L1CAM	2
axon-axon and axon-oligodendrocyte contacts	2
abutting cells	2
periodic cytoskeletons	2
flat 2D membranes	2
distinct 1D periodic “strips”	2
terminally differentiated neuronal and glial cell types	2
NSCs	2
periodic structures	2
locally periodic, one-dimensional (1D) membrane cytoskeleton	2
neural stem cells (NSCs) and NSC-derived neurons, astrocytes, and oligodendrocytes	2
spectrin-actin-based membrane cytoskeleton	2
pro-inflammatory transcripts	2
anti-inflammation responsive, HuR counter-regulatory protein	2
anti-inflammatory cytokine IL-19	2
3′ UTR of TNFα	2
RNA EMSA	2
naive VSMCs	2
FXR1 siRNA-treated VSMCs	2
Conditioned media	2
inflammatory mRNAs	2
diseased but not normal arteries	2
RNase-treated extracts	2
HuR-interacting protein	2
HuR target transcripts	2
fragile-X-related protein (FXR1)	2
given lesion	2
site-specific DNA lesion	2
stretches of DNA	2
specialized polymerase, Pol V	2
replicative polymerases	2
large collections of single DNA molecules	2
gaps	2
homologous recombination and translesion synthesis (TLS)	2
daughter strand gaps	2
replication-blocking lesions	2
neurons cultured	2
entire Borcs7 coding sequence	2
mouse Borcs7 gene	2
multisubunit complex, BLOC-one-related complex (BORC)	2
PV+ interneurons	2
microtubule-associated kinase NEK7	2
pyramidal cells	2
NEK7-deficient PV+ interneurons	2
parvalbumin (PV+) interneurons	2
cortical wiring	2
pyramidal cells and interneurons	2
cortical circuits	2
morphology and targeting areas	2
glutamatergic pyramidal cells and GABAergic interneurons	2
TCR-pMHC microclusters	2
CD28-CD80 complexes	2
peripheral supramolecular activation cluster (pSMAC)	2
costimulatory ligand	2
TCR peptide-bound major histocompatibility complex (pMHC) and leukocyte-function-associated antigen 1 (LFA-1) intracellular activation molecule 1 (ICAM-1) dynamics	2
, T cell receptor (TCR) signaling complexes, integrins, and costimulatory molecules	2
PHD3 substrate	2
p53 ubiquitination	2
p53-DUB binding domain	2
PHD3 hydroxylates p53	2
two deubiquitinating enzymes (DUBs), USP7 (HAUSP) and USP10	2
multitude of ligases	2
proto-oncogene	2
BLM-expressing cells	2
c-Jun targets	2
2,584 gene promoters	2
c-Jun in cells expressing BLM	2
Fbw7α-dependent c-Jun degradation	2
BS patient-derived BLM mutants	2
Functionally defective Fbw7α mutants	2
transcription factor c-Jun and its E3 ligase,	2
MIB1-ubiquitylated BLM	2
Bloom syndrome (BS) patients	2
BLM helicase	2
ESCRT proteins	2
SHH on ART-EVs	2
AXL, RAB18, and TMED10 (ART) and SHH	2
EV subtype	2
Chmp1a null mice	2
human cerebral organoids	2
mouse cortex and cerebellum	2
pontocerebellar hypoplasia	2
ESCRT-III member CHMP1A	2
SummaryEndosomal sorting complex required for transport (ESCRT) complex proteins	2
TRAF6	2
receptor intracellular domain	2
RIP2-deficient mice	2
downstream effector RIP2	2
death receptor p75NTR	2
granule neurons (CGNs)	2
ALS/FTD-FUS	2
Transportin 1/2	2
neuronal FUS	2
human neural networks	2
ex vivo mouse CNS model	2
endogenous FUS	2
pathological inclusions	2
cytoplasmic stress granules	2
subset of early-onset amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients	2
pathological cytoplasmic inclusions	2
primarily nuclear RNA-binding protein FUS (fused in sarcoma)	2
iPSC line	2
transcriptome, and epigenome data	2
clonal variants	2
iPSCs within a line	2
fibroblast-derived iPSC lines	2
nucleotide-dependent tetramerization	2
cellular dNTPs	2
C350S mutant	2
allosteric nucleotide binding site	2
C341, C350, and C522	2
redox-active cysteines	2
redox-sensitive enzyme	2
subset of non-cycling immune cells	2
dNTP triphosphohydrolase (dNTPase)	2
Plk1-binding-deficient mutant	2
wild-type WAC	2
polo-box domain of Plk1	2
Cyclin-dependent kinase 1 (Cdk1) phosphorylates WAC	2
coiled-coil region	2
WW domain-containing adaptor protein	2
key mitotic regulator Polo-like kinase 1 (Plk1)	2
three distinct chromatin structures	2
active RNAP II	2
densely packed chromatin	2
active marks and RNA polymerase II (RNAP II)	2
less compact chromatin	2
condensed large aggregates	2
repressive histone methylation marks	2
spatially dispersed larger nanodomains	2
active histone methylation marks	2
spatially segregated nanoclusters	2
histone acetylation marks	2
different histone modifications	2
genome-wide higher-order chromatin structures	2
chromatin environments	2
mechanical sensing	2
cilia formation	2
different hiPSC-derived ECs	2
hiPSC-derived ECs lacking cilia	2
human induced pluripotent stem cell (hiPSC)-derived ECs	2
venous, capillary, and progenitor ECs	2
individual disease-associated variants	2
GPCR signaling	2
G protein Gαolf	2
extensive set	2
complete analytical framework	2
GPCR pathways	2
clinical variants	2
components of G protein-coupled receptor (GPCR) signaling cascades	2
diverse neural circuits	2
defined projections	2
i.e., mGRASP)	2
soma of IC neurons	2
large synaptic contacts	2
descending ipsilateral projections	2
CC mEPSCs	2
CC axons expressing channelrhodopsin	2
IC regions	2
small, medium, and large synapses	2
CC projections	2
defined corticocollicular (CC) connections	2
centromeric nucleosome	2
DNA-binding site of the complex	2
monomeric construct of Ndc10	2
core complex of CBF3 alone	2
kinetochore components	2
essential complex	2
point centromeres	2
third centromere DNA element	2
centromere binding factor 3 (CBF3) complex	2
diagnostic and therapeutic target	2
PD-L1 and EGFR	2
increased immunosuppressive environment	2
ALIX-deficient tumors	2
immunocompetent mouse model	2
human breast cancer tissues	2
ALIX-depleted cells	2
surface PD-L1 expression	2
basal-like breast cancer (BLBC) cells	2
transport (ESCRT)-associated protein ALIX	2
multivesicular body (MVB)	2
immunosuppressive transmembrane protein PD-L1	2
limiting trans regulators	2
3′ end of genes	2
synthetic inducible promoter	2
huntingtin with long polyglutamine repeats	2
nonproteasomal substrates	2
microtubule-associated protein tau (MAPT)	2
autophagosome-lysosome fusion step	2
major intracellular proteolytic pathways	2
autophagy-lysosome system	2
basolateral amygdala	2
stimulus-specific recruitment of neurons	2
defined gustatory cortex neurons	2
potentially toxic food	2
CXCL12 stimulation	2
F-actin-rich structures	2
B cell surface	2
mutated actin binding domain of WIP (WIPΔABD)	2
WASp-interacting protein (WIP)	2
main cytoskeletal regulator	2
SummaryWiskott-Aldrich syndrome protein (WASp)	2
virally encoded deSUMOylase	2
latent HCMV	2
deSUMOylase inhibitors	2
naturally latent HCMV	2
LUNA-deficient viruses	2
putative catalytic cysteine	2
deSUMOylases	2
conserved Asp-Cys-Gly motif	2
cellular PML bodies	2
latency-associated gene product (LUNA)	2
subset of viral genes	2
antibodies against MERS-CoV infection	2
MERS-4 neutralizes MERS-CoV	2
several reported antibodies	2
“up” position in the S trimer	2
Structural modeling	2
shallow groove on the RBD interface	2
β5-β6 loop	2
outside of the RBD-DPP4 binding interface	2
RBD	2
isolated human antibody MERS-4	2
unique epitope	2
receptor-binding domain (RBD) of the spike (S) glycoprotein	2
cellular receptor dipeptidyl peptidase 4 (DPP4)	2
Middle East respiratory syndrome coronavirus (MERS-CoV)	2
IFN-γR/STAT1 signaling axis	2
local cytokine landscape	2
antigen-negative tumor cells	2
tumor-infiltrating myeloid cells	2
Ly6G– myeloid cells	2
tumor-infiltrating CD11b+	2
HDACi	2
antigenicity of tumors	2
cytotoxic CD8+ T cells	2
tumor-expressed antigens	2
cell-associated antigens	2
DNGR-1 ligand	2
Myosin II-deficient necrotic cells	2
DNGR-1+ cDC1s	2
F-actin and myosin II	2
Latex beads	2
myosin II, an F-actin-associated motor protein	2
actin-binding proteins	2
cellular F-actin	2
synthetic ligand	2
In vitro polymerized F-actin	2
dead cells	2
exposed actin filaments	2
dead cell-associated antigens	2
SummaryConventional type 1 DCs (cDC1s)	2
polarized growth	2
NDR-related kinase Orb6	2
upstream CDK	2
downstream kinases	2
sequential, kinase-specific waves	2
different mitotic kinases (CDK, NIMA-related, Polo-like, and Aurora)	2
quantitative phosphoproteomics	2
upstream master regulators	2
cyclin-dependent kinases (CDKs)	2
chromatin accessibility	2
new open chromatin sites	2
activated genes	2
pre-existing open transcription start sites	2
comprehensive, data-rich resource	2
negative regulators of mTORC1	2
diverse biological processes and pathways	2
Rex1GFP reporter	2
genetic basis	2
cancer-relevant pathways	2
fusion transcripts	2
enhancer hijacking	2
topologically associated domains	2
overexpressed cancer driver genes (e.g., TERT, ERBB2, CDK12, CDK4)	2
1,100 genes	2
Cancer Genome Atlas	2
1,448 cancers	2
multiple patient cohorts	2
systematic cataloging of genes	2
synaptic vesicle fusogenicity	2
active zone ultrastructure	2
calyx of Held, a CaV2.1 channel-exclusive presynaptic terminal	2
CAST/ELKS protein family	2
presynaptic active zone proteins	2
voltage-gated Ca2+ channels (VGCCs)	2
RA gradient	2
explants and intact embryos	2
SFC model	2
determination front	2
Neighboring cells	2
alternative models	2
non-elongating tail explant system	2
spatial gradients	2
fibroblast growth factor (FGF), Wnt, and retinoic acid (RA) pathways	2
precursors of the vertebral column	2
structures of macromolecular machines	2
heterogeneous mixture of protein complexes	2
native proteasomes	2
human cell extract	2
heterogeneous mixtures	2
genomics and proteomics	2
SummaryMulti-protein complexes	2
two fluorescently labeled loci	2
single DNA replication forks in living cells	2
Rbfox splicing factors	2
Rbfox knockout	2
active form of calpain3 protease	2
hundreds of gene transcripts	2
global protein synthesis	2
Rbfox deletion	2
adult mouse skeletal muscle	2
highly conserved Rbfox1 and Rbfox2 alternative splicing regulators	2
calpain, autophagy-lysosome, and ubiquitin-proteasome systems (proteostasis)	2
neurons in layers II and III	2
EC-hippocampal loop	2
layer Va	2
telencephalic areas	2
hippocampal output circuit	2
hippocampus-memory system	2
two circuits	2
EC-layer Vb neurons	2
lateral entorhinal cortex	2
similar circuitry	2
neurons in layers Va, II, and III	2
layer Vb neurons	2
medial entorhinal cortex	2
hippocampal-cortical interactions	2
main outputs of EC	2
immunonegative for Ctip2	2
superficial-sublayer LVa	2
hippocampal projections	2
transcription factor Ctip2	2
deep-sublayer Vb	2
main entorhinal outputs	2
V of the entorhinal cortex (EC)	2
earliest regulators	2
forebrain Ptf1a	2
Ptf1a cKO	2
sex-biased genes	2
knockout brain	2
gonadectomized animals	2
reproductive organs	2
sex-biased behaviors	2
conditional Ptf1a-deficient mice (Ptf1a cKO)	2
several hypothalamic nuclei	2
various neurons	2
third ventricle	2
certain neuroepithelial cells and immature neurons	2
perinatal critical period	2
IL-4/13-competent WT	2
wild-type (WT)	2
IL-2/IL-2 antibody complex	2
IL-25/IL-33 mini-circles	2
RORαcre/GATA3fl/fland Tie2cre/RORαfl/flmice	2
loss- and gain-of-function mouse models	2
ILC2 number	2
Circulating ILC2s	2
peripheral blood and the joints of rheumatoid arthritis (RA) patients, serum-induced arthritis (SIA), and collagen-induced arthritis (CIA)	2
the 3D genome	2
TAD borders	2
CTCF binding sites	2
Zebrafish A/B compartments and TADs	2
topologically associating domains (TADs)	2
active and inactive chromatin (A/B compartments)	2
Zebrafish chromosomes	2
situ Hi-C maps	2
cortico-amygdalar cholinergic terminals	2
[18F] FEOBV radiotracer	2
two distinct macroscopic cholinergic projections	2
cortico-amygdalar regions	2
older human adults	2
BF	2
cortico-amygdalar projection system	2
brain’s cortical and amygdalar cholinergic input	2
cholinergic neurons of the basal forebrain (BF)	2
Aβ3-42-associated toxicity	2
aspartic protease ASP-12	2
intestine-activated TCS	2
innate immunity-associated transmembrane protein CLEC-41	2
PQM-1 coordinates neuron-activated TCS	2
GATA zinc-finger transcription factor	2
neurons or the intestine	2
systemic stress signaling pathway	2
distal tissues	2
scale	2
taller and sheet-like vertical laminae	2
DDC gene	2
extra horizontal laminae on the surface of scales	2
yellow gene	2
wing scales	2
specific scale morphologies	2
exquisitely finely sculpted material	2
cuticular skeleton of a butterfly wing scale cell	2
4-[3′-(2″-chlorophenyl)-2′-propen-1′-ylidene]-1-phenyl-3,5-pyrazolidinedione (CPYPP)	2
shrink spines	2
Rac1GEF subunit engulfment and cell motility protein 1 (ELMO1)	2
NMDAR-mediated LTD-causing stimuli	2
Postsynaptic NMDAR-dependent long-term depression (LTD)	2
kinesin-4 motor KIF21B	2
Lrrc4−/− mice	2
suppressed N-Methyl-D-aspartate receptor (NMDAR)-dependent synaptic plasticity	2
NGL-2 (Lrrc4−/− mice)	2
presynaptic adhesion molecule netrin-G2	2
trans-synaptically	2
excitatory postsynaptic scaffolding protein PSD-95	2
leucine-rich repeat-containing postsynaptic adhesion molecule	2
SummaryNetrin-G ligand 2 (NGL-2)/LRRC4,	2
calcium signals	2
AChR clustering	2
L-type calcium currents (LTCCs)	2
L-type channels (CaV1.1)	2
center of muscle fibers	2
acetylcholine receptors (AChRs)	2
motor neurons and muscles	2
p53R273H-expressing cells	2
RasV12-transformed epithelia	2
epithelial monolayer	2
normal epithelial cells	2
p53R273H- or p53R175H-expressing cells	2
mammalian cell culture and mouse ex vivo systems	2
tumor suppressor protein	2
cytoplasmic microtubules	2
integrin-Src family kinase (SFK)-FAK signaling	2
FERM domain of FAK	2
plasma membrane Ca2+ ATPase (PMCA)	2
primary sensory neurons	2
atypical kinesin KIF26A	2
cargos	2
SummaryKinesin superfamily proteins (KIFs)	2
extracellular chaperones	2
cultured neuronal cells	2
two previously described forms of αS oligomers	2
surface of α-synuclein oligomers	2
exposed hydrophobic regions	2
two abundant extracellular chaperones, clusterin and α2-macroglobulin	2
extracellular α-synuclein oligomers	2
pancreatitis patients	2
plausible molecular targets	2
pancreas-specific HIF1α expression	2
murine and human pancreatitis	2
hypoxia-inducible factor 1α (HIF1α) transcription factor	2
Inflamed tissues	2
common gastrointestinal disorders	2
epithelial cell sheet	2
cell junctions	2
multiple cells	2
actin-binding proteins, vinculin and afadin	2
activated α-catenin	2
SummaryAdherens junctions (AJs)	2
authentic cDC1s	2
cDC generation	2
human bone marrow progenitors	2
IRF8-dependent CD141+ cDC1s	2
CCR7 ligands	2
OP9-DL1-induced cDC1s	2
primary splenic cDC1s	2
OP9-DL1 induced IRF8-dependent	2
murine immortalized progenitors and primary bone marrow cells	2
OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1)	2
cDC1-like” cells	2
immature “	2
cDC1s (in humans)	2
DC growth factor FLT3 ligand (FLT3L)	2
pathogens and tumors	2
subset of classical dendritic cells (cDCs)	2
heterodimeric proteins	2
genes whose products	2
full functional knockout of PlGF	2
PlGF-DE knockin mouse	2
VEGF-A/PlGF heterodimer function	2
PlGF knockout and wild-type mice	2
Plgf, Vegf-a, Vegfr-1, and Vegfr-2	2
VEGF-A.	2
vascular endothelial growth factor receptor 1 (VEGFR-1)	2
PlGF variant	2
PlGF-DE	2
VEGF) family	2
vascular endothelial growth factor (	2
proangiogenic member	2
growth factor (PlGF)	2
dephosphorylate Atg32	2
Far complex	2
ppg1Δ cells	2
cytoplasmic region (amino acid residues 151–200) of Atg32	2
Ppg1 or Far proteins	2
Ppg1-binding proteins	2
Far complex proteins, Far3, Far7, Far8, Far9, Far10, and Far11	2
PP2A (protein phosphatase 2A)-like protein phosphatase Ppg1	2
Atg32 with Atg11 (an adaptor protein for selective autophagy)	2
mitophagy receptor Atg32	2
pre-malignant and malignant lesions	2
dihydroorotate dehydrogenase (DHODH)	2
distal part of the electron transport chain (ETC)	2
glycolysis, tricarboxylic acid (TCA) cycle, and fatty acid β-oxidation	2
targeted metabolomics	2
subpopulation of dMSNs	2
optogenetically labeled striatal single-unit recordings	2
identified MSNs in behaving animals	2
striatal direct and indirect pathway medium spiny neurons (dMSNs and iMSNs	2
PDIA1 and Drp1 oxidoreduction	2
Cys oxidation-defective mutant Drp1	2
EC-targeted PDIA1	2
diabetic or PDIA1+/− mice	2
biotin-labeled Cys-OH trapping probe	2
mitochondrial fission protein Drp1	2
thiol reductase	2
protein disulfide isomerase A1 (PDIA1)	2
excess reactive oxygen species (ROS)	2
Piwi-NLS with SV40-NLS fails	2
additional Piwi-NLS	2
Piwi-NLS	2
Impα members	2
least expressed	2
bipartite nuclear localization signal (NLS)	2
Importinα (Impα)	2
N terminus and PIWI-interacting RNA (piRNA)	2
transposons transcriptionally	2
Drosophila ovarian somatic cells (OSCs)	2
IFN-β and IFN-stimulated genes	2
subset of mature miRNAs	2
Microprocessor complex	2
secreting IFNs	2
interferons (IFNs)	2
individual chromosomes	2
subset of chromosomes	2
specific centromeres	2
chromosome-specific aneuploidy	2
Human chromosomes	2
Env V2-apex	2
soluble Env trimers	2
soluble and full-length Env constructs	2
CDRH3 loop	2
antibody lineage	2
Ab-Env complexes	2
Protocol C cohort	2
viral Env	2
autologous clade	2
apex-targeting antibody lineage	2
humoral immune system	2
neutralizing antibody lineages and viruses	2
HIV envelope glycoprotein (Env)	2
 a known repressor	2
BCL11A expression	2
primary human CD34+ progenitor cell-derived erythroblasts	2
Pogz+/− mice	2
erythroid-specific intragenic regulatory regions	2
Bcl11a promoter	2
adult hematopoietic cells	2
 Pogz	2
zinc-finger protein, pogo transposable element with zinc-finger domain (POGZ)	2
globin genes	2
stress-responsive transcription factor	2
anterior dentate gyrus of women	2
ventral hippocampus of male and female mice	2
excitatory forebrain neurons	2
Kruppel-like factor 9 (Klf9)	2
embryonal carcinomas	2
miRNA specifically	2
globally demethylated DNA	2
subset of pure seminomas	2
histology subtypes	2
seminoma, embryonal carcinoma, yolk sac tumor	2
major recognized histologic subtypes	2
samples with seminoma components	2
high-dimensional assays	2
primary testicular germ cell tumors (TGCTs)	2
hypoxia-activated pro-drug TH-302	2
dual mTORC1/2 inhibitor AZD2014	2
different tumor compartments	2
FRET biosensor	2
hypoxic regions	2
oxygen-sensitive nanoparticles	2
clinically relevant inhibitors	2
hypoxic microenvironment of pancreatic ductal adenocarcinoma (PDAC)	2
advanced intravital imaging	2
important ATP-dependent regulator	2
alternate energy substrate	2
Many tissues oxidize fat	2
principal hyperglycemic hormone	2
TDP1 ubiquitylation	2
topoisomerase therapy-resistant rhabdomyosarcoma	2
catalytically inactive mutant	2
TOP1 poisons	2
deubiquitylase	2
multiple clinical settings	2
topoisomerase-mediated chromosomal breaks	2
tyrosyl DNA phosphodiesterase 1 (TDP1)	2
DNA-protein crosslinks	2
β cells and insulin-responsive tissues	2
insulin granule vesicles in β cells	2
normal autophagy	2
autophagy-hyperactive mice	2
knockin (Becn1F121A) mice	2
insulin-producing β cells	2
stress-induced lysosomal degradative pathway	2
Golgi twin	2
midbody	2
Golgi cluster	2
non-degradable GBF1 mutant	2
intercellular bridge of telophase cells	2
SCFβTrCP ubiquitin ligase complex	2
F-box protein βTrCP	2
Ser292 and Ser297 by casein kinase-2	2
ARFGEF GBF1	2
inhibitory commissural interneurons	2
dorsally located interneurons	2
specific inputs	2
large motoneurons	2
ventral excitatory ipsilateral interneurons	2
motoneurons in a larval zebrafish spinal cord hemisegment	2
two types of interneurons	2
subsets of motoneurons	2
SummarySpinal interneurons	2
drug-sensitive cells	2
Kif7 knockdown	2
variety of kinase inhibitors	2
Smoothened, KRAS, EGFR, and PDGFR)	2
number of oncogenic molecules	2
microtubule-based organelles	2
PU.1 and CEBPA functionally	2
Cebpa null bone marrow	2
set of enhancers	2
factors PU.1	2
viable clinical avenue	2
GBA-PD	2
fly models	2
NAD+ precursors	2
NAD+ pool	2
nicotinamide phosphoribosyltransferase (NAMPT)	2
Human neurons	2
NAD+ precursor nicotinamide riboside (NR)	2
Patient neurons	2
GBA-related PD (GBA-PD)	2
patient-derived induced pluripotent stem cells	2
autophagy-deficient tumor cells	2
glutamine-deprived autophagy-deficient cells	2
AAT expression	2
activated NRF2	2
NAD+-dependent histone deacetylase	2
AAT (amino acid transporter) gene expression	2
autophagy-defective tumor cells	2
intracellular materials	2
 Tau	2
retrotransposons in Drosophila expressing human wild-type or mutant Tau	2
multiple HERV-Fc1 genomic loci	2
long interspersed nuclear element 1 and endogenous retrovirus clades	2
several retrotransposons	2
636 human brains	2
human postmortem brain tissue and Drosophila melanogaster models	2
dominant-negative RBP4 alleles	2
physiological basis	2
maternal and fetal genomes	2
placenta and developing eye	2
RBP carries vitamin A (retinol)	2
deletion homozygotes	2
dam and offspring	2
N terminus of retinol-binding protein (RBP4)	2
oocyte-derived mRNA	2
early tactile processing	2
layer 4 of S2	2
non-canonical feedback circuit	2
wS1 neurons	2
wS2 and wS1	2
S2L4 neurons	2
S2L4 → S1 neurons	2
putative S2L4 → S1 feedback neurons	2
organized somatotopically	2
major feedback pathway	2
Neurons in layer 4 of wS2 (S2L4)	2
mice, whisker primary (wS1) and secondary (wS2) somatosensory cortices	2
the circuit basis	2
superficial and deep layers	2
lower areas	2
feedback projections	2
higher areas	2
cortical areas	2
intrathecal LPS	2
intraplantar formalin	2
Intrathecal AIBP	2
neuroinflammation, and glial activation	2
TLR4 dimerization	2
spinal myeloid cell lipid rafts	2
inflammatory signaling	2
LPS-induced TLR4 dimerization	2
activated microglia	2
Toll-like receptor-4 (TLR4)	2
neuroinflammatory-mediated spinal nociceptive processing	2
SummaryApolipoprotein A-I binding protein (AIBP)	2
dynamic signaling pathway	2
acutely isolated mouse cortical neurons	2
VGSC currents	2
guanosine diphosphate (GDP) analog GDPβs	2
CaSR-deficient neurons	2
vast majority of cultured mouse neocortical neurons	2
allosteric modulators of the calcium-sensing receptor (CaSR) cinacalcet, calindol, calhex, and NPS 2143	2
second messenger pathways	2
local anesthetic and antiepileptic drugs	2
SummaryVoltage-gated sodium channels (VGSCs)	2
bioenergetic	2
OXPHOS-induced old fibroblasts	2
OXPHOS-dependent iNs	2
glycolysis-dependent fibroblasts	2
old donors	2
Direct fibroblast-to-induced neuron (iN) conversion	2
aging human neurons	2
 the human brain	2
major target	2
CEP120 ciliopathy alleles	2
CEP120 C2B	2
putative binding partners	2
Genome-engineered cells	2
second C2 domain	2
three C2 domains	2
ciliopathy-associated centriolar protein CEP120	2
functional cilia	2
ripple-associated computations	2
the CA3 and the DG	2
hub functionally	2
within and between hippocampi	2
widespread connectivity of MCs	2
 MCs	2
granule cells	2
pronounced, ripple-coherent, excitatory and inhibitory synaptic input	2
CA3 area	2
active neuronal network	2
sharp wave-ripple complexes (SWRs)	2
hippocampal dentate area	2
mossy cells (MCs)	2
definitive lymphomyeloid progenitors and lymphoid cells	2
BCL11a and β-globin	2
B lymphocytes	2
Blood cells	2
arterial-type HE expressing DLL4	2
MAPK/ERK signaling pathways	2
ETS1 overexpression	2
arterial program	2
lymphoid progenitors and hematopoietic stem cells (HSCs)	2
human pluripotent stem cell (hPSC) technologies	2
myosin IIa-deficient B cells	2
membrane-presented antigens	2
myosin IIa-deficient follicular B cells	2
splenic marginal zone, peritoneal B1b, and germinal center B cells	2
bone marrow B cell precursors	2
myosin IIa heavy chain	2
non-muscle myosin IIa	2
helper T cells	2
larval and adult olfactory receptors	2
comprehensive stimulus spectrum	2
full repertoire of the peripheral olfactory system	2
compact chromosomes	2
condensin’s Smc4 subunit	2
ATP hydrolysis-deficient condensin	2
condensin ATPase	2
large ring-shaped protein assemblies	2
structural maintenance of chromosomes (SMC) family of ATPases	2
condensin complex	2
interphase chromatin	2
multiple layers of inhibitory and excitatory presynaptic connections	2
collision-detecting neurons	2
spatially incoherent controls	2
colliding objects	2
coherently expanding visual stimuli	2
muscarinic acetylcholine receptors	2
presynaptic circuits	2
presynaptic input network	2
grasshopper visual system	2
one such neuron	2
presynaptic neural networks	2
collision course	2
track objects	2
SummaryVisual neurons	2
robust synthetic oscillators	2
multi-cellular systems	2
natural clocks	2
vertebrate tissue	2
anterior segmentation and differentiation zone	2
posterior progenitor zone	2
gene extrinsic sources	2
segmentation clock genes in zebrafish	2
single transcripts	2
hpiNs and other programmed neuronal populations	2
successfully programmed cells	2
CAMK2A::GFP reporter gene	2
 well-differentiated, excitatory glutamatergic neurons	2
poorly differentiated neuronal progenitors	2
hpiN cultures	2
human patterned induced neurons (hpiNs)	2
variety of cell types	2
lysosome biogenesis	2
ALS-afflicted flies	2
Selective XPO1 inhibitors	2
several established longevity models	2
HLH-30 in the nucleus	2
nuclear export protein XPO-1/XPO1	2
transcription factor HLH-30/TFEB	2
locus coeruleus	2
Slc6a15 and Lin28b, both major depressive disorder (MDD)-associated genes	2
EP3 receptor	2
druggable receptors	2
high-confidence transcripts	2
mouse noradrenergic neurons in vivo	2
behavior and neuropsychiatric disease models	2
CNS norepinephrine system	2
male animals	2
glutamine and GABA synthesis	2
late-stage R6/2 mice	2
spatial brain proteome	2
striatal and cortical neurons	2
previously reported downstream-of-gene transcripts (DoGs)	2
viral NS1 protein	2
poly(A) sites	2
host transcription	2
host RNA polymerase II (Pol II) and mRNA processing machinery	2
pro-inflammatory signaling circuits	2
TNF-mTORC1 signaling	2
metabolic inputs	2
STAT1-dependent gene expression (e.g., CXCL11 and TNFSF13B)	2
decreased NF-κB-mediated gene expression (e.g., PTGS2, IL-6, and IL-8)	2
key effector cells	2
Resident mesenchymal tissue components	2
metabolic master regulators	2
extracellular tau	2
neuronal secretomes	2
trisomy of chromosome 21 (trisomy 21)	2
presenilin-1 mutant and amyloid precusor protein duplication secretomes	2
chromosome 21	2
rat brain	2
human iPSC-derived neuronal models	2
extracellular molecules	2
key AP-1 family member Fosl2	2
cell signaling and transcription factor pathways	2
terminal TEX cell subset	2
important host-pathogen or host-tumor stalemate	2
exhausted T (TEX) cells	2
DC3000D36E T3E library system	2
different sets of death-T3Es	2
Pseudomonas fluorescens and Agrobacterium tumefaciens heterologous delivery systems	2
reactive oxygen species burst	2
T3E library	2
T3E library in N. benthamiana leaves	2
29 DC3000 T3Es singly and in pairs	2
modularized system	2
Effectorless polymutant DC3000D36E	2
complex repertoire of type III secretion effector (T3E) proteins	2
two-tiered innate immune system of Nicotiana benthamiana and other plants	2
tomato DC3000	2
bacterial pathogen Pseudomonas syringae pv.	2
resulting aboveground plant body	2
shoot stem cells	2
shoot apices	2
cells in the peripheral shoot meristem region	2
key regulator, SHOOTMERISTEMLESS (STM)	2
 shoot stem cells in Arabidopsis	2
FT INTERACTING PROTEIN 3 (FTIP3) and FTIP4	2
two multiple C2 domain and transmembrane region proteins	2
shoot meristem	2
driving master regulators	2
PCBP2, ESRP2, and MBNL2	2
renal cell carcinoma (RCC)	2
several RBPs	2
cancerous tissues	2
sequence-specific RBPs	2
post-transcriptional regulatory factors	2
DHX9 and other interactome helicases	2
top candidate DHX9 helicase	2
helicases, RNA processing, DNA repair, and chromatin factors	2
yet uncharacterized interactors	2
known R-loop-associated factors SRSF1, FACT, and Top1	2
S9.6 antibody	2
biological roles	2
displaced single-stranded DNA	2
RNA/DNA hybrid	2
SummaryR-loops	2
RNF12 E3 ubiquitin ligase activity	2
distal regulatory region	2
catalytic RING domain	2
distinct RNF12 functional modules	2
XLID mutants	2
developmentally relevant substrates	2
RNF12/RLIM E3 ubiquitin ligase	2
recently identified XLID gene	2
embryonic stem cell model	2
XLID genes	2
Lhfpl4/Garlh4−/− mice	2
inhibitory postsynaptic sites	2
NL2 binding proteins	2
transmembrane protein at inhibitory postsynaptic sites	2
(NL2)	2
excitatory and inhibitory synapses	2
perivascular macrophages	2
migratory TAMs	2
blood vessel	2
motile cancer cells	2
motile TAMs	2
CXCR4 in monocytes	2
newly arrived monocytes	2
motile, streaming TAMs	2
functionally distinct TAMs	2
migratory macrophages	2
TAM subsets	2
SummaryTumor-associated macrophages (TAMs)	2
RNA Pol II factors	2
 H3K4 and H3K36 methylation	2
histone H2BK120 ubiquitination	2
RNA Pol II subunits SPT4, SPT6, and PAFc	2
transcription-associated factors	2
RAM RNA binding domain	2
transcriptional output	2
recombinant RNMT-RAM	2
cap methyltransferase activity	2
mammalian mRNA cap methyltransferase, RNMT-RAM	2
mechanistic gene expression network	2
 lin28a, zic2b, and foxn4	2
matrix metalloproteinase9	2
 Ascl1 in mouse and zebrafish retina	2
Müller glia (MG)-derived progenitor cells (MGPCs)	2
let-7 microRNA	2
sonic hedgehog, smoothened, and patched1	2
developmentally inevitable Sonic hedgehog signaling	2
Müller glia cells of the zebrafish retina	2
CSF1R inhibitors	2
myeloid cell axis	2
switching PDAC subtypes	2
difficult-to-treat model	2
potent selective inhibitor of CSF1R. AZD7507	2
genetic PDAC model	2
human PDAC	2
autochthonous models	2
human PDAC stroma	2
dominant leukocyte population	2
dense desmoplastic stroma	2
spine plasticity	2
extrasynaptic AMPARs	2
SynGAP from spines	2
single-particle tracking	2
SEP-GluA1	2
(Fz7) receptors	2
postsynaptic Frizzled-7	2
endogenous Wnts	2
extracellular modulators	2
anticancer therapeutics	2
superior target of LUBAC destabilization	2
LTM-mediated HOIL-1L/SHARPIN dimerization	2
trimeric LUBAC	2
single globular domain	2
UBL domains of HOIL-1L and SHARPIN heterodimerize	2
LUBAC-tethering motifs (LTMs)	2
binding regions of the trimeric LUBAC complex	2
co-crystal structure	2
stable trimeric LUBAC	2
ubiquitin-associated (UBA) domains of HOIP and the ubiquitin-like (UBL) domains of two accessory subunits	2
two accessory subunits, HOIL-1L and SHARPIN	2
catalytic HOIP subunit	2
linear ubiquitin chains	2
SummaryThe linear ubiquitin chain assembly complex (LUBAC)	2
mesenchymal stem cell-like epigenomic phenotype	2
AP-1/SOX binding elements	2
candidate functional tissue enhancers	2
resembled IDH-wild-type primary glioblastoma	2
gliomas	2
G-CIMP-high primary tumors	2
initially lower-grade gliomas	2
200 tumors	2
77 patients	2
diffuse gliomas	2
G-CIMP-low subtype	2
IDH mutant G-CIMP-high subtype	2
glioblastoma patients	2
bona fide biomarkers	2
primary model	2
Targeting and reactivating latent cells	2
SAC-controlled APC/C substrates	2
unattached kinetochores	2
mitotic checkpoint complex	2
deubiquitinase USP9X	2
every chromosome	2
metazoan Ca2+ signals	2
cytosolic Ca2+ sensor	2
Miro1 EF1 mutants	2
Miro1-dependent MiST	2
Miro1 EF1 domain	2
Miro1/KIF5B/tubulin complex	2
EF-hand domain 1	2
mitochondrial protein Miro1	2
[Ca2+]c	2
dysregulated [Ca2+]c	2
bioenergetics output	2
([Ca2+]m)	2
cisplatin and PARP inhibitors	2
cells and ovarian cancer patients	2
synergistic drug combinations	2
quantitative map	2
classes of chemotherapy	2
625 genes	2
human mammary epithelial cells	2
quantitative chemical-genetic interaction map	2
human skeletal muscle organoid-like platform	2
vascular endothelial cells, pericytes, and motor neurons	2
key isogenic cellular constituents	2
fully human iPSC-derived, complex, multilineage muscle models	2
3D platform	2
incurable forms	2
human skeletal muscle tissue	2
Artificial muscles	2
patients with Duchenne, limb-girdle, and congenital muscular dystrophies	2
three-dimensional (3D) artificial skeletal muscle tissue	2
human skeletal muscle models	2
brain-computer interfaces	2
hand grip	2
parietal signals	2
3D environments	2
prosthetic limbs	2
movement plans	2
H/ACA box scaRNAs	2
telomerase RNA component (TERC)	2
small nuclear RNA (snRNA) pseudouridylation	2
small Cajal body-specific RNAs (scaRNAs)	2
ncRNAs	2
PARN and TOE1	2
nuclear small non-coding RNAs (ncRNAs)	2
mRNA poly(A) tails	2
substrates of PARN and TOE1	2
nuclear granule-associated deadenylases	2
target of EGR1 protein 1 (TOE1)	2
ribonuclease (PARN)	2
nutrient-depleted microenvironments	2
effector memory T cells	2
exogenous lipids in media	2
reductive glutaminolysis	2
effector memory T (TEM) cells	2
naive (TN) or central memory T (TCM) cells	2
nutrient-poor environment	2
effector memory CD4 T cells	2
solid tumor microenvironment	2
limited nutrients	2
photosynthetic carbon dioxide-assimilating cell factories	2
main carbon storage compound glycogen	2
different growth stages	2
energy input	2
high-energy metabolites	2
subset of metabolically divergent (MD) ChRCC	2
CIMP-RCC	2
major histologic subtypes	2
altered metabolic pathways	2
RCC subtypes	2
chromophobe RCC	2
papillary RCC	2
clear cell RCC	2
three major histologic subtypes	2
histologically defined cancers	2
cell carcinoma (RCC)	2
persistent viruses	2
memory pool	2
CX3CR1int cells	2
hepatitis C virus (HCV) (ChAd3-NSmut)	2
CX3CR1int CD8+ T cells	2
early memory	2
inflationary pools	2
CX3R1int cells	2
CMV and vaccine-induced inflationary T cells	2
cytomegalovirus (CMV) and adenovirus-vectored vaccines	2
memory CD8+	2
T cell memory	2
human allele	2
UK Biobank study	2
451,099 people	2
common FGF21 allele (A:rs838133)	2
macronutrients consumed	2
FGF21 analogs	2
growth factor 21 (FGF21)	2
specific miRs	2
miRs 212/132	2
sperm RNA	2
adult male mice	2
comprehensive functional screen	2
transport-regulating proteins	2
genes in pathways	2
16,007 individual genes	2
cerebral cortical neurons	2
adult mammals	2
diverse enhancer elements	2
single target gene	2
hijack enhancers	2
tumor cell oncogenes	2
Similar enhancer-docking sites	2
diverse cancers	2
MYC promoter	2
common and conserved CTCF binding site	2
MYC gene	2
diverse cancer-specific super-enhancers	2
MYC resides	2
2.8 Mb TAD	2
aggressive tumor cells	2
Mind Bomb E3 ubiquitin ligases	2
ubiquitin-acceptor lysines	2
RIPK1’s	2
MIB2’s E3 activity	2
MIB2-mediated ubiquitylation	2
RIPK1-FADD association	2
 RIPK1 oligomerization	2
C-terminal portion of RIPK1	2
ubiquitylating lysine residues	2
E3 ubiquitin ligase Mind Bomb-2 (MIB2)	2
nanostructural control	2
signaling microdomain organization	2
/cAMP signals	2
smaller and more short-lived β2AR	2
whole hearts	2
isolated basal cardiomyocytes	2
organized membranes	2
basal cardiomyocytes	2
base of the heart	2
tumors with SCMs	2
PD-1 and PD-L1	2
recurrent GATA3 SCM	2
11 genes	2
lower-grade gliomas	2
alternative splice junctions	2
8,656 TCGA tumors	2
splice-site-creating mutations (SCMs)	2
H4R3me2s and H3K9me2	2
 JMJD1B	2
JMJD1B−/− mice	2
distinct clusters of genes	2
 promoter regions	2
intermediate, H4R3me1	2
methylarginine residues	2
arginine demethylation	2
the histone codes	2
readers	2
arginine methyltransferases	2
TMPRSS2, RET, FGFR3, ALK, and ESR1	2
druggable fusions	2
sole driver	2
intact kinase domain	2
multiple fusion calling tools	2
9,624 tumors	2
hidden responders	2
multiple hits	2
wild-type Ras cell lines	2
MEK inhibitors	2
phenocopying variants	2
Cancer Genome Atlas (TCGA) PanCanAtlas project	2
“hidden responders	2
hippocampal map	2
existing place fields	2
plasticity-inducing stimuli	2
complex spikes	2
juxtacellular stimulation	2
place cells	2
silent neurons	2
evoking spike trains	2
freely moving mice	2
42 hippocampal neurons	2
firing fields	2
hippocampal place cells	2
external world	2
non-overlapping representations	2
virions	2
role of neuraminidases	2
C-terminal tail of IgA subtypes	2
antigen binding sites	2
complex N-linked glycans	2
influenza A and other enveloped viruses	2
cell-surface attachment	2
IgA molecules	2
human IgA molecules	2
commensal bacterial flora	2
SummaryImmunoglobulin A (IgA)	2
NKp46-expressing cells	2
 NKp46	2
mature NK cells	2
TRAIL protein	2
NKp46-deficient mice	2
ILC1s and NK cells	2
murine natural cytotoxic receptor mNKp46/NCR1	2
intrinsic pathways	2
subset of natural killer (NK) cells	2
liver-resident type 1 innate lymphoid cells (ILC1s)	2
apoptosis-inducing ligand	2
distinctly spatially distributed FG-Nup⋅NTR interactions	2
O-linked β-N-acetylglucosamine-modified FG-Nups	2
FG-Nup214 sequence	2
FG-Nup153	2
archetypal-fuzzy complex	2
export receptor CRM1	2
FG-Nup214	2
many individual FG motifs	2
“archetypal-fuzzy” complex	2
FG-Nups	2
selective barrier	2
SummaryPhenylalanine-glycine-rich nucleoporins (FG-Nups)	2
internalized tau	2
aggregated tau	2
Anti-tau antibodies	2
monomeric tau	2
abnormal, disease-specific forms of microtubule-binding protein tau MAPT	2
memory T cell population	2
human memory CD8+ T cells	2
TCF1)-expressing memory-like subset of CD8+ T cells	2
TCF7 (a.k.a	2
memory population	2
human hypothalamus	2
reduced brain-derived neurotrophic factor expression	2
upregulated, predominantly microglial genes	2
Downregulated genes	2
Pomc neurons	2
downregulated genes	2
mouse Agrp neurons	2
individuals with Prader-Willi syndrome (PWS)	2
disease mechanisms and therapeutic targets	2
separate roles of nAChRs	2
acetylcholine receptors (nAChRs)	2
nearby subordinate genes	2
discrete set of enhancers	2
SNAG-domain transcription repressor GFI1	2
LSD1 inhibitors	2
LSD1 knockdown AML cells	2
demethylase-defective mutant	2
LSD1 at sites of LSD1 binding	2
 LSD1’s histone demethylase activity	2
club cell p53 knockout mice	2
repetitive inhalations of lipopolysaccharide (LPS)	2
bronchial epithelial club cells lack p53	2
genetically modified mice	2
airway epithelial p53	2
steady background light	2
photoreceptor synapses	2
background light	2
LRIT1 in mice	2
neurotransmitter release apparatus	2
postsynaptic ON-bipolar cells	2
principal receptor	2
cone photoreceptor synapses	2
cell adhesion-like molecule, LRIT1	2
postprandial lipid excursions	2
polyphosphorylation of targets	2
Multiple genes	2
conserved network of proteins	2
polyphosphorylated proteins	2
lysine residues on yeast proteins Nsr1 and Top1	2
non-enzymatically and covalently	2
chains of inorganic phosphates	2
SummaryPolyphosphates (polyP)	2
critical cell-intrinsic regulator	2
widespread astrogliosis in the CNS	2
astrocytes of adult mice	2
conserved MAP3K13 (also known as leucine zipper-bearing kinase [LZK])	2
mammalian CNS	2
oncogenic transcriptional co-activators YAP/TAZ	2
mechanotransduction-regulated signals	2
protein tyrosine phosphatase PTPN14	2
TNBC cells	2
human 5q33.2–35.3	2
Chromosome 5q	2
SummaryTriple-negative breast cancers (TNBCs)	2
sensory cortex	2
trains of sensory stimuli	2
barrel cortex (S1b) and a secondary visual area (LM)	2
primary visual cortex (V1) and auditory cortex (Au)	2
temporal filters	2
large portions of cortex	2
mice expressing voltage-sensitive fluorescent proteins (VSFP)	2
multiple cortical areas	2
different mice and different sensory areas	2
mouse sensory cortex	2
MYC-like medulloblastoma	2
majority of the other group 3 subset and group 4 patients	2
SHH and a subset of group 3 patients	2
heterogeneous transcriptional input	2
apoptotic and neuronal signaling	2
MYC lesions	2
large cohort of SHH (Sonic Hedgehog), group 3, and group 4 medulloblastomas	2
different transcriptional subgroups	2
brain cancer medulloblastoma	2
next generation of iPSC-based antigen-specific immunotherapies	2
homogeneous subset of CD8αβ+ antigen-specific T cells, designated iPSC-derived thymic emigrants (iTEs)	2
3D thymic culture system	2
mature naive T cells	2
CD4+CD8+ double-positive T cells	2
iPSC-derived CD8 single-positive T cells	2
OP9/DLL1 system	2
pluripotent stem cell (iPSC)-derived	2
MBS homomers	2
selective drugs	2
complexes with single-chain binding sites	2
single-chain binding sites	2
cofactor-binding MBS homomers	2
monomers and other homomers	2
homologous MBS homomers	2
ligands and ligand-binding pockets	2
binding cofactors and metals	2
homomers with multi-chain binding sites (MBSs)	2
ligand-binding sites	2
IDH1-mutated glioma	2
pyrroline 5-carboxylate reductase 1 (PYCR1)	2
excess glutamine-derived proline	2
IDH1-mutated cells	2
cells expressing mutant IDH1	2
IDH1 R132H enzyme	2
gliomas and other tumors	2
canonical Hsf1 target	2
known phenotypic capacitor	2
antifungal drug	2
Budding yeast cells	2
Heat shock factor 1 (Hsf1)	2
cell signaling and transport machinery	2
important FGF signaling regulator	2
FGF receptor-containing vesicles	2
interacting protein NDE1/NDEL1	2
both mutants	2
lungs and limbs	2
developing lung endoderm and limb mesenchymal cells	2
microtubule network	2
variety of cellular cargos	2
regulatory proteins LIS1 and NDE1	2
cytoplasmic dynein motor	2
various destinations	2
membranous organelles and protein complexes	2
additional regulated genes	2
ER-bound loci	2
normal uterine growth	2
uterus	2
Estrogen receptor α (ER) and glucocorticoid receptor (GR)	2
SummarySteroid hormone receptors	2
homeostatically regulated auxin pool	2
major subcellular pathway	2
single plant cell systems	2
fluorescent auxin analog	2
nucleus and the surrounding compartments	2
Aux/IAA transcriptional repressor proteins	2
auxin regulatory network	2
phytohormone auxin	2
sensory neurons, microglial cells, and spinal interneurons	2
first integration relay	2
GABAergic interneurons	2
inhibitory synapses on lamina IIi somata	2
mechanical pain	2
Freund’s complete adjuvant	2
high-threshold C-fibers	2
local excitatory synapses	2
spinal networks	2
C-LTMR-derived TAFA4 chemokine	2
pleasant touch	2
SummaryC-low-threshold mechanoreceptors (C-LTMRs)	2
specified ensembles of neurons	2
opsin excitation	2
imaging beam	2
cell types and layers	2
red-shifted indicator jRCaMP1a	2
neurons expressing blue light-sensitive opsins (ChR2 and GtACR2)	2
multiple neuronal cell types	2
SummarySensory information	2
balanced excitatory networks	2
multisensory stimulation	2
net-zero balanced inputs	2
medial/parietal excitatory and inhibitory hubs	2
sensory areas	2
long-range excitatory and local inhibitory circuits	2
spontaneous slow waves	2
medial and parietal association cortex	2
excitatory or inhibitory neurons	2
fluorescence resonance energy transfer sensor yellow cameleon (YC2.60)	2
calcium reporter mouse lines	2
multimodal association cortex	2
patterned activity	2
perceptual information	2
DNA binding proteins	2
proximal −1 nucleosome	2
class of Reb1 sites	2
bound transcription factor	2
high-resolution binding map of yeast Reb1	2
SLIM-ChIP (short-fragment-enriched, low-input, indexed MNase ChIP	2
/IGF-1-signaling mutants	2
DC and intestinal necrosis waves	2
core transcription factors	2
cell-type-specific interaction networks	2
epiblast stem cells (EpiSCs) or Nanog-deficient ESCs	2
individual SEs	2
complex, spatial networks	2
promoter-capture Hi-C	2
large domains of active chromatin	2
super-enhancers (SEs)	2
SummaryTranscriptional enhancers	2
drug-resistant cancer cells	2
RTK inhibitors	2
PHLDA1 alone	2
HER2+ breast cancer cells	2
breast and renal cancer patients	2
endometrial cancer cells	2
fibroblast growth factor receptor (FGFR) inhibition	2
RTK-driven cancer	2
drugs targeting receptor tyrosine kinase (RTK) networks	2
complex II of the electron transport chain	2
bacterial-containing phagosomes	2
AT-null S. aureus	2
small interfering RNA (siRNA) targeting NLRP3	2
Primary human monocytes	2
inflammasome-dependent cytokines (IL-1β/IL-18)	2
NLRP3 inflammasome	2
alpha toxin (AT) expression	2
Staphylococcus aureus respiratory infection	2
different white matter regions	2
callosal oligodendrocyte networks	2
astrocyte network in the corpus callosum	2
glial networks	2
connexin 47	2
oligodendrocyte	2
acute brain slices of the mouse corpus callosum	2
energy substrate	2
DNA replication factor	2
MBT	2
isolated nuclei in vitro	2
Human NuRD complexes	2
pre-MBT Xenopus embryos	2
MTA2-containing assemblage of the nucleosome remodeling and histone deacetylation complex NuRD	2
specific origins	2
embryo of Xenopus laevis	2
potency assay	2
human PBMCs	2
activated PBMCs	2
responder PBMCs	2
quantitative RNA-based array	2
two assay systems	2
involved effector pathways	2
calcium channel nanodomains	2
Cav2.1 and Cav2.2 microdomains	2
Munc13-3-deficient synapses	2
electrophysiological and two-photon Ca2+	2
parallel-fiber AZs	2
active zones (AZs)	2
release sensors	2
Cav channels	2
distinct groups of glomeruli	2
moth’s antennal lobe	2
scented targets	2
naive moths	2
two-choice experiments (odorant versus solvent)	2
odorants	2
individual female	2
functional subunits of the antennal lobe	2
olfactory glomeruli	2
ecologically relevant and chemically diverse monomolecular odorants	2
moths	2
dorsal surface of the antennal lobe	2
functional map	2
insect′s brain	2
first olfactory neuropil	2
nectar sources and oviposition sites	2
hawkmoths, Manduca sexta	2
primary human plasma cells	2
80,000 clones	2
target cells co-encapsulated into droplets)	2
specific binders	2
individual clones	2
unspecific antibodies	2
excess of hybridoma cells	2
IgG per assay	2
antibody binding	2
dual-color normalized fluorescence readout	2
important class of all drug targets	2
Many antibody screening formats	2
IO	2
cerebellar complex spikes	2
behaving animals HCN1 channels	2
HCN channels	2
pacemaker currents	2
IO neurons	2
Hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels	2
neurons in the inferior olive (IO)	2
climbing-fiber-mediated complex spikes	2
nerve roots	2
tangentially migrating neurons in the SPR	2
Ntn1 confines rhombic lip-derived neurons	2
CNS-PNS boundary	2
mutant hindbrain	2
sub-pial region (SPR)	2
CNS neurons	2
cranial nerves	2
receptor DCC	2
nerve entry sites	2
PNS	2
pial surface	2
several cranial nerves	2
highly motile population	2
rhombic lip	2
newborn neurons	2
local CIs	2
emerging neural network	2
basal forebrain progenitors	2
mammalian forebrain	2
correct number of cortical interneurons (CIs)	2
excitatory projection neurons and inhibitory interneurons	2
SummaryCortical networks	2
repeat DNA	2
tRNA modification enzymes	2
RCMT mutants	2
mobile element-derived sequences	2
Dnmt2 and	2
two (cytosine-5) RNA methyltransferases,	2
repeat regions	2
 integrins or E-cadherin	2
Crumbs, Par3/Bazooka, or ZO-1	2
Pak1 kinase	2
kinase assays	2
overlapping set of polarity substrates	2
aPKC and Pak1	2
Drosophila and mammalian epithelia	2
second kinase, Pak1	2
aPKC kinase activity	2
aPKC kinase	2
small GTPase Cdc42	2
telomere-protecting protein	2
stabilizer	2
disease-associated SBDS mutants	2
SBDS patients	2
Shwachman-Bodian-Diamond syndrome (SBDS) gene	2
forward genetic screen	2
HEAT SHOCK PROTEIN 70 (HSP70)	2
protective chaperones	2
heat shock factors (HSFs)	2
key environmental variable	2
defined group of protein pathways	2
iCM	2
fibroblast	2
protein relational networks	2
translation factors, and chromatin-binding proteins	2
specific functional classes of proteins	2
cardiomyocyte-like cells (iCM)	2
human Argonaute 2 system	2
CRISPR-Cas9, CRISPR-Cpf1, CRISPR-Cascade	2
binding and cleavage assays	2
kinetically model	2
especially high-specificity guide sequences	2
CRISPR-associated nucleases	2
membrane-embedded proteins	2
extra- or intracellular solutions	2
fluorescent labels	2
ligand- and voltage-gated ion channels	2
cell type, and protein of interest	2
recordings	2
SummaryFluorescent labels	2
real world object location recognition task	2
superficial MEC	2
motor-related self-motion signals	2
identified MEC neurons	2
cue-based signals	2
neurons in the superficial medial entorhinal cortex (MEC)	2
effective tool	2
wild-type version of the defective disease-causing enzymes	2
adrenal hyperplasia	2
mouse kidney capsule and intra-adrenal	2
secreted steroid hormones	2
expressed steroidogenic enzymes	2
steroid-secreting cells	2
PKA and LHRH pathways	2
fibroblasts, blood-, and urine-derived cells	2
human induced steroidogenic cells (hiSCs)	2
functional steroidogenic cells	2
submembrane cytoskeleton	2
subset of, but not all, junctional complexes	2
actin filaments and capping proteins	2
nanoscale voids	2
cytoskeleton meshwork	2
relaxed spectrin tetramers	2
N and C termini of β-spectrin, F-actin, protein 4.1, tropomodulin, and adducin	2
membrane-preserved erythrocytes	2
native ultrastructure of the cytoskeleton	2
∼200-nm-long spectrin tetramers	2
triangular network of actin-based junctional complexes	2
submembrane cytoskeleton of metazoan cells	2
textbook prototype	2
phytosulfokine (PSK) peptide hormones	2
ERF115, ERF114, and ERF109	2
(ERF) transcription factors 115, 114, and 109	2
ethylene response factor	2
root apical meristem	2
proximal meristem (PM)	2
QC	2
Arabidopsis prohibitin protein PHB3	2
surrounding actively divided stem cells in Arabidopsis	2
four mitotically inactive quiescent center (QC) cells	2
root stem cell niche	2
DNA damage repair factor MSH6	2
transcription regulator EML1	2
plant and human histone readers	2
reader hits	2
types of histone peptides	2
putative reader domains	2
high-throughput surface plasmon resonance imaging (SPRi) platform	2
CaSR-mediated Gαq/11 endomembrane signaling	2
 clathrin structures	2
 Gαq/11 and Gαi/o pathways	2
class C GPCR calcium-sensing receptor (CaSR)	2
adaptor protein-2 σ subunit (AP2σ)	2
multiple G-protein pathways	2
endomembrane	2
plasma membrane (PM) and endocytic-derived signaling pathways	2
G-protein-coupled receptor (GPCR) signaling	2
promoter-proximal pausing	2
PPP sites	2
unscheduled RNA-DNA hybrids (R-loops)	2
human tumor suppressor BRCA2	2
promoter-proximal pausing (PPP) sites	2
disease model system	2
Human CDKL5	2
αJ helix-containing C terminus	2
kinase activity	2
neuronal cilia transition zones	2
unusual αJ helix	2
CDK and mitogen-activated protein kinases (MAPKs)	2
 human CDKL1, CDKL2, CDKL3, and CDKL5	2
underexplored kinases	2
CDK-Like (CDKL) proteins	2
cyclin-dependent kinase (CDK) family member	2
varied microbial communities	2
T6SS effectors	2
certain incoming effector proteins	2
secreting cells	2
several T6SS components	2
opportunistic pathogen Serratia marcescens	2
two redundant DsbA proteins	2
rival bacterial cells	2
toxic effector proteins	2
widely occurring nanomachine	2
many extra-cytoplasmic proteins	2
periplasmic enzyme DsbA	2
colonic DNA methylome	2
pro-proliferative signaling pathways	2
negative feedback regulators	2
colonic epithelium of young and aged mice	2
diet-induced obesity mouse model	2
young age groups	2
 all these datasets	2
searchable, interactive database	2
the neurodegeneration-related modules	2
AD tissue	2
new AD dataset	2
previously reported “disease-associated microglia”—expressing interferon-related or proliferation modules	2
microglial subsets	2
Alzheimer’s disease (AD) model	2
new tauopathy model datasets	2
diverse mouse models	2
CNS myeloid cells	2
co-regulated gene modules	2
CNS-resident immune cells	2
L2/3 of awake animals	2
small boutons	2
Large boutons	2
L2/3 of adult mouse visual cortex	2
excitatory axonal boutons	2
primary sensory input	2
persistent presynaptic structures	2
primary human AML	2
terminal myelomonocytic program	2
lymphoid culture	2
murine HSPCs	2
lymphoid leukemias	2
myeloid culture	2
HOXA gene expression	2
B-acute lymphoblastic leukemia	2
T-acute lymphoblastic leukemia	2
normal human bone marrow cells	2
human acute leukemia	2
transcription factor gene IRX3	2
Iroquois homeodomain	2
fertile adult mice	2
Nanog-null PGCLCs	2
Nanog-null ESCs	2
Nanog-null PGCs	2
positively regulated direct target	2
reduced nuclear β-catenin protein	2
exosomes containing β-catenin	2
undifferentiated hiPSCs	2
mesoderm cells	2
subrenal space or injured hearts	2
Purified CD82+ cells	2
late-stage mesoderm cells	2
tetraspanin family glycoprotein, CD82	2
human-induced pluripotent stem cell (hiPSC)-derived cardiomyocyte (CM)-fated progenitors (CFPs)	2
synaptic SNARE proteins	2
N-terminal proline-rich domain	2
trans SNARE complex assembly	2
PRRT2 selectively	2
reconstituted single vesicle and bulk fusion assays	2
pre-synaptic terminals	2
memory counterparts	2
stimulatory spots	2
Naive CD8 T cells	2
cell-sized stimulatory spots	2
continuous stimulatory surfaces	2
major resting human T cell subsets	2
in vitro 2D platforms	2
motile kinapses	2
antigen-presenting surfaces	2
mutant IDH1	2
NADPH-requiring pathways	2
2-HG synthesis	2
multiple types of human cancer	2
RyR arrangement	2
nearby nanodomains	2
 junctophilin-2	2
molecular maps	2
RyR channels	2
RyR-inhibiting protein junctophilin-2	2
accessory or regulatory proteins	2
significant gaps	2
sub-plasmalemmal nanodomains	2
single RyRs	2
punctate labeling	2
DNA-PAINT	2
molecular partners	2
ryanodine receptors (RyRs)	2
calcium release sites of cardiomyocytes	2
spatial organization of proteins	2
ARTI host response pathways	2
STAT1/2 pathway	2
IPS	2
influenza prediction gene lists	2
ARTIs	2
acute influenza	2
influenza pediatric signature (IPS)	2
interferon-stimulated genes (ISGs)	2
 different viral pathogens	2
acutely ill pediatric patients	2
CD8 T cell transcriptional circuitry	2
respiratory tract viral infections (ARTIs)	2
fertilization-induced ROS production	2
activated or fertilized eggs	2
fertilization-induced Ca2+ wave	2
homeostastic and stress response signaling pathways	2
second messengers	2
nuclease domains	2
clear unifying model	2
opposing strands	2
HNH and the RuvC nuclease domains	2
R-loop	2
non-target strand	2
target strand of dsDNA	2
single-guide RNA	2
Cas9, a type II CRISPR-Cas effector complex	2
CRISPR RNAs (crRNAs)	2
Cas proteins	2
RNA-guided surveillance complexes	2
outside the dorsal pallium	2
avian brains	2
VP-specific mammalian Dbx1	2
avian brain	2
radially migrating neurons	2
tangential migratory neurons	2
several pallial sources	2
entire lineage of defined chick telencephalic progenitors	2
ovo electroporation	2
non-cortical pallial sources	2
transient populations	2
glutamatergic subplate-, Cajal-Retzius-, and ventral pallium-derived populations	2
naturally competent bacteria	2
lytic effectors	2
prey cells	2
cognate immunity proteins	2
VgrG or PAAR proteins	2
Five different effectors	2
Acinetobacter-specific genes	2
conserved T6SS components	2
highly dynamic T6SS	2
Acinetobacter baylyi ADP1	2
set of effectors	2
competing bacteria	2
SummaryBacteria use type VI secretion systems (T6SSs)	2
weakly immunogenic epitopes	2
subdominant B cells	2
subsequent long-lived components	2
subdominant B cells in the GC	2
germinal center (GC) B cells	2
soluble heterologous antigen	2
discrete immunodominant and subdominant moieties	2
neutralizing epitopes	2
heterologous viral strains	2
functionally required epitopes	2
conventional vaccines	2
evolving pathogens	2
FcγRIIB-SHP-1/-2 signaling pathway	2
FcγRIIB/SHP-1/2 signaling pathway	2
α-syn fibrils	2
SHP-1 and 2	2
receptor for α-syn fibrils	2
neighboring neurons	2
α-synuclein (α-syn)	2
C2-domains of Syt1 and phospholipids	2
reconstitution assay	2
Syt1-dependent fusion	2
idh3a flies	2
metabolite, alpha-ketoglutarate (αKG)	2
Krebs cycle enzyme	2
isocitrate dehydrogenase 3a (idh3a)	2
synaptic vesicles (SVs)	2
Synaptotagmin1 (Syt1)	2
TERT CGI	2
several cancers	2
TERT promoter mutant cancers	2
two TERT alleles	2
5-methyl-CpG	2
TERT promoter DNA	2
repressed chromatin	2
inactive allele	2
expressed allele	2
TERT CpG island (CGI)	2
Telomerase Reverse Transcriptase (TERT) gene	2
promoter of	2
steroid hormone receptor DAF-12	2
sex determination pathway	2
essential hermaphrodites	2
hermaphrodites	2
hermaphrodite and male	2
two sexes	2
various species	2
excitatory neuron lineage	2
dorsal telencephalic progenitors	2
excitatory neurons and glia	2
mouse cortex	2
isolated HME	2
TSC2 mutations	2
DEPDC5, NPRL2, and TSC1/2	2
AKT3, MTOR, and PIK3CA	2
Radiographically indistinguishable lesions	2
FCD/HME brain tissue	2
mTOR pathway genes	2
cancer-causing population	2
PRMT5 or downstream targets	2
BCSC maintenance	2
pre-clinical PRMT5 inhibitor	2
patient-derived BCSCs	2
established tumor xenografts	2
FOXP1 promoter	2
FOXP1, a winged helix/forkhead transcription factor	2
key in vitro and in vivo regulator	2
breast cancer stem cells (BCSCs)	2
small population of tumor cells	2
neurocircuitry	2
SF1 neurons	2
potentially dangerous environments	2
VMH steroidogenic factor 1 (SF1) neurons	2
battery of behavioral assays	2
potentially hostile environments	2
homeostatic drives	2
C. rodentium constitutively expressing Ler	2
conventional mice	2
master virulence regulator ler	2
specific commensals	2
Kan, Van, and Met	2
(Met)	2
vancomycin (Van) or metronidazole	2
Bioluminescent and kanamycin (Kan)-resistant C. rodentium	2
colonic mouse pathogen Citrobacter rodentium	2
HSC quiescence	2
Hlf-deficient mice	2
toxic insults	2
quiescent HSCs	2
intact HSC pool	2
transcription factor hepatic leukemia factor (HLF)	2
deep somatic tissues	2
visceral organs	2
peptidergic nociceptive afferents	2
mechanically gated ion channel PIEZO2	2
nicotinic acetylcholine receptor subunit alpha-3 (CHRNA3)	2
mechanoinsensitive “silent” nociceptors	2
nociceptors	2
inflammatory mediator nerve growth factor (NGF)	2
subset of peptidergic C-fiber nociceptors	2
method and software	2
nitrogenous waste	2
glucose, glutamine, and palmitate	2
protein ABAT	2
metabolite 4-aminobutyrate	2
genome-scale metabolic model	2
human white and brown adipocytes	2
different substrates and perturbagens	2
Seahorse Extracellular Flux (XF) Analyzer	2
synthetic Aβ oligomers	2
humanized monoclonal antibody raised against Aβ	2
amyloid-β peptide (Aβ)	2
nanobody	2
extracellular chaperone clusterin	2
types of samples	2
CSF of individuals	2
highly sensitive single vesicle and single-cell-based assays	2
human CSF	2
small soluble protein aggregates	2
GR binding	2
mouse bone-marrow-derived macrophages	2
distal elements	2
enhancers of target genes	2
glucocorticoid receptor (GR)	2
tumor-biopsy-derived cultures	2
Assaying patient-derived lung cancer cultures	2
mixed cell cultures	2
immunofluorescence-based functional assay	2
patient-derived cell cultures	2
tumor biopsies	2
patient’s living cancer cells	2
in vitro functional assay	2
tumor DNA or RNA analysis	2
genomic addresses	2
octamer-like motif in Panct1 RNA	2
 pluripotency genes	2
TOBF1 physically	2
canonical Oct-Sox motif	2
transient octamer binding factor 1 (TOBF1)	2
putative X-chromosome-encoded protein A830080D01Rik	2
lncRNA Panct1	2
embryonic stem cell (ESC) maintenance	2
noncoding RNAs (lncRNAs)	2
parallel pathway and downstream station	2
hindbrain and peripheral components	2
downstream PLR circuitry	2
vacated PLR targets	2
eye-reflex pathway	2
RGC axons	2
pupillary light reflex (PLR) midbrain targets	2
downstream circuits	2
designated midbrain targets	2
specific retinal ganglion cells (RGCs)	2
parallel pathways	2
poly-synaptic circuits	2
sensory information	2
16pdel and 16pdup neurons	2
16pdup neurons	2
16pdel neurons	2
16pdel and 16pdup carriers	2
duplication carriers	2
macrocephaly in deletion carriers (16pdel)	2
16p11.2 region	2
downstream effectors, matrix metallopeptidase 9 (MMP9) and colony-stimulating factor 1 (CSF1)	2
vascular endothelial growth factor A/vascular endothelial growth factor receptor 1 (VEGF-A/VEGFR1) signaling	2
Cav1 inhibition	2
MAMs uniquely	2
recruited inflammatory cell populations	2
lung and breast cancer pulmonary metastasis	2
anti-metastatic regulator	2
bone-marrow-derived cells	2
Caveolin-1 (Cav1)	2
so-called metastasis-associated macrophages (MAMs)	2
tumor-associated macrophages	2
future anti-malarial transmission-blocking vaccines	2
species-specific antibodies	2
function-critical site of the fusion/cd loop	2
class II viral fusion protein	2
conserved gamete membrane fusion protein HAP2	2
current anti-malarial vaccine targets	2
highly integrated inter-endosomal communication system	2
heterogeneous VEE populations	2
Receptor/Gαs endosomal	2
serine 410	2
EE-localized β2-adrenergic receptor	2
adaptor protein APPL1	2
additional VEE-localized GPCRs	2
prototype GPCR	2
luteinizing hormone receptor (LHR)	2
early endosome (VEE)	2
recently discovered endosomal compartment	2
complex signaling pathways	2
glucose, glutamine, and serine metabolic pathways	2
SRC family and c-KIT tyrosine kinases	2
MYC synthetic lethal partners	2
MYC-driven, BRAFi-resistant cells	2
resensitize cells	2
transcription factor, c-MYC (MYC)	2
in vitro and in vivo resistance models	2
matched pre-treatment and post-relapse patient tumors	2
BRAF-mutant melanoma	2
BRAF/MEK inhibitors	2
subgroup of MB	2
BMI1 or ERK	2
CHD7 expression	2
G4 MB cells	2
ERK inhibitor DUSP4	2
primary human MB cells	2
diverse physiological contexts	2
activity-dependent dendritogenesis in vitro	2
FosRSINE1 transcript	2
unprecedented molecular link	2
Pol II factories	2
Fos promoter	2
FosRSINE1-encoded transcript	2
Fos gene (FosRSINE1)	2
eSINE	2
Pol III	2
Pol III cofactor complex TFIIIC	2
Enhancer SINEs (eSINEs)	2
activity-regulated genes	2
subset of short interspersed nuclear elements (SINEs)	2
distally located enhancers	2
comparable synapses	2
core synaptic proteins and molecular pathways	2
active zone proteins	2
human NMJs	2
mouse NMJs	2
Human NMJs	2
experimentally accessible model synapse	2
lower motor neuron	2
various types of post-translational modifications	2
another ASK1-negative regulator	2
thioredoxin (Trx)	2
protein arginine methyltransferase 1 (PRMT1)	2
TRIM48-interacting partner	2
tripartite motif 48 (TRIM48)	2
various interacting molecules	2
oxidative stress-responsive kinase	2
main hippocampal subregions	2
action potentials and local field potentials (LFPs)	2
hippocampus-dependent spatial associative memory	2
rat hippocampus	2
BC-PC synapse	2
GABAergic basket cell (BC)-Purkinje cell (PC) synapse	2
output synapses of these neurons	2
fast-spiking, parvalbumin-expressing GABAergic interneurons	2
Ca2+ sensor	2
7 (Syt7)	2
B zone organizer cells	2
major inducer cells	2
LTα1β2+ B cells	2
two functionally distinct fibroblast subsets	2
perivascular fibroblast precursors	2
splenic white pulp (WP)	2
two distinct subsets	2
stromal cell network	2
chemokine-expressing stromal cells	2
B cell compartmentalization	2
osteocyte-mediated PLR	2
TGF-β signaling (TβRIIocy−/−)	2
perilacunar/canalicular matrix	2
cellular target	2
(TGF-β) signaling	2
Transforming growth factor beta	2
RANKL/RANK signaling axis	2
anti-viral memory CD8 T cells	2
CD169+ MZMs	2
replicative niche	2
Marginal zone macrophages (MZMs)	2
microbial antigens	2
Macrophages and dendritic cells (DCs)	2
bloodborne pathogens	2
P/Q-type voltage-gated calcium channel or glutamate receptor δ2	2
Knockout mice	2
CF terminals	2
 PCs	2
newborn mice	2
populations of nearby CF terminals	2
neighboring PCs	2
early-formed redundant CF to PC synapses	2
climbing fiber (CF) to Purkinje cell (PC) network	2
developing cerebellum	2
active neurons	2
translation-related genes	2
complex set of mRNAs	2
gene expression programs	2
L. pneumophila	2
Lgt and SidE families of effectors	2
effector families	2
mTORC1 inhibitors	2
SidE/SdeABC (SidE) effector family	2
Legionella glucosyltransferase (Lgt) effector family	2
two families of translocated L. pneumophila effector proteins	2
intracellular bacterial pathogen Legionella pneumophila	2
mucus-detaching protease	2
membrane-bound meprin β	2
secreted cysteine protease	2
bacterial protease Arg-gingipain (RgpB)	2
inactive pro-form of meprin β	2
ex vivo small intestinal organoid and cell culture experiments	2
meprin β	2
bacterial overgrowth	2
host metalloprotease	2
additional platform	2
FAD-mutant GS complexes	2
downstream GS-mediated carboxypeptidase cleavage of APP	2
FAD patient-derived fibroblast cultures	2
endogenous disease-relevant genes	2
non-neuronal patient cells	2
in vitro model system	2
diseased brain	2
Aβ42 fragment	2
components of the γ-secretase (GS) complex	2
presenilin (PSEN) 1 and 2	2
cycles	2
methionine and folate cycles	2
NTDs in Gldc-null embryos	2
Mthfr-null mouse embryos	2
glycine decarboxylase (Gldc)-deficient embryos	2
Methionine cycle inhibitors	2
FOCM functional outputs	2
methionine cycle	2
folate one-carbon metabolism (FOCM)	2
divergent eukaryote	2
plant-like calcium-dependent protein kinase 4 (CDPK4) and a homolog of serine/arginine-rich protein kinases (SRPK1)	2
Haploid female and male gametocytes	2
sedentary Drosophila	2
octopamine feeding	2
female flies	2
exercise stimulus	2
Female flies	2
Male Drosophila	2
refined low- or high-fat diets	2
control diet	2
refined high-fat diets	2
SNX27 retromer pathway	2
functional retromer complex	2
component of the retromer complex	2
RabGTPase Rab8	2
autocrine-produced laminin	2
streak-like structures	2
laminins	2
Drosophila embryonic hemocytes	2
moving cells	2
exogenous matrix	2
cells in culture	2
CDK4- and CDK6-cyclin complexes	2
CIP/KIP family members	2
CDK4/6-containing ternary complexes	2
D-type cyclins	2
INKs	2
p21CIP1 and p27KIP1 CDK inhibitors	2
 INK family CDK inhibitors	2
D3- and virus-type cyclins	2
Cdc37-Hsp90 relinquishes CDK6	2
 ATP-competitive inhibitors	2
Hsp90 kinase clients	2
Cdc37-Hsp90 system	2
adaptor co-chaperone Cdc37	2
mTOR-independent factor Eif6	2
developing organ	2
cofactor, Hcf-1	2
set of critical genes	2
four-chambered organ	2
nascent heart	2
Ronin or related THAP proteins	2
developmentally and metabolically essential genes	2
hyperconserved promoter sequence	2
primordial DNA transposon	2
SummaryRonin (THAP11)	2
recombinant neutralizing antibodies	2
infection inhibitors	2
the GAG-dependent/sialylated glycan-independent alternative entry pathway	2
apical pocket of the JCV major capsid protein	2
post-attachment co-receptor glycans	2
JCV-neutralizing monoclonal antibodies	2
asialo-GM1	2
non-sialylated non-GAG co-receptor glycans	2
PML mutant strains	2
wild-type and PML mutant JCV strains	2
alternative attachment receptors	2
non-sialylated glycosaminoglycans (GAGs)	2
wild-type JCV	2
sialylated glycans	2
brains of PML patients	2
JCV strains	2
JC polyomavirus (JCV)	2
YAP and TFCP2	2
YAP-dependent transcription	2
YAP co-factor	2
TEAD target gene expression	2
YAP-TEAD interaction	2
YAP binding motif (YBF)-containing transcription factors	2
transcription co-factor	2
WW-PSY interaction	2
SMA motor neurons	2
catalogue of RNAs	2
in vivo transcriptome	2
SMN protein	2
Bcl11b-dependent CD5+NK1.1− γδ	2
Bcl11b-independent CD5−NK1.1	2
non-lymphoid tissues	2
lymphoid tissues	2
CD5−NK1.1+ and Granzyme B+	2
T cells in the periphery	2
zinc-finger transcription factor B cell leukemia/lymphoma 11b (Bcl11b)	2
fetal thymus	2
unique subset of innate-like γδ T cells	2
diverse signals downstream	2
population of directionally selective retinal ganglion cells	2
heterogeneous spike outputs	2
common stimulus	2
neighboring M1s	2
mouse M1s	2
stereotyped circuit elements	2
M1 type	2
photosensitive retinal ganglion cells	2
PanIN-like bystander lesions	2
true precursor PanINs	2
co-existence of mucinous and non-mucinous lesions	2
bystanders in adjacent healthy tissues	2
non-mucinous lesions	2
duct-derived tumors	2
pancreatic intraepithelial neoplasias (PanINs)	2
acinar-derived tumors	2
ductal and acinar cells	2
identical oncogenic drivers	2
single TCA cycle enzyme	2
iron-sulfur clusters	2
key components of the iron-sulfur cluster biogenesis family of proteins	2
respiratory chain (RC) complex I and II	2
human and mouse FH-deficient cells	2
mouse and human cell lines	2
enzyme of the tricarboxylic acid (TCA) cycle	2
SummaryFumarate hydratase (FH)	2
senescent cancer cells	2
second drug	2
BCL2 family inhibitor ABT263	2
Senescent melanoma and lung cancer cells	2
RAS mutant lung cancer	2
multiple aurora kinase inhibitors	2
compound screen	2
MAP kinase pathway	2
SWI/SNF component SMARCB1	2
MM cases	2
EZH2 inhibitors	2
BCL6 and IRF1	2
germinal center B cells	2
repressors of IRF4	2
histone methyltransferase	2
in vitro and in vivo sensitivity	2
UTX mutant cells	2
isogenic cell system	2
several malignancies	2
H3K27 demethylase UTX	2
histone	2
TACE substrates	2
complexes with iRhom2	2
iRhom2 N-terminal cytoplasmic tail	2
TACE shedding stimuli	2
numerous inflammatory and growth-promoting agents	2
TACE biology	2
activating ligands of the EGFR	2
cytokine TNF	2
membrane-tethered signaling molecules	2
TACE (TNF-α-converting enzyme)	2
surface metalloproteases	2
tumor-specific therapeutic target	2
xenograft tumor growth	2
APC-mutated CRC	2
β-TrCP and USP7	2
β-catenin deubiquitination	2
CID-deleted APC truncation	2
β-catenin inhibitory domain (CID) in APC	2
various APC-truncated isogenic lines	2
tumor suppressor gene adenomatous polyposis coli (APC)	2
male and female germ cells	2
somatic metazoan cells	2
improperly 3′ end-trimmed 28S rRNA, 5S rRNA, and snoRNA precursors	2
Loss-of-function mutants	2
metazoan-specific member of the DEDDh 3′-5′ single-stranded RNA exonucleases	2
Drosophila melanogaster Rexo5 (CG8368) protein	2
Notch-dependent oncogenic pathways	2
MCL and other B cell malignancies	2
CLL lymph node biopsies	2
MCL xenograft model	2
Notch-regulated lineage-restricted enhancer complex	2
Notch-dependent MCL cell lines	2
oncogene MYC	2
Notch-bound distal enhancers	2
MCL cell lines	2
Notch transcription complexes	2
Notch-regulated transcripts	2
Notch target genes	2
mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL)	2
mature small B cell lymphomas	2
P/Q-type VGCC in mammalian terminals	2
major synaptic vesicle pools	2
P/Q-type, but not N-type, VGCC	2
mammalian hippocampal neurons	2
functional motif	2
P/Q-type and N-type VGCC	2
SummaryVoltage-dependent Ca2+ channels (VGCC)	2
structurally condensed lamina-associated heterochromatic domains	2
transcription factor binding sites	2
mouse and human iPSCs	2
global protein SUMOylation	2
DNA damage response kinases ATR and ATM	2
ATR-activating factor TOPBP1	2
central DNA damage and replication stress responders	2
regulated modification sites	2
SUMO and phosphoproteomic technologies	2
SUMOs (small ubiquitin-like modifiers)	2
several post-translational modification (PTM)-based signaling networks	2
eukaryotic DNA	2
individual cortical OLs	2
myelin internodes	2
young adulthood	2
new OLs	2
corticospinal tract or optic nerve	2
motor cortex	2
young adult mice	2
mature myelinating OLs	2
existing population	2
adult-born OLs	2
mouse central nervous system	2
myelin-forming oligodendrocytes (OLs)	2
pre-existing variants	2
ensemble of genetic backgrounds	2
adaptive mutations	2
large recombinant library	2
chemotherapeutic drugs	2
unique haplotype combinations	2
diploid cells	2
genetically diverse populations of budding yeast, S. cerevisiae	2
pre-existing and de novo genetic variation	2
Arc-PSD95 postsynaptic complexes	2
Arc-PSD95 complexes	2
1.5-MDa complexes	2
many Arc-interacting proteins	2
wild-type and knockout mice	2
native complexes	2
endogenous Arc gene	2
Venus fluorescent protein	2
activity-regulated neuronal protein	2
reduced IIS	2
FKH in the gut	2
insulin receptor substrate 1 knockout mouse intestine	2
related nutrient transporters	2
AKT and Target of Rapamycin	2
Drosophila FoxA transcription factor homolog Fork Head (FKH)	2
reduced intestinal insulin/insulin growth factor (IGF) signaling (IIS)	2
nutrient-sensing signaling networks	2
major thymic and peripheral populations of IL-21+ cells	2
FoxP3+ TREG cells	2
mature TFH cells	2
natural (n)TH21 cells	2
naturally occurring population	2
significant population of newly activated thymic and peripheral CD4+ T cells	2
follicular B cell helper (TFH) cells	2
mature CD4+	2
hindlimbs	2
absence of SARM1	2
young NMNAT2-deficient mice	2
widespread Wallerian-like axonopathy	2
related, non-injury axonopathy	2
WldSmutant mouse	2
synapse-specific tetraspanin	2
Hippocampal interneuron currents	2
neuronal surface in pyramidal neurons	2
large intracellular gephyrin aggregates	2
GABAAR and gephyrin clusters	2
LHFPL4 knockout mice	2
GABAAR subunits	2
tetraspanin LHFPL4	2
transmembrane accessory proteins	2
Neutralizing monoclonal antibodies (mAbs)	2
core epitope	2
basic residues in strand C of the V2 region	2
Potent autologous tier 2 neutralizing responses	2
Envs	2
soluble trimers	2
wild-type rabbits	2
apex bnAb region	2
prototype V2-apex bnAbs	2
inferred precursors	2
HIV isolates	2
rare “glycan hole” at the V2 apex	2
Env) trimer	2
HIV envelope glycoprotein (	2
protein-glycan region	2
B cell receptors	2
real time	2
disease settings	2
invasive breast and pancreatic cancers	2
mammary gestation	2
crypt cells of the small intestine	2
osteocytes within the bone	2
RhoA in a variety of native tissues	2
a RhoA-fluorescence resonance energy transfer (FRET) biosensor mouse	2
small GTPase RhoA	2
dendritic growth	2
presynaptic cytoskeleton	2
ubiquitous and essential protein	2
GOSR2 gene)	2
Golgi SNARE (SNAP [soluble NSF attachment protein] receptor) protein Membrin	2
V-ATPase catalytic subunit A	2
cytokine-inducible SH2-containing protein (CISH)	2
granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion	2
host suppressor of cytokine signaling (SOCS) protein functions	2
V-ATPase complexes	2
endogenous antigens	2
myeloid-derived suppressor cells	2
local innate immunity	2
macrophage populations	2
(COX-1)	2
cyclo-oxygenase	2
microsomal prostaglandin E synthase-1 (mPGES-1)	2
post-inflamed site	2
natural killer cells, secreting interferon γ (IFNγ)	2
efferocytosing mononuclear phagocytes	2
diabetic Fh1βKO mice	2
islets from human donors with type 2 diabetes (T2D)	2
critical cysteines in GAPDH, GMPR, and PARK 7/DJ-1	2
elevated intracellular fumarate	2
Fh1βKO mice	2
mitochondrial or cytosolic FH	2
pancreatic β cells (Fh1βKO mice	2
Krebs cycle enzyme fumarate hydratase (FH)	2
un-replicated DNA	2
newly synthesized Halo-tagged Scc1 protein (pulse-chase or pcFRAP)	2
non-fluorescent HaloTag ligand	2
chromatin in G1	2
selective photobleaching	2
entrapped DNAs	2
Smc and kleisin (Scc1) subunits	2
KamiCas9 system	2
differentiated human iPSC	2
constitutive Cas9 system	2
Mutant huntingtin (HTT)	2
adult mouse neuronal and glial cells	2
Huntington’s disease (HD)	2
Cas9 protein	2
KamiCas9 self-inactivating editing system	2
sequence of genes	2
chaperone network	2
ATPases Rvb1 and Rvb2	2
highly conserved AAA+	2
foci or condensates	2
many chaperones	2
Hsp40, Hsp70, Hsp90, AAA+, CCT, and small Hsps	2
naturally joined (NAJ) chaperone complex	2
large chaperone functional supercomplex	2
core chaperones (67) and cochaperones (15) of Saccharomyces cerevisiae	2
∼700 Rhodopsin-family receptors	2
Rhodopsin-family GPCRs	2
single-molecule microscopy-based assays	2
single human cell line	2
60 receptors	2
mostly individual receptors	2
Rhodopsin-family G protein-coupled receptors (GPCRs)	2
evolutionarily divergent species	2
highly conserved regulatory interactions	2
SMRN	2
primary metabolite regulators and enzyme targets	2
small molecule regulatory network (SMRN) of the model organism Escherichia coli	2
fragmented, biochemical literature	2
small molecule-enzyme regulatory interactions	2
endogenous small molecules	2
repair Schwann cell	2
AP-1 motifs	2
Schwann cell-specific genes (e.g., Nedd4l)	2
particular miR-21 and miR-34	2
certain micro RNAs in repair Schwann cells	2
AP-1 transcription factor C-JUN	2
several long non-coding RNAs in Schwann cells	2
repair cells	2
combined whole-genome, coding and non-coding RNA and CpG methylation study	2
cell type or tissue	2
organellar organization	2
8,000 proteins	2
acutely isolated mouse primary neurons	2
organellar maps	2
amino acids in cell culture [SILAC])	2
metabolic labeling	2
rs6877329-C risk allele	2
transcription start site of ELL2	2
predicted enhancer element	2
G > C	2
species-specific interactions	2
host ANP32A	2
highly acidic stretch in avANP32A	2
hydrophobic motif of avANP32A	2
human- and avian-signature vPols	2
Unrelated SIM sequences	2
avian-signature vPol	2
hydrophobic SUMO interaction motif (SIM)-like sequence	2
host SUMOylation	2
avian ANP32A.	2
uncharacterized 33 amino-acid insertion	2
human ANP32A	2
host ANP32A	2
avian viruses	2
viral RNA polymerase (vPol)	2
c-Myb-controlled enhanced survival circuit	2
non-repressible c-Myb	2
miR-150-c-Myb survival circuit	2
Bcl-2 and Bcl-xL	2
anti-apoptotic targets of c-Myb	2
key circuit	2
miR-150-deficient memory CD8 T cells	2
memory precursor and terminal effector CD8 T cells	2
CD8 T cell memory	2
miR-150 negatively	2
MBF gene promoters	2
reduced MBF-dependent ribonucleotide reductase (RNR) expression	2
SETD2 tumor suppressor	2
lysosomal, immune-related, and lipid metabolic genes	2
PGRN-deficient mouse brains	2
diacylglycerides and phosphatidylserines in fibroblast and enriched lysosome lipidomes	2
polyunsaturated triacylglycerides	2
normal and other pathologic groups	2
mouse neurons	2
neuronal ceroid lipofuscinoses (NCL) and Niemann-Pick type C (NPC)	2
neural basis	2
mouse vision	2
stimulation	2
Optogenetic inactivation	2
task	2
simple probabilistic observer model	2
steering wheel	2
brain access	2
eye tracking	2
head-fixed	2
unparalleled genetic tractability and brain atlases	2
next generations of synthetic receptors	2
generalizable blueprint	2
modular dCas9-synR platform	2
diverse, therapeutically relevant multi-gene expression circuits	2
specific disease markers	2
natural inputs	2
various classes of native ectodomain scaffolds	2
core dCas9 synthetic receptor (dCas9-synR) architecture	2
highly programmable and portable nuclease-deficient CRISPR/Cas9 (dCas9) signal transduction module	2
class of chimeric receptors	2
designer cells	2
powerful experimental tool	2
SummarySynthetic receptors	2
appropriately functioning vertebrate promoter-associated epigenome	2
multivalent interactions	2
non-methylated DNA and histone H3 lysine 4 trimethylation (H3K4me3)	2
actively transcribed gene promoters	2
vertebrate SET1 complex	2
appropriate gene promoters	2
promoter-associated epigenome	2
highly transcribed genes near parS	2
arm alignment	2
parS-proximal regions of the chromosomal arms	2
chromosome-partitioning protein ParB.	2
centromeric parS site	2
Caulobacter SMC	2
chromosomal arms	2
left and the right arms of the chromosome	2
chromosomes (SMC) complex	2
alternative splicing drivers (AS drivers	2
cancer-related pathways	2
protein domain families	2
thousands of tumor samples	2
functional network	2
quantified proteome	2
key chromatin modifiers	2
functional protein correlation network	2
11,000 phosphopeptides	2
9,000 proteins	2
colorectal cancer cell lines	2
isobaric labeling	2
endothelium of blood vessels	2
converted Ly6Chigh monocytes	2
blood-patrolling monocytes	2
Ly6Clow-depleted mice	2
patrolling Ly6Clow monocytes	2
inflammatory Ly6Chigh monocytes	2
 muramyl dipeptide (MDP)	2
NOD2 receptor	2
circulating monocytes	2
adult CNS progenitor cells	2
PC-derived factor	2
 an ex vivo cerebellar slice model	2
OPC differentiation	2
PC-conditioned medium	2
Pdgfbret/ret mice	2
parenchymal non-vessel-associated PC-like cells (PLCs)	2
CNS-resident pericytes (PCs)	2
neurovascular niche	2
Notch-dependent intestinal tumors	2
homeostatic regulators	2
adult fly intestinal progenitor cells	2
otherwise normal animal	2
endodermal gut cells	2
host interior	2
mouse stem cell allografts	2
functional mouse immune system	2
“allogenized” mouse model	2
allogeneic stem cells and their derivatives	2
graft-infiltrating human lymphocytes and splenocytes	2
human hematopoietic and immune cells	2
stem cell-derived allografts	2
embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) derivatives	2
broadly NAbs (bNAbs)	2
components of multivalent vaccines	2
prototype	2
subset of tier-2 viruses	2
BG505 SOSIP.v6 trimers	2
resulting next-generation SOSIP.v5 trimers	2
glycoprotein (gp)120 and gp41 subunits of SOSIP trimers of the BG505 and other genotypes	2
new disulfide bonds	2
native Env	2
engineered BG505 SOSIP.664 trimer	2
native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer	2
receptor types	2
Golgi tendon organs	2
muscle spindles	2
Egr3 knockout mice	2
fracture site	2
functional proprioceptors	2
transcription factor Runx3	2
Fractured bones	2
3-month-old mice	2
proprioceptive system	2
fractured bones of neonatal mice	2
Zscan4 expression	2
E3 ubiquitin ligase activity	2
major components of the maintenance DNA methylation machinery	2
2C-like mESCs	2
two-cell (2C) embryos	2
Mouse ESCs (mESCs)	2
knockout hESCs	2
HOPX reporter	2
blood-forming endothelial cells	2
candidate regulator	2
HOPX, a non-DNA-binding homeodomain protein	2
hierarchically rank genes	2
different mesodermal origins	2
human embryonic stem cell (hESC)-derived cardiac progenitor cells (CPCs) and KDR+/CD34+ endothelial cells	2
prostate stem and progenitor cells	2
niche organization	2
functional spheroid assays	2
basal stem cells	2
clonal maps	2
proximal ducts	2
Rare lineage-restricted luminal stem cells	2
apoptotic luminal cells	2
entire glandular network	2
Basal progenitors	2
directed epithelial migration streams	2
bipotent basal progenitors	2
discrete niches in juxta-urethral ducts	2
multipotent basal stem cells	2
adult human prostates	2
clonal marks	2
noncoding RNA transcripts	2
TNRC6A, NAT10, MED14, and WDR5	2
histone-modifying complexes	2
mediator complex	2
CCR4-NOT complex	2
purified nuclear lysates	2
human GW182 paralogs TNRC6A/B/C	2
NKX2-1 in humans	2
embryonic septum	2
large subsets of basal forebrain cholinergic neurons	2
cholinergic septohippocampal projection neurons	2
embryonic septal neuroepithelium	2
subsets of cortical, striatal, and pallidal neurons	2
transcription factor NKX2-1	2
stem-like glioma cells	2
stem cell marker CD44	2
CD44-expressing cells	2
CD44 cleavage	2
CD44ICD	2
human glioma	2
hypoxic and perivascular tumor regions	2
glioma mouse model	2
HIF-2α (but not HIF-1α)	2
intracellular domain of stem cell marker CD44 (CD44ICD)	2
stem versus bulk glioma cells	2
perivascular niche	2
glioma stem cells	2
glioma stemness	2
-inducible factors	2
eye imaginal disc	2
downstream Notch effectors	2
microRNA miR-7	2
proneural gene l’sc	2
complex gene regulatory network	2
sheet of neuroepithelial cells	2
largest visual processing center	2
medulla	2
40,000 neurons	2
Substantial portions of conserved sequence	2
large overlapping domains	2
discrete repressor module	2
distinct activity domains	2
endogenous ZRS in mice	2
classes of vertebrates	2
ancient group of highly conserved cis regulators	2
zone of polarizing activity regulatory sequence (ZRS)	2
sonic hedgehog (Shh) in the limb bud	2
core fucosylation of PD-1	2
core fucosyltransferase	2
cell-surface PD-1 expression	2
core fucosylation pathway	2
CRISPR-Cas9 system	2
PD-1 and its ligand	2
cell death 1 (PD-1)	2
theoretical spectra-mass spectrometry)	2
key DNA repair gene, Xpa	2
epidermal progenitor cells	2
skin-expressed genes	2
skin transcriptome	2
environmental insults	2
highly regenerative barrier	2
TARP γ-2	2
AMPA-type glutamate receptors (AMPARs)	2
E6.5 primitive streak cells	2
non-committed epiblast	2
polycomb subunits	2
systematic single-cell RNA sequencing (seq) of conceptuses	2
epiblast and primitive endoderm (PrE) lineages	2
mouse inner cell mass (ICM)	2
signaling feedback or apoptotic priming	2
growth signaling pathway inhibitors	2
KRAS/PIK3CA double-mutant colorectal cancers (CRCs)	2
growth signaling	2
universal and tissue-specific sensitizing combinations	2
models of KRAS mutant colorectal, lung, ovarian, and pancreas cancers	2
KRAS effectors MEK, ERK, and PI3K.	2
particular pathways	2
KRAS mutant cancers	2
effector and feedback pathways	2
microglia population	2
substantial population of quiescent long-lived cells	2
microglial progenitor cells	2
distinct nuclear and cytoplasmic Lsm complexes	2
decapping enhancer	2
weak donor sites	2
regulated exons	2
3′ UTR AU-rich elements	2
P bodies	2
site of snRNP biogenesis	2
Cajal bodies	2
additional U4/U6.U5 tri-small nuclear ribonucleoprotein particle (tri-snRNP) components	2
/SART3	2
Pat1b/Lsm2-8/U6 snRNA	2
spliceosomal U6 small nuclear RNA (snRNA)	2
Lsm2-8 heptamer	2
nuclear complex of Pat1b	2
Lsm1-7 heptamer	2
mRNA in complex	2
cytoplasmic 5′	2
processing bodies (P bodies)	2
SummaryPat1 RNA-binding proteins	2
HCMV miR-	2
disease model	2
GG individuals	2
HCMV seropositivity	2
HCMV-peptide-specific CTLs	2
HCMV-infected GG fibroblasts	2
3′ UTR of ERAP1 G variant	2
3′ UTR of ERAP1	2
ERAP1 3′ UTR	2
rs17481334 G variant	2
specific CTLs	2
HCMV pp65495-503 peptide	2
patients with melanoma and colorectal cancer	2
malignant tissues	2
 a tumorigenic environment	2
tumor sites	2
chemokines enriched	2
RNA sequencing and functional assays	2
T helper (Th)-like Treg subsets	2
T cells (Tregs)	2
human hematopoiesis	2
cDC lineage	2
DNGR-1 (CLEC9A) and CD141 (BDCA-3)	2
subset known as cDC1	2
 cDCs	2
large fraction of multipotent lymphoid early progenitors (MLPs)	2
monocyte and granulocyte poiesis	2
a mouse lymphoid-primed multipotent progenitor	2
the common myeloid progenitor (CMP)	2
DC precursor	2
dendritic cells (cDCs)	2
tumor-associated CD8+ T cells	2
costimulatory ligands	2
tumor-associated CD11c+ dendritic cells (DCs)	2
interferon-γ (IFN-γ)-producing cytotoxic CD8+ T cells	2
pancreatic ductal adenocarcinoma (PDA)	2
CBP-CrebA-COPII pathway	2
 Rac1 synergistically	2
CREB-binding protein (CBP)	2
C4 da neurons	2
many secretory pathway-related genes	2
Drosophila class IV dendritic arborization (da) (C4 da) neurons	2
Golgi outposts (GOPs)	2
maturing ependyma	2
embryonic ventricular zone	2
neuronal heterotopias	2
the embryonic cortex	2
postnatal ventricular zone	2
Cyfip1/Abi WRC subunit	2
Blocking Neogenin	2
the cadherin complex	2
 Arp2/3	2
netrin/RGM receptor, Neogenin	2
ependymal junction	2
actin nucleation machinery	2
cadherin-based adherens junctions	2
microbial metabolites	2
isolated pancreatic islets	2
3T3-L1 adipocytes	2
trimethylamine-N-oxide (TMAO)	2
microbial-host co-metabolites	2
isogenic C57BL/6J mouse population	2
microbiome-derived metabolites	2
developing follicles	2
mature egg	2
follicle cells (FCs)	2
integrin receptor	2
specialized extracellular matrices	2
SummaryBasement membranes (BMs)	2
prefrontal circuits	2
axo-axonic inhibition	2
chandelier cells	2
AIS of prefrontal pyramidal cells	2
mature pyramidal cells	2
somatodendritic compartment	2
intracellular chloride	2
LIMD1, AJUBA, and WTIP	2
glutamic acid residue (E390)	2
AGO3 utilization	2
AGO3 and the LIMD1 family member WTIP	2
TNRC6A and downstream effector DDX6	2
LIMD1 binding	2
Ser 387	2
distinct interfaces	2
AGO-TNRC6 containing miRISC complex	2
TNRC6 proteins	2
Argonaute (AGO) proteins	2
microRNA-induced silencing complex (miRISC)	2
multiple circuits	2
injurious stimuli	2
freely behaving mice	2
minimal input	2
cutaneous nociceptors	2
nociceptor sensory neurons	2
harmful stimuli	2
panel of target genes	2
endoderm GRN	2
Mixl1, Eomesa, Smad2, Nanog, Mxtx2, and Pou5f3	2
many endodermal determinants	2
Ta/Tbx16-regulated homeodomain transcription factor Mixl1	2
gene regulatory networks (GRNs)	2
key endodermal determinants	2
Ta and Tbx16 targets	2
important contributions	2
downstream transcriptional networks	2
T/Brachyury homolog A (Ta)	2
SummaryT-box transcription factors	2
several brain areas	2
inputs and outputs	2
BF VGAT neurons	2
 the lateral hypothalamic area (LHA)	2
basal forebrain (BF)	2
somatostatin (SOM) neurons and GABAergic (VGAT) neurons	2
regulatory neural circuits	2
NDP/FZD4 interaction	2
FZD4 M105V	2
vitreoretinopathy (FEVR)	2
ligand norrin (NDP)	2
tetraspanin TSPAN12	2
different CNS structures	2
vascular β-catenin signaling	2
specific combinations of accessory proteins and ligands	2
Frizzled (FZD) receptor complexes	2
surface-expressed iGluRs	2
PDZ ligand interactions	2
de novo kainate receptors	2
model iGluR cargo	2
kainate receptor subunit GluK2	2
PTENα phosphatase	2
PTENα-CaMKII-NR2B signaling	2
dementia patients	2
hippocampus of PTENα-deficient mice	2
sites T305/306	2
distinctive N terminus	2
PTEN family members	2
PTEN family	2
SummaryPTEN (phosphatase and tensin homology deleted on chromosome 10)	2
important oncogenic signaling pathway	2
N-terminal DOC domain	2
E3 ligase HECTD3	2
second	2
CUL5, Elongin B, and Elongin C	2
HSP90 client kinase CRAF	2
two independent degradation pathways	2
siRNA screen	2
cancer therapeutics	2
HSP90 inhibitors	2
many oncogenic protein kinases	2
HSP90 chaperone	2
IFNγ pathway	2
γδ progenitors	2
Vγ usage	2
IL-17A-secreting γδ	2
either IL-17A or IFNγ	2
two distinct developmental pathways	2
γδ T cell contributions	2
major physiological regulator	2
TRβ in the VMH	2
TRβ in the VMH of adult mice	2
brain area	2
TR-beta isoform (TRβ)	2
ligand-inducible transcription factors	2
thyroid hormone receptors (TRs)	2
health issue	2
NOTCH1/SNAI1/MEF2C signaling axis	2
myogenic differentiation transcription factor	2
human ERMS	2
normal muscle	2
self-renewing myf5+ TPCs	2
zebrafish ERMS cells	2
intracellular NOTCH1 (ICN1)	2
zebrafish transgenic model	2
embryonal rhabdomyosarcoma (ERMS)—a common pediatric cancer of muscle	2
SummaryTumor-propagating cells (TPCs)	2
circulating toxins	2
Pomc-expressing cell lineage	2
post-mitotic cells	2
newly emerging AgRP neurons	2
newly proliferated tanycytes	2
putative hypothalamic neural progenitor cells	2
proopiomelanocortin (POMC) neurons	2
monosodium glutamate (MSG)	2
BBB (AgRPOBBB)	2
expressing agouti-related protein (AgRP)	2
CD11c+ AT macrophages	2
Dectin-1 expression	2
MyD88 KO mice	2
chow- and HFD-fed MyD88 KO mice	2
proinflammatory CD11c+ AT macrophages (ATMs)	2
adipose tissue (AT)	2
(HFD)-fed mice	2
either APPL1 or MYO6	2
endosomal lipid	2
endosomes	2
cortical actin filaments	2
peripheral endosomes	2
two of its cargo adaptor proteins, GIPC and TOM1/TOM1L2	2
Myosin VI (MYO6)	2
RAB5-positive signaling endosomes	2
key node	2
muscle and adipose tissues	2
GLUT4 in vivo	2
direct substrate of protein kinase B (AKT)	2
Thioredoxin interacting protein (TXNIP)	2
muscle and adipose tissues	2
glucose transporter (GLUT)4 storage vesicles	2
SummaryGrowth factors	2
control and mutant MNs	2
VCP-mutant ACs	2
patient-specific valosin-containing protein (VCP)-mutant MNs	2
functional populations of spinal cord MNs and ACs	2
SummaryMotor neurons (MNs) and astrocytes (ACs)	2
cell-cycle-regulated fate determinants	2
labeled endogenous cyclin D1	2
all-in-one reporter	2
individual fate determinants	2
all-in-one cell cycle reporter	2
fluorescently tagged endogenous proliferating cell nuclear antigen (PCNA)	2
well-defined mural cell populations	2
stage- and lineage-specific markers	2
vasculogenic lineage tree	2
MEK inhibitor	2
CD274+ capillary and DLK1+ arteriolar PCs	2
MB-derived PCs	2
proliferative PCs, SMCs, and mesenchymal stem/stromal cells	2
primitive PDGFRβ+CD271+CD73− mesenchymal progenitors	2
clonogenic cultures	2
clonal mesenchymal progenitor mesenchymoangioblast (MB)	2
smooth muscle cells (SMCs)	2
mesoderm-derived pericytes (PCs)	2
human pluripotent stem cell (hPSC) models	2
progenitors and lineage-restricted cells	2
vasculogenic cells	2
DC/T cell/natural killer (NK) cell recruitment	2
upregulating genes	2
TLR3-TICAM-1-interferon regulatory factor (IRF)3-IFN-β axis	2
activated tumor-specific CTLs in lymphoid tissues	2
anti-PD-L1 antibody	2
tumor-associated antigen	2
anti-PD-L1 therapy	2
safe vaccine adjuvant	2
anti-tumor CTLs	2
TLR3-specific RNA agonist, ARNAX	2
cross-prime antigen-specific cytotoxic T lymphocytes (CTLs) via Toll-like receptor 3 (TLR3)	2
Double-stranded RNA triggers dendritic cell (DC)	2
anti-programmed cell death-1 (PD-1)/PD ligand 1 (L1)-unresponsive tumors	2
iron-related transcripts	2
HIF2α-inducible gene	2
duodenal Regnase-1	2
Regnase-1−/− mice	2
endonuclease Regnase-1	2
iron-controlling gene, transferrin receptor 1 (TfR1)	2
RUNX1-ETO-expressing cells	2
stem cell-like transcriptional network	2
two fusion proteins	2
different regulators, the t(8;21) expressing RUNX1-ETO and the t(3;21) expressing RUNX1-EVI1	2
RUNX1 DNA-binding domain	2
RUNX1 locus	2
two types of AML	2
different mutant regulators	2
transcriptional regulator genes	2
various biological systems	2
TF binding	2
examined peak-calling programs	2
different accessibility assays (DNase-seq, ATAC-seq)	2
motif sequence	2
TF binding motifs	2
bound sequence	2
amygdala	2
thalamo-LA synaptic transmission	2
22q11DS gene Dgcr8	2
lateral amygdala (thalamo-LA projections)	2
22q11DS mouse models	2
H. polygyrus EVs	2
ST2-deficient mice	2
larval challenge	2
EV-alum	2
EV antibodies	2
IL-33 receptor subunit ST2	2
type 1 and type 2 immune-response-associated molecules (IL-6 and TNF, and Ym1 and RELMα)	2
gastrointestinal nematode Heligmosomoides polygyrus	2
many parasites release extracellular vesicles (EVs)	2
old HSCs	2
p53-positive subpopulation	2
constitutively active form of JAK2 (V617F)	2
distinct subpopulation of old HSCs	2
hematopoietic stem cell (HSC) compartment	2
distinct subpopulations of neurons	2
IL-NAc circuit	2
pain-predictive cue (PPC-avoidance)	2
approach-avoidance task	2
infralimbic (IL) cortex and nucleus accumbens (NAc)	2
telomerase-deficient, drug-resistant melanomas	2
BRAF inhibitor	2
strong engineered alleles	2
drug-naive tumors	2
mouse models of melanoma	2
pro-oncogenic aberrations	2
invasive Gram-negative bacteria	2
rheostat	2
NOD1/2 pathways	2
proliferating and stagnant intracellular bacteria	2
 TIFA	2
large signaling complexes	2
bacteria replicating free	2
bacterial metabolite heptose-1,7-bisphosphate (HBP)	2
TRAF-interacting forkhead-associated protein A (TIFA)-dependent cytosolic surveillance pathway	2
peptidoglycan sensor NOD1	2
Cytosol-invasive bacteria	2
incoming pathogens	2
SummaryIntestinal epithelial cells (IECs)	2
multiple herpesviruses	2
Kaposi-sarcoma-associated herpesvirus immunoevasin	2
EBV types I and II	2
B cell receptor complex	2
complement cascade	2
cell cycle, innate and adaptive immune pathways	2
EBV virome	2
lytic B cell proteome	2
cellular and 69 EBV proteins	2
conditional Burkitt lymphoma models	2
host and EBV proteins	2
oral hairy leukoplakia	2
nasopharyngeal carcinoma	2
infectious mononucleosis	2
distinctive peptidome and functions of HLA-B∗46:01	2
peptide antigens	2
HLA-B∗46:01 peptidome	2
HLA-B∗46:01 peptides	2
low-diversity peptidome	2
C1-specific natural killer (NK) cell receptor	2
exceptional HLA-B allotype	2
C1 epitope	2
common HLA-B allele	2
HLA-B∗15:01 and HLA-C∗01:02	2
SummaryHLA-B∗46:01	2
stellate cells in layer II	2
pyramidal neurons in layer III and layer II	2
superficial layers of the MEC	2
unitary excitatory connections	2
local networks	2
local microcircuitry	2
hexagonal firing field of grid cells	2
grid cells in the medial entorhinal cortex (MEC)	2
primary T cell pool	2
TCR-signaled thymocytes	2
gene encoding ThPOK	2
activating enhancers	2
NKT and Treg subsets	2
I- and II-mediated selection	2
inappropriate T lineages	2
SATB1-deficient thymocytes	2
lineage-specifying factors, including ThPOK, Runx3, CD4, CD8, and Treg factor Foxp3	2
genome organizer, SATB1	2
post-selection thymocytes	2
Runx3 and ThPOK transcription factors	2
host cytoplasm	2
conserved components of the eukaryote DNA replication and repair machinery	2
viral replisome component H5	2
ATR activator TOPBP1	2
viral polymerase E9	2
cytoplasmic DNA viral factories	2
host involvement	2
 their genomes	2
DNA viruses	2
patient-specific iPSC-derived midbrain neurons	2
miniature, EPSCs	2
PD-causing mutant	2
wild-type parkin	2
induced pluripotent stem cells (iPSCs) of PD patients	2
midbrain neurons	2
spontaneous excitatory postsynaptic currents (sEPSCs)	2
key targetable A. fumigatus counter-defenses	2
A. fumigatus	2
non-neutropenic murine model	2
murine alveolar macrophages (AMΦs)	2
ROI in vitro	2
fumigatus strain	2
Aspergillus	2
copper-binding transcription factor AceA	2
invasive aspergillosis	2
placental miRNAs	2
tumor suppressors or apoptosis inducers	2
putative target genes	2
spongiotrophoblast layer	2
paternal allele	2
host Sfmbt2 gene	2
paternal allele in the placenta	2
Sfmbt2	2
miRNA cluster	2
entire Sfmbt2	2
miRNA precursor sequences	2
intron 10 of the Sfmbt2 gene	2
One of the largest miRNA clusters	2
CD95L-mediated signaling	2
caspase-10 and cFLIP coordinately	2
cFLIP and caspase-10	2
caspase-8-knockout cells	2
co-operative/hierarchical binding model	2
caspase-8 homolog, caspase-10	2
death-receptor-bound FADD	2
regulator cFLIP	2
GABAA receptors	2
α7-, α4β2-, and α6-containing nAChRs	2
α-bungarotoxin, epibatidine, and conotoxin MII	2
major classes of presynaptic and postsynaptic nAChR tested	2
α7-type nAChRs	2
combinations of α and β subunits	2
Neuronal nAChRs	2
nicotinic acetylcholine receptors (nAChRs)	2
key lifespan determinant	2
immune-endocrine axis	2
IMD/NF-κB	2
intracellular negative regulators of the IMD/NF-κB pathway	2
aging brain	2
SIRT1 activators	2
SIRT1 agonist metformin	2
Rorc promoter	2
STAT3 deacetylation	2
pharmacological agonists	2
deacetylates proteins	2
trait and disease alleles	2
geographically distinct breeds	2
dog	2
modern breeds	2
New World dog	2
diverse dataset of dog breeds	2
modern domestic dog breeds	2
α-Ketoglutarate	2
oncogene-expressing hepatocytes	2
galectin-3 and α-ketoglutarate paracrine signals	2
aggressive HCCs	2
regenerative nodules and adenomas)	2
benign lesions	2
human hepatocarcinogenesis	2
progenitors in a model	2
various models tumors	2
 all models	2
HPCs and hepatocytes	2
transformed hepatocytes	2
various hepatocarcinogenesis mouse models	2
human data	2
molecular interactions	2
 complex embryonic environments	2
nuclear transcriptomes	2
comprehensive network of coding and non-coding RNAs and cis-regulatory modules	2
different cellular compartments (ribosomes and nucleus)	2
migratory neural crest and myocardial cells	2
in vivo transcriptional landscape	2
biotagging toolkit	2
tissue-specific drivers and cell-compartment-specific effector lines	2
biotinylate target proteins	2
genetically encoded components	2
versatile, tissue-specific binary in vivo biotinylation system	2
individual cell types	2
precise tools	2
complex organisms	2
essential JNK/en/Pc/Hox gene regulatory network	2
Hox genes abdominal-A and Abdominal-B.	2
central abdominal region	2
thoracic and abdominal segments	2
silencing PcG bodies	2
en locus	2
Polycomb (Pc)	2
MCs	2
posterior determinant engrailed (en)	2
specific “mixer cells” (MCs)	2
independent morphogenetic domains	2
anterior and posterior compartments	2
segmented tissues	2
postsynaptic protein complexes	2
target-derived NGF	2
different cellular compartments	2
TrkA signaling endosomes	2
sympathetic neuron dendrites	2
distal-axon-derived TrkA signaling endosomes	2
TrkA kinase activity	2
synaptic protein clusters	2
subset of TrkA endosomes	2
TrkA signaling endosomes	2
somata of sympathetic neurons	2
Target-derived NGF signals	2
preganglionic neurons	2
target fields	2
SummarySympathetic neurons	2
in vivo other sites	2
yeast cell extracts	2
ubiquitin-binding Ufd1-Npl4 complex	2
ubiquitylated CMG helicase	2
partners of budding yeast Cdc48	2
segregase”	2
Cdc48	2
Mcm7 helicase subunit	2
Cdc45-MCM-GINS (CMG) DNA helicase	2
genetically heterogeneous malignancies	2
common and actionable extrinsic pathways	2
normal CD34+ cells	2
p38MAPK inhibitors	2
various other growth factors and inflammatory cytokines	2
AML cell growth	2
IL-1 receptor	2
 AML patients	2
IL-1β and IL-1 receptors	2
normal progenitors	2
AML patients	2
myeloid progenitors	2
pro-inflammatory cytokine interleukin-1 (IL-1)	2
94 cytokines	2
ex vivo functional screen	2
postsynaptic spines	2
cortical axonal boutons and dendritic spines	2
lipogenesis in vivo	2
Primary hepatocytes	2
mutation	2
γ1 subunit (γ1D316A)	2
catalytic subunit of CK2	2
kinesin family	2
adipogenesis	2
evolutionarily conserved sirtuin family of nicotinamide adenine dinucleotide (NAD)+-dependent protein deacetylases	2
local α cell-derived GLP-1 by DPP-4 inhibitors	2
systemic GLP-1 agonists	2
DPP-4 inhibitor sitagliptin	2
intestinal GLP-1	2
locally derived insulin secretagogues	2
paracrine GLP-1	2
PBRM1 mutated subtypes of human ccRCC	2
human ccRCC	2
physiological preclinical ccRCC mouse model	2
mouse and human ccRCC	2
either gene alone	2
second most commonly mutated gene	2
SMARCAD1 peaks	2
H3R26Cit peaks	2
overlapping regions	2
Smarcad1 KD cells	2
H3R26Cit ChIP-seq peaks	2
Smarcad1 knockdown (KD) embryonic stem cells	2
SMARCAD1 binding	2
ten histone modifications	2
histone peptides	2
H3 arginine 26 citrullination (H3R26Cit) peptides	2
AZ matrix	2
nanoscale AZ matrix unclustering	2
AZ machinery	2
AZ matrix, VGCCs, and putative release sites	2
AZ	2
voltage-gated calcium channels (VGCCs) and synaptic vesicles	2
active zone (AZ) matrix	2
gene encoding VGLUT2 in dopamine neurons	2
many VStr neurons of adult mice	2
VTA dopamine neurons	2
VTA-VStr dopamine system	2
co-transmit glutamate in the ventral striatum (VStr)	2
vesicular glutamate transporter 2 (VGLUT2)	2
SummaryDopamine neurons	2
m6A mRNA methylation machinery	2
genes (e.g., ADAM19)	2
GSC-grafted mice	2
GSC growth	2
RNA demethylase FTO	2
RNA methyltransferase complex	2
mitochondrial-only form of Gpx3	2
Mia40 oxidoreductase	2
Mitochondrial Gpx3	2
hitherto known IMS-import pathways	2
non-AUG codon	2
18-amino acid N-terminally extended form	2
IMS-localized Gpx3	2
major H2O2 sensor in yeast	2
redox-active cysteine residues	2
conserved hydrogen peroxide scavenging and signaling molecules	2
SummaryThiol peroxidases	2
3c0:eIF1 association	2
scanning PIC	2
3c0:eIF5 interaction	2
3c0:eIF1 interaction	2
scanning pre-initiation complex (PIC)	2
3c2 faces 40S protein uS15/S13	2
Arg-53 and Leu-96	2
3c1 contacts eIF1	2
stoichiometric complex	2
3c1 and 3c2	2
ribosome-binding surface of eIF1	2
N-terminal part, 3c0, binds eIF5	2
three parts	2
N-terminal domain (NTD) of eIF3c	2
gate-keeper protein eIF1	2
solvent-accessible side of the 40S ribosome	2
DNase-independent function of TREX1	2
TREX1 mitotic phosphorylation sites	2
Trex1−/− mouse embryonic fibroblasts expressing TREX1 wild-type or phosphor-mutants	2
OST subunit RPN1	2
mitotic phosphorylation sites	2
 PP1/PP2-type serine/threonine phosphatase	2
C-terminal Serine-261 by Cyclin B/CDK1	2
mitosis TREX1	2
C terminus of TREX1	2
self-DNA	2
N-terminal DNase domain of TREX1	2
TNF-α/RIPK1/RIPK3/MLKL pathway	2
immortalized human p53-defective fimbrial epithelium	2
Trp53−/− mouse oviduct epithelium	2
P4 receptors (PRs)	2
p53-defective FT cells	2
reactive oxygen species (ROSs) and hemoglobin-rich follicular fluid (FF)	2
FT epithelial cells	2
cells with DNA double-strand breaks (DSB)	2
FT fimbria epithelium	2
fallopian tube (FT) epithelium	2
SummaryHigh-grade serous ovarian carcinoma (HGSOC)	2
reference population database	2
uncharacterized variants	2
known G6PD variants	2
identified amino acid variants in glucose-6-phosphate dehydrogenase (G6PD)	2
enzymopathy	2
dephosphorylated replisomes	2
replication inhibitors	2
protein phosphatase 1 (PP1)	2
DDK inhibitors PHA-767491	2
DNA-bound Mcm4	2
 Xenopus laevis egg extracts and human cells	2
MCM2-7 proteins	2
essential targets	2
SummaryDbf4-dependent kinases (DDKs)	2
dense, multi-channel probes	2
4,096-channel array	2
detected spikes	2
multiple electrodes	2
high-density, large-scale multielectrode arrays	2
muscle stem cell progeny	2
antagonistic Wnt signaling pathways	2
non-canonical Wnt7a/Fzd7/Rac1 signaling	2
Wnt/β-catenin	2
muscle fusion	2
supernumerary nuclei	2
larger myotubes	2
Wnt/β-catenin target genes	2
muscle progenitor cells	2
canonical Wnt/β-catenin pathway	2
R-spondin (Rspo) family of secreted proteins	2
-mediated signals	2
neuronal network	2
Rab4-dependent vesicular	2
Drosophila larvae	2
ventral ganglion	2
synapse-bearing region	2
tail domain of Kinesin-2α/KIF3A/KLP64D subunit)	2
rat embryonic fibroblasts	2
FK506 binding protein (FKBP) and FKBP-Rapamycin binding domain (FRB) conjugation assays	2
synaptic region of the larval ventral ganglion	2
Drosophila axons	2
endocytic, recycling, and degradative pathways	2
sorting endosomes	2
IDH mutant subtype	2
IDH mutant-enriched subtype	2
set of predominantly intrahepatic CCA cases	2
RNA expression	2
bile ducts	2
aging organisms	2
NAD+-limited environments	2
sirtuin mutants	2
conserved catalytic sirtuin domain	2
Sir2 ortholog, SIRT1	2
NAD+-depleted environment	2
catalytic domain of yeast Sir2	2
laboratory animals and humans	2
histone demethylase	2
interaction partners Coi7p and Lia5p	2
heterochromatin protein 1 (HP1)-like protein	2
-mediated positive feedback loops	2
PTEN-deficient malignancy	2
S6K1 and TAMs	2
PTEN-deficient glioblastoma cells	2
TAM family tyrosine kinase AXL	2
AD80 coordinately	2
increased mTOR-S6K1 co-association	2
PTEN-deficient leukemia cells	2
S6K1-targeting AD80	2
S6K1 inhibitor LY-2779964	2
PTEN-deficient T cell leukemia	2
S6K1 inhibitors	2
specific long-chain fatty-acid-containing dihydroceramides	2
population-based prospective cohorts	2
closely related lipids	2
group of sphingolipids	2
plasma of mice	2
tissue metabolic pathways	2
AcCoA accumulates	2
thioesterase glyoxalase II (Glo2)	2
thioester	2
S-acetyl intermediate	2
nearby lysine	2
mitochondrial lysine deacetylase Sirtuin 3 (Sirt3)	2
N-acetylates lysine residues	2
key intermediate	2
SummaryAcetyl coenzyme A (AcCoA)	2
host cell cytoskeleton	2
cytoskeleton-targeting drugs	2
viral RF	2
microtubules and intermediate filaments	2
 similar architecture	2
MR766 African strain and the H/PF/2013 Asian strain	2
Dengue virus-infected cells	2
pore-like openings	2
human hepatic cells and neural progenitor cells	2
host cell organelles	2
virus-induced membranous replication factories (RFs)	2
positive-strand RNA virus	2
Zika virus (ZIKV) infections	2
global concern	2
integrin β3 subunit	2
αvβ3 antagonist	2
transforming growth factor β (TGF-β) pathway	2
human primary fibroblasts	2
β3 expression	2
Polycomb protein CBX7	2
ITGB3 (integrin beta 3 or β3)	2
precisely localized endocytic zones	2
perisynaptic endocytic zones	2
non-synaptic TfRs	2
postsynaptic AMPA-type receptors (AMPARs)	2
preferential sites	2
optically static clathrin-coated structures	2
transferrin receptors (TfRs)	2
dendrites of cultured hippocampal neurons	2
pHluorin-tagged receptors	2
individual endocytic vesicles	2
neuronal dendrites	2
HIF inhibitors	2
chemotherapy-induced GSTO1 expression	2
pluripotency factors	2
SRC → STAT3 signaling	2
ryanodine receptor RYR1	2
carboplatin-induced BCSC enrichment	2
GSTO1 expression	2
hypoxia-inducible factor 1 (HIF-1) and HIF-2	2
glutathione S-transferase omega 1 (GSTO1)	2
cancer stem cells (BCSCs)	2
FRDA patients	2
frataxin ubiquitination	2
RING E3 ligase RNF126	2
frataxin E3 ligase	2
residual frataxin	2
mitochondrial protein frataxin	2
transplanted macrophage progenitors	2
tissue resident AMs	2
alveolar macrophages (AMs)	2
wave of IL-13-producing type 2 innate lymphoid cells (ILC2s)	2
epithelium-derived alarmin interleukin-33 (IL-33) in newborn mice	2
complex immunological milieu	2
TrspRIPKO mice	2
(NF-E2-related factor 2)	2
Trsp-KO mice (TrspIns1KO)	2
proopiomelanocortin-positive neurons	2
Leptin signals	2
hypothalamic cells and pancreatic β cells	2
Trsp-KO (TrspRIPKO) mice	2
rat-insulin-promoter-driven-Cre (RIP-Cre)	2
conditional knockout (KO) of selenocysteine-tRNA (Trsp)	2
targeted oxidative-stress murine model	2
orthologous subunits of human Swi/Snf	2
catalytic subunit Snf2	2
Swi/Snf complex	2
yeast Swi/Snf	2
Swi/Snf	2
partial Swi/Snf complexes	2
subunits of the Swi/Snf complex	2
nucleosomes on DNA or evicting histones	2
12-subunit Swi/Snf chromatin remodeling complex	2
myeloid loci	2
successfully transformed cells	2
DNA-DSBs	2
B lineage genes	2
Identified hotspots	2
prominent targets	2
B lineage-specific genes	2
1,000 sensitive regions	2
leukemia-inducing oncogenes	2
primary B cell precursors	2
myeloid leukemia	2
myeloid-specific genes	2
lymphoid leukemia	2
lymphoid-specific genes	2
human semen	2
vasectomized mice	2
resulting pregnancies	2
uninfected females	2
infected males	2
ZIKV RNA	2
Infectious virus	2
 semen	2
immunodeficient AG129 mice	2
Western hemisphere	2
-dependent hubs	2
endosomes and the ER	2
Membrane contact sites	2
ER-localized phosphatase PTP1B.	2
endocytosed receptors	2
NAADP-dependent contacts	2
ER-endosome contact sites	2
enlarged late endosomes/lysosomes	2
target endo-lysosomal ion channel, TPC1	2
Ca2+-mobilizing messenger NAADP	2
endosomes and the endoplasmic reticulum (ER)	2
endo-lysosomal system	2
SummaryMembrane contact sites	2
skeletal myocytes, osteocytes, and chondrocytes	2
hPSC-derived somite cells	2
in vivo somitogenesis	2
distinct developmental stages	2
in-vitro-differentiating cells	2
somite cells	2
BMP and transforming growth factor β (TGF-β) signaling	2
WNT-β-catenin	2
conserved pathways	2
nascent and developed somites	2
human presomitic mesoderm	2
somitogenesis-stage human embryos	2
skeletal muscles and bones and cartilage of the vertebrae	2
unique cell and tissue types	2
methylated H3K9 occupancy	2
fetal liver and cell-cycle genes	2
 CRL4 in mouse liver	2
H3K79 mutant in cells	2
DCAF8 substrate receptor	2
CRL4 ubiquitin ligase	2
postnatal mouse liver	2
fetal and cell-cycle genes	2
H3 methylation	2
histones H2A and H2B	2
Sgo2-dependent, but Mad2-independent, APC/C-inhibitory pathway	2
first, but not second, lysine, glutamic acid, asparagine (KEN) box in Mad3	2
Sgo2 and some (Bub1, Mph1/Mps1, and Mad3), but not all (Mad1 and Mad2), components of the SAC	2
CPC with Klp9/MKLP2 (kinesin-6)	2
components of the chromosome passenger complex (CPC)	2
Securin and Cyclin B	2
 the anaphase-promoting complex/cyclosome (APC/C)	2
ATXN1L-CIC-ETS transcription factor axis	2
ATXN1L expression	2
CIC protein	2
ATXN1L deletion	2
several lineages	2
transcriptional repressor of ETV1, ETV4, and ETV5	2
MEK1/2 inhibitor trametinib	2
two KRAS mutant pancreatic cancer cell lines	2
RAS- and RAF-mutant cancers	2
MEK and RAF inhibitors (MAPKi)	2
HIV-1-infected macrophages	2
multispectral flow cytometry	2
fixed and live-cell fusion assays	2
luciferase and GFP reporter viruses	2
internalize HIV-1 particles	2
macrophage-lineage cells	2
long-lived viral reservoirs	2
testis-specific knockout	2
meiotic proteins	2
meiotic knockdown and complementation system	2
late prophase I spermatocytes	2
mouse spermatogenesis	2
in vivo meiotic knockdown and protein complementation system	2
RAD51 knockouts	2
mammalian meiosis	2
meiosis-specific DMC1	2
ubiquitous RAD51	2
TELO2:mTORC1 binding	2
endogenous inhibitor of mTOR	2
mTORC1:substrate binding	2
3′ kinase-related kinase (PIKK) stabilizer, TELO2,	2
phosphatidyl inositol	2
MAPK-interacting kinase (MNK)	2
numerous stimuli	2
mechanistic target of rapamycin (mTOR)	2
UBE2L3 polymorphisms	2
molecular rheostat	2
mature-IL-1β production	2
pro-IL-1β	2
indirect target	2
UBE2L3 ubiquitin conjugase	2
non-proteolytic targets	2
caspase-1 substrates	2
interleukin 1 alpha (IL-1α) and HMGB1	2
non-substrate alarmins	2
newly induced pro-interleukin 1 beta (IL-1β)	2
inflammasome signaling scaffolds	2
non-invasive tools	2
Cdkn1c-luciferase mice	2
imprinted Cdkn1c expression	2
maternal dietary protein in utero	2
Cdkn1c alleles	2
paternally inherited (silent)	2
chromatin-modifying drugs	2
sensitive allele-specific reporters	2
SummaryImprinted genes	2
ESC enhancers and super-enhancers	2
iPSC genome	2
thousands of hypermethylated regions	2
female cells	2
selection of transcripts	2
translation	2
cofilin-1 mRNA	2
rich repertoire of axonal miRNAs	2
Xenopus laevis retinal ganglion cell (RGC) axons	2
critical translational regulators	2
subsets of mRNAs	2
Different guidance cues	2
brain wiring	2
RNA looping	2
individual interactions	2
data-informed kinetic simulation	2
core CA sequence	2
enlarged and dynamic hydrophobic groove	2
non-canonical GGA sequence	2
respective target sequences	2
KH3-KH4 di-domain	2
β-actin mRNA	2
oncofetal RNA-binding protein	2
SummaryZipcode binding protein 1 (ZBP1)	2
cell-type-specific gene expression and epigenomic profiling	2
NuTRAP mouse	2
limited cell input	2
whole adipose tissue or in vitro adipocyte cell lines	2
various adipocyte populations in vivo	2
cell-type-specific translating mRNA and chromatin	2
“NuTRAP	2
Various in vivo tissues	2
reward delivery areas	2
subsequent wakefulness	2
rewarded working memory task	2
electrochemical biosensors	2
neocortex and hippocampus	2
less active and more labile neurons	2
sensory and behavioral contexts	2
stable subnetworks of neurons	2
mature visual cortex	2
less active excitatory neurons	2
visual context	2
highly active excitatory neurons and parvalbumin-positive (PV+) interneurons	2
mature cortex	2
neurons in primary visual cortex	2
null allele (Mx1-Cre;Brca1F22–24/5382insC)	2
mutant huBRCA1/5382insC allele	2
huBRCA1 knockin allele (Brca1BRCA1/BRCA1)	2
hematopoietic stem cells (HSCs)	2
the embryonic hematopoietic system (Vav1-iCre;Brca1F22–24/F22–24)	2
generated mice	2
tissue-specific tumor suppressor	2
well-known DNA repair pathway component	2
triglyceride and diacylglycerol lipase activities	2
network of CES2-regulated lipids	2
human CES2	2
primary human hepatocytes	2
carboxylesterase 2 (CES2) and arylacetamide deacetylase (AADAC)	2
lean and obese humans	2
liver biopsies	2
serine hydrolases	2
large family of multifunctional enzymes	2
resource of small molecules	2
West Nile, dengue, and chikungunya viruses	2
medically relevant viruses	2
physiologically relevant primary cells	2
a potent inhibitor	2
AXL expression	2
placental-derived cells	2
receptor tyrosine kinase inhibitors	2
attachment factor AXL	2
FDA-approved nucleoside analogs	2
38 drugs	2
microscopy-based assay	2
two different strains of Zika virus	2
2,000 bioactive compounds	2
vaccines or specific therapeutics	2
emerging arthropod-borne flavivirus	2
SummaryZika virus	2
cerebellar microcircuits	2
major Ca2+ sensor	2
excitatory terminals	2
synaptotagmin 1 (Syt1)	2
expressed synaptotagmin 2 (Syt2)	2
BC terminals	2
Purkinje cell (PC) synapses	2
GABAergic basket cell (BC)	2
+ sensor	2
inhibitory output signals	2
canonical nucleosomes	2
H3t-containing nucleosomes	2
canonical H3 proteins	2
normal spermatogenesis	2
differentiating spermatogonia	2
haploid germ cells	2
mouse testis-specific and replication-dependent histone H3 variant H3t	2
cell-type-specific epigenomic landscape	2
histotype-specific immune microenvironment	2
Kras;Lkb1-driven tumor histopathology spectrum	2
CD11b+ Gr-1+ tumor-associated neutrophils (TANs)	2
downregulated MHC genes	2
ASC-specific immunosuppressive environment	2
pro-inflammatory and immunomodulatory genes	2
mucinous and acinar adenocarcinomas	2
adenosquamous carcinoma (ASC) tumors	2
predominant progenitors	2
CC10+ cells	2
Ad5-SPC-Cre cohorts	2
Ad5-CC10-Cre-infected mice	2
cells expressing surfactant protein C (SPC) or club cell antigen 10 (CC10)	2
progenitor cell-type-restricted adenoviral Cre	2
Lkb1 (Kras;Lkb1)	2
one store	2
Ca2+ stores	2
discrete Ca2+ store	2
PTH unmasks high-affinity IP3 receptors	2
intracellular Ca2+ stores	2
IP3 and cAMP	2
carbachol and parathyroid hormone (PTH)	2
SummaryInositol 1,4,5-trisphosphate (IP3)	2
immune cell contacts	2
Src kinase Lck	2
infected and uninfected mixed-population T cells	2
virus-induced cell-cell contacts	2
nuclear and cytosolic acetyl-CoA	2
histone acetyltransferases	2
nuclear ACSS2	2
exogenous acetate	2
two-carbon acetyl units	2
ACSS2 and the mitochondrial ACSS1	2
acetyl-CoA from acetate	2
nuclear-cytosolic acetyl-CoA synthetase 2 (ACSS2)	2
key metabolic intermediate	2
-CoA	2
H3K79 methyltransferase	2
H3K79me2/3 marked genes	2
unmethylated CpG regions	2
MLL-AF4 binding	2
subset of gene targets	2
epigenetic pathways	2
(MLL) gene	2
mixed-lineage leukemia	2
defined cancers	2
classical secretory pathway	2
CQ-inducible Par-4 secretion	2
normal cells in mice and cancer patients	2
anti-malarial drug, chloroquine (CQ)	2
tumor suppressor proteins	2
experience-dependent motor output	2
neuron pair	2
transcript-specific dunce mutant	2
phosphodiesterase 4d ortholog dunce	2
nuclear RNA binding protein	2
cellular stress pathway	2
hangover gene	2
environmental signal integrator PIF4	2
DET1/COP1 and HY5 regulatory modules	2
PIF4 targets	2
elongation growth	2
PIF4 protein	2
thermosensory elongation	2
ELONGATED HYPOCOTYL 5 (HY5)	2
DE-ETIOLATED 1 (DET1)	2
central signaling hub	2
transcription factor PHYTOCHROME INTERACTING FACTOR 4 (PIF4)	2
developing vasculature	2
cilia-dependent Notch-specific target	2
 zebrafish foxc1b	2
endothelial primary cilia	2
arterial-fated vessels	2
developing vMCs in zebrafish embryos	2
vertebrate vascular system	2
mural cells (vMCs)	2
Nbs1 protein	2
hematopoietic cells in vivo	2
Mre11 interface	2
108-amino-acid Nbs1 fragment	2
Mre11 interaction domain	2
Nbs1 mutant mice (Nbs1midmice)	2
essential and non-essential Mre11 complex functions	2
three Mre11 complex components	2
Mre11 complex (Mre11, Rad50, and Nbs1)	2
functional cell-based assays	2
primary resting CD4 T and TZM-bl cells	2
large GTPase dynamin-2	2
virus particle	2
key research areas	2
CBS domains of IMPDH2	2
IMPDH2 (versus IMPDH1)	2
SFA complex	2
cystathionine-β-synthase (CBS) domain of IMPDH2	2
PPIA-SFA binary complex	2
inosine-5′-monophosphate dehydrogenase 2 (IMPDH2)	2
immune suppressant	2
receptor cyclophilin	2
mixed polyketide and non-ribosomal peptide synthase natural product	2
Sanglifehrin A (SFA)	2
SummaryNatural products	2
the evolutionarily conserved determinants	2
FOXO factors	2
Caenorhabditis elegans	2
excess dietary sugar	2
dFOXO target genes encoding epigenetic regulators	2
Drosophila homolog of forkhead box O (FOXO) transcription factors	2
Excess dietary sugar	2
unhealthy, high-sugar diet	2
aging populations	2
unhealthy diets	2
many developmental enhancers	2
common motif	2
non-overlapping sites	2
overlapping repressor and activator binding sites	2
engineered transcriptional repressor gradient	2
activator binding sites	2
functional enhancer	2
artificial enhancers	2
engineered transcription factor gradients	2
 a fully synthetic transcriptional platform	2
transcription factor proteins	2
iPSC-based disease model	2
low-dose rapamycin	2
cochlear epithelial cells	2
mutant pendrin aggregates	2
anion exchanger	2
anion exchanger pendrin	2
congenital defects	2
joint	2
evolutionarily conserved N-glycan chains	2
second and the third modules	2
four-module ectodomain	2
entire ectodomain of LRP6 in solution	2
full-length LRP6	2
multiple crystal structures	2
higher order signaling platform	2
large modular ectodomain	2
single-pass membrane glycoprotein	2
SummaryLDL-receptor-related protein 6 (LRP6)	2
glial-specific genes	2
aging brain cortex	2
neuronal subpopulations	2
all brain regions	2
microglia- and endothelial-specific genes	2
hippocampus and substantia nigra	2
oligodendrocyte-specific genes	2
ten human brain regions	2
region- and cell-type-specific consequences	2
Neil3−/−ruptured hearts	2
Differentially methylated genes	2
cardiac epigenome	2
fibroblast-enriched cell fraction	2
base excision repair enzyme NEIL3	2
stabilizing scar	2
novel objects	2
Slm2-null mice	2
SLM2-expressing-pyramidal neurons and interneurons	2
Tomosyn2, LysoPLD/ATX, Dgkb, Kif21a, and Cask	2
Neurexin1-3 pre-mRNAs	2
Sam68 and SLM1	2
conserved family of RNA binding proteins	2
deep cerebellar nuclei	2
neighboring Purkinje cells	2
ionotropic gamma-Aminobutyric acid receptor (GABAARs)	2
presynaptic gamma-Aminobutyric acid producing (GABAergic) network	2
populations of Purkinje cells	2
populations of Purkinje cells in brain slices and in vivo	2
critical connections	2
iPS cell and mouse models	2
three-dimensional cardiac microtissues	2
human iPS cell models	2
regulatory subunit, PRKAG2	2
entire BRCA1-A complex	2
nucleosome-linked ubiquitin chains	2
BRCC45/Merit40 pairs	2
dimer of Abraxas/BRCC36 heterodimers	2
distorted V-shape architecture	2
two Abraxas/BRCC36/BRCC45/MERIT40 tetramers	2
active core complex	2
histone H2A and H2AX	2
BRCA1-A deubiquitinase	2
dual-specificity and allosteric components	2
intrinsic RET dual-specificity kinase activity	2
phospho-S909	2
HRD motif	2
unconventional activation-loop serine phosphorylation site	2
JM hinge	2
otherwise catalytically deficient RET activation-loop mutant	2
phospho-site	2
juxtamembrane (JM) segment	2
tyrosine kinase domain	2
highly variable intracellular sequences	2
extracellular ligand-binding portions	2
highly homologous catalytic domains	2
unprotected cells	2
sensitive co-cultures	2
conserved target sequences	2
gRNA combinations	2
two antiviral gRNAs	2
single antiviral gRNA	2
proviral DNA	2
guide RNA (gRNA)-directed CRISPR/Cas9 system	2
provirus	2
core MICOS protein	2
native OPA1-containing high molecular weight complexes	2
multiple MICOS components	2
mitochondrial contact site and cristae organizing system (MICOS) and Optic atrophy 1 (OPA1)	2
broad range of biological and pathological contexts	2
various organisms and tissues	2
poorly characterized patterning regulators	2
previously known dorsoventral patterning transcription factors	2
spinal neural tube	2
major cell identity regulators	2
transcriptionally active genes	2
 broad H3K27me3 domains	2
embryonic and adult tissues	2
Foxp3 expression	2
suppressor of cytokine signaling 3 (SOCS3)	2
transcription factor Spi-B	2
subset of Treg cells in vivo and in vitro	2
Id3-deficient or E47-overexpressing Treg cells	2
E47 antagonist Id3	2
Foxp3 transcription	2
active telomerase	2
young and elderly subjects	2
transitory subpopulations	2
largely dormant cells	2
TSCM pool	2
differentiated subsets of memory T cells	2
stem cell-like memory T (TSCM) cells	2
naive precursors	2
mature specialized tissues	2
developmental lineages	2
lineage-restricted transcriptional programs	2
EZH2-deficient human embryonic stem cells (hESCs)	2
Polycomb complex PRC2	2
histone methyltransferase EZH2	2
yet-uncharacterized signals	2
equatorial furrowing	2
midzone and equatorial membrane	2
centralspindlin binding	2
unilateral furrowing	2
chemical genetic and optogenetic tools	2
furrow formation	2
equatorial plasma membrane	2
RhoGEF ECT2	2
equator	2
furrow	2
active enhancer elements	2
H3K4me1 histone marks	2
chromatin modifier MLL3	2
pioneer factor FOXA1	2
 enhancer elements	2
FOXA1 occupancy	2
top FOXA1-interacting protein	2
histone-lysine N-methyltransferase (MLL3)	2
ERα-positive MCF-7 breast cancer cells	2
H3K4 mono- and dimethylation (H3K4me1 and H3K4me2)	2
PD brain	2
complex I ROS-generating domain	2
LON-ClpP proteolytic quality control axis	2
toxic reactive oxygen species (ROS)-producing mitochondria	2
signalosome-like structures	2
components Frizzled and Strabismus	2
four core proteins	2
stoichiometric nucleus	2
transmembrane proteins Frizzled and Flamingo	2
core protein complex	2
opposite cell ends	2
developing epithelia	2
rigid multivalent reader modules	2
functional network of interactions	2
charged platform	2
multiple histone PTMs	2
stable unit	2
triple reader module (PHD-BRD-PWWP)	2
multiple PTMs	2
flexible linkages	2
Reader assemblies	2
DNA and histone post-translational-modifications (PTMs)	2
cell class	2
striatopallidal synapse	2
PD models	2
striatopallidal input	2
presynaptic metabotropic glutamate receptors	2
mouse GPe astrocytes	2
exact cellular underpinnings	2
somatodendritic membrane of striatopallidal neurons	2
dopamine receptors	2
 the striatopallidal pathway	2
external globus pallidus (GPe) neurons	2
striatopallidal pathway	2
prevailing circuit model	2
BDNF and Arc loci	2
key learning genes	2
CTCF knockdown	2
cadherin and learning-related genes	2
hippocampus of adult mice	2
CTCF in postmitotic neurons	2
SummaryCCCTC-binding factor (CTCF)	2
functional phosphatase interactome	2
every evolutionary family	2
phosphatase catalytic and regulatory subunits	2
phosphatase catalytic domains	2
physical interactome	2
relatively understudied phosphatases	2
two classes of enzymes	2
rod photoreceptor	2
single sensory neuron	2
GRN	2
downstream cognate effectors	2
unannotated rod-enriched transcripts	2
developing NRL-positive (rods) and NRL-negative (S-cone-like) mouse photoreceptors	2
transcription factor NRL	2
differentiating rod photoreceptors	2
interdependence of signaling pathways	2
cell types and cell assemblies	2
SummaryGene regulatory networks (GRNs)	2
DCV exocytosis	2
component of the exocytotic fusion complex	2
activated form of syntaxin-1A	2
chromaffin cells and neurons of these mice	2
dense core vesicle (DCV) exocytosis	2
SummaryCalcium-dependent activator protein for secretion 1 (CAPS1)	2
splicing regulators	2
transcripts encoding components	2
Bcl-x pre-mRNA	2
SRSF10 and hnRNP K	2
hnRNP F/H	2
stimulatory hnRNP F/H proteins	2
repressor hnRNP K	2
5′ splice site of Bcl-xS	2
normally growing cells	2
pro-apoptotic Bcl-xS	2
-x	2
pro-death and pro-survival splice variants of Bcl	2
SummaryRNA binding proteins and signaling components	2
RNA-binding proteins	2
recombinant Ccr4-Not	2
preparations of native Ccr4-Not	2
RNA-binding protein Mmi1	2
exonucleases alone	2
intact complex	2
fully recombinant Ccr4-Not complex	2
in-vitro-reconstituted system	2
3′ poly(A) tails of eukaryotic mRNAs	2
heterogeneous tissues	2
 publicly available EWAS datasets	2
 the ENCODE, Roadmap Epigenomics, and BLUEPRINT projects	2
454 samples (tissues, primary cell types, and cell lines)	2
DNase I hypersensitive sites	2
set of EWAS-identified differentially methylated positions	2
cell type-specific regulatory component	2
non-genetic variants	2
less adipose stroma	2
breast cancer subtypes	2
(TCGA) breast tumors	2
constituent cell types	2
individual cell types	2
neonatal lymphocytes	2
neonatal naive CD8+ T cells	2
consistently positioned nucleosomes	2
the innate and adaptive arms of the human immune system	2
range of immune system effector cells	2
BLUEPRINT Epigenome Project	2
whole-genome bisulfite sequencing datasets	2
mouse and human	2
primary and metastatic disease	2
microglia specifically repress Itga4 (CD49D)	2
chromatin landscapes	2
recruited BMDMs	2
brain-resident microglia	2
distinct transcriptional networks	2
primary and metastatic brain tumors	2
tumors of the brain	2
bone-marrow-derived macrophages (BMDMs)	2
irradiation-based lineage tracing	2
normal tissue-resident macrophages	2
members of these complexes	2
specific non-histone protein complexes (e.g., the preinitiation complex TFIIIC)	2
RPSs	2
aged and CR cells	2
tRNA genes	2
5S rDNA	2
non-histone protein-complex-bound RPSs	2
DNA helicase Rrm3p	2
ribosomal DNA (rDNA) and non-rDNA locations (e.g., silent replication origins and tRNA genes)	2
various natural replication pause sites (RPSs)	2
difficult-to-replicate chromosomal sites	2
, most notably, DNA polymerase eta (Polη)	2
specialized translesion DNA synthesis (TLS) proteins FANCJ-RAD18-PCNA	2
multiple DNA repair networks	2
proteome of telomeres in cancer cells	2
proximity-dependent biotinylation (BioID)	2
stalled or collapsed replication forks	2
sustained Mdm2-expression	2
p53-deficient cells	2
p53-inducible gene product	2
freshly isolated thymocytes	2
murine embryonic fibroblasts	2
tumor-derived U2OS cells	2
network of coupled oscillatory subunits	2
Drosophila circadian system	2
light- and temperature-sensitive neuronal subgroups	2
brain clock neurons	2
wild-type flies	2
circadian network	2
two input pathways	2
regulatory subunit of the primase	2
specific subset of replication initiation and cell division genes	2
cellular DNA precursor pools	2
HU-insensitive class II ribonucleotide reductase	2
recombination structures	2
Sulfolobus solfataricus with HU	2
DNA precursors	2
deoxyribonucleoside triphosphates	2
class I ribonucleotide reductase	2
many organisms, hydroxyurea (HU)	2
murine hepatic steatosis regulatory axis	2
hepatic target gene of ABL1-PPARγ2-MLL4	2
Pparg2 (encoding PPARγ2)	2
overnutrition-activated ABL1 kinase	2
transactivation	2
steatotic target genes of PPARγ2	2
histone H3 lysine 4 methyltransferase MLL4/KMT2D	2
hepatic steatotic transcription factor	2
specific CHDs	2
NuRD complexes	2
heterologous CHDs	2
CHD	2
layer specification	2
core ATPase subunits of the NuRD complex	2
inhibitory receptors PD-1 and LAG3	2
Tfh-related transcription factors Bcl6 and Tcf7 (encoding TCF-1)	2
class of infecting virus	2
(Th) cells	2
CD4+ T helper	2
Granzyme B (GzmB)+ CD4+ CTLs	2
granzyme-mediated cytotoxic T cell (CTL) potential	2
+ T cells	2
targeting SIRT2	2
SIRT2 in BLBC cells	2
lysine residue K116	2
SIRT2 deacetylates Slug protein	2
SIRT2 overexpression	2
basal-like breast cancer (BLBC)	2
Slug protein	2
RTK coactivation dependencies	2
SWI/SNF deficiencies	2
rhabdoid tumor patients	2
PDGFRα and FGFR1	2
PDGFRα inhibitor pazopanib	2
MRT cells	2
AKT and ERK1/2 pathways	2
dual inhibitor ponatinib	2
Inhibitor combinations	2
coactivated in MRT cells	2
receptor tyrosine kinases (RTKs) PDGFRα and FGFR1	2
SWI/SNF subunit SMARCB1	2
Malignant rhabdoid tumors (MRTs)	2
 human cancers	2
VMH	2
low-fat diet	2
VMHKO mice	2
mice lacking ABHD6 from neurons of the ventromedial hypothalamus (VMHKO)	2
endocannabinoid 2-arachidonoylglycerol (2-AG)	2
monoacylglycerol hydrolase	2
β-Hydrolase domain 6 (ABHD6)	2
IRE1/XBP1 signaling pathway	2
IRE1 loss-of-function conditions	2
sugarbabe, a Gli-like zinc-finger transcription factor	2
enterocytes (ECs) of the Drosophila midgut	2
the IRE1/XBP1 endoplasmic reticulum (ER) stress signaling module	2
triglyceride usage	2
the ciliary proteins MKKS and TALPID3	2
outer segments	2
basal body docking	2
adult photoreceptors	2
inner retinal cells	2
ciliary vesicles	2
basal bodies	2
developing retina	2
actin crosslinking factor 1 (MACF1)	2
KAT2A inhibition	2
normal hemopoietic stem-progenitor cells	2
diverse genotypes	2
primary human AMLs	2
clinically actionable candidates	2
many other genes	2
DOT1L, BCL2, and MEN1	2
several established therapeutic targets	2
AML-specific cell-essential genes	2
genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screening platform	2
additional therapeutic targets	2
aggressive cancer	2
male sex chromosomes	2
FA-BRCA pathway	2
distinct histone marks	2
BRCA2 (FANCD1) and SLX4 (FANCP)	2
BRCA1 (FANCS), MDC1, and RNF8	2
FA core factors FANCA, FANCB, and FANCC	2
network of FA and DDR proteins	2
(DDR) factors	2
eight mouse models	2
male germline	2
human pluripotent stem cell (hPSC)-derived midbrain dopamine (mDA) neurons	2
age-inducing tool	2
iPSC model	2
fetal-stage cells	2
metabolic sensors SIRT1 and AMPK	2
ATF7IP and SETDB1 knockout cells	2
SETDB1 in genome-wide assays	2
HUSH complex	2
 SETDB1	2
nuclear SETDB1 protein	2
binding partner ATF7IP	2
histone methyltransferase SETDB1	2
acetylated Oct4	2
Otx2 expression	2
Otx2 enhancer	2
hyper-acetylated	2
NAD-dependent deacetylase, SirT1	2
different set of enhancers	2
naive preimplantation epiblasts	2
enhancer landscape	2
translation system	2
 genes, pathways	2
>48,000 gene pairs	2
quantitative synthetic genetic arrays	2
EspG binding of Arf1	2
virulence effector EspG	2
extracellular infections, enteropathogenic (EPEC) and enterohaemorrhagic (EHEC)	2
Arf1 activator ARNO	2
small GTPases Arf and Rac1	2
distinct NuRD subcomplexes	2
NuRD subunit paralogue	2
sites of DNA damage	2
GATAD2A/NuRD	2
the MYND domain	2
NuRD/ZMYND8 target genes	2
active promoters and enhancers	2
genome-wide binding sites	2
NuRD	2
mutually exclusive NuRD subcomplexes	2
GATAD2A and GATAD2B	2
NuRD subunit GATAD2A.	2
PPPLΦ motifs	2
MYND domain of ZMYND8	2
number of putative DNA-binding zinc finger proteins	2
versatile multi-protein complex	2
nucleosome remodeling and histone deacetylase)	2
lipoproteins and other key materials	2
transcytotic GTPase Rab11	2
endocytic recycling compartment	2
β-CTFs of APP	2
β-secretase inhibitor	2
APP and lipoproteins	2
soma-to-axon transcytosis	2
fAD mutant neurons	2
isogenic human iPSC-derived neurons	2
neuroactive metabolite	2
clinically relevant compound vigabatrin	2
glutamate decarboxylase	2
GABA-mimesis	2
multiple GABA-ergic targets	2
GABA-mimetic	2
high-frequency GABA-ergic transmission and gamma-band oscillations	2
elevated CNS L-proline	2
Prodh-deficient mice	2
PRODH and L-proline	2
SummaryProline dehydrogenase (PRODH)	2
multiple rhodopsins	2
early to mid-third-instar stage	2
brain, ventral nerve cord, and body wall	2
 trpA1-expressing neurons	2
Bolwig organ	2
light-sensing Bolwig organ	2
two rhodopsins, Rh5 and Rh6	2
mid- and late-third-instar larvae	2
Early third-instar larvae	2
thymic T cell subsets	2
ALCL tumor cells	2
 conserved transcription factor binding motifs	2
TCR and CTLA-4	2
ALK− ALCL	2
NPM-ALK-positive (ALK+) and NPM-ALK-negative (ALK−) anaplastic large-cell lymphoma (ALCL)	2
non-canonical pathway	2
human and murine neutrophils	2
immune-complex- and fMLF-induced signaling	2
previously uncharacterized, PI3K-dependent, non-canonical, pro-apoptotic signaling pathway, FcγR-PI3Kβ/δ-Cdc42-Pak-Mek-Erk	2
insoluble immune complexes	2
agonist-activated PI3Ks	2
Many neutrophil cell surface receptors	2
bacterial and fungal infections	2
peripheral blood leukocytes	2
Miro1 in mature neurons	2
axons and dendrites	2
primary regulator	2
mitochondrial transport machinery	2
important components	2
mitochondrially targeted proteins	2
glutamate dehydrogenase pathway	2
leucine-dependent DILP release	2
IPC bodies	2
DILP2 and DILP5	2
minidiscs (MND), a leucine transporter	2
Ca2+-imaging and ex vivo cultured larval brains	2
hemolymph	2
brain IPCs	2
Drosophila, insulin-like peptides (DILP2 and DILP5)	2
insulin-producing cells (IPCs)	2
human RNA methyltransferases	2
RNA binding tunnel	2
Cβ atom of the methionine portion of the molecules	2
SAM analogs	2
SAM and 7-methyl guanosine diphosphate (7-MeGpp)	2
one bound to S-adenosylmethionine (SAM) and	2
cat and macaque visual cortex	2
oriented stimulus	2
anucleate blood lineages	2
ribosome rescue factors PELO and HBS1L	2
ribosome recycling factor ABCE1	2
3′ UTRs of mRNAs	2
post-termination unrecycled ribosomes	2
anucleate lineages	2
new mRNA or ribosomes	2
maturing reticulocytes	2
genomic imprints	2
DNA methyltransferase proteins	2
MERVL/Zscan4 transcriptional network	2
MERVL/Zscan4 state	2
earliest upregulated transcripts	2
Single-cell transcriptomics	2
preimplantation embryos	2
MERVL endogenous retrovirus	2
Zscan4 cluster	2
decondensed chromatin	2
specific histone modifications	2
previously identified tissue-specific enhancers	2
silent promoters	2
bivalent promoters	2
series of mouse embryonic stem cells (mESCs)	2
 histone modifications (H3K4me1, H3K4me3, H3K27me3, and H3K27ac)	2
DNA methylome	2
model of human ERα+ breast cancer	2
truncated and wild-type PRLR	2
Stat1−/−mouse embryonic fibroblasts	2
tumor and no normal samples	2
matched normal tissues	2
Stat1−/−primary mammary tumors	2
cancer subtype	2
SummaryEstrogen receptor alpha-positive (ERα+) luminal tumors	2
unifying therapeutic target	2
NAD+-dependent mitochondrial deacylases SIRT3 and SIRT5	2
nicotinamide mononucleotide (NMN)	2
major NAD+ biosynthetic pathway	2
 nicotinamide phosphoribosyltransferase (Nampt)	2
 rod or cone photoreceptor-specific deletion	2
PAXX and XLF	2
V(D)J recombination	2
RAG-cleaved DNA ends	2
nonhomologous end-joining (NHEJ)	2
XRCC4 superfamily	2
XRCC4 and XLF (PAXX)	2
WS patients	2
Cxcr4 desensitization	2
long-lived PCs	2
survival niches	2
immature plasmablasts	2
antigen-specific PCs	2
knockin mouse model	2
bone marrow (BM)	2
different RNA substrates	2
alternative conformations	2
Rrp44da exosome	2
conformation, (Rrp44da)	2
central channel of the RNA exosome	2
essential catalytic subunit, Rrp44	2
3′–5′ ribonuclease complex	2
ribosomal quality control hub	2
cognate heterooligomers	2
polypeptide exit tunnel	2
newly synthesized snRNP proteins	2
small nuclear RNA (snRNA)	2
pICln-bound proteins	2
SMN complex	2
assembled snRNP	2
PRMT5-complex subunit pICln	2
common core of pre-mRNA processing small nuclear ribonucleoprotein particles (snRNPs)	2
SMN complexes	2
assembly chaperones	2
crowded environment of cells	2
COOLAIR transcripts	2
non-contiguous DNA sequence	2
multi-helix junctions	2
evolutionarily divergent Brassicaceae species	2
COOLAIR exons	2
A. thaliana COOLAIR secondary structure	2
functionally distinct A. thaliana FLC haplotype	2
single non-coding SNP	2
complex multi-domain structure	2
distally polyadenylated transcript	2
major COOLAIR variants	2
A. thaliana FLC locus	2
antisense lncRNAs	2
stage-specific proximal and distal regulatory elements	2
protein-coding regions	2
six lepidopteran genomes	2
butterfly, Heliconius erato	2
high-quality, functionally annotated genome assembly	2
butterflies and moths	2
regulatory loci	2
neuronal Rap1	2
CNS Rap1	2
multiple hypothalamic nuclei	2
small GTPase Rap1	2
underlying neurobiological pathways	2
alanine tRNA gene of mtDNA	2
mouse line	2
heterozygous mtDNA mutator mice	2
colonic crypts of founder mice	2
set of potentially promising biomarkers	2
 larger cohorts	2
two additional, independent cohorts	2
patients from control individuals	2
several module genes	2
central components	2
highly connected MS gene module	2
patient-derived CD4+ T cells	2
MS patient-derived CD4+ T cells	2
extracellular face of presynaptic release sites	2
α2δ proteins	2
RIM-dependent readily releasable vesicle pool	2
gabapentin and pregabalin	2
psychiatric drugs	2
α2δ gene family	2
auxiliary subunit of the presynaptic calcium channel	2
retrotransposon	2
ZF-MIWI2	2
MILI-null mice	2
ZF-MIWI2 fusion protein	2
promoter region of a type	2
zinc finger (ZF)	2
fusion protein of MIWI2	2
piRNA-associated MIWI2	2
PIWI-interacting RNAs (piRNAs)	2
two PIWI family proteins	2
mouse embryonic germ cells	2
mammalian embryonic germ cells	2
HBx null mcHBV-Gluc gene expression	2
dominant-negative SMC6	2
HBx-dependent activity	2
minicircle HBV (mcHBV) reporter system	2
CRL4HBx E3 ligase	2
SMC5/6 complex	2
CRL4HBx substrates	2
structural maintenance of chromosomes (SMC) complex proteins SMC5 and SMC6	2
DDB1-CUL4-ROC1 (CRL4	2
HBV covalently closed circular DNA (cccDNA) genome	2
hepatitis B virus (HBV) regulatory protein X (HBx)	2
synaptic membrane	2
reservoir of receptors	2
excess μ3A	2
dendritic membrane	2
truncated μ3A	2
 full-length μ3A	2
dendritic μ3A and AMPAR to recycling endosomes (REs)	2
pyramidal neurons	2
AP-3 subunits)	2
AP-3A. Synaptic scaling	2
μ subunit (μ3A) of the adaptor protein complex	2
AMPA-type glutamate receptor (AMPAR) trafficking	2
PPTg excitatory inputs	2
cue-elicited anticipatory approach responding	2
PPTg cholinergic or glutamatergic inputs	2
cue	2
food receptacle	2
cue presentation	2
PPTg-to-VTA cholinergic or glutamatergic inputs	2
VTA	2
PPTg excitatory and inhibitory inputs	2
PPTg-to-VTA phenotypically distinct inputs	2
PPTg-to-VTA inputs	2
pedunculopontine tegmental nucleus (PPTg)	2
distinct innervations	2
serine 115	2
MRN complex	2
 MRNIP	2
C5orf45 as MRNIP for MRN-interacting protein (MRNIP)	2
binding partner of the MRE11-RAD50-NBS1 (MRN) damage-sensing complex	2
human protein C5orf45	2
previously uncharacterized regulators	2
“memory-associated” genes	2
administration of vorinostat	2
Tcf4-deficient and WT mice	2
hippocampal mRNA and methylated DNA	2
CA1 area of the hippocampus	2
spatial and associative learning and memory	2
ultrasonic vocalization	2
Tcf4 haploinsufficient mice	2
transcription factor Tcf4	2
LUBAC-dependent signaling pathways	2
previously unrecognized factor	2
gene activation pathways	2
SPATA2 abolishes	2
NOD2-signaling complexes	2
TNFR1- and	2
constitutive direct binding partner of HOIP	2
catalytically active component of the linear ubiquitin chain assembly complex (LUBAC)	2
human malaria parasite, P. falciparum	2
different Plasmodium spp.	2
overactive AMPK	2
rodent malaria parasites	2
opposite	2
many intracellular pathogens	2
master regulator of energy homeostasis AMP-activated protein kinase	2
cancer and infection	2
Nrf2 agonists	2
intrinsic and extrinsic stress surveillance pathways	2
wild-type (WT) animals	2
il17d−/− mice	2
tumors and virally infected cells	2
Nrf2 induced IL-17D	2
cytokine IL-17D	2
transcription factor nuclear factor erythroid-derived 2-like 2 (Nrf2)	2
KLF15 overexpression	2
reduced Srebf1	2
coactivator SRC1	2
corepressor RIP140	2
Srebf1 promoter	2
LXR/RXR	2
key regulator of gluconeogenesis	2
fasting-induced transcription factor KLF15	2
Srebf1 expression	2
transcription factor SREBP-1c	2
nutritional environment	2
behaving animals	2
long-term memory task	2
right CA3	2
left CA3	2
CA3-CA1 synapses whose afferents	2
archaerhodopsin-expressing boutons	2
proton pump archaerhodopsin	2
synaptic transmission	2
Notch ligand and cell-cycle-inhibitor genes	2
Lgr5+ cells	2
subset of Lgr5+ cells	2
lineage-restricted genes	2
stem and mature absorptive and secretory cells	2
second, abundant population	2
two distinct cell populations	2
single Lgr5+ cells	2
selected stem- and lineage-specific transcripts	2
ISC compartment	2
absorptive and secretory lineages	2
intestinal bipotential progenitors	2
immediate progeny	2
SummaryLgr5+ intestinal stem cells (ISCs)	2
anti-apoptotic BCL2	2
BMF expression	2
conserved RELA-binding motif	2
rs539846-A risk allele	2
intron 3 of B cell lymphoma 2 (BCL2)-modifying factor (BMF)	2
highly associated variant	2
C>A	2
SNP rs539846	2
highly associated SNPs	2
adult B cell malignancy	2
lymphocytic leukemia (CLL)	2
EF-G and tRNA	2
Elongation factor G (EF-G)	2
cytoplasmic pool	2
anterior and posterior PAR proteins	2
parameter-free mathematical model	2
opposing domain	2
PAR-2 molecules	2
cortical PAR-2	2
spatially segregated PAR proteins	2
opposing cortical domains	2
PAR proteins	2
Escherichia coli and Mycobacterium smegmatis	2
in vivo assay	2
homologs of the IMP TatC	2
membrane proteins (IMPs)	2
ESC identity	2
cardiomyocyte-specific differentiation program	2
Erk5 signaling	2
BET bromodomain family proteins	2
Erk5 kinase	2
XMD compounds	2
naive and primed pluripotency	2
MCL1 inhibition	2
t(8:21)-containing cells	2
BET proteins	2
MCL1 protein	2
anti-apoptotic factor MCL1	2
KIT promoter	2
t(8;21) AML	2
stem cell factor receptor tyrosine kinase KIT	2
promoter-proximal paused RNA polymerases	2
1,400 genes	2
active RNA polymerases	2
SummaryBromodomain and extra-terminal domain (BET) family inhibitors	2
mutation classes	2
gene-to-intergenic rearrangements	2
sense-to-antisense gene fusions	2
estrogen receptor (ER)-negative tumors	2
intermixed stromal cells	2
RNA sequencing data	2
cytoplasmic signaling pathways	2
Slack channels	2
related potassium channels	2
wild-type Slack channels	2
protein phosphatase 1 (PP1) targeting protein, Phactr-1	2
Slack mutants	2
neurons or transfected cells	2
optical biosensor assay	2
protein kinase C.	2
Slack C-terminal residue	2
pharmacological activators	2
cytoplasmic C-terminal domain of Slack sodium-activated potassium (KNa) channels	2
key post-injury communication relay	2
glial InR-inhibited flies	2
severed axons	2
adult glia	2
conserved receptor	2
transcriptional target draper	2
InR/Akt1 activity	2
axonal debris	2
local ensheathing glia	2
downstream effector Akt1	2
insulin-like receptor (InR)	2
evolutionarily conserved insulin-like signaling (ILS) pathway	2
molecular underpinnings	2
damaged neurons	2
glial cells	2
presynaptic GABABRs	2
synaptically released glutamate	2
GABABR2 subunits	2
GABABR diffusion	2
NMDA receptors (NMDARs) using glutamate	2
alternatively spliced GABABR1a subunits	2
two distinct sushi domains	2
active presynaptic GABAB receptors (GABABRs) at nerve terminals	2
spatial organization of chromosomes	2
nuc1 null mutants	2
entire short arm of chromosome 4	2
active rRNA genes	2
mostly inactive protein-coding genes	2
sub-telomeric regions	2
nucleolar protein NUCLEOLIN 1 (NUC1)	2
nucleolus-associated chromatin domains (NADs)	2
molecular gatekeeper	2
young MICU1−/− mice	2
one allele of EMRE	2
EMRE expression	2
Older MICU1−/− mice	2
reduced ATP	2
viable MICU1−/− mice	2
afflicted patients	2
 MICU1	2
MICU1−/− mitochondria	2
MICU2, MCU, and EMRE	2
mitochondrial calcium uniporter	2
eIF3d-eIF3e module	2
metabolic mRNAs	2
fermentable carbon source	2
components of the mitochondrial electron transport chain	2
Schizosaccharomyces pombe cells	2
global transcriptomic, proteomic, and metabolomic profiling	2
multi-subunit eukaryotic translation initiation factor eIF3	2
AT2 receptor	2
inguinal adipose tissue	2
sRA mice	2
brain RAS (sRA mice	2
brain RAS	2
peripheral RAS	2
circulating and/or adipose RAS	2
brain renin-angiotensin system (RAS)	2
subsequent innate and adaptive immune responses	2
virus-specific cytotoxic T cells	2
IFN receptor	2
co-stimulatory markers	2
cGAS/STING cytosolic DNA-sensing pathway	2
SAMHD1-deficient cells and mice	2
restriction factor	2
medium nutrients	2
self-renewing hPSCs	2
oxidative pentose phosphate pathway	2
chemically defined media	2
hPSC bioenergetics	2
classical GPCR signaling pathways	2
D3 dopamine receptors (D3R)	2
β-arrestin-dependent signaling	2
neuromodulatory GPCRs	2
arrestin-dependent signaling	2
G protein	2
important signaling effectors	2
uncoupling receptor and G protein	2
alternatively spliced transcripts	2
spliced RNAs	2
additional RNA binding sites	2
EJC subunit	2
BTZ (MLN51 or CASC3)	2
alternative nonsense-mediated mRNA decay pathways	2
high-confidence EJC deposition sites	2
four RNA binding EJC components eIF4A3, BTZ, UPF3B, and RNPS1	2
bona fide EJC binding sites	2
spliced mRNAs	2
AT-rich common fragile sites	2
non-tumorigenic cells	2
colorectal and breast cancer patients	2
subunit of RNR	2
dUTP pyrophosphatase (dUTPase) and ribonucleotide reductase (RNR)	2
intracellular WNT and SHH signaling pathways	2
common signaling node	2
GLI2 and β-CATENIN	2
human GSCs	2
murine Ink4a/Arf-deficient astrocytes	2
CULLIN3 knockdown	2
target molecule of CULLIN3	2
CYCLIN E	2
CULLIN3 ubiquitin ligase	2
glioblastoma stem cells (GSCs)	2
differentiation 1 (ID1)	2
Adora2a, P2ry1, Gpr6, and Grik3 in the LGE and striatum	2
Sp9 promoter	2
Ascl1 directly	2
striatonigral neurons	2
striatopallidal MSN progenitors	2
Sp9-null mice	2
postmitotic striatopallidal MSNs	2
nearly all striatal MSNs	2
LGE progenitors	2
transcription factor Sp9	2
lateral ganglionic eminence (LGE)	2
striatonigral and striatopallidal neurons	2
SummaryStriatal medium-sized spiny neurons (MSNs)	2
ERK1/2 phosphorylates RAM serine-36	2
pluripotency-associated genes	2
cohort of neural-associated genes	2
pluripotency-associated factors	2
cohort of pluripotency-associated genes	2
mRNA cap methyltransferase activating subunit RAM	2
2-AG signaling	2
CB1 and presumably CB2 receptors	2
inner and middle molecular layers	2
excitatory input	2
cannabinoid CB1 receptor knockout mice	2
2-AG synthesizing enzyme, diacylglycerol lipase α	2
one of the two major endocannabinoids	2
2-arachidonoylglycerol (2-AG)	2
precise mechanisms	2
exhausted HBV-specific T cells	2
Interleukin (IL)-12	2
HBV-specific T cells	2
functional cytomegalovirus (CMV)-specific T cells	2
glucose supplies	2
HBV-specific T cells	2
intrahepatic environment	2
glucose transporter, Glut1	2
distinct ubiquitin linkages	2
single site in ubiquitin	2
particular linkage	2
distinct sites in ubiquitin	2
837 reactions	2
K48 chains	2
dual-specificity E3 ligase	2
phosphoubiquitins	2
serine 20, serine 57, and serine 65	2
multi-milligram quantities of ubiquitin	2
cellular barriers	2
IL-11 and IL-6:soluble IL-6R complexes	2
apical extracellular space	2
basolaterally supplied IL-11	2
basolateral side	2
gp130 complexes	2
IL-6R:	2
apical and basolateral sides of polarized cells	2
IL-11R1/2:gp130 complexes	2
IL-11R1 or IL-11R2, two IL-11α-receptor splice variants	2
small number of discrete cell types	2
discrete cell types	2
overexpress genes	2
two discrete subtypes of medium spiny neurons (MSNs)	2
numerous marker genes	2
neurons, astrocytes, oligodendrocytes, ependymal, immune, and vascular cells	2
differentiated, distinct cell types	2
mouse striatum	2
sarcomas	2
Ng2/Cspg4-expressing pericytes	2
stabilizing β-catenin	2
human sarcomas	2
Trp53 tumor suppressor gene	2
cells expressing Ng2/Cspg4	2
Trp53 tumor suppressor	2
cell expressing Ng2/Cspg4	2
 the pericyte	2
One cell type	2
established ligands	2
RET tyrosine kinase	2
cardiac GFRA2 signaling pathway	2
Gfra2 mutants	2
differentiating mouse and human pluripotent stem cells	2
GFRA2 expression	2
Glycosylphosphatidylinositol-anchor containing neurotrophic factor receptor, Glial cell line-derived neurotrophic factor receptor alpha 2 (Gfra2)	2
cardiac progenitors (CPs)	2
surface marker	2
human olfaction	2
mouse or human ORs	2
multiple transgenic lines	2
M71 MouSensor	2
known M71 ligands	2
“MouSensors	2
predicted homeodomain binding site sequence, TAATGA	2
21-bp sequence	2
specific cloned OR coding sequences	2
homotypic glomeruli	2
odorant receptor (OR)	2
main olfactory epithelium	2
olfactory sensory neurons (OSNs)	2
potential cell of origin	2
lymphoid-primed multipotent progenitor population	2
Mll-AF4	2
earliest definitive hematopoietic cells	2
conditional Mll-AF4-expressing mouse model	2
SummaryMLL-AF4+ infant B cell acute lymphoblastic leukemia	2
chemically induced astrocytes	2
astroglial progenitor cells	2
primary astrocytes	2
Induced mouse astrocytes	2
mammalian fibroblasts	2
different types of neural cells	2
endoderm differentiation gene sox17	2
prechordal plate progenitors	2
transcriptional repressor goosecoid (gsc)	2
organizer	2
photoactivatable Nodal receptor	2
cell-cycle-regulated ELG1 alleles	2
retained PCNA	2
elg1Δ cells	2
disassembly-prone PCNA mutants	2
elg1Δ yeast	2
PCNA on DNA	2
ring-shaped polymerase clamp PCNA from DNA	2
major subunit of a replication factor C-like complex, Elg1-RLC	2
genome maintenance factor Elg1	2
active Arf1	2
Arf1 GEFs	2
different effectors	2
plasticity	2
known Arl1-effector complexes	2
DCB domain-binding residues	2
Residues in the DCB domain	2
crystal structure of human Arl1	2
dimerization and cyclophilin binding (DCB) domain	2
Arf-like GTPase Arl1	2
BIG1 and BIG2	2
paralog, BIG2	2
related GEF BIG1	2
guanine nucleotide exchange factor (GEF	2
cis-Golgi	2
cis-	2
GTPase Arf1	2
free specks	2
speck-forming cells	2
peritonitis and group B streptococcus infection model	2
stromal population	2
primary cells and tissues	2
assembled inflammasome complexes (“specks”)	2
fluorescent adaptor protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC)	2
dearth of tools	2
activated inflammasome complex	2
metabolic-redox sensor	2
pluripotency transcription factor OCT4	2
hESCs generated cells	2
OCT4lo cell population	2
OCT4 cysteine residues	2
endogenous antioxidant glutathione (GSH)	2
hESC pluripotency	2
oncogenic EGFR-mediated lung cancers	2
Lung cancer samples	2
EGFR inhibitors	2
lung and glioblastoma tumor growth	2
tumor suppressor promoters	2
C/EBPα transcription factor	2
DNA demethylase TET oncogene family member 1 (TET1)	2
multiple unrelated tumor suppressors	2
oncogenic epidermal growth factor receptor (EGFR)	2
steroid hormone	2
feedback network	2
impaired protein phosphatase 1	2
sperm mutant gsp-4	2
ASJ neurons	2
temperature-sensing neurons (ASJ)	2
tissue network	2
various body tissues	2
aggregate surface	2
the isolation membrane	2
Ape1 aggregates	2
a 2:1 heterotrimer	2
propeptide trimer	2
dodecameric Ape1 bodies	2
trimeric coiled-coil structure	2
Ape1 propeptide	2
receptor Atg19	2
major selective cargo protein in budding yeast, aminopeptidase I (Ape1)	2
isolation membrane	2
lipidated Atg8	2
specific cargo	2
Cargo receptors	2
protein aggregates and organelles	2
various cargoes	2
T-bet- and NF-κB-mediated pathways	2
Brd4 binding	2
T-bet target genes	2
genes and enhancers	2
Th1 genes	2
form of the super elongation complex (SEC)	2
Mediator and P-TEFb	2
histone demethylation	2
epithelial gene promoters	2
exogenous MOF	2
EMT-inducing signals	2
MOF acetyltransferase	2
histone H3K4 methylation	2
epithelial but not mesenchymal cells	2
histone demethylase LSD1	2
synaptic ribbons	2
synaptic ribbon density	2
afferent neurons post-synaptic	2
synapses and calcium channels	2
smaller vesicles	2
Ghost ribbons	2
ghost ribbons	2
ribbon-like structures	2
Ribeye protein	2
two zebrafish genes	2
sensory systems	2
non-spiking cells	2
protein Ribeye	2
SummarySynaptic ribbons are structures	2
gene and condition-specific components	2
Antisense regulated genes	2
GFP tag	2
unidirectional transcriptional terminator	2
yeast genes	2
overlapping gene	2
several of such RNAs	2
unannotated transcripts (SUTs)	2
TMEM16F conditional knockout mice	2
phospholipid scramblase	2
Ca2+-dependent ion channel	2
Spinal microglia	2
two dispersed populations, Camk2a+ neurons and GFAP+ glia	2
noradrenergic neurons of the compact, bilateral locus coeruleus	2
three different genetically defined cell populations	2
cell body and dendrites	2
virtually any cell type	2
recombinase-responsive mouse lines	2
hM3Dq toolkit	2
mutated human Gq-coupled M3 muscarinic receptor (hM3Dq)	2
TNF necroptosis pathway	2
key necroptosis-signaling molecules	2
IFN	2
Tnf+/+ macrophages	2
soluble TNF antagonist	2
Tnf−/− macrophages	2
TNF	2
deubiquitinase cylindromatosis (CYLD)	2
IFN receptors	2
TLR4, TNF, and type	2
multiple receptors on macrophages	2
RIPK3/MLKL-dependent form	2
stop cells	2
lamprey model	2
brainstem neurons	2
suitable platform	2
GTLM cocktail	2
primitive erythroid progenitors in the yolk sac	2
murine iEPs	2
murine and human fibroblasts	2
Gata1, Tal1, Lmo2, and c-Myc (GTLM)	2
induced erythroid progenitors/precursors (iEPs)	2
minimal set of factors	2
group of well characterized genes	2
lineage-restricted transcriptional network	2
variable (including noisy) signals	2
core module	2
upstream MEK	2
phosphorylated MEK and ERK	2
cellular signaling systems	2
environmental stimulus	2
promising immunotherapeutic target	2
human STING	2
synthetic cyclic dinucleotide	2
host type I IFN signaling	2
two AML models	2
leukemia-specific T cells	2
STING agonist, DMXAA	2
leukemia-bearing animals	2
animals with disseminated acute myeloid leukemia (AML)	2
tumor DNA	2
interferon (IFN)	2
PD-specific phenotypes	2
elevated RBFOX1	2
disease phenotypes	2
midbrain dopaminergic neurons	2
patient-specific, induced pluripotent stem cells (iPSCs)	2
concordant downstream signaling pathways	2
various genetic backgrounds	2
DENR (OMIM:	2
unrelated human subjects	2
(p.C37Y and p.P121L)	2
postnatal projection neurons	2
binding partner Mcts1	2
murine cerebral cortical neurons	2
mRNA translation re-initiation factor DENR	2
plasma histidine	2
GPT in PH1 mice	2
glutamic-pyruvate transaminase (GPT, also known as the alanine-transaminase ALT)	2
histamine precursor histidine	2
AGT-deficient mice	2
PH1 patients	2
known biomarkers	2
alanine:glyoxylate aminotransferase (AGT) deficiency	2
Runx1 expression	2
recently specified endothelial progenitors	2
E8.5 intra-embryonic progenitors	2
emerging endothelial progenitors	2
ETV2::GFP reporter mouse	2
a specialized subset of endothelium	2
hematopoietic stem cells (HSCs) and progenitor cells	2
RNA-binding repertoire of IMP2	2
let-7 miRNA recognition elements (MREs)	2
insulin-like growth factor 2 mRNA-binding protein 2 (IMP2)	2
let-7	2
glioblastoma stem cells (GSCs) lack LIN28	2
 stemness	2
normal embryonic and some cancer stem cells	2
LIN28A/B	2
let-7 miRNA family	2
Vγ9Vδ2 TCR	2
Vγ9Vδ2 TCRs	2
ubiquitously expressed butyrophilin A1 (BTN3A1)	2
activating signals	2
dysregulated mevalonate pathway	2
phosphorylated intermediates	2
Vγ9Vδ2 T cells	2
analogue Basimglutant	2
APPswe/PS1ΔE9 and 3xTg-AD male mice	2
/PS1ΔE9 mice	2
Basimglurant (RO4917523)	2
orally bioavailable mGluR5-selective negative allosteric modulator CTEP	2
Aβ plaques	2
APPswe/PS1ΔE9 mouse model	2
cellular prion proteins	2
Aβ oligomers	2
metabotropic glutamate receptor 5 (mGluR5)	2
SummaryBeta-amyloid (Aβ) oligomers	2
prominent haploinsufficient tumor suppressor gene	2
HD-PTP/PTPN23	2
HD-PTP expression	2
unaltered remaining allele	2
Ptpn23+/−-derived tumors	2
tumor suppressor gene cluster 3p21.3)	2
PTPN23 gene	2
ESCRT protein (HD-PTP	2
KIR nanoclusters	2
larger KIR nanoclusters	2
kinase ZAP-70 or phosphatase SHP-1	2
KIR2DS1 and DAP12 nanoclusters	2
lysine in KIR2DS1	2
transmembrane amino acid 233	2
inhibitory counterpart KIR2DL1	2
Activating KIR2DS1	2
human primary natural killer cells and cell lines	2
paired killer Ig-like receptors (KIR), KIR2DL1 and KIR2DS1	2
nanoscale organization	2
cell surfaces and immune synapses	2
nanoscale clusters	2
immune cell receptors	2
exocyst subunit Exo70	2
invadopodia-related genes	2
cortactin foci	2
patients’ tumor biopsies	2
BRAFV600E-driven murine melanoma model	2
F-actin and cortactin foci	2
BRAFV600Emelanoma cells	2
melanoma patients	2
oncogenic BRAFV600Emutation	2
N1-Box blocks	2
Notch nuclear factor, CSL,	2
transgenic zebrafish	2
cultured human cells and zebrafish embryos	2
Notch1-specific destruction signal (N1-Box)	2
TNC cells	2
trunk NC (TNC) cells	2
chick and zebrafish embryos	2
homogeneous population	2
cranial NC (CNC) cells	2
(NC) cells	2
previously identified mitochondrial proteins	2
recently identified mitochondrial proteins	2
intracellular microenvironments	2
specialized facility	2
sub-compartmental location of a given protein of interest	2
procollagen export	2
small soluble cargoes	2
largely functional ERESs	2
individual ER-Golgi intermediate compartments (ERGICs)	2
tER elements	2
larger structures	2
TFG organizes transitional ER (tER) and ER exit sites (ERESs)	2
abundant protein	2
Tet enzymes	2
Tet1/2 double	2
2i (MAPK and GSK3β inhibitors)	2
sub-telomeres	2
Tet1/2/3 triple-knockout ESCs	2
Tet1 and Tet2 double-knockout ESCs	2
SummaryTen-eleven translocation (Tet) family proteins	2
Ccr4-Not imprinting complex	2
another subunit of the complex, Not5	2
central scaffold of the Ccr4-Not complex	2
mitochondrial integral membrane	2
MCU heterooligomeric complex	2
MCU and MCUR1	2
minimal, highly conserved regions of coiled-coil domain	2
MCU regulator 1 (MCUR1)	2
mouse cardiomyocytes and endothelial cells	2
MCU complex assembly	2
matrix Ca2+	2
Ca2+ Uniporter (	2
poorly studied, melanoma-associated serine/threonine kinase 19 (STK19)	2
Integrator, Cohesin, PHF3, ASC-1, SCAF4, SCAF8, and SCAF11	2
numerous proteins and complexes	2
searchable database, bioLOGIC	2
factors and pathways	2
tau misfolding	2
overexpressing TIA1	2
wild-type (WT) and tau knockout mice	2
TIA1 interactome	2
brain-protein interactome network	2
RNA-binding protein (RBP) TIA1	2
dendritic tau	2
microtubule associated protein tau	2
molecular cascades	2
in vitro EGFP-Col10a screening system	2
effective combination of transcriptional factors (TFs)	2
potential signal pathways	2
unsupervised model	2
217 single cells	2
several key regulators	2
sequentially differentiated cell layers	2
SummaryThe growth plate (GP)	2
proximal tubule cells	2
Na+/K+-ATPase	2
corresponding supercomplex formation	2
respiratory complex I	2
Mutated EHHADH	2
hydroxyacyl- and acylcarnitines	2
mitochondrial trifunctional protein (MTP)	2
mutated EHHADH	2
proximal tubule	2
electrolytes and low-molecular-weight nutrients	2
third codon of the peroxisomal protein EHHADH	2
E2F-dependent transcription	2
critical 4-Mb region of chromosome 21	2
aberrantly differentiated cells	2
mutated GATA1	2
engineered iPSCs	2
human induced pluripotent stem cells (iPSCs) and genome-editing technologies	2
cellular disease models	2
glucose transporter GLUT2	2
catabolize lactate	2
normoxic cells	2
export lactate	2
hypoxic cancer cells	2
metabolic symbiosis	2
Normoxic cancer cells	2
p-S6	2
lactate transporter MCT1	2
distal hypoxic cells	2
MCT4	2
glucose and lactate transporters GLUT1	2
remaining blood vessels	2
potent angiogenesis inhibitors	2
one such mouse model	2
certain human tumors and mouse models	2
VEGF inhibitors	2
glucagon-stimulated EGP	2
basal EGP	2
peri-ER membrane export pathway	2
developing spinal cord	2
MyoVa-Ca2+ channel interactions	2
cue side	2
freed vesicles	2
ER channels	2
micromolar Ca2+	2
inositol 1,4,5-trisphosphate and ryanodine receptors	2
two major ER Ca2	2
common binding site	2
Ca2+-dependent motor protein myosin Va (MyoVa)	2
Ca2+ sensor and effector	2
ER) Ca2+ channels	2
endoplasmic reticulum (	2
new membrane on the cue side	2
attractive cues	2
growth cones	2
epithelial and mesenchymal genes	2
neuroectoderm- and surface ectoderm-derivative cells	2
epithelial genes	2
CECs in neural progenitors	2
mesenchymal genes	2
neuroectoderm derivatives	2
CECs in fibroblasts	2
several other transcription factors	2
repressor of mesenchymal genes	2
derivative of the surface ectoderm	2
human corneal epithelium cells (CECs)	2
transcription factor OVOL2	2
neuroectoderm and surface ectoderm	2
embryonic ectoderm	2
CAF-derived, HGF-mediated c-Met/FRA1/HEY1 cascade	2
STAM NASH-HCC mouse model	2
direct downstream effector	2
 FRA1	2
CAF-derived HGF	2
presence of α-SMA(+) CAFs	2
cancer-associated fibroblasts (CAFs)	2
tumor-initiating cells (T-ICs)	2
melanoma metastases	2
matrix metalloproteinase 9 (MMP9)	2
SLNCR1, AR, and	2
’s conserved region	2
brain-specific homeobox protein 3a (Brn3a) and the androgen receptor (AR)	2
sensitive technique we term RATA (RNA-associated transcription factor array)	2
lncRNA SRA1	2
highly conserved sequence	2
lncRNA, SLNCR1	2
abundantly expressed lncRNA	2
many functional lncRNAs	2
non-coding RNAs (lncRNAs)	2
one isoform	2
precise blend of functionally distinct splice isoforms	2
axonal and dendritic compartments	2
neuron-specific (E6) alternative 3′-terminal exon	2
general (E7)	2
cell polarity gene Cdc42	2
alternatives in mammalian neurons	2
many 3′-terminal exons	2
protein repertoires	2
rat PVL model	2
selectively upregulated component	2
transplanted immature hiPSC-Astros	2
PVL mouse model	2
mature ones	2
immature astrocytes	2
human pluripotent stem cells (hiPSC-Astros)	2
oligodendrocyte progenitor cells (OPCs)	2
passive support cells	2
Passenger donor lymphocytes	2
B cell MHC class II	2
donor CD4 T cells	2
allo-specific B cells	2
cognate help	2
recipient cellular and humoral alloimmunity	2
passenger donor CD4 T cells	2
mouse cardiac transplant models	2
Donor-derived tissue-resident lymphocytes	2
solid organ allografts	2
antibody-coated target cells	2
NKG2C− and NKG2C+ adaptive NK cells	2
interferon (IFN)-γ promoter	2
NK cell populations	2
60 NKG2C−/− donors	2
(NKG2C−/−)	2
adaptive natural killer (NK) cells	2
cohesin and other SMC proteins	2
interior of the cohesin ring	2
DNA motor proteins	2
protein obstacles	2
nucleosome arrays	2
individual nucleosomes	2
prey’s DNA	2
sole T6SS	2
T6SS-dependent and T6SS-independent toxins	2
T6SS core machinery	2
second activator	2
TfoX homolog TfoY	2
regulator TfoX.	2
underlying regulatory network	2
SummaryType VI secretion systems (T6SSs)	2
PYY in vitro	2
diabetic rat islets	2
glucagon-like peptide-1 (GLP-1) receptor antagonist	2
gut hormone peptide tyrosine tyrosine (PYY)	2
humoral factor	2
RYGB animals	2
diabetic Goto-Kakizaki (GK) rat model	2
SummaryRoux-en-Y gastric bypass (RYGB)	2
migration-associated genes	2
indirect targets	2
direct miR-9 targets	2
indirect miR-9 targets	2
control NPCs	2
SZ NPCs	2
subset of SZ NPCs	2
control neural progenitor cells (NPCs)	2
microRNA-9 (miR-9)	2
Kif21b-null mice	2
KIF21B-deficient neurons	2
processive motor protein	2
neuronal and in vivo function	2
cellular assays	2
Kif21b knockout mice	2
kinesin KIF21B	2
inter-stereociliary links	2
shorter stereocilia	2
WHRN-L	2
WHRN-S	2
a subset of hair cells	2
WHRN-S expression	2
hair cell types	2
major long (WHRN-L) and short (WHRN-S) isoforms of WHRN	2
spontaneous and targeted Whrn mutants	2
stereocilia elongation	2
Usher syndrome type II	2
SummaryWHRN (DFNB31)	2
mouse embryonic fibroblasts (MEFs)	2
mammary epithelial cells (MECs)	2
KRAB-domain zinc finger protein Roma/Zfp157	2
previously unknown targets of ATM	2
cofactor ATMIN	2
DNA-damage-responsive kinase ATM	2
colorectal and other malignancies	2
TIL-rich tumors	2
components of the antigen-processing machinery	2
HLA genes	2
microsatellite-stable tumors	2
tumor-infiltrating lymphocytes (TILs)	2
recurrently mutated genes	2
incident colorectal cancers (CRCs)	2
EGFR-inhibitor-resistant cancers	2
EGFR-inhibitor-resistant lung cancer cells	2
EGFR mutant glioblastoma and lung cancers	2
PKM2 in EGFR mutant brain and lung cancers	2
PAR-binding capability	2
poly-ADP ribose	2
nuclear PKM2	2
EGFR mutant cancer cells	2
developing neural tube	2
developmental site	2
dorsally and ventrally derived OPs in culture	2
ventral counterparts	2
young adult spinal cord or corpus callosum	2
ventrally and dorsally derived OPs	2
dual-color reporter mice	2
embryonic CNS	2
ventricular germinal zones	2
distinct ventral and dorsal domains	2
progenitors (OPs)	2
licking motor output	2
whisker sensory stimulus	2
whisker stimulation	2
PV and VIP neurons	2
SST neurons	2
vasoactive intestinal peptide-expressing (VIP), and somatostatin-expressing (SST) neurons	2
Parvalbumin-expressing (PV),	2
layer 2/3 of the primary somatosensory barrel cortex	2
genetically defined GABAergic inhibitory neurons	2
reward spout	2
diversity of largely local inhibitory interneurons	2
select DNA-binding proteins	2
newly deposited nucleosomes	2
remodel nucleosomes	2
Isw1 and Chd1	2
Okazaki fragment synthesis	2
newly synthesized genomes	2
neurons of different origins	2
layer cells	2
receptors Robo2	2
two layers	2
repellent ligand Slit	2
developing medulla cortex	2
medulla primordium	2
Specific types of neurons	2
Drosophila visual center	2
arrangement of neurons of different origins	2
functional neural circuit	2
wide variety of neurons	2
two distinct MSN subpopulations	2
 IP3-evoked Ca2+ signals	2
A2A adenosine receptors	2
dopamine-insensitive MSNs	2
D1 dopamine receptors	2
IP3-induced Ca2	2
subpopulation of MSNs in the NAc core	2
Ca2+- releasing messenger inositol 1,4,5-triphosphate (IP3)	2
medium spiny projection neurons (MSNs) of the NAc	2
nucleus accumbens (NAc)	2
SNARE CTD and LD	2
SNARE disassembly	2
folded CTD	2
partially assembled trans-SNARE complex	2
SNARE N-terminal domain (NTD)	2
C-terminal domain (CTD)	2
linker domain (LD) of the SNARE complex	2
optical tweezers	2
synaptic SNARE complex	2
disassemble SNARE complexes	2
soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) receptors (SNAREs)	2
SPAT-1, the Bora ortholog	2
C. elegans embryos	2
three conserved phosphorylated residues	2
first 225 amino acids of Bora	2
Cyclin B	2
Plk1 activator	2
conserved Bora protein	2
actin filament growth	2
actin rings and axons	2
axons grew	2
retinal ganglion cells and dorsal root ganglia neurons	2
every neuron type	2
periodic subcortical actin cytoskeleton	2
spinal cord and optic and sciatic nerves	2
α-adducin knockout mice	2
actin rings	2
neuronal subcortical cytoskeleton	2
actin-binding protein adducin	2
a therapeutic target	2
NRF-2 repressor Kelch-like ECH-associated protein 1 (Keap1)	2
transcription factor nuclear factor erythroid 2-related factor (NRF-2)	2
glycogen synthase kinase-3 (GSK-3)	2
female and male Drosophila	2
human use	2
cell adhesion molecule Neurexin	2
Drosophila melanogaster and mice	2
postmitotic neurons	2
class I bHLH proteins	2
invertebrate and vertebrate neurobiology	2
class I/II bHLH transcription factors	2
 a broad number of tissues	2
Class I bHLH proteins	2
highly conserved transcription factors	2
class I/II basic-helix-loop-helix (bHLH) family	2
varied diet	2
dopamine-associated value signals	2
valued sucrose solution	2
reinforcers	2
Dopamine signals	2
one of these reinforcers	2
food and sucrose solution	2
nucleus accumbens core	2
Akt signaling	2
glucose induces thioredoxin-interacting protein (Txnip)	2
metabolic building blocks	2
dormant cells	2
glucose in the subretinal space	2
transplanting wild-type rods	2
cone-dependent high-resolution central vision	2
functional structures	2
mitochondrial-rich inner segments	2
cone visual pigment-rich outer segments (OSs)	2
glucose metabolites	2
pig model	2
rod photoreceptor genes	2
liver X receptor α (LXRα)	2
high-density lipoproteins	2
cholesterol uptake	2
lipoprotein remodeling	2
cholesterol transport proteins	2
hepatic ERα	2
ERα in the liver	2
hepatic estrogen receptor α (ERα)	2
MLL-induced leukemia	2
termination site	2
distinct ME3 group accumulated MLL-ENL	2
many homeobox genes	2
DOT1L-mediated histone methylation	2
ME5 genes	2
two distinct clades	2
165 direct target genes	2
chromatin and RNA Pol II	2
leukemogenic transcription factors	2
potential causal agents	2
ST69, ST73, ST95, ST127, ST131, and ST144	2
NEC-associated strains	2
preterm and 22 term infants	2
early intestinal microbiome	2
uropathogenic E. coli (UPEC) colonization	2
extremely preterm infants	2
 Par3	2
organogenesis downstream	2
remodeling ZA	2
apical determinant Par3/Bazooka	2
β-catenin (β-cat/Arm) phosphorylation	2
Cdc42 effector P21-activated kinase 4 (Pak4/Mbt)	2
a model neuroepithelial cell	2
circumferential belt of adherens junction (AJ) material	2
zonula adherens (ZA)	2
key target of oxytocin	2
adult Oxtr-null mice	2
absence of Oxtr	2
neuronal surface	2
chloride cotransporter KCC2	2
Oxtr-null mice	2
neuronal GABA neurotransmission	2
receptor (Oxtr)	2
labeled clones	2
perpendicular OCD	2
trabecular cardiomyocytes	2
inner, transmural, and mixed clones	2
four types of clones	2
labeled single cells	2
labeled cells	2
brainbow multicolor system	2
sheet-like structures	2
cardiac trabeculae	2
noncentromeric regions of chromosomes	2
monoubiquitin-fused CENP-A mutant	2
dimerization domain fusion mutants	2
dimerization mutants	2
CENP-A ubiquitylation	2
newly synthesized CENP-A	2
pre-existing ubiquitylated CENP-A	2
CUL4A-RBX1-COPS8 E3 ligase activity	2
variant CENP-A	2
de novo DNA methyltransferases	2
G9a/GLP complex	2
H3K9me2-depleted cells	2
G9a/GLP-dependent H3K9me2 mark	2
GLP	2
histone H3 lysine 9 methylases	2
marks	2
allele-specific histone modifications	2
ICRs	2
Ca2+-sensing machinery	2
synaptic proteins SNAP-25 and synaptotagmin 1/2	2
PRRT2-silenced neurons	2
docked synaptic vesicles	2
parasympathetic nervous system	2
preganglionic axons	2
parasympathetic innervation	2
leptin in embryos	2
embryonic life	2
Leptin-deficient mice	2
sympathetic and parasympathetic branches	2
cell-cell contact triggers	2
pri-let-7 maturation	2
pri-let-7 miRNAs	2
let-7 microRNAs (miRNAs)	2
paralogous Hippo pathway transcriptional co-activators and oncoproteins	2
YAP1 and TAZ	2
common leukemias	2
patients with acute leukemia (AML)	2
BRG1 recruitment	2
nucleosome remodeler BRG1	2
PML/RARA, nucleophosmin (NPM), and topoisomerase II beta (TOP2B)	2
wild-type PML/RARA expression	2
RA-resistant clone	2
retinoic acid (RA)-sensitive acute promyelocytic leukemia (APL) cell line	2
discrete therapeutic target	2
anxiolytic pathway	2
BLA dynorphin-expressing neurons	2
BLA-BNST input	2
BNST	2
glutamate inputs	2
amygdala neurons	2
BLA-BNST projections	2
bed nucleus of the stria terminalis (BNST)	2
basolateral amygdala (BLA) inputs	2
SummaryKappa opioid receptors (KORs)	2
associated deubiquitinases	2
Lys63-Ub and Met1-Ub	2
LUBAC components	2
catalytic LUBAC subunit HOIP	2
Met1-Ub-specific deubiquitinase OTULIN	2
linear ubiquitin assembly complex (LUBAC)	2
Met1-linked ubiquitin (Met1-Ub)	2
receptor-signaling complexes	2
non-degradative polyubiquitin	2
network of bNAb-targeted glycans	2
mosaic of dense clusters	2
soluble, recombinant trimer (BG505 SOSIP.664)	2
broadly neutralizing antibodies (bNAbs)	2
multiple under-processed structures	2
glycan-processing enzymes	2
glycans on the trimer surface	2
array of N-linked glycans	2
HIV-1 envelope glycoprotein trimer	2
vertebrate public TCRs	2
limited TCR repertoire	2
cross-reactive public TCRs	2
self and foreign antigens	2
zebrafish TCR repertoire	2
the zebrafish TCR repertoire	2
germline gene sequences (public clones	2
TCR clones	2
T cell receptor (TCR)	2
unrecognized intracellular PC sensor	2
phosphatidylcholine (PC)	2
NLRP3 inflammasome in macrophages	2
many adaptive downstream target genes	2
“metabolically activated” macrophages	2
CS patient brain tissue	2
7,8-dihydroxyflavone and amitriptyline	2
pharmacological mimics	2
neurotrophin	2
brain-derived neurotrophic factor (BDNF)	2
Synaptotagmin 9 (SYT9)	2
Cockayne syndrome B (CSB)	2
PHD3-dependent hydroxylation of MAPK6	2
MAPK6 (Erk3)	2
different nodes of signaling networks	2
hydroxylases	2
hundreds of potential substrates	2
asparagine hydroxylase FIH	2
proline hydroxylase PHD3	2
family of 2-oxoglutarate- (2OG) dependent enzymes	2
intra- and inter-molecular protein-protein interactions	2
acid hydroxylation	2
proteasome and CCT/TRiC	2
proteasome and CCT/TRiC chaperonin	2
substantial fraction of the proteome	2
quiescent fibroblasts	2
wild-type and autophagy-deficient cells	2
autophagy-deficient primary human fibroblasts	2
long-lived proteins and damaged organelles	2
lymphoma initiating pro-B cells	2
lymphoma initiating cells	2
one p53 allele	2
p53 target PUMA	2
lymphoma initiating pre-B cells	2
one Mcl-1 allele	2
pro-apoptotic BIM and PUMA	2
B lymphoid progenitors	2
emergency hematopoiesis	2
translational activators	2
processing bodies	2
mid-oogenesis	2
wild-type oocyte dorso-anterior corner	2
Orb in nurse cells	2
similar protein complement	2
Processing bodies in nurse cells	2
translational activator	2
sufficient Orb/CPEB	2
edge of processing bodies	2
future embryonic axes	2
gurken/TGF-α mRNA	2
Drosophila oocytes	2
Siglec-G-deficient mice	2
OxLDL-specific IgM	2
plasma and peritoneal cavity of Siglec-G-deficient mice	2
B-1 cell-derived natural IgM	2
Siglec-G in B cells	2
atherosclerosis-prone mice	2
myeloid cells and B-1 cells	2
several immune cells	2
sialic acid-binding immunoglobulin-like lectin G (Siglec-G)	2
metabolic byproducts	2
oxidized LDL (OxLDL)	2
major human pathogen	2
transcript isoforms	2
distinct sites	2
plasmodial promoters	2
highly AT-rich genome of P. falciparum	2
transcription start sites (TSSs)	2
comprehensive map	2
RCC disease subset	2
T cell infiltrates	2
hypoxia, metabolism, MAP kinase, NRF2-ARE, Hippo, immune checkpoint, and PI3K/AKT/mTOR)	2
chromatin modifier genes	2
clear cell, chromophobe, and papillary RCC	2
major genomic subtypes	2
various histologic types	2
renal cell carcinomas (RCCs)	2
RNA, and protein expression	2
mitotic inhibitors	2
SMAD4 mutant tumor cells	2
osteosarcoma cell lines	2
genetically or histologically defined subsets of tumor cell lines	2
many cancer driver genes	2
protein-protein interaction data	2
additional data sets	2
specific cancer driver genes	2
exome sequencing data	2
cancer-specific vulnerabilities and therapeutic targets	2
cartilaginous callus tissue formation	2
Col10a1 expression	2
Sox6 expression	2
Teads binding	2
effector of Hippo pathway	2
many organs	2
large HEAT repeat protein of cohesin	2
spine and C-terminal hook of Pds5	2
repeat fold	2
spine of the Pds5 HEAT	2
conserved Scc1 region	2
yeast L. thermotolerans	2
Wapl, Scc3, and Pds5	2
Smc1, Smc3, and kleisin (Scc1) subunits	2
two neighboring African groups	2
lipid and amino-acid-derived metabolites	2
predicted virulence, amino acid, and vitamin metabolism functions	2
hunter-gatherer gut	2
predictive carbohydrate and xenobiotic metabolic pathways	2
Bantu	2
US Americans	2
Bantu gut microbiome	2
Prevotellaceae, Treponema, and Clostridiaceae	2
hunter-gatherers	2
BaAka rainforest hunter-gatherers and their agriculturalist Bantu neighbors	2
gut bacterial communities	2
varying environments	2
Pds5-Scc1 interface	2
conserved surface patch	2
elongated HEAT repeat	2
complex between budding yeast Pds5	2
cohesin complex embraces chromosomes	2
centrosomes	2
force-transmitting device	2
one-cell C. elegans embryo	2
minus-end-directed motor dynein	2
two centrosomes	2
mammalian and fly brains	2
conserved family of CarT-like transporters	2
CarT cDNA	2
behavioral assays	2
carcinine in laminar glia	2
CarT gene	2
organic cation transporter, CarT (carcinine transporter)	2
photoreceptor	2
perisynaptic glia	2
photoreceptor-released histamine	2
first visual ganglion (lamina) of Drosophila	2
various transmitters	2
recycling pathways	2
 Pif1	2
ssDNA/dsDNA junction	2
bound ssDNA	2
tailed dsDNA and ADP-AlF4–	2
Domain 2B of BaPif1	2
ssDNA binding elements	2
short helix	2
Pif1 signature motif of BaPif1	2
α helix	2
SF1B DNA helicases	2
β hairpin	2
ADP-AlF4– and two different single-stranded DNAs (ssDNAs)	2
helicase domain of human Pif1 and Bacteroides sp Pif1 (BaPif1)	2
unwinding double-stranded DNAs (dsDNAs), DNA/RNA hybrids, and G quadruplex (G4) structures	2
conserved SF1B DNA helicase	2
iPSC-derived AD human neurons	2
presenilin-knockout fibroblasts	2
phospho-Tau	2
mTORC1 tethering	2
nuclear calcium	2
Sestrin2 expression	2
these cells	2
amino acid sensing of mechanistic target of rapamycin complex 1 (mTORC1)	2
auto-lysosomal system	2
poxvirus membrane	2
viral reticulon-like protein	2
aggregated three-dimensional (3D) tubular networks	2
viral structural proteins	2
purified A17 protein	2
latter cell proteins	2
cellular reticulon-like proteins	2
conserved viral transmembrane protein	2
lipoprotein membrane bilayer	2
crescents and spherical particles	2
first viral structures	2
enveloped DNA viruses	2
KEAP1 overexpression	2
lentiviral reporter system	2
parallel correlation-type motion detectors	2
BC-SAC circuit	2
SAC soma	2
SAC dendrites	2
sustained and transient On BC types	2
mouse retina	2
bipolar cells (BCs)	2
SACs	2
pair of cell types	2
types of starburst amacrine cells (SACs)	2
parallel On and Off pathways in the retina	2
end of the ∼45-nm-long coiled coil	2
the SMC head domains	2
various architectures	2
SMC dimers	2
highly flexible polymers	2
Smc2-Smc4 coiled coils	2
the S. cerevisiae condensin complex	2
Smc2-Smc4 dimers	2
SMC proteins	2
higher-order chromosome organization	2
chromosomes (SMC) protein complexes	2
physiological context	2
hepatic GCK expression	2
GCK promoter	2
heterogenous nuclear ribonucleoprotein L (hnRNPL)	2
lncLGR specifically	2
fasted mice	2
lncLGR knockdown	2
long non-coding RNA (lncRNA) named liver GCK repressor (lncLGR)	2
hepatic GCK	2
glucose-consuming to a gluconeogenic organ	2
hepatic glucokinase (GCK)	2
coincident CA3 and CA1 place cell spikes	2
CA3 and CA1 cells	2
CA3 and CA1 of rat dorsal hippocampus	2
reactivated spike trains	2
recently encoded information	2
individually or in combination	2
UBE2C, UBE2S, and UBE2D. Genetic deletion	2
three E2s	2
UBE2S.	2
two APC/C-interacting E2 ubiquitin-conjugating enzymes	2
tolerogenic/pro-inflammatory cells	2
differentiated DCs	2
steady-state and inflammatory DCs	2
Satb1 expression	2
protective immunity	2
tumor-associated DCs	2
tumor-promoting Galectin-1 and IL-6	2
ovarian tumors	2
Satb1 in activated Zbtb46+inflammatory DCs	2
 the H2-Ab1 promoter	2
Notch expression	2
Notch1 promoter	2
major histocompatibility complex class II (MHC II) expression	2
inflammatory DCs	2
conventional dendritic cells (DCs)	2
conditional knockout mouse	2
SummarySpecial AT-rich sequence-binding protein 1 (Satb1)	2
P. aeruginosa Exotoxin A	2
bZIP transcription factor ZIP-2	2
C. elegans ortholog of mammalian CCAAT-enhancer-binding protein gamma	2
surveillance or “effector-triggered” pathways	2
biosynthetic folate cycle	2
Nine mutants	2
1,000+ E. coli deletion mutants	2
C. elegans folate	2
C. elegans lifespan	2
E. coli folate synthesis	2
diet or microbiota	2
biosynthetic enzymes	2
coding and 5′ UTRs	2
upstream open reading frames	2
exponentially growing yeast	2
ten-residue window	2
emergent polypeptides	2
codons matching rare tRNAs	2
beginning of coding regions	2
major DNA damage response proteins	2
damage foci	2
recently discovered TET enzymes	2
DNA base	2
(5hmC)	2
Cdk1 system	2
Xenopus extracts	2
Xenopus cyclin B1-Cdk1-Cks2 with Wee1A in vitro	2
Cdk1-Cks and Cks-phosphosubstrate complexes	2
suprastoichiometric Cks	2
Cdk1-Cks-phosphosubstrate complexes	2
substoichiometric Cks	2
ternary Cdk1-Cks-phosphosubstrate complexes	2
primed Cdk1 substrates	2
Suc1/Cks proteins	2
control and Cpt2A−/− mice	2
interscapular BAT	2
Cpt2A−/− BAT	2
thermoneutral housing	2
thermogenic genes	2
Cpt2A−/− interscapular brown adipose tissue (BAT)	2
adipose bioenergetics	2
fatty acid oxidation (Cpt2A−/−)	2
continuously fluctuating environment	2
selected synapses	2
large heads	2
spines	2
inhibitory inputs	2
active spines	2
dendritic segments	2
somatic inhibitory inputs	2
dendritic trees	2
spine inputs	2
inhibitory postsynaptic currents	2
neuronal outputs	2
hierarchical Oct4 bindings	2
stem cell-specific enhancers	2
somatic cell-specific enhancers	2
Oct4 occupancy	2
bound and unbound	2
core pluripotency factor Oct4	2
specific interactors	2
chromatin-related proteins	2
nucleosome remodeling complexes	2
extensive manual annotation	2
epigenetic communication network	2
chromatin communication model	2
histone and cytosine modifications	2
untimely Fin1-kinetochore association	2
fin1Δ mutants	2
SAC protein Bub1	2
protein phosphatase PP1	2
kinetochore protein Fin1	2
Cdc14 early anaphase release (FEAR)	2
14-3-3 protein, Bmh1	2
bona fide Rag2GFP+ Treg precursors	2
recirculating CCR6+CCR7−Rag2pGFP− T cells	2
Treg precursors	2
intrathymic Treg pool	2
Rag2pGFPCcr7−/− mice	2
medullary epithelium	2
thymus medulla	2
Foxp3+ regulatory T cell (	2
H2A.Z.1K3R3 mESCs	2
de-repressed promoters	2
H2A.Z.1 chromatin	2
BET family member BRD2	2
tandem bromodomain proteins	2
murine ESCs (mESCs)	2
PRC1 target residues (H2A.Z.1K3R3)	2
H2A.Z.1 monoubiquitylation (H2A.Z.1ub)	2
active and poised, bivalent genes	2
variant H2A.Z	2
particular alloantigens	2
expanded population	2
class I allopeptide-specific CD4 T cell population	2
donor hematopoietic antigen-presenting cells	2
MHC class II alloantigen	2
direct-pathway CD4 T cell alloresponses	2
self-restricted allopeptide	2
converging promoters	2
underwound and potentially single-stranded DNA	2
yeast system	2
microtubule-associated protein	2
mutant flies	2
wdr62 mutants	2
active MTOC	2
Pericentrin-like protein (Plp)	2
active interphase microtubule-organizing center (MTOC)	2
fly neural stem cells (neuroblasts)	2
fly ortholog of WDR62	2
flies and vertebrates	2
Rictor KO memory T cells	2
mTORC2-deficient memory T cells	2
core component of mammalian target of rapamycin complex 2 (mTORC2)	2
short-lived effector cells (SLECs) and memory precursor cells (MPECs)	2
antigen-specific naive CD8 T cells	2
single molecule, L-selectin	2
virus-specific CD8+ T cells	2
 mucosal and visceral organs	2
vaccinia and influenza	2
two evolutionally distinct viruses	2
L-selectin on effector CD8+ T cells	2
activated T cells	2
effector CD8+ T cells	2
cytotoxic chemicals and cytokines	2
Serum-free culture	2
extracellular culture environment	2
highly variable gene clusters	2
operon gene organization	2
ordered protein complex assembly pathways	2
highly expressed proteins	2
structure-based assembly predictions	2
subunit-encoding genes	2
prokaryotic organisms	2
heteromeric protein complexes	2
key lineage regulators	2
lineage specific genes	2
highly coordinated transcriptional program	2
traditional lineage tree	2
mature cell	2
their developmental chronology computationally	2
population of hematopoietic cells in zebrafish	2
LRRC19, REGs, altered microbiotas	2
gut Lactobacillus	2
regenerating islet-derived (REG) protein-mediated microbiotas	2
chemokines	2
LRRC19-associated chemokines CCL6, CCL9, CXCL9, and CXCL10	2
gut tissues	2
gut immune receptor leucine-rich repeat (LRR) C19	2
healthy gut immune system	2
host cell receptors	2
organized matrix	2
bulkiness of PfEMP1	2
PfEMP1 binding pockets on IgM	2
bulky C terminus	2
arc-shaped backbone	2
flexible N terminus	2
C- shaped molecule	2
turtle	2
randomly oriented Fab2s units	2
dome-like core	2
human IgM, PfEMP1	2
cryo-molecular electron tomography structures	2
PfEMP1 in complex with non-immune immunoglobulin M (IgM)	2
dynein motor, Rab7a	2
enzymatically active kinesin-1 motor protein	2
microtubule bundles	2
Drosophila melanogaster S2 model cell system	2
vast network of factors	2
kinesin and dynein motor proteins	2
organelles, mRNA, and proteins (“cargo”)	2
maternal and embryonic transcripts	2
three mouse PKN isoforms	2
Rho family-responsive PKN kinases	2
diversely regulated subgroups	2
PKC) family	2
protein kinase C (	2
Cdkn1b)	2
poly-ubiquitin	2
Mekk1 signaling	2
liver, spleen, and bone marrow	2
iNKT cell populations	2
Map3k1)	2
epidermal stem cells	2
CD26 and CD44	2
immune cell infiltrate	2
LRIG1+	2
Oncogenic β-catenin expression	2
subpopulation of interfollicular epidermal cells	2
β-catenin activation	2
sebaceous gland	2
ectopic hair follicles	2
LRIG1+ stem cells	2
different stem cell populations	2
adult epidermis	2
native microenvironments	2
native pancreatic tissue	2
E-cadherin mobility	2
mammary, brain, liver, and kidney tissue	2
live tissue	2
tumor epithelia	2
-cadherin-mediated cell-cell junctions	2
tumor-derived signals	2
reactive stromal compartment	2
senescence-induced osteoclastogenesis	2
senescence-associated secretory phenotype factor, IL-6	2
local osteoclastogenesis	2
senescent osteoblasts	2
reactive senescent osteoblasts	2
tumor-derived factors	2
metastases	2
metastatic bone lesions	2
advanced breast cancer patients	2
microtubule-dependent mitochondrial mechanosensor microdomains	2
failing and colchicine-treated cells	2
mitochondrial proton gradient	2
Colchicine in healthy cells	2
calcium propagates	2
failing cardiomyocytes	2
human failing cardiomyocytes	2
healthy and heart failure cardiomyocytes	2
 the sarcolemma	2
nanopipette indent specific locations	2
cardiomyocytes from failing hearts	2
originators	2
progenitors in other organs and tissues	2
temporally distinct cardiac progenitors	2
different heart regions	2
Mesp1-expressing cardiac progenitors	2
myocardial layer of the heart	2
Mesp1-expressing cells	2
Mesp1 progenitors	2
distinct sources of cardiac progenitors	2
NIPBL mutant line	2
PKR inhibitor	2
NIPBL mutant lymphoblastoid cells	2
NIPBL-deficient lymphoblastoid cells	2
unmodified RNAs	2
RNA-sensing kinase PKR	2
deacetylase HDAC8	2
downstream interneurons	2
evolutionarily conserved CaMKI/IV and Raf pathway	2
single-cell memory	2
single thermosensory neuron	2
C. elegans neurons	2
primary culture system	2
MLL-rearranged leukemias	2
xenotransplant model	2
combination of ABT-199 and DOT1L inhibitors	2
t(4;11) cell line	2
DOT1L-mediated H3K79me2/3	2
BCL-2 family members	2
BCL-2 gene	2
MLL/AF4	2
BCL-2-specific BH3 mimetic ABT-199	2
t(4;11) patient cells	2
key target genes	2
MLL/AF4 fusion protein	2
aggressive cancers	2
specific molecular pathways	2
prion	2
[SWI+].	2
prion-like aggregates	2
asparagine-rich region of Mss11	2
Mss11, Sap30, and Msn1	2
multiple other proteins	2
yeast prion [SWI+]	2
yeast prion proteins	2
solitary NE cells	2
bifurcation area	2
developing lungs	2
small clusters called neuroepithelial bodies (NEBs)	2
airway tubes	2
NE cells	2
neuroendocrine (NE) cells	2
small GTPase RAB11	2
library of clinically used drug molecules	2
2-aminopurine fluorescence	2
permanganate probing	2
four-way junction	2
two products	2
GEN1 dimer interface	2
helical arms	2
extensive DNA binding interface	2
monomer of active GEN1	2
functional unit in the crystal	2
elaborated FEN-XPG family fold	2
GEN1 protein	2
one such context-specific target gene	2
TGF-β/SMAD3	2
BTIC-promoting and BTIC-suppressing contexts	2
distinct epigenomes of breast-tumor-initiating cells (BTICs)	2
tumor promoter or a tumor suppressor	2
transforming growth factor beta (TGF-β) signaling pathway	2
single-fiber chromosome combing	2
pharmacological inducer	2
hydroxyurea (HU)	2
RECQL5 depletion	2
JAK2V617F-expressing cells	2
DNA helicase RECQL5	2
patients with myeloproliferative neoplasms (MPNs)	2
common oncogenic lesion	2
newly replicated ori DNA	2
MukB-ParC interaction	2
steady-state DNA supercoiling	2
majority of active TopoIV molecules catalyzing decatenation	2
immobile molecules	2
replication origin region (ori)	2
∼15 TopoIV molecules per cell	2
individual TopoIV molecules	2
SMC (structural maintenance of chromosomes) complex	2
type II topoisomerase TopoIV	2
depolarizing mitochondria	2
pro-degenerative protein SARM1	2
intra-axonal Ca2+	2
substrate, NMN	2
NAD-biosynthetic enzyme NMNAT2	2
multiple additional Mmi1 targets	2
RNA helicase DDX5/Dbp2	2
unspliced precursor	2
exosome specificity factor Mmi1	2
“decay-promoting” introns	2
Sequence elements	2
specific intron-containing transcripts	2
natural populations and species	2
blood of human, cow, and carp	2
annotated genomes	2
samples or groups of individuals (http://RefFreeDMA.computational-epigenetics.org)	2
RRBS reads	2
ad hoc genomes	2
RefFreeDMA software	2
nine species (human, mouse, rat, cow, dog, chicken, carp, sea bass, and zebrafish)	2
reduced representation bisulfite sequencing (RRBS)	2
stress fibers	2
Myo1b knockdown	2
Myo9b knockdown	2
lamella	2
circumferential non-muscle myosin 2A-associated actin filament arrays	2
Myo18a knockdown	2
Myo10 knockdown	2
prostate cancer cell lines	2
recently determined cryoEM-derived hexagonal lattice	2
in situ and in vitro	2
extensive interaction network	2
zinc finger motif in pUL31	2
pseudorabies virus NEC	2
tight-fitting membrane vesicles	2
heterodimeric nuclear egress complex (NEC)	2
conserved herpesvirus proteins pUL31 and pUL34	2
herpesvirus capsids	2
Elovl6 KO mice	2
beige fat	2
mitochondrial electron transport chain components	2
C18 species	2
C16 non-essential fatty acids	2
Long Chain fatty acids 6 (Elovl6)	2
many transcriptional pathways	2
different APOBEC3 enzymes	2
wobble model	2
APOBEC3F E289 and HIV-1 Vif R15	2
interface contacts	2
microsecond molecular dynamic simulations	2
robust structural model	2
APOBEC3F-Vif interface	2
APOBEC3 and Vif biology	2
polyubiquitin ligase complex	2
cellular CBF-β	2
HIV-1 Vif protein	2
family DNA cytosine deaminases	2
macrophage parts	2
systemic amyloid deposits	2
large complement-coated targets	2
activated CR3	2
excess plasma membrane	2
extensive membrane ruffles	2
adhesion integrin	2
complement receptor 4 (CR4)	2
unfused M2 macrophage precursors	2
large and complement-opsonized materials	2
IL-4-induced MGCs	2
systematic in vitro analysis	2
giant cells (MGCs)	2
olivocerebellar module	2
two independent transgenic mouse mutants	2
awake behaving mice	2
awake behaving animals	2
actin-severing proteins ADF	2
regulated actin filaments	2
LINC complex	2
nuclear lamina	2
enlarged focal adhesions	2
hyperproliferation of differentiated cells	2
actin-severing proteins ADF and CFL1	2
insulin-induced, class I PI3K-dependent Akt signaling	2
early APPL1-positive endosomal compartment	2
primary hepatocyte model	2
 class II PI3K-C2β kinase-dead mice	2
class II PI3Ks	2
phosphoinositide 3-kinases (PI3Ks),	2
cortical microcircuits	2
specific tactile stimuli	2
axons in the somatosensory cortex	2
somata, dendrites	2
single dendrites and axons in layer 1	2
hundreds of neurons three-dimensionally distributed in layers 2 and 3	2
tetracycline-inducible expression system	2
cortical neurons of the adult common marmoset (Callithrix jacchus), a small New World primate	2
adeno-associated virus vectors	2
GECI	2
genetically encoded calcium indicators (GECIs)	2
liver hepatocytes	2
key angiocrine factor	2
pericentral markers	2
close family member of Rspo3	2
β-catenin-dependent zonation	2
central fate	2
endothelial compartment of the central vein	2
signaling molecule Rspondin3	2
central veins	2
Metabolic zonation	2
different metabolic pathways	2
mitochondrial acetyl-CoA synthetase (ACSS1)	2
emerging substrate	2
mitochondrial acetate	2
GEM	2
functional genome-scale metabolic model (GEM)	2
adjacent noncancerous liver samples	2
HCC tumors	2
apoptotic machinery	2
rapid inducers	2
Raptinal in whole organisms	2
mitochondrial complex I, III, and IV function	2
mitochondrial membrane potential/coupled respiration	2
mitochondrial voltage-dependent anion channel function	2
mechanistically diverse panel of apoptotic stimuli	2
named Raptinal	2
several antimicrobial peptides	2
inflammasome-defective mice	2
E. coli burden	2
Aim2−/− mouse colons	2
Aim2−/− mouse microbiota	2
commensal Escherichia coli	2
cytosolic DNA sensor AIM2	2
diverse pattern recognition receptors	2
pattern molecules	2
persistent herpesviruses	2
CD8+ T cell memory	2
adenovirus vaccine	2
conserved networks	2
homing receptors and anti-apoptotic pathways	2
persistent pathogens, murine and human cytomegalovirus (CMV)	2
adenovector encoding a model antigen (beta-galactosidase)	2
divergent CD8+ T cell memory pools	2
substantial CD8+ T cell populations	2
adenoviral vectors	2
long-term memory pools	2
antigen-specific CD8+	2
chromosome interaction domains (CIDs)	2
divergent, promoter-proximal noncoding RNAs (ncRNAs)	2
nuclear RNA exosome	2
many protein-coding and noncoding loci	2
lysine 56-acetylated histone H3 (H3-K56Ac)	2
nucleosomes flanking promoters of protein-coding genes	2
histone variant H2A.Z	2
mammalian IDO1	2
Lactobacillus-containing probiotic	2
early HIV-infected humans	2
gut-resident Lactobacillus	2
SIV-infected rhesus macaque	2
2,3-dioxygenase 1 (IDO 1)	2
immunomodulatory enzyme	2
HIV/simian immunodeficiency virus (SIV) immunopathogenesis	2
mucosal barrier-promoting Th17 cells	2
Sec machinery	2
SecYEG structures	2
cytoplasmic side of SecY and signal peptides	2
previously unknown peptide-bound crystal structure of SecYEG	2
cytoplasmic loop	2
hourglass-shaped channel	2
cytoplasmic loop of SecG	2
peptide-bound SecYEG	2
intact SecYEG	2
conserved protein-conducting channel	2
bacterial SecYEG translocon	2
phosphomimic MCM2 mutant	2
serine 41 (S41)	2
PTEN dephosphorylates MCM2	2
minichromosome maintenance complex component 2 (MCM2)	2
nuclear PTEN	2
PI3K)-AKT cascade	2
phosphatidylinositol 3-kinase (	2
MSN subpopulations	2
striatal pathways	2
eCB-, adenosine-, and ERK signaling	2
ERK cascade	2
striatonigral cells	2
endocannabinoid (eCB)-dependent LTD	2
striatopallidal synapses	2
small-conductance Ca2+-activated K+ channels (SKs) of the dorsolateral striatum	2
cell-type-specific forms of corticostriatal long-term synaptic depression (LTD)	2
two pathways	2
striatonigral and striatopallidal pathways	2
medium spiny neurons (MSNs)	2
lamin A	2
PARP1 mono-ADP ribosylation	2
CtIP deacetylation	2
Lamin A promotes SIRT6-dependent DNA-PKcs (DNA-PK catalytic subunit)	2
endogenous activator of SIRT6	2
lamin A and SIRT6	2
Hutchinson-Gilford progeria syndrome (HGPS)	2
truncated prelamin A termed progerin	2
LMNA gene	2
mechanical support	2
nuclear lamins	2
mouse and man	2
wound monolayer	2
actomyosin stress fibers	2
desmosomal) junctions	2
molecular components of adherens and tight (	2
first 70 or so rows of epidermal cells	2
receptor EphB2	2
ephrin-B1	2
lead-edge cells	2
scab and healthy granulation tissue	2
cut epidermal-edge cells	2
skin wound	2
proteomic resource	2
PAF1 complex component, parafibromin (CDC73)	2
C18orf25 and the SMC5/6 and PAF1 complexes	2
virus-induced SUMO targets	2
nuclear-replicating RNA pathogen, influenza virus	2
spatial-temporal determinants	2
subventricular zone	2
basal divisions	2
parvalbumin-expressing interneurons	2
Somatostatin-expressing interneurons	2
subcortical telencephalon	2
major subgroups of cortical interneurons	2
fate-restricted domain	2
lateral ventricles	2
spatial and temporal domains	2
neuronal subtypes	2
mammalian telencephalon	2
antigen-induced transcription factor	2
“unhelped” CD8 T cells	2
helper-derived IL-21	2
CD4 help	2
 voltage-gated sodium channels	2
calcineurin-dependent manner	2
dentate granule cells	2
rs12291063 CC genotype	2
heterogeneous nuclear ribonucleoprotein D0B	2
transcriptional regulator	2
major T allele	2
adult and pediatric cohorts	2
minor C allele of rs12291063	2
BDNF SNPs	2
BDNF locus	2
SummaryBrain-derived neurotrophic factor (BDNF)	2
spinal-intrinsic serotonergic interneurons	2
proliferating pMN-like progenitors	2
new motor neurons	2
descending axons	2
5-HT1A receptors	2
pMN progenitor cells	2
diffuse serotonin	2
zebrafish regenerate spinal motor neurons	2
salient stimuli	2
dopamine in the SC	2
SC slices	2
zona incerta	2
A13, a small dopamine cell group	2
intermediate multimodal/motor SC	2
D2 receptors	2
superficial visual SC	2
D1 receptors	2
dopamine-related genes in the SC	2
dopaminergic system	2
retinorecipient midbrain structure	2
superior colliculus (SC)	2
neural responses	2
CENP-A histone complex	2
right-handed DNA loop	2
distal CDEII segment	2
CBF3 complex	2
 +0.6 units	2
centromere determining elements (CDEI, CDEII, and CDEIII)	2
yeast point centromere	2
centromeric histone H3 variant CENP-A.	2
histone octasomes	2
A-to-I	2
small hairpin RNA lentivirus transduction	2
logistic model	2
editing enzyme ADAR	2
normal and cancerous breast tissues	2
intact Wnt signaling	2
PDGF signaling	2
diminished TCF7L2	2
LDLR knockout background	2
Wnt-signaling coreceptor LRP6	2
MYBPC3 in control hPSC-CMs	2
gene encoding myosin-binding protein C	2
hPSC-CMs	2
electrophysiology, bioenergetics	2
glucocorticoid analog dexamethasone	2
thyroid hormone, IGF-1	2
simple screen	2
human induced pluripotent stem cell (hiPSC) model of hypertrophic cardiomyopathy (HCM)	2
human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs)	2
activated integrin α5β1	2
ESCRT-0/I, containing histidine domain-containing protein tyrosine phosphatase (HD-PTP) and ubiquitin-associated protein 1 (UBAP1)	2
α5β1 integrins	2
USP9x	2
integrin α5β1 in vitro	2
endocytosed integrins	2
JMML cells	2
hiPSC-derived myeloid cells	2
NS/JMML hiPSCs	2
JMML bone marrow mononuclear cells	2
hiPSC-derived NS/JMML myeloid cells	2
subset of therapy refractory cells	2
differentiated cancer cells	2
cancer stem cells (colon-CSCs)	2
neonatal Fc-receptor	2
highly sialylated IgG glycovariants	2
Fc-fragment-dependent manner	2
Human mononuclear phagocytes	2
human donor immune system	2
human IgG subclass	2
IVIg preparations	2
IgG) antibodies	2
SummaryImmunoglobulin G (	2
Neuroligin-4-dependent GABAergic synapses	2
hippocampal CA3 region	2
model brain region	2
Neuroligin-4 knockout mice	2
synaptic adhesion protein Neuroligin-4	2
sda mutant phenotypes	2
mature DE-cadherin	2
intact aminopeptidase domain	2
Recombinant Sda	2
germline stem cells (GSCs)	2
Drosophila testicular niche	2
aminopeptidase Slamdance (Sda)	2
nucleolar cap regions	2
nucleolar architecture	2
rDNA	2
transcriptionally active genomic regions	2
key gene-regulatory factors	2
MNase footprints	2
H2A.Z-containing nucleosomes	2
sites of histone H2A.Z localization	2
several regulatory proteins	2
small MNase footprints	2
two chromatin-remodeling complexes	2
micrococcal nuclease (MNase) footprinting	2
chromatin architecture	2
gene regulatory factors	2
ER+ breast cancer	2
non-homologous end-joining (NHEJ) pathways	2
ER binding regions	2
APOBEC3B (A3B)	2
key transcriptional driver	2
SummaryEstrogen receptor α (ERα)	2
common pool of targets	2
overlapping sites	2
two factors	2
binding motif	2
Popdc2 gene	2
cardiac outflow tract	2
anterior heart field	2
adult heart	2
homeobox transcription factors NKX2-5	2
organized and diffuse intestinal tissues	2
B cell immunometabolism	2
oral antigens	2
dietary vitamin B1	2
iLP	2
vitamin B1	2
intestinal lamina propria (iLP)	2
Peyer’s patches (PPs) and IgA+ PCs	2
Naive B cells	2
IgA+ plasma cells (PCs)	2
TBP and DNA promoters	2
large polyQ repeat	2
neuronal and muscle-specific transcription factors	2
Different polyQ repeats	2
different polyQ repeats in mouse muscle	2
TATA-box-binding protein (TBP)	2
large polyQ (105 glutamines)	2
knockin mouse models	2
expanded polyQ repeats	2
adult-onset patients	2
juvenile cases	2
HIV-2 and SIVs	2
HIV-1 primary isolates	2
Env mutants	2
HIV-1 in IFITM-expressing T lymphocytes	2
HIV-1 virions	2
viral producer cells	2
HIV-1 envelope glycoprotein (Env)	2
HIV-1 and other viruses	2
interferon-induced transmembrane (IFITM) proteins	2
specific niches	2
cell contact trigger	2
T6SS machinery	2
different subassemblies of the machinery	2
opportunist pathogen Serratia marcescens and functional fluorescent fusions of key components of the T6SS	2
attacking neighbor cell	2
toxic proteins	2
bacterial nanomachine	2
SummaryThe Type VI secretion system (T6SS)	2
 JAG1-NOTCH4	2
PDX tumors	2
anti-estrogens	2
2 ER+ patient cohorts	2
/HEY gene signature	2
NOTCH4/HES	2
xenograft (PDX) tumors	2
patient-derived samples	2
anti-estrogens tamoxifen	2
estrogen receptors (ERs)	2
cancers (BCs)	2
ErbB4 signaling	2
endothelial coculture	2
combination of miRNAs	2
A luciferase assay	2
m/hESC-CMs	2
microRNAs, miR-125b-5p, miR-199a-5p, miR-221, and miR-222 (miR-combo)	2
several microRNAs	2
coculturing m/hESC-CMs	2
murine and human embryonic-stem-cell-derived cardiomyocytes (m/hESC-CMs)	2
-cell-derived cardiomyocytes	2
Th17 stem-cell-like population	2
IL-2 in DCs	2
NFAT signaling	2
lung CD103+ dendritic cells (DCs)	2
spontaneously firing Purkinje cells	2
T-type voltage-gated Ca2+ current	2
local, activity-dependent calcium	2
calcium-activated potassium channels (IK, KCa3.1)	2
constantly available pool of nodal sodium channels	2
targets in the cerebellar nuclei	2
Cerebellar Purkinje cells	2
myelinated axons in the brain	2
various potassium channel types	2
myelinated axons	2
Gr1low cells	2
triglyceride-rich environment	2
pertussis-toxin-sensitive receptor axis	2
plasma CCL4	2
CD68+ macrophages	2
endothelial interface	2
Gr1low monocytes	2
bone marrow progenitors	2
non-classical Ly6C/Gr1low monocytes	2
poloxamer 407	2
heterogeneous effector cells	2
player	2
neutrophil degranulation	2
 autophagy-deficient neutrophils	2
experimental autoimmune encephalomyelitis	2
several neutrophil-mediated inflammatory and autoimmune disease models	2
 myeloid-specific autophagy-deficient mice	2
round cells	2
ROCK2 kinase	2
lysophosphatidic acid (LPA)	2
neural processes	2
PAK1 and CDK5 kinases	2
KIF2A. Brain-derived neurotrophic factor (BDNF)	2
MT destabilizer KIF2A	2
molecular mechanisms and signaling networks	2
Microtubules (MTs)	2
labile domains of MTs	2
fly ortholog)	2
unacetylated tubulin	2
a longer axon	2
minor processes	2
cultured rodent neurons	2
control animal	2
fidgetin knockout mouse	2
their axons	2
acetylated (stable) MT mass	2
MT in the stable domain	2
Traditional MT-severing proteins	2
labile domain	2
stable domain	2
conserved 5′-3′ cytoplasmic exoribonuclease	2
hundreds of mimRNAs	2
RNA duplexes	2
messenger-interacting mRNAs (mimRNAs)	2
complementary tails of 3′-overlapping mRNAs	2
3′-overlapping messengers	2
double-stranded RNA-dependent nuclear phenomena	2
3′-complementary mRNAs	2
many 3′-overlapping mRNAs	2
humans with immunodeficiencies	2
human lymphopoiesis	2
CRISPR/Cas9 off-target modifications	2
broad T cell receptor (TCR) repertoire	2
mature T cell populations	2
JAK3-deficient cells	2
T cell in vitro differentiation system	2
SCID patient-specific induced pluripotent stem cells (iPSCs)	2
poorly functioning B cells (T–B+NK–)	2
circulating T cells and natural killer (NK) cells	2
Janus family kinase JAK3 gene	2
BMP target gene	2
α-integrin subunit	2
β-integrin cytoplasmic tail	2
conserved NPXY motifs	2
downstream Mad transcription factor	2
BMP receptor	2
ECM protein collagen IV	2
ECM receptors	2
cell’s local ECM environment	2
3D tissue	2
Gammaproteobacteria	2
subcortical visual circuitry	2
relay cell	2
numerous RGCs cluster	2
brainbow AAVs	2
numerous retinal terminals	2
relay cells	2
∼20 RGCs	2
dorsal lateral geniculate nucleus	2
retinal ganglion cells (RGCs) and relay cells	2
retinogeniculate synapses	2
kind of sheltered folding environment	2
vestibule of the ribosome exit tunnel	2
small zinc-finger domain protein	2
cryoelectron microscopy	2
single translating ribosomes	2
collapsed or partially structured folding intermediates	2
exit tunnel	2
ribosome exit tunnel	2
Miwi2-null cells	2
Mili-null cells	2
several LTR retrotransposons	2
long terminal repeat (LTR) retrotransposons	2
younger LINEs	2
long interspersed nuclear elements (LINEs)	2
retrotransposons in mouse male germ cells	2
stereocilia MET channel complex	2
tips of the tallest stereocilia	2
TMCs	2
immature stereocilia	2
Tmc1Δ/Δ;Tmc2Δ/Δmice	2
mice expressing TMC1-mCherry and TMC2-AcGFP	2
TMC proteins	2
MET complex	2
Transmembrane channel-like 1 and 2 (TMC1 and TMC2)	2
inner ear sensory hair cells	2
multinucleate senescent cells	2
activated Ras coordinately	2
key senescence effectors p21 and p16	2
damaged mitoses	2
mitotic genes	2
primary human fibroblasts	2
multinucleate OIS cells	2
additional signaling lipids	2
 phosphoinositides	2
common phosphoinositide-binding target	2
91 pleckstrin homology (PH) domains	2
signaling hubs	2
phosphoinositides	2
docking sites	2
distinctive lipids	2
imprinted locus	2
the intergenic differentially methylated regions (IG-DMRs)	2
entire locus	2
Gtl2-Rian-Mirg locus	2
maternal microRNAs (miRNAs) and long non-coding RNAs (lncRNAs)	2
re-acidifies lysosomes	2
acidic nanoparticles	2
PS1KO cells	2
either PS1 or the V0a1 subunit of vATPase	2
PS1KO) cells	2
Presenilin 1 knockout (	2
vATPase V0a1 subunit	2
Tcl1-PnPase pathway	2
PnPase overexpression	2
mitochondrial polynucleotide phosphorylase (PnPase)	2
pluripotency biomarkers	2
oocyte-enriched factors Tcl1 and Tcl1b1	2
embryonic spinal cord	2
essential dependence receptor ligand	2
dependence receptors	2
netrin receptors DCC and neogenin	2
Netrin-1−/− embryos	2
netrin-1 gene-trap mice	2
Netrin-1−/− mice	2
netrin-1 floxed and netrin-1 null mouse lines	2
wild-type netrin-1 protein	2
netrin-1-β-galactosidase protein chimera	2
previously studied netrin-1 loss-of-function gene-trap mice	2
netrin-1 loss-of-function mice	2
dependence ligand	2
nervous system, vasculature, lung, pancreas, muscle, and mammary gland	2
tet genes	2
tet2/3 double mutant larvae	2
downstream gata2b/scl/runx1 transcriptional network	2
hematopoietic stem cell (HSC) emergence	2
Tet2 and Tet3	2
major 5-methylcytosine dioxygenases in the zebrafish embryo	2
single-, double-, and triple-mutant genotypes	2
zebrafish orthologs of Tet1, Tet2, and Tet3	2
among Tet enzymes	2
Tet family members	2
Tet1, Tet2, and Tet3)	2
Tet family of methylcytosine dioxygenases (	2
intrinsically labile sites	2
genomic TF landscapes	2
small fraction of sites	2
unoccupied, methylated CTCF recognition sequences	2
abundant TF	2
transcription factor (TF) occupancy sites	2
maternal serotonin-based signal	2
serotonergic system	2
seasons	2
seasonal climate	2
snail	2
freshwater pond snail (Lymnaea stagnalis)	2
non-genetic information	2
changing environment	2
Developing embryos	2
constantly changing environments	2
different combinations of Erk1 and Erk2 alleles	2
mouse placenta and embryo	2
ERK1/2 MAP-kinase signaling pathway	2
effector kinases	2
mechanically stable target proteins	2
multiple mutant pore-1 loops translocate substrates	2
six pore-1 loops	2
pore-1-loop variants	2
translocating protein substrates	2
pore-1 loops	2
axial channels of ClpX and related hexameric AAA+ protein-remodeling rings	2
many members of the TRIM family	2
TRIM protein	2
retroviral capsid	2
higher-order oligomerization of TRIM5α	2
TRIM5α RING domain	2
Ubc13-Ub conjugate	2
TRIM5α:Ubc13-Ub interactions	2
K63-linkage-specific E2	2
TRIM5α retroviral restriction factor	2
lysine 63 (K63)	2
tripartite motif (TRIM) protein family of RING E3 ubiquitin (Ub)	2
certain mollusk shells	2
pigmentation	2
normal tadpoles	2
post-fertilization calcium wave	2
Xenopus laevis cell cycle oscillator	2
deterministic biochemical oscillator	2
FLT3-ITD AML	2
MAPK signaling pathways	2
common, FLT3-ITD-specific gene expression and chromatin signature	2
MAP kinase (MAPK) inducible transcription factor AP-1 and RUNX1	2
FLT3 transmembrane domain (FLT3-ITD)	2
patients suffering from AML	2
signaling genes	2
leukemic growth	2
mutated growth factor receptors	2
epigenetic regulatory machinery and signaling molecules	2
limb precursors	2
cells of the embryo flank	2
RA-, β-catenin/TCF/LEF-, and FGF-signaling pathways	2
Tbx genes	2
RA signaling	2
Tbx4 expression	2
Tbx5 expression	2
Hox gene inputs	2
retinoic acid (RA)- and β-catenin-signaling pathways	2
general PCNA unloader	2
PCNA unloading	2
Chlorella virus DNA ligase	2
Okazaki fragment ligase Cdc9	2
chromosomes in the wake of replication forks	2
S. cerevisiae Elg1 replication factor C-like complex (Elg1-RLC)	2
oncogenic derivative chromosomes	2
five human cancers	2
evolving diploid- and tetraploid-derived populations	2
aneuploid fitness landscape	2
oncogenes and tumor suppressor genes	2
experimentally inspired stochastic model	2
human neoplasms	2
mesolimbic DA signaling	2
NTS neurons	2
nucleus accumbens (NAc) medial shell	2
dopamine (DA) neurons within the VTA	2
GLP-1 receptors	2
high-fat food intake	2
midbrain ventral tegmental area (VTA)	2
chemogenetic tools	2
endogenous GLP-1	2
nucleus tractus solitarius (NTS)	2
small population of brainstem cells	2
Central GLP-1	2
appetite suppressants	2
SummaryGlucagon-like peptide-1 (GLP-1) and its analogs	2
mixed ubiquitin chains	2
homotypic lysine-11 linkages	2
heterotypic lysine-11-linked chains	2
cell-cycle regulator cyclin B1	2
lysine-11 and lysine-48 linkages	2
heterotypic polyubiquitin chains	2
mammalian proteasome	2
pure homotypic lysine-11-linked chains	2
lysine-11 polyubiquitination	2
atypical ubiquitin chains	2
lysine-48 polyubiquitin chains	2
regulators in IFN-I pathways	2
functional gene database	2
randomly selected genes	2
unknown genes	2
related pathways	2
host genes	2
parasite genetic loci	2
1,054 host genes	2
Plasmodium yoelii malaria parasite	2
RNA and Vasa binding	2
germline-specific RNA helicase Vasa	2
highly conserved N-terminal LOTUS domain	2
SGNH hydrolases	2
RNA-binding maps	2
two Oskar domains	2
polar granule component, and germ cell-less mRNAs	2
RNA-binding protein	2
Oskar protein	2
serines 102 and 408 and threonine 1074	2
Hh pathway	2
energy sensor	2
Gli transcription factors	2
nuclear matrix subcompartment	2
component of the m6A RNA methyltransferase complex	2
Spen and Wtap	2
SPOC domain RNA binding proteins Rbm15	2
several of the top hits	2
ranked list	2
single X chromosome in female cells	2
urbilaterian	2
achatin D-peptide	2
predicted achatin receptors	2
several metazoan GPCRs	2
Platynereis ortholog of vertebrate thyrotropin-releasing hormone (TRH) receptors	2
conserved families of achatin, FMRFamide, RGWamide, FLamide, and elevenin receptors	2
known families	2
19 receptors	2
identified ligands	2
GPCRs of the annelid Platynereis	2
complex peptide mixtures	2
GPCR-peptide pairs	2
several metazoans	2
neuropeptide repertoire	2
largest class of neuromodulators	2
(ERAD) pathway	2
downstream cell death pathway(s)	2
different WNV strains	2
EMC2, EMC3, SEL1L, DERL2, UBE2G2, UBE2J1, and HRD1	2
sub-library	2
20,121 genes	2
Nile virus (WNV)	2
nucleoporin MEL-28/ELYS	2
inactive MCM-2–7 complexes	2
condensin I complexes	2
CDC-45-MCM-GINS (CMG) DNA helicase	2
chromosomal axes	2
DNA replicates	2
specific MGE derivatives	2
dorsal, identity	2
MGE	2
the rostral telencephalon	2
Fgf signaling	2
de-regulated genes	2
OTX2 binding motif	2
Otx2 cKO ventral forebrain	2
Otx2 conditional knockout (cKO) mice	2
Otx2 homeodomain transcription factor	2
stressed neurons	2
 a Lis1/Ndel1-dependent regulator	2
dynein-driven cargo	2
high affinity Lis1/Ndel/dynein complex	2
Lis1/Ndel1 complex	2
lysosomes, autophagosomes, mitochondria, and signaling endosomes	2
range of organelles	2
stress-induced activator p25	2
channel clustering	2
channel confinement	2
dispersed CRAC channels	2
PM microdomains	2
(CRAC) channels	2
store-operated Ca2+ release-activated Ca2	2
spatially restricted signals	2
(PM)	2
plasma-membrane	2
polarized cells or cells	2
mitochondrial dehydrogenases	2
Mcu−/− mice	2
mitochondrial permeability transition pore	2
in vivo myocardial ischemia-reperfusion injury model	2
pore-forming subunit of the MCU channel	2
conditional, cardiomyocyte-specific, mutant mouse	2
mitochondrial calcium uniporter (MCU) channel	2
neuronal activity	2
olfactory sensory neuron axons	2
parenchymal IOSs	2
transgenic mouse lines	2
odor-evoked IOSs	2
mouse olfactory bulb	2
well-described micro-architecture	2
intrinsic optical signal	2
functional MRI	2
short-lived secretory cells	2
basal population	2
basal layer	2
multipotent stem cells and committed precursors	2
secretory and multiciliated luminal cells	2
pseudostratified epithelium	2
mouse tracheal epithelial lineage	2
lung, liver, pancreas, and prostate	2
figures	2
Bucky ball	2
scaffold protein Dazap2 (Mdazap2)	2
signaling clusters	2
effective Ca2	2
endothelial cells of mice	2
TxIP motif of IP3R3	2
either EB3	2
myosin light chain	2
phospholipase Cβ	2
pro-inflammatory mediator	2
α-thrombin	2
S/TxIP EB-binding motif	2
core component of the microtubule plus-end protein complex	2
 microtubule-associated end-binding protein 3 (EB3)	2
Mps1 in C. elegans	2
substrate motif	2
many nematode species	2
phospho-docking sites	2
kinetochore-localized scaffold protein Knl1	2
Mps1 kinase	2
primary attachment site	2
Checkpoint signal	2
spindle checkpoint	2
learning animal	2
neuromodulated, synapse-restricted molecule	2
translational regulator Orb2A tags specific synapses of mushroom body neurons	2
class of dopaminergic neurons	2
some, but not all, learning experiences	2
ever-changing environment	2
young flies	2
Cysteine residues	2
several hundred cysteine residues	2
oxidative isotope-coded affinity tags (OxICAT)	2
cysteine residues on protein surfaces	2
key lipid synthetic enzyme	2
tumor-prone TP53–/–mice	2
Scd1 inhibitor	2
master tumor suppressor p53	2
unsaturated fatty acids	2
stearoyl-coenzyme A desaturase 1 (Scd1)	2
endogenous inhibitor of SirT1, Deleted-in-Breast-Cancer-1 (Dbc1)	2
 SirT1	2
NAD+-dependent deacetylase SirT1	2
human blood and tonsillar TFH cells	2
memory TFH cells	2
CXCR5loPD-1− and CXCR5loPD-1lo cells	2
extrafollicular stages	2
TFH cells	2
TFH cells expressing interferon-γ (IFN-γ), interleukin-17 (IL-17), or Foxp3	2
tonsillar CXCR5loPD-1loCCR7lo	2
blood and tonsils	2
numerous subtypes of follicular helper T (TFH) cells	2
peripheral blood and tonsils	2
human T helper (TH) cells	2
-cell analysis technologies	2
non-CpG genomic regions	2
microDNA abundance	2
MSH3 DNA mismatch repair protein	2
homologous recombination and non-homologous end joining repair pathways	2
various DNA repair proteins	2
chicken cells	2
microDNA origins	2
set of human cancer cell lines	2
lamin-associated heterochromatin	2
5′-UTR of full-length LINE-1 elements	2
tissue types	2
<400-base extrachromosomal circles	2
ECM-induced filopodia formation	2
ECM-induced, but not VEGF-induced, NRP1 signaling	2
developing zebrafish in vivo	2
neighboring stalk cells	2
filopodial bursts	2
filopodia-studded endothelial tip cells	2
competitive setting	2
Bmal1-deficient T cells	2
circadian reporter	2
transcription factor BMAL1	2
components of E3 ubiquitin ligases	2
primary target of mir-17∼92	2
embryonic stem cell (ESC)-derived LMC-MNs	2
mir-17∼92 cluster	2
sensorimotor circuit	2
distal limb mesenchyme	2
Limb-innervating lateral motor column MNs (LMC-MNs)	2
peripheral muscles	2
SummaryMotor neurons (MNs)	2
forelimb M1	2
noradrenergic receptors	2
subpopulation of L5B neurons (L5Benhanced neurons	2
excitatory drive	2
L5Bsuppressed neurons	2
L5B output neurons	2
awake mice	2
layer 5B (L5B) pyramidal neurons	2
primary motor cortex (M1)	2
anti-APOBEC3 activity	2
non-CRL-associated host cofactors	2
novel cofactor, cyclophilin A (CYPA)	2
MVV Vif	2
BIV Vif	2
non-primate lentiviral Vif proteins	2
lentivirus genus, including primate (HIV-1 and simian immunodeficiency virus macaque [SIVmac]) and non-primate (FIV, BIV, and MVV) viruses	2
proteomic, biochemical, structural, and virological techniques	2
viral factors	2
CRL complexes	2
APOBEC3 antiviral proteins	2
non-canonical cofactor CBFβ	2
hijacks a host Cullin-RING ubiquitin ligase (CRL) complex	2
accessory protein Vif	2
infectious prions	2
aerial parts of the plant (stem and leaves)	2
contaminated soil	2
living plant	2
prion-containing preparation	2
diverse origins	2
prion-contaminated plants	2
Wild-type hamsters	2
wheat grass roots and leaves	2
excretory materials (urine and feces)	2
diluted brain homogenate	2
Small quantities of PrPSc	2
infectious prion protein (PrPSc)	2
protein-based infectious agents	2
cancer therapeutic	2
Synthetic CDNs	2
long-lived immunologic memory	2
established tumors in mice	2
STING agonists	2
murine STING	2
human STING alleles	2
synthetic cyclic dinucleotide (CDN) derivatives	2
mouse STING agonist DMXAA	2
specific agonists	2
host STING pathway	2
tumor-resident dendritic cells	2
DIS3L2 overexpression	2
TUTases	2
5′ exonuclease DIS3L2	2
uridylated transcript intermediates	2
terminal uridylyl transferases (TUTases) ZCCHC6 and ZCCHC11	2
tails	2
nontemplated uridylate-rich tails	2
truncated mRNA decay intermediates	2
mitochondria, DNA, proteins, and membrane lipids	2
known major regulators of ciliogenesis	2
cilia in multi-ciliated cells (MCCs) of the epidermis	2
transition zone protein B9D1/MSKR-1	2
neural tube	2
Xenopus left-right (LR) organizer, the gastrocoel roof plate (GRP)	2
Smad2-dependent transforming growth factor β (TGF-β) signaling	2
many molecules or signal transduction pathways	2
sensory-related functions	2
small cellular organelle	2
short patches	2
hundreds beyond mammals	2
exonic architectures	2
short, 5′-biased patches	2
thousands of previously unannotated genes	2
vertebrates and the echinoid sea urchin	2
long noncoding RNAs	2
specific neuronal circuitry	2
contralateral side	2
projection area of the perforant pathway (i.e., outer molecular layer of the dentate gyrus) of the stimulated side	2
In vivo microdialysis	2
APP transgenic mice	2
hippocampal perforant pathway	2
channelrhodopsin	2
stabilized step-function opsin	2
the pentose phosphate pathway	2
ataxia telangiectasia mutated (ATM)	2
ubiquitous chromatin-associated protein	2
NAT	2
aged-matched controls	2
Alzheimer’s disease patients	2
brain tissue samples	2
Hmgb2 protein	2
Short oligonucleotides	2
 Hmgb2	2
high-mobility group box 2 (Hmgb2)	2
Lrp1-AS directly	2
Lrp1 expression	2
NAT of low-density lipoprotein receptor-related protein 1 (Lrp1)	2
majority of NATs	2
natural antisense transcripts (NATs)	2
SummaryLong non-coding RNAs (lncRNAs)	2
immune adjuvant	2
intra-tumor IFN-I and MHCII expression	2
tumor immune microenvironment	2
vaccination	2
mice bearing HER2+ mammary gland tumors	2
PSM-loaded HER2 antigen	2
TRIF- and MAVS-dependent pathway	2
proteasome- and lysosome-dependent pathways	2
PSM-loaded antigen	2
porous silicon microparticle (PSM)-based cancer vaccine	2
cancer vaccine adjuvants	2
nanometer-size particles	2
two Drosophila species	2
parents and their hybrids	2
trans regulators	2
cis sequences	2
F1 hybrids	2
two closely related Drosophila species, D. melanogaster and D. sechellia	2
cis-acting elements and trans-acting factors	2
cis-acting elements (surrounding RNA sequence and secondary structure) and trans-acting factors	2
individual editing sites	2
double-stranded RNA structures	2
RNA (Adar) proteins	2
adenosine deaminase	2
maturing mRNAs	2
tau proteostasis	2
β-secretase and γ-secretase inhibition	2
mutated APP	2
genetic forms of AD	2
intracellular tau	2
pathogenic Aβ peptides	2
human-stem-cell-derived forebrain neurons	2
APP protein	2
Aβ peptide fragments	2
client-loading complex	2
stable heterohexameric client-loading complex Hsp902Hsp702HopGR	2
monomeric Hsp70	2
client and Hsp70	2
fragment of the glucocorticoid receptor (GR)	2
Hop, p23, and a client protein	2
eukaryotic Hsp90/Hsp70/Hsp40	2
Hsp70 and client proteins	2
nucleotide exchange factor	2
Hsp40 cochaperone	2
heat shock protein 70 (Hsp70) system	2
networks of chaperones	2
repair sites	2
NHEJ core complex	2
Ku and Ku-associated proteins	2
Ku ubiquitylation	2
NEDD8 E2-conjugating enzyme, UBE2M	2
depleting cells	2
DNA-damage sites	2
ubiquitin-like protein, NEDD8	2
anti-cancer drug	2
Ku70/Ku80 (Ku) heterodimer	2
DSB ends	2
predominant DNA double-strand break (DSB) repair pathway	2
Nonhomologous end-joining (NHEJ)	2
ubiquitin and ubiquitin-like molecules	2
many DNA-repair proteins	2
systems-level layer	2
Proteomes hierarchically cluster	2
2,000+ E. coli proteins	2
chromosomal folA gene encoding dihydrofolate reductase (DHFR)	2
E. coli proteome	2
host cytoskeleton	2
actin tails	2
dividing Lm	2
bacterial cell surface	2
host-derived actin	2
intracellular Listeria monocytogenes (Lm)	2
complex environments	2
microtubule tracks	2
mouse seminiferous tubules	2
SUN1/KASH5 nuclear envelope bridges	2
diverse eukaryote species	2
meiotic prophase	2
nuclease recruitment scaffold	2
UHRF1 and components of the Fanconi anemia	2
ICL lesions	2
ERCC1 and MUS81	2
ICL repair nucleases	2
UHRF1-deficient cells	2
ICL-containing DNA	2
ICL-recognition activities	2
DNA interstrand crosslink (ICL) lesions	2
binding factor	2
ubiquitin-like with PHD and RING finger domain 1 (UHRF1)	2
ATRX KO cells	2
silenced imprinted alleles	2
ATRX/H3.3	2
heterochromatic sites	2
ATRX/Daxx	2
replication-independent histone variant	2
highly conserved viral interface	2
NPBP peptide	2
NPBP/ΔNPNTD complex	2
NP-RNA complexes	2
NP oligomerization	2
EBOV VP35 (NPBP, residues 20–48)	2
intrinsically disordered peptide	2
molecular bases	2
noncognate RNAs	2
newly synthesized NP	2
RNA template	2
template-free form	2
RNA-template-bound form	2
(EBOV) nucleoprotein (NP)	2
POMC and AgRP neurons	2
mediobasal hypothalamus	2
general integrator	2
S6K1 signaling	2
S6K1 in pro-opiomelanocortin (POMC) and agouti-related protein (AgRP) neurons	2
hormonal and nutrient signals	2
ribosomal S6K1	2
uninfected and virus-infected cells	2
cytoplasmic viral RNA sensor MDA5	2
MDA5 multimer formation	2
phosphomimetic MDA5-S828D mutation	2
IFN and IFN-inducible gene expression	2
RIOK3 knockout	2
MDA5 C-terminal region	2
RIO kinase 3 (RIOK3)	2
PP1α and PP1γ phosphatases	2
MAVS adaptor	2
MDA5 filament	2
viral dsRNA	2
cytoplasmic viral double-stranded RNA (dsRNA) sensor	2
pharmacological tools	2
central neurons	2
molecular identity	2
CA1 hippocampal pyramidal cells	2
postsynaptic stimuli	2
trains of synaptic input	2
sAHP	2
intermediate-conductance Ca2+-dependent K+ (IKCa)	2
Ca2+-dependent	2
-gated K+ channels	2
ATF4-null mice	2
ATF4 in rodent hippocampal neurons	2
direct in vitro and in vivo	2
transcription factor ATF4 negatively	2
This deadly cocktail	2
p53-deficient transformed cells	2
cell-cycle checkpoints	2
multifunctional protein E4F1	2
another factor	2
p53, E2F1, and BMI1	2
group of key transcriptional regulators	2
prosecretory genes	2
Wnt signaling pathway	2
function-blocking antibodies against Notch receptors	2
absorptive cells	2
secretory and absorptive cell lineages	2
Notch and Wnt signaling	2
multiple inputs	2
rear head	2
NL	2
front head of a kinesin dimer	2
pulling NL	2
kinesin monomers	2
neck linker (NL)	2
two heads	2
plus-end of microtubules	2
intracellular cargos	2
two-headed motor	2
cancer-associated variant	2
RB1 variants	2
cNHEJ.	2
cancer-derived cells	2
NHEJ components XRCC5	2
amino terminal domain	2
RB1’s cell-cycle function	2
canonical non-homologous end-joining (cNHEJ)	2
retinoblastoma tumor suppressor protein (RB1)	2
binding	2
FANCD2 foci formation	2
mitomycin C. Knockdown cells	2
ICLs in vitro and in vivo	2
toxic DNA interstrand crosslinks (ICLs)	2
(FA) pathway	2
two animal models of MS and in culture	2
Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD)	2
increased insoluble proteome	2
MS pathological samples	2
cortical lesions of human MS pathological samples	2
hallmark mediators of necroptosis	2
necrotic cell death pathway	2
proinflammatory cytokine	2
Tumor necrosis factor α (TNF-α)	2
endogenous sources	2
mammalian and yeast cells	2
short cruciform-forming sequences	2
IRs	2
inverted repeat sequences (IRs)	2
near pairing centers	2
chromosome pair	2
haploid gametes	2
homologous chromosomes (homologs)	2
synaptonemal complex (SC)	2
key metabolic genes	2
lipogenic transcription factor SREBP	2
Drosophila adipocyte triglyceride lipase (ATGL) (Brummer)	2
key antagonist	2
PGC-1/spargel (PGC-1/srl)	2
transcriptional cofactor PGC-1α	2
lipids in the heart	2
rat cortical tissues	2
 frontal and temporal lobes of nonhuman primate	2
temporal, frontal, occipital, and parietal cortices	2
different cortical regions	2
type of neuron	2
persistent Na+ current	2
distinct subpopulation of neurons	2
human cortical slices	2
CD40-deficient mice	2
signaling loop	2
CD40L and CD40 expression	2
CD40L (TNFSF5) and CD40 (TNFRSF5)	2
developing mouse sympathetic neurons	2
autocrine signaling loop	2
innervation	2
neurotrophic theory	2
target-derived factors like nerve growth factor (NGF)	2
fumarate and succinate	2
α-KG	2
 α-ketoglutarate (α-KG)	2
miR-424 downregulates IDH3α	2
isocitrate dehydrogenase 3α (IDH3α)	2
oxidative phosphorylation	2
TGF-β1- or PDGF-induced CAFs	2
critical metabolites	2
SummaryCancer-associated fibroblasts (CAFs)	2
complex tissue samples	2
composite methylomes	2
broad range of biological systems	2
three in vitro models	2
collections of single-cell methylomes	2
many samples	2
single cells (scWGBS)	2
small cell populations (μWGBS)	2
whole-genome bisulfite sequencing (WGBS) assay	2
Crispr/Cas system	2
coding introns	2
exchangeable, MiMIC-like Trojan exon construct	2
range of commonly used transcription factors	2
palette of Trojan exons	2
lines containing suitable MiMIC (Minos-mediated integration cassette) transposons	2
effector transgene	2
coding sequences of T2A peptide	2
splice acceptor site	2
intronically inserted “plug-and-play” cassettes (called “Trojan exons”)	2
native gene	2
introns between coding exons)	2
“coding introns”	2
encoded effectors	2
senescence inducer	2
nucleolar-5S RNP-p53 pathway	2
certain rRNA-processing factors	2
ribosome-free fraction	2
RPL11, RPL5, and 5S rRNA	2
5S ribonucleoprotein particle (RNP) complex	2
stem-cell-specific, niche-related signals	2
ISCs, female germline stem cells	2
ISC-to-enterocyte (EC) lineage differentiation, and ISC-to-enteroendocrine (EE) lineage differentiation	2
ISC survival	2
publicly available interaction databases	2
405 genes	2
adult Drosophila intestine	2
Drosophila and mammals	2
rapidly self-renewing tissue	2
Satellite-cell-specific knockout of Scrib in mice	2
dividing daughter cells	2
potent tumor suppressor	2
one of the major cell-polarity proteins	2
adult muscle	2
resident skeletal muscle stem cells	2
oncogenic fusion protein	2
EWS-FLI1-correlated and anticorrelated genes	2
 E2F and AP-1	2
classes of EWS-FLI1-regulated genes	2
strongly affected mark	2
histone H3K27 acetylation	2
 promoters, enhancers, and super-enhancers	2
Reduced EWS-FLI1 expression	2
driving oncogene	2
reference epigenome maps	2
EWS-FLI1 fusion protein	2
Ewing sarcoma cells	2
factor fusion proteins	2
axodendritic contact	2
NMDA receptors on developing dendrites	2
neurotransmitter glutamate	2
developing axons	2
mouse model of APL	2
human blasts	2
TGF-β receptor	2
homeodomain repressor factor TGIF	2
TGF-β tumor suppressor pathway	2
Dnmt3L ADD	2
ADD	2
repetitive sequences and non-promoter CpG islands	2
mutant germ cells	2
Dnmt3L histone H3 binding domain (ADD)	2
catalytically inactive adaptor Dnmt3L	2
mammalian gametogenesis	2
nucleoid-MIOREX complexes	2
mitochondrial network	2
MIOREX complexes	2
mitochondrial organization of gene expression (MIOREX) complexes	2
large expressosome-like assemblies	2
native and intact complexes of mitochondrial ribosomes	2
spatially organized	2
mitochondrial proteome	2
genetic system	2
succinate dehydrogenase (SDH)	2
PTEN-like mitochondrial phosphatase PTPMT1	2
potent glucose-lowering agent	2
small molecule alexidine	2
live zebrafish	2
antifungal combinations	2
protein phosphatase calcineurin	2
azoles	2
widely deployed antifungals	2
leading human fungal pathogen, Candida albicans	2
antifungal drug combinations	2
susceptible counterparts	2
 multidrug-resistant pathogens	2
selective naive T cell functions	2
either naive or memory T cells	2
phosphoinositide 3-kinase pathway	2
p110δ catalytic subunit	2
hematopoietic stem cell transplantation (HSCT)	2
senescent cells	2
local interactions	2
heterochromatin in Hutchinson-Gilford progeria	2
senescence-associated heterochromatic foci (SAHF)	2
“nonself	2
CD4 T cell subsets	2
CI-Treg cells	2
converted CD4 T cell population	2
lamina propria	2
CI-Treg populations	2
T cell-intrinsic TGFβ signaling	2
+ Treg (CI-Treg) cells	2
MHC-class-I-restricted CD4+Foxp3	2
cognate antigens	2
large-intestine-associated microenvironment	2
 CD4 T cells	2
CD8 T cell lineages	2
Resource	2
cortical network of TAU mice	2
amyloid mice	2
TAU mice	2
hippocampal network	2
hippocampus of amyloid mice	2
immune gene modules	2
synaptic genes	2
“TAU” transgenic mice (mutant human MAPT gene)	2
amyloid” transgenic mice (mutant human APP, PSEN1, or APP/PSEN1)	2
four lines of	2
cellular subcompartment	2
ligand-bound integrins	2
nearby late endosomes/lysosomes	2
Arf subfamily GTPase	2
populate adhesions	2
eat-2 mutants	2
clk-1 mutants	2
feeding-defective eat-2 mutants	2
mitochondrial clk-1 mutants	2
ribosomes of the daf-2 mutant	2
long noncoding RNA (lncRNA), transcribed telomeric sequence 1 (tts-1)	2
normal strains of Caenorhabditis elegans	2
ribosome-associated RNAs	2
cellular energy	2
p53 tumor suppressor	2
USP24 deubiquitinase	2
endogenous HPRT locus	2
ubiquitinated p53	2
purified USP24 protein	2
USP24-depleted cells	2
Functional USP24	2
USP24 deubiquitinates p53	2
activated neurons	2
brain atlas	2
reference brain	2
c-fos-GFP+ neurons	2
immediate-early-gene c-fos	2
male brain	2
human lung carcinomas	2
HUWE1-depleted cells	2
TIAM1 ubiquitylation site	2
MDCKII cells	2
RAC activator TIAM1	2
E3 ubiquitin ligase HUWE1	2
two transcriptomes	2
bowhead whale genome	2
the longest-living mammal	2
bowhead whale (Balaena mysticetus)	2
proliferating stem cells	2
basal cell layer	2
epidermal stem cells in live mice	2
metabolic organs	2
NHEJ in fission yeast	2
C terminus of Xlf1	2
Cdk1 phosphorylates residues	2
fission yeast XLF ortholog	2
NHEJ pathway	2
key recombination factors	2
Cyclin-dependent kinase 1 (Cdk1)	2
DNA double-strand breaks (DSBs): homologous recombination (HR) and nonhomologous end-joining (NHEJ)	2
nonessential G1/S target genes	2
MBF-regulated Cdc18Cdc6 replication origin-licensing factor	2
normally inconsequential MBF-regulated S-phase cyclin Cig2	2
MBF-regulated Ctp1CtIP	2
Homology-directed repair proteins	2
Nrm1 corepressor	2
many dosage-sensitive proteins	2
E2F-regulated G1/S genes	2
G1/S regulon of genes	2
deregulated mafr-1 expression	2
insulin signaling pathway genes daf-18/PTEN	2
high carbohydrate diet	2
lipogenesis enzymes fasn-1/FASN and pod-2/ACC1	2
developing reproductive system	2
vitellogenin family of proteins	2
RNA Pol III and Pol II transcripts	2
human Maf1	2
C. elegans MAFR-1	2
conserved repressor of RNA polymerase (Pol) III transcription	2
vast majority of “disallowed” genes	2
voltage-gated Ca2+ channels	2
Abcc8/SUR1 subunit of KATP channels	2
insulin secretion pathway	2
functionally mature β cells in mice	2
genomic positions	2
cancer breakpoints	2
fusion genes	2
cancer (ETV1, FOXP1, and microRNA cluster C19MC)	2
patients hit genes	2
endocardial Notch signaling	2
crucial downstream transcriptional effector	2
VegfR2, Nrp1, and VegfR3	2
several crucial components	2
coronary lumens	2
Hand2 mutant hearts	2
endocardium-to-endocardium-based cell signaling	2
direct transcriptional regulator	2
 a Notch endocardium-to-myocardium signaling pathway	2
endocardial Hand2	2
hypotrabeculated ventricles	2
intraventricular septum defects	2
patent tricuspid valve	2
endocardium	2
myocardial, neural crest, and epicardial cell populations	2
basic-helix-loop-helix (bHLH) transcription factor Hand2	2
endodermal structures	2
Smad1/5/8 signaling	2
the NvBMP/NvRGM/NvChordin expression domain	2
side	2
BMP-dependent Smad1/5/8 gradient	2
cnidarian Nematostella vectensis	2
conserved BMP coreceptor	2
Repulsive guidance molecule (RGM)	2
BMP signaling regulators	2
dorsoventral axis	2
H3K4 demethylation	2
AR-regulated enhancers	2
these sites	2
AR-regulated enhancer sites	2
androgen-stimulated enhancers	2
H3K4me2 demethylation	2
histone 3 threonine 6 phosphorylation (H3T6ph)	2
AR/LSD1-associated enhancer sites	2
coactivates androgen receptor (AR)	2
histone 3 lysine 4 (H3K4)	2
SummaryLysine-Specific Demethylase 1 (LSD1, KDM1A)	2
WT1 silencing	2
DNA hydroxymethylation	2
TET2/IDH1/IDH2 mutant AML	2
WT1 mutant AML patients	2
5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC)	2
embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs)	2
endothelial and hematopoietic genes	2
hemogenic endothelial cells	2
erythroid, megakaryocytic, myeloid, and lymphoid lineages	2
p53−/− reprogrammed cells	2
reprogrammed cells	2
transcription factors ERG, GATA2, LMO2, RUNX1c, and SCL	2
clonal multilineage hematopoietic progenitors	2
embryonic and adult somatic fibroblasts	2
lineage-specific transcription factors	2
growth factor and a protease	2
FBL-1 protein, an extracellular matrix (ECM) component fibulin	2
many invertebrates	2
svh-1 and svh-2 genes	2
HGF receptor homolog SVH-2	2
HGF/plasminogen-like protein SVH-1	2
ancestral form	2
growth factor (HGF) and fibrinolytic serine protease plasminogen	2
GSC-specific autocrine/paracrine loop	2
activated Rac1	2
orthotopic models of glioblastoma	2
NPCs or NSTCs	2
neural progenitor cells (NPCs) or NSTCs	2
PlexinA2/D1 receptors	2
nonstem tumor cell (NSTC) population	2
subset of tumor cells	2
Glioma stem cells (GSCs)	2
cancer cell compartments	2
endosome-to-Golgi retrieval	2
SFT2D2, ZDHHC5, and GRINA	2
three multipass membrane proteins	2
multipass membrane-spanning proteins	2
CD8-CIMPR reporter protein	2
∼90 genes	2
image-based antibody-uptake assay	2
endosome-to-Golgi retrieval pathway	2
lysosomal hydrolases	2
cation-independent mannose 6-phosphate receptor (CIMPR)	2
prototypical cargo protein	2
bacterial and viral pathogens	2
essential membrane trafficking pathway	2
telomerase haplo-insufficient somatic cells	2
Terc+/− ntESC clone pups	2
Terc+/− cells	2
telomeres of telomerase haplo-insufficient (Terc+/−) mouse cells	2
ntESCs	2
telomeres of telomerase haplo-insufficient cells	2
pluripotent human embryonic stem cells (ntESCs)	2
telomerase haplo-insufficient donor cells	2
telomerase genes	2
FDH-iPSCs	2
 karyotypically normal iPSCs	2
WNT pathway	2
PORCN overexpression	2
essential WNT processing enzyme PORCN	2
JNK- and IKK-dependent signaling	2
AgRP cells	2
agouti-related peptide (AgRP)-expressing neurons of the hypothalamus	2
c-Jun N-terminal kinase 1 (JNK1)- and inhibitor of nuclear factor kappa-B kinase 2 (IKK2)-dependent signaling	2
FAK/Tiam1/Rac1/PAK1	2
Rac1 effector PAK1	2
RacGEF Tiam1	2
several myeloid and lymphoid malignancies	2
available drugs	2
patients with acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPNs)	2
FLT3 and KIT receptors	2
RGMa-specific antibody	2
Akt dephosphorylation	2
RGMa-neogenin	2
myelin oligodendrocyte glycoprotein (MOG)-specific Th17 cells	2
interleukin-17-producing CD4+ T cells (Th17 cells)	2
repulsive guidance molecule-a (RGMa)	2
unique and powerful imaging tool	2
conditional Slit2 allele	2
Slit ligands	2
Slit/Robo and DCC/Netrin pathways	2
commissural tract	2
fasciculus retroflexus (FR)	2
medial habenula axons	2
Robo3 receptor	2
mouse embryos and postnatal brains	2
axonal tracts	2
transparentize mouse brains	2
multiscale data sets	2
urothelial differentiation component	2
muscle-invasive bladder cancers	2
luminal and basal-like subtypes	2
cancer-shared and bladder-cancer-specific components	2
 other components	2
 tumor cells	2
bladder cancer transcriptome data sets	2
large-scale data	2
relevant information	2
NADH dehydrogenase	2
action potentials	2
short exposures	2
immortalized and primary mouse colonic L cells	2
a metabolite	2
H3K9me3-sparse regions	2
H3K9me3-dense regions	2
strands of gene bodies	2
chromatin-rich regions of the genome	2
XPC−/− cells	2
XPC−/− background	2
cutaneous squamous cell carcinomas (cSCCs)	2
transcriptionally silent genomic regions	2
heterochromatic and late-replicating regions	2
SGOC metabolic network	2
expansive and heterogeneous functions	2
given pathway	2
NADPH, and glutathione synthesis	2
nucleotide synthesis	2
SGOC network	2
SummaryThe serine, glycine, one-carbon (SGOC) metabolic network	2
emerging dicer deficiencies	2
potentially druggable target	2
dicer-deficient contexts	2
wild-type dicer backgrounds	2
ribonuclease complex Translin/Trax (TN/TX)	2
pre-miRNA degrading activity	2
pre-miRNA degrading enzyme	2
Dicer-antagonist assay	2
dicer deficiency	2
microRNA (miRNA) generating enzyme, dicer	2
canonical ribonucleoprotein (RNP) complexes	2
protein-modifying enzymes	2
conserved terminal loop (CTL) of pre-let-7	2
Lin28a/TuT4-mediated uridylation	2
RNA-specific cofactor	2
E3 ligase Trim25	2
non-let-7 pre-miRNAs	2
Lin28a-mediated pre-let-7 uridylation	2
substrate-specific cofactors	2
pre-let-7	2
pre-microRNAs (pre-miRNAs)	2
TuT4-mediated pre-let-7 uridylation	2
conserved RNA binding protein	2
cellular RNA targets	2
SummaryRNA binding proteins	2
schizophrenia-associated noncoding SNPs	2
L-type calcium channel (CACNA1C) risk locus	2
prefrontal cortex and -induced pluripotent stem cell–derived neurons	2
noncontiguous proximal and distal regulatory elements	2
schizophrenia genome-wide significant loci	2
functional annotations	2
expression quantitative trait loci (eQTL)	2
schizophrenia variants	2
noncoding sequence	2
large portion of common variant loci	2
STP-REST axis	2
TNBC patients	2
human TNBCs	2
ubiquitin-ligase βTRCP	2
conserved REST phospho-degron	2
REST tumor suppressor protein	2
SCYL1, TEX14, and PLK1 (“STP axis”)	2
oncogenic network	2
aggressive triple-negative breast cancer subtype (TNBC)	2
types of hippocampus-dependent memory	2
hippocampus-dependent tasks	2
combined MEC and hippocampal lesions	2
hippocampus rats	2
water maze	2
remaining active cells	2
active hippocampal cells	2
medial entorhinal cortex (MEC) cells	2
brain structure	2
primary cortical projections	2
entorhinal cortex	2
competing termination factors Pcf11 and Nrd1	2
CF IA	2
short RNAs	2
Pcf11/Clp1 subcomplex of cleavage factor IA (CF IA)	2
Pol II flap loop	2
termination factor and phosphorylated isoforms of the Pol II C-terminal domain (CTD)	2
RNA polymerase II (Pol II) transcription complex	2
humanized 1H3	2
targeting B7x	2
surviving mice	2
B7x-expressing tumors	2
clone 1H3	2
therapeutic monoclonal antibodies	2
human B7x immunoglobulin variable (IgV) domain	2
normal human tissues and immune cells	2
B7 family	2
(B7-H4 or B7S1)	2
human T lymphocytes	2
costimulatory molecule	2
different CD161-expressing T cell populations	2
interleukin (IL)-12 plus IL-18	2
CD161+TCRγδ+ T cells	2
CD161+ CD4+	2
different T cell subsets expressing CD161	2
human T lymphocytes of all lineages	2
C-type lectin CD161	2
developing epithelial tubule	2
murine epididymal tubules	2
single epithelial tubule	2
operons in prokaryotic systems	2
coregulation	2
pathways or complexes	2
mRNA granules	2
multiple granules per cell	2
Specific glycolytic mRNAs	2
unstressed, actively growing cells	2
P-bodies and stress granules	2
translationally repressed mRNAs	2
defined cytoplasmic sites	2
membrane-permeable glutamate precursor	2
incretin-unresponsive, insulin-secreting β cell line and pancreatic islets	2
insulin granules	2
malate-aspartate shuttle	2
AMPAR complex	2
AMPAR NTD	2
key binding sites on the TARP itself	2
LBD surface	2
path of TARP contacts	2
TARP interaction region on the NTD	2
NTD-LBD linker	2
distal N-terminal domain (NTD)	2
AMPAR ion channel and ligand binding domain (LBD)	2
AMPAR auxiliary subunits	2
SummaryAMPA-type glutamate receptors (AMPARs)	2
polymerizing F-actin cables	2
junctional and cortical actin cytoskeletons	2
a truncated version of Cdh5	2
mutant embryos	2
zebrafish cdh5 gene	2
ESCRT-II machinery	2
Vps25ENU/ENUMouse Embryonic Fibroblasts	2
Vps25ENU/ENUmutants	2
Vps25-null embryos	2
Vps25 (Vps25ENU)	2
 a polydactylous mouse line	2
Transport II)	2
component of ESCRT-II (Endosomal Sorting Complex Required	2
 Vacuolar protein sorting 25, Vps25	2
different receptors and ligands	2
associated signaling molecules	2
cellular network	2
germline pluripotency	2
 SET-2	2
set-2- and wdr-5.1-deficient germlines	2
animals lacking set-2, ash-2	2
SET-2/SET1, WDR-5.1, and ASH-2	2
 Caenorhabditis elegans	2
conserved SET1/MLL methyltransferases	2
SummaryHistone H3 Lys 4 methylation (H3K4me)	2
tumor necrosis factor (TNF) and lymphotoxin-α (LT-α)	2
HOIP-deficient cells	2
tumor necrosis factor receptor 1 (TNFR1)	2
catalytically active LUBAC component	2
linear ubiquitin linkages	2
known ubiquitin ligase	2
HOIL-1, HOIP, and SHARPIN	2
amyloid burden	2
several vascular protective compounds	2
neural crest-derived SMCs	2
LRP1 expression	2
neural-crest-derived SMCs	2
lipoprotein receptor, LRP1	2
Aβ metabolism	2
brain-vasculature-specific attributes	2
neural crest progenitors	2
vascular smooth muscle cells (SMCs)	2
majority of aged people	2
walls of cerebral arteries	2
extracellular matrix remodeling (SPARC)	2
already established lung metastases	2
multilayered epithelia	2
insulin-like growth factor	2
Tachykinin-producing enteroendocrine cells	2
surrounding muscle	2
diet-stimulated midgut growth	2
newly eclosed mutant flies	2
enteroendocrine cell-less flies	2
newly eclosed scute loss-of-function mutant flies	2
secretory enteroendocrine cells	2
enterocytes and visceral muscle	2
surrounding niche cells	2
adult Drosophila midgut	2
various complexes	2
TOES oligonucleotides	2
activator SRSF1	2
complex containing only hnRNP F/H	2
quadruplex	2
coexisting discrete states	2
ESE	2
U2 snRNP	2
ESE sequence	2
U2AF65 binding	2
5′ end of exon 7	2
intron 7	2
repressing sequences	2
intron 6	2
exonic splicing enhancer (ESE) sequence	2
SMN2 exon 7	2
targeted bifunctional oligonucleotide enhancer of splicing (TOES)	2
selected exons	2
core set of regeneration-associated signaling pathways	2
pStat3)	2
3-kinase [PI3K], β-catenin, and	2
core set of signaling cascades (Mapk/Erk	2
heparin-binding EGF-like growth factor (HB-EGF) and cytokines	2
Insulin, Igf-1, and fibroblast growth factor (FGF) signaling components	2
glia (MG) in the zebrafish retina	2
consensus Stat-binding sites	2
fish and mammals	2
injured retina	2
Jak/Stat signaling pathway	2
Leptin and Gp130-coupled receptors	2
Müller glia (MG)	2
damaged retina	2
metastatic PROX1	2
pro-apoptotic member of the BCL2 family, BCL2L15	2
direct PROX1 target genes	2
subpopulation of colon cancer progenitor/stem cells	2
homeobox transcription factor PROX1	2
metastatic colorectal cancer cells	2
colorectal cancers	2
tumor transplants	2
actin-binding protein filamin A	2
Prox1 deletion	2
mouse adenomas and human CRC	2
organoid cultures	2
subpopulation of Prox1-transcription-factor-expressing cells	2
SN domains	2
tryptophan-binding pockets	2
deep surface valleys	2
long protruding arms	2
MTDH-SND1 binding interface	2
two well-defined pockets	2
two MTDH tryptophan residues	2
two SN domains (SN1/2)	2
extended protein groove	2
11-residue MTDH peptide motif	2
high-resolution crystal structure of MTDH-SND1 complex	2
diverse cancer types	2
SummaryMetadherin (MTDH) and Staphylococcal nuclease domain containing 1 (SND1)	2
stromal ECM genes	2
stromal-derived extracellular matrix (ECM) proteins	2
human pancreatic CTCs	2
epithelial-stromal interface	2
gene transcript	2
epithelial and mesenchymal markers	2
biphenotypic expression	2
stem-cell-associated gene Aldh1a2	2
primary tumors and tumor-derived cell lines	2
individual CTCs	2
SummaryCirculating tumor cells (CTCs)	2
liver cancer samples	2
blocking LCAD	2
medium- and long-chain acyl-CoA dehydrogenases (MCAD and LCAD)	2
-CoA.	2
fatty acid β-oxidation (FAO)	2
acetyl-CoA in cancer cells	2
SummaryHypoxia-inducible factor 1 (HIF-1)	2
novel signaling pathways	2
interdigitated neighbors	2
membrane ruffling	2
activated Rac	2
monolayer	2
cellular sheets	2
actin-containing protrusions	2
interdigitated, desmosome-rich monolayer	2
mammary-derived MCF10A cells	2
confluent cultures	2
cellular boundaries	2
Brd4-suppressed intestines	2
Brd4-depleted mice	2
BET protein Brd4	2
inducible and reversible transgenic RNAi mouse model	2
First-generation BET inhibitors	2
first chromatin readers	2
family proteins	2
DECID complex	2
hypophosphorylated UPF1	2
NMD factor	2
the RNA helicase DHX34	2
 the decay-inducing complex (DECID)	2
exon junction complex	2
premature termination codon	2
SMG1, UPF1, and the translation termination factors eRF1 and eRF3 (SURF)	2
adult NSCs	2
Dlx2-dependent neurogenesis	2
Jmjd3-deleted SVZ cells	2
I12b enhancer of Dlx2	2
embryonic brain	2
neural enhancers	2
neurogenic enhancer elements	2
developing and adult mice	2
Jmjd3 deletion	2
adult subventricular zone (SVZ) NSCs	2
critical activator	2
lysine 27 (H3K27) demethylase	2
adult mammalian brain	2
humoral and innate immune-cell phenotypes	2
Bcl6RD2MUT animals	2
Bcl6−/− mice	2
functional GC-TFH cells	2
RD2 domain	2
trafficking receptors	2
nascent GC aggregates	2
cognate T helper cells	2
interfollicular zone	2
Bcl6RD2MUT antigen-engaged B cells	2
RD2 repression domain	2
Bcl6 transcriptional repressor	2
p53-responsive BH3 family member PUMA	2
multiple settings	2
widely used chemotherapeutic, doxorubicin	2
single experimental system	2
proapoptotic BH3 proteins NOXA and PUMA	2
many postmitotic cell types	2
modestly deregulated MYC	2
overexpressed oncogenes	2
position of disordered segments	2
Many paralogs	2
yeast proteins	2
terminal and internal disordered segments	2
terminal or internal intrinsically disordered segments	2
yeast, mouse, and human proteins	2
isoforms (α1-chimaerin and α2-chimaerin)	2
GTPase)-activating protein (RacGAP) α-chimaerin (chimerin)	2
α2 isoform of Rac-specific guanosine triphosphatase (	2
expanded universe of translated products	2
conserved reading frames	2
 cytosolic transcripts	2
vast majority of footprints	2
nonribosomal sources	2
80S footprints	2
early AUGs	2
footprints	2
multiple, overlapping open reading frames (ORFs)	2
 protein-coding regions	2
5′ UTRs and long noncoding RNAs (lncRNAs)	2
many regions of the transcriptome	2
normal and diseased human brains	2
chromosome 15q13.2-13.3	2
Many neurons	2
normal human brain tissue	2
 a minority of cells	2
tetrasomy 1q	2
chromosome 1q	2
patient with hemimegalencephaly (HMG)	2
normal brain tissue	2
germline trisomy of chromosome 18	2
three normal and two pathological human brains	2
targeted sequences	2
exosomal miRNAs	2
reporter lentiviral vectors (LVs)	2
Dicer-deficient cells	2
multivesicular bodies	2
/P bodies	2
cell cytoplasm	2
targeted transcripts	2
individual miRNAs	2
exosomes	2
macrophages and endothelial cells (ECs)	2
acceptor cells	2
RelA:IRF5 interaction domain	2
subset of key inflammatory genes	2
RelA:IRF5 cistrome	2
IRF5 and	2
noncanonical composite PU.1:ISRE motif	2
canonical IRF-binding (interferon-stimulated response element [ISRE]) motif	2
protein:DNA microarrays	2
highly transcribed genes	2
bacterial lipopolysaccharide	2
Regulatory Factor 5 (IRF5)	2
genomes and transcriptomes	2
28S rRNA	2
aberrant melatonin system	2
unusual thermogenesis	2
genome of NMR	2
genomes of DMR and other more conventional animals	2
 oxygen-carrying globins	2
divergent insulin peptide	2
related subterranean rodents	2
naked mole rat (NMR, Heterocephalus glaber)	2
genome of the Damaraland mole rat (DMR, Fukomys damarensis)	2
carbon dioxide and ammonia	2
dark, unventilated environments	2
histone-H2A-specific E3 ligase	2
BRCA1/BARD1 RING domains	2
nucleosomal context	2
K127-129	2
C-terminal tail on lysines 127 and 129	2
BRCA1/BARD1 specifically ubiquitylates histone H2A	2
BRCA1/BARD1 ubiquitin ligase	2
DNA satellite repeat regions	2
heterodimeric ubiquitin (E3) ligase	2
RING domain proteins BRCA1 and BARD1	2
phosphoproteome and metabolome data	2
liver-type phosphofructokinase 1	2
allosteric effectors	2
phosphorylated metabolic enzymes	2
important hormone	2
time-course phosphoproteome and metabolome data	2
protein phosphorylation and metabolites	2
multiple molecular networks	2
CF synaptic inputs	2
γ-2 PC-KO mice	2
Arc/Arg3.1 in PCs	2
strongest CF	2
PCs of γ-2 PC-KO mice	2
CF inputs	2
(γ-2 PC-KO mice	2
major AMPA receptor auxiliary subunit	2
PC-selective deletion of stargazin (TARP γ-2)	2
competing inputs	2
TIE2-expressing macrophages	2
vascular TIE2	2
VEGFR2 inhibition	2
VEGF receptor 2 (VEGFR2) blockade	2
late-stage RIP1-Tag2 pancreatic neuroendocrine tumors (PNETs) and MMTV-PyMT mammary adenocarcinomas	2
context-dependent TIE2 receptor agonist/antagonist and proangiogenic factor	2
SummaryAngiopoietin-2 (ANG2/ANGPT2)	2
cell death network	2
GLuc PCA platform	2
14-3-3τ binding	2
14-3-3τ	2
Ser/Thr kinase	2
previously unknown interactions	2
apoptotic and autophagic modules	2
∼3,600 protein-pair combinations	2
complementary fragments of a luciferase reporter	2
different set	2
zinc-responsive toxicities	2
original Cys positions	2
zinc-binding residue (His)	2
corresponding zinc-binding Cys residues	2
native Drosophila Tau	2
zinc-binding-deficient mutant Tau∗ (Tau∗C2A)	2
Cys residues	2
human Tau mutant (hTauR406W, or Tau∗)	2
Drosophila tauopathy model	2
melanoma phenotype determinant MITF	2
invasive cells	2
poorly invasive cells	2
subpopulations of poorly invasive cells	2
inherently invasive cells	2
heterogeneous setting	2
zebrafish-melanoma xenograft model	2
tumor-cell subpopulations	2
protein machinery	2
ROS and antimicrobial proteins	2
oxidative signaling scaffold	2
NE first	2
the cytosol	2
membrane-associated complex	2
neutrophil elastase (NE)	2
impermeable organelles	2
antimicrobial proteins	2
potent antibodies	2
open forms of cytokine receptors	2
higher-order IL-3 receptor-signaling complex	2
CSL362 still	2
“open-like” IL3Rα mutants	2
closed conformation	2
IL-3 binding site	2
NTD epitope of CSL362	2
unique “open	2
granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-5, and IL-13 receptors	2
anti-leukemia antibody CSL362	2
IL-3 receptor α chain (IL3Rα)	2
activated T cell product	2
(IL-3)	2
stress-response network	2
predefined DNA-damage stress-response network	2
p53 targets	2
high-confidence p53-regulated genes	2
p53/REs, TFIIB/Pol II	2
antisense RNA	2
transcription factor IIB (TFIIB) and RNA polymerase (Pol) II near REs	2
REs and other regulatory elements	2
2,183 unsplit REs	2
p53-bound recognition elements (REs)	2
Many p53 targets	2
suppressor p53	2
PI3K- and MAPK-mediated signaling pathways	2
insulin-sensitive tissues	2
ex vivo culture experiments	2
blood-borne factors	2
endocrine factors	2
humoral and neuronal signals	2
light input pathway	2
injured adult optic nerve and spinal cord	2
axonal pathfinding	2
Neogenin raft association	2
RGMa or Neogenin peptides	2
RGMa and Neogenin subdomains	2
bone morphogenetic protein (BMP)	2
axonal growth	2
receptor Neogenin	2
gzmA−/− recipients	2
gzmA−/− NK, cells	2
natural killer	2
gzmA−/− mice	2
Tc cells	2
mice lacking perforin or granzyme B	2
organism from liver and spleen	2
sublethal dose of the identified mouse pathogen Brucella microti, wild-type (WT) and granzyme A (gzmA)−/− mice	2
cytolytic cell granzymes	2
radiation field	2
in vivo orthotopic models	2
in vitro invasion assays	2
unirradiated, viable circulating tumor cells	2
migrating tumor cells	2
Granulocyte-macrophage colony stimulating factor (GM-CSF)	2
migrating breast cancer cells	2
field of the radiation beam	2
primary tumor cells	2
CenH3CENP-A loading	2
a model	2
unique DNA-binding domain	2
CenH3CENP-A	2
centromeres in S and G2 phase	2
nonphosphorylatable HJURP mutant	2
dedicated chaperone HJURP	2
histone H3 variant CenH3	2
flap structures	2
viral/bacterial VRR-Nuc proteins	2
dimerization interface	2
VRR-Nuc domain of FAN1	2
5′ flap structures in vitro	2
FAN1 orthologs	2
symmetric four-way junctions	2
Holliday junction resolvases (HJRs)	2
three representatives	2
many bacteria and viruses	2
standalone domain	2
“VRR-Nuc”)	2
virus-type replication-repair nuclease (	2
eukaryotic protein	2
interstrand DNA crosslinks	2
structure-selective DNA repair nuclease	2
definitive HSCs	2
Runx1+ cells in the E7.5 extraembryonic region	2
heartbeat	2
hemogenic endothelium of the dorsal aorta (DA)	2
extra- to intraembryonic region	2
subset of this population	2
Runx1+Gata1− population	2
Gata1 expression	2
two Runx1+ populations	2
adult bone marrow	2
E10.5 aorta-gonad-mesonephros (AGM) region	2
Runx1+ cells in embryonic day 7.5 (E7.5) embryos	2
definitive hematopoietic stem cells (HSCs)	2
centromeric regions	2
partner of histone H3K36 demethylase KDM8	2
family of JmjC-containing lysine demethylases	2
164 often overlapping protein complexes	2
1,738 different human proteins	2
11,464 protein-protein interactions	2
high-confidence (85% precision) network	2
293 proteins	2
known and predicted chromatin-related proteins	2
protein-protein interaction map	2
tagged human proteins	2
multicomponent protein complexes	2
replication and transcription machineries	2
stable protein filaments	2
compacted nucleoids	2
fully compacted nucleoids	2
nucleoid-like particles	2
mitochondrial transcription factor A (TFAM)	2
main protein component	2
1,000–10,000 copies of mtDNA	2
active copies of mtDNA	2
EZH2 catalytic inhibitors	2
histone Lysine 27 trimethylation	2
histone-methylation inhibitor DZNep	2
IFN-JAK-STAT1 tumor-suppressor signaling	2
interferon-γ receptor 1 (IFNGR1)	2
MYC-driven, but not PI3K-driven prostate cancer	2
EZH2-overexpressing epithelial tumors	2
lipolytic enzymes adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL)	2
KDM4A/JMJD2	2
H3K9 histone demethylase	2
ubiquitin ligase RNF8	2
local chromatin environment	2
G protein suppressor 2 (GPS2)	2
peroxisome proliferator-activator receptor γ (PPARγ) in adipocytes	2
specific promoter and/or enhancer regions	2
appropriate DNA-binding sites	2
promoters of IR and other insulin pathway modulators	2
physiological regulator	2
NUCKS targets	2
NUCKS knockout mice	2
insulin receptor (IR)	2
insulin signaling components	2
H3K36me3 axis	2
H3K36me3-decorated transcriptionally active genomic regions	2
H3.3K36M transgene	2
oncogene and H3K36me3/2 demethylase	2
KDM4A/JMJD2A	2
Replication Protein A (RPA) and RAD51	2
C-terminal binding protein interacting protein (CtIP)	2
SETD2 methyltransferase	2
I-SceI-induced DNA double-strand break (DSB) sites	2
depleting SETD2	2
histone H3K36	2
BCL2 family inhibitor	2
ROS scavenger N-acetyl-L-cysteine	2
normal bone marrow	2
relapsed AML	2
normal and cancer cells	2
wider range of functional genotypes	2
genes they control	2
negative-feedback transcription factors	2
Eubacteria kingdom	2
frequently encountered network motif	2
destabilized proteins	2
sulfonylurea KATP channel inhibitor administration	2
second mouse line expressing an N-terminal truncated MPC2 protein (Mpc2Δ16)	2
Mitochondrial pyruvate carrier 2 (Mpc2)	2
initially quiescent adult HSCs	2
nerve growth factor and collagen 1	2
different Steel factor (SF)-containing cocktails	2
distinct self-perpetuating differentiation programs	2
HSC subtypes	2
APOBEC activity	2
PIK3CA gene	2
HPV+ HNSCC	2
HPV− HNSCC	2
exomes of HPV+ and HPV− head and neck squamous cell carcinomas (HNSCCs)	2
HPV-associated tumors	2
virally infected cells	2
different hematologic malignancies	2
NKp46-high donors	2
NKp46 on NK cells	2
 immature dendritic cells	2
transplanted animals	2
human and mouse natural killer (NK) cells	2
major killer receptor	2
ubiquitin-like proteins of the SUMO family	2
Adrm1-binding domain	2
critical lysine	2
SUMOylation sites	2
SUMO E3 enzyme PIASy	2
SUMO deconjugating enzyme xSENP1	2
ubiquitinated substrates	2
Adrm1, another proteasome subunit	2
docking site	2
proteasomal 19S regulatory particle	2
cellular target proteins	2
SUMO polypeptides	2
unconventional replication intermediates	2
persistent ssDNA stretches	2
mutation spectrum	2
nearly half of wild-type yeast cells	2
double-strand break (DSB)-induced replication (BIR)	2
dysfunctional replication forks	2
resected double-strand breaks	2
long single-stranded DNA (ssDNA)	2
interneurons in the cerebellum	2
electrical synapse networks	2
coronal slices	2
sagittal slices	2
converging interneurons	2
single Purkinje cell	2
functional synapses	2
broad area	2
Purkinje cells	2
postsynaptic Purkinje cells	2
molecular layer interneurons	2
cerebellar interneurons	2
local inhibitory circuits	2
posttranscriptionally spliced genes	2
splicing-inhibited transcripts	2
unaffected transcripts	2
+ genes	2
tRNA synthetase, nuclear pore, and spliceosome functions	2
∼1,700 genes	2
 several mRNAs	2
stress response proteins	2
oxidative and reductive pathways	2
nicotinamide nucleotide transhydrogenase	2
TCA cycle	2
citrate by reductively carboxylating α-ketoglutarate (AKG) via NADPH-dependent isocitrate dehydrogenase (IDH)	2
decarboxylating pyruvate	2
different downstream pathways	2
 the liver and adipose tissue	2
several key metabolic regulators	2
paralogous phosphorylation site S714	2
disabling NMD	2
Stn1 and Ten1, the partners of Cdc13	2
DDR and NMD pathways	2
one of the components of CST	2
single-stranded DNA (ssDNA) production	2
telomere in mammals and yeast	2
CST complex, nonsense mediated decay (NMD), and DNA damage response (DDR) proteins	2
large and diverse set of proteins	2
steroid	2
a “	2
steroidogenic Th2 cells	2
helminth infection model	2
Th2 cells in vitro and in vivo	2
steroid pregnenolone	2
undiscovered Th2 signaling molecules	2
various cytokines	2
tumor immunity	2
helminth infections	2
Th2) cells	2
SummaryT helper 2 (	2
melanocortin system	2
circulating glucagon	2
Lepob/ob mice lacking neuropeptide Y (NPY) or gamma-aminobutyric acid (GABA) in AgRP neurons	2
Lepob/ob/MC4R-null mice	2
(SF1) neurons	2
LepRb in pro-opiomelanocortin (POMC) neurons	2
agouti-related peptide (AgRP)-expressing neurons	2
re-expressing leptin receptors (LepRb) in subgroups of neurons	2
diabetic Lepob/ob or Leprdb/db mice	2
specific subgroups of neurons	2
prominent tumor-suppressor gene	2
broad range of tissues	2
Ctcf hemizygous knockout mice	2
higher-order chromatin organization	2
cortical growth	2
miR-7 binding sites	2
Ak1 and Cdkn1a (p21)	2
miR-7 target genes	2
embryonic cortex	2
miR-7 sponge transgenic mice	2
 cortical neural progenitors	2
microRNA-7 (miR-7)	2
cerebral corticogenesis	2
radial glia fibers	2
migrating neurons	2
CoREST/REST transcriptional repressor complex	2
cortical wall	2
Per-deficient or mutant mice	2
BMAL1-CLOCK complex	2
CRYPTOCHROME (CRY)	2
the circadian transcription factors BMAL1 and CLOCK	2
PERIOD (PER)	2
cell’s free surface	2
cancer cell groups in vitro and in vivo	2
TRIM27 and MRTF-B	2
integrin β1 mRNA	2
TRIM27/MRTF-B complex	2
LCs and FCs	2
forefront and following cells (FCs)	2
leading cells (LCs)	2
cohesive groups	2
GCLCs in vivo	2
primitive tumors	2
germ-cell-specific proteins	2
fetal germ cells	2
germ-cell-like cells (GCLCs)	2
murine seminiferous tubules	2
Undifferentiated iPSCs	2
AZF-deleted iPSC lines	2
three Y chromosome azoospermia factor (AZF) regions	2
infertile men	2
Drosophila, mouse and other species	2
Individual lymphatic endothelial cells	2
subcutaneous lymphatic network	2
precursor sprouting	2
lyc1 mutants	2
frequently mutated gene	2
zebrafish mutant, lymphatic and cardiac defects 1 (lyc1)	2
precursor cells	2
SummaryLymphatic vessels	2
exponential growth	2
tricarboxylic-acid cycle (providing NADH	2
mRNAs, proteins, posttranslational modifications	2
yeast batch cultures	2
enough oxygen	2
Piwi/piRNA system	2
repetitive loci	2
repetitive segments of the genome	2
late-generation prg-1 mutants	2
histone H3 lysine 4 demethylases	2
RNAi proteins	2
reduced daf-2 insulin/IGF-1 signaling immortalized prg-1 strains	2
DAF-16/FOXO longevity transcription factor	2
prg-1 mutants	2
RNAi mutants	2
C. elegans Piwi mutant prg-1	2
Piwi/piRNA pathway	2
parallel, nonredundant control signals	2
arousal regulators	2
glutamate-dependent output	2
integral controller	2
OHN→HANOHR2 module	2
constant OHN input	2
HAN output	2
downstream arousal regulator, the histamine neurons (HANs)	2
optogenetically stimulated OHNs	2
computational frameworks	2
OH peptides	2
multiple excitatory transmitters	2
diverse environmental cues	2
orexin/hypocretin neurons (OHNs) and OHR2 receptors	2
vesicular Na+/H+ exchangers	2
intracellular vesicles	2
proton leak	2
proton-loading transporter	2
cytosolic H+	2
wild-type NHE7	2
H+ and alkalinize vesicles	2
cytosolic K+	2
NHE6, NHE7, and NHE9	2
these exchangers	2
highly conserved Na+/H+ exchangers NHE6, NHE7, and NHE9	2
intracellular compartments	2
H+-ATPases and ClC-chloride transporters	2
Ras, Nedd4-1	2
human cancer samples and cancer cells	2
E3 ligase Nedd4-1, Ras, and PTEN	2
frequently mutated proto-oncogenes	2
SummaryRAS genes	2
intracellular reactive oxygen species	2
prolonged survival	2
 the lungs and liver	2
TSPAN2 knockdown	2
lung adenocarinomas	2
p53-mutated lung cancer cells	2
a transmembrane protein	2
noninvasive tumors	2
invasive tumors	2
cancer-risk alleles	2
previously reported and as-yet-unidentified cancer genes	2
Differentially methylated loci	2
interrogated cancer risk polymorphisms	2
comprehensive meQTL catalog	2
3,649 primary human tumors	2
polymorphic alleles	2
physiological and pathological contexts	2
DNA methylation quantitative trait loci (meQTL)	2
CNV gains	2
early- and late-replicating domains	2
parental fibroblasts	2
human ρ° cells	2
mitochondrial complex III inhibitor antimycin	2
haploid human cells	2
posttranscriptional regulatory elements	2
human transcripts	2
linear and structural RNA cis-regulatory elements	2
resulting sequence-to-gene-expression mapping	2
short, noncoding, vertebrate-conserved RNA sequences	2
bidirectional reporter system	2
3′ UTRs of human transcripts	2
functional regulatory elements	2
combined experimental/computational technology	2
RNA cis-regulatory elements	2
heterochromatic H3K9 methylation	2
euchromatic H3K4	2
network of chromatin regulators	2
spr-5 mutant worms	2
H3K4me1/me2 and H3K9me3 methyltransferases, an H3K9me3 demethylase, and an H3K9me reader	2
multiple chromatin-modifying factors	2
euchromatic H3K4me2 mark	2
C. elegans histone H3 lysine 4 dimethyl (H3K4me2) demethylase spr-5	2
epigenetic information	2
downstream D-MKK3-D-p38 MAPK signaling cascade	2
neighboring cardiomyocytes (CMs)	2
nonmyocytic pericardial cells (PCs) of the Drosophila heart	2
nearby cells	2
oxygen species (ROS)	2
MARV-infected cells	2
Nrf2-dependent pathway	2
Nrf2-deficient mice	2
MARV VP24	2
Nrf2-dependent genes	2
panoply of cytoprotective genes	2
Keap1-mediated inhibition	2
Keap1 Kelch domain	2
negative regulator of nuclear transcription factor erythroid-derived 2 (Nrf2)	2
VP24 of MARV binds Kelch-like ECH-associated protein 1 (Keap1)	2
SummaryMarburg virus (MARV)	2
nucleic acid motors	2
base pairs unwound	2
GC-rich DNAs	2
pause	2
guanine-cytosine (GC) base pairs	2
deoxythymidine triphosphate	2
replicative helicases	2
T7 gp4	2
 SOSS1 assembly	2
neither SOSSC	2
two distinct surfaces	2
SOSSAN and ssDNA	2
35 nt ssDNA	2
SOSSAN/B1/C	2
12 nt ssDNA	2
SOSSAN/B1	2
SOSSB1 and SOSSC	2
N-terminal half of SOSSA (SOSSAN) in complex	2
SOSSA, SOSSB1, and SOSSC senses single-stranded DNA (ssDNA)	2
replicative MCM helicase	2
telomeres in budding yeast	2
two PP1 docking motifs	2
telomeric protein	2
CDK and DDK kinase activities	2
eukaryotic origins of DNA replication	2
additional male pronucleus	2
male pronucleus-depleted (MPD) zygotes	2
female pronucleus-depleted (FPD) mouse zygotes	2
parental pronuclei	2
either the sperm or the oocyte	2
parental pronucleus	2
zygotes enucleated	2
pronuclei of zygotes	2
reprogramming factors	2
functional insulin-producing cells	2
β-like cells	2
human intestinal “organoids”	2
 diabetic mice	2
intestinal neoislets	2
Neoislet cells	2
crypt base	2
“neoislets	2
intestinal crypt cells	2
wide spectrum of tissues	2
three β cell “reprogramming factors”	2
in vivo screen	2
interconvert terminally differentiated cells	2
mouse and human cells	2
subunit of the PBAF chromatin remodeling complex	2
SBMA patients	2
SBMA mice	2
mutant males	2
polyQ-AR in the periphery	2
full-length polyQ-AR	2
AR113Q knockin and human bacterial artificial chromosome/clone (BAC) transgenic mice	2
patients and mouse models	2
motor neuronopathy	2
lower motor neurons	2
polyglutamine androgen receptor (polyQ-AR)	2
new drug combinations	2
evolutionarily close strains	2
human non-small-cell lung cancer, melanoma, and breast cancer stem cells	2
E. coli, E. faecalis, S. aureus, and S. cerevisiae	2
clinically relevant microbes	2
dosage space	2
previously unsampled regions	2
drug-sensitive and -resistant cells	2
several interacting drugs	2
identified chemical probe	2
pluripotent markers	2
ABCB1 (MDR1) and ABCG2 (BCRP)	2
fluorescent compound (Kyoto probe 1 [KP-1])	2
hit molecules	2
fluorescent chemical libraries	2
small-molecule fluorescent probe	2
MMTV-neu transgenic mice	2
many metastasis genes	2
pleiotropic positive regulator	2
multiple in vivo models	2
genetically engineered mice	2
histone demethylase RBP2	2
human breast cancer gene-expression data sets	2
distinct sensory fields	2
higher-order adult dendrites	2
truncated Cut	2
truncated Cut homeodomain transcription factor	2
adult dendrites	2
larval dendrites	2
known ecdysone effectors	2
Cysteine proteinase-1 (Cp1)	2
expression screen	2
independent sensory fields	2
distinct dendritic trees	2
class of Drosophila sensory neurons	2
local inputs	2
defective condensin	2
segregation-competent chromosomes	2
 NCT	2
the first Nrc1 bromodomain	2
Hat1-Mis16 acetyltransferase complex	2
core centromere	2
similar genomic regions	2
NCT and condensin	2
Nrc1 BET-family tandem bromodomain protein (SPAC631.02), casein kinase II (CKII), and several TAFs	2
BtMinpp-OMVs	2
gastrointestinal proteases	2
outer membrane vesicles (OMVs)	2
Bacteroides thetaiotaomicron (BtMinpp)	2
mammalian InsP6 phosphatase (MINPP)	2
prominent gut bacteria	2
candidate InsP6 phosphatases	2
gastrointestinal microbiome	2
essential ligand	2
intestinal tissue-expressed B7-H1	2
CD11c+CD11b+ lamina propria cells	2
intestinal parenchyma	2
bone marrow chimeric and knockout mice	2
dextran sodium sulfate (	2
B7-H1-deficient mice	2
human and mouse intestinal epithelium	2
receptor PD-1	2
SummaryB7-H1 (PD-L1) on immune cells	2
bona fide substrate of SPOP	2
Prostate-cancer-associated mutants of SPOP	2
AR splicing variants	2
full-length AR	2
hinge domain of androgen receptor (AR)	2
Ser/Thr-rich degron	2
human prostate cancers	2
SPOP E3 ubiquitin ligase gene	2
hierarchical signaling network model	2
Wnt and BMP	2
Dickkopf-related Wnt antagonists	2
preexisting bone	2
re-epithelialized Runx2−/sp7+ osteoblasts	2
preosteoblasts upregulate sp7	2
distal tip of the regenerative blastema	2
progenitor population	2
Localized Wnt/β-catenin signaling	2
proliferative Runx2+ preosteoblasts	2
Wnt/β-catenin-dependent epithelial to mesenchymal transformation (EMT) of osteoblasts	2
fin amputation	2
dedifferentiated, lineage-restricted osteoblasts	2
fully regenerate lost bone	2
distinct substrate classes	2
autonomous CaMKII	2
LTD-type stimuli	2
GluA1 S831	2
distinct substrate class	2
traditional substrates	2
” CaMKII	2
subunit GluA1	2
AMPA-type glutamate receptor (AMPAR)	2
phospho-T286-induced “autonomous”	2
(CaM)-dependent protein kinase II (CaMKII) and other kinases	2
two DNA binding surfaces	2
protein-protein interface	2
cGAS mutants	2
two molecules of DNA	2
dimeric cGAS	2
DNA-bound cGAS	2
cGAMP- and sulfate-bound forms	2
human cGAS	2
type I interferons and other cytokines	2
adaptor protein STING	2
second messenger cGAMP	2
cyclic GMP-AMP (cGAMP) synthase (cGAS)	2
Cytosolic DNA	2
DNA in the cytoplasm	2
ribosome-EF-G complex	2
EF-G	2
EF-G and S12	2
critical contact	2
conserved amino acid residues of S12	2
ribosomal head	2
ribosomal protein S12 in solution	2
crystallographic and biochemical experiments	2
closely related decapeptide antibiotics dityromycin and GE82832	2
elongation factor G (EF-G), a universally conserved guanosine triphosphate hydrolase (GTPase)	2
KDM5B in triple-negative breast cancer cells	2
MDA-MB 231 breast cancer cells	2
estrogen-receptor-positive breast cancer	2
triple-negative breast cancer	2
histone deacetylase 1 (HDAC1)	2
 the nucleosome remodeling and deacetylase (NuRD) complex	2
trimethylated histone mark H3K4me3	2
PHD3 finger	2
unmodified histone H3 (H3K4me0)	2
PHD1 finger	2
second, PHD fingers of KDM5B	2
first and third	2
three PHD fingers	2
multiple conserved chromatin-associated domains	2
histone lysine demethylase KDM5B	2
five MCPH-associated WDR62 mutants	2
wild-type human WDR62	2
neural progenitor cells (NPCs)	2
WDR62 knockdown	2
WD40-repeat protein 62 (WDR62)	2
long noncoding antisense RNAs	2
African green monkeys	2
human and monkey liver cells	2
APOA1 expression	2
short antisense oligonucleotides	2
Targeting APOA1-AS	2
histone-modifying enzymes	2
APOA1 gene	2
∼50 kb chromatin region	2
APO cluster	2
two neighboring genes	2
APOA1-AS in cultured cells	2
negative transcriptional regulator	2
endogenously expressed long noncoding natural antisense transcript, APOA1-AS	2
high-density lipoprotein (HDL)	2
A1 (APOA1)	2
nuclear extracts	2
duplex small RNAs	2
nuclear Ago2	2
Nuclear Dicer	2
targeted RNA	2
nuclear RNA	2
Small RNAs	2
Argonaute-2 (Ago2) and RNAi factors Dicer, TRBP, and TRNC6A/	2
cytoplasm of mammalian cells	2
powerful regulator	2
proteins and membrane lipids	2
cellular machine	2
mechanoreceptor neurons	2
polyunsaturated phospholipids	2
polyunsaturated fatty acid (PUFA)	2
TRN plasma membranes	2
membrane phospholipids in C. elegans touch receptor neurons (TRNs)	2
arachidonic acid (AA), an omega-6 polyunsaturated fatty acid	2
native MeT channels	2
neuronal cell membranes	2
transduction (MeT) channels	2
HCMV growth	2
cellular mRNAs	2
HCMV UL38 mTORC1-activator	2
host genome	2
translationally regulated cellular mRNA repertoire	2
polyribosome formation	2
known TOR components	2
ChE-MAP	2
diverse library of deletion mutants	2
chemically inhibited Tor2 kinase	2
orthogonal inhibitor	2
Tor2 in S. cerevisiae	2
secondary targets	2
rapamycin analogs	2
nutrient-signaling pathway	2
conserved protein	2
new inhibitors of target of rapamycin (TOR)	2
clinically available drugs	2
cell culture models	2
synergistic targets	2
FOXO3 enhancer binding	2
H3K27ac, RNAPII, enhancer RNAs)	2
“open” and “closed” chromatin	2
active subset of enhancers	2
box O (FOXO) transcription factors	2
major iron transporter	2
lysosomal compartments	2
entry receptor NRAMP2	2
SEC61A and VCP	2
SEC61A and valosin-containing protein (VCP)	2
Sindbis virus (SINV), the prototypical alphavirus	2
model Drosophila cells	2
insect-borne human pathogens	2
MICU1 EF hands	2
mitochondrial Ca2+ current (IMCU)	2
polybasic region	2
the polybasic region	2
two interacting coiled-coil domains of MCU	2
MICU1 N-terminal polybasic domain	2
mitochondrial matrix side of the inner mitochondrial membrane	2
mitochondrial calcium	2
mitochondrial matrix Ca2+	2
axonal mitochondria	2
potential sites	2
localized hot spots	2
presumptive branching sites	2
Translational machinery	2
stalled mitochondria	2
nerve growth factor (NGF)	2
functionally important assemblies of RNA binding proteins	2
β zipper structures	2
arginine-glycine rich domain of FUS	2
low-complexity domain	2
higher-order FUS ribonucleoprotein assemblies	2
C-terminal domain (CTD) of RNA polymerase II	2
abundant nuclear RNA binding protein FUS	2
mouse eggs	2
Sr2+	2
normal offspring	2
strontium application	2
TRPV3 channels	2
TRP agonists	2
calcium-permeant channels	2
whisker-guided cues	2
response areas	2
prism	2
primary visual cortex	2
monocular prism	2
primary visual cortex of young mice	2
heterogeneous inputs	2
vision and whiskers	2
nearby space	2
cutaneous versus deep tissue pain pathways	2
deep sensory neurons	2
muscle and visceral organs	2
cutaneous neurons	2
deep tissue innervation	2
sensory innervation	2
many epidermis-projecting TrkA lineage neurons	2
transcription factor Runx1	2
superficial and deep tissues	2
dorsal root ganglion	2
TrkA lineage neurons	2
pain-related sensory neurons	2
powerful experimental platform	2
adrenocorticotropic hormone	2
human growth hormone	2
anterior pituitary hormone-producing cells	2
mature lens fibers	2
placode-derived trigeminal ganglia	2
fibroblast growth factor signaling	2
BMP inhibitor Noggin	2
cranial placodes	2
placode-derived tissues	2
interscapular brown-fat mitochondria	2
inguinal mitochondria	2
inguinal white adipose tissue	2
obesity-resistant strains	2
Obesogenic mouse strains	2
UCP1 knockout (KO) mice	2
lipid or carbohydrate substrates	2
UCP1-dependent thermogenesis	2
UCP1	2
brown-fat mitochondria	2
inguinal “white” adipose depot of cold-acclimated mice	2
brite/beige-fat mitochondria	2
uncoupling protein UCP1	2
certain white adipose tissue depots	2
non-SUMOylated RIM1α	2
CaV2.1 calcium channels	2
lysine residue K502	2
RIM1α SUMOylation	2
molecular switch	2
(SUMO-1)	2
small ubiquitin-like modifier 1	2
active zone protein Rab3-interacting molecule 1α (RIM1α)	2
rapid, activity-dependent quantal presynaptic release of neurotransmitter	2
nonreplicating M. tuberculosis	2
leaderless genes	2
 a starvation model	2
leaderless mRNAs	2
leaderless transcriptome	2
Shine-Dalgarno sequence	2
leaderless transcripts	2
primary TSS	2
M. tuberculosis promoters	2
5′ triphosphate-enriched libraries	2
replicating and nonreplicating states	2
key signaling system	2
Notch interactions	2
calcium-dependent phospholipid binding	2
Jagged-1 C2 domain residues	2
human Delta-like-1, and the evolutionary distant Drosophila Serrate	2
class of Notch ligands	2
 phospholipid bilayers	2
C2 phospholipid recognition domain	2
N terminus of human Jagged-1	2
region of Jagged-1 ligand	2
extreme N termini of the ligands	2
Notch receptor with Delta/Serrate/Lag-2 (DSL) ligands	2
metazoan organisms	2
core cell-cell signaling system	2
Schaffer collaterals	2
action potential-evoked presynaptic Ca2+ transients	2
postsynaptic NMDARs	2
local postsynaptic NMDARs	2
astrocytic K+ current	2
hippocampal CA3-CA1 synapses	2
DSBs	2
active sites of adjacent polymerases	2
3′ ends	2
gapped intermediate	2
opposing breaks	2
3′ overhanging strands	2
primer-template substrate	2
prokaryotic NHEJ polymerases	2
primer strand	2
break termini	2
NHEJ polymerases	2
major DNA double-strand break (DSB) repair pathways	2
end-joining (NHEJ)	2
particular loci	2
virtually the whole genome	2
three origins	2
different cohort of replication origins	2
specific sensory-motor connections	2
semaphorin-based system	2
 these reflex arcs	2
monosynaptic sensory-motor connectivity	2
Sema3E-PlexinD1 signaling	2
neurons in Sema3Eoff motor pools	2
neurons in Sema3E+ motor pools	2
proprioceptive sensory afferents	2
sensory-motor connections	2
select group of motor pool targets	2
selective monosynaptic connections	2
group Ia proprioceptive afferents	2
specific paradigm	2
Ire1 mutant photoreceptors	2
fatty acid transport protein (fatp)	2
targets of regulated Ire1-dependent decay (RIDD)	2
Ire1 mutant retinas	2
Xbp1 mutant photoreceptors	2
interrhabdomeral space	2
Spacemaker/Eyes	2
rhabdomere	2
Drosophila Ire1 mutant photoreceptors	2
transcription factor Xbp1	2
homeostatic signaling pathways	2
vertebrate visual system	2
tectum	2
subset of RGC axons	2
outer portions of the retina	2
dendritic processes	2
inner plexiform layer	2
presynaptic amacrine and postsynaptic tectal cell targets	2
zebrafish RGCs	2
cell-adhesive transmembrane protein Teneurin-3 (Tenm3)	2
corresponding synaptic partners	2
different subtypes of retinal ganglion cells (RGCs)	2
intrinsically supersaturated proteins	2
metastable subproteome	2
supersaturated proteins	2
another class of axons	2
one class of axons	2
dLGN and corticogeniculate innervation	2
aggrecanase expression	2
dLGN	2
cortical axons	2
neonatal dLGN	2
repulsive CSPG	2
chondroitin sulfate proteoglycan (CSPG)	2
retino- and corticogeniculate innervation	2
thalamic relay neurons	2
retina and visual cortex	2
dorsal lateral geniculate nucleus (dLGN)	2
different classes of axons	2
PP4/Smek1 complex	2
catalytic subunit PP4c	2
cortical/cytoplasmic Par3	2
Smek1 substrate	2
cell polarity protein Par3	2
regulatory subunit of the serine/threonine protein phosphatase PP4	2
progenitor cells (NPCs)	2
miRNA biogenesis pathway	2
Ago2-cleaved precursor miRNAs	2
Ago2-cleaved pre-miR-451	2
poly(A)-specific ribonuclease (PARN)	2
unknown nuclease	2
3′ end of the Ago2-cleaved pre-miR-451 intermediate	2
3′ arm of the pre-miR-451 precursor hairpin	2
erythropoietic miRNA	2
RNA-induced silencing complex (RISC)	2
Argonaute (Ago) proteins	2
ribonuclease III enzyme Dicer	2
precursor hairpins	2
∼22-nucleotide double-stranded RNAs	2
similar, but not dissimilar, spatial locations	2
dentate gyrus of the hippocampus	2
symmetrically dividing Lgr5+ stem cells	2
stem cell pools	2
glandular epithelium	2
pyloric gland	2
multiple Lgr5+ cells	2
resident Lgr5	2
limited reservoirs	2
pyloric epithelium	2
melanoma invasion suppressor	2
exogenous guanosine	2
de novo GTP biosynthesis	2
intracellular GTP pools	2
tumor xenografts	2
several GTP-bound (active) Rho-GTPases	2
amounts	2
human melanoma	2
purine nucleotides	2
guanosine monophosphate reductase (GMPR)	2
substantia nigral neurons	2
ambient CaM	2
+-free CaM (apoCaM)	2
prebinding of Ca2	2
Ca2+/CaM binding	2
edited channels	2
Ca2+-bound calmodulin (Ca2+/CaM)	2
IQ domain	2
CaV1.3 transcripts	2
CaV1.3 channels (CDI)	2
epicenter	2
pacemaking neurons	2
+ portals	2
dominant Ca2	2
SummaryCaV1.3 ion channels	2
first-order synapses	2
convergent SA and RA inputs	2
SA and RA afferents	2
individual sensory neurons	2
vibrissa column	2
different fluorescent markers	2
afferent synapses	2
rapidly adapting (RA) mechanosensory neurons	2
slowly adapting (SA) mechanosensory neurons	2
second-order neurons	2
distinct types of sensors	2
columnar structure	2
one vibrissa	2
central afferents of all touch neurons	2
several different types of touch sensory neurons	2
rodent tactile vibrissae	2
TET2-targeting miRNAs	2
cellular 5hmC	2
TET2-wild-type acute myeloid leukemia	2
miR-125b, miR-29b, miR-29c, miR-101, and miR-7	2
several TET2-targeting miRNAs	2
normal hematopoiesis	2
>30 miRNAs	2
key tumor suppressor	2
5-hydroxylmethylcytosine (5hmC)	2
Ten-Eleven-Translocation 2 (TET2) gene	2
critical coordinator	2
tumor suppressor PICT1	2
third component of this complex	2
ribosomal subcomplex, the 5S ribonucleoprotein particle (RNP)	2
ribosomal proteins RPL5 and RPL11	2
mouse double minute 2 (MDM2) homolog	2
proto-oncogenes and tumor suppressors	2
ABHD6 inhibitors	2
interface of glycerophospholipid metabolism	2
several lipid substrates	2
 in vitro	2
in vivo substrates	2
 peripheral tissues	2
targeted antisense oligonucleotides (ASOs)	2
endocannabinoid 2-arachidonylglycerol (2-AG)	2
key lipase	2
/β hydrolase domain 6 (ABHD6)	2
serine hydrolase α	2
cell-type-invariant chromatin states	2
cell-type-specific as	2
cell-type-invariant Pol II-bound regions	2
histone H2A.Z	2
∼1,500 neuronal and glia-specific genes	2
RNA polymerase II (Pol II) CAST-ChIP	2
A-EJ long deletions	2
alternative end-joining (A-EJ)	2
CtIP/MRE11-dependent long-range deletions	2
the Bloom syndrome gene product, BLM	2
appropriate double-strand break (DSB) repair pathway	2
second endogenous noncircadian clock	2
circalunar clock	2
circadian and circalunar clocks	2
casein kinase 1δ/ε	2
monthly clock	2
nocturnal light	2
worm’s forebrain	2
distinct nucleus of the worm’s forebrain	2
core circadian oscillator genes	2
endogenous circadian and circalunar (monthly) clocks	2
marine worm Platynereis dumerilii	2
endogenous clocks	2
daily (circadian) clock	2
multiple rhythms	2
ectopic LSD1 expression	2
tumorigenicity in vivo	2
multiple cancer cell lines and breast tumor samples	2
bona fide deubiquitinase of LSD1	2
human deubiquitinases	2
many types of tumors	2
critical chromatin modulator	2
originating tumor genome	2
standard cell lines	2
endocrine-drug-resistance etiologies	2
deeply sequenced PDX models	2
human, cell line, and PDX endocrine-response studies	2
Estrogen-receptor-positive PDXs	2
PDX-specific somatic events	2
major intrinsic subtypes	2
patient-derived xenografts (PDXs)	2
cellular regulator	2
isolated LINE-1 ribonucleoproteins	2
enzymatic active site mutant SAMHD1	2
LINE-1 retrotransposition	2
Several domains of SAMHD1	2
mutant SAMHD1s of Aicardi-Goutières syndrome patients	2
LINE-1 and LINE-1-mediated Alu/SVA retrotransposition	2
viral Vpx protein	2
HIV/simian immunodeficiency virus (SIV) infectivity	2
Aicardi-Goutières syndrome gene product SAMHD1	2
active autonomous retrotransposons	2
SummaryLong interspersed elements 1 (LINE-1)	2
correctly proportioned neural and mesodermal tissues	2
T-box family members	2
mesodermal derivatives	2
oversized neural tube	2
neurogenic genes	2
genomic recognition sites	2
T-box proteins	2
frog embryos	2
neuromesodermal stem cells	2
Eomesodermin, and VegT	2
T-box proteins Brachyury	2
in vivo genome-wide regulatory inputs	2
T-box transcription factor family	2
skeletal muscle or nervous system	2
mesoderm or neurectoderm	2
human type 2 diabetic beta cells	2
delta cells	2
Nkx6.1-deficient beta cells	2
Nkx6.1-regulated genes	2
mature beta cells	2
Nkx6.1-controlled gene regulatory network	2
essential evolutionary conserved component	2
RAB8B morphants	2
Xenopus laevis and Danio rerio	2
RAB8B overexpression	2
Wnt target genes	2
Rab GTPase RAB8B	2
RNAi screen	2
signal downstream	2
LRP5/6 coreceptors	2
/β-catenin signaling	2
nviRNAs	2
novel virus-inducible RNAs (nviRNAs)	2
abundant unannotated loci	2
IRF3 and NFκB	2
known messenger-RNA-encoding loci	2
paused polymerase	2
associated machinery	2
human antiviral gene regulatory network	2
factors interferon regulatory factor 3 (IRF3) and nuclear factor κB (NFκB)	2
cortical networks	2
preconfigured, highly active minority	2
familiar and novel environments	2
brain states	2
multiple layers of the entorhinal-hippocampal loop	2
cortical populations	2
mammalian model	2
many, but not all, organ systems	2
hypomorphic (mTORΔ/Δ) alleles	2
mechanistic target of rapamycin (mTOR) hypomorphic mouse model	2
poor biofilm formers	2
swarming colonies	2
environmental and clinical settings	2
naturally monoflagellated bacteria	2
flagellar synthesis regulator, FleN	2
independently evolved hyperswarmers	2
surface-associated environments	2
planktonic populations	2
surface-associated communities	2
bacteria in nature	2
new cell type	2
pluripotent neoblasts	2
highly flexible systems	2
Almost all planarian muscle cells express PCGs	2
planarian body wall	2
many PCGs	2
subepidermal layer of nonneoblast cells	2
position control genes (PCGs)	2
public database	2
unique resource	2
108 FDA-approved drugs	2
differentially regulated proteins	2
strong cell line clusters	2
5,578 proteins	2
core cancer proteome	2
protein kinases)	2
10,350 proteins	2
NCI-60 panel	2
NCI-60 cell line collection	2
surface of naturally dividing cells	2
nocodazole, S-Trityl-L-cysteine, or RO-3306	2
naturally dividing cells	2
clathrin-coated pit formation	2
known H2Bub1 interactome	2
 SWI/SNF	2
H2Bub1-rich chromatin	2
proteins and protein complexes	2
preferentially interacting human proteins	2
affinity matrix	2
chromatin template	2
histone H2B on lysine 120 (H2Bub1)	2
cell surface of macrophages	2
CSF-1-producing carcinoma cells	2
WASp−/− macrophages	2
orthotopic and transgenic models	2
hematopoietic-cell-specific Wiskott-Aldrich syndrome protein (WASp)	2
epidermal growth factor (EGF)-secreting tumor-associated macrophages (TAMs) and colony-stimulating factor 1 (CSF-1)-secreting breast carcinoma cells	2
proposed pathway	2
TRPM8 protein	2
inverse OPRM agonist naloxone	2
cold-sensor TRPM8	2
addicted patients	2
abstinent patients	2
μ-opioid receptors (OPRMs)	2
specific repressors	2
mammalian activators	2
yeast GAL genes	2
single Kit promoter nucleosome	2
active enhancer	2
Kit enhancer	2
mast cells)	2
Kit, a mammalian gene	2
GAL genes	2
 a gatekeeper	2
epithelial cancer	2
human keratinocytes and human tumors	2
transcription factor GLI2	2
Ihh deficiency	2
sebaceous gland tumor model	2
lung and lymph node metastases	2
Ihh-deficient mice	2
benign squamous papilloma	2
epidermal Indian hedgehog (Ihh)	2
basal cell carcinoma	2
many different organs	2
homologous PHF3	2
histidine residue	2
atypical aromatic-cage-like binding site	2
the mitotic spindle	2
histone H3K4me3	2
plant homeodomain (PHD) finger	2
stemness genes	2
Inducer Obliterator 3 (Dido3)	2
Jag1-Notch pathway	2
signaling protease	2
hippocampi	2
cognate Notch receptor	2
membrane-anchored full-length Jagged1 (Jag1)	2
membrane-bound cellular substrates	2
Transmembrane BACE1	2
sole secretase for generating β-amyloid (Aβ)	2
nascent 60S ribosomes	2
RPL5/RPL11/5S rRNA preribosomal complex	2
one of the three components	2
either RPL5 or RPL11	2
specific RNA polymerase III cofactor	2
5S rRNA synthesis	2
noncoding rRNA	2
three	2
noncoding 5S ribosomal RNA (rRNA)	2
preribosomal complex	2
squamous esophageal epithelium	2
CC region	2
MM	2
gastric SCs	2
posterior midgut and the middle midgut	2
enterocytes at the boundary	2
adult gastrointestinal tract	2
BMP-like Dpp signaling pathway	2
SCs	2
Distinct populations of somatic stem cells (SCs)	2
series of epithelia	2
Cdk/Cdc5	2
untimely Cdc5 expression	2
chromosomal interactions	2
activating Mus81-Mms4	2
CDC5 and MMS4 mutants	2
Mus81-Mms4 nuclease	2
cell-cycle kinases Cdk and Cdc5	2
DNA joint molecules (JMs)	2
live human cell model	2
rare events	2
intermediate-stage lesions	2
HNF4α network	2
PanIN-like cells	2
pancreatic intraepithelial neoplasia (PanIN) precursors	2
10–22 cells	2
one PDAC line	2
pancreatic tissue	2
advanced-stage cancer	2
medulla cortex of the Drosophila optic lobes	2
adult fly brains	2
model organism like Drosophila	2
miR-294/miR-302 family	2
Rb proteins	2
differentiation-inducing miRNAs	2
additional miRNAs (miR-26a, miR-99b, miR-193, miR-199a-5p, and miR-218)	2
cells in G1	2
Rb family	2
retinoblastoma (Rb) family proteins	2
embryonic stem cell (ESC) cell cycle	2
miR-294 and miR-302 microRNAs	2
excitatory and inhibitory scaffold assembly	2
inhibitory and excitatory synapses	2
PSD-95 versus gephyrin	2
Nlg1 point mutants in neurons	2
unique tyrosine (Y782)	2
gephyrin by Nlg1 peptides	2
Nrx1β binding	2
aggregating Nlg1	2
Nrx1β or nonactivating HA antibodies	2
Nlg1 in neurons	2
postsynaptic density protein 95 (PSD-95) scaffold	2
) and neuroligin-1 (Nlg1)	2
(Nrx1β	2
evolutionarily conserved IIS	2
proteotoxic proteins	2
ubh-4 human ortholog uchl5	2
tissue-specific proteasome inhibitor	2
proteasome-associated deubiquitinating enzyme ubh-4	2
FOXO transcription factor DAF-16 in C. elegans	2
decreased IIS	2
insulin/IGF-1 signaling (IIS)	2
mammalian cGAS	2
noncanonical cyclic dinucleotide	2
conventional (3′-5′) cyclic dinucleotides	2
hSTING variants	2
useful adjuvant or immunotherapeutic	2
diverse hSTING receptors	2
Cyclic [G(2′-5′)pA(3′-5′)p]	2
single 2′-5′ phosphodiester bond	2
noncanonical cyclic dinucleotide, cyclic [G(2′-5′)pA(3′-5′)p]	2
cGAS product	2
natural variants of human STING (hSTING)	2
downstream receptor called STING	2
enzyme called cGAMP synthase (cGAS)	2
cyclic GMP-AMP (cGAMP)	2
cytosol of mammalian cells	2
foreign DNA	2
core nucleotidyltransferase	2
family of innate immunity sensors	2
cGAS zinc ribbon	2
divergent C-terminal domains	2
RNA-sensing enzyme, 2′-5′ oligo-adenylate synthase (OAS)	2
catalytic core of cGAS	2
core enzymatic nucleotidyltransferase scaffold	2
unanticipated zinc-ribbon DNA-binding domain	2
crystal structure of human cGAS	2
cyclic GMP-AMP synthase (cGAS)	2
NDUFA4 protein	2
additional COX subunit	2
patient muscle	2
abnormal subassemblies	2
control muscle	2
one- and two-dimensional blue-native polyacrylamide gels	2
denaturing gels	2
(NADH:ubiquinone oxidoreductase) subunit	2
mitochondrial respiratory chain complex	2
consanguineous pedigree	2
many cases	2
epigenome maps of human cells	2
three-dimensional genome organization	2
specific domains and repressive regions	2
active regulatory regions	2
CpG-dense regions	2
human lung fibroblasts	2
somatic replication-dependent H1 subtypes	2
key chromatin components	2
canonical, replication-dependent somatic histone H1 subtypes (H1.1, H1.2, H1.3, H1.4, and H1.5)	2
 DNA junctions	2
different 5′ nucleases	2
base of the junction	2
conserved capped-helical gateway	2
5′ flap of a nick junction	2
5′ end junctions	2
diverse substrates	2
5′ nucleases	2
cellular DNA	2
structure-specific 5′ nucleases	2
SummaryHuman flap endonuclease 1 (FEN1)	2
bivalent domains	2
>2,500 “orphan” bivalent domains	2
developmental regulatory genes	2
H3K4me3/H3K27me3 bivalent domains	2
mouse primordial germ cells (PGCs)	2
RhoGAP family	2
family members p63 or p73	2
tetramerization domain of p53	2
RhoGAP domain of ArhGAP11A	2
RhoGAP ArhGAP11A	2
Rho GTPase activation proteins (RhoGAPs)	2
large LDs	2
paralog of the ER tubule-shaping protein DP1/REEP5	2
whole animals	2
Drosophila fat bodies	2
overexpression of atlastin	2
dominant-negative mutant	2
endoplasmic reticulum (ER) membranes	2
major fat storage organelles	2
SummaryLipid droplets (LDs)	2
precise connections	2
tightly regulated signaling network	2
BMP and neurotrophin pathways	2
Erk-specific dual-specificity phosphatase, Dusp6	2
Smad1 (pSmad1L)	2
neurotrophin signaling	2
Erk1/2 transcription	2
carboxy-terminal phosphorylation of Smad1 (pSmad1C)	2
bone morphogenetic proteins (BMPs)	2
Erk1 and Erk2—two key neurotrophin effectors	2
neurotrophin-mediated sensory axon growth	2
different cues	2
developing sensory neurons	2
FH-associated oncogenesis	2
extramitochondrial metabolic pathways	2
FH1-deficient cells	2
cytosolic FH	2
FH1-deficient cells and tissues	2
mitochondrial and cytosolic FH isoforms	2
leiomyomas, renal cysts	2
Krebs cycle enzyme, fumarate hydratase (FH)	2
mutated metabolic enzymes	2
adult primate fibroblasts	2
defined, integration-free iNPs	2
iNP-derived cells	2
enriched population of spinal motor neurons	2
hindbrain genes	2
iNPs	2
induced pluripotent stem cell (iPSC) colonies	2
Induced neural progenitor (iNP)	2
chemically defined medium containing leukemia inhibitory factor (LIF), transforming growth factor (TGF)-β inhibitor SB431542, and glycogen synthase kinase (GSK)-3β inhibitor CHIR99021	2
adult human and monkey fibroblasts	2
GluR-IIA	2
postsynaptic receptor fields	2
GluR-IIA-type glutamate receptor subunits	2
glutamatergic Drosophila neuromuscular junction	2
functional neural circuits	2
input number counter	2
CaMKIIα and calcineurin	2
dual fluorescence resonance energy transfer (FRET) imaging platform	2
postsynaptic enzymes	2
pure populations of human iPSC-derived melanocytes	2
Hermansky-Pudlak syndrome and Chediak-Higashi syndrome patient-specific induced PSCs (iPSCs)	2
adult melanocytes	2
pure populations	2
hESC-derived melanocytes	2
SOX10::GFP human embryonic stem cell (hESC) reporter line	2
NC and melanocyte precursor fates	2
WNT, BMP, and EDN3 signaling	2
Pluripotent stem cell (PSC) technology	2
pigment-producing cells of neural crest (NC) origin	2
dystonia models	2
synaptic sites	2
messenger RNAs	2
torsin mutants	2
primary megaRNP envelopment	2
AAA-ATPase	2
herpes-type viruses	2
large ribonucleoprotein (megaRNP) granules	2
endogenous gene loci	2
cotranscriptional cleavage (CoTC)-type terminator elements	2
mammalian Pol II terminator elements	2
human β-globin terminator mechanism	2
Pol II terminator sequences	2
known and potential Pol II promoter sequences	2
promoter databases	2
DNA-encoded terminator elements	2
endogenous telomerase	2
nonfunctional hTERT messenger RNA	2
 this second element	2
oligonucleotide	2
intron/exon junctions	2
element within intron 8	2
exons 7 and 8	2
exon 6/intron junction	2
 bp repeats	2
A 1.1 kb region	2
bp intronic sequences	2
hTERT exons 5–10	2
functional splice isoforms	2
mostly nonfunctional products	2
messenger RNA of human telomerase (hTERT)	2
somatic tissues	2
molecular substrates	2
calyx of Held nerve terminal	2
synaptobrevin, SNAP-25, and syntaxin	2
recycling vesicles	2
surroundings of the replisome	2
replication factor	2
broad list of proteins	2
known replisome components	2
human replisome and replisome-associated factors	2
proteins on nascent DNA chains	2
LTag initiator/helicase	2
narrow minor groove region	2
histidine residues of the AAA+ domains	2
OBDs	2
origin binding domains (OBDs) and Zn and AAA+ domains	2
origin DNA	2
two multidomain LTag subunits	2
viral replication origin	2
initiator/helicase	2
SV40 large tumor antigen (LTag)	2
Simian virus 40 (SV40)	2
DNA tumor virus	2
multiple chaperones	2
analogous assemblies	2
eukaryotic replication and transcription machineries	2
2 micron minichromosome	2
subtelomeric chromatin	2
amino terminal tail of Mcm2 binds histones	2
replisome progression complex	2
Mcm2-7 helicase	2
FACT (facilitiates chromatin transcription) complex	2
Mcm2 helicase subunit	2
yeast cell extract	2
replisome components	2
reactive glia	2
brains of MPTP-induced hemiparkinsonian rhesus monkeys	2
neurons, astrocytes, and myelinating oligodendrocytes	2
transplanted autologous rhesus monkey iPSC-derived neural progenitors	2
iron-sulfur cluster binding	2
(ACO2)	2
mitochondrial Aconitase2	2
three cysteine residues	2
protein succination targets	2
Fh1 (murine FH)-deficient mice	2
cells and renal cysts	2
intracellular fumarate	2
gene encoding the Krebs cycle enzyme fumarate hydratase (FH)	2
p300 and C/EBP proteins	2
livers of patients	2
β pathway	2
p300-C/EBPα/	2
fewer C/EBPα/β-p300 complexes	2
dominant-negative p300	2
old WT mice	2
/β complexes	2
tripartite p300-C/EBPα	2
young S193D mice	2
old wild-type (WT) mice	2
C/EBPα-S193D knockin mice	2
aging liver	2
hepatic steatosis	2
functional visual system	2
symmetric mitoses	2
neural progenitor pool	2
Drosophila visual system	2
anticancer or anti-inflammatory agents	2
atypical IKKs	2
structure of TBK1	2
structural platform	2
multidomain architecture of TBK1	2
canonical IKK	2
close homolog inhibitor of κB kinase ε (IKKε)	2
ubiquitination sites	2
lysines 30 and 401	2
K63-linked polyubiquitination	2
An intact TBK1 dimer	2
kinase, ubiquitin-like, and scaffold/dimerization domains	2
nearly full-length TBK1	2
2.4 Å-resolution crystal structure	2
pathogen-associated inflammatory signals, TANK-binding kinase 1 (TBK1)	2
nuclei of tolerant macrophages	2
Constitutively active PP2Ac	2
multiple proinflammatory/proapoptotic pathways	2
signal-promoting TLR4-MyD88 complex	2
constitutively active PP2Ac	2
protein phosphatase 2A catalytic subunit α (PP2Ac)	2
endotoxin-tolerant macrophages	2
MyD88 interactome	2
intracellular adaptor of most TLRs	2
identified genes	2
epiregulin, an ErbB1 ligand	2
ErbB1 signaling	2
1,700 genes	2
NFκB loop	2
amplifier	2
animal models	2
nonimmune cells	2
IL-6 amplifier/Inflammation amplifier)	2
NFκB signaling	2
IL-6-triggered positive feedback loop	2
neither presynaptic nor postsynaptic processes	2
presynaptic specializations and sublaminar organization	2
BC axon terminals	2
IPL-like neuropil	2
partner cells	2
MG individually or in combination	2
projections from Müller glia (MG)	2
dendrites of ACs and RGCs	2
bipolar cell (BC) axon terminals	2
cell bodies of amacrine cells (ACs) and retinal ganglion cells (RGCs)	2
retinal inner plexiform layer (IPL)	2
open or closed channel structure	2
clasp knife	2
spring	2
One mutant	2
first transmembrane domain	2
periplasmic lipid-aqueous interface	2
equivalent S. aureus F47	2
E. coli I49	2
periplasmic region of the protein	2
Escherichia coli and Staphylococcus aureus chimeras	2
best-studied mechanosensors	2
osmotic “emergency release valve	2
highly conserved bacterial mechanosensitive channel	2
similar agents	2
patients receiving sunitinib	2
patients with metastatic renal cell carcinoma	2
sunitinib and interferon alfa	2
tumor’s adaptation	2
vascular endothelial growth factor receptor	2
SG	2
AR expression	2
Poorly differentiated human sebaceous carcinomas	2
AR signaling	2
proliferative SG progenitors	2
functional AR	2
androgen receptor (AR) and p53	2
sebaceous gland (SG)	2
retinoic acid receptors	2
peroxisome proliferator-activated receptor delta	2
highly occupied target regions	2
large numbers of factors	2
-cancer-associated TFs	2
NRs and other breast	2
highly interconnected regulatory matrix	2
resulting network	2
breast cancer cell line MCF-7	2
breast-cancer-associated transcription factors (TFs)	2
24 NRs	2
regulatory map	2
nuclear receptors (NRs)	2
PAK4-PKC/SRC network	2
distinct phosphoproteome	2
downstream product	2
RUNX1 protein	2
RUNX1 gene	2
Individual MLL fusion proteins	2
novel fusion proteins	2
important epigenetic regulator	2
(MLL) protein	2
Mixed Lineage Leukemia	2
steady-state mRNAs	2
developmental patterning gene	2
high-resolution imaging assays	2
different cells in a population	2
virus transcript	2
antagonist	2
viral nuclear export protein (NEP)	2
erroneous splice site	2
spliced virus product	2
bicistronic nonstructural segment	2
progeny virions	2
cancer-derived somatic mutational catalogs	2
blind source separation problem	2
mutational processes	2
thousands of cancers	2
fertilized egg	2
Aβ42(43)	2
PS/γ-secretase function	2
PS1 mutants and inverse GSMs	2
kcat)	2
PS/γ-secretase-bound Aβ42	2
Aβ40 or Aβ38	2
Aβ38, and Aβ43	2
presenilin (PS)/γ-secretase	2
in vitro and in living cells	2
familial mutations and γ-secretase modulators (GSMs)	2
NMDA receptor (NMDAR) function	2
neurons in the adult forebrain	2
dendritic spines of pyramidal neurons	2
 the mature central nervous system	2
ligand, netrin-1	2
colorectal cancer (DCC)	2
complexes and organelles	2
terminal zygotic buds	2
bud site	2
parental mitochondria	2
Sup35p-GFP [PSI+].	2
buds	2
[psi-] × [PSI+] crosses	2
midzone of supramolecular complexes (polysomes and Sup35p-GFP [PSI+])	2
supramolecular complexes and organelles	2
septin annulus	2
zygote midzone	2
haploid cells of Saccharomyces cerevisiae	2
critical molecular target	2
CD38-dependent pathway	2
CD38-dependent and -independent pathways	2
signaling pathway involving nicotinic acid adenine dinucleotide phosphate (NAADP), a calcium mobilizer	2
Peroxisome proliferator-activated receptor γ (PPARγ)	2
endocannabinoid and prostaglandin signaling	2
AD animals	2
spatial learning	2
β-site amyloid precursor protein cleaving enzyme 1 (BACE1)	2
β-amyloid (Aβ)	2
endocannabinoid 2-arachidonoylglycerol	2
primary enzyme	2
Monoacylglycerol lipase (MAGL)	2
effective medications	2
clathrin/AP1 and clathrin/AP3 carriers	2
AP1 and AP3 dynamics	2
K44A dominant-negative mutant of dynamin	2
/AP3 carriers	2
clathrin/AP1	2
clathrin/AP2 pits	2
burst	2
AP2 and AP3 counterparts	2
clathrin/AP1 coats	2
endocytic clathrin/AP2 pits and vesicles	2
intracellular clathrin/AP1 and clathrin/AP3 carriers	2
chimeric fluorescent protein (clathrin light chain, σ adaptor subunits, or dynamin2)	2
relatively sparse, diffraction-limited, fluorescent objects	2
spinning-disk confocal microscope	2
endosomes and the trans-Golgi network	2
SummaryClathrin/AP1- and clathrin/AP3-coated vesicular carriers	2
antagonism	2
X.	2
reduced H3K27me3 elsewhere	2
mutually exclusive domains	2
genome-wide chromatin immunoprecipitation	2
X chromosomes and somatic genes	2
dissected mutant germlines	2
germline-expressed genes	2
repressive H3K27me3	2
C. elegans Polycomb repressive complex 2	2
MES-6	2
key chromatin regulators	2
MES proteins	2
wide range of cancers	2
tumor xenograft growth	2
β-catenin signaling targets	2
HDAC6 deacetylase activity	2
central molecule of the canonical Wnt signaling pathway, β-catenin	2
endosomal-lysosomal pathway	2
the deacetylase HDAC6	2
number of tumor types	2
lineage-specific cancer progenitor cells	2
pentaspan membrane glycoprotein	2
additional constructs	2
set of DNA fragments	2
adult nervous system	2
distinct, small subsets	2
exogenous genes	2
GAL4 lines	2
novel neuronal cell types	2
useful lines	2
6,650 lines	2
adult brain and ventral nerve cord	2
fragment	2
 dissected nervous systems	2
transcriptional enhancer	2
different, defined fragment of genomic DNA	2
 each line	2
Drosophila genome	2
DNA sequence motifs	2
leg chordotonal organ	2
Several patterns	2
wing, haltere, and eye)	2
dorsal but not ventral discs	2
ventral, but not dorsal, discs (legs, genital, and antenna)	2
multiple discs	2
active fragments	2
large regions	2
eye, antenna, leg, wing, haltere, or genital imaginal discs	2
1,200 reporter genes	2
third-instar larval imaginal discs	2
GAL4 reporter genes	2
genome of Drosophila melanogaster	2
6,000 fragments	2
reduced S6K2	2
phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways	2
serine/threonine kinase S6K2	2
sporadic FTD neurons	2
patient-specific cellular models	2
intracellular and secreted PGRN	2
PGRN S116X induced pluripotent stem cells	2
FTD patient	2
control subject	2
multiple induced pluripotent stem cell lines	2
regulatory motif	2
short- and low-amplitude stimuli	2
feedbacks	2
Experiments and modeling	2
C/EBPβ	2
nondividing adipocytes	2
proliferating preadipocytes	2
one part	2
intact embryos	2
halved embryos	2
living mouse embryos	2
phagocyte NADPH oxidase complex	2
catalytic component	2
SIRPα cytoplasmic immunoreceptor tyrosine-based inhibitory motifs	2
natural ligand, CD47	2
human myeloid cells	2
SIRPα mutant mice	2
 a negative regulator	2
myeloid-inhibitory receptor SIRPα	2
clearance mechanisms	2
aggregated protein scaffold	2
additional in vivo studies	2
NCC constituents	2
misfolded β-tubulin	2
plasminogen−/− mice	2
plasminogen-activating system	2
 a cofactor and substrate	2
insoluble oligomers	2
soluble intracellular proteins	2
In vitro and in vivo models	2
mouse cohorts	2
human telomeres	2
mouse telomeres	2
wild-type and transgenic telomerase reverse transcriptase mice	2
Normal populations of humans and mice	2
p38 mitogen-activated protein kinase signaling pathway	2
key proinflammatory cytokine interleukin-1β	2
tonic inhibitory current	2
hippocampal slices	2
α5 subunit	2
α5-subunit-containing γ-aminobutyric acid type A (α5GABAA) receptors	2
apoptotic corpses	2
recruited hemocytes	2
apoptotic debris	2
winner clones	2
dmyc-induced supercompetition	2
genes in winner cells	2
“loser cells	2
competition (“winner cells”	2
genes wasp	2
growing population	2
slow dividing cells	2
MuSK expression	2
histological and behavioral assays	2
SOD1G93A mice	2
nerve terminals	2
retrograde signaling pathway	2
immature APLNR+PDGFRα+ mesoderm	2
endothelium and primitive blood cells	2
VE-cadherin-negative KDRbrightAPLNR+PDGFRαlow/− hematovascular mesodermal precursors (HVMPs)	2
VE-cadherin+CD235a+CD41a− early hematopoietic cells	2
VE-cadherin+CD73+ non-HEPs	2
true HEPs	2
VE-cadherin+CD73−CD235a/CD43− phenotype	2
 human pluripotent stem cells (hPSCs)	2
definitive hematopoietic cells	2
human HE progenitors (HEPs)	2
SummaryHemogenic endothelium (HE)	2
mosaic mutant cells	2
granule cell precursors	2
developing hindbrain	2
FGF8 or SHH signaling	2
nearly all GFP-expressing cells	2
floxed allele	2
inducible FlpoER transgene	2
GFPcre fusion protein	2
targeted allele (R26MASTR)	2
invertebrate model organisms	2
critical functions of genes	2
scattered mutant cells	2
matricryptins and integrins	2
α3β1 integrins	2
climbing fiber terminals	2
matricryptin endostatin	2
collagen XVIII	2
growth factors and ECM molecules	2
target-derived growth factors, extracellular matrix (ECM) molecules, and matricryptins (proteolytically released fragments of ECM molecules)	2
synaptic partners	2
SummaryTrans-synaptic organizing cues	2
behavioral control circuits	2
neuropeptide autoreceptors	2
LNvs	2
PDF/neurotransmitter corelease	2
Gα,s-cAMP pathway	2
autoreceptors	2
functional PDFR	2
PDF receptor (PDFR)-expressing dorsal clock neurons	2
neuropeptide PDF (pigment dispersing factor)	2
lateral-ventral pacemaker neurons (LNvs)	2
central circadian clock neurons	2
melanogaster flies	2
cell types of the eye	2
 a conserved, transcription-factor-encoding ovo gene	2
previously undescribed planarian eye transcription factors	2
invertebrate eyes	2
bestrophin-1 and Usher syndrome genes	2
several planarian eye genes	2
vertebrate retinal pigment epithelium	2
melanin synthesis enzymes	2
solute transporters	2
optic pigment cells	2
Drosophila and vertebrates	2
orthologs of genes	2
Planarian photoreceptors	2
planarian Schmidtea mediterranea	2
eye transcriptome	2
millions of invertebrate species with visual systems	2
different partners	2
GPS	2
entire aGPCR class	2
GPCR proteolytic site (GPS) motif	2
prototypical aGPCR LAT-1/Latrophilin in Caenorhabditis elegans	2
transgenic assay	2
canonical 7TM receptors	2
second largest group of seven-transmembrane-spanning (7TM) receptors	2
SummaryAdhesion class G protein-coupled receptors (aGPCR)	2
clustered Pcdh expression	2
excitatory postsynaptic currents	2
CTCF-deficient neuron	2
53 isoforms of the clustered protocadherin (Pcdh) genes	2
CTCF-deficient and control cortex and hippocampus	2
390 transcripts	2
functional somatosensory mapping	2
CTCF-cKO mice	2
dorsal telencephalon	2
postmitotic projection neurons	2
conditional knockout (cKO) of CTCF	2
CCCTC-binding factor (CTCF)	2
silent Variant Surface Glycoprotein genes	2
eukaryote	2
active origins	2
replication initiator ORC1/CDC6	2
organization	2
discrete transcription units	2
Trypanosoma brucei genome	2
replication initiation sites	2
volatile amines	2
main olfactory pathway	2
hard-wired, parallel input stream	2
dorsal TAAR glomeruli	2
TAAR genes	2
 a sensory neuron population	2
previously described class I and class II domains	2
TAAR projection	2
dorsal olfactory bulb of the mouse	2
discrete subset of glomeruli	2
TAARs	2
small family of evolutionarily conserved olfactory receptors	2
trace amine-associated receptors (TAARs)	2
specific glomeruli	2
1,000 odorant receptors in mice	2
podocyte foot process architecture	2
Robo2 signaling	2
nephrin null mice	2
Robo2 knockout mice	2
Slit2-Robo2 signaling	2
adaptor protein Nck	2
nephrin in the kidney	2
basal surface of mouse podocytes	2
kidney glomerular filtration barrier	2
podocyte slit-diaphragm protein	2
repulsive guidance cue Slit	2
cell surface receptor	2
important accessory cell population	2
inflammatory monocyte marker Ly6C	2
subset of CD169+ macrophages	2
low-motility contacts	2
subcapsular region of the lymph node	2
Toxoplasma gondii mouse infection models	2
analyses in mice	2
nonneural cells	2
 a microRNA, miR-9	2
toxic progerin	2
 a mutated prelamin A	2
precursor called prelamin A.	2
major isoform of LMNA	2
neural derivatives of lamin A	2
HGPS patient cells	2
clustered DSBs	2
98 breakpoint junctions	2
one or more chromosomes	2
multiple clustered double-stranded DNA breaks (DSBs)	2
rearrangements	2
ten patients	2
 the structural variation landscape	2
MAGL inhibitors	2
enhanced endocannabinoid signaling	2
AD mouse model	2
neuroinflammatory prostaglandins	2
primary arachidonic acid pool	2
monoacylglycerol lipase (MAGL)	2
neurotoxic stimuli	2
proteins, nucleic acids, and small molecules	2
designer PUF proteins	2
subsets of target sites	2
PUF-RNA interactions	2
 a specific protein partner	2
members of the PUF (Pumilio and FBF) family of eukaryotic mRNA regulators	2
low- and high-affinity sites	2
vast array of RNAs	2
high-throughput sequencing, and sequence-specificity landscapes	2
RNA-protein interactions	2
RNA binding proteins	2
FADD-caspase-8 complex	2
RIPK3-dependent signaling (including necrosis)	2
FADD-caspase-8-cFLIPL complex	2
FADD, RIPK3 double-knockout mice	2
caspase-8-deficient mice	2
caspase-8-like protein	2
adapter molecule, FADD	2
initiator caspase of the death receptor pathway of apoptosis	2
dendritic input	2
synaptic and extrasynaptic NMDARs	2
h-channel conductance (Gh) of the cell	2
perisynaptic transporters	2
spine NMDARs	2
ambient glutamate	2
CA1 pyramidal neurons	2
dendritic shafts	2
extrasynaptic NMDARs	2
expressing and nonexpressing cell types	2
variant histone H2Av	2
GAGA factor	2
Dll regulatory DNA	2
transcriptional activators and repressors	2
extended configuration	2
Dll-nonexpressing cells this DNA	2
Dll promoter	2
5′ regulatory region	2
cells that express Dll	2
Distalless (Dll)	2
tagged chromatin	2
binding sites (lacO)	2
Regulatory DNA	2
individual loci	2
insects and vertebrates	2
olfactory circuit	2
olfactory bulb of mice	2
corresponding domain	2
antennal lobe of valence-specific output neurons	2
set of activated receptors	2
attractive and aversive odorants	2
behavioral screen	2
complex sensory input	2
detected stimuli	2
degradation product of purines	2
hepatic clock	2
nucleotides in the body	2
gerbil, guinea pig, and chinchilla	2
traveling waves on Reissner's membrane	2
elastic structure	2
middle ear	2
tones itself	2
passive detector of sound	2
PAp domain	2
KR5 peeling	2
ligand-binding site of KR1	2
plasminogen activators	2
structures the loop	2
kringle array	2
chloride ions	2
PAp and SP domains	2
closed plasminogen	2
tissue-type and urokinase-type plasminogen activators	2
 plasmin	2
 an open form	2
fibrin clots	2
kringle domains	2
five kringle domains (KR1-5), and a serine protease (SP) domain	2
Pan-apple (PAp) domain	2
Circulating plasminogen	2
primary fibrinolytic protease plasmin	2
proenzyme precursor	2
tumor-specific vulnerability	2
key Myc client	2
subset of normal regenerating cells	2
cycling pre-B/B cells	2
premalignant pre-B/B cells	2
elevated Myc	2
prelymphomatous stage of the Eμ-Myc lymphoma model	2
endogenous eIF4F	2
newly developed inducible RNAi platform	2
eIF4F an attractive antineoplastic target	2
eukaryotic initiation factor (eIF)4F complex assembly	2
collection of resources	2
miRNAs or other pathways	2
miRNA knockout mice	2
18 lines	2
germline-transmitted miRNA knockout mice	2
targeted ES cell lines	2
miRNA targeting vectors	2
numerous evolutionarily conserved miRNAs	2
conditional, reporter-tagged knockout-first mice	2
patient tissues	2
Soluble regulatory proteins	2
C5b6-C7-C8β-C8α-C9 arc	2
central MAC-perforin (MACPF) domains	2
complement components	2
antibody labeling	2
 the larger sC5b9 assembly	2
soluble, regulated form of the pore	2
cryo-electron microscopy reconstruction	2
crystal structure of the first assembly intermediate, C5b6	2
bacteria and other pathogens	2
membrane attack complexes (MACs)	2
 a dendritic channelopathy	2
dendritic Ih	2
wild-type and fmr1−/ymice	2
CA1 region	2
h-channel subunit HCN1	2
fmr1−/yversus wild-type mice	2
initial population of progenitor cells	2
key effectors	2
lineage-specific receptor signaling pathway	2
positive transcriptional feedback loops	2
SummaryProgenitor cells	2
canonical cis elements	2
neural extensions	2
miRNA and RBP sites	2
Genes encoding RNA binding proteins (RBPs) and transcription factors	2
full-length neural extended transcripts	2
unannotated extensions	2
3′ untranslated region (UTR)	2
majority of fly transcripts	2
variety of dissected tissues	2
stranded mRNA-seq	2
complex genotype-phenotype mapping	2
 the host genome	2
pathway-bearing plasmid	2
replicate populations	2
plasmid-borne metabolic pathway	2
cytokine LIF	2
embryonic stem cell self-renewal	2
Oct4 activation domain fusion	2
undifferentiated phenotypes	2
repressing regions	2
activating regions	2
coding sequence of Oct4 or Xlpou91 (the Xenopus homolog of Oct4)	2
pluripotency in vivo	2
specific protein isoforms	2
critical MYC target	2
elevated MYC	2
SRSF1 knockdown	2
transcription factor TEAD1	2
signaling kinase MKNK2	2
subset of transcripts	2
SRSF1 protein	2
two noncanonical E-boxes	2
lung-cancer cell lines	2
lung carcinomas	2
two oncogenes	2
transcription factor oncoprotein MYC	2
potent proto-oncogene	2
SR protein splicing factor	2
unicellular lineage	2
Hippo components of the amoeboid holozoan Capsaspora owczarzaki	2
unicellular ancestors of animals	2
Scalloped,	2
coactivator Yorkie	2
kinases Hippo and Warts	2
Hippo pathway components	2
recently sequenced holozoan genomes	2
nonbilaterian animals	2
key members of the Hippo pathway	2
single exon)	2
37-amino-acid-long intracellular region	2
isoforms of dTRPA1	2
direct heat sensor	2
mutant nociceptors	2
dTRPA1-C/D reporter	2
two previously unidentified protein isoforms of dTRPA1	2
nociceptive heat	2
transient receptor potential (TRP) family	2
thermally sensitive neurons	2
somatosensory neurons	2
King Faisal Specialist Hospital and Research Centre	2
physiologically active form of vitamin D3	2
known MS risk allele rs2248359-C	2
93 individuals	2
prefrontal cortex samples	2
brain dataset	2
cerebellum and frontal cortex samples	2
North American Brain Expression Consortium (NABEC)	2
134 individuals	2
post-mortem samples	2
UK Brain Expression Consortium (UKBEC)	2
neurologically healthy adults	2
three independent datasets	2
1,25-dihydroxyvitamin D3.MethodsWe	2
neighboring gene, CYP24A1	2
many novel susceptibility loci	2
patients with an FCDE	2
trials	2
interferon beta (ETOMS, CHAMPS, BENEFIT, and REFLEX) and glatiramer acetate (PreCISe)	2
following disease-modifying drugs (DMDs)	2
‘silent’ magnetic resonance imaging lesions	2
FCDE	2
useful potential targets	2
miR-205-5ps	2
tissues and plasma of breast carcinoma patients	2
cells or animal models	2
Bcl-w and miR-205-5p	2
miR-205-5p expression	2
miR-205-5p CpG islands	2
IR-induced Bcl-w	2
Bcl-w	2
pathological stimuli	2
primary cardiomyocytes	2
miR-103/107 in C57BL/6J mice	2
NADPH oxidase subunit p22phox	2
HIV co-receptor CCR5	2
CCR5 knockdown SMIG	2
respective targets	2
two different genes	2
concatenated hairpins	2
optimized spacer	2
Spacer sequences	2
CD4 intronic sequence	2
spacer	2
truncated or including stop codons	2
GFP-based sequences	2
Spacer sequence	2
intercalated sequence (“spacer”)	2
polymerase II-dependent promoters	2
Synthetic microRNA (miRNA) minigenes (SMIGs)	2
PDAC and TNBC tumor models	2
KRAS expression	2
miR-873 nanoparticles	2
overexpression of KRAS	2
ERK and PI3K/AKT	2
3′ UTR of KRAS mRNA	2
PDAC and TNBC cell lines	2
miR-873 expression	2
potential regulator of KRAS	2
triple-negative breast cancer (TNBC)	2
one of the most frequently mutated proto-oncogenes	2
useful prediction tool	2
known related miRNAs	2
new SMs	2
miRNA in the heterogeneous network	2
SM	2
heterogeneous network	2
potential miRNA-SM associations	2
drug small molecules (SMs)	2
Targeting microRNAs (miRNAs)	2
cirrhotic background	2
miRNA-based molecules	2
liver nodules	2
TG221 CCl4-treated mice	2
miR-199a-3p mimics	2
anti-miR-221 oligonucleotides	2
dysplastic foci	2
spectrum of lesions	2
nodular lesions	2
TG221 mice	2
hepatotoxin carbon tetrachloride (CCl4)	2
TG221 transgenic mouse	2
cirrhotic model	2
microRNA (miRNA)-based molecules	2
hepatocellular carcinomas (HCCs)	2
CIRBP and HADHB	2
miR-329 and miR-495	2
HADHB−/− 3T3 cells	2
pri-miR-329	2
pre-miR-329	2
adductor muscle of mice	2
unaffected miR-495-3p	2
late-upregulated miR-329-3p	2
cold-inducible RBP (CIRBP) and hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta (HADHB)	2
selected precursor microRNAs	2
RNA binding proteins (RBPs)	2
14q32 locus	2
anti-cancer therapies, and drug delivery systems	2
aptamer 05-MB231	2
aptamers 14A-MCF7	2
normal cell lines	2
cancer and leukemia cell lines	2
Aptamer 05-MB231 targets MDA-MB-231 cells	2
series of metastatic bone and lung cancer cell lines	2
Aptamer 07-MB231	2
three breast cancer cell lines: MCF7, MDA-MB-231, and T-47D. Aptamer 14A-MCF7	2
cell-ExSELEX	2
Ds-containing DNA aptamers	2
high-affinity DNA aptamers	2
fifth letter in a DNA library	2
hydrophobic unnatural base, 7-(2-thienyl)imidazo[4,5-b]pyridine (Ds)	2
artificial extra base pairs (unnatural base pairs)	2
several cell cycle-related genes	2
aging histone H3.3	2
H3K36me3-hMSH6-SKP2 triplex complex	2
histone H3 36th lysine (H3K36me3)	2
substrate histone H3	2
polyubiquitin-binding protein p62	2
several human tumor tissues	2
in vitro-transcribed (IVT) mRNAs	2
well-characterized soluble agonists	2
cells and in tissue samples	2
individual pathways	2
type I interferon and inflammatory cytokine production	2
RNA-based vaccines	2
chymase-specific inhibitor	2
single-stranded RNA aptamer	2
HA28-treated myocardial infarction group	2
vehicle-treated myocardial infarction group	2
HA28-treated group	2
new chymase-specific inhibitory RNA aptamer	2
mast cell chymase, an angiotensin II-generating enzyme	2
competitive endogenous RNA (ceRNA) for miR-454-3P.	2
lncRNA799 and TBL1XR1 expression	2
transducing β-like protein 1-related protein (TBL1XR1)	2
lncRNA799 knockdown	2
SiHa cells	2
lymphatic metastasis	2
adjacent normal tissue	2
cervical cancer tissue	2
cervical cancer samples	2
lncRNA799 expression	2
cervical cancer	2
cervical cancer too	2
available clinical studies	2
circulating circRNAs	2
ideal biomarkers	2
endogenous, abundant, and stable non-coding RNAs	2
IL-17A	2
stromal cell growth	2
β-catenin expression	2
interleukin-17A (IL-17A) and β-catenin	2
Giant cell tumors of bone (GCTBs)	2
tumor promoter	2
HER2-positive subtype	2
Cancer Genome Atlas (TCGA) database	2
key developmental gene	2
Motor neuron and pancreas homeobox 1 (MNX1)	2
K most similar neighbors (hybrid of cell-line-oriented and drug-oriented)	2
drug pair	2
cell line pair	2
similar cell lines	2
drug similarity networks	2
cell-line similarity networks	2
patients’ tumors	2
Human cell lines	2
TuD hairpins	2
TuD motif	2
perfectly matched target sites	2
miR-7 seed match target site	2
individual TuD7-containing transcripts	2
individual ciRS-7 transcripts	2
expressed TuD hairpins	2
TuD transcripts	2
RNA polymerase II-directed expression plasmids	2
identical vector formats	2
ciRS-7 and TuD-containing miRNA suppressor transcripts	2
expressed anti-miRNA Tough Decoy (TuD) hairpins	2
miRNA-7 (miR-7) sponge	2
naturally occurring circular RNA (circRNA),	2
targeting miRNAs	2
DNA-encoded RNA molecules	2
-3p	2
FOXM1 and MGMT (i.e., two targets of miR-370-3p).Our data	2
miRNA-370-3p/TMZ treatment	2
miR-370-3p	2
cfc-miR-370-3p	2
cell-free circulating miRNA-370-3p (cfc-miR-370-3p)	2
miRNA-370-3p in GBM (T-miR-370-3p)	2
“Prognostic miRNA Database	2
biomarkers and therapeutic agents	2
microRNAs (miRs)	2
AMPK/C/EBP β/miR-1a-3p/GRP94 pathway	2
direct allosteric AMPK activator	2
C/EBP β	2
un- or misfolded proteins	2
3′ UTR of GRP94	2
hearts of mice	2
H2O2in vitro	2
neonatal rat ventricular cells (NRVCs)	2
ischemic heart	2
leukemia, lymphoma, and multiple myeloma	2
biomedical and clinical applications	2
class of small molecule ligands	2
Oligonucleotide aptamers	2
potentially any genomic loci	2
HIT-Cas9 system	2
orthogonal Cas9	2
hybrid drug inducible CRISPR/Cas9 technology (HIT-Cas9)	2
Optimized terminal device	2
embryonic stem cells (ESCs) and mesenchymal stem cells (MSCs)	2
several human cell types	2
nuclear export signal (NES)	2
access of genome	2
4-hydroxytamoxifen (4-OHT)	2
mutated human estrogen receptor (ERT2)	2
Pax6 heterozygous islets	2
target protector	2
miR-7 binding site	2
3′ UTR luciferase reporter	2
mouse Pax6	2
Tough decoys (Tuds) against miR-7 and miR-375	2
mouse pancreatic β-insulinoma cell line	2
Pax6	2
miR-375 target specific sites	2
mice heterozygous	2
paired box 6 gene (PAX6)	2
pancreas, digestive, and central nervous systems	2
Aniridia patients	2
ischemic muscles	2
capillaries and muscle fibers	2
Matrigel plug model	2
new microvessels	2
miR-26b mimics	2
EC growth	2
predicted gene targets	2
multiple human EC types	2
conserved candidate	2
Several miRNAs	2
human miRNA mimic library	2
novel DMD biomarkers	2
multiple highly expressed miRNAs	2
piRNA-like sRNAs	2
Specific serum	2
miRNA (including miR-483) and snRNA-fragment abundance	2
DMD patient sera	2
One novel candidate biomarker, miR-483	2
miRNA, small nuclear RNA [snRNA], and PIWI-interacting RNA [piRNA] loci	2
Differentially abundant sRNAs	2
wild-type, dystrophic mdx, and mdx mice	2
four muscle types	2
Extracellular small RNAs (sRNAs)	2
putative target	2
potent regulator of arteriogenesis	2
risk factor control population	2
human PAD patients	2
plasma miR-199a-5p	2
single intramuscular anti-miR-199a-5p injection	2
FAL in mice	2
pro-arteriogenic gene expression (IKKβ, Cav1)	2
mechanosensitive miR-199a-5p	2
biomimetic reversed flow waveform	2
collateral artery segments	2
mechanosensitive microRNA, miR-199a-5p	2
endogenous collateral arteries	2
deregulated miRNA-19b-3p-based miRNA-circRNA-lncRNA-mRNA network	2
predicted miRNAs target genes	2
differentially expressed mRNAs	2
differentially expressed RNA transcripts	2
competing endogenous RNA (ceRNA) network of circRNA-miRNA-mRNA	2
lncRNA-mRNA co-expression network, miRNA-mRNA target prediction network	2
selected mRNAs and ncRNAs	2
mRNA, lncRNA, and circRNA microarrays and microRNA sequencing	2
OLF patients	2
OLF tissues	2
lncRNA, mRNA, circRNA, and microRNA	2
ligamentum flavum (OLF)	2
HIV promoter	2
iPS-derived macrophage	2
histone structure	2
functional macrophages	2
shPromA-transfected iPSCs	2
HIV-1 promoter region (shPromA)	2
Human iPSCs	2
TGS technology	2
HIV field	2
(iPSC)-derived hemato-lymphopoietic cells	2
induced pluripotent stem cell	2
transplanted hemato-lymphopoietic cells	2
HIV-1 promoter	2
short hairpin RNA (shRNA)	2
HIV-1 patients	2
retinal layers	2
wild-type mice and rabbits	2
photoreceptor cilia	2
homozygous three-dimensional iPSC-derived retinal organoids	2
1655A>G homozygous and compound heterozygous LCA10 primary fibroblasts	2
CEP290 c.2991+	2
the best-performing molecule	2
panel of antisense oligonucleotides	2
oligonucleotide therapeutics	2
LCA10 individuals	2
neonatal mouse brain	2
lentiviral vectors and adeno-associated virus vectors	2
lateral ventricle	2
hippocampal architecture	2
injected brains	2
intracranial administration	2
heart, xiphisternum, liver, pancreas, and gut	2
systemic PFV vector	2
reporter gene constructs	2
PFV vectors	2
(PFV) vectors	2
Prototype foamy virus	2
Viral vectors	2
primary and mature miR-206, HDAC4, and various atrogenes	2
plasmid DNA expressing HGF	2
extra HGF	2
miR-206 expression	2
HDAC4 and atrogenes	2
pri-miR-206	2
c-met receptor	2
hSOD1-G93A transgenic mice	2
skeletal muscle tissue	2
HGF expression	2
muscle-atrophic conditions	2
HGF/c-met signaling	2
muscle progenitors	2
uridine-depleted Cas9 mRNA	2
5-methoxyuridine UD	2
active and less immunogenic mRNA	2
whole blood and mice	2
cell lines and primary human CD34+ cells	2
double-stranded RNAs	2
mRNA of uridines	2
Cas9 mRNA	2
natural Cap 1	2
active, less immunogenic second-generation Cas9 mRNAs	2
First-generation Cas9 mRNAs	2
Cas9 expression	2
mRNA expressing Cas9	2
Cas9/guide RNA (Cas9/gRNA) system	2
COL7A1 mutations	2
dermal-epidermal junction	2
type VII collagen	2
genetically corrected 3D skin equivalents	2
corrected COL7A1	2
transduced keratinocytes and fibroblasts	2
integration-deficient lentivirus	2
primary RDEB keratinocytes	2
site-specific guide RNAs	2
exon 2 (c.189delG; p.Leu64Trpfs*40)	2
five guide RNAs	2
grafted 3D skin equivalents	2
dermal-epidermal adhesion	2
COL7A1-encoding type VII collagen	2
Recessive dystrophic epidermolysis bullosa (RDEB)	2
skin and mucosa	2
Recessive dystrophic epidermolysis bullosa	2
essential platform	2
MB patients	2
miR-217 in HDMB03 cells	2
predicted target genes SIRT1, ROBO1, FOXO3, and SMAD7 in HDMB03 cells	2
primary human MB samples	2
miRNA-mRNA	2
miRNA-mRNA pairs	2
MB samples	2
downregulated miRNAs	2
normal cerebellar tissues	2
human MB samples	2
clinically challenging, childhood brain tumor	2
Medulloblastoma (MB)	2
agonistic DNA aptamers	2
CD200R1−/− mice	2
5-day allo-MLCs	2
agonistic aptamer	2
resulting conjugate	2
5′ end of this aptamer	2
20-kDa polyethylene glycol (PEG) chain	2
human and murine allogeneic-mixed lymphocyte cultures (allo-MLCs)	2
cytotoxic T-lymphocytes (CTLs)	2
CD200R1 DNA aptamer CCS13	2
Aptamer motifs	2
recombinant murine and human CD200R1	2
CD200R1 agonist	2
cross-species (murine and human)	2
polyethylene glycol-modified (PEGylated) DNA aptamer	2
Functional aptamers	2
invasive human BCs	2
3′ UTR of GSK3β mRNA	2
mTOR/S6 axis	2
(GSK3β) mRNA	2
3′ UTR of Glycogen synthase kinase-3β	2
BC cells	2
matrix metalloproteinase-2 (MMP-2) abundance	2
c-Jun phosphorylation	2
miR-137 deletion	2
human high-grade BC T24T and UMUC3 cells	2
N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)-induced invasive BC mouse model	2
human BC cells with isorhapontigenin (ISO)	2
human bladder cancer (BC) tissues	2
mini-gene mouse model	2
CEP290 in cell lines	2
AAV genome	2
one set of diseases (retinitis pigmentosa and Leber congenital amaurosis (LCA)	2
recombinant adeno-associated virus (AAV)	2
UCA1 regulatory axis	2
RNA-RNA network	2
miRNA-binding sites	2
co-regulated antisense LINC01764	2
mRNA 3′-UTRs	2
microRNA (miRNA)-induced degradation	2
ANLN, BIRC5, IPO7, KIF2A, and KIF23	2
miR-135a, miR-143, miR-214, and miR-1271	2
expression correlation and RNA-RNA-binding prediction	2
[MAPK] inhibition	2
in vitro (i.e., RNA silencing and mitogen-activated protein kinase	2
CDR1AS, MALAT1, and TUG1 downregulation	2
HOTAIR, and UCA1 upregulation	2
colorectal cancer (CRC) patients	2
circRNAs in biopsies and serum exosomes	2
Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs)	2
T-ALL patients	2
co-expression and regulatory network	2
potential supplements	2
drugs 5-fluorouracil, ascorbate, and trastuzumab targeting miR-1246	2
T-ALL cell line	2
T-ALL	2
regulatory loop miR-429-MYCN-MFHAS1	2
regulatory modules	2
TF WT1/SOX4/REL	2
relapse network	2
key nodes	2
pediatric T-ALL	2
initially diagnosed pediatric T-ALL samples	2
initially diagnostic samples	2
diagnosis and relapse paired samples	2
pediatric T cell acute lymphoblastic leukemia (T-ALL)	2
Pol III promoters	2
Pol III start site	2
active H1 promoter	2
7SK and U6 promoters	2
regular Pol III start site	2
two polymerase complexes	2
extended messenger transcripts	2
three commonly used human Pol III promoters (7SK, U6, and H1)	2
guide RNAs in CRISPR-Cas systems	2
RNAi applications	2
short hairpin RNAs	2
defined transcription start and termination sites	2
Gene-external type 3 Pol III promoters	2
distinct subsets of genes	2
three RNA polymerases (Pol I, II, and III)	2
known cardiac miRNAs	2
current repertoire	2
mature heart	2
numerous biological processes and signaling pathways	2
developing murine heart	2
polyadenylated RNAs and miRNAs	2
transcription factors (TFs) and microRNAs (miRNAs)	2
β-hemoglobinopathies	2
HBB locus	2
genome editing HSPCs	2
gene-edited HSPCs	2
small molecules, UM171 and SR1	2
culturing fluorescence-activated cell sorting (FACS)-enriched HBB-targeted HSPCs	2
immunodeficient NSG mice	2
repopulating cells	2
rAAV6 endocytosis	2
rAAV6 post-electroporation	2
β-globin (HBB) locus	2
RNA-guided (single-guide RNA [sgRNA]; CRISPR)-Cas9 nuclease (Cas9/sgRNA) and rAAV6-mediated HR	2
miR-125b-Stard13-RhoA-α-SMA signaling cascade	2
miR-125b-induced α-SMA expression	2
downstream molecules, Mrtf-A and Srf	2
RhoA-specific GTPase-activating protein	2
START) domain containing 13 (Stard13)	2
StAR-related lipid transfer (	2
CCl4-treated mice	2
α-SMA expression	2
immortalized HSC cell line	2
basal and transforming growth factor β (TGF-β)-induced alpha-smooth muscle actin (α-SMA) expression	2
culture-activated primary HSCs	2
profibrogenic genes	2
human intestinal barrier	2
simulated gastrointestinal fluids	2
human intestinal follicle-associated epithelium	2
RGD-modified bacteriophage	2
non-surface modified	2
cell culture supernatant	2
mammalian DNA cassette	2
major coat protein pVIII	2
arginine-glycine-aspartic acid (RGD) motif (an integrin-binding peptide)	2
particular bacteriophage	2
new generation of filamentous bacteriophage	2
effective vector	2
modulatory non-coding RNAs	2
CR-vector	2
newly infected cells	2
HIV expression	2
mycophenolic acid (MPA) selection	2
cell culture systems	2
various therapeutic payloads	2
several CR-vectors	2
target cellular reservoirs	2
budding viral particles	2
HIV-expressed proteins	2
conditionally replicating vectors (CR-vectors)	2
HIV-1 infection	2
YG8R mouse heart	2
endogenous FXN gene	2
selected plTALEVP64s	2
YG8R mouse model	2
best effectors	2
Adeno-associated viruses	2
different Friedreich ataxia (FRDA) primary fibroblasts	2
2 plTALESunTag	2
FXN gene promoter or intron 1	2
14 sequences	2
plTALEVP64, plTALEp300, and plTALESunTag	2
Many effectors	2
transcriptional activator (TA) such as VP64 or P300	2
regulatory region of the FXN gene	2
Platinum TALE (plTALE) proteins	2
GAA trinucleotides	2
Friedreich’s ataxia patients	2
real power tool	2
ideal gene promoter	2
specific gene promoter	2
liposome system, nano-particle system, polyetherimide (PEI) system	2
novel molecular tools	2
mutant huntingtin binding aptamers	2
elongated polyglutamine segment	2
HD NPCs	2
MS3 transfection	2
endogenous mutant huntingtin	2
MS3 aptamer	2
normal, neuronal progenitor cells (NPCs)	2
expanded polyglutamine tract	2
C-terminal CTD-II domain	2
lysines K2932/K2934	2
set of G-quadruplex-forming DNA aptamers (MS1, MS2, MS3, MS4)	2
primary amino acid sequence	2
polyglutamine tract	2
P62	2
inflammation-related factors, e.g., TNFR1, CLYD, EGR1, NFκB, TLR4, and PPARγ	2
H-Ras overexpression	2
IGFII 3′ UTR	2
IGFII promoter-enhancer chromatin loop	2
cascade of P62-tumor necrosis factor alpha (TNF-α)-CUDR-CTCF-insulin growth factor II (IGFII)-H-Ras signaling	2
human tumor tissues	2
Inflammatory and autophagy-related gene P62	2
potential ncRNA-protein interacted pairs	2
effective computational tool	2
RPI-Pred, IPMiner, RPISeq-RF, lncPro, and RPI-SAN	2
five established prediction tools	2
Four benchmark datasets	2
ncRNA binding proteins	2
random forest (RF) model	2
RNA and protein sequences	2
deep-learning stacked auto-encoder network	2
specific ncRNA	2
non-coding RNAs (ncRNAs) and proteins	2
TLR4 activation	2
reference formulation	2
stable nucleic acid lipid particles	2
prediction model	2
murine antigen-presenting cells	2
strong agonists	2
human Toll-like receptor (TLR) 2, 3, 7, and 9	2
neither lipidoids nor DOTAP	2
cationic lipids	2
lipid component	2
dioleoyltrimethylammoniumpropane (DOTAP)	2
poly(DL-lactic-co-glycolic acid) (PLGA) and cationic lipid-like materials (lipidoids)	2
siRNA in lipid-polymer hybrid nanoparticles (LPNs)	2
non-viral nanoparticulate delivery approaches	2
cytosol of target cells	2
antiviral and anti-inflammatory agents	2
small interfering RNA (siRNA)	2
combination dantrolene/AON	2
AON treatment groups	2
quadriceps and diaphragm	2
different muscles	2
oral dantrolene	2
AON doses	2
dantrolene/AON combination	2
short-term mdx dystrophic mouse studies	2
human DMD cultures	2
rescued dystrophin protein	2
partially functional dystrophin protein	2
anti-sense oligo-nucleotides (AONs)	2
AFP and a second HCC pre-mRNA biomarker	2
novel dual-targeting tsRNAs	2
HPV-16-transduced or hepatoblastoma-derived human tissue culture cells	2
rationally designed suicide RNAs	2
secondary target binding domains	2
intended target splice site	2
tsRNA 3′ end	2
unstructured, mismatched target binding domains	2
marker of hepatocellular carcinoma (HCC) or human papillomavirus type 16 (HPV-16) pre-mRNA	2
alpha fetoprotein (AFP)	2
herpes simplex virus thymidine kinase	2
activity and target specificity of trans-splicing RNA (tsRNA)	2
etiologies	2
chromatin, protein, and other RNAs	2
significant open reading frame (ORF)	2
kind of non-coding RNA (ncRNA)	2
Long non-coding RNA (lncRNA)	2
valuable drug	2
c-Fos-BMP signaling	2
osteogenesis-associated genes (e.g., Ocn and PICP)	2
GLP2 in osteosarcoma cells	2
rescued NF-κB	2
c-Myc, PKM2, and CyclinD1 in osteosarcoma cells	2
osteosarcoma cells in vivo and in vitro	2
human osteosarcoma cells	2
GLP2	2
proglucagon-derived peptide	2
Glucagon-like peptide 2 (GLP2)	2
anti-Lcn2-3WJs in mice	2
otherwise quiescent astrocytes	2
reactive astroglial cells	2
reactivity-associated genes	2
packaging RNA (pRNA)-derived three-way junction (3WJ) motif	2
cells of the CNS	2
Lipocalin 2 (Lcn2)	2
Reactive astrocytes	2
neurite growth	2
entangled cells	2
glial fibrillary acidic protein (GFAP) and vimentin (Vim)	2
Activated astrocytes overexpress intermediate filaments	2
personalized, donor template-free RGNs	2
non-integrating lentiviral vectors carrying RNA-guided Cas9 endonucleases (RGNs)	2
 hematopoietic cells	2
microbicidal reactive oxygen species (ROS)	2
neutrophils and macrophages	2
Cytochrome b-245 heavy chain gene (CYBB)	2
patient-specific point mutations	2
prespecified genomic sequence	2
CRISPR/Cas9 prokaryotic adaptive immune system	2
MHCII fibers	2
important proteins	2
key components of the DAPC	2
nearly all fibers	2
sarcolemma	2
members of the DAPC	2
revertant fibers	2
fiber types	2
untreated mdx muscle	2
members of the dystrophin-associated glycoprotein complex (DAPC)	2
tc-DNA	2
muscle, cardio-respiratory function, heart, and the CNS	2
tricyclo-DNA (tc-DNA) antisense oligonucleotides	2
standard formulation	2
cryo-concentrated NF55/pDNA nanoparticles	2
stable and homogeneous nanoparticles	2
applicability of particles	2
NF55/pDNA nanoparticles	2
previously designed efficient cell-penetrating peptide NF55	2
stable particles	2
high bioactivity of constituents	2
nanoparticle drugs	2
HSV-1 entry glycoproteins	2
random DNA controls	2
ocular infection	2
in vitro and ex vivo studies	2
cognate host receptors	2
HSV-1 gD	2
45-nt-long DNA aptamer	2
small DNA aptamer	2
HSV-1 envelope glycoprotein gD	2
ocular herpes	2
viral glycoproteins	2
Herpes simplex virus type 1 (HSV-1)	2
potent EGS variants	2
engineered EGS variants	2
EGS-expressing constructs	2
MCMV-infected mice	2
viral growth	2
MCMV-infected cells	2
shared mRNA region of MCMV capsid scaffolding protein (mCSP)	2
murine cytomegalovirus (MCMV)	2
promising agents	2
tRNA processing enzyme	2
ribonuclease P (RNase P)	2
External guide sequence (EGS) RNAs	2
major CYP enzyme or drug transporters	2
unconjugated and GalNAc3-conjugated 2′-MOE-ASOs	2
nine transporters tested	2
BCRP and P-gp	2
nine transporters	2
10 μM)	2
three efflux transporters, P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and bile salt export pump (BSEP)	2
three renal uptake transporters, organic anion transporter 1 (OAT1), OAT3, and OCT2	2
hepatic uptake transporters, organic cation transporter 1 (OCT1), organic anion transporting polypeptide 1B1 (OATP1B1), and OATP1B3	2
nine major transporters	2
CYP1A2, CYP2B6, and CYP3A4	2
CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4	2
hepatocyte-specific asialoglycoprotein receptors	2
high-affinity ligand	2
2′-MOE-ASO	2
single triantennary N-acetyl galactosamine (GalNAc3)-conjugated ASO	2
four 2′-O-(2-methoxyethyl)-modified antisense oligonucleotides (2′-MOE-ASOs)	2
Antisense oligonucleotides	2
possible polymorphisms	2
pharmacodynamics of sequence-specific oligonucleotide therapeutics	2
recombinant replicon systems	2
endogenous targets	2
guide strand central region complementarity	2
fully complementary targets and targets	2
open-source, customizable, and computationally light RACE-SEQ bioinformatic pipeline	2
5′ RNA ligase-mediated rapid amplification of cDNA ends (RACE-SEQ)	2
DNA-directed RNAi drug TT-034	2
small interfering RNA (siRNA) analogs	2
discrete clones	2
quasi-species mutants	2
RNAi-active guide strands	2
endogenous RNAi targets	2
free unconjugated nanoparticles	2
gold nanoparticles	2
laser irradiations	2
aptamer-conjugated AuNPs	2
cancer tissue	2
radioactive glucose	2
desired cells	2
synthetic anti-tumor aptamers	2
tumor-bearing mice	2
Ehrlich carcinoma	2
aptamer-conjugated, 37-nm spherical gold nanoparticles	2
cell-specific DNA aptamers	2
gold nanoparticles (AuNPs)	2
Novel nanoscale bioconjugates	2
many HIV-1 strains	2
identical RNAi targets	2
central part of all six targets	2
APOBEC3G (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G, A3G)	2
domains specifying reverse transcriptase (RT), integrase, vpu, gp120, and p17	2
RNAi targets	2
two independent cohorts of patients	2
six regions of HIV-1	2
selected RNA targets of HIV-1	2
AON allele-specific silencing	2
collagen VI protein	2
exon 15 of COL6A3	2
series of AONs	2
Collagen-VI-related congenital muscular dystrophy (COL6-CMD)	2
gapmer AON	2
RNA strand of a DNA-RNA duplex	2
endogenous endonuclease known as RNase H	2
Gapmer antisense oligonucleotides (AONs)	2
nearly all Bethlem myopathy patients	2
Ullrich congenital muscular dystrophy patients	2
COL6A1, COL6A2, and COL6A3	2
three major α chains of collagen type VI	2
MPM tumors	2
cellular chemosensitivity	2
multiple miR-31 target binding sites	2
bipotential transcriptional regulator	2
NCI-H2452 cells	2
miR-31 null	2
variety of other cancers	2
many MPM tumors	2
genomic fragile site, 9p21.3	2
MicroRNA-31 (miR-31)	2
Malignant pleural mesothelioma (MPM)	2
insoluble ataxin-3	2
antisense oligonucleotide injection	2
modified ataxin-3 protein	2
SCA3 mouse model	2
truncated ataxin-3 protein	2
ATXN3 pre-mRNA	2
predicted exonic splicing signals	2
proteasomal protein degradation pathway	2
mutant ataxin-3 protein	2
expanded polyglutamine stretch	2
ATXN3 gene	2
exon 10	2
theragnostic reagents	2
late endosomal and lysosomal marker protein	2
lysosomal-associated membrane protein 1 (LAMP-1)	2
selected aptamers	2
endosomal fractions	2
endosomal pathway	2
series of DNA aptamers	2
serum creatinine and urine albumin	2
current diagnostic biomarkers	2
mouse Adam33	2
series of homologous ASOs	2
lead ASOs from (human) MRC-5 cells	2
biocleavable linkage	2
lipophilic tail	2
unconjugated ASOs	2
hexadecyloxypropyl ASO conjugates self-assemble	2
ADAM33 mRNA	2
cationic lipid	2
several gapmer ASOs	2
ADAM33 expression	2
the gapmer ASOs	2
novel hexadecyloxypropyl conjugates of the ASOs	2
(siRNAs), single-stranded small interfering RNAs (ss-siRNAs), locked nucleic acid (LNA) gapmer antisense oligonucleotides (ASOs)	2
traditional duplex small interfering RNAs	2
four classes of gene silencing agents	2
MRC-5 lung fibroblasts	2
asthma susceptibility gene ADAM33	2
Multiple chemical designs	2
RISC complex	2
clinical pipeline	2
REP 2139 and REP 2165	2
REP 2165 in plasma and organs	2
REP 2139 in mice and cynomolgus monkeys	2
unmodified riboadenosines	2
REP 2139 analog	2
acidified human plasma	2
selected riboadenosines	2
Pekin ducks	2
human plasma, CD-1 mice, cynomolgus monkeys	2
serum and tissues	2
different REP 2139 analogs	2
nucleic acid polymer (NAP)	2
human BC patients	2
BC cell growth	2
p27 transcription	2
3′ UTR of 	2
miR-196b transcription	2
ETS2 mRNA	2
ATG7 upregulated FOXO1 (forkhead box protein O 1) expression	2
tumorigenic growth	2
human bladder urothelial carcinoma and N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-induced mouse invasive BC	2
ATG7 expression	2
Human bladder cancer (BC)	2
next generation models	2
efficacious LNPs	2
novel combinations of siRNAs and LNPs in vitro	2
ordinary differential equation (ODE)-based model	2
leading systems	2
influenza and respiratory syncytial virus (RSV) infection	2
broad-spectrum antiviral target	2
MAPK-activated protein kinase 2	2
p38 mitogen-activated protein kinase (MAPK) signaling pathway	2
lead candidates	2
broad-spectrum antiviral	2
influenza and respiratory syncytial virus	2
broad range of herpesvirus infections	2
mRNA targets	2
conserved viral proteins	2
antiviral therapeutics	2
D4 and A8	2
individual constructs	2
multiple HIV RNA transcripts	2
HIV splice donor and acceptor sites, D4, A5, A7, and A8	2
Five constructs	2
 HIV-producing cells	2
HSV-tk	2
RNA trans-splicing junctions	2
Conventional PCR and Sanger sequencing	2
six of ten candidate RNA trans-splicing constructs	2
HSV-tk RNA transcripts	2
fusion RNA transcripts	2
HIV-expressing cells	2
Trans-spliced mRNAs	2
cells expressing HIV	2
different HIV splice donor or acceptor sites	2
ten HIV RNA trans-splicing constructs	2
HIV-producing cells	2
herpes simplex virus thymidine kinase-ganciclovir (HSV-tk/GCV) cell suicide system	2
viral functions	2
viral targets	2
hijacked cellular processes	2
systemically delivered RALA-iNOS nanoparticles	2
MDA-MB-231-luc-D3H1 tumors	2
mice bearing micrometastases	2
Nanoparticulate RALA/CMV-iNOS or RALA/hOC-iNOS	2
SCID mice	2
female BALB/c	2
MDA-MB-231-luc-D3H1 cells	2
highly aggressive MDA-MB-231 human breast cancer model	2
[CMV]-driven or transcriptionally regulated human osteocalcin [hOC]-driven)	2
constitutively active cytomegalovirus	2
nanoparticles in immunocompetent C57BL/6 mice	2
cationic peptide vector, RALA, and plasmid DNA	2
nanoparticular formulation	2
patients undergoing clinically indicated retinectomy	2
human retinal explants	2
two vectors	2
reporter gene with and without WPRE	2
AAV2 vectors	2
transgene cassette of adeno-associated virus (AAV)	2
woodchuck hepatitis virus posttranscriptional regulatory element (WPRE)	2
clinical lung cancer	2
human lung cancer cells	2
TTF-1 promoter	2
miR-7 expression	2
novel target of miR-7	2
p-T-miR-7 group	2
human lung cancer cells in vivo	2
nude mice model	2
eukaryotic vector of TTF-1-promoter-operated expression of miR-7 (termed as p-T-miR-7)	2
promoter of TTF-1, a lineage-specific oncogene	2
promising tumor suppressor	2
gene technique	2
transformed structures of the adjacent tissues	2
presented aptamers	2
panel of correspondent antibodies	2
Protein targets	2
tumor cells, connective tissues, and blood vessels	2
whole transformed lung cancer tissues	2
three DNA aptamers	2
commercially available monoclonal antibodies	2
Nucleic acid aptamers	2
use	2
nucleic acid sequences of anti-CD aptamers	2
vital genes in CD-positive cells	2
aptamer oligomerization	2
agonist and antagonist of CD receptors	2
HIV/AIDS	2
anti-CD aptamers	2
popular antigens	2
Cluster of differentiation (CD) proteins	2
fluorescent dye or therapeutic agent	2
diverse targets	2
Nucleic acid-based aptamers	2
treated adult mdx mice	2
delivery routes	2
mouse model of DMD	2
dystrophin and myostatin pre-mRNAs	2
myostatin expression	2
myostatin pre-mRNA	2
truncated form of the protein	2
disrupted reading frame of dystrophin pre-mRNA	2
cancer targets	2
within cancer cells	2
PDL1+ tumor cells	2
trans-suppression lymphocyte assay	2
RRV-miRPDL1 vectors with Pol II or Pol III promoter	2
various configurations	2
RRV expressing cytosine deaminase (yCD2)	2
shRNA (RRV-shPDL1) or microRNA30-derived shRNA (RRV-miRPDL1) using Pol II or Pol III promoters	2
Retroviral replicating vectors (RRV)	2
number of immunosuppressive molecules	2
Interferon alpha (IFN-α)	2
nonhomologous end joining (NHEJ)	2
different HBV-specific guide RNAs	2
CRISPR/Cas9 system in HepG2 cells expressing the HBV receptor sodium taurocholate cotransporting polypeptide (NTCP)	2
infectious HBV	2
nuclear cccDNA	2
cytoplasm of infected cells	2
HBV DNA in capsids	2
nucleoside analogues	2
covalently closed circular DNA (cccDNA)	2
infected hepatocytes	2
SSOs in vitro	2
novel modifier	2
anionic SSOs	2
ZEN-modified SSO	2
dystrophin deficient mdx mice	2
2′OMePS SSO	2
ZEN-modified 2′OMe phosphorothioate (PS) oligonucleotide	2
cultured H2K cells	2
unmodified 2′OMe oligonucleotides	2
ends of a 2′-O-methyl (2′OMe) oligonucleotide	2
ZEN modifier	2
mutant dystrophin pre-mRNA	2
new SSO non-base modifier (a naphthyl-azo group, “ZEN™”)	2
target pre-mRNA	2
Splice switching oligonucleotides (SSOs)	2
LNP-based siRNA delivery systems	2
highly shielded LNPs	2
exogenous targeting ligand	2
endogenous targeting ligand	2
apolipoprotein E (ApoE)	2
steric barrier	2
multicomponent lipid nanoparticles (LNP)	2
naturally occurring long non-coding RNAs (lncRNAs)	2
small hairpin RNAs (shRNAs) from vectors	2
Pompe disease	2
muscle specific glycogen synthase	2
quadriceps, diaphragm, and heart of Pompe mice	2
lysosomal glycogen	2
muscle specific glycogen synthase and activity	2
diaphragm	2
quadriceps	2
glycogen synthase transcripts	2
Pompe mice	2
cell penetrating peptide (GS-PPMO)	2
muscle specific glycogen synthase (Gys1)	2
phosphorodiamidate morpholino oligonucleotide (PMO)	2
recombinant human GAA (rhGAA)	2
glycogen in skeletal and cardiac muscles	2
deficiency of acid α-glucosidase (GAA; EC 3.2.1.20)	2
developing nonviral gene delivery system	2
melanoma tumors	2
melanoma tumors in mice	2
murine melanoma and endothelial cells	2
plasmid DNA encoding short hairpin RNA against MCAM (pMCAM)	2
melanoma cell adhesion molecule (MCAM)	2
splice-modulating antisense oligonucleotides	2
murine Pah gene	2
phenotypically normal Pahenu2/+heterozygous mice	2
Vivo-morpholinos (VMO)	2
morpholinos and locked nucleic acids	2
two oligonucleotide chemistries	2
normal PAH gene	2
Exon 11	2
blood L-Phe	2
liver and kidney	2
(Pah) gene	2
phenylalanine hydroxylase	2
cryptic splice sites or pseudoexon insertions	2
control tumor xenografts	2
RPN2-silenced highly metastatic osteosarcoma xenografts	2
RPN2 silencing	2
highly metastatic human osteosarcoma cells	2
osteosarcoma patient biopsies	2
N-oligosaccharyl transferase complex	2
ribophorin II (RPN2)	2
specific gene promoters	2
nuclear transcripts	2
miRNA processing machinery	2
Multiple components	2
nucleolus and chromatin	2
sub-nuclear structures	2
certain miRNAs	2
nucleus of the mammalian cell	2
therapeutic targets or disease biomarkers	2
canonical paradigm	2
genome-encoded small RNAs	2
new class of hybrid nanomaterial platform	2
therapeutic gene	2
phage/polymer complexes	2
positively charged phage	2
phage complex	2
transgene cassette	2
tumor-targeting ligand	2
M13 bacteriophage virus particles	2
two classes of nanomaterial systems	2
novel hybrid system	2
phage vectors	2
bacteriophage capsid	2
mammalian cellular barriers	2
Bacteriophages (phage), viruses	2
gene transfer applications	2
general platform	2
modified pre-miR-451 structure	2
Agos 1, 3, and 4	2
endogenous miRNAs	2
shRNA	2
completely complementary stem	2
pre-miR-451 structure	2
Ago proteins	2
transfected siRNA	2
patient's immune system	2
nondiluted serum	2
multivalent binders	2
cell-based plaque forming assay	2
antigen binding fragment (Fab) of antivesicular stomatitis virus polyclonal antibodies	2
oncolytic virus, vesicular stomatitis virus	2
plasmid and circular DNA vectors	2
oncogenic vector integrants	2
genome of human cells	2
Ministring DNA	2
isogenic circular covalently closed DNA counterparts	2
parental plasmid precursors	2
rapidly and slowly dividing human cells	2
necessary eukaryotic expression elements	2
unwanted bacterial sequences	2
mini linear covalently closed DNA vectors	2
bacterial sequences	2
Conventional plasmid DNA vectors	2
TALENs	2
human hTERT gene	2
immortalized porcine fibroblasts	2
Cloned embryos	2
One CMAH knockout clone	2
biallelic modifications	2
three independent clonal populations of cells	2
single colony	2
transcription activator-like effector nuclease (TALENs) pairs	2
designed plasmids	2
CMAH gene	2
100 mm dishes	2
Immortalized cells	2
outgrowing colonized cells	2
human telomerase reverse transcriptase (hTERT) gene	2
primary porcine fetal fibroblasts	2
immortalizing porcine cells	2
large domesticated animals	2
human and murine somatic cells	2
noncancerous immortalized cell lines	2
phosphorodiamidate morpholino oligomer chemistry	2
Becker muscular dystrophy-like dystrophin transcript	2
exons 2–7	2
normal dystrophin transcript	2
single copy of exon 2	2
normal and exon 2 duplication cells	2
cell-penetrating peptide	2
phosphorodiamidate morpholino oligomer	2
oligomer analogues	2
dystrophin transcript	2
cell-penetrating peptide and 2′-O-methyl phosphorothioate oligonucleotides	2
phosphorodiamidate morpholino oligomers	2
commonly duplicated exon	2
exon 2	2
oligonucleotide delivery formulations	2
MCTS model	2
spheroid	2
delivery agent	2
two- and three-dimensional culture models	2
splice-switching antisense oligonucleotides	2
various oligonucleotide delivery formulations	2
small avascular tumors	2
multicellular tumor spheroid (MCTS)	2
commonly used delivery vehicles	2
lipoplexes and polyplexes	2
three-dimensional tumor	2
cancer and other diseases	2
tumor-specific aptamers	2
IL-6R	2
free ce6	2
IL-6R presenting (IL-6R+) cells	2
AIR-3A-	2
AIR-3A yielding	2
human interleukin-6 receptor (IL-6R) binding RNA aptamer,	2
photosensitizer chlorin e6 (ce6)	2
cargo molecules	2
brain, breast, prostate, and skin cancers	2
certain chemicals	2
3′-DNA/siRNA constructs	2
serum nucleases	2
ss siRNA (construct III)	2
single-stranded guide-3′-DNA/	2
double-stranded RNA structure	2
constructs I and II	2
3′-DNA mini-hairpin	2
SIRT1 guide strand	2
Construct IV	2
noncancer and cancer cells	2
SIRT1 mRNA and protein	2
Constructs I	2
cancer-specific survival factor	2
RNAi target	2
/ss siRNA	2
guide-3′-DNA/ss siRNA, and (IV)	2
following constructs	2
3′-nuclease-resistant mini-hairpin structure	2
passenger-3′-DNA/ds siRNA	2
3′ end of passenger RNA	2
homologous mRNA target	2
guide RNA	2
passenger RNA	2
Ago2 and C3PO, endonucleases of the RNA-induced silencing complex (RISC)	2
single-stranded (ss) guide and passenger RNAs	2
double-stranded small interfering RNA (ds siRNA)	2
shorter dimyristyl (C14) chains	2
distearyl (C18) chains	2
1.5 mol % PEG-lipid	2
carbons long	2
dialkyl chains	2
LNPs to plasma lipoproteins	2
lipid particles	2
polyethylene glycol lipid (PEG-lipid) components	2
rodents and nonhuman primates	2
hepatic genes	2
short interfering RNAs	2
miRNA function	2
new ZEN-AMOs	2
ZEN-AMOs	2
2′OMe RNA backbone	2
single-stranded oligonucleotide	2
near each end	2
novel compound, N,N-diethyl-4-(4-nitronaphthalen-1-ylazo)-phenylamine (“ZEN”)	2
unnatural modified nucleic acid residues	2
high binding affinity compounds	2
locked nucleic acid (LNA) residues	2
Second generation AMOs	2
-Methyl RNA nucleotides (2′OMe) with phosphorothioate (PS) internucleotide linkages	2
First generation AMOs	2
mature miRNA	2
steric blocking antisense reagents	2
Anti-microRNA oligonucleotides (AMOs)	2
native biological context	2
class of therapeutic oligonucleotides	2
Htt mRNA	2
unformulated hsiRNA	2
mRNA of huntingtin	2
functional hsiRNAs	2
lipid formulation	2
hydrophobically modified siRNAs (hsiRNAs)	2
primary neurons	2
primary neurons in culture	2
neuroscience research	2
interstitial renal and/or glomerular CD40	2
interstitial and glomerular foci	2
CD40 in glomeruli	2
CD40 antibody	2
activating	2
Generation 2.5 CD40 ASO	2
antisense oligonucleotides (ASOs) targeting CD40	2
clinical application	2
isosequential 2OMePS counterparts	2
2FPS AONs	2
human cell cultures	2
DMD cell and animal models	2
two different 2’-substituted AONs (2’-F phosphorothioate (2FPS) and 2’-O-Me phosphorothioate (2OMePS)	2
spinal muscular atrophy models	2
2F/pre-mRNA duplex	2
ILF2/3 proteins	2
2’-deoxy-2’-fluoro (2F)	2
specific exons	2
antisense oligonucleotides (AONs)	2
Becker muscular dystrophy patients	2
shorter but partly functional dystrophin protein	2
DMD gene	2
alternate targets	2
J-Lat 9.2 cell latency model	2
heterochromatin and TGS	2
novel siRNA target, si143	2
novel 5′LTR targets	2
siRNA panel	2
viral 5′LTR	2
tandem NF-κB motifs	2
HIV-1 by siRNA (PromA)	2
mammalian genes	2
animal model of age-related macular degeneration (AMD)	2
novel types of RNA	2
TLRs or RIG-	2
novel types of synthetic RNA	2
Toll-like receptor 3 (TLR3)	2
synthetic small interfering RNAs (siRNAs)	2
US Food and Drug Administration (FDA)-approved adeno-associated virus (AAV)-vectors	2
SSOs and Cep290 skipped mRNA	2
2’-OMePS-SSO	2
wild-type mouse	2
fibroblasts of affected patients	2
mutant cryptic exon	2
splice-switching oligonucleotides (SSO)	2
premature stop codon	2
cryptic exon	2
strong splice donor site	2
common disease-causing mutation	2
Leber congenital amaurosis	2
therapeutically neglected form of osteopetrosis	2
trabecular bone mass	2
ADO2 mice	2
Clcn7G213RADO2 mice	2
scrambled siRNA	2
human osteoclasts	2
RAW264.7 cells	2
silenced transfected mutant mRNA/EGFP in HEK293 cells	2
CLCN7G215R-, CLCN7R767W-, and CLCN7R286W-specific siRNAs	2
ClC-7 chloride/hydrogen antiporter	2
CLCN7 gene	2
antiviral agents	2
two anti-HIV-1 molecular scaffold prototypes	2
HIV-1, SIVmac, or SHIV	2
primary human CD4+	2
HIV-1-preinfected SupT1 cells	2
Myr(+)AnkGAG1D4 vector	2
SupT1 cells	2
third-generation lentiviral vector	2
2LTRZFP	2
N-myristoylated Myr(+)AnkGAG1D4 protein	2
2-LTR-circle junction of HIV-1 cDNA	2
newly incoming viruses	2
capsid-binder AnkGAG1D4	2
intracellular antivirals	2
zinc finger protein (2LTRZFP)	2
ankyrin repeat protein (AnkGAG1D4)	2
alternative therapeutic agents	2
Designed molecular scaffolds	2
ZFN protein pairs	2
CD34+ hematopoietic stem/progenitor cells	2
ZFN protein backbone	2
tandem nuclear localization signal (NLS) repeats	2
zinc-finger nuclease (ZFN) proteins	2
site-specific nucleases	2
mutant KRAS CRC	2
promising therapeutic agent	2
RAS/mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT pathways	2
EGFR signaling cascade	2
mutant KRAS	2
two major branches in EGFR pathway	2
miR-4689 directly targets v-ki-ras2 kirsten rat sarcoma viral oncogene homolog (KRAS) and v-akt murine thymoma viral oncogene homolog 1(AKT1)	2
mutant KRAS CRC tissues	2
normal mucosa	2
miR-4689 expression	2
KRASG12V overexpressed cells	2
one of the significantly down-regulated miRNAs	2
mature miRNA oligonucleotide (miR)-4689	2
dysregulated miRNAs	2
wild-type KRAS and BRAF genes	2
human embryonic kidney 293 and MRC5 cells	2
exogenous KRASG12V	2
mutant KRAS cancers	2
microRNA (miRNA)	2
iRed	2
orthotopic mouse model	2
dSC iRed	2
highest shRNA yield	2
modified iRed	2
cognate 4′-thio derivatives, i.e., dSA iRed, dSG iRed, dSC iRed, and ST iRed	2
one type of adenine (A), guanine (G), cytosine (C), or thymine (T) nucleotide unit	2
polymerase chain reaction (PCR)-amplified 4′-thioDNA	2
series of iRed	2
U6 promoter and shRNA	2
minimum sequence of iRed	2
intelligent shRNA expression device (iRed)	2
small interfering RNA (siRNA) and plasmid DNA (pDNA) expressing short hairpin RNA (shRNA)	2
enriched libraries	2
aptamer sequences	2
selected libraries	2
aptamer libraries	2
high-throughput next-generation sequencing and bioinformatics	2
commercially interesting targets	2
diagnostic assays	2
diverse commercial applications	2
promoter associated ncRNAs	2
HIV reservoirs	2
HIV-1 U3 promoter region	2
NF-κB region	2
antisense strands of siRNA	2
virally encoded long-asRNA	2
Viral miRNAs	2
microRNAs (miRNAs), antisense (as)RNAs, and short interfering (si)RNA	2
noncoding RNAs (ncRNA)	2
overwhelming majority of patients	2
integrated provirus of HIV-1	2
UNA sequences	2
drug delivery system (DDS) molecules	2
new, effective LNA-DNA gapmer structure	2
hepatic tropism	2
gapmer	2
13-mer gapmer ASO	2
UNA wing	2
“second wing	2
7-mers of unlocked nucleic acid (UNA)	2
5′-α-tocopherol–conjugated 4-	2
5′-end of the ASO sequence	2
13-mer LNA (locked nucleic acid)-DNA gapmer antisense oligonucleotide (ASO)	2
α-tocopherol–conjugated siRNA	2
α-tocopherol conjugation	2
efficient system	2
novel antiviral agents	2
bulge-type, imperfect complementarity	2
RNA-type iMIRs	2
full-length HCV (genotype 1b)	2
iMIRs and locked nucleic acids (LNAs)	2
non-nucleotide residues	2
novel oligonucleotides	2
mouse BW-adjusted dose	2
single animal species, either mouse or monkey	2
ASOs within the same species	2
two animal species (mouse and monkey)	2
nine antisense oligonucleotides (ASOs)	2
toxicological animal species	2
TanSat data	2
TanSat and OCO-2 SIF products	2
MODIS NDVI, EVI and GPP	2
OCO-2 SIF	2
remote sensing datasets	2
monthly SIF products	2
retrieved SIF	2
Fe Fraunhofer lines	2
micro spectral window	2
region of the O2-A band of the Atmospheric Carbon dioxide Grating Spectroradiometer (AGCS) module	2
atmospheric O2	2
carbon-based macromolecules	2
aerobic organisms	2
Atmospheric oxygen (O2)	2
numerical simulations	2
essential players	2
metalized integer spin ladders or chains	2
Luttinger liquids	2
charge sector	2
topologically non-trivial Luttinger liquid	2
topologically-trivial Luttinger liquid	2
large easy-plane spin anisotropy	2
doped spin-1/2 ladder	2
reanalysis datasets	2
observations and simulations	2
Various metrics	2
subtropical dry zone	2
efficient devices	2
perovskite active layer	2
bilayer structure	2
[6,6]-phenyl-C61-butyric acid methyl ester (PCBM) layer	2
sol-gel derived ZnO layer	2
improved devices	2
symbiosis	2
components of the bilayer	2
low-temperature processed, thermally stable, efficient perovskite solar cells	2
electron transport bilayer	2
quantum simulator	2
diatomic molecules	2
superconducting quantum simulator	2
toy model	2
laser	2
maser	2
physical structure of molecules	2
electromagnetic radiation	2
quantum systems	2
indirect factor	2
bHLH factor TT8	2
MYB transcription factor PAP1	2
anthocyanin biosynthetic and regulatory genes	2
SDE2 expression	2
conserved nuclear-localized ubiquitin-like (UBL) superfamily protein, silencing defective 2 (SDE2)	2
locus At4G01000	2
aboveground tissues	2
Arabidopsis mutant	2
MBW subunits	2
MYB, bHLH and WD40 subunits	2
conserved transcriptional MBW complex	2
BCC-CSM1.1 model	2
SODA reanalysis	2
EnOI assimilation	2
Atlantic meridional overturning circulation (AMOC)	2
North Atlantic	2
Hadley Centre Sea Ice and Sea Surface Temperature (HadISST) dataset	2
initialization	2
extratropics of the North Atlantic	2
Brillouin zone	2
Weyl and Dirac points	2
No. 198 and No.	2
glide-invariant planes	2
No. 205 (Pa-3)	2
(Pbca)	2
No. 61	2
orthogonal screw rotation axes	2
No. 19	2
two bands	2
electron’s energy bands	2
three-dimensional noncentrosymmetric materials	2
generic quantum system	2
many-body localized system	2
random-field XXZ model	2
western-central tropical Pacific	2
subsurface	2
eastern Pacific	2
top model layer	2
FWF	2
tropical Pacific	2
GFDL MOM5-based simulations	2
state-of-the-art ocean models	2
RFF formulations	2
small number of cells	2
4- and 8-cell stage embryos	2
candidate intra-embryonic heterogeneous genes	2
early mouse embryos	2
two single cells	2
single-cell transcriptome repeatedly	2
IPCC in its Fourth and Fifth Assessment Reports	2
recoverable fossil fuels	2
feedback sum	2
models’ near-term predictions	2
Intergovernmental Panel on Climate Change (IPCC)	2
irreducibly simple climate-sensitivity model	2
several invertebrate lineages	2
Chengjiang-type	2
famous soft-bodied preservation of Burgess Shale-	2
probable phosphatized scalidophoran worm embryo and other fossils	2
arthropod appendages	2
pyritized colonial organism	2
first fossil antipatharian corals	2
remarkably preserved pedicle	2
linguloid brachiopods	2
shallow-water aspect	2
fauna	2
Lower Ordovician Fenxiang Formation	2
recently discovered locality	2
invertebrate fossils	2
past	2
taphonomic windows or Konservat-Lagerstätten	2
fossil material	2
shallow-water marine environments	2
mineralized skeletons	2
geological past	2
DNA vectors	2
epitope-tree	2
cell lineages of a cancer	2
panel of eAbs and antibody-retargeted CTLs	2
single-target technologies	2
engineered antibodies (eAbs)	2
range of medicinal plant species	2
secondary metabolism (vinblastine, nicotine, artemisinin, taxol and ginsenoside)	2
signaling molecule jasmonic acid (JA)	2
different medicinal plants	2
MYC, MYB, WRKY and AP2/ERF	2
Several transcription factor families	2
biosynthetic genes	2
wide range of diseases (cancer, malaria, etc.)	2
wide spectrum of secondary metabolites	2
present model	2
simple sensitivity-focused model	2
doi:10.1007/s11434-014-0699-2)	2
(Sci Bull 60:122–135, 2015	2
Monckton of Brenchley et al.	2
irreducibly simple climate model	2
doi:10.1007/s11434-015-0806-z	2
(Sci Bull, 2015.	2
epigenetic machinery	2
regulatory units	2
TEs	2
multiple TEs	2
many long non-coding RNAs (lncRNAs)	2
somatic DNA	2
intact TE-derived endogenous viral particles	2
human and mouse embryos	2
TE-derived proteins	2
various families of TEs	2
mobile genomic sequences of DNA	2
biological sciences	2
basic and translational neuroscience	2
neuromodulation toolboxes	2
muscle cells and touch receptor neurons	2
mec-4-specific neurons	2
myo-3-specific muscle cells	2
transgenic Caenorhabditis elegans	2
remote magnetic field	2
trains of action potentials	2
ultrasensitive fluorescent calcium indicator GCaMP6s	2
HEK-293 cells	2
exogenous magnetoreceptor, an iron-sulfur cluster assembly protein 1 (Isca1)	2
optical fiber or wire electrode	2
highly value molecules	2
limited numbers of common precursors	2
phenylpropanoids, terpenoids and alkaloids	2
specialized metabolites in medicinal plants	2
analytical chemical technologies	2
functional genomics	2
modern pharmacy	2
specialized (or secondary) metabolites	2
small vortices	2
wreck location	2
fallen trees	2
squall line	2
apex of a bow echo	2
cruise ship	2
Oriental Star	2
trigonal bipyramidal complexes	2
quasi two dimensional hexagonal lattice structure	2
Co/Ni-based materials	2
high Tc superconductors	2
local electronic structures	2
p-orbitals of anions	2
d-orbitals of cations	2
quasi two dimensional electronic environment	2
key ingredients (gene)	2
square lattice	2
high Tc) superconductors, cuprates and iron-based superconductors	2
recently emergent framework	2
epidemic clone	2
either New Delhi metallo-β-lactamase 1	2
coproduces extended-spectrum β-lactamase (ESBL)	2
sequence type ST648 and	2
MCR-1-carrying E. coli E15017	2
three human isolates of the mcr-1-positive Escherichia coli (E15004, E15015 and E15017)	2
mcr-1-positive bacterial host reservoirs	2
super-bugs	2
mcr-1 gene	2
food animals and human beings	2
mobile colistin resistance gene (mcr-1)	2
multidrug-resistant Gram-negative pathogens	2
ultimate line of refuge	2
monolayer FeSe on SrTiO3	2
nematic fluctuations	2
heavily electron doped FeSe films	2
iron-based superconductors	2
iron-based, especially iron-chalcogenide, superconductors	2
STO phonons	2
FeSe electrons	2
known Fe-based superconductors	2
bulk FeSe	2
SrTiO3 (STO) substrate	2
Monolayer FeSe films	2
coflow design	2
wider interconnect of the anode side	2
interconnect structures	2
different designs	2
anode-supported SOFC	2
anode-supported planar SOFC	2
comprehensive 3D model	2
solid oxide fuel cell (SOFC) components	2
normal circulating DNA	2
longitudinal ctDNA-based liquid biopsies	2
circulating tumor DNA (ctDNA)	2
latest blood born markers	2
diagnostic platform	2
optimum RNN classifier	2
supervised classifier recurrent neural network (RNN)	2
mRMR feature list	2
large gene expression data set	2
normal tissues/cancers	2
widely and rarely expressed genes	2
formation of tissues	2
tissue-specific gene expression	2
publicly available resources, plasmid data	2
synthetic plasmids	2
model and nonmodel organisms	2
microbial cell population	2
genomes of naturally occurring plasmids	2
genetic parasites of microorganisms	2
non-dense breasts or malignant calcifications cases	2
benign calcifications cases	2
non-dense breast cases	2
dense breast cases	2
malignant calcifications	2
benign calcifications	2
breast calcifications	2
three radiologists	2
Three hundred and five patients	2
potential circRNA-targeted agent	2
AD associated circRNAs	2
AD-associated biological process and pathways	2
AD-associated circRNAs	2
Panax notoginseng saponins (PNS)	2
best contact predictors	2
CASP12 free modeling targets	2
protein residue contacts	2
residue-residue contacts	2
PDE surface residues	2
target binding site	2
various PDE isoforms	2
PDE surfaces	2
PDE:BAY60–7550 interactions	2
catalytic pockets of six PDE isoforms	2
highly selective PDE2A inhibitor (BAY60–7550)	2
PDE isoforms	2
catalytic sites of PDE isoforms	2
selective PDE inhibitors	2
human phosphodiesterase (PDE) proteins	2
ABC membrane protein structures	2
molecular dynamics trajectory	2
ABC membrane proteins	2
proposed metrics	2
functionally crucial regions	2
standardized measures	2
user-friendly web server	2
independent data set	2
optimal feature set	2
extremely randomised tree	2
putative GHBPs	2
GHBP	2
growth hormone	2
soluble carrier growth hormone binding protein (GHBP)	2
different manufacturing sites	2
fibrillar protein FHA	2
unique fingerprint spectrum	2
Intrinsic Fluorescence	2
AlPO4 adjuvant	2
Secondary structure alpha-helix and beta-sheet content of DT and TT	2
Diphtheria Toxoid (DT), Tetanus Toxoid (TT), and chemically-modified Filamentous Haemagglutinin (FHA)	2
continuous porous surface	2
submicron particles	2
adsorbed proteins	2
AlPO4 adjuvant suspension	2
adsorbed antigens	2
aluminum phosphate (AlPO4) adjuvant	2
Fluorescence, LD, and SEM	2
several analytical tools	2
commercialized vaccine products	2
empirical baseline	2
BxPC-3 cancer cell line	2
diabetic orthotopic xenograft group	2
cellular membrane	2
nuclear gaps	2
liver metastasis	2
larger tumors	2
streptozotocin (STZ)	2
Diabetic nude mice	2
individuals in the euglycemic group	2
HIF-1α expression	2
pancreatic cancer patients	2
BxPC-3 cells in culture	2
HIF-1α siRNA	2
pancreatic parenchyma	2
hyperglycemia environment	2
vivo and in vitro models	2
patients with pancreatic cancer	2
clinical pancreatic cancer tissues	2
hypoxic tumor microenvironments	2
variants S324F	2
wild type-RpsA	2
mutant and wild type RpsA structures	2
mutations S324F	2
Ser324Phe, Glu325Lys, Gly341Arg	2
conserved region	2
eleven isolates	2
PZA-resistance but pncAWT isolates	2
PZA drug	2
18 PZA-resistant but wild type pncA (pncAWT) MTB isolates	2
PZA resistant isolates	2
(MTB) pncA gene encoded, pyrazinamidase (PZase)	2
active form, pyrazinoic acid (POA)	2
first-line anti-tuberculosis drugs	2
fibrin, collagen I and self-assembling peptide-based hydrogels	2
promising hydrogels	2
I, alginate, chitosan, methylcellulose, Matrigel, fibrin, gellan gum, self-assembling peptides and proteins, poly(ethylene glycol), methacrylates, and methacrylamides	2
hyaluronic acid, collagen type	2
Hydrogel polymers	2
three-dimensional networks	2
enormous variety of hydrogel-based systems	2
L-arabinose ferulate	2
subfamily 5 (SF5)	2
type A Fae125	2
detergentless microemulsions	2
two acceptors of different size and lipophilicity (prenol and L-arabinose)	2
vinyl ferulate	2
Three novel feruloyl esterases (Fae125, Fae7262 and Fae68) from Talaromyces wortmannii overexpressed in the C1 platform	2
2-dodecanol, 7-hydroxycadalene, indole-3-(4'-oxo)butyric acid, nerolidol-2, trans-nerolidol, eugenol, benzene propanoic acid, 2-methyl-1-undecanol, germacren-4-ol	2
bioactive phytochemical compounds	2
silico simulations	2
ADMET, docking and molecular dynamics	2
herbal compounds	2
various venomous toxins	2
bioactive phytochemicals	2
venom of kraits (Bungarus caeruleus) one of the six most poisonous snakes	2
group of closely related neurotoxic proteins	2
arrays of detrimental toxins	2
serpents	2
Venomous reptiles	2
licensed, first-line B-ALL treatment	2
patient-derived acute lymphoblastic leukemias with B-Cell origins (B-ALL)	2
sensitive cell lines	2
leukemia group of cell lines	2
National Cancer Institute NCI-60 human cancer cell line panel	2
phosporylation of eIF2α in HEK293T cells	2
related kinases PERK, HRI, and IRE1	2
Several compounds	2
triazolo[4,5-d]pyrimidine scaffold	2
series of GCN2 inhibitors	2
major ISR kinases	2
Drug-like, potent and selective chemical inhibitors (valid chemical probes)	2
adaptive signaling pathways	2
isomer of poly-sarcosine	2
poly-alanine	2
adsorption layer	2
two polymers	2
polymer-water mixture	2
poly(ethylene-glycol) and poly-sarcosine	2
therapeutic nanoparticles	2
two promising hydrophilic polymers	2
abundant serum protein	2
human serum albumin	2
growth factors IGF-1, TGF-β3	2
hyaline cartilage	2
hyaline, hypertrophic)	2
type of cartilage produced	2
signature of hypertrophic cartilage	2
collagen X	2
cartilaginous extracellular matrix (Collagen II and Aggrecan)	2
two of the most important constituents	2
human mesenchymal stem cells both with and without nanoparticles	2
hypertrophic collagen	2
osteoarthritic patients	2
fields of biophysics and biochemistry, biomedicine, and materials science	2
structurally intact, well-definedDNA origami shapes	2
DNAorigami nanostructures	2
proteins, dyes, and nanoparticles	2
functional species	2
attractive substrates	2
almost arbitrarily shaped molecular nanostructures	2
proposed mechanistic network	2
healthy, non-steatotic livers	2
reactive oxygen species (ROS) and LPO	2
phenomenological mathematical model	2
underlying mechanistic network	2
QuestionDonor liver organs	2
maternal and fetal bloodstreams	2
in-vivo organ	2
defective placentation	2
several classifications of data set	2
force field	2
different force fields	2
selected data set	2
classified data set	2
scaffold of ligand	2
DFG-loop state (DFG-in/out loop)	2
whole set of protein–ligand complexes	2
ligand and amino acid residues of protein (IFIE-sum	2
p38 mitogen-activated protein (MAP) kinase	2
myeloid compartment	2
macrophage subsets	2
group-related immune cell clusters	2
mass and flow cytometry datasets	2
cell clusters	2
specific cell clusters	2
Analysis frameworks	2
large panel of computational tools	2
single viral genus	2
family of novel but conserved cyclophilins	2
higher order structures	2
genera	2
Mimivirus CYNs	2
canonical CYNs	2
viruses of the other genera of this family	2
CYNs of all members of the Mimivirus genus	2
Megavirales genomes	2
CYN sequences	2
unique CYN	2
unique peptide insertions	2
novel CYN	2
member of the Mimiviridae family of the Megavirales order	2
Acanthamoebaae polyphaga mimivirus	2
first complete genome sequence	2
order Megavirales	2
giant DNA genomes	2
large variety of client proteins	2
large group of protein prolyl isomerase (PPIase)	2
cyclophilin (abbreviated here as CYN) family	2
biomedical literature references and abstracts	2
publicly available medical risk factor reference repository	2
two different biomedical evidence databases	2
real blockchain infrastructure	2
Biomedical evidence data versioning	2
retrieved data	2
sensitive domain	2
biomedical evidence data	2
number of authoritative databases	2
FHIRChain-based decentralized app	2
HL7 Fast Healthcare Interoperability Resources (FHIR) standard	2
blockchain-based architecture	2
blockchain-based systems	2
National Coordinator for Health Information Technology (ONC)	2
tamper-proof distributed ledger	2
Masked Authenticated Messaging extension module	2
wearable and embedded devices	2
distributed ledger technologies	2
algorithms, data, and models	2
on-demand digital healthcare ecosystem	2
soluble and mechanical factors	2
Mechanics and biochemical signaling	2
biochemical and biophysical cues	2
extra cellular matrix of the stroma	2
corresponding stroma	2
institution-centric to patient-centric data sharing	2
Patient-centered interoperability	2
different hospital systems	2
business entities	2
multiple lead candidates	2
lysine and arginine residues on histone proteins	2
bioreactor modeling	2
predictive tools	2
transcriptional regulation programs	2
bioreactors	2
Microbial producers	2
Industrial bioreactors	2
clinical laboratories	2
existing expertise and instrument	2
service laboratories	2
protein molecular variants	2
clinical examples	2
time-of-flight mass spectrometer and the Orbitrap; and MS/MS (tandem-in-space, tandem-in-time and data acquisition)	2
quadrupole mass filter	2
metabolic profiling	2
corresponding technologies	2
circulating tumor DNA	2
circulating tumor cells	2
proteins)	2
resulting structures	2
self-perpetuating and self-correcting systems	2
gradient	2
late ones	2
early amino acids	2
pairwise residue contact energies matrices	2
‘ancient’ ones	2
‘recent’ amino acids	2
co- and post-translationally folding proteins	2
tested protein groups	2
amino acid species	2
genetic code's codons	2
bacteria to mammalian cells	2
diagnostic and subtyping purposes	2
informatics infrastructure and analytical pipelines	2
clinical microbiology laboratories	2
sequencing and computational technologies	2
respiratory secretions, cerebrospinal fluid, stool, blood and tissue	2
increasing variety of biological specimens	2
putative pathogens	2
next-generation sequencing (NGS)	2
clinical specimen	2
nucleic acid material	2
mutation sites	2
beneficial mutation sites	2
carefully curated search motifs	2
recent and experimentally confirmed molecules	2
hormone abscisic acid	2
nitric oxide sensor	2
cyclic nucleotide cyclases	2
signalling and stimulus-response pathways	2
novel components	2
plant molecules	2
functional centers	2
hidden plant signalling molecules	2
receptor molecules	2
complex domain architecture	2
proteins from prokaryotes and other eukaryotes	2
receptors and signalling molecules	2
“healthy” gut microbiota	2
gut microbial communities	2
host genetics	2
different sections of chickens' gut	2
gut-associated immune system	2
gastrointestinal tract (GIT) of chickens	2
stable taxonomy	2
various state-of-the-art omics technologies	2
members of both sexual and asexual morphs	2
Several distantly related Aspergillus-like fungi	2
monophyletic genera	2
Penicillium and Talaromyces	2
T. marneffei)	2
Talaromyces (e.g. the medically important thermally dimorphic ‘P. marneffei’ endemic in Southeast Asia	2
Penicillium subgenus Biverticillium	2
three genera	2
consolidated species concept	2
phenotyping to chemotyping (e.g. lipotyping, proteotypingand metabolotyping)	2
traditional morphotyping	2
various biological, biochemical and computational technologies	2
environment, economy, biotechnology and medicine	2
diverse, phenotypically polythetic genera	2
FAD-binding region of the LAAOs in gastropods	2
vertebrate clade	2
mollusc clade	2
two major clusters	2
aGG sub-region	2
FAD-GG sub-region	2
FAD-binding sequence	2
five sub-regions (bFAD, FAD, FAD-GG, GG, and aGG)	2
amine oxidase family	2
flavoproteins	2
231 samples	2
unique sequences	2
LAAOs	2
conserved 47-amino-acid FAD-binding region	2
fungi, invertebrates, and vertebrates	2
Translated amino acid sequences	2
210 other organisms	2
LAAO-conserved FAD-binding regions	2
obtained nucleotide sequences	2
amplified 143-bp fragments	2
conserved FAD-binding region of LAAO	2
gastropods and other invertebrates	2
twelve gastropod genera	2
conserved FAD-binding region of the L-amino acid oxidase (LAAO) genes	2
gut microbial community	2
resistant starch	2
Coprococcus, Butyricimonas, Succinivibrio, Campylobacter and Phascolarctobacterium	2
meat in the diet	2
Bacillus and Anaerovorax	2
omnivorous group	2
Anaerofustis, Butyricimonas, Campylobacter, Coprococcus, Dehalobacterium, Phascolarctobacterium, rc4.4, RFN20, Succinivibrio and Turicibacter	2
Anaeroplasma, Anaerovorax, Bacillus, Coprobacillus and Solibacillus	2
diverse gut microbiome	2
traditional herbivorous cattle	2
fecal samples of the omnivorous cattle	2
country parks	2
leftover barbeque food waste	2
wild cattle straying	2
rice fields	2
draft animals	2
hypothetical and known TFs	2
3NN graph	2
hypothetical and experimentally characterized TFs	2
Colombos database	2
DNA-binding transcription factors (TFs) in Escherichia coli K-12	2
MPFS	2
paired data	2
microarray, RNA-sequencing (RNA-seq), and single-cell RNA-seq	2
various technologies	2
multisubunit client complexes	2
two flanking chaperone modules	2
unstructured, flexible loop	2
CFBP linker	2
first molecular foundation	2
CFBP linkers	2
discernible motif	2
diverse in sequence	2
CFBP-type DFIs	2
FCBP-type DFI	2
FKBP and CYN modules	2
flexible linker	2
3TPR domain	2
either of two conformations: CYN-linker-FKBP (CFBP) or FKBP-3TPR-CYN (FCBP)	2
DFIs	2
dual-family immunophilin (DFI)	2
novel class of immunophilins	2
cyclophilin (CYN) and FK506-binding protein (FKBP)	2
two classical immunophilin families	2
plot	2
meningococcal genome	2
virulent and apathogenic strains	2
healthy carrier from infected individuals	2
clear causative elements	2
pharyngeal mucosal epithelium	2
commensal organism	2
upper respiratory tract of the human population	2
Neisseria meningitidis (Nm)	2
reference materials	2
variant callers	2
recent low-frequency variant callers	2
paired tumor-normal samples	2
whole genome or exome sequencing	2
traditional variant callers	2
somatic single nucleotide variants	2
appropriate pipeline	2
state-of-the-art variant callers	2
targeted applications	2
different underlying models	2
variant calling pipelines	2
higher- and primary-order chromatin structures	2
chromosome architecture	2
Hi-C and ATAC-seq	2
“higher-order” and “primary-order” chromatin structures	2
hierarchical organization of chromatin	2
middle-income countries	2
proposed system	2
Four other classifiers	2
imbalanced data	2
mixed-type data in imbalanced datasets	2
rs5128, rs2893157, rs662799, and Apolipoprotein-E2/E3/E4)	2
Single nucleotide polymorphisms (rs1801177, rs708272, rs320, rs328, rs2066718, rs2230808, rs5880,	2
725 subjects	2
new dyslipidemia diagnosis system	2
related tasks	2
digital pathological images	2
digital histopathological images	2
sequencing genomes	2
linked-reads	2
highly-multiplexed genome partitioning and barcoding	2
known ones	2
novel markers	2
available cure	2
multiple disease types	2
commonly used statistical models	2
Artificial Neural Networks (ANN)	2
immunodeficient patients	2
viral micro-environments	2
VDPV outbreaks	2
less divergent sequences	2
two categories	2
highly divergent iVDPV2 from cVDPV2 sequences	2
cVDPV2 and iVDPV2 sequences	2
type 2 VDPV	2
iVDPV chronic infections	2
cVDPV outbreaks	2
individuals with primary immunodeficiency (immunodeficiency-associated VDPV [iVDPV]	2
vaccine-derived poliovirus (VDPV)	2
analysis architectures	2
comprehensive Everything as a Service (XaaS) solutions	2
ready-to-use technologies	2
complex IT architectures	2
academic research institutions	2
many overall concepts	2
clinical environments	2
analytical software tools	2
Next-Generation Sequencing (NGS)	2
w/t PP13	2
larger placentas and newborns	2
uterine vessels	2
pregnant rodents	2
truncated variant of PP13	2
A/C” or “C/C”	2
A/A” genotype in the -98 position	2
promoter PP13 variant	2
polymorphic PP13 variants	2
additional generic drugs	2
low dose aspirin	2
Generic drugs	2
newborn disabilities	2
Hypertensive disorders	2
reversed (not reverse-complement) sequences	2
information ruling nucleotide-protein relations	2
mitochondrial genetic codes	2
CDA and tRNA synthetase classes	2
alanine, leucine, serine, and valine)	2
CDA-whole organism associations	2
tRNA synthetase class I/II (aminoacylate the 2′/3′ hydroxyl group of the tRNA's last ribose, respectively)	2
Fujimoto's tetrahedral codon stereo-table	2
Negative/positive CDAs	2
pyrimidines	2
purines	2
ZXX/XXZ	2
first and last nucleotides identical, codon structure XZX)	2
palindromic codons	2
histones and non-coding RNAs	2
genes encoding metabolic enzymes	2
ligand-responsive MarR family transcription factors	2
pathway intermediates	2
catabolic enzymes	2
anabolic pathways	2
regulatory circuits	2
prioritizing disease genes and pathways	2
independent ccRCC patient datasets	2
NOD2, RRM1, CSRNP1, SLC4A2, TTLL1 and CNTN1	2
several known ccRCC causative genes	2
list of candidate disease genes	2
interacting genes	2
transcriptome and protein-protein interactions	2
causative mutations and disease genes	2
tumor suppressor genes, oncogenes, and dysregulated pathways	2
renal cell cancer (RCC)	2
Clear cell renal cell carcinoma (ccRCC)	2
big data bioinformatics software	2
distributed computing environment	2
modern cloud computing and big data programming frameworks	2
biological and biomedical data	2
independent tissue	2
functionally equivalent and non-equivalent orthologs	2
homology groups	2
mouse and rat	2
orthologous genes	2
mouse and rat liver	2
predicted orthologs	2
functionally equivalent ones	2
complex homologous gene families	2
functional orthologs	2
co-expression network	2
multi-gene family orthologs	2
GitHub link https://github.com/raunaq-m/MultiRes	2
false positive SNPs	2
true k-mers	2
false positives	2
correction tools	2
MultiRes on simulated and real viral population datasets	2
genomes and sequenced reads	2
Frames are sets of non-orthogonal basis functions	2
erroneous or rare variants	2
reads of a viral population	2
Next Generation Sequencing (NGS) data	2
artificial proteins	2
currently functioning molecules	2
existing life forms	2
organisms themselves	2
Biological molecules	2
classical biological sequence alignment problem	2
different computing platforms	2
various computing platforms	2
different biological data analysis applications	2
popular computing platforms	2
big biological data	2
state-of-the-art HPC platforms	2
high performance computing (HPC) platforms	2
massive computational resources	2
deepest biological functions	2
biologists and computer scientists	2
life sciences	2
traditional data analysis platforms	2
high-throughput sequencing projects	2
good knowledge base	2
different parts of the system	2
overlapping but different scientific domains	2
biological information	2
information	2
regulative assets	2
Biological systems	2
DNA fragments or assemblies	2
key biodiversity measure	2
Multiple indices	2
microbial ecology	2
collection of flexible tools	2
R software package SigTree	2
phylogenetic branches	2
evolutionary phylogeny	2
multiple related microbial species (or operational taxonomic units)	2
several promising candidates	2
apoE3-like molecules	2
“structure correctors”	2
Mimetic peptides	2
various molecules (Nrf2 target genes, metallothioneins, paraoxonase)	2
IL-2 production	2
CD4+ and CD8+ lymphocytes	2
anti-inflammatory M2	2
apoE isoforms	2
viral and host molecules	2
herpes simplex type-1, hepatitis C and human immunodeficiency viruses	2
regions and residues	2
truncated apoE forms	2
apoE structural domains and isoforms	2
three structural different apoE isoforms	2
plasma lipoproteins	2
34kDa glycoprotein	2
Apolipoprotein E (apoE)	2
non-specialist and life scientists	2
NMR specialists	2
suitable and popular analytical resources	2
molecule of interest	2
nuclear spin	2
chemical compounds and biomolecules	2
many similarly-labelled molecules	2
third class	2
single pores	2
single fluorescently-labelled molecules	2
many pores	2
fluorescence signal	2
first class	2
three major classes	2
complex filter	2
nuclear envelope barrier	2
CCM components of cyanobacteria	2
freshwater than marine cyanobacteria	2
CCM	2
basic molecular components	2
freshwater, marine, and alkaliphilic β-cyanobacteria	2
CCM components	2
PCC 7327, Cyanobacteriumstranieri PCC 7202, and Spirulina subsalsa PCC 9445	2
Pleurocapsa sp	2
three moderate alkaliphiles	2
alkaliphiles	2
transport systems, carboxysomal β-CA, CcaA,	2
strong alkaliphiles	2
medium-affinity ATP-dependent HCO3− transporter BCT1	2
Na+/HCO3− symporter	2
β-carboxysome formation	2
ccmKLMNO cluster	2
standard genes	2
form 1B of Rubisco	2
β-carboxysome shell proteins	2
β-cyanobacteria	2
, Cyanobacterium spp., Spirulina subsalsa PCC 9445, and 6 strong alkaliphiles (i.e. Arthrospira spp.)	2
PCC 7327, Synechococcus spp.	2
Pleurocapsa sp.	2
moderate alkaliphiles	2
cyanobacteria	2
alkaline environments	2
CCM of cyanobacteria	2
freshwater and marine cyanobacteria	2
CO2-limited environments	2
various habitats	2
active site of Rubisco	2
antibody's binding site	2
H3 loop	2
antibody structure	2
Antibody structures	2
different substances	2
proteins of the immune system	2
post-translational modified proteins	2
molecular modeling and simulation	2
available online platforms	2
modified sites	2
almost all proteins	2
Lomonosov supercomputer	2
search space	2
active site of the target protein	2
protein atoms	2
novel parallel docking SOL-P program	2
protein and ligand atoms	2
selected target protein atoms	2
target protein atoms	2
probe ligand atoms	2
moveable protein atoms	2
breeding germplasm	2
sweet cherry	2
closely related cultivars of a species	2
multiple SNP detection platforms	2
sweet cherry cultivars	2
five closely related genotypes of sweet cherry	2
genetically constrained species	2
genome-wide polymorphisms	2
best platforms	2
germplasm	2
Rosaceae family	2
economically important non-climacteric tree fruit crop	2
Sweet cherry (Prunus avium L.)	2
superior cultivars of economically important species	2
public–private product development partnerships	2
automated surveillance systems	2
diagnostic laboratories and POC test readers/devices	2
Connectivity solutions	2
cost-effective multiplex surveillance platforms	2
sentinel populations	2
single specimen	2
New sample in-answer out nucleic acid amplification technologies	2
NTD diagnostics	2
Road Map	2
149 countries	2
Neglected Tropical Diseases (NTDs)	2
long established cell factory	2
Chinese hamster ovary cells	2
voltage sensor of voltage-gated potassium channels	2
pore helix	2
pore helix of the potassium channel	2
family of potassium ion channel proteins	2
related protein	2
regular secondary structures	2
chemicals, nutraceuticals, and drug precursors	2
Several value-added products	2
supplement of cofactors and substrates	2
cell-free environment	2
rate-limiting metabolic pathways	2
many valuable biologically active compound and commodity chemicals	2
biomolecular engineering	2
fastest growing class of therapeutic agents	2
toxin peptides	2
selective analogs	2
target epitope	2
existing peptide or protein-based therapeutics	2
potentially interesting drug target	2
Bilirubin Transporter Family	2
members of the Organic Anion Transporter family	2
Bilitranslocase is bilirubin membrane transporter	2
transmembrane protein bilitranslocase	2
membrane models	2
transmembrane helix–helix interactions	2
transmembrane regions	2
unsolved proteins	2
unique ones	2
transmembrane protein structures	2
European & Developing Countries Clinical Trials Partnership (EDCTP)	2
six continents	2
72 countries	2
331 different institutions	2
research teams	2
top global funders	2
NID research projects	2
public and private donors	2
Neglected infectious diseases (NIDs)	2
bolster MMP datasets	2
analog sets	2
irrelevant, contextually dissimilar MMPs	2
existing MMP search algorithms	2
pairs of compounds	2
analog series	2
challenging field	2
Biomedical images	2
interactive applications	2
lines, contours, or boundaries of bones, organs, vessels, and cells	2
low-dimensional representation	2
trigonometric spline	2
large-scale circular datasets	2
sophisticated and faster statistical tools	2
different Ramachandran plots	2
large germplasm collections	2
interesting alleles of genes	2
Targeted resequencing	2
bioinformatic pipelines	2
CIAT germplasm collection	2
cassava accessions	2
breeding populations	2
cassava reference genome	2
chromosome-level assembly	2
different accessions	2
largest cassava germplasm collection	2
International Center for Tropical Agriculture (CIAT)	2
rice or maize	2
economically important crops	2
starch, food, feed and ethanol industries	2
competitive resource	2
one of the most important food security crops	2
ontologies	2
ontology types	2
ensemble classifier	2
two concepts	2
structured vocabulary	2
many drug designers	2
intuitive nature	2
publicly available bioactivity databases	2
previously unknown molecular pairs	2
matched pairs	2
entire Chagas disease research community	2
best drugs	2
Chagas patients	2
globe	2
Latin America	2
parasite Trypanosoma cruzi	2
American trypanosomiasis	2
activity of enzymes that bind DNA	2
ERE	2
estrogen receptor	2
excess E2	2
random sequences of DNA	2
estrogen response element (ERE)	2
two successive DNA base pairs	2
hormonal system	2
endocrine-disrupting molecule	2
endocrine system	2
natural molecule	2
17β-estradiol (E2)	2
editing reagents	2
various genome editing tools	2
specific DNA target site	2
suitable template	2
homologous recombination-based double-strand break repair pathway	2
error-prone, non-homologous end joining repair system	2
targeted double-stranded DNA cuts	2
variety of reagents	2
introducing genes	2
defective genes	2
ligand CCL21	2
CC chemokine receptor 7 (CCR7)	2
seven microseconds MD trajectory	2
tightly packed proteins	2
manageable set of communities	2
intramolecular network	2
protein MD simulation	2
Gaussian mixture models	2
manageable set	2
large MD simulation spatiotemporal datasets	2
biomolecular simulations	2
Protein structure	2
investigated patients	2
patient-specific genetic variant combinations	2
new hypotheses	2
selected articles	2
clinical datasets	2
first category	2
Genetic Background	2
intelligently all available information	2
clinical information	2
biotechnology and health sciences	2
present article	2
glassy systems	2
frozen glasses and freeze-dried protein powders	2
amorphous phases	2
biological molecules	2
solid and liquid phases	2
active pharmaceutical ingredient	2
proteins in liquid solutions	2
commonly available set	2
amorphous solids	2
either frozen solutions or lyophilized powders	2
many biotherapeutic drugs	2
mobile phones	2
image processing-based systems	2
anatomic components and lesions	2
types of lesions	2
biology of the retina	2
automatic image processing tools	2
particular methods and tools	2
strategies	2
sophisticated computational algorithms	2
various genomes	2
short DNA fragments	2
whole metagenomic shotgun sequencing	2
whole environments	2
novel microbial genomes	2
whole metagenome shotgun sequencing	2
tissue biopsy	2
tested classifiers	2
involved axillary lymph nodes	2
multilayer perceptron neural network	2
Three other classifiers	2
5-year breast cancer recurrence prediction	2
growing abnormal cells	2
layer I of frontal cortical areas	2
thalamic connections	2
cortical neurons.3.The	2
striatal dendritic spines	2
(PD)	2
CD19-negative relapsed leukemia	2
leukemic blasts	2
surface of leukemic blasts	2
patients with relapsed and refractory B-cell acute leukemias	2
anti-CD19 chimeric antigen receptor T cells (CART19)	2
anti-CD19/CD3 bispecific antibody blinatumomab and	2
non-tumor specific T cells	2
bispecific antibodies	2
chimeric antigen receptors	2
immunoglobulins	2
cell based immunotherapies	2
robotic platforms	2
Multiple arm flexible devices	2
dedicated suturing devices	2
Various exchangeable accessories	2
Single-use devices	2
painless sedation-free endoscopy	2
Computer assisted and super flexible self-propelled colonoscopes	2
different overtube devices	2
Variable stiffness endoscopes	2
colonic folds	2
Attachable caps, flaps, or balloons	2
new endoscopes	2
additional cameras	2
extended viewing field	2
dye-spray or virtual chromoendoscopy	2
cells or tissues	2
important topic	2
biological images	2
texture analysis systems	2
specific tissues or cells in a biological sample	2
visual textures	2
verbal fluency	2
multiconformation reconstruction)	2
multiple coexisting structures in the same specimen	2
small complexes (e.g., membrane proteins)	2
large range of complexes	2
instruments and software	2
large and flexible macromolecular complexes	2
growth supplement	2
viral vaccine samples	2
single dose HSV529 vaccine sample	2
six-times concentrated sample of HSV529 candidate vaccine sample	2
three signature peaks of cholesterol	2
HSQC NMR	2
formulation of growth supplement	2
cholesterol working standard	2
cholesterol reference spectrum	2
replication-deficient Herpes Simplex Virus (HSV) type 2 candidate vaccine HSV529	2
process-related impurity	2
immune cells, endothelial cells, fibroblasts, and others	2
tumour microenvironment (TME)	2
Extracellular microRNAs	2
synthetic SINEUPs	2
mRNA of interest	2
SINEUP molecules	2
partially overlapping protein-coding mRNAs	2
family of antisense long non-coding RNAs	2
mRNA secondary structure	2
monoclonal antibodies (MAbs)	2
primary factories	2
Chinese Hamster Ovary (CHO) cells	2
Mammalian cells	2
expanded codons	2
del- and swinger RNA	2
tryptic non-canonical peptides	2
corresponding, previously described non-canonical transcripts	2
Detected non-tryptic non-canonical peptides	2
detected non-canonical peptides	2
preferentially non-canonical tryptic peptides	2
mono-, dinucleotides after trinucleotides (delRNAs)	2
silent mono- and dinucleotides)	2
tetra- and pentacodons (codons	2
non-canonical tryptic peptides	2
experimentally added digestion enzyme(s)	2
new and existing sequences	2
superfamily, families and subfamilies	2
5000 related membrane fatty acid desaturase sequences	2
two mammalian fatty acid desaturases	2
double bonds	2
diverse superfamily of enzymes	2
Membrane fatty acid desaturases	2
orphan disease space	2
therapeutic opportunities	2
various model organisms	2
Target based chemical screens	2
therapeutic indications	2
clinical and modelling agendas	2
Respiratory Tract Diseases	2
clinically important disease categories	2
QSP, pharmacometrics and systems biology models	2
silico mathematical modelling	2
U.S. Food and Drug Administration (FDA)	2
non NSAID comparison drugs	2
Connectivity Map platform	2
drugs of interest	2
immortalised human cell lines	2
blood (n=344) and post-mortem brain	2
AD and by NSAIDs (Sulindac, Piroxicam, Paracetamol, Naproxen, Nabumetone, Ketoprofen, Diclofenac and Aspirin)	2
pathways (KEGG database	2
anti-inflammatory compounds	2
inflammatory pathways	2
non steroidal anti inflammatory (NSAID) drugs	2
ageing society	2
ER intrabody technology	2
ErbB-2, EGFR, VEGFR-2, Metalloproteinase MMP2 and MMP9, β-amyloid protein, α-synuclein, HIV gp120, HCV core	2
disease-relevant targets	2
extracellular targets	2
parenteral application	2
CRISPR/Cas9 or antibody therapies	2
neurodegenerative disorders	2
complex diseases	2
MbT-Tool	2
biomass synthesis	2
+, NO3−, NO2−, N2)	2
N-sources	2
MbT-Tool's code	2
aerobic heterotrophs, nitrifiers, denitrifiers, methanogens, sulphate reducers, sulphide oxidizers and fermenters	2
different microbial functional groups	2
Thermodynamic Electron Equivalents Model	2
microbial pathways	2
new computational tool	2
biologists, ecologists, modellers and engineers	2
balanced reactions	2
nutrient amounts and products	2
evolving ontologies	2
biomedical ontologies	2
ontology-based mappings and annotations	2
different ontologies	2
Biomedical ontologies	2
flexible facility	2
affordable biologics	2
monoclonal antibody market	2
large manufacturing facilities	2
related bioinformatic tools	2
eukaryote genomes	2
various bioinformatic tools	2
discriminant function	2
non-coding RNA genes	2
genome sequence	2
two different kinds of neuromodulation	2
growing cohort of patients	2
lipid supplementation	2
supplement	2
separate set of experiments	2
polar lipid supplement	2
glutamate, lactate, and glucose	2
absence of supplementation	2
sequenced genome	2
entire repertoire of TFs and unconventional regulators	2
search tools	2
newly developed platforms	2
TFs (especially transcriptional activators)	2
bioinformatic and experimental high-throughput tools	2
recognizable DBD or effector domain	2
so-called “moonlighting” transcription factors	2
overlapping binding regions	2
DNA-binding sites of TFs	2
effector domains	2
well-defined and easily recognizable DNA binding motifs	2
DBDs	2
positively or negatively acting co-regulators	2
second domain	2
variety of DNA-binding domain (DBD) modules	2
master gene products	2
new allosteric drugs	2
X-ray crystallographic data and structures	2
amino acid networks	2
interacting networks	2
Globular proteins	2
new, integrated platform	2
TECAN Freedom EVO liquid handler	2
Protein Maker purification system	2
traditional FPLC system	2
necessary purified protein samples	2
Protein Maker	2
downstream assays	2
concurrent samples	2
clarified harvest	2
mAb product	2
in-process intermediates	2
various wash buffers	2
Protein A	2
purified antibodies or antibody fragments	2
various in vitro assays	2
Protein Maker liquid handling system	2
vitro and in vivo assays	2
monoclonal antibodies (mAbs) and antibody fragments	2
research and development environment	2
large pool of sequences	2
papain-like cysteine protease structural theme	2
protein structure networks	2
atomistic MD-simulation	2
proteases	2
active site residues	2
new type of granulin domain	2
Several of the proteases	2
occluding loops	2
targeting signals	2
known plant proteases	2
cysteine protease genes	2
D. capensis	2
Cape sundew, Drosera capensis	2
novel proteases	2
Carnivorous plants	2
individual miRs, TFs, and target genes	2
regulatory organization	2
genes in serine, glycine and one carbon metabolism	2
p53, c-MYC, HIF1α	2
combined network	2
miRs and oncogenic TFs	2
one of the first reference maps	2
regulatory miRs	2
40 metabolic enzymes	2
(c-MYC, HIF1α and p53), sterol regulatory element binding protein 1 (SREBP1)	2
oncogenic transcription factors (TFs)	2
multiple miRs	2
computational prediction	2
additional miRs	2
key metabolic enzymes	2
microRNAs (miR)	2
oncoproteins, c-MYC, HIF1α and p53	2
de novo fatty acid synthesis, and serine and glycine metabolism	2
Entirely swinger-encoded proteins	2
short mitogenome	2
partly regular proteins	2
thirteen recognized, mitochondrial protein-coding genes	2
regular and swinger parts	2
186 peptides	2
swinger peptides	2
contiguous swinger parts	2
regular parts	2
entirely swinger-encoded peptides	2
swinger RNA	2
single peptides	2
Contiguous regular- and swinger-encoded residues	2
part regular, part swinger RNA	2
regular and swinger transcriptions	2
exchanged nucleotides	2
human mitochondrial peptides	2
tissue chip technology	2
commercializing tissue chips	2
existing partnerships	2
major organ systems	2
tissue chips	2
vitro animal models	2
vivo systems	2
Microphysiological systems (organs-on-chips, tissue chips	2
shelterin complex	2
telomerase and DNA polymerase alpha-primase (polα-primase)	2
CST	2
diverse range of organisms	2
(Cdc13/Ctc1, Stn1, Ten1)	2
shelterin (TRF1, TRF2, TIN2, RAP1, POT1, TPP1) and CST	2
telomerase, a ribonucleoprotein (RNP) reverse transcriptase	2
ends of eukaryotic chromosomes	2
circulating nucleic acids biomarkers	2
cell-free circulating tumor-specific mutant DNA and RNA (including mRNA and non-coding RNA)	2
minimally invasive serial blood samples	2
subpopulations in diverse lesions	2
intratumoral heterogeneity	2
local or metastatic site	2
single tumor sample	2
stabilometry domain	2
electroencephalography (EEG) domain	2
2004–2007 National R&D&I Plan	2
Spanish Ministry of Education and Science	2
particular time series regions	2
data types	2
Time series	2
medical field	2
BCG IT	2
production scale lots of BCG IT product	2
reconstituted lyophilized BCG IT product	2
baseline	2
Coulter Counter Multisizer 4® instrument	2
BCG immunotherapeutic (BCG IT), or ImmuCyst® product	2
non-muscle invasive bladder cancer	2
live attenuated bovine tubercle bacillus	2
Bacille Calmette–Guerin, BCG,	2
(chemo)informatic tools	2
information technologies	2
computational tools and databases	2
novel leads and drug candidates	2
whole drug discovery pipeline	2
Big data	2
voluminous datasets	2
Clusters of genes	2
dentist–patient communication	2
interactive communication technologies	2
implant supported prosthetic treatments	2
patients of potential implants	2
real cases	2
Hard and soft dental tissues	2
mobile application	2
implant cases	2
Real case photographs	2
dentists	2
verbal explanations	2
patient's mind	2
field of dentistry	2
paper-based dictionaries	2
online references	2
randomly selected biomedical words	2
newly emerging scientific vocabulary	2
wider clinical and translational science community	2
MD-CTS	2
first public resource	2
mobile and desktop online reference	2
New vocabularies	2
extra-cellular ligands TGFB1, FGF2 and TNF	2
transcription factors and microRNAs	2
CEBPA, CDK1, CX3CL1, EGR1, E2F1, ERBB2, LRP1, HSP90AA1 and ZNF148	2
analyzed microarrays	2
associated ResNet database	2
microRNA–mRNA networks	2
Several protein–protein interaction networks	2
highly modulated genes	2
seed set	2
three brain regions (cerebellum, frontal cortex and caudate nucleus)	2
human post-mortem microarrays	2
critical molecular players	2
human phenotypes	2
NMR and MS-based detection technologies	2
liquid chromatography (LC)	2
chromatography system	2
Metabonomics/metabolomics	2
small sample set	2
diabetic brains	2
neurotransmitters GABA and NAAG and sugar metabolites sorbitol, gluconic acid, xylitol, ribitol, arabinotol, and erythritol	2
lipophilic amino acids leucine/isoleucine, proline, methionine, phenylalanine, and tyrosine	2
important metabolites	2
identified or putatively identified metabolites	2
controls and the SDB samples	2
in-house database	2
ZICpHILIC column	2
subjects diagnosed with schizophrenia, depression, bipolar disorder (SDB), diabetes, and controls	2
53 post-mortem brain samples	2
dystrophin complexome	2
tubulin, vimentin, desmin, annexin, proteoglycans and collagens	2
variety of protein species	2
core dystrophin complex	2
cytoskeleton-sarcolemma-matrisome axis	2
dystrophin-glycoprotein complex	2
dystroglycans, sarcoglycans, syntrophins, dystrobrevins, sarcospan, laminin and cortical actin	2
enormous assembly of proteins	2
intracellular cytoskeleton	2
variety of sarcolemmal, cytosolic and extracellular proteins	2
membrane cytoskeletal protein dystrophin of 427kDa	2
associated components	2
multi-subunit protein complexes	2
pre-incision complex	2
NER core factors	2
DNA expanded bubble	2
disordered link regions	2
protein–protein interaction “beads”, or modules	2
“beads on a string”	2
NER pre-incision complex	2
Xeroderma pigmentosum complementation group A (XPA)	2
nucleotide excision repair (NER) pathway	2
essential scaffolding proteins	2
disordered protein regions	2
efficient inhibitors	2
CYP17A1	2
key residues of Phe114, Ile371, Val482, and Asn202	2
tighter binding	2
I-helix of CYP17A1	2
active pocket	2
CYP17A1 and inhibitors	2
four different complexes	2
molecular dynamics (MD) simulation	2
CYP17A1 and inhibitors i.e., abiraterone and TOK-001	2
androgen steroid	2
(CYP17A1)	2
Cytochrome P450 17A1	2
self-assembling protein nanoparticles	2
influenza, human immunodeficiency virus, and respiratory syncytial virus	2
innovative new vaccines	2
well-ordered arrays	2
multiple copies of subunit antigens	2
assemblies of polypeptides	2
antigen nanoparticles	2
isolated, highly purified antigenic protein subunits	2
modern vaccines	2
killed, inactivated, or live-attenuated pathogens	2
19th and early 20th century vaccines	2
many diseases	2
prior	2
statistical contexts	2
Lists of rat strains and species-specific genes and QTLs	2
sequenced rat strains	2
disease pathways	2
altered networks	2
suite of tools	2
rat, human and mouse genes	2
vocabularies/ontologies	2
biological data	2
collection of controlled vocabularies and ontologies	2
RGD houses mouse and human genes and QTLs	2
rat genes, QTLs and strains	2
http://rgd.mcw.edu)	2
Rat Genome Database (RGD	2
laboratory rat	2
disease-related loci	2
promising molecules	2
putative cationic and amphipathic anticancer peptides	2
F2 and F5 fractions	2
404 and 424 peptides	2
breast cancer cell line (MCF-7) and normal epithelium cell line (Vero)	2
Two of HPLC-separated mucous fractions (F2 and F5)	2
A. fulica mucus	2
anticancer peptides	2
snail mucous peptides	2
giant African snail Achatina fulica	2
mucous glycoproteins	2
workflow design	2
published datasets	2
collection of common integration sites (CIS)	2
several thousand viral integration genome targets	2
integration sites (IS)	2
testing dataset	2
Retroviral Transposon Tagged Cancer Gene Database (RTCGD)	2
integrated systems biology framework	2
category of scale-free networks	2
graph models	2
virus and viral vector integration genome targets	2
next generation sequencing	2
Transcriptomics and metabolomics	2
blood chemicals	2
10,000 metabolites	2
cell subpopulations	2
blood transcriptomics	2
subpopulations of blood cells	2
human immunology	2
complicated genomics applications	2
three APIs	2
API	2
functionalities, reference implementations	2
SMART Genomics	2
Google Genomics	2
three currently available Genomics APIs	2
APIs	2
multiple genomic data sources	2
software developers	2
special protocols	2
different applications, platforms, and even organizations	2
genomics data	2
clinics and research institutions	2
genomic information	2
low-barrier hydrogen bond	2
hydrogen nucleus	2
OH bond	2
106, 440–4].	2
characteristic hydrogen bond (H bond) between p-coumaric acid chromophore and Glu46	2
Photoactive yellow protein (PYP)	2
given causal site in the genome	2
cells reside	2
overall environment	2
chemoreceptors	2
different chemoattractants	2
differing environments	2
cell colonies	2
chemotaxis signalling cascade	2
agent-based population model	2
3D protein structures	2
Jsmol package	2
original PDB structures	2
interacting molecules	2
protein models	2
two related 3D structures	2
portal	2
publicly available structure database resource (SNP2Structure, https://apps.icbi.georgetown.edu/snp2structure)	2
mutated protein structures	2
non-synonymous single nucleotide polymorphisms (nsSNPs)	2
various classes of drug combinations	2
synergistic and antagonistic dose regions	2
full dose–response matrix	2
large-scale anticancer drug combination experiment	2
individual drugs	2
various dose pairs	2
existing reference models	2
drug combination	2
multi-targeted drug combinations	2
Indian Ascaris population	2
new sequence variants	2
global Ascaris population	2
separate cluster of Indian isolates	2
Genotype G1	2
previously reported and prevalent genotype G1	2
widely used genetic marker, internal transcribed spacer1 (ITS1)	2
Ascaris population	2
infecting strains	2
different Ascaris species	2
morphologically identical Ascaris species	2
protein/nucleic acid assemblies	2
popular alternatives	2
pseudoatomic structural models	2
many biological assemblies	2
new bioinformatics tools	2
field of knotted proteins	2
Molecular simulations	2
functional advantage(s) knots	2
open knot	2
Knotted proteins	2
disparate pathways	2
different subsystems	2
many biochemical pathways	2
pars compacta of the substantia nigra	2
clinical intervening	2
classification systems	2
papillary, tubular, mucinous (colloid), and poorly cohesive carcinomas	2
alternative World Health Organization system	2
intestinal and diffuse types	2
two well-recognized classification systems	2
gastric cancer clinic	2
fourth most common cancer	2
highly heterogeneous disease	2
Gastric cancer	2
ribosomal ‘turnstile’	2
processive protein biosynthetic complex	2
trees of molecular substructures	2
ancient RNA molecules	2
‘metabolic-first’ origin of proteins	2
encoded proteins	2
protein structural domains and proteomes	2
molecular repertoires and molecules	2
structural parts	2
ideographic (historical, retrodictive) and nomothetic (universal, predictive) scientific frameworks	2
particular variant	2
variable host niches	2
eubacteria	2
remarkable timing-system	2
bioinformatics and theoretical models	2
circadian timing system	2
particular clock genes	2
clock components	2
clock network	2
computational clock models	2
organismal	2
output target genes	2
distinct set of core-clock genes and proteins	2
powerful endogenous timing system	2
adjacent genes in the same DNA strand	2
microbial transcripts	2
microorganisms and viruses in oral and gut microbiomes	2
metagenomics or metatranscriptomics	2
human niches	2
high performance bioinformatic tools	2
enzymes or/and knocking-out genes	2
threatened and other species	2
emerging diseases	2
conservation examples	2
diversity of wildlife	2
R-package	2
tabular and graphical forms	2
important scientific research area	2
Clusters of Orthologous Groups (COGs)	2
various virus and bacteria genomes	2
BOG (Bacterium and virus analysis of Orthologous Groups)	2
outer retina including retinitis pigmentosa (RP), Usher syndrome (USH), Leber congenital amaurosis (LCA), gyrate atrophy (GA), juvenile neuronal ceroid lipofuscinosis (NCL), Best vitelliform macular dystrophy (BVMD) and age related macular degeneration (AMD)	2
retinal cell types	2
normal and pathological retinogenesis	2
ideal platform	2
induced pluripotent stem cell (IPSC)-derived retinal cells and tissues	2
effective treatment options	2
photoreceptors or retinal pigment epithelium (RPE)	2
new pharmaceutically relevant compounds	2
corresponding operating enzymes	2
known histone modifications	2
important tools	2
several epigenetic targets	2
large set of enzyme families	2
Histone modifications	2
histone post-translational modifications	2
active forms of the enzyme	2
archaeo-eukaryotic primases	2
free and bound primases domains	2
first phosphodiester bond	2
repeatedly (Okazaki fragments)	2
lagging strand primers	2
Primases are single-stranded DNA dependent RNA polymerases	2
primase	2
parent to daughter cells	2
gene pools	2
genomes of viruses	2
biological sequences	2
known sequence	2
“genomic dark matter	2
presence of substrate	2
PDZ1 domain of the neighbouring monomer	2
one of the key residues	2
LA loop of protease	2
fixed β-sheet	2
highly flexible region	2
minimal functional unit	2
chaperonic and protease activities	2
heat shock protein	2
aggressive tumours	2
two chemotherapeutic agents (doxorubicin and etoposide)	2
two cell lines (SH-SY5Y and UKF-NB-3)	2
three separate NB chemoresistant cell line models	2
chemoresistant cell lines	2
Three miRNAs	2
subcultured chemoresistant cell line	2
Four miRNAs	2
three NB chemoresistance models	2
miRNA profiling platform	2
parental and subcultured cell lines	2
validated chemoresistance model	2
doxorubicin (SH-SY5Y, UKF-NB-3) or etoposide (SH-SY5Y)	2
SH-SY5Y and UKF-NB-3 cells	2
individual and/or networks of miRNAs	2
drug resistant tumours	2
whole-genome metagenomics	2
16S rRNA and spo0A genes	2
large diversity of endospore-formers	2
three mammalian gut microbiomes	2
well-known habitats of Firmicutes	2
bacterial group (spo0A and gpr)	2
published metagenomic datasets	2
functional players	2
wide variety of environments	2
Several Firmicutes species	2
dominant bacterial group	2
microbial world	2
particular case	2
Patchwork Model	2
similar compounds	2
group or cluster	2
reaction sequences	2
conserved reactions	2
contiguous enzymes	2
particular pathway	2
bacterium Escherichia coli K-12	2
galactanases	2
wild-type and three variants	2
D58N and G306A	2
Tmchanges	2
S185D/Q188T	2
D182N, D58N, Y295F	2
Tmis	2
/A156R. Variants Y295F	2
S185D/Q188T, G104D	2
D182N and	2
PROPKA designed variants	2
enzyme design tool	2
validated pKaprediction tool	2
PROPKA 3.0	2
thermophile organism Myceliophthora thermophila	2
structure of β-1,4-galactanase	2
mesophilic organism Aspergillus aculeatus	2
New variants of β-1,4-galactanase	2
differentially expressed gene subsets	2
interactive visualization module	2
SBML files	2
final networks	2
respective, non-redundant super-networks	2
enriched KEGG metabolic and signaling pathways	2
non-programmer users	2
above-mentioned modules	2
Existing tools	2
controlled, curated background	2
molecular pathway databases	2
high throughput genomic technologies	2
immunotherapy armamentarium	2
A2a receptor antagonists	2
A2a receptor pathway	2
A2a receptor	2
usurping pathways	2
inhibitory receptors	2
powerful computational tools	2
highly recombinogenic bacterium	2
Streptococcus pneumoniae (the pneumococcus)	2
Nav1.4 α/β1 interface	2
reversible protein–protein interface	2
irreversible bound protein	2
β protein” structure	2
another “all	2
location of TANA	2
plethora of 3D templates	2
“all β proteins” (Ig-like, Ig)	2
α subunit	2
cells of hamster ovary (CHO)	2
mutant type (T109A, N110A, herein called TANA)	2
Nav1.4 channels	2
adjacent amino acids	2
3D-template	2
pore-bearing Nav1.4 α subunit with (ii) site-directed mutagenesis (SDM)	2
weakly homologous 3D templates	2
twilight zone	2
β1 subunit of the skeletal muscle voltage-gated sodium channel (Nav1.4)	2
neuronal necrosis	2
NADPH oxidase (NOX1	2
melastatin-like transient receptor potential 2 (TRPM-2) channels	2
ADP-ribose molecules	2
glycohydrolase hydrolyzes PAR polymers	2
poly(ADP-ribose) (PAR) polymers	2
peroxynitrite (ONOO−)	2
superoxide (O2−)	2
nNOS forms nitric oxide (NO)	2
cyt c	2
intracellular Ca2	2
plasma membrane Na+–Ca2+ exchanger	2
cathepsins B and D and DNase II	2
cytochrome c (cyt c), truncated apoptosis-inducing factor (tAIF) and endonuclease G (endoG)	2
two enzymes, calpain I and neuronal nitric oxide synthase (nNOS)	2
receptor-operated cation channels	2
subtype of glutamate receptor	2
(NMDA) receptors	2
-d-aspartate	2
N-methyl	2
presynaptic nerve terminals	2
plant-associated niches	2
many genera	2
Bacillus and Paenibacillus	2
plant associated genera	2
Known and predicted LPs and PKs	2
predicted LPs and type I PKs	2
several novel clusters of PKs and LPs from genomes	2
web based prediction tools	2
novel structurally diverse secondary metabolites	2
huge sequence repository	2
type I PKs or LPs	2
published prediction tools	2
underlying gene clusters of LPs and PKs in the Bacillales	2
structural diversity	2
remarkable diverse number of polyketides (PKs) and lipopeptides (LPs)	2
polyketide synthases and non-ribosomal peptide synthetases	2
variety of secondary metabolite gene clusters	2
Firmicutes	2
Bacillus and related genera in the Bacillales	2
terminal carbon atoms	2
ensuing radical	2
CH bond of a subterminal carbon atom	2
higher alkanes	2
propane and n-butane	2
phylotypes	2
Desulfosarcina–Desulfococcus cluster of the Deltaproteobacteria	2
strain BuS5	2
ethane, propane and n-butane	2
sulfate-reducing pure or enriched cultures	2
deep-sea and terrestrial sediments	2
source gas	2
gases in interstitial water	2
gaseous alkanes in anoxic sediments	2
deep-sea environments	2
terrestrial environments	2
aerobic microorganisms	2
short chain, gaseous alkanes ethane, propane, n- and iso-butane	2
SENP inhibitors	2
protein-based, peptidyl and small molecule inhibitors	2
different cancers and other diseases	2
sumoylated and unsumoylated proteins	2
isopeptidase activity	2
two glycine residues	2
pro or inactive form of SUMO	2
SUMO specific proteases (SENPs)	2
mature or active form	2
small ubiquitin-like modifier (SUMO) proteins	2
P2X7 antagonists	2
vivo	2
less active form of this enzyme	2
phosphorylated form of GSK-3	2
hippocampal amyloid plaques	2
prominent amyloid plaques	2
human APP mutant protein	2
familial Alzheimer's disease (FAD)	2
J20 mice	2
expresses APP	2
neuroblastoma cell line	2
senile plaques	2
β-amyloid, Aβ42 peptide	2
α-secretase and β-secretase respectively	2
non-pathogenic and pathologic forms	2
large variety of neural and non-neural cells	2
Amyloid precursor protein (APP)	2
life and materials science	2
realistically large model systems	2
non-covalent interactions	2
benefits and backdraws of adding dispersion (D) and hydrogen-bond (H) correction terms	2
absent or inaccurate functional annotations	2
different types of methods	2
cerebellar cell populations	2
cerebellar astrocytes and granule neurons	2
P2Y13 receptors	2
dual protein phosphatase, DUSP2	2
glutamate-induced excitotoxicity	2
P2Y13-mediated ERK1/2 signaling	2
Nrf2/heme oxygenase-1 (HO-1) axis	2
Gi-coupled receptors	2
cerebellar granule neurons	2
glycogen synthase kinase-3 (GSK3) and ERK1/2 signaling	2
P2Y1 receptors	2
ADP analogues	2
related P2Y1 receptor	2
Cerebellar astrocytes and granule neurons	2
one of the most recently identified nucleotide receptor	2
ADP-specific P2Y13 receptor	2
newly discovered proteins	2
fetal/cardiac myosin heavy chains (MYH6 and MYH7) and a myosin light-chain kinase	2
multiple Ca2+ release channels	2
cardiac-specific Ca2+ kinase	2
soluble/diffusible proteins	2
well-coordinated network	2
antiviral drug Zidovudine/AZT	2
HIV-infected and uninfected counterpart cells	2
several hundred differentially regulated proteins	2
CD4+ T-cell line	2
genome-wide proteomes	2
numerous cofactors	2
novel proteins/enzymes	2
number of patients	2
UL54-mutation alone	2
UL97 gene	2
combined UL97/UL54-mutations	2
UL54-gene	2
UL97-gene	2
polymerase-gene (UL54)	2
HCMV phosphotransferase-gene (UL97)	2
antiviral drugs	2
three antivirals ganciclovir (GCV), foscarnet (PFA) and cidofovir (CDV)	2
indices	2
NMR spectra	2
testis organogenesis	2
new cell types	2
genital disc	2
direct targets Src42A and Sec63	2
sevenless ligand Boss	2
Abd-B target genes	2
adult testes	2
pre-meiotic cell populations	2
neighboring somatic cyst cells	2
pre-meiotic germline spermatocytes	2
male embryonic gonads	2
stem cell niche positioning	2
embryonic, larval and pupal stages	2
Drosophila testis organogenesis	2
Hox gene Abd-B	2
PMFs	2
inlA–mEcad complex	2
extended MD simulations	2
inlA–	2
inlA and Ecad	2
umbrella sampling	2
Listeria monocytogenes	2
internalin A (inlA) and human or murine E-cadherin (Ecad)	2
nanomedicine and nanomaterials	2
host-guest systems	2
putative ligand portal	2
stable beta-barrel fold	2
cognate binding proteins	2
lipophilic molecules	2
beta-clamshell family of intracellular lipid binding proteins (iLBPs)	2
putative therapeutic target	2
mINDY (SLC13A5)	2
different mammalian SLC13 family members	2
fatty acid and cholesterol synthesis, glucose metabolism and ß-oxidation	2
mINDY-imported citrate	2
mINDY in mice	2
(Slc13a5, NaCT)	2
Indy and its mammalian homolog mINDY	2
D. melanogaster and C. elegans	2
Yet) gene	2
Indy (I'm Not Dead	2
role of mitochondria	2
ATP synthesis	2
pro-resolution lipid mediator, Lipoxin A4	2
IMI consortia	2
whole value chain of pharmaceutical R&D	2
IMI projects	2
i.e., academic institutions, small and medium enterprises, patients, and regulatory authorities	2
health-care ecosystem	2
key actors	2
large pharmaceutical companies	2
new medicines	2
European Federation of Pharmaceutical Industries and Associations (EFPIA)	2
(a potentially functionalised) lignin sample	2
quantitative HSQCs	2
random oligomeric units	2
second-most abundant polymer after cellulose	2
low intensity light	2
vivo experimentation	2
different types of cancer cells	2
PrestoBlueTM assays	2
LDH release activity	2
far-infrared exposures	2
PrestoBlueTM cell viability assays	2
Lactate dehydrogenase (LDH) cytotoxic activity	2
human cancer and normal cell lines	2
exposed and sham-exposed cells	2
selected far infrared light (3400nm, 3600nm, 3800nm, 3900nm, 4100nm and 4300nm) and visible and near infrared wavelengths	2
HEM) cells (control)	2
human epidermal melanocytes (	2
human breast cancer (MCF7) cells	2
visible and infrared light range	2
selected cancer and normal cells	2
LEDs-based exposure system	2
localized joint and soft tissue wound healing	2
studying one homolog	2
unifying theme	2
fundamental similarities	2
abundant but poorly characterized RecQ homolog	2
RECQ1 helicase	2
RECQ1, BLM, WRN, RECQ4, and RECQ5β.'Although	2
kingdoms of life.'Human	2
highly conserved family of DNA-unwinding enzymes	2
RecQ helicases	2
silico tools	2
genomic organization	2
different strains of C. pseudotuberculosis isolates	2
different strains of C. pseudotuberculosis	2
interesting bacterium	2
Corynebacterium pseudotuberculosis genome	2
databases of mutations	2
Epb4.1 (band 4.1)	2
third Spnb1 mutation (spectrin-1β c)	2
spectrin-1β pedigrees	2
band 4.1	2
one pedigree	2
RBC protein spectrin-1β	2
three pedigrees	2
Ank1EX34 pedigree	2
RBC structural protein ankyrin-1	2
novel single nucleotide variation (SNV)	2
One pedigree	2
ENU-treated mice	2
N-ethyl-N-nitrosourea (ENU) mutagenesis	2
Murine models	2
purified recombinant CB2 receptor	2
derivative of cholesterol in detergent micelles	2
high affinity ligand	2
maltose binding protein	2
recombinant CB2 in E. coli cells	2
functionally active receptor	2
specific pharmaceuticals	2
large superfamily of G protein-coupled receptors (GPCR)	2
seven transmembrane-domain integral membrane protein	2
Cannabinoid receptor CB2	2
structural and computational biologists	2
cell biologists and molecular biologists	2
new variants	2
Combinatorial protein libraries	2
novel interaction interface	2
original albumin-binding surface	2
albumin-binding sites	2
interesting evolutionary system	2
Finegoldia magna	2
streptococcal protein G and protein PAB	2
albumin-binding regions	2
several homologous domains	2
Albumin binding	2
various surface proteins	2
small, three-helical protein domain	2
predicted targets	2
oxidative muscle	2
Hsp27 predicted targets	2
two muscles of HspB1-null mice	2
cytoskeletal proteins (Desmin) and antioxidants (Sod1)	2
members of Hsp families (Hsp20, Cryab, Hsp70a1a, and Hsp90aa1), regulators of apoptosis (Fas, Chuk, and caspase-3), translation factors (Eif4E, and Eif4G1)	2
predicted partners of Hsp27	2
direct interactors of Hsp27	2
interactors	2
crucial node	2
electric generators, conductors, condensers, switches, and other components of electrical circuits	2
electrical transformers	2
respective uremic toxins	2
applied electric potential	2
hemodialysis membranes	2
membrane's thickness	2
Theoretical modeling	2
capillaries' walls	2
respective molecules	2
walls of dialyzers' capillaries	2
uremic toxins	2
currently used hemodialysis membranes	2
uremic toxin middle molecules	2
multi-class outcome datasets	2
real-world, high-dimensional, gene-expression datasets	2
nominal and ordinal multi-class targets	2
Lung Adenocarcinoma	2
different types of cancer	2
multiple classes	2
smallest set(s	2
“omics” data	2
panel of genes	2
beta-adrenergic receptor pathways	2
beta-adrenergic receptor (β-AR) signaling	2
sliding counterpart	2
cracks	2
zigzag cracks	2
hard-coated ultra-soft substrates	2
sharp and flat counterparts	2
fracture mechanisms	2
larger hierarchical wrinkle structures	2
thin hard films	2
Nano-wrinkled topographies	2
hierarchical nano-wrinkles	2
film and elastic substrate surface	2
Hierarchical wrinkled structures of films on these substrates	2
distinct tribological material	2
ultra-soft substrate materials	2
two compared substrate materials	2
ultrasoft polyurethane and harder polycarbonate substrates	2
diamond-like carbon (DLC) and titanium nitride thin films	2
hard films on soft, flexible polymers	2
pads	2
thick hard stratum corneum layer pads	2
bulk (soft tissue)	2
bulk (epidermis, dermis, hypodermis)	2
new materials	2
every chromatogram	2
chromatogram peaks	2
given multiple sequence alignment (MSA)	2
bidirectional sequencing runs	2
per-peak and per-nucleotide basis	2
chromatograms and corresponding sequences	2
molecular sequences	2
chromatograms	2
Automated DNA sequencers	2
emerging polypeptide chain	2
entire transcriptomes	2
particular codons	2
particular segments of the mRNA	2
certain codons	2
multiple, so-called synonymous, codons	2
amino acid residue	2
BRCA1 protein	2
multiple binding sites and functional domains	2
RING and BRCT domains	2
BRCA1 and ATM/ATR kinases	2
BRCA1 BRCT domain	2
BRCA1 and other proteins	2
BRCA1 RING domain	2
BRCT domain	2
N-terminal RING domain	2
three domains or regions	2
multi-domain protein	2
arene-arene, cation-arene and anion-arene interactions	2
cation-arene and anion-arene binding	2
RNA-dependent pathways	2
nascent strands of mRNA	2
multiple protein assemblies	2
modified Affinity Grid surfaces	2
bacterial protein synthesis machinery	2
functionally relevant framework	2
multiple components of cellular pathways	2
molecular imaging platform	2
biological processes	2
Cryo-Electron Microscopy (EM)	2
Mathematical and computational models	2
reaction system	2
protein interactors	2
three identified genes	2
(underexpressed) and CDH2 (overexpressed)	2
T-cell Acute Lymphoblastic samples	2
sixteen genes	2
forty two hub genes	2
Oncomine database	2
genes encoding hub proteins	2
Acute Lymphoblastic Leukemia (ALL)	2
Notch1 associated proteins	2
query in STRING database	2
Notch1 protein name	2
peripheral blood T and B lymphocytes, monocytes, and neutrophils	2
Notch receptors	2
many developmental systems	2
one software package	2
different cell populations	2
overlapping, but different subsets of cells	2
movies	2
PACT, Autozell, and TLA	2
three cell tracking programs	2
bright field microscopy images	2
nanostructured surfaces	2
computer software	2
mechanistic interpretation of models	2
family of chemicals	2
carcinogens and non-carcinogens (for rats)	2
reactivity of molecules	2
electronic surrounding	2
Chemical structures	2
Kohonen maps	2
non-congeneric chemicals	2
carcinogenicity model	2
structural intermediates	2
many different data acquisition protocols and software solutions	2
native context of the cell	2
repeating macromolecular elements	2
protein nanomachines	2
tip of the thumb-loop	2
(Tx-xyl)	2
Thermobacillus xylanilyticus	2
glycoside hydrolase family 11 xylanase	2
so-called thumb-loop	2
new class of enzymes	2
currently known structures	2
crystalline cellulose	2
bacterial proteins	2
divalent metal binding site	2
first members	2
glycoside hydrolases	2
fungal origin	2
cell surface display technology	2
enzyme applications	2
Chinese enzyme market	2
worldwide enzyme market	2
feed industry, food processing and cosmetic products	2
representative industrial applications of enzymes	2
specialized catalysts	2
focused libraries	2
external electron donor	2
oxidized and non-oxidized chain ends	2
crystalline part of cellulose	2
common cellulases	2
novel class of enzymes	2
polysaccharide monooxygenases (PMOs or LPMOs which stands for lytic PMOs), cellobiose dehydrogenases (CDHs) and members of carbohydrate-binding module family 33 (CBM33)	2
economically viable biofuels	2
aromatic clusters	2
TIM-barrel fold proteins	2
“model system	2
Family 10 xylanases	2
TIM-barrel fold structure	2
classes of industrial enzymes	2
Family 10 or glycosyl hydrolase 10 (GH10) xylanases	2
presence of proteases	2
bacteria, marine algae, plants, protozoans, insects, snails and crustaceans	2
plethora of organisms	2
Various xylanases	2
important class of industrial enzymes	2
large protein repertoire	2
catalysts of interest	2
reaction product	2
Inovirus particles	2
chelate effect	2
second link	2
large repertoire	2
rare protein molecules	2
phage display	2
different host organisms	2
new host organisms	2
mammalian and insect cell lines	2
bacterial and yeast species	2
suitable host organism	2
proteins and biological systems	2
novel substrates	2
targeted libraries	2
x-ray structures and sequence alignment	2
improved or novel functionalities	2
non-heme monooxygenases and dioxygenases	2
biosensors, fine chemicals, biofuels, pharmaceuticals, food ingredients and polymers	2
metal ion complexes	2
NADH or NADPH	2
reduction equivalents	2
unreactive chemical compounds	2
one or two oxygen atoms	2
ubiquitous enzymes	2
novel functionalities	2
chiral building blocks	2
currently available computational resources	2
web servers, databases and other computational tools	2
desirable variants	2
target enzymes	2
powerful biocatalysts	2
wild-type luciferases	2
mutant luciferases	2
enhanced beetle luciferases	2
particular assay	2
wild-type beetle luciferases	2
Many novel beetle luciferases	2
fireflies and other beetles	2
Luciferase enzymes	2
de novo designed enzymes	2
key active site residues	2
combinatorial libraries	2
recently reported de novo functional proteins	2
structural, catalytic, sensory, and regulatory functions	2
multifaceted macromolecules in living systems	2
chemicals and pharmaceuticals	2
optimal bioprocesses	2
modelling research framework	2
mathematical models of biological systems	2
biological systems and processes	2
tractable mechanistic models	2
intracellular environment of microorganisms	2
appropriate screen	2
cellular targets	2
high-value products in living cells	2
biosynthetic and physiological pathways	2
useful bioactive compounds	2
plant polyketides	2
type III PKSs	2
novel “unnatural” polyketides	2
heterologous expression	2
heterologous organisms	2
polyketides	2
chalcones, stilbenes and curcuminoids	2
plant type III polyketide synthetic pathway	2
CoA-linked starter molecule	2
malonyl units	2
small homodimeric proteins	2
Plant type III PKS enzymes	2
type I, type II or type III polyketide synthases (PKSs)	2
one of three classes of enzymes	2
important group of secondary metabolites	2
central catabolic pathways	2
poly(3-hydroxybutyrate)	2
microbial cells factories	2
ArcBA and CreBC systems	2
industrially-relevant metabolites	2
ArcBA and CreBC two-component signal transduction systems	2
electron acceptors and alternative carbon sources	2
microbial cell factory par excellence	2
model facultative aerobe Escherichia coli	2
different biocatalysts	2
restricted O2 supply	2
pts, pgi, zwf, gnd, pyk, ppc, pckA, lpdA, pfl gene knockout	2
main metabolic pathways	2
natural products and biofuel productions	2
specialty chemicals	2
highly novel and effective bio-catalysts	2
microbial consortia engineering	2
consortial assembly templates	2
different resource usage motifs	2
promising ecological theories	2
cellular factories	2
engineering project	2
chassis re-circuit	2
appropriate promoter and ribosome binding sites	2
toxic intermediates or byproducts	2
non-native hosts	2
engineered biosynthetic pathways	2
target compounds	2
product yields	2
designed cellular host	2
wide range of molecules and fine chemicals	2
genome-scale metabolic model of Arthrospira	2
Arthrospira factories	2
genome sequences and metabolic models	2
desired products	2
raw materials (i.e. CO2 and sun light	2
food, feed, fuel and pharmaceutical industries	2
many valuable compounds	2
increased biomass	2
α-amylase and GFP	2
recombinant protein production system	2
prokaryotic and eukaryotic organisms	2
certain antifoams	2
cells or product	2
Aequorea-based fluorescent reporter proteins	2
bacterial export and periplasmic protein organization	2
improved proteins	2
interchain disulfide bonds	2
covalent oligomers	2
Green Fluorescent Protein (GFP)	2
popular reporter protein	2
contaminating cellular proteins	2
authentic N-termini	2
periplasmic space of Gram negative bacteria	2
Recombinantely produced proteins	2
bacterial periplasm	2
natural diversity	2
industrially relevant genotype-to-phenotype links	2
chemicals, materials and fuels	2
biomass-derived feedstocks	2
genome-scale technologies	2
Saccharomyces cerevisiae and Escherichia coli	2
succinic acid, malic acid and lactic acid	2
several organic acids	2
carboxylic acid-producing microbes	2
primary building blocks of industrial chemicals	2
sustainable fuels and chemicals	2
new medicinal compounds	2
assembly line	2
growing intermediates	2
final stereochemistry of chiral centres	2
discrete domains	2
constituent enzymes	2
intact polyketide synthase proteins	2
genetically engineered systems	2
native multienzyme assembly lines	2
modular polyketide synthases	2
Numerous bioactive natural products	2
cell factory	2
compatible methods and models	2
components, enzymes and metabolites	2
well-characterized parts	2
high-quality predictive models	2
novel biological functions and systems	2
chassis strains	2
novel production pathways	2
bulk or high value chemicals	2
renewable resources	2
Cell factories	2
metagenomic tools	2
lumped community models	2
suitable experimental and computational tools	2
natural communities	2
synergistic combinations of different microbial species	2
omnipotent microbes	2
individual microbial strains	2
cellulosome/designer cellulosome-bearing recombinant microorganisms	2
free enzymes	2
insoluble substrates (i.e. crystalline cellulose)	2
Complexed cellulases (i.e. cellulosomes)	2
recombinant microbial strains	2
valuable product (i.e. butanol, ethanol, and hydrogen) biosynthesis	2
natural metabolic pathways	2
natural enzyme systems	2
natural cellulolytic microorganisms	2
consolidated bioprocessing, CBP)	2
cellulosic biomass	2
dedicated cellulase production	2
high-value products (e.g. solvents, fuels, building blocks	2
abundant and attractive substrate	2
Cellulose waste biomass	2
wide range of compounds	2
terpene biosynthetic enzymes	2
pharmaceuticals, flavour and fragrance additives	2
terpenoids in S. cerevisiae	2
–omics technologies	2
contemporary metabolic engineer	2
desirable end-products	2
malate, valine and limonene	2
ethanol, isobutanol, 1-butanol and tyrosine and furfural tolerance	2
unwanted enzymes	2
Escherichia coli and Saccharomyces cerevisiae	2
Microbial biocatalysts	2
diamines, organic acids and alcohols	2
C. glutamicum strains	2
wastes and unprocessed sources)	2
important industrial microorganism	2
wide range of industrially relevant compounds	2
variety of corynebacterial strains	2
glutamate and lysine	2
amino acid-producing workhorse of fermentation industry	2
industrially important metabolites	2
efficient tools	2
Lactic acid bacteria (LAB)	2
VHb expression	2
“partner proteins	2
certain product	2
endpoint	2
“black box” variety	2
“VHb technology	2
antibiotics and petrochemical replacements	2
wide variety of heterologous organisms	2
first bacterial hemoglobin	2
hemoglobin (VHb) from Vitreoscilla	2
corresponding component	2
computational algorithms	2
particular compounds	2
new separations	2
NAD+ metabolome	2
targeted, quantitative assay	2
complex samples	2
related nucleotides	2
NAD+ biosynthetic intermediates	2
sirtuins and other NAD+-consuming enzymes	2
coenzyme	2
Nicotinamide adenine dinucleotide (NAD+)	2
massive extended detectable metabolites	2
LC-MS/MS-based un-targeted plant metabolomics	2
emerging technology	2
unknown metabolites	2
un-targeted MS and MS/MS data	2
individual metabolites	2
authentic standard compounds	2
resulting N-PLS-DA model	2
three-dimensional array of the predictor block	2
Jamu medicines	2
role of plants	2
Jamu formula	2
Jamu	2
predictors	2
Jamu medicine	2
ingredients of Jamu formulas	2
many plants	2
Indonesian blended herbal medicines (Jamu)	2
KNApSAcK Family DB	2
transcriptomics, proteomics and metabolomics	2
Omics fields	2
omics fields	2
different research fields	2
endogenous metabolites	2
high-throughput technology	2
xenobiotic exposure	2
LC-MS-based metabolomics	2
technical platform	2
high-throughput metabolomics	2
metabolic system	2
suspected metabolites	2
Traditional bioanalytical platforms	2
endogenous metabolism	2
Changes in metabolic systems	2
complex herbal mixtures	2
plant metabolites	2
many compounds in herbal products	2
Untargeted metabolomics	2
herbal supplements	2
natural remedies	2
herbal products	2
traditional Chinese medicines	2
Natural remedies	2
molecular entities	2
novel metabolites or metabolites	2
isobaric compounds	2
range of metabolites	2
mass spectrometry based metabolomics	2
dietary biomarkers	2
small metabolites	2
dietary exposure	2
metabolomics researchers	2
novel secondary analysis tools	2
Many different tools	2
network visualizations	2
measured metabolites	2
lists of altered metabolites	2
metabolomics secondary analysis tools	2
Modern biochemical databases	2
dozens of altered metabolites	2
number of computational tools	2
vast swaths of data	2
LC-MS data	2
state-of-the-art data-analysis software	2
sample list set	2
sample storage	2
entire experimental pipeline	2
hyphenated mass spectrometry platform	2
complex and versatile model organism, Leishmania donovani	2
LC-MS metabolomics pipeline	2
various stimuli or drugs	2
modified nucleosides m2G and m22G	2
either A or U.	2
C-N bond	2
s-trans m2G26:C/A/U44 and s-cis m2G26:A/U44	2
opposite base	2
two rotamers of m2G	2
either s-cis or s-trans rotamers	2
methylated nucleic acid bases	2
adjacent bases	2
majority of eukaryotic tRNAs	2
N2, N2-dimethylguanosine (m22G)	2
E. coli tRNAs	2
N2-methylguanosine (m2G)	2
N2 group of guanine	2
wide variety of positions	2
four canonical nucleotide bases	2
bulky groups	2
Modified nucleic acid bases	2
application case	2
membrane modeling tools	2
membrane area	2
Membrane Packing Problem	2
small substances	2
many biochemical and biophysical disciplines	2
classes of data	2
chemical fragment in a dataset	2
number of expert systems	2
structural alerts	2
individual mammalian species	2
precursor structure lipid IVa	2
domain in LPS	2
differential residues of TLR4/MD-2 complexes	2
reference ligand	2
lipid IVa the structurally related synthetic compound Eritoran (E5564)	2
lipid IVa versus LPS and lipid A	2
LPS and lipid A	2
human, murine, canine and equine species	2
unpaired activity-sequence dualism	2
respective TLR4 amino acid sequences of the latter species	2
canine TLR4/MD-2	2
equine cells Lipid IVa	2
potent agonists like E. coli-type lipid A.	2
agonism)	2
Toll-like receptor 4 (TLR4)/myeloid differentiation factor 2 (MD-2) receptor complex	2
tested mammalian species	2
hexa-acylated structure	2
Lipid A of the prototypic E. coli-type	2
tetra-acylated precursor of lipid A	2
Lipid IVa	2
(a) protein kinases (PK) and (b) G-protein coupled receptors (GPCR)	2
two different classes of widely investigated pharmaceutical targets	2
successful SBDD	2
virtual libraries	2
receptor homology models	2
drug designers	2
corpus of knowledge	2
versatile role of water	2
preclinical candidates	2
identified hits	2
structure-based drug design (SBDD)	2
species-specific sequences	2
structurally and functionally important protein sites	2
five applications	2
SCSs or words	2
natural English language	2
low-rank samples	2
rare or non-existent SCSs	2
structure-specific SCSs and immunological adjuvants	2
non-redundant amino acid database	2
English sentence	2
protein amino acid sequence	2
short constituent sequences (SCSs)	2
fundamental biochemistry problem	2
query molecule	2
screening databases of molecules	2
large libraries of molecules	2
molecules in existing chemical libraries	2
new medical drugs	2
Escherichia coli and Pseudomonas aeruginosa	2
transporter components	2
multidrug efflux pumps of the Resistance Nodulation Division (RND) protein super family	2
open source R software environment	2
test set objects	2
final QSPR model	2
H-atoms	2
3D structures	2
favorable models	2
Dragon software	2
polycyclic aromatic compounds (PAC)	2
QSPR models	2
empirical regression models	2
new computational models	2
protein-protein complexes	2
different combinations of descriptors	2
ranked list of candidates	2
initial “bin” of candidate compounds	2
Computational predictions	2
collision induced dissociation (CID) spectrum	2
biological or synthetic	2
collision induced dissociation cell	2
selected precursor ion	2
chemical database	2
set of candidate compounds	2
authentic standard	2
unknown	2
vast array of compounds	2
single method	2
compounds in complex mixtures	2
fifth problem	2
several graph classes	2
graph structured data	2
Chemical compounds	2
template-free loop structure modeling	2
“mini protein folding problem	2
three-dimensional structures of loops	2
multiple sources of evidence	2
proteasomesubunits	2
anintrinsically disordered protein	2
mixture of different oligomeric species	2
recombinant Ump1	2
yeast Ump1 inE. coli	2
interior of the nascent proteasome areactivated	2
two precursorcomplexes	2
20S proteasome	2
short-livedmaturation factor	2
number of cofactors	2
blood vessels, lungs, and the heart	2
damaged body parts	2
nanoscale architectures	2
nanoscale components	2
wide range of nanotechnologies	2
integrated transcription factors and	2
dual regulatory system	2
CX3CL1, SEMA6D and IL12B	2
extra-cellular ligands	2
actin cytoskeleton pathways	2
adherence junction	2
KEGG and canonical pathways	2
microRNA targeted genes	2
new microRNAs (miR-132, miR-133a1, miR-181-1, miR-182, miR-218-1, miR-29a, and miR-330)	2
microRNA regulatory networks	2
shortest path	2
direct interaction	2
biomolecular networks	2
several microarray gene expression datasets	2
Parkinson's disease (PD) critical molecular players, drug targets	2
biocomputer	2
control unit, memory, and wires (busses)	2
arithmetic logic unit	2
input / output device	2
biological microprocessor	2
general purpose computer system	2
similar machine	2
engineering principles	2
silicon computers	2
real biological samples	2
peaks in all samples	2
fragment ions	2
landmark peaks	2
multiple peak entries of the same metabolite	2
GC×GC/TOF-MS	2
chromatin regions	2
conventional silent heterochromatin	2
diauxic∼early stationary phase growing	2
Sir3-associated cluster regions	2
PAU genes	2
recently identified secondary binding site	2
rDNA region	2
32 telomere proximal regions	2
ChIP on chip assays	2
diauxic∼early stationary phase cells	2
fluorescent signals	2
multiple punctations	2
logarithmic phase cells	2
silent heterochromatin domains	2
SIR complexes	2
Sir2, Sir3 and Sir4 proteins	2
two TLR4/MD-2/agonist subunits	2
defined m-shaped complex	2
counter-TLR4/MD-2 unit	2
corresponding murine and equine TLR4/MD-2 complexes	2
crystal and modeled structures	2
wedge-shaped region	2
mammalian TLR4/MD-2 complexes	2
imperfect (underacylated and backbone-flipped), low affinity ligand	2
Lipid IVA	2
ligands like lipid IVA	2
two areas in the wedge	2
TLR4, MD-2 and ligand itself	2
triangular interface or “wedge	2
three-dimensional (3D-) models	2
mechanistically relevant side chains	2
differential amino acids	2
prototypic ligands lipid A, lipid IVA and Eritoran	2
mono and dimeric crystal structures	2
three-dimensional models of TLR4/MD-2/ligand complexes	2
corresponding X-ray crystallographic data	2
hitherto known Toll-like receptor 4 (TLR4) and myeloid differentiation factor 2 (MD-2) complexes	2
human, murine, equine and canine species	2
prototypic E. coli -type lipid A and its precursor lipid IVA	2
three datasets	2
putatively most representative compounds	2
structurally diverse compounds	2
protein structure models	2
beta-strands and loops connecting them	2
amino acid in beta-strands	2
least two central strands	2
beta-sheets	2
Classical mechanics	2
genomic projects	2
plant clades	2
specific plant comparative genomic databases	2
enormous number of sequences	2
Suitable bioinformatics tools	2
draft genomic sequences	2
new high-throughput sequencing technologies	2
highly ranked residues	2
spatial clusters	2
functionally important sites	2
structural and evolutionary information	2
functionally important residues or regions	2
many new structures	2
protein functional sites	2
protein ligand binding site prediction	2
protein functional site	2
important macromolecules	2
gene and protein sequences	2
transporter protein	2
open-to-the-inside and open-to-the-outside conformations	2
putative ancestral monomeric protein	2
symmetry axis	2
helical transporter proteins	2
highly symmetric substrates	2
single chain proteins	2
transporters and channels	2
single chain membrane proteins	2
two or more copies of the same protein chain	2
transporters, receptors, or channels	2
Helical membrane proteins	2
Plasmodium parasite	2
selective tool	2
parasite membrane	2
proteins or organelles	2
food vacuole	2
malaria parasite, Plasmodium	2
peptide/antidipeptide pair	2
dipeptides XY	2
atomic balls	2
pockets and cavities in the molecule	2
union of balls	2
macromolecule	2
unifying mathematical framework	2
various compounds	2
multi-target activity spaces	2
different categories of small molecules	2
non-specific binding events	2
multiple biological targets	2
two replicates	2
peak	2
two popular but disparate peak callers, CisGenome and MACS2	2
Additional biological replicates	2
ENCODE and modENCODE projects	2
Biological replicates	2
transcription factors, enzymes and epigenetic marks	2
DNA-binding molecules	2
core promoter sequences	2
crucial regulatory elements promoters, enhancers	2
individual gene regulatory elements	2
identical genome	2
Metazoan life	2
Sphyngobium yanoikuyae	2
alcohol dehydrogenase	2
cofactor binding site architecture	2
SeSaM library S. mutans NADH oxidase 2 variants	2
Double mutant 93R94H	2
several rationally designed cofactor binding site mutants	2
strictly NADH specific water-forming Streptococcus mutans NADH oxidase 2	2
cofactors, NADH and NADPH	2
NAD(P)H oxidase	2
sole byproduct	2
Soluble water-forming NAD(P)H oxidases	2
general scenario	2
folded structures	2
so-called “never born biopolymer” project	2
random proteins and RNAs	2
sequence space	2
primitive organocatalysis	2
realistic model	2
Ser-His	2
others?”We	2
long-chain copolymers (proteins and nucleic acids, respectively)	2
building blocks (amino acids, or nucleotides)	2
macromolecules on prebiotic Earth	2
specific and functional sequences	2
non dynein protein called Swallow	2
two of its binding partners	2
bivalent or polybivalent scaffold	2
pair of disordered chains	2
primarily disordered monomeric partners	2
dimerization engine	2
various partners	2
hub protein	2
diverse systems	2
multiple protein complexes	2
multi-subunit complex dynein	2
essential component	2
protein called LC8	2
One highly conserved hub	2
small number of partners	2
proteins in interaction networks	2
LSD1 catalytic site	2
amino group	2
aromatic rings	2
1,2-disubstituted cyclopropane ring	2
amino group of the cyclopropylamine	2
aromatic rings of the compounds	2
Binding simulation	2
(1R,2S)-NCD41	2
corresponding (1S,2R)-isomers	2
optically active compounds of NCD18, NCD25, and NCD41	2
cyclopropane ring	2
mixtures of (1S,2R)- and (1R,2S)-disubstituted cyclopropane rings	2
three lysine-phenylcyclopropylamine conjugates, NCD18, NCD25, and NCD41	2
lysine-specific demethylase 1 (LSD1)	2
new chemical groups	2
sequence) specific label proteins	2
mature naïve T cells	2
RTEs in the periphery	2
recent thymic emigrants (RTEs)	2
newly generated SP thymocytes	2
lymphopoiesis in the thymus	2
mononuclear aluminium	2
superoxide radicals	2
proteic sidechains	2
protein's sidechains	2
protein buried sites	2
metals	2
serum transferrin	2
tritable groups	2
main low molecular mass and high molecular mass molecules	2
blood, citrate and serum transferrin	2
hydrolytic species	2
high molecular mass peptides	2
low molecular mass chelants	2
biological environments	2
biology” metal	2
aluminium in biological environments	2
protein frameworks	2
extraneous elements	2
various payloads	2
bona fide affinity label of HSA	2
J-FLYEE-NH2 (7-E)	2
limited subset of amino acids (R, S, E, F, Y, l, M, W, and Q)	2
potentially reactive thioester labeling entity	2
peptide functionality	2
significant outliers	2
protein target, human serum albumin (HSA)	2
library pools	2
affinity label	2
4-mercaptobenzoyl linker in thioester format	2
biotinyl moiety	2
variable peptidyl component	2
library component (1)	2
affinity labels	2
kinetic labeling library	2
neuromodulator	2
signaling molecule and downstream product of ATP	2
relatively new Omics-platform	2
diversity of enzymes	2
rumen microbiota	2
veterinaries, animal nutritionists and microbiologists	2
microbiotas of livestock like chicken, pig and ruminants	2
specific research object	2
live science	2
main Omics-technologies (genomics, transcriptomics, proteomics and metabolomics)	2
investigated microbiota	2
present ecological niches	2
highly complex biological samples	2
ectonucleotidase in CNS	2
good target	2
TNAP in the central nervous system (CNS)	2
TNAP degrades substrates	2
wide spectrum of physiological substrates	2
one of the four isozymes in humans and mice	2
Tissue-nonspecific alkaline phosphatase (TNAP)	2
GVHD murine models	2
FoxP3+ regulatory T cells (Tregs)	2
adenosine agonists	2
adenosine A2A receptors (A2AR)	2
recent transplant patients	2
antigenically foreign	2
many types of cancers	2
chronic granulomatous disease (CGD), severe combined immunodeficiency (SCID)	2
many disorders	2
human muscarinic acetylcholine receptor 3 (hM3R)	2
human CC chemokine receptor 3 (CCR3)	2
small molecule antagonists	2
important class of drug targets	2
G-protein coupled receptors (GPCRs)	2
experimental structural information	2
microbial, eukaryotic, and viral transcripts	2
entire community	2
RNA-Seq	2
insect, plant, and fungi-associated RNA-viruses	2
aldehyde dehydrogenase and monosaccharide-binding protein	2
spirochaete flagellin gene	2
Methanocellales transcripts	2
tanks	2
Archaeal diversity	2
bacterial and eukaryotic communities	2
leaf litter through-fall	2
bromeliads	2
Wg25	2
16 classes	2
majority of transcripts in one tank (Wg24)	2
25 phyla	2
specific presence of eukaryotes	2
RNA-viruses	2
wide array of bacteria, archaea, and eukaryotes	2
Costa Rica	2
tropical bromeliads	2
‘tanks’)	2
water catchments	2
microbial, eukaryotic, and viral communities	2
21st century technologies	2
Metagenomics, metatranscriptomics, metaproteomics, metabolomics and SIP-omics	2
different parts of an ecosystem	2
biological information (DNA, RNA, proteins and metabolites)	2
P2X1 receptor	2
neutrophils and platelets on inflamed endothelia	2
inflamed arteriolar endothelia	2
laser-induced injury mouse model	2
small arteries	2
platelet agonists	2
protein hydrophilic groups	2
hydration water	2
proton Nuclear Magnetic Resonance (NMR) spectra	2
hydrated lysozyme	2
amide vibrational modes of hydrated lysozyme	2
hydrophilic moieties of proteins	2
water monolayer	2
solvent of life	2
cardiovascular disease	2
Aging western populations	2
global population of older people	2
cancer research	2
complex datasets	2
ML tools	2
biomedical and the bioinformatics field	2
many research teams	2
high or low risk groups	2
many different subtypes	2
ion channels families	2
channel-specific blockers	2
computationally derived Kir channels	2
re-engineered peptide toxins	2
channel outer vestibule	2
TPN-sensitive and TPN-insensitive channels	2
human or zebrafish Kir1.1 channel isoforms	2
epithelial rat Kir1.1 channel	2
highly selective and potent blocker	2
bee venom	2
21 amino acid peptide	2
tertiapin (TPN)	2
NMR structures	2
computationally-derived channel structures	2
nearly any known vertebrate or invertebrate channel	2
chimeric Kir channels	2
eukaryotic constitutively active Kir2.2 channel	2
(Kir) channels	2
family of inwardly rectifying potassium	2
channel-specific probes	2
heteromeric channels	2
well established targets	2
large family of membrane proteins	2
desired lineage	2
cancer-, hematopoietic-, and neural crest-derived stem cells	2
P1 and P2 receptors	2
several artificial agonists and antagonists	2
natural ligands	2
ligands for purinergic receptors	2
One of the oldest signaling systems	2
osteochondral defects	2
modern society	2
P2X4R in cardiac myocytes	2
sarcolemmal pathway	2
small molecule drug	2
global systemic eNOS	2
tissue-specific KO	2
endothelium and monocytes	2
P2X4R	2
post-infarct, pressure overload, and calsequestrin (CSQ) overexpression models	2
cardiac-specific P2X4R overexpressing mouse line	2
cyclic GMP	2
fluorescent probe	2
P2XR agonist 2-methylthioATP (2-meSATP)	2
murine ventricular myocytes	2
cardioprotective, calcium-dependent enzyme endothelial nitric oxide synthase (eNOS)	2
P2X4 receptor (P2X4R), a ligand-gated ion channel	2
compute resources	2
Amazon's cloud computing infrastructure	2
Globus Genomics system	2
enhanced Galaxy workflow system	2
“Globus Genomics” system	2
advanced tools	2
skilled personnel	2
bioinformatics software	2
powerful computational infrastructure	2
Next generation sequencing (NGS) technologies	2
GPCRs in living cells	2
Fluorescent probes	2
oligomeric assemblies	2
useful tool compounds	2
high affinity GPCR ligands	2
Novel fluorescent derivatives	2
highly rigidified ligands	2
A3AR at TM2	2
biogenic amine receptors	2
target and off-target GPCRs	2
specific regions of the nucleoside analogues	2
rigid A3AR agonist congeners	2
normally flexible ribose with bicyclic analogues	2
closely related A1AR and A3AR	2
A2AAR structures	2
selective P2Y14R antagonist PPTN	2
Nonphosphate-containing ligands of the P2YRs	2
outer portions of the transmembrane (TM) domains	2
agonist-bound and antagonist-bound P2Y12R	2
anti-thrombotic target	2
P2Y12 receptor (P2Y12R)	2
known agonists and antagonists	2
A3AR agonists	2
pharmacological probes and potential therapeutic agents	2
selective agents	2
G protein-coupled receptors (GPCRs), e.g. adenosine receptors (ARs) and P2Y receptors (P2YRs)	2
extracellular nucleosides and nucleotides	2
software implementations	2
total populations	2
discrete-state stochastic methods	2
biochemistry, chemistry and physics	2
theoretical modelling and simulation	2
Natural systems	2
similar components	2
transcription factors NF-κB and hypoxia-inducible factor (HIF)	2
overall inflammatory microenvironment	2
cultured cell systems	2
purine nucleoside adenosine functions	2
pathogenic species of Entamoeba	2
fascinating parasite	2
gastrointestinal parasite Entamoeba histolytica	2
insoluble aggregates called neurofibrillary tangles (NFTs)	2
neuron specific microtubule-associated protein	2
abnormal tau aggregates	2
observational tool	2
physiological, genetic, and molecular approaches	2
plant organisms	2
within plants	2
plants and human pathogens	2
fresh fruits and vegetables	2
contaminated plants	2
compatible blood	2
serological phenotyping	2
blood group SNVs	2
orphan blood group antigens	2
novel SNVs	2
reference sequence	2
Australian population	2
rare and novel RHD alleles	2
rare or novel alleles	2
known SNVs	2
commercial microarray platforms	2
blood group antigens	2
35 blood group systems	2
encoding antigens	2
1568 alleles	2
number of blood group systems	2
multi-task master regulator	2
5′ splice sites	2
abundant intronic latent	2
intronic microRNAs	2
spliceosomal cavity	2
active core components	2
five U snRNPs	2
spliceosomal U	2
ADAR2	2
RNA editing enzymes ADAR1	2
5′-end and 3′-end processing components	2
additional pre-mRNA processing components	2
five spliceosomal U	2
specific supraspliceosomes	2
five-spliceosomal U snRNPs	2
protein splicing factors and	2
vitro assembled spliceosome	2
splicing active native spliceosomes	2
huge (21MDa) and highly dynamic RNP machine	2
mammalian cell nucleus	2
Pol II transcripts	2
two modulators	2
cholesterol and PIP2 binding sites	2
two lipid modulators	2
cytosolic residues	2
types of channels	2
PIP2 with neomycin	2
Kir2–PIP2 interactions	2
regulatory phospholipid, phosphatidylinositol-4,5-bisphosphate (PIP2)	2
Kir channels	2
many diverse organisms	2
rapidly developing technologies	2
new and exciting areas	2
select examples	2
protein structure and function prediction tools	2
microRNA annotation and prediction software	2
DNA/RNA sequencing	2
many new targets	2
newly developed technologies	2
important molecular pathways	2
new and fascinating areas	2
tolerant animals	2
brown and white adipose tissues	2
RNA-based therapeutics	2
novel class of regulatory determinants	2
active brown adipose tissue (BAT) in adult humans	2
genes and non-coding RNAs	2
ENCODE project	2
L. Flintoft (Nature Reviews Genetics 11, 455, 2010)	2
dark matter	2
boar taint	2
porcine hepatic	2
numerous endogenously and exogenously produced agonists and antagonists	2
several nuclear receptors	2
skatole in pigs	2
boar-tainted meat	2
tryptophan metabolite skatole (3-methylindole)	2
several xenobiotic and endogenous compounds	2
major family of enzymes	2
Cytochrome P450 (CYP450)	2
single specific signaling systems	2
architecture of signaling systems	2
different sets of proteins	2
protein structural fold prediction problem	2
adequate representation	2
amino acid substitution matrices	2
three-dimensional (3D) space	2
amino acid sequence of a protein	2
non-linear constructs	2
linear DNA constructs	2
agarose, polyacrylamide gels	2
formed DNA concatemers	2
concatemers	2
200mM NaCl	2
concatemers the oligonucleotides	2
concatemers of double stranded DNA	2
Two strands of synthetic oligonucleotides	2
duplex DNA concatemeric molecules	2
synthetic oligonucleotides	2
sequence-specific binding ligand	2
repetitive copies of the same segments of sequences	2
genomic tools	2
genome-scale modeling	2
precursors and cofactors of artificial de novo biosynthetic pathways	2
MCF hosts	2
Genome-scale metabolic flux models	2
genome-scale metabolic flux modeling	2
de novo biosynthetic pathway builders	2
MCF host	2
de novo biosynthetic pathway identification (i.e., rational, heterologous, or artificial)	2
target bio-commodity	2
biofuels and high value chemicals	2
Microbial cell factories (MCFs)	2
group of methods	2
multiple gene expression datasets	2
genome-scale metabolic reconstructions	2
medical research	2
disease datasets	2
chaotic network	2
protein interactions	2
purpose-built databases	2
suitable analytic tools	2
altered microenvironment	2
aberrant or modulated molecular environments	2
host–pathogen interaction networks	2
causative agent Mycobacterium tuberculosis and host, Homo sapiens	2
different data sources	2
organisms sharing a common environment	2
Infectious diseases	2
computational systems biology and synthetic biology tools	2
combinatorial experimental tools	2
knowledge and computational tools	2
computational and experimental tools	2
various biochemical applications	2
comprehensive systems toxicology assessment framework	2
technical and conceptual foundation	2
technical foundations	2
systems toxicology assessment framework	2
many other types of variation	2
slowly evolving and rapidly evolving regions	2
GC-rich and GC-poor regions	2
compositionally homogenous blocks	2
functional non-protein-coding RNAs	2
protein-coding exons	2
well-characterised functional components	2
wide variety of elements	2
affected cells	2
genetic makeup	2
actionable targets	2
transcriptomics and proteomics	2
biomarker panel	2
hepatotoxic chemical	2
idiosyncratic liver toxicants	2
external test sets	2
training sets	2
hold-out test set	2
20 (6h and 24h) metabolites	2
41 metabolite or smaller subsets	2
various pathways	2
selected metabolites	2
Forty-one metabolites	2
single dose of vehicle	2
Male Sprague–Dawley rats	2
two overt hepatotoxicants (acetaminophen and carbon tetrachloride), two idiosyncratic hepatotoxicants (felbamate and dantrolene), and three non-hepatotoxicants (meloxicam, penicillin and metformin)	2
Seven compounds	2
mechanism-based biomarker panel	2
distal enhancer/silencer elements	2
bacterial and eukaryotic genomes	2
Homotypic clusters	2
CRE architecture building blocks	2
TF species	2
Many adjacent TF binding sites	2
simple and common building blocks in promoters and other CREs	2
TF molecules	2
cis-regulatory elements (CREs)	2
arch	2
geometry	2
arch plaques	2
wall of the brachiocephalic artery	2
flow field	2
aortic arch	2
fat diet	2
arteries with and without plaque	2
Two cases	2
geometries	2
numerical modelling	2
mouse aortic arch	2
atherosclerotic plaques	2
arterial tree	2
particular sites	2
Atherosclerotic plaques	2
MS-based technologies	2
kinases, phosphatases, their substrates, and phospho-binding proteins	2
phosphorylation machinery	2
individual phosphoproteins and kinases	2
New bioinformatics tools	2
major platforms	2
unique phosphopeptides	2
network of kinases, phosphatases and phospho-binding proteins	2
serine, threonine and tyrosine	2
cupin HNLs	2
(AcHNL)	2
Acidobacterium capsulatum ATCC 51196	2
novel cupin HNL	2
substrate scope	2
interesting, powerful hydroxynitrile lyases	2
class of cupin HNLs	2
recombinant expression in Escherichia coli	2
cupin fold	2
bacterial HNLs	2
pharmaceutical and chemical industry	2
versatile building blocks	2
chiral cyanohydrins	2
hydrogen cyanide (HCN)	2
Hydroxynitrile lyases (HNLs) are powerful carbon–carbon bond forming enzymes	2
distinct viral RNAs	2
involved sequences	2
one or more complementary binding domains	2
trans-splicing sites	2
Splice sites	2
exonic splice enhancers	2
splice sites	2
trans-splice partner sequences	2
strong regular or cryptic splice sites	2
strong cryptic or regular viral splice sites	2
cellular or viral sequences	2
human adenovirus type 5	2
highly transforming 100kDa super T antigen	2
identical viral transcripts	2
sequences and gene products	2
Simian Virus 40 (SV40)	2
p53 protein	2
Neurospora crassa	2
FRQ protein	2
spatial oscillators	2
Nonlinear systems	2
Katchalsky boundary conditions	2
impermeable cell membrane	2
semipermeable nuclear membrane	2
modelling framework	2
(non-linear) partial differential equations	2
protein–protein (and/or protein-mRNA) interactions	2
mathematical tools	2
specific signalling pathways	2
upstream targets	2
important historic landmarks	2
next-generation agents	2
new drug classes	2
novel agents	2
potent derivative lenalidomide	2
immunomodulatory drug thalidomide	2
first-in class proteasome inhibitor bortezomib	2
3 major new targeted agents	2
high-dose chemotherapy with stem cell (ASCT) support	2
conventional combination of oral melphatan+prednisone	2
one of the most common haematological malignancies	2
bone marrow and extramedullary sites	2
number groups	2
(CST)	2
CMP-sialic acid transporter (CST)	2
best-characterised NST	2
in-vitro assays	2
NST	2
crystallising membrane proteins	2
UDP-galactose, UDP-N-acetylglucosamine, UDP-N-acetylgalactosamine, GDP-fucose, UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose and CMP-sialic acid transporters	2
several NSTs	2
endoplasmic reticulum and Golgi apparatus	2
cytosol and nucleus	2
specific nucleotide sugars	2
nucleotide sugar transporters	2
eukaryotes, bacteria and archaea	2
male phenotypes	2
prospective partners	2
mate	2
open, or facultative, niche environments	2
 a minimal theoretical model	2
FGF sources	2
limited supply of FGFs	2
murine spermatogenesis	2
anatomically defined niche	2
DE axis	2
HDAC4-modulating compounds	2
disease axis	2
repressed genes	2
PD iPSC-derived dopamine neurons	2
transcriptional repressor histone deacetylase 4 (HDAC4)	2
GBA-N370S PD risk variant	2
neuronal cultures	2
iPSC)-derived dopamine neurons	2
pluripotent stem cell (	2
heterozygous mutant Ppm1d hematopoietic cells	2
cytotoxic DNA damaging agents including cisplatin	2
DNA damage response regulator	2
mutations in PPM1D (protein phosphatase Mn2+/Mg2+-dependent 1D)	2
particular clones	2
target regulatory elements	2
neural precursor cells	2
unique primed and active chromatin regions	2
broad molecular framework	2
UV-induced mutant clones	2
outcompeted wild-type cells	2
transgenic mouse epidermis	2
normal human epidermis	2
single-allele p53 mutation (Trp53R245W; p53∗/wt)	2
sun-exposed epidermis	2
Atoh1+cells of Atoh1(9S/T-A)CreERT2mice	2
ATOH1 protein	2
phosphomutant Atoh1(9S/T-A)CreERT2line	2
multilineage intestinal clones	2
+ cells (Atoh1(WT)CreERT2mice)	2
secretory progenitors	2
transcription factor Atoh1	2
apparently committed progenitors	2
 self-renewing stem cells	2
regulatory genome	2
validated enhancers	2
 small sub-domains	2
large tracts	2
putative enhancers	2
non-ESC-specific processes	2
enhancer set	2
NANOG, OCT4, H3K27ac, and H3K4me1	2
minority of regions	2
human embryonic stem cells (ESCs)	2
functional enhancers	2
transcription factor (TF) binding	2
male nPSCs	2
female X chromosomes	2
male X chromosome	2
neutral mutations	2
entire crypt	2
mutated stem cell	2
active stem cells	2
somatic clones	2
human colonic epithelium	2
aged HSC compartment	2
cell type latent-HSCs	2
secondary recipients	2
multipotent (five blood-lineage) output	2
primary recipients	2
subset of functional cells	2
multipotent HSCs	2
phenotypic HSC compartment	2
myeloid-restricted repopulating progenitors (MyRPs)	2
chronically inflamed brain	2
type 1 MPs	2
inflammatory metabolic signals	2
somatic and directly induced NSCs	2
succinate-SUCNR1 axis	2
extracellular succinate	2
succinate receptor 1 (SUCNR1)/GPR91 on NSCs	2
Inflammatory MPs	2
transplanted somatic and directly induced NSCs	2
immunometabolites	2
endosteal vasculature	2
small molecule deferoxamine	2
non-leukemic HSCs	2
Remodeled endosteal regions	2
splenic vascular niches	2
central marrow	2
stromal cells, and osteoblastic cells	2
pro-inflammatory and anti-angiogenic cytokines	2
Endosteal AML cells	2
vasculature in central and endosteal bone marrow regions	2
angiogenic factors	2
Acute myeloid leukemia (AML) cells	2
marrow vascular niches	2
 SMAD2/3	2
macrophages, myoblasts to adipocytes, and human fibroblasts	2
co-occupies OCT4 target loci	2
reprogramming factors and co-activators	2
induced pluripotent stem cell (iPSC)	2
constitutively active SMAD2/3	2
mature functional cells	2
cellular identity	2
“trap	2
TE-specific endosiRNAs	2
repressive histone marks	2
Dicer or Ago2 expression	2
ARGONAUTE2 (AGO2)-bound small RNAs	2
sense/antisense transcripts	2
RB family proteins	2
ERK signaling pathway	2
2i ESCs	2
two small-molecule inhibitors (2i ESCs)	2
hyper-phosphorylated RB protein	2
crucial molecular pathways	2
dynamic chromatin/transcription landscape	2
splicing and signaling factors, and glucose/mitochondria regulators	2
cell-cycle and transcriptional regulators	2
pioneer factors (NFYA/B, DMRT1, and hormone receptors)	2
open chromatin	2
core pluripotency genes (OCT4 and NANOG)	2
embryonic developmental genes	2
differentiating c-KIT+ spermatogonia	2
bulk and single-cell RNA transcriptomes (RNA-seq)	2
DNA methylation and open chromatin (ATAC-seq)	2
adult spermatogonial stem cells (hSSCs)	2
epigenetic memories	2
reprogrammed embryos	2
inappropriate cell types	2
donor-cell-specific genes	2
major epigenetic roadblock	2
donor nucleus	2
resultant embryos	2
cloned animals	2
state-specific proteins	2
intermediate cell populations	2
live naive cells	2
naive-specific cell surface proteins	2
Several naive-specific, but not primed-specific, proteins	2
naive and primed human PSCs	2
unmodified naive cells	2
Naive cells	2
naive and primed states	2
human hematopoietic stem cell differentiation	2
maturing megakaryocytes	2
immature multi-lymphoid progenitors	2
myeloid and lymphoid progenitors	2
fetal liver, cord blood, bone marrow, and peripheral blood	2
resulting dataset	2
many small pools of cells	2
genome-wide reference maps	2
rapidly evolving lncRNAs	2
early human embryos	2
transgenic mouse cells	2
unusual, highly dispersed organization	2
XIST RNA	2
naive human embryonic stem cells	2
early human pre-implantation embryos	2
long noncoding RNAs (lncRNAs) XACT and XIST	2
endogenous stem cells in culture	2
endogenous MaSCs	2
YAP-induced mammary stem/progenitor cells	2
Differentiated mammary gland, neuronal, and pancreatic exocrine cells	2
primary differentiated mouse cells	2
closely related paralogue TAZ	2
exogenous YAP	2
autologous tissue-specific stem cells in culture	2
human-interspecies chimeras	2
experimental chimeras	2
intra- and inter-species chimeras	2
Experimental chimeras	2
organized, normally developing tissue	2
naive human pluripotency	2
naive human cells	2
cultured human pluripotent cells	2
in-vitro-manipulated HSPCs	2
various progenitor classes	2
distinct HSPC subtypes	2
four Wiskott-Aldrich syndrome patients	2
distinct bone marrow and peripheral blood lineages	2
>89,000 clones	2
vector integration sites (ISs)	2
human hematopoietic system	2
stem/progenitor cells (HSPCs)	2
CEP290 LCA patients	2
full-length CEP290	2
antisense morpholino	2
RPE and optic cups	2
three-dimensional optic cups	2
differentiated photoreceptors	2
cilia-related gene CEP290	2
congenital amaurosis (LCA)	2
cell autonomously in culture	2
progenitor cell	2
early-born neurons	2
primate cortical progenitors	2
adherent two-dimensional (2D) and organoid three-dimensional (3D) culture systems	2
humans and three nonhuman primates	2
cortical progenitor cell output	2
humans and other animals	2
three primary tissue layers	2
interspecies chimeras	2
hPSC pluripotency	2
gastrula-stage embryos	2
human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs)	2
three tissue layers	2
wild-type males	2
X-linked tumor suppressor Notch	2
 ISCs	2
adult Drosophila intestinal stem cells (ISCs)	2
additional components	2
2i and a2i cells	2
serum cells	2
blastocyst cells	2
alternative ground state a2i	2
model of temporal hierarchy	2
exogenous NeuroD4	2
NeuroD4 promoter	2
repressor REST	2
Cultured astrocytes	2
mouse and human astrocytes	2
NeuroD4	2
shared target genes	2
distinct neurogenic programs	2
glutamatergic or GABAergic neurons	2
postnatal mouse astrocytes	2
mutant stem/progenitor clones	2
hematopoietic system, and the male germline	2
expanded mutant stem and progenitor cell populations	2
another stem cell system	2
single-cell molecular dataset	2
 key molecules	2
enriched population	2
non-HSCs	2
single-cell gene expression assays	2
single-cell functional assays	2
murine HSCs	2
bulk HSC populations	2
contaminating non-HSCs	2
multiple HSC subtypes	2
highly regenerative system	2
CDK6 protein	2
human HSC subsets	2
least	2
long-term (LT)-HSCs	2
dormant hematopoietic stem cell (HSC) subsets	2
naive human pluripotent cells	2
previously reported naive human ESCs	2
bivalent chromatin domains	2
human pluripotent cells	2
conventional human ESCs	2
combination of five kinase inhibitors	2
endogenous OCT4 distal enhancer activity	2
naive human ESCs	2
SummaryEmbryonic stem cells (ESCs) of mice and humans	2
methylation machinery	2
reciprocal molecular links	2
chromatin complex	2
MBD3/NuRD complex	2
reprogramming factor NANOG	2
epiblast-derived stem cells	2
reprogramming intermediates	2
essential scaffold subunit of the NuRD complex	2
Nucleosome Remodeling and Deacetylase (NuRD) complex	2
mouse testis	2
alternative and dynamic model	2
GFRα1+ cells	2
syncytial states	2
single stem cell pool	2
entire GFRα1+ population	2
individual GFRα1+ cells	2
syncytial spermatogonia	2
GFRα1+ stem cells	2
singly isolated (As) spermatogonia	2
mouse spermatogenic stem cells	2
pluripotent circuitry	2
naive pluripotency transcription factors	2
RNA binding protein Pum1	2
conserved small zinc finger protein Zfp706	2
Fgf/Erk and GSK3/Tcf3 modules	2
differentiation-permissive culture	2
transposon integrations	2
-renewal circuitry	2
digestive tract	2
mammalian intestine	2
region-specific differentiation markers	2
epithelial crypt-like structures	2
colonic injury model	2
new cultures	2
mature progenitors	2
mouse fetal intestinal progenitors	2
Established cultures	2
highly similar progenitor population	2
Fetal Enterospheres (FEnS)	2
proliferative, immature progenitors	2
human and mouse fetal intestine	2
proliferative resident stem cells	2
adult intestinal epithelium	2
cross-platform resource	2
TF circuitry	2
different cell compartments	2
GATA1 and GATA2 programs	2
erythroid and neutrophil lineages	2
paradigmatic GATA-PU.1 axis	2
endogenous pituitary stem cells	2
appropriate endocrine cell types	2
endocrine cells in vivo	2
SOX2- and SOX9-expressing progenitors	2
HMG box transcription factors SOX2 and SOX9	2
population of adult pituitary progenitors	2
missing endocrine cells	2
Prdm14- and Nanog-binding cis-acting regulatory region	2
 the de novo methyltransferases (Dnmt3a and Dnmt3b)	2
 imprinted genes	2
Major satellites, intracisternal A particles (IAPs)	2
migratory PGCs and early embryos	2
small-molecule inhibitors (called 2i)	2
primordial germ cells (PGCs) and early embryos	2
bone morphogenetic protein	2
pluripotency transcription factors	2
pluripotency-associated enhancers	2
Oct4+/− ESCs	2
reduced Oct4 expression	2
transcription factors Oct4 and Nanog	2
SummaryEmbryonic stem cell (ESC) pluripotency	2
functional telomeres	2
de novo DNA methyltransferase 3b	2
Nanog by small hairpin RNA (shRNA)	2
promoters of Oct4 and Nanog	2
 LIF	2
control ESCs	2
critically short telomeres (Tert−/−ESCs)	2
mouse embryonic stem cells (ESCs)	2
pituitary tumors	2
p130-E2F4-SIN3A repressive complex	2
SRR2 enhancer of the Sox2 gene	2
differentiation p27	2
p27 null iPSCs	2
brain, lung, and retina	2
ectopic Sox2	2
tumor suppressor p27	2
pluripotency genes in differentiated cells	2
functional placement of Esrrb	2
Nanog−/− pre-iPSCs	2
Nanog−/− EpiSCs	2
Nanog−/− ESCs	2
Estrogen-related receptor b (Esrrb)	2
Nanog-reponsive genes	2
minor fraction of genes that Nanog binds	2
Nanog-responsive genes	2
distinct functionally inducible Nanog proteins	2
direct Nanog target genes	2
SNS	2
AGM HSC niche	2
mediators of the sympathetic nervous system (SNS)	2
AGM	2
functional and phenotypic HSCs	2
transcription factor Gata3	2
aorta-gonads-mesonephros (AGM) region	2
first adult-repopulating hematopoietic stem cells (HSCs)	2
core pluripotency factors	2
Leukaemia inhibitory factor (LIF)	2
nuclear receptor Esrrb	2
genome localization and transcriptome data sets	2
critical targets	2
glycogen synthase kinase-3 (Gsk3)	2
ESCs and postimplantation epiblast stem cells (epiSCs)	2
postimplantation epiblast cells	2
(Prdm1)	2
set of pluripotency genes	2
(NuRD) complex	2
Chromatin remodeling proteins	2
array of different cell types	2
seemingly homogeneous cell population	2
embryonic stem cell (ESC) populations	2
mouse epiblast stem cells (epiSCs)	2
 primordial germ cells (PGCs)	2
key determinants	2
objective cell culture-based system	2
ESC population	2
group of PRC targets	2
PRC and elongating RNAPII (S5p+S7p+S2p+)	2
PRCs and RNAPII-S5p	2
unproductive RNAPII (S5p+S7p−S2p−)	2
developmental PRC targets	2
PRC targets	2
primed RNA polymerase II (RNAPII)	2
repressor complexes (PRCs)	2
regulatory miRNAs	2
miR-125 and miR-181 families	2
lineage-specific markers	2
primary Polycomb ortholog of PRC1 complexes	2
five orthologs of the Drosophila Polycomb protein (Cbx2, Cbx4, Cbx6, Cbx7, and Cbx8)	2
Polycomb repressive complex 1 (PRC1) components	2
multiple homologs	2
Mammalian genomes	2
Polycomb Group (PcG)	2
human and mouse pluripotent stem cells	2
placental trophoblast	2
cells coexpressed mesodermal genes	2
trophoblast-associated genes	2
mesodermal genes	2
BRACHYURY (BRA)	2
ERK)	2
hESCs and mouse epiblast-derived cells	2
neural stem cells or fibroblasts	2
Incompletely reprogrammed cells	2
chimera-competent iPSCs	2
tamoxifen-regulatable fusion, Stat3ERT2	2
glycogen synthase kinase	2
ground state culture	2
granulocyte colony stimulating factor (Gcsf)	2
activating receptor (GY118F)	2
EpiSCs a Jak/Stat3	2
Lif receptor	2
postimplantation embryos	2
transcription factor Stat3	2
Jak kinase	2
mouse embryonic and induced pluripotent stem cells	2
cytokine leukemia inhibitory factor (Lif)	2
diseased tissues	2
adult cells	2
unique ESC epigenotype	2
another set	2
early differentiation genes	2
one set	2
gene activators	2
repressive epigenetic regulators	2
transcript variants	2
pluripotent embryonic stem cells (ESCs)	2
inner cell mass (ICM) cells of blastocysts	2
Oct4-associated proteins	2
stem cell transcription factors	2
Oct4 itself	2
varied set of proteins	2
considerably expanded set of Oct4-binding proteins	2
transcription factor Oct4	2
circuitry	2
several target genes	2
components of the TGF-β, Notch, and Wnt signaling pathways	2
ESC network	2
166 proteins	2
Sall4, Tcfcp2l1, Dax1, and	2
Oct4 partners	2
Oct4-interacting proteins	2
several pluripotency transcription factors	2
satellite cell pool	2
Pax7+ cells	2
proliferating myogenic cells	2
uninjured muscle	2
quiescent Pax7+ satellite cells	2
receptor tyrosine kinase signaling inhibitor	2
Sprouty1 (Spry1)	2
satellite cell compartment	2
 a subpopulation	2
quiescent adult Pax7+ cells	2
adult satellite cell pool	2
transcription factor Pax7 marks satellite cells	2
primitive hematopoietic cells	2
Cited2-deficient background	2
downstream target of p19Arf)	2
encoding p16Ink4a and p19Arf)	2
lymphoid and myeloid lineages	2
adult HSC maintenance	2
p300/CBP-binding transcriptional coactivator Cited2	2
stem cell-derived gametes	2
adult mouse interfollicular epidermal stem cells	2
previously unidentified reservoir	2
Lrig1-positive cells	2
interfollicular epidermis	2
junctional zone compartment	2
sebaceous gland and interfollicular epidermis	2
adult epidermal lineages	2
Lrig1-expressing cells	2
stem cells in culture	2
Myc target gene	2
sebaceous glands and infundibulum	2
human interfollicular epidermal stem cells	2
susceptible mouse strains	2
FVC-infected cells	2
cytotoxic CD8	2
conventional dendritic cells 1 (cDC1s)	2
retroviral capture	2
erythroblasts in the red pulp	2
incoming blood-borne retroviruses	2
CD169-expressing macrophages	2
splenomegaly-inducing retrovirus Friend virus complex (FVC) infection	2
permissive lymphocytes	2
subcapsular sinus and marginal zone metallophilic macrophages	2
blood-borne retroviruses	2
intracellular bacterial pathogens	2
septin cytoskeleton	2
dividing bacterial cells	2
autophagic and lysosomal machinery	2
septin cages	2
Shigella cell growth	2
bacterial mutants lacking cardiolipin	2
highly curved membranes of Shigella	2
curvature-specific phospholipid	2
cytosolic Shigella	2
cytoskeletal proteins	2
4-stranded bridging sheet	2
displaced V1V2	2
CD4 and gp120	2
coreceptor-mimicking antibody	2
One structure	2
partially open soluble native-like Env trimers (SOSIPs)	2
3.54 Å and 4.06 Å cryoelectron microscopy structures	2
Env's apex	2
V1V2 loops	2
Receptor binding	2
host receptor CD4	2
trimer of gp120-gp41 heterodimers	2
heterologous Envs	2
Env	2
one superinfected individual	2
four superinfected women	2
distinct HIV envelope glycoproteins (Env)	2
second strain	2
broad range of circulating HIV strains (broadly neutralizing antibodies [bnAbs]	2
HCMV and other viruses	2
innate pathways	2
Cullin4 E3 ligase complex	2
functionally unknown HCMV protein UL145	2
helicase-like transcription factor (HLTF)	2
viral genes	2
comprehensive panel of viral mutants	2
final screen	2
three orthogonal proteomic/transcriptomic screens	2
proteasome or lysosome	2
host antiviral restriction factors	2
cytomegalovirus (HCMV)	2
agricultural systems	2
plant pathogen in wild hosts	2
studied A. thaliana populations	2
single strain	2
crop systems	2
specific sublineages	2
genetically identifiable pathogenic sublineages	2
1,524 genomes	2
a ubiquitous pathogenic clade	2
common Pseudomonas lineage	2
natural host Arabidopsis thaliana	2
wild pathosystems	2
single pathogenic lineages	2
first-generation pre-erythrocytic vaccines	2
diverse pipeline of novel vaccine candidates	2
human malaria parasites Plasmodium falciparum and P. vivax	2
highly effective and durable vaccines	2
infant gut	2
Maternal gut strains	2
distinct maternal sources	2
Maternal skin and vaginal strains	2
multiple body sites	2
infant pioneering microbes	2
maternal microbial reservoir	2
public antibody clonotypes	2
known HIV-reactive antibodies	2
publicly available antibody repertoire sequencing datasets	2
three donors	2
identified public clonotype	2
representative antibodies	2
multiple HIV-infected individuals	2
“public” antibody clonotypes	2
multiple HIV-infected donors	2
antibody repertoires	2
Env-specific antibodies	2
single antibody lineages	2
B cells	2
potent bnAb B cell lineages	2
improbable mutations	2
bnAb B cell lineages	2
bnAb B cell receptors (BCR)	2
 viral envelopes (Envs)	2
activation-induced cytidine deaminase (AID)-catalyzed somatic mutations	2
SummaryHIV-1 broadly neutralizing antibodies (bnAbs)	2
herd immunity	2
mosquito vectors	2
ZIKV-specific enrichment	2
ZIKV genomes	2
at-risk regions	2
Zika virus (ZIKV) epidemic	2
SLC4A7 mutants	2
wild-type SLC4A7	2
human macrophage cell lines	2
 phagocytosed beads or bacteria	2
bicarbonate transporter SLC4A7	2
in vivo gene regulatory network	2
members of the P. falciparum AP2 transcription factor family	2
stage-specific sets of regulatory regions	2
respective mRNA transcript	2
transposase accessible chromatin sequencing (ATAC-seq)	2
functionally relevant proteins	2
resulting pathogenicity	2
genus Plasmodium	2
heterochromatic genes	2
erythrocyte remodeling machinery	2
key gametocyte-specific genes	2
differentiating gametocytes	2
Many P. falciparum heterochromatic genes	2
small set of conserved HP1-associated genes	2
surface antigens	2
fast-evolving multi-gene families	2
Common targets	2
different Plasmodium species, strains, and life cycle stages	2
heterochromatin landscapes	2
(HP1) occupancy	2
genome-wide heterochromatin protein 1	2
intestinal interface	2
receptor TLR2	2
large soluble polysaccharide	2
intestinal macrophages	2
microbe-derived molecule(s)	2
mouse intestinal microbiota	2
Helicobacter hepaticus	2
microbe-derived molecules	2
Complex molecular pathways	2
host and its microbiota	2
S. flexneri	2
GBP encapsulation	2
ubiquitin coating of Shigella	2
existing GBP coats	2
bacterial ubiquitin ligase	2
interferon-induced GTPase family of guanylate-binding proteins (GBPs) coats Shigella flexneri	2
professionally cytosol-dwelling bacteria	2
interferon-enhanced immunity	2
cell-autonomous immunity	2
epithelial-cell-derived Pla2g1b	2
infective H. polygyrus L3 larvae	2
IL-4R-signaling	2
susceptible mice	2
common-gamma chain-dependent signaling	2
intestinal helminths Heligmosomoides polygyrus or Nippostrongylus brasiliensis	2
tissue-embedded larvae	2
resistant mice	2
host-derived endogenous anthelmintic	2
epithelial-cell-derived phospholipase A2 group 1B (PLA2g1B)	2
intestinal helminth infections	2
non-enveloped progenitors	2
two virus families	2
structurally related capsids	2
diversified family of fish viruses	2
ORF of the viral replicase	2
∼1,100 bp open reading frame (ORF)	2
extensive gene overlap	2
family Hepadnaviridae	2
reverse-transcribed DNA genomes	2
SummaryHepatitis B viruses (HBVs)	2
CF mice	2
CF epithelial cells	2
RGD peptide ligand	2
anti-β1-integrin antibodies	2
surface sphingosine	2
β1-integrins downregulate acid ceramidase expression	2
luminal pole of bronchial epithelial cells	2
ceramide platforms	2
mice and humans with CF	2
luminal membrane of upper-airway epithelial cells	2
patients with cystic fibrosis (CF)	2
intact membrane-bound compartments	2
immune-regulated cellular pathway of defense	2
active tuberculosis	2
sputum of human patients	2
spacious proteolytic phagolysosomes	2
interferon-gamma-stimulated and Rab20-dependent membrane trafficking pathway	2
 Mtb-containing phagosomes	2
intracellular pathogen Mycobacterium tuberculosis (Mtb)	2
aging-associated microbiota	2
tumor necrosis factor (TNF)-deficient mice	2
young, conventionally raised mice	2
aged germ-free mice	2
PfEMP1s	2
ICAM-1-binding PfEMP1s	2
multiple Plasmodium falciparum genomes	2
specific sequence motif	2
intercellular adhesion molecule 1 (ICAM-1)	2
group of PfEMP1 proteins	2
various endothelial receptors	2
PfEMP1 family	2
fish survival	2
anti-TNF-α neutralizing antibodies	2
soluble decoy receptor	2
CyHV-3 ORF12	2
Behavioral fever	2
warmest compartment	2
multi-chamber tanks	2
native carp pathogen	2
cyprinid herpesvirus 3	2
common carp	2
warmer places	2
endotherms and ectotherms (e.g., fish)	2
complex transcriptional network	2
partly overlapping sets of target genes	2
ApiAP2 proteins	2
different ApiAP2 factors	2
shared cis promoter elements	2
mutants and developmental stages	2
asexual and sexual stages	2
blood stages	2
AP2-O and AP2-SP proteins	2
infectious ookinetes	2
ten ApiAP2 genes	2
majority of ApiAP2 genes	2
sequence-specific transcription factors	2
family of apicomplexa-specific proteins containing AP2 DNA-binding domains (ApiAP2s)	2
motor-binding TRAP family members	2
gamete-containing parasitophorous vacuole membrane	2
rodent-infecting P. berghei and human-infecting P. falciparum parasites	2
MTRAP-deficient mutants	2
Blood stage forms of the malaria parasite Plasmodium express a TRAP family protein called merozoite-TRAP (MTRAP)	2
parasite submembrane actomyosin motor	2
TRAP proteins	2
phylum of apicomplexan parasites	2
SummarySurface-associated TRAP (thrombospondin-related anonymous protein) family proteins	2
co-stimulatory molecule B7.2	2
surface MHCII	2
MARCH8 and mMHCII	2
C-terminal cytoplasmic region of SteD	2
surface mMHCII	2
E3 ubiquitin ligase MARCH8 and mMHCII	2
Golgi network	2
Mel Juso cells	2
effector SteD	2
surface-localized mature MHC class II (mMHCII)	2
SPI-2 type III secretion system (T3SS) of intracellular Salmonella enterica	2
Flaviviridae genomes	2
conserved regulatory mark	2
dengue, Zika, yellow fever, and West Nile virus	2
RNA genomes of other Flaviviridae	2
one viral genomic region	2
inactivating m6A	2
HCV genome	2
m6A sites	2
infectious viral particles	2
YTHDF proteins	2
m6A demethylase	2
m6A methyltransferases	2
m6A-modified mRNA	2
m6A-binding YTHDF proteins	2
important barrier	2
transmitted founder and chronic viruses	2
transmitted founder HIV-1	2
viral envelope glycoproteins	2
HIV-1 strains	2
in vivo relevance	2
diverse enveloped viruses	2
SummaryInterferon-induced transmembrane proteins (IFITMs)	2
Relish target genes	2
Pickle’s	2
NF-κB dimer combinations	2
Relish homodimers	2
histone deacetylase dHDAC1	2
NF-κB protein Relish	2
NF-κB dimer repertoire	2
Drosophila nuclear IκB	2
recognition receptors	2
resulting acidic environment	2
pathogenic mycobacteria	2
individual mycobacteria	2
infecting bacteria	2
virulence determinant MarP	2
cultured macrophages	2
viable mycobacteria	2
phagolysosomal fusion	2
external carbon source	2
ATF parasites	2
β-oxidation intermediates	2
exogenous myristate	2
putative fatty acid β-oxidation enzymes	2
naive animal	2
adipose tissue forms (ATFs)	2
third major reservoir	2
well-established mouse model	2
two major niches	2
extracellular parasite	2
saliva	2
recent Brazilian epidemic	2
currently circulating Zika virus isolates	2
bacterial endosymbiont of insect	2
Wolbachia pipientis	2
Zika vector, Aedes aegypti mosquitoes	2
molecular players and complex mechanistic layers	2
varied host environments	2
malaria and African trypanosomiasis	2
Several parasitic protozoa	2
diverse and often hostile ecological niches	2
numerous metazoan hosts and insect vectors	2
Protozoan parasites	2
transmission-blocking drugs	2
sexual and asexual parasites	2
asexual blood and liver stages	2
metabolically quiescent stage V gametocytes	2
endoperoxides and 4-aminoquinolines	2
well-characterized antimalarials	2
13,983 unique compounds	2
Saponin-lysis Sexual Stage Assay (SaLSSA)	2
large chemical libraries	2
first infected cell	2
infectious unit	2
different viral genomes	2
90 individual cells	2
881 viral plaques	2
Full-length sequences	2
novel hosts	2
SummaryGenetic diversity	2
spectrin network of the erythrocyte cytoskeleton	2
SUB1-processed merozoite surface MSP1	2
surface-bound MSP1	2
inefficiently processed MSP1 mutant	2
host erythrocyte cytoskeleton	2
molecular scaffold protein	2
parasite protease SUB1	2
large precursor	2
abundant merozoite surface protein, MSP1	2
progeny merozoites	2
endogenous SNAT1 substrate	2
activated primary human CD4+ T cells	2
lineage of SIVcpz/HIV-1 viruses	2
Vpu variants	2
SNAT1 antagonism	2
SNAT1, a β-TrCP-dependent Vpu substrate	2
serine carriers SERINC3/5	2
amino acid transporter SNAT1	2
viral accessory proteins Vpu	2
immune functions	2
T cell surface	2
cell surface immunoreceptors	2
germ-free animals	2
peptidoglycan recognition and signaling cascade PGRP-LE/Imd/Relish	2
commensal strain Lactobacillus plantarumWJL(LpWJL)	2
metazoan physiology	2
mononuclear cytopenias	2
wild-type fish	2
bacterial ESX-1	2
apoptotic infected macrophages	2
granuloma necrosis	2
Granuloma macrophages	2
new bacterial growth niches	2
infected apoptotic macrophages	2
Newly recruited macrophages	2
forming tuberculous granuloma	2
macrophage recruitment	2
mycobacterial ESX-1 virulence locus	2
multiple lines	2
AID technology	2
ookinete-to-oocyst and sporozoite-to-liver stage transitions	2
late-stage schizonts	2
calcium-regulated protein phosphatase, calcineurin	2
auxin-inducible degron (AID)	2
rodent malaria parasite	2
rapid, specific, and inducible chemical-genetic tool	2
malarial parasite, Plasmodium	2
unified model	2
evolutionally related HIV-1/SIV accessory protein Vpr	2
Vpx-DCAF1 interface	2
N- or C-terminal SAMHD1 sequences	2
Vpx lineages	2
molecular determinants	2
SIV that infects sooty mangabeys (SIVsmm)	2
SAMHD1 N-terminal “degron” sequences	2
mandrill SAMHD1	2
cullin-4 substrate receptor, DCAF1, and N-terminal and SAM domains	2
SIV that infects mandrills (SIVmnd-2)	2
ternary complex of Vpx	2
host cullin-4 ubiquitin ligase	2
SAMHD1 N or C terminus	2
two lineages of the accessory protein Vpx	2
SIVs	2
myeloid and resting T cells	2
SAMHD1 triphosphohydrolase	2
A. fumigatus infection	2
exogenous IL-1β	2
Dectin-1 signaling	2
downstream adaptor protein CARD9	2
pattern recognition receptor Dectin-1	2
neutrophilic MDSCs	2
distinct subset of neutrophilic myeloid-derived suppressor cells (MDSCs)	2
Aspergillus fumigatus and Candida albicans	2
human pathogenic fungi	2
pro-inflammatory antifungal immune responses	2
immunocompetent individuals	2
barcoded mutants	2
cloned mutants	2
targetability of kinases cdpk1, gsk3, tkl3, and PBANKA_082960	2
published kinome screens	2
P. berghei kinome	2
barcode sequencing (barseq)	2
single mouse	2
complex pools of barcoded mutants	2
haploid blood stages	2
dozens of vectors	2
Plasmodium berghei genome	2
long homology arms	2
large-scale resource of barcoded vectors	2
mouse and in man	2
CLECSF8 polymorphism	2
opsonized bacteria	2
pulmonary leukocytes	2
C-type lectin receptor CLECSF8 (CLEC4D, MCL)	2
many PRRs	2
future vaccine candidates	2
in vitro parasite-neutralizing activity	2
human-compatible vaccine formulation	2
Aotus monkeys	2
vaccine-inducible strain-transcending parasite-neutralizing antibody	2
merozoite adhesin	2
P. falciparum reticulocyte binding protein homolog 5 (PfRH5)	2
vaccines in nonhuman primates	2
strain-specific protection	2
pathogenic blood-stage infection	2
SummaryAntigenic diversity	2
surface protein family	2
diverse CIDRα1 variants	2
individuals in malaria-endemic regions	2
EPCR-binding region	2
natural EPCR ligand	2
EPCR-binding surfaces of CIDRα1 domains	2
CIDRα1 sequences	2
CIDRα1:EPCR complexes	2
CIDRα1 domains of PfEMP1	2
PfEMP1 family of surface proteins	2
macrophage reservoir	2
nonmacrophage-tropic CXCR4-using virus	2
CCR5-using macrophage-tropic and otherwise weakly macrophage-tropic transmitted/founder viruses	2
healthy and dead or dying	2
Infected T cells	2
HIV-1-infected CD4+ T cells	2
viral entry receptors	2
community resource	2
multi-omic data types	2
host and microbiome	2
experimental test beds	2
integrated data sets	2
disease-specific cohorts	2
human-associated microbial communities	2
reduced RICH2 binding	2
naturally occurring tetherin polymorphism	2
Rac-GAP-containing protein RICH2 (ARHGAP44)	2
C-type lectin pattern recognition receptors	2
hemi-immunoreceptor tyrosine-based activation motifs (hemITAMs)	2
tetherin cytoplasmic tail	2
spleen tyrosine kinase (Syk)	2
cytoplasmic tails of tetherin dimers	2
conserved tyrosine residues	2
retroviral particles	2
hominid tetherins	2
enveloped viral particles	2
SummaryTetherin (BST2/CD317)	2
cell contacts	2
cytotoxic immune effector cells	2
F-actin in target cells	2
pUL135 expression	2
F-actin filaments in target cells	2
WAVE2 regulatory complex	2
abl interactor 1 (ABI1)	2
clinical HCMV strains	2
UL/b’	2
UL/b’ domain	2
laboratory-adapted HCMV strains	2
evasion genes	2
host biology	2
cell-autonomous innate immune system	2
two N-myristoylated PPs	2
P. berghei PPs	2
predicted PPs	2
P. falciparum phosphatome	2
Plasmodium berghei protein phosphatome	2
protein phosphatases (PPs)	2
malaria parasite kinome	2
Tde-Tdi couples	2
T6SS-dependent fitness in vivo	2
siblings cells	2
A. tumefaciens used Tde effectors	2
planta coinfection assay	2
Tde toxins	2
A. tumefaciens T6SS	2
cognate immunity protein, Tdi	2
conserved HxxD motif	2
previously known polymorphic toxins and nucleases	2
family of type VI DNase effectors (Tde)	2
effectors/toxins	2
many Proteobacteria	2
widespread molecular weapon	2
SummaryThe type VI secretion system (T6SS)	2
TNF-related apoptosis-inducing ligand (TRAIL)	2
infiltrating neutrophils	2
neutrophil-recruiting chemokine CXCL1	2
stromal nonhematopoietic tissue	2
NK-, NKT-, and T cell-secreted IL-22	2
potent antiviral effector cells	2
, murine cytomegalovirus (MCMV)	2
primary infection	2
viral progeny	2
host short linear protein-protein interaction motif	2
M2 LIR	2
highly conserved LC3-interacting region (LIR)	2
unexpected destination of the plasma membrane	2
essential autophagy protein LC3	2
cytoplasmic tail of IAV M2	2
(M2) ion-channel protein	2
Matrix	2
virus (IAV)	2
retinoid X receptor alpha (RXRα)	2
intracellular Leishmania	2
uninfected Kupffer cells	2
parasite Leishmania donovani	2
liver-resident macrophages (Kupffer cells)	2
host-derived inflammatory signals	2
in vitro infection studies	2
serum cholesterol	2
VL mouse liver	2
L. donovani-interacting hepatic cells	2
pre-miRNA processor Dicer1	2
Leishmania surface glycoprotein gp63, a Zn-metalloprotease	2
infective parasites	2
VL mice	2
L. donovani infection	2
VL liver	2
miR-122 expression	2
liver-specific microRNA-122	2
direct or indirect targets	2
lipid metabolic genes	2
murine VL liver	2
experimental murine model	2
VL patients	2
liver and spleen tissue macrophages	2
donovani causes visceral leishmaniasis (VL)	2
pleiotropic inhibitor	2
TRAIL DRs	2
herpesvirus modulator	2
virus infected cells	2
DRs	2
UL141 binding	2
natural ligand TRAIL	2
ectodomains of both human TRAIL DRs	2
TNF family cytokines	2
human cytomegalovirus (HCMV) UL141 glycoprotein	2
TNFR superfamily	2
SummaryDeath receptors (DRs)	2
Na+ efflux ATPase	2
potent class of antimalarials	2
Na+-ATPases of lower eukaryotes	2
parasite plasma membrane protein	2
infected erythrocyte cytosol	2
permeability pathways	2
host erythrocyte plasma membrane	2
important parasites	2
efficient regulatable system	2
PRF and NMT expression	2
parasite invasion, and N-myristoyltransferase (NMT)	2
two essential P. berghei genes: profilin (PRF), a protein	2
Toxoplasma gondii, Plasmodium berghei, and Plasmodium falciparum	2
robust conditional expression system	2
blood-, liver-, and mosquito-stage parasites	2
ApiAP2 transactivation domains	2
Apicomplexan AP2 (ApiAP2) family transcription factors	2
functional transcriptional activation domains	2
practical regulatable expression system	2
steC-null and kinase-deficient mutant strains	2
known MEK activatory residues, S218 and S222	2
negative regulatory helix	2
previously unstudied phosphorylation site	2
serine 200 (S200)	2
MAP kinases MEK and ERK, myosin light chain kinase (MLCK) and Myosin IIB	2
Salmonella SPI-2 type III secretion effector	2
 a dense meshwork of F-actin	2
Human tetherin’s	2
mitogen-activated protein kinase TAK1	2
TNF-receptor-associated factor TRAF6	2
endocytic motif	2
tetherin’s extracellular domain	2
NFκB-dependent proinflammatory gene expression	2
virus sensor	2
Vpu-defective HIV-1	2
physically tethering virions	2
interferon-induced viral restriction factor tetherin (CD317/BST2)	2
pattern-recognition receptors	2
pathogen-specific or aberrantly located molecular motifs	2
palmitoylating others	2
actin-myosin invasion motor	2
asexual-stage P. falciparum parasites	2
stage Plasmodium falciparum	2
3′ and 5′UTRs	2
developing zygote	2
CDPK1 translationally	2
arrested parasites	2
developmentally arrested parasites	2
sexual stages	2
asexual blood stage of the parasite	2
rodent malaria parasite Plasmodium berghei	2
SummaryCalcium-dependent protein kinases (CDPKs)	2
attractive, druggable, antimalarial target	2
lysyl-tRNA synthetase	2
two amino acids	2
parasite lysyl-tRNA synthetase	2
P. falciparum cytosolic lysyl-tRNA synthetase	2
yeast deletion strains collection	2
blood and liver stages	2
fungal secondary metabolite	2
Plasmodium falciparum blood- and liver-stage proliferation	2
natural product library	2
liver- and blood-stage infections	2
drug-resistant parasites	2
next-generation antimalarials	2
pathogen and host GEFs	2
ARNO cooperated	2
phosphoinositide phosphatase effector SopB-induced PIP3 generation	2
pathogen-containing macropinosomes	2
host Arf-family GEFs	2
activated Arf1	2
Invading Salmonella	2
Salmonella guanine nucleotide exchange factor (GEF) SopE	2
P1-type ATPases	2
bacilli	2
mycobacterial cytoplasm	2
inside macrophages	2
burst of free zinc	2
host cell metallothioneins and zinc exporter ZnT1	2
mycobacterial genes encoding heavy metal efflux P-type ATPases CtpC, CtpG, and CtpV	2
intracellular mycobacteria	2
exogenously applied PRR agonists	2
exogenously administering TLR ligands	2
Syk/CARD9 pathway	2
CLR Mincle	2
C-type lectin receptors (CLRs)	2
fungus Fonsecaea pedrosoi	2
parasite's antigen repertoire	2
stumpy-specific PAD1 marker	2
stumpy forms	2
proliferative “slender forms	2
parasite antigenic variants	2
extracellular parasite Trypanosoma brucei in host blood	2
viral latency products	2
growth-suppressive DDR	2
viral latent oncoprotein EBNA3C	2
primary B cells	2
DDR kinases ATM	2
latent episomes	2
indefinitely proliferating lymphoblastoid cell lines	2
primary human B cells	2
oncogenic herpesvirus	2
SummaryEpstein-Barr virus (EBV)	2
likely regulator of energy metabolism (SNF1/KIN)	2
conserved regulator of clathrin uncoating (GAK)	2
putative SR protein kinase (SRPK)	2
functional clusters of kinases	2
Anopheles stephensi mosquitoes	2
Phenotyping mutants	2
putative Plasmodium ePKs	2
conventional ePKs	2
genetically tractable rodent parasite Plasmodium berghei	2
mammalian host and mosquito vector	2
Plasmodium falciparum ePKs	2
eukaryotic protein kinases (ePKs)	2
“danger response” pathway	2
MKP1/c-Fos activation	2
damage-inducing hyphae	2
fungal burdens	2
hypha formation	2
MKP1 and c-Fos activation	2
c-Jun activation	2
first MAPK phase	2
C. albicans	2
oral epithelial cells	2
normal oral flora	2
experimental research tool	2
Plasmodium chromosome	2
linear PAC (L-PAC)	2
pbcen5-containing plasmids	2
Plasmodium gene-synteny map	2
chromosome 5 of the rodent parasite P. berghei	2
putative centromere (pbcen5)	2
parasite's centromere	2
Plasmodium artificial chromosome (PAC)	2
cloning vectors	2
artificial chromosome	2
intracellular niche	2
Salmonella-induced filaments	2
adaptors p47	2
ATPase valosin-containing protein (VCP/p97)	2
AAA+	2
host substrates	2
C-terminal protein tyrosine phosphatase (PTPase) domain	2
Salmonella-containing vacuoles (SCVs)	2
cytokine IFN-γ	2
protective antibodies	2
liver-stage parasites	2
vaccine-induced MSP-1-specific CD4+ T cells	2
blood-stage parasites	2
replication-defective viral vaccine vectors expressing the malaria antigen merozoite surface protein-1 (MSP-1)	2
liver and blood stages of infection	2
NKT cells and microbes	2
CD1d molecules	2
N. aromaticivorans cell wall α-glycuronosylceramides	2
mitochondrial counterpart	2
microbial PDC-E2	2
signature antibodies	2
homologous enzyme of Novosphingobium aromaticivorans, an ubiquitous alphaproteobacterium	2
mitochondrial Pyruvate Dehydrogenase Complex E2 (PDC-E2)	2
signature autoantibodies	2
distinct T3SSs	2
SipA postentry	2
SPI2 effector SifA	2
late endosomes	2
nonphagocytic cells and macrophages	2
cytoplasmic face of the SCV	2
microtubule-dependent motors	2
customized Salmonella-containing vacuoles (SCVs)	2
SPI2 effectors	2
actin-binding SipA	2
SPI1 effectors	2
two type III secretion systems (T3SSs), SPI1 and SPI2	2
fittest of the older patients	2
cancer receiving no chemotherapy	2
ADL or IADL scale	2
instrumental activities of daily living (IADL)	2
breast and colorectal cancer	2
355,502 cancer patients	2
grey literature	2
$1000/month	2
urban domicile	2
rural domicile	2
processed food	2
traditional African diet	2
traditional African, urbanised and processed food	2
Generalised linear and logistic regression models	2
food frequency questionnaire	2
community-based controls	2
colorectal cancer cases	2
Interactive graphs	2
youngest and oldest patients	2
splines	2
-standardised estimates	2
Web-based interactive graphs	2
user	2
online interactive graphs	2
log-cumulative hazard function	2
endometrial and kidney cancers	2
obese no-surgery population	2
OS population	2
surgery and no-surgery cohorts	2
endometrial and kidney cancer	2
surgery cohort	2
OS cohort	2
developed CRC	2
no-surgery obese population	2
607 obese patients	2
breast, endometrial, kidney and lung cancer	2
OS (no-surgery cohort	2
individuals who underwent OS (surgery cohort	2
English National Health Service	2
studied geographies	2
staged cases	2
CCG (Clinical Commissioning Group) indicators	2
bladder, breast, colorectal, endometrial, lung, ovarian, prostate, renal, NHL, and melanoma)	2
one of ten cancer sites	2
healthcare commissioning organisations	2
geographically-defined populations	2
breast symptoms	2
majority of women	2
symptom groups	2
symptomatic women	2
epidemiological studies	2
Asian ethnic origin	2
fresh fruit and tea	2
cereal, cooked and salad/raw vegetables	2
vasectomy	2
wife or partner	2
212,039 men	2
large middle-aged population-based cohort	2
screen-detected and interval cancers	2
type of regression model	2
Dutch databases	2
5-year age groups	2
person-years	2
invasive breast cancer incidence	2
diagnostic and clinical data sources	2
ring sideroblasts	2
subtypes combined	2
chronic myeloid leukaemia	2
therapy-related AML	2
aggressive entities	2
acute myeloid leukaemias (AML)	2
socio-demographically representative UK population	2
many myeloid malignancy subtypes	2
similarly aged younger women	2
mouth cancer incidence	2
Mumbai cancer registry	2
younger women	2
survey populations	2
recently treated cancer survivors	2
incident or prevalent cancer cases	2
diagnostic case-mix of respondents	2
35	2
Asian or Black patients	2
colon or breast cancer	2
affluent patients	2
brain, lung and pancreatic cancer	2
109,477 initially sampled cancer patients	2
incident and prevalent cases	2
relevant populations of cancer patients	2
sampling frame	2
cancer patient surveys	2
post-sampling mortality	2
patients with DLBCL in the UK	2
fitter patients	2
age/fitness spectrum	2
intensively treated patients	2
denovo DLBCL	2
2137 patients	2
DLBCL 2004–2012	2
representative UK population	2
aggressive curable cancer	2
diffuse large B-cell lymphoma (DLBCL)	2
summer months	2
patients with melanoma	2
larger UK cancer registries	2
thinner melanomas	2
winter	2
high-dose insulin	2
sulfonylureas, insulin, metformin or TZDs	2
antidiabetic medications	2
Kentucky Medicaid Database	2
prostate cancer (PCa)	2
high grade tumors	2
insulin-like growth factor receptor (IGFR)	2
prostate tumors	2
modified DNA duplexes	2
parsimonious model of MLL1-CXXC and TET3-CXXC DNA binding	2
formyl- and carboxyl-modifications	2
Methyl-,	2
cytosine modifications (5-methyl, 5-hydroxymethyl, 5-formyl, 5-carboxyl) in CpG and non-CpG context	2
MLL1-CXXC and TET3-CXXC sequence specificity	2
symmetric DNA duplex	2
CXXC domain of TET3	2
CpG specific DNA binding domains	2
CXXC domains	2
CckA-CtrA pathway	2
highly conserved nature	2
CckA-CtrA signal transduction pathway	2
stable NstA	2
Cori	2
CtrA regulated promoters	2
small sub-set	2
chromosomal origin of replication, Cori	2
master cell cycle regulator	2
(CtrA~P)	2
PAS-B domain of CckA	2
cell cycle histidine kinase,	2
topoisomerase IV inhibitor, NstA	2
freshwater bacterium Caulobacter crescentus	2
CckA-CtrA two-component signaling system	2
developmental pathways	2
RNA pol II transcripts	2
cellular mRNA	2
recruits complexes	2
5′ end of RNA pol II-transcribed RNA	2
Dr. Soller Matthias and Dr. Fray Rupert	2
wide range of viruses	2
eukaryotic RNA	2
Dr. Matthias Soller and Dr. Rupert Fray	2
mitochondrial messenger RNAs	2
mitochondrially-encoded ribosomal and transfer RNAs	2
mammalian mitochondrial epitranscriptome	2
mitochondrial transcripts	2
oxidative phosphorylation machinery	2
mitochondrially-encoded genes	2
lost and common sites	2
CTCF occupancies	2
gained sites	2
lost and common	2
classical CTCF binding motif	2
i.e. common sites	2
fewer sites	2
arrested cells	2
human breast cells 226LDM	2
number of primary tissues	2
hypo- and non-PARylated CTCF	2
highly PARylated CTCF form	2
poly(ADP-ribosyl)ation (PARylation)	2
evolutionarily conserved and ubiquitously expressed architectural protein	2
DNA damage sensors	2
cellular metabolism	2
epigenetic signals	2
master transcriptional regulators	2
C. crescentus	2
cell division proteins	2
oligotrophic environments	2
free-living Alphaproteobacterium	2
tRNA aminoacylation	2
ribosome-associated aa-RSs	2
yeast ribosomes	2
four yeast aa-RSs	2
tRNA synthetases (aa-RSs)	2
small ribosomal subunit and aminoacyl-	2
five 3′-tRFs and one 5′-tRF	2
(ranc-3′-tRFs)	2
5′ (ranc-5′-tRFs) and 3′-part of tRNAs	2
ribosome-associated tRFs	2
Saccharomyces cerevisiae transfer RNA (tRNA)-derived fragments (tRFs)	2
short regulatory RNAs	2
(ranc) RNAs	2
Ribosome-associated noncoding	2
non-fibrotic lungFCSfetal calf serum	2
deacetylaseH3K9me3histone H3 lysine 9 trimethylationAREAUUUA-rich elementHuRhuman antigen RELAV1ELAV-like RNA binding protein 1TTPTristetraprolinCUGBP2CUG triplet repeat, RNA binding protein 2F-NLfibroblast	2
1DNMTDNA methyltransferaseHAThistone	2
A3′-UTR3′-untranslated regionα-SMAα-smooth muscle actinECMextracellular matrixCOL1collagen	2
E2IPFidiopathic pulmonary fibrosisDACDecitabineHMThistone methyltransferaseEZH2enhancer of zeste homolog	2
β1COX-2cyclooxygenase-2TIA-1T-cell intracellular antigen-1PGE2prostaglandin	2
acidTGF-β1transforming growth factor-	2
COX-2 expression	2
3′-UTR mRNA binding protein TIA-1 (T-cell intracellular antigen-1)	2
3′-untranslated region (3′-UTR) luciferase reporter assay	2
EZH2 HMT inhibitor 3-deazaneplanocin A (DZNep)	2
G9a histone methyltransferase (HMT) inhibitor BIX01294	2
DNA demethylating agent Decitabine (DAC)	2
pan-histone deacetylase inhibitor suberanilohydroxamic acid (SAHA)	2
normal lung fibroblasts	2
profibrotic cytokine transforming growth factor-β1 (TGF-β1)	2
patients with idiopathic pulmonary fibrosis (IPF)	2
deficient PGE2	2
antifibrotic gene	2
main antifibrotic metabolite PGE2	2
Cyclooxygenase-2 (COX-2)	2
Plant Gene Regulatory Mechanisms and Networks	2
simple theoretical framework of causality scenarios	2
plants and other systems	2
‘chicken-and-egg’ problem	2
stress-induced transcription factors	2
primary stress targets	2
local higher-order structure	2
DNA with histone proteins	2
Rrn3 factor	2
rRNA expression	2
Rrn3 overexpression	2
ribosomal transcription factor Rrn3	2
ribosomal DNA loci	2
RNA polymerase I density	2
major component of cellular RNA	2
controls in fetal and adult tissues	2
fetal somatic tissues	2
Low protein diet	2
Cells and organisms	2
hnRNP A1 over-expressing cells	2
neuroblastoma cells	2
3′UTR region	2
Drp1 mRNA	2
heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1)	2
mitochondria and peroxisomes	2
Dynamin-related protein 1 (Drp1)	2
Dr. Tetsuro Hirose and Dr. Shinichi Nakagawa	2
long noncoding RNA taxonomy1	2
precursor molecules	2
noncoding DNA elements	2
gene-targeted model mice	2
cultured cell lines	2
enhanced FOXM1 DNA damage repair gene expression network	2
DNA damage sensors, mediators, signal transducers and effectors	2
Swi–Snf binding	2
extensive array of strongly positioned, deacetylated nucleosomes	2
distinctly bound Cyc8–Tup1	2
Cyc8–Tup1 in a cyc8 mutant	2
ATP-dependent chromatin remodelling complex Swi–Snf	2
repressed FLO1 promoter region	2
Rpd3p	2
yeast histone deacetylases,	2
adjacent regions	2
Tup1p localisation	2
cyc8 deletion mutant strains	2
ordered array of strongly positioned nucleosomes	2
DNase I hypersensitive site	2
extensive FLO1 upstream region	2
Cyc8–Tup1 complex	2
distinct subset of subtelomeric genes	2
yeast flocculation gene, FLO1	2
Multifaceted Modification	2
reported KDM inhibitors	2
KDMs	2
2-oxoglutarate- (2OG) dependent JmjC subfamily	2
flavin-dependent KDM1 subfamily	2
two distinct subfamilies of demethylases (KDMs)	2
Nε-methyllysine residue demethylation	2
lysine and arginine residues	2
ligand binding pocket	2
key architectural elements	2
different riboswitch structures	2
K-turns or closely related structures	2
specific protein binding site	2
widespread structure motif	2
different biological scenarios	2
different chromatin modifications	2
readers or writers	2
specific reader proteins	2
histone proteins	2
Myc proteins	2
Targeting capping	2
c-Myc-induced capping	2
enzyme SAHH	2
c-Myc expression	2
Serine-5 of the C-terminal domain	2
RNA pol II	2
capping enzymes	2
capping enzymes, RNGTT and RNMT–RAM	2
first transcribed nucleotide	2
5′ to 5′ triphosphate bridge	2
first transcribed nucleotide of RNA pol II transcripts	2
cap structure	2
co-factors including histone acetyltransferases and RNA pol II kinases	2
promoter region of genes	2
human tumour types	2
growth factor-independent c-Myc expression	2
mainly protamine-based structure	2
histone-based chromatin	2
sole inducer	2
X-rays	2
protamine-based chromatin	2
transient DNA strand breaks	2
chromatin-remodeling complexes	2
protamine-based structure	2
nucleosomal, histone-based structure	2
Haploid spermatids	2
next generation	2
new unique diploid genome	2
maternal genome	2
haploid paternal genome	2
E. coli degradosome	2
intricate post-transcriptional networks	2
representative degradosome of Escherichia coli	2
divergent bacterial lineages	2
assemblies of key RNA enzymes	2
bacterial kingdom	2
Bacterial transcripts	2
defined 3′ end of the transcribed RNA	2
cytoplasmic polyadenylation	2
PARN, CCR4/NOT, maskin, pumilio, Xp54 (Ddx6, Rck), other P-body components and isoforms of the cap binding initiation factor eIF4E.Finally	2
MAPK, Aurora A, CamKII, cdk1/Ringo and cdk1/cyclin	2
potential roles of kinases	2
CPE-mediated polyadenylation	2
subunits of cleavage and polyadenylation specificity factor (CPSF), symplekin,	2
cytoplasmic polyadenylation machinery	2
CPE binding protein (CPEB) in Xenopus oocytes	2
3′ untranslated region of mRNAs	2
cytoplasmic polyadenylation elements (CPEs)	2
many animal species	2
specific mRNAs in the cytoplasm	2
different types of fish strain	2
GHT and selectively bred strains	2
fish strains	2
growth hormone transgenic (GHT) and selectively-bred salmon strains	2
first proteomic insights	2
anthropogenic animal strains	2
Poly I:	2
many metabolic and cellular pathways	2
growth-selected fish	2
systems driving protein synthesis	2
growth-enhanced strain	2
PBS (control) or Poly I:C	2
GHT and growth-selected strains	2
rapidly-growing fish strains	2
growth systems	2
coho salmon (Oncorhynchus kisutch)	2
skeletal muscle proteomics	2
growth hormone (GH) transgenesis (GHT)	2
control individuals	2
patients with nephronophthisis	2
nephronophthisis-related ciliopathy patients	2
upregulated proteins	2
discriminating proteins	2
gel fractionated extracellular vesicle proteins	2
age- and gender-matched controls	2
Extracellular vesicles	2
non-invasive protein biomarkers	2
general model	2
rice and Arabidposis thaliana	2
key monocot and dicot species	2
Arabidopsis proteins	2
several pairs of motifs	2
motifs pSXpS	2
shared motif-containing proteins	2
nineteen pS motifs	2
2307 phosphopeptides	2
3189 phosphoproteins	2
6537 phosphopeptides	2
evolutionary divergent plants	2
monocot Oryza sativa	2
largest subclasses in flowering plants the dicot Arabidopsis thaliana	2
two model species	2
pre-existing phosphoproteomics data	2
soluble matrisome-associated components	2
complex network of extracellular matrix (ECM) and ECM-associated proteins	2
unfractionated and non-enriched tissues	2
cathepsins and proteins of the S100 family	2
core matrisomal proteins	2
DDA MS	2
unfractionated murine lung	2
spectral library	2
non-enriched and ECM enriched tissue	2
extracellular matrix (ECM) and ECM-associated proteins	2
redox sensitive Cysteine residues	2
muscle types	2
adult and old mice	2
two metabolically distinct skeletal muscles, quadriceps and soleus	2
reduced and reversibly oxidised Cysteine residues	2
Contracting skeletal muscle	2
oxidative slow twitch fibres	2
fast twitch glycolytic fibres	2
metabolically distinct tissues	2
metabolic and cytoskeletal proteins	2
reduced and reversibly oxidised Cys residues	2
individual redox sensitive Cys residues	2
global proteome	2
higher proportion of mitochondria	2
soleus	2
quadriceps a predominantly glycolytic muscle	2
two metabolically distinct murine skeletal muscles	2
redox proteome	2
functionally important locations	2
Conserved Cys residues	2
reactive thiol groups on Cysteine (Cys) residues	2
important signalling molecules	2
different muscle types	2
mutation-containing epitopes	2
breast cancer and leukemia	2
shared immunogenic peptides	2
established cell lines	2
immunogenic epitopes	2
initial HLA-I-typed antigen collection	2
multi-peptide anticancer vaccines	2
cancer peptides	2
four or two different cell lines	2
aberrantly translated genes	2
mutation-containing peptides	2
tested breast cancer cells	2
breast cancer cell line	2
different breast cancer cell lines	2
one cell line	2
1921 proteins	2
3196 MHC class I ligands	2
immunoprecipitation	2
catalog of peptides	2
mechanisms of the most commonly used adjuvant	2
HLA Class-I and Class-II antigen presenting pathways	2
Several novel immunological relevant cellular pathways	2
alum adjuvants	2
used adjuvants	2
SignificanceAluminum salts	2
immunological pathways	2
HLA class I antigen processing and presentation pathway	2
DAMP sensing pathways like TLR or NOD1 activation	2
two novel pathways	2
aluminum hydroxide Al(OH)3	2
aluminum adjuvants	2
Aluminum-based adjuvants	2
ubiquitinome	2
single sample	2
modified peptide identifications	2
cell lysates and brain tissue	2
SignificanceA K-ε-diglycine (diGly) mark	2
mouse brain tissue	2
vivo samples	2
endogenous, unstimulated ubiquitinome	2
SILAC labeled cell lines	2
non-labeled and	2
23,000 diGly peptides	2
antibody beads	2
filter plug	2
Orbitrap HCD cell	2
three fractions	2
identified ubiquitylation sites	2
K-ε-diglycine (diGly) remnant	2
culprit protein	2
patients with various types of amyloidosis	2
number of cardiac and fat tissue biopsies	2
deposits	2
ATTR) amyloidosis	2
AL and transthyretin (	2
abundant plasma proteins	2
immunoglobulins and transthyretin	2
one potentially amyloidogenic protein	2
fibril precursors	2
fibril proteins	2
amyloid proteins	2
non-AL amyloidosis	2
monoclonal immunoglobulin light chain amyloidosis (AL)	2
tissue deposits	2
specific amyloid fibril protein	2
fibrils and amyloids	2
medically important protein assembly states	2
heterogeneous mixtures and assemblies	2
stoichiometries, interactions	2
gluten intolerant individuals	2
distribution of sequences	2
manually verified sequences	2
first manually curated open-source wheat gluten protein sequence database (GluPro V1.0)	2
curated sequence database	2
complete reviewed Viridiplantae database	2
GluPro V1.0 database	2
discovery proteomics dataset	2
gluten protein sub-types	2
α-gliadin proteins	2
coeliac toxic motifs	2
coeliac toxicity	2
different types of gliadin and glutenin components	2
discrete unique full length protein sequences	2
gluten proteins	2
manually a curated database (GluPro V1.0)	2
comprehensive and well annotated sequence databases	2
gluten-free diet	2
diverse range of food products	2
biomolecule survival	2
bone hydroxyapatite crystals	2
bone or dentine	2
selected non-collagenous proteins	2
multiple European archaeological sites	2
archaeological bovine bone and dentine samples	2
skeletal remains at archaeological sites	2
informative biomolecule	2
Ancient DNA (aDNA)	2
potential new targets	2
sand flies and mammals	2
insect vector and macrophage host cells	2
hexose-containing virulence factors	2
axenic culture	2
mutant Leishmania line	2
sugars, and amino and fatty acids	2
various nutrients	2
gut of a sand fly vector	2
C. jejuni proteins	2
Campylobac er jejuni secretome	2
supernatants from C. jejuni stains M1 and 81–176.Biological significanceThis study	2
CJM1_0791 and CJM1_0395	2
human CACO-2 tissue culture cells	2
LC/MS and SILAC datasets	2
FT3SS	2
putative novel proteins	2
(flgG mutant) strains	2
C. jejuni M1 wild type and flagella-deficient	2
flagellar type III secretion system (FT3SS)	2
non-flagellar proteins	2
bacterial gastroenteritis	2
Campylobacter jejuni	2
laboratory and industrial environments	2
several food products	2
food technology	2
different research areas	2
particular biological system	2
certain food products	2
claims	2
proteasome and actin cytoskeleton	2
mouse lung proteome	2
prototypic modified risk tobacco product (pMRTP)	2
different proteomics technologies	2
systems toxicology assessment frameworks	2
immune-related, surfactant metabolism, proteasome, and actin cytoskeleton protein clusters	2
proteomics data sets	2
cigarette smoke (CS)	2
reverse-phase protein microarrays	2
Selected differentially expressed proteins	2
prototypic MRTP (pMRTP)	2
conventional cigarettes	2
several serious diseases	2
differential diagnostic biomarker	2
sera of 198 lung cancer and non-cancerous lung disease patients	2
several serum proteins	2
lung disease patients	2
optimal meta-markers	2
two patient groups	2
meta-marker	2
two proteins SERPINA4	2
meta-marker model	2
best ‘meta-marker’, or combination of biomarkers	2
lung cancer biomarker candidates	2
clinical serum samples	2
serum-based differential diagnostic biomarkers	2
currently known vacuolar substrates	2
red clover	2
chloroplastic PPO substrate	2
chloroplastically located	2
protected proteins	2
PPO the forage protein	2
active PPO	2
freshly ingested down boli	2
intracellular protein targets	2
chloroplastic enzyme PPO	2
rumen-protected protein	2
lands and water	2
ingested protein-N	2
grazing cattle	2
protein targets of PPO	2
enzyme and substrates	2
preferentially retained proteins	2
mutant than wild-type proteomes	2
wild-type and mutant red clover	2
rumen inoculum	2
wild-type red clover and a low PPO mutant	2
feed down-boli	2
fresh forage feeds	2
PPO mediated protein-quinone binding	2
high protein ruminant feed	2
Red clover (Trifolium pratense L.)	2
less nitrogenous waste	2
rumen-stable protein content of feed	2
particle exposures	2
anti-proliferative proteins LMNA	2
BrdU incorporation	2
Cellular LDH	2
two physicochemically distinct respirable particles titanium dioxide (TiO2) and carbon black (CB)	2
A549 human lung epithelial cell line	2
cytotoxicity assays	2
different gluten containing species	2
set of peptide markers	2
processed food products	2
wheat specific markers	2
gluten containing cereals (wheat, rye, barley and oats) and non-gluten containing flours (corn, soy and rice).A unique set of wheat gluten marker peptides	2
target peptides	2
triple quadrupole mass spectrometer	2
single gluten protein sequence	2
peptide sequences	2
multi-enzymatic digestion (LysC, trypsin and chymotrypsin)	2
set of specific analytical targets	2
TIMP1, APOA1, C6orf58, and BPIFB1 (LPLUNC1)	2
COPD and the asymptomatic smoker group	2
differentially abundant proteins	2
former smoker group	2
mucin/trefoil proteins	2
cell-free sputum supernatant	2
current asymptomatic smokers	2
four study groups	2
age- and gender-matched individuals	2
induced sputum samples	2
chronic-exposure-to-disease model	2
parallel-group clinical study	2
small- or large-scale data sets	2
multiple large datasets	2
originating protein	2
original mixture	2
Identified peptides	2
protein sequence database	2
observed tandem mass spectra	2
amino acid sequences of peptides	2
computer cluster	2
single computer	2
filtered data	2
ProLuCID XCorr	2
peptide hit	2
selected candidate peptides	2
fragment ions of candidate peptides	2
cross-correlation scoring function	2
candidate peptide	2
candidate peptides	2
protein sequence databases	2
tandem mass spectrometry	2
S. aureus antigens	2
bloodstream invasion	2
S. aureus infection	2
dangerous pathogen	2
SignificanceS. aureus	2
conserved S. aureus proteins	2
selected S. aureus proteins	2
patients developing sepsis	2
recombinant S. aureus proteins	2
Luminex-based FLEXMAP 3D™ assays	2
S. aureus extracellular proteins	2
immune memory	2
first chicken beadomes	2
low-affinity and/or low abundance protein-protein interactions	2
Biological significanceSILAC	2
cell biology and immunology communities	2
DT40 cell-line	2
common epitope tags	2
beadomes’ (non-specific proteins binding to beads	2
non-specific DT40 ‘	2
DT40 proteome	2
abundant proteins	2
new potential binding partners	2
chicken pre-B cell-line DT40	2
Fanconi anaemia core complex	2
4-kinase 2β subunit (PI5P4K2β)	2
phosphatidyl inositol 5-phosphate	2
genuine binding partners	2
multiple affinity resins	2
two cell-lines	2
tag-less control cell-line	2
doubly tagged target endogenous protein	2
cell-line stably	2
true interacting partners	2
specifically interacting partners	2
members of protein complexes	2
Pierre Thibault and Anne-Claude Gingras	2
larger, multisite phosphorylation motifs	2
specific consensus sequences	2
identified sites	2
cellular signal transduction pathways	2
constitutively active kinase	2
vivo phosphorylation site	2
least one CK2 hierarchical consensus motif	2
1600 human proteins	2
specific combinations of canonical determinants	2
multiple phosphodeterminant residues	2
priming proline-directed kinase	2
optimal consensus sequences	2
consensus determinants	2
phosphoserine residues	2
transgenic Nrf2(−/−) mouse model	2
known Nrf2-regulated proteins	2
potent Nrf2 inducer	2
dimethyl fumarate	2
CDDO-me (bardoxolone methyl)	2
different disease conditions	2
cytochrome P4502A5 (CYP2A5; 17.2-fold), glutathione-S-transferase-Mu 3 (GSTM3; 6.4-fold), glutathione-S-transferase Mu 1 (GSTM1; 5.9-fold), ectonucleoside-triphosphate diphosphohydrolase (ENTPD5; 4.6-fold), UDP-glucose-6-dehydrogenase (UDPGDH; 4.1-fold) and epoxide hydrolase (EPHX1; 3.0-fold)	2
43 proteins	2
CDDO-me (3mg/kg; i.p.)	2
WT and Nrf2(−/−) mice	2
twenty-one proteins	2
potent inducer, methyl-2-cyano-3,12-dioxooleana-1,9(11)dien-28-oate (CDDO-me; bardoxolone -methyl)	2
Nrf2 null mice (Nrf2(−/−))	2
phosphoproteomic experiments	2
single phosphopeptides	2
turbo-SLoMo	2
phosphopeptide	2
spectral pairs	2
Plasmodium falciparum schizont phosphoproteome	2
phosphorylation site localisation tools	2
modified version of SLoMo (turbo-SLoMo)	2
Mascot Percolator	2
therapeutic targets or biomarkers	2
candidate proteins or pathways	2
brain banks	2
various ethnicities, age-groups or sub-types of VaD using brain samples	2
fellow researchers	2
quantitative proteomics	2
testable hypothesis	2
VaD and matched control subjects	2
VaD cortex	2
differential proteome	2
reference data set	2
reported proteome	2
VaD subjects	2
iron-storage proteins (FTL, FTH1)	2
reduced ATP5A	2
SOD1 and NCAM	2
n=10 per group	2
confidently identified proteins	2
pathologically confirmed cases of VaD and matched non-neurological controls	2
Brodmann area 21	2
pooled lysates	2
iTRAQ-2D-LC–	2
novel, clinically useful diagnostic tools	2
biomarker candidates	2
healthy counterparts	2
plasma of human neuroblastoma patient plasma samples	2
candidate biomarker Complement C3,	2
different plasma proteins	2
human neuroblastoma	2
unique murine model	2
neuroblastoma patients	2
candidate plasma biomarker	2
Complement C3	2
TH-MYCN+/+ mouse model	2
cohort of human neuroblastoma plasma samples	2
plasma of TH-MYCN+/+ mice	2
complement C3 protein	2
candidate plasma biomarkers	2
homozygous mice	2
human MYCN oncogene	2
multiple copies	2
differentially-expressed proteins	2
potential plasma biomarkers	2
neuroblastoma cancer cells	2
creatine kinase, enolase and malate dehydrogenase	2
certain proteins in serum	2
Serum proteins	2
established experimental model	2
serum proteome	2
Atlantic salmon, Salmo salar	2
number of humoral components of immunity	2
Atlantic salmon	2
established cohabitational experimental model	2
atypical alphavirus	2
SAV subtype 3 (SAV3)	2
marine Atlantic salmon, Salmo salar, and rainbow trout, Oncorhynchus mykiss	2
aetological agent	2
Salmonid alphavirus	2
4000 randomly selected MS/MS spectra	2
forward and decoy protein sequence database	2
high-accuracy LTQ-Orbitrap mass spectrometers	2
C-13 peak	2
various M. tuberculosis clades	2
multiple vaccine and diagnostic platforms	2
key antigens	2
various clades of M. tuberculosis	2
three key immunodominant proteins	2
Antigen 85A, B, and C	2
individual isolates	2
Antigen85 B	2
clades and phylogenetic neighbors	2
phylogenetically distinct clades	2
six M. tuberculosis strains	2
protein abundance	2
sole antigen repertoire	2
vaccine constructs	2
mycobacterial secretome	2
Antigen85 A, B, and C,	2
Antigen 85 complex proteins	2
diagnostic and vaccine candidates	2
several hundred proteins	2
multi-analyte systems	2
clinical biochemistry labs	2
measurement system	2
Every experimenter	2
characterising measurement systems	2
proteomics researchers	2
qualitative clinical assays	2
clinical diagnostic laboratories	2
many industries	2
peptide adsorption	2
single-level calibrant	2
fresh samples	2
multiple peptides	2
sample solvent	2
many peptides	2
standard protein digest	2
biobanking blood derived samples	2
three types of blood preparations	2
microarray assays	2
serum and plasma	2
antibody arrays	2
independent material	2
EDTA standard tubes	2
caldesmon 1 (CALD1)	2
Single binder and sandwich assays	2
343 unique proteins	2
373 antibodies	2
384 biotinylated samples	2
16 individuals	2
Serum and EDTA plasma	2
antibody suspension bead arrays	2
various analytical platforms	2
extensive collections of specimen	2
source code	2
Pride-asap binaries	2
PRIDE experiments	2
multiple PRIDE experiments	2
PRIDE database	2
identified spectra	2
open source software application and library	2
ECM proteins	2
lipid-metabolism-related proteins	2
glycolysis-related proteins	2
VCAN mRNA	2
PFKFB2 mRNA	2
lysocardiolipin acyltransferase 1 (LCLAT1), lumican (LUM), and versican (VCAN)	2
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2)	2
infant patients	2
proteome of RV	2
Tetralogy of Fallot (TOF)	2
isotope labelled cross-linkers	2
Biological significanceCross-linking/mass spectrometry (CLMS)	2
basic open source application	2
standard quantitative proteomics software	2
identified cross-links	2
readily available cross-linker BS3-d0/4	2
cross-linked human serum albumin (HSA)	2
Dynamic proteins and multi-protein complexes	2
antibiotics, antifungals and anticancer agents	2
vital source of novel drugs	2
Salinispora and Micromonospora	2
many commercially important species	2
clinically important species	2
Candidate NAPs	2
S. coelicolor	2
“missing” nucleoid proteins	2
nucleoid-associated proteins	2
novel nucleoid-associated proteins (NAPs)	2
S. coelicolor nucleoids	2
valuable set of candidates	2
uncharacterised protein families (SCO5783, SCO5592, SCO3793, SCO6482)	2
SCO1210, SCO5405, SCO4229, SCO3198)	2
recognisable classes of transcription factor (SCO2140, SCO4493, SCO1839,	2
pleiotropic response regulator AfsQ1	2
global transcriptional regulators BldD and CRP	2
known major NAPs HupA, HupS, sIHF and Lsr2	2
model actinomycete Streptomyces coelicolor	2
isolated nucleoids	2
novel NAPs	2
industrially-important species	2
missing proteins	2
Actinobacteria	2
set of NAPs	2
highly abundant transcriptional regulators	2
Nucleoid-associated proteins (NAPs)	2
be-spoke exclusion lists	2
Mass Spectrometry instrumentation	2
given sample	2
contaminating peptides	2
empirically generated lists	2
several model organisms (Homo sapiens, Caenorhabditis elegans, Saccharomyces cerevisiae and Xenopus laevis)	2
empirically generated be-spoke exclusion lists	2
undesired contaminant peptides	2
exclusion lists	2
non-specific protein contamination	2
abundant contaminant proteins	2
reagents (e.g. trypsin)	2
user (e.g. keratin from hair and skin)	2
undesirable contaminants	2
protein sample	2
undesirable peptides	2
community-wide open set	2
proteomics community	2
robust tools	2
ten top tips	2
convenient—if poorly implemented—set of tools	2
JIA patients	2
macrophage activation factor	2
extended oligoarticular patients	2
immunopurified synovial VDBP	2
SF of oligoarticular patients	2
truncated isoform of vitamin D binding protein (VDBP)	2
patient subgroups	2
Cy dyes	2
57 patients	2
SF samples	2
large number of joints	2
synovial fluid (SF) proteome	2
parvalbumin β-isoforms (β1, β2, β3, β4 and β6)	2
β5 isoform	2
β7 parvalbumin isoform	2
signature peptides	2
isoforms of parvalbumin in muscle	2
carp	2
stable isotope-labelled amino acid ([2H7] l-leucine)	2
skeletal muscle of common carp (Cyprinus carpio)	2
multiple isoforms of parvalbumin (β1-7)	2
tissues of fish	2
mouse macrophage cell line J774A.1	2
B. pseudomallei ADS	2
arcA and arcC defective mutants	2
parental type I strain 153 arcA and arcC	2
arginine deiminase system (ADS)	2
parental type I. AD and CK (encoded by arcA and arcC)	2
isogenic types II and III	2
flagellin, arginine deiminase (AD) and carbamate kinase (CK)	2
B. pseudomallei strain 153 type I	2
isogenic colony morphology types II	2
primary clinical cultures	2
several molecules	2
cell metabolism (malate dehydrogenase, pyruvate kinase, and ATPase Na+/K+)	2
enzymes/transporters	2
non-membrane proteins	2
clathrin and Rab-7)	2
pro-Th2 DC	2
One of the most down-regulated molecules	2
CD18 and CD44	2
MHC class II molecules	2
triplicate biological samples	2
immature, pro-Th1 and pro-Th2 DCs	2
plasma membrane-enriched fractions	2
Th lymphocyte subsets	2
CLU precursor	2
MMP-1, MMP-3 and TSP-1	2
CILP-1, CLU, MMP-1, MMP-3 and TSP-1	2
aggrecan core protein, cartilage oligomeric matrix protein (COMP), fibronectin, fibromodulin, thrombospondin-1 (TSP-1), clusterin (CLU), cartilage intermediate layer protein-1 (CILP-1), chondroadherin (CHAD) and matrix metalloproteinases MMP-1 and MMP-3	2
Tryptic peptides	2
Mascot search engine	2
Swiss-Prot database	2
five most abundant peptides	2
Bruker amaZon ion trap instrument	2
culture medium supernatants	2
six days	2
interleukin-1beta (IL-1β, 10ng/ml), with or without carprofen, a non-steroidal anti-inflammatory drug	2
equine metacarpophalangeal joints	2
secretome of articular cartilage	2
main resources	2
ProteomeXchange consortium	2
valuable smaller and/or more specialized repositories	2
available data mining and visualization tools	2
NCBI Peptidome	2
PRoteomics IDEntifications database (PRIDE)	2
Global Proteome Machine Database (GPMDB)	2
main existing resources	2
several mass spectrometry (MS) based proteomics repositories	2
enzyme ATP-citrate lyase	2
fatty acids and other lipids	2
one group comprised proteins	2
two predominant groups of Nrf2-regulated proteins	2
three independent groups of mice	2
robust reproducible list of Nrf2-dependent proteins	2
livers from Nrf2−/− and wild type mice	2
wide range of gene products	2
Nrf2-deficient mice (Nrf2−/−)	2
antioxidant response element (ARE)	2
multiple cellular defence proteins	2
Mascot and ProteinPilot Paragon	2
standard six protein mix	2
nLC-ESI MSMS and nLC-MALDI MSMS analysis routes	2
Y-STRs of the PPY23 set	2
variant types	2
Y phylogeny	2
short flanking segments	2
DYS385a,b, DYS481 and DYS390	2
145 distinct alleles	2
repeat and flanking regions	2
SNPs/indels	2
distinct alleles	2
novel Y-STR variants	2
distinct sequence-based alleles	2
sample set	2
diverse Y chromosomes	2
markers of the PowerPlex® Y23 [PPY23] System	2
PowerSeq™ Auto/Mito/Y System kit	2
Promega’s prototype	2
23 Y-STRs	2
robust framework	2
Short tandem repeats on the male-specific region of the Y chromosome (Y-STRs)	2
NGS data	2
DNA standards	2
Illumina MiSeq® platform	2
selected 16 CpG sites	2
saliva samples	2
disease state individuals	2
independent cohorts	2
proposed model	2
genes NHLRC1, SCGN and CSNK1D.	2
different genomic regions	2
blind test set	2
training set	2
Illumina’s genome-wide methylation platforms	2
1156 whole blood samples	2
age-associated CpG sites	2
accurate model	2
’s lifetime	2
crime scene	2
recovered biological material	2
clothing	2
semen and DNA evidence	2
clothing of victims	2
two semen donors	2
multiple washes and stains	2
school uniform-type clothing	2
items of clothing in the washing machine	2
semen-derived DNA	2
wash	2
donor of the semen on the stained clothing	2
second donor	2
∼1:1 mixture of DNA	2
two donor semen samples	2
multiple washes	2
laundered once	2
semen donors	2
semen-stained sites	2
non-biological or biological detergent	2
Stained and unstained items (socks)	2
wardrobe	2
single donor or a 1:1 mixture from two donors)	2
fresh semen	2
Items of UK school uniform (T-shirts, trousers, tights)	2
stained clothing	2
one or more washes	2
one or more individuals	2
semen deposition	2
laundered items of clothing	2
items	2
source of the C3	2
HGDP panel	2
16 Ecuadorian individuals	2
single nucleotide polymorphisms	2
appropriate demographic model	2
forward-time simulations	2
First Americans	2
Japan 6Kya	2
Ecuadorian populations	2
high-density autosomal SNP genotypes	2
additional migration 6Kya	2
Ecuador and Japan	2
haplogroup	2
nearby Native American populations	2
haplogroup C3	2
South America	2
underlying mathematical model	2
different replicates	2
resampling replicates	2
simulated and laboratory-generated replicates	2
contributor	2
multiple LTDNA replicates	2
queried contributor	2
profiling replicates	2
low-template and/or degraded samples	2
EMP00645 (Romanies) and EMP00646 (Turks)	2
haplogroups M5a1	2
haplogroup H12	2
mitochondrial control region	2
three ethnic groups (Albanians, Turks and Romanies)	2
marker set	2
marker sets	2
available kits	2
PPY23 marker set	2
forensic casework	2
subsets of Y-STR markers	2
null, duplicate and off-ladder alleles	2
PowerPlex Y23 System (PPY23, Promega Corporation, Madison, WI)	2
short-tandem repeat (STR) loci (DYS19, DYS389I, DYS389II, DYS390, DYS391, DYS392, DYS393, DYS385ab, DYS437, DYS438, DYS439, DYS448, DYS456, DYS458, DYS635, GATAH4, DYS481, DYS533, DYS549, DYS570, DYS576, and DYS643)	2
19,630 Y-chromosomes	2
alleged fathers or originators of DNA traces	2
origin of twins	2
twin uncle	2
twin father	2
blood sample of the child of one twin	2
two twins	2
sperm samples	2
Monozygotic (MZ) twins	2
combinations of Y-SNP and Y-STR markers	2
Y-SNPs	2
resequencing ∼9Mb of DNA	2
Y-chromosomal lineages	2
wide range of biotechnology and healthcare applications	2
bacterial physiology	2
iron·g−1 DCW	2
cellular magnetism	2
alternative electron acceptor (sodium nitrate)	2
carbon source (lactic acid)	2
powerful analytical tool	2
Magnetospirillum gryphiswaldense MSR-1 and magnetosomes (nanoscale magnetic organelles with biotechnological applications	2
sex linked gene SlAP3 by TALENs and CRISPR/Cas9	2
S.latifolia protoplasts	2
synthetic cytokinins	2
A. rhizogenes	2
unique combination	2
independent T-DNA insertions	2
T1 generation	2
stable transformants	2
Agrobacterium rhizogenes strains	2
GUS reporter	2
S. latifolia tissues	2
Several agrobacterial strains	2
synthetic derivatives	2
sex-determination systems	2
Silene latifolia	2
biogenic copper nanoparticles	2
copper nanoparticles	2
stable, uniform elemental (zero-valent)	2
energy resources	2
bioproduction of nanoparticles	2
toxic substrates	2
Producing nanoparticles	2
nanoparticle production	2
immobilised enzymatic microfluidic devices	2
immobilised microfluidic device	2
fewer chemicals	2
counterpart	2
TK in the device	2
l-erythrulose	2
TK-catalysed reaction	2
supplied TK	2
immobilise transketolase (TK) in PMMA microfluidic devices	2
glutaraldehyde cross-linker	2
linking NTA	2
PMMA surface	2
His-tag/Ni-NTA interaction	2
PMMA microfluidic devices	2
histidine-tagged enzymes	2
promising platforms	2
Poly(methyl methacrylate) (PMMA) microfluidic devices	2
B. coagulans strains	2
vanillin, ferulic acid, and alkali-lignin samples	2
sugar fractions of glucose, xylose and arabinose	2
unstructured growth model	2
wheat straw hydrolysates	2
growth model	2
unstructured mathematical model	2
Logistic, Gompertz, Baranyi, Richards & Stannard, and Schnute)	2
different mathematical models	2
lignocellulose-related sugars glucose, xylose, and arabinose	2
lignin-containing fermentation media	2
Three Bacillus coagulans strains	2
new jobs	2
Spanish economy	2
R&I and Agriculture, Food and Environment policy managers	2
new ones	2
existing value chains	2
wastes and residues and other non-conventional sources of biomass	2
industrial bioproducts and bioenergy	2
food, agriculture and forestry	2
targeted sectors	2
agri-food, biotech and biomass sectors	2
private sectors	2
agricultural and biotechnological sciences	2
biological resources	2
researchers in the CCBIO	2
biomarker research	2
highly sophisticated research	2
formal bioethical enquiry	2
ethos	2
biomarker community	2
researchers and practitioners in the laboratory	2
Centre for Cancer Biomarkers (CCBIO)	2
working cancer biomarker research centre	2
complex terrain	2
different literatures	2
binders	2
specific and highest affinity antibodies	2
antigen microarrays	2
relevant antibodies	2
one of the scFvs	2
glutamate receptor interacting protein 2 (GRIP2)	2
E3 ubiquitin-protein ligase (CHFR)	2
recurrent and non-recurrent bladder tumours	2
healthy pancreas	2
pancreatic ductal adenocarcinoma	2
clinical tissue samples	2
microarray format	2
134 antigens	2
library of 456 single-chain variable fragment (scFv) binders	2
relevant molecules	2
antibody microarrays	2
informative target molecules	2
suitable antibodies	2
selected antibodies	2
almost every target of interest	2
Recombinant binder libraries	2
classical agglutination assay	2
aligned clusters	2
colloidal particles	2
agglutination assay	2
well dispersed suspension	2
dispersed particles	2
particle aggregates	2
aggregates of 200nm magnetic particles	2
nanoparticle form	2
solvated nickel ions	2
palladium and platinum nanoparticles	2
platinum group metals	2
bulk form of the same metal	2
many industrial and medical applications	2
Metal nanoparticles	2
Desulfovibrio species	2
anaerobic sulfate reducing bacteria	2
Desulfovibrio alaskensis G20	2
component fractions of DDGS	2
bioethanol industry	2
wheat DDGS production	2
protein fraction of wheat DDGS	2
fine and commodity chemicals	2
future substrate	2
current animal feed	2
polymeric sugars, proteins and oils	2
Wheat DDGS	2
wheat-based dried distiller's grain with solubles (DDGS)	2
distilleries and bioethanol plants	2
byproduct streams	2
glycerol, rapeseed meal and municipal solid waste (MSW)	2
Various potential feedstocks	2
lead actors	2
biobased chemicals	2
container	2
cavities	2
main ferritin family proteins	2
metal nanoparticles	2
ferritins	2
protein cage	2
Ferritin family proteins	2
allogeneic regenerative medicine product	2
current pharmaceuticals-based regulatory model	2
appropriate and viable regulatory protocols	2
blood transfusion markets	2
valuable nanoparticles	2
suitable bacterial chassis	2
biological nanoparticle synthesis	2
anti-microbial silver nanoparticles	2
species of the fungus Phoma	2
range of metallic nanoparticles	2
number of organisms	2
nanoparticle-sensing devices	2
sensing mechanisms	2
quantum dots (QDs) and gold nanoparticles	2
nanoparticle tools	2
para-magnetism	2
similar bulk compound	2
points	2
class of material	2
Metallic nanoparticles	2
Finnish study samples	2
Finland or Iceland	2
population isolates	2
low-frequency alleles	2
enriching sets	2
large study samples	2
disease-associated low-frequency alleles	2
GWA-studies	2
interrogated genetic variants	2
large-scale whole-genome and whole-exome sequencing studies	2
common disease-predisposing variants	2
large-scale structural projects	2
70 proteins	2
test case	2
purified human proteins or protein domains	2
diversity of protein domains	2
similar number of protein domains	2
human protein domains	2
SGC	2
high-quality antigens	2
vivo loss-of-function model	2
embryos	2
Xbra, Chd, Gsc, Shh, Sox3 and Sox17	2
regional markers	2
dorsal structures	2
Xenopus tropicalis embryos	2
nuclear receptor-mediated transcription	2
BRCA2 pathway	2
issues	2
science and society	2
DNA and medical information	2
English-speaking publics	2
representative sample	2
Say’ global survey	2
‘Your DNA	2
scientists and clinicians worldwide	2
large genomic datasets	2
genetic technology	2
Oral-Facial-Digital or Smith-Lemli-Opitz syndromes	2
molecularly confirmed TARPS	2
affected males	2
RBM10 transcript	2
maternally inherited RBM10 frameshift variant	2
hands	2
bilateral syndactyly	2
healthy and non-consanguineous parents	2
RNA binding motif protein	2
talipes equinovarus	2
new DBA-linked genes	2
consortium	2
EuroDBA registries	2
patient registries	2
dedicated clinical and biological researchers of DBA	2
ERARE-funded European DBA consortium (EuroDBA)	2
known DBA-linked genes	2
diagnosed patients	2
one of several ribosomal protein (RP) genes	2
face, hands, heart, or urogenital region	2
DBA patients	2
Diamond-Blackfan anemia (DBA)	2
Networking (EURO-CDG, the European Reference Networks (MetabERN))	2
Patient services	2
prevalent CDG	2
CDG family	2
HCP	2
joint venture model	2
necessary infrastructure	2
electronic health record	2
'joint venture' model	2
patients (or parents of patients	2
former patients	2
reinterpreted variants	2
healthcare professionals (HCPs)	2
UCSC Genome Browser)	2
“transcript 4”	2
shorter, alternate KANK1 transcript	2
KANK1 aberrations	2
KANK1 with or without DOCK8	2
single copy number variant	2
large data sources	2
gene transcripts	2
9p region	2
variety of genetic testing platforms	2
chromosome 9p24.3	2
current study	2
existing studies	2
general population of Canada	2
general and Aboriginal populations	2
standard drinks	2
Fetal Alcohol Spectrum Disorders (FASD)	2
mother and developing fetus	2
affected child	2
long arm of chromosome 22	2
40 genes	2
parents of affected children	2
potentially pathogenic CNVs	2
laboratory technology	2
Persian families	2
A, p.Glu172Lys)	2
c.514G>	2
Glu229*)	2
relevant parents	2
index cases	2
AGPAT2 coding region	2
affected and unaffected members of two families	2
O-acyltransferase-2 (AGPAT2)	2
gene encoding 1-acylglycerol-3-phosphate	2
CGL type 1	2
selected patients	2
adults with complicated epilepsy	2
King’s College Hospital patient group	2
two independent groups	2
Separate clinicians ordered array CGH and separate platforms	2
King’s College Hospital	2
National Hospital	2
adult patient group	2
Sonic Hedgehog pathway	2
urinary tract malformations	2
gastro-intestinal atresias (esophageal, duodenal and anal)	2
FOXF1, MTHFSD,	2
FOX gene cluster	2
Cardiac malformations, Tracheo-Esophageal fistula, Renal and Limb malformations)	2
VACTERL association	2
additional malformations	2
tracheo-esophageal fistula	2
Esophageal atresia	2
set of scenarios	2
Numerical simulation	2
patient transfer	2
different hospitals	2
regular wards and intensive care units)	2
hospital environments	2
single infectious individual	2
theoretical hospital network	2
enterobacteria producing the K. pneumoniae Carbapenemase (KPC, an enzyme that inactivates several antimicrobials)	2
carbapenem class of antibiotics	2
hospitals	2
Active surveillance systems	2
Healthcare-associated infections	2
different transmission niches	2
first transmission modelling	2
RSV A	2
RSV B	2
heterologous group	2
homologous RSV group	2
asymptomatic individuals	2
smaller households	2
larger households	2
members of the same household	2
community exposure	2
2009/2010 RSV season	2
47 households	2
493 individuals	2
individual level transmission model	2
5 population	2
IntroductionRespiratory syncytial virus (RSV)	2
infectious disease dynamics and transmission models	2
close interpersonal contact	2
adult carriers	2
older children	2
close contacts	2
pneumococcal carriers	2
close (i.e. relatively intimate) contact	2
household contacts	2
physical (i.e. skin-to-skin)	2
566 individuals	2
S. pneumoniae carriage	2
social contacts	2
two identical coupled populations	2
stochastic simulation	2
couplings	2
heterogeneous-mixing models	2
contact-based models	2
transmission modeling	2
contact network	2
disease transmission models	2
diverse epidemiological research community	2
general summary and distance metric	2
rapidly fit models	2
open access library	2
lymphatic filariasis	2
complex individual-based simulation	2
dispersed and multi-dimensional data	2
new index cases	2
rodent and fleas	2
secondary pneumonic case	2
bubonic case	2
infected rat fleas	2
bubonic and pneumonic plague	2
model assumptions	2
rat flea	2
new bubonic cases	2
statistical and mathematical models	2
plague	2
constructing models	2
accurate measures and models	2
new partnerships	2
individuals in stable partnerships	2
single individuals	2
three nested pair-formation models	2
susceptible-infected-susceptible dynamics	2
generic STI	2
multivariate state-space models	2
juvenile lice	2
adult lice	2
known active farms	2
isolated farms	2
Atlantic salmon production cycles	2
two sets of multivariate autoregressive state-space models	2
Industry-based data sets	2
sea lice on salmon farms	2
salmon producers	2
pest	2
surrounding ecosystem	2
sea lice on farms	2
salmon aquaculture industry	2
marine parasites	2
serological surveys	2
last outbreak case	2
departments of the study area	2
catalytic models	2
administrative subdivisions called departments	2
N = 22,342)	2
bluetongue in French cattle	2
vector-borne pathogen	2
Bluetongue virus	2
vector and asymptomatic components	2
incidence cases	2
two-strain models	2
rural endemic setting	2
susceptible classes	2
observed time series	2
several virus serotypes	2
several mechanistic models	2
serotypes and asymptomatic infections	2
virus serotypes	2
practically identifiable combination	2
mosquito-borne disease	2
commonly used compartmental model	2
particular dataset	2
vector-borne disease models	2
vector-borne disease epidemiology	2
incipient ERAs	2
elevated-risk areas (ERAs)	2
specific Mycobacterium bovis genotypes	2
cattle outbreaks	2
cattle industry	2
Bovine tuberculosis (bTB)	2
STI	2
chlamydia transmitting partnerships	2
heterosexual partners	2
likely age combinations	2
new heterosexual partnerships	2
men in Britain	2
new sex partners	2
surveys	2
compartmental transmission model	2
new heterosexual partners	2
common bacterial STI	2
Chlamydia trachomatis (chlamydia)	2
sexually transmitted infections (STI)	2
Heterosexual partners	2
combinations of controls	2
wild Norway rats	2
rodent population	2
Norway rat	2
slum urban settings	2
human leptospirosis	2
Norway rat (Rattus norvegicus)	2
urban slum environments	2
primary reservoir of pathogenic leptospires	2
urine	2
set of surviving models	2
infectious birds	2
two commercial broiler farms	2
suite of MDV models	2
pathogen of chickens	2
Marek's disease virus (MDV)	2
pedagogical tool	2
outbreak data	2
training options	2
historical outbreak	2
(H1N1) 2009 viruses	2
pandemic influenza	2
parsimonious mathematical model	2
F. necrophorum load	2
D. nodosus load	2
F. necrophorum model	2
individual feet	2
D. nodosus model	2
past and future D. nodosus and F. necrophorum load	2
continuous-time Markov model	2
bacteria/swab	2
healthy, interdigital dermatitis (ID), or severe footrot (SFR)	2
feet	2
D. nodosus and F. necrophorum	2
longitudinal study of footrot on one UK farm	2
Another anaerobe	2
ovine footrot	2
virulent, invasive, anaerobic bacterium	2
aged-structured heterogeneous population	2
Hong Kong	2
2009 pandemic	2
antibody titre classes	2
influenza epidemics	2
Bartonella species	2
ecologies	2
S. fonquerniei	2
zoonotic Bartonella elizabethae complex in Madagascar	2
outdoor-dwelling, highland-endemic S. fonquerniei	2
Synopsyllus fonquerniei and Xenopsylla cheopsis fleas	2
rodent hosts	2
Nested sequences	2
B. phoceensis 1 and B. rattimassiliensis 1	2
early age class individuals	2
Known zoonotic agents	2
four Bartonella spp.	2
standard epidemiological models	2
ectoparasites	2
R. rattus rodents	2
five distinct species of Bartonella (B. elizabethae 1, B. elizabethae 2, B. phoceensis 1, B. rattimassiliensis 1, and B. tribocorum 1)	2
associated arthropod ectoparasites	2
invasive Rattus rattus hosts	2
potentially zoonotic Bartonella spp.	2
broad range of vertebrate hosts	2
erythrocytic bacteria	2
Bartonella spp.	2
infectious disease modellers	2
challenge	2
estimated transmissibility	2
network of infectious disease modellers	2
recent Ebola epidemic	2
SARS, pandemic influenza	2
one model	2
renewal equation	2
general population and health care workers	2
standard stochastic compartmental model	2
one poultry epidemic	2
H5N1 in Bangladesh	2
zoonotic transmission component	2
outbreaks	2
poultry epidemic	2
infected premises	2
H5N1 outbreaks	2
poultry transmission component	2
set of competing nested models	2
poultry farm spatial and population information	2
separate poultry transmission and zoonotic transmission components	2
confirmed human cases	2
poultry sector	2
Dhaka region of Bangladesh	2
H5N1 epidemics	2
human–animal interface	2
intensifying farming system	2
newly emerging influenza strains	2
Highly pathogenic avian influenza H5N1	2
PROSPERO Registration	2
regular hand hygiene	2
Medline, Embase, PubMed, Cochrane Library, CINAHL and grey literature	2
different years, countries, diseases and administered drugs	2
helminths and non-helminths	2
two very simplified models	2
new modelling framework	2
similar people	2
coverage	2
snail population	2
type of data set	2
schistosome infection	2
instances the models	2
sub-districts	2
transmission models	2
8 endemic districts	2
three transmission models	2
human demography	2
entire population	2
A. lumbricoides and hookworm infection	2
different subsets	2
individual-based stochastic model	2
age structured partial differential equation (PDE) deterministic framework	2
One model	2
hookworm infection	2
African countries	2
high-transmission settings	2
EPIONCHO and ONCHOSIM projections	2
residual latent infections	2
27 communities	2
two West African transmission foci	2
mass (annual or biannual) distribution of ivermectin	2
onchocerciasis transmission models EPIONCHO and ONCHOSIM	2
last collected TF prevalence data point	2
multiple endemic districts	2
range of mathematical and statistical models	2
least well performing model	2
deterministic transmission model	2
best performing model	2
9 districts	2
district-specific transmission coefficient	2
SIS model	2
unique trachoma endemic countries	2
de-identified trachoma endemic districts	2
different statistical and mechanistic models	2
World Health Organization and its partners	2
immunising individuals	2
simple ODE models	2
health programme	2
predictive epidemiological modelling	2
stakeholders	2
multi-model ensemble	2
out-of-sample, or validation, intervention data	2
Single models	2
constructed multi-model ensemble	2
three regions	2
respective models	2
three major LF endemic regions	2
three case study sites	2
first multi-model ensemble of three lymphatic filariasis (LF) models (EPIFIL, LYMFASIM, and TRANSFIL)	2
single model	2
bioterrorism weapon	2
full data set	2
epidemic modelling literature	2
celebrated Abakaliki smallpox data	2
semi-mechanistic model	2
paremeterising such models	2
underlying population	2
outbreak simulations	2
infector	2
transmission-linked cases	2
school age children	2
age-assortative contacts	2
non-school settings	2
cluster of less age-assortative contacts	2
1–2 clusters	2
2–3 clusters	2
9–15 clusters	2
five countries	2
varicella-zoster virus (VZV)	2
transmission model	2
Contact clusters	2
clusters of contacts	2
Transmission models	2
infectious and susceptible individuals	2
disease relevant, data-derived networks	2
dynamically changing networks	2
outbreak-invariant network	2
computationally intensive simulation	2
simple contagion on a known contact network	2
bronchiolitis hospitalisations	2
epidemics	2
complex demodulation	2
northern regions	2
extensive linked dataset	2
temperate and tropical Western Australia	2
annual or biennial winter epidemics	2
large, long-lasting outbreaks	2
Middle East respiratory syndrome	2
female sea lice	2
deterministic models	2
Sea lice (Lepeophtheirus salmonis)	2
cross-sectional design	2
optimal design	2
households	2
different households	2
household models	2
household-stratified epidemic models	2
natural target	2
many infectious diseases	2
highest and lowest-risk ethnic groups	2
highest and lowest-risk subpopulations	2
nationally representative surveys	2
top decile of lifetime sex partners	2
coherent wholes?MethodsWe	2
core-group	2
lifetime sexual partners	2
sexually transmitted infections	2
fast-growing open-source platform	2
information on the internet	2
pre-existing analysis tools	2
line-list data	2
validity of data	2
schema	2
people, software and institutions	2
‘EpiJSON’	2
divergent ways data	2
Cape Town	2
previously treated patients	2
subsequent infections	2
first latent infection	2
latent TB	2
early adulthood	2
HIV-negative patients	2
ResultsThe model	2
Cape Town community	2
Latently infected individuals	2
age-structured simulation model	2
HIV-positive population	2
HIV-negative population	2
(TB)	2
affected farms	2
under-sampled host populations	2
herd breakdowns	2
145 cattle	2
defined sub-population of M. bovis	2
UK cattle industry	2
bovine tuberculosis	2
Mycobacterium bovis	2
purely uphill fitness landscape	2
detailed population dynamics model	2
escape mutations	2
transmitting host	2
living alone	2
public transportation	2
pets at home	2
European Influenza Surveillance Network	2
cohorts of self-reporting volunteers	2
internet-based system	2
epidemiologically different settings	2
outbreak guidelines	2
early warning/identification systems	2
definitions	2
international policy guidelines and research agendas	2
overwhelming health care systems	2
standard host–vector model	2
simple ODE formulation	2
PDE model	2
previous age-structured models	2
original PDE framework	2
biting insects	2
single antigenic type of influenza	2
population-representative serum	2
repeated, periodic collections	2
serological data sets	2
surveillance system	2
idealised household model	2
many relatively small cliques	2
finite stockpile of vaccine	2
limited set of resources	2
multi-host, multi-agent systems	2
primarily single-host, single-agent systems	2
multiple host species and multiple infectious agents (i.e., multi-host, multi-agent systems	2
Many disease systems	2
influenza modelling	2
hospital and community infection	2
first known Ebola outbreak	2
affected regions	2
novel infectious agents	2
ever increasing corpus of sequence data	2
inferential frameworks	2
Basic epidemiological and evolutionary models	2
pathogen phylogenies	2
field of phylodynamics	2
vector-borne disease	2
different host groups	2
vector-borne, macroparasitic	2
neglected tropical diseases	2
multiple hosts	2
environmental stages, vectors, intermediate hosts	2
directly transmitted pathogens	2
livestock disease modelling	2
many livestock diseases and regions of the world	2
human diseases	2
geocoded locations	2
infectious diseases of livestock	2
emerging phase of epidemics	2
endemic models	2
specific diseases	2
systems of weakly-coupled large sub-populations	2
many applied contexts	2
stochastic as well as deterministic models	2
epidemic models	2
populations of pathogens	2
small households or hosts themselves	2
large sub-populations	2
sub-populations (groups, patches,...)	2
network epidemic models	2
general theory	2
simplest network epidemic models	2
five topics	2
new, free and open-source platform	2
real and simulated outbreak datasets	2
classes and methods	2
community of epidemiologists, statisticians, modellers and bioinformaticians	2
R. OutbreakTools	2
unified platform	2
different, complementary approaches and tools	2
complex and diverse data	2
2009 A/H1N1 influenza post-pandemic era	2
unprotected individuals	2
infected hosts	2
larger, less mixed and partially protected populations	2
small and isolated community	2
HR wave on TdC	2
past pandemics	2
92 of 284 islanders	2
remote island of Tristan da Cunha (TdC)	2
dynamical model	2
novel mechanistic model	2
infecting strain	2
Epidemiological models	2
2009 pandemic virus	2
two waves	2
notable waves	2
North-west region	2
time-series	2
pandemic	2
influenza A (H1N1) pdm’09	2
daily lab-confirmed case reports	2
influenza A (H1N1) pdm’09 in India	2
current Compulsory Scrapie Flocks Scheme (CSFS)	2
medium or large flocks strategies	2
small flocks	2
stochastic age- and prion protein (PrP) genotype-structured model	2
blood-based assay	2
recto-anal mucosa-associated lymphatic tissue (RAMALT) biopsies	2
scrapie agent	2
classical scrapie	2
large fraction of farms	2
simulated outputs	2
~25,000–35,000 birds	2
catching-team visits	2
Larger flocks	2
major British catching company	2
poultry house	2
additional environmental class	2
deterministic S-E-I-R model	2
British commercial poultry industry	2
highly pathogenic avian influenza (HPAI)	2
one population	2
limited stockpile of vaccine	2
spatially segregated populations	2
idealised measure	2
airborne viruses	2
ubiquitous distribution	2
social and physical environments	2
Guinea Bissau population	2
intimate contact	2
members of the same family	2
household infectivity	2
living quarters	2
single roof	2
different families	2
many large households	2
3000 houses	2
temperate latitudes	2
population in Guinea Bissau	2
temperate countries	2
Varicella zoster virus (VZV)	2
infected farms	2
parsimonious dynamical model	2
different dynamical models	2
statistical risk factor models	2
“SIS”-type dynamical models	2
main reservoir	2
cattle farms	2
Escherichia coli O157 infection	2
specific fungal cultivars	2
termite hosts	2
fungus-growing termites	2
termite host species	2
termite host genus	2
different carbon sources	2
carbon-source use	2
Termitomyces strains	2
carbohydrate and protein availability	2
varying carbon sources	2
single-factor growth assays	2
nests of three termite species	2
termite farmers	2
specific, optimal cultivar growth substrates	2
specific symbionts	2
genus-specific fungal symbionts	2
Fungus-growing termites	2
regional phyllosphere fungal community	2
host plant populations	2
host genotype	2
members of Dothideomycetes and Eurotiomycetes	2
total of 1575 taxonomic operational units (OTUs) of fungi	2
ITS2 sequences	2
alba leaves	2
Mussaenda pubescens var.	2
phyllosphere fungal community	2
host plant genotype	2
Phyllosphere fungi	2
waxcap fungi	2
coal-spoil soils	2
fungal biomass (ergosterol)	2
typical upland grassland site	2
coal-spoil grassland communities	2
woodlands and Clavariaceae/Hygrophoraceae (‘CHEG’ fungi)	2
Root-associated basidiomycetes	2
woodland and grassland habitats	2
soil fungal populations	2
Metabarcoding (28S rRNA, D1 region)	2
coal-spoil	2
sheep-grazed grasslands	2
Regraded bare coal-spoil	2
eight former colliery sites	2
territory	2
weakest competitor	2
environmentally realistic novel 3-dimensional system	2
three-species community	2
simplistic pair-wise interactions in a 2-D plane	2
laboratory microcosms	2
Wood decay basidiomycete fungi	2
competing individuals	2
adjacent communities	2
multiple soil samples	2
many identical haplotypes	2
629 maize-field soils	2
natural A. flavus populations endemic	2
asexual species	2
European grasslands	2
systemic fungal endophytes of grasses	2
livestock in the third summer	2
invertebrates in the first summer	2
endophyte growth	2
endophyte infected perennial ryegrass	2
host grass Lolium perenne	2
systemic grass endophyte Epichloë festucae var. lolii	2
metabolically active community	2
one forest	2
different forests	2
total community	2
active fungal community	2
specific fungal taxa	2
mature European forests	2
needles of Norway spruce	2
functionally important and metabolically active taxa	2
quiescent taxa	2
Foliar fungal species	2
indigenous rhizosphere fungal communities	2
T. diversifolia residues	2
Total fungal and AMF abundance	2
G. margarita	2
AMF Gigaspora margarita abundance	2
T. diversifolia	2
total fungal abundance	2
‘Foxy-2’ inoculation	2
Tithonia diversifolia residues	2
S. hermonthica presence	2
Fos-BCA ‘Foxy-2’	2
clayey and sandy soil	2
total fungal and arbuscular mycorrhizal fungal (AMF) taxa in rhizospheres of maize	2
strigae (Fos), a soil-borne biocontrol agent (BCA) against Striga hermonthica	2
f.sp.	2
Fusarium oxysporum	2
S. cerevisiae monocultures	2
low-functioning communities	2
keystone species	2
high- and low-functioning wine communities	2
S. cerevisiae and its competitors	2
functional impacts	2
species-poor communities	2
antagonistic species	2
extremely species-rich communities	2
fermenting wine	2
later colonising cord-forming species	2
beech (Fagus sylvatica) wood	2
wood decay fungi	2
natural substrata	2
microclimatic environment	2
community development	2
wood decay communities	2
predecessor	2
predecessor mycelium	2
one competitor	2
mycelia cords	2
opponent's territory	2
dominant competitor	2
CO2 production	2
wood decay ascomycetes and basidiomycetes	2
volatile and diffusible chemicals	2
wood territory	2
dead wood	2
Fungal species	2
regional and global models	2
N fractionation model	2
Hobbie and Hobbie (2006)	2
fine roots	2
Total NPP	2
root NPP	2
hyphal	2
automated minirhizotron	2
fungal hyphae	2
California mixed-forest ectomycorrhizal fungal (EMF) ecosystem	2
situ soil observatory	2
Mycorrhizal fungi	2
large global pool of carbon	2
two new species, Penicillium floreyi and Penicillium chainii	2
four ‘Chrysogenum complex’ fungi	2
Penicillium rubens	2
‘Fleming species’	2
multiple type isolates	2
Underground lines	2
London Underground rail transport system	2
Penicillium isolates	2
species-specific diagnostic PCR	2
four cryptic species	2
P. chrysogenum	2
every sampled region of the Earth	2
ubiquitous airborne fungus	2
Penicillium chrysogenum	2
individual EM fungi	2
fungal productivity	2
intra- and interspecific richness	2
intra- and interspecific diversity	2
Ectomycorrhizal (EM) fungal communities	2
biomass of individuals within communities	2
model experimental systems	2
gradient of 1–8 species of EM fungi	2
ectomycorrhizal (EM) fungi	2
belowground microbial communities	2
range of ecosystems	2
aboveground organisms	2
early marine environment	2
spring post-smolts	2
feeding areas	2
summer and fall in the ocean	2
brain, gill, and muscle	2
parr	2
four tissues (brain, gill, muscle, and liver)	2
gene expression (cGRASP 44K microarray)	2
juvenile Coho salmon (Oncorhynchus kisutch) physiology	2
ageing mouse models	2
evolutionarily conserved mechanisms or pathways	2
uniform genetic backgrounds	2
mouse ageing models	2
research proposals	2
new research models and tools, infrastructure	2
NHPs	2
products and devices	2
NHP models	2
measles virus	2
live-attenuated measles virus vaccines	2
measles virus isolates	2
measles patients	2
filtered secretions	2
genetically engineered mouse models (GEMs)	2
clustered regulated interspaced short palindromic repeats (CRISPR)/CRISPR-associated endonuclease 9 (Cas9) system	2
state-of-the-art patient-derived xenografts	2
simple two-dimensional cell cultures	2
various preclinical tumor models	2
therapeutic hypothesis	2
high quality drug candidates	2
drug’s pharmacodynamics	2
right patient population	2
Pharmacological Audit Trail (PhAT)	2
suitable model species	2
Zebrafish larvae	2
higher vertebrates	2
suitable vertebrate model organism	2
company pipelines	2
NC3Rs-industry data sharing projects	2
non-rodent species	2
small molecule compounds	2
large molecule biotherapeutics	2
NHP	2
potential new medicines	2
Non-human primates (NHPs)	2
numerous types of gene set collections	2
p53 signaling pathway (hsa04115)	2
multiple myeloma	2
drug panobinostat	2
real datasets	2
simulated datasets	2
relevant pathways	2
widely used individual methods	2
prominent GSE tools	2
sorting pathways	2
GSE tools	2
Multiple GSE tools	2
large-scale transcriptome datasets	2
Npl4 and Ufd1 in vivo	2
Npl4 RNAi-associated adult-onset neurodegenerative phenotypes	2
TAR DNA-binding protein-43 homolog (TBPH)	2
Npl4 RNAi flies	2
developing motor neurons	2
Ufd1 in Drosophila melanogaster	2
Ufd1 in vivo	2
Paget's disease of the bone and frontotemporal dementia (IBMPFD)	2
VCP-Ufd1-Npl4 complex	2
HPS patients	2
HPS mouse models	2
HPS mice or patients	2
defective endothelium	2
HPS6 deficient WPBs	2
VWF tubulation	2
(BLOC-1 subunit) deficient mice	2
HPS1 (BLOC-3 subunit), HPS6 (BLOC-2 subunit), and HPS9	2
VWF into plasma after desmopressin (DDAVP) stimulation	2
WPBs	2
highly-multimerized form	2
Von Willebrand factor (VWF)	2
-2, -3, AP-3 (adaptor protein complex-3) and HOPS (homotypic fusion and protein sorting complex)	2
BLOC (biogenesis of lysosome-related organelles complex)	2
HPS protein associated complexes	2
lysosome-related organelles (LROs)	2
platelet granules and endothelial Weibel-Palade bodies (WPBs)	2
additional filament-forming proteins	2
two CTP synthases (Ura7p and Ura8p) and two asparagine synthetases (Asn1p and Asn2p)	2
glutamine-utilising enzymes	2
translational initiation machinery and glucose and nitrogen metabolic pathways	2
filament-forming proteins	2
filaments in vivo	2
4159 strains	2
novel filament-forming proteins	2
open reading frame-GFP collection	2
filament-forming metabolic enzymes	2
optic lobes	2
CTPsyn RNAi	2
CTPsyn mutants	2
Optic lobes	2
neuroepithelial stem cells in Drosophila optic lobes	2
cytoophidia in bacteria, yeast, fruit flies and humans	2
filamentous subcellular structures	2
nucleotide CTP	2
CTP synthase (CTPsyn)	2
population of guide RNAs	2
three or more independent single guide RNAs (sgRNAs)	2
13,501 genes	2
genome-wide CRISPR library	2
many human disease-causing genes	2
highly conserved gene networks	2
genes in this organism	2
Drosophila cells	2
feed, food, and fuel	2
major world crop species	2
model genetic system	2
network of elements	2
conditional regulatory elements	2
maize G4 motifs	2
hypoxia (group VII ERFs)	2
key regulatory genes	2
G4 motifs	2
sequence-specific and potassium-dependent G4 DNA structures	2
Several genic G4 motifs	2
5′ end of the first intron	2
antisense strand	2
two locations	2
G4 motif hotspots	2
non-repetitive genomic regions	2
maize (Zea mays L., B73 AGPv2)	2
149,988 non-telomeric G4 motifs	2
large-genome model plant species	2
telomere repeat DNA and other non-telomeric genomic loci	2
Sequence motifs	2
highly versatile genetic structures	2
duplex B-form DNA	2
single-stranded DNA molecules	2
quadruple helix	2
guanine base quartets	2
class of nucleic acid structures	2
G-quadruplex (G4) elements	2
Drosophila in small metabolic chambers	2
smallest animals	2
social context	2
individuals in metabolic chambers	2
Energy expenditure	2
particular genotypes	2
yeast, mice and monkeys	2
range of organisms	2
DR's ability	2
large pools	2
desired sequences	2
DNA binding factors	2
large metagenomic libraries	2
novel enzymes	2
novel gene sequences	2
target gene families	2
uncultured microorganisms	2
10× Genomics dataset	2
several candidate marker genes	2
2D visualization	2
rare cell populations	2
deep multi-layer generative model	2
deep variational autoencoder for scRNA-seq data (VASC)	2
traditional bulk RNA-seq data	2
original scRNA-Seq data	2
cell sub-populations and lineages	2
Single-cell RNA sequencing (scRNA-seq)	2
different genome assemblies, strains, and species	2
rapid annotation transfer tool (RATT)	2
reference and query genomes	2
coordinate conversion file	2
GATK and SAMtools/BCFtools	2
cross-cultivar or cross-version genomic alignments	2
four DNA-seq datasets	2
Freebayes and SAMtools	2
flexible toolkit	2
reference-based genome assembly and annotation tool (RGAAT)	2
compatible public dataset	2
version-dependent annotation files	2
updated genome assemblies	2
new genome sequences	2
genome resequencing projects	2
different cell types/tissues	2
one cell type/tissue	2
combinations of motifs	2
cell type/tissue-specific TrEns	2
different short motifs	2
human primary cells and tissues	2
FANTOM5 consortium	2
known TrEns	2
enhancers’ DNA code	2
transcribed enhancers (TrEns)	2
standardized processed data	2
large collection of human and mouse datasets	2
processed data library	2
Python library	2
two main modules	2
topologically-associated domains (TADs)	2
Genome Interaction Tools and Resources (GITAR)	2
interacting topological domains	2
chromatin segments	2
hybrid rice and other crops	2
“first-generation” and “second-generation” hybrid rice systems	2
male sterile line and hybrid rice	2
stable recessive nuclear male sterile lines	2
“third-generation” hybrid rice breeding system	2
photoperiod- and thermo-sensitive genic male-sterile lines (second-generation)	2
“two-line” hybrid rice system	2
“three-line” hybrid rice system	2
major cereal crop	2
RNF126 negatively	2
TP53-binding protein 1 (53BP1), and receptor-associated protein 80 (RAP80)	2
total ubiquitin FK2	2
H2A histone family member X (H2AX)	2
catalytically-inactive mutant RNF126 (CC229/232AA)	2
wild type RNF126	2
another E3 ligase, RNF168	2
UV laser micro-irradiation-induced stripes	2
E3 ligase ring finger protein 126 (RNF126)	2
Ubiquitin and ubiquitin-like modifications	2
center of the circle plot	2
colored segments	2
length-fixed bars	2
rounded and nice-looking graph	2
rectangular graph	2
genotyping and sequencing technologies	2
PTM sites	2
similar tools	2
independent dataset	2
nitration and nitrosylation sites	2
Protein nitration	2
community of plant sciences	2
curated data	2
various pathogens	2
user-friendly database	2
three major crops (maize, rice, and wheat)	2
model plant Arabidopsis	2
public pathogenesis-related gene expression samples	2
High-throughput transcriptomics technologies	2
PTMD database	2
associated PTMs	2
disease–gene network	2
six classes	2
known PDAs	2
PTM associations	2
neurologic diseases	2
23 types of PTMs	2
749 proteins	2
1950 known PDAs	2
well-curated database	2
integral resource of PTM–disease associations (PDAs)	2
highly frequent HLA alleles	2
3,707,562/1,146,961 potential neoantigens	2
NetMHCpan v2.8/v4.0	2
mutant/wild-type peptides	2
human leukocyte antigen (HLA) allele information	2
somatic mutation data	2
comprehensive tumor-specific neoantigen database (TSNAdb v1.0)	2
Tumor-specific neoantigens	2
single-cell DNA methylomes	2
Three genes	2
samples in humans, mice, Arabidopsis, and rice	2
bulk BS-seq data	2
computational pipeline	2
single-cell bisulfite sequencing (BS-seq) data	2
group of cells	2
important epigenetic mark	2
disease samples	2
various cell types/tissues	2
six different species	2
RNA-seq datasets	2
tissue- and species-specific manners	2
exon(s)	2
serum diagnostic panel	2
potential serum biomarkers	2
osteopontin (OPN), myeloperoxidase (MPO), runt-related transcription factor 2 (RUNX2), and growth differentiation factor 2 or bone morphogenetic protein 9 (BMP-9)	2
insulin-like growth factor I (IGF1)	2
HO− samples	2
HO+ and HO− groups	2
blood serum proteins	2
Subsequent quantitative ELISA	2
resulting HO	2
subjects with (HO+) and without (HO−) heterotopic ossification	2
relative and absolute quantitation (iTRAQ) and high-throughput antibody arrays	2
isobaric tags	2
potential and novel biomarkers	2
validated biomarkers	2
bone in soft tissue	2
tumor patient’s cfDNA	2
66 patients	2
cfDNA of Chinese NSCLC patients	2
tumor and healthy individuals	2
valuable biomarkers	2
circulating cell-free DNA (cfDNA)	2
early diagnostic tools	2
Non-small-cell lung cancer (NSCLC)	2
blood of COPD patients	2
selected miRNAs	2
MAPK pathway	2
different cancer-related pathways	2
miR-320 family	2
nine miRNAs	2
patients developing cancer	2
534 individuals	2
2741 participants of COSYCONET	2
patient and biomaterial base	2
COPD-centered German COPD and SYstemic consequences-COmorbidities NETwork (COSYCONET) study	2
patients diagnosed	2
core signaling networks	2
high-throughput RNA interference (RNAi) screening technologies	2
triple-negative breast cancer (TNBC) subtyping	2
rich RNA resources	2
genomic codes	2
mRNAs and non-coding RNAs (ncRNAs)	2
driver mutations and risk loci	2
gene expression regulatory machineries	2
microRNA targets	2
high-linked signaling adaptors	2
important epitranscriptomic marker	2
sRNA species	2
different mouse cell types	2
rsRNAs	2
sRNA datasets	2
end users’ input	2
additional species	2
bacteria, yeast, plant, and animal kingdoms	2
wide range of 68 species	2
potential RNA modification sites	2
canonical sRNAs	2
sRNA-seq data	2
rRNA- and tRNA-derived sRNAs (SPORTS1.0)	2
existing software and pipelines	2
new categories of sRNAs	2
tRNA-derived sRNAs (tsRNAs) and rRNA-derived sRNAs (rsRNAs)	2
small nucleolar RNA (snoRNAs)	2
piwi-interacting RNAs (piRNAs)	2
previously well-characterized sRNAs	2
sRNA categories	2
mature miRNAs	2
XPO5′s nucleo-to-cytoplasmic transport ability	2
prolyl isomerase Pin1	2
ERK kinase	2
exportin-5 (XPO5)	2
precursor miRNAs (pre-miRNAs)	2
Drosha and Dicer	2
miRNA genes	2
conserved small non-coding RNAs	2
functional proteins	2
YT521-B homology (YTH) family proteins	2
“writer” (adenosine methyltransferase), “eraser” (m6A demethylating enzyme), and “reader” (m6A-binding protein)	2
three classes of proteins	2
mRNA and non-coding RNA (ncRNA)	2
realm	2
reader proteins	2
YTH domain-containing proteins	2
different complexes	2
YT521-B homology (YTH) domain-containing proteins	2
methyltransferase complex	2
mRNAs, tRNAs, rRNAs, and long non-coding RNAs (lncRNAs)	2
variety of eukaryotic RNAs	2
internal RNA modification	2
sophisticated codes	2
different types of RNA molecules	2
protein microarrays	2
“CRC genes	2
known and new reactive antigens	2
SEREX antigen database	2
CRC and control samples	2
differential pathways	2
APC, AXIN1, E2F4, MSH2, PMS2, and TP53	2
Ribosomal proteins (e.g., RPL7, RPL22, and RPL27A) and CRC-related genes	2
EIF2 and mTOR signaling	2
unique DIRAGs	2
15,417 human cDNA expression clones	2
32 colorectal cancer (CRC) patients	2
enriched networks	2
differentially-reactive antigens (DIRAGs)	2
colon cancer immunome	2
synthetic genome field	2
partially-completed synthetic yeast genome project	2
artificial genome	2
Advanced genomic writing technologies	2
synthetic genome	2
customized cell	2
customized cells or organisms	2
real image	2
previously identified proteins	2
real 2-DGE image	2
two-dimensional Gaussian distribution	2
Synthetic proteins	2
background noise	2
fuzzy spots	2
vertical and horizontal streaking	2
highly reproducible system	2
specialized software programs	2
Traditional Chinese Medicine	2
diet, prebiotics, probiotics, synbiotics, antibiotics	2
gastrointestinal (GI) tract (including esophageal, gastric, colorectal, liver, and pancreatic cancers)	2
Human gut microbiota	2
deep learning applications	2
deep learning architectures	2
two main components	2
biomedical field	2
medical images, electroencephalography, genomic and protein sequences	2
biological and physiological data	2
biological and medical technologies	2
Circulating MVs	2
red blood cells, leukocytes, platelets, or other organs and tissues	2
extracellular vehicles	2
plasma membrane of almost all eukaryotic cells	2
small vesicles	2
Microvesicles (MVs	2
COX-2 ablated cells	2
COX-2-ablated cells	2
MIF-COX-p53 axis	2
glioblastomas, ependymoma, and colon adenomas	2
oncogenes and related transcripts	2
various regulators, antagonists, and co-modulators of p53	2
COX-2−/− fibroblasts	2
COX-2−/− cells	2
FK506 binding proteins	2
fibroblast growth	2
preformed intracellular stores	2
COX2−/− fibroblasts	2
COX-2−/− but not wild-type (WT) or COX-1−/− mice	2
macrophage migration inhibitory factor (MIF)	2
isozymes	2
COX-1 or COX-2 knockout lung fibroblasts	2
two closelyassociated cyclooxygenase isozymes, COX-1 and COX-2	2
essential topological axes	2
paclitaxel and doxorubicin networks	2
non-tumor cells	2
client proteins of interphase microtubules	2
apoptosis signaling pathways	2
possible secondary targets	2
MTA interactome nodes	2
randomized network	2
merged network	2
non-cancerous human cell	2
MTA targets	2
MTAs on normal cells	2
commonly-used anti-cancer drugs	2
microtubule-targeting agents (MTAs)	2
several cancer and RNA expression profile datasets	2
given dataset	2
cancer, miRNA, and mRNA expression datasets	2
solution framework	2
different categories	2
normal and tumor tissues	2
MicroRNA (miRNA)	2
source code and selected datasets	2
almost all the significant genes and pathways of the original dataset	2
ConsensusPathDB	2
rectal and lung cancers	2
complete datasets	2
5% genes	2
significant genes and pathways	2
Deciphering important genes and pathways	2
correction models	2
WCFM_SVM model	2
established parameter estimation model	2
parameter estimation model	2
linear finite element model	2
tetrahedral finite element parameter estimation model	2
in-house data acquisition platform	2
virtual surgery simulation	2
three genes including CSRP1, MYL9, and GUCA2B.	2
cancer gene expression datasets	2
informative genes	2
redundant genes	2
irrelevant and redundant genes	2
entire set of genes	2
potential orthologs	2
closely-related species	2
Orthology relations	2
significant set of 7SK-responsive P-TEFb target genes	2
TAR in HEK293 cells	2
Epstein-Barr virus-expressed RNA 2 (EBER2) and HIV-1 TAR	2
RNA chimera	2
inhibitor hexamethylene bis-acetamide-inducible protein 1 (HEXIM1)	2
viral transactivator of transcription (Tat), e.g.	2
viral transactivator Tat	2
promoter proximal paused RNA polymerase II	2
inactive positive transcription elongation factor b (P-TEFb)	2
transactivating response element (TAR) structure of the nascent HIV-1 transcript	2
starting regions of ORFs	2
general ribosomes	2
number of genes	2
classical stress-induced regulatory system	2
different RNA structuromes	2
different cell lines and tissues	2
intricate structures	2
characteristics, bioinformatics tools	2
plant miRNA and lncRNA identification	2
key regulatory molecules	2
thousands of non-coding RNAs (ncRNAs)	2
extensive samples	2
alternative polyA (pA) site	2
single gene	2
distinct polyadenylation sites	2
different 3′ ends	2
individual RNA transcripts	2
class of nanoscale oligonucleotide-probes	2
molecular beacons (MBs)	2
single RNA transcripts	2
NamiRNA–enhancer–target gene activation network model	2
nucleus and cytoplasm	2
nuclear activating miRNAs (NamiRNAs)	2
new type of miRNAs	2
3′UTR of target genes	2
class of endogenous non-coding RNAs	2
novel cancer biomarkers	2
microarray and sequencing technologies	2
responsive patients	2
chosen patients	2
indicators or markers	2
tissue or organ of a specific type of cancer	2
Cancer therapy agents	2
CYP2A6 rs138978736	2
rs138978736	2
missense mutations CYP2A6 rs60823196	2
polymorphisms of CYP2A6	2
exons of CYP2A6	2
consecutive gastric cancer patients	2
gene encoding cytochrome P450 2A6 (CYP2A6)	2
Chinese patients	2
Gastric carcinoma	2
GCGR and GLP-1R paralogs	2
type-I amino acids	2
binding sites of antagonist MK-0893	2
type-II amino acids	2
clinically validated drug targets	2
Paralogous protein receptors in glucagon-like subfamily, glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R)	2
known target protein receptor family G-protein coupled receptors (GPCRs)	2
drug-binding pockets	2
unintended proteins	2
targeted drugs	2
target gene of miR-503	2
ESCC tissue	2
several human cancers	2
one of the most aggressive cancers	2
key primate-specific lncRNAs and miRNAs	2
primate or even human-specific ncRNAs	2
primate lineage	2
many primate-specific ncRNAs	2
two important RNA classes	2
ncRNAs (lncRNAs)	2
essentially all life forms	2
parasites and host organisms	2
unparalleled system	2
piRNA repression pathway	2
I-R and P-M systems	2
master repressors	2
P-element-induced wimpy testis (PIWI)-interacting RNAs (piRNAs)	2
good system	2
TE insertions	2
host genomes	2
genomes, transcriptomes, and proteomes of the host organisms	2
enhancer itself	2
eRNAs	2
enhancer RNAs (eRNAs)	2
many enhancer elements	2
cis-regulatory molecules	2
physiological conjugated forms of PCs	2
dietary PCs	2
cancer, and cardiovascular diseases	2
modulated pathways	2
vitro cell experiment	2
PCs from rosemary (Rosmarinus officinalis), olive oil, and resveratrol	2
Dietary phenolic compounds (PCs)	2
RNA modification m6A	2
RNA binding proteins or regulatory RNAs	2
writer complexes (methylase) and eraser (RNA demethylase) proteins	2
field of epitranscriptomics	2
RNA demethylases	2
mRNAs and long noncoding RNAs	2
RNA molecule	2
cellular parasites	2
domain of transcription enhancers	2
group of RNAs	2
Enhancer-derived RNAs (eRNAs)	2
histone modifying complexes	2
enhancer-like non-coding genes	2
modifying protein complexes	2
source and an inhibitory regulator of miRNA	2
microRNA (miRNA) pathways	2
lncRNA biology	2
heterogeneous group of largely uncharacterised transcripts	2
long non-coding RNA (lncRNA)	2
newly-discovered transcriptome	2
different types of protein arrays	2
versatile and robust platform	2
protein array	2
current cancer biomarkers	2
computed tomography and biopsy	2
specific cell-free nucleic acids	2
ctDNAs in cancer patients	2
circulating tumor DNAs (ctDNAs)	2
(SLC19A1) and thymidylate synthetase (TYMS)	2
genes encoding solute carrier family 19 member 1	2
1B1 (SLCO1B1) and dihydrofolate reductase (DHFR)	2
genes encoding solute carrier organic anion transporter family member	2
genes encoding thiopurine methyltransferase (TPMT), nudix hydrolase 15 (NUDT15), and potentially inosine triphosphatase (ITPA)	2
maintenance phase, 6-mercaptopurine (6-MP) and methotrexate (MTX)	2
primary drugs	2
Pediatric acute lymphoblastic leukemia (ALL)	2
general isobaric tags	2
HIV-regulated host proteins	2
Human immunodeficiency virus-1 (HIV-1)	2
PIK3CA-mutated luminal A patients	2
positive regulatory loop (PDGF-D/FLT1/SHC1)	2
luminal A patients	2
luminal A breast cancer patients	2
master regulator (PDGF-D), a second regulator (FLT1) and an output node (SHC1)	2
breast cancer samples	2
luminal-A breast cancer samples	2
one of a few genes	2
pathological type	2
Mutated genes	2
LIR searching tools	2
cross-platform tool	2
identified LIRs	2
Recombinogenic LIRs	2
Long inverted repeat explorer (Lirex)	2
evolutionarily and functionally important structures	2
Long inverted repeats (LIRs)	2
ovarian, breast luminal, lung, endometrial, stomach, head and neck, leukemia, and skin cancers	2
colon, brain, prostate, and kidney cancers	2
common cancer types	2
cancer founding clone	2
blood, serum, and plasma	2
circulating tumor cells (CTCs) and cell-free DNAs (cfDNAs)	2
vitamin-related gene polymorphisms	2
vitamin pharmacogenomics	2
active metabolites	2
transporter genes of drugs	2
Predictive biomarkers	2
rheumatoid arthritis, and multiple sclerosis	2
focal adhesion complex (FAC)	2
Simple ‘bedside’ biomarkers	2
Inflammatory diseases	2
childhood PMF	2
monozygotic twin brothers	2
twin pair samples	2
sample of younger brother	2
adult PMF cases	2
cured younger brother	2
drug-responsive genes	2
younger brother	2
treatment regimen	2
monozygotic twin pair	2
JAK2, MPL, or CALR	2
human bone marrow	2
dysfunctional lysine (de)acetylation machineries	2
lysine acetyltransferase (KAT) and lysine deacetylase (KDAC) complexes	2
astrocytes and oligodendrocytes	2
enzymes and cofactors	2
publicly available data	2
global big data archive	2
existing INSDC members	2
worldwide scientific communities	2
variety of sequencing platforms	2
raw sequence reads	2
International Nucleotide Sequence Database Collaboration (INSDC), GSA adopts four data objects (BioProject, BioSample, Experiment, and Run)	2
data repository	2
Genome Sequence Archive (GSA; http://bigd.big.ac.cn/gsa or http://gsa.big.ac.cn)	2
huge sequence data	2
to-use platform	2
valuable sequence resource	2
Banksia genus	2
1927 potential simple sequence repeat (SSR) markers	2
dry-Mediterranean type shrublands	2
similar GO annotations	2
B. hookeriana, N. nucifera, and	2
N. nucifera	2
Nelumbo nucifera	2
Swiss-Prot, Clusters of Orthologous Groups (COG), and NCBI non-redundant (NR) protein databases	2
39,686 unigenes	2
59,063 unigenes	2
four plants of B. hookeriana	2
four leaf samples	2
RNA-seq and de novo assembly	2
Banksia hookerianarepresents a species	2
biodiversity hotspot	2
vegetation of southwestern Australia	2
genomes and proteomes	2
photosynthetic organisms	2
smaller proteins	2
cyanobacterial orthologs	2
plant nucleus	2
endosymbiotic proteins	2
animal proteins	2
Plant genes	2
gene ontology group of ribosome	2
smallest proteins	2
larger exons	2
Multicellular species	2
[∼176 nucleotides (nt)]. Streptophyta	2
Metazoan proteins	2
eukaryotic lineages	2
different phylogenetic lineages	2
shorter proteins	2
longer proteins	2
public database resources	2
integrated web tools	2
normal and malignant hematopoiesis	2
popular omics data resources	2
normal and malignant erythropoiesis	2
large number of datasets	2
genome-wide sequencing technologies	2
group of highly-expanded T cell receptor clones	2
P=3.3E−03 for CD8+ T cells)	2
P=1.7E−07 for CD4	2
P=1.9E−07 for CD8+ T cells	2
highly-expanded T cell clones	2
P=7.6E−06 for CD8+ T cells)	2
P=2.7E−09 for CD4+	2
P=1.4E−04 for	2
six nondiabetic controls	2
four type 2 diabetes (T2D) patients	2
individual T1D patients	2
spectrum of TCRs	2
potential autoreactive T cell receptors (TCRs)	2
autoreactive T cells	2
95 genes	2
genetic epistatic network	2
cardiac muscle contraction pathways	2
glycosaminoglycan biosynthesis	2
6 pathways	2
risk functional modules	2
protein–protein interaction (PPI) knowledge	2
susceptible pathways	2
expanded genetic network	2
CAD and control samples	2
SNP datasets	2
Wellcome Trust Case Control Consortium (WTCCC)	2
SNP omics	2
susceptible pathways and modules	2
human gut microbiome	2
protocol	2
spike-in genomes	2
454 FLX+	2
rRNA gene sequencing	2
fresh as well as stored fecal samples	2
human feces	2
eubacterial: human genomic DNA marker genes=227.9:1)	2
high molecular weight (>23kb) metagenomic DNA	2
host genomic DNA contamination	2
resulting functional networks	2
type 2 diabetes (T2D) patients	2
deep sequencing dataset	2
microbial functional units	2
microbial functional network	2
Non-supervised Orthologous Groups (eggNOG) orthologous groups	2
evolutionary genealogy of genes	2
KEGG orthologous groups	2
complete microbial gene network	2
networks of microbial species	2
health-care professionals	2
key variants of drug metabolizing enzymes and transporters	2
pharmacogenomics of phase-I drug metabolizing enzymes and transporters	2
specific genetic variants	2
numerous drugs	2
drug metabolizing enzymes and transporters	2
patient-specific induced pluripotent cells (iPSCs)	2
even functional assays	2
peripheral biomarkers	2
brain imaging	2
demographic and in-depth information	2
subgroups of AD patients	2
complex and divergent pathways	2
repetitive regions	2
TGS long reads	2
long repeats	2
short reads	2
de novo genome assemblies	2
genomics community	2
long read sequencer MinION	2
real-time applications	2
biological pore	2
DNA bases	2
nanopore technology	2
first commercial sequencer	2
human-sized genomes	2
Pacific Biosciences (PacBio)	2
third-generation sequencing (TGS) technology	2
successful second-generation sequencing (SGS) technology	2
QC steps	2
final library	2
resulting DNA	2
starting DNA	2
cohort of around 600 samples	2
human cardiomyopathies	2
multi-modal cardiac models	2
multi-scale model	2
multi-scale patient-specific cardiac models	2
patient-specific cardiac computer modeling	2
non-invasive and invasive diagnostic tools	2
heart-related pathways	2
predicted pathways	2
non-expressed	2
biomedical publication databases	2
two prediction platforms	2
potentially involved pathways	2
primarily cardiac patients (myocardium, blood cells, and serum)	2
microarray or TaqMan PCR-based platforms	2
patients with different diseases (cardiomyopathies, Alzheimer’s disease, bladder cancer, and ocular cancer)	2
different tissues and body fluids	2
non-detectable miRNAs	2
non-expressed miRNAs	2
tissue, serum, peripheral blood mononuclear cells or other body fluids	2
wide range of tissues and body fluids	2
e.g., fetus	2
two distinct mice microarray platforms	2
mice and human samples	2
human cardiomyocytes	2
diagnostic or prognostic biomarkers	2
⩾200 nucleotides	2
group of non-coding RNAs	2
small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC)	2
diverse etiologies	2
“hostile” environment	2
glial cells (astrocytes, microglia, and oligodendrocytes)	2
malfunctioning DDR	2
DDR machinery	2
certain components	2
complex biological system	2
basic machinery	2
several chromatin remodelers	2
C-terminal-binding protein interacting protein (CtIP)/Sae2, exonuclease 1 (EXO1), Bloom syndrome protein (BLM)/Sgs1, DNA2 nuclease/helicase	2
MRN/X complex	2
ataxia telangiectasia and Rad3-related protein (ATR)	2
3′ ssDNA	2
long 3′ single-stranded DNA (ssDNA) tail	2
homologous recombination (HR) or non-homologous end-joining (NHEJ) pathways	2
number of endogenous and exogenous agents	2
PARylation and ubiquitination	2
DNA repair factors	2
docking platform	2
PAR chains	2
DNA damage sensor	2
poly(ADP-ribose) polymerases (PARPs)	2
Protein poly ADP-ribosylation (PARylation)	2
DNA repair-deficient mouse models	2
orchestrated signaling pathway	2
full hematopoietic lineages	2
primitive cell type	2
Hematopoietic stem cells (HSCs)	2
tissue-specific stem cells	2
nearly all of the eukaryotic organisms	2
UFM1-specific proteases (UfSPs)	2
UFM1 chains	2
UFM1	2
E3	2
UFM1-specific ligase 1 (UFL1)	2
active site of the E2	2
activated UFM1	2
E2	2
UFM1-conjugating enzyme 1 (UFC1)	2
E1	2
UFM1-activating enzyme, ubiquitin-like modifier-activating enzyme 5 (UBA5)	2
newly-identified ubiquitin-like proteins	2
Ubiquitin-fold modifier 1 (UFM1)	2
simulation scenarios	2
prospective cohort of patients	2
elastic net	2
low-dimensional datasets	2
reliable Cox models	2
Cox proportional hazards model	2
Prognostic models	2
fast-growing cancer cells	2
TOP1-induced DNA lesions	2
TOP1 on the DNA	2
TOP1 relaxes supercoiled DNA	2
Mammalian topoisomerase 1 (TOP1)	2
precursors of microRNAs	2
competing endogenous RNAs	2
many lncRNAs	2
another group of transcripts	2
torpid ground squirrels	2
TUG1–HSF2 axis	2
euthermic animals	2
liver, heart, and skeletal muscle tissues of the hibernating thirteen-lined ground squirrels (Ictidomys tridecemlineatus)	2
group of non-coding transcripts	2
Mammalian hibernation	2
whole genome sequences	2
long sequences	2
binary images	2
field of CHD	2
556 patients	2
cardiac tissue collection	2
affected member	2
approximately 4200 participants	2
DNA collection	2
10th Revision (ICD-10)	2
cardiovascular malformations	2
affected families	2
patients and their parents (trios)	2
specific circRNAs	2
candidate circRNAs	2
host genes	2
Several circRNAs	2
exonuclease-treated sequencing sample	2
575 circRNA species	2
heart tissue	2
adult murine heart	2
comprehensive catalogue of RNase R-resistant circRNA species	2
emerging player	2
circular RNAs (circRNAs)	2
many disease subtypes	2
individual database	2
prominent lncRNA antisense noncoding RNA in the INK4 locus (ANRIL)	2
genomic variants	2
current lncRNA databases	2
variety of public data repositories	2
versatile molecules	2
monophyletic clusters	2
two phyla (Proteobacteria and Firmicutes)	2
11,939 rRNA sequences	2
latest release of LVTree	2
prokaryotic taxonomy	2
16S rRNA sequence phylogeny	2
collapsed branches	2
tree branches	2
ARB-SILVA website	2
viewer	2
All-Species Living Tree (LVTree)	2
interactive viewer	2
various eicosanoids	2
COX-1-/- and COX-2-/- cells	2
IL-1β induced WT cells	2
proinflammatory cells	2
“eicosanoid storm	2
upregulated COX-1 mRNA	2
COX-1	2
PGE2, PGD2, leukotriene B4 (LTB4), PGF1α, thromboxane B2 (TXB2), and PGF2α	2
NAD(P)H dehydrogenase quinone 1 (NQO1), aryl hydrocarbon receptor (AhR), peroxiredoxin, phospholipase, prostacyclin synthase, and prostaglandin E synthase	2
glutathione S-transferase (GST), superoxide dismutase (SOD),	2
augmented COX-1 mRNA	2
protein–protein interactome map	2
COX-1-/- or COX-2-/- cells	2
specifically-induced transcripts	2
COX-2-/- or COX-1-/- mice	2
arachidonic acid (AA) to prostaglandins (PGs)	2
inducible COX-2	2
constitutively-expressed cyclooxygenase 1 (COX-1)	2
next-generation sequencing (NGS)-based studies	2
available big-data applications	2
stochastic and heterogeneous single-cell transcriptome signal	2
inter-institutional scRNA-seq datasets	2
biological signals	2
single-cell RNA-seq studies (scRNA-seq)	2
corresponding RNA-binding proteins	2
Many lncRNAs	2
one large class of non-coding RNAs (ncRNAs)	2
broadly-defined hierarchical structures	2
so-called topologically associating domains (TADs)	2
self-associating domains	2
stable, multilevel hierarchical structures	2
interphase chromosomes	2
chromosomal structures	2
multi-threaded version of EDISON-WMW	2
high-throughput omics datasets	2
molecular biomarkers	2
randomly-generated data	2
large sample cohorts	2
two groups of samples	2
non-tumor or normal tissues	2
tumor and non-tumor samples	2
tumor diversity	2
FokI allele T.	2
Hispanics and Asians	2
allele contrast, homozygote, heterozygote, dominant, and recessive models	2
54 articles	2
PubMed, EMBASE, China National Knowledge Infrastructure (CNKI), and China Biology Medical (CBM)	2
Candidate articles	2
different ethnic populations	2
gene encoding the vitamin D receptor (VDR)	2
zebrafish and other model organisms	2
CRISPR/Cas	2
many model systems	2
CRISPR/Cas technology	2
clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas)	2
zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs)	2
urine proteome and metabolome	2
cerebrospinal fluid and blood	2
roadmap of urine biomarker era	2
rRNA genes	2
RNAPI machinery	2
ancient eukaryotes	2
RNAPI in T. brucei	2
core promoters of protein-coding genes	2
strains of T. cruzi and T. brucei	2
eukaryotic rRNA promoters	2
Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major	2
DNA sequence of promoters	2
RNAPI transcription machinery	2
(rRNA) genes	2
RNA polymerase I (RNAPI)-dependent promoters	2
Karolinska Institute	2
Tomas Lindahl	2
larger population	2
risk allele C	2
patients with T2DM	2
combined population	2
Genotypes CT	2
C allele of rs2237892 variant	2
complications	2
TD2M	2
single nucleotide polymorphism (SNP) rs2237892	2
different alleles	2
synthetic metagenome	2
best tools	2
potential and preferential tools	2
data storage	2
annotation pipelines	2
online tools	2
peer-reviewed scientific media	2
well-known tools	2
IMG/M	2
simulated metagenomics data	2
several commonly-used online tools	2
bioinformatics pipelines	2
metagenomic sequences	2
existing bioinformatics tools	2
next-generation sequencing (NGS) platforms	2
CVTree and 16S rRNA analyses	2
newly-sequenced genomes	2
new server	2
monophyletic and non-monophyletic taxa	2
species and strains	2
interactive, collapsible, and expandable tree display	2
cluster of 64 cores	2
server	2
alignment-free and whole-genome-based web server CVTree3	2
sequenced genomes	2
faithful phylogeny	2
metagenomics	2
microbial lipases	2
environmentally-friendly industry	2
microbial enzymes	2
huge diversity of enzymes	2
uncultured microbial world	2
environmental sample	2
environmental DNAs	2
identified prokaryotes	2
fungal community of the gray mangroves of the Red Sea	2
anaerobic producers of cellulosomes	2
e.g., producers of secreted cellulases	2
several commercially-used fungi	2
mangrove-associated	2
specific microbial communities	2
soil sediments	2
dominant phylum	2
Red Sea coast	2
gray mangrove rhizosphere and bulk soil samples	2
Red Sea gray mangroves (Avicennia marina)	2
specific fungal populations	2
microbiology	2
wide microbial diversity	2
terrestrial organic matter	2
tropical coastlines	2
deep-sea brines of the Red Sea	2
unexplored viral communities	2
lower-interface	2
typical marine bacteria	2
upper-interface	2
Kebrit Deep	2
insect-infecting Iridoviridae	2
algae and plants	2
brine–seawater interfaces	2
particle-attached viral communities	2
different brine–seawater interface samples	2
unusual biotopes	2
novel extremophiles	2
thriving populations	2
extreme and unique environments	2
Red Sea	2
deep-sea brines	2
PacBio Sequencing	2
small-size laboratories	2
PacBio long reads	2
accurate short reads	2
full-length transcripts or fragments	2
gene isoforms	2
extended repetitive regions	2
longer reads	2
personal genomes	2
current reference assemblies	2
highly-contiguousde novo assemblies	2
second-generation sequencing (SGS) technologies	2
Pacific BioSciences	2
Single-molecule, real-time sequencing	2
body’s immune system	2
host and host-associated microorganisms	2
main symbiotic ecosystem	2
numerous causal genes	2
autoantigen microarrays	2
multiplexed high-throughput screening platform	2
cerebrospinal fluid, synovial fluid	2
common biologic materials	2
multi-color labeled secondary antibodies	2
Ig subtypes	2
IgG, IgM, IgA, and IgE	2
Different isotypes of autoantibodies	2
special antigenic epitopes	2
molecular modified proteins	2
cell matrix proteins, mucosal/secreted proteins, glomeruli, and other tissue-specific proteins	2
phospholipid proteins	2
cell nuclear components (nucleic acids and associated proteins)	2
wide variety of self-antigens	2
autoantigen arrays	2
solid surface	2
self-antigens	2
autoantibody repertoire	2
broad range of self-antigens	2
STR alleles	2
allele sequences	2
African American samples	2
frequently-observed variants	2
alternative repeat unit patterns	2
intra-repeat SNPs	2
documented sequences	2
STRait Razor v2.0	2
African Americans, Caucasians, and Hispanics)	2
3 major U.S. population groups	2
forensically-relevant Y-chromosome STRs	2
given repeat motif	2
repeat regions of STRs	2
single nucleotide polymorphisms (SNPs	2
individual nucleotide sequences	2
short tandem repeat (STR) alleles	2
(MPS) technology	2
ESCC samples	2
minimal common regions	2
covering CCND1	2
Tumor genomes	2
102 genes	2
non-synonymous somatic mutations (NSSMs)	2
nine ESCC samples	2
55 cases	2
Whole-genome SNP arrays	2
additional samples	2
matched blood samples	2
nine pairs of ESCC	2
key components in transforming growth factor-β (TGF-β)	2
different signaling pathways	2
one epigenetic element	2
genetic and epigenetic elements	2
reliable, sensitive, and specific biomarkers	2
specific and sensitive biomarker candidates	2
saliva and tears	2
noninvasive biomarkers	2
several emerging technologies	2
synthesis diffusion degradation model	2
different powerful and widely-used models	2
maternal segmentation coordinate genebicoidplays	2
torpid and aroused animals	2
phosphorylated PDH	2
pyruvate dehydrogenase kinase (e.g., PDK4)	2
Pyruvate dehydrogenase (PDH)	2
phospho-mammalian target of rapamycin (mTOR)	2
phospho-ribosomal protein S6 (RPS6) in the heart	2
phospho-glycogen synthase kinase 3α (GSK3α)	2
phospho-IR	2
insulin/insulin-like growth factor-1 (IGF-1) signaling	2
white adipose tissue (WAT) of torpid animals	2
phospho-insulin receptor (IR)	2
phospho-insulin receptor substrate (IRS-1)	2
six different tissues of torpid versus aroused gray mouse lemurs	2
insulin signaling pathway	2
primate species	2
Gray mouse lemurs (Microcebus murinus)	2
lemur intestine	2
glutathione (and others)	2
jejunum of the torpid animals	2
several chemokines (MCP-1 and MIP-2)	2
cytokines (IL-12p70 and M-CSF)	2
anti-inflammatory cytokines	2
aroused animals	2
duodenum and jejunum	2
pro-inflammatory cytokines (IL-6 and TNF-α)	2
small intestine (duodenum, jejunum, and ileum) and large intestine of aroused and torpid lemurs	2
gut of these animals	2
gray mouse lemur (Microcebus murinus) of Madagascar	2
rodent hibernation	2
gray mouse lemurs	2
five other tissues	2
thioredoxin 1	2
HSP60 in liver of torpid animals	2
various organs of control (aroused) and torpid gray mouse lemurs, Microcebus murinus	2
mouse lemurs	2
acetyl-histone H3 in the heart of torpid lemurs	2
Ser10-phosphorylated histone H3	2
aroused and torpid animals	2
phosphorylated eIFs	2
Thr172-phosphorylated AMPKα	2
six tissues of torpid and aroused gray mouse lemurs	2
gene transcription (histone H3)	2
energy homeostasis (AMP-activated protein kinase, or AMPK, signaling pathway), mRNA translation (eukaryotic initiation factor 2α or eIF2α, eukaryotic initiation factor 4E or eIF4E, and initiation factor 4E binding protein or 4EBP)	2
selected protein targets	2
primate hypometabolism	2
one of few primate species	2
primate organs	2
crucial roles of MAPKs	2
primary source of lipid fuel	2
white adipose	2
brown adipose	2
ERK1/2, p38, MEK, and JNK	2
Brown adipose tissue	2
MAPK subfamily	2
torpor-responsive genes	2
specific MAPK signal transduction pathways	2
stress-related proteins p53 and heat shock protein 27 (HSP27)	2
extracellular signal-regulated kinases (ERKs), c-jun NH2-terminal kinases (JNKs), MAPK kinase (MEK), and p38	2
six organs of control (aroused) versus torpid gray mouse lemurs, Microcebus murinus	2
mitogen-activated protein kinase (MAPK) family members	2
signal transduction cascades	2
selected species of primates	2
human biomedicine	2
inducible torpor	2
lemur torpor	2
altered expression	2
crucial genes	2
squirrel models	2
ground squirrels	2
peroxisome proliferator activated receptor gamma (ppargc), ferritin (fth1), and protein chaperones	2
liver and brown adipose tissue	2
select genes	2
apoptosis, hypoxia signaling	2
antioxidant defense	2
liver, kidney, skeletal muscle, heart, and brown adipose tissue	2
five tissues	2
control (aroused) versus torpid lemurs	2
squirrel and bat hibernation	2
primate	2
primates	2
Madagascar lemur species	2
variety of mammals	2
diverse classes of transcripts	2
long npcRNAs or ncRNAs (lnpcRNAs or lncRNAs)	2
non-protein-coding RNAs (npcRNAs or ncRNAs)	2
transcriptional units	2
high-throughput sequencing technology	2
MS/MS peptide spectral library	2
enhanced functionality	2
Skyline Panorama repository	2
YPED’s database search results	2
targeted proteomics module	2
overlapping peptides/proteins	2
distinct peptides/proteins	2
several scoring outputs	2
new modules	2
entire proteomics community	2
single laboratory, group of laboratories	2
Yale Protein Expression Database (YPED)	2
significantly-enhanced bioinformatics suite and database	2
web links	2
web resources	2
numerous data resources	2
antineoplastic drugs	2
cardiovascular drugs	2
right drugs	2
healthcare providers	2
pharmacogenomic research	2
candidate sires	2
chosen males	2
wild population of edible dormice	2
multiple paternity	2
investigated litters	2
population of edible dormice	2
polymorphic microsatellite loci	2
COLONY and GERUD software	2
selected females	2
male individuals	2
free-living dam-offspring groups	2
G. glis	2
genetic mating system	2
edible dormouse	2
promiscuous mating system	2
small rodent species	2
multiple sired litters	2
arboreal, nocturnal, hibernating rodent	2
edible dormouse (Glis glis)	2
Bismarck archipelago and Solomon Islands	2
sub-fossil specimens	2
separate species	2
number of evolutionarily distinct taxa	2
Bougainsville Island	2
neighbouring regions	2
mitochondrial DNA)	2
number of possible cryptic species	2
Rattus genus	2
re-represents	2
information processing organ	2
mind/brain	2
basic operation of mind	2
computationally tractable guide	2
biological, cognitive, and social sciences	2
research questions	2
meta-theoretical ontology of biological systems	2
brain and biobehaviour	2
Christian Stephan	2
Martin Eisenacher	2
important parts of the PSI standards	2
basic graphical user interface	2
set of example Java classes	2
read and write files	2
standards	2
recently released application programming interfaces (APIs)	2
proteomics software	2
data model	2
three HUPO-PSI data standards	2
standardised formats	2
nicotinic receptors	2
voltage gated Ca2+v channels	2
isolated type-1 cells	2
nicotinic antagonists vecuronium	2
GABA receptors	2
GABA, muscimol and baclofen) or inhibition (using bicuculline and 5-aminovaleric acid)	2
isolated rat glomus cells	2
afferent carotid sinus nerve	2
chemoreceptor glomus cells of the carotid body	2
humans the intravenous anaesthetic propofol	2
sham-operated group	2
main peripheral chemoreceptors	2
carotid bodies	2
peripheral and central chemoreceptors	2
glottis	2
jet	2
pathological tracheas	2
larynx	2
medical images	2
Realistic airways	2
Computational fluid dynamics simulations	2
compressive goitre (a thyroid gland enlargement)	2
many pathologies	2
human trachea	2
breath-holding test	2
visual analogue scale	2
dyspnoea-related word cues	2
dyspnoea-specific cues	2
isocapnic respiratory loading	2
unloaded breathing	2
Isocapnic hypercapnia	2
dyspnoea stimuli	2
inspired gases	2
stabilized PETCO2 (isocapnia)	2
end-tidal CO2 (PETCO2)	2
sensor's surface	2
non-heparinised flowing animal blood	2
sensor's	2
in-house constructed ultra-rapid sensor	2
computer-controlled test rig	2
toxic fluorophore	2
Commercial optical oxygen sensors	2
peripheral and central nervous components	2
underlying mechanisms	2
motor outputs	2
central respiratory network	2
chemo- and mechanosensory reflexes	2
neuromechanical feedback	2
Diaphragm motor evoked potential	2
established ventilator users	2
intracortical inhibitory or facilitatory circuits	2
non-users of home ventilation	2
long-term users	2
paired stimulation	2
SLN paraganglia	2
cytoplasm to nucleus in cultured HELA cells	2
IL-1β and TNF-α	2
successful single fibre recordings	2
IL-1β or TNF-α	2
bifurcation of the superior laryngeal nerve	2
isolated superfused rat glomus cells	2
pro-inflammatory cytokines: interleukin-1 beta (IL-1β) and tumour necrosis factor-α (TNF-α)	2
oxygen (PO2) (O’Leary et al., 2004)	2
Vagal paraganglia	2
two separate days	2
Ten subjects	2
breathing air	2
end-tidalPCO2(PETCO2)that	2
one Lrp4-MG patient	2
Lrp4 subgroup	2
primary lymphoid follicles	2
EOMG thymi	2
CD10+ germinal centers	2
secondary follicles	2
control or Lrp4-MG thymi	2
Lrp4-MG and control thymic sections	2
Primary CD23+ lymphoid follicles	2
B-cells, lymphoid follicles and Hassall's corpuscles	2
normal architecture	2
Lrp4-MG thymi	2
immunosuppressive drugs	2
EOMG patients	2
four non-MG controls	2
immunosuppressive drugs)	2
thymus samples	2
early-onset AChR MG (EOMG)	2
another postsynaptic neuromuscular antigen	2
low-density lipoprotein receptor-related protein 4 (Lrp4)	2
novel subpopulation of MG patients	2
pathogenic autoantibodies	2
autoinflammatory component of disease	2
resistant disease subsets	2
mixed innate and adaptive immunopathogenesis	2
extracapsular tissues	2
disease epicentres	2
colchicine and IL-1 pathway blockade	2
ACPA+ RA cases	2
called palindromic RA cases	2
autoinflammatory genes	2
immunological disease continuum model	2
high titre specific autoantibodies	2
serum autoantibodies	2
ME/CFS patients	2
ME/CFS individuals	2
various antigens including neurotransmitter receptors	2
natural killer cell cytotoxicity	2
ME/CFS	2
IgA receptors	2
IgA Fc receptor FcαRI (CD89)	2
IgA complexes	2
IgAV IgA1 antibodies	2
patients with IgAV	2
Gd-IgA1 complexes	2
galactose-deficient (Gd-)IgA1	2
IgA nephropathy immune complexes	2
neutrophil infiltration	2
complement factors	2
IgA1-immune deposits	2
Henoch-Schönlein purpura	2
Immunoglobulin A vasculitis (IgAV)	2
health care systems	2
Indirect costs	2
hospitalisations, outpatients, and medication	2
six studies	2
2226 articles	2
skin and internal organs	2
disease-associated HLA alleles	2
HLA molecules	2
IMD model	2
human leukocyte antigen (HLA) alleles	2
IMDs	2
Pinpointing IMD risk genes and autoimmune targets	2
missing autoantigens	2
Chronic immune-mediated disorders (IMDs)	2
lesser researched areas	2
SLE-related antibodies	2
Maternal anti-SSA antibodies	2
SLE offspring	2
1853 hits	2
cohort and 4 case-control studies	2
SLE or SLE-related antibodies	2
systematic review	2
patient populations	2
interferons or glatiramer acetate	2
lumping term ‘VGKC-complex antibodies’	2
heterogeneous group of patients	2
LGI1 and Caspr2	2
patients with antibodies	2
older males	2
anti-LGI1 patients, anti-Caspr2 patients	2
antibodies to voltage-gated potassium channels (VGKCs)	2
first semi-automated assay	2
normal human serum	2
RA and SLE patients	2
diphenyleneiodonium (DPI)	2
neutrophil elastase	2
citrullinated histones	2
well	2
imaged neutrophils	2
3-dimensional confocal laser scanning microscopy (3D-CLSM)	2
Sytox green	2
Immune complexes (ICxs)	2
B-cell surface	2
target molecule CD22	2
IL-6 and TNF	2
CD22 on the BCR	2
B-cell receptor (BCR) signalling complex	2
patients with systemic lupus erythematosus (SLE)	2
B-cell-directed non-depleting monoclonal antibody	2
novel, more reliable diagnostic tools	2
conceptual frame	2
β1AR-directed autoimmunity	2
versatile diagnostic tests	2
native, cell-based reporter systems	2
test antigen	2
native β1AR	2
synthetic mimics	2
conformational epitope	2
synthetic epitope mimics	2
autoantibodies	2
autoantibodies stimulating β1AR-mediated cAMP-production (i.e. agonistic β1AR autoantibodies	2
autoantibodies against β1-adrenergic receptors (β1AR)	2
anti-TNF agents	2
IGRA results	2
indeterminate IGRAs	2
patients without IMID	2
patients with IMID	2
published evidence-base	2
new blood tests	2
immunosuppressive medications	2
immune-mediated inflammatory diseases (IMID)	2
T-cell interferon-gamma release assays (IGRAs)	2
Wss1 in yeast	2
replication-coupled DNA-dependent metalloproteases	2
specialized repair pathway	2
several laboratories	2
many common chemotherapeutics	2
physical and chemical crosslinking agents	2
exomes or whole genomes	2
APOBEC cytidine deaminases	2
tobacco smoke	2
multiple different mutational signatures	2
human melanomas and urothelial cancers	2
aristolochic acid	2
simulated sunlight	2
number of different mutagen-exposed cellular systems	2
putative cancer-causing agents	2
mutagenic agents	2
Reporter gene assays	2
variant environments	2
many microbial pathogens	2
mammal-infective cells	2
highly unusual T. brucei mitochondrial genome (the kinetoplast)	2
tsetse-infective cells	2
oxidative and crosslink-induced DNA damage	2
mammal-infective T. brucei cells	2
mammal	2
testse fly midgut	2
replicative life cycle forms	2
nuclear and mitochondrial genomes of the parasite	2
genetically tractable eukaryotic microbe and important human and animal parasite	2
African trypanosome Trypanosoma brucei	2
number of widely conserved DNA repair pathways	2
radiosensitizing agents	2
PAR metabolism	2
PRKDC (DNA-PK)	2
RAD51 foci	2
olaparib and PDD00017273	2
PARP1/2/3 inhibitor olaparib	2
first in class, specific, and cell permeable PARG inhibitor, PDD00017273	2
poly(ADP-ribose) glycohydrolase (PARG)	2
multiple ADP-ribose subunits	2
DNA binding the poly(ADP-ribose) polymerase family of enzymes (PARPs)	2
human ASCIZ/ATMIN-deleted lymphoma cells	2
immortalized and primary ASCIZ/ATMIN-deficient murine embryonic fibroblasts	2
replication blocking agent aphidicolin	2
substrates KAP1, p53 and H2AX	2
essential developmental transcription factor	2
ATMIN, ZNF822)	2
prolonged DNA replication blocks	2
proteome or transcriptome	2
spontaneous Rad52 foci	2
exogenous DNA damaging agents	2
Aged yeast cells	2
original mother cell	2
new daughter cell	2
PPP-family protein phosphatases	2
serine residue 134	2
threonine 117	2
oxidative DNA lesions and double-strand DNA breaks	2
stalled DNA replication forks	2
Human single-stranded DNA-binding protein 1 (hSSB1)	2
DNA repair models	2
bona-fide pathway	2
double-stranded repair templates	2
novel branches of nick-initiated HR (nickHR)	2
double-strand break (DSB)-centered view	2
initiating lesions	2
single-strand breaks (nicks)	2
early HR models	2
specific clients	2
Cdt1 in cells from affected individuals	2
PIP-degron binding	2
inter-domain connecting loop	2
p21 PIP box sequence itself	2
Cdt1, DNMT1, PolD3p66 and PolD4p12	2
PCNA and PCNA-interacting proteins (PIPs)	2
PCNA inhibitors T3 and T2AA	2
Proliferating cell nuclear antigen (PCNA)	2
certain HR deficient tumours	2
PARG inhibitor-induced stalled replication forks	2
homologous recombination (HR) proteins	2
PARG inhibition	2
novel and specific PARG inhibitor PDD00017273	2
PARG and BRCA1, BRCA2, PALB2, FAM175A (ABRAXAS) and BARD1	2
perturbed forks	2
endo- and exoglycosidase activities	2
Poly(ADP-ribose) glycohydrolase (PARG)	2
poly(ADP-ribose) polymerase (PARP) inhibitors	2
Poly(ADP-ribosylation) of proteins	2
DNA repair proteins	2
UVA-induced ROS	2
cellular photosensitizers	2
solar UVA	2
biological impact	2
incident sunlight	2
unrepaired UVB-induced DNA lesions	2
apparently normal sun-exposed skin	2
non-melanoma skin cancers	2
potentially mutagenic UVB-induced DNA lesions	2
Solar UVB	2
translesion synthesis polymerases	2
DNA-damaging agents	2
archaeon Haloferax volcanii	2
many archaeal species	2
paralogue of RadA	2
Rad51/Dmc1 in eukaryotes	2
RecA in bacteria	2
three phospho-binding domains	2
singly and multiply-phosphorylated forms of XRCC1 and XRCC4	2
aprataxin and APLF binding	2
divergent of the three FHA domain family members	2
complex of phosphorylated XRCC4	2
single-stranded and double-stranded DNA break repair pathways	2
XRCC1 and XRCC4 scaffold molecules	2
casein kinase 2-phosphorylated forms	2
primary binding targets	2
homologous forkhead-associated (FHA) domain	2
key DNA-repair proteins	2
Aprataxin, aprataxin and PNKP-like factor (APLF) and polynucleotide kinase phosphatase (PNKP)	2
ZMM crossover pathway	2
another unknown nuclease	2
autonomous endonuclease	2
Mre11 cofactor Sae2 (Com1)	2
Tetrahymena Exo1	2
entry site	2
yeast model	2
Mre11	2
ciliated protist Tetrahymena	2
ZMM-dependent crossovers	2
DNA joint molecules	2
major meiotic nuclease	2
programmed meiotic DSBs	2
long ssDNA tails	2
3′ single-stranded DNA (ssDNA) tails	2
5′-DNA ends at a double-strand break (DSB)	2
3-NBA adducts	2
3-NBA-DNA adducts	2
Xpa-WT and Xpa-Null cells	2
integrated lacZ reporter gene in HUFs	2
smokers’ lung cancer (codons 157, 158, 175, 245, 248, 273, 282	2
non-transcribed strand	2
Xpa-WT and Xpa-Null HUF cultures	2
TP53-mutant clones	2
wild-type (Xpa-WT) counterparts	2
Xpa-Null Hupki mice	2
HUF immortalisation assay	2
genomes of Xpa-Null cells	2
(Xpa-Null) human TP53 knock-in (Hupki) embryo fibroblasts (HUFs)	2
reporter gene lacZ.	2
human tumour suppressor gene TP53	2
variety of experimental systems	2
transversions	2
diesel exhaust	2
highly mutagenic compound	2
3-Nitrobenzanthrone (3-NBA)	2
nucleosomal environment	2
clustered DNA damage	2
isolated lesions	2
bistranded AP site/8-oxoG residues	2
Clustered damaged sites	2
histone core and nucleosomal dispersion	2
bistranded AP sites	2
clustered DNA damage sites	2
CHO-K1 nuclear extract	2
non-nucleosomal DNA	2
purified APE1	2
single AP site	2
nucleosomal DNA templates	2
cell DNA	2
cell’s repair machinery	2
cells lacking ATMIN	2
ASCIZ)	2
ATM-INteracting protein ATMIN	2
53BP1 protection complex	2
DNA damage kinase ATM	2
sites of unrepaired DNA lesions	2
p53-binding protein 1 (53BP1)	2
Unresolved replication intermediates	2
ICL-induced double-strand breaks	2
two different human cell lines	2
MUS81 knockout murine cells	2
SLX4 scaffold protein	2
proportion of cellular MUS81-EME1	2
mitomycin C.	2
DNA interstrand crosslinks (ICL)	2
branched DNA substrates	2
conserved structure-selective endonuclease	2
NAD catalytic domain	2
three dimensional structure	2
pinpoint sites	2
diverse protein family	2
members of the PARP family	2
majority of enzymes	2
human NAD metabolic enzymes	2
four eukaryotic model species	2
NAD biosynthetic and degrading enzymes	2
manifold of NAD degrading enzymes	2
NAD degrading enzymes	2
almost all species in all clades	2
cellular pool	2
important cofactor	2
specific human PARP proteins	2
appropriate genetic model organisms	2
important signalling systems	2
distribution of enzymes	2
archaeal genome	2
PARP homologues	2
Several dsDNA viruses	2
ancient environment	2
ancestral eukaryote	2
last common ancestor of all eukaryotes	2
terminal ADP-ribose	2
macrodomain proteins	2
mono and poly(ADP-ribosyl) transferases	2
five types of PARP proteins	2
PARP genes	2
small number of eukaryotic species	2
six major eukaryotic supergroups	2
protein ADP-ribosylation	2
terminal ADP-ribose unit	2
macrodomain proteins (MacroD1, MacroD2 and TARG1)	2
glycohydrolase (PARG) and ADP-ribosylhydrolase 3 (ARH3)	2
family of enzymes called poly(ADP-ribose) polymerases (PARPs)	2
chains of repeating ADP-ribose nucleotide units	2
Poly(ADP-ribose) (PAR)	2
replication licensing proteins	2
humans patients	2
licensed origins	2
whole repair machinery	2
many repair proteins	2
diversity of DNA damaging agents	2
multiprotein assemblies	2
hetero-filament	2
XRCC4, XLF, Artemis and DNA	2
proteins, including DNA ligase IV (LigIV)	2
Ku heterodimer	2
NHEJ DNA-PKcs	2
sequence-threaded homology models	2
SUMO E3 ligase Pli1	2
high-throughput synthetic genetic arrays	2
previously unidentified ICL-resolution pathway	2
standard genetics	2
yeast Schizosaccharomyces pombe	2
novel conserved FA component, FAN1 (Fanconi anemia-associated nuclease 1, or FANCD2/FANCI-associated nuclease 1)	2
several DNA repair systems	2
Conversely yeasts	2
specialized ICL-repair system, the Fanconi anemia (FA) pathway	2
higher and lower eukaryotes	2
type of adduct	2
DNA interstrand cross-links (ICLs)	2
repair-proficient cells	2
human or murine genome	2
UNG2 functional lymphoblastoid cells	2
DNA-dUrd	2
Ung+/+and Ung−/−mouse embryonic fibroblasts	2
genomic dUrd	2
Control samples	2
(dUrd)	2
genomic 2′-deoxyuridine	2
various polymerases	2
extension tracks	2
PCNA on the D-loop	2
redundant pathways	2
D-loops	2
TLS polymerases	2
Pol δ	2
wide variety of potentially lethal DNA lesions	2
residue Lys81	2
N-terminal amino group in Val2	2
site-specific NEIL3 mutant V2P	2
monofunctional DNA glycosylase	2
5-hydroxy-2′-deoxycytidine (5OHC) and 5-hydroxy-2′-deoxyuridine (5OHU) in ssDNA	2
hydantoin lesions spiroiminodihydantoin (Sp) and guanidinohydantoin (Gh) in single-stranded (ss) and double-stranded (ds) DNA efficiently	2
GD NEIL3	2
glycosylase domain (GD) of human DNA glycosylase	2
damaged bases	2
DNA glycosylases	2
stalled or blocked replication forks	2
Rad51 and Mre11 proteins	2
obstacle	2
ssDNA binding protein RPA	2
leading or lagging strands	2
various DNA substrates	2
Srs2 helicase	2
synthesis-dependent strand-annealing pathway (SDSA)	2
untimely recombination	2
budding yeast Srs2 protein	2
synthesis-dependent strand-annealing pathway	2
D-loop substrate	2
Pol δ and Pol η	2
three helicases (Mph1, Srs2 and Sgs1)	2
invaded primer	2
polymerases Pol δ and Pol η	2
undamaged homologous sequence	2
WRN protein	2
damaged DNA template	2
WRN helicase/exonuclease	2
post-replicative gaps	2
fork	2
distinct genetic dependencies	2
specialised DNA polymerases	2
jobs	2
Odd-Job Man	2
Saccharomyces cerevisiae helicase Srs2	2
complex protein-protein interaction networks	2
Many helicases	2
damaged template DNA	2
ionizing radiation	2
genotoxic chemicals	2
endogenous and exogenous agents	2
double-stranded DNA breaks (DSBs)	2
Gram-positive organisms	2
post-incision NER complex	2
excised oligonucleotide	2
Bacillus stearothermophilus	2
PcrA helicase	2
C-terminal region of UvrD	2
post-incision nucleotide excision repair complex	2
UvrC and the lesion-containing oligonucleotide	2
unstructured C-terminal region	2
truncated UvrD protein	2
unstructured region at the C-terminus of UvrD	2
component of the post-incision complex	2
UvrD, a superfamily 1A helicase	2
short oligonucleotide	2
bacteria the UvrC nuclease	2
primary neural cells	2
Tdp1−/−, Aptx−/− or Tdp1−/−/Aptx−/− astrocytes	2
Tdp1−/− and Tdp1−/−/Aptx−/− double knockout astrocytes	2
camptothecin-induced Top1-SSBs	2
Tdp1−/− or Aptx−/− single knockouts	2
Tdp1−/−/Aptx−/− double knockout quiescent mouse astrocytes	2
oxidative and alkylation-induced SSBs	2
3′-topoisomerase-1 (Top1) peptide	2
subset of single-strand breaks (SSBs)	2
tyrosyl DNA phosphodiesterase (TDP1)	2
breaks	2
5′-termini	2
3′-termini in aprataxin-defective neural cells	2
APTX-defective cells	2
DNA single- and double-strand break repair machinery	2
mutations of aprataxin (APTX)	2
nucleases and checkpoint pathways	2
core component of the replication fork	2
ssDNA production	2
cdc13-1 mrc1Δ strains	2
cdc13-1 mutants	2
cdc13-1 mrc1Δ	2
similar growth	2
defective allele	2
cdc13-1 and yku70Δ telomere capping mutants	2
DNA replication fork machinery	2
Mrc1 (Mediator of Replication Checkpoint 1)	2
countless areas	2
healthcare and pharmaceutical industry	2
longevity biotechnology	2
Modern AI	2
real world evidence pipeline	2
novel molecular compounds	2
novel biological targets	2
causal models	2
formerly incompatible dynamic and static data types	2
age predictors	2
living organisms, tissues, and cells	2
cellular and in vivo HD models	2
cytosolic proteostasis pathways	2
dedicated proteostasis machinery	2
mitochondria-endoplasmic reticulum interactions	2
ATP-dependent chaperones and proteolytic machinery	2
proteasome and the autophagy pathways	2
misfolded clients	2
chaperone machinery	2
misfolded mHtt	2
mutant huntingtin (mHtt)	2
polyglutamine repeats	2
nutritional/exercise stimuli	2
anabolic stimuli	2
aged muscle	2
‘upstream’ drivers	2
muscle proteostasis	2
fundamental environmental cues	2
121,749 individuals	2
eligible studies	2
leukocyte TL	2
STR studies	2
12,083 individuals	2
STR cohorts	2
Twenty-five studies	2
low-and-middle income countries	2
23 studies	2
longitudinal studies	2
total population	2
BackgroundOlder people	2
common inflammatory drivers	2
everyday tasks	2
learning and memory functions	2
behavioral settings	2
crucial structure	2
one such preferentially vulnerable region	2
Medial temporal lobe	2
certain regions	2
deteriorating organ systems	2
C-reactive protein (CRP)	2
SMD=1.00, 95%CI: 0.40–1.61) and 8568 pre-frail (SMD=0.33, 95%CI: 0.04–0.62) participants	2
6757 robust participants	2
3 longitudinal studies	2
35 studies	2
inflammatory biomarkers	2
single interpretive framework	2
cell cytoplasm and nucleus	2
senescent ECM	2
barrier epithelia	2
resident memory T cells (TRM)	2
environmental stressors and antigens	2
dopaminergic neurons of the substantia nigra	2
neuronal population	2
latent Mycobacterium tuberculosis	2
immunoregulatory cytokines and chemokines	2
virally infected and malignant cells	2
reduced ccf-mtDNA	2
PMS cases	2
circulating cell-free mitochondrial DNA (ccf-mtDNA)	2
neurodegenerative component	2
cell-free mitochondrial DNA (ccf-mtDNA)	2
nuclear mitochondrial sequences (NUMTs)	2
radiolabeled compounds	2
MC-I selective inhibitors	2
3H-dihydrorotenone	2
cardiomyocyte SMP	2
BCPP-BF, -EF, -EM on MC-I	2
damaged neuronal areas	2
18F-BCPP-EF	2
living brain	2
neurodegenerative diseases	2
PET imaging probes	2
European haplogroups	2
nuclear SNPs (rs17160128 and rs12460243)	2
European-descent and African-descent individuals	2
nuclear SNPs en masse	2
previous marginally associated nuclear SNPs	2
1025 individuals of European-descent, African-descent, or admixed Hispanic	2
CHARTER cohort	2
mitochondrial DNA (mtDNA) haplogroup and nuclear genetic associations	2
three principal visual pathways	2
midget, parasol and bistratified RGCs	2
chronic LHON	2
acute LHON	2
13 patients	2
central vision	2
glaucoma-related models	2
Topical CoQ10	2
DARC (p<0.05) and Brn3 (p<0.01)	2
whole retinal mounts	2
Apoptotic Retinal Cells)	2
TPGS vehicle	2
either CoQ10/TPGS micelles	2
Adult Dark Agouti (DA) rats	2
different retinal ganglion cell (RGC) models	2
co-solubilised with α–tocopherol polyethylene glycol succinate (TPGS)	2
mitochondrial-targeted antioxidant	2
Coenzyme Q10 (CoQ10)	2
European origin women	2
younger cohort	2
older cohort	2
(N=2278)	2
two independent cohorts of European origin women	2
remaining quinone analogues	2
impaired mitochondrial bioenergetics	2
LHON fibroblast cell lines	2
four quinone analogues (CoQ1, CoQ10, decylubiquinone and idebenone)	2
computer models	2
TCA cycle and the respiratory chain	2
computer modelling	2
mitochondrial respiratory chain complexes	2
intracellular haemoglobin	2
individuals with Parkinson's	2
cerebellar circuitry	2
Mitochondrial haemoglobin	2
mitochondrial haemoglobin	2
outer membrane of the organelle	2
cerebellar mitochondria	2
n=18)	2
male cerebellum	2
female cerebellum samples	2
cortical region, substantia nigra	2
Parkinson's and matched control human post-mortem brains	2
human mitochondrial haemoglobin	2
mitochondrial haemoglobin (p<0.05)	2
haemoglobin in the mitochondria	2
MFN2 expression	2
fragmented mitochondria	2
Mitochondrial fusion and fission-related proteins	2
time-lapse fluorescence microscopy	2
ROS, OCR and ECAR assay	2
mitoribosome	2
LSU mt-rRNAs mutations	2
SSU mt-rRNA	2
natural structural context	2
corresponding sites	2
human mitoribosomal LSU	2
mitoribosomal SSU	2
large subunit (LSU)	2
small subunit (SSU)	2
mitochondrial rRNAs (mt-rRNAs)	2
mt-tRNA genes	2
protein encoding and	2
Marker plasmid open-source software	2
mitochondrial networks	2
cells lacking mtDNA	2
respiratory deficient cells	2
differentially imported fluorescent marker proteins	2
flexible networks	2
Hb proteins	2
cells containing mitochondria	2
PD brain mitochondria	2
PD and control brains	2
mitochondrial Hb	2
Parkinson's disease brain	2
mitochondrial Hbs	2
old and young mitochondria	2
aged brain	2
mitochondrial Hba	2
ageing brain and muscle	2
Purkinje Cell Degeneration mouse	2
mitochondrial fraction	2
pcd5jmouse brain	2
inner membrane space	2
Hbs	2
Hba and Hbb	2
degenerating brain	2
α and β haemoglobin (Hba and Hbb) proteins	2
cellular organelle	2
blood of most vertebrates	2
iron-containing proteins	2
lupus, rheumatoid arthritis, multiple sclerosis, and primary sclerosing cholangitis	2
diabetes, kidney, liver, and heart disease, cancer, Alzheimer and Parkinson disease	2
emphysema, Tourette's syndrome, bipolar disorder, schizophrenia, post-traumatic stress disorder (PTSD)	2
asthma, atopy, gluten and many other food and chemical sensitivity syndromes	2
broad array of chronic, developmental, autoimmune, and degenerative disorders	2
centers in the brainstem	2
ancient pathways in the brain	2
altered mitochondrial and cellular macromolecule content	2
choreographed sequence of anti-inflammatory and regenerative pathways	2
danger	2
metabolic intermediates like ATP and ADP, Krebs cycle intermediates, oxygen, and reactive oxygen species (ROS)	2
indole, pterin, 1-carbon and polyamine metabolism	2
vitamin availability	2
chemical, physical, or biological threats	2
cells and hosts	2
GGQ motif	2
two of which (Pth3 and Pth4)	2
predicted peptidyl tRNA hydrolases	2
S. pombe	2
mitochondrial stop codon recognition factor	2
Schizosaccharomyces pombe, strains lacking Mrf1	2
key subunits of the respiratory complexes	2
excellent diagnostic tool	2
mt-tRNAMet	2
complex V antibodies	2
additional products	2
decreased complexes I and IV	2
MTFMT protein	2
two sisters	2
tRNA formyltransferase (MTFMT) gene	2
recently discovered mitochondrial methionyl-	2
pathogenicity scoring system	2
conservation panel	2
standardised panel of organisms	2
single organism	2
standard panel of organisms	2
mt-tRNA variants	2
higher mammals (m.11789C/Y421H)	2
unique bovine variant	2
single mtDNA haplotype	2
extant herd	2
complete mitochondrial DNA sequence	2
near-homozygous nuclear genome	2
Chillingham herd of wild Northumbrian cattle	2
novel conceptual framework	2
PGC-1 coactivators	2
complex nuclear transcriptional machinery	2
LHON mutation carriers	2
large, well characterised LHON cohort	2
retinal ganglion cells	2
mitochondrial localization of proteins	2
new mitochondrial disease genes	2
carefully selected classifiers	2
many classifiers	2
mapped nuclear genetic loci	2
novel mitochondrial disease genes	2
comprehensive experimentally derived mitochondrial proteome	2
VL strains	2
fewer polymorphic AFLP fragments	2
skin isolates	2
Strains in the latter clade	2
two major clades, Southern Ethiopia (SE) and Sudan/Northern Ethiopia (SD/NE)	2
four clusters	2
rRNA gene	2
DNA probe	2
region in Sudan	2
VL and PKDL strains	2
skin, spleen or bone marrow	2
HIV/VL	2
lymph node, spleen or bone marrow	2
different patient tissues	2
kDNA minicircle sequencing	2
36 Ethiopian and Sudanese L. donovani strains from VL, PKDL and HIV/VL patients	2
immune-competent and -suppressed people, post-kala azar dermal leishmaniasis (PKDL) and HIV/VL co-infections	2
Visceral leishmaniasis (VL)	2
pathogenic lineages	2
held-out testing set	2
training dataset	2
concise set of rules	2
machine learning algorithms	2
curated database	2
pre-specified loci repeat	2
Mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing	2
single blood sample	2
single mosquito bites	2
individual human hosts	2
rest	2
multiple mosquito bites	2
unrelated parasite haplotypes	2
three extensively sampled individuals	2
parasite haplotypes	2
distinct parasite haplotypes	2
three of the individuals	2
serial blood samples	2
multiple parasite genotypes	2
individuals sampled	2
co-infecting parasite genotypes	2
co-infecting parasite haplotypes	2
parasite clones	2
three of the participants	2
single peripheral blood sample	2
Serial blood samples	2
parasite genotypes co-infecting asymptomatic adults	2
genetically distinct parasite genotypes	2
Malaria-infected individuals	2
post-VL elimination context	2
emerging ISC1 population in the ISC	2
ISC1 versus CG parasites	2
host/extracellular environment	2
pathways and molecules	2
nucleotide salvage pathway	2
known virulence factors, immunogens and surface proteins	2
small indels	2
ISC1 population	2
ISC	2
Core Group (CG), main population	2
new and emerging genotype	2
ISC1 genetic group	2
Nepalese hilly districts	2
visceral leishmaniasis (VL)	2
responsible agent	2
public health tool	2
scientific community and public health authorities	2
Lusophone space	2
six cross-border genetic clusters	2
24-loci MIRU-VNTR	2
minor clades	2
Latin American and Mediterranean (LAM) strains	2
five CPLP countries	2
423 multidrug-resistant isolates	2
largest CPLP M. tuberculosis molecular and drug susceptibility dataset	2
member-states	2
Community of Portuguese Language Speaking Countries (CPLP)	2
Publisher	2
author(s)	2
apical membrane antigen 1 (AMA1) and immune mapped protein 1 (IMP1)	2
parasite genomes	2
best antigens	2
optimal delivery systems	2
novel multi-valent vaccines	2
combinations of anticoccidial antigens	2
current live vaccines	2
susceptible isolates	2
ionophores	2
novel anticoccidial vaccines	2
Many antigens	2
scalable, cost-effective subunit or recombinant vaccines	2
Eimeria species parasites	2
species C. chauvoei	2
Three conserved flagellar genes (fliC)	2
metal iron transportation genes	2
glycosyl hydrolases	2
locally collinear blocks (LCBs)	2
C. chauvoei circular genome sequences	2
genus Clostridium	2
far sequenced genomes of species	2
C. septicum	2
Clostridia cluster I group	2
Sporulation and germination process related genes	2
CRISPR type I-B system	2
hemolysin and bacterial spore formation genes	2
C. chauvoei strains	2
Similar prophages	2
two regions containing DnaA boxes	2
origin of replication (oriC)	2
field strain 12S0467	2
DSM 7528T (ATCC 10092T)	2
C. chauvoei type strain	2
circular genome sequences	2
typically fatal histotoxic myonecrosis	2
black leg	2
(C.) chauvoei is a Gram-positive, spore forming, anaerobic bacterium	2
goats in Sardinia	2
novel BTV serotype	2
tested extant serotypes	2
serum of BTV-X ITL2015 infected goats	2
BTV-25, 26, 27s and BTV XJ1407	2
BTV-X ITL2015	2
specific RT-qPCR targeting Seg 2 of BTV-X ITL2015	2
BTV-25 from Switzerland	2
last discovered BTV XJ1407	2
recently isolated BTV-27s from Corsica	2
Seg 2 of BTV-X ITL2015	2
two blood samples (BTV-X ITL2015 strains 34200 and 33531	2
whole genome sequence	2
blood and serum samples	2
healthy goats	2
putative novel BTV serotype	2
novel Bluetongue virus (BTV) serotypes	2
circulating seasonal influenza viruses	2
B/Brisbane/60/2008 vaccine virus	2
antigenic 120-loop region of HA	2
20 B/Victoria-lineage viruses	2
Bulgarian 3C.2a viruses	2
S312R and HA2 substitutions I77V and G155E	2
unique HA1 substitutions N171K	2
subclade 3C.3a vaccine virus	2
antigenic sites A and B	2
HA positions	2
Bulgarian A(H3N2) strains (subclade 3C.2a)	2
A/California/7/2009 vaccine virus	2
proteins MP, NP, NS and PB2	2
neuraminidase (NA)	2
four antigenic sites	2
vaccine virus	2
57 A(H1N1)pdm09 isolates	2
6B.1, 3C.2a and 1A genetic groups	2
sequenced influenza A(H1N1)pdm09, A(H3N2) and B/Victoria-lineage viruses	2
B/Victoria-lineage viruses (24%) and A(H3N2) viruses	2
detected influenza viruses	2
2015/2016 season	2
novel genetic variants	2
normal vaginal microbiota	2
commensal creatures	2
even more alien species	2
Bifidobacterium, Staphylococcus	2
taxon-rich and diverse bacterial communities	2
Algoriphagus aquatilis, Atopobium vaginae, Burkholderia fungorum, Megasphaera genomosp species	2
vaginal microflora	2
opportunistic infections	2
several novel BV-associated bacteria (BVAB)	2
species)	2
many novel phylotypes	2
128 BV-positive women	2
subjects without BV	2
community of vaginal bacteria	2
healthy and BV-affected vaginal microbial ecosystems	2
broad-range PCR-DGGE and gel imaging analysis system	2
normal women	2
BV-positive women	2
vaginal microbiota	2
Bacterial vaginosis (BV)	2
infected animal	2
different lesion sites	2
distinct viral populations	2
2 or more animals	2
6 different animals	2
7 samples	2
series of outbreaks	2
polyprotein coding region of the FMDV genome	2
7.6kb nucleotide fragment	2
single farm	2
infected cattle	2
FMD virus (FMDV) populations	2
unique polymorphic populations	2
RNA genome replication, foot-and-mouth disease (FMD) virus samples	2
regions of Vietnam	2
northern Vietnam	2
H9 viruses	2
distinct H9 genotypes	2
Chinese human isolates of A/H7N9 and A/H10N8	2
internal genes	2
H9N2 viruses	2
2 of A/H5N6	2
A/H9N2	2
influenza H7	2
M gene Ct<26	2
swabs/pools	2
virus positive	2
pooled oropharyngeal swabs	2
live bird markets (LBM)	2
viruses in chickens	2
influenza H5 viruses	2
A/H9N2 viruses	2
low pathogenicity avian influenza viruses (LPAIV)	2
two sources	2
social network	2
infected network members	2
uninfected individuals	2
two data sources	2
infectious disease surveillance systems	2
variety of settings	2
public health applications	2
specific migration routes	2
Iron Curtain	2
European ones	2
non-European countries	2
viral isolates	2
Central/Eastern Europe	2
different occasions	2
Western Europe	2
globally representative HIV-1 subtype B strains	2
United States	2
sub-epidemic	2
Western World	2
Human immunodeficiency virus type 1 (HIV-1)	2
various STs	2
B. burgdorferi s.l.	2
IGS haplotypes	2
birds (B. garinii and B. valaisiana) or lizards (B. lusitaniae)	2
mammals (B. afzelii, B. bavariensis, and Borrelia spielmanii)	2
genospecies	2
fraction of STs	2
Borrelia genospecies	2
different STs	2
B. garinii and B. bavariensis	2
B. afzelii	2
questing I. ricinus ticks	2
Borrelia garinii, Borrelia lusitaniae and Borrelia valaisiana	2
human cases of LB	2
Borrelia afzelii and Borrelia bavariensis	2
European B. burgdorferi s.l.	2
Ixodes ricinus lysates	2
183 LB cases	2
B. burgdorferi s.l	2
patients with Lyme borreliosis (LB)	2
Borrelia burgdorferi sensu lato isolates	2
eight multilocus sequence typing scheme housekeeping genes (MLST) and 5S-23S rDNA intergenic spacer (IGS)	2
IFN-free direct-acting antiviral regimen	2
patients with genotype 1b	2
IFNL4 ss154949590 TT/TT genotype	2
HCV genotype 2a	2
carrying the TT/TT genotype	2
ΔG allele carriers	2
ss469415590 variant	2
CHC patients	2
SHC individuals	2
129 individuals who had spontaneously cleared HCV (SHC)	2
interferon alpha-2b and ribavirin)	2
chronic hepatitis C (CHC) patients	2
individuals of African ancestry	2
novel gene, interferon lambda 4 (IFNL4)	2
dinucleotide variant ss469415590	2
adaptive alleles	2
different haplotypic backgrounds	2
β-globin polymorphisms	2
meta-population genetic model	2
classical restriction fragment length polymorphism haplotypes	2
distinct genetic backgrounds	2
malaria-protective β-globin polymorphisms, sickle-cell (βS) and β0-thalassaemia	2
epidemiological models	2
evolutionary epidemiology theory	2
red blood cell stages	2
malaria species	2
virulent strain	2
mixed-strain infections	2
P. chabaudi	2
less-virulent clones	2
highly virulent clones	2
virulent clone	2
P. yoelii infections	2
limited set	2
animal model systems	2
mixed-strain parasitemia	2
Plasmodium chabaudi	2
mixed-strain Plasmodium yoelii	2
murine model systems	2
mixed-strain Plasmodium vivax inocula	2
multiple complementary epidemiological models	2
human malaria	2
different parasite systems	2
multiple strains (clonal populations)	2
individual infection	2
common site	2
Nt 1762	2
single mutations	2
wild type sequence	2
HBeAg positive individuals	2
30–34years age-group	2
wild type BCP sequences	2
BCP	2
Long An cohort	2
Study subjects	2
basal core promoter (BCP) double mutations (nt 1762T, 1764A)	2
wild migrating birds	2
as-yet unsampled reservoir	2
overwintering birds	2
common ancestor of H5N8 in the Republic of Korea	2
eastern regions	2
overwintering waterfowl and domestic ducks	2
western provinces	2
Jeonbuk province	2
Republic of Korea	2
new strain	2
novel H5N8 virus	2
HPAI Asian-origin H5N1 lineage	2
Highly pathogenic avian influenza (HPAI)	2
FMD free countries	2
chronic carrier animals	2
epidemiological units	2
reference tree	2
one sequence	2
future epidemics	2
available samples	2
different herds	2
eight premises	2
45 foot-and-mouth disease virus (FMDV) genome sequences	2
different epidemiological units	2
genetic diversity of viruses	2
Full-genome sequences	2
first multiplex panel of microsatellite markers	2
largest panel of microsatellite markers	2
multiplex microsatellite panel	2
infective life cycle stage	2
several life cycle stages	2
15 loci	2
abattoir	2
cattle livers	2
38 liver flukes	2
remaining 11 loci	2
four loci (Fh_1, Fh_8, Fh_13 and Fh_14)	2
null alleles	2
established isolate (Shrewsbury; Ridgeway Research)	2
adult F. hepatica	2
Thirty-five loci	2
F. hepatica genome sequence	2
potential microsatellites	2
economically important pathogen of sheep and cattle	2
Genotype I	2
DENV-1	2
selected viruses	2
various DENV serotypes/genotypes	2
DENV-3 strains	2
DENV-3 and DENV-4 isolates	2
countries in the region	2
regionally endemic	2
Cosmopolitan DENV-2 isolates	2
Genotype I.	2
Cosmopolitan genotype, Genotype I and Genotype II	2
DENV-2, -3 and -4	2
-3, and -4	2
predominant serotype	2
dengue virus serotype 1 (DENV-1)	2
confirmed dengue cases	2
serotypes and genotypes of the viruses	2
capital city	2
Dengue fever	2
cryptic species	2
Culicoides taxonomy	2
Many informal species groupings	2
subgenera	2
range of internationally important pathogens	2
biological vectors	2
humans, livestock and equines	2
Culicoides Latreille biting midges (Diptera: Ceratopogonidae)	2
underlying molecular clocks	2
important hematophagous insects	2
Brazilian populations	2
sandflies and mosquitoes	2
Alexandre A. Peixoto	2
haemoplasmas and other Mollicute species	2
concatenated data set	2
pneumoniae group of Mycoplasmas	2
gapA and dnaK concatenated data set	2
broad selection of Mollicute species	2
dnaK sequences	2
gapA sequences	2
Mollicute species	2
Partial glyceraldehyde-3-phosphate dehydrogenase (gapA) and heat shock protein 70 (dnaK) gene sequences	2
two protein-encoding housekeeping genes	2
several Mycoplasma species	2
Nine species of uncultivable haemoplasmas	2
putative effector islands	2
COG4253 and gp27 domain	2
several key genes	2
negligible APEC isolates	2
T6SS3 locus	2
meningitis E. coli	2
ECOR groups B2	2
T6SS2 locus	2
various E. coli pathotypes	2
versatile VgrG islands	2
T6SS1 locus	2
virulent phylogenetic groups D and B2	2
T6SS loci	2
APEC collections	2
T6SS1, T6SS2 and T6SS3 loci	2
472 APEC isolates	2
three T6SS loci	2
APEC genomes	2
three distinguishable and conserved T6SS loci	2
Avian pathogenic Escherichia coli (APEC) strains	2
P. chabaudi clones	2
AMA-1 predicted clone-transcending binding	2
antigenic locus	2
(MSP-119)	2
Merozoite Surface Protein-119	2
recombinant Apical Membrane Antigen-1 (AMA-1)	2
two malaria antigens	2
unrelated antigen, Keyhole Limpet Haemocyanin (KLH)	2
key antigenic loci	2
pair of clones	2
genetically distinct P. chabaudi clones	2
rodent malaria Plasmodium chabaudi	2
parasite genotypes	2
different continents	2
clinically relevant outbreak strains	2
infectious M. abscessus isolates	2
bacteriophage insertions and recombination hotspots	2
closely related outbreak strains	2
UK outbreak isolates	2
two Brazilian derived CRM strains	2
27,598 core genome single nucleotide polymorphisms (SNPs)	2
globally diverse MAB strains	2
publically available genomes	2
patients with pulmonary infections in the United States (US) (NJH8 and NJH11) and one type MAB-B strain (CCUG 48898)	2
two unrelated MAB strains	2
skin infections	2
two Brazilian MAB-B epidemic isolates (CRM-0019 and CRM-0020)	2
clinical MAB strains	2
surgical patients	2
MAB-B	2
bolletii (MAB-B).	2
abscessus (MAB-A) and M. abscessus subsp.	2
subspecies, M. abscessus subsp.	2
skin and respiratory infections	2
(MAB) species	2
Mycobacterium abscessus	2
Rapidly growing, non-tuberculous mycobacteria (NTM)	2
n=10)	2
main 1967/68 outbreak	2
FG sequences	2
VP1 sequences	2
contemporary outbreaks	2
cell culture isolates (n=6)	2
clinical epithelium samples (n=13)	2
full genome (FG) sequences	2
VP1 region	2
earlier UK FMD outbreaks	2
lamb products	2
infected bone marrow	2
FMD virus (FMDV) serotype O	2
smaller FMD outbreaks	2
large epidemic of foot-and-mouth disease (FMD)	2
cattle isolates	2
caprine isolates	2
sheep cheeses	2
human and bovine isolates	2
Ovine isolates	2
additional host species	2
ovine-associated	2
three main ovine CCs	2
multiple CCs	2
MLST CCs	2
CC5, CC522, CC133 and CC522 respectively	2
spa types (t002, t1534, t2678 and t3576)	2
Three main CCs (CC133, CC522 and CC700)	2
novel MLST alleles	2
97 new ovine isolates	2
293 ovine isolates	2
human S. aureus profiles	2
Europe (n=153), Africa (n=28), South America (n=14) and Australia (n=1)	2
sheep and sheep products	2
S. aureus isolates	2
ovine-associated S. aureus	2
single geographic location (country or region	2
multiple countries and continents	2
four loci	2
initial 61 potential VNTR regions	2
footrot (GB, Australia)	2
Seventy-seven isolates	2
global collection of isolates	2
molecular typing tool	2
polymorphic tandem repeats	2
causal agent of footrot	2
Gram-negative, anaerobic bacterium	2
number of variant amino acid residues	2
currently available HPV pseudoviruses	2
HPV58	2
HPV18, HPV31, HPV45	2
consensus L1 sequences	2
minority variant	2
surface-exposed residue diversity	2
HPV18 and	2
known neutralizing antibody epitopes	2
surface-exposed domains	2
intra-type entropy	2
vaccine antibodies	2
HPV6, HPV11 and HPV52	2
non-surface-exposed residues	2
Americas, Africa, Asia and Europe	2
1281 sequences	2
naturally-occurring, intra-type polymorphisms	2
vaccine-relevant HPV genotypes	2
existing full length L1 sequences	2
L1 surface-exposed domains	2
major capsid protein, L1,	2
current and next generation vaccines	2
cervical cancer-associated genotypes including HPV31, HPV33, HPV45, HPV52 and HPV58	2
multivalent HPV vaccine	2
cervical cancer (HPV16/18) and genital warts (HPV6/11)	2
prevalent genotypes	2
current HPV vaccines	2
distinct genotypes and intra-type variants	2
host cell polymerases	2
NoV GII.4 variants	2
GII.4-2010 variant	2
endemic GII strains	2
(New Orleans) variants	2
GII.4-2006b (Minerva) and GII.4-2010	2
GII.4 strains	2
particularly GII.4	2
Genogroup II NoV	2
2054 enrolled children	2
NoV genotypes	2
industrializing countries	2
industrialized countries	2
network of linked subpopulations	2
alpha and beta forms of thalassaemia	2
hotspots	2
sickle cell free	2
neighbouring populations	2
sickle cell ‘hotspots’	2
Greece and Italy	2
historically malarious regions	2
haemoglobin (haemoglobinopathies)	2
copy variable region	2
Tanzanian population (n=922)	2
chemokine gene CCL3L1	2
multiple introductions	2
MSMs	2
rest of the sequences	2
F1 and C subtypes	2
local transmission network	2
Bucharest area	2
local transmission network (monophyletic clade)	2
heterosexual route	2
HIV-1 subtype B patients	2
subtype B strains	2
unique recombinant forms (URFs)	2
several CRFs	2
newly diagnosed individuals	2
subtype F1	2
non-B subtypes and circulating recombinant forms (CRFs)	2
HIV-1 subtype B	2
antivirals and tetravalent vaccines	2
human monoclonal antibodies	2
NS protein	2
significant viral genetic diversity	2
Venezuela and vice versa	2
Latin American region	2
NS1, NS2A and NS4B proteins	2
non-structural (NS) proteins	2
four serotypes	2
Twenty-one DENV full-length genomes	2
dengue viruses (DENV)	2
clinical Leishmania strains	2
different genetic groups	2
distinct drug-resistant group of Nepalese and Indian L. donovani	2
Indian or Nepalese ones	2
African and European strains	2
population history simulations	2
African strains	2
certain older Indian strains	2
microsatellite phylogenies	2
Microsatellites and SNPs	2
diverse strains of the L. donovani complex isolates	2
small geographic area	2
L. donovani strains	2
panel of standard microsatellite loci	2
species of the Leishmania donovani species complex	2
two population groups	2
study populations	2
identified haplotypes, SAA/C–HHC	2
two haplotypes	2
SNP positions	2
SAA and SAC population groups	2
haplotypes, SAA-HHE and SAC-HHE	2
sequenced region	2
complex putative haplotypes	2
Δ32 deletion mutant	2
one Caucasian individual	2
non-synonomous amino acid	2
novel SNP (+258G/C)	2
single-nucleotide polymorphisms (SNPs), indels and intragenic haplotypes	2
Full length CCR5 sequences	2
two promoters	2
CCR5 open reading frame (ORF)	2
9.2kb continuous region	2
South African African (SAA) and Caucasian (SAC) populations	2
CCR5 genes	2
promoter and regulatory regions	2
complement of SSRs	2
Brazilian isolates	2
tracts	2
number of mononucleotide, dinucleotide, pentanucleotide, heptanucleotide, and octanucleotide SSRs	2
non-tetranucleotide SSR in the 16 strains	2
H. influenzae pan-genome	2
previously uncharacterised tetranucleotide SSR loci	2
known tetranucleotide SSR loci	2
major mediators	2
tetranucleotide repeats	2
988 SSR associated loci	2
12 genomes	2
four complete H. influenzae genomes	2
SSRs	2
multiple strains of H. influenzae	2
surface exposed structures	2
Rd KW20 genome	2
Simple sequence repeat (SSRs) of DNA	2
dinucleotide polymorphic microsatellite markers	2
partial genomic microsatellite libraries	2
house infestations	2
silvatic populations	2
domestic and silvatic populations of R. prolixus	2
silvatic populations of R. prolixus	2
palm and/or metal roofs	2
unplastered adobe walls	2
rural housing	2
Rhodnius prolixus	2
geographically distinct regions	2
novel multilocus genotypes	2
small geographical area	2
geographically comprehensive panel of isolates	2
Peruvian samples	2
one sub-group	2
regional populations	2
micro- and minisatellites	2
Scottish C. parvum samples	2
mutant CHIT1 genotype	2
different geographical areas	2
worldwide populations	2
non-endemic countries	2
PCR-based assay	2
five villages	2
693 individuals	2
chitotriosidase genotype	2
malarial and intestinal helminth infections	2
parts of West Africa	2
Caucasians and other populations	2
chitotriosidase unstable and enzymatically inactive	2
chitinolytic enzyme	2
Human chitotriosidase (CHIT1)	2
matrix component substrate of ADAMTS9	2
neural crest (NC) derivative tissues, the pronephros and the pancreas	2
many structures during organogenesis	2
entire ADAMTS family	2
Xenopus genomes	2
ADAMTS family	2
Xenopus laevis and Xenopus tropicalis	2
19 members of the ADAMTS family	2
human family	2
secreted, multi-domain matrix-associated zinc metalloendopeptidases	2
ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin type I motifs)	2
Drosophila post-embryonic brain	2
cortex and perineurial glia	2
glia in the brain	2
overlapping sets of genes	2
neuronal genes	2
known glial genes	2
FGF or insulin receptor	2
Drosophila post-embryonic CNS tissue	2
developing invertebrate and vertebrate nervous systems	2
differentiated glial cells	2
specific subtypes of glia	2
Glial cells	2
pillar cells	2
focal adhesion scaffold protein	2
contacting hair cells	2
centriolar isoform Cenexin	2
tetrameric Shaker-like potassium channel	2
inner ear in mice	2
multitude of genes	2
highly specialized cells	2
organ of Corti	2
important collagen biosynthesis enzyme	2
widely separated animal phyla	2
intracellular type-IV collagen	2
endoplasmic reticulum resident protein	2
type-IV collagen-producing cells	2
collagen-modifying enzyme	2
dPlod RNA and protein	2
fly genome	2
lysyl hydroxylase	2
Drosophila LH3 (dPlod)	2
lysyl hydroxylase (LH) family of enzymes	2
cross-regulatory communication pathways	2
potentially interacting genes	2
core set of data	2
emerging structure	2
two gene families	2
previously undetected sites	2
left forelimb	2
matching virtual sections	2
fully described probes	2
full 3D data set	2
spatially comprehensive set	2
complex system	2
Frizzled (Fzd) receptor genes (in mouse and human)	2
fundamental cell communication systems	2
patients affected by critical limb ischemia (CLI) and DFUs	2
Group B	2
Group A	2
Group B.There	2
-five patients	2
two groups: group A (patients	2
ischemic DFUs	2
ischemic diabetic foot ulcers (DFUs).MethodsConsecutive patients	2
dedicated CTO PCI	2
CTO	2
experienced centers	2
CTO percutaneous coronary intervention (PCI) equipment	2
larger study populations	2
recent STEMI	2
high-risk patients	2
68 patients	2
RH-PAT, hs-CRP, and Lp-PLA2	2
patients with previous ST-elevation myocardial infarction (STEMI)	2
high-sensitive C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase-A2 (Lp-PLA2)	2
SGLT-expressing cells	2
hyperglycemic Fh1βKO mice	2
renal tubular cells and cardiomyocytes	2
diabetic Goto-Kakizaki rats	2
hyperglycemic Fh1βKO and β-V59M gain-of-function KATP channel mice	2
Protein succination	2
sodium-glucose transport (SGLT) inhibitor phlorizin	2
Mice lacking fumarase (Fh1) in their β cells (Fh1βKO mice)	2
intestinal/neuronal/adipose tissue inter-organ communication network	2
corpora cardiaca	2
glucagon-like, adipokinetic hormone (AKH)	2
Bursicon α/DLgr2	2
neuronal receptor DLgr2	2
hormone Bursicon α	2
enteroendocrine cells in the adult Drosophila intestine	2
novel diabetes executer protein VDAC1	2
VDAC1 inhibitor	2
db/db mice	2
T2D islets	2
specific VDAC1 inhibitors and antibodies	2
antibodies and inhibitors	2
crucial metabolic coupling factor ATP	2
plasma membrane of the insulin-secreting β cells	2
islets from T2D and non-diabetic organ donors	2
ATP-conducting mitochondrial outer membrane voltage-dependent anion channel-1 (VDAC1)	2
electron transport chain complexes	2
the transcriptional co-activator PGC-1α	2
PML-nuclear bodies	2
high-OXPHOS tumors	2
high-OXPHOS HGSOC	2
PML-PGC-1α axis	2
low-OXPHOS	2
two molecular subgroups	2
in HGSOC	2
SummaryHigh-grade serous ovarian cancer (HGSOC)	2
patients in the OTR group	2
validated proliferation signature	2
18-FDG uptake	2
FDG response group	2
OXPHOS transcriptional response (OTR) group	2
Two tumor groups	2
multiple mitochondrial metabolic pathways	2
mitochondrial metabolites	2
primary breast cancer	2
transcriptomics, and metabolomics	2
dynamic FDG-PET-CT	2
fasted mice tissues	2
acetylated Raptor	2
intermediary proteins	2
Leu metabolite	2
intermediary enzymes	2
mTORC1 regulator, Raptor	2
Leu metabolite acetyl-coenzyme A (AcCoA)	2
Leucine (Leu)	2
mTOR) complex 1 (mTORC1)	2
NTS and ARC	2
5-HT2CR agonist obesity medications	2
sufficient subpopulation of 5-HT2CRs	2
POMCARC knockdown	2
5-HT2CR agonists	2
subset of POMCNTS neurons co-expressed 5-HT2CRs	2
hypothalamic arcuate nucleus (POMCARC)	2
pro-opiomelanocortin neurons	2
brainstem nucleus of the solitary tract (5-HT2CRNTS)	2
5-HT2CRs specifically	2
2C receptors (htr2c; 5-HT2CR)	2
Medications targeting 5-hydroxytryptamine (5-HT; serotonin)	2
antioxidant N-acetylcysteine	2
KO-AOX versus KO mice	2
KO alone	2
double KO-AOX mutants	2
AOX-transgenic mouse	2
severely myopathic skeletal muscle-specific COX15 knockout (KO) mouse	2
potential therapeutic tool	2
coenzyme Q	2
SummaryAlternative oxidases (AOXs) bypass respiratory complexes III and IV	2
cells in vitro and in vivo	2
de novo glutamate, glutamine, and nucleotide synthesis	2
extracellular glutamine	2
support cells	2
aspartate/glutamate transporter	2
tumor-suppressor protein p53	2
substrate channeling	2
quinone and quinol	2
complex III	2
supercomplexes by complex I	2
quinol	2
supercomplexes	2
mammalian heart mitochondrial membranes	2
alternative quinol oxidase (AOX)	2
local quinone and cytochrome c pools (substrate channeling)	2
minimal functional units	2
respiratory supercomplexes, comprising complexes I, III, and IV	2
thermogenic fat bioenergetics	2
adipose cardiolipin	2
rare human CRLS1 variant	2
adipose thermogenesis	2
brown and beige fat	2
mouse and human adipocytes	2
cardiolipin synthase (Crls1)	2
brown and beige adipose	2
mitochondrial phospholipid cardiolipin	2
thermogenic fat	2
local lipolysis	2
metabolically active	2
133xenon washout	2
Arterial and dialysate samples	2
abdominal subcutaneous white adipose tissue (WAT)	2
CT guidance	2
supraclavicular BAT	2
BAT so microdialysis catheters	2
lean, healthy men	2
in vivo human brown adipose tissue (BAT) physiology	2
novel resources	2
epigenomically unique class of lineage-defining genes	2
bivalent Polycomb-silenced domains	2
chromatin machinery	2
skeletal muscle FIH mutants	2
asparaginyl hydroxylase	2
factor inhibiting HIF (FIH)	2
HIF transcription factor	2
β-catenin and PPARγ activation	2
anti-inflammatory milieu	2
cDC2 DCs	2
PPARγ pathway	2
Wnt/β-catenin pathway in cDC1 DCs	2
conventional dendritic cells (cDCs) in VAT	2
array of innate and adaptive immune cells	2
immune site	2
adipose tissue (VAT)	2
multiple, yet-to-be-discovered pathways	2
first in vivo evidence	2
PD-relevant mesencephalic dopaminergic neurons and microglia	2
metabolically active tissues	2
mito-QC	2
basal mitophagy in vivo	2
Elegant mouse reporters	2
depolarization-induced mitophagy	2
PTEN-induced kinase 1 (PINK1)	2
favorable gut ecosystem	2
bloom of Proteobacteria	2
fecal cholesterol	2
AbcG8, and ApoA1	2
cholesterol efflux proteins AbcA1	2
infected IECs	2
cholesterol biosynthetic pathway	2
colon-associated anaerobic commensals	2
mucosal O2	2
mitochondrial cardiolipins	2
cytosolic energy	2
sugar transporter Sglt4	2
global proteomic and targeted metabolomics and lipidomics	2
enteric pathogen Citrobacter rodentium	2
ingested pathogens	2
key longevity-associated hormones	2
circulating IGF-1	2
H2S-producing enzyme cystathionine γ-lyase (CGL)	2
long-lived mouse strains	2
hydrogen sulfide (H2S)	2
growth hormone (GH) and thyroid hormone	2
mouse growth	2
dietary amino acids	2
non-matched diets	2
“exome-matched” diets	2
fruit fly Drosophila melanogaster	2
balanced diet	2
PI3K p110δ-Akt-dependent pathway	2
CD4+ T cells and dendritic cells	2
cohort of free-living people	2
high-fat diet-fed animals	2
+ effector memory-like T cells	2
CD44hi-CCR7lo-CD62Llo-CXCR3	2
non-lymphoid, inflammatory sites	2
high-fat diet-fed donors	2
Memory CD4+ T cells	2
adipose and vascular tissue	2
β cell-specific transcription factor networks	2
PLUTO	2
key β cell transcription factor	2
lncRNA PLUTO	2
β cell-specific transcriptional networks	2
β cell-specific lncRNAs and transcription factors	2
human pancreatic β cells	2
thousands of long non-coding RNAs (lncRNAs)	2
glycolytic enzymes, and pathways	2
glucose transporters	2
myonuclei	2
peroxisome proliferator-activated receptor-γ coactivator1α (PGC1α)	2
transcription factor EB (TFEB)	2
tumor-induced IL-6	2
immunotherapy	2
mouse PDA	2
cachectic mice	2
plasma corticosterone	2
Multiple intratumoral immune pathways	2
transcriptional master regulator of ketogenesis	2
autochthonous pancreatic ductal adenocarcinoma (PDA)	2
pre-cachectic mice	2
HIFα prolyl hydroxylases (PHDs) and TET 2-oxoglutarate dependent dioxygenases	2
L-2-hydroxyglutarate formation	2
OGDH or LIAS mutants	2
non-hydroxylated form	2
two mitochondrial genes, oxoglutarate dehydrogenase (OGDH) and lipoic acid synthase (LIAS)	2
near-haploid human cells	2
small molecule metabolites	2
low oxygen environments	2
SummaryHypoxia-inducible transcription factors (HIFs)	2
NADPH availability	2
redox-sensitive transcription factor NRF2	2
circadian transcription factors BMAL1 and CLOCK	2
human cells, mouse tissues	2
redox cofactor NADPH	2
ubiquitous timekeeping system	2
islet	2
specific stimulation	2
 hubs	2
hub cells	2
β cell population	2
individual β cells	2
islets of Langerhans	2
primary murine brown and beige adipocytes	2
isoprenaline-stimulated respiration	2
human primary brown adipocytes	2
lean healthy men	2
glucocorticoid prednisolone	2
brown adipose tissue (BAT) in adult humans	2
Labrador retrievers and FCRs	2
assistance dogs	2
Labrador retrievers	2
closely related flat-coat retriever (FCR)	2
β-MSH and β-endorphin coding sequences	2
pro-opiomelanocortin (POMC)	2
Labrador retriever dogs	2
AMPK systemically	2
AMPK γ2 subunit	2
conserved, ubiquitously expressed, heterotrimeric serine/threonine kinase	2
Many lipids	2
∼5,600 unique species	2
Resting platelets	2
wealth of species	2
genetically unrelated individuals	2
resting, thrombin-activated, and aspirinized platelets	2
multiple fatty acids and oxidized species	2
lipidomic circuit	2
different mTORC1 complexes	2
specific amino acids in assorted compartments	2
late endosomes and lysosomes	2
surface of multiple intracellular compartments	2
important amino acid sensors	2
amino-acid-regulated mechanistic target of rapamycin complex 1 (mTORC1)	2
OPA1-dependent cristae remodeling pathway	2
cristae remodeling pathway in vivo	2
apoptotic, necrotic, and atrophic stimuli	2
 the optic atrophy 1 (OPA1)-dependent cristae remodeling pathway	2
potential pharmacologic target	2
abdominal adipogenesis	2
diminished gluteal	2
progenitor types	2
abdominal versus gluteal adipocyte progenitors	2
common LRP5 allele	2
WNT co-receptors LRP5	2
WNT pathway genes	2
CCK neuropeptide	2
CCKLPBN neurons	2
discrete CCKLPBN→SF1VMH neurocircuit	2
CCKLPBN glucoregulatory neurons	2
(SF1)-expressing neurons of the ventromedial nucleus of the hypothalamus (SF1VMH)	2
steroidogenic-factor 1	2
population of glucose-sensing cells (glucose inhibited)	2
lateral parabrachial nucleus cholecystokinin (CCKLPBN) neurons	2
AA derivatives	2
conserved regulator	2
plasma LDL-C.	2
LX mimetics	2
bioactive AA-derivatives	2
bile salt export pump Abcb11	2
leukotrienes (LTs) and lipoxins (LXs)	2
>100,000 individuals	2
plasma LDL-C and HDL-C.	2
omega-6 polyunsaturated fatty acids including arachidonic acid (AA)	2
PrRP in brainstem	2
loxSTOPlox-PrRP mouse	2
gut-derived hormone cholecystokinin (CCK)	2
separate population of leptin-insensitive PrRP neurons in the brainstem	2
RFamide PrRP	2
dorsomedial hypothalamic nucleus (DMH)	2
population of neurons	2
brain receptors (Lepr)	2
various nutrition pathways	2
Drosophila AcCoA synthetase	2
ach1 mutant	2
autophagy genes	2
nucleocytosolic AcCoA-synthetase Acs2p	2
AcCoA precursor acetate	2
CoA-transferase ACH1	2
nucleocytosolic acetyl-coenzyme A (AcCoA) production	2
as-yet-elusive metabolic circuitries	2
damaged cellular material	2
transcription factor gene support	2
human pancreas	2
etiological genes	2
NKX2-2	2
consanguineous patients	2
key transcriptional regulators	2
patients with diabetes	2
ob/ob mice	2
growth suppressor Cadm1	2
miR-375-targeted genes	2
miR-184 in leptin-deficient ob/ob mice	2
microRNA-induced silencing complex	2
(Ago2)	2
target Argonaute2	2
pancreatic islets of insulin-resistant mouse models and type 2 diabetic human subjects	2
microRNA pathway	2
islets from type 2 diabetic organ donors	2
KATP channel blocker tolbutamide	2
Na+ channels	2
elevated intracellular ATP/ADP	2
the principal hyperglycemic hormone	2
true physiological regulator of AMPK	2
acetyl-CoA carboxylase in intact cells	2
ADP and AMP	2
p53-modulating drugs	2
various metabolic pathways	2
ApoE−/− mice	2
ApoE−/− strain	2
key mitochondrial protein	2
uncoupling protein 1 (UCP1)	2
cold-acclimated ApoE−/− and Ldlr−/− mice	2
plaque-associated microvessels	2
lipid deposition	2
apolipoprotein E−/− [ApoE−/−] and LDL receptor−/− [Ldlr−/−] mice	2
two genetic mouse knockout models	2
atherosclerotic lesions	2
small low-density lipoprotein (LDL) remnants	2
excess glucocorticoids	2
regulator of human adipogenesis	2
proadipogenic PPARγ axis	2
LMO3 overexpression	2
murine adipogenesis	2
GC receptor	2
11β-hydroxysteroid dehydrogenase type-1 (HSD11B1)	2
adipocyte fraction	2
human obese visceral adipose tissue	2
GC-dependent gene LIM domain only 3 (LMO3)	2
PD-GBA	2
impaired autophagy and dysfunctional proteasomal pathways	2
ATP synthase	2
p62/SQSTM1, ubiquitinated proteins, and insoluble α-synuclein	2
proteasomal machinery	2
glucocerebrosidase (gba) gene	2
diverse molecular functions	2
numerous phosphorylation sites	2
dynamic phosphoproteome	2
Akt/mTOR signaling network	2
core component of the mTORC2 complex	2
Akt substrate, SIN1	2
several diverse insulin-regulated kinases	2
physiological substrates	2
large-scale phosphoproteomics data	2
5,705 proteins	2
37,248 phosphorylation sites	2
insulin signaling network	2
protein phosphorylation networks	2
T-bet-deficient, but not wild-type, CD4+	2
adaptive	2
adaptive immunity (T-bet−/−xRag2−/−)	2
T-bet−/−mice	2
T-bet-deficient hosts	2
visceral adipose tissue	2
young T-bet−/− mice	2
immune cell transcription factor T-bet	2
mitochondrial RNA granules	2
large ribonucleoprotein structures	2
GRSF1 and RNase P	2
mitochondrially encoded proteins	2
classical and tRNA-less RNA precursors	2
nascent mitochondrial RNA	2
discrete foci	2
isoform of GRSF1	2
(G-rich sequence factor 1)	2
specialized domains	2
groups of animals	2
thermoneutrality mice	2
multiple mice	2
individual mouse	2
brown fat	2
imprinted delta-like homolog 1/preadipocyte factor (Dlk1/Pref1) and iodothyronine deiodinase type 3 (Dio3) functions	2
nest	2
mouse chromosome 12	2
imprinted gene cluster	2
adipogenic and thermoregulatory gene pathways	2
fasted human subjects	2
PYY3-36 and GLP-17-36 amide	2
healthy, normal-weight human subjects	2
PYY and GLP-1	2
Peptide YY (PYY) and glucagon-like peptide 1 (GLP-1)	2
brain controls appetite	2
major public health issue	2
weaker site	2
ADP, and ATP	2
tighter site	2
ADP binding sites	2
regulatory subunit of SNF1	2
physiologically relevant protein phosphatase	2
long-sought metabolite	2
activation loop segment of the catalytic subunit	2
mammalian AMP-activated protein kinase	2
extracellular glucose	2
SNF1 protein kinase complex	2
central carbon metabolism	2
respiring cells	2
glycolytic enzyme triosephosphate isomerase (TPI)	2
feedback inhibitor	2
PYK substrate phosphoenolpyruvate (PEP)	2
PYK activity	2
regulator pyruvate kinase (PYK) in yeast	2
overall mitochondrial H2O2	2
mitochondrial ROS in vivo	2
living flies	2
thoracic muscle mitochondria	2
phenol, MitoP.	2
arylboronic acid	2
triphenylphosphonium (TPP) cation	2
probe, MitoB	2
mitochondrial H2O2 in vivo	2
peroxide (H2O2)	2
sensory and motor systems	2
hypothalamic/pituitary axis	2
enteric nervous system	2
enteric neurons	2
vasopressin-like system	2
insulin-producing neurons	2
brain-gut circuit	2
autonomic neurons and hormones	2
fluid, and ion balance	2
simple and genetically amenable alternative	2
Invertebrate models	2
isolated muscles	2
homozygous knockin mice	2
14-3-3s	2
nonphosphorylatable alanine	2
14-3-3 binding	2
14-3-3 binding phospho-Thr649 (equivalent to Thr642 in human AS160)	2
Gpr119 agonism	2
PYY(3-36)	2
wild-type (WT) mouse tissue	2
NPY−/− mice	2
Endogenous PYY	2
human and mouse colon	2
acylethanolamine receptor, Gpr119	2
Enteroendocrine L cells	2
YY (PYY)	2
widely used antidiabetic drug metformin	2
CaMKK inhibitor	2
Ca2+ ionophore, A23187	2
extracellular flux analyzer	2
ADP:	2
these	2
AICAR, 2-deoxyglucose, hydrogen peroxide, metformin, phenformin, galegine, troglitazone, phenobarbital, resveratrol, and berberine	2
AMPK in WT cells	2
oligomycin and dinitrophenol	2
Mitochondrial poisons	2
isogenic cell lines stably expressing AMPK complexes containing AMP-sensitive (wild-type, WT) or AMP-insensitive (R531G) γ2 variants	2
wide variety of agents	2
weak insulin/Igf signaling (IIS) pathway mutants	2
TORC1 branch of the TOR pathway	2
TOR mutants	2
feeding rapamycin	2
inhibitory drug rapamycin	2
TOR kinase	2
evolutionarily diverse organisms	2
major nutrient-sensing pathway	2
(TOR) pathway	2
closely associated insulin granules	2
discrete microdomains	2
[Ca2+]i	2
p110α and p110β isoforms of PI3K	2
AgRPp110β null mice	2
AgRPp110α null mice	2
POMCp110α null mice	2
p110α-deficient POMC neurons	2
POMCp110β null mice	2
p110β PI3K catalytic subunits	2
agouti-related protein (AgRP) neurons	2
hypothalamic pro-opiomelanocortin (POMC) and	2
cellular energy reserves	2
AMP/ATP	2
glycogen-binding domain	2
outer branches	2
outer chains of glycogen using phosphorylase	2
upstream kinases	2
allosteric inhibitors	2
single α1→6 branch	2
series of branched oligosaccharides	2
conserved domain	2
β subunits	2
purified L cells	2
sodium glucose cotransporter 1 and ATP-sensitive K+ channels	2
α-methylglucopyranoside	2
primary L cells	2
L cells	2
enteric hormone	2
SummaryGlucagon-like peptide-1 (GLP-1)	2
melanocortin-4 receptors (MC4Rs)	2
serotonin 2C receptor (5-HT2CR) agonists	2
regulatory nucleotides AMP	2
mammalian and yeast AMPK homologs	2
nuclear receptor-regulated genes	2
cultured myofibers	2
mitochondrial biogenesis	2
oxidative fibers	2
increased expression	2
null, heterozygous, and transgenic mice	2
nuclear receptor corepressor RIP140	2
receptor signaling	2
AMPK with β-guanidinopropionic acid (β-GPA) feeding	2
5′-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR)	2
young and old rats	2
functionally limiting coactivators	2
mutation-containing versus receptor haploinsufficent primary cells	2
coexpressed wild-type receptor	2
PPARγ coactivators	2
DNA and ligand binding domains of human PPARγ	2
RUNX1/ETO-driven AML	2
G1 CCND-CDK complexes	2
immunodeficient murine hosts	2
patient-derived AML cells	2
approved drug	2
CCND2 expression	2
Cyclin D2 (CCND2)	2
cancer-specific but highly challenging therapeutic targets	2
leukemic fusion protein RUNX1/ETO	2
inflammation-driven cancer	2
SASP inhibition	2
alternative splicing of genes	2
screen candidates	2
SASP components	2
SASP regulators	2
senescence-associated secretory phenotype (SASP)	2
pediatric population	2
term	2
immune cold	2
Histone H3 subgroups (hemispheric G34R/V and midline K27M)	2
CD8+ tumor-infiltrating lymphocytes	2
BRAF_V600E or NF1 mutation)	2
pleomorphic xanthoastrocytoma ([PXA]-like	2
somatic POLE/POLD1 mutations	2
mismatch repair deficiency	2
hypermutator tumors	2
patients with newly diagnosed non-brainstem high-grade glioma (HGG)	2
bevacizumab (BEV)	2
combination immunotherapy	2
TMB low NSCLCs	2
non-small-cell lung cancer (NSCLC)	2
suite of therapeutic compounds	2
female host	2
male clone	2
extrachromosomal double minutes	2
Genes encoding PDGF receptors	2
exogenous mutagens or viruses	2
two cancers	2
two facial tumor clones	2
contagious cancer cells	2
host innate immunity	2
specific intragenic sites	2
possible driver	2
serial biopsies of vincristine-treated CTVTs	2
clonally transmissible cancer	2
canine transmissible venereal tumor (CTVT)	2
poorly infiltrated tumors	2
FcγR binding	2
anti-CTLA-4 in inflamed tumors	2
inflamed tumors	2
CD16a-V158F high affinity polymorphism	2
advanced melanoma	2
mouse model expressing human Fc-gamma receptors (FcγRs)	2
antagonistic epitopes	2
CRD2-4	2
CD40 agonists	2
membrane distal CRD1	2
potent antagonists	2
CRD2-4 binding mAbs	2
human immunoglobulin G2 isotype	2
membrane-distal cysteine-rich domain 1 (CRD1)	2
mAb formats	2
CD40 extracellular region	2
nine hCD40 mAbs engaging epitopes	2
diverse range of functions	2
receptor function	2
SummaryAnti-CD40 monoclonal antibodies (mAbs)	2
mAb-opsonized tumors	2
lymphoid cells	2
immunomodulatory mAb	2
myeloid chemo-attractants and interferon gamma	2
anti-CD27 stimulated CD8+ T and natural killer cells	2
anti-huCD27, varlilumab	2
huCD27 transgenic mice	2
multiple lymphoma models	2
anti-CD27/CD20 combination	2
extended panel of immunomodulatory mAbs	2
direct tumor-targeting mAb, anti-CD20	2
immunomodulatory receptors	2
SummaryMonoclonal antibodies (mAbs)	2
human T-ALL of the TLX+ clinical subtype	2
T cell acute lymphoblastic leukemia (T-ALL)	2
ICN1 signaling	2
intracellular domain of Notch1 (ICN1)	2
ubiquitin ligase Cbl-b	2
immature T cells	2
GEF Vav1 unexpectedly	2
SummaryRho guanine exchange factors (GEFs)	2
HIF-1α/VEGF-A axis	2
human breast cancer	2
HIF target gene	2
two key HIF isoforms	2
hypoxic tumor microenvironment	2
small subsets of tumors	2
infant population	2
Genomic aberrations	2
lower-grade tumors	2
Histone wild-type subgroups	2
TOP3A rearrangements in H3.3K27M	2
FBXW7 in H3.3G34R/V	2
histone-mutant subgroups	2
1,000 cases	2
publicly available datasets	2
diffuse intrinsic pontine glioma	2
pediatric high-grade glioma	2
157 unpublished cases	2
normal vasculature	2
patient-derived biopsies	2
patient-derived xenografts (PDX)	2
acute myeloid leukemia	2
BM vasculature	2
altered bone marrow (BM) microenvironment	2
SWI-SNF and JAK2-STAT3 pathways	2
early drivers	2
driver mutations	2
299 samples	2
panel of 365 genes	2
liquid biopsy biosources	2
gene panels	2
n = 518 late-stage validation cohort	2
early- and late-stage non-small-cell lung cancer	2
platelet RNA-sequencing libraries	2
RNA biomarker panels	2
promising biomarker sources	2
tumor-educated blood platelets (TEPs)	2
SummaryBlood-based liquid biopsies	2
poor-quality and insufficiently selective chemical probes	2
complementary biological reagents	2
Chemical probes	2
valuable reagents	2
Small-molecule chemical probes or tools	2
CRC TIAM1	2
nuclear TIAM1	2
TAZ/YAP target genes	2
Nuclear TIAM1	2
TAZ/YAP	2
critical antagonist	2
identified regulatory loop	2
Syk inhibition	2
Syk signaling	2
Hoxa9 overexpression	2
transcription factor PU.1	2
direct target of miR-146a	2
targetable signaling pathways	2
myeloid progenitor cells	2
myeloid leukemogenesis	2
B cell malignancies	2
PD-1/PD-L1 signaling	2
cynomolgus monkeys	2
B cells and bone marrow plasma cells	2
human plasma cells and patient-derived myeloma cells	2
target molecule	2
CD45 phosphatase	2
multiple myeloma (MM) tumor cells	2
B cell lineage marker FcRH5	2
anti-FcRH5/CD3 T cell-dependent bispecific antibody (TDB)	2
MRD cells	2
in vivo environment	2
resistant, dormant cells	2
primary ALL cells	2
rare subpopulation	2
patient-derived xenografts of acute lymphoblastic leukemia (ALL)	2
proliferation-sensitive dyes	2
BCL9L/caspase-2/BID axis	2
MDM2 and BID	2
TP53-WT and mutant cells	2
xenograft models	2
aneuploid tumors	2
colorectal cancers and cell lines	2
aneuploid genomes	2
major adult neurogenic stem cell niche	2
human gliomas	2
cell-cycle and stem cell genes	2
Mutant SVZ cells	2
proliferative subventricular nodules	2
SVZ cells	2
SVZ markers	2
Stem and transit amplifying/progenitor cell populations	2
reduced α-ketoglutarate	2
grossly dilated lateral ventricles	2
subventricular zone (SVZ)	2
p110α subunit of PI3K	2
a driver	2
BRAF/NRAS/PTEN mutant tumors	2
BRAF and NRAS mutant melanoma cells	2
MAPK-pathway inhibitors	2
Nelfinavir profoundly sensitizes BRAF and NRAS mutant melanoma cells	2
PAX3 and MITF expression	2
potent suppressor	2
HIV1-protease inhibitor nelfinavir	2
melanoma survival oncogene MITF	2
mitogen-activated protein kinase (MAPK)-targeted therapy	2
multiple instances	2
patient-derived xenograft model	2
MYCN-amplified neuroblastoma	2
diverse models	2
Aurora Kinase A inhibitor MLN8237	2
BCL-2 inhibitor ABT-199	2
large drug screen	2
high-risk neuroblastoma	2
acute leukemia	2
tractable aberrant epigenetic circuitry	2
MLL fusions and MOZ-TIF2	2
KDM4C/PRMT1	2
chimeric transcription factors	2
H3K9 demethylase	2
various MLL and non-MLL leukemias	2
H4R3 methyltransferase	2
oncogenic transcription programs	2
epigenetic modifying enzymes	2
blood-based “liquid biopsies	2
multiclass cancer	2
blood platelets	2
EGFR, or PIK3CA tumors	2
MET or HER2-positive, and mutant KRAS	2
six different tumor types	2
localized and metastasized tumors	2
platelet samples	2
SummaryTumor-educated blood platelets (TEPs)	2
H3K36me3-deficient tumor xenografts	2
WEE1 inhibitor AZD1775	2
H3K36me3-deficient cells	2
ribonucleotide reductase subunit	2
H3K36me3-deficient cancers	2
synthetic lethal interaction	2
H3K36 trimethylation (H3K36me3)	2
P53-MYC interactions	2
relapsed human tumors	2
aggressive tumors	2
MYCN-driven medulloblastoma	2
serial medulloblastoma biopsies	2
clinical reagents	2
h2 variants	2
key hinge and CH1 cysteines	2
hinge and CH1 domains	2
unique arrangement of hinge region disulfide bonds	2
subfraction of h2, h2B	2
anti-CD40, -4-1BB, and -CD28	2
immune-stimulatory mAbs	2
immunoglobulin isotypes, human IgG2 (h2)	2
SummaryMonoclonal antibody (mAb) drugs	2
myeloma patients	2
DTP3 ablates myeloma xenografts in mice	2
D-tripeptide	2
JNK kinase MKK7	2
NF-κB-regulated antiapoptotic factor GADD45β	2
upregulating p16INK4a	2
pro-angiogenic factor VEGF-A.	2
tumor suppressor p16INK4a	2
transcription complex	2
p185BCR-ABL+B-acute lymphoid leukemia	2
lymphoid malignancies	2
cell cycle kinase CDK6	2
close homolog CDK4	2
CRC subtype	2
oncogenic signaling	2
significant subsets of CRCs	2
NO-dependent feedback loop	2
vascular endothelial growth factor expression	2
endothelial layers	2
hypoxia inducible transcription factors (HIFs)	2
FH-associated cysts	2
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-mediated antioxidant response pathway	2
Kelch-like ECH-associated protein 1 (KEAP1)	2
fumarate modifies cysteine residues	2
HIF prolyl hydroxylases	2
hypoxia inducible factor (HIF)	2
leiomyomata, renal cysts	2
human tumor suppressor	2
SummaryThe Krebs cycle enzyme fumarate hydratase (FH)	2
INK4 family members	2
p18INK4C in human GBM	2
astrocytic lineage	2
feedback regulatory circuit	2
p16INK4Ain primary astrocytes	2
established GBM cells	2
p18INK4Cin p16INK4A-deficient primary astrocytes	2
p16INK4Aand p18INK4Cresulted	2
p18INK4C in GBM cells	2
frequent p18INK4Cand p16INK4Acodeletion	2
patients negative	2
passenger mutations	2
known cancer gene FLT3	2
Cancer Cell	2
Distinguishing drivers	2
Nature Medicine	2
known human MM dysregulated genes	2
Eμ-xbp-1s lymphoid and MM cells	2
bone lytic lesions	2
Eμ-xbp-1s transgenics	2
Eμ-XBP-1s	2
XBP-1 spliced isoform (XBP-1s)	2
ESCRT-III polymers	2
essential regulatory factor	2
persisting microtubules	2
CC2D1B-depleted cells	2
CHMP7-ESCRT-III axis	2
reforming NE	2
chromatin disks	2
regulator of ESCRT polymerization	2
nuclear membrane (NM)	2
endosomal sorting complex required for transport (ESCRT) machinery	2
“repressive” nucleosome	2
differential partners	2
reshuffling nucleosomes	2
foxd3-expressing premigratory NC	2
foxd3-mutant cells	2
transient embryonic stem cell-like population	2
neural crest (NC)	2
laser wounding	2
boundaries	2
boundary cells	2
actomyosin cables	2
distinct compartments	2
supracellular cables	2
compartment boundaries	2
cells and inducible mice	2
fluorescent cilia and cell cycle biosensor	2
basal body of cilia	2
cell cycles	2
extra centrosomes	2
increased NOX-generated reactive oxygen species (ROS)	2
centrosome amplification	2
extra centrosomes-associated secretory phenotype (ECASP)	2
3D mammary organoids and zebrafish models	2
interleukin-8 (IL-8)	2
paracrine-signaling axis	2
supernumerary centrosomes	2
subset of cancer cells	2
excess material	2
medial area	2
E-cadherin density	2
actomyosin cytoskeleton	2
endocytic machinery	2
apical cell area	2
DDR network	2
meiotic and post-meiotic genes	2
X chromosome accrues DDR proteins	2
histone H3-lysine-9 methyltransferase SETDB1	2
DDR proteins	2
DNA damage response (DDR) network	2
Asynapsed homologs	2
D. discoideum	2
niche-derived growth signals	2
ISC intrinsic hexosamine synthesis	2
stem cell extrinsic growth signal	2
Drosophila midgut model	2
different CNS regions	2
distinct post-natal cell lineages	2
embryonic Pdgfra+ cells in the CNS	2
pericyte lineage	2
E13.5 Pdgfra+ cells	2
Pdgfra+ pre-OPCs	2
Pdgfra+ cells	2
post-natal OPC progeny	2
brain and spinal cord	2
post-natal OPCs	2
bulk and single-cell transcriptomics resources	2
oligodendrocyte precursor cells (OPCs)	2
pancreatic sub-compartments	2
precursor pools	2
delaminating endocrine cells	2
trailing ducts	2
ductal progenitors	2
growing ducts	2
self-renewing acinar-committed precursors	2
multipotent precursors	2
termini of growing ducts	2
self-renewing precursors	2
single-cell transcriptional profiling	2
lateral membranes	2
proximal-distal axis	2
planar polarized Myosin-II	2
haltere	2
MMP1/2 proteases	2
Stubble protease and basal matrix	2
apical extracellular matrix	2
wings and legs of Drosophila	2
plane of the tissue	2
SummaryEpithelial tissues	2
TOG2 domain	2
complete tubes	2
incomplete ones	2
growing but not shrinking ends	2
positively charged microtubule-binding peptide	2
TOG1 domain	2
C-terminal domain of CLASP2	2
free tubulin	2
three TOG-like domains	2
Mammalian CLASPs	2
physical barriers	2
microtubule-destabilizing agents	2
cytoplasmic linker-associated proteins (CLASPs)	2
cell-cell contact	2
N-cadherin-based cell-cell adhesions	2
nucleoplasmic PCYT1A	2
yeast and in fly photoreceptors	2
endogenous PCYT1A	2
nuclear localization signal mutants	2
yeast, fly, and mammalian cells	2
abundant phospholipid in eukaryotic membranes	2
Phosphatidylcholine (PC)	2
complex mixture of phospholipids (PLs)	2
organelle membranes	2
r4, and r6	2
cyp26b1/c1 expression	2
adjacent segments	2
r3 or r5 cells	2
r2, r4, and r6	2
cyp26b1 and cyp26c1 in r3 and r5	2
rhombomeres r3 and r5	2
retinoic acid degrading enzymes, cyp26b1 and cyp26c1	2
another segment	2
remodeling kinases	2
unpaired or interlocked chromosomes	2
nuclear rim	2
prominent scaffold	2
nuclear membrane-spanning proteins	2
primary direct platform	2
autophagic precursor membranes	2
phosphatidylinositol 3-phosphate (PI3P)	2
LC3 family members	2
Developmental Cell	2
scaffold protein APC	2
epithelial wound gap	2
wound of cell debris	2
hemocytes, Drosophila macrophages	2
wound	2
pupal fat body cells	2
equivalent of vertebrate adipocytes in Drosophila	2
MO and off-target sequence	2
control or target MOs	2
core gene regulatory network	2
KO and KD embryos	2
frog Xenopus tropicalis	2
mesoderm-specifying Brachyury paralogs	2
(KD) genes	2
morpholino oligomers (MOs)	2
CSL-related corepressors	2
Notch co-activator Mastermind	2
Notch-ON conditions	2
CSL molecules	2
Notch-OFF nuclei	2
DNA-binding factor CSL	2
MYO6-dependent actin cages	2
neighboring populations	2
F-actin cages	2
myosin motor	2
unique myosin	2
MYO6 (myosin VI)	2
damaged, ubiquitinated mitochondria	2
aberrant mechanosensing	2
costameres	2
PKC and non-muscle myosin	2
non-muscle myosin	2
healthy adult heart tissue	2
mechanosensitive adaptor protein talin on substrates	2
single cardiomyocyte adhesions	2
 a stiffer environment	2
proB cells	2
CD19−IL-7R+ compartment	2
endogenous ETV6 locus	2
Genome-engineered hPSCs expressing ETV6-RUNX1	2
differentiating human pluripotent stem cells (hPSCs)	2
developmentally restricted CD19−IL-7R+ progenitor compartment	2
first-trimester human embryos	2
first emerging B cells	2
ETV6-RUNX1 cALL	2
childhood acute B-lymphoblastic leukemia (cALL)	2
morphogen signals	2
ligand Sonic Hedgehog (SHH)	2
ciliary membrane	2
Hh signal	2
oncoprotein	2
Smoothened (SMO)	2
tetraspan protein	2
unannotated gene	2
Negative regulators	2
two different cell types	2
multiple signaling and differentiation assays	2
top hits	2
positive and negative pathway components	2
autophagy protein	2
CCPG1 gene	2
discrete motif	2
mammalian ATG8 proteins	2
LIR motif	2
core autophagy proteins	2
non-canonical cargo receptor	2
ER-resident protein	2
cell-cycle progression gene 1 (CCPG1)	2
elegant model	2
Nodal and/or Fgf signaling	2
endoderm progenitors	2
first two cell tiers	2
cell-autonomous Fgf signaling inhibitor Dusp4	2
single morphogen gradient	2
PAR network	2
distinct functional assemblies	2
CDC-42-dependent assembly	2
anterior	2
PAR-3-dependent assembly	2
distinct, specialized aPKC-containing assemblies	2
Caenorhabditis elegans zygote	2
one side of the cell	2
spatially defined membrane domain	2
functionally polarize cells	2
animal cell types	2
core unit of the PAR protein network	2
SummaryThe conserved polarity effector proteins PAR-3, PAR-6, CDC-42, and atypical protein kinase C (aPKC)	2
overlapping sets of genes and transposable elements	2
HRDE-1 and Aquarius	2
germline Argonaute HRDE-1	2
conserved RNA helicase Aquarius/EMB-4	2
nascent RNA transcripts	2
Argonaute proteins	2
blastula-to-gastrula stage	2
limiting replication initiation factor Drf1	2
checkpoint kinase Chk1 at the MBT	2
bulk transcription and cell-cycle checkpoints	2
many metazoan embryos	2
distinct RNA helicases	2
MVH complex containing PIWI proteins, piRNAs, and slicer products	2
Mouse Vasa Homolog (MVH)	2
pre-piRNA intermediate	2
16-nt by-product	2
MILI slicing	2
nuclear MIWI2	2
target-derived piRNAs	2
PIWI protein MILI	2
poorly understood adaptive pathway	2
RNAs called PIWI-interacting RNAs (piRNAs)	2
downstream effector Pak6	2
vaccinia virus protein F11	2
pro-proliferation cues	2
endocrine specification	2
un(der)phosphorylated Ngn3	2
developing pancreas	2
earliest endocrine cell type	2
phosphomutant form of Ngn3	2
Replacing wild-type protein	2
multiple serine-proline sites	2
cyclin-dependent kinase	2
proneural transcription factor Neurogenin3 (Ngn3)	2
regulatory network architecture	2
neural and mesodermal tissue	2
newly generated mesodermal cells	2
opposing retinoic acid (RA) and Wnt signals	2
spinal cord and trunk mesoderm tissue	2
network controlling bipotent neuromesodermal progenitors (NMPs)	2
SummaryTranscriptional networks	2
THADA mutant flies	2
uncoupler	2
sarco/ER Ca2+ ATPase (SERCA)	2
cold	2
THADA knockout flies	2
different climates	2
select transcripts	2
polyribosomes days	2
properly spliced transcripts	2
stable RNAs	2
developmentally regulated IRTs	2
Meiotic intron-retaining transcripts (IRTs)	2
weak splice sites	2
Retained introns	2
pyruvate FRET-sensor reporter mouse line	2
glycolytic metabolite	2
posterior, more undifferentiated PSM	2
organogenesis-stage mouse embryos	2
epithelial surface cells	2
combination of theory and experiments	2
blastoderm	2
apolar daughter cells	2
Daughter cells	2
8-cell stage embryo	2
isolated blastomeres	2
reduced system	2
decisive cue	2
embryonic lineage	2
extra-embryonic trophectoderm	2
many tasks	2
multitude of guidance cues	2
fascinating cells	2
complex developmental origins	2
tissues within the body	2
multifunctional innate immune cells	2
XO females	2
XX males	2
Sex chromosomally abnormal models	2
Ohno's hypothesis	2
mouse and human germ cells	2
autosomal gene output	2
X gene	2
developmental signaling pathways	2
decapentaplegic signaling	2
APC/C degrades dNek2	2
(dNek2)	2
Wg modulator, Drosophila Nek2	2
developing Drosophila eye	2
anaphase-promoting complex or cyclosome (APC/C)	2
master cell-cycle regulator	2
insulated neighborhoods	2
distance-independent contacts	2
Shh TAD	2
regulatory contacts	2
Shh expression	2
Shh enhancers	2
Shh locus	2
highly organized topologically associating domains (TADs)	2
distant enhancers	2
epithelial and mesenchyme-like tissues	2
EpB3b interactions	2
intracellular EphrinB1 domains	2
immediate tissue interfaces	2
long-distance cell-cell contacts	2
Cellular protrusions	2
liver bud	2
zebrafish liver	2
adjacent lateral plate mesoderm (LPM)	2
organs in the body	2
large areas of the brain	2
neuronal structure	2
Receptor Protein Tyrosine Phosphatase RPTP69d	2
 Robo receptors in the brain	2
Drosophila higher-order brain circuits	2
Slit and Robo receptors	2
wiring brain circuits	2
Robo receptors	2
Round-About (Robo) receptors	2
axonal wiring molecule Slit	2
robust and faithful experimental system	2
human germline	2
active chromatin marks (H3K4me3 or H3K27ac)	2
demethylation-resistant regions	2
Repressive chromatin marks (H3K9me2/3)	2
PGC-like cells	2
human and mouse germline	2
naive embryonic stem cells	2
elutriation and single-cell flow cytometry	2
rpl mutant	2
 the organ boundary gene LIGHT-SENSITIVE HYPOCOTYL 4	2
organ boundaries	2
key shoot development pathways	2
central and peripheral regions	2
Arabidopsis homeodomain protein REPLUMLESS (RPL)	2
relatively inaccessible region of the shoot apical meristem	2
ductal network	2
residual milk and cell corpses	2
live phagocytic neighbors	2
dying neighbors	2
mammary alveolar epithelia	2
second pregnancy	2
epithelial tree	2
Rac1 in mammary epithelia	2
opposing aPKC pockets	2
CR3 inhibitory arms	2
stable apical Par complexes	2
Par3/Baz CR3	2
either CR3 motif	2
phospho-acceptor site	2
efficient in vitro substrate	2
either motif	2
high-affinity anchor	2
second CR3 motif	2
P-loop/αB/αC contacts	2
aPKC kinase N lobe	2
PKC consensus site	2
CR3 motif	2
substrate access	2
primed aPKC kinase domain	2
tight inhibitory complex	2
Par3 conserved region 3 (CR3)	2
adherens junctions (AJs)	2
phosphorylates Par3/Baz	2
high-affinity interaction	2
epithelial apical domains	2
Par3/Baz (Bazooka in Drosophila)	2
key apical-basal polarity determinant and Par complex component	2
protein kinase C (aPKC)	2
former programs the hemogenic endothelium	2
paracrine input of Tgfβ3	2
endothelial cells themselves	2
Notch ligand Jagged1a	2
transforming growth factor β (TGFβ)	2
an endothelial-to-hematopoietic transition (EHT)	2
embryonic dorsal aorta	2
hematopoietic progenitor cells (collectively known as HSPCs)	2
mature blood lineages	2
PRG-1-deficient animals	2
adhesome components src, paxillin	2
postsynaptic density	2
intracellular PRG-1 C terminus	2
presynaptic LPA receptors	2
glutamatergic synapses	2
postsynaptic plasticity-related gene 1 (PRG-1)	2
noncentrosomal microtubules	2
Shot/Patronin ncMTOCs	2
apical-basal microtubule arrays	2
Both proteins	2
axis determinants	2
Par-1 polarity kinase	2
existing microtubule minus ends	2
 γ-tubulin	2
cortical ncMTOCs	2
microtubule minus-end-binding protein, Patronin	2
actin-binding domain	2
noncentrosomal microtubule organizing centers (ncMTOCs)	2
cortical anchor	2
spectraplakin, Short stop (Shot)	2
polarizing differentiated cells	2
Asterless (Asl)	2
Polo-docking site	2
conserved centriole protein Sas-4	2
older mother and a younger daughter	2
centriole pair	2
alphoid DNA	2
Mis18 complex	2
KAT7-containing acetyltransferases	2
new CENP-A or histone H3.3 assembly	2
heterochromatic H3K9me3 modification	2
ectopic alphoid DNA integration site	2
Tethering KAT7	2
histone H3-K9 trimethylase Suv39h1	2
centromeric CENP-A assembly	2
acetyltransferase KAT7/HBO1/MYST2	2
CENP-A assembly factor M18BP1	2
CENP-A assembly	2
adjacent chromatin	2
pericentric heterochromatin	2
part of the long α-satellite (alphoid) DNA array	2
Human centromere chromatin	2
chromatin containing histone H3 variant CENP-A	2
endosomal oxysterol-binding protein ORP1L	2
ER-localized VAP	2
ER-derived cholesterol	2
ER and endocytic organelles	2
subpopulation of differentially regulated contact sites	2
Ca2+-dependent ligand, S100A11	2
intraluminal vesicles (ILVs)	2
endocytosed EGFR	2
ER-localized phosphatase, PTP1B	2
ER-MVB contacts	2
ER and multivesicular endosomes/bodies (MVBs)	2
AP-2 cargo engagement	2
Fcho1/2 interdomain	2
temporary Fcho1/2⋅Eps15/R⋅AP-2 ternary complexes	2
unstructured Eps15/R C terminus	2
distinct DPF-based codes	2
 fleeting	2
, AP-2 assemblies	2
two endocytic pioneers	2
spacing-dependent DPF triad	2
Eps15/R⋅Fcho1 μ-homology domain complex	2
endocytic pioneers Fcho1/2 and AP-2	2
early-arriving endocytic pioneers Eps15/R	2
arrayed Asp-Pro-Phe (DPF) motifs	2
cargo-sorting lattice	2
discrete coat constituents	2
SummaryClathrin-coated vesicles	2
in vivo, ex vivo, and in vitro	2
complement component C3a	2
external layer of the tissue	2
animal hemisphere	2
amphibian epiboly	2
multilayered tissues	2
repressive and activating transcriptional regulators, GLI2 and GLI3	2
morphogen Sonic hedgehog (SHH) in the chick and zebra finch	2
members of related taxa	2
in vivo biological function	2
FGFR1-SPRY2 signaling axis	2
airway basal cells	2
Fgfr1 or Spry2 in basal cells of the adult mouse trachea	2
steady-state airway epithelium	2
several initially permitted options	2
key nodes in the network	2
Shh-induced transcription factors	2
several domains	2
broadly expressed transcriptional activators	2
entire transcriptional programs	2
specific transcription factor binding	2
direct gene-regulatory inputs	2
distinct progenitor populations	2
in vitro differentiation system	2
different neuronal subtypes	2
multiple molecularly distinct progenitor domains	2
morphogen-induced transcriptional network	2
powerful resource	2
TEAD/YAP factors	2
hematopoietic specification	2
dynamic core regulatory network model	2
purified embryonic stem cell-derived cells	2
entire developmental pathway	2
tissue-specific transcription factors	2
specific gene expression programs	2
cellular spatial domain	2
geometric edges	2
developing lateral organs	2
plant GTPase of the Rab family of membrane-trafficking regulators	2
cell edges	2
Previously unidentified membrane vesicles	2
important additional cellular spatial domain	2
Arabidopsis endomembrane system	2
biochemically distinct domains	2
individual faces	2
Polyhedral plant cells	2
anisotropic cell wall growth	2
methylation-deficient trophoblast	2
Polycomb Repressive Complex 1 protein	2
several methylation-regulated genes	2
key placental regulator Ascl2	2
Dnmt3a/3b mutants	2
extraembryonic lineage	2
Drosophila wing imaginal disc growth	2
 our tools	2
larger bioimaging platform	2
computer-science background	2
broad audience	2
4D confocal imaging	2
contours	2
user-friendly graphical user interfaces	2
time-lapse microscopy	2
powerful optogenetic system	2
optogenetic component expression	2
neural tube and the embryo’s enveloping layer epithelium	2
apical polarity protein Pard3	2
precise subcellular location of proteins in multicellular organisms	2
single cells in culture	2
Light-induced heterodimerization	2
living vertebrate embryo	2
specific cells	2
specific subcellular regions	2
heterochromatin body formation	2
Pdd1p and RNA	2
phosphorylated residues of Pdd1p	2
the Heterochromatin Protein 1-like protein Pdd1p	2
heterochromatin body component Jub1p	2
heterochromatin bodies	2
diverse eukaryotes	2
higher-order heterochromatin bodies	2
SummaryHeterochromatic loci	2
single cells or groups of cells	2
conserved transcription factor foundation	2
marmoset embryos	2
Embryo culture experiments	2
alternative signaling pathways	2
marmoset primate blastocysts	2
preimplantation epiblast	2
core transcriptional circuitry	2
embryonic stem cells and diapaused embryos	2
naive pluripotency in vivo	2
expression modules	2
discrete embryonic cell types	2
preimplantation mammalian embryo	2
trans-regulators	2
mRNA UTRs	2
Specific cis-regulatory elements	2
Many mRNAs	2
retracting cell body	2
protrusive front	2
microRNA miR-430	2
Nodal and Lefty	2
temporal window	2
endogenous Nodal	2
phosphorylated Smad2	2
specific zebrafish Nodal biosensor	2
antagonist Lefty	2
reaction-diffusion system	2
long-range signaling gradient	2
morphogen Nodal	2
tissues in embryos and adults	2
neuronal cell types	2
zebrafish retina	2
key fate-influencing transcription factors	2
equipotent early RPCs	2
determinative machinery	2
RPCs	2
retinal progenitor cells (RPCs) in vertebrates	2
cells in vivo	2
cadherin junction	2
pre-migratory and migratory neural crest cells	2
migratory stem cell population	2
stable junctions	2
Various cell types	2
Minute−/+ cells	2
JAK-STAT ligand Unpaired-3	2
stem and differentiated cells	2
weak tissues	2
biophysical modeling	2
homeostatic tissue	2
adult Drosophila posterior midgut	2
potentially harmful cells	2
lifetime	2
aortic endothelium	2
peritruncal plexus ECs	2
aortic lumen	2
peritruncal endothelial cells (ECs)	2
outflow tract	2
wall of the developing aorta	2
encircling capillary network	2
peritruncal plexus	2
CA stems	2
absent or misplaced CA stems	2
intra-ventricular coronary arteries (CAs)	2
embryonic Cxcl12-null hearts	2
embryonic and post-natal life	2
receptor CXCR4	2
chemokine CXCL12	2
Shh morphogen gradient	2
key effector Smoothened	2
Shh receptor Patched1	2
Sonic hedgehog (Shh)	2
ventral spinal cord	2
diverse classes of neurons and glia	2
neural stem and progenitor cells	2
functional N-terminal, membrane-inserting, curvature-sensing/driving amphipathic helix	2
wild-type CALM	2
either adaptor	2
“necked”/“closed” CCVs	2
“open” clathrin-coated pits (CCPs)	2
two cargo-selecting, clathrin adaptors, CALM and AP2	2
mammalian endocytic CCVs	2
three most abundant proteins	2
endocytic clathrin-coated vesicles (CCVs)	2
crowded tissue environment	2
isotropic and rigid form	2
relatively isotropic metaphase cortex	2
Cdc42/aPKC/Par6	2
lateral cell surfaces	2
apical protein complexes	2
Cdc42, aPKC, and Par6	2
Diaphanous-mediated cortical actin nucleation	2
Pbl/Ect2	2
model epithelium	2
RhoGEF Pbl/Ect2	2
cortical actomyosin organization	2
tissue-specific cofactor	2
Meis binding	2
Hox motifs	2
subset of Meis prebound sites	2
Hox-positive and -negative arches	2
Meis occupancy	2
developing vertebrate head	2
series of segments	2
Hoxa2 in the branchial arches	2
Meis, Pbx, and	2
homeodomain TFs Pbx and Meis	2
Hox proteins	2
VEGF-induced blood vessels	2
ERG in vivo	2
ErgcEC-KOembryos	2
ERG-deficient endothelial cells	2
Wnt receptor Frizzled-4	2
postnatal retina and tumors	2
ERG (ErgiEC-KO)	2
ERG (ErgcEC-KO)	2
junctional integrity	2
ETS transcription factor ERG	2
polarized neural stem cells	2
apicobasal polarity	2
activated aPKC	2
cyclin-dependent kinase 2 (Cdk2)	2
N-terminal site of the cell-cycle inhibitor p27Xic1	2
the apically localized serine/threonine kinase aPKC	2
 mammalian systems	2
apicobasally polarized neuroepithelial cells in Xenopus laevis	2
apicobasally polarized stem cells	2
Rab regulators	2
motor linkers	2
coiled-coiled proteins	2
tethering complexes	2
Rab2, Rab4, Rab5, Rab6, Rab7, Rab9, Rab18, Rab19, Rab30, and Rab39	2
diverse proteins	2
known components	2
Drosophila orthologs of known effectors	2
Rab	2
comprehensive set of Drosophila Rabs	2
any, effectors	2
organelles and vesicles	2
peripheral membrane proteins	2
artificial chromosomes	2
chromatin factors	2
repetitive DNA sequences	2
complex kinetochore machinery	2
CENP-A, centromeres	2
centromere-specific histone H3 variant	2
JNK and Dpp	2
AP-1 and Schnurri binding sites	2
transcriptional regulatory module	2
proapoptotic gene reaper	2
SummaryJun N-terminal kinase (JNK)	2
abi mutants	2
filopodia-like extensions	2
tips	2
Arp2/3 complex-mediated actin assembly	2
extended proline rich motif	2
Ena/VASP EVH1 domain	2
/VASP proteins	2
specialized signaling compartments	2
microvasculature of brain and retina	2
luminal VEGFR1	2
circulation or the parenchymal side	2
histamine, IGFBP3, and LPA	2
highly polarized environment	2
quiescent stem cells	2
blood-brain barrier glia	2
underlying neural stem cells	2
insulin/insulin-like growth factor pathway	2
blood-brain barrier glial cells	2
quiescent neural stem cells	2
Drosophila CNS	2
H4K20me1-specific demethylase PHF8	2
 CENP-A	2
 the 	2
 the histone H4	2
 chicken and human cells	2
highly repetitive sequences	2
chicken centromeres	2
centromere-specific histone modifications	2
additional proteins	2
centromere-specific histone CENP-A.	2
vertebrate cells	2
important intermediate	2
appropriate functional site	2
frequent Wilson-disease-causing ATP7B mutant	2
hepatocytes	2
canalicular pole of hepatocytes	2
p62 subunit of dynactin	2
canalicular area of hepatocytes	2
bile	2
excess copper	2
copper transporter ATP7B.	2
essential yet toxic metal	2
TGN	2
subunit of the retromer complex	2
endosomal membrane	2
VARP ankyrin repeat/Rab32:GTP complex structure	2
Mutant versions of VARP	2
SNARE complex formation	2
VARP binding	2
endosomal/lysosomal R-SNARE VAMP7	2
Rab32/38 effector	2
cytolinker protein Shot	2
minus ends of acentrosomal microtubule bundles	2
medial actomyosin network	2
wild-type embryos	2
apical medial actomyosin network	2
placodal cells	2
centrosomal attachment	2
apicobasal axis	2
salivary glands in the fly embryo	2
continuous lumen of the trans-Golgi network	2
vWF quanta	2
ribbon architecture	2
main WPB cargo	2
von Willebrand factor (vWF)	2
secretory carriers	2
endothelial-specific secretory granules	2
SummaryWeibel-Palade bodies (WPBs)	2
cytoplasmic scaffolds	2
Polo/Plk1 specifically	2
domain in Drosophila Cnn	2
centrosomes mature	2
pair of centrioles	2
cell organizers	2
stem cells or intermediate progenitors	2
a transcription factor	2
activated Dia	2
DiaFH1FH2-mediated nucleation	2
Dia directly	2
long, stable filopodia	2
Diaphanous (Dia) and Enabled (Ena)	2
diverse protrusions	2
individual actin regulators	2
microtubule-generating pathways	2
usually dominant centrosome	2
preexisting ones	2
Drosophila embryonic spindle forms	2
organized, bipolar mass of microtubules	2
Plk4-Cep152 complex	2
ectopic membranous sites	2
tethering Cep152	2
partner protein, Cep152	2
maternal Plk4	2
master regulator of centriole formation	2
polarity protein Pard6γb	2
eye field cells	2
ectopic Laminin1	2
eye field	2
basal lamina	2
optic vesicle cells	2
optic vesicles	2
marginal cells	2
core cells	2
margin of the eye field	2
Neuroepithelial organization	2
regions of the neural plate	2
presumptive eye cells	2
misshapen and misplaced tubules	2
tip cell anchorage	2
renal tubules	2
alary muscles	2
anterior tubules	2
specific distal tubule cell	2
renal tubules of Drosophila	2
PPE	2
Brk binding sites	2
Brk protein	2
promoter-proximal element (PPE)	2
distally located CRMs	2
cis-regulatory system controlling brinker (brk) expression	2
Summarycis-regulatory modules (CRMs)	2
enclosure	2
nascent ring	2
hole	2
polarized exocytosis	2
live-cell imaging and computational modeling	2
Cdc42 GTPase-activating proteins	2
Cdc42 activity	2
distinct plasma-membrane domains	2
mother and daughter cells	2
NRP1 cytoplasmic domain	2
full-length NRP1 or constitutively active ERK	2
endothelial tubulogenesis	2
Nrp1cytomutation	2
EAA1+ endosomes	2
Rab5+	2
endocytosed VEGFR2	2
PDZ-dependent interaction between NRP1 and VEGF receptor 2 (VEGFR2) complex and synectin	2
NRP1 cytoplasmic tail (Nrp1cyto)	2
1 (NRP1)	2
mitotic centrosome-nucleated microtubules	2
actin-based cell cortex	2
microtubule-based spindle	2
Rac1 and Rab7 activities	2
Active Rac1	2
LC3, a core autophagy regulator	2
enlarged autophagosomes	2
Rac1 effector TBC/RabGAP Armus (TBC1D2A)	2
TBC/RabGAPs	2
catabolic and degradative pathways	2
centromere core	2
endogenous centromeres	2
histone modifications H3K9me3	2
specific DNA sequence motifs	2
neocentromere	2
∼40 kb region	2
centromere-specific histone H3 variant CENP-	2
native centromeres	2
neocentromere-containing chromosomes	2
chicken DT40 cells	2
chromosome-engineering system	2
Hec1 and cyclin B2	2
Cdh1-activated anaphase-promoting complex (APCCdh1)	2
Cdk1-activating subunit, cyclin B2	2
cyclin-dependent kinase 1 (Cdk1)	2
Hec1 severely	2
mouse oocytes	2
Ndc80/Hec1 subunit of the highly conserved Ndc80 kinetochore complex	2
Src-mediated syndecan-4 phosphorylation	2
syndecan-4 phosphorylation	2
αVβ3 engagement	2
 α5β1	2
syntenin binding	2
Src phosphorylates syndecan-4	2
membrane-intercalated proteoglycan syndecan-4	2
α5β1 and αVβ3 integrins	2
integrin adhesion complex dynamics	2
DA	2
endothelial, arterial, and HSC programs	2
VEGFA short isoform	2
Vegfa hypomorphs and isoform-specific (medium/long) morphants	2
dorsal aorta (DA)	2
medium/long Vegfa isoforms	2
regulator ETO2 in embryogenesis	2
arterial cells	2
VEGFA pathway	2
endothelial and hematopoietic stem cell (HSC) specification	2
β'-COP WD-repeat domains	2
dilysine-containing cargo	2
cognate motifs	2
either domain	2
homologous α-COP domain	2
KKxx motifs	2
basic side chains of β'-COP	2
carbonyl groups in the motif backbone	2
terminal carboxylate group and first lysine residue	2
center of the β'-COP propeller	2
complementary patches	2
N-terminal WD-repeat domain of β'-COP	2
KxKxx motifs	2
C-terminal KKxx or KxKxx motifs	2
Golgi stack	2
embryonic gonadal somatic cells	2
p38α and p38β	2
Gadd45γ-deficient embryos	2
somatic cells of the developing gonads	2
Sry expression	2
testis-determining gene, Sry	2
kinase MAP3K4	2
Crumbs anisotropy	2
myosin II	2
placode border	2
supracellular actomyosin cable	2
protein Crumbs	2
Drosophila salivary glands	2
tubulogenesis	2
epithelial sheets	2
tubular structures	2
cargo-to-coat communication system	2
CCP	2
endocytic adaptor beta-arrestin	2
Smurf2 ubiquitin ligase	2
receptor’s first cytoplasmic loop	2
receptor-containing endocytic vesicle	2
Receptor ubiquitination	2
Nonubiquitinated receptors	2
enclosing CCPs	2
μ-opioid neuropeptide receptors	2
endocytic cargoes	2
proapoptotic c-Abl	2
Mig6 actively	2
c-Abl-Tyr488	2
mammary ducts	2
Errfi1 (encoding Mig6)	2
mammary epithelial cells	2
tyrosine kinase c-Abl	2
ErbB receptor	2
ligand deprivation	2
receptor tyrosine kinase signaling	2
specific growth factors	2
animals lacking p27	2
Cks2−/− cortical progenitor cells	2
Cks2−/− cells	2
Cks2−/− knockout mouse model	2
closely related CKS2	2
CDK inhibitors	2
ubiquitin ligase complex SCFSKP2	2
two CKS proteins	2
evolutionarily conserved cyclin-dependent kinase (CDK) subunits	2
immediate chromosomal environment	2
Xi CGIs	2
classes of CGI	2
de novo methyltransferase Dnmt3b	2
primary pathway	2
CpG islands (CGIs)	2
chromosomal protein Smchd1	2
mechanically stiff and rounded metaphase cortex	2
Ect2 first	2
actomyosin contractile ring	2
RhoGEF	2
Cdk1 substrate, Ect2	2
identified molecules	2
CNS midline	2
damaged siblings	2
midline cells	2
Jra expression	2
monomeric tubulin	2
cortical microtubules	2
cortical β-tubulin	2
Jun transcription factor Jun-related antigen (Jra)	2
microtubule-stabilizing GTPase mitochondrial Rho (Miro)	2
transcriptomes of single cells	2
pilot screen	2
ventral midline of the embryonic Drosophila CNS	2
pan-ciliary transcription factor, Rfx	2
fd3F regulates motility genes	2
motile cilia regulator	2
vertebrate Foxj1	2
distinct motile and sensory ciliary zones	2
retrograde transport genes	2
TRPV ion channels	2
Ch-specific axonemal dyneins	2
fd3F regulates genes	2
(Ch) neurons	2
mechanosensory cilium of chordotonal	2
Drosophila Forkhead box (Fox) gene, fd3F	2
hugely diverse structures	2
endocytic recycling pathway	2
 a transferrin-positive endocytic compartment	2
FAM116A- and Rab14-depleted cells	2
ADAM family protease ADAM10/Kuzbanian	2
cell-surface N-cadherin	2
early and recycling endosomes	2
Rab14 intermediate recycling compartment	2
 an intermediate compartment of the transferrin-recycling pathway	2
Rab14 and its GEF FAM116A	2
candidate Rab GDP-GTP exchange factors (GEFs) FAM116A and AVL9	2
vesicle trafficking pathways	2
intact AP3	2
wild-type δ-adaptin	2
AP3 complex in mouse mocha fibroblasts	2
VAMP7 SNARE motif	2
linker of the δ-adaptin subunit of AP3	2
AP3 trafficking adaptor	2
late compartments	2
late endocytic compartments	2
comprehensive stem cell proteomic resource	2
blastocysts by flow cytometry	2
viable lineage progenitors	2
Identified markers	2
specific cell populations	2
lineage-specific cell-surface markers	2
27 antibodies	2
four embryo-derived stem cell lines	2
large-scale proteomic resource	2
source of embryonic (ES), epiblast (EpiSC), trophoblast (TS), and extraembryonic endoderm (XEN) stem cell lineages	2
mammalian embryos	2
symmetric divisions	2
F-actin/myosin-2	2
plane	2
plane of the epithelium	2
spindles in the epithelium	2
embryonic epithelium	2
limb bud	2
ectopic site	2
classical ZPA	2
ETS gene family	2
ZPA	2
ZPA boundary	2
multiple GABPα/ETS1 sites	2
two groups of ETS transcription factors	2
cis-regulator ZRS	2
zone	2
recycling pathway	2
operable cases of pancreatic ductal adenocarcinoma (PDAC)	2
organotypic microenvironments	2
3D matrices	2
cell rear	2
active α5β1	2
Rab25-expressing cells and tumors	2
back of invading cells	2
lysosomally targeted integrins	2
ligand-occupied, active-conformation α5β1 integrin	2
cell collectives	2
complement proteins	2
receptor C3aR	2
complement fragment C3a	2
migrating mesenchymal cells	2
cohesive clusters	2
migratory cells	2
light chain binding motif	2
splice variant of SKIP	2
two kinesin light chain binding motifs	2
microtubule-organizing center	2
Arl8 and SKIP	2
bacteria's replicative vacuole	2
light chain of kinesin-1	2
Salmonella effector protein	2
 a target	2
SifA and kinesin-interacting protein, aka PLEKHM2)	2
soluble protein SKIP	2
small GTPase Arl8	2
efficient and sustained kinetochore-microtubule interactions	2
complete set of kinetochores	2
widely scattered kinetochores	2
 the kinetochore	2
kinesin-8 motor Kip3	2
ortholog of vertebrate XMAP215/ch-TOG)	2
lateral surface	2
plus end	2
syndecan-4-regulated integrin endocytic pathway	2
fibroblasts and keratinocytes of RhoG null mice	2
dermal wounds	2
RhoG in mice	2
syndecan-4-binding domain of fibronectin	2
integrin trafficking pathways	2
cell-extracellular matrix contacts	2
Sox3 and Snail transcription factors	2
ectodermal and mesendodermal	2
two main territories	2
ectodermal derivatives	2
Sox3-positive cells	2
Snail-expressing cells	2
Snail2 and Sox3 factors	2
endoderm	2
subset of epiblast cells	2
developing amniote embryos	2
Wingless signaling	2
conserved secreted feedback inhibitor	2
well-established cell competition factor	2
APC or axin)	2
Wg signaling	2
Wingless-responding cells	2
prospective wing cells	2
wing imaginal discs	2
 a Drosophila Wnt homolog	2
 Importin β	2
nuclear components	2
chromosomal substrates	2
early anaphase	2
histone H3 (Thr3, Ser10, and Ser28)	2
Repo-Man:PP1 complex	2
protein phosphatase 1 γ (PP1γ)	2
SummaryRepo-Man	2
blood stem cell regulator TAL1/SCL	2
transcriptional enhancer elements	2
PDZK1IP1 protein	2
known hematopoietic regulators	2
five factors	2
17,263 regions	2
primary human megakaryocytes	2
GATA1, GATA2, RUNX1, FLI1, and TAL1/SCL	2
five key hematopoietic transcription factors	2
genome-wide binding sites	2
individual lineages	2
combinations of transcriptional regulators	2
specific core proteins	2
cytoplasmic core proteins	2
transmembrane core proteins, Flamingo, Frizzled, and Strabismus	2
within puncta	2
two key core proteins, Flamingo and Frizzled	2
prepupal and pupal wings	2
discrete membrane subdomains	2
adherens junctions of epithelial cells	2
Brat-mediated system	2
Mad and dMyc mRNAs	2
potent differentiation factor	2
Brain Tumor (Brat)	2
differentiating cystoblast (CB)	2
one daughter cell	2
Pumilio (Pum) and Nanos (Nos) translational repressors	2
ovarian germline stem cells (GSCs)	2
Fgf8 signaling	2
primary target of miR-9	2
knockdown	2
microRNA—miR-9	2
progenitors self-renew	2
centriole inner cartwheel	2
engaged centrioles in normal wild-type cells	2
centriole overduplication	2
extra centriolar DSas-6/Ana2	2
Sak/Plk4 kinase	2
extra DSas-6/Ana2	2
centriole proximal ends	2
SAStubules specifically	2
inner cartwheel of the centriole	2
extended tubules (SAStubules)	2
overexpressed Drosophila	2
inner “cartwheel” structure	2
conserved proteins (ZYG-1/Sak/Plk4, SAS-6, SAS-5/Ana2, and SAS-4)	2
cell-cell and cell-matrix interactions	2
localized BMP guidance cues	2
tubule cells	2
Collagen IV	2
attract hemocytes	2
tubules	2
VEGF/PDGF ligands	2
guidance signals	2
outgrowing Drosophila renal tubules	2
organs in the body cavity	2
stretched chromosome region	2
free edge	2
Rac1 activity	2
Sdf1 directionally	2
initially polarizing cells	2
motile cells in the embryo	2
cluster of cells	2
two kinases	2
phosphomimetic mutations	2
1δ/ɛ (CK1δ/ɛ) and Dbf4-dependent Cdc7 kinase (DDK)	2
casein kinase	2
two different kinases	2
separase or cohesin	2
PP2A phosphatase	2
shugoshin/MEI-S332 proteins	2
centromeric Rec8	2
pair of chromatids	2
dyad chromosomes	2
cohesin's α-kleisin subunit (Rec8)	2
chiasmata holding bivalent chromosomes	2
maternal and paternal kinetochores	2
diploid precursors	2
 haploid gametes	2
inactivating proteins	2
lysosomal hydrolase DNase II	2
isolated CCVs	2
peripheral compartment	2
endocytosed cation-independent mannose 6-phosphate receptor (CIMPR)	2
rerouted AP-1	2
APs	2
endogenous subunit	2
FKBP and rapamycin-binding domain-containing construct	2
siRNA-resistant, FKBP-tagged subunits of the adaptor protein (AP) complexes of clathrin-coated vesicles (CCVs)	2
rapamycin-induced heterodimerization	2
rapidly inactivating proteins	2
TBX5 mutations	2
key downstream effectors	2
N-Cadherin and β-Catenin	2
distinct cues	2
Tbx4 in hindlimbs)	2
appropriate three-dimensional configuration	2
bones, muscles, and tendons	2
musculoskeletal system	2
 a specific class of ILPs	2
Drosophila FoxO transcription factor	2
DILP6 expression	2
specific DILP (Dilp6)	2
canonical IIS pathway	2
insulin/IGF signaling (IIS)	2
the environment	2
retromer network	2
proposed TGN-localized tether Rab6-interacting protein-1	2
activator of the minus-end directed microtubule motor dynein	2
p150glued component of dynactin	2
specific combinations of the sorting nexins (SNX), SNX1, SNX2, SNX5, and SNX6	2
membrane-bound subcomplexes	2
four mammalian retromers	2
cargo-selective and membrane-bound subcomplexes	2
GPR-1/2 and LIN-5	2
one-celled embryo	2
casein kinase 1 gamma CSNK-1 and a PIP2 synthesis enzyme (PPK-1)	2
Gα regulators GPR-1/2	2
conserved PAR proteins	2
histone H3K9me3	2
CENP-A, CENP-B, CENP-C, and H3K4me2	2
tTA transcriptional activator	2
several tet-repressor (tetR) fusions	2
tetracycline operator (tetO)	2
CENP-B box	2
one completely artificial synthetic monomer	2
CENP-B binding site	2
one natural monomer	2
dimeric α-satellite repeat	2
active kinetochore	2
human artificial chromosome (HAC)	2
cohesin in nondividing cells	2
mushroom-body neurons	2
polytene chromosomes in salivary glands	2
TEV protease	2
postmitotic cells	2
sister-chromatid disjunction	2
α kleisin subunit (Rad21)	2
highly conserved multisubunit complex	2
polarized microtubule cytoskeleton	2
Capu pathway	2
capu mutants	2
Spire overexpression	2
spire mutants	2
Latrunculin A	2
overexpressed truncated Cappuccino	2
capu and spire mutants	2
isotropic mesh of actin filaments	2
Cappuccino and Spire	2
actin nucleators Cappuccino and Spire	2
developing HF	2
certain HFs	2
follicular outer root sheath	2
epithelial Shh signaling	2
remaining stem cells	2
resulting follicular stem cell niches	2
skin epithelium	2
Shh signal tranducer Smoothened	2
vitro hepatocyte assay	2
rainbow trout and common carp	2
hepatocyte suspensions	2
liver in vivo	2
vivo and in vitro samples	2
suspensions of freshly isolated or cryopreserved primary hepatocytes	2
vitro incubations	2
feed containing the pesticide methoxychlor (MXC)	2
Rainbow trout and common carp	2
vitro fish hepatocyte assays	2
isolated primary fish hepatocytes	2
male-predominant genes	2
Estrogen Receptor-beta transcription	2
Hepatic Estrogen Receptor-alpha mRNA	2
Estrogen receptor-beta	2
female-specific Vitellogenin	2
Cytochrome P-45019a	2
Aquat Toxicol 105, 41–48)	2
untreated fish	2
Nuclear receptor subfamily 5 group number 1b	2
Double sex and mab-related protein, Sry-related HMG box-9a	2
Anti-Mullerian Hormone	2
(Danio rerio)	2
testes and liver of adult zebrafish	2
transcription of genes	2
synthetic estrogen 17α-ethinyl estradiol (EE2)	2
miR-621 and/or SETDB1	2
p53-signaling pathway	2
miR-621 and/or SETDB1 axis	2
3′ UTR of SETDB1	2
Dual-luciferase reporter assays	2
miR-621 and SETDB1 in HCC tissues	2
in vivo and in vitro assays	2
HCC tissues and cells	2
 normal liver cells	2
bolus of intravitreal aflibercept (standard of care)	2
clinically relevant choroidal neovascularization lesions	2
laser-induced choroidal neovascularization model	2
ADVM-022-derived aflibercept	2
ADVM-022, an adeno-associated virus vector encoding aflibercept	2
dosing schedule	2
frequent intravitreal injections	2
several approved therapies	2
albumin locus in hepatocytes	2
corrective copy of the IDUA gene	2
replacement enzyme	2
glycosaminoglycans (GAG)	2
lysosomal hydrolase α-L-iduronidase (IDUA)	2
conjunctival scarring	2
rabbit conjunctival tissues	2
MRTF-B mRNA	2
MRTF-B LYR nanoparticles	2
MRTF-B siRNAs	2
LYR nanoparticles	2
non-targeting formulation	2
targeting peptide Y (LYR)	2
DOTMA/DOPE lipid	2
LPR formulation	2
human conjunctival fibroblasts	2
targeting or non-targeting peptides	2
LPR nanoparticle formulations	2
optimized lipid-peptide-siRNA (LPR) nanoparticles containing MRTF-B siRNAs	2
siRNA therapies	2
cytoskeletal gene expression	2
(MRTF/SRF) pathway	2
myocardin-related transcription factor/serum response factor	2
double-stranded small interfering RNA (siRNA) molecules	2
new recombinant BCG vaccines	2
Guinea pigs	2
recombinant strain	2
copy of phoP-phoR	2
BCG-Japan	2
M. bovis allele of phoP-phoR	2
BCG-Prague’s immunogenicity	2
M. bovis allele of phoP	2
BCG-Prague	2
phoP of the PhoP-PhoR two-component system	2
number of genetically distinct substrains	2
live tuberculosis vaccine Mycobacterium bovis BCG (Bacille Calmette-Guérin)	2
in vivo Matrigel assay	2
pericyte coverage	2
angiopoietin-1 promoter	2
angiopoietin-1 gene and protein expression	2
microRNA-532-5p mimic	2
luciferase assay	2
BACH1, HIF1AN, and EGLN1	2
potential candidates	2
angiopoietin-1 transcription	2
microRNA-532-5p inhibitory targets	2
microRNA-532-5p-overexpressing pericytes	2
anti-microRNA, microRNA-mimic	2
murine muscular pericytes	2
skeletal muscle and adventitial pericytes	2
human microRNAs	2
alternative co-inhibitory and senescence program	2
PD-1 knockdown	2
HBV-associated HCC viral antigens	2
endogenous or genetically engineered specificity	2
co-inhibitory pathways	2
pro-inflammatory PD-L1hi liver microenvironment	2
3D microdevice	2
control lentiviral vector	2
lentiviral (LV)-shPD-1 consistently	2
Antigen-specific and intrahepatic CD8 T cells	2
endogenous or TCR-redirected, antigen-specific CD8 T cells	2
co-inhibitory receptor PD-1	2
viral tumor antigens	2
HBV-related HCC	2
Checkpoint inhibitors	2
mixture of iPSC-CMs	2
microRNAs and proteins in the exosomes	2
several cytokines and exosomes	2
iPSC-CM structural framework	2
A-, H-, and I-bands	2
aligned myofibrils	2
iPSC-CMs co-cultured	2
failing myocardial tissues	2
human induced pluripotent stem cells (iPSC-CMs)	2
differentiated cardiomyocytes	2
pluripotent hiPSCs	2
hiPSC cultures	2
HIF1α-peroxisome proliferator-activated receptor (PPAR) axis inhibition	2
hypoxia inducible factor (HIF)1α mRNA	2
xenotransplantation assay	2
serum- and albumin-free media	2
myocardial cells	2
active cellular agents	2
cell adhesion-promoting factor	2
secretory component of mouse embryonic fibroblast (MEF)	2
Milk fat globule-EGF factor 8 protein (MFG-E8)	2
statin preparations	2
EndMT and vascularization	2
wound vascularization	2
miR-148b mimics	2
in vivo model	2
related signaling	2
endothelial-to-mesenchymal transition (EndMT)	2
TGF-β pathway	2
the vasculature	2
Transforming growth factor beta (TGF-β)	2
GMP-compatible hESC-ECP	2
immunocompromised/immunocompetent mice	2
several murine models	2
remainder of the subset	2
60% CD31+/CD144+)	2
mostly endothelial	2
clinical-grade cell line RC11	2
multiple preclinical models	2
human stem cell-derived endothelial cell product (hESC-ECP)	2
Pluripotent stem cell-derived differentiated endothelial cells	2
tumor-resident cDCs and macrophages	2
tumor-infiltrating T cells	2
population of DT-sensitive macrophages	2
tumor myeloid compartment	2
melanoma tumor antigen	2
recruited tumor cDCs	2
cross-presenting cDC1	2
melanoma-specific TRP-2 TCR	2
tumor-resident cDCs	2
CD11c+ cells in CD11c.diphtheria toxin receptor (DTR) mice	2
B16 melanoma model	2
conventional dendritic cells (cDCs)	2
TCR gene-engineered T cells	2
immunosuppressive microenvironment	2
CD19 CAR	2
catalytic domain of caspase 9	2
an optimal compact single-protein rapamycin caspase 9 (rapaCasp9)	2
two-protein format	2
rapamycin-induced caspase 9 suicide gene	2
apical caspase caspase 9	2
FRB fragment of mTOR	2
safe and widely available immunosuppressive pharmaceutical	2
suicide gene	2
AAV transgene	2
miR-T	2
AAV-transduced cells	2
two antiviral proteins	2
additional miR-T.	2
luciferase expression	2
tetracycline-regulated on switches	2
region of a miR-21 target sequence (miR-21-T)	2
tetracycline aptamer	2
Two on switch architectures	2
complementary competing strand	2
microRNA target sequence (miR-T)	2
ligand-bound aptamer	2
novel class of small regulatory on switches	2
scientific and clinical applications	2
RNA switches	2
lymphoma cell-specific CD8/CD4-dependent T cell immunity	2
CpG-STAT3dODN induced expression of genes	2
unconjugated STAT3dODN	2
CpG7909 co-injected	2
CpG7909 alone	2
syngeneic A20 lymphoma	2
systemic CpG-STAT3dODN administration	2
human OCI-Ly3 lymphoma	2
human and mouse lymphoma cells	2
CpG-STAT3dODN blocked STAT3 DNA binding and activity	2
(dODN)	2
high-affinity decoy oligodeoxynucleotide	2
STAT3 inhibitor	2
clinically relevant TLR9 agonist (CpG7909)	2
dual-function molecule	2
Toll-like receptor 9 (TLR9)/MyD88 and STAT3 transcription factor signaling	2
activated B cell-like type diffuse large B cell lymphomas (ABC-DLBCLs)	2
non-Hodgkin’s lymphoma	2
siRNA conjugates	2
non-human primate	2
preclinical species	2
advanced designs	2
multiple siRNAs	2
strands of the double-stranded siRNA duplex	2
2′-deoxy-2′-fluoro and 2′-O-methyl ribosugar modifications	2
chemically modified small interfering RNA (siRNA) designs	2
asialoglycoprotein receptor	2
synthetic triantennary N-acetylgalactosamine ligand	2
AAV8-antiVEGFfab in patients with NVAMD	2
× 1010 GC of AAV8-antiVEGFfab	2
× 	2
total RD	2
Tet/opsin/VEGF mice	2
null vector-injected eyes	2
model of type 3 choroidal neovascularization (NV)	2
human VEGF in retina (rho/VEGF mice)	2
anti-human VEGF antibody fragment (antiVEGFfab)	2
VEGF-neutralizing protein	2
many patients with neovascular age-related macular degeneration (NVAMD)	2
γδ CAR-T cell products	2
responder alpha beta T (αβT) lymphocytes	2
processed peptide	2
Expanded CAR-transduced Vδ2 cells	2
tumor cells in vitro	2
GD2-expressing cancer cell lines	2
Vδ1 and Vδ2 subsets	2
GD2-targeting CAR	2
defined cell surface tumor antigens	2
Chimeric antigen receptors (CARs)	2
professional antigen-presenting cells	2
Gamma delta T (γδT) lymphocytes	2
single vectors	2
triple AAV vectors in pig retina	2
retina of a mouse model	2
recombinant ALMS1	2
mouse photoreceptors	2
full-length transcripts	2
number of aberrant transcripts	2
expected full-length products	2
(ALMS)	2
Usher syndrome type 1D or Alström syndrome type	2
dual AAV vectors	2
sequential H1N1 and H3N2 challenges	2
trivalent formulation	2
three strains of influenza H1N1, H3N2 (X31), and B (Massachusetts) as sa-RNA vaccines	2
μg mRNA	2
synthetic mRNA and sa-RNA expressing influenza virus hemagglutinin	2
antigen of interest	2
virally derived	2
antigen of interest and self-amplifying RNA (sa-RNA)	2
synthetic mRNA molecules	2
Two RNA vaccine platforms	2
cell free	2
RNA-based vaccines	2
New vaccine platforms	2
lentivirally modified HSPCs	2
lentiviral integration sites	2
xenotransplantation mouse model	2
immune-deficient (nonobese diabetic/severe combined immunodeficiency/interleukin-2 gamma receptor null [NSG])	2
repopulating human HSPCs	2
patients with β-thalassemia or sickle cell disease	2
multiple normal human donors	2
primary CD34+ cells	2
CD34+ hematopoietic stem and progenitor cells (HSPCs)	2
ParvOryx01 results	2
infected tumors	2
antibody formation	2
blood-brain/tumor barrier	2
tumor and peripheral blood	2
resection cavity	2
intratumoral or intravenous injection	2
recurrent glioblastoma patients	2
oncolytic parvovirus	2
preclinical glioma models	2
rat H-1 parvovirus (H-1PV)	2
malignant brain tumors	2
Oncolytic virotherapy	2
P. aeruginosa biofilm aggregates	2
12-patient randomized clinical trial	2
tobramycin and tobramycin combined with ceftazidime	2
ex vivo CF sputum	2
ex vivo model	2
non-bactericidal, low-dose nitric oxide (NO)	2
structured, antibiotic-tolerant bacterial aggregates	2
cystic fibrosis (CF)	2
bronchopulmonary colonization	2
C57BL6/J wild-type mice	2
Rpgr−/yand C57BL/6JRd9/Boc)	2
two relevant animal models	2
codon-optimized RPGR	2
rhodopsin kinase promoter	2
wild-type variant	2
RPGR protein	2
full-length correct RPGR protein	2
mutated RPGR variant	2
deleted RPGR	2
highly repetitive nucleotide sequences	2
purine-rich region of RPGRORF15(which	2
the retina-specific isoform of the gene encoding retinitis pigmentosa GTPase regulator (RPGRORF15)	2
XLRP cases	2
X-linked retinitis pigmentosa (XLRP)	2
mouse hemophilia B model	2
effective lentiviral gene therapy vector	2
standard lentiviruses	2
reverse-transcription products	2
standard lentivirus	2
HIV-1 particles	2
wild-type genome	2
unique genomic structure	2
novel lentiviral vector (LTR1)	2
functional cis elements	2
wild-type HIV-1 genome	2
vector particles	2
partially overlap wild-type HIV-1 gag and env genes	2
Lentiviral vector genomic RNA	2
multiple types of OV-resistant or chemoresistant cancer	2
VSV-directed oncolysis	2
Nrf2 signaling	2
Chemoresistant A549 lung cancer cells	2
different murine syngeneic and xenograft tumor models	2
OV-resistant cancer cells	2
antioxidant compound sulforaphane (SFN)	2
viral oncolysis	2
vesicular stomatitis virus Δ51 (VSVΔ51) replication	2
antioxidant network	2
Oncolytic viruses (OVs)	2
vector genotoxicity	2
desired expression	2
late-gestation AAV-hFIX transfer	2
recombinant adeno-associated vector (AAV)-human factor IX (hFIX)	2
regulated miR-208a targets	2
cardiomyocyte-specific miR-208a	2
synthetic oligonucleotide	2
anti-miR-208a	2
anti-miR	2
miRNA-targeting oligonucleotides	2
functional let-7b-5p	2
target gene, TGFBR1	2
cultured endothelial cells (ECs)	2
miRNAs co-expressed in patients’ myocardium and vasculature	2
peripheral plasma	2
leftover material	2
exosomes (endogenous nanoparticles)	2
pericardial sac	2
pericardial fluid (PF)	2
transplanted EGFP-positive cones	2
donor and host retinas	2
DsRed retinas	2
photoreceptor layer	2
EGFP-positive cones	2
host retinas	2
efficient cells	2
embryonic day 15.5 high-EGFP population	2
distinct subpopulations of Chrnb4-EGFP-expressing cells	2
EGFP-positive cells	2
native CHRNB4 protein	2
mature cones	2
sub-population of early retinal progenitors	2
competent cells	2
combined	2
myocardium and heart valves	2
frequent regimen	2
ERT schedule	2
mouse model of mucopolysaccharidosis type VI (MPS VI)	2
adeno-associated viral vector serotype 8 (AAV2/8)	2
several lysosomal storage diseases (LSDs)	2
new HIV-1 vaccine delivery platform	2
Rhesus macaques	2
IDLV-Env-based vaccine	2
Durable polyfunctional Env-specific T-cell responses	2
tier 1 MW965.26 pseudovirus	2
anti-V2 and anti-CD4 binding site antibodies	2
Monkeys' sera	2
predominant cross-clade gp120-directed response	2
antibodies and T-cell responses	2
prime	2
rhesus monkeys	2
SIV-based IDLV in nonhuman primates	2
Integrase defective lentiviral vectors (IDLV)	2
effective HIV-1 vaccine	2
bone diseases	2
mouse and rat models	2
PEGylated form of APT-F2	2
four cellular receptors	2
APT-F2	2
human FGF2	2
novel RNA aptamer, APT-F2	2
patients with bone diseases	2
FGF2 antagonists	2
Fibroblast growth factor 2 (FGF2)	2
broadly specific, and cross-reactive	2
T cells/106 splenocytes	2
BALB/c and outbred CD1-Swiss mice	2
chimpanzee adenovirus and/or poxvirus modified vaccinia virus Ankara (MVA) vaccines	2
two mosaic vaccines	2
bivalent mosaic of conserved-region T cell immunogens	2
integration-deficient lentiviral vector platform	2
novel candidate vaccines ZVex.tHIVconsv1 and ZVex.tHIVconsv2	2
virally vectored vaccines	2
majority of currently circulating and reactivated HIV-1 strains	2
vaccine-induced T cells	2
HIV type 1 (HIV-1)	2
extracellular disease-related proteins	2
cancer cells extracellularly	2
series of selective and powerful EDCs	2
CD20, CD38, CD56, CD147, or dysadherin	2
potent small molecule inhibitor of the NKA	2
corresponding cancer-related target	2
EDCs	2
extracellular drug conjugate or EDC	2
important cancer-related proteins	2
plasma membrane ion pump	2
human Na+/K+-ATPase (NKA)	2
malaria vaccine	2
key target age group	2
immune responses	2
immunization regimen	2
Gambian and United Kingdom (UK) adults	2
Induced antibodies	2
CD8+ and CD4+ T cells secreted cytokines	2
modified vaccinia virus Ankara (MVA)	2
cellular immunity	2
four cohorts	2
138 Gambian and Burkinabe children	2
European malaria-naive and Kenyan semi-immune adults	2
multiple epitope string (ME-TRAP)	2
pre-erythrocytic antigen thrombospondin-related adhesion protein	2
circulating LV particles	2
LV-transduced cells	2
DCs cross-present immunogenic antigen	2
functional effector T cells	2
repopulating DCs	2
DTR (diphtheria toxin receptor) model	2
murine CD11c	2
directly transduced DCs	2
immunization site	2
vaccine-specific T cells	2
highly effective vaccination vehicles	2
Recombinant lentiviral vectors (LVs)	2
parenchymal liver cells	2
epigenetic drugs	2
novel HSC-targeting vehicle	2
multiple histone methylation modifications	2
antibody-liposome-DZNep targeting vehicle	2
naked form	2
histone methyltransferase inhibitor 3-deazaneplanocin A (DZNep)	2
histone methylation	2
biological therapeutics	2
vaccinia virus expressing a prodrug converting enzyme	2
vaccinia virus genomes	2
SKOV-3 or HepG2 xenografts	2
cups and oncolytic vaccinia virus	2
polymeric cup formulation	2
inertial cavitation	2
physical stimuli	2
intravenous injection	2
throughout tumors	2
Oncolytic viruses (OV)	2
suppressive cART	2
HIV-1-infected individuals	2
resting CD4+	2
highly genetically diverse and replication-competent viruses	2
attenuated HIV-1 Tat protein	2
latency-reversing agents (LRAs)	2
protein kinase C activators, and histone deacetylase inhibitors (HDACi)	2
Various cytokines	2
infants and children	2
Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara ME-TRAP	2
10 week-old infants	2
Chimpanzee Adenovirus 63 Modified Vaccinia Ankara ME-TRAP heterologous prime-boost immunization	2
5–12 months old	2
four different age-groups	2
Gambian and Burkinabe children	2
target age group	2
Kenyan adults	2
malaria-naive European volunteers	2
Multiple epitope thrombospondin adhesion protein (ME-TRAP) and	2
Chimpanzee Adenovirus	2
local chromatin and DNA architecture	2
HMGA1, HMGB1, and WIBG	2
protein coding sense strand	2
novel long noncoding RNA (lncRNA)	2
encoded ion channels	2
cystic fibrosis transmembrance conductance regulator (CFTR) gene	2
non-essential coding regions	2
active TALENs	2
dystrophin locus	2
myogenic lineage	2
skeletal myoblasts and dermal fibroblasts	2
cells from Duchenne patients	2
disrupted reading frame	2
DNA repair template	2
widespread CNS delivery	2
either of the target genes	2
adenoassociated virus serotype 6 (AAV6)	2
SOD1G93A ALS mouse model	2
NSC34 SOD1G93A cells	2
ALS tissue culture model	2
motor neuronal-like NSC34 cell line	2
PRDX3 or NRF2 genes	2
antioxidant genes	2
damaged tissue	2
damaged liver tissue	2
caspase-3 signaling pathway	2
liver toxin	2
Nanog, Oct4, Sox2, c-kit, and HoxB4	2
stem cell genes	2
cultured CD34+ cells	2
adherent human CD34+ cells	2
neurological disorders	2
endogenous gene in the brain	2
injectable engineered zinc finger protein	2
alternative DNA-binding domain	2
ATF	2
hippocampus and cerebellum	2
brain of an adult mouse model	2
Ube3a expression	2
engineered zinc finger-based artificial transcription factor (ATF)	2
gene regulators	2
long antisense transcript	2
brain-specific genetic imprinting	2
maternal copy of UBE3A	2
monogenic hereditary disorders	2
zinc finger nucleases, transcription activator-like effector nucleases (TALENs), meganucleases, and the CRISPR/Cas9 system	2
common nuclease-based platforms	2
deleterious genes or genome sequences	2
specific sites in the genome	2
core molecule	2
CSF1-Fc conjugate	2
putative CSF1 targets	2
CSF1-dependent macrophages	2
urokinase, tumor necrosis factor, and interleukin 6	2
candidate mediators	2
infiltrating macrophages	2
Csf1r-EGFP positive macrophages	2
Csf1r-enhanced green fluorescent protein (EGFP) reporter gene in MacGreen mice	2
Fc conjugate of colony-stimulating factor (CSF) 1	2
pluripotent stem-cell–derived sensory neurons	2
mature dorsal root ganglia	2
largely homogeneous population of neurons	2
majority of the visible light spectrum	2
blind patients	2
adeno-associated virus vector	2
blind rats expressing mVChR1	2
VChR1-expressing cells	2
Chlamydomonas channelrhodopsin-1	2
chimera of Volvox channelrhodopsin-1	2
modified Volvox channelrhodopsin-1 (mVChR1)	2
VChR1 gene	2
VChR1 protein	2
Volvox-derived channelrhodopsin-1, VChR1,	2
Chlamydomonas channelrhodopsin-2 (ChR2)	2
blind rats	2
clinical settings	2
gut-specific chemotaxis	2
small intestine-specific chemotaxis	2
expression of molecules	2
Expanded allospecific Treg	2
relevant exogenous inflammatory signals	2
human Treg	2
key target organs	2
populations of alloantigen-specific Treg	2
antigen-specific regulatory T-cells (Treg)	2
best stable gene transfer vector	2
murine brain	2
GFP or the lysosomal enzyme, arylsulphatase A (ARSA)	2
murine MSCs (mMSCs)	2
physiological promoters	2
simian macaque foamy virus envelope	2
self-inactivating foamy virus vector (FVV)	2
cytotoxic cationic polymers	2
genotoxic viral promoters	2
current vectors	2
Mesenchymal stromal cells (MSCs)	2
human cellular model	2
AND-1_WASKO cell lines	2
WASp-deficient Plts	2
WASp-deficient MKs	2
hESCs-WASKO-derived MKs and Plts	2
CD34+CD41+ progenitors, megakaryocytes (MKs), and Plts	2
megakaryocytic linage	2
hESCs-WT	2
CD34+CD45+ progenitors	2
human embryonic stem cell lines (hESCs)	2
(WASKO	2
two isogenic WAS knockout	2
terminally differentiated lymphocytes and myeloid cells	2
alternative serotypes	2
HAdV-5 vector	2
alternative vectors	2
human adenovirus serotype 5 (HAdV-5)	2
Recombinant vectors	2
Tumor-specific aptamers	2
neutrophil defensin, and clusterin	2
histone 2B	2
annexin A5	2
annexin A2	2
aptamer-associated protein biomarkers	2
peripheral blood of lung cancer and metastatic lung cancer patients	2
microemboli in clinical samples	2
CTCs, apoptotic bodies	2
A549 lung adenocarcinoma culture	2
normal lung cells and lymphocytes	2
lung cancer cell biomarkers	2
postoperative tissues	2
lung adenocarcinoma cells	2
specific affinity probes	2
mesenchymal cancer cells	2
epithelial markers	2
Circulating tumor cells (CTCs)	2
potent adjuvants	2
difficult or neglected disease targets	2
adenoviral vaccine vector	2
relatively weak aluminium-based adjuvant	2
Alhydrogel adjuvant	2
CPG 7909	2
AMA1 protein vaccine	2
IgG antibody responses	2
regimens	2
MVA and/or protein-in-adjuvant	2
promising “mixed-modality” regimens	2
chimpanzee adenovirus ChAd63 and the orthopoxvirus MVA	2
recombinant vectored vaccines	2
Alhydrogel adjuvant with and without CPG 7909	2
blood-stage Plasmodium falciparum malaria parasite	2
AMA1 antigen	2
difficult disease targets	2
effective vaccines	2
vascular tissue and cells	2
SENCR expression	2
human umbilical endothelial cell (HUVEC)	2
pluripotency of pluripotent cells	2
directed and hemogenic routes	2
new differentiation protocols	2
Friend Leukemia Integration virus 1 (FLI1) gene	2
vascular-enriched long noncoding RNA	2
wide range of target receptors	2
breast cancer cell lines SKBR3 and BT474	2
cognate oncogenic receptor Her2	2
three protein ligands	2
clinically approved anti-Her2 antibody trastuzumab	2
transferrin, an anti-MHC class I antibody	2
crosslink receptor:cargo–biotin complexes	2
biotinylated cargo	2
receptor:cargo complexes	2
antibody–drug conjugates	2
oncogenic receptors	2
standard of care antibodies	2
cell surface HER2	2
Fcab	2
unique structure and/or epitope of FS102	2
HER2-high PDX tumor models	2
quantitative polymerase chain reaction (qPCR)	2
combination of trastuzumab and pertuzumab	2
FS102 in patient-derived xenografts (PDXs)	2
FS102 is a HER2-specific Fcab (Fc fragment with antigen binding)	2
several cartilage degradation–related genes	2
MIA rats	2
Several cartilage degradation-related genes	2
rats’ articular cartilage	2
miR-101 mimic and miR-101 inhibitor	2
different expressed genes	2
miR-101 inhibitor	2
normal cartilage of rats	2
miR-101 silencing	2
rats’ knees	2
miR-101 mimic or miR-101 inhibitor	2
) rats	2
Mono-iodoacetate-induced arthritis (MIA	2
Ewing's sarcoma	2
autologous tumor cells	2
Eight patients	2
TGFβ1and TGFβ2 knockdown	2
pg/106 cells	2
Median product release granulocyte-macrophage colony-stimulating factor expression	2
vaccinations)	2
gamma interferon-enzyme-linked immunospot (γIFN-ELISPOT)	2
unmodified autologous tumor cells	2
106–2.5 	2
separate cohort	2
advanced/metastatic Ewing's sarcoma	2
perforin-deficient FHL	2
cytokine hypersecretion	2
Reconstituted CD8+ lymphoblasts	2
peptide-loaded targets	2
reconstituted T cells	2
polyclonal CD8+ T cells	2
perforin-reconstituted NK cells	2
irradiated recipients	2
mature T and NK cells	2
perforin-deficient mice	2
different murine models	2
lineage-specific perforin promoter	2
ubiquitous phosphoglycerate kinase promoter	2
human perforin gene	2
lentiviral vectors (LV)	2
familial hemophagocytic lymphohistiocytosis (FHL)	2
tumor PD-L1 expression	2
miR-197/CKS1B/STAT3-mediated network	2
microRNA regulatory cascade	2
miR-197 mimic sensitizes PD-L1high drug-resistant cells	2
various oncogenic genes (Bcl-2, c-Myc, and cyclin D1)	2
miR-197-mediated CKS1B/STAT3 axis	2
platinum-resistant NSCLC specimens	2
immunoinhibitory signals	2
chemoresistant non-small-cell lung cancer (NSCLC)	2
miR-197/CKS1B/STAT3-mediated PD-L1 network	2
Programmed cell death ligand-1 (PD-L1)	2
predicted off-target sites	2
sarcolemmal membrane	2
human dystrophin expression	2
dystrophin mRNA transcript	2
DMD patient myoblasts	2
exon 51 splice acceptor	2
two ZFNs	2
resulting dystrophin transcript	2
essential splicing sequences	2
targeted exon	2
single injection of scAAV9-siPTEN	2
self-complementary AAV9 expressing siPTEN (scAAV9-siPTEN)	2
severe SMA (SMNΔ7)	2
established mouse model	2
adeno-associated vector serotype 6 (AAV6) expressing shRNA	2
SMA mouse model	2
SMN-deficient motor neurons	2
survival motor neuron 1 (SMN1) gene	2
Spinal muscular atrophy (SMA)	2
Whole exome sequencing and diagnostic biomarkers	2
defective α2	2
TRα1 and α2	2
muscle creatine kinase	2
reverse T3	2
dysmorphic facies	2
thyroid hormone alpha (RTHα)	2
gene locus	2
α2 protein	2
nuclear receptors (TRα1, TRβ1, TRβ2)	2
relatively constant mitochondrial population	2
aqueous regions	2
inner and outer membrane	2
residual genome	2
symbiotic ancestors	2
gatekeepers	2
cellular energy production	2
almost all eukaryotic cells	2
membrane bound organelles	2
MDT involvement	2
ambiguous genitalia	2
key members of the team	2
structure of the multidisciplinary team (MDT)	2
tertiary centre	2
β-catenin immunohistochemistry	2
novel putative drivers	2
one subset	2
subsets of our Wnt genes	2
patient cohorts	2
primary tumour gene expression databases	2
90 genes	2
differentiating lines	2
/Rspo2	2
phosphorylated RB	2
pro-differentiation BMP4 and EPAS1 proteins	2
SK-N-BE(2)-C and SH-SY5Y cell-lines	2
numerous transcription factors and signalling pathways	2
ninety Wnt target genes	2
neuroblastoma-specific Wnt3a/Rspo2-driven transcriptome	2
c-MYC and MYCN proteins	2
neuroblastoma cell lines	2
Alk, Akt and MEK/ERK signalling	2
oncogenic signalling pathways	2
developing sympathoadrenergic lineage of the neural crest	2
taxonomy of cancer sites	2
range of common and rarer cancer sites	2
presenting symptoms	2
endogenous protein of interest	2
novel PTMs	2
chemical inhibitor PYR41	2
ubiquitin E1 activating enzyme	2
PD-L1 mono- and multiubiquitination	2
gefitnib and SCH772984	2
EGFR pathway	2
Chemical inhibitors	2
glycosylated PD-L1	2
mono- and multiubiquitination of PD-L1	2
clinically important protein programmed cell death ligand 1 (PD-L1)	2
tyrosine phosphorylation, acetylation, ubiquitination, and SUMOylation 2/3	2
set of high-affinity, high-specificity posttranslational modification (PTM) enrichment tools	2
8 metabolites	2
histologically normal squamous esophageal mucosa	2
histologically normal tissue	2
histologically normal, BO, and EAC tissue	2
nonneoplastic Barrett's	2
9 patients	2
cancer cohort	2
EAC and BO	2
adjacent histologically normal tissues	2
patients with EAC, BO, and normal esophagus	2
Barrett's patients	2
Patients with Barrett's esophagus (BO)	2
PI3K/AKT-inhibitor–like profile in normal cells	2
cell cycle suppressor compounds	2
multicellular spheroids	2
cyclin B1, CDK1, and CDC25C.	2
p21 expression	2
entire treated cell population	2
senescence-associated β-galactosidase activity	2
benzimidazolone compound, CB-20903630	2
found hits	2
growth inhibition and senescence-associated β-galactosidase assays	2
One hundred and forty-seven virtual hits	2
lead-like compounds	2
virtual library	2
resulting classification model	2
active or inactive	2
3517 compounds	2
neural network	2
differentially affected biological process networks	2
potential senescence agonists	2
selective senescence inducers	2
genotoxic stimuli	2
symptomatic dengue cases	2
wide variety of different animal hosts	2
many ancient and borrowed elements	2
parasite asexual stages	2
apicomplexan infections	2
Toxoplasma gondii, Plasmodium spp, and Cryptosporidium	2
drug transporter	2
trypanosomiasis patients	2
aquaglyceroporin (AQP2), a parasite solute and drug transporter	2
melarsoprol-resistant parasites	2
sleeping sickness	2
technical know-how	2
mathematical transmission model	2
co-endemic areas	2
filarial nematode Loa loa)	2
African eye worm	2
gambiense-HAT epidemiology	2
human and putative animal reservoirs	2
Latent human infections	2
national and international stakeholders	2
440000 cases	2
Trypanosoma brucei gambiense causes human African trypanosomiasis (HAT)	2
NTD implementers	2
new colleagues	2
programs and partners	2
Areas in conflict	2
(NTD) programs	2
parasites and their hosts	2
several replication protein components and complexes	2
etiological agents	2
Vicious Worm’	2
versatile drug	2
veterinary medicine	2
glutamate-gated chloride channels	2
Physiology or Medicine	2
veterinary and human medicine	2
free-living nematodes	2
key free-living species	2
genomes of free-living and parasitic species	2
parasitic species	2
many nematodes	2
common animals	2
alternative diagnostics	2
intestinal helminths	2
ivermectin and vaccination	2
remote populations	2
community-based services	2
Village health workers (VHWs)	2
artesunate monotherapies)	2
Greater Mekong subregion (GMS)	2
candidate P. vivax vaccine	2
tachysporozoites causing primary infection	2
Plasmodium vivax sporozoites	2
every sporozoite	2
intestinal bilharzia	2
human blood fluke Schistosoma mansoni	2
genome and epigenome components	2
‘inheritance system	2
blood-stage inoculum	2
CHMI models	2
within-host pharmacokinetic and pharmacodynamic (PK/PD) models	2
colder areas	2
early hominins	2
virulent species	2
trophic niches	2
parasite fauna	2
infected prey	2
specialist individuals	2
parasite infections	2
specialised subgroups	2
specific food items	2
smaller niches	2
free-living species	2
population trophic niche	2
two membranes	2
flagellum skeleton	2
complex cytoskeletal structure	2
flagellum attachment zone (FAZ)	2
antimalarial drug	2
qinghaosu (artemisinin)	2
2015 Nobel Prize	2
intracellular and extracellular eukaryotic parasites	2
, parasites	2
host–pathogen context	2
three kingdoms of life	2
Extracellular vesicles (EVs)	2
vector control tools	2
Vector-borne diseases (VBDs)	2
trypanocidal drugs	2
PDE inhibitors	2
breakthroughs	2
PDEB2	2
cAMP phosphodiesterases PDEB1	2
parasite ACs	2
downstream components	2
trypanosomatid adenylyl cyclases (ACs) and phosphodiesterases (PDEs)	2
different disease stages	2
future models	2
Indian subcontinent	2
neglected tropical disease (NTD) visceral leishmaniasis (VL)	2
wildlife and human systems	2
within-individual host–parasite ecosystems	2
ecosystem ecology	2
space, energy, and resources	2
diversity of entities (e.g., parasitic organisms, commensal symbionts, host immune components)	2
multiple parasite species	2
disease in dogs	2
parasite–host–vector triangle	2
first entire genome sequence of a Leishmania parasite	2
Single-celled malaria parasites	2
Many multicellular organisms	2
seasonal environments	2
compound class	2
trypanosomatid diseases	2
nitro drug	2
nitroaromatic compounds	2
protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp	2
unique or highly divergent proteins	2
subpopulation of trypanosomes	2
distinct variant surface glycoproteins (VSGs)	2
‘hard-wired’ genome	2
glycolytic intermediates	2
rapidly proliferating cells	2
antimonial drugs	2
PKDL patients	2
Post kala-azar dermal leishmaniasis (PKDL)	2
spatially variable environments	2
pathogen populations	2
present blocks	2
appropriate paediatric praziquantel formulation	2
African infants and preschool children	2
effective, protective anti-parasite vaccine	2
recombinant peptide antigens	2
millions of them	2
wild apes	2
human Plasmodium falciparum	2
numerous new Plasmodium species	2
captive and wild-living apes	2
within-host environment	2
different specialized stages	2
mosquito-specific ookinete and young oocyst stages of the parasite	2
transient structures	2
vertebrate host and mosquito vector	2
many unique subcellular structures and organelles	2
co-regulated mRNA cohorts	2
functionally related proteins	2
group of mRNAs	2
Several RNA-binding proteins	2
predicted RNA-binding proteins	2
trans-acting factors	2
several regulated mRNAs	2
untranslated regions	2
responsible cis-elements	2
many tumour cells	2
resistant parasites	2
several relevant genes	2
putative target molecules	2
three commonly used classes of anthelmintics	2
anticancer pharmacopoeia	2
poison’	2
artemisinin resistance	2
parasitised erythrocytes	2
CBA or CB57BL/6 mice	2
trypanosomes in tsetse flies	2
ITN programs	2
insecticide treated bednets (ITNs)	2
vulnerable populations	2
(RBM) partnership	2
highly sensitive and specific tools	2
specialized molecular machinery	2
postgenomic era	2
parasite stages	2
specialized male and female sexual stages (gametocytes)	2
vertebrate hosts	2
natural setting	2
evolutionary ecologists	2
intimately and specifically mosquitoes and Plasmodium co-	2
wild vector populations	2
transgenic mosquitoes	2
major health problem	2
digested haem	2
host serum iron transporters	2
metazoan parasites	2
parasitic protozoa	2
host iron	2
host iron resources	2
pathogenic prokaryotes and eukaryotic parasites	2
host proteins and inorganic chelates	2
essential trace metal	2
vast majority of organisms	2
tick vector	2
co-ingested strains	2
co-grazing non-vaccinated cattle	2
vaccinated animals	2
elements of the vaccine	2
polymorphic genomic markers	2
vaccine strains in immunised cattle	2
resident tick populations	2
Theileria parva	2
live vaccine	2
several of these diseases	2
geographical and epidemiological bases	2
‘neglected tropical diseases’ (NTDs)	2
malaria-resistant transgenic mosquitoes	2
external environment of a mosquito	2
mammal-infective stages	2
cytotoxic T lymphocyte (CTL)-based immunotherapy	2
single cytoskeletal motors	2
pMHC-triggered TCRs	2
TCR–pMHC bonds	2
local cytoskeleton machinery	2
conventional receptor–ligand associations	2
MHC molecules (pMHCs) arrayed	2
sparse antigenic peptides	2
αβ T cell receptors (TCRs)	2
mast cells and leukocytes	2
different immune cells	2
adhesion receptors	2
microbial and non-microbial challenges	2
lymphoid homing receptors	2
Vδ1 T cell naïve (Tnaïve)	2
initially diverse and private TCR repertoire	2
adaptive αβ T cells	2
human Vδ1 T cells	2
unconventional lymphocytes	2
new and dangerous pathogens	2
highly expressed fastidious class I alleles	2
wide variety of infectious pathogens	2
poorly expressed promiscuous class I alleles	2
complicated mammalian systems	2
single dominantly expressed class I molecule	2
major histocompatibility complexes (MHCs) of typical mammals	2
constantly stimulated and dynamic environment	2
specific oral barrier	2
immune cell network	2
tissue-specific cues	2
dietary and airborne antigens	2
diverse commensal microbiome	2
plethora of triggers	2
immune signals	2
phagosomal cargo	2
many phagocytic cells	2
phagosomal content	2
endosomal and lysosomal compartments	2
specialized immune cells	2
microbial pathogens and dead cells	2
related microbial strains	2
distant infection sites	2
appropriate infection models	2
inflammasome signaling	2
cytosolic multiprotein platforms	2
immune pathways	2
childhood undernutrition	2
experimental animals, in vitro models	2
immunoepigenome of malnourished parents	2
CTLA-4 in adult mice	2
individuals in the human population	2
host-derived RNA molecules	2
pathogen sensors	2
NMD or RNA exosome machineries	2
viral RNA molecules	2
faulty cellular transcripts	2
Nonsense-mediated decay (NMD)	2
cellular RNA molecules	2
shared ligands	2
extracellular domain of CTLA-4	2
conventional T cells	2
Regulatory T (Treg) cells	2
cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)	2
kinetic proofreading models	2
pMHC	2
induced rebinding	2
cell receptors (TCRs)	2
abundant low-affinity ‘self’-peptide MHC ligands	2
rare high-affinity ‘foreign’ peptide MHC (pMHC) ligands	2
LMs	2
specialized proresolving LMs	2
associated bioactive lipid mediators (LMs)	2
circulating leukocyte transcriptome	2
common systemic inflammatory pathways	2
major surgical procedures	2
complotype	2
inherited set of common variants	2
individual polymorphisms	2
disease-linked polymorphic variants	2
common complement polymorphisms	2
viral, mycobacterial and helminth infections	2
one of a number of spleen tyrosine kinase-coupled C-type lectin receptors	2
first non-Toll like receptor	2
Syk-coupled C-type lectin receptor Dectin-1	2
finely balanced system	2
vascular compartment	2
freely circulating and marginated (i.e. slowly transiting) pools	2
CXC chemokine receptor 4/stromal-derived factor 1 axis	2
B cells, T cells and mast cells	2
p110δ isoform of PI3K	2
phosphoinositide 3-kinases (PI3Ks) phosphorylate PtdIns(4,5)P2	2
two important signalling pathways	2
antigen receptors	2
global territories	2
United Kingdom	2
extra manufacturing vessels	2
additional staff	2
situating the facility	2
mesenchymal stromal cell product	2
cost of goods model	2
key opinion leaders	2
local, responsive manufacturing	2
patient-specific therapies	2
(CGT) field	2
precision medicines	2
embryonic and induced	2
pluripotent stem cell therapeutic space	2
next generation therapeutics	2
disruptive, high-value curative cell and gene-based regenerative medicines	2
regenerative medicine sector	2
MSC secretome	2
patients with MS.DiscussionOur	2
higher-passage MSCs	2
C-MSCcm	2
control subjects (C-MSCcm) and those with MS (MS-MSCcm)	2
MSC-conditioned medium (MSCcm)	2
autologous mesenchymal stromal cells (MSCs)	2
promising products	2
advanced health care therapies	2
manufacturing platform	2
Decentralized manufacturing	2
manufacturing technology and support systems	2
professional-level jobs	2
business	2
sites or geographic regions	2
decentralized manufacturing	2
traditional centralized model	2
Phenotypic and functional assays	2
large-scale, fully Good Manufacturing Practice–compliant, autologous macrophage cell therapy product	2
cell product in excipient	2
GMP-compliant macrophage products	2
final cell product	2
CliniMACS Prodigy cell sorting system	2
dextran-coated SPION	2
DiscussionA positively charged	2
exogenous cells	2
hepatic parenchyma	2
hepatic portal vein	2
SPION-labeled BMDMs	2
–derived macrophages (BMDMs)	2
SPION labeling	2
Fe/cell)	2
mouse and human origin	2
µg/mL	2
mV; Rienso)	2
clinically approved SPION ferumoxytol	2
formerly approved ferumoxide (−6.7 mV; Endorem)	2
positively charged SPIONs	2
cell health and iron uptake assays	2
new set of superparamagnetic iron oxide nanoparticles (SPIONs)	2
recently described chemical design	2
reliable, clinically applicable cell-tracking agent	2
liver disease	2
metastatic gastrointestinal and lung cancer	2
science and technology	2
malignant and nonmalignant conditions	2
variety of therapeutic agents	2
cryopreserved master cell bank	2
cryopreserved TRAIL-expressing MSCs	2
conventional freezing media	2
MSCs in 5% DMSO (v/v)	2
fresh, continually cultured cells	2
cryopreserved genetically modified MSCs	2
human serum albumin ZENALB 4.5	2
dimethyl sulfoxide (DMSO)	2
genetically modified cell therapy product	2
cryopreserved allogeneic MSCTRAIL cell bank	2
patients with metastatic lung cancer	2
pro-apoptotic protein tumor necrosis factor–related apoptosis inducing ligand (TRAIL)	2
monolayer and microcarrier culture	2
increased BM-hMSC yield	2
BM-hMSC donors	2
microcarriers in HPL-containing medium	2
HPL-containing medium	2
BM-hMSCs in fetal bovine serum (FBS)- and human platelet lysate (HPL)-containing media	2
human mesenchymal stromal cell (hMSC) culture	2
medium and associated reagents	2
BM-hMSC expansion	2
BM-hMSC donor line	2
BM-hMSCs in PRIME-XV SFM	2
either fetal bovine serum (FBS) or PRIME-XV serum-free medium (SFM)	2
monolayer with medium	2
marrow–derived hMSCs (BM-hMSCs)	2
off-the-shelf and patient specific therapies	2
human mesenchymal stromal cells (hMSCs)	2
control macrophages	2
cirrhotic patients' apheresis-derived CD14 monocytes	2
control and cirrhotic macrophages	2
cytokine and chemokine polymerase chain reaction array	2
number of genes (MMP-9, CCL2, interleukin [IL]-10 and TNF-related weak inducer of apoptosis	2
mature macrophages cultured	2
matrix metalloproteinases [MMP]-9, MMP-12 and TNF-related weak inducer of apoptosis	2
transforming growth factor-β, α-smooth muscle actin, phosphatidylserine receptor)	2
alanine transaminase, bilirubin, aspartate transaminase)	2
murine liver fibrosis model	2
controls and cirrhotic patients	2
either recombinant TRAIL or MSC-secreted sT.ConclusionsThese	2
secreted flT	2
cell surface flT and secreted flT	2
recombinant TRAIL	2
MSC-sT cells	2
cell-surface TRAIL	2
flT-transduced MSCs (MSC-flT)	2
soluble TRAIL	2
sT-transduced MSCs (MSC-sT)	2
MSC-derived soluble TRAIL.ResultsThe transduction	2
transduced MSCs	2
lentiviruses expressing flT or an isoleucine zipper-fused sT. TRAIL expression	2
TRAIL-expressing MSCs	2
soluble form (sT)	2
MSCs expressing full-length human TRAIL (flT)	2
pro-apoptotic tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)	2
plastic ware and tubing sets	2
larger range of units	2
TNC yields	2
larger but useable UCB units	2
automated umbilical cord processing systems	2
banks	2
products stored	2
stored inventories	2
transplant centers	2
colony-forming units	2
genetically diverse inventories globally	2
umbilical cord blood (UCB)	2
key stakeholders	2
selected expert reference panel of US and UK thought leaders	2
more-than-minimally manipulated clinically led autologous cell therapy products	2
three prospective manufacturing models	2
clinician-led autologous cellular therapies	2
development pipeline	2
affordable autologous cell therapy supply	2
sustainable and investable business model	2
two or three sites	2
single market authorization	2
multiple manufacturing sites	2
more-than-minimally manipulated autologous cell therapies	2
Albumin and urea synthesis	2
tissue processing	2
standard collagenase	2
liver specimens	2
normal and diseased liver tissues	2
Liberase and NAC in combination	2
isolated hepatocytes	2
Liberase and N-acetylcysteine (NAC)	2
diseased liver	2
hepatocyte isolation	2
Delta1 ligand-mediated progenitor culture	2
heterogeneous CD34+ progenitor compartment	2
stem cell factor and dexamethasone	2
Delta1 pre-expanded cells	2
micro-scale ambr suspension bioreactor	2
Delta1 Notch ligand	2
+ cord blood cells or equivalent cells	2
process	2
cell doses	2
cartilage matrix	2
cartilage defect	2
porcine cartilage defect model	2
synovial MSC suspension	2
non-treated control kneesConclusionsLeaving	2
MSC-treated knees	2
MSCs	2
defects	2
arthroscopic control	2
subgroup of two pigs	2
transgenic green fluorescent protein (GFP) pig	2
fluorescence-labeled synovial MSCs	2
knee	2
Synovial MSCs	2
MSCs treated and non-treated control knees	2
knees of seven pigs	2
Cartilage defects	2
porcine MSCs	2
pig modelMethodsThe	2
synovial mesenchymal stromal cells (MSCs)	2
erythrocytes in the aspirate	2
allogeneic bone graft	2
concentrated aspirate	2
viable and functional osteoprogenitors	2
15 patients of an elderly cohort	2
intraoperative orthopedic use	2
Bone marrow aspirate (BMA)	2
different tissue sources	2
quality-control MSC batches	2
Nile red/DAPI ratio	2
microplate assay	2
mixed cell populations	2
less mature cells	2
day-21 BM MSCs	2
flow cytometry or microplate assay	2
day-21 MSCs	2
less granular cells	2
Nile red fluorescence	2
FABP4 protein	2
granular cells	2
BM donors	2
red staining	2
fat pad, cartilage and umbilical cord	2
Skin fibroblasts	2
peroxisome proliferator activated receptor-γ and fatty acid binding protein (FABP)4 transcripts	2
Oil red staining	2
21-day in vitro assay	2
bone marrow (BM) MSCs	2
mature fat cell contamination	2
manufactured MSC batches	2
regenerative and immuno-privileged cells	2
Klebsiella pneumoniae (ST45)	2
Virulent Klebsiella pneumoniae ST45 carrying blaCTX-M-15	2
positive mother and neonate ESBL-PE colonization	2
Intensive care Unit	2
304 neonates	2
Neonatal ESBL-PE sepsis	2
Selected isolates	2
ESBL colonization	2
/mothers/guardians	2
blood culture	2
tertiary hospital	2
extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)	2
atypical pneumonia-associated bacterial pathogens	2
respiratory specimens	2
automated DNA extraction device	2
low-cost, time-saving and accurate diagnostic tool	2
Lightmix® multiplex RT-PCR assay	2
different in-panel organisms	2
multiplex RT-PCR	2
singleplex RT-PCR assays	2
culture and viral PCR	2
common agents of pneumonia	2
clinical respiratory specimens	2
fastidious bacterial pathogens	2
new, commercially available Lightmix® multiplex RT-PCR assay	2
culture or serology	2
fastidious bacteria	2
B. parapertussis	2
B. pertussis	2
penicillin derivatives	2
Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella spp.	2
fastidious respiratory pathogens	2
common viruses and bacterial pathogens (e.g. Streptococcus pneumoniae)	2
ruminant pathogen	2
Vpma proteins	2
individual PLMs	2
respective Vpma	2
TX-114 phase proteins	2
M. agalactiae cytadhesion	2
Vpma-specific polyclonal antisera	2
PLMU in sheep	2
expresses VpmaU	2
PLMV mutant expressing VpmaV	2
HeLa and sheep mammary epithelial (MECs) and stromal (MSCs) cells	2
vitro adhesion assays	2
wildtype strain PG2	2
six Vpmas	2
single well-characterized Vpma lipoproteins	2
‘Phase-Locked’ Mutants (PLMs)	2
typical mycoplasma attachment organelle	2
multiple surface lipoproteins	2
dynamin-related atlastin and mitofusin proteins	2
cytosolic innate immune system	2
outer membrane of pathogen-containing vacuole	2
GBPs and IRGs	2
dynamins	2
C-terminal isoprenylation	2
three human and murine GBP isoforms	2
members of the dynamin superfamily	2
human GBPs	2
higher primates	2
IRGs	2
another family of dynamin-related GTPases	2
immunity-related GTPases (IRGs)	2
large oligomeric innate immune complexes	2
pathogen containing vacuolar compartments	2
individual GBPs	2
Several binding partners	2
viruses to bacteria and protozoa	2
interferons and other pro-inflammatory cytokines	2
family of dynamin-related large GTPases	2
Guanylate-binding proteins (GBP)	2
infected persons	2
multiple stains	2
several strains	2
immediate family	2
developed countries sources	2
several individuals harbored strains	2
mothers and children	2
Similar strains	2
glmM amplicon	2
3 genes	2
50 individuals	2
H. pylori DNA	2
H. pylori organisms	2
glmM, recA and hspA. Concentration	2
H. pylori strains	2
H. pylori infected families	2
complete families	2
pathogenic mycoplasma species	2
surface antigenic variation systems	2
Xer1 recombinase	2
‘Vpma immune evasion proteins	2
gene chimeras	2
intragenic deletions	2
target Vpma	2
corresponding Vpma-specific antibody	2
several in vitro generations	2
Vpma	2
Xer1-disrupted PLMs	2
alternative Vpma phenoytpes	2
Vpma-specific antibodies	2
anti-Vpma antibodies	2
PLMs	2
single Vpma product	2
stable phase-locked mutants (PLMs)	2
xer1 recombinase gene	2
abundant multiple surface lipoproteins	2
vpma genes	2
minimalist microbes	2
large multigene families	2
small genomes mycoplasmas	2
additional antimicrobial classes	2
predicted β-lactam resistance (PBP type 13:16:20)	2
19F/ST1421 lineage	2
years 2010–2011 isolates	2
years 2006–2009 isolates	2
Eighty-two STs	2
72 isolates	2
PCV7 serotype 6B	2
Post-PCV7	2
common serotype	2
serotype 14	2
PBP types and other resistance determinants	2
pilus genes	2
serotypes, sequence types (STs)	2
CDC’s Streptococcus lab bioinformatics pipeline	2
children≤5years old	2
PCV7 introduction	2
; n=79)	2
16 hospitals	2
IPD isolates	2
invasive strains	2
public hospitals	2
25 isolates	2
known New Delhi metallo-β-lactamase-1 (NDM)-carrying plasmid	2
isolates in our dataset	2
SHV-27	2
ESBL-positive, encoding CTX-M-15, SHV-2,	2
antimicrobial resistance genes	2
third generation cephalosporins	2
MDR K. pneumoniae isolates	2
Kilifi County Hospital (KCH)	2
invasive K. pneumoniae isolates	2
extended-spectrum β-lactamases (ESBLs)	2
nosocomial infections	2
Multidrug resistant (MDR)	2
new antimalarial compounds	2
several lipids	2
P. vivax malaria	2
several plasma metabolites	2
biliverdin, bilirubin, palmitoylcarnitine, stearoylcarnitine, phosphocholine, glycerophosphocholine, oleic acid and omega-carboxy-trinor-leukotriene	2
Top predicted metabolites	2
150 patients	2
high-resolution metabolomics platform	2
vendor	2
barrier access and open cages	2
irradiated chow	2
major phyla, alpha- and beta diversity	2
(V1–V2 region, Illumina MiSeq)	2
five mice per room/facility	2
Fresh feces	2
different mouse rooms/facilities	2
Intestinal Microbiota	2
variety of murine models	2
S. flexneri 2a	2
mutant bacteria	2
periplasmic and outer membrane proteins	2
parent bacteria	2
(S. flexneri 2a) and 8.3-fold (S. sonnei)	2
outer membrane and periplasmic proteins	2
predicted cytoplasmic protein impurities	2
remaining proteins	2
S. flexneri 2a and S. sonnei GMMA	2
Predicted outer membrane and periplasmic proteins	2
S. flexneri 2a and S. sonnei	2
1696 (bacteria)	2
2306 proteins	2
GMMA-producing strains	2
solubilized cells	2
hyperblebbing mutants of Shigella flexneri 2a and Shigella sonnei	2
Generalized Modules	2
Outer membrane blebs	2
clinical A. fumigatus isolate	2
Invasive aspergillosis	2
V. cholerae or ETEC	2
infant mice	2
known inhibitor	2
second messenger	2
outer membrane porin OmpT	2
V. cholerae	2
two pathogens	2
corresponding salt (silver or zinc nitrate) with aqueous extract of Caltropis procera fruit or leaves	2
dominant bacterial causes	2
Vibrio cholerae and enterotoxic Escherichia coli (ETEC)	2
new and safer niches	2
distant inner organs	2
cytoplasm of mammary duct epithelium and macrophages	2
culture and immunohistochemistry	2
organs and host niches	2
experimental sheep intramammary infection	2
extracellular bacteria	2
Internalized M. agalactiae	2
quantitative gentamicin invasion assays	2
intracellular mycoplasmas	2
cultured human (HeLa) and ruminant (BEND and BLF) host cells	2
economically important pathogen	2
yet unknown signaling system	2
host specific signal substrate	2
important carbon-source	2
ArcAB regulatory system	2
inductor inducible system	2
H. influenzae	2
lactate utilization system	2
nasopharyngeal colonization	2
mutant strain	2
corresponding lctP knockout strain	2
COPD isolate NTHi 2019-R	2
l-lactate dehydrogenase (lctD) and permease (lctP)	2
non-typeable (NTHi) isolate 2019 and laboratory prototype strain Rd KW20	2
H. influenzae type b	2
frequent commensal of the human nasopharynx	2
Gram-negative bacillus	2
cell surface component	2
close relative H. influenzae	2
H. parainfluenzae	2
O-antigen	2
O-antigen-containing LPS glycoforms	2
putative O-antigen ligase	2
ABC transporter system	2
ribitol phosphate or deoxytalose	2
Three H. parainfluenzae isolates	2
glycosyltransferase genes	2
ABC transporter	2
encoding galactofuranose synthesis/transfer enzymes	2
O-antigen synthesis	2
encoding enzymes	2
two main groups	2
O-antigen loci	2
hmg locus	2
glnA and pepB	2
O-antigen biosynthesis gene cluster	2
commensal H. parainfluenzae isolates	2
occasional pathogen	2
normal commensal of humans	2
Haemophilus parainfluenzae	2
Gram negative bacteria	2
Lipopolysaccharide O-antigens	2
P. multocida or M. haemolytica	2
BRD and other infections	2
broad-spectrum OMV based vaccines	2
outer membrane proteins P2 and OmpA	2
uncharacterized outer membrane protein	2
serotype 1-specific antigen	2
three major immunogenic proteins	2
outer membrane proteins OmpA	2
OMV types	2
respective donor strain	2
P. multocida and M. haemolytica outer membrane vesicles (OMVs)	2
P. multocida and M. haemolytica	2
Commercially available vaccines	2
cattle backgrounding and feedlot industry	2
major bacterial causative agent	2
Mannheimia haemolytica	2
snuffles in rabbits	2
fowl cholera in birds, atrophic rhinitis in pigs	2
wide range of animal hosts	2
Pasteurella multocida	2
ciliate species	2
morphologically-identical species	2
sampling sites	2
oxygen-depleted habitats	2
TGA stop codon	2
ciliates’ stop	2
Chlorella vulgaris	2
green algal endosymbiont	2
S. minus	2
surrounding particles	2
protective coating	2
endosymbiotic algae	2
large freshwater protist	2
ciliate Spirostomum semivirescens	2
Corythion dubium (Taránek 1881)	2
Corythion constricta (Certes 1889)	2
Corythion spp.	2
globally ubiquitous taxa	2
AP testate amoeba assemblages	2
Testate amoebae on the Antarctic Peninsula (AP)	2
polar regions	2
ecological and palaeoecological datasets	2
Precise and sufficiently detailed morphological taxonomy	2
Southeastern Pacific and Southwestern Atlantic	2
Durvillaea stocks	2
phytomyxean parasite of brown algae	2
late cysts	2
early plasmodia	2
28S non-coding gene	2
brown algae	2
sister species of the marine parasite Maullinia ectocarpii	2
order Phagomyxida (Phytomyxea, Rhizaria)	2
partial 18S and the partial 18S-5.8S-28S regions	2
host thalli	2
distinct hypertrophies (galls)	2
South-Eastern Pacific (Central Chile and Chiloe Island) and South-Western Atlantic (Falkland Islands, UK)	2
bull kelp Durvillaea (Phaeophyceae, Fucales)	2
obligate parasite	2
nov.,	2
Maullinia braseltonii sp.	2
obligate endoparasites of angiosperm plants	2
Apicomplexa and dinoflagellate algae	2
sense transcripts	2
long, polycistronic antisense transcripts	2
conserved sequence motif	2
major RNA processing sites	2
many apicoplast transcripts	2
3′ poly(U) tails	2
chloroplasts of some related organisms (chromerids and dinoflagellate algae)	2
Plasmodium and many other parasitic apicomplexan species	2
protist groups	2
aquatic food-web and biogeochemical models	2
foodweb structure	2
specific (SNCM) or general non-specific (GNCM) prey	2
non-constitutive mixotrophs (NCMs)	2
constitutive mixotrophs (CMs)	2
photoautotrophs lacking phagotrophic capacity	2
phagoheterotrophs lacking phototrophic capacity	2
eco-physiological context	2
planktonic protists	2
phytoplankton and microzooplankton	2
many protists	2
euphotic aquatic systems	2
“microzooplankton	2
photoautotrophic “phytoplankton”	2
Planktonic protists	2
Arranging organisms	2
intracellular replicating forms	2
intracellular forms of T. copemani G2	2
G1 and T. cruzi	2
VERO cells	2
intracellular amastigote of T. copemani G1 and G2	2
four cell lines	2
G1 and G2	2
T. cruzi strain-10R26	2
two newly described genotypes, T. copemani G1 and G2	2
woylie (Bettongia penicillata)	2
several threatened/endangered marsupial species	2
Trypanosoma copemani	2
Canary Islands	2
Gambierdiscus species	2
islands	2
G. excentricus	2
Atlantic	2
G. australes	2
G. polynesiensis	2
well supported sister clade	2
three G. silvae strains	2
nuclear rRNA	2
largest of the hypotheca	2
hatchet-shaped and Plate 2″″	2
Plate formula	2
many scattered pores	2
thick smooth theca	2
hypotheca	2
rocky shores of the Canary Islands (NE Atlantic Ocean)	2
tide pools	2
new photosynthetic dinoflagellate species, Gambierdiscus silvae sp. nov.	2
NE Atlantic Ocean	2
tropical areas	2
Species of the dinoflagellate genus Gambierdiscus	2
conventional antibiotics	2
spores and cysts	2
prestalk and stalk cells	2
sheathed column of decaying cells	2
droplet of amoeboid cells	2
simple fruiting structures	2
stalk cells or cysts	2
walled spores	2
dcsa-/dcsb- mutant	2
spore and cyst walls	2
normal stalks	2
fruiting bodies	2
Dcsa- mutants	2
two cellulose synthase genes, DcsA and DcsB	2
distant relative Polysphondylium pallidum (Ppal)	2
cellulose-rich stalk and spore cells	2
multicellular fructifications	2
Genetically tractable Dictyostelium discoideum amoebas	2
walled cysts	2
Amoebas and other freely moving protists	2
mitochondrial stress response genes and genes	2
drug-treated parasites	2
complex III inhibitor antimycin A	2
synchronous Plasmodium falciparum	2
nuclear-encoded mitochondrially-targeted proteins	2
Many organisms	2
mitochondrial genomes of Plasmodium sp.	2
antimalarial drug atovaquone	2
FAZ and the flagellar pocket	2
sub-populations of the ER	2
procyclic form trypanosomes	2
TbVAP RNAi	2
tagged TbVAP	2
integral ER membrane proteins	2
orthologue of VAMP-associated proteins (VAPs)	2
T. brucei protein	2
bloodstream form trypanosomes	2
‘FAZ ER’	2
sheet of endoplasmic reticulum	2
cytoplasmic FAZ cytoskeleton	2
flagellar and cytoplasmic components	2
complex flagellum attachment zone (FAZ)	2
single flagellum	2
important human parasites	2
neuroprotective sterols	2
sterol 26-hydroxylase	2
Cyp27a1−/− mice	2
CTX patients	2
primary brain cultures	2
former stereochemistry is a liver X receptor (LXR) ligand	2
acid	2
pregnane X receptor (PXR)	2
7α-Hydroxycholest-4-en-3-one	2
primary mouse brain cultures	2
additional sterol 26-hydroxylase	2
brain and circulation of Cyp27a1−/− mice	2
cholesterol metabolites and precursors	2
Cyp27a1 knockout mice (Cyp27a1−/−)	2
CYP27A1 gene	2
(25R)26-hydroxy and ultimately a (25R)26-acid group	2
cholesterol and ring-hydroxylated sterols	2
acidic and neutral pathways of bile acid biosynthesis	2
Cytochrome P450 (CYP) 27A1	2
adipose and non-adipose tissues	2
human gene encoding ATGL	2
specific murine ATGL inhibitor (Atglistatin®)	2
cell- or tissue-specific manner	2
different genetic mouse models	2
ligands of nuclear receptors	2
crucial energy substrates	2
fatty acids (FAs)	2
intracellular triglyceride	2
critical analytes	2
Metabolomics and lipidomics	2
zinc distribution	2
free fatty acid and zinc binding	2
allosteric link	2
chemically extremely diverse entities	2
essential metal ions	2
neurodegenerative peptides	2
lipids and hydrophobic molecules	2
transport protein	2
mammalian blood plasma	2
Oil1p in Y. lipolytica	2
mammalian perilipins	2
perilipin 1 expressing control strain	2
perilipin-like protein Pln1p	2
Saccharomyces cerevisiae mutant	2
LD	2
TAG lipolysis	2
mutant overexpressing OIL1	2
Oleaginicity Inducing LD protein	2
coding gene	2
protein of the oleaginous yeast Yarrowia lipolytica	2
intracellular lipid droplets (LDs)	2
triacylglycerol (TAG)	2
Oleaginous microorganisms	2
circulating lipoproteins	2
LAL-deficient (Lal−/−)	2
triacylglycerols in lysosomes of multiple cells and tissues	2
cholesteryl esters	2
known enzyme	2
Lysosomal acid lipase (LAL)	2
world's third most important oil crop	2
diacylglycerol acyltransferase (DGAT) and phospholipid:diacylglycerol acyltransferase	2
diacylglycerol, phosphatidylcholine and acyl-CoAs	2
individual lipid classes	2
developing seeds	2
oilseed rape (Brassica napus L)	2
available agricultural land	2
recently identified yeast protein	2
peripheral mitochondrial protein, TAMM41	2
peripheral p55 cross-reactive mitochondrial protein	2
rat heart, liver and brain mitochondria	2
mitochondria of H9c2 cells	2
PA/PI binding protein, PITPNC1, and CDS1 immunoreactivity	2
CDS1 gene	2
peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1α and β)	2
two highly-related genes, CDS1 and CDS2	2
mitochondria and endoplasmic reticulum of mammalian cells	2
phosphatidylglycerol, cardiolipin and phosphatidylinositol (PI)	2
CDP-diacylglycerol	2
phosphatidic acid (PA)	2
CDP diacylglycerol synthase (CDS)	2
membrane lipids of eukaryotic cells	2
oxygenated lipids	2
cultured lung epithelial cells	2
Similar oxygenation products	2
oxygenated derivatives of less frequently occurring polyenoic fatty acids	2
hydroxy-octadecadienoic acids, hydroxy- and keto-eicosatetraenoic acid, hydroxy-docosahexaenoic acid	2
oxidized fatty acid residues	2
different phosphatidylethanolamine and phosphatidylcholine species	2
human red blood cells this mixture	2
complex mixture of oxidation products	2
lipid extracts	2
cultured human lung epithelial cells	2
recombinant PA-LOX	2
oxygenated membrane lipids	2
red blood cells membrane lipids	2
15S-hydro(pero)xyeicosatetraenoic acid	2
free arachidonic acid	2
secreted lipoxygenase (PA-LOX)	2
immunocompromized patients	2
life-threatening infections	2
gram-negative pathogen	2
second lipoprotein	2
first lipoprotein	2
one distal end of CETP	2
fewer ternary complexes	2
HDL-CETP-LDL ternary complexes	2
binary complexes (e.g., HDL-CETP and LDL-CETP)	2
CETP-lipoprotein binary complexes	2
agents (Torcetrapib, Dalcetrapib and Anacetrapib) on CETP structure, CETP-lipoprotein complex formation and CETP-mediated cholesteryl ester (CE) transfer	2
Cholesteryl ester transfer protein (CETP) inhibitors	2
secreted products	2
siRNA targeting Lamp-1 or the V-ATPase	2
bafilomycin-A1	2
Atg12±Atg7-siRNA)	2
acidic lysosomal compartment	2
AT-CM	2
conditioned media (AT-CM)	2
RAW264.7 macrophages	2
Non-polarized (“M0”)	2
dead adipocytes	2
lipid-droplets (LDs)	2
adipose tissue (AT) foam cells (FC)	2
cellular stores	2
basolateral chylomicron release	2
connected members of the basolateral vesicular chylomicron excretion machinery	2
apolipoprotein B	2
members of the fatty acid uptake complex	2
central regulator of metabolism	2
cytosolic lysophosphatidylcholine (LPC) production	2
fatty acid-uptake complex	2
newly synthesized bile acid-phospholipid conjugate ursodeoxycholate-lysophosphatidylethanolamide (UDCA-LPE) blocked iPLA2ß	2
calcium-independent membrane phospholipase A2 (iPLA2ß)	2
apical heterotetrameric plasma membrane protein complex	2
polarized human intestinal tumor derived cell line CaCo2	2
senescent keratinocytes	2
living keratinocytes	2
sphingomyelin and cholesterol	2
detoxified fragments of lysenin and theta toxins	2
exogenous sphingomyelin (BODIPY-SM)	2
specialized lipid domains	2
adhering human keratinocytes	2
signaling platforms	2
lipid membrane domains	2
lipid submicrometric domains	2
Membrane lipid raft model	2
Sepp Kohlwein	2
Opinion Articles	2
dominant analytical technology	2
cyclopentanoperhydrophenanthrene skeleton	2
entire complement of molecules	2
intestinal DGAT1	2
apical surface of enterocytes	2
whole-body DGAT1−/− and DGAT1 inhibitor-treated mice	2
(I-DGAT1−/−)	2
small intestine and liver	2
DGAT1 in mice	2
Acyl-CoA:	2
Plant Lipid Biology	2
emerging field of lipidomics	2
mutants of model species	2
ubiquitous bio-active components of cells	2
phosphorylated derivatives	2
Srebp1c (p<0.05, C/HF and HF/HF vs C/C).ConclusionOur	2
Sirt3 (p<0.01, HF/HF vs C/C)	2
HF fed offspring of mothers	2
offspring livers	2
lipid metabolism (Rev-Erbα, Rev-Erbβ, RORα, and Srebp1c)	2
core clock genes (Clock, Bmal1, Per2, Cry2) and clock-controlled genes	2
C/C, C/HF, HF/C and HF/HF	2
four offspring groups	2
C or HF diet	2
control (C, 7%kcal fat) or HF (45%kcal fat) diet	2
non-alcoholic steatohepatits (NASH)	2
individual phospholipid classes	2
ethanolamine phospholipid molecular species	2
different brain areas	2
polyunsaturated fatty acid contents	2
four major phosphoglycerides	2
ether derivatives)	2
DHA-supplementation	2
phosphoglyceride	2
cortex, hippocampus and cerebellum	2
Major phospholipids	2
nutritionally-sufficient diet	2
DHA-supplemented diet	2
dietary docosahexaenoic acid (DHA)	2
brain lipids	2
ageing populations	2
C18:1 fatty acid	2
saturated and unsaturated alkyl chains	2
human and bacterial MGL	2
cap of Yju3p	2
MGL cap region	2
covalently bound substrate analog	2
free form	2
MGL from Saccharomyces cerevisiae called Yju3p	2
cap region of this protein	2
humans and bacteria	2
free fatty acids and glycerol	2
monoglycerides (MGs)	2
group of α/β-hydrolases	2
Monoglyceride lipases (MGLs)	2
Tim P. Levine and Anant K. Menon	2
cellular lipid landscape	2
endocytic organelles	2
ER contact sites	2
ER and endocytic pathway	2
diverse range of functionally distinct organelles	2
extensive and dynamic network of MCSs	2
autophagosome formation	2
autophagy pathways	2
range of autophagy substrates	2
unwanted organelles	2
dysfunctional proteins	2
energy substrates	2
proteins and cell organelles	2
LDs in A0H0 macrophages	2
functional lysosomes	2
intact autophagy	2
cathepsin B	2
TG-rich LD accumulation	2
A0H0 mice	2
ATGL and HSL (A0H0)	2
lipase-deficient macrophages	2
vitro TG hydrolase activity	2
hormone-sensitive lipase (H0)	2
organs and cells	2
cytosolic LDs	2
triglycerides (TGs)	2
lysosomal acid lipase	2
Breakdown products	2
damaged organelles and misfolded proteins	2
TG lipase	2
cultured primary murine HSCs	2
physiological regulators	2
G0/G1 switch gene-2	2
liver and adipose tissue	2
hormone-sensitive lipase (HSL) deficiency, a known RE hydrolase (REH)	2
major enzymes	2
pathogenic stimuli	2
cytosolic lipid droplets	2
Hepatic stellate cells (HSCs) store triglycerides (TGs) and retinyl ester (RE)	2
PI3Kδ, γ or β	2
several mouse models	2
Class I PI3K isoforms	2
isoform-selective, small-molecule PI3K inhibitors	2
Class II PI3Ks	2
phospholipid PI3P	2
Class III	2
innate immune cells at sites	2
particular receptor sub-types	2
four isoforms	2
many different cell surface receptors	2
‘second messenger’	2
phospholipid ‘PIP3’	2
four Class I isoforms	2
three Class II PI3K isoforms (PI3KC2α, C2β, C2γ) and a single Class III PI3K.	2
K isoforms (PI3Kα,β,γ,δ)	2
disease conditions	2
ω-6 and ω-3 PUFAs	2
total ethanolamine phospholipids	2
PE fraction of plasmalogen-deficient tissues	2
docosahexaenoic acid	2
head group ethanolamine	2
diacyl glycerophospholipid	2
plasmalogen-deficient mice	2
RCDP patients	2
plasmalogen biosynthesis	2
mammalian cellular membranes	2
group of ether glycerophospholipids	2
Ethanolamine plasmalogens	2
sterol molecules	2
two types of antifungal drugs	2
PI binding deficient mutant	2
membrane compartments	2
phosphatidylinositol (PI)	2
Sec14 family of phosphatidylinositol transfer proteins	2
Sfh3p)	2
PI3K, ERK, and CREB signaling pathway	2
LPAR1-Gi/o	2
cPA and LPA	2
cPA and LPA in NB1RGB cells	2
LPA receptor LPAR1, Gi/o protein, phosphatidylinositol-3 kinase (PI3K), extracellular-signal-regulated kinase (ERK), and cyclic adenosine monophosphate response element-binding protein (CREB)	2
NB1RGB cells	2
hyaluronic acid synthesis	2
hyaluronan synthase 2 messenger RNA and protein	2
cPA and LPA dose-dependently	2
particle exclusion and enzyme-linked immunosorbent assays	2
human fibroblasts (NB1RGB cells)	2
human osteoarthritis synoviocytes	2
metabolically stabilized cPA derivative, 2-carba-cPA	2
sn-2 and sn-3 positions of its glycerol backbone	2
unique cyclic phosphate ring	2
analog of the growth factor-like phospholipid lysophosphatidic acid (LPA)	2
naturally occurring phospholipid mediator	2
Cyclic phosphatidic acid (cPA)	2
physiological SM carriers/donors	2
HDL-like particles	2
both, a- and nSMases	2
caveolin-dependent pathways	2
exogenous SM	2
CATH.a cells	2
high-density lipoprotein (HDL)-associated BODIPY-SM	2
both, acid (a)SMase and neutral (n)SMases	2
BODIPY-ceramide	2
endocytosis BODIPY-SM	2
Golgi and the ER	2
internalized BODIPY-fluorescence	2
bacterial sphingomyelinase (SMase)	2
exogenously added BODIPY-SM	2
murine neuronal cell line (CATH.a)	2
fluorescently-labeled SL turnover	2
exogenous sources	2
one of the main raft constituents	2
Sphingomyelin (SM)	2
specialized membrane microdomains	2
Neuronal sphingolipids (SL)	2
rather redundant pathway	2
intracellular HDL transport routes	2
SR-BI, F1-ATPase and CD36	2
liver, macrophages and endothelium	2
tissues and cell types	2
HDL holo-particles	2
HDL particle	2
liver and steroidogenic tissues	2
HDL of elderly subjects	2
acute phase protein serum amyloid A	2
healthy young and elderly subjects	2
composition and function of HDL	2
high-density lipoproteins (HDL)	2
coronary deaths	2
identified cell surface glycoproteins	2
vitro model system	2
subset of the detected obesity modulated cell surface glycoproteins	2
surfaceome maps	2
primary adipocytes	2
chemoproteomic Cell Surface Capture (CSC) technology	2
subproteome	2
adipocyte cell surface proteome, or surfaceome	2
enlarged adipocytes	2
excess adipose tissue	2
either enzyme	2
neuronal receptors	2
peripheral nerve axons	2
spinal cord and hippocampus	2
NTE-mediated PtdCho homeostasis	2
neuronal soma	2
PtdCho synthesis	2
phospholipid-binding protein	2
nascent PtdCho complexed	2
two free fatty acids	2
phosphatidylcholine (PtdCho)	2
neuronal mitochondrial phospholipids	2
polyunsaturated fatty acid-associated phospholipid	2
diacyl-phospholipid	2
oleoyl-CoA.	2
Ca2+-calmodulin tonically-inhibits	2
diacyl-phospholipids	2
liberates sn-2 fatty acid and lysophospholipids	2
essentially all neurons	2
two related phospholipases	2
(iPLA2β) and neuropathy target esterase (NTE)	2
calcium-independent phospholipase	2
low resource settings	2
CIN2+ and <=CIN1	2
viral gene expression	2
<=CIN1	2
colposcopy clinic	2
prospective cohort of Scottish women	2
routinely taken cervical LBC samples	2
HPV E4 and cellular minichromosome maintenance (MCM) proteins	2
liquid based cytology (LBC) samples	2
suffering	2
transient HPV infections	2
human papillomavirus (HPV) DNA testing	2
blood donor controls	2
patients with shingles	2
recent shingles	2
Mean antibody titres	2
acute zoster	2
441 controls	2
zoster patients	2
active zoster	2
healthy population controls	2
patients with recent shingles	2
shingles patients	2
novel diagnostic tests	2
range of pathogens	2
pathogenic filoviruses	2
rearranged viral strains	2
miRNA expression	2
minor rearranged viral populations	2
archetype BKPyV strains	2
archetype strains	2
7/9 PyVAN patients	2
Rearranged BKPyV strains	2
8.9-fold (bkv-miR-B1-3p) and 8.7-fold (bkv-miR-B1-5p	2
-miR-B1-3p and bkv-miR-B1-5p miRNA expression	2
TCR architectures	2
specific miRNA assays	2
2 controls	2
-miR-B1-3p and bkv-miR-B1-	2
JC polyomavirus	2
polyomavirus-encoded microRNAs	2
polyomavirus-associated nephropathy (PyVAN)	2
ritonavir-boosted PI monotherapy	2
previously unidentified minority variant protease mutations (G73D, I54T, L89V)	2
potential samples	2
minority variants	2
Public Health England laboratories	2
available frozen plasma samples	2
local Sanger sequencing resistance tests	2
PI monotherapy	2
ritonavir-boosted protease inhibitor (PI) monotherapy	2
combination antiretroviral therapy	2
PIVOT trial	2
previously untested, low-prevalence cohort	2
HCV genotypes 2l and 2r	2
positive pool	2
5/175 DPS pools	2
HCV core and NS5B.ResultsWith the dilution series	2
6mm punches	2
positive pools	2
875 HIV-positive subjects	2
replicate DPS	2
samples stored	2
pooled and individual dried plasma spots (DPS)	2
large HIV-positive cohort	2
molecular laboratory facilities	2
frozen samples	2
large sample repositories	2
rural Nepal	2
Cord blood RSV antibody	2
paired maternal and infant samples	2
RSV antibody microneutralization assay	2
Nasal swabs	2
respiratory illness	2
maternal and infant cord blood	2
infants in a resource-limited setting	2
RSV-specific antibody (ab)	2
2016–2017 A(H3N2) influenza viruses	2
recently proposed 3C.2a2 subclade	2
new 3C.2a1 subclade	2
3C.2a clade	2
three separate subgroups	2
influenza A(H3N2) viruses	2
2016–2017 influenza vaccine	2
ResultsInfluenza A(H3N2)	2
Hemagglutinin sequences	2
influenza-like illness	2
A(H3N2) viruses	2
influenza A(H3N2).ObjectivesTo	2
established rapid assays	2
tertiary care setting	2
LDA and ARIES	2
fluA, RSV and fluB	2
unselected fresh clinical samples	2
stored respiratory samples	2
retrospective study arm	2
laboratory developed RT-PCR assays (LDA), ICT (BinaxNOW) and DFA.MethodsAnalytical and clinical performance	2
rapid molecular assay, ARIES FluA/B & RSV	2
molecular assays	2
different airway pathogens	2
first vaccine HBV vaccine dose	2
HBsAg children	2
additional children	2
Hepatitis B e-antigen positive	2
625 patients	2
screening campaign	2
extended panel of HBV serology tests	2
HBsAg-positive cases	2
Hepatitis B surface antigen (HBsAg)	2
HIV positive children	2
HBV cases	2
HBV among HIV-infected children and adolescents	2
vulnerable HIV-infected group	2
first HBV vaccine dose	2
unknown primary tumor	2
patients with oropharyngeal squamous cell carcinoma or cancer	2
node metastases	2
cervical lymph	2
FNAC material	2
HPV PCR assay	2
HPV positive cases	2
HPV negative cases	2
HPV SPF10-LiPA25 assay	2
formalin fixed paraffin embedded (FFPE) histological material	2
FNAC slides scrapings	2
unknown primary tumor (CUP)	2
HPV in oropharyngeal squamous cell carcinoma (OPSCC)	2
NoV genogroups	2
asymptomatic and symptomatic children	2
real-time one-step RT-PCR.ResultsOne hundred and four (41.1%) NoVs	2
outpatient children	2
NoV in symptomatic and asymptomatic children	2
summer	2
712 patients	2
1452 patients	2
respiratory tract specimens	2
two tertiary care hospitals	2
consecutive CAP and HAP patients	2
respiratory virus infections	2
categories of patients on the intensive care unit (ICU)	2
US and Australian community studies	2
Winter/Spring	2
Coronavirus (8%), Enterovirus (5%), Respiratory syncytial virus (3%), Metapneumovirus virus (2.5%) and Parainfluenza virus 3 (1.8%)	2
positive swabs	2
nose/throat swabs	2
nose and throat swabs	2
Health workers	2
cohort of 263 northern Vietnam households	2
(sub)tropical developing countries	2
screening population	2
Onclarity test	2
5 nucleic acid tests	2
second sample	2
HC2, RealTime and Aptima	2
<CIN2	2
sample pairs	2
protein test	2
Hologic Aptima	2
RNA based test—	2
BD Onclarity and Genera PapType	2
Abbott Realtime	2
One sample	2
women with abnormal cytology	2
cervical samples	2
woman	2
two samples	2
SurePath and PreservCyt	2
different HPV tests	2
PreservCyt and SurePath	2
transport media	2
tertiary care paediatric hospital	2
D-IF.ConclusionsRADTs	2
RT-PCR positive samples	2
D-IF.Sensitivity	2
combination of the respective assays	2
tertiary care centre	2
nasal washings	2
BinaxNow Influenza AB® (BNI) and BinaxNow RSV® (BNR)	2
influenza viruses and respiratory syncytial virus (RSV)	2
antigen detection tests (RADTs)	2
closely monitored pediatric oncology patients	2
4 remained VZV-seronegative	2
VZV-specific CD4+ T cells	2
VZV-seronegative	2
VZV-specific CD4+	2
immunized patients	2
solid tumor (n=7)	2
-one patients	2
chemotherapy	2
VZV-seronegative pediatric oncology patients	2
VZV vaccination	2
live-attenuated varicella vaccine	2
VZV-seronegative cancer patients	2
immunocompromised children	2
diagnostic testing panel	2
influenza C virus	2
seven segments	2
nearly complete sequences	2
6 samples	2
Influenza C	2
ResultsInfluenza D	2
influenza C and D viruses	2
patient respiratory samples	2
human influenza C virus	2
novel virus	2
newly proposed genus of influenza virus (influenza D)	2
Sequencing technology	2
full genome sequences	2
current diagnostic assays	2
viral pathogen	2
nasopharyngeal swabs	2
consensus sequences	2
NGS sequences	2
current standard diagnostic test	2
target independent NGS	2
targeted pathogens	2
viral respiratory pathogens	2
patients infected with the Q80K genotype 1a variant	2
Scottish cohort	2
prevalent baseline polymorphism	2
Four patients	2
RAVs	2
Q8 K polymorphism	2
HCV virus	2
Amino acid positions	2
ABI 3710XL DNA sequencer	2
1.4kb amplified product	2
NS3/4A region	2
PIs boceprevir, telaprevir and simeprevir	2
, treatment-naïve, HCV genotype 1 patients (n=146)	2
PI treatment-naïve HCV genotype 1 Scottish cohort	2
RAVs/polymorphisms	2
pre-treatment resistance associated amino acid variants (RAVs)	2
BackgroundProtease inhibitors (PI)	2
novel vector-borne RNA viruses	2
vector-borne RNA viruses	2
zoonotic reservoir	2
minority of RNA viruses	2
Multiple viruses	2
influenza A (p<0.0001) or respiratory syncytial virus (p<0.0001)	2
adenovirus species B (p<0.01) or C (p<0.05)	2
GenBank database	2
two new species C rhinoviruses	2
Partial structural region sequences	2
non-ALRI children	2
Human rhinoviruses (HRV) species A, B and C	2
pathogenic respiratory viruses	2
221 young children	2
samples collected	2
comprehensive range of respiratory viruses	2
tandem multiplex real-time PCR assay	2
young children of Papua New Guinea (PNG)	2
CMV viraemia	2
D+R+ and D−R+ group	2
lower risk D+R+ and D−R+ patients	2
valganciclovir prophylaxis	2
transplant centres	2
12 UK solid organ transplant centres	2
solid organ transplants	2
era	2
individual gB genotype infections and mixed genotype infections	2
gB groups	2
intravenous ganciclovir	2
n=239)	2
multiple infections	2
gB genotypes	2
different cytomegalovirus (HCMV) glycoprotein B (gB) genotypes	2
different parental strains	2
genome sequence of G10P[11] strains	2
strains from symptomatic and asymptomatic neonates	2
bovine-human reassortant strains	2
human parental strain	2
Gene segments encoding NSP1, 2 and 3	2
strain N155	2
gene sequences	2
human and bovine rotaviruses	2
bovine or human rotavirus strains	2
gene segment	2
I321, other human and bovine strains	2
Nucleotide and amino acid sequence similarity	2
symptomatic G10P[11] rotavirus isolate N155	2
11 gene segments	2
complete genome sequencing	2
G10P[11] strain I321	2
neonate	2
whole genome of a G10P[11] isolate (N155)	2
VP4, VP6, VP7 and NSP4 genes of the exclusively asymptomatic G10P[11] strain I321.ObjectivesIn	2
BackgroundRotavirus G10P[11]	2
CMV seropositive recipients	2
D+/R−)	2
seronegative recipients of organs from seropositive donors	2
cohort of 486 recipients	2
large renal transplant cohort	2
recipient serostatus	2
seropositive donor	2
seronegative recipients	2
donor tissues	2
latent virus	2
vaccines and antimalarial drugs	2
squirrel monkey-adapted P. falciparum parasite	2
adapted parasite	2
original parasite	2
adapted strain	2
trophozoites and schizonts	2
edge of the infected red blood cell	2
original parasites	2
adapted ring-stage parasites	2
FCB strain	2
splenectomized squirrel monkeys (Saimiri sciureus)	2
nine laboratory strains of P. falciparum	2
infection models	2
blood stages of infection	2
tropical and subtropical areas of the world	2
asexual blood stages of the Plasmodium falciparum parasite	2
P. knowlesi	2
P. falciparum tether structure	2
PkMAHRP2-localized amorphous structures	2
swollen ends	2
plate-like structure	2
SMC	2
P. knowlesi-infected erythrocyte	2
erythrocyte membrane	2
Sinton Mulligan's clefts (SMC)	2
amorphous structures	2
P. falciparum-infected erythrocyte	2
tether structure	2
P. knowlesi ortholog of MAHRP2	2
Plasmodium knowlesi-infected erythrocyte	2
nascent membranous structures	2
host erythrocyte malaria parasites	2
malarial infections	2
Zoledronic acid	2
VD3 and 22-OCT	2
IFN-γ-KO mice	2
vehicle-treated animals	2
interferon (IFN)-γ in VD3-treated B10 and B6 mice	2
P. falciparum (Pf) in human red blood cells	2
VD receptor knockout (KO) mice	2
Reduced parasitemia	2
VD3 and its analog, 22-oxacalcitriol (22-OCT)	2
vivo murine models	2
active form of vitamin D (VD)	2
1α,25-dihydroxyvitamin D3 (calcitriol, VD3)	2
intermediate and definitive hosts	2
Shared haplotypes	2
M. bilis	2
phylogenies	2
either mink from Scotland (n=40)	2
internal transcribed spacer II (ITS2) locus	2
trematodes in mustelids (principally otters)	2
Looss, 1899 (Trematoda: Opisthorchiidae)) in otters	2
Loos, 1899 and Metorchis crassiusculus (Rudolphi, 1809)	2
Odening, 1962 (synonymous with Metorchis albidus (Braun, 1893)	2
(Trematoda: Opisthorchiidae) and Metorchis bilis (Braun, 1790)	2
Pseudamphistomum truncatum, (Rudolphi, 1819)	2
experimental and field settings	2
tissues, faeces, and oocysts	2
(R2=0.006)	2
study groups	2
Quantitative real-time PCR test	2
caecal tissues	2
tenella oocysts	2
beta-actin (actb)	2
four chicken-specific reference qPCR assays	2
Eimeria tenella in chicken tissue	2
quantitative real-time PCR (qPCR)	2
non-subjective, quantitative, tools	2
highly pathogenic parasites	2
Golgi of the bloodstream and procyclic parasite forms	2
complex poly-N-acetyllactosamine-containing type N-linked and GPI-linked glycans	2
Golgi-associated protein GRASP	2
hemagglutinin epitope-tagged TbGT8	2
underlying protein cores	2
anti-AcP115 antibody	2
bloodstream form of T. brucei	2
stage-specific glycoprotein	2
acidic ecto-protein phosphatase AcP115	2
several glycoproteins	2
band	2
mutant lysate	2
broad protein band	2
wild type and TbGT8 null-mutant T. brucei	2
poly-N-acetyllactosamine-containing glycans	2
tomato lectin	2
tetracycline-inducible conditional null T. brucei mutant	2
mammalian bloodstream form of the parasite	2
βGal β1-3N-acetylglucosaminyltransferase activity	2
UDP-GlcNAc:	2
branched side chain	2
glycosyltransferase TbGT8	2
branched N-acetyllactosamine and lacto-N-biose units	2
unusual glycosylphosphatidylinositol-anchor side chain structures	2
procyclin surface glycoproteins	2
procyclic form of Trypanosoma brucei	2
skin and draining lymph nodes	2
spatially separated tissue sites	2
draining lymph node (dLN)	2
site of infection	2
fluorescent reporter genes	2
P. falciparum and P. vivax isolates	2
antimalarials pyrimethamine	2
Thai isolate EU266602	2
PoDHFR	2
plasmodial enzymes	2
Methotrexate Sepharose column	2
Escherichia coli BL21 (DE3)	2
TS null bacterial strain	2
DHFR chemical knockout	2
putative dhfr-ts of Plasmodium ovale	2
validated antimalarial drug target	2
Plasmodial bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS)	2
mammalian host immune system	2
cuticle of adult H. polygyrus	2
Anti-CTL-1 antibody	2
19-kDa band in H. polygyrus ES (HES)	2
secreted proteins of adult N. brasiliensis (NES)	2
Hp-CTL-1 and Nb-CTL-1	2
Polyclonal antibodies	2
free-living infective larval (L3) stage	2
Nb-CTL-2 transcripts	2
gut-dwelling adult stages	2
H. polygyrus and N. brasiliensis genes	2
lectin domains of mammalian immune system proteins CD23 and CD206	2
C. elegans CLEC-48, 49 and 50	2
CTL superfamily	2
key conserved sequence motifs	2
encode predicted signal peptides	2
Nb-CTL-1 191 aa and Nb-CTL-2 183 aa	2
predicted Hp-CTL-1 protein	2
short additional N-terminal domains	2
single-CRD proteins	2
3 new C-type lectins	2
cDNA libraries	2
Heligmosomoides polygyrus and Nippostrongylus brasiliensis	2
experimental rodent systems	2
gastrointestinal nematode parasites	2
additional non-lectin domains	2
multiple canonical carbohydrate-recognition domains (CRDs)	2
key developmental and structural roles	2
Many members	2
metazoan phyla	2
C-type lectin superfamily	2
MnVit	2
relatively small group of experienced laboratories	2
Donor variance	2
number of laboratories	2
micronuclei appreciably	2
S9 mix	2
micronucleated cells (mnt)/1000 cells	2
8 laboratories	2
human lymphocyte in vitro micronuclei tests (MnVit)	2
intravenous administration	2
comets in bone marrow or liver of mice	2
bone marrow or blood micronucleus tests	2
mouse lymphoma assay	2
small colony tk mutants	2
TMPTA in bacteria or mammalian cells in vitro	2
range of in vitro and in vivo genotoxicity tests	2
overprint varnishes, inks and a variety of wood, plastic and metal coatings	2
reactive diluent and polymer building block	2
sources of free radicals	2
trifunctional acrylate monomer	2
Trimethylolpropane triacrylate (TMPTA)	2
nine laboratories	2
four laboratories	2
presence or absence of cytochalasin B	2
exogenous metabolic activation (S9)	2
standard collection form	2
13 laboratories	2
vitro micronucleus assays	2
negative control samples	2
vitro micronucleus assay	2
experienced laboratories	2
participating laboratories	2
Cr(VI) induced gastrointestinal tumors	2
MOA	2
non-genotoxic MOAs	2
[Cr(VI)].	2
hexavalent chromium	2
gastrointestinal tumors	2
mutagenic vs. non-mutagenic MOA	2
alternative MOAs	2
vivo genotoxicity	2
U.S. and international regulatory agencies and organizations	2
Eastmond [Mutat Res 751 (2012)	2
mutagenic or non-mutagenic MOA	2
environmental chemicals	2
U.S. EPA	2
specific cancer	2
RBC Pig-a MF	2
3 chemicals	2
RET Pig-a MF	2
Twelve chemicals	2
RBC Pig-a assay	2
Thirteen chemicals	2
collaborating laboratories	2
single doses of N-nitroso-N-ethylurea	2
total RBCs (RBC Pig-a assay	2
Pig-a assay	2
RETs in whole blood	2
Pig-a mutants	2
recently developed PIGRET assay	2
peripheral red blood cells (RBCs) and reticulocytes (RETs)	2
Pig-a mutant cells	2
mutagenicity of chemicals	2
X-linked phosphatidylinositol glycan class A gene (Pig-a in rodents, PIG-A in humans)	2
vivo mutation assay	2
argon plasma jet kinpen	2
assay or cell type	2
colony formation assay	2
micronucleus formation assay	2
different testing systems	2
argon plasma jet (kinpen)	2
new treatment option	2
heat sensitive materials and human or animal tissue	2
Cold atmospheric pressure plasmas	2
CTA −derived variant MT clones	2
p16 and p53 pathways	2
CDKN2A/B locus	2
MT clones	2
B(a)P- immortalised MT lines	2
benzo(a)pyrene-induced MT clones	2
test batteries	2
Syrian hamster embryo cell transformation assay (SHE CTA)	2
case examples	2
two chemicals	2
several Cr(VI) datasets	2
relevant tissues and species	2
hexavalent chromium (Cr(VI))	2
specific carcinogens	2
tissue, species, or strain	2
typical laboratory animal models	2
Genotoxicity Testing Working Group	2
Ames+TGR and Ames+in vivo MN+TGR	2
Ames+in vitro CA	2
Ames+in vivo MN	2
89.3%/nc)	2
Ames+in vitro CA+in vivo MN+TGR	2
, Ames+in vivo MN+TGR (87.5%/nc),	2
following combinations	2
carcinogens and 4 non-carcinogens)	2
80 chemicals	2
TGR test	2
293 carcinogens and 86 non-carcinogens)	2
379 chemicals	2
CGX dataset	2
carcinogenicity and in vitro genotoxicity data, i.e., Ames and chromosome aberration (CA) tests	2
Carcinogenicity and Genotoxicity eXperience (CGX) dataset	2
lung cells	2
colloidal amorphous SiO2	2
test groups	2
pulmonary inflammation	2
Fpg-sensitive sites	2
two amorphous SiO2	2
smaller PPS	2
9nm-SiO2	2
larger primary particle size (PPS)	2
30nm-SiO2 and 55nm-SiO2	2
rat precision-cut lung slices	2
Comet assay	2
Fpg (Formamidopyrimidine DNA glycosylase)-sensitive sites	2
neither nanomaterial	2
negative control	2
-SiO2	2
alkaline Comet assay	2
differently sized amorphous SiO2 nanomaterials	2
intestinal stem cells reside	2
duodenal villi	2
increased γ-H2AX immunostaining	2
crypt micronuclei	2
Cr(VI)-treated mice	2
Micronuclei and γ-H2AX immunostaining	2
crypt enterocytes	2
positive control	2
50mg/kg cyclophosphamide	2
Swiss roll sections	2
Crypt enterocytes	2
vehicle control)	2
duodenum	2
crypt health	2
duodenal tumors	2
hexavalent chromium [Cr(VI)] in drinking water	2
whole smoke aerosol	2
combined data-set	2
TA98, TA100, YG1024, YG1042 and Escherichia coli (WP2 uvrA pKM101)	2
three remaining strains	2
diluting airflow	2
strain TA104	2
TA1535, TA97, TA102 and TA104	2
regulatory environment	2
aerosol 35mm spread-plate format	2
TA97, TA104, TA1535, TA1537 and TA102	2
3R4F reference mainstream cigarette smoke	2
Smoking Robot	2
Vitrocell® VC	2
TA1535, TA1537, TA97, TA102 and TA104	2
Salmonella typhimurium strains	2
Ames assay	2
second VC 10 Smoking Robot	2
strain YG1042	2
smoke-exposure set-up	2
quartz-crystal microbalances	2
E. coli strain WP2 uvrA	2
four Salmonella strains	2
diluted mainstream cigarette-smoke	2
metabolic activation system	2
four strains of Salmonella typhimurium (TA98, TA100, YG1024 and YG1042) and one strain of Escherichia coli (WP2 uvrA pKM101)	2
Vitrocell® VC 10 exposure system	2
3R4F reference cigarettes	2
mainstream smoke	2
semi-volatiles and short-lived products of combustion	2
smoke aerosol	2
complex gaseous mixtures and aerosols	2
critical areas	2
parental germ cell exposures	2
classes of chemical contaminants	2
epigenetic “foot-printing” of organisms	2
epigenetic factors	2
identical twins	2
extensive set of compounds	2
current regulatory genotoxicity battery	2
human bronchial epithelial cell line	2
panel of well-characterised genotoxic and non-genotoxic compounds	2
microscopy-based system	2
pre-screening tool	2
novel in vitro genotoxicity test	2
multiple scientific fields	2
laser microbeam induced DNA lesions	2
different laser systems	2
live mammalian cells	2
repair proteins	2
laser microbeams	2
endogenously and exogenously produced lesions	2
Ames, micronucleus and HPRT forward mutation assays	2
vitro OECD genotoxicity test battery	2
current OECD recognised genotoxicity assays	2
well defined and appropriate in vitro assays	2
wide-ranging nano-containing consumer products	2
nanotechnology industry	2
MACS purification platform	2
flowsheet	2
MACS purification	2
integrated processing platform	2
gas permeable vessels	2
T-flasks	2
different process technologies	2
allogeneic CAR-T cell bioprocess	2
capacity of downstream processing (DSP) technologies	2
microcarrier-based bioreactors	2
multi-plate bioreactors	2
competing cell culture technologies	2
allogeneic mesenchymal stromal cells (MSCs)	2
different manufacturing platforms	2
different candidate technologies	2
advanced decisional tool	2
STR, ML and PB	2
hollow fiber bioreactor (HF) and a packed-bed bioreactor (PB)	2
multi-layer vessel (ML), a stirred tank bioreactor with microcarrriers (STR)	2
umbilical cord-derived mesenchymal stromal/stem cell expansion	2
different cell culture technologies	2
process developer	2
input consumables	2
mature cells	2
cell-derived factor	2
dynamic mechanistic model	2
commonly recognised inhibitory metabolites or cytokines	2
scalable bioreactors	2
erythroblast culture	2
highly efficient erythroblast culture	2
Red Blood Cell based products	2
emerging clean meat industry	2
established industry players	2
academic researchers	2
current biomedical products	2
biomedical and therapeutic applications	2
biomedical industry	2
existing products	2
Large-scale cell culture	2
emerging industry	2
product lines	2
many technologies and products	2
emerging biotechnology industry	2
animal slaughter)	2
Clean meat	2
parametrically parsimonious and well-behaved building blocks	2
stochastic or spatially complex systems	2
standard mathematical tools	2
associated mathematical framework	2
specific model instances	2
set of model building blocks	2
parsimonious framework	2
specialised skill sets	2
yet realistic models	2
accessible tools	2
bioprocess industry	2
intracellular content (product, DNA and host cell protein)	2
empirical model	2
cell paste, supernatant, DNA and protein	2
E. coli cell broth	2
fermentation broths	2
industrially relevant E. coli fermentation system producing antibody fragments (Fab′)	2
industrial wastewater	2
original isoproturon	2
transformation products	2
sodium citrate buffer	2
real wastewater	2
Polyethylene glycol (PEG)	2
Cd2+	2
metal ions Cu2	2
synthetic mediator HBT	2
synthetic mediators	2
natural mediators	2
0.3U/mL laccase and 1mM 1-hydroxybenzotriazole (HBT)	2
relatively strong withdrawing electron group (NHCON(CH3)2)	2
laccase alone	2
Trametes versicolor laccase	2
transplastomic plant tissue culture bioprocesses	2
TetC yields	2
fragment C of tetanus toxin (TetC)	2
temporary immersion culture	2
periodic pneumatic suspension of liquid medium	2
RITA® temporary immersion bioreactors	2
callus tissue	2
Nicotiana tabacum shoots	2
suspension culture	2
Plant tissue culture	2
recombinant biopharmaceutical proteins	2
Transplastomic plants	2
column overflow	2
volumetric productivities	2
non-foamed cells	2
foamed cells	2
surfactin yields	2
B. subtilis cells	2
surface of the test cylinders	2
high density polyethylene (HDPE) and stainless steel (SS) cylinders	2
Pseudomonas fluorescens biofilms	2
computational fluid dynamics simulations	2
valuable liquids	2
biofilm surface	2
nozzle	2
test cylinder	2
cylindrical surfaces	2
fluid dynamic gauging	2
cellulases cocktail	2
given experimental dataset	2
parameter estimation problem	2
insoluble cellulose polymers	2
amorphous cellulose	2
cellulases (endoglucanase, exoglucanase, and β-glucosidase)	2
detailed mechanistic model	2
enzymatic catalysis-based cellulosic biorefineries	2
RAM and OM	2
low frequency acoustic energy	2
Shaken flasks	2
automated	2
bioprocess	2
key process economics driver	2
patient-specific iPSC-derived neurons	2
2D-planar tissue culture technologies	2
drug screening products	2
cells from microcarriers	2
microcarriers in stirred-tank systems	2
animal-free reagents	2
cell culture substrate	2
microcarrier-based processes	2
allogeneic hMSCs	2
cellular therapeutics	2
currently available technologies	2
Many human mesenchymal stem/stromal cell (hMSC) bioreactor-based manufacturing processes	2
planar vessels	2
non-animal derived materials	2
different growth media (with and without serum)	2
four different enzymes	2
two types)	2
two types of microcarrier	2
four different donors	2
Dasgip bioreactors	2
100mL spinner flasks	2
15mL ambr™ bioreactors	2
microcarriers in spinner flasks of hMSCs	2
complete microcarrier suspension	2
different bioreactors	2
cell density cultures	2
modified tris-base phosphate (TBP) medium	2
Chlorella sorokiniana	2
mPBr platform	2
scaled-out platform	2
shaken wells	2
24-well microplate format	2
novel orbitally shaken twin-well mPBr	2
Miniature photobioreactors (mPBr)	2
automated cell culture	2
hMSC flow cytometry analysis	2
hMSCs cultured	2
residual dissociation agent	2
CompacT SelecT automated cell culture platform	2
BM-hMSC donor lines	2
multiple patients	2
hypothetical product	2
donor hMSC lines	2
five BM-hMSC lines	2
bone marrow derived human mesenchymal stem cells (BM-hMSCs)	2
cell-based therapy bioprocesses	2
input material	2
hMSC cells	2
Steriflip® vacuum filter	2
spinner flask	2
microcarrier/cell suspensions	2
two different donors	2
relatively large microcarriers	2
suitable enzyme	2
two entities	2
microcarriers’ surface	2
5L bioreactor	2
SoloHill microcarriers	2
hMSC culture	2
cells on microcarriers in bioreactors	2
allogeneic therapies	2
solid supports	2
similar GOS yields	2
BbgIV immobilised	2
successive GOS synthesis batches	2
supports	2
maximum GOS yield	2
glyoxal agarose	2
galactooligosaccharides (GOS)	2
amino-ethyl- and glyoxal-agarose	2
bifidobacterial β-galactosidase BbgIV	2
dispersed gas phase	2
industrially relevant fed-batch cultures	2
miniature bioreactor system	2
miniature bioreactor	2
μ24 bioreactor system	2
conventional shake flask cultures	2
head space aeration	2
Direct gas sparging	2
headspace aeration	2
headspace sparging	2
novel, single-use 24-well parallel miniature bioreactor system	2
new biopharmaceutical products	2
various types and sizes of shaken bioreactors	2
cylindrical reactors and Erlenmeyer flasks	2
two stirred reactors	2
DISMT and pH probe results	2
cylindrical and Erlenmeyer flask bioreactors	2
orbitally shaken bioreactors (OSRs)	2
antibiotics in the medium	2
ESCs	2
neural precursors	2
murine Oct-4-GiP ESC line	2
manual and automated bioprocessing	2
key bioprocess variables	2
ESCs in microwell formats	2
integrated automation platform	2
highly skilled and experienced person	2
well characterized cells	2
clinically important pathogens	2
environmental microbes	2
AMR genes	2
Gram negative opportunists	2
pathogens (e.g. carbapenem-resistance genes KPC, OXA-48 and NDM-1)	2
several new AMR genes	2
diversity of antimicrobial resistance (AMR) genes	2
opportunistic bacterial pathogen	2
dynamical models	2
stochastic extensions	2
gLV model	2
soil metaphenome	2
microbiome and available resources	2
metaphenome	2
next frontier	2
carbon and other nutrients	2
Soil microorganisms	2
shared bioindicators	2
global microbial observing system	2
Southern Hemisphere	2
polar oceans	2
open ocean	2
vast regions	2
first synthesis	2
ocean ecosystems	2
key ecosystem services	2
distribution of phytoplankton	2
harmful algal blooms	2
marine phenomena	2
Microbial observation	2
agriculture, human/animal health and biotechnology	2
single host or host population	2
different but mutually compatible MAPs	2
‘modular microbiomes’—synthetic microbial consortia	2
genetically variable hosts	2
theoretical and experimental roadmap	2
human-specific pathways	2
Guanylate Binding Proteins (GBPs)	2
Interferon-inducible GTPases	2
host cell effector pathways	2
cytokine interferon gamma (IFNγ)	2
intracellular parasite Toxoplasma gondii	2
flux-signaling metabolites	2
set of new candidates	2
commensal gut microbiota	2
constituent microbes	2
culture collections	2
many new species	2
fastidious and mostly strictly anaerobic bacteria	2
enteric microorganisms	2
natural environments	2
fellow RNA polymerases	2
errorless RNAs	2
proteinaceous enzymes	2
active centres	2
erroneous nucleoside triphosphate (NTP)	2
correct substrates	2
Trigger Loop	2
new catalytic domain	2
repertoire of available systems	2
phage recombination systems	2
group of recombinases	2
mobile DNA elements)	2
DNA site-specific recombinases are enzymes	2
prokaryotic chromosomes	2
host lineage	2
additional chromosomes plasmids	2
extra-chromosomal genetic elements	2
well studied human fungal symbiont	2
damage response framework	2
niche specific mycobiomes	2
ubiquitous transient or persistent human colonisers	2
competitive environments	2
antibiotics or contact mediated killing systems	2
diffusible compounds	2
warning	2
volatile organic compounds	2
bacterial competitors	2
fungal effectors	2
battery of secreted effector proteins	2
host plant	2
range of subcellular locations	2
diverse plant proteins	2
membrane compartment	2
Extra-Haustorial Membrane	2
haustorium	2
Late blight	2
different body sites	2
different types of relationships	2
host microenvironment	2
pathogen of the immunocompromised or patients	2
commensal coloniser	2
several frontline drugs	2
many host species	2
One particularly important parasite taxon	2
metazoan hosts	2
Pathogenic protozoa	2
protein raincoat	2
resident B. subtilis cells	2
effective communal barrier	2
resultant protein	2
organized lattice	2
small secreted protein called BslA	2
water, solvents, and biocides	2
architecturally complex, highly hydrophobic community	2
Gram-positive soil bacterium Bacillus subtilis biofilm	2
inhabitants	2
sessile biofilm communities	2
diverse species of bacteria	2
different setups	2
whole interacting metabolome	2
intracellular metabolite	2
deeply layered logic circuits	2
programmable RNA-based switches	2
logic gates	2
synthetic biological systems	2
essential trace metals	2
two emerging arenas	2
Cryptococcus and Candida—yeasts	2
infected host	2
iron, zinc, manganese and copper	2
essential trace nutrients	2
host IRG proteins	2
parasite virulence proteins	2
TLR11 and TLR12	2
recognition proteins	2
interferon-inducible effector proteins (IRG proteins)	2
distinctive recognition proteins	2
definitive host, the domestic cat	2
small rodents	2
ubiquitous protozoan parasite, Toxoplasma gondii	2
agriculture and natural ecosystems	2
parental lineages	2
hybrid pathogens	2
latter group	2
mutualistic symbionts, endophytes and pathogens	2
novel niches	2
diverse eukaryotic taxa	2
ecological and biological concepts	2
intracellular resources	2
Microbial growth	2
well-armed foe	2
specialised human pathogen	2
B. pseudomallei (BPS)	2
B. mallei primarily infects Equus spp	2
Two species	2
warm and humid climates	2
group of soil-dwelling Gram-negative organisms	2
Burkholderia genus	2
normal human flora	2
Staphylococcus aureus or Clostridium difficile	2
latter vaccines	2
many human pathogens	2
new anti-infective vaccines	2
methodological blend	2
natural ecosystems	2
small, reduced complexity microbial consortia	2
less appreciated layer	2
genetic regulatory networks	2
potent drug combinations	2
conceptual and technical foundation	2
established antibiotics	2
drug candidates	2
drug combinations	2
Combining antibiotics	2
LGTs	2
shared habitat	2
donor prokaryotes	2
number of lineages	2
diverse prokaryotes	2
microbial parasites	2
complete genomes	2
long-read sequencing technologies	2
finished (gapless, high-quality) genomes	2
fragmented assemblies	2
large pieces	2
jigsaw puzzle	2
diverse systems that bacteria	2
spatial and temporal regulators	2
nucleoid occlusion factors	2
chromosome (nucleoid)	2
Bacterial cells	2
high-throughput sequencing methods	2
natural antisense RNA transcripts	2
ncRNAs, virulence gene-associated ncRNAs	2
P. falciparum ncRNAs	2
otherwise non-specific enzyme complexes	2
noncoding RNAs (ncRNAs)	2
active or repressed virulence genes	2
members of clonally variant virulence multigene families	2
dynamic host environments	2
eukaryotic unicellular pathogen Plasmodium falciparum	2
selected examples	2
bacterial determinants	2
pathogenic clones	2
large numbers of bacterial isolates	2
RNA helicases	2
RNA helicases and Toll-like receptors	2
two types of viral sensor	2
rapidly evolving viral proteins	2
viral Pathogen-Associated Molecular Patterns (PAMPs)	2
viral sensors	2
unexpected roles	2
general motor adapters	2
Hook protein	2
motor proteins kinesin-3 and dynein	2
U. maydis and Aspergillus nidulans	2
Ustilago maydis	2
biotechnological applications	2
complex dynamical systems	2
defined systems	2
mix of microbes	2
Two major structural families	2
bilayer of the cytoplasmic membrane	2
Bacterial mechanosensitive channels	2
external and internal inputs	2
cyclic-AMP-CRP regulatory system	2
Pseudomonas putida CRPs	2
E. coli, Mycobacterium tuberculosis	2
several other bacterial species	2
classic regulatory system	2
Escherichia coli cyclic-AMP receptor protein (CRP)	2
dysbiotic microbiota	2
defined mixture of harmless, health-associated bacteria	2
undefined faecal samples	2
viable therapeutic target	2
human intestinal microbiota	2
novel drug candidates	2
host cell machinery	2
human immunodeficiency virus type-1 (HIV)	2
obligatory intracellular pathogen	2
candidate pathogen	2
culture system or animal model of infection	2
vaccines and other biological products	2
novel microbes	2
unbiased next-generation sequencing (NGS)	2
consensus polymerase chain reaction (PCR), microarrays	2
–host interactions	2
viruses and hosts	2
Genomic information	2
novel and known viruses	2
High throughput, deep sequencing assays	2
environment and/or consumers	2
plant and animal pathogenic oomycetes	2
several chemicals	2
extracellular and intracellular effectors	2
cellular disease agents	2
aquaculture, agriculture and forestry	2
gene encoding a PBP 3	2
wild-type B. pseudomallei	2
ceftazidime-resistant strains	2
49 genes	2
commonly used culture media	2
subsequent ceftazidime-resistant variants	2
initial ceftazidime-susceptible isolates	2
six patients with melioidosis	2
oral antibiotics	2
penicillin-binding protein (PBP) in a Gram-negative bacillus (Burkholderia pseudomallei)	2
cephalosporin drug ceftazidime	2
fungal cell surface	2
Many of the fungal genes	2
potential fungal invaders	2
commensal on mucosal surfaces	2
human pathogenic yeast Candida albicans	2
epithelial barriers	2
normal microbial flora	2
novel coding sequences	2
second generation sequencing platforms	2
microarray technology	2
bacterial gene expression	2
factors and sequences	2
range of pathways	2
telomeric expression site (ES)	2
one VSG gene	2
dense protective coat of Variant Surface Glycoprotein (VSG)	2
populations of bacterial pathogens	2
geospatial information	2
related organisms	2
single nucleotide polymorphisms (SNPs) and insertions or deletions (indels)	2
populations of pathogenic bacteria	2
fungi and other chitin-containing parasites	2
humans and other vertebrates	2
carbohydrate skeleton of the fungal cell wall	2
evolutionarily divergent fungal pathogens	2
many fungal pathogens	2
evolutionarily conserved regulators	2
reproduction	2
tip extension	2
normal-shaped, growing hyphae	2
specific kinesins and sterol-rich apical microdomains	2
Tea cell-end marker proteins	2
polarisome Bud1-GTPase module	2
mating structures	2
diverse host tissues	2
effector repertoire	2
LEE (non-LEE effectors)	2
locus of enterocyte effacement (LEE) pathogenicity island	2
best-described EPEC effectors	2
numerous bacterial ‘effector’ proteins	2
delivery system	2
enteropathogenic E. coli (EPEC)	2
host cell targets	2
intracellular replicative niche	2
non-phagocytic epithelial cells	2
two distinct type III secretion systems	2
thirty specialised effector proteins	2
wider bacterial world	2
Neisseria	2
meningococcus	2
three closely related bacteria, Neisseria meningitidis, Neisseria gonorrhoeae and Neisseria lactamica	2
high-throughput nucleotide sequencing	2
maize crops	2
seed companies	2
old/obsolete varieties	2
stress-prone environments	2
elite heat-tolerant maize varieties	2
drought-tolerant maize seed	2
climate-resilient maize	2
maize yields	2
sub-Saharan Africa (SSA)	2
neighbor	2
accessible system	2
pieces	2
leaf epidermis	2
Pavement cells	2
climate change ready crops	2
several disciplines/technologies	2
climate-resilient crops	2
precise phenotyping	2
genomics-enabled technologies	2
germplasm collections	2
farmer's field	2
different disciplines/technologies	2
climate resilient crops	2
stem tissues	2
prominent control point	2
pectin modification	2
oriented growth	2
DELLA and BLH proteins	2
shoot apical meristem	2
constantly changing environment	2
Environmental stimuli	2
phytoplasma effector genes	2
infected computers	2
phytoplasma effectors	2
stem proliferations)	2
witch's brooms	2
fascinating array	2
virulence proteins (effectors)	2
plant hosts	2
small bacterial pathogens	2
Candidatus genus Phytoplasma	2
growth regulators	2
roots and shoots	2
organ growth	2
AIL/PLT proteins	2
shoot	2
different parts of the root tip	2
AIL/PLT protein gradient	2
stem cell daughter cells	2
clade of two-AP2 domain proteins	2
AINTEGUMENTA-LIKE/PLETHORA (AIL/PLT) transcription factor family	2
meristematic cell descendants	2
apical meristems	2
shoot tip	2
root tip	2
flanking genes	2
certain TE families	2
‘junk DNA’	2
terrestrial biosphere	2
plant–fungal symbioses	2
early and more recently evolved land plants	2
newly discovered fungal mutualists	2
early plant–fungal partnerships	2
earliest land plants	2
variety of potential fungal associates	2
land plant–fungal symbioses	2
photosynthetically fixed organic carbon	2
mineral nutrients	2
symbiotic fungi	2
hormonal and genetic systems	2
simple setup	2
modified leaves	2
Many regulators	2
centre of the flower	2
two carpels	2
multiple polarity systems	2
complex tissue structure	2
coordination	2
Arabidopsis gynoecium	2
paradigm	2
Several proteins	2
two or more nutrients	2
Signalling pathways	2
edaphic and endogenous signals	2
plant root system (root system architecture, RSA)	2
evolving cellular, structural and biochemical approaches	2
putative effector proteins	2
fundamental effector biology	2
Plant pathogens	2
cells across tissues	2
Plant tissue growth	2
chromosomal-level assemblies	2
optical mapping	2
third generation genomic technologies	2
gold standard reference sequences	2
contiguities	2
genetic and physical maps	2
genomic technologies	2
individual research groups	2
community-wide consortia	2
dedicated research facilities	2
plant genome assembly projects	2
ubiquitin-like protein SUMO	2
ubiquitin-mediated proteasome	2
many transcriptional regulators	2
wide variety of transcription factors and cofactors	2
multi-model ensembles	2
crop disease models	2
crop growth	2
CAM genes	2
complete gene set	2
model CAM species	2
diverse model CAM species	2
candidate CAM-associated genes and proteins	2
Crassulacean acid metabolism (CAM)	2
complex multi-scale experiments and models	2
mechanical cell wall	2
experiments and models	2
passive and non-stressed material	2
important physical mediator	2
key signaling components	2
promoter motifs	2
single time series data sets	2
large-scale expression data sets	2
resource reallocation model	2
agricultural crop production	2
polymer derived processing inhibitors	2
lignin network	2
wall materials	2
various wall polymers	2
commodity chemicals	2
renewable, highly abundant resource	2
polyphenol lignin	2
numerous polysaccharides	2
various polymer networks	2
sophisticated composite material	2
biomass of plants	2
Arabidopsis mRNAs	2
first methylation maps	2
eukaryote mRNA	2
plant messenger RNAs	2
plant cell surface components	2
septin GTPases	2
cuticle and plant cell wall	2
plant surface	2
specialised infection cells	2
intact cuticles of their plant hosts	2
Many plant pathogenic fungi	2
robotic-assisted imaging platforms and computer vision-assisted analysis tools	2
crop germplasm	2
input resources	2
food and fuel	2
microbiome co-inhabitants	2
microbes including competitors, (myco)parasites and even potential co-operators	2
secreted molecules	2
microbial plant pathogens	2
almost every environment	2
novel oils	2
different key metabolic pools	2
perennial arable crops	2
non-constitutively expressed resistance traits	2
insect pheromones	2
insecticidal compounds	2
secondary metabolite pathways	2
wild ancestors	2
SLMs	2
Crop plants	2
pyrethroids, neonicotinoids and butenolides	2
currently used insecticides	2
small lipophilic molecules (SLMs)	2
Secondary plant metabolites	2
amazing P450 toolkit	2
P450 engineering	2
marketable products	2
blue roses	2
antimalarial drug precursor artemisinic acid	2
pharmaceutical, cosmetic, fragrance and flavour, or polymer industries	2
plant natural metabolites	2
Cytochromes P450	2
transient expression	2
various genes	2
susceptible plants	2
emerging threats	2
Plant-infecting viruses	2
bioactive specialized metabolites	2
rice and tomato	2
major crops	2
phytochemicals in crops and medicinal plants	2
flavonoids in Arabidopsis	2
transcriptomes and metabolomes	2
model plant Arabidopsis thaliana	2
advanced metabolomics	2
phytochemicals (plant metabolites)	2
Phytochemical genomics	2
first cell-wide spatial proteome map	2
sub-cellular niches	2
spatial proteomics	2
localisation of proteins	2
distinct prFMN forms	2
long-lived C4a-based radical species	2
prFMNiminium azomethine ylide	2
prFMN-dependent reversible (de)carboxylase	2
flavin prenyltransferase	2
ubiquitous microbial UbiDX system	2
recently discovered cofactor	2
Prenylated flavin (prFMN)	2
clinically-relevant drugs	2
Disease-associated proteins	2
analytical toolbox	2
various biological substrates	2
molecular classes	2
thin tissue sections	2
small subset of these	2
successful therapeutic agents	2
small molecules and other reagents	2
potentially toxic oligomers	2
heterologous hosts	2
engineered pathways	2
Plant Kingdom	2
drugs and other high-value chemicals	2
transcriptomes and/or genomes	2
heterologous production species	2
plant natural product pathways	2
DNA sequencing and synthesis technologies	2
thousands of plants, animals and microbes	2
organismal metabolome	2
metabolomics datasets	2
tens to hundreds of thousands of low molecular weight metabolites	2
foundations and obstacles	2
global open-access databases	2
recently emerging ecosystem	2
omics areas	2
laboratories worldwide	2
metabolome of organisms	2
Metabolome	2
specific data sharing culture	2
organisms’ biochemical repertoires	2
agriculture of the future	2
completely ‘novel enzyme chemistries’	2
non-natural products	2
naturally evolved pathways	2
synthetic metabolic networks	2
repertoire of existing enzymes	2
naturally existing pathways	2
value-added compound	2
endogenous metabolic network of an organism	2
several genetic systems	2
chemical biologists	2
conserved and unique metabolic pathways	2
comparative phylometabolomics	2
excellent samples	2
vast natural diversity	2
wild type enzymes	2
cofactor-independent enzymes	2
P450 monooxygenases	2
promising catalysts	2
standard domain inhibitors	2
PROTAC compounds	2
epigenetic domains	2
BET bromodomain subfamily	2
bromodomain reader domains	2
cell-active chemical probes	2
new chemical probes	2
chemical genetics	2
biologically active small molecules (chemical probes)	2
synthetic CO2-fixation pathways	2
CO2-concentrating mechanisms	2
CO2-fixing enzyme in photosynthesis	2
photosynthetic CO2-fixation	2
future food and biofuel supply	2
wide range of monoterpenes and their derivatives	2
microbial production systems	2
emerging tools	2
functional pathways	2
novel catalytic building blocks	2
valuable chemicals in engineered microbial factories	2
unusual members of the P450 superfamily	2
pharmaceuticals and drug metabolites, steroids and antibiotics	2
important chemicals	2
wild-type and engineered P450s	2
wide range of chemical scaffolds	2
biocatalysts	2
multitude of diverse substrate selectivities	2
high-activity P450-cytochrome P450 reductase enzyme P450 BM3	2
selected soluble bacterial P450s	2
P450 enzymes	2
novel P450s	2
superfamily of monooxygenase enzymes	2
Cytochrome P450 enzymes (P450s)	2
plant non-heme iron oxygenases	2
hypoxia-responsive transcription factors	2
Plant non-heme iron-dependent oxygenases	2
different subclasses of this enzyme family	2
wide range of biological molecules	2
Non-heme iron-dependent oxygenases	2
alkaloid pathways	2
medically important scaffolds	2
plant biocatalysts	2
chemo-enzymatic settings	2
biocatalysis and bioengineering	2
alkaloid biosynthesis	2
benzylisoquinoline and monoterpene indole alkaloids in plants	2
Metabolic pathways	2
human IL-1β	2
high-affinity human monoclonal antibody	2
pro-inflammatory cytokine	2
Interleukin-1beta (IL-1β)	2
enzyme cocktails	2
many novel enzymes	2
endogenous enzymes	2
isopod Limnoria	2
house GH-secreting and LPMO-secreting bacteria	2
mutualism	2
diverse enzyme-secreting gut microflora	2
GHs	2
Lignocellulose-consuming animals	2
multiple lignocellulolytic enzymes	2
termite guts	2
lignocellulose-rich environments	2
Meta-omics	2
peroxidases and laccases	2
white-rot fungi and certain bacteria	2
brown-rot fungi	2
glycoside hydrolases (GHs)	2
multiple complementary enzymes	2
SpyTag/SpyCatcher technology	2
biofilms with enzymes or nanoparticles	2
amyloid biomaterials	2
Synthetic biology applications	2
stem cell culture	2
Spy networks	2
T-cell activation	2
multiple SpyCatchers	2
targeting-antibody	2
protein architectures	2
covalent peptide interaction	2
protein partner SpyCatcher	2
isopeptide bond	2
seemingly opposing claims	2
highly specific genome-editing tool	2
RNA-guided nucleases	2
chemically distinct partners	2
5nm thick film	2
fundamental cellular functions	2
range of distinct proteins	2
lipid moieties	2
highly complex designed material	2
GBL-based designs	2
GBL-based circuits	2
range of new building blocks	2
main inter-cellular signal	2
γ-butyrolactones (GBLs)	2
natural circuits	2
soil bacteria	2
quorum sensing mechanisms	2
Signalling circuits	2
LOV-based FPs	2
emerging class of fluorescent reporters	2
green fluorescent protein (GFP)	2
flavin-binding LOV (light, oxygen, or voltage sensing) domain	2
new sources of genetically encoded fluorescent proteins (FPs)	2
plant and bacterial photoreceptor proteins	2
Chromophore-binding domains	2
Catalytic metallodrugs	2
superoxide dismutase mimics, thiol oxidants, and transfer hydrogenation catalysts	2
classes of catalytic redox modulators	2
reports	2
metal catalysts	2
protein ligand	2
large protein ligand	2
small catalysts	2
chemical systems	2
low-molecular-weight metal complexes	2
catalytic centres	2
Metal ions	2
known major classes of protein lipidation	2
chemical proteomic technology	2
tagged-lipidated proteins	2
multifunctional labels	2
small ‘clickable’ chemical reporters	2
protein lipidation	2
disease context	2
Protein lipidation	2
vitrified samples	2
transition state analogues	2
Hydrolysable and non-hydrolysable phosphate analogues	2
indispensable tools	2
Analogues of phosphate esters and anhydrides	2
phosphate-handling enzymes	2
desired enzymes	2
excellent enzymes	2
carbon–carbon bonds	2
biologically important compounds	2
de novo metalloproteins	2
naturally occurring metal ion sites	2
miniature artificial scaffolds	2
de novo proteins	2
metallo-porphyrin, mononuclear and multinuclear metal ion sites	2
coordinated metal ion	2
artificial metalloproteins	2
cellular extracts	2
individual molecules and biomolecular complexes	2
novel fluorophores	2
large multicomponent systems	2
interaction partners and ligands	2
platinum drugs	2
new delivery and targeting systems	2
PtIV prodrugs	2
biodegradable proteins and peptides (e.g. EGF, heparin, herceptin, somatostatin and TAT)	2
functionalized carbon nanotubes (CNTs) and nanorods, hollow Prussian blue (HPB), magnetic iron oxide and gold nanoparticles, liposomes, nanogels and polymers	2
Pt centres	2
platinum-based	2
widely used anticancer drugs	2
novel protein targets	2
reactive oxygen and nitrogen species, and electrophiles	2
Protein cysteine residues	2
immune therapeutics	2
immune modulators	2
inflammatory signals	2
tumor associated antigens	2
“kick start	2
OV therapy field	2
Oncolytic viruses (OVs), viruses	2
rational therapeutic combinations	2
tumor-specific T cells	2
immune checkpoint blocking antibodies (ICBs)	2
different cytokines	2
unstable plaques	2
matrix metalloproteinase	2
complex fibrotic plaques	2
fatty streak	2
modified lipoproteins	2
diverse proposals	2
numerous experimental systems	2
cytokine interleukin-1β (IL-1β)	2
Th17 inducing cytokines	2
recently discovered subset of T helper cells	2
medical and optical imaging	2
live animal models	2
subjects/objects	2
small objects	2
electromagnetic waves	2
Microscopy and medical imaging	2
commercial confocal as well as laser- and LED-based widefield microscopes	2
live samples expressing GFP	2
wider range of researchers	2
specialised, complex hardware	2
dynamic, living samples	2
molecular labels	2
light microscopy	2
pathogenic NF-κB signalling	2
clinically useful, NF-κB-targeting medicine	2
systemic NF-κB inhibition	2
human malignancies	2
individual inflammatory mediators	2
MAPK p38 pathway	2
two critical serine residues	2
MAPK p38	2
kinase MK2 (MAPK activated kinase 2)	2
mitogen-activated protein kinase (MAPK) p38 signaling pathway	2
tumour necrosis factor and many other inflammatory mediators	2
RNA-destabilizing protein	2
Tristetraprolin (TTP)	2
co-ordinating cell–cell adhesion	2
primary receptor	2
adjacent epithelial cells	2
transmembrane receptor	2
coxsackie and adenovirus receptor (CAR)	2
normoxic cultured stem cells	2
vitro culture of cells	2
glucose alone	2
UCP2 inhibitor, genipin	2
ketone body, acetoacetate	2
cultured hMSCs	2
ATP	2
hypoxic in vivo environment	2
individual cell-level dynamic phenotypes	2
label-free dynamic phenotype	2
dyes/labels	2
microvascular environment	2
CCM patient cohorts	2
three known CCM proteins, CCM1/KRIT1, CCM2 and CCM3/PDCD10	2
accessible lesions	2
SUR2B/Kir6.2	2
H9c2 cells with adenovirus containing Kir6.2AFA, a mutant form of Kir6.2	2
2,4-dinitrophenol (DNP; 10mM)	2
100nM)	2
Kir6.2/SUR2B protein complexes	2
embryonic heart H9c2 cells	2
Kir6.1	2
SUR2B and Kir6.1 form vascular smooth muscle type of KATP channels	2
SUR2A and Kir6.2 form cardiac type of KATP channels	2
SUR2B. SUR1 and Kir6.2 form pancreatic type of KATP channels	2
regulatory, ATP-binding subunit, SUR1,	2
pore-forming inward rectifier, Kir6.1 or Kir6.2	2
intracellular ATP	2
ATP-sensitive K+	2
miRNA-silencing machinery	2
two miRNAs	2
miR-221 and miR-146a	2
increased AGO2 expression	2
primary human dermal lymphatic endothelial cells (HDLECs)	2
AGO2 mRNA 3′UTR	2
haematopoietic and endothelial cells	2
functional non-coding RNAs	2
domain model	2
structural RNA domains	2
conserved structural domains	2
blood and tissues of humans and other mammals	2
abundant components	2
short fragments	2
several eukaryotic and prokaryotic species	2
Ro60 protein	2
newly identified family of non-coding stem-bulge RNAs (sbRNAs)	2
prokaryotic species	2
related RNAs	2
family of small non-coding Y RNAs	2
many small non-coding RNAs	2
PRC2.This article	2
pre-existing histone modifications	2
two major PcG protein complexes	2
cytoplasmic adaptor proteins	2
RhoA who's GEFs	2
Cdc42 and	2
two well characterized RhoGTPases	2
variety of these adaptor proteins	2
junctional, cytoplasmic adapter proteins	2
TJ themselves	2
polarized epithelia	2
apical and basolateral membrane domains	2
Tight junctions (TJ)	2
many cellular signaling pathways	2
impaired defense system	2
sophisticated system	2
proteins, lipids or nucleic acids	2
harmful agents	2
suite of monoclonal antibodies	2
medication	2
PiZZ individuals	2
latent protein	2
monomeric α1-antitrypsin	2
conformers	2
polymer-specific antibody	2
suitable probe	2
homozygous (PiZZ) individuals	2
hepatocyte endoplasmic reticulum (ER)	2
Z mutant (Glu342Lys)	2
pulmonary tissues	2
small amount of proteins	2
cellular system	2
PHPT1 protein	2
PHPT1 splice variant	2
different secondary structures	2
variant C-terminal end of the proteins	2
HeLa cells the splice variant protein	2
non-sense mediated mRNA decay pathway	2
PHPT1 transcript variant 6	2
PHPT1 locus	2
variant transcripts	2
variant proteins	2
human PHPT1 locus	2
splice variant transcripts	2
bacteria, plant or fungi	2
14kDa enzyme	2
serine, threonine and tyrosine residues	2
subjacent ECM	2
integrin-associated proteins	2
nascent podosomes	2
connective tissue barriers	2
subjacent extracellular matrix	2
actin cores	2
podosomal actin core	2
integrin linked kinase (ILK)	2
core of filamentous actin (F-actin)	2
circular configuration	2
podosomal components	2
exact intracellular signalling pathways	2
podosome maturation	2
integrin ligands	2
SDF 1-a	2
soluble factors and chemokines	2
migrating dendritic cells (DCs)	2
leading lamellae	2
integrin-based adhesions	2
mitochondrial protein synthesis apparatus	2
effective cures	2
brain, liver, skeletal muscle, heart and other organs	2
multiple respiratory chain (RC) enzymes	2
function blocking anti E-cadherin antibody or siRNA	2
mESC adhesion	2
tyrosine-phosphorylated STAT3 or β-catenin	2
chemically defined, weakly adhesive biomaterial substrates	2
E14 and R1 mESC lines	2
cytokine, leukaemia inhibitory factor (LIF)	2
Mouse embryonic stem cells (mESCs)	2
thiol groups of cysteine residues	2
hydroxyl group of serine and threonine residues	2
N-terminal amine group of a protein	2
non-lysine sites	2
amine groups of lysine side-chains	2
ubiquitin-proteasome and autophagy-lysosome systems	2
variety of pathways and transcription factors	2
Insulin-Akt pathway	2
transcription factors FoxO	2
degradation systems	2
ubiquitin-proteasome and the autophagy-lysosome systems	2
Two major protein degradation pathways	2
macroscopically non-inflamed ileal biopsies	2
newly-synthesised phosphatidylinositol 16:0/18:1	2
control and Crohn's disease macrophages	2
patients with Crohn's disease	2
healthy control individuals	2
heat-killed Escherichia coli	2
terminal ileum and large bowel	2
cytosolic p40phoxsubunit	2
dual F-actin/lipid-binding module	2
p40PX changed	2
full length p40phoxproteins	2
cytochalasin D	2
p40phoxand	2
Pure actin	2
p40PX in neutrophil extracts	2
mutant p40PX	2
lipid-binding modules	2
PX domains	2
full length protein	2
F-actin co-localisation	2
isolation (p40PX)	2
Phox homology (PX) domain	2
peripheral lamellar compartment	2
Full length p40phoxexpressed in COS cells	2
one of the cytosolic components of NADPH oxidase	2
enzyme system	2
Cytosolic components	2
Y167F,	2
substituted amino acid (F>Y>	2
wild-type rabbit PepT1	2
Y56F-PepT1	2
wild-type PepT1.Intriguingly	2
five (Y12, Y56, Y91, Y167 and Y345)	2
four of the nine TMD residue tyrosines (Y64, Y287, Y345 and Y587)	2
retaining wild-type PepT1-like pH dependence	2
TMD tyrosines	2
plasma membrane of Xenopus laevis oocytes	2
individual TMD tyrosines	2
transmembrane domains (TMDs) of rabbit PepT1	2
conserved tyrosines	2
site-directed mutagenesis and zero-trans transport assays	2
number of classes of drugs, including β-lactam antibiotics and angiotensin-converting enzyme (ACE) inhibitors	2
cytoplasmic Bcl2	2
Prefrontal brain cortex	2
prefrontal brain cortex	2
mitochondrially encoded cytochrome oxidase subunits 1 and 3 in hippocampus	2
serine 171	2
mitochondrial glucocorticoid receptor	2
hippocampus and prefrontal brain cortex of Wistar male rats	2
mitochondrial phosphoisophorms	2
etiological causes	2
mucus secretory cells of the stomach	2
gastric cancer cells	2
gastric tumour cells	2
surface mucus secretory cells	2
either of the other two trefoil proteins, TFF2 and TFF3	2
almost all human TFIZ1	2
normal human gastric mucosa	2
previously uncharacterised protein, TFIZ1	2
covalently bound heterodimer	2
gastric tumour suppressor trefoil protein TFF1	2
R282E-expressing oocytes	2
4-aminobenzoic acid	2
neutral dipeptide Gly-l-Gln	2
R282E- and R282D-PepT1	2
R282E/D341R- and R282D/D341R-PepT1	2
charge pair	2
conserved negatively charged residue, aspartate341 (D341) in transmembrane domain 8	2
R282E-PepT1	2
R282 mutants	2
Neutral (R282A, R282Q) or negatively charged (R282D, R282E) substitutions	2
positive (R282K) or physiologically titratable residue (R282H)	2
rabbit PepT1 arginine282 (R282, transmembrane domain 7)	2
conserved charged residues	2
β-lactam antibiotics and angiotensin-converting enzyme inhibitors	2
number of drugs	2
NOXs	2
whole family of NOXs	2
neutrophil oxidase	2
oxidase	2
wall of the phagocytic vacuole	2
‘professional’ phagocytic cells	2
NADPH (nicotinamide adenine dinucleotide phosphate) oxidase (NOX)	2
pathogenic parasites	2
vitelline stores	2
heavily cross-linked eggshell precursor proteins	2
eggshell	2
purified eggshells	2
purified eggshell	2
whole parasite eggs	2
Fe in the female parasite	2
eggs and purified eggshells	2
whole male and whole female adult worms	2
likely progenitor cells	2
vitelline cells	2
schistosome ferritin sequences	2
egg-stages and adult males	2
Vitelline Fe	2
Fe stores in vitelline cells of S. japonicum	2
abundant Fe in vitelline (eggshell-forming) cells of the female system	2
parasite eggs	2
developing and tropical nations	2
human blood fluke, Schistosoma japonicum	2
extracellular matrices	2
important trace element	2
Iron (Fe)	2
mammalian, parasitic and bacterial systems	2
binding surface	2
highly conserved basic residue in helix II of the J-domain	2
vivo assay	2
modified chimeric Hsp40s	2
four helices (I–IV) and the loop regions of the J-domains	2
conserved amino acid residues and motifs	2
integral membrane-bound ER Hsp40	2
J-domain of ERj1	2
Hsp40 chimera	2
E. coli Hsp70, DnaK.	2
Gln substitution	2
modified derivatives	2
soluble (cytosolic or endoplasmic reticulum (ER)-lumenal)	2
Hsp40 chimeras	2
thermosensitivity of a dnaJ cbpA mutant Escherichia coli strain (OD259)	2
vivo functional assay	2
number of divergent Hsp40s of mammalian and parasitic origin (malarial Pfj1 and Pfj4, trypanosomal Tcj3, human ERj3, ERj5, and Hsj1, and murine ERj1)	2
J-domain of a prokaryotic Hsp40 (DnaJ)	2
chimeric Hsp40 proteins	2
partner Hsp70	2
Hsp40	2
Hsp40 signature domain, the J-domain	2
multiple heat shock protein 40 (Hsp40) and heat shock protein 70 (Hsp70) proteins	2
prokaryotic and eukaryotic cells	2
sub-type of receptors	2
αβ1-integrins in the luminal epithelium of the mammary gland	2
hormones and growth factors	2
α- and β-chain dimers	2
family of adhesion receptors called integrins	2
liver-enriched transcription factors	2
Williams’ medium E.	2
liver-enriched transcription factors (C/EBPα and β, HNF4α and RXRα)	2
pituitary gland extract	2
dexamethasone, epidermal growth factor and pituitary gland extract	2
fresh Williams’ medium E	2
Adult rat hepatocytes	2
hepatocytes in culture	2
simple culture system	2
Freshly isolated hepatocytes	2
Gag-AUG sequences of them	2
HIV-1, 2, SIVmac and SIVagm	2
human T cells	2
replication-competent reporter HIV-1	2
lentiviral system	2
eIF4A2-specific short-hairpin RNA (shRNA)	2
MT4C5 cells	2
DEAD-box protein	2
eukaryotic translation initiation factor 4A isoform 2 (eIF4A2)	2
human T cell line	2
ZIKV biology	2
anti-ZIKV monoclonal antibodies (mAbs)	2
Additional therapeutics	2
Several ZIKV vaccine candidates	2
ZIKV vaccines and immunotherapeutics	2
World Health Organization	2
ZIKV infected mothers	2
Caribbean islands	2
ZIKV infections	2
Pacific Islands	2
mosquito-vectored flavivirus	2
influenza, Human immunodeficiency virus (HIV), dengue virus (DENV), chikungunya virus (CHIKV), Ebola virus, and Zika virus (ZIKV)	2
infectious pathogens	2
effective new vaccines	2
specific vaccines	2
numerous infectious diseases	2
wider distribution of isolates	2
purified recombinant C-terminus of the protein	2
distinct geographical areas of the world	2
described protein	2
sequence homology	2
unique C-terminus	2
reference H37Rv strain	2
clinical isolate MTB423	2
Mtb oxidoreductase (MRGA423_21210)	2
New York, NY, USA)	2
C strain of Mtb (a clinical isolate	2
protein TBCG_03312	2
urines of TB patients	2
unique 21-mer Mtb peptide sequence (VVLGLTVPGGVELLPGVALPR)	2
Mycobacterium tuberculosis (Mtb) biomarkers	2
patients' serum or urine samples	2
pathogen-specific biomarkers	2
several family-level lineages	2
Chlamydiaceae family	2
obligate intracellular bacteria	2
Chlamydiales order	2
functional accessory Sec system	2
glycosyl hydrolases and adhesins	2
cell wall compartment	2
two glycosidases	2
ΔsecA2 mutant CWP fraction	2
CWP fraction	2
Ply protein	2
ΔsecA2 cell surface	2
ΔsecA2 mutant cells	2
TIGR4 cells	2
ΔpsrP mutant	2
Cell wall protein (CWP) fractions	2
airway epithelial cells	2
locus encoding a serine-rich repeat surface protein PsrP. Mutant strains	2
genes encoding a SecY2A2 accessory Sec system	2
Streptococcus pneumoniae TIGR4	2
optimal model of C. trachomatis in minipigs	2
transcervical inoculation)	2
upper genital tract	2
minipig	2
upper porcine genital tract	2
sexually mature Göttingen minipigs	2
globally requested human Chlamydia vaccine	2
Advanced animal models	2
new drug treatments and vaccines	2
granuloma	2
facultative anaerobe	2
endoplasmic reticulum (ER) stress-inducing agents	2
chronic granulomatous disease (CGD) patients	2
TLR4 and MyD88 signalling	2
human primary monocyte-derived dendritic cells	2
multiple non-viral stimuli	2
Protein kinase RNA activated (PKR)	2
(MyD88) pathway	2
myeloid differentiation primary response gene 88	2
microbial stimulation	2
heterodimeric mycobacterial receptors, macrophage C-type lectin (MCL) and macrophage inducible C-type lectin (Mincle)	2
bacteria and viruses	2
early intracellular vacuoles	2
host and pathogen architecture	2
T3SS complexes on the EB surface	2
extracellular C. trachomatis elementary bodies (EBs)	2
virulence effector proteins	2
C. trachomatis uses a type III secretion system (T3SS)	2
non-phagocytic host epithelial cells	2
obligate intracellular bacterial pathogen	2
internal tissues	2
epithelial or endothelial host barriers	2
surface of host cells	2
human organs	2
Bacterial pathogens	2
β-glucan rich compounds	2
soluble purified β-glucans	2
first model	2
beta-glucan rich ligands	2
archetypical models	2
beta-glucan receptor Dectin-1	2
β-Glucans	2
potential effector proteins	2
Plasmodium berghei orthologue	2
3′-5′-cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG)	2
Salmonella infection	2
autoimmune encephalomyelitis	2
malaria or trypanosomiasis	2
erythroid, parenchymal and immune cells	2
distinct receptors	2
multi-functional cytokine	2
Erythropoietin (EPO)	2
FcγRIIa H131R genotype	2
GPIIIa PlA1/A2	2
GPIIIa PlA1/A1 genotype	2
S. aureus–platelet interactions	2
patients with infective endocarditis	2
FcγRIIa H131R genotype of healthy volunteers	2
GPIIIa platelet antigen PlA1/A2	2
endocarditis pathogens	2
GPIIb/IIIa and FcγRIIa platelet receptors	2
Cardiac vegetations	2
Dectin-1 deficient animals	2
pulmonary bacilli burdens	2
wild-type and Dectin-1 deficient mice	2
Syk/CARD9-coupled receptor, Dectin-1	2
Mycobacterium tuberculosis (Mtb)	2
pathogenic growth	2
extracellular lavage fluid	2
fungal siderophore system	2
immunosuppressed mice	2
entire siderophore system	2
extracellular siderophores	2
extra- and intracellular siderophores (low-molecular mass iron chelators)	2
variety of pathogens	2
HLA class I antigen presentation	2
molecular mechanisms of genes	2
ubiquitous but potentially oncogenic Epstein–Barr virus	2
Persistent viruses	2
cerebral malaria	2
malaria parasitemia	2
Plasmodium berghei ANKA	2
co-infected	2
Rab families of Apicomplexa	2
host cell modulatory proteins	2
nutrient and drugs	2
intracellular parasites	2
endoplasmic reticulum and trans-Golgi stacks	2
morphological structures	2
destinations	2
vesicle	2
secretory organelles (rhoptries, micronemes and microspheres)	2
Maurer's clefs	2
apicoplast, the food vacuole	2
red blood cell cytosol	2
secreted Plasmodium proteins	2
peptide motifs	2
predicted signal peptides	2
putative secretory pathway proteins	2
family of Rab GTPases	2
protozoan phylum Apicomplexa	2
transport vesicles	2
ras super-family	2
subgroup of small GTP-binding proteins	2
Rab genes	2
severely affected country	2
rash	2
119 children	2
CV-A10	2
CV-A16	2
CV-A6 and CV-A10	2
inpatients and outpatients	2
EV-A71	2
diagnosed cases	2
Four serotypes of enterovirus A (EV-A71, Coxsackievirus (CV) A6, A10, and A16)	2
three main referral centres	2
paediatric intensive care units	2
infectious diseases wards	2
outpatient clinics	2
hospitalized cases	2
enterovirus A71 (EV-A71)	2
, foot and mouth disease (HFMD)	2
urine Ultra	2
persons with HIV co-infection	2
Ultra on urine	2
positive urine Ultra assay	2
HIV-infected patient	2
initial Xpert® MTB/RIF (Xpert) assay	2
Xpert® MTB/RIF Ultra assay (Ultra)	2
factor(s)	2
M. africanum	2
unsuspected outbreaks	2
lineages of Mycobacterium africanum (lineage 5, 31.8%; lineage 6	2
TB strains of lineage 4	2
unique cases	2
2309 MTBC isolates	2
prospectively sampled pulmonary TB patients	2
MethodsMycobacterium tuberculosis complex (MTBC) isolates	2
uninfected ones	2
HIV-infected MSD cases	2
Cryptosporidium, Giardia, and enteroaggregative Escherichia coli (aatA only)	2
uninfected	2
418 controls	2
one per LSD case	2
children with moderate-to-severe diarrhea (MSD) and less-severe diarrhea (LSD)	2
possible biomarkers	2
environmental enteropathy	2
environmental mycobacteria	2
M. avium in duodenal tissue	2
MMP-1 and cytokines	2
negative controls	2
MMP-1 in duodenal tissue	2
IL-1β and IL-6 in duodenal tissue	2
wide-range of Th1, Th2 and Th17 cytokines	2
M. avium	2
48 patients	2
cytometric bead array	2
unstimulated samples	2
M. avium lysate	2
normal submitted duodenal biopsies	2
endoscopy patients	2
Mycobacterium avium antigens	2
aetiology	2
scrub typhus	2
single serum sample	2
hundred and three patients	2
Indian NICUs	2
ampicillin and gentamicin	2
5%).ConclusionsThe recommended first-line antimicrobial agents	2
two babies	2
combination of ampicillin and gentamicin	2
commonly prescribed drug	2
17.5%)	2
piperacillin-tazobactam	2
community-acquired sepsis	2
two most commonly prescribed antimicrobials	2
prescribing antimicrobials	2
155 babies	2
prescribed antimicrobials	2
208 babies	2
survey days	2
standardized web-based electronic data entry form	2
Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children (GARPEC) study	2
neonatal intensive care units (NICUs)	2
resistant Enterobacteriaceae	2
E. coli and K. pneumoniae	2
third-generation cephalosporins and carbapenems	2
3GCR K. pneumoniae	2
CR E. coli	2
3GCR E. coli	2
carbapenem-resistant (CR) E. coli	2
third-generation cephalosporin-resistant (3GCR) Escherichia coli	2
countries without AMR data	2
ResistanceMap database	2
sample of countries	2
linear models	2
smear-negative TB cases	2
-LAMP	2
954 sputum samples	2
culture-negative participants	2
smear-negative TB samples	2
smear-positive TB samples	2
sputum samples	2
375 culture-confirmed TB cases	2
molecular test comparison	2
fresh or frozen samples	2
conventional tests	2
direct smears	2
two sputum samples	2
‘probes	2
central placebo recipient	2
34968 placebo recipients	2
cholera cases	2
24667 placebo recipients	2
hundred and eight cholera cases	2
surrounding residents	2
placebo recipients	2
inactivated OCVs	2
two cholera-endemic settings	2
inactivated oral cholera vaccines (OCVs)	2
person to person	2
drug-resistant tuberculosis	2
culture isolates	2
fluoroquinolone-based regimen	2
fluoroquinolone resistance	2
Xpert MTB/RIF and Hain line probe assays	2
29-year-old Nigerian woman	2
successful WGS	2
Whole genome sequencing (WGS) of culture isolates	2
second-line tuberculosis drugs	2
index pregnant cases	2
38 cases	2
42 cases	2
-four cases	2
CCHF cases	2
large geographical area	2
BackgroundCrimean-Congo hemorrhagic fever (CCHF)	2
new vaccine candidates	2
secondary and heterotypic responses	2
four dengue serotypes	2
Serotype-specific plaque-reduction neutralization tests (PRNT)	2
DENV seropositivity	2
seroconverted subjects	2
DENV prevalent subjects	2
dengue virus (DENV)-naïve subjects	2
seropositive subjects	2
dengue serological test (IgG indirect ELISA)	2
territories	2
important public health problem	2
cohort children	2
pyrethroid resistant malaria vector	2
low transmission area	2
LLIN users	2
LLINs among the study cohort	2
5862 children	2
study clusters	2
cohort of children in villages of the Keshkal sub-district	2
main malaria vector Anopheles culicifacies	2
long-lasting insecticidal nets (LLINs)	2
BackgroundSubclinical (asymptomatic) cases of malaria	2
human and livestock populations of Kinshasa and DRC	2
mosquitoes in Kinshasa	2
Chikungunya, o’nyong’nyong, and Rift valley fever viruses	2
mosquito pools	2
pools of female mosquitoes	2
viruses using reverse transcription PCR (RT-PCR) assays	2
genera and sampling locations	2
battery-powered aspirators	2
BG-Sentinel traps	2
five municipalities of Kinshasa, DRC.MethodsMosquitoes	2
Democratic Republic of the Congo (DRC)	2
important emerging diseases	2
efficacious vaccine	2
safer, shorter, and more efficacious drug regimens	2
multidrug-resistant cases	2
drug-resistant forms of the disease	2
drug-resistant forms	2
existing drug-susceptible cases	2
global leaders	2
resource-poor settings	2
MRSA and 3GC-resistant E. coli	2
3GC-resistant E. coli and Klebsiella species	2
3GC-resistant E. coli, 3GC-resistant Klebsiella species, and MRSA	2
invasive samples	2
ResistanceMap repository	2
third-generation cephalosporin (3GC)-resistant Escherichia coli, methicillin-resistant Staphylococcus aureus (MRSA), and 3GC-resistant Klebsiella species	2
hospitals and in the community	2
three most common bacteria	2
last-resort	2
vancomycin and linezolid in S. aureus	2
Acinetobacter species	2
Carbapenem resistance	2
nalidixic acid among Salmonella Typhi	2
methicillin-resistant Staphylococcus aureus (MRSA	2
least one identified pathogen	2
blood cultures	2
SRL Diagnostics	2
microorganism(s)	2
patient blood cultures	2
private laboratory network	2
mass gathering participants	2
group members	2
members of a collective	2
collective	2
aggregate	2
emerging infections	2
-based reporting systems	2
20 cases	2
fatal cases	2
year, country, gender, occupation, number of infected individuals	2
structured form	2
ProMED search engine	2
‘melioidosis’	2
keyword	2
human melioidosis	2
limited sources	2
rotavirus vaccine	2
urban and semi-rural settings	2
rotavirus, norovirus, Shigella, or Campylobacter	2
16%)	2
norovirus (24%), Campylobacter (20%), Salmonella (18%), and Shigella	2
positive samples)	2
commonly detected pathogen	2
Vietnamese children	2
107 cases	2
neonatal intensive care facilities	2
Vietnamese hospital	2
many low- and middle-income countries	2
subtype 1b	2
selected genotype 1 HCV-infected patients	2
pegylated interferon	2
case of a 72-year-old Caucasian male	2
patients with genotype 1	2
direct antiviral agents (DAAs)	2
extrapulmonary TB	2
clinical algorithms	2
HIV-infected inpatients	2
almost all cases	2
hundred and eighty adult HIV-positive patients	2
Diagnostic ultrasound	2
adult HIV-positive patients	2
prospective case series	2
HIV-positive inpatients	2
dynamic BRB	2
HRECs and HRAs co-cultured on 3-D scaffolds	2
COX-2 immunoreactivity	2
predominant prostanoids	2
changes in oxygen environment	2
3-D scaffolds	2
arachidonic acid metabolites	2
Media and cells	2
3-D biodegradable hydrogel scaffolds (AlgiMatrix or Geltrex)	2
2-D surfaces	2
hyperoxia, intermittent hypoxia (IH)	2
standard doses of ketorolac, ibuprofen, and/or caffeine	2
Mono- and co-cultures of HRECs and HRAs	2
2-D cultures	2
blood-retinal-barrier (BRB)	2
representative biomimetic paradigm	2
co-cultures of human retinal endothelial cells (HRECs) and human retinal astrocytes (HRAs) on 3-dimensional (3-D) hydrogel scaffolds	2
systemic caffeine	2
Topical ocular ketorolac	2
blocking CRTH2	2
central nervous system, kidney, intestine, lung, hair and skin, bone and cartilage, and in cancer	2
CRTH2	2
prostaglandin	2
Th2 cells (CRTH2; alternative name DP2)	2
chemoattractant receptor homologue	2
second major PGD2 receptor	2
Prostaglandin (PG) D2	2
protospacer adjacent motif (PAM)	2
single-nucleotide homologous insertions	2
numerous infrequent indels	2
highly preferred indel	2
specific indel	2
1,000 genomic sites	2
SummaryThe CRISPR-Cas9 system	2
replication initiation and elongation complexes	2
checkpoint kinase	2
Rad53 itself	2
unstructured loop region of Cdc45	2
forkhead-associated (FHA) interaction motifs	2
budding yeast Saccharomyces cerevisiae	2
 distinct replication complexes	2
checkpoint kinase Rad53	2
replicative helicase component Cdc45	2
immovable protein barriers	2
leading and lagging strand templates	2
DPC	2
independent DPC proteases	2
SummaryDNA-protein crosslinks (DPCs)	2
noncanonical eIF2 signaling pathway	2
PERK signaling	2
canonical stress markers	2
proteostasis- and actin cytoskeleton-related proteins	2
Sema3A-p-eIF2α pathway	2
75 proteins	2
protein phosphatase 1	2
unfolded protein response (UPR) kinase PERK	2
translation initiation factor eIF2α	2
extracellular cue Sema3A	2
mitotic ripoptosomes	2
Polo-like kinase 1 (PLK1)	2
ripoptosome complexes	2
Caspase-8 activating ripoptosome complexes	2
SummaryReceptor-interacting protein kinase (RIPK)	2
interactomes	2
BET protein modules	2
several interactions	2
two classes of extra-terminal (ET)-domain binding motifs	2
BET BRDs	2
group of proteins	2
603 unique interactors	2
pan-BET BRD inhibitor JQ1	2
BRD2, BRD3, BRD4, and BRDT	2
SummaryTargeting bromodomains (BRDs) of the bromo-and-extra-terminal (BET) family	2
advancing replisome	2
nascent leading strand	2
lagging-strand polymerase Pol δ	2
origin blocked rightward leading strands	2
lagging-strand primer	2
rightward leading strands	2
origin sequence	2
start sites	2
purified yeast proteins	2
origin-dependent replication system	2
template strands	2
α-primase	2
parental DNA duplex and DNA polymerase	2
bidirectional CMG helicases	2
eukaryotic replication origins	2
divergent cryptic promoters	2
adjacent sequences	2
RSC chromatin remodeler	2
protein-coding direction	2
cryptic promoters	2
Rap1-regulated gene promoters	2
transcription factor Rap1	2
divergent noncoding transcription	2
active eukaryotic gene promoters	2
“anti-evolution” drugs)—in	2
nucleotide excision repair protein UvrA.	2
RNA polymerase subunit RpoB	2
hypermutator alleles	2
highly divergent bacterial species	2
DNA translocase Mfd	2
twist	2
RNA base pairs	2
MDA5 molecule	2
filament-forming residues	2
predominantly hydrophobic interface contacts	2
filament-forming interfaces	2
bound nucleotide analogs	2
different helical twists	2
MDA5-dsRNA filaments	2
cryoelectron microscopy (cryo-EM) structures	2
multiprotein type I interferon signaling platform	2
helical filaments on dsRNA	2
Long cytosolic dsRNA	2
SummaryDouble-stranded RNA (dsRNA)	2
deregulated lncRNAs	2
RNA:DNA hybrid (R-loops)	2
extended, polyadenylated lncRNAs	2
Integrator complex	2
active protein coding	2
ubiquitous Pol-II-associated transcription elongation factor SPT6	2
non-polyadenylated	2
RS-exons	2
EJC factor Magoh	2
several human RS-exons	2
annotated RS-exons	2
cryptic microexons	2
EJC	2
peripheral factors PNN and RNPS1	2
core EJC factors	2
constitutive RS-exons	2
recursive 5′ splice site (RS-5ss)	2
preceding exon	2
“RS-exon	2
checkpoint-signaling cascade	2
checkpoint adaptor Rad9	2
p21-activated kinase Cla4 phosphorylates H4T80	2
H4 threonine 80 (H4T80ph)	2
DNA-damage-regulated histone modification	2
complex genomic loci	2
complex Pax6 gene	2
several gene loci	2
protein bridges	2
highly predictive heteromorphic polymer (HiP-HoP) model	2
transposase-accessible chromatin using sequencing [ATAC-seq]), and structural anchors (CCCTC-binding factor [CTCF])	2
chromatin accessibility (assay	2
epigenetic marks (H3K27ac)	2
connected chain of units	2
simple polymer	2
3D macromolecular structures	2
human HeLa or murine lymphoid cells	2
Pol II active site	2
detectable spliced products	2
upstream exons	2
spliceosome-bound intermediates	2
nearly all spliced exons	2
5′ splice site	2
splicing intermediates	2
elongating Pol II-spliceosome complexes	2
Pol II S5P CTD	2
active spliceosomes (both snRNA and proteins)	2
antibodies against RNA polymerase II (Pol II)	2
MNase-digested chromatin	2
protein coding genes in mammals	2
newly synthesized and parental histones	2
POLE3-POLE4 and histones	2
minimal domains	2
histones H3-H4	2
POLE3-POLE4 subcomplex of the leading-strand polymerase, Polε	2
poorly characterized network of histone chaperones, remodelers, and binding proteins	2
repeat-containing fraction of the human genome	2
variety of cancer cells	2
perinucleolar compartment	2
nuclear body	2
hundreds of pyrimidine tract-binding protein (PTBP1)-specific motifs	2
lncRNA PNCTR	2
top-scoring hit	2
genetically normal short tandem repeats	2
high-density RBP recognition arrays	2
previously unknown transcripts	2
multiple copies of specific RNA-binding proteins (RBPs)	2
many long noncoding RNAs (lncRNAs)	2
ribonuclease	2
autoinhibitory pocket	2
present substrates	2
inter-protomer surface	2
duplex recognition site	2
sRNA RprA	2
numerous substrates	2
5′ end of RNA substrates	2
ribosome collisions	2
leading ribosome	2
60S interactions	2
ubiquitination targets of ZNF598	2
an extensive 40S-40S interface	2
collided di-ribosome structure	2
slower leading ribosome	2
trailing ribosome	2
collided di-ribosome	2
minimal unit	2
ubiquitinates stalled ribosomes	2
pathologic translation complexes	2
entire γH2AX domains	2
ubiquitin and 53BP1	2
histone H1	2
HR-repaired DSBs	2
SAGA complex	2
histone H2B lysine 120	2
NHEJ- and HR-specific chromatin events	2
multiple DSBs	2
DSB-induced chromatin	2
SummaryDouble-strand breaks (DSBs)	2
new histones	2
landscape of histone post-translational modifications (PTMs)	2
old modified histones	2
new naive histones	2
SummaryChromatin organization	2
m6A RNA methyltransferase	2
∼64-cell blastocysts	2
SAM synthetase Mat2a	2
methylation target	2
Mouse 16-cell embryos	2
critical adenosine	2
methylation-structured RNAs	2
random pool of RNAs	2
deep-cut groove	2
extra N-terminal module	2
methyltransferase domain	2
crystal structure of human METTL16	2
second m6A writer METTL16	2
single-stranded context	2
thousands of transcripts	2
METTL3/METTL14 heterodimer	2
signaling hub	2
alternative STING-dependent gene expression program	2
alternative STING signaling complex	2
DNA damage response factors	2
DNA binding protein IFI16	2
cytosolic DNA receptor cGAS	2
DNA sensing adaptor STING	2
keratinocytes and other human cells	2
small non-coding RNA	2
mTORC1 pathway	2
translation and neuron differentiation enhancer	2
molecular sponge	2
HuD interaction signal	2
abundant, small non-coding RNA Y3	2
predominant HuD target	2
mTORC1-responsive ribosomal proteins and translation factors	2
1,304 mRNAs	2
HuD target sites	2
motor neuron-like cells	2
HuD RNA interactome	2
nucleotide resolution map	2
RNA-binding protein HuD	2
the single-strand break repair protein XRCC1	2
DNA replication inhibitor	2
DNA replication proteins LIG1 or FEN1	2
damaged or misincorporated nucleotides	2
normal S phase cells	2
endogenous poly(ADP-ribose)	2
stochastic DNA breaks	2
SummaryPoly(ADP-ribose)	2
essential chromatin remodeling complex	2
lineage-specific transcription	2
nucleosome remodeling and deacetylation (NuRD) complex	2
inducible system	2
SummaryChromatin remodeling complexes	2
specialized deadenylase	2
Caf1 only trims poly(A)	2
general deadenylase	2
nuclease enzymes	2
fully reconstituted biochemical system	2
mRNA deadenylation	2
Ccr4 and Caf1/Pop2—that	2
Ccr4-Not complex	2
poly(A)-binding protein Pab1/PABP	2
eukaryotic mRNAs	2
brake	2
integral signaling component	2
optimized double-degron system	2
mitotic kinases CDK1	2
chromosomal cohesin	2
Scc2 mutations	2
stable cohesin constituent	2
Scc3, Pds5, and Scc2	2
hook-shaped HEAT repeat proteins	2
universally conserved features	2
initial de novo transcribing complex	2
open promoter complex	2
RNAP cleft	2
σ54 (σN), the major bacterial variant sigma factor	2
unique transcription system	2
template strand deep	2
multi-subunit RNA polymerases (RNAPs)	2
irreparably damaging stalled replication forks	2
chaperone-defective FANCD2 mutant	2
Lys4 of histone H3 (H3K4) at replication forks	2
damaged replication forks	2
lysine methyltransferase SETD1A	2
newly replicated DNA	2
Fanconi anemia and homologous recombination pathways	2
pS5-CTD of Pol II	2
influenza virus transcriptase	2
interface of PB1, P3, and the flexible PB2 C-terminal domains	2
Ser5-phosphorylated CTD (pS5-CTD) peptide	2
co-crystal structure of influenza C virus polymerase (FluPolC)	2
nascent host RNAs	2
capped RNA primers	2
C-terminal domain (CTD) of RNA polymerase II (Pol II)	2
heterotrimer composed of PB1, PB2, and PA subunits (P3 in influenza C)	2
SummaryInfluenza virus RNA polymerase (FluPol)	2
replisome’s	2
leading- and lagging-strand priming	2
single-stranded DNA exposure	2
core replisome itself	2
Okazaki fragment	2
daughter-strand gaps	2
Lagging-strand lesions	2
Pole4−/−p53+/− mice	2
Pole4 null mice	2
Pole4−/− mouse and POLE1 mutant human cells	2
outbred strains	2
inbred strains	2
entire Polε complex	2
Budding yeast orthologs of POLE3 and POLE4	2
major leading strand polymerase	2
four-subunit complex	2
SummaryDNA polymerase ε (POLE)	2
polyglutamine proteins	2
fibrillar structure	2
solid-like assemblies	2
liquid-like assemblies	2
cells and in vitro	2
huntingtin’s polyQ tract and proline-rich region	2
reversible liquid-like assemblies	2
huntingtin exon1 proteins	2
yeast, and in vitro	2
huntingtin exon1 assemblies	2
intracellular aggregates	2
N-terminal exon1 fragments of the protein	2
abnormally long polyglutamine tract	2
Nrd1-Nab3-Sen1 complex	2
non-coding transcripts (ncRNA)	2
atypical UBZ domain	2
distal ubiquitin	2
ZHA (ZUFSP helical arm)	2
two ubiquitin binding domains	2
minimal catalytic domain	2
seventh DUB family	2
novel DUB	2
ZUFSP/C6orf113	2
enzymes (DUBs)	2
malate dehydrogenase 1 (MDH1)	2
reduced nicotinamide adenine dinucleotide (NADH)	2
recently developed cell model	2
appropriate isogenic cellular models	2
active RIPK1 kinase	2
functional UBA domain of cIAP1	2
cIAP1-mediated and UBA-assisted ubiquitylation	2
ubiquitin-associated (UBA) domain of cellular inhibitor of apoptosis (cIAP)1	2
downstream kinases and NF-kB transcriptional responses	2
(NF-κB)-dependent checkpoints	2
transient intermediate	2
nitrosating cellular nitric oxide species	2
dominant end effectors	2
disulfides	2
S-nitrosated proteins	2
S-nitroso bond	2
Ht-REC	2
 intra-chromosomal insertions	2
vertebrate Rtel1	2
rtel-1 mutant meioses	2
rtel-1 and brc-1 mutants	2
mismatch repair	2
BRCA1 homolog BRC-1 counteract Ht-REC	2
RTEL1 and HIM-6/BLM helicases	2
mitotic and meiotic cells	2
heterologous sequences	2
key pathway	2
principal XR-PID binding factor	2
RNA-binding protein hnRNPK	2
Xist-dependent Polycomb recruitment	2
Xist B-repeat element	2
600 nt sequence	2
Xist RNA Polycomb Interaction Domain (XR-PID)	2
PRC1 complexes	2
chromosome-wide H2A lysine 119 ubiquitylation	2
PCGF3/5-PRC1 complex	2
Polycomb-repressive complexes PRC1 and PRC2	2
ATPase motor	2
C-terminal ATPase lobe	2
ALC1 at sites of DNA damage	2
poly(ADP-ribose) (PAR)-binding macro domain	2
oncogene-encoded chromatin-remodeling enzyme	2
Smc1-Smc3 heads	2
early anaphase of budding yeast	2
next cell cycle	2
phase	2
cohesin Smc3	2
cohesin Scc1	2
RING/U-box E3 ligases	2
UbVs in cells	2
closed E2∼Ub conformation	2
dimeric XIAP	2
UbV	2
E2∼Ub binding site	2
phosphorylated CBL	2
monomeric UBE4B, phosphorylated active CBL, or dimeric XIAP	2
RING or U-box domain of a distinct E3 ligase	2
three ubiquitin variants (UbVs)	2
U-box E3 ubiquitin ligases	2
several EGF-stimulated prostate and breast cancer lines	2
epidermal growth factor (EGF)-stimulated cells	2
known PI(3,4)P2 4-phosphatase	2
Mcf10a cytosol	2
major PI(3,4)P2 phosphatase	2
PI(3,4)P2 3-phosphatase	2
PI(3,4,5)P3 3-phosphatase	2
PTEN tumor suppressor	2
 3- or 5-phosphatases	2
lipid messenger PI(3,4,5)P3	2
PI3K signaling pathway	2
K6-linked polyubiquitin	2
main E3 ligase	2
K6-ubiquitinated proteins	2
K6-, K11-, and K48-linked polyubiquitin	2
confocal fluorescence microscopy	2
superior affinity reagents	2
K33 affimer	2
high-affinity ubiquitin interactors	2
K6- and K33-linkage-specific “affimer” reagents	2
polyubiquitin signals	2
Linkage-specific antibodies	2
ubiquitin chain types	2
m6A-reader YTHDF2	2
YTHDF2-binding consensus	2
MII transcriptome	2
branch of m6A RNA-regulatory pathway	2
N6-methyladenosine (m6A)-modified mRNA	2
parallel loss-of-function screens	2
multiplexed or arrayed format	2
genome-wide, sequence-verified, arrayed CRISPR library	2
DNA loops	2
Smc heads	2
ATP molecules	2
end of the rod	2
Smc head domains	2
interarm space	2
prokaryotic Smc dimers	2
49 nm coiled-coil “arm	2
“hinge” dimerization domain	2
ABC ATPase “head”	2
SMC subunits	2
DNA double helices	2
chromosome superstructure	2
SummaryMulti-subunit SMC complexes	2
Armadillo/β-catenin	2
Hyd/UBR5	2
ubiquitylated chromatin proteins	2
various cellular substrates	2
AAA ATPase	2
UBR5-dependent ubiquitylation	2
functionally relevant substrate	2
Groucho/TLE	2
activated Armadillo/β-catenin	2
Drosophila and human cell lines	2
HECT E3 ubiquitin ligase Hyd/UBR5	2
Wnt-activated β-catenin	2
Groucho/TLE co-repressors	2
T cell factors (TCF)	2
Wnt-responsive enhancers	2
Wnt enhanceosome	2
enhancer complexes	2
activator-bound intermediate complex	2
alternative σ54 factor and cryoelectron microscopy	2
RNAP active site	2
single-stranded template DNA	2
open promoter complex (RPo)	2
double stranded	2
closed promoter complex (RPc)	2
RNA polymerases (RNAPs)	2
TNF signaling pathway	2
RIPK1 in complex	2
complex-II	2
RIPK1-kinase-dependent apoptosis	2
FADD/caspase-8	2
RIPK1 at residue S321	2
downstream effector kinase MK2	2
receptor, TNFR1	2
driver of NUT midline carcinoma	2
chromatin-bound BRD4	2
BRD4 knockdown	2
methyltransferase G9a	2
epigenetic reader BRD4	2
RFWD3-deficient cells	2
RPA32 subunit of RPA	2
new FA subtype	2
WD40 repeats of RFWD3 (I639K)	2
ubiquitylates replication protein A (RPA)	2
DNA interstrand crosslinks (ICLs)	2
PARK2-deficient tumors	2
endothelial nitric oxide synthase (eNOS)	2
PI3K/Akt/mTOR inhibitors	2
enhanced phosphatidylinositol 3-kinase/Akt (PI3K/Akt) activation	2
protein-coding circRNA	2
heavy polysomes	2
in-frame STOP codon	2
linear transcript	2
circ-ZNF609	2
conserved species	2
murine and human myoblasts	2
family of transcripts	2
SummaryCircular RNAs (circRNAs)	2
direct TCF-SRF target genes	2
TCF Elk-1 mutants	2
TCF-independent TSSs	2
remote regulatory sites	2
hundreds of transcription start site (TSS) regions	2
H4K16ac, H3K27ac, H3K9acK14ac, and H3K4me3	2
ERK-regulated ternary complex factor family of SRF partner proteins	2
ERK signaling	2
tri-nuclease complex	2
SLX4 binding	2
MUS81’s conserved N-terminal HhH domain	2
SLX4 co-ordinates the SLX1 and MUS81-EME1 nucleases	2
replication forks and recombination intermediates	2
three individual nucleases	2
SLX1-SLX4, MUS81-EME1, and XPF-ERCC1	2
three DNA repair structure-selective endonucleases	2
MUS81-EME1 endonuclease	2
potentially toxic structures	2
replication and recombination intermediates	2
mouse nuclear transfer embryos	2
chromatin modifier USP21	2
chromatin modifier combinations	2
resistant genes	2
oocyte factors	2
H3K9me3, H3K27me3, and H2AK119ub1 from transplanted nuclei	2
mouse embryonic fibroblast nuclei	2
SMC arms	2
flanking DNA	2
chromosomal loading sites	2
peptide insertions	2
Natural SMC sequences	2
bacterial Smc arm	2
 barrier	2
∼47-nm-long SMC arms	2
closed tripartite ring	2
connecting coiled-coil “arm	2
hinge“ dimerization domains	2
ATPase “head” and “	2
TRAIL/TRAIL-R system	2
cancer microenvironment	2
tumor-supportive immune cells	2
lung adenocarcinoma patients	2
MDSC presence	2
receptor of CCL2, CCR2	2
myeloid-derived suppressor cells (MDSCs) and M2-like macrophages	2
TRAIL-induced secretome	2
TRAIL-resistant cancer cells	2
TRAIL/TRAIL-R	2
resistant cancers	2
necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)	2
53BP1 localization	2
RUVBL1 methylation	2
histone H4K16 acetylation	2
position R205	2
PRMT5 targets RUVBL1	2
cofactor of the TIP60 complex	2
encoded transcript	2
transcription elongation factors (TEFs) such as polymerase-associated factor 1 (Paf1)	2
SummaryRNA polymerase II (Pol2)	2
nuclear surveillance pathways	2
strong NNS binding sites	2
alternative transcription starts	2
surveillance factor binding	2
Upregulated transcripts	2
oligo(A) tailing	2
many growth-related mRNAs	2
promoter-proximal sites	2
Mtr4 (TRAMP complex) and Nab3 (NNS complex)	2
exosome cofactors	2
transcriptome-wide binding sites	2
pre-mRNA transcripts	2
nuclear RNA surveillance system	2
O-linked protein ADPr	2
hundreds of other targets	2
HMG proteins	2
PARP-1 automodification domain	2
Three endogenous serine ADPr sites	2
serine-specific ADPr of histones and PARP-1 itself	2
cells lacking HPF1	2
recently identified regulator of PARP-1	2
histone PARylation factor 1 (HPF1)	2
biochemical basis	2
histone serine ADPr marks	2
possible amino acid residues	2
different amino acids	2
SummaryADP-ribosylation (ADPr)	2
phosphoacceptor amino acid	2
Cdk-counteracting phosphatases	2
Cdk target sites	2
model substrate, Ndd1	2
threonine residues	2
late Cdk substrates	2
the abundant PP2ACdc55 phosphatase	2
the budding yeast model	2
cyclin-dependent kinase (Cdk) activity	2
quantitative model	2
Artemis endonuclease	2
Exo1 execute resection	2
Mre11 exonuclease	2
Plk3 phosphorylates CtIP	2
-NHEJ	2
c-NHEJ	2
additional lesions	2
G1 cells	2
non-homologous end joining (c-NHEJ) repairs DNA double-strand breaks (DSBs)	2
associated protein	2
poly-lysine tag	2
ubiquitination-resistant eS10 ribosomes	2
primary ribosomal target	2
40S protein eS10	2
nascent truncated proteins	2
ribosome-associated quality control (RQC) pathway	2
ZNF598-mediated stalling	2
ubiquitin ligases	2
several ribosomal proteins	2
cellular stressors	2
functional lincRNAs	2
different nuclear fractions	2
human HeLa cells	2
protein-coding and lincRNA genes	2
processivity factor PCNA	2
replisome-associated factors Mrc1	2
sophisticated machine	2
leading- and lagging-strand templates	2
DNA polymerases α, δ, and ε and other proteins	2
Cdc45-MCM-GINS (CMG) replicative DNA helicase	2
molecular machine	2
regular arrays	2
lysine acetyltransferases Gcn5 and Esa1	2
nucleosome remodelers INO80 or ISW1A	2
FACT-associated Nhp6 protein	2
context of chromatin	2
non-specific MCM helicase loading	2
fully chromatinized templates	2
purified yeast replication proteins	2
enzyme-enzyme TA system	2
ADP-ribosylation	2
thymidines on single-stranded DNA	2
antitoxin (DarG) a macrodomain protein	2
domain of unknown function (DUF) 4433	2
toxin of the system (DarT)	2
global pathogen Mycobacterium tuberculosis	2
various bacteria	2
TA system	2
A12.2 C-terminal domain	2
bridge helix	2
Pol I elongation complex	2
one of the elongation complexes	2
upstream and downstream DNA duplexes	2
protrusion domain	2
clamp head	2
clamp domain	2
Two modules in Pol	2
Pol I open complex	2
elongating Pol I	2
three cryo-EM structures	2
molecular architecture	2
apo Pol I	2
pre-ribosomal RNA	2
14-subunit enzyme	2
SummaryRNA polymerase I (Pol I)	2
I-E and I-F systems	2
three CRISPR-Cas systems	2
high-density populations	2
Serratia cells	2
type I-E, I-F, and III-A CRISPR-Cas systems	2
Many bacterial populations	2
CRISPR-Cas adaptive immunity	2
invaders	2
freely diffusible InsP3 message	2
coincident yet geographically distinct Ca2+ signals	2
nuclear Ca2+	2
either NFAT protein	2
cytoplasmic Ca2	2
nuclear InsP3 receptors	2
inner nuclear envelope	2
sub-plasmalemmal Ca2+ microdomains	2
distinct sub-cellular InsP3 and Ca2+ signals	2
NFAT1 and NFAT4	2
-dependent transcription factor isoforms	2
two Ca2+	2
coexpressed transcription factors	2
MCC-APC/C complex	2
two Cdc20 molecules	2
the APC/C	2
ABBA-KEN-ABBA cassette	2
amino-terminal KEN box	2
ABBA-KEN-ABBA motifs	2
KEN box	2
ABBA motifs	2
microtubule poisons	2
active APC/C-Cdc20	2
recently identified ABBA motif class	2
Anaphase Promoting Complex/Cyclosome (APC/C)	2
Mitotic Checkpoint Complex (MCC)	2
Spindle Assembly Checkpoint (SAC)	2
major class of post-transcriptional regulators	2
mRNA target	2
representative small-RNA precursor	2
various precursor RNAs	2
stable 3′ fragments	2
bacterial regulatory small RNAs	2
key recognition determinant	2
single-stranded segment	2
uridine two nucleotides downstream	2
Salmonella enterica	2
essential endoribonuclease RNase E	2
cleavage products	2
endoribonuclease	2
major endoribonucleases	2
dynamic protein complexes	2
SUMO-SIM networks	2
SUMO-SIM network	2
SUMO modified proteins	2
functional SUMO interaction motifs (SIMs)	2
GEI-17 and another RC component, the kinase BUB-1	2
SUMO substrate	2
SUMO E3 ligase GEI-17/PIAS	2
chromokinesin KLP-19	2
multi-protein ring complex (RC)	2
oocyte meiosis	2
individual filaments	2
Filament end capping	2
5′ end of RAD-51-ssDNA filaments	2
C. elegans, RFS-1/RIP-1	2
RAD51 paralog complex	2
Various regulatory proteins	2
helical nucleoprotein filaments on single-stranded DNA (ssDNA)	2
RAD51 recombinase	2
TCF-deficient MEFs	2
MRTFs	2
MRTF-dependent SRF target gene expression	2
general antagonists	2
TCFs	2
Rho-regulated myocardin-related transcription factor (MRTF) SRF cofactor family	2
cytoskeletal gene targets	2
TCF-dependent SRF direct target genes	2
integrated SRF ChIP-seq and Hi-C data	2
transcription factor serum response factor (SRF)	2
ERK-regulated ternary complex factors (TCFs)	2
total mass of metaphase chromosomes	2
wild-type and Ki-67-depleted chromosomes	2
Prophase chromosomes	2
entire mitotic chromosome complement	2
elusive chromosome compartment	2
specialized DNA replication-coupled DPC repair pathway	2
SPRTN protease	2
Ruijs-Aalfs syndrome (RJALS) patient cells	2
various DNA binding substrates	2
specialized DNA-dependent and DNA replication-coupled metalloprotease	2
exogenous agents	2
Cellular, biochemical, and structural studies	2
Xenopus laevis egg extracts	2
DPC-processing protease	2
SummaryCovalent DNA-protein crosslinks (DPCs)	2
cell cycle genes	2
multiple enhancers	2
previously unrecognized protein in the network	2
400 proteins	2
protein of interest	2
chromatin-bound partners	2
chromatin-associated proteins (SICAP)	2
OSN protein network	2
Oct4, Sox2, and Nanog (OSN)	2
network of transcription factors	2
positive feedback	2
toxic SCI entanglements	2
condensin DNA supercoiling activity	2
G2/M, Top2	2
intrinsic feature of type II topoisomerases (Top2)	2
replicated chromatids	2
chromatid intertwines (SCIs)	2
Dishevelled polymers	2
clathrin-coated pits	2
monomeric DEP	2
swapped dimer	2
DEP domain of Dishevelled	2
biophysical and cell-based assays	2
Wnt effector	2
DIX domain	2
Wnt signalosome	2
signal-activated transmembrane receptors	2
oligomerizing hub proteins	2
“signalosomes”	2
7-nt RNA	2
complex set of determinants	2
additional pausing	2
major pausing determinant	2
RNA exit channel	2
Region sigma 3.2	2
6-mer RNA	2
immobilized transcription complexes	2
lac promoter	2
short transcripts	2
bacteria, RNA polymerase (RNAP)	2
DNA double-strand break repair pathway choice	2
p53 and the ubiquitin-specific protease USP28	2
p53-interacting protein	2
tumor suppressor protein 53BP1	2
regulatory component of LUBAC-mediated NF-κB signaling	2
high-affinity binding partner of CYLD and HOIP	2
LUBAC substrates	2
TNF receptor 1 signaling complex	2
conserved PUB-interacting motif	2
SPATA2 binding	2
catalytic CYLD USP domain	2
non-canonical PUB domain	2
spermatogenesis-associated protein 2 (SPATA2)	2
catalytic subunit HOIP	2
deubiquitinases OTULIN and CYLD	2
cellular signaling pathways	2
central, interaction-prone proteins	2
rewire protein interaction networks	2
fusion products	2
Fusion products	2
post-translational modifications	2
regulatory sites	2
highly connected hub genes	2
parent genes)	2
thousands of putative fusion proteins	2
fusion protein products	2
hot spots	2
prevalent partners	2
unstructured domains	2
intrinsically disordered regions	2
protein-protein interaction domains	2
Catalytic centers	2
numerous RNA-binding domains (RBDs)	2
529 HeLa cell RBPs	2
 1,174 binding sites	2
RNA-binding sites of native RBPs	2
non-membrane-enclosed compartments (signalosomes)	2
avidity-dependent AXIN binding	2
polymerizing TNKS and TNKS2 sterile alpha motif (SAM) domains	2
poly(ADP-ribosyl)ates	2
polymeric master scaffolding protein AXIN	2
pool of active β-catenin	2
Wnt-dependent cancers	2
poly(ADP-ribose) polymerase (PARP) Tankyrase (TNKS and TNKS2)	2
diverse CE clan proteins	2
Salmonella Typhimurium SseL.	2
accessory domains	2
unstructured ubiquitin binding region	2
Xanthomonas XopD	2
previously reported effectors	2
novel family members	2
CE clan	2
ubiquitin/ubiquitin-like complexes	2
Five crystal structures	2
Chlamydia, Rickettsia, and Xanthomonas	2
ubiquitin/ubiquitin-like cross-reactive enzymes	2
Salmonella, Escherichia, and Shigella	2
K63-linkage-specific deubiquitinases	2
deSUMOylase, deubiquitinase, or, even, acetyltransferase activities	2
ubiquitin-like modifications (SUMO and NEDD8)	2
specific hydrolases	2
CE clan proteases	2
host signaling pathways	2
secreted effector proteins	2
SummaryPathogenic bacteria	2
CIP-box proteins	2
multiple accessory factors	2
large array of rDNA repeats	2
rDNA-associated protein Tof2	2
CIP-box motifs of the Dna2 nuclease	2
two related groups	2
CIP-boxes	2
“Ctf4-interacting-peptide” or CIP-box	2
Pol α and helicase	2
new Ctf4 partners	2
trimeric adaptor Ctf4	2
Pol α lagging-strand polymerase	2
leading-strand polymerase directly	2
DNA polymerases and many other factors	2
lateral dimer interface	2
subunits e and g	2
F1Fo monomer	2
cryo-EM map	2
two monomers	2
subunit f	2
lumenal membrane surface	2
bacterial b subunit	2
Subunit 8 (A6L in human)	2
subunits a, b, f, i, and 8	2
vertical helices	2
c-ring rotor	2
Horizontal helices of subunit a	2
60 dimer subunits	2
yeast Yarrowia lipolytica mitochondria	2
complete, dimeric F1Fo-ATP synthase	2
replisomal interaction hub	2
Chl1’s	2
Ctf4 interaction	2
reconstituted Chl1-Ctf4-GINS assembly	2
GINS and polymerase α	2
conserved interaction motif	2
cohesive links	2
chromosomal cohesin complex	2
Eco1 acetyltransferase	2
coordinated intra- and intermolecular interactions	2
triage clients	2
cytosolically exposed transmembrane domains	2
family of chaperones	2
non-inserted mitochondrial membrane protein precursors	2
polyglutamine aggregates	2
Ubiquilin’s UBL domain	2
the Ubiquilin-client complex	2
intramolecular UBL domain	2
attached ubiquitin engages Ubiquilin’s UBA domain	2
bound clients	2
Ubiquilin family proteins	2
mitochondrial membrane proteins	2
long polyUb chains	2
propargylated Ub	2
crystal structure of MINDY-1 (also known as FAM63A)	2
previously unannotated domain	2
K48-linked polyUb	2
MINDY-family DUBs	2
MINDY (motif interacting with Ub-containing novel DUB family)	2
Ub-conjugated substrates	2
enzymes (DUBs) remove ubiquitin (Ub)	2
peptidyl-tRNA hydrolase	2
positively charged surface patches	2
primary amine group of amino acids on charged tRNA molecules	2
acetyltransferase	2
one such toxin	2
toxin-antitoxin modules	2
non-growing persisters	2
Salmonella population	2
non-growing, antibiotic-insensitive cells	2
NETs	2
Retargeting a NET39 fragment	2
specific myogenic genes	2
NET39, Tmem38A, and WFS1	2
three muscle-specific NETs	2
nuclear envelope-genome contacts	2
nuclear envelope transmembrane proteins (NETs)	2
primordial germ cells and early embryos	2
naive ESCs	2
replication foci	2
maintenance methylation machinery	2
essential targeting factor for DNMT1	2
active mechanisms (Aicda, Tdg, and Tet1-3)	2
naive hypomethylated ones (serum-to-2i)	2
primed hypermethylated embryonic stem cells (ESCs)	2
MDA5 oligomerization	2
stem and end binding	2
RIG-	2
a MDA5-like helicase domain	2
chimera	2
chMDA5	2
long filaments	2
polar head-to-tail orientation	2
1:1 and 2:1 complexes of chMDA5 with short dsRNA	2
RIG-I. Structures	2
overall footprint	2
LGP2 caps blunt, 3′ or 5′ overhang dsRNA ends	2
Co-crystal structures of chicken (ch) LGP2 with dsRNA	2
MDA5 and RIG-I signaling	2
Non-signaling LGP2	2
MDA5 sense virus-derived short 5′ppp blunt-ended or long dsRNA	2
efflux inhibitors	2
multiple biological pathways	2
efflux systems	2
tolC expression	2
central component TolC	2
multi-drug efflux genes	2
sub-group termed persisters	2
isogenic bacterial population	2
multiple phenotypes	2
whole-genome CRISPR knockout libraries	2
histone ADP-ribosylation and PARP-1 automodification	2
DNA damaging agents	2
PARP-1-dependent in trans ADP-ribosylation of histones	2
PARP-1 catalytic ADP-ribosylation activity	2
PARP-1 in cells	2
robust protein complex	2
histone PARylation factor 1 (HPF1; also known as C4orf27)	2
c-FLIPL	2
co-operative hierarchical binding model	2
procaspase-8:c-FLIPS	2
DED-mediated procaspase-8 oligomer assembly	2
procaspase-8:c-FLIPL	2
procaspase-8:c-FLIPL/S heterodimer	2
unbound c-FLIPL/S	2
functional reconstituted DISC	2
pro-apoptotic (c-FLIPL only) or anti-apoptotic (c-FLIPL/c-FLIPS) regulators	2
cohort of proteins	2
mRNA capping	2
RNMT inhibitor	2
RNMT regulatory domain	2
CDK1-cyclin B1	2
cap guanosine	2
7-methylguanosine (m7G) cap	2
RNA polymerase II transcripts	2
translation-competent mRNA	2
Smc ATPase heads	2
N-terminal cleavage fragments of Scc1 (NScc1)	2
Smc1, Smc3, Scc1, Wapl, Pds5, and Scc3 subunits	2
Smc3/Scc1 interface	2
Scc2/4 complex	2
cohesin’s Scc1, Smc1, and Smc3 subunits	2
’s two ATPase sites	2
Smc3 acetylation	2
ATPase sites	2
’s highly conserved ABC-like ATPase machinery	2
heart of cohesin	2
cohesin protectors Eco1 in yeast and Sororin in human cells	2
mutants of cohesin	2
yeast genetics	2
Smc3 subunit	2
Eco1 acetylates	2
cellular antagonist Wapl	2
BRCT/Abraxas complex	2
N-terminal sequence	2
BRCT/Abraxas	2
serine 404 (S404)	2
phosphorylated serine-proline-x-phenylalanine (pSPxF) motif including Abraxas, Bach1/FancJ, and CtIP	2
BRCA1-BRCT domains	2
HR-compromised cells and tumors	2
G4-stabilizing drugs	2
53BP1 or REV7	2
the G4-stabilizing compound pyridostatin (PDS)	2
guanine-rich (G-rich) telomeric repeats	2
collapsed forks	2
Stalled replication forks	2
SummaryG-quadruplex (G4)-forming genomic sequences	2
interacting domains	2
nuclear architecture	2
non-Lamin B1-bound late domains	2
late-replicating genome	2
Lamin B1	2
Rif1 coats late-replicating domains	2
ULK1 LIR motif	2
LC3B, GABARAPL1, and GATE-16	2
unlipidated and lipidated	2
golgin	2
dynamic pool	2
pericentriolar matrix	2
Atg8 homolog GABARAP	2
novel interaction partners	2
Golgi proteins	2
ULK complex	2
structured RNAs	2
human telomerase RNA component (hTR/TERC)	2
DGCR8/exosome complex	2
human telomerase RNA	2
hRRP6-containing nucleolar form	2
subunits of the nuclear exosome	2
variety of cellular RNAs	2
alternative DGCR8 complex(es)	2
mature small nucleolar RNA (snoRNA) transcripts	2
several types of cellular RNAs	2
Microprocessor complex (DGCR8/Drosha)	2
replicative helicase and polymerase	2
avian DT40 cells	2
BU-1 locus	2
catalytic activity or zinc-finger of PrimPol	2
leading strand G4 structures	2
recently described primase-polymerase (PrimPol)	2
multiple specialized DNA helicases and polymerases	2
G4s in vertebrates	2
SummaryG quadruplexes (G4s)	2
dynamic, multi-domain proteins	2
monomeric PARP-1	2
remaining PARP-1 domains	2
flexibly linked N-terminal zinc fingers	2
PARP-1’s signaling response	2
PARP-1’s multi-domain architecture	2
BRCA-deficient tumor cells	2
burst of poly(ADP-ribose) synthesis	2
DNA single-strand breaks (SSBs)	2
key eukaryotic stress sensor	2
SummaryPoly(ADP-ribose)polymerase 1 (PARP-1)	2
recombination-mediated DNA lesions	2
fork protection complex	2
 recombination intermediates	2
late-replicating regions	2
natural pausing sites	2
DNA recombination structures	2
generated alleles	2
G2/M.	2
Smc5/6 components	2
Saccharomyces cerevisiae cell-cycle-regulated alleles	2
conserved Smc5/6 complex	2
ubiquitin adducts	2
novel DNA repair regulator	2
USP-family enzymes	2
CtIP/MRN	2
CtIP and the MRE11-RAD50-NBS1 (MRN) complex	2
protein ubiquitylation	2
individuals with mutated FA proteins	2
physiologically occurring DNA:RNA hybrids	2
FA-depleted cells	2
DNA:RNA hybrids	2
FA-deficient mice	2
simple aldehydes	2
functional FA pathway	2
transcription-associated R-loops (DNA:RNA hybrids)	2
fatal malignancies	2
hepatocytes and nephrons	2
Adh5−/−Fancd2−/− mice	2
DNA crosslink repair protein	2
formaldehyde adducts	2
Adh5−/− mice	2
enzyme alcohol dehydrogenase 5 (ADH5/GSNOR)	2
endogenous formaldehyde	2
cognate DUB partner	2
inactive pseudo DUB	2
targeting proteins SHMT2 and RAP80	2
dimer of heterodimers (super dimers)	2
inactive BRCC36 homodimer	2
active BRCC36-KIAA0157 heterodimer	2
pseudo DUB MPN– proteins KIAA0157	2
MPN+ domain protein BRCC36	2
distinct macromolecular complexes	2
lysine-63-linked ubiquitin chains	2
-dependent deubiquitinating enzyme (DUB)	2
closed one	2
open mRNA latch conformation	2
40S head	2
subunit interface	2
configuration of eIF3	2
48S PICs	2
5′ end of the mRNA	2
40S ribosomal subunit, eIF1, eIF1A, eIF3, ternary complex (eIF2-GTP-Met-tRNAi), and eIF5	2
pre-initiation complex (PIC)	2
host-derived reactive oxygen species	2
lipoylation and mono-ADP-ribosylation	2
sirtuin-dependent reversible protein ADP-ribosylation system	2
sirtuin-associated macrodomain protein	2
Staphylococcus aureus and Streptococcus pyogenes	2
sirtuins	2
earlier described classes	2
hitherto unrecognized class of sirtuins	2
ancient family of NAD+-dependent deacylases	2
genome-wide trans-recognition network	2
yet another class of small RNAs	2
 the IESs	2
limited set of internal eliminated sequences (IESs)	2
ciliate Tetrahymena	2
germline and somatic genomes	2
ciliated protozoans	2
diverse evolutionary solutions	2
CLR:RAMP complexes	2
GPCR	2
class of accessory membrane proteins	2
variable C-terminal peptide residues	2
RAMPs	2
related GPCRs	2
C termini	2
β-turn structure	2
shared binding site on CLR	2
RAMP2 extracellular domain heterodimers	2
RAMP1 and AM-bound CLR:	2
CGRP analog-bound CLR:	2
GPCR:RAMP complexes	2
cardiovascular and lymphatic systems	2
peptides calcitonin gene-related peptide (CGRP) and adrenomedullin (AM)	2
G protein-coupled receptor (GPCR) calcitonin receptor-like receptor (CLR)	2
receptor activity-modifying proteins (RAMP1-3)	2
basal transcription components	2
TAF3 mutants	2
H3K4me3 in vitro	2
known H3K4me3 binding region of TAF3	2
PI interaction site	2
TATA box binding protein-associated factor	2
PHD finger of TAF3	2
PI interactors	2
myogenic genes	2
nuclear PI5P	2
lipid kinase PIP4K2B	2
important signaling molecules	2
SummaryPhosphoinositides (PI)	2
co-existing cytoplasmic transcription factor isoforms	2
different isoform combinations	2
NFAT regulatory domain	2
SP-3 motif	2
open channels	2
store-operated Orai1/CRAC channels	2
intracellular Ca2+	2
two closely related transcription factor isoforms, NFAT1 and NFAT4	2
ERK target	2
intact MFN1T562	2
proapoptotic BCL-2 family member BAK	2
mitochondria tethering	2
MEK/ERK cascade	2
heptad repeat (HR) 1 domain	2
atypical ERK site	2
mitogen-activated protein (MAP) kinase cascade member extracellular-signal-regulated kinase (ERK) phosphorylates the pro-fusion protein mitofusin (MFN) 1	2
key tumor suppressor and genome stability network	2
BLM and TOP3A/RMI1/RMI2	2
critical residues	2
BLM-TopBP1 interaction	2
absence cells	2
BLM-TopBP1 binding	2
ubiquitylation and degradation (Wang et al., 2013)	2
SummaryThe Bloom syndrome helicase BLM and topoisomerase-IIβ-binding protein 1 (TopBP1)	2
K33-linked Ub chains	2
atypical K29-	2
linkage-specific components in the Ub system	2
crystal structure of this complex	2
K29/K33-linked diUb	2
N-terminal Npl4-like zinc finger (NZF1) domain of the K29/K33-specific deubiquitinase TRABID	2
K29- and K33-linked chains	2
human HECT E3 ligases UBE3C and AREL1 assemble K48/K29- and K11/K33-linked Ub chains	2
Several atypical chain types	2
structurally and functionally distinct ubiquitin (Ub) chains	2
linkages	2
mixed or branched chains	2
K29 linkages	2
one of the ubiquitin moieties	2
NZF1 domain of TRABID	2
ubiquitin moieties	2
hydrophobic patches	2
K29-linked diubiquitin	2
HECT E3 ligase UBE3C and the deubiquitinase vOTU	2
ubiquitin chain-editing complex	2
K29 chains in vitro	2
different linkage types	2
minority MOMP	2
minority of mitochondria	2
downstream caspases	2
regulated, membraneless organelles	2
weakly interacting blocks	2
alternative solvent environment	2
membraneless organelles	2
Sequence determinants	2
phase-separated organelles	2
primary constituent of nuage or germ granules	2
disordered tails of Ddx4	2
nucleoli, Cajal and PML bodies, and stress granules	2
proteinaceous and membraneless organelles	2
membrane-encapsulated compartments	2
transcriptional pause sites	2
BRCA1/SETX complexes	2
R-loop-mediated BRCA1 binding sites	2
BRCA1 null breast tumors	2
R-loop-rich termination regions (TRs)	2
untranscribed strand of relevant R-loop structures	2
ssDNA breaks	2
adjacent γ-H2AX accumulation	2
specific, physiological binding partner, senataxin (SETX)	2
subset of transcription termination regions	2
normal transcriptional intermediates	2
Jarid2 methylation	2
Eed core component of PRC2	2
cofactor of PRC2	2
histone H3 lysine 27 (H3K27me2/3)	2
Polycomb machinery	2
SummaryPolycomb Group (PcG) proteins	2
multivalent network of context-specific individually weak interactions	2
nascent polypeptide exit tunnel	2
adjacent ligase domain	2
Listerin’s C-terminal RWD domain	2
Listerin’s N-terminal domain	2
ribosome-bound NEMF	2
60S and peptidyl-tRNA	2
nascent chain-containing 60S-Listerin-NEMF complex	2
3.6 Å cryo-EM structure	2
nuclear export mediator factor (NEMF)	2
nascent chain-60S complexes	2
numerous empty 60S	2
rare stall-generated 60S	2
low-abundance ubiquitin ligase	2
60S-housed nascent polypeptides	2
alternative VPS34-independent autophagy-initiating pathways	2
PI(5)P in VPS34-inactivated cells	2
compromised autophagosome formation	2
autophagic precursors	2
5-kinase PIKfyve	2
phosphatidylinositol	2
PI(3)P effectors	2
specific autophagic effectors	2
product of class III PI3K VPS34	2
SummaryPhosphatidylinositol 3-phosphate (PI(3)P)	2
ubiquitin-SUMO signaling circuitry	2
DVC1-p97 ubiquitin segregase complex	2
SUMO-targeted ubiquitin ligase RNF4	2
polyubiquitylation	2
SUMO E3 ligases PIAS1/PIAS4	2
FA ubiquitin ligase core complex	2
ATR kinase	2
FANCD2 (the ID complex)	2
tumor suppressor proteins FANCI and	2
central components of the Fanconi anemia (FA) DNA repair pathway	2
ubiquitylated proteins	2
ubiquitin-binding site of Dss1	2
two basic regions	2
I13, I44, and L69	2
complementary binding region	2
acidic and hydrophobic residues	2
K63 and K48	2
phylogenetically conserved proteasome subunit Dss1 (Sem1)	2
least one other substrate receptor	2
proteasome subunits Rpn10 and Rpn13	2
many women	2
developing embryo	2
fetal Aldh2	2
severely depleted hematopoietic stem and progenitor cells	2
rescued neonates	2
wild-type mothers	2
Aldh2−/−Fanca−/− embryos	2
Fanconi anemia DNA repair pathway gene Fanca	2
 embryos	2
reactive aldehydes	2
Pregnant mice	2
genotoxins	2
mother and embryo	2
ribosome-associated quality control pathway	2
60S-Listerin complex	2
cryo-EM reconstruction	2
60S- from 80S-nascent chain complexes	2
ribosome splitting factors Hbs1, Pelota, and ABCE1	2
minimal components	2
purified factors	2
E3 ligase Listerin	2
partially translated nascent polypeptide	2
Environmental stress-induced genes	2
subunit of the Set1 K4 methyltransferase complex	2
Jhd2, the K4me3 demethylase	2
gene-specific K4me3	2
alanine 15-proline 16 (A15-P16) peptide bond	2
Histone H3 (H3) lysine 4 trimethylation (K4me3)	2
“2i” signaling pathway inhibitors	2
quantitative time-lapse movies	2
individual ESCs	2
functionally important regulatory factors	2
SummaryCell populations	2
Cancer-associated BAF180 mutants	2
PRC1 and PRC2 polycomb group complexes	2
BAF180, a PBAF subunit	2
ATM phosphorylation site	2
transcription globally	2
subset of DNA DSBs	2
PBAF remodeling complex	2
neighboring DNA double-strand breaks (DSBs)	2
transcribed regions of the genome	2
somatic chromatin	2
oocyte-specific linker histone B4	2
transplanted chromatin	2
pluripotent type	2
two alternative partners of the NNS complex	2
NNS targets	2
Nrd1-Trf4 interaction	2
two alternative forms of the NNS complex	2
domain of Nrd1p	2
Trf4-Air2-Mtr4 (TRAMP) complex polyadenylates NNS target RNAs	2
noncoding RNA genes	2
NNS complex	2
Nrd1-Nab3-Sen1 (NNS) complex	2
Rpt6-Rpt3 ATPase pair	2
amino terminus of Rpt6	2
ATPase dedicated chaperone	2
protein, hereafter named Adc17	2
yeast Rpt6 thermosensitive proteasome mutant	2
stressed cells	2
initially nonfibrillogenic partner	2
kinetically trapped dimers	2
head-to-head orientation	2
similar surfaces	2
amyloidogenic and nonamyloidogenic variants of β2-microglobulin	2
heterogeneous populations of oligomeric species	2
cytosolic quality control pathway	2
Bag6 client	2
Bag6-associated clients	2
juxtahydrophobic lysine residues	2
N-terminal Ubl domain of Bag6	2
primary Bag6-dependent ligase	2
MLP degradation pathway	2
ubiquitin ligase RNF126	2
Bag6 complex	2
Mislocalized proteins (MLPs)	2
hydrophobic signals	2
membrane surrounding Salmonella	2
Atg16L1-deficient MEFs	2
Atg16L1 mutants	2
PtdIns(3)P effector	2
Atg16L1 directly	2
WIPIs, WD-repeat PtdIns(3)P effector proteins	2
autophagosome formation sites	2
PtdIns(3)P synthesis	2
Atg12–5-16L1 recruitment	2
LC3-conjugating Atg12–5-16L1 complex	2
endoplasmic reticulum-localized phosphatidylinositol 3-phosphate (PtdIns(3)P) synthesis	2
primary colonization site	2
bovine rectal mucus	2
bacteriophage-encoded “anti-sRNA”	2
mRNA substrate sequence	2
core genome regulatory sRNA, GcvB	2
(AgvB)	2
abundant Hfq-interacting sRNAs	2
bacteriophage-derived regions of the EHEC genome	2
mRNA sequences	2
Shine-Dalgarno translation initiation sequence	2
repeated trinucleotide motifs of A-R-N (A-A/G-any nucleotide)	2
RNAs in enterohemorrhagic Escherichia coli (EHEC)	2
in vivo RNA sequence requirements	2
regulatory small RNAs (sRNAs)	2
core RNA chaperone	2
conserved FA DNA repair pathway	2
multisubunit monoubiquitin E3 ligase	2
in vitro reconstitution	2
FA core complex subunits	2
monoubiquitination module	2
three proteins (FANCB, FANCL, and FAAP100)	2
minimal subcomplex	2
catalytic FANCL E3 ligase subunit	2
native avian FA core complex	2
multisubunit FA core complex	2
impaired DNA repair pathway	2
DNA interstrand crosslinkers	2
presented antigens	2
antibody-producing plasma cells	2
best receptors	2
surface antibody	2
T cell	2
man-made vaccines	2
helper T cells and antigen-presenting B cells	2
long noncoding transcript	2
COOLAIR proximal splice acceptor site	2
FLC gene body histone demethylation	2
core spliceosome component PRP8	2
FLC promoter region	2
major sense transcript poly(A) site	2
set of long noncoding antisense transcripts	2
many genomes	2
individual Ub linkage types	2
endogenous LUBAC complex	2
unphosphorylated OTULIN	2
HOIP binding	2
PIM	2
Met1-polyUb signaling	2
LUBAC component HOIP	2
PUB domain	2
conserved PUB-interacting motif (PIM)	2
Met1-linked polyUb	2
deubiquitinase	2
nuclear factor κB (NFκB) transcription factor and other processes	2
Met1-linked “linear” Ub chains	2
XPF-ERCC1 nuclease specificity	2
vertebrate SLX4	2
 a synthetic replication fork	2
DNA crosslink	2
dual incisions	2
Mini-SLX4-XPF-ERCC1	2
DNA forks	2
XPF-ERCC1 nuclease activity	2
Recombinant mini-SLX4	2
DNA crosslinking agents	2
N-terminal domain of SLX4 (mini-SLX4)	2
contracted hematopoietic stem cell pool	2
epithelial cancers	2
Slx4-deficient mice	2
associated nucleases	2
three nucleases (XPF-ERCC1, MUS81-EME1, and SLX1)	2
in vivo RNF4	2
C-terminal RING domain	2
ubiquitin-E2-conjugating enzyme thioester complex	2
RING E3 ligases	2
potential diagnostic and therapeutic targets	2
H3K4me3 demethylase	2
DNA binding factor ETS-1	2
miR-31 promoter	2
haboring EMSY amplification	2
human breast samples	2
METABRIC cohort	2
antimetastatic microRNA	2
cells in vitro	2
sporadic breast and ovarian cancers	2
EMSY gene	2
Cdc45 replication factor	2
potential checkpoint factor	2
U2 snRNA	2
Cus2 protein	2
Ser5 of the largest subunit’s heptad repeat	2
intron-containing genes	2
in vivo RNA labeling	2
RNA-stimulated adenosine triphosphatase (ATPase)	2
Prp5 protein (Prp5p)	2
2-oxoglutarate/Fe(II) oxygenases	2
eRF1 NIKS motif	2
invariant lysine	2
Jumonji domain-containing 4 (Jmjd4), a 2-oxoglutarate- and Fe(II)-dependent oxygenase, catalyzes carbon 4 (C4) lysyl hydroxylation of eRF1	2
highly conserved sequence motifs	2
N terminus of eRF1	2
eukaryotic release factor 1 (eRF1)	2
release factor complex	2
peptidyl-	2
gaseous signals	2
central hubs	2
group VII ERFs	2
ABSCISIC ACID INSENSITIVE5 (ABI5)	2
N-end rule pathway	2
plant-specific transcriptional regulators, the group VII ethylene response factors (ERFs)	2
important signaling compound	2
SummaryNitric oxide (NO)	2
Atg1 kinase	2
isolation membrane	2
site of autophagosome formation	2
Phosphorylated Atg9	2
multimembrane-spanning protein Atg9	2
consensus peptide arrays	2
Atg1 kinase substrates	2
vacuole/lysosome	2
highly conserved intracellular trafficking pathway	2
favored kinase-phosphoacceptor combinations	2
favored substrate	2
PAK4-peptide complexes	2
threonine-specific kinase MST4	2
serine-specific kinase PAK4	2
multiple kinases	2
“DFG+1” residue	2
kinase activation segment	2
phosphoacceptor residue	2
many serine-threonine kinases	2
tyrosine or serine-threonine specific	2
xeroderma pigmentosum variant (XP-V) patient cells	2
Pol η-dependent pathway	2
PrimPol UV lesion bypass pathway	2
ultraviolet (UV) light-damaged DNA templates	2
Primase-Polymerase (PrimPol; CCDC111), an archaeal-eukaryotic primase (AEP) in eukaryotic cells	2
pristine DNA template	2
UV-induced pyrimidine-pyrimidone (6-4) photoproduct	2
damaged DNA templates	2
G2 phase cells	2
nuclear enzyme	2
two PrimPol-like (PPL) proteins	2
genomes of trypanosomatids, a group of kinetoplastid protozoa	2
DNA-dependent primase and/or polymerase activity	2
additional eukaryotic AEP-like proteins	2
DNA primase	2
single archaeo-eukaryotic primase (AEP)	2
increased H3K9me3	2
hypoxia-induced heterochromatin-like context	2
chromatin spreads	2
large structural proteins and nucleoside triphosphatases	2
site A3	2
RNA component of ribonuclease MRP	2
sequences flanking A3	2
snoRNAs U3, U14, snR30, and snR10	2
sequences flanking A2	2
pathway of 18S rRNA synthesis	2
sites A0–A2	2
C-terminal domain (CTD) of Rrp5	2
large, highly conserved ribosome synthesis factor Rrp5	2
numerous preribosomal RNA (pre-rRNA) binding sites	2
type I (Cascade) family	2
helical component	2
archaeon Sulfolobus solfataricus	2
conjugative plasmids in Staphylococcus epidermidis	2
DNA or RNA targets	2
Cas10 subunit	2
Type III complexes	2
three main types (I–III	2
CRISPR-associated (cas) genes	2
Interference complexes	2
Regularly Interspaced Palindromic Repeats (CRISPR) system	2
obligatory non-native disulfides	2
ER reductase	2
non-native disulfides	2
low-density lipoprotein receptor (LDLR)	2
one of the identified substrates	2
client repertoire	2
number of endogenous substrates	2
limited number of substrates	2
endoplasmic reticulum (ER) of mammalian cells	2
protein disulfide isomerase family of proteins	2
microtubule attachment sites	2
centromeres in G1 phase	2
Scc2–Scc4 cohesin loader	2
pericentromeric replication origins	2
Sld3–Sld7 replication initiator proteins	2
Ctf19 kinetochore complex	2
budding yeast Dbf4-dependent kinase (DDK)	2
microtubule attachment	2
psi-no-more (PNM) mutations	2
highly charged residues	2
one of a Gly-Gly pair	2
[PSI+].	2
N terminus of Sup35	2
one of the oligopeptide repeats (R2)	2
associated prion-based [PSI+] trait	2
prion protein Sup35	2
conserved genome defense system	2
insect and vertebrate piRNA pathways	2
somatic and germline cells	2
essential primary piRNA biogenesis factor	2
Many identified genes	2
ovarian somatic piRNA pathway	2
∼50 genes	2
small RNA silencing system	2
piRNA (PIWI-interacting RNA)	2
translating ribosomes	2
translation products	2
Listerin localization	2
80S complexes	2
Hbs1 function	2
60S-nascent chains	2
ubiquitin ligase Listerin	2
unique 60S-nascent chain-tRNA complex	2
ribosome recycling factors Hbs1/Pelota/ABCE1	2
Stalled 80S ribosome-nascent chain complexes	2
nascent proteins	2
defective translation products	2
Aberrant proteins	2
defective mRNAs	2
IFNγ target genes	2
STAT1-interacting protein	2
β-arrestin1 an essential negative regulator of STAT1 and IFNγ signaling (Mo et al., 2008)	2
scaffold protein β-arrestin1	2
tyrosine phosphatase TC45	2
transducer and activator of transcription 1 (STAT1)	2
 the Tet1 and Tet2 proteins	2
Ten-Eleven Translocation proteins Tet1 and Tet2	2
embryonic germ cell (EGC) lines	2
imprinted control regions (ICRs)	2
expression of loci	2
oncogenes	2
cell-cycle inhibitor p21	2
p14ARF tumor suppressor pathway	2
human Formin-2 (FMN2) protein	2
cyclin-dependent kinase inhibitor p21	2
ARF tumor suppressor	2
cytosol and mitochondria	2
proapoptotic BH3 proteins	2
photoactivatable GFP-Bax	2
nonapoptotic cells	2
cytosolic Bax	2
cytosol of nonapoptotic cells	2
proapoptotic Bcl-2 protein Bax	2
N-terminal phospho-SQ/TQ domain of 53BP1	2
Brca1-deficient cells	2
toxic nonhomologous end joining (NHEJ)	2
53BP1-dependent class switch recombination (CSR)	2
Rif1−/− mice	2
repetitive human genome	2
primate and human lineage-specific transposable elements	2
nearby transcripts	2
somatic and germline tissues	2
human chromosome 21	2
hundreds of locations	2
mouse nucleus	2
transposon-derived human regulatory regions	2
heterologous regulatory environment	2
almost complete single copy of human chromosome 21	2
transchromosomic mouse strain	2
long-term epigenetic memory (imprints, CpG islands on the X chromosome, germline-specific genes)	2
E16.5 PGCs	2
E6.5 epiblast	2
mouse primordial germ cells (PGCs) and preimplantation embryos	2
LC3C-specific interactions	2
aromatic residue	2
noncanonical LIR	2
remaining ATG8 orthologs	2
cells lacking either protein	2
autophagy receptor NDP52	2
ATG8 orthologs	2
ATG8 family	2
ATG8 on autophagosomal membranes	2
Autophagy receptors	2
core exosome	2
structured targets	2
stalled exosome substrates	2
oligoadenylated reads	2
cleavable proteins (split-CRAC)	2
Unspliced pre-mRNAs	2
CUT and SUT classes of non-coding RNA, snoRNAs and, most prominently, pre-tRNAs and other Pol III transcripts	2
wild-type Rrp44 and catalytic mutants	2
two structural subunits (Rrp41, Csl4) and a cofactor (Trf4) of the yeast exosome	2
nucleases (Rrp44, Rrp6)	2
noncanonical form of scurvy	2
sulfenic acid	2
H2O2-generating system	2
sulfenic acid donor	2
ER proteins	2
ER thiol oxidases	2
reticulum (ER) thiol oxidases	2
protein waste	2
pool of intracellular amino acids	2
yeast, mammalian cells	2
many cellular proteins	2
RNA, Hfq and RNase E.	2
5′-end of the cognate-pairing “seed	2
monophosphate group	2
defined site in a target RNA	2
sRNA	2
ternary complex of Hfq, sRNA and mRNA	2
target mRNAs	2
small non-coding RNAs (sRNAs) in bacteria	2
equal major pivot	2
gametes	2
Cdh15 and AK008011 loci	2
new imprinted gDMRs	2
fates	2
paternal alleles	2
gametes and preimplantation embryos	2
Transient and imprinted maternal germline DMRs (gDMRs)	2
maternally imprinted loci	2
 maternal-methylation free postimplantation mouse embryos (Dnmt3L-/+)	2
nucleosomal histones	2
nucleosome-occluded DNA sequences	2
two abundant classes of DNA binding proteins	2
histone octamers	2
SummaryTranscription factors (TFs) and	2
local signals	2
 MAPs	2
MT-bound Dcx	2
ADP-bound Kif1a motor domain	2
Dcx's linker sequence (e.g., W146C, K174E)	2
Vamp2, a cargo of Kif1a	2
structurally conserved paralogue, doublecortin-like kinase 1 (Dclk1)	2
kinesin-3 motor protein	2
growing family of microtubule (MT)-associated proteins (MAPs)	2
(Dcx)	2
viral factor	2
Ec RNAp	2
RNAp active center	2
RNAp-promoter interactions	2
RNAp-DNA interaction	2
amino-terminal σ70 domain region 1.1 (R1.1)	2
β′ jaw domain	2
Gp2-Ec β′ jaw domain complex	2
high-resolution solution structure	2
transcriptionally proficient promoter-complex (RPo) formation	2
β′ subunit	2
jaw domain of the Escherichia coli (Ec) RNA polymerase (RNAp)	2
non-DNA-binding transcription factor	2
T7 phage-encoded small protein Gp2	2
“residue-nucleotide” interaction map	2
Another glutamic acid	2
“ADP-switch” motif	2
divergent Walker A glutamic acid residue	2
conserved “R-hand” motif (RxDxxxR)	2
R-finger residue	2
AAA+ model	2
transcription activator PspF	2
ATPase protomers	2
nucleotide-binding pockets	2
oligomeric ATPases	2
proteins (ATPases	2
apoptosis-inactive/autophagy-inhibitory and apoptosis-active/autophagy-permissive sites	2
Bim and Beclin 1	2
dynein motor complex	2
mislocalizing Beclin 1	2
Beclin 1-LC8 interaction	2
autophagy regulator	2
Beclin 1	2
cell death-deficient Bim	2
cells and in vivo	2
dynein light chain 1 (DYNLL1/LC8)	2
proapoptotic BH3-only Bcl-2 family member	2
interaction networks and signaling pathways	2
signaling, development, and disease genes	2
distinct interaction partners	2
conserved binding motifs	2
posttranslational modification sites	2
disordered regions	2
tissue-specific protein segments	2
constitutive, tissue-specific, and other alternative exons	2
tissue-specific protein-coding exons	2
DISC model	2
 a functional DISC reconstitution model	2
procaspase-8 DED2	2
Mutating key interacting residues	2
caspase-activating chain	2
DED domains	2
procaspase-8 molecules	2
alternative DISC model	2
structural modeling	2
TRAIL-Rs or DED-only proteins	2
core DISC components	2
native TRAIL DISC	2
key multiprotein complex	2
conserved gradient-forming system	2
freely diffusible monomers	2
cell poles	2
ATP-bound MipZ dimers	2
polar ParB complexes	2
ATPase MipZ	2
determinants	2
spatial organization of cells	2
ATM-dependent protein phosphatase PPM1G	2
specific isoform of USP7 (USP7S)	2
USP7 itself	2
deubiquitylation enzyme USP7/HAUSP	2
Nijmegen breakage syndrome gene product	2
essential Rad51 recombinase at serine 14 (S14)	2
Polo-like kinase 1 (Plk1)	2
broken DNA	2
 other substrates	2
Prx Tpx1	2
abundant antioxidant enzymes	2
2-Cys peroxiredoxins (Prx)	2
Integrator and dephosphorylates Ser5	2
snRNA genes	2
 a CTD Ser5 phosphatase	2
Integrator subunits	2
phospho-Ser7 mark	2
RNA Pol II-associated protein 2 (RPAP2)	2
Pol II-transcribed small nuclear (sn)RNA genes	2
gene type-specific Integrator complex	2
transcription/RNA processing factors	2
Ser5, and Ser7	2
consensus Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7	2
multiple heptapeptide repeats	2
SummaryThe carboxy-terminal domain (CTD) of the large subunit of RNA polymerase II (Pol II)	2
core gene expression machinery	2
monomers RNMT and RAM	2
 a C-terminal RNA-binding domain	2
N-terminal RNMT-activating domain	2
previously uncharacterized protein	2
mammalian cap methyltransferase, RAM (RNMT-Activating Mini protein)/Fam103a1	2
obligate component	2
guanosine cap	2
7-methylguanosine cap	2
catenated and uncatenated DNAs	2
sister DNAs of circular but not linear minichromosomes	2
cohesin's three subunit interfaces	2
kb circular minichromosomes	2
MreB filaments	2
 a membrane-binding actin filament	2
double filaments	2
purified TmMreB	2
N-terminal amphipathic helix in EcMreB	2
membrane insertion loop	2
many, if not all, MreBs	2
T. maritima and E. coli	2
cell wall synthesis machinery	2
short filaments	2
bacterial cytoskeleton	2
actin MreB	2
core component	2
cFLIP isoforms	2
Ripoptosome assembly	2
Ripoptosome formation	2
RIP1, FADD, caspase-8, caspase-10, and caspase inhibitor cFLIP isoforms	2
Ripoptosome”	2
2 MDa intracellular complex	2
intracellular platform	2
cell death pathways	2
regulatory hot spot	2
RNAP “clamp” region	2
RNAP elongation complex	2
promoter-directed transcription	2
transcription elongation factor Spt4/5 overlap	2
TFE WH domain	2
TFE winged helix (WH) and Zinc ribbon (ZR) domains	2
promoter DNA, TBP, TFB, TFE, and RNAP	2
archaeal transcription initiation complex	2
fluorescently labeled recombinant M. jannaschii RNAP system	2
archaeal RNAP	2
eukaryotic RNAPII	2
archaeal homolog TFE	2
several Cln2-, Clb3-, and Clb2-specific Cdk1 targets	2
G1-specific targets	2
docking element	2
major budding yeast cyclins (the G1/S-cyclin Cln2, S-cyclin Clb5, G2/M-cyclin Clb3, and M-cyclin Clb2)	2
cyclin subunit	2
substrate docking sites	2
JNK1–Bcl-2 pathway	2
nNOS, iNOS, or eNOS	2
S-nitrosylation substrates, JNK1 and IKKβ	2
autophagosome synthesis	2
potent cellular messenger	2
Several autophagy regulators	2
cancer, and neurodegeneration	2
long-lived and aggregate-prone proteins	2
3′ cleavage poly(A) sites	2
5′–3′ exonuclease Xrn2	2
helicase protein	2
gene poly(A) signals	2
elongating Pol II	2
RNA/DNA hybrid structures (R-loops)	2
(Pol II)-transcribed genes	2
mammalian RNA polymerase II	2
p85 SH2 domains	2
pY-binding site	2
extended RTK motif	2
RTK's pYXXM motif	2
RTK phosphopeptides	2
cSH2, nSH2, and iSH2	2
three p85 domains	2
C-terminal region of the p110β catalytic subunit	2
cSH2 contact residue	2
p85 regulatory subunit	2
C-terminal SH2 domain (cSH2)	2
p110β/p85β complex	2
3-kinases (PI3Ks)	2
histone tetramer	2
two members of this class, Nap1 and Vps75	2
distinct class of histone chaperone	2
Nucleosome assembly proteins (Nap proteins)	2
dimer of H3 and H4	2
ubiquitous chaperone Asf1	2
SummaryHistone chaperones	2
DNA repair genes	2
SEN1 genetically	2
R loop structures	2
nontranscribed strand	2
hybrids	2
RNA protein complexes	2
RNA:DNA hybrids	2
Sen1 helicase	2
nonpolyadenylated as well as some polyadenylated RNA polymerase II transcripts	2
nonamyloidogenic human wild-type β2m (Hβ2m)	2
rare conformer	2
nonnative peptidyl-prolyl trans-isomer	2
nonnative amyloidogenic intermediate	2
truncation variant of the naturally amyloidogenic protein β2-microglobulin (β2m)	2
amyloidogenic intermediates	2
partially folded protein species	2
stalled transcription complexes	2
Mfd protein	2
Bacterial TCR	2
damage	2
transcription-independent “global” NER pathway	2
repressive chromatin	2
silent locus	2
G4 forming sequence	2
G4 forming sequences	2
G-quadruplex (G4) structures	2
daughter strands	2
constitutively expressed, endogenous yeast genes	2
3′ splice sites	2
Phosphorylated polymerase	2
serine 2	2
serine 5	2
carboxy-terminal domain of the paused polymerase large subunit	2
intron	2
two reporter genes	2
3′ end of the intron	2
junction substrates	2
active site metal ion	2
(5′)RNA-DNA(3′) junction	2
crystal structures of a type 2 RNase H	2
different in vivo substrates	2
single ribonucleotide	2
duplex DNAs	2
four ribonucleotides	2
RNA/DNA hybrids	2
classes of RNase H hydrolyze RNA	2
 nm chromatin fibers	2
bulk 30 nm chromatin fiber	2
Xi	2
facultative heterochromatin	2
Xa and the Xi	2
euchromatin and facultative heterochromatin	2
transcriptionally active (Xa) and inactive (	2
nucleolus and the Cajal body	2
two nuclear organelles	2
major nuclear pathways	2
SUMO targets	2
closely related Nop56 and 15.5K proteins	2
K467 and K497	2
Nhp2 and Nop58 (also known as Nop5)	2
combined in vitro and in vivo	2
small nucleolar ribonucleoprotein complexes (snoRNPs)	2
nucleolar SUMOylated proteins	2
large and small ribosome subunits	2
subnuclear organelle	2
palindrome-dependent hairpin intermediates	2
cruciform cleavage pathway	2
recombination protein RecA.	2
hairpin nuclease SbcCD	2
246 bp interrupted DNA palindrome	2
chromosome of Escherichia coli	2
DNA palindromes	2
 the structural elements	2
nucleotide-binding leucine-rich repeat receptors (NLRs)	2
Hsp90-Rar1-Sgt1 complexes	2
Hsp90-CS-CHORD ternary complex	2
CHORD and CS domains	2
plant Rar1 and Sgt1	2
separate but interacting proteins	2
mammalian melusin and Chp1	2
CS domains	2
CHORD domains	2
cysteine- and histidine-rich domains (CHORD)-containing protein Rar1	2
cochaperone Sgt1	2
NLR receptors	2
nonmethylated CpG islands	2
CpG DNA	2
nonmethylated CpG DNA	2
zinc finger CxxC (ZF-CxxC) domain	2
H3K36-specific lysine demethylase enzyme KDM2A.	2
enigmatic elements	2
promoters and gene regulatory units	2
nonmethylated cytosine/guanine base pairs (CpGs)	2
MR genes	2
ZNF711 and JARID1C	2
two other XLMR genes	2
XLMR gene PHF8	2
C. elegans PHF8 homolog	2
XLMR gene	2
subset of PHF8 target genes	2
another XMLR protein, ZNF711	2
PHD domain of PHF8	2
di- and monomethylated lysine 9 of histone H3 (H3K9me2/me1)	2
C. elegans homolog F29B9.2	2
XLMR protein PHF8	2
25S/5.8S rRNAs	2
27S precursor	2
20S pre-rRNA	2
 yeast pre-rRNA	2
20S precursor	2
early processing sites	2
35S primary transcripts	2
metabolically labeled cultures	2
prolonged replication blocks	2
HU-stalled forks	2
XRCC3 protein	2
cells of dNTPs	2
Hydroxyurea (HU)	2
binding sites at gene promoters	2
HtrA2 knockout cells	2
chemical inhibitor	2
WT1 binding partner	2
serine protease HtrA2	2
transcriptional regulator of genes	2
Wilms' tumor suppressor protein WT1	2
physical and functional links	2
late pre-60S ribosomes	2
family of exonucleases	2
 a catalytic domain	2
mature 5′ ends of 5.8SS and 25S rRNAs	2
previously unidentified 5′–3′ exonuclease	2
mature ribosomes	2
two helicases	2
protein blocks (primarily transcription complexes) in vivo	2
E. coli replisomes	2
blocking protein-DNA complex	2
blocked forks	2
SummaryNucleoprotein complexes	2
TM helix-destabilizing residues	2
recognition motif	2
rhomboid substrates	2
rhomboids	2
widespread rhomboid family of intramembrane proteases cleave transmembrane domain (TMD) proteins	2
preribosomal regions	2
target sequences	2
snoRNAs	2
release	2
modifications close to helix 34	2
six snoRNAs	2
catalytic point mutants	2
helix 34	2
Four major binding sites	2
helix 44	2
pre-rRNAs	2
18S and 25S rRNA regions	2
helicase Prp43	2
pre-rRNA-binding sites	2
different RNA helicases	2
selective kinase inhibitors	2
Nek9 noncatalytic C-terminal domain	2
tyrosine mutant	2
related kinase Nek6	2
Tyrosine mutants	2
tyrosine side chain	2
drug-like molecule	2
NIMA-related kinases	2
Nek6, Nek7, and	2
readthrough transcripts	2
short noncoding genes	2
pA sites	2
protein-coding genes in S. cerevisiae	2
molecular and mechanistic underpinning	2
DNA breathing	2
SWI/SNF and RSC	2
H3 K56	2
designer nucleosomes	2
defined acetylated lysine residues	2
histone octamers, nucleosomes, and nucleosomal arrays	2
genetically encoding acetyl-lysine	2
homogeneously and site-specifically acetylated recombinant histones	2
homogeneously acetylated histones	2
N- to C-terminal substrate	2
substrate-binding tyrosine loops	2
EM density maps	2
Hsp104 domains	2
first nucleotide-binding domain (NBD1)	2
cryoelectron microscopy maps	2
various cellular activities) cassette	2
(ATPases	2
yeast prions	2
ordered amyloid assemblies	2
amorphous aggregates	2
protein-remodeling machine Hsp104	2
PINK1-deficient cells	2
mitochondrial permeability transition pore (mPTP)	2
increased ROS	2
mitochondrial complex I and II substrates	2
glucose transporter	2
mitochondrial Na+/Ca2+ exchanger	2
physiologically that PINK1	2
PINK1-deficient mammalian neurons	2
mitochondrial kinase	2
individual chains	2
engineered mutations	2
articulated helical hairpin fold	2
one Cdc31 and two Sus1 chains	2
long, gently undulating α helix	2
central region of Sac3 (the CID domain)	2
crystal structure of Sus1 and Cdc31	2
nuclear pores (NPCs)—“gene gating”—that	2
yeast Sac3:Cdc31:Sus1:Thp1 (TREX-2) complex	2
aggregation-prone proteins	2
short-lived regulatory proteins	2
proteasome's proteases	2
Excess p62	2
largely distinct clients	2
ubiquitin-proteasome and autophagy-lysosome pathways	2
subkinetochore chromatin	2
Sim3 escort	2
CENP-ACnp1 receptor/assembly factor	2
budding yeast point centromeres	2
CENP-ACse4	2
unique hexameric nucleosome	2
intact CENP-ACnp1 chromatin	2
CENP-ACnp1 in vitro	2
centromere localization	2
ortholog of budding yeast Scm3Sc	2
Fission yeast sim1 mutants	2
weak or noncanonical pA signals	2
pA site	2
downstream terminator sequence	2
(pA) signal	2
active silencing complex	2
enhanced affinity anchor site	2
guide strand	2
seed sequence	2
guide-strand-target interactions	2
model PIWI/MID domain protein	2
reconstituted in vitro target recognition system	2
PIWI/MID domain of an Argonaute protein	2
guide RNA strand	2
“seed sequence”	2
auxiliary factors	2
conserved loops	2
2′O-methyl oligonucleotides targeting conserved loops (LooptomiRs)	2
landing pads	2
highly conserved loops	2
favorable cleavage site	2
loop of pri-miR-18a	2
microRNA precursor, pri-miR-18a	2
RNAP-σ54 closed complex	2
AAA+ activator	2
σ54 alone	2
activator proteins	2
closed complex	2
major variant sigma factor σ54	2
single-stranded form	2
open complexes	2
RNA polymerase (RNAP) and double-stranded promoter DNA	2
closed promoter complexes	2
pre-snoRNAs	2
snoRNA genes	2
exosome/Rrp6	2
alternative poly(A) polymerase Tfr4 adenylates major precursors and processing intermediates	2
“fail-safe” mRNA-like signal	2
main Nrd1/Nab3-dependent site	2
two classes of precursors	2
independently transcribed snoRNAs	2
nonpolyadenylated snoRNAs in yeast	2
major poly(A) polymerase Pap1	2
large cleavage and polyadenylation complex	2
stalled/blocked replication forks	2
ortholog of FANCM in fission yeast Fml1	2
model Holliday junctions	2
core complex component FANCM	2
FANCD2 and FANCI	2
(FA) core complex	2
repressive	2
cis-regulatory region	2
CTCF binding site	2
histone H3 phosphoacetylation	2
−2.4 kb element	2
noncoding RNA (LINoCR)	2
downstream enhancer	2
flanking enhancer elements	2
negative regulatory element	2
enhancer-blocking protein CTCF	2
bacterial lipopolysaccharide (LPS)	2
lysozyme gene	2
Ser13-Cdc37 in vivo	2
Hsp90 complexes in yeast and in human tumor cells	2
isolated Cdc37	2
chaperone-targeted protein phosphatase 5 (PP5/Ppt1)	2
nonspecific phosphatases	2
pSer13-Cdc37 in the H-C-K complex	2
ternary complex with Hsp90 and kinase (H-C-K)	2
binary complex with a kinase (C-K)	2
uncomplexed Cdc37	2
cochaperone protein Cdc37	2
Pygo-BCL9/Legless complex	2
cofactor (BCL9/Legless)	2
PHD finger (of Pygo)	2
PHD-HD1 complex	2
two different H3K4me peptides	2
PHD, HD1	2
ternary complexes	2
(H3K4me)	2
histone H3 tail methylated at lysine 4	2
cognate HD1 domains	2
human and Drosophila Pygo PHD fingers	2
normal and malignant cells	2
β-catenin/Armadillo	2
Wnt signal	2
Sin and other serine recombinases	2
robust model	2
synapsis mutants	2
helix-turn-helix DNA-binding domains	2
unexpected synaptic interface	2
Sin resolvase system	2
regulatory site synapse	2
synaptic complexes	2
properly oriented sites	2
negative supercoiling	2
interwound synaptic complex	2
serine recombinase family	2
many site-specific recombination systems	2
additional transcription factors (secondary effectors)	2
recipient transcription factors (primary effectors)	2
basal machinery	2
promoter-proximal nucleosome	2
c-fos promoter	2
second transcription factor, NFI	2
chromatin modifying complexes	2
periplasmic component	2
multidrug efflux pumps	2
periplasmic component of a drug efflux pump, AcrA.	2
contact point	2
shallow intraprotomer grooves in the TolC trimer	2
partially open state	2
Escherichia coli outer membrane protein TolC	2
outer membrane component	2
energy-activated pumps	2
membranes of Gram-negative bacteria	2
natural and artificial Pol II terminator sequences	2
RNA transcript	2
DNA-dependent RNA polymerases	2
3′LTR poly(A) signal	2
5′LTR poly(A) signal	2
synthetic element (SPA)	2
5′LTR promoter with CMV or the 3′LTR poly(A) signal	2
mutant or hybrid HIV-1 plasmids	2
3′LTR juxtaposition	2
RNA polymerase II elongation	2
5′LTR promoter and 3′LTR poly(A) signal	2
transcription-dependent gene loop structure	2
episomal plasmid in HeLa cells	2
chromosomal integrant	2
chromatin assembly factors	2
escort	2
centromeres in S and G2 phase-arrested cells	2
newly synthesized CENP-ACnp1	2
increased H3)	2
nucleoplasm	2
SHNi-TPR family	2
Hif1S. cerevisiae	2
known histone binding proteins NASPHuman	2
, centromeric chromatin	2
histone H3 variant CENP-ACnp1	2
USP1 knockout strain	2
 a noncleavable mutant	2
persistent PCNA monoubiquitination	2
constitutively chromatin-bound, monoubiquitinated FANCD2	2
FANCD2 and PCNA monoubiquitination	2
stable genetic system	2
USP1 in chicken cells	2
translesion polymerases	2
Stress granules (SGs)	2
stress-granule-like complex	2
I-dsRNA specifically	2
hyperedited dsRNA (I-dsRNA)	2
modified RNA itself	2
inosine (I)	2
adenosine (A) residues	2
RNA (ADARs)	2
adenosine deaminases	2
double-stranded RNAs (dsRNAs)	2
extended single-stranded regions	2
nascent and the parental strands	2
 model replication fork structures	2
yeast Rad5	2
damaged templates	2
discontinuities	2
Rad5-dependent postreplicational repair pathway	2
different Rad6-Rad18-dependent means	2
template DNA strand	2
UAA/UAG codons	2
different mitochondrial protein, mtRF1a	2
One human mitochondrial protein	2
ribosome (class II)	2
peptidyl-tRNA (class I)	2
13 polypeptides	2
hematopoietic PTB paralog ROD1	2
nPTB mRNA	2
nPTB exon 10	2
neuronally restricted nPTB	2
RNA substrate	2
repressive splicing regulator, polypyrimidine tract binding protein (PTB)	2
sites of substrate binding	2
GroEL itself	2
cysteines substituted	2
cysteine in a bound substrate protein	2
many parts of the central cavity	2
bound polypeptide	2
consecutive GroEL apical domains	2
resulting electron density maps	2
homogeneous subsets	2
nonnative malate dehydrogenase (MDH)	2
GroEL binary complexes	2
central cavity of an open ring	2
nonnative protein	2
regulatory layers	2
rich data sets	2
efficiently translated mRNAs	2
RNA polymerase II occupancy	2
exponentially growing fission yeast	2
key gene-expression intermediates	2
rereplicated DNA	2
small fragments of double-stranded DNA	2
recombinant Cdt1	2
licensing system	2
checkpoint pathways	2
licensing protein Cdt1	2
replication licensing system	2
interdisciplinary clinical team	2
chronic visceral and chronic neurovisceral ASMD	2
infantile neurovisceral ASMD	2
recombinant human ASM (olipudase alfa)	2
liver, spleen, cardiovascular, pulmonary, and neurological/developmental	2
major organ system involvement	2
various research and clinical fields	2
international group of ASMD experts	2
CNS and peripheral nerves	2
multiple organs including spleen, liver, lung, bone marrow, lymph nodes	2
gene encoding acid sphingomyelinase (ASM)	2
Glb1W274L mice	2
catalytic nucleophile of β-gal (β-gal−/−)	2
Glb1 gene (Glb1W274L)	2
common human missense mutation W273L	2
Morquio syndrome type B	2
mouse β-gal encoding gene, Glb1,	2
lysosomal hydrolase β-galactosidase (β-gal)	2
common co-morbidities	2
general population controls	2
several organ systems	2
selected comorbidities	2
PKU cohort	2
alopecia, urticaria, gallbladder disease, rhinitis, esophageal disorders, anemia, overweight, GERD, eczema, renal insufficiency, osteoporosis, gastritis/esophagitis and kidney calculus	2
18,455 matched, non-PKU controls	2
clinicians treating PKU patients	2
International Classification of Diseases, Ninth Revision (ICD-9) codes	2
United States insurance claims databases	2
adult PKU patients	2
various organ systems (e.g. dermatological, renal, respiratory, gastrointestinal, hematological, and others)	2
large databases	2
high and labile blood phenylalanine	2
newborn period	2
active moiety (PAA)	2
pre-prodrug GPB	2
older UCD patients	2
, PAA and PAGN	2
PBA, PAA, and PAGN	2
14)	2
nitrogen scavengers	2
urinary PAGN (UPAGN)	2
glutamine (PAGN)	2
active nitrogen scavenger phenylacetic acid (PAA)	2
phenylbutyric acid (PBA)	2
pre-prodrug	2
(caregivers	2
written emergency protocol	2
meal	2
alarm clock	2
26 countries	2
self-reported hepatic GSD.Results249 GSD patients	2
(caregivers of) patients	2
multiple countries	2
GSD patient organizations	2
ultra-rare disorders	2
Morquio A	2
vitro neutralizing antibodies (NAb)	2
antidrug-binding (total antidrug antibodies, TAb)	2
Thirteen patients	2
nursing assistance	2
elosulfase alfa infusions	2
additional patient	2
patient's sibling	2
elosulfase alfa 1.0 mg/kg once weekly (qw)	2
20)	2
patients with Morquio A syndrome	2
3 sequential doses of elosulfase alfa (0.1, 1.0, and 2.0 mg/kg/week	2
MOR-002 (ClinicalTrials.govNCT00884949) and MOR-100 (NCT01242111)	2
Morquio A syndrome	2
Morquio A syndrome (mucopolysaccharidosis IVA)	2
Elosulfase alfa	2
immunoglobulin E	2
12 participants	2
Allergy and Infectious Diseases	2
clinical National Institute	2
unaffected population	2
261 participants	2
pegvaliase-naïve participants	2
Phe to trans-cinnamic acid and ammonia	2
Pegvaliase, PEGylated recombinant Anabaena variabilis phenylalanine ammonia lyase (PAL)	2
placebo groups	2
pegvaliase group	2
pooled pegvaliase and pooled placebo groups	2
pooled placebo group	2
pooled (20 mg/day and 40 mg/day) pegvaliase group	2
20 mg/day placebo group	2
pegvaliase and placebo groups	2
PRISM-2 participants	2
RDT	2
adults with PKU.MethodsPRISM-2	2
adult phenylketonuria (PKU)	2
recombinant Anabaena variabilis phenylalanine ammonia lyase (PAL) enzyme	2
broad range of pediatric and adult central nervous system (CNS) disorders	2
intracerebroventricular (ICV), or intraventricular, devices	2
MDRI domain	2
dermatan sulfate	2
Multidimensional Fatigue Scale	2
Life Inventory	2
blinded groups	2
Twelve subjects	2
ultra-rare lysosomal disease	2
vestronidase alfa in mucopolysaccharidosis VII (Sly syndrome)	2
heterogeneous study populations	2
ultra-rare diseases	2
infantile versus juvenile gangliosidoses	2
juvenile gangliosidosis	2
infantile GM2-gangliosidosis cerebellar cortex	2
juvenile GM1-	2
infantile GM1-gangliosidosis	2
cerebellar cortex	2
corpus callosum, caudate and putamen	2
smaller brain substructures	2
enlarged cerebral cortex	2
cerebral cortex and other smaller structures)	2
gangliosidoses	2
Age-matched controls	2
total brain, and intracranial volumes	2
caudate, putamen, corpus callosum, ventricles	2
Cerebellar cortex and white matter	2
infantile, 5 juvenile)	2
childhood gangliosidoses	2
specific brain structures	2
hypophagia, cough, nasal congestion, rhinorrhea, rash/papule	2
controlled ammonia	2
types of UCDs	2
nitrogen scavengers)	2
nitrogen conjugation agents	2
2/5 patients	2
one splice-site	2
different pathogenic MTO1 variants	2
known MTO1 deficiency cases	2
two female siblings	2
high-energy demand tissues	2
evolutionarily conserved protein	2
MTO1 (Mitochondrial tRNA Translation Optimization 1)	2
previously reported subjects	2
abnormal in vitro aminoacylation assays	2
(p.Val174del)	2
(p.Ala154Val)	2
mutations c.461C	2
mitochondrial phenylalanine tRNA	2
patients with mucopolysaccharidoses	2
enough patients	2
multinational studies	2
children with neuronopathic mucopolysaccharidoses	2
families, and health care providers	2
MPS population	2
test manuals	2
internet resources	2
consensus panel	2
various age groups	2
Delphi panel	2
diverse protocols	2
early onset clinical phenotypes	2
MPS I, II, and III	2
brain in the mucopolysaccharidoses (MPS)	2
Sensitive, reliable measurement instruments	2
prebiotic GMP-MF	2
Tyr	2
intestinal microbes	2
GMP-MF.ConclusionsThe Tyr	2
ingestion of AA-MF	2
quinolinic acid	2
Trp in the kynurenine pathway	2
phenol sulfate	2
microbiome-derived compounds	2
gut origin	2
Tyr and Trp	2
neuropsychological tests	2
GMP-MF	2
24-h urine samples	2
plasma (n=18) and urine (n=9) samples	2
low-Phe diet	2
(GMP-MF).MethodsSubjects	2
glycomacropeptide medical foods	2
subjects with PKU consuming amino acid medical foods (AA-MF)	2
monoamine metabolites	2
Tyr and serotonin	2
monoamine neurotransmitters	2
drug compounds	2
promising in vitro model	2
embryonic-like stem cells	2
two types of NLSDM-iPSCs	2
c.541delAC	2
first patient	2
fibroblasts of two patients	2
NLSDM-induced pluripotent stem cells (NLSDM-iPSCs)	2
triacylglycerol lipolysis	2
wide variety of cell types	2
neutral lipid in organelles	2
patients in clinic	2
similar surveys	2
adequate clinic staffing	2
Freehauf et al., 2013)	2
(Vockley et al., 2014)	2
US	2
0–4years age group	2
clinics	2
Forty-four clinics	2
medical professionals	2
phenylketonuria (PKU) clinics	2
Eighteen patients	2
pediatric parent	2
Twenty-five patients	2
investigational triheptanoin (UX007)	2
deficient tricarboxylic acid (TCA) cycle intermediates	2
Anaplerotic metabolites	2
medium odd-chain fatty acid	2
potentially toxic fatty acid intermediates	2
-chain fatty acid oxidation disorders (LC-FAOD)	2
individual patient	2
skeletal radiographs	2
consensus of panel members	2
international panel of physicians	2
Asfotase alfa	2
recurrent fractures	2
gene encoding tissue-nonspecific alkaline phosphatase (TNSALP)	2
patients with NP-C	2
large combined cohort of patients with NP-C and controls	2
mixture of visceral, neurological and psychiatric items	2
second cluster	2
age sub-group	2
sign and symptom of NP-C.ResultsTwo main clusters of symptoms	2
5-year sub-groups	2
two sub-groups	2
NP-C cases and controls	2
early-onset NP-C and age-matched controls	2
two previously published cohorts	2
n=164)	2
combined patient cohort	2
BackgroundNiemann-Pick disease Type C (NP-C)	2
deficient TCA cycle intermediates	2
anaplerotic metabolites	2
MCT oil	2
cardiac support (ventilation, ECMO, vasopressors)	2
8 infants	2
critical emergencies	2
LC-FAOD patients	2
Long-chain fatty acid oxidation disorders (LC-FAOD)	2
velaglucerase alfa infusions	2
home setting	2
velaglucerase alfa clinical development program	2
trained and qualified medical personnel	2
scheduled infusions	2
initial infusions	2
home infusions	2
velaglucerase alfa	2
adipocyte lipids	2
lipodystrophy)	2
glucogenic hormone	2
C-terminal peptide of fibrillin-1	2
developing adipocytes	2
undifferentiated mesenchymal stem cells	2
genes encoding fibrillin-1 in vertebrates	2
three human fibrillin genes	2
FBN1-associated lipodystrophy	2
FBN1 gene	2
fibrillin-1 protein	2
FANTOM5 project	2
non-obese	2
adipose tissue of obese women	2
fat tissue	2
mouse fibrillin-1	2
Fbn1 gene	2
inbred mouse strains	2
depleted or abnormal adipose tissue	2
growth factor TGFβ	2
FBN1 gene in humans	2
large glycoprotein	2
digital microfluidics platform	2
fluorimetric assay	2
MS/MS assay	2
4-methylumbelliferyl substrates	2
comparable fluorimetric assays	2
6-enzymes	2
6 lysosomal enzymes	2
GAA (4.5), IDUA (13.6), GLA (18.2), SMPD1 (11.4), GBA (6.8), and GALC (25.0).DiscussionA 6-plex MS/MS assay	2
screen positive samples per 100,000 newborns	2
single MS/MS instrument	2
bench	2
screen positive samples	2
~43,000 de-identified dried blood spot (DBS) punches	2
α-galactosidase A (GLA), α-iduronidase (IDUA) and sphingomyeline phosphodiesterase-1 (SMPD-1))	2
activities (acid α-glucosidase (GAA), galactocerebrosidase (GALC), glucocerebrosidase (GBA),	2
developing Pompe, Mucopolysaccharidosis-I (MPS-I), Fabry, Gaucher, Niemann Pick-A/B, and Krabbe diseases	2
younger groups	2
aged ≥50	2
females than males of all groups	2
Successive age groups	2
untreated patients	2
Age groups	2
younger adults	2
G6PD enzymes	2
common polymorphism	2
glucose-6-phosphate dehydrogenase (G6PD)	2
Moderate/strong inhibitors of CYP isoenzymes	2
US patients	2
hepatic CYP enzyme family	2
Prescribed drugs	2
two national databases	2
cytochrome P450 (CYP) metabolizing medications	2
additional medications	2
pharmacotherapies	2
(GD1)	2
patients with Gaucher disease type	2
Genetic background	2
potentially harmful drug–drug interactions (DDIs)	2
UCD population	2
baseline ammonia	2
glycerol phenylbutyrate	2
adult and pediatric UCD patients	2
patients with urea cycle disorders (UCDs)	2
retrospective study	2
side effects	2
Gastrointestinal symptoms	2
7 subjects	2
11 affected subjects	2
n=16 subjects	2
-FAOD	2
total 24 patients	2
triheptanoin, a specialized medium odd chain (C7) triglyceride	2
largest cohort of patients	2
stored long-chain fatty acids	2
chain fatty acid oxidation disorders (LC-FAODs)	2
current ERTs	2
high mannose structures	2
mixture of sialylated glycans	2
agalsidase beta	2
various high mannose structures	2
α(1–3)-linked fucose or β(1–2)-linked xylose	2
mainly tri-mannose structures	2
Fabry mice	2
primary human Fabry fibroblasts	2
male Fabry mice	2
two commercially produced α-Galactosidase-A enzymes	2
cross-linked homo-dimer	2
BY2 Tobacco cell culture	2
lysosomal enzyme α-Galactosidase-A.	2
atypical PLAN subtype	2
One other patient	2
5 children	2
POLG-deficient liver cells	2
several mitochondrial genes	2
POLG mutated patients	2
mutant POLG	2
control and patient cell lines	2
several regulators	2
POLG gene	2
fibroblasts of five patients	2
several patients	2
widely used antiepileptic drug	2
important class of extracellular matrix proteins	2
closely related genes	2
alternative transcription start sites	2
MAZ, SP1, GTF2I and KLF4	2
several motifs	2
unique subset of transcription factors	2
candidate enhancer regions	2
22 LTBP2 promoters	2
embryonic and fetal tissues	2
lowest expressed gene	2
alternative promoters	2
range of mesenchymal and other cell types	2
different transcripts	2
single predominant transcription start site region	2
protein and nucleotide sequences	2
FANTOM5 CAGE database	2
seven gene family members	2
TGFβ family members	2
unique domain, the 8-cysteine transforming growth factor beta (TGFβ) binding domain	2
superfamily of extracellular matrix (ECM) proteins	2
fibrillins and latent transforming growth factor binding proteins (LTBPs)	2
MPS patient	2
sibling reports	2
patients with MPS	2
GAG catabolism	2
skeletal disease	2
MPS I, II, and VI	2
mucopolysaccharidoses (MPS)	2
Pompe disease patients	2
cultured skin fibroblasts	2
endogenous GAA	2
cross-reactive immunologic material (CRIM)-negative patients	2
infantile Pompe patients	2
infantile-onset form	2
deficiency of acid α-glucosidase (GAA; EC, 3.2.1.20)	2
36 patients	2
antibody positive patients	2
antibody-negative counterparts	2
antibody positive group	2
study visit	2
anti-idursulfase IgG antibodies	2
Thirty-two patients	2
intravenous idursulfase weekly	2
idursulfase administered intravenously	2
glutathione forms	2
free glutathione	2
oxidized glutathione forms	2
lymphocytes of patients	2
total and reduced glutathione	2
, plasma and erythrocytes	2
oxidized and reduced forms of glutathione	2
plasma and tissues	2
ABCD1 gene	2
two exon gene	2
one single patient	2
18 patients	2
three additional patients	2
ZNF469 and PRDM5	2
BCS affected patients	2
small joints	2
hyperelasticity of the skin	2
blue sclerae	2
Keratoconus or keratoglobus	2
PRDM5	2
retinal ganglion cell layer	2
heterozygous glucocerebrosidase mutation carriers	2
known and novel GBA1 variants	2
hitherto unknown pathogenic variants	2
GBA1 gene	2
Hcy, methionine, S-adenosylmethionine, and S-adenosylhomocysteine	2
“human only” (HO)	2
human CBS promoter	2
human CBS transgene	2
mouse cbs gene	2
new mouse model	2
CBS-deficient homocystinuria	2
cystathionine gamma-lyase	2
homocysteine (Hcy)	2
Cystathionine beta-synthase (CBS)	2
surviving cbs (−/−) mice	2
Moribund cbs (−/−) mice	2
Surviving cbs (−/−) mice	2
female cbs (−/−) mice	2
Hcy lowering compound betaine or the cysteine donor N-acetylcysteine	2
majority of mice	2
classical homocystinuria (Watanabe et al., PNAS 92 (1995) 1585–1589	2
knockout mouse model	2
Cystathionine beta-synthase (CBS) deficient homocystinuria	2
AdoCbl and CNCbl	2
cobalamin form	2
cobalamin	2
mutant protein MMACHC-R161Q	2
AC50’s for AdoCbl, MeCbl, (CN)2Cbi and OHCbl	2
CNCbl.	2
cobalamins	2
different cobalamins	2
apo forms	2
thermolabile proteins	2
MMACHC-wt and MMACHC-R161Q	2
either unbound or bound to different cobalamins (Cbl)	2
wild-type and mutant MMACHC proteins	2
late-onset cblC (MMACHC-R161Q)	2
Methylmalonic aciduria and homocystinuria, cblC type	2
truncated protein (p.Cys66LeufsX99)	2
mononucleotide repeat in exon 1	2
coding exons of the PCFT gene	2
Pakistani origin	2
consanguineous family	2
10 individuals	2
intestinal folate transporter PCFT	2
several mutant CBS proteins	2
different chaperones	2
purified I278T	2
chaperone glycerol	2
tetramer form of the enzyme	2
Rescuable mutants	2
three other mutant CBS proteins	2
cysteine-free media	2
yeast media	2
osmolyte chemical chaperones glycerol, trimethylamine-N-oxide, dimethylsulfoxide, proline or sorbitol	2
yeast on cysteine-free media	2
human mutant CBS proteins	2
cystathionine beta-synthase (CBS) gene	2
optimally grown E. coli	2
alternative steady-state solution	2
populations of non-linear large-scale kinetic models	2
stoichiometric model	2
optimally grown Escherichia coli	2
constructed kinetic models	2
underlying optimization problem	2
simpler stoichiometric models	2
types of models	2
target molecules in cells	2
Kinetic models	2
Large-scale kinetic models	2
labeled carbon	2
13C tracing	2
methanol auxotrophic strain	2
formaldehyde detoxification operon (frmRAB)	2
genes encoding for adenylate cyclase (cyaA)	2
best strains	2
xylose or ribose minimal media	2
heterologous enzymes from the ribulose-monophosphate (RuMP) pathway	2
pentose utilization	2
five-carbon (C5) sugars	2
natural gas and biogas-derived methane	2
bioproduction of chemicals	2
potentially attractive substrate	2
valuable plant derived products	2
linkers	2
heterologous ketocarotenoid intermediates	2
ketocarotenoids	2
(e.g. phoenicoxanthin, canthaxanthin and 3-OH-echinenone)	2
plant-based transient expression system	2
valuable ketocarotenoids	2
plant system	2
Nicotiana benthamiana	2
CRTZ and CRTW enzymes	2
N-terminal module	2
enzyme fusions	2
carotenoid pigments	2
fusion enzymes	2
vivo color complementation assays	2
pZ-W enzyme fusions	2
flexible linker sequences	2
non-endogenous intermediates	2
new to nature” enzyme fusions	2
3, 3ˈ β-carotene hydroxylase (CRTZ) and 4, 4ˈ β-carotene oxygenase (CRTW)	2
Several routes of intermediates	2
two hydroxyl and keto moieties	2
hydroxylase and an oxygenase enzyme	2
natural red colorant	2
high-value ketocarotenoid astaxanthin	2
native fatty acid synthesis pathway	2
introduced thioesterase	2
strain expressing sfp (phosphopantetheinyl transferase) and car (carboxylic acid reductase)	2
combined (C8–OH and C10–OH) titer	2
isopropyl myristate solvent overlay	2
optimal promoters and ribosomal binding sites	2
carboxylic acid reductase and C8-preferring fatty acyl-ACP thioesterase	2
Synechocystis sp.	2
first synthetic pathway	2
either long (C12-C18) or short (C2-C4) chain-length products	2
fuel, cosmetics, and health products	2
fatty acids and fatty alcohols	2
wide range of versatile carbon products	2
conventional anthocyanin production platforms	2
tobacco cell cultures	2
wide range of highly-decorated anthocyanins	2
13C-labelled anthocyanins	2
suitable system	2
small scale fermenters	2
conventional plant cell cultures	2
cell suspension cultures	2
novel anthocyanin, acylated cyanidin 3-O-(coumaroyl) rutinoside	2
cyanidin 3-O-rutinoside, delphinidin 3-O-rutinoside	2
tobacco lines	2
genes encoding biosynthetic enzymes	2
alternative sources	2
anthocyanins commercially	2
food and cosmetic industries	2
dietary context	2
many fruits and flowers	2
widely distributed, glycosylated, water-soluble plant pigments	2
carbohydrate mixtures	2
new biochemical pathways	2
new substrates	2
P. putida strain co-utilized xylose	2
products of E. coli xylA (xylose isomerase) and xylB (xylulokinase)	2
Escherichia coli proton-coupled symporter XylE.	2
Intracellular intake	2
broad substrate range quinone-dependent glucose dehydrogenase	2
gcd gene	2
dead end product D-xylonate	2
D-glucose	2
disaccharide	2
Thermobifida fusca	2
knocked-in β-glucosidase BglC	2
native proteins PP1015-PP1018	2
ABC complex	2
enzymatic complement of this strain	2
D-cellobiose and D-xylose metabolism	2
heterologous genetic modules	2
disaccharides and pentoses	2
biochemical network	2
organic acids, aromatic compounds and some hexoses (glucose and fructose)	2
original isolate	2
P. putida KT2440	2
genome-edited derivative of the soil bacterium	2
platform strain Pseudomonas putida EM42	2
glycolytic, pentose phosphate, TCA cycle, amino acid, and energy and cofactor metabolites	2
metabolome of seven industrial strains of E. coli	2
full length RIP-LC-MS/MS method (FullRIP)	2
central, amino acid, energy, nucleotide, and cofactor metabolism	2
102 metabolites	2
high-throughput quantitative metabolomics	2
other, ecologically important, traits	2
glycerol-based bioprocesses	2
re-engineered strains	2
HOG pathway	2
evolved lineages	2
multiple evolved lineages	2
necessary pathways	2
many alternative nutrient sources	2
model eukaryote Saccharomyces cerevisiae	2
realistic models of E. coli	2
small example	2
underlying metabolic model	2
rate-optimal solution set	2
yield-optimal solution set	2
original problem	2
linear-fractional program	2
mathematical theory	2
constraint-based modeling	2
metabolic yields	2
CEN.PK high-producing strain	2
p-CA	2
downregulated transporters	2
CEN.PK low and high-producing strains	2
deleted genes	2
amino acids and sugars	2
CEN.PK strain	2
S288c background	2
CEN.PK background	2
S288c or CEN.PK.We	2
two strain backgrounds	2
low- and high-producers of p-coumaric acid	2
transcriptome and intracellular metabolome	2
batch and chemostat cultivations	2
precursor of multiple secondary aromatic metabolites	2
targeted compound	2
robust and efficient cell factories	2
bioenergy crops	2
senesced plant biomass	2
co-express NahG and CatA	2
engineered plants	2
plastid-targeted versions of bacterial salicylate synthase (Irp9) and feedback-resistant 3-deoxy-D-arabino-heptulosonate synthase (AroG)	2
shikimate pathway	2
endogenous salicylic acid (SA) pool	2
plastid-targeted bacterial salicylate hydroxylase (NahG) and catechol 1,2-dioxygenase (CatA)	2
green factories	2
advantageous hosts	2
organic carbon skeletons	2
corrosive catalysts	2
petroleum-derived chemicals	2
polymer precursors	2
adipic acid, terephthalic acid, and caprolactam	2
industrially relevant chemicals	2
dicarboxylic acid	2
Muconic acid (MA)	2
FH-deficient cancers	2
human FH-deficient tumours	2
enzymes of the central carbon metabolism	2
potentially novel regulatory residues	2
functionally relevant phosphosites	2
putative regulatory phosphorylation-sites of metabolic enzymes	2
fumarate hydratase (FH) deficient cells	2
proteomics, phosphoproteomics, and metabolomics experiments	2
cost-competitively manufacture malonyl-CoA-derived compounds	2
source pathway	2
malonyl-CoA sink pathway	2
sensor-invertor	2
malonyl-CoA biosensors	2
sensor actuator	2
microbial cell factory	2
biocatalytic function	2
malonyl-CoA sensing capability	2
genetically-encoded metabolite sensor	2
transcriptional factor-based malonyl-CoA sensor	2
engineered biosystem	2
designed genetic/biomolecular circuits	2
internal cellular signal	2
Transcriptional factor-based biosensors	2
heterologous pathways	2
malonyl-CoA	2
fatty acids, phenylpropanoids, flavonoids and non-ribosomal polyketides	2
range of important compounds	2
basic building block	2
Malonyl-CoA	2
community contributions	2
bioinformatics and cheminformatics community	2
design, build, test and learn pipeline	2
biological engineer bench desk	2
large combinatorial retrosynthesis design space	2
novel design tools	2
next generation compounds	2
chemical repertoire	2
industrial biotechnology	2
previously inaccessible natural products and analogs	2
plant synthetic biology	2
medicinally important bioactives	2
suite of bespoke triterpene analogs	2
new-to-nature	2
suites of molecules	2
multi-gene constructs	2
gram-scale quantities of purified triterpene	2
triterpenes, one of the largest and most structurally diverse families of plant natural products	2
yeast platform	2
wealth of genes	2
plant genomics	2
source species	2
corresponding alcohols	2
exogenous acetate, propionate and butyrate	2
aor1+2 double knockout strain	2
role of each gene	2
aor and adhE isoforms	2
acetogen	2
bi-functional aldehyde/alcohol dehydrogenase (AdhE)	2
aldehyde: ferredoxin oxidoreductase (AOR) and alcohol dehydrogenase	2
industrial waste gases	2
fuel ethanol	2
Clostridium autoethanogenum	2
acetogenic bacteria	2
bubble reactor	2
recycling enzyme	2
cofactor supply	2
five enzymes	2
oxidative pathway of uronic acids	2
vitro reaction set-up	2
natural product	2
chemical building block	2
central intermediate	2
α-Ketoglutarate (aKG)	2
prokaryotic metabolic networks	2
organic cofactors	2
models of Mycobacterium tuberculosis	2
missing biosynthetic pathways	2
universally essential cofactors	2
vast array of publications	2
enzyme-cofactor association data	2
large-scale gene essentiality datasets	2
71 manually curated genome-scale models	2
especially cofactors and prosthetic groups	2
pool of other organic molecules	2
core biomass components	2
macromolecular building blocks	2
important chemical	2
chassis	2
increased n-butanol titres	2
rex and hydA	2
1,3-propanediol synthesis	2
hydA (hydrogenase), rex (Redox response regulator) and dhaBCE (glycerol dehydratase)	2
pivotal genes	2
first reported in-frame deletion mutants	2
robust tool kit	2
ethanol and 1,3-propanediol	2
Clostridium pasteurianum	2
industrially important chemical and potential liquid transportation fuel	2
by-product of the biodiesel industry	2
energy and fuels	2
renewable routes	2
fossil fuel reserves	2
model enzyme - renilla luciferase	2
inducible expression system	2
wild-type Pgrac(σA) promoter	2
several promoters	2
B. subtilis promoter library	2
improved system	2
B. subtilis 168 cell-free system	2
0.8µM GFP	2
improved B. subtilis WB800N-based system	2
several B. subtilis-based cell-free systems	2
industrial importance	2
established model organism	2
Gram-positive soil bacterium, Bacillus subtilis	2
genetic logic circuits and biosynthetic pathways	2
DNA regulatory elements	2
systematic design context	2
Cell-free transcription-translation systems	2
anchor reactions	2
isocitrate lyase (EC 4.1.3.1) and L-tryptophan indole-lyase (EC 4.1.99.1)	2
currently known biochemical reaction space	2
two or more molecules	2
cellular biochemical repertoire	2
renewable carbon sources	2
Microbial cell factories	2
lignocellulosic materials	2
lipid-overproducing strain	2
endogenous xylulokinase	2
Scheffersomyces stipitis	2
xylitol dehydrogenase	2
xylose reductase	2
lipids or citric acid	2
major pentose	2
microbial oils and organic acids	2
range of products	2
biotechnological chassis	2
engineered strains	2
bacterial system	2
eukaryotic systems	2
promising source of oils	2
Oleaginous yeasts	2
Microbial oils	2
protein inclusions	2
vast majority of tagged proteins	2
dense protein aggregates	2
targeting peptides	2
un-tagged enzymes	2
fused enzymes	2
1,2-PD producing strains	2
empty BMC	2
glycerol dehydrogenase, dihydroxyacetone kinase, methylglyoxal synthase and 1,2-propanediol oxidoreductase	2
N-terminal targeting peptides	2
starting material	2
1,2-PD synthesising factory	2
Pdu BMC	2
targeting sequences	2
BMC	2
propionic acid	2
1,2-propanediol (1,2-PD)	2
Bacterial microcompartments (BMCs)	2
chemicals in S. cerevisiae	2
native transporter	2
genes in competitive pathways	2
ATP-binding cassette (ABC) transporter PDR12	2
competing pathways	2
native Ehrlich pathway	2
model eukaryotic microorganism of industrial significance	2
chemical industry	2
value-added products	2
versatile platform intermediates	2
Short branched-chain fatty acids (SBCFAs, C4-6)	2
acetyl-CoA carboxylase encoding gene ACC1	2
post-translational de-regulated version	2
precursor malonyl-CoA	2
4.85±0.31mgL−1 resveratrol	2
3-deoxy-D-arabino-heptulosonate-7-phosphate and ARO7 encoding chorismate mutase	2
over-expressed feedback-insensitive alleles of ARO4 encoding	2
2.73±0.05mgL−1 resveratrol	2
tyrosine ammonia-lyase from Herpetosiphon aurantiacus, 4-coumaryl-CoA ligase from Arabidopsis thaliana and resveratrol synthase from Vitis vinifera	2
tyrosine intermediate	2
expensive substrates, p-coumaric acid or aromatic amino acids	2
food supplement and cosmetic ingredient	2
natural antioxidant compound	2
flavonoids, polyphenols, and polyketides	2
p-coumaric-acid derived secondary metabolites	2
attractive platform host	2
developed S. cerevisiae strain	2
aromatic compound	2
Δpdc5Δaro10 strain background	2
tyrosine ammonia-lyase TAL from Flavobacterium johnsoniaeu, DAHP synthase ARO4K229L, chorismate mutase ARO7G141Sand E. coli shikimate kinase II (aroL)	2
p-coumaric acid of 1.93±0.26gL−1	2
bifunctional chorismate synthase-flavin reductase Aro2p	2
pentafunctional enzyme Aro1p	2
aromatic amino acid pathway	2
shikimate kinase	2
chorismate mutase	2
different versions of feedback-resistant DAHP synthase	2
ARO10 and pyruvate decarboxylase PDC5	2
phenylpyruvate decarboxylase	2
p-coumaric acid-overproducing Saccharomyces cerevisiae platform strain	2
polyphenols, flavonoids, and some polyketides	2
valuable chemical building block	2
aromatic amino acids	2
p-Coumaric acid	2
active pharmaceutical or nutraceutical ingredients	2
diverse biological functions	2
numerous plant secondary metabolites	2
Aromatic amino acids	2
controlled fed-batch fermentation	2
Bacillus cereus	2
novel β-alanine-pyruvate aminotransferase	2
synthetic pathway	2
metabolic modeling	2
β-alanine biosynthetic route	2
efficient cell factory	2
superabsorbent polymers and acrylic plastics	2
potential chemical building block	2
3-Hydroxypropionic acid (3HP)	2
global CO2 emissions	2
plastic monomers	2
organic acid and aldehydes by living cells	2
3-hydroxypropionic aldehyde (reuterin)	2
SFA1 gene encoding S-(hydroxymethyl)glutathione dehydrogenase	2
S. cerevisiae strains	2
robust cell factories	2
industrial-scale production	2
biodegradable polymers	2
sustainable acrylates	2
Biologically produced 3-hydroxypropionic acid (3HP)	2
phytyl ester synthase	2
Wax esters	2
Nicotiana benthamiana leaves	2
chloroplast targeted fatty acyl reductases (FAR) and wax ester synthases (WS)	2
lubricant and surfactant production	2
diverse industrial uses	2
Wax esters and fatty alcohols	2
petrochemical derivatives	2
lipid compounds	2
future bio-based economy	2
acyl-CoA-dependent Δ6-desaturase	2
several novel triacylglycerol species	2
microalga	2
docosahexaenoic acid content	2
heterologous elongase	2
endogenous fatty acid biosynthetic pathway	2
Ostreococcus tauri	2
picoalga	2
high value omega-3 long chain polyunsaturated fatty acid docosahexaenoic acid (DHA)	2
diatom Phaeodactylum tricornutum	2
transgenic seed oil	2
minimal gene set	2
high value polyunsaturated fatty acid docosahexaenoic acid	2
eicosapentaenoic acid in Arabidopsis seeds	2
neutral, polar and acyl-CoA pools	2
non-native long chain polyunsaturated fatty acids in transgenic plants	2
differentiating hDPCs	2
complexes in hDPC conditioned medium	2
STC2 and PAPP-A	2
stanniocalcin-2 (STC2- a recently discovered inhibitor of PAPP-A)	2
IGF-2 (an activator of PAPP-A)	2
differentiating cell cultures	2
- an IGFBP-4 proteinase)	2
pregnancy associated plasma protein-A (PAPP-	2
IGFBP-4 expression	2
abundantly expressed IGFBP species	2
components of the IGF axis	2
exception of IGF1 and IGFBP1	2
differentiating human dental pulp cells (hDPC)	2
IGFBP proteases)	2
relevant ancillary proteins	2
genes in the axis	2
bone and other tissues	2
foetal and adult skeleton	2
IGF1 and IGF2	2
several IGFBP proteases	2
six soluble high affinity IGF binding proteins (IGFBP1-6)	2
two cognate cell surface receptors (IGF1R and IGF2R)	2
two growth factors (IGF1 and IGF2)	2
cardiopulmonary system	2
VEGF-A promoter HRE region	2
mutants (C218A; C221A)	2
VEGF-A expression	2
39 kDa form	2
HRE region	2
fetal lung	2
FDLE cultured	2
adjacent 3′ sites	2
hypoxia response element (HRE)	2
VEGF-A promoter	2
regions of the rat and human	2
nuclear sub-population of Spry2	2
16HBE14o-)	2
immortalised human bronchial epithelial cells	2
primary fetal distal lung epithelial cells (FDLE)	2
vascular endothelial growth factor-A (VEGF-A)	2
fibroblast growth factor-10 (FGF-10)	2
primary cue	2
developing mammalian lung	2
tubular growth	2
Sprouty2 (Spry2)	2
different branches of the N-acetylgalactosaminyltransferase	2
sequence of ActR-IIB	2
EA2 peptide	2
X. laevis embyrogenesis	2
GALNT16 (GALNTL1) genes	2
human GALNT6	2
African clawed frog (Xenopus laevis)	2
two N-acetylgalactosaminyltransferases (xGalNAc-T6 and xGalNAc-T16)	2
mammalian forms of these enzymes	2
large family of polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts)	2
mucin-type O-linked glycans in animals	2
hydrological barriers	2
less viable gametes	2
Thermally challenged salmonids	2
natal spawning sites	2
endogenous energy stores	2
capital breeders	2
ecosystems and human societies	2
migratory keystone species	2
migratory fish species	2
river systems	2
carotenoid metabolism pathways	2
carotenoid-based ornaments	2
cichlid fishes (Perciformes: Cichlidae)	2
proximate mechanisms	2
Carotenoid pigments	2
Animal colors	2
mammalian epitopes	2
similar genes	2
putative orthologues	2
Abundant NOS2 mRNA	2
NOS3 antibody staining	2
exogenous cyclic GMP	2
variety of nitrodilators	2
model and non-model fish species	2
endothelial NO synthase (NOS3)	2
structural (immunohistochemistry of skeletal muscle	2
non-mammalian vertebrates	2
inhalation	2
inhaled NO	2
long-lived tissue metabolites	2
cardiac S-nitrosothiols and NO-hemes	2
blood, liver and kidney	2
S/N-nitroso compounds and NO-hemoglobin in blood	2
S-nitrosothiols, N-nitrosamines and NO-heme products	2
blood (plasma and erythrocytes) and tissues (heart, liver, lung, kidney and brain)	2
ppm NO	2
major NO metabolite classes	2
tissue NO metabolites	2
heart and other organs	2
pre-eclampsia	2
important reservoir of NO bioactivity	2
mitochondrial bc1 complex	2
potential NiR enzymes xanthine oxidoreductase, mitochondrial aldehyde dehydrogenase	2
sGC inhibitor ODQ	2
scavengers (cPTIO and oxyhemoglobin)	2
arteries and veins	2
nitrite reductase	2
NO–sGC	2
isolated pre-constricted chorionic plate arteries (CPAs) and veins (CPVs)	2
wire myography	2
uncomplicated pregnancies	2
human placental blood vessels	2
local tissue metabolites	2
placental vasculature	2
variety of disease models	2
Ironwood Pharmaceuticals	2
novel, orally available sGC stimulators	2
NO-sGC-cGMP signaling	2
small molecule drugs	2
sGC stimulators	2
cardiovascular, pulmonary, renal, gastrointestinal, central nervous system, and hepatic pathologies	2
signaling system	2
prosthetic heme group of sGC	2
gasotransmitter	2
guanosine-5′-triphosphate (GTP) to cyclic guanosine-3′,5′-monophophate (cGMP)	2
Nitric oxide (NO)-sensitive soluble guanylyl cyclase (sGC)	2
treatment RXNO	2
Salivary RXNO	2
EBC nitrate or nitrosation products (RXNO)	2
dietary nitrate	2
EBC nitrite	2
low and high-nitrate groups	2
saliva and exhaled breath condensate (EBC)	2
low-nitrate ‘placebo’	2
beetroot-based high-nitrate supplement	2
healthy adult volunteers	2
native lowlanders	2
high-altitude dwellers	2
Tibetan highlanders	2
weight-adjusted systemic NO synthesis	2
base RUSF group	2
RUSF-Arg/Citr group	2
asymmetric dimethylarginine	2
plasma arginine	2
ion-exchange elution (Biochrom-30, Biochrom, UK)	2
Plasma amino acids	2
weekly chloroquine	2
daily chloroquine	2
RUSF+Arg/Citr (Arg, 0.2  g/kg/day; Citr	2
SCD.MethodsSixteen children	2
SubjectsTwenty-nine children	2
daily ready-to-use supplementary food (RUSF) fortified with arginine (Arg) and citrulline (Citr) vs. non-fortified RUSF	2
olfactory bulbs and cultured neuroblastoma cells	2
Nos3 protein	2
murine Nos3as NAT	2
important gaseous neurotransmitter nitric oxide (NO)	2
mRNAs encoding nitric oxide synthase (NOS)	2
specific examples	2
long natural antisense transcripts (NATs)	2
protein conformational landscape	2
related diflavin oxidoreductase cytochrome P450 reductase	2
three tissue specific nitric oxide synthase (NOS) isoenzymes	2
NO3−-rich beetroot juice	2
used NO3−-rich beetroot juice	2
nitrite NO3−, and NO	2
salivary NO2−	2
beetroot juice	2
NO3− rich beetroot juice	2
46 subjects	2
antimicrobial NO	2
cariogenic bacteria	2
salivary nitrate	2
reduced forms nitrite (NO2−) and nitric oxide (NO)	2
inorganic nitrate (NO3−)	2
heart, lungs, kidney, brain and liver	2
several tissues	2
plasma, lung, heart and liver	2
NOx species	2
total nitrate and nitrite species (NOx)	2
i.v. or i.n.	2
SNO groups	2
intravenous (i.v.) and intranasal (i.n.)	2
new GSNO analogues	2
varying ratios of S-nitrosothiol (SNO) moieties per molecule	2
novel analogues of S-nitrosoglutathione (GSNO)	2
S-nitrosophytochelatins (SNOPCs)	2
elusive Fe(II)-nitrite adduct	2
two isomers	2
globins	2
nitrite adducts	2
nitrite adducts of globins	2
COX-2, and gp91phox	2
iNOS/sGC/PKG pathway	2
CYP4A1 mRNA	2
iNOS and COX-1 mRNA and protein expression	2
s.c.	2
20-hydroxyeicosa-6(Z),15(Z)-dienoic acid	2
competitive antagonist	2
COX-1 protein expression	2
iNOS mRNA	2
LPS-treated rats	2
arachidonic acid in renal microsomes	2
6-keto-PGF1α	2
gp91phox, p47phox (NOXO2; organizer subunit of gp91phox), and nitrotyrosine (an index for peroxynitrite production)	2
phosphorylated vasodilator stimulated phosphoprotein	2
iNOS-heat shock protein 90 complex formation	2
COX-1 and CYP4A1 mRNA and protein expression	2
iNOS and COX-2	2
renal and cardiovascular tissues of rats	2
COX-1 and CYP4A1	2
iNOS, soluble guanylyl cyclase (sGC), protein kinase G (PKG), COX-2, gp91phox (NOX2; a superoxide generating NOX enzyme)	2
4A1-derived 20-HETE and CYP2C23-dependent antiinflammatory mediator formation	2
proinflammatory mediators	2
cyclooxygenase (COX)-2-derived vasodilator prostanoids	2
inducible nitric oxide (NO) synthase (iNOS)-derived	2
endotoxemic mice	2
stable synthetic analog of 20-hydroxyeicosatetraenoic acid (20-HETE), N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine (5,14-HEDGE)	2
KCl capsules	2
[nitrite] and [nitrate]	2
blood, saliva and urine samples	2
brachial artery	2
8mmol KCl	2
8mmol KNO3)	2
oral inorganic nitrate	2
pathogenic stimulus	2
entero-salivary circulation	2
endogenous NO biosensor	2
guanylyl cyclase	2
single endothelial cells and neurones	2
novel biosensors	2
synthase enzyme	2
NO-activated guanylyl cyclase	2
electrodes in cells and tissues	2
guanylyl cyclase-coupled receptors	2
functional Gγ	2
less sporangia	2
Pigpg1-silenced lines	2
gene encoding the Gβ subunit, Pigpb1	2
non-oomycete Gγ subunits	2
P. infestans	2
gene encoding a Gγ subunit	2
heterotrimeric G-protein subunits Gα and Gβ	2
notorious plant pathogen	2
additional phenotypes	2
Cyp51A-independent and Cyp51A-dependent, azole resistance mechanisms	2
A. fumigatus in this patient	2
microevolution	2
Galleria mellonella infection model	2
certain drug resistant isolates conidiation	2
Poor conidiation	2
various antifungal stressors	2
itraconazole, voriconazole and/or posaconazole resistant	2
azole susceptible	2
first 2 strains	2
non-synonymous mutations	2
non-synonymous single nucleotide polymorphisms	2
single chronic granulomatous disease patient	2
A. fumigatus strains	2
A. fumigatus in patients	2
specific niche environments	2
diversity of truffles in this region	2
indicum and Tuber cf.	2
distinct lineages, Tuber cf.	2
(SSR) markers	2
Internal transcribed spacer (ITS) and simple sequence repeat	2
Tuber indicum complex	2
number of specimens	2
edible ascocarps	2
ectomycorrhizal ascomycete	2
Tuber indicum	2
single particular amino acid	2
analysed aminotransferases	2
proteinogenic amino acid	2
aromatic amino acids and lysine	2
l-Lys, Phe and Tyr biosynthesis	2
histidine, lysine, and aromatic amino acids	2
aminotransferases	2
versatile enzyme	2
ARO8, ARO9, YER152C, and BNA3 genes	2
different and rapidly changing environments	2
key sources of nitrogen	2
Amino acids	2
unwounded cells	2
wheat pathogen Zymoseptoria tritici cellular ATP	2
peroxisome-derived Woronin bodies (WBs)	2
perforate septa	2
hyphal cells	2
direct environment	2
strictly anaerobic oral bacteria	2
16S rDNA sequencing	2
specific mitochondrial respiration inhibitor Antimycin A	2
several non-albicans Candida species	2
C. albicans specific	2
dissolved oxygen (dO2)	2
oxygen sensors	2
strictly anaerobic species	2
young oral biofilms	2
often observed and investigated fungal species	2
healthy oral ecosystem	2
planta growth	2
pathogenicity and virulence mutants	2
epiphytic fungi	2
planta observations	2
leaf-surface growth	2
computer simulation	2
internal versus external growth	2
fungal stains	2
extended epiphytic growth	2
early entry	2
GFP-tagged Z. tritici	2
Septoria leaf blotch	2
new set of molecular tools	2
wildtype strain IPO323	2
homologue of the ubiquitin-like autophagosomal protein Atg8	2
peroxisomal import signal	2
mitochondrial acetyl-CoA dehydrogenase	2
LifeAct actin-binding peptide	2
histone H1 homologue	2
ER signalling and retention peptide	2
plasma membrane-located Sso1-like syntaxin	2
codon-optimised version of GFP (ZtGFP)	2
either enhanced green-fluorescent protein (eGFP)	2
actin cytoskeleton, peroxisomes and autophagosomes	2
plasma membrane, endoplasmic reticulum (ER), chromosomes	2
set of 17 vectors	2
fluorescent organelle markers	2
cellular roles	2
fungal model system Ustilago maydis	2
XlnR Knock-out strain	2
mixed culture	2
aspergilli	2
XlnR knock-out strains	2
stable mixed microbial system	2
mixed colonies	2
two fungi in wheat bran	2
various enzymes (e.g. pectinases, amylases) and metabolites (e.g. citric acid)	2
two filamentous fungi	2
A. niger and A. oryzae	2
produced bioactive molecules	2
natural and man-made environments	2
heterogeneity	2
heterogeneous population of conidia	2
single colony of A. niger	2
conidia on a conidiophore	2
hydrophobic moving object	2
8-day-old conidia	2
older spores	2
cell wall of 2-day-old conidia	2
5- and 8-day-old spores	2
metabolic probe Tempone	2
Pigmented conidia	2
asexual reproductive structures	2
Conidia of Aspergillus niger	2
ascomycete Aspergillus nidulans	2
basidiomycete Ustilago maydis	2
fungal hypha	2
fungal cell’s inventory	2
Peroxisomes (POs)	2
sorbic acid	2
cytochrome c oxidase	2
SHAM, salicylhydroxamic acid	2
resting conidia	2
presence of transcripts	2
intracellular polyol, trehalose	2
Resting conidia	2
Aspergillus niger conidia	2
M. oryzae	2
reporter strain	2
cytoplasm during mitosis)	2
GFP-NLS	2
novel mitotic reporter strain	2
T. reesei and the other fungi	2
CAZy transcripts	2
biomass in the mixed cultures	2
enzyme activities	2
minority of the mixed culture filtrates	2
mycelial biomass of A. niger	2
secondary metabolite producing gene clusters	2
highly induced genes in mixed cultures	2
T. reesei CAZy transcripts	2
two-species mixed culture	2
small subset of P. chrysogenum CAZy genes	2
respective straw monocultures	2
majority of the mixed cultures	2
carbohydrate active enzyme (CAZy) encoding transcripts	2
RNA-seq reads	2
species-specific rRNA	2
wild-type strains of Aspergillus niger, Trichoderma reesei and Penicillium chrysogenum in two and three mixed species shake-flask cultures	2
mixed communities	2
nature fungi	2
lignocellulose mixed cultures	2
lignocellulose saccharification	2
better cocktails	2
one or two chromosomes	2
genomic background of the other strain (Fo47)	2
Fol4287 chromosomes	2
chromosomes of this strain	2
RFP-tagged histones	2
parental genomes	2
hybrid offspring	2
marker histones (GFP- and RFP-tagged)	2
single nucleus	2
parental lines	2
F. oxysporum	2
viable heterokaryotic hyphae	2
incompatible strains	2
incompatible strains of Fusarium oxysporum	2
conidial anastomosis	2
asexual fungal pathogens	2
unbranched and branched hyphae	2
sister nuclei	2
aneuploidy of ChrR.	2
multiple nuclei	2
multiple nucleoli	2
ribosomal RNA genes	2
extrachromosomal molecules	2
nucleolar fragments	2
mononuclear cell compartments	2
filaments called hyphae and pseudohyphae	2
commensal yeast, Candida albicans	2
high-quality toolbox	2
novel technologies	2
unusual classes of BGCs	2
novel algorithms	2
fungal genomes	2
widely different compounds	2
enzyme (super)families	2
evolutionarily related species and isolates	2
BGCs	2
biosynthetic gene clusters (BGCs)	2
chemical structures	2
fungal natural products	2
accompanying specialized metabolic diversity	2
fungal taxonomic diversity	2
Fungal natural products	2
specific sites in cells	2
Chs2 on the serine at position 222	2
septa of yeast and hyphae	2
YFP-tagged versions of the class I chitin synthases	2
yeast and hyphal cells	2
chitin synthases	2
C. albicans class	2
chs2Δchs8Δ mutant	2
two class I enzymes, Chs2 and Chs8	2
polarized tips of growing buds and hyphae, and sites of septation	2
three different enzyme classes	2
four chitin synthases	2
dysfunctional plc-1 gene	2
plc-1 gene	2
phospholipase C inhibitor 3-nitrocoumarin	2
plasma membrane H+-ATPase	2
fluorescence dye FM4-64	2
wildtype and KO plc-1	2
gene product non-functional	2
RIP mutated strain (RIP plc-1)	2
knockout mutant (KO plc-1)	2
tip-localized phospholipase C	2
internal stores	2
growing tips	2
phospholipase C	2
filamentous fungus Neurospora crassa	2
antifungal drugs	2
Slt regulatory pathway	2
pezizomycotina subphylum	2
limited phylogenetic distribution	2
SltB	2
VPS pathway	2
SltA and SltB	2
Slt and Vps pathways	2
SltB protein	2
slt loci	2
single slt mutants	2
sltA sltB double null mutants	2
kinase HalA	2
sltΔ mutants	2
cation	2
null sltB mutant	2
medium alkalinization	2
variety of monovalent and divalent cations	2
null sltA mutant	2
pseudo-kinase and a serine-endoprotease	2
putative functional domains	2
1272 amino acid protein	2
fungi of the pezizomycotina subphylum	2
zinc finger transcription factor SltA	2
plant pathogenic filamentous fungus	2
CBR gene family members	2
azole fungicides	2
additional electron donor	2
fatty acid, sphingolipid and sterol biosynthesis	2
ΔZtCBR1 strains	2
wheat leaves	2
ΔZtCBR1 mutant strains	2
vitro and in planta conditions	2
three possible microsomal CBRs	2
fully sequenced genome	2
one microsomal CBR	2
model yeast Saccharomyces cerevisiae	2
sphingolipids and sterols	2
fatty acids and complex lipids	2
important family of electron transfer proteins	2
Microsomal cytochrome b5 reductases (CBRs)	2
electron transfer enzymes	2
Many fungicides	2
agricultural fungicides	2
one of the most economically damaging diseases of wheat worldwide	2
Ascomycete fungus	2
Septoria tritici blotch (STB)	2
new molecular tools	2
Fungal Genetics and Biology	2
ascomycete fungus	2
’s most serious plant diseases	2
one of the world	2
Septoria blotch of wheat	2
eGFP and mCherry expressing wild-type strains in planta	2
laser scanning confocal microscopy	2
Cy3 filter set	2
epi-fluorescence	2
RFP	2
ex planta	2
four epi-fluorescence filter sets	2
four RFPs	2
RFPs	2
sdi1 locus of Zymoseptoria tritici	2
mRFP, TagRFP, mCherry and tdTomato	2
set of four vectors	2
suitable corresponding filter set	2
bright red-fluorescent protein (RFP)	2
red and green fluorescent proteins	2
red-fluorescent “cousins”	2
fluorescent proteins (FPs)	2
STB epidemics	2
field trial site	2
wheat germplasm	2
wheat cultivars	2
Z. tritici isolates	2
Another gene	2
several sources of resistance	2
quantitative trait loci (QTL) or meta-QTL	2
genome regions	2
formerly effective genes	2
qualitative resistances	2
minority of Z. tritici isolates	2
Zymoseptoria tritici (formerly Mycosphaerella graminicola)	2
Septoria tritici blotch (STB) of wheat	2
FM4-64	2
ascomycete Neurospora crassa	2
polarisome protein ZtSpa2	2
exocyst protein ZtExo70	2
GFP-fusions	2
hyphal Spitzenkörper	2
hyphal apex	2
dye FM4-64	2
small GTPase ZtRab11	2
myosin light chain ZtMlc1	2
small GTPase ZtSec4	2
hyphae of the wheat pathogen Zymoseptoria tritici	2
apical site	2
expanding cell tip	2
secretory vesicles	2
novel fungicides	2
secretion regulators	2
polarity factors	2
Fungal hyphae	2
Z. tritici over-expression libraries	2
isogenic progenitor	2
over-expression strain	2
Rotor-HDA robot	2
putative DNA binding proteins, GTPases or kinases	2
32 genes	2
pilot over-expression library	2
Z. tritici Δku70 strain	2
over-expression vectors	2
latest generation of binary BSMV VIGS vectors	2
DNA-based vectors	2
infectious viral RNA	2
Several variants of BSMV vectors	2
VIGS vector	2
RNA virus Barley stripe mosaic virus (BSMV)	2
certain species	2
Virus-induced gene silencing (VIGS)	2
growing research community	2
improved technologies	2
one of the most economically important diseases of wheat (Triticum aestivum)	2
Septoria tritici blotch	2
Zymoseptoria tritici (previously Mycosphaerella graminicola, teleomorph, Septoria tritici, anamorph)	2
EU agriculture	2
STB disease	2
food and animal feed crop	2
crop yields	2
shared environment	2
host crop	2
wheat in the EU	2
notable pathogen of wheat	2
Septoria tritici Blotch (STB)	2
foliar diseases of wheat	2
weakest promoter	2
α-tubulin promoter Ptub2	2
Pnar1, PlaraB and Pex1A	2
sodium acetate	2
maltodextrin), l-arabinofuranosidase B (PlaraB; induced by arabinose and repressed by glucose), galactose-1-phosphate uridylyltransferase 7 (Pgal7; induced by galactose and repressed by glucose) and isocitrate lyase (Picl1	2
promoter region of Z. tritici nitrate reductase (Pnar1; induced by nitrogen and repressed by ammonium), 1,4-β-endoxylanase A (Pex1A; induced by xylose	2
gene for enhanced green-fluorescent protein (egfp)	2
5 inducible/repressible promoter systems	2
inducible/repressible promoter	2
conditional mutants	2
gene deletion mutants	2
good candidates	2
Essential fungal-specific proteins	2
novel anti-fungal targets	2
new fungicides	2
novel fungicide target proteins	2
positive interaction partner	2
one of the two-hybrid libraries	2
ZtAtg8 in Z. tritici	2
autophagy proteins ZtAtg4	2
even larger genes	2
5′ and 3′ regions	2
5742bp with introns	2
large chitin synthase gene	2
five proteins	2
full-length cDNAs	2
small-to-medium sized proteins	2
cDNA fragments	2
3 libraries	2
yeast and hyphal stages of the wheat pathogen Zymoseptoria tritici	2
three yeast two-hybrid libraries	2
interacting factors	2
essential protein	2
essential fungal proteins	2
Good candidates	2
new fungicide targets	2
Pathogenic fungi	2
infection stages	2
GFP	2
codon-optimized ZtGFP	2
expressed cytoplasmically	2
Aequorea coerulescens GFP (AcGFP), enhanced GFP (eGFP) from Aequorea victoria and a novel Zymoseptoria tritici codon-optimized eGFP (ZtGFP)	2
Fluorescent proteins (FPs)	2
putative new anti-fungal targets	2
host and the pathogen	2
wheat pathogen Zymoseptoria tritici (formerly Mycosphaerella graminicola)	2
mutant or avirulent wildtype strains	2
individuals of the same or different genotypes	2
host leaves	2
mutants or wildtype variants of Zymoseptoria tritici	2
Z. tritici mutant strains	2
set of molecular tools	2
expressing eGFP-Rab7 homologue (ZtRab7)	2
late endosomes and vacuoles	2
eGFP-labelling a Rab5-homologue (ZtRab5)	2
actin patches	2
actin-binding protein fimbrin (ZtFim1)	2
enhanced green-fluorescent protein (eGFP)	2
various fungi	2
growing tip	2
membranes and associated proteins	2
Hyphal growth	2
multiple overlapping DNA fragments	2
genetically modified Z. tritici strains	2
integration	2
single copies	2
various green and red fluorescent fusion constructs	2
point-mutation H267L.	2
carboxin-resistant sdi1R allele	2
single “soft-landing” site	2
succinate dehydrogenase (sdi1) locus	2
targeting regulatory elements	2
genome of this wheat pathogen	2
mutant alleles or fluorescent fusion-protein constructs	2
YRBC of constructs	2
different dominant selectable marker cassette	2
four vectors	2
detailed experimental protocol	2
homologous recombination	2
30bp overlap sequences	2
multiple DNA fragments	2
site-specific recombination systems	2
DNA of interest	2
restriction enzyme sites	2
fungus Zymoseptoria tritici	2
conditional mutant protein alleles	2
Many pathogenic fungi	2
various alcohols	2
guanine nucleotide exchange factor for eIF2	2
eukaryotic translation initiation factor 2B (eIF2B)	2
likely translational target	2
human pathogenic fungus, Candida albicans	2
butanol, ethanol and isoamyl alcohol	2
Many molecules	2
marker proteins	2
three markers	2
component of the minus-end located γ-tubulin ring complex	2
homologue of the mammalian plus-end binding protein EB1	2
enhanced green-fluorescent protein to α-tubulin (ZtTub2)	2
microtubules and accessory proteins	2
microtubules and microtubule-associated proteins	2
invasive fungal species	2
parasitization-related abilities	2
parasitization-related ability diversity	2
clonal lineage	2
56 isolates of H. minnesotensis	2
single nucleotide polymorphisms with clone-corrected samples	2
SCN host	2
H. minnesotensis isolates	2
different combinations of H. minnesotensis and soybean cyst nematode samples	2
samples of H. minnesotensis	2
soybean crops	2
soybean cyst nematode	2
dominant parasitoid	2
fungal parasitoid, Hirsutella minnesotensis,	2
well-characterized, human pathogenic yeast Cryptococcus neoformans	2
96 or more isolates	2
appropriate analytical software	2
amplified fragment length polymorphisms	2
individuals and clades	2
sample of isolates of the taxon	2
several conserved, unlinked gene sequences	2
individual strains or clones	2
major phylogenetic clades, molecular groups, or subpopulations of a species	2
haploid eukaryotes	2
many biological species	2
9th International Conference on Cryptococcus and Cryptococcosis (ICCC9)	2
primary effector cell	2
Cryptococcus gattii	2
normal immune systems	2
severely immunocompromised	2
Cryptococcus neoformans	2
cryptococcal species	2
new, inducers of CAZymes	2
various plant polysaccharides	2
carbon-starved cultures	2
complex plant polysaccharides	2
inducing sugars	2
plant-derived carbohydrates	2
high number of genes encoding CAZymes	2
industrially important fungus Aspergillus niger	2
Mpd inhibitor nitrophenide	2
incompletely formed or aborted ascospores	2
ascus cell wall	2
cleistothecia, and asci	2
conidia of the ΔmpdA strain	2
mycelial growth	2
mannitol in whole cultures	2
vegetative hyphae	2
mannitol 1-phosphate dehydrogenase (MpdA)	2
conidia and ascospores	2
Neosartorya fischeri	2
one of the main compatible solutes	2
polyol mannitol	2
visible disease symptom	2
infection sites	2
dark brown granules	2
conidia of the ΔMocod2 mutant	2
rice plants	2
MoCOD1 and MoCOD2	2
two Zn(II)2Cys6 TF genes	2
TF genes	2
rice blast pathogen	2
N-mannan synthesis	2
C.albicans cells	2
reporter proteins	2
ACT1 promoter	2
C.albicans Hex1 or Sap2 signal sequences plus carboxy-terminal FLAG3 and His6 tags	2
glycosylation reporters	2
Saccharomyces cerevisiae Suc2	2
single N-linked glycosylation site	2
new synthetic C. albicans reporters	2
major fungal pathogen	2
Candida albicans cell surface proteins	2
large multinuclear macrophages	2
UV-killed or morphogenesis-defective mutant Candida	2
live cell video microscopy	2
host phagocytes	2
C. albicans and innate immune cells	2
macrophage lysis	2
phagocyte and pathogen	2
HSF1 CE2 deletion mutant	2
HSE-containing genes	2
CE2 region	2
C. albicans HSF1 mutants	2
CE2 region of Hsf1	2
C. albicans cells	2
warm blooded animals	2
genes with heat shock elements (HSEs)	2
major fungal pathogen of humans, Candida albicans	2
evolutionarily conserved heat shock transcription factor Hsf1	2
plasma membrane high affinity K+ transporter	2
S. cerevisiaeTRK1	2
effluxing Na+	2
plasma membrane Na+/H+ antiporter	2
Saccharomyces cerevisiaeNHA1	2
‘calcium auxotrophy’	2
pmcA and pmcB	2
-ATPase homologues	2
halA−sltA− (and sltA−) strains	2
vacuolar system	2
yeast homologues	2
zinc-finger transcription factor	2
ESCRT-III	2
nudA1 tips	2
DidB-GFP	2
Vps32-GFP over-expression	2
fraction of the permease	2
glutamate transporter AgtA	2
(the ATPase disassembling ESCRT-III)	2
DidBDid2regulating Vps4	2
motile early endosomes	2
‘associated’ component DidBDid2	2
key structural component Vps32	2
largely uncharacterized Aspergillus nidulans ESCRT-III	2
multivesicular endosomes	2
ESCRT-III heteropolymers	2
antifungal agents	2
two hot spot regions of Fks1 the target protein of echinocandins	2
major structural component of the fungal cell wall	2
non-competitive inhibitors	2
clinical armory	2
newest class of antifungal agents	2
congenic virulent C. albicans strains NGY152 and SC5314	2
morphogenesis, fermentation and translation	2
RPMI 1640	2
rabbit	2
renal infections	2
C. albicans SC5314 transcriptome	2
Candida albicans cells	2
two unknown GpiPs	2
DFG5, PHR1, PGA4 and PGA62	2
thin cell wall	2
sensitive strains	2
library of 45 mutants	2
silico predicted GpiPs	2
putative GPI anchored proteins (GpiPs)	2
adhesins, glycosyltransferases, yapsins and superoxide dismutases	2
GPI-anchor remnants	2
GlycosylPhosphatidylInositol (GPI)-anchored proteins	2
highly glycosylated proteins	2
outer layer of the Candida albicans cell wall	2
ubiquitin system	2
pyroptosis, and necroptosis	2
cellular garbage	2
fibrillin and fibrillin-binding proteins	2
blood vessels, lung, skin and ocular ligaments	2
elastic fibre formation	2
elastic and non-elastic tissues	2
extensible polymers	2
Catherine Rabouille	2
Special Issues of SCDB	2
annexins and galectins	2
proteins families	2
several cytosolic proteins	2
conventional endoplasmic reticulum (ER)/Golgi network	2
highly evolved system	2
new molecular setups	2
migrating clusters	2
collectively migrating groups of cells	2
various cellular systems	2
migratory cluster of cells	2
chemical cues	2
highly coordinated collectives	2
individual entities	2
Drosophila myogenesis	2
niche-like neighboring tissue	2
myogenic cells	2
quiescent satellite cells	2
adult-specific myoblasts	2
mesoderm-derived muscle stem cell lineages	2
large adult-specific flight muscles	2
vertebrate muscles	2
specific flight muscles of the fly	2
muscles of the adult fly	2
larval muscles of Drosophila	2
differentiated multinucleate muscle cells	2
mesodermal in origin	2
PRR biology	2
different classes of PRRs	2
germline encoded pattern recognition receptors (PRRs)	2
potential invaders	2
macrophages and dendritic cells	2
Antigen presenting cells	2
invasive fungal infections	2
different articles	2
wider audiences	2
biomedical sciences face	2
academic science communicators and social scientists	2
learned societies	2
individual scientists, science networks	2
wider public, clinicians, other scientists or policy makers	2
regenerative myofibers	2
neuromuscular or myotendinous junctions	2
Nuclei in myofibers	2
periphery of the myofiber	2
mature contractile cell	2
Cellular structures	2
hundreds of myoblasts	2
myofibers)	2
Muscle cells	2
unique cellular architecture	2
Skeletal muscle cells	2
teachers and scientists worldwide	2
lessons freely available online	2
mainstream curriculum biology content	2
powerful teaching tools	2
curriculum-relevant biology topics	2
adjunct support materials	2
biology lessons	2
university partner schools	2
teaching assistants	2
primary and secondary schools	2
mammalian oocytes and early embryos	2
actin-mediated pressure gradient	2
off-center nucleus	2
oocyte nucleus	2
adult body plan	2
future dorso-ventral axis of the embryo	2
animal pole	2
worm, sea urchin, frog and some fish	2
self-cells	2
bactericidal missile	2
MAC	2
pore-forming toxin of the complement system	2
experiences and resources	2
academic science	2
networks of drosophilists	2
dedicated websites, blogs, journal articles, conference presentations and workshops	2
fellow scientists	2
teacher seminars	2
educational YouTube videos	2
portfolios of funding organisations	2
model organism Drosophila	2
outreach networks	2
non-model species	2
capitulum of the sunflower family (Asteraceae)	2
CYC genes	2
Flower forms	2
spectraplakin functions	2
Drosophila Shot	2
mostly mammalian contexts	2
epithelia, oocytes and muscles	2
mammalian spectraplakins dystonin	2
functional domains	2
Drosophila spectraplakin Short stop (Shot)	2
higher animals or humans	2
invertebrate genetic model organisms	2
enormous functional diversity	2
wide variety of tissues	2
cell adhesions	2
microtubules, intermediate filaments	2
multiple isoforms	2
characteristic functional domains	2
Spectraplakin genes	2
plakins, spectrins and Gas2-like proteins	2
three protein families	2
Spectraplakins are evolutionarily well conserved cytoskeletal linker molecules	2
emerging themes	2
reactive oxygen species and reactive nitrogen species	2
different groups of vertebrates	2
chondrocranium	2
cartilage in the cranial region	2
muscle attachment points	2
feeding apparatus	2
central nervous system and sensory structures	2
cartilage in the head	2
facial bones	2
cartilage	2
cartilaginous skull	2
minor spliceosome	2
specific components	2
U12-type introns	2
components of the minor spliceosome	2
highly conserved 5′ splice site and branch point sequence	2
rare group of introns	2
U12-dependent (minor) spliceosome	2
large variety of cell types	2
main factors	2
evolutionarily conserved family of proteins called caspases	2
membrane remodelling machinery	2
various cellular locations	2
transplantable membrane fission machinery	2
sub-complex of this machinery (ESCRT-III)	2
endosomal membranes	2
evolutionarily conserved membrane remodelling machinery	2
Transport (ESCRT) proteins	2
Endosomal Sorting Complex	2
growing list of confirmed and proposed molecules	2
distinct γδ T cell populations	2
TCR repertoires	2
conventional αβ T cells	2
total T cell pool	2
key adhesion molecules	2
cell and the extracellular matrix (ECM)	2
integrin-associated complexes (IACs)	2
custom-made glycans	2
recombinant glycoproteins	2
homogenous N- and O-glycans	2
required machinery	2
serine or threonine residues	2
different N-glycan structures	2
limited repertoire	2
CMP-N-acetylneuraminic acid, plants	2
nucleotide sugars	2
Golgi-resident N-glycan processing enzymes	2
complex N-glycans	2
mammals and plants	2
intricate organ system	2
developing ear in mouse, chicken and zebrafish embryos	2
membranous labyrinth	2
otic epithelia	2
embryonic hindbrain	2
region of cranial ectoderm	2
cell types of the inner ear	2
semicircular canal ducts	2
non-sensory structures	2
thin squamous cells	2
thickened sensory epithelium	2
flask-shaped hair cells	2
many different differentiated cell types	2
patches of sensory epithelia	2
series of interlinked, fluid-filled chambers	2
accelerometer	2
microphone	2
precision sensory organ	2
important enzymes	2
secretase rhomboids	2
secretase class of rhomboid proteases	2
wider rhomboid-like superfamily of proteases and pseudoproteases	2
earliest discovered members	2
conserved intramembrane serine proteases	2
types of cells	2
every model system	2
Camillo Golgi	2
rete diffusa nervosa	2
reticulum of fibers	2
individual units	2
versatile meiotic model system	2
variety of different organisms	2
DNA double-strand break (DSB)	2
budding yeast cells	2
AMR	2
two rising cells	2
genetic material and cell organelles	2
primary septum	2
contractile actomyosin ring (AMR)	2
emerging drugs	2
stable catalytically inactive PTEN mutants	2
clinical cohorts	2
sufferers of Cowden disease	2
PTEN gene	2
numerous classes of functionally distinct mutations	2
broadly expressed phosphatase	2
3-kinase (PI3K) signalling network	2
core inhibitory component	2
certain anticancer drugs	2
distinct MAPK pathways	2
classical negative feedback regulators	2
key spatiotemporal regulators	2
different MAPK isoforms	2
(MAPK) phosphatases (MKPs or DUSPs)	2
Dual-specificity MAP kinase	2
distinct forelimb-forming, hindlimb-forming and interlimb territories	2
broad region of the flank	2
lateral plate mesoderm (LPM)	2
rostral–caudal axis	2
paired appendages in vertebrates	2
many common signalling networks	2
forelimbs and hindlimbs	2
hindlimbs in the lower body	2
forelimbs in the upper body	2
two pairs of limbs	2
new environments	2
coding, non-coding or both	2
cncRNAs	2
protein coding and non-coding functions	2
bi-functional RNAs	2
coding RNAs	2
several previously annotated non-coding RNAs	2
protein coding	2
Many regulatory RNAs	2
high-throughput sequencing	2
cellular and organismal gene expression programs	2
open reading frame region	2
one mature product	2
messenger RNA precursors (pre-mRNAs)	2
cellular and molecular basis	2
proinflammatory cytokine tumor necrosis factor (TNF)	2
cellular and molecular underpinnings	2
two separate cell populations	2
universal neuroprotective chaperone	2
membrane-fusing SNARE complex	2
human CSPα-encoding DNAJC5 gene	2
flies, worms and mice	2
Hsc70 chaperones	2
DnaJ domain of CSP	2
post-Golgi membranes	2
string	2
DnaJ/Hsp40 family of co-chaperones	2
Cysteine string protein (CSP)	2
variety of contexts	2
single cells and tissues	2
metaphase: NuMA (Mud, LIN-5) and dynein	2
two of the key players	2
cell and the tissue	2
developing neural tissue	2
transport intermediates	2
scission of membranes	2
Microtubules, actin filaments and motor proteins	2
actin and microtubule cytoskeletons	2
developing network	2
specialised fusion tip cells	2
airways of insects or the vascular system of vertebrates	2
separate tubular structures	2
migratory pathways	2
Tip cells	2
neighbours	2
Tip or leading cells	2
outgrowing tips or leading edge of developing tubules	2
tissue primordia	2
specialised cells or groups of cells	2
asymmetrically dividing cells	2
particular microenvironment or `niche'	2
receptor binding epitopes of TGFβ	2
TGFβ and related precursors	2
mature ligand	2
N-terminal prodomain	2
one or several peptide bonds	2
proteases of the proprotein convertase (PC) family	2
BMP and Nodal subgroups	2
specific type I and II receptor kinases	2
TGFβ family	2
Secreted cytokines	2
susceptibility gene	2
autosomal dominant leukodystrophy	2
LMNB1 gene (encoding lamin B1)	2
B-type lamins in somatic cells	2
nuclear envelopes	2
LAP2α and nucleoplasmic lamins	2
tissue progenitor cells	2
nucleoplasmic A-type lamin pool	2
chromatin organization	2
retinoblastoma protein-mediated pathway	2
lamin A/C–LAP2α complex	2
chromatin-associated, nucleoplasmic LEM protein, lamina-associated polypeptide 2α (LAP2α)	2
cichlid model system	2
entire cichlid family	2
cichlid colours	2
one of the most species-rich families of vertebrates	2
Cichlid fishes	2
one of its ligands Jagged-1	2
extracellular regions of human Notch-1	2
core signalling pathway	2
putative intestinal sensors	2
emerging model system	2
C. elegans and Drosophila melanogaster	2
invertebrate model systems	2
“transceptors	2
canonical receptors	2
differentiated epithelial cells	2
potential new drug targets	2
metabolically important intestinal nutrient sensors	2
nutritional information	2
gastrointestinal signals	2
trypanosomatid glyoxalase enzymes	2
complete and functional glyoxalase pathway	2
methylglyoxal toxicity	2
d-lactate	2
parasite glyoxalase enzymes	2
sensu stricto lactoylglutathionylspermidine lyases (EC 4.4.1.-) and hydroxyacylglutathionylspermidine hydrolases (EC 3.2.1.-)	2
trypanosomatid parasites Trypanosoma cruzi and Leishmania spp	2
equivalent enzymes	2
glutathione-dependent glyoxalase pathway forming d-lactate, involving lactoylglutathione lyase (GLO1; EC 4.4.1.5) and hydroxyacylglutathione hydrolase (GLO2; EC 3.2.1.6)	2
reactive metabolite	2
glycolysis and other metabolic pathways	2
two commonly used bipolar disorder treatments (valproic acid and lithium)	2
cell signalling pathways	2
isogenic cell culture	2
social amoeba Dictyostelium	2
non-sentient model systems	2
pharmacological researchers	2
associated signalling pathways	2
cell and animal models	2
mutant huntingtin, tau and ataxin 3)	2
aggregate-prone intracytoplasmic proteins	2
Cytoplasmic components	2
long-lived proteins and organelles	2
numerous systems	2
many vertebrate phyla	2
cells and structures	2
adjacent tissues	2
two signaling centers	2
telencepahlic hemisphere	2
medial and lateral faces	2
longitudinal stripes	2
distinct signaling centers	2
sheet of neuroepithelium	2
early cortical primordium	2
new class of agents	2
systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)	2
lipid raft involvement	2
certain lipids and proteins	2
distinct areas in the plasma membrane	2
Lipid rafts	2
mixed T cell chimerism	2
recipient effector CD8 T cells	2
mixed chimerism	2
recipient-derived CD8 T cells	2
donor-derived	2
memory and effector T cells	2
) (FCC) regimen	2
fludarabine, cyclophosphamide, and alemtuzumab (	2
severe aplastic anemia (SAA)	2
tumor-specific peptides	2
post-transplantation CD8+ T cell response	2
Thirty-one patients	2
Thirty-seven patients	2
Fourteen patients	2
allogeneic SCT	2
51 patients with AML	2
azacitidine (AZA)	2
source of toxigenic C. difficile	2
uncooked processed foods	2
cooked food	2
two of them	2
toxigenic C. difficile	2
eaten raw	2
cooked meals	2
food samples	2
tpi gene	2
pathogenic C. difficile	2
poultry a potential reservoir	2
RT 001	2
3 different PCR-ribotypes (039/2, 205 and 001/FLI01)	2
isolated C. difficile strains	2
healthy and five diseased animals	2
Thirteen isolates	2
samples from diseased poultry	2
I) samples from healthy poultry	2
Egyptian C. difficile	2
potential zoonotic agent	2
less common anaerobic bacteria	2
less frequently isolated species	2
anaerobic isolates	2
encountered species	2
subset of the non-identified strains	2
less commonly encountered species more strains	2
gram-positive anaerobic cocci	2
Bilophila wadsworthia, Prevotella spp.	2
MALDI-TOF MS	2
V6 database	2
V5 database	2
6309 anaerobic isolates	2
optimized database (db5989 [V5 database] + ENRIA MSPs)	2
Biotyper database	2
MSPs of anaerobic strains	2
well characterized anaerobic strains	2
widely available platform	2
clinical anaerobic isolates	2
several ‘expertise laboratories’	2
solvent producing organism Clostridium pasteurianum	2
rare, hypertransformable variants	2
extraintestinal and fecal C. difficile isolates	2
hematoma	2
abscess and feces	2
C. difficile isolates	2
thigh	2
large femoral abscess	2
postoperative hematoma	2
Above-knee amputation	2
extensive necrosis of the right leg	2
skin ulcers	2
82-year-old woman	2
feces of the patient	2
different C. difficile strains	2
C. difficile infection	2
large postoperative abscess	2
extraintestinal C. difficile isolates	2
Extraintestinal infections	2
media in blood culture bottles	2
BacT/ALERT FN Plus	2
BACTEC-Lytic	2
tested bottle/system combinations	2
minority of BC isolates	2
Anaerobic bacteria	2
clinical and reference strains	2
BACTEC-Lytic bottles	2
Prevotella disiens and Prevotella intermedia	2
BacT/ALERT-FN Plus	2
Eggerthella lenta and Prevotella bivia	2
Finegoldia magna, Peptostreptococcus anaerobius, Propionibacterium acnes, Clostridium novyi and Clostridium clostridioforme	2
five Gram-positive strains	2
Gram-negative Porphyromonas gingivalis	2
anaerobic strains	2
6.21-19-31 h	2
BacT/ALERT-FN Plus and BACTEC-Lytic	2
average TTP per bottle	2
bottles	2
Gram-positive anaerobes	2
Gram-negative anaerobes	2
BacT/ALERT-FN Plus and BACTEC-Lytic bottles	2
corresponding system	2
bottle	2
Standard suspension of bacteria	2
Gram-positive	2
48)	2
balanced and diverse collection of anaerobic bacterial strains	2
BACTEC-Lytic/9000 (Becton Dickinson, Sparks, USA)	2
(bioMérieux, Marcy l’Étoile, France)	2
BacT/ALERT-FN Plus/3D	2
two blood culture (BC) bottles/systems	2
transcriptional regulator, CdtR,	2
R20291ΔPaLoc model strains	2
Toxins A and B.	2
Pathogenicity locus (PaLoc)	2
Clostridium difficile transferase (CDT)	2
three different commensal gut bacteria	2
downregulated pathways	2
Enterococcus caccae upregulated genes	2
ABC transport pathway	2
Enterococcus caccae	2
phenotypically, quercetin	2
Single Molecule RNA sequencing via Helicos technology	2
quercetin treated and non-treated groups	2
commensal gut microbes Ruminococcus gauvreauii, Bifidobacterium catenulatum and Enterococcus caccae	2
commensal gut microbes	2
fruits and vegetables	2
one of the most abundant polyphenols	2
stable second copy of the gene	2
candidate essential genes	2
Null mutants	2
gene essentiality	2
Essential genes of pathogens	2
current conjugation protocols	2
chromosome of R20291	2
standard BHI media	2
choice of media	2
C. difficile strains	2
recipient C. difficile	2
important clinically relevant strains	2
Clostridium difficile infection	2
microbiome of pigs	2
GI tract of dogs	2
SYN-004 efficiently hydrolyses penicillins and cephalosporins, the most widely used IV beta-lactam antibiotics	2
P1A, a beta-lactamase	2
intravenous beta-lactam antibiotics	2
orally-delivered, non-systemically available therapeutics	2
P1A and SYN-004	2
precursor, P1A.	2
beta-lactamase enzymes, P3A	2
residual antibiotics	2
beta-lactamase enzymes	2
complex ecosystem	2
Clostridium difficile, Clostridium acetobutylicum, Clostridium beijerinckii, Clostridium botulinum, Clostridium perfringens, Clostridium sporogenes, Clostridium pasteurianum, Clostridium ljungdahlii, Clostridium autoethanogenum and even Geobacillus thermoglucosidasius	2
clostridial species	2
DNA transfer	2
cancer delivery vehicles	2
mariner transposon	2
sigma factor	2
manner of application specific modules	2
pyrE host	2
high copy number plasmids	2
uracil prototrophy	2
pyrE allele	2
ACE vectors	2
mutagen	2
ClosTron technology	2
pyrE mutant (a uracil auxotroph)	2
‘pseudo-suicide’ vectors	2
necessary gene systems	2
simple roadmap	2
effective systems	2
useful industrial chassis	2
heroes and villains	2
ClosTron mutants	2
ideal control strain	2
variant created (CRG20291)	2
hamster infection model	2
Clostridium difficile BI/NAP1/027 strain R20291 and ClosTron-derived ermB mutants	2
infectious dose	2
soil types	2
clay soil	2
D. nodosus survival	2
intercalating dye, PMA	2
D. nodosus specific probe	2
D. nodosus in different soils	2
bacterial reservoirs	2
Dichelobacter nodosus (D. nodosus)	2
differential medium	2
Neutral Red	2
four	2
direct plating	2
CCMB-TAL	2
pH indictor (1% Neutral Red)	2
C. difficile and other fecal flora	2
preceding broth enrichment	2
5% sheep's blood	2
four different, selective solid media; Cycloserine-cefoxitin fructose agar (CCFA), Cycloserine-cefoxitin egg yolk agar (CCEY), ChromID C. difficile and tryptone soy agar (TSA)	2
two different rich media, cycloserine-cefoxitin fructose broth (CCFB) and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme (CCMB-TAL)	2
spores/vegetative cells	2
research setting	2
tier 2 nAbs	2
medium-dose SHIV infection	2
High-titer animals	2
unimmunized and low-titer animals	2
homologous tier 2 SHIVBG505	2
Env trimers	2
recombinant native-like (SOSIP)	2
selected groups	2
hard-to-neutralize (tier 2) chimeric simian-human immunodeficiency virus (SHIV) challenge	2
HIV neutralizing antibodies (nAbs)	2
spectrum of immunomodulatory molecules	2
extraordinarily successful parasites	2
heavy chain, not CDR L1	2
CDR L1	2
HIV-1 N276 glycan barrier	2
long CDR H3s	2
VRC01 lineage bnAbs	2
maturation pathways	2
VRC01 UCA	2
reverted VRC01-class bnAbs	2
high-probability unmutated common ancestor (UCA) of the VRC01 lineage	2
preventative HIV-1 vaccine	2
VRC01-class broadly neutralizing antibodies (bnAbs)	2
human primary leukocytes	2
blood cancer models	2
endothelial cells or leukocyte subsets	2
specific organs	2
leukocyte subsets	2
individual leukocyte subsets	2
specific vascular beds	2
bone marrow output	2
number of leukocytes	2
venular walls	2
ACKR1-presented CXCL2	2
junctional chemokine “depot”	2
Transmigrating neutrophils	2
atypical chemokine receptor 1 (ACKR1)	2
main producers of CXCL2	2
TNF-stimulated endothelial cells (ECs) and pericytes	2
chemokines CXCL1 and CXCL2	2
cytokine-stimulated mouse cremaster muscles	2
complex structure of venular walls	2
directional cues	2
molecular sensors	2
electrostatically bound PIP5 kinases	2
diacylglycerol (DAG)	2
phosphoinositide-4-phosphate (PI(4)P), PI(4,5)P2, and PI(3,4,5)P3	2
area of plasma membrane	2
AHR pathway	2
Wnt-β-catenin signaling	2
dietary ligands	2
environmental sensor aryl hydrocarbon receptor (AHR)	2
barrier surface	2
compartments	2
fluctuating external environment	2
epithelium and immune compartment	2
efficient and semiquantitative map of epitopes	2
potentially distracting non-neutralizing epitopes	2
human broadly neutralizing antibodies	2
previously unidentified epitopes	2
polyclonal sera	2
known epitopes	2
HIV-1 envelope glycoprotein vaccine candidate, BG505	2
Mapping epitopes	2
ZEB2 expression	2
transcription factor LXRα	2
tissue-specific identities of macrophages	2
open niches	2
bone-marrow precursors	2
five different macrophage populations	2
Clec4f-cre, Itgax-cre, and Fcgr1-cre mice	2
Zeb2 expression	2
transcription factor ZEB2	2
broadly protective pan-ebolavirus therapeutic molecules	2
multifunctional mAb and related clones	2
potent naturally occurring mAb	2
relevant animal models	2
EBOV, BDBV, and SUDV	2
glycoprotein (GP) base region	2
potent mAb, EBOV-520	2
ebolavirus disease	2
human survivors	2
three ebolaviruses infectious for humans: Ebola (EBOV), Sudan (SUDV), and Bundibugyo (BDBV) viruses	2
distinct class of broadly neutralizing human mAbs	2
multiple ebolaviruses	2
SOSIPs and virion-bound Envs	2
Env base	2
non-neutralizing epitopes	2
closed, neutralizing antibody-bound structures	2
virion-bound Envs	2
soluble and virion-bound Env structures	2
spin-labeled SOSIPs	2
ligand-free, CD4-bound, inhibitor-bound, and antibody-bound SOSIPs	2
virion-bound envelopes	2
Soluble envelopes (SOSIPs)	2
host-receptor CD4 and coreceptor	2
(Env)	2
individual Tfh and B cells	2
PD-L1-PD-1 interactions	2
germinal center territory	2
follicle-guidance receptor CXCR5	2
follicle	2
ensemble of bystander B cells constitutively expressing PD-1 ligand 1 (PD-L1)	2
programmed cell death-1 (PD-1) molecule	2
(Tfh) cells	2
helper	2
Nippostrongylus brasiliensis infection	2
Il7raCre/+Tnfsf4fl/flmice	2
OX40L on ILC2s (Il7raCre/+Tnfsf4fl/flmice)	2
Th2 and Treg cells	2
lung and adipose tissue	2
co-stimulatory molecule OX40L on group 2 innate lymphoid cells (ILC2s)	2
innate and adaptive immune cells	2
Prkcb−/− B cells	2
germinal centers and plasma cells	2
mice whose B cells lack PKCβ	2
SummaryPKCβ-null (Prkcb−/−) mice	2
IL-17 and GM-CSF	2
autoimmune Th17 cells, ILCs, and stromal cells	2
inflamed joints of rheumatoid arthritis patients	2
GM-CSF-producing ILCs	2
either ILCs or radio-resistant stromal cells	2
IL-2, IL-33, or CpG DNA	2
expressed CD25, IL-33Ra, and TLR9	2
Activated synovial ILCs	2
inflamed joints	2
synovial-resident innate lymphoid cells (ILCs)	2
cytokine GM-CSF	2
interleukin-17 (IL-17)	2
fibroblast-like synoviocytes	2
arthritogenic Th17 cells	2
other inflammatory cells	2
IL-4-STAT6 signaling pathway	2
IL-4 stimulus	2
NF-κB p65 cistrome	2
STAT6-repressed enhancers	2
subset of IL-4-repressed genes	2
decreased lineage-determining transcription factor, p300, and RNA polymerase II binding	2
IL-4-activated STAT6 transcription factor	2
GM-CSF and IL-4 stimulation	2
differentiated monocytes	2
in vivo inflammatory DCs	2
in vivo inflammatory macrophages	2
macrophage colony-stimulating factor (M-CSF) or granulocyte macrophage colony-stimulating factor (GM-CSF)	2
human in vivo and in vitro generated mononuclear phagocytes	2
physiological counterparts	2
in vitro generated monocyte-derived dendritic cells (moDCs) and macrophages	2
fibroblastic stromal cells	2
cryptopatches (CPs) and isolated lymphoid follicles (ILFs)	2
oxysterol ligand 7α,25-hydroxycholesterol (7α,25-OHC)	2
ILC3s with a lymphoid-tissue-inducer (LTi) phenotype expressed G-protein-coupled receptor 183 (GPR183)	2
environmental signals	2
3 innate lymphoid cells (ILC3s)	2
RAS mutant cancers	2
cell-intrinsic PD-L1 expression	2
PD-L1 mRNA	2
human lung and colorectal tumors	2
kinase MK2	2
3′ UTR of PD-L1 mRNA	2
AU-rich elements	2
AU-rich element-binding protein tristetraprolin (TTP)	2
tumor cell PD-L1 expression	2
immunosuppressive protein PD-L1	2
necrotic cells	2
active IL-33	2
N-terminal CCP module pair (CCP1/2)	2
cytokine’s activated state)	2
mouse and human IL-33	2
Nippostrongylus brasiliensis	2
IL-33, group 2 innate lymphoid cell (ILC2) and eosinophilic responses	2
recombinant HpARI	2
three predicted complement control protein (CCP) modules	2
IL-33-suppressive 26-kDa protein	2
H. polygyrus Alarmin Release Inhibitor (HpARI)	2
interleukin-33 (IL-33) pathway	2
mouse parasite Heligmosomoides polygyrus	2
TCR-signaling dependent	2
MAP-kinase signaling pathway	2
shared signaling complex	2
signaling complex between T1/ST2 (the IL-33R) and EGFR	2
ligand, amphiregulin	2
type-2 helper T cells (Th2 cells)	2
interleukin-33 (IL-33)	2
-intestinal helminth infections	2
autophagy-deficient neutrophil precursors	2
mitochondrial respiration	2
fatty acids or pyruvate	2
accumulated lipid droplets	2
Atg7-deficient neutrophil precursors	2
blood cell lineages	2
critical and short-lived mediators	2
Human alveolar macrophages	2
mycobacterial sojourn	2
CCR2+ monocytes	2
circulating CCR2+ monocytes	2
chemokine CCL2	2
STING cytosolic sensing pathway	2
mycobacterial membrane phenolic glycolipid (PGL)	2
growth-permissive monocytes	2
initially infected resident macrophage	2
infecting mycobacteria	2
First-responding resident macrophages	2
optically transparent zebrafish	2
lung-resident alveolar macrophages	2
lung alveoli	2
aerosol droplets	2
tuberculosis (Mtb)	2
nAb elicitation	2
BG505 SOSIP trimer	2
immunogens in nonhuman primates	2
recombinant trimers	2
neutralizing antibody (nAb)-based HIV vaccine	2
virion surface molecule	2
stabilized recombinant HIV envelope trimers	2
multiple homogeneous cross-clade immunogens	2
engineered 201-433 disulfide bond	2
gp120 and gp41	2
covalent linker	2
SOSIP.664 and native Env trimers	2
stabilized, soluble clade C Env (16055 NFL)	2
Env fusion machinery	2
well-ordered clade C Env trimers	2
high-resolution clade C structure	2
A, B, and G structures	2
high-resolution clade	2
native-like trimers	2
HIV-1 envelope glycoprotein (Env) design	2
canopy of glycans	2
creative solutions	2
cluster of conserved basic residues	2
bovine antibodies	2
HCDR3	2
CDRs of PGT145	2
three Env protomers	2
trimer 3-fold axis	2
long anionic HCDR3 of PGT145	2
apex bnAb, PGT145	2
apex of the surface HIV envelope (Env) trimer	2
quaternary epitope	2
prophylactic and therapeutic agents	2
vaccine targets	2
neutralizing antibodies (bnAbs)	2
promising substrate	2
anti-programmed cell death protein-1 antibodies	2
activating FcγRs	2
anti-CD25 antibody	2
tumor site	2
inhibitory Fc gamma receptor (FcγR) IIb	2
existing anti-CD25 antibodies	2
tumor-infiltrating Treg cells in mice and humans	2
anti-CD25 antibodies	2
regulatory T (Treg) cells	2
small microbes	2
large neutrophil infiltrates and clusters	2
cooperative clusters	2
numerous neutrophils	2
ROS extracellularly	2
large microbes	2
numerous pathogens	2
phagocyte	2
ROS intracellularly	2
Small microbes	2
interleukin (IL)-1β expression	2
differential localization of ROS	2
important oral barrier	2
interleukin 6 (IL-6)	2
gingiva-resident T helper 17 (Th17) cells	2
key oral barrier	2
oral microbiome and tissue-specific signals	2
key signals	2
Site-specific commensal bacteria	2
barrier sites	2
SummaryImmuno-surveillance networks	2
inflammatory iNOS+ macrophages	2
iNOS+ macrophages	2
GM-CSF-dependent FcγRIII+PD-L2+CD209a+ moDCs	2
Flt3+CD11c−MHCII+ monocytes	2
Sfpi1+/− mice	2
moDCs or microbicidal macrophages	2
FcγRIII+PD-L2−CD209a−iNOS+ macrophages	2
Flt3−CD11c−MHCII−PU.1lo monocytes	2
DC lineage	2
FcγRIII+PD-L2+CD209a+, GM-CSF-dependent moDCs	2
NR4A1- and Flt3L-independent, CCR2-dependent, Flt3+CD11c−MHCII+PU.1hi subset	2
specialized monocyte progenitor subsets	2
microbicidal macrophages or monocyte-derived dendritic cells (moDCs)	2
Ly6Chi monocytes	2
reservoir”	2
intestinal Th17 cell	2
germ-free and antibiotic-treated mice	2
CCL20/CCR6 axis	2
intestinal cells in Kaede mice	2
antineutrophil cytoplasmatic antibody (ANCA)-associated glomerulonephritis	2
kidneys of patients	2
class II-restricted CD8+ T cell responses	2
class II HLA-peptide complex	2
distinct co-expressed TCRα chains	2
circulating CD8+ T cells	2
class II-restricted CD8+ T cells	2
small subset of HIV-infected individuals	2
human leukocyte antigen (HLA) class II-restricted CD8+ T cell responses	2
recombinant cytomegalovirus vector	2
macaque SIV vaccine trial	2
Cd4-deficient mice	2
SummaryCD8+	2
epitopes on HIV or other pathogens	2
native trimers	2
progressively less-mutated design intermediates	2
germline-targeting prime	2
wild-type and germline-targeting trimers	2
Design intermediates	2
PGT121 inferred-germline knockin mice	2
PGT121 inferred-germline B cells	2
PGT121-class supersite bnAbs	2
germline-reverted precursors	2
stabilized Env trimers	2
supersite-bnAb germline precursors	2
Wild-type Env glycoproteins	2
common bnAbs	2
(Env) trimer	2
HIV envelope	2
the N332 supersite	2
IL-2-independent networks	2
IL-2-JAK-controlled pathways	2
signaling framework	2
serine/threonine kinase AKT	2
phosphatidylinositol (3,4,5)-trisphosphate (PIP3)	2
IL-2-JAK-independent SRC family Tyr-kinase-controlled signaling network	2
regulators of chromatin	2
IL-2 receptors	2
Janus kinases (JAKs)	2
cytotoxic T cells (CTL)	2
fundamental cytokine	2
(IL-2)	2
CD95 non-apoptotic signaling pathway	2
lupus mice	2
cell-penetrating CID peptide	2
S1P receptor 3	2
produced sphingosine-1-phosphate (S1P)	2
Src homology 3 domain of phospholipase Cγ1	2
CD95 domain called calcium-inducing domain (CID)	2
regulatory cells	2
cl-CD95L promoted T helper 17 (Th17)	2
systemic lupus erythematosus (SLE) patients	2
skin-derived endothelial cells	2
Metalloprotease-cleaved CD95L (cl-CD95L)	2
ligand (CD95L)	2
early responders	2
IgM+ MBCs	2
IgG+ MBCs	2
T cell-independent B220−CD138+ IgM+ plasma cells	2
IgG+B220+CD138+ plasmablasts	2
T cell-dependent IgM+ and	2
antibody-secreting cells	2
high affinity, somatically hypermutated Plasmodium-specific IgM+ MBCs	2
unmutated IgD+ MBC population	2
somatically hypermutated immunoglobulin M+ (IgM+) and IgG+ MBC subsets	2
Long-lived murine Plasmodium-specific MBCs	2
Plasmodium-specific MBCs	2
distinct MBC subsets	2
long-lived plasma cells and rapidly reactive memory B cells (MBC)	2
bite	2
virus-permissive myeloid cells	2
inoculation site	2
edema	2
Mosquito bites	2
inflammatory niche	2
Semliki Forest virus and Bunyamwera virus	2
mosquito-borne virus infections	2
mosquito bite sites	2
Zika and dengue	2
many medically important viruses	2
aegypti mosquitoes	2
“cytoprotectant”	2
 the nematode Brugia malayi	2
cysteine protease inhibitors	2
cystatin F (CF)	2
armory of granule-localized toxins and hydrolases	2
multifunctional leukocytes	2
pDC-CD24+CD38hi	2
SLE patients	2
pDC-CD24+CD38hi Breg cell interactions	2
 IFN-α	2
healthy B cells	2
systemic lupus erythematosus (SLE)	2
IFN-α and CD40 engagement	2
 IL-10-producing CD24+CD38hi	2
CD19+CD24hiCD38hi (immature) B cells	2
plasmacytoid dendritic cells (pDCs) and Breg cells	2
regulatory B (Breg) cells	2
TLR system	2
IFNGR	2
murine equivalent S200L	2
S180L polymorphism	2
intracellular Mycobacterium tuberculosis (Mtb)	2
mitogen-activated protein kinase (MAPK) p38 phosphorylation	2
Mal-dependent IFN-γ receptor (IFNGR) signaling	2
interferon-gamma (IFN-γ) receptor signaling	2
Toll-like receptor (TLR) adaptor Mal (encoded by TIRAP)	2
GSK-3 inhibitors	2
lymphocytic choriomeningitis clone 13	2
murine gamma-herpesvirus 68	2
in vivo CD8+ OT-I CTL function	2
GSK-3 inhibitors in mice	2
CD8+ CTLs	2
Tbx21 transcription	2
PD-1 expression	2
key upstream kinase	2
serine-threonine kinase	2
(GSK-3, isoforms α and β)	2
Glycogen synthase kinase 3	2
upstream signaling pathway	2
co-receptor PD-1	2
IFN-I signaling pathway	2
Sod1−/−and wild-type mice	2
 Sod1	2
superoxide dismutase 1 (Sod1)	2
 the redox pathways	2
local environmental niche	2
resident epithelial cells	2
TGF-βRII and ILC chemoactivity	2
airway lumen	2
type 2 innate lymphoid cells (ILCs)	2
epithelial cell-derived TGF-β1	2
epithelial cell-derived cytokine TGF-β	2
potentially antigenic particles	2
mucosal sites	2
general hub	2
actin and tetraspanin networks	2
BCR, BAFFR, CXCR4, CXCR5, CD40, and TLR4	2
several receptors	2
compromised Wiskott-Aldrich Syndrome Interacting Protein (WIP) function	2
GM-CSF-eosinophil axis	2
eosinophil peroxidase	2
GM-CSF independent	2
eosinophil effector functions	2
activated intestinal eosinophils	2
interleukin-23 (IL-23)-granulocyte macrophage colony-stimulating factor (GM-CSF) axis	2
crucial effectors	2
intestinal eosinophils	2
CD46-deficient patients	2
increased glycolysis and oxidative phosphorylation (OXPHOS)	2
AA-sensing Ragulator-Rag-mTORC1 complex	2
amino acid (AA) transporter LAT1	2
intracellular domain CYT-1	2
complement receptor CD46	2
activated human T cells	2
aged Apoe−/−Ltbrfl/flTagln-cre mice	2
vascular smooth muscle cell lymphotoxin β receptors (VSMC-LTβRs)	2
unusual set of dendritic cells and B cells	2
CD4+, CD8+, T regulatory (Treg) effector and central memory cells	2
primed CD4+ T cells	2
artery TLOs (ATLOs)	2
aged Apoe−/− mice	2
SummaryTertiary lymphoid organs (TLOs)	2
neutrophil rTEM	2
local LTB4-NE axis	2
neutrophil adhesion molecule Mac-1	2
JAM-C	2
EC JAM-C by neutrophil elastase (NE)	2
venular JAM-C	2
lipid chemoattractant leukotriene B4 (LTB4)	2
EC junctional adhesion molecule-C (JAM-C)	2
mouse cremasteric venules	2
extravascular tissue	2
vascular lumen	2
phospholipid PIP2	2
area of membrane	2
centrosome and granules	2
TCR-bearing intracellular vesicles	2
moving centrosome	2
T cell receptors (TCRs)	2
rearward-flowing actin	2
initially actin-enriched contact	2
actin-rich projections at the leading edge	2
CTLs approached targets	2
virally infected and tumor cells	2
SummaryCytotoxic T lymphocytes (CTLs)	2
latent TGF-β	2
latent transforming growth factor-β (TGF-β)	2
effector Treg cells	2
human anti-malarial antibodies	2
candidate merozoite surface-protein vaccine	2
Ab-C′ inhibitory activity	2
high-density parasitemia	2
merozoite surface proteins 1 and 2	2
C1q fixation	2
non-inhibitory	2
human antibodies	2
(Ab-C′) inhibition	2
Antibody-mediated complement-dependent	2
acquired human anti-malarial antibodies	2
additional pathway	2
RA-RARα	2
Th17 effectors	2
Th1 lineage specifying genes	2
receptor RARα	2
phenotypically stable Th subset	2
CD4+ T-cell lineages	2
phenotypically distinct T helper cells	2
Foxo1−/− GC-Tfh cell population	2
germinal center Tfh cells (GC-Tfh)	2
ICOS ligand	2
Foxo1 genetic deletion	2
Tfh cell genes	2
phosphoinositide-3 kinase	2
co-receptor ICOS	2
high-affinity, class-switched antibodies	2
SummaryT follicular helper (Tfh) cells	2
Drosophila maintained	2
evolutionarily conserved “scavenger receptor-JNK-type 1 cytokine” cassette	2
fat storage	2
JAK-STAT activation	2
scavenger-receptor (crq) and JNK-dependent manner	2
JAK-STAT-activating cytokine upd3	2
JAK-STAT signaling	2
Drosophila genetics	2
fatty foods	2
human and mouse mononuclear phagocyte system	2
highly conserved gene transcripts	2
Human and mouse monocytes and macrophages	2
CD11b+CD64+ monocyte-derived macrophages	2
human dermal CD14+	2
murine homologs	2
precursor-progeny relationship	2
dermal CD14	2
human blood CD14+ monocytes	2
tissue-resident population of monocyte-derived macrophages	2
human dermal CD14+ cells	2
as-yet unknown murine counterpart	2
murine CD103+ DCs and CD64−CD11b+ DCs	2
human tissue CD141hiXCR1+CLEC9A+ DCs and CD1c+ DCs	2
DC network	2
SummaryDendritic cells (DCs), monocytes, and macrophages	2
IL-13-expressing ILC2s	2
antigen-specific T cells	2
MHCII-expressing ILC2s	2
ILC2s in vivo	2
two mouse models	2
2 innate lymphoid cells (ILC2s) release interleukin-13 (IL-13)	2
Treg cell	2
exosomal pathway	2
Dicer-deficient or Rab27a and Rab27b double-deficient Treg cells	2
various immune cells	2
+ T regulatory (Treg) cells	2
AP-1 family members of transcription factors	2
Nonhematopoietic cells	2
AhR-sufficient controls	2
AhR-deficient mice	2
imiquimod-induced model	2
endogenous ligand FICZ	2
AhR antagonists	2
lesional skin of psoriasis patients	2
AhR-activating ligands	2
draining lymph node	2
activated lung dendritic cells	2
ILC2-derived IL-13	2
papain stimulated ILC2s and Th2 cells	2
protease-allergen papain	2
distinct subsets of T helper (Th) cells	2
human and murine macrophages	2
ImmGen project	2
smokers and patients with chronic obstructive pulmonary disease (COPD)	2
human alveolar macrophages	2
stimulus-specific programs	2
central transcriptional regulators	2
current M1 versus M2-polarization model	2
macrophage transcriptomes	2
polarized Th1 cells	2
IL-6-deficient mice	2
IFN-γ and STAT1 signaling	2
mice lacking interferon-γ (IFN-γ), STAT1, or RAG-1	2
peritoneal membrane	2
IL-6-mediated T helper 1 (Th1) cell effector commitment	2
CD8α+ dendritic cells and iNKT cells	2
various costimulatory and coinhibitory molecules	2
multiple forms of α-galactosylceramide	2
variety of different glycolipid antigens	2
single type of cell, the CD8α+ DEC-205+ dendritic cell	2
particular glycolipid antigen	2
principal presenters	2
invariant natural killer T cells (iNKT cells)	2
hematopoietic cell types	2
examined cell populations	2
intracellular C3a	2
patients with autoimmune arthritis	2
intracellular C3-activation-system	2
CTSL-generated C3a	2
endosomal and lysosomal C3 and CTSL	2
Resting T cells	2
C3b	2
biologically active C3a	2
T cell-expressed protease cathepsin L (CTSL)	2
activation fragments C3a and C3b	2
key component, C3	2
critical serum-operative component	2
DZ CXCL12-expressing reticular cells	2
DZ cells	2
CD73+ memory compartment	2
CXCR4-deficient cells	2
DZ centroblast	2
 the LZ	2
CXCR4-deficient GC B cells	2
dark zone (DZ) and light zone (LZ)	2
SummaryGerminal center (GC) B cells	2
BAFFR signaling pathway	2
BCR and Igα	2
Syk and the BCR-associated Igα signaling subunit	2
ERK and PI3 kinase	2
Syk-deficient cells	2
follicular B cells	2
key signal transducer	2
Syk tyrosine kinase	2
“tonic” BCR survival signal	2
receptor for BAFF and the B cell antigen receptor (BCR)	2
IL-1 receptor 1	2
IL-1R2 from pro-IL-1α	2
activated caspase-1	2
cytosolic IL-1 receptor 2 (IL-1R2)	2
key danger signal	2
Interleukin-1α (IL-1α)	2
innate immune pathway	2
sterol-lipid effector	2
broad range of viruses	2
potent paracrine inhibitor	2
macrophage-synthesized and -secreted oxysterol	2
naturally occurring oxysterols	2
25-hydroxycholesterol (cholest-5-en-3β,25-diol, 25HC)	2
sterol mediators	2
sterol network	2
IL-23-driven inflammatory axis	2
splenic and colonic GMPs	2
(GM-CSF) blockade	2
granulocyte macrophage-colony stimulating factor	2
Extramedullary hematopoiesis	2
erythroid and lymphoid progenitors	2
granulocyte-monocyte progenitor (GMP) production	2
bone marrow and spleen	2
proliferating hematopoietic stem cells	2
upstream hematopoietic stem and progenitor cells (HSPC)	2
mature cell populations	2
short-lived neutrophils and inflammatory monocytes	2
mucosal dendritic cells, ILCs, and the intestinal microbiota	2
intestinal ILCs	2
key molecule	2
TRUC mice	2
key disease trigger	2
Helicobacter typhlonius	2
CD103−CD11b+ dendritic cells	2
Tbx21−/−Rag2−/− ulcerative colitis (TRUC) mice	2
interleukin-17A (IL-17A)-producing IL-7Rα+ innate lymphoid cells (ILCs)	2
Vav signaling	2
C-type lectin receptor, CLEC-2, on platelets	2
lymphatic endothelial and fibroblastic reticular cells	2
glycoprotein podoplanin (PDPN)	2
stromal scaffolds	2
parenchymal tissues	2
human setting	2
targeted immunotherapies	2
human and mouse DC subsets	2
tissue DC subsets	2
skin-draining lymph node DCs	2
migratory counterparts	2
blood CD141+ DCs	2
Cutaneous CD141hi DCs	2
cross-presenting soluble antigens	2
majority of CD1c+ and CD14+ tissue DCs	2
human interstitial dermis, liver, and lung	2
CD141hi DC	2
pathogens, vaccines, and tumors	2
migratory cross-presenting DCs	2
Several DC subsets	2
DETC and Aire+ mTEC	2
invariant DETC repertoire	2
Aire+ mTECs	2
first thymocytes	2
+ dendritic epidermal T cell (DETC) progenitors	2
invariant Vγ5	2
Rankl+ lymphoid tissue inducer cells	2
first cohorts of Aire+ mTECs	2
autoimmune regulator (Aire)-expressing medullary thymic epithelial cells (mTECs)	2
specialized microenvironment	2
Card9 signaling	2
Prkcd−/− mice	2
Prkcd−/− cells	2
Dectin-1, Dectin-2, or Mincle stimulation	2
lacking PKCα, PKCβ, or PKCθ	2
Prkcd−/− dendritic cells	2
canonical NF-κB control	2
protein kinase C-δ (PKCδ)	2
core Card9 module	2
CLR proximal signals	2
adaptor protein Card9	2
fungi and other forms of microbial or sterile danger	2
major pattern recognition receptors	2
kinase Syk	2
SummaryC-type lectin receptors (CLRs)	2
Arl8b silenced cells	2
phagosome-lysosome fusion	2
CD1 antigen-presenting complexes in lysosomes	2
Arl8b-HOPS	2
HOPS) complex members	2
Arf-like GTPase Arl8b	2
trafficking shRNA library	2
effector versus memory and naive T cells	2
cytokine and chemokine receptors	2
key cytolytic effector molecules, adhesion molecules	2
Akt-related kinases	2
T cell antigen receptor (TCR) and the cytokine interleukin 2 (IL-2)	2
protein kinase B	2
cytotoxic T cells (CTL), Akt	2
PPARγ and signal transducer and activators of transcription 6 (STAT6)	2
IL-4 signaling	2
Proinflammatory molecules	2
distinct subsets of cells	2
PPARγ signaling	2
distinct inflammatory milieu	2
lipid-activated transcription factor	2
SummaryPeroxisome proliferator-activated receptor γ (PPARγ)	2
Foxp3+ cells	2
intestinal T cells	2
IL-17A+IFN-γ+ population	2
IL23R gene	2
immune receptors	2
HSP90-CDC37 chaperone complex	2
C-terminal inhibitory site	2
total Lck	2
unstimulated naive T cells and thymocytes	2
catalytically active Lck	2
kinase Lck	2
monocyte-derived inflammatory DC subset	2
T cell-restored immunodeficient hosts	2
IL-6 and IL-23,	2
colitogenic cytokines	2
toll-like receptors	2
inflamed mesenteric lymph nodes and colon	2
receptor for CD103	2
monocyte-derived inflammatory DCs	2
Gut conditioned CD103+ DCs	2
the intestine	2
cells (DCs)	2
polarized centrosome	2
TCR transgenic OT-I CTLs	2
centrosome and lytic granules	2
central supramolecular activation complex (cSMAC)	2
lytic granules	2
Th cells	2
Th cell subsets	2
ERK1 and ERK2	2
distinct STATs	2
Th1, Th2, and Th17 cells	2
IL-12-induced STAT4 transcription factor activation	2
IL-10-producing T helper 1 (Th1) cells	2
T cells producing interleukin-10 (IL-10) and interferon-γ (IFN-γ)	2
ganglioside-enriched, detergent-resistant plasma membrane microdomains	2
Th2 cell-type cytokine-biasing αGalCer analogs	2
cell-surface CD1d proteins	2
Th2 cell-type cytokine-biasing ligands	2
glycolipid presentation	2
αGalCer-CD1d complexes	2
αGalCer) analogs	2
NKT cell activating α galactosylceramide (	2
T helper 1 (Th1) cell- and Th2 cell-type cytokines	2
-restricted natural killer T cells (NKT cells)	2
polyclonal Treg cells	2
virus-nonspecific Treg cells	2
virus-specific CD4+ T cells	2
FV-specific clones	2
β chain of an FV-specific TCR	2
transgenic Treg cells	2
T cell receptor (TCR) repertoire	2
FV-specific CD4+ T cells	2
added Treg cells	2
regulatory T (Treg) cells	2
unresolving noncytopathic Friend virus (FV) infection	2
IL-23 in the intestine	2
 Foxp3	2
recipients lacking IL-23p19	2
Foxp3-deficient T cells	2
naive T cell-derived Foxp3+ cells in the colon	2
cell transfer model	2
innate and T cell-mediated inflammatory pathways	2
(IL-23)	2
immature DCs (iDCs)	2
Neuropilin-1 (Nrp-1)	2
proinflammatory stimuli	2
regulatory T (Treg) cells and naive helper T (Th) cells	2
number of MHC class II-peptide complexes	2
immunological synapses	2
apoptosis inducers	2
murine γ-herpesvirus	2
 Bim	2
herpes simplex virus	2
gene encoding Fas (Fas)	2
gene encoding Bim (Bcl2l11)	2
BH3-only protein Bim	2
multiple receptors	2
CD1a+ Langerhans cells	2
intraepithelial vaginal Langerhans and CD4+ T cells	2
HIV-1 rapidly	2
ex vivo human organ culture system	2
alternative therapeutants	2
N. perurans	2
attenuated one	2
attenuated clone	2
IL1β, MHC-1, PCNA, lysozyme and IL10	2
wild clone	2
Th2 cytokines IL10, IL6 and IL4/13A. PCNA and AG-2	2
transcription factor GATA3	2
cell receptor MHC-1	2
proinflammatory cytokine IL1β	2
amoebic clones	2
infected and uninfected cells	2
12 genes	2
h pi	2
triplicate inserts	2
inoculated gill cells	2
gill cells	2
long pseudopodia	2
short pseudopodia	2
amoebae-like cells	2
18S rRNA mRNA	2
h cytolysis	2
small foci	2
phagocytosed fluorescent beads	2
passage attenuated or a recent wild clone of N. perurans	2
apical seawater	2
permeable cell culture supports	2
rainbow trout gill derived cell line, RTgill-W1	2
causative agent of amoebic gill disease (AGD)	2
Neoparamoeba perurans	2
sod1 and il1β in triploid gills	2
cat, hsp70, sod1, saa5, crp/sap1a and crp/sap1b in liver	2
diploid gills	2
saa5 and crp/sap1a	2
crp/sap1b in diploid gills	2
gr, il1β	2
cat and sod2 in diploid livers	2
diploid counterparts	2
oxidative stress and immune-related genes	2
triploid and diploid Atlantic salmon	2
multiple gene copies	2
in-vivo trials	2
teleostean inhibitory factors	2
transcription factors, hormone receptors and micro- and long noncoding RNAs	2
immune-gene-encoding nucleic acids	2
potential biomarker genes	2
cytokine-signalling networks	2
pattern-recognition pathways	2
clotting cascade	2
additional fish-specific paralogs)	2
teleostean regulatory factors	2
various fish species	2
teleostean sequences	2
almost complete set	2
regulatory devices	2
specialised cells	2
biochemical signalling cascades	2
preformed immune effectors	2
induced gene products	2
concerted network	2
mammalian homologues	2
expanded salmon CRP/SAPs	2
salmon CRP/SAPs	2
Atlantic salmon challenged with Aeromonas salmonicida (aroA(-) strain)	2
main acute phase protein (APP)	2
four CRP/SAPs	2
recombinant cytokines (rIL-1β and rIFNγ) in primary head kidney cells	2
one of the major acute phase proteins	2
serum amyloid A-5 (SAA-5)	2
salmon CRP/SAP-1a	2
member of group II	2
salmon CRP/SAP-3	2
group I family	2
SAP-1c and CRP/SAP-2	2
/SAP-1a	2
Salmon CRP	2
fish/amphibian specific group (group II)	2
universal group (group I)	2
two distinct sub-families	2
CRP/SAP genes	2
CRP/SAP-1a, CRP/SAP-1b, CRP/	2
five C-reactive protein (CRP)/serum amyloid P component (SAP) like molecules	2
Atlantic salmon (Salmo salar) whole-genome database	2
MHC molecules	2
MHC class I and II molecules	2
gIi bound gMHCI and II molecules	2
co-transfected cells	2
either class I or II molecules	2
endomembrane systems	2
gIi and gMhcI or II genes	2
12 organs	2
gIi gene	2
teleosts	2
gIi sequence	2
designed degenerate primers	2
grass carp Ii (gIi)	2
Ii and MHC molecules	2
major histocompatibility complex (MHC) class II molecules	2
important immune molecule	2
invariant chain (Ii)	2
stickleback-Gyrodactylus system	2
common ectoparasite	2
less virulent parasite	2
innate and Th1-type adaptive response genes	2
sympatric host	2
two distinct Gyrodactylus species	2
geographically isolated host populations	2
Gyrodactylus parasites	2
three-spined stickleback	2
local parasites	2
hosts and parasites	2
proapoptotic NF-κB-dependent signalling routes	2
active NF-κB factors	2
HEK-293 cells	2
TCBP1 variants	2
TCBP1 mRNA isoforms	2
five	2
healthy trout	2
liver, spleen, and head kidney tissues	2
distinctive protein motifs	2
pentraxin domain	2
comparably shorter signal peptide	2
224-aa-long TCBP2 protein	2
functional factor	2
premature termination codon	2
TCBP1-5	2
shortest mRNA isoform	2
complement component C1q domain	2
large signal peptide	2
245-aa protein	2
TCBP1-1	2
longest mRNA isoform	2
alternative splice sites	2
multiple TCBP1 transcript variants	2
rainbow trout (Oncorhynchus mykiss)	2
respective cDNA sequences	2
-2	2
Two ‘trout C-polysaccharide-binding proteins,’ TCBP1	2
furunculosis vaccine	2
ploidy groups	2
unvaccinated controls	2
triploids	2
unvaccinated fish	2
liquid paraffin adjuvant	2
phosphate buffered saline	2
Diploid and triploid Atlantic salmon	2
two ploidies	2
diploid fish	2
disease outbreaks	2
Sterile triploid fish	2
fish Tlrs	2
Tlr1 and/or Tlr2 in human but also fish cell lines	2
Tlr1 and Tlr2	2
transfected cell lines	2
carp Tlr1-Tlr2 heterodimers	2
ligand Pam3CSK4	2
heterodimer structure of human TLR1-TLR2	2
carp sequences	2
various immune organs and cell types	2
tlr genes	2
mammalian TLR1 and TLR2	2
carp tlr1, tlr2a and tlr2b support	2
intracellular TIR domain	2
full-length coding sequence of tlr1, tlr2a and tlr2b from common carp (Cyprinus carpio)	2
fully functional BCR	2
surface-bound immunoglobulin	2
shark B cells	2
mammals, spiny dogfish CD79α	2
pokeweed mitogen	2
spiny dogfish immunoglobulin heavy chains	2
spleen, epigonal and Leydig organ	2
immune tissues	2
Spiny dogfish	2
multiple transcription factors	2
5′ flanking region	2
SaCD79α gene	2
205 amino acids	2
spiny dogfish CD79α cDNA	2
spiny dogfish (Squalus acanthias) CD79α (SaCD79α)	2
surface of B cells	2
CD79α protein	2
B cell antigen receptor complex	2
Igα)	2
consistent user interface	2
open-source code of CTFFIND4	2
goCTF program	2
resulting 3D reconstruction map	2
influenza hemagglutinin trimer	2
published single-particle cryo-EM dataset	2
signal preserved power spectrum	2
single-particle cryogenic electron microcopy (cryo-EM)	2
hypothetical noiseless volume	2
unfiltered volume	2
filtered and unfiltered volumes	2
fast and computationally efficient implementation	2
serial real-space filters	2
effective local de-noising filter	2
resulting reconstruction	2
particle images	2
high-resolution volumes	2
de-noising single particle reconstructions	2
conserved fragments	2
dRP lyase domain fold	2
heterologous supersecondary structures	2
asymmetric, globular domain	2
self-compatible fragments	2
supersecondary structures	2
seven Cryo-EM facilities	2
modular workflow system called Scipion (de la Rosa-Trevín et al., 2016)	2
large-scale projects	2
said undergraduates and researchers	2
realm of cryoEM	2
undergraduates and researchers	2
T20S proteasome and TRPV1 ion channel	2
three targets	2
Coot, Phenix	2
manual molecular modeling programs	2
published atomic structures	2
student modelers	2
competition	2
cryoEM and molecular modeling fields	2
Å–2.1 	2
2016 Cryo-EM Model Challenge	2
12 maps	2
unique set	2
Cryo-EM maps	2
unique part of a density map	2
compact, contiguous region	2
scoring models	2
chain traces	2
Unsuccessful models	2
correct conformations	2
Challenge	2
3D models	2
successful and unsuccessful models	2
submitted models	2
full atom structure models	2
Cα models	2
local dense points	2
Protein tertiary structure modeling	2
α-synuclein fibrils	2
fibril core region	2
two mutant sites between hAS and mAS	2
intra-molecular distance restraints	2
remarkably similar secondary structure	2
mAS	2
mAS fibrils	2
mouse α-synuclein (mAS) fibrils	2
single protofilament	2
atomic structure of human α-synuclein (hAS) fibrils	2
untrained citizen scientists	2
fully annotated particle set	2
Galaxy Zoo	2
citizen science projects	2
manually curate datasets	2
open web	2
particle selection	2
reconstruction pipeline	2
two-dimensional templates	2
single-particle datasets	2
cryo-electron microscopy (cryo-EM) micrographs	2
various datasets	2
motion-compensated tomogram	2
tilt-series	2
electron cryo-tomography (cryoET)	2
polymer ensemble	2
micrographs of rigid as well as very flexible helical assemblies	2
automated tracing tool MicHelixTrace	2
number of micrographs	2
helical specimens	2
example project	2
Gatan K2 direct-detection device	2
Automated data pipelines	2
computer science field	2
fast CMOS detectors	2
higher-resolution structures	2
tilted sample	2
approximation	2
two-dimensional (2D) plane	2
cryo-electron tomograms	2
cellular ultrastructures and macromolecular complexes	2
small regions of the protein subunits	2
fraction of the aliphatic protons	2
methyl proton region	2
swollen SBMV	2
pentamers and hexamers of protein subunits	2
swollen virus pattern	2
fine fringes	2
icosahedral surface lattice	2
Model calculations	2
swollen SBMV in solution and in microcrystals	2
compact SBMV in solution and in microcrystals	2
Ca2+ and Mg2+ ions	2
native SBMV	2
compact and swollen southern bean mosaic virus (SBMV) particles	2
GFP)	2
diacylglycerol in cellular membranes	2
vaccinia virus (with YFP)	2
array of sections	2
localisation and electron microscopy images	2
integrated optical microscope	2
scanning electron microscope	2
imaging systems	2
partial vacuum	2
acrylic resin	2
two filters	2
map surfaces	2
intermediate-to-low resolution maps	2
local scoring functions	2
Electron Microscopy Data Bank	2
benchmark set of volume alignments	2
set of scoring functions	2
complex molecular structures	2
large facilities	2
cryoEM laboratory	2
X-ray crystallographic community	2
crystal pucks	2
new CryoEM grid boxes storage system	2
noisy, low-dose, biological datasets	2
voxel grid	2
Super-Regions	2
rest of the volume	2
user inputs	2
hierarchical segmentation layers (named Super-Regions)	2
many practical applications	2
complete volumes	2
many biological volumes	2
convenient tools	2
four different test cases	2
non-experienced users	2
individual segments	2
Fourier-space	2
optimal linear filters	2
new implementation	2
pseudo-repeats of tropomyosin	2
steric blocking model	2
Individual pseudo-repeats with Ca2+	2
pseudo-repeats	2
subdomains 3 and 4 of actin	2
active state the tropomyosin pseudo-repeats	2
‘blocked’ position on actin (over subdomains 1 and 2)	2
tropomyosin pseudo-repeats	2
troponin complex	2
resulting density maps	2
bound Ca2+	2
skeletal actin	2
muscle thin filaments	2
collagen/BAp microstructure	2
cancer-bearing bones	2
Collagen/BAp microstructure	2
immature matrix	2
osteocytes	2
cancer-bearing bone tissues	2
B16F10 melanoma cells	2
osteocyte network and collagen/biological apatite (BAp) microstructure	2
circumambient matrix	2
dense network	2
additional protein structures, forcefields, and water models	2
water model	2
native and fully extended states	2
villin headpiece domain	2
multiple independent simulations	2
protein surface residues	2
hydrogen-bonding interactions and hydrophobic contacts	2
folded proteins	2
scientific and engineering challenge	2
T. thermophilus	2
type IV pili	2
pseudopilus	2
heterotrimeric complex	2
another pseudopilin, GspK	2
EpsI/GspI	2
type II secretion system pseudopilins	2
canonical pilin-like folds	2
two, Tt1218 and Tt1219	2
main structural type IV pilin, PilA4	2
one, Tt1222	2
cluster of pilus-like proteins	2
thermophile Thermus thermophilus	2
three type IVa pilins proteins	2
surface of the bacterial cell	2
Type IV pilins	2
M- and CID-regions	2
Sac3 TPR-like repeats	2
S. cerevisiae TREX-2 complex	2
4.9Å resolution structure	2
Sac3 N-terminus	2
additional three putative α-helices	2
M-region of TREX-2	2
5.3Å resolution cryo-EM reconstruction	2
S. cerevisiae complex	2
region and Sac3CID:Sus1:Cdc31 region	2
TPR-like repeats of the Sac3M region	2
Baculovirus-infected Sf9 cells	2
Saccharomyces cerevisiae TREX-2 complex	2
Sac3CID region	2
Cdc31 and two Sus1 chains	2
Sac3M region (residues ∼100–551)	2
Thp1 and Sem1	2
two modules	2
Thp1, Sem1, Cdc31, and Sus1 bind	2
Sac3 scaffold	2
general mRNA nuclear export factor Mex67:Mtr2	2
Transcription-export complex 2 (TREX-2 complex)	2
individual viruses	2
single tomograms	2
specific processes	2
repetitive biological structures	2
electron tomograms	2
native cellular environment	2
various specimens	2
detailed workflow	2
cryo-electron microscope	2
fluorescence image	2
entire specimen area	2
Optimized microscope control software	2
transfer shuttle	2
stable and clean imaging environment	2
specially modified high-numerical aperture objective lens	2
new cryo-stage	2
correlated cryo-fluorescence and cryo-electron microscopy	2
dry environment	2
specific objects	2
electron micrograph	2
fluorescence signals	2
transcription factor HNF1β	2
nuclear import protein Importin-α	2
Importin-α	2
HNF1β NLS peptide	2
NLS and Importin-α	2
HNF1β 229KKMRRNR235 sequence	2
deletion constructs	2
spectrum of Importin-α isoforms	2
DNA binding domain of HNF1β	2
nuclear protein import receptor, Importin-α	2
nuclear localisation signal (NLS)	2
ovarian clear cell carcinoma (CCC)	2
transcription factor hepatocyte nuclear factor 1β (HNF1β)	2
host cell plasma membrane	2
otherwise clearly defined bilayer structure	2
unbound protein	2
low-resolution structure of Env	2
large surface	2
regions outside of the central trimer	2
YFP-tagged protein	2
step-shaped protomers	2
hollow trimer	2
native MLV Env	2
proline rich region (PRR)	2
natively membrane anchored MLV Env	2
murine leukemia virus (MLV)	2
retroviral Env	2
single viral envelope glycoprotein (Env)	2
macro	2
microscope set-up	2
tomogram	2
sample in the microscope	2
detailed structures	2
cells and other biological samples	2
fascinating autophagy machinery	2
Many proteins	2
small membrane structures	2
vesicle’s inner membrane	2
double membrane-bound vesicles	2
cytoplasmic cargo material	2
lysosomal system	2
Macro-autophagy (autophagy)	2
EMDB and PDB entries	2
fully-fledged Volume browser	2
EM community	2
Volume slicer	2
members of the EM community	2
3D EM reconstructions	2
EMDB entries	2
Volume slicer – a web-based slice viewer	2
web application	2
EM maps	2
interactive interface	2
different sources of protein annotations	2
UniProt sequences	2
EMDB/PDB structures	2
new web platform	2
cryo Electron Microscopy area	2
rigid fusions of targets	2
novel high-resolution structures	2
secreted and intracellular human proteins	2
crystal-packing interactions	2
mammalianized version of bacterial maltose-binding protein (mMBP)	2
rigid or cleavable fusions	2
highly post-translationally modified eukaryotic proteins	2
electron cryomicroscope	2
support structures	2
vitrified specimens	2
suspended foils	2
Gold supports	2
amorphous carbon foils	2
All-gold supports	2
wide range of biological molecules and specimens	2
several representative datasets	2
Relion (Scheres, 2012) and Frealign (Grigorieff, 2007)	2
cryoEM software	2
outputs	2
simulated CTF	2
near-atomic resolution cryo electron microscopy (cryoEM) reconstruction	2
additional ClpP1 or ClpP2 subunit	2
chain of ClpP1/ClpP2 heterodimers	2
ring complex	2
partially denatured protease	2
mono-oligomers	2
heterotetramers and heterohexamers	2
heterodimers	2
intact heptamer and tetradecamer	2
selected charge states	2
stoichiometries	2
2×(4ClpP1+3ClpP2) tetradecamer	2
4ClpP1+3ClpP2)+(3ClpP1+4ClpP2) and 2×(3ClpP1+4ClpP2	2
double ring	2
4ClpP1+3ClpP2 and 3ClpP1+4ClpP2	2
heptameric rings	2
equal number of ClpP1 and ClpP2 subunits	2
double ring tetradecamer	2
cyanobacterium Synechococcus elongatus	2
ClpXP1/P2 protease	2
chamber of sequestered proteolytic active sites	2
eubacteria and most eukaryotes	2
Clp protease	2
native polymer	2
two incompatible atomic models	2
native polymers	2
helical polymer	2
small, conserved subunit	2
∼50nm hollow, needle-like structure	2
major extracellular portion	2
many Gram-negative bacteria	2
essential virulence determinants	2
internal residues	2
surface residues	2
protein surface the lattice	2
dispensable virus recognition domain	2
crystal contacts	2
polyhedrins	2
selenomethionine crystals	2
seven previously uncharacterised types of cypoviruses	2
number of insect viruses	2
ancient system	2
GTP conformation	2
Mg2+:EF-Ts	2
(2.2Å resolution) and EF-Tu:GDPNP:pulvomycin:	2
(1.9Å resolution), EF-Tu:GDPNP:EF-Ts	2
two structures of EF-Tu:GDP:EF-Ts (2.2 and 1.8Å resolution), EF-Tu:	2
following reaction intermediates	2
EF-Tu and EF-Ts	2
EF-Ts	2
aminoacylated tRNA	2
EF-Tu:GTP	2
guanine-nucleotide exchange factors	2
superfamily of guanine-nucleotide binding proteins	2
Translation elongation factor EF-Tu	2
1:1:1 complex	2
2:2:2 complex	2
low resolution hLGR5–mRspo2Fu1-Fu2–mZNRF3ecto ternary complex structure	2
C-terminal half	2
horseshoe-like fold	2
LGR ectodomains	2
particularly potent Rspo2 ligand	2
mouse Rspo2 (mRspo2Fu1-Fu2)	2
signalling competent fragment of	2
ectodomain variant of human LGR5 (hLGR5ecto)	2
high resolution crystal structure	2
generic interaction determinants	2
Rspo1-4	2
LGR4-6	2
Wnt receptor Frizzled	2
E3 ligase activity	2
Rspo–E3 complex	2
ternary LGR–	2
Frizzled-specific E3 ubiquitin ligases	2
stem cell markers LGR4-6	2
cell surface receptor families	2
cross-linking members	2
stem cell growth factors	2
four secreted R-spondin (Rspo1-4) proteins	2
proposed extensions	2
crystallography software	2
macromolecular crystallography	2
MRC format standard	2
leading software packages	2
different software packages	2
header	2
three-dimensional electron microscopy field	2
MRC binary file format	2
partially disordered macromolecular assemblies	2
trimeric antigens	2
multivalent vaccines	2
N-terminal inserts	2
trimeric spike on the capsid surface	2
polyhistidine tag	2
N-terminal extended HBcAg	2
major immunodominant epitope	2
amino and carboxy termini	2
Heterologous sequences	2
core antigen of hepatitis B virus (HBcAg)	2
Virus-like particles	2
different direct electron detectors	2
highly ordered TMV	2
high-resolution cryo-EM map	2
450,000 asymmetric units	2
side-chain specific manner	2
negative carboxyl chains	2
atomic-resolution structure of TMV	2
DED movie frames	2
K2 Summit and Falcon II	2
two direct electron detector cameras	2
test specimen	2
tobacco mosaic virus (TMV)	2
new detectors	2
wave of atomic-resolution structures	2
direct electron detectors (DED)	2
improved graphical user interface	2
noisy micrographs	2
anaerobic and aerobic Rex-family members	2
different structural bases	2
aerobic Rex	2
syn in NAD+	2
two distinct orientations of nicotinamide ring	2
C-terminal Rossmann-fold domain	2
reduced or oxidized	2
N-terminal winged-helix domain	2
operator DNA	2
first structures of Rex-family members	2
crystal structures of apo-RSP, RSP/NADH and RSP/NAD+/DNA	2
anaerobic microorganisms	2
Thermoanaerobacter ethanolicus	2
Rex proteins	2
Rex-family repressors	2
gold labels	2
final stitched image	2
whole mesh of the grid	2
overview area	2
STEM detector	2
focused ion beam scanning electron microscope	2
correlation software	2
GFP-expressing astrocytes	2
commercial cryo-ultramicrotome	2
GFP-tagged astrocytes	2
region of interest	2
slice	2
specific cells or groups of cells	2
light/fluorescence microscopies	2
ion channels or transporters	2
inter/intracellular communications	2
microglia, astrocytes, neurons	2
slices of brain tissue	2
Acute brain slices	2
cationic ligands	2
aromatic cage of three tryptophan residues	2
cellular ligand	2
bacterial model system	2
bacteria and eukaryotes	2
ligand-binding domain of cereblon	2
protein cereblon	2
important anticancer agents	2
derivatives lenalidomide and pomalidomide	2
datasets and density maps	2
unit sphere	2
tilt-pairs	2
images and density maps	2
Pairs of electron micrographs	2
incorrect maps	2
single particles	2
AAA+ proteins	2
AAA+ domains of dynein	2
different AAA+ domains	2
dynein AAA+	2
Saccharomycescerevisiae crystal structure	2
long antiparallel coiled-coil stalk	2
microtubule track	2
motile element	2
one long polypeptide	2
hexameric rings	2
related core AAA+ domain	2
diverse range of functionalities	2
Proteins of the AAA+ family	2
AAA+ protein family (ATPases	2
dynein heavy chain	2
microtubule based molecular motors	2
large protein complexes	2
Cucurbita pepo	2
younger tissues	2
older and younger ZYMV-infected leaves	2
younger ZYMV-infected leaves	2
long tubes	2
bundles of filaments	2
long tubular structures	2
scrolls and pinwheels	2
cytosol of roots and leaves	2
CIs	2
cylindrical inclusions (CIs)	2
viral inclusion bodies	2
7dpi)	2
first true leaf	2
stem and apical meristem (5dpi)	2
cotyledons ZYMV	2
Cucurbita pepo L. plants	2
Zucchini Yellow Mosaic Virus (ZYMV)	2
proposed filter	2
single-axis tomographic reconstructions	2
simple Fourier angular filter	2
3D reconstructions	2
reconstructed object	2
electron tomography	2
calculated 3D reconstruction	2
potassium channel MloK1	2
high-end graphic processing units (GPUs)	2
multi-CPU clusters and computer	2
crystal-induced limited search space	2
randomly oriented particles	2
2D crystal	2
adjacent proteins	2
membrane and soluble proteins	2
well-ordered two-dimensional (2D) crystals	2
ultra-flat cryo-preparations	2
reported tool	2
high quality sections	2
ionizer the ribbon	2
newly formed section ribbon	2
second micromanipulator positions the grid	2
conductive eyelash	2
ribbon sticks	2
electrically conductive fiber	2
micromanipulators	2
two micromanipulators	2
setup	2
operators	2
successful ribbon collection	2
section ribbons	2
eyelashes and grids	2
flies away	2
Steady hands	2
nascent ribbon	2
operator	2
first sections of the ribbon	2
electron microscopy grid	2
frozen section ribbon	2
vitreous sections (CEMOVIS)	2
bulk biological specimens	2
single-particle based helical reconstruction	2
well-ordered helical structures	2
expert user	2
novice	2
user-friendly interface	2
individual programs of the software	2
two micrographs	2
reference specimen Tobacco Mosaic Virus (TMV)	2
multiple symmetry solutions	2
electron cryomicrographs	2
artificial replacements	2
dental tissues	2
multi-directional strain components	2
HAp crystals	2
improved multi-scale Eshelby model	2
hydroxyapatite (HAp) crystallites	2
multi-scale architecture of human enamel	2
two-level composite structure	2
hierarchical mineralized tissue	2
Human enamel	2
user community	2
archives	2
specialised software	2
3DEM structures	2
visual analysis pages	2
2D slices of tomographic reconstructions	2
volume viewer	2
Electron Microscopy Data Bank (EMDB) and Protein Data Bank (PDB)	2
3D electron microscopy (3DEM) structures	2
Protein Data Bank in Europe (PDBe)	2
depletion zones	2
observed transient phase	2
poly(acrylic acid) and poly(styrene sulfonate-co-maleic acid)	2
novel atmospheric scanning electron microscope	2
bound nucleotide	2
ATP-bound state	2
intrafilament contacts	2
ParM filaments	2
ParM filament	2
Escherichia coli R1 plasmid	2
type II plasmid segregation system	2
cytomotive filament of the ParMRC system	2
actin-like protein ParM	2
hydrophilic and neutral or selectively charged surface	2
selected detergents	2
support film	2
hydrophobic complexes	2
number of particles	2
transmembrane complexes	2
glow discharge	2
holes of carbon films	2
large macromolecular complexes	2
individual particles	2
electron cryo-microscopy (cryo-EM) data	2
orthorhombic crystal	2
distal region	2
PFR	2
triplet microtubules	2
electron dense structures	2
first cryo-electron tomographic images	2
novel structures	2
unperturbed flagella	2
axoneme	2
intricate tripartite, fibrous structure	2
paraflagellar rod (PFR)	2
canonical 9+2 axoneme	2
uni-cellular protist	2
thinned samples	2
substructures of adherent cells	2
nucleoplasmic reticulum	2
virus-induced vesicular structures	2
PrV pUL34-GFP/pUL31 coexpressing mammalian cells	2
viral pUL31)	2
fluorophore-tagged protein (pUL34-GFP of pseudorabies virus, PrV, the nuclear membrane-anchored component of the nuclear egress complex of the Herpesviridae	2
in-column epi-fluorescence and reflected light cryo-microscope	2
BESSY II electron storage ring	2
beamline U41-XM	2
transmission soft X-ray cryo-microscope (HZB TXM)	2
K-absorption edge of oxygen penetrate biological samples	2
Soft X-rays	2
‘water-window’ wavelength region	2
vitreous samples	2
SPINE2-Complexes Target Tracker application	2
crystal of a protein complex	2
SPINE2-Complexes project the developers	2
protein–protein complexes	2
underlying PiMS data model	2
LIMS	2
academic laboratories	2
research environment	2
suitable mapping layer	2
legacy database	2
PiMS database	2
different automated imagers	2
high-throughput environments	2
user interface	2
database layer	2
user-interface layer	2
96-well (or higher density) plates	2
robotic systems	2
high-throughput environment	2
series of modified constructs	2
pure recombinant proteins	2
structural biology laboratories	2
cell culture scientist	2
completely sterile environment	2
Protein yields	2
various flask formats	2
293T and 293S GnTI− cells	2
multiple protein constructs	2
customised CompacT SelecT cell culture robot	2
numerous samples	2
skilled cell culture scientists	2
Transient transfections	2
modern structural biology pipeline	2
Traditional mammalian expression systems	2
unrelated organisms	2
natural host	2
host cell surface receptors	2
host-protein)	2
recently elucidated paramyxovirus-, arenavirus-, and poxvirus-host protein complex crystal structures	2
poxvirus immunomodulators	2
European SPINE2-Complexes initiative	2
viral immunomodulators	2
plethora of proteins	2
Large complicated viruses	2
rapidly evolving and diverse pathogens	2
single crystals	2
materials of biological interest	2
leucine sidechain	2
hydrophobic environment	2
hydrogen-bonding arrangement	2
μ2 subunit of the clathrin adaptor protein complex AP2	2
acetyl-YEQGL-amide	2
C-terminus of mammalian P2X4 receptors	2
trafficking motif	2
YEQGL motif	2
5-residue peptide acetyl-YEQGL-amide	2
cross-linking data	2
crystal structure of RNA polymerase II	2
amino acid pairs	2
functional complexes in solution	2
location of secondary binding sites	2
drug site 1	2
dansylated amino acids	2
different dansylated amino acids	2
either drug site 1 (dansyl-l-asparagine, dansyl-l-arginine, dansyl-l-glutamate) or drug site 2 (dansyl-l-norvaline, dansyl-l-phenylalanine, dansyl-l-sarcosine)	2
six dansylated amino acids	2
co-crystal structures of HSA in complex	2
drug pockets	2
different dansylated amino acid compounds	2
drug molecules	2
two primary binding sites	2
Human serum albumin (HSA)	2
photo-sensitive Drosophila tissues	2
dynamically extending microtubules	2
end-binding-protein 1 foci	2
weak particles	2
denoised images	2
particle probability image	2
particle feature probability image	2
noisy biological images	2
4k CCD camera	2
TMV segments	2
second helical form of TMV	2
previous cryo-EM structure	2
4.6Å TMV structure	2
CCD camera	2
test object	2
second distinct helical form with RNA (cryo-EM)	2
stacked disks	2
highly ordered organisation	2
plant virus	2
Tobacco mosaic virus (TMV)	2
new eukaryotic proteins	2
methodological variants	2
crystallized proteins	2
vectors and host systems	2
multiple (typically 9–20) truncated constructs	2
focused chemical libraries	2
variety of chemical series	2
families of proteins	2
384-well format	2
newly expressed proteins	2
Hundreds of genomes	2
novel potential chain combinations, laminins 312 (α3, β1, γ2) and 422 (α4, β2, γ4)	2
known laminin isoforms	2
laminin 323 (α3, β2, γ3)	2
recombinant C-terminal coiled-coil fragments of all chains	2
possible heterotrimeric combinations	2
laminin chain assembly	2
different laminin isoforms	2
coiled-coil domain of the 11 identified laminin chains (α1–5, β1–3, γ1–3)	2
potential heterotrimeric chain combinations	2
heterotrimeric, multidomain proteins	2
hydrophobic chamber	2
side chains of twelve valine residues	2
large internal chamber	2
two different types of dodecameric particles	2
solution B. licheniformis	2
B. subtilis protein	2
Bacilli	2
dodecameric particles	2
trp RNA-binding attenuation protein (TRAP)	2
tryptophan biosynthetic genes	2
Anti-TRAP (AT) protein	2
terminals	2
active zone	2
population of synapses	2
defined vesicle pools	2
individual reconstructed terminals	2
dissociated hippocampal cultured neurons	2
FM-styryl dyes	2
single synapses	2
pris	2
synapses set	2
test sample	2
bacteriophage PRD1	2
tilted specimens	2
series of tomograms	2
final reconstruction	2
spatially variant CTF	2
sub-tomograms containing identical particles	2
stromal collagen	2
numerical simulation	2
abnormal collagen fibril organisation	2
rge corneas	2
stromal proteoglycans	2
cuprolinic blue stain	2
corneal periphery	2
peripheral cornea and limbus in birds	2
affected birds	2
rge chick cornea	2
dominant collagen lamellae directions	2
rge eye	2
misshapen corneas of mature chickens	2
stromal extracellular matrix	2
associated proteoglycans	2
low density centre	2
small (∼2nm), surface-disordered ferrihydrite subunits	2
ferritin protein shell	2
protein shell	2
eight channels	2
one core	2
HAADF images	2
polycrystalline (ferrihydrite) subunit structure	2
cores	2
controlled electron fluence	2
individual hepatic ferritin cores	2
high angle annular dark field (HAADF) images	2
intracellular iron	2
major iron storage protein	2
tightly associated 30nm fibers	2
associated arms	2
replisome couples	2
couples	2
replisomes in HeLa cells	2
short segments of replicons	2
model of replisome couples	2
independent replisomes	2
replisomes in human HeLa cells	2
DNA segments	2
eukaryotic organisms including vertebrate cells	2
loop of newly synthesized DNA	2
two replisomes	2
transfected daughter HepG2 cells	2
two daughter cells	2
different nucleoli	2
vicinity	2
labeled nucleolus-associated chromatin	2
original ones	2
vast majority of daughter cells	2
labeled chromatin	2
regions in transfected HepG2 cells	2
photoconvertible histone H4-Dendra2	2
nucleolus organizer region-bearing chromosomes	2
nucleolus-associated chromatin	2
various chromatin regions	2
chromosome territories	2
Mammalian chromosomes	2
active site pocket	2
Leu593 and Val601 of the P-loop	2
ethanolamine moiety of C52	2
αC helix and DFGL region	2
DFG-Asp-in and αC-Glu-out conformation	2
focused library	2
Mer complexed with compound-52 (C52: 2-(2-hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine), a ligand	2
activation loop residue	2
autoinhibited αC-Glu-out conformation	2
high-resolution structure of Mer	2
nucleotide cofactor	2
Mer adaptor proteins	2
numerous carcinomas	2
Mer knockout mice	2
antiapoptotic and transforming signals, Mer (MerTK)	2
retroviral oncogene v-Eyk	2
mammalian ortholog	2
one of the sister chromatids	2
NORs in metaphase	2
HeLa derived cell line stably expressing UBF-GFP	2
individual NOR	2
UBF-loaded NORs	2
emerging daughter cells	2
telophase HeLa and LEP cells	2
different chromosomes	2
cultured mammalian cycling cells	2
Upstream Binding Factor (UBF)	2
RNA polymerase I transcription machinery	2
Essential components	2
clusters termed Nucleolus Organizer Regions (NORs)	2
vertebrate striated muscles (skeletal and cardiac)	2
fish skeletal muscle myosin filaments	2
rabbit cardiac myosin filaments	2
unperturbed helical filament	2
unperturbed helix	2
430Å repeat	2
Single filament images	2
rabbit cardiac muscle	2
negatively stained isolated myosin filaments	2
myopathies	2
myosin and myosin binding protein C (MyBP-C)	2
cardiac muscle myosin filament proteins	2
cardiac myopathies	2
large sacs of ER membranes	2
Rtn4a antibody	2
large vesicles	2
antibodies against Rtn4a	2
assembling NE	2
edges of membranes	2
Rtn4a localises	2
growing Xenopus oocyte nuclei	2
cytoplasmic membranes	2
membranes in the cytoplasm	2
Reticulon 4a (Rtn4a)	2
respective chromosome territories	2
elongated chromatin protrusions	2
intranucleolar NORs (supposedly non-competent)	2
nucleoli	2
non-competent NORs	2
position of NORs	2
respective chromosome homologs	2
transcriptionally competent NORs	2
rDNA-bearing chromosomes	2
NOR-bearing chromosomes	2
HeLa and LEP cells	2
transformed HeLa and primary LEP cells	2
two human-derived cell lines	2
specific chromosomes	2
competent, and non-competent NORs	2
particular chromosomal sites in clusters termed nucleolus organizer regions (NORs)	2
human ribosomal genes	2
mammalian interphase nucleus	2
vaccines and other biologics	2
solubility enhancer	2
standard membrane-feeding assays	2
Antibodies against Pfs25-containing nanoparticles	2
aluminum-based adjuvant	2
E. coli-derived particles	2
transmission-blocking epitopes	2
target antigens	2
E. coli SHuffle strain	2
resulting protein chimera	2
regions of the ectodomains of either Pfs25 or Pfs48/45	2
ciliated protozoan, Tetrahymena thermophila	2
self-assembling protein, granule lattice protein 1 (Grl1p)	2
subunit antigens	2
P. falciparum proteins Pfs25 and Pfs48/45	2
sexual stages of Plasmodium species	2
transmission-blocking vaccine	2
active hsEH	2
satisfactory amounts of functional enzyme	2
cost-effective and rapid E. coli prokaryotic system	2
C-terminal domain of hsEH	2
eukaryotic cells HEK293-F	2
full-length enzyme	2
pure recombinant enzyme	2
active protein	2
enzymatic and structural in vitro studies	2
non-bioactive molecules	2
corresponding diols	2
epoxyeicosatrienoic acids (EETs)	2
endogenous anti-inflammatory and cardio-protective signalling mediators	2
human soluble Epoxide Hydrolase (hsEH)	2
two independent vectors	2
bicistronic vector	2
2A signal peptide	2
heavy chain	2
several different signal peptides	2
light chain	2
previous best secretor	2
different combinations of signal peptides	2
different signal peptides	2
broadly neutralizing antibody (VRC01)	2
secretion signal peptides	2
Pichia pastoris (Komagataella phaffi)	2
largest STIM1 wild type fragment	2
longer 30.5 kDa fragment	2
soluble well folded 15N,13C isotope-labeled cytosolic coiled coil fragments	2
two 15N,13C isotope-labeled cytosolic coiled coil fragments	2
three coiled coil domains	2
functionally relevant cytosolic part of STIM1	2
Orai/CRAC channel	2
ER – plasma membrane (PM) junctions	2
calcium sensor	2
two recombinant wild type fragments of the stromal interaction molecule 1 (STIM1)	2
dynamic kinetochore-microtubule interface	2
growing microtubule plus end	2
Ndc80 holo complex	2
depolymerising microtubule ends	2
fission yeast complex	2
human complex	2
microtubule lattice	2
TIRF)-microscopy assays	2
four subunits	2
reconstituted Ndc80 holo complex	2
fission yeast Ndc80 holo complex	2
plus end of the spindle microtubule	2
outer kinetochore	2
stable kinetochore-microtubule attachment	2
Mal3/EB1 microtubule plus-end tracking protein	2
Dis1/chTOG microtubule polymerase	2
multiple microtubule-associated proteins	2
plus ends of the spindle microtubules	2
sole, platform	2
Ndc80 (Hec1), Nuf2, Spc24 and Spc25	2
conserved outer kinetochore protein complex	2
functional oligomeric and monomeric tau	2
expressed tau proteins	2
host strain	2
wild type and FTPD-17 pathogenic tau	2
truncation products	2
recombinant tau	2
Pure tau	2
Recombinant tau protein	2
infected cell lysates	2
three serotypes of PV	2
antisera	2
autoinduction system	2
Polioviral proteins VP0, VP3, VP1, and 3AB	2
non-infectious reagents	2
live to inactivated polio vaccine	2
principal HIV coreceptor, CCR5	2
highly potent HIV entry inhibitor	2
analog of the human chemokine protein RANTES/CCL5	2
low-resource regions	2
anti-HIV drugs	2
effective anti-HIV vaccine	2
protein expression constructs	2
cellular lysates	2
fluorescent label	2
covalent bond-forming tag/domain pair	2
soluble aggregates	2
time-consuming Western blots	2
low-expressing proteins	2
different affinity tags	2
many constructs	2
well-folded and active protein	2
high-purity and high-quality human-cl rhFVIII product	2
-cl rhFVIII	2
pathogens tested	2
potential harmful compounds	2
animal-derived products	2
total FVIII protein	2
active FVIII	2
high-purity rhFVIII product	2
process- and product-related impurities	2
essentially all host-cell proteins	2
affinity resin (VIIISelect)	2
chromatography columns	2
industrial-scale human-cl rhFVIII purification	2
European Medicines Agency	2
human cell-line	2
first rFVIII	2
(Nuwiq®), a new generation recombinant factor VIII (rFVIII)	2
IntroductionHuman-cl rhFVIII	2
Different chemicals	2
range of alternative acceptors	2
electron acceptor	2
molecular oxygen	2
226Umg−1)	2
1-methyl-β-galactopyranoside	2
tested substrates	2
SDS–PAGE	2
C-terminal His-tag the enzyme	2
enzyme per L of growth culture	2
Fusarium sambucinum cultures	2
gene encoding a galactose oxidase (GalOx)	2
highly-pure stoichiometric GYS1:GN1 complex	2
intact human or rodent muscle tissues	2
recombinant GYS1	2
several well-characterised and uncharacterised Ser/Thr residues	2
bicistronic pFastBac™-Dual expression vector	2
GYS1 and GN1	2
Stoichiometric GYS1:GN1 complex	2
human glycogenin-1 (GN1)	2
functional human muscle glycogen synthase (GYS1)	2
fusion tag	2
mixture of other additives (trehalose, sorbitol and sucrose) and β-mercaptoethanol	2
2mM β-mercaptoethanol	2
combination of 1% glycerol	2
Tris–HCl	2
immobilized-metal affinity column	2
refolding recombinant CES1	2
CES1 protein	2
bacterial expression systems	2
active metabolites, drugs and prodrugs	2
various ester- and amide-containing molecules	2
Human liver carboxylesterase 1 (CES1)	2
HSA–Lewisb glycoconjugates	2
periplasmic space of Escherichiacoli	2
C-terminus of the protein	2
putative extracellular binding domain	2
recombinant form of BabA	2
outer membrane protein BabA.	2
gastric epithelium	2
Lewisb antigens	2
unstructured elements	2
predominantly β-sheet conformation	2
uniformly-labelled fibrils	2
first 13C and 15N SSNMR spectra	2
recombinant medin	2
pure, uniformly 13C,15N-labelled medin	2
SUMO-medin fusion protein in Escherichia coli	2
site-specifically labelled protein	2
fibrillar medin	2
13C- and 15N-labelled protein fibrils	2
Alzheimer’s amyloid-β peptides	2
several amyloid assemblies	2
Structural models	2
localised amyloid	2
main fibrillar component of human aortic medial amyloid (AMA)	2
50-amino acid protein medin	2
soluble fraction	2
-tagged human KMO enzyme	2
active FLAG™	2
KMO inhibitors	2
human KMO	2
many in vitro expression systems	2
KMO insoluble	2
Recombinant human KMO protein production	2
(KMO)	2
Kynurenine 3-monooxygenase	2
within coding DNA	2
aberrant mRNA species	2
CAB-2 gene	2
functional RNA processing elements	2
prematurely polyadenylated mRNAs	2
native MCP and DAF coding regions	2
human tissues and cell lines	2
DAF region	2
Northern blots	2
Another prematurely polyadenylated species	2
MCP coding region of CAB-2	2
AATAAA site	2
790 base species	2
DAF region of the CAB-2 coding sequence	2
1500 base species	2
total CAB-2 mRNA	2
base mRNA species	2
expected 2300 base CAB-2 mRNA species	2
recombinant complement activator blocking protein, CAB-2 (a fusion of membrane co-factor protein, MCP, and decay accelerating factor, DAF)	2
CHO-K1 cell lines	2
strong viral promoters	2
permanently transfected mammalian cells	2
Recombinant glycoproteins	2
needle-shaped crystals of l-selenomethionine substituted PlcHR2	2
heterodimeric protein complex	2
advanced μ-focus synchrotron beam lines	2
native organism P. aeruginosa	2
mammalian endothelial cells	2
Xcp (TypeII) secretory system	2
twin arginine translocase (TAT)	2
fully folded heterodimer (PlcHR2)	2
17kDa chaperone (PlcR2)	2
P. aeruginosa PlcH	2
wide range of bacterial and fungal pathogens	2
growing family of virulence factors	2
opportunistic pathogen Pseudomonas aeruginosa	2
hemolytic phospholipase C/sphingomyelinase	2
tyrosine residue (Tyr177)	2
Ser/Thr kinase PLK4 auto-phosphorylated	2
distinct exposed sites	2
bacteria overexpressing λ-phosphatase	2
unphosphorylated kinases	2
heavily phosphorylated	2
nine kinases in Escherichia coli	2
insoluble protein	2
heterogeneous recombinant protein preparations	2
MD proteins	2
Optimal anti-aggregation agents	2
total MD protein	2
culture additives	2
highest expressing clone	2
small-scale cultures	2
TLR4 pathway	2
respective receptor, RP105 and TLR4	2
heterogeneous collection of oligomers	2
Myeloid differentiation proteins	2
well-structured α-helix	2
hydrophobic solvents	2
minimal media	2
highly hydrophobic transmembrane domain of Fukutin-1	2
His6 tag	2
N-terminal domain of Fukutin-1	2
N-terminal transmembrane domain	2
ER/Golgi	2
N-terminal transmembrane domain of these proteins	2
Fukutin and other members of this family	2
α-dystroglycan	2
family of putative O-linked glycosyltransferases	2
untagged hCypA and hPCNA	2
automatically prepared minimal buffers	2
generic commercially available pre-packed columns	2
original cell culture	2
untagged hPCNA	2
untagged hCypA	2
ÄKTAxpress™ chromatography system	2
untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) from Escherichia coli	2
ubiquitous family of transmembrane proteins	2
full-length recombinant tetraspanin	2
second extracellular loop	2
highly-defined α-helical secondary structure	2
homogenous species	2
protein solution	2
array of detergents	2
Full-length hCD81	2
recombinant molecule	2
second extracellular loop (EC2) of hCD81confirmed the antigenicity	2
P. pastoris protoplasts	2
Hepatitis C virus E2 glycoprotein	2
Human CD81 (hCD81) protein	2
members of the Arp2/3 complex	2
pArc-34 associated proteins	2
one of the members of the well characterized Dictyostelium Arp2/3 complex	2
native Dictyostelium protein complexes	2
either a C- or N-terminal location	2
additional green- or yellow fluorescent protein (GFP or YFP) tags	2
constitutive actin 15 promoter	2
native protein complexes	2
tag and a calmodulin binding peptide (CBP)	2
TAP tag	2
C-terminal or N-terminal fusion of the protein	2
native proteins and protein complexes	2
series of expression vectors	2
canonical base pairs	2
sub-motifs	2
related structures	2
regulatory RNA structures	2
specific substrate structures	2
called epitranscriptome	2
structuredness of RNAs	2
nucleobases	2
heavily modified genes	2
genetic and structural information	2
RNA nucleotides	2
mouse acutely isolated primary hepatocytes	2
additional systems	2
immortalized tissue culture lines	2
particular protein	2
nucleotides	2
nucleotidyl transferases	2
vitro or chemically synthesized RNAs and protein extracts	2
RNA-protein complexes	2
versatile animal model system	2
additional gene editing tools	2
designer endonuclease and other gene editing technologies	2
CRISPR-Cas9	2
particular project	2
zebrafish gene editing toolkit	2
Zebrafish (Danio rerio)	2
clustered regular interspersed short palindromic repeat (CRISPR) systems including Cas9, Cas12a, and structure-guided nucleases	2
functionally important intermediates	2
RNA’s folding landscape	2
epsilon reverse transcriptase (RT) enzyme	2
upper stem	2
ε-HBV RNA	2
intron construct	2
P5c hairpin of the group	2
isolated NMR active nuclei pairs	2
full-length 53 nt construct	2
9 kDa 28 nt sequence	2
2,8-13C2-adenosine resonances	2
epsilon (ε) RNA element of the duck Hepatitis B virus	2
9 kDa and a 15 kD construct	2
2,8-13C2-adenosine 2′-O-TBDMS-phosphoramidite building block	2
tP5abc subdomain of the Tetrahymena group I ribozyme	2
21 nucleotide (nt) tP5c stem construct	2
5-13C-uridine 2′-O-TBDMS-phosphoramidite building block	2
structural ensembles	2
isolated 13C-1H-spin topologies	2
5-13C-uridine and a 2,8-13C2-adenosine building block	2
atom-specific 13C labeled RNA building blocks	2
major ground state and minor populated excited states	2
RNA structural ensembles	2
bi-clusters	2
subsets of samples	2
subsets of interrelated metabolites	2
metabolic phenotyping data	2
gut metagenomes	2
available bacterial genomes	2
TMA-producing bacteria	2
whole gut metagenomes	2
human-associated bacterial isolate genomes	2
anaerobic glycyl radical-containing, choline-TMA lyase, CutC and the aerobic carnitine monooxygenase	2
dietary choline and carnitine in the human gut	2
trimethylamine (TMA)	2
diverse hosts	2
high-value compounds and food additives, e.g. polyunsaturated fatty acids and glycolipids	2
challenging class of proteins	2
heterologous membrane proteins	2
biotechnological and biomedical context	2
many essential roles of lipids	2
microbial cells	2
different organisms	2
organelles and plasma membranes	2
pool of structurally highly diverse, amphipathic lipids	2
interior	2
∼30 Å hydrophobic film	2
microbial cell culture	2
host strains, tags and promoters	2
recombinant prokaryotic and eukaryotic membrane proteins	2
microbial expression systems	2
high quality membrane protein crystals	2
Integral membrane proteins	2
water soluble proteins	2
MS-based structural biology	2
heterogeneous or transient	2
proteins and protein assemblies	2
structural biology toolkit	2
expensive software	2
specialised hardware	2
scanning FCS	2
slowly diffusing species	2
commercial turnkey confocal systems	2
FoCuS-scan, scanning FCS software	2
large-scale acquired sets of FCS data	2
molecular diffusion dynamics	2
cells and tissue slices	2
transparent and semi-transparent biological micro-structures	2
3D tomographic reconstructions	2
relatively thick samples	2
Rytov approximation	2
final tomographic reconstruction	2
sinograms	2
focus-tunable lens	2
One sinogram	2
liquid focus-tunable lens	2
obtained circular contour	2
mathematical imaging methods	2
time-lapse microscopy image sequences	2
colour overlays	2
EGFR and rab5 positive endosomes	2
fluorescently labelled receptor	2
accurately segment cells	2
Confocal microscopy	2
transcription machinery	2
data-analysis tools	2
single molecules in cells	2
common workflows	2
protein-bound mRNA	2
RNA and proteins at 365nm wavelength (photoactivatable-ribonucleoside-enhanced crosslinking, PAR-CL)	2
yeast RNA interactome	2
infectious meningitides	2
parenchyma	2
special labeling	2
putative dendritic cells and macrophages	2
neutrophils, T cells	2
cortical meninges	2
fluorescent pathogens (lymphocytic choriomeningitis virus, Trypanosoma brucei or Plasmodium berghei)	2
selected cell types express fluorescent proteins	2
reporter mice	2
superficial brain parenchyma	2
thinned cortical skull of the anesthetized mouse	2
unperforated skull	2
unsupported membranes	2
case of the meninges	2
pathogens and cells of the immune response	2
brain parenchyma	2
gateway	2
viral and microbial infections	2
RNAs, proteins, and RNA-protein complexes	2
high-resolution 3D structural models	2
aggregation-free, monodispersed preparations	2
atomic-level models	2
macromolecules and their complexes	2
number of macromolecules	2
atomic-level resolution models	2
Structural biology tools	2
ribonucleic acids (RNA)	2
single-stranded HDR template DNA	2
microinjection in murine zygotes	2
chemically modified synthetic guide RNAs	2
RNP complex into cells	2
recombinant Cas9 protein	2
components in the host cell	2
plasmid or viral vectors	2
CRISPR components	2
suitable DNA templates	2
New genetic material	2
ribonucleoprotein (RNP) complex in cells	2
Cas9 endonuclease	2
podosome ring model	2
discrete points	2
localization microscopy images	2
traditional microscopy images	2
podosome rings	2
underlying extracellular matrix	2
podosome ring	2
integrins and integrin-associated proteins	2
f-actin core	2
extracellular matrix of macrophages, osteoclasts, and dendritic cells	2
Podosomes are adhesive structures	2
Parasite DNA	2
well-established GVR35 mouse model	2
CSF samples	2
Aldo Castellani	2
Trypanosoma brucei spp.	2
physiologically relevant context	2
potential tuberculosis drugs	2
control compounds	2
first line tuberculosis drug	2
M. tuberculosis growth	2
mammalian macrophages	2
compound on mammalian cells	2
Many drug development pipelines	2
multi- and extensively-drug resistant forms of Mycobacterium tuberculosis	2
DNA binding proteins and enzymes	2
mica	2
RNAP>	2
muscovite mica	2
three constituent biopolymers	2
molecular components	2
mica surface	2
RNAP and DNA template	2
two λPR promoters	2
simple tandem gene model	2
active RNAP-DNA complexes	2
mica support surface	2
negatively charged polysaccharides	2
one promoter	2
AFM images	2
σ70RNAP and RNAP	2
reaction mix	2
holoenzyme (σ70RNAP) on linear DNA	2
E. coli RNA polymerase (RNAP)	2
heparin and heparan sulphate (HepS)	2
specific neural stem cell populations in the brain	2
conventional confocal microscopy	2
mushroom body neuropils	2
deep brain structures	2
neuronal stem cells	2
variety of different transcripts and proteins	2
i.e., exons, 3′UTR, and introns	2
different regions of a single gene	2
immunofluorescence and smFISH probes	2
whole-mount Drosophila larval and adult brains	2
thick, complex tissues	2
cytokine IL-1	2
NEMO (NF-κB essential modulator) clusters	2
different biological problems	2
visualization, analysis and exporting tools	2
de novo user interfaces	2
existing TrackMate modules	2
evolving framework	2
TrackMate environment	2
extensible platform	2
several visualization and analysis tools	2
single and multi-channel image variants	2
simple and intuitive user interface	2
single-particles	2
Fiji plugin	2
open source	2
unligated linker	2
duplicated sequences	2
sample barcodes	2
short fragments of mRNA	2
cDNA library	2
different physiological contexts	2
mRNA’s ORF	2
assembly of polypeptides	2
accessory factors	2
reactions	2
longer RNA substrates	2
short synthetic RNAs	2
multi-protein Ccr4-Not and Pan2-Pan3 complexes	2
vitro deadenylation assay	2
deadenylation enzymes	2
3′ end of almost every eukaryotic mRNA	2
bright-field and dark-field imagery	2
label free detection channels	2
human eye	2
otherwise unappreciated populations of cells	2
IFC-derived data sets	2
automated cell classifier	2
CellProfiler Analyst	2
“user-friendly” platforms	2
high-dimensional data	2
cells and subcellular compartments	2
image processing pipeline	2
open-source software CellProfiler	2
imaging flow cytometer (the proprietary .cif file format	2
data files	2
digital imagery	2
complex, often heterogeneous biological samples	2
high content, information rich image data	2
CRISPR/Cas9 edited founders	2
wide range of protocols	2
new mutants	2
mosaic founders	2
sequencing and computational tools	2
modern biological computational tools	2
polypeptides and proteins	2
scientific discoveries	2
distinct species	2
random molecules	2
large pools (libraries)	2
Multispectral imaging flow cytometry	2
fluorescently labeled LC3 and lysosomal markers	2
fluorescently labeled LC3 puncta	2
cytoplasmic LC3	2
dysfunctional organelles and cellular components	2
every cell	2
multispectral imaging flow cytometry	2
researcher	2
RNA and RNA-RNA interactions	2
Functional RNA molecules	2
individual replication forks within living cells	2
helicase genes	2
G4 quadruplexes	2
progressing replication forks	2
DNA helicases	2
microRNAs, bacterial small RNAs	2
RNA-DNA hybrid and RNA-RNA duplexes	2
2D ROESY NMR spectroscopy	2
short RP and SP mP-modified RNA diastereomers	2
combination of anion-exchange and reversed-phase HPLC	2
RP and SP-configurated RNA diastereomers	2
mP-modified RNA	2
proteins or small molecules	2
nucleic acid backbone and binding partners	2
valuable probe	2
Methylphosphonate(mP)-modified RNA	2
unwind DNA substrates	2
nucleoprotein substrates	2
unwind nucleic acids	2
naked DNA and RNA	2
protein-nucleic acid complexes	2
true substrates of helicases	2
many different types of proteins	2
naked nucleic acids	2
nucleic acid duplexes	2
nucleic acid lattice	2
subfamily of translocases	2
http://genesilico.pl/trnamodpred/.	2
eukaryotic tRNAs	2
another source	2
one species	2
newly sequenced genomes	2
query tRNAs	2
MODOMICS database	2
known tRNA modification enzymes	2
proteome of a cell	2
set of protein sequences	2
input one or more unmodified tRNA sequences	2
tRNA sequences	2
computational method tRNAmodpred	2
different tRNA molecules, organisms and organelles	2
various types of modifications	2
several different enzymes	2
numerous chemically altered nucleosides	2
RELION image-processing package	2
test cases	2
widely available motion correction packages	2
relatively small protein complex	2
high symmetry virus, flexible protein complex	2
RELION and standalone motion correction and centring programs	2
several scripts	2
sample particles	2
cryo electron microscopy samples	2
range of software	2
improved CMOS cameras	2
direct electron detectors	2
CCP-EM software suite	2
Flex-EM	2
newly processed map of Apo-GroEL	2
different biological systems	2
intermediate-to-low resolution density maps	2
Flex-EM/MODELLER	2
Three Dimensional Electron Microscopic reconstructions	2
image processing software	2
imaging hardware	2
negative staining	2
preparing samples	2
intact eukaryotic cells	2
multiply charged peptide and protein ions	2
selected ion species	2
singly charged ion species	2
multiply charged	2
extraction field	2
multiply charged species	2
singly charged species	2
electric ion extraction field	2
multiply charged ions	2
desolvation region	2
desorbed plume	2
AP-to-vacuum inlet	2
MALDI plume	2
ion source	2
generated ions	2
atmospheric pressure (AP) MALDI ion sources	2
predominantly multiply charged ions	2
iPSC culture	2
standardized donor vectors	2
human iPSC culture	2
CAG promoter-driven transgenes	2
PPP1R12C gene	2
exemplary locus	2
pre-defined loci	2
nuclease technologies	2
popular TALEN and CRISPR/Cas9	2
randomly integrated transgenes	2
virus or transposon vectors	2
isogenic or diverse genetic backgrounds	2
iPSC sub-clones	2
differentiation reporters	2
constitutive cell labels	2
cryo-EM field	2
irregular complexes, organelles or whole cells	2
processing software	2
image recording	2
zebrafish larvae	2
image collection	2
VAST Pipettor	2
Petri dish or other container	2
individually targeted larvae	2
LP Sampler	2
well of a 96 well plate	2
bulk reservoir	2
another larva	2
subsequent larvae	2
specific part of each larva	2
larva	2
desired tissue or organ system	2
confocal or fluorescence microscope	2
upright microscope	2
on-board camera of the system	2
2–7 dpf zebrafish larvae	2
zebrafish researchers	2
set of tools	2
VAST BioImager system	2
novel platforms	2
complex cell populations	2
96-well plates	2
described assay	2
human iPSC lines	2
high-content platform	2
key determinant components	2
large panel of cell lines	2
human iPSC initiative (HipSci)	2
large cohorts of healthy and diseased individuals	2
comprehensively characterise cells	2
FISH probes	2
images of pairs of transcripts	2
charged-coupled-device camera	2
laboratories (i.e., a wide-field fluorescence microscope	2
light microscope	2
two different nascent transcripts	2
intronic probes	2
specific human genes	2
Nascent transcripts	2
diverse backgrounds	2
genome-edited iPS cell clones	2
specific sgRNAs	2
genomic sequences of iPS cells	2
human iPS cells	2
CRISPR–	2
OME specifications	2
facilities and public data repositories	2
HCS experiments	2
Bio-Formats and OMERO	2
experimental and analytic metadata	2
image data	2
several HCS screening systems	2
recorded image data	2
Java library	2
Bio-Formats	2
metadata specification	2
OME Data Model	2
several open source tools	2
OME Consortium	2
wider community	2
different data	2
multiple, large sets of heterogeneous structured and unstructured data	2
transgenic platform	2
bacterial artificial chromosomes	2
large genomic DNA constructs	2
function discovery tool	2
examples of proteins	2
mKO2 tagged Cysteine proteinase 1 (Cp1) and Troponin-I (TnI)	2
live markers	2
new fluorescent proteins	2
abdominal muscles	2
fixed pupal tissues	2
confocal microscopy	2
Macrozoom microscopy	2
smaller population of persistent muscles	2
doomed muscles	2
alternative fates of larval muscles	2
recombinant eukaryotic membrane proteins	2
difficult targets	2
membrane protein structures	2
488nm excitation	2
1.49 NA objective	2
final instrument	2
electronic components	2
double-sided scanning mirror	2
array of pinholes	2
two lenslet arrays	2
three micro-optics arrays	2
many optical components	2
“instant structured illumination microscope” (iSIM)	2
http://biocomp.chem.uw.edu.pl/CABSdock/.	2
CABS-dock web server	2
chosen receptor fragments	2
user’s friendly web server	2
known binding site	2
protein receptor surface	2
cell-cycle annotated genes	2
previously published datasets	2
captured cell	2
dividing populations of cells	2
large numbers of single cells	2
freely available, custom-written analysis software	2
different commonly used green emitting fluorescent dyes	2
unmodified turnkey commercial system	2
far-red fluorescent emitters	2
custom-built setups	2
STED-FCS technology	2
membrane-incorporated labelled entities	2
STED-FCS	2
STED microscopy	2
cellular and model membranes	2
covalent bonds	2
protein cross-linking	2
larger and more complex systems	2
two machineries	2
pure, transcription-coupled-to-translation system	2
transcriptional apparatus	2
fellow RNAP molecules	2
cellular entities	2
RNA polymerase (RNAP) complexes	2
two new inhibitors	2
self-assembly of Aβ40	2
positive, negative, non-specific binding, or colloidal)	2
self-assembly pathways	2
heterogeneous mixture of assembling species	2
transiently populated intermediate	2
RING-finger ubiquitin ligases in solution	2
RING-finger domain of ICP0	2
variety of cellular proteins	2
viral RING-finger E3 ubiquitin ligase	2
first proteins	2
co-evolution viruses	2
poly-ubiquitin chain	2
ubiquitin–proteasome system	2
STBEX in normal and pathological pregnancies	2
STBEX detection	2
anti-PLAP Dynabead capture	2
fl-NTA	2
PLAP positive EV	2
placental perfusate	2
PLAP positive	2
Individual 10KP and 150KP samples (n=8)	2
samples/pool)	2
‘standard’ 10KP and 150KP pools	2
PLAP and exosome markers	2
150,000×g pellet	2
STB marker placental alkaline phosphatase (PLAP) and a STB exosome (STBEX) fraction (	2
10,000×g pellet	2
STB microvesicle (STBMV) fraction	2
fresh placental perfusates	2
contaminating red blood cells	2
human placental perfusate (n=8)	2
microvesicle and exosome enriched fractions	2
Fluorescence Nanoparticle Tracking Analysis (fl-NTA)	2
conventional flow cytometry	2
STBEV	2
multiple types and sizes of syncytiotrophoblast (STB) extracellular vesicles (EV)	2
wild-type, native protein	2
kinetically trapped, three-helical folding intermediate	2
amino acid side-chains	2
four-helical bacterial immunity protein	2
proteins (FPOP)	2
partially folded intermediate species	2
globally unfolded/disordered structures	2
sorter	2
waste stream or center stream catch (CSC)	2
original pre-sort sample	2
target and non-target populations	2
calculation	2
original particles	2
rare populations and precious samples	2
particles in the sorted fraction	2
sort product	2
original sample	2
target particles	2
sorted fraction	2
existing databases	2
manually curated associations	2
sentences	2
biomedical abstracts	2
disease–gene associations	2
flexible technology	2
given gene product	2
popular model Drosophila	2
proteins, lipids, nucleic acids, glycogen, and even whole organelles	2
‘enhanced-mitophagy’ assay	2
mitochondria en masse	2
markers/tracers	2
majority of assays	2
spectrum of pharmaceutical drugs	2
damaged and misfolded proteins	2
hypomethylated transcription factor binding motifs	2
TCGA data	2
probe-dense regions	2
Probe Lasso	2
colon cancer- and healthy colon-samples	2
sub-sample	2
neighbouring significant-signals	2
discreet differentially methylated regions (DMRs)	2
significant hits	2
Illumina 450K BeadChip	2
vitro fusion assay	2
small single-membrane autophagic precursors containing ATG16L1 and mATG9 proteins	2
autophagosome precursor structures	2
different compartments	2
important catabolic pathway	2
XPLOR-NIH platform	2
homodimers of Vps75	2
histone chaperone Vps75	2
engineered sties	2
thio-reactive nitroxyl spin locations	2
generate models	2
Orienting domains	2
larger multi domain polypeptides or complexes	2
new 450k users	2
currently most popular pipelines and packages	2
numerous integrated analysis pipelines and stand-alone packages	2
International Cancer Genome Consortium (ICGC) and the International Human Epigenome Consortium (IHEC)	2
epigenome-wide association studies (EWAS) and related projects	2
popular platform	2
450K BeadChips	2
recently developed oxidative bisulfite (oxBS) chemistry	2
Infinium HumanMethylation450 (450K) BeadChip	2
high-throughput applications	2
open source platforms	2
Drosophila researchers	2
Drosophila model system	2
systems level image datasets	2
Drosophila research community	2
complex bioimage informatics pipelines	2
large scale projects	2
emerging research field	2
Bioimage Informatics	2
imagery	2
entire populations of adult organisms	2
sophisticated imaging technologies	2
molecular and cellular components	2
advanced genetic toolkit of Drosophila	2
microscopic imaging	2
established and emerging tools	2
powerful genetics	2
highly conserved pathway	2
many of the lines	2
variety of lines	2
“hyb” software	2
BLAST, BLAST+, BLAT, pBLAT and Bowtie2 read alignment programs	2
test dataset	2
high-throughput sequencing datasets	2
chimeric reads	2
CLASH experiments	2
“hyb” bioinformatics pipeline	2
non-chimeric cDNA reads	2
chimeric sequences	2
single chimeric RNA molecule	2
two RNA molecules	2
RNA–RNA duplexes	2
two proteins, Sam68 and T-STAR	2
protein-single stranded RNA complexes	2
RNA targets	2
identified RNA binding proteins (RBPs)	2
passive molecules	2
direct and indirect RNA–protein interactions	2
reconstituting RNAs	2
homogenous RNA	2
current state of technology	2
RNA–protein complexes	2
large number of RNA–protein complexes	2
virtual and biochemical screening	2
active-site directed compounds	2
“open” PTP structures	2
PTP-directed small molecules	2
potent and selective PTP inhibitors	2
important biological tools	2
individual PTPs	2
human PTP genes	2
Protein tyrosine phosphatases (PTPs)	2
suitable and safe immunotherapies	2
suitable therapy	2
component resolved concept	2
extract-based	2
elaborate in vivo assays	2
fast and cheap in vitro assays	2
fold and IgE binding epitopes	2
spectrum of allergy eliciting proteins	2
experimentally obtained epitopes	2
currently available allergen-antibody complexes	2
protein fold families	2
surface exposed areas	2
major allergens	2
zebrafish genome	2
F2 families	2
mutagenised males	2
cryopreserving sperm samples	2
F1 founder	2
F2 parents and individual F3 fry	2
Allele-specific PCR single nucleotide polymorphism (	2
multiple alleles	2
every protein-coding gene	2
loss of function allele	2
zebrafish mutation project (ZMP)	2
conventional qPCR	2
1440 lymphoblastoid cells	2
microfluidic arrays	2
large number of single cells	2
eukaryotic transcripts	2
multiple signalling pathways	2
Specific inhibition	2
individual Notch family members	2
multitude of other signalling pathways	2
4 Notch receptors	2
widely used small molecule γ-secretase inhibitors	2
mouse and human neural stem cells	2
immediate Notch target gene hairy and enhancer of split 5 (Hes5)	2
human and mouse origin	2
stem cell systems	2
highly specific inhibitors	2
cell-based luciferase reporter assays	2
NRR of Notch2	2
four antibodies	2
NRR of Notch1	2
Six antibodies	2
ligand binding domain or the negative regulatory region (NRR) of Notch1 and Notch2	2
antibody phage display library	2
single chain Fvs	2
Anti-Notch antibodies	2
individual family members	2
specific Notch receptors	2
cell surface ligands	2
four different mammalian Notch receptors	2
chromatin and chromatin-bound protein complexes	2
demembranated sperm nuclei	2
Xenopus cell-free system	2
paired sister chromatids	2
eukaryotic cell cycle	2
eggs of the South African clawed toad, Xenopus laevis	2
cell-free extracts	2
cloned targets	2
diffracting crystals	2
selected protein target	2
automatically generated and annotated multiple sequence alignment	2
putative homologues	2
pool of possible alternative targets	2
Scottish Structural Proteomics Facility (SSPF)	2
structural proteomics pipeline	2
expression system	2
homologous protein	2
Selected targets	2
high resolution structural model	2
respective phosphopeptide in samples	2
extracted ion chromatograms	2
MS/MS gradient runs	2
hundreds of peptides	2
abundant unmodified peptides	2
phosphorylated peptides	2
piggyBac resources	2
Sleeping Beauty transposon system	2
piggyBac transposon system	2
disrupted loci	2
attractive system	2
(2007)	2
phenotype projects	2
178 strains	2
nine commonly used inbred strains	2
cohorts of animals	2
laboratory mice	2
inbred strains of mice (Paigen and Eppig (2000) [1])	2
Jackson Laboratory	2
excellent structural and sequence databases	2
right system	2
structurally related proteins	2
medium to large cohorts	2
human genomic DNA	2
unmethylated counterparts	2
vitro methylated λ-DNA fragments	2
methylated DNA immunoprecipitation (MeDIP) assay	2
ideal whole genome methylation (methylome) assay	2
different pluripotency genes	2
one donor cell-type	2
cultured somatic cell nuclei	2
pluripotency and housekeeping genes	2
endogenous maternal transcripts	2
mammalian nuclei	2
oocytes and early embryos	2
GV	2
nuclei of mammalian somatic cells or cultured cell lines	2
Germinal Vesicle (GV)	2
immensely enlarged nucleus	2
first meiotic prophase	2
Full-grown Xenopus oocytes	2
yeast to vertebrate cells	2
side of microtubules	2
‘centromere reactivation system’	2
kinetochores	2
individual kinetochore–	2
multiple kinetochores	2
confocal and multiphoton microscopy	2
different fluorescent probes	2
standard fluorescence microscope	2
physical basis	2
unusually thin region of fluorescence excitation	2
cell–substrate regions	2
neurons, endocrine, neuroendocrine and exocrine cells	2
ubiquitous second messenger	2
loop regions of G-DNA molecules	2
G-DNA stem	2
possible kinetic intermediates	2
base substitutions (inosine, thioguanine and mixed tetrads)	2
G-DNA stems	2
G-DNA	2
gas phase simulations	2
classical explicit solvent molecular dynamics simulations	2
force fields	2
sugar-phosphate backbone and ions	2
H-bonding	2
empirical force fields	2
guanine quadruplex (G-DNA) molecules	2
Vi-IgGR1	2
anti-Vi IgG	2
coating of Vi and protein	2
commercial ELISA and in-house ELISAs	2
16/138 and Vi-IgGR1, 2011	2
in-house ELISAs	2
biotinylated Vi	2
U.S. reference reagent Vi-IgGR1, 2011	2
plain Vi vaccine	2
volunteers which received either Vi conjugate vaccine	2
pool of sera	2
human anti-Vi IgG. 16/138	2
infants and young children	2
Vi capsular polysaccharide (Vi) conjugate vaccines	2
light obscuration	2
parenteral drug products	2
poliovirus type 2 potency	2
p < 0.0001) and type 3	2
poliovirus type 1	2
IPOL vaccine	2
exposures	2
vitro potency	2
Freezing VeroPol	2
subset of exposed IPVs	2
vaccine vial	2
Sanofi Pasteur (IPOL)	2
Statens Serum Institut (VeroPol) and multi-dose vaccine vials	2
samples of single-dose vaccine vials	2
freezing IPVs	2
ongoing immunization services	2
oral poliovirus vaccine	2
inactivated poliovirus vaccines (IPVs)	2
non-therapeutic proteins	2
Prolastin, Alfalastin, and Trypsone	2
Additional protein bands	2
main protein band	2
Trypsone 88.0%, Prolastin 78.0%, and Alfalastin 69.5%	2
Alfalastin 88.1%, Prolastin 76.9%, and Trypsone 70.8%	2
Europe (Respreeza, Prolastin, Alfalastin, Trypsone)	2
four plasma-derived α1-PI products	2
α1-PI concentrates	2
purified plasma-derived alpha1-proteinase inhibitor (α1-PI) concentrates	2
biosimilarity	2
US-licensed reference pegfilgrastim	2
in vitro and in vivo bioactivity	2
US-licensed pegfilgrastim reference product	2
in vitro proliferation assays	2
proposed pegfilgrastim biosimilar	2
Intas Pharmaceuticals Limited	2
long-acting form	2
pegylated form of filgrastim, “pegfilgrastim”	2
chemotherapy regimen	2
human granulocyte-colony stimulating factor (G-CSF, filgrastim)	2
stable and pure product	2
tested viruses	2
non-enveloped hepatitis A virus	2
Pasteurisation inactivated enveloped viruses	2
validated scale-down models	2
aliquots of production intermediates	2
test viruses	2
therapeutic preparation of A1PI,	2
two reagents	2
two different capture reagents	2
circulating therapeutic aglycosylated IgG1 (MAB3) in human subject	2
complex matrix	2
certain subpopulations of the target of interest	2
capture reagents	2
Capture reagents	2
pig and broiler farms	2
air samples	2
thermophilic Campylobacter spp.	2
livestock samples	2
real samples	2
artificially contaminated surfaces	2
swab samples	2
surface water samples	2
attenuated live vaccine strain of Francisella tularensis subsp.	2
Bacillus anthracis	2
Gram-positive Bacillus thuringiensis Berliner var.	2
magnetic particles	2
microfluidic chip system	2
DNA from swabs, air, and water samples	2
complex sample matrices	2
complex forming agents and nonionic surfactants	2
Factor C of Limulus-based detection systems	2
supramolecular structure of endotoxin	2
even hazardous amounts of endotoxin	2
nonionic surfactants and components	2
various buffer systems	2
samples containing nonionic surfactants	2
drug products	2
biopharmaceutical drug products	2
broad field of applications	2
endotoxins (Lipopolysaccharides)	2
Limulus Amebocyte Lysate (LAL)	2
free cysteine-34	2
albumin preparation	2
free cysteine-34.Commercially available albumins	2
albumins	2
albumin from LFB (Vialebex®)	2
different albumins	2
hydroxyl, peroxyl or free radicals	2
four commercially available albumins	2
pharmaceutical human albumin preparations	2
viruses, impurities, and non-human glycan structures	2
highly pure product	2
two non-human glycans	2
Terminal galactose-α-1,3-galactose and N-glycolylneuraminic acid	2
four model viruses (xenotropic murine leukemia virus, mice minute virus, reovirus type 3, and suid herpes virus 1)	2
8–15 log10	2
impurities and viruses	2
293H cells	2
virus removal nanofilter	2
novel affinity chromatography adsorbent	2
scalable unit operations	2
potential impurities and viruses	2
rFVIIIFc manufacturing process	2
long-acting coagulation factor	2
Recombinant factor VIII Fc fusion protein (rFVIIIFc)	2
trafficking or scaffold proteins	2
transgenic tissue and non-neural cell lines	2
Cx36-deficient mouse	2
fixed and living tissue	2
Cx36-EGFP reporter	2
distributed electrical synapses	2
fluorescent puncta	2
genomic locus	2
transgenic mice expressing Cx36	2
Cx36-EGFP transgenic	2
many brain regions	2
(Cx36)-containing electrical synapses	2
Connexin 36	2
differentiation	2
blastomere or blastomere-like program	2
developmental hierarchy	2
damaged or aged mature somatic cells	2
two haploid gametes	2
four points	2
tenet of this model	2
unified dualistic model	2
stress-induced PGCCs	2
Polyploid giant cancer cells (PGCCs)	2
Differentiated somatic cells	2
differentiated somatic cells	2
Waddington’s epigenetic landscape	2
new embryonic genome	2
parental genome	2
haploid sperm and egg	2
organoid and mouse models	2
novel Cas9 variants	2
CRISPR/Cas9 and modified versions	2
emerging immune biomarkers	2
key mechanisms	2
majority of CRC patients	2
immunosuppressive tumor microenvironment	2
poorly antigenic tumor cells	2
complex tumor microenvironment	2
MMRp/MSS tumors	2
mismatch-repair proficient (MMRp)/microsatellite stable (MSS) tumors	2
MMRd/MSI tumors	2
metastatic setting	2
particular genetic subgroup of mismatch-repair deficient (MMRd)/microsatellite instable (MSI) CRC	2
cancer immunotherapies	2
downstream effector targets	2
epigenetic and transcriptional co-regulators	2
upstream modifiers	2
type of oncogenes	2
fusion protein PAX3-FOXO1	2
recurrent fusion transcription factors	2
Driver oncogenes	2
equilibrated diet	2
medical nutritionist	2
“food complements	2
food-related component	2
metastatic cancers	2
certain types of cancers	2
established cancer	2
foods, nutrients and nutraceuticals	2
diverse set of biological pathways	2
various types of non-coding RNAs	2
requisite ‘writer’ proteins	2
DNA or histones	2
vast majority of patients	2
BCR-ABL1	2
tyrosine kinase inhibitors (TKI)	2
constitutively active tyrosine kinase BCR-ABL1 fusion protein	2
hematopoietic stem cell (HSC)	2
Chronic myeloid leukemia (CML)	2
ovarian cancer stem cells (OCSC)	2
ovarian cancers	2
serous intra-epithelial carcinoma (STIC)	2
ovarian surface epithelium (OSE)	2
Ovarian cancer	2
abdominal cavity	2
extensive metastases	2
highly lethal disease	2
pivotal factors	2
liver and lungs	2
metastatic PDAC cells	2
ABCG2 and c-Met	2
miR-200 family	2
metastatic program	2
extremely aggressive neoplasm	2
Esophageal CSC markers	2
esophageal CSCs and related metastases	2
tumor sub-population of so-called cancer stem cells (CSCs)	2
highly aggressive tumors	2
Esophageal cancers (EC)	2
PDAC metastasis	2
patient selection tools	2
Kuppfer cells in the liver	2
pre-metastatic niches	2
distant organ	2
mesenchymal transcriptomic subtype	2
multiple heterogeneous subclones	2
Key mutated driver genes	2
extremely aggressive malignancy	2
crucial therapeutic targets	2
downstream transcriptional targets and functions	2
FOXO3-FOXM1 axis	2
FOXO3 and FOXM1 transcription factors	2
conventional and newly emerged molecularly targeted therapies	2
essential PI3K-Akt, Ras-ERK and JNK/p38MAPK signalling cascades	2
FOXO3 and FOXM1 forkhead box transcription factors	2
CSC-targeting agents	2
microRNA-mediated pathway inhibitors	2
Wnt and Hedgehog	2
developmental signalling pathways	2
potential CSC targets	2
cancer researchers	2
TGFβ pathway	2
TGFβ target genes	2
TGFβ-driven transcription	2
tumour promoter	2
Transforming Growth Factor-beta (TGFβ) pathway	2
multiple cancer hallmarks	2
highly interconnected FBPs	2
SCF-type ligases and other ubiquitin ligases	2
common signalling hubs or response pathways	2
multiple FBPs	2
oncogenes and tumour suppressor genes	2
substrate specifying subunit of Skp1-Cul1-FBP (SCF)-type E3 ubiquitin ligases	2
F-box proteins (FBP)	2
hallmark areas	2
wide range of high-priority targets	2
hallmark area	2
interdisciplinary teams	2
many key pathways and mechanisms	2
180 scientists	2
international task force	2
alternate and compensatory pathways	2
therapy-resistant immortalized cells	2
prostate cancer and other cancer types	2
AR antagonists (anti-androgens)	2
androgen synthesis	2
Androgen receptor (AR)	2
conventional cytotoxic regimens	2
cyclin dependent kinases or components of the PI3K signaling pathway	2
conventional genotoxic drugs	2
suppressors	2
tumor suppressors p53 and p16/pRB	2
oxidative environments	2
DNA damaging agents	2
hedge	2
malignant cell populations	2
important areas	2
prioritized target sites	2
priority approaches	2
vitamin D and B, selenium, carotenoids, PARP inhibitors, resveratrol, and isothiocyanates	2
centrosome clustering	2
five priority targets	2
many different pathways	2
affected patient	2
potent anti-tumor cocktails	2
anti-angiogenic compounds	2
essential tumorigenic pathways	2
broader acting and more effective inhibitory cocktail	2
plant-derived compounds	2
(10) resveratrol	2
enterolactone, (9)	2
(1) oleanolic acid, (2) tripterine, (3) silibinin, (4) curcumin, (5) epigallocatechin-gallate, (6) kaempferol, (7) melatonin, (8)	2
prototypical phytochemical compounds	2
broadly acting anti-angiogenic natural products	2
tumor promoting fibroblasts	2
tumor vessels	2
pathological tumor vasculature	2
mixture of non-toxic natural compound	2
different angiogenic factors	2
important target”	2
anti-angiogenic drugs	2
subset of the patients	2
clinically approved anti-angiogenic drugs	2
growing tumors	2
existing vasculature	2
new blood vessels	2
HTLV-1 clonality	2
HTLV-1-infected T cell clones	2
expanded clones of HTLV-1-infected T cells	2
adult T-cell leukaemia/lymphoma (ATLL)	2
Human T lymphotropic virus type 1 (HTLV-1)	2
β-blockers	2
Relevant signal pathways	2
nicotine and β-adrenoceptors	2
adrenoceptors in tumour tissues	2
β-Blockers	2
Nicotine and its derivatives	2
Stress hormones	2
various tissues of the body	2
β-Adrenoceptors	2
patients with cancer	2
obatoclax, (−)-gossypol, and ABT-263	2
BH3-only proteins	2
malignancies	2
Bcl-2 family of proteins	2
gastrointestinal cancers	2
Bcl-2 family	2
another important pathway	2
different proteins of Bcl-2 family	2
cancer applications	2
individual “hits” or “targets	2
network framework	2
numerous research groups	2
virus-associated cancers	2
first virus	2
Epstein-Barr virus	2
deregulated Myc	2
Latency-associated EBV gene products	2
nuclear extra-chromosomal episomes	2
latent Epstein–Barr virus (EBV)	2
subset of BL	2
activated oncogenes	2
immunoglobulin gene loci	2
Myc oncogene	2
aggressive B cell tumour Burkitt's lymphoma (BL)	2
endocrine systems	2
non-retinal light reception	2
ERP research	2
conserved roles and distributions of ERPs	2
comparative framework	2
Ubiquitous in non-mammalian vertebrates, extra-retinal photoreceptors (ERPs)	2
GIP in the upper small intestine	2
high GI carbohydrates	2
K cells	2
intact glucose-induced insulinotropic peptide receptor (GIPR)	2
GI sucrose	2
slowly digestible, completely absorbable, low glycemic index (GI) sugar isomaltulose	2
glucose–fructose dimers	2
key modulator	2
several pathways	2
key protein complex	2
mammalian or mechanistic Target of Rapamycin (mTOR) Complex-1 (mTORC1)	2
new partner of metabolic enzymes	2
numerous metabolic enzymes	2
RNA-binding activity	2
many metabolic enzyme genes	2
areas of biology	2
diverse animals	2
human lifespan	2
whole-genome and -exome sequencing (WHS and WES)	2
islet genome	2
susceptibility variants	2
causative transcripts	2
mystery	2
best understood transcriptional regulators	2
Nuclear receptors	2
useful therapeutic target	2
ovary, uterus, placenta, testis and prostate	2
olfactory and gonadotropin-releasing hormone systems	2
multifunctional secreted proteins	2
growth-limited inter-follicular NHEKs	2
formulations combining l-cystine and thiamin	2
l-cystine and thiamin	2
P-IC components	2
P-IC-treated cells	2
cells in MGM	2
calcium d-pantothenate and folic acid	2
50 μM)	2
l-cystine	2
-in vitro correlate; P-IC)	2
combination of these (Panto[vi]gar	2
l-cystine, thiamin, calcium d-pantothenate and folic acid (a proposed metabolite of p-aminobenzoic acid)	2
following four ingredients	2
Test compounds	2
MGM plus test compound	2
keratinocyte basal medium lacking cystine, thiamin, calcium d-pantothenate, folic acid and biotine (minimal growth medium [MGM])	2
keratinocyte basal medium	2
growth-limited NHEKs	2
diffuse telogen effluvium	2
oral formulation containing l-cystine, thiamin, calcium d-pantothenate, medicinal yeast, keratin and p-aminobenzoic acid (Panto[vi]gar®)	2
hair-follicle-associated keratinocytes	2
normal human epidermal keratinocytes (NHEKs) of the epidermal skin layer	2
sun care actives	2
oleosome-based sun care formulations	2
sun screen actives	2
vitro reconstructed human tissues	2
commercial formulation	2
sunscreen actives	2
experimental oleosome-based SPF 30 product	2
commercial SPF 30 formulation	2
experimental oleosome-based SPF 30 formulation	2
IL-1α, IL-6 and IL-8	2
Untreated tissues	2
arachidonic acid cascade marker PGE2	2
Inflammatory cytokines IL-1α, IL-6 and IL-8	2
commercial SPF 30 beach product	2
Experimental oleosome-based SPF 30 product	2
MatTek EpiDerm™ tissues	2
topically applied sunscreens	2
vitro human epidermal skin equivalent tissues (MatTek EpiDerm™)	2
aeroterrestrial algae	2
cytoplasm and plastids	2
charopyhte algae	2
snow algae	2
ambient air	2
Chloromonas sp. and in the charopyhte algae	2
naturally occurring secondary carotenoids	2
Chlamydomonas nivalis and Chlainomonas sp.	2
microalgae	2
Zygogonium ericetorum and Klebsormidium crenulatum)	2
snow algae (Chlamydomonas nivalis, Chlainomonas sp. and Chloromonas sp.) and charophyte green algae (Zygnema sp.,	2
ideal objects	2
aeroterrestrial habitats	2
Snow algae and green algae	2
multiple active site residues	2
photochemistry	2
Several of the POR variants	2
coenzyme or substrate	2
new improved structural model	2
previous homology models	2
proposed NADPH/Pchlide binding site	2
number of residues	2
number of active site variants	2
POR and active site residues	2
Pchlide molecule	2
protochlorophyllide (Pchlide)	2
Protochlorophyllide oxidoreductase (POR)	2
Schiff base ligand	2
three different cancer cell lines	2
fluorescence quenching spectra	2
Cu (II) complex	2
two compounds to CT-DNA (1:2)	2
calf thymus DNA and BSA	2
new ligand and complex	2
[Cu(C20H22NO3)2]·H2O	2
copper (II) complex	2
novel Schiff base [C20H23NO3],	2
non-treated control	2
UV-B exposed samples	2
especially tyrosine and guanosine	2
Respective compounds	2
UV radiation	2
aromatic amino acids, nucleic bases and nucleosides	2
primary polar metabolites	2
UV-A radiation (315–400nm)	2
sun simulator	2
alpine habitat	2
four algal species	2
specialized autotrophic microorganisms	2
restricted biological diversity	2
high ultraviolet (UV) radiation	2
high mountain habitats	2
Extremophilic green algae and cyanobacteria	2
chain segments	2
prime-sites	2
helical structure	2
2,2,2-trifluoroethanol (TFE)	2
spectroscopic tools	2
firefly luciferase	2
larger cohorts of patients	2
serum carbonylated proteins	2
serum fibronectin and hyaluronic acid	2
moderate to severe facial photoaging	2
sebum and tonicity 2weeks	2
dietary supplement VISCODERM®	2
hyaluronic acid and fibronectin	2
elastin and carbonylated proteins	2
hydration and tonicity	2
Facial sebum	2
VAS photoaging score	2
patients affected	2
carbonylated proteins	2
hyaluronic acid	2
Facial photoaging	2
Dietary supplement and placebo	2
n=15)	2
Pearls; IBSA FARMACEUTICI ITALIA Srl, Lodi, Italy) containing Pycnogenol®, collagen, coenzyme Q10, low-molecular-weight hyaluronic acid, chondroitin sulfate and glucosamine sulfate (n=15) or placebo	2
pharmaceutical formulation (VISCODERM®	2
30 women	2
first study	2
fibronectin, elastin, neutrophil elastase 2, hyaluronic acid and carbonylated proteins	2
potential druggable sites	2
class F GPCR	2
TM domain of SMO	2
well-defined cholesterol interaction site	2
extracellular tips of helices TM2 and TM3	2
class A GPCRs	2
cholesterol containing lipid bilayers	2
transmembrane (TM) domain	2
class F G-protein-coupled-receptor (GPCR) Smoothened (SMO)	2
Hedgehog signals	2
allosteric modulators	2
springboard	2
bound lipids	2
A2aR-mini-Gs association	2
in vivo-mimetic membrane model	2
different conformational states	2
Adenosine A2a receptor	2
HAP2 interaction sites	2
mucin-like region	2
EGF-like motifs	2
cystine ladder-like module	2
insertions	2
viral class II proteins	2
additional species-specific motifs	2
horseshoe-shaped arrangement	2
three amphipathic helices	2
target membrane interaction surface	2
green alga Chlamydomonas reinhardtii HAP2 ectodomain	2
available X-ray structure	2
several species-specific functional regions	2
species gametes	2
several eukaryotic kingdoms	2
viral class II fusion proteins	2
cellular fusion protein HAP2	2
different cargoes	2
tryptophan-acidic cargoes	2
KLC TPR domains	2
unbound KLC TPR domain	2
JIP3 binding	2
TPR1s	2
two KLC2 TPR domains	2
KLC TPR1	2
kinesin-1 cargo binding site	2
cargo JIP3	2
crystal structure of the KLC2 tetratricopeptide repeat (TPR) domain	2
kinesin-1 light chain (KLC)	2
numerous cellular cargoes	2
proteinase	2
rest of the trimer	2
proteolytic cleavage site	2
N-terminal region of one CPIII chain	2
two different chains of CPIII	2
two CUB domains	2
C-propeptide trimer of procollagen III (CPIII)	2
active CUB1CUB2 fragment of PCPE-1	2
fibrillar procollagens	2
C-propeptides	2
secreted protein	2
SummaryProcollagen C-proteinase enhancer-1 (PCPE-1)	2
near complete EphA2 receptor	2
nanoclusters of PIP molecules	2
kinase surface	2
positively charged patches	2
phosphatidylinositol phosphates (PIPs)	2
transmembrane, juxtamembrane (JM), and kinase domains	2
cytoplasmic region of EphA2	2
receptor tyrosine kinase family	2
bilayer binding surface	2
clusters multiple phosphate head-groups	2
key determinant	2
phospholipid membranes	2
APH PA-sensing hub	2
phosphatidic acid (PA)-enriched membranes	2
surface of the micronemes	2
microneme exocytosis	2
acylated pleckstrin homology domain-containing protein (APH)	2
specific phosphatidic acid effector	2
specialized apical organelles	2
phylum of Apicomplexa	2
falciparum and Toxoplasma gondii	2
3D electron microscopy maps	2
scoring function	2
crosslink data	2
attachment receptors	2
receptor fragment of GT1b ganglioside	2
native, infectious BKV	2
3.4-Å cryoelectron microscopy structure	2
full repertoire of cellular receptors	2
infectious BKV virion	2
capsid assembly	2
multivalent BKV vaccine	2
immunosuppressed patients	2
polyomavirus (BKV)	2
atomistic modeling	2
Fc isotypes	2
IgG1, IgG2, and IgG1 Fc with mutations (M255Y/S257T/T259E)	2
engineered specific Fc-FcγR interactions	2
specific Fc receptors (FcγRs)	2
SummaryFragment crystallizable (Fc) region of immunoglobulin G (IgG) antibody	2
shallow membranes	2
shallow eisosomes	2
curved eisosomes	2
dense protein coat	2
 eisosomes	2
BAR protein Pil1	2
scaffold-like membrane coats	2
yeast plasma membrane compartments	2
BAR-domain coating	2
elusive protein assemblies	2
vitreous sections	2
crowded cellular environments	2
elusive structures	2
thick cells	2
native cellular context	2
wide variety of sequences	2
glycine or alanine	2
acceptor serine	2
peptide binding cleft	2
sugar donor, UDP-xylose, and various acceptor peptides	2
human xylosyltransferase 1 (XT1)	2
selected serine residues	2
peptide O-xylosyltransferases	2
core protein and long glycosaminoglycan (GAG) chains	2
animal extracellular matrix	2
SummaryProteoglycans (PGs)	2
rank-ordered list of related PDB structures	2
cognate reactants or products	2
bound and cognate ligands	2
ligand-enzyme complexes	2
cognate ligands	2
biologically relevant bound ligands	2
alternative sigma factors	2
σG and σE	2
treble-clef zinc finger fold	2
single Zn2+	2
symmetrical homodimer	2
 two alternative sigma factors, σG and σE	2
solution structure of anti-sigma factor CsfB	2
anti-sigma factors	2
Sigma factors	2
alternative sigma (σ) factor subunits of RNA polymerase	2
monobody binding	2
previously solved structures	2
bound and uncomplexed sides	2
one side of the channel	2
channel-monobody complex	2
fluoride currents	2
different monobody	2
single-channel electrophysiological recordings	2
primary crystal lattice contacts	2
small, soluble crystallization chaperones	2
(Fluc) channels	2
dual-topology fluoride	2
kinase N-lobe	2
unrelated kinases	2
site-specific information	2
client kinase/Cdc37 complex	2
lobe interface	2
allosteric network	2
determinant	2
stronger client	2
normal and neoplastic cells	2
Hsp90/Cdc37 chaperone system	2
many signaling networks	2
SummaryReceptor tyrosine kinase FGFR3	2
detergent-free environment	2
small membrane proteins	2
SapNPs encircle membrane proteins	2
detergent-solubilized form	2
SapNP-reconstituted proteins	2
different transmembrane cross-sectional areas	2
various types of lipids	2
lipid-bilayer systems	2
lipid and saposin components	2
SapNP formation	2
SummarySaposin-derived lipid nanoparticles (SapNPs)	2
adventitiously bound HEPES, polyethylene glycol, and phosphate molecules	2
binding site residues and water molecules	2
different peptide side chains	2
Ala-Leu, Phe-Ala, Ala-Gln, and Asp-Glu	2
four physicochemically diverse dipeptides	2
PepTSt in complex	2
Streptococcus thermophilus	2
Twenty-eight peptides	2
 different peptide side chains	2
wide range of substrates	2
dietary di- and tripeptides	2
SummaryProton-dependent oligopeptide transporters (POTs)	2
reordering	2
NADH-reduced enzyme	2
ubiquinone-binding site	2
critical structural elements	2
highly active preparation of Bos taurus complex I	2
active complex I	2
energy-conserving inner membrane	2
SummaryComplex I (NADH:ubiquinone oxidoreductase)	2
TssB1C1 sheath	2
structural template	2
P. aeruginosa R2 pyocin	2
T4 phage and R-type pyocins	2
contractile machines	2
sheath structures	2
Vibrio cholerae VipAB and Francisella tularensis IglAB structures	2
T6SS sheath	2
H1-T6SS P. aeruginosa TssB1C1 sheath	2
contractile bacteriophages and pyocins	2
tail sheaths	2
two T6SS components, TssB/VipA and TssC/VipB	2
distinct group	2
three type VI secretion systems (T6SSs), H1-, H2-, and H3-T6SS	2
dimeric Slit2-N ligand	2
Robo1 oligomerization	2
central Ig domains	2
compact dimers	2
negative stain electron microscopy reconstruction	2
Ig1-4 and Robo1 Ig5	2
Slit binding	2
Slit-Robo an attractive therapeutic target	2
important signaling pathway	2
essential repulsive cue	2
(Robo) receptors	2
purified and reconstituted systems	2
bacterial membrane protein YidC	2
medium-resolution cryoelectron microscopy structures	2
expanded two-metal-ion architecture	2
DNA and RNA polymerases, nucleases such as Cas9, and splicing ribozymes	2
many two-metal-ion enzymes	2
structurally conserved positions	2
basic amino acids and monovalent cations	2
the cell	2
 DNA and RNA	2
phosphodiester bonds	2
PDB archive	2
public PDB archive	2
programmatically accessible web service	2
stand-alone web server	2
validation module	2
crystallography, nuclear magnetic resonance, and cryoelectron microscopy communities	2
expert task forces	2
three-dimensional structures of biological macromolecules	2
deposition, biocuration, and validation tool	2
Worldwide PDB	2
cryo-EM structure	2
chaperone-usher pili	2
4.2-Å resolution cryo-EM structure	2
unique and hostile environment of the urinary tract	2
foothold	2
helical pilus rods	2
bladder and kidney	2
type 1 and P pili of uropathogenic Escherichia coli (UPEC)	2
surface of many bacterial pathogens	2
long, supramolecular protein fibers	2
SummaryAdhesive chaperone-usher pili	2
large portion of TamB.	2
TamB963-1138	2
nascent membrane proteins	2
hydrophobic side of an amphipathic β strand	2
β taco structure	2
hydrophobic interior	2
concave, taco-shaped β sheet	2
TamB. TamB963-1138	2
conserved DUF490 domain	2
crystal structure of TamB amino acids 963–1,138	2
TAM	2
partner protein TamA.	2
translocation and assembly module (TAM)	2
unfolded polypeptides	2
“molecular pencil sharpener	2
TldD/E	2
Peptide substrates	2
hollow core of the heterodimer	2
novel metal-containing active site	2
TldD subunit	2
unmodified peptide	2
mature antibiotic	2
modified MccB17 precursor peptide	2
N-terminal leader sequence	2
heterodimeric metalloprotease	2
TldE	2
combination of biochemical and crystallographic methods	2
microcin B17 (MccB17), an Escherichia coli thiazole/oxazole-modified peptide toxin	2
TldE proteins	2
different ECM networks	2
FBN1/LTBP1 binding site	2
flexible pivot	2
two independent epitopes	2
LTBP1 anchors	2
latency-associated propeptide (LAP)/TGF-β binding site	2
C-terminal LTBP1 fragment	2
near-linear domain organization	2
(FBN1E2cbEGF1)	2
four-domain FBN1 fragment, EGF2-EGF3-Hyb1-cbEGF1	2
major reservoir of TGF-β	2
FBN1 binds latent TGF-β binding proteins (LTBPs)	2
key mitochondrial phosphatase	2
detailed structural models	2
catalytic elements	2
catalytic loop	2
structural integrator	2
catalytically important N-terminal WDPNWD motif	2
Oligomeric states	2
enzymatically active dodecameric form	2
catalytic domain	2
activating N-terminal regulatory sequences	2
atypical Ser/Thr phosphatase	2
mitochondrial membrane protein	2
diverse set of client proteins and complexes	2
Hsp90 dimer	2
unique region of Pih1p	2
multiple DII domains	2
Tah1p-	2
-Pih1p	2
single copy of Tah1p	2
open basket	2
one Rvb1p/Rvb2p hetero-hexamer with domains II (DIIs)	2
359-kDa complex	2
small nucleolar ribonucleoproteins, RNA polymerase II, and complexes containing phosphatidylinositol-3-kinase-like kinases	2
multi-subunit complexes	2
specialized Hsp90 co-chaperone	2
Rvb1p-Rvb2p AAA-ATPases, Tah1p, and Pih1p in yeast	2
neighboring pocket	2
SARA, endofin, and three CHMP4 isoforms	2
HD-PTPBro1	2
Crystallographic structures	2
Bro1 proteins	2
CHMP4/ESCRT-III	2
HD-PTP Bro1 domain	2
conserved hydrophobic region	2
SARA/endofin N termini	2
tumor supressor HD-PTP	2
ligand-activated transforming growth factor β/bone morphogenetic protein (TGFβ/BMP) receptors	2
endosomal adaptor proteins	2
RBR E3s	2
closed E2∼Ub	2
steric wedge	2
RING E3s	2
Zn2+-loop II	2
short extension of HHARI RING1	2
RBR-type E3s	2
E3 active-site cysteine	2
substrate or substrate-linked Ub	2
E3 active site	2
open E2∼Ub	2
RBR RING1s	2
E2 to substrate	2
closed E2∼Ub conformations	2
RINGs	2
E2∼ubiquitin (E2∼Ub)	2
types of E3	2
canonical RING domains	2
RING1 domains	2
SummaryRING-between-RING (RBR) E3s	2
whole Cul2 complex	2
Cul2 versus Cul5 recognition	2
Cul2 and pVHL-EloBC	2
new pose of Rbx1	2
full-length Cul2	2
Cul2, Rbx1, Elongin B, Elongin C, and pVHL	2
pentameric CRL2VHL complex	2
chemical inducers	2
large dynamic complexes	2
specific substrate proteins	2
E2 conjugating enzymes	2
ubiquitin proteasome system	2
SummaryCullin RING E3 ubiquitin ligases (CRLs)	2
ancestral precursor	2
primordial architecture	2
ring-shaped structures of proteasome and HslV.	2
crystals and electron microscopy preparations	2
continuous helices	2
unique architecture	2
dodecameric complex	2
hypothetical bacterial protease Anbu (ancestral beta subunit)	2
bacterial protease HslV	2
eukaryotes, archaea, and some bacteria	2
self-compartmentalizing proteases	2
eukaryotic mechanosensitive ion channel	2
lipid tails	2
inner pore and selectivity filter	2
K+ channels (TREK-1, TREK-2, and TRAAK)	2
mechanosensitive two-pore domain (K2P)	2
domain III	2
L-histidine binding	2
hexamer	2
MtATP-PRT	2
SummaryMtATP-phosphoribosyltransferase (MtATP-PRT)	2
ExProSE ranks an allosteric pocket first or second	2
allosteric sites	2
potential modulators	2
dataset of apo/holo pairs	2
ensemble of protein structures	2
Protein Structural Ensembles	2
obstructing glycans	2
LG1 and LG2 surfaces	2
integrin β1 subunit	2
critical integrin-binding glutamic acid residue	2
LG1 and LG2	2
C terminus of the coiled coil	2
LG domains	2
first three laminin G-like (LG) domains of the α1 chain	2
∼50 residues of α1β1γ1 coiled coil	2
minimal integrin-binding fragment of mouse laminin-111	2
heterotrimeric laminins	2
important laminin receptors	2
cell-adhesive glycoproteins	2
zymogen and activated forms	2
full-length MASP dimers	2
EGF-CUB2 junction	2
two CUB2 domains	2
CUB1-EGF-CUB2 dimer of each MASP	2
+-bound MASP dimers	2
MASP-2 cleaves C4 and C4b-bound C2	2
recognition component (mannose-binding lectin, serum ficolins, collectin-LK or collectin-K1) and a serine protease (MASP-1 or MASP-2)	2
overall M-band organization	2
muscle nanomechanics	2
∼135 pN. A cellular competition assay	2
unconventional architecture	2
 an isoform-specific myomesin interdomain sequence	2
incomplete immunoglobulin-like domain	2
obscurin(-like-1):myomesin complex	2
architectural and functional determinants	2
physical obscurin(-like-1):myomesin connection	2
myosin crosslinker myomesin	2
giant ruler titin	2
homolog obscurin-like-1,	2
network of modular proteins	2
sarcomeric cytoskeleton	2
distal centriole-capping protein CP110	2
kinase Nek1, another ciliopathy-associated protein	2
novel C2HC zinc finger array	2
tubulin-binding TOG (tumor overexpressed gene) domain	2
genetically heterogeneous ciliopathy	2
ends of elongating and shrinking cilia	2
peripheral microtubule array	2
thin cell projections	2
new class of substrate-binding proteins	2
FOSs in FusABC	2
EF hand-like calcium-binding motif	2
structure of FusA	2
open and closed conformations	2
substrate-binding protein FusA	2
strains encoding FusABC	2
short-chain FOSs	2
Strains encoding SfuABC	2
one of two types of FOS ATP-binding cassette (ABC) transporters	2
fructooligosaccharides (FOSs)	2
ESCRT pathways	2
UBAP1 structure	2
related ESCRT regulator Alix	2
closed and flexible coiled-coil domain	2
coiled-coil domain of HD-PTP	2
growth factor receptors and integrins	2
subunit UBAP1	2
ESCRT-	2
tumor suppressor phosphatase HD-PTP	2
ubiquinated receptors	2
mitogenic receptors	2
glycine receptor	2
water equilibrium density simulations	2
serotonin receptor (5-HT3R) structure	2
sub-nanometer pores	2
better tools	2
MAM domain of NRP1	2
inter-strand space	2
MAM domain of human NRP1	2
protein construct	2
linker region preceding the MAM domain	2
ectopic domain of the NRPs	2
MAM domain of NRP	2
single-pass transmembrane receptors	2
(NRPs)	2
direct interaction site	2
surface plasmon resonance	2
LRP6PE3 and KRM1Kringle-WSC	2
β-propeller/EGF repeats (PE) 3 and 4 of the Wnt co-receptor LRP6 (LRP6PE3PE4), the cysteine-rich domain 2 (CRD2) of DKK1, and KRM1ECD	2
low-resolution complex crystal structure	2
Wnt co-receptor Lrp5/6, Dkk, and Krm	2
WSC domain	2
Kringle, WSC, and CUB structural domains	2
rigid molecule	2
ectodomain of human Kremen1 (KRM1ECD)	2
three crystal structures	2
hallmark secreted antagonists	2
Dickkopf (Dkk) proteins	2
co-receptors	2
1 and 2	2
DnaJ phosphoproteins	2
phospho-switch	2
highly conserved J-domain residue, Lys58	2
hairpin loop	2
CSP's extreme N-terminal α helix	2
Mammalian CSP	2
humans and model organisms	2
/Hsp40 chaperone family	2
DnaJ	2
SummaryCysteine string protein (CSP)	2
families of peripheral membrane proteins	2
PIP-containing membranes	2
highly positively charged loop	2
canonical, non-canonical, and dual PIP-binding sites	2
2D density landscape	2
Coarse-grained simulations	2
GRP1 PH domain	2
pleckstrin homology (PH) domains with phosphatidylinositol phosphate (PIP)-containing lipid bilayers	2
molecular simulation pipeline	2
inter-domain linker	2
FliG domain stacking	2
FliGMC ensembles	2
FliGC helix	2
two central hinges	2
FliM middle (FliMM) and FliG middle (FliGM) domains	2
conformer ensembles	2
stator contacts	2
distant FliG C-terminal (FliGC) helix	2
Multi-subunit FliM-FliG rotor rings	2
in vitro and in cells	2
key charged residues	2
paxillin LD1 and LD2 motifs	2
R8 surface	2
canonical triple-helix arrangement	2
four-helix bundle of the talin R8 domain	2
LD motif of DLC1	2
Rho GAP	2
liver cancer 1 (DLC1)	2
actomyosin contractile machinery	2
adhesion sites	2
integrin-mediated cell adhesion	2
receptor crystal structures	2
highly conserved aqueous pocket	2
internal Na+ ion	2
δ-opioid and M2 muscarinic receptors	2
largest superfamily of membrane proteins	2
exported DNA receptors	2
DD region	2
two disulfide bonds	2
unique DD region	2
filament models	2
structurally identical type IV pilins	2
different DUS motifs	2
meningococcal ComP and Neisseria subflava ComPsub	2
DNA-uptake sequence (DUS) motif	2
intrinsic DNA-binding ability	2
minor pilin	2
DNA receptors	2
type IV pilins	2
filamentous nano-machines	2
free DNA	2
kinase catalytic domain	2
calcium/calmodulin binding	2
basic loop interaction site	2
 the C-terminal autoregulatory domain	2
well-established calcium/calmodulin site	2
novel dimerization-regulated calcium/calmodulin-binding site	2
basic DAPK signature loop	2
calcium/calmodulin-dependent members of the death-associated protein kinase (DAPK) family	2
calcium/calmodulin	2
many protein kinases	2
mAb A32	2
ID2 complexed	2
A32 epitope region	2
novel probe	2
known neutralizing epitope	2
CD4-triggered full-length gp120	2
ID2 expresses C1-C2 epitopes	2
inter-layer disulfide bond	2
CD4-bound conformation	2
ID	2
minimal structural unit of the HIV-1 Env	2
A32-like region	2
independent molecule	2
inner domain (ID) of gp120	2
first and second constant (C1-C2) regions of gp120 (A32-like epitopes)	2
transitional epitopes	2
EGF10-13	2
informed model	2
single flexible linkage between EGF9 and EGF10	2
EGF4-7	2
rigid, bent conformation	2
EGF4-13 region	2
residual dipolar couplings	2
EGF4-13 region of human Notch1 (hN1)	2
multiple repeats of epidermal growth factor (EGF)-like domains	2
large extracellular portion of Notch	2
short-range signal	2
adjacent cell	2
Delta/Serrate/Lag-2	2
core metazoan signaling pathway	2
VP1 and the minor capsid proteins	2
discrete contacts	2
two shells of electron density	2
enigmatic minor structural proteins, VP2 and VP3	2
human polyomaviruses	2
major structural protein components	2
polyomavirus	2
infectious virions and VP1-only virus-like particles in cell culture	2
immunosuppressed	2
transplant patients	2
SecY channel	2
pre-protein	2
cytoplasmic face of SecYEG	2
signal sequence	2
ATPase SecA	2
pre-proteins	2
endoplasmic reticular membrane of eukaryotes (Sec61)	2
plasma membrane of bacteria and archaea (SecYEG/β)	2
Sec translocon	2
selective NAK inhibitors	2
NAK kinase family	2
two drug candidates	2
BIKE in complex	2
kinases AAK1	2
NAK family members	2
potential drug targets	2
approved or investigational drugs	2
kinase family	2
Parkinson's and prostate cancer	2
(NAK) family	2
highly diverse Numb-associated kinase	2
cholesterol-rich membrane of influenza A	2
spherical virion	2
dengue outer envelope	2
coarse-grained molecular dynamics simulation	2
envelope of the dengue virion	2
near-atomic resolution computational model	2
insect cell membranes	2
membrane proteins (PDB: 3J27)	2
envelope of membrane proteins	2
dengue virion	2
membrane-proximal configurations	2
EphA2 ectodomain	2
surface of the bilayer	2
otherwise flexible ectodomain	2
complete EphA2 ectodomain	2
wild-type and mutant FN2 domains	2
mutant K441E	2
FN2 preferentially	2
site comprising K441, R443, R465, Q462, S464, S491, W467, F490, and P459–461	2
Multiscale molecular dynamics simulations	2
membrane-proximal fibronectin domain 2 (FN2) of the ectodomain	2
intracellular kinase	2
N-terminal ectodomain binds ligands	2
high-affinity Y220C mutant binders	2
subsite	2
open and closed states	2
pyrrole moiety	2
transient protein state	2
cryptic, transiently open hydrophobic subpocket	2
crevice	2
different classes of small molecules	2
extended crevice on the surface of the protein	2
destabilizing p53 cancer mutation Y220C	2
polymerase domain	2
Polθ tetramer	2
Polθ helicase domain	2
crystals	2
Hel308 family	2
related helicases	2
bound nucleotides	2
helicase domain of human Polθ	2
subset of these	2
range of cancer cell types	2
crucial alternative non-homologous end-joining factor	2
polymerase theta (Polθ)	2
3–8 protein components	2
ten assemblies	2
map feature points	2
relevant components	2
3D-electron microscopy density map	2
Endo180 N-terminal region	2
L-shaped structure	2
triple-helical and denatured collagen	2
FN2 and CTL1 domains	2
shallow trench	2
L-shaped arrangement of these domains	2
ricin-like domain, a fibronectin type II (FN2) domain, and two C-type lectin (CTL) domains	2
N-terminal region of Endo180	2
C-type mannose receptor and its homolog Endo180 (or uPARAP, for urokinase plasminogen activator receptor-associated protein)	2
area of the transition zone	2
GTPase-activating protein RP2	2
active Arl3	2
Arl3 transport network	2
Arl3 itself	2
N-terminal amphipathic helix of Arl3	2
LLxILxxL motif	2
newly identified Arl3 binding partner	2
effectors Unc119 and PDE6δ	2
myristoylated and farnesylated ciliary cargo molecules	2
specific release factor	2
ciliary protein Arl3	2
many developmental signaling pathways	2
small antenna-like cellular protrusions	2
classical monomethylase	2
target lysine	2
multiple methyl groups	2
MLL SET domains	2
inactive MLL4-tagged SET domain construct	2
MLL4 SET domain	2
targeting domains	2
SET domains	2
core multiprotein complex	2
catalytic SET domain	2
six members	2
MLL family	2
higher eukaryotes the MLL (or KMT2) family	2
H3K4-specific modification enzymes	2
histone H3 lysine-4	2
intestinal protease trypsin	2
two immunoglobulin-like folds	2
PepT1 and PepT2	2
bacterial and mammalian homologs	2
conserved peptide-binding site	2
bacterial homologs	2
Recent crystal structures	2
members of the POT family of proton-coupled oligopeptide transporters	2
di- and tri-peptides in the gastrointestinal tract	2
hepatitis B capsid	2
ultrastable gold substrates	2
direct electron detector data	2
contrast transfer function	2
single-particle electron cryomicroscopy (cryo-EM)	2
potential therapeutic reagents	2
heterophilic and homophilic interactions	2
SNP in CD6	2
three SRCR domains of CD6 and two N-terminal domains of CD166	2
 T cells	2
another cell surface receptor, CD166	2
N-terminal immunoglobulin superfamily (IgSF) domain	2
membrane proximal domain of CD6	2
three scavenger receptor cysteine rich (SRCR) domains	2
high-energy imidazolate intermediate	2
switch	2
six- and five-coordinate species	2
active site Mn(II)	2
inactive mutant of IGPD2 from Arabidopsis thaliana	2
3-(1H-imidazol-4-yl)-2-oxopropyl dihydrogen phosphate	2
imidazoleglycerol phosphate (IGP)	2
SummaryImidazoleglycerol-phosphate dehydratase (IGPD)	2
number of metazoan chromatin-associated proteins	2
SKI/SNO/DAC domain	2
BAF45a/PHF10 subunit of the SWI/SNF complex	2
hitherto unidentified N-terminal winged helix DNA binding domain	2
mostly benign tumors of the CNS	2
INI1/hSNF5/SMARCB1 subunit	2
SWI/SNF subunits	2
/SNF complexes	2
nuclear pore entrance	2
mature messenger ribonucleoparticles	2
similar motif	2
many nucleoporins	2
series of repeating sequence motifs	2
Mex67 NTF2-like domain (Mex67NTF2L)	2
C. thermophilum Sac3N	2
Sac3, Sus1, Cdc31, and Mex67:Mtr2	2
in vitro reconstituted complex	2
Chaetomium thermophilum TREX-2	2
Sac3 N-terminal region (Sac3N)	2
mRNA nuclear export factor, Mex67:Mtr2	2
TREX-2 also	2
Thp1, Sem1, Sus1, and Cdc31 bind	2
a Sac3 scaffold	2
gene expression pathway	2
GTP-hydrolyzing enzyme	2
GTP-binding protein	2
trGTPases	2
γ-phosphate of GTP	2
unusual polar residue	2
putative catalytic site	2
suboptimal polar residue	2
characteristic monovalent cation	2
nucleotide-binding site of Ski7C	2
individual domains of Ski7C	2
 either intact guanosine triphosphate (GTP) or guanosine diphosphate-Pi	2
translational GTPase (trGTPase) Hbs1	2
(Ski7C)	2
C-terminal region of Ski7	2
faulty mRNAs	2
cytoplasmic exosome in budding yeast	2
marginally stable globular domains	2
model misfolded protein	2
detailed structural basis	2
yeast cofactor homolog	2
stable mutant form	2
set of randomly mutated VHL sequences	2
quality control machinery	2
eukaryotic refolding and degradation pathways	2
marginally stable protein	2
SummaryThe human von Hippel-Lindau (VHL)	2
substates in the apo I-domain	2
multiple substates	2
I-domain	2
intermediate affinity state	2
α helix 7	2
allosteric antagonist inhibitor	2
inactive I-domain	2
low-affinity I-domain	2
existing crystallographic structures	2
three substates	2
conformational substates	2
apo I-domain	2
plasma membrane of leukocytes	2
SummaryLymphocyte function-associated antigen 1 (LFA-1)	2
different subfamilies	2
prolyl 3- and prolyl 4-hydroxylase active sites	2
human hypoxia-inducible factor (HIF) prolyl hydroxylases (PHDs)	2
prolyl hydroxylases	2
uS12 hydroxylase structures	2
Tpa1p in complex with NOG, 2,4-PDCA, and 1-chloro-4-hydroxyisoquinoline-3-carbonylglycine (a more selective prolyl hydroxylase inhibitor)	2
broad-spectrum 2OG oxygenase inhibitors; N-oxalylglycine (NOG) and pyridine-2,4-dicarboxylate (2,4-PDCA)	2
homolog from Saccharomyces cerevisiae (Tpa1p): OGFOD1	2
human uS12 prolyl 3-hydroxylase (OGFOD1)	2
Pro62 of the small ribosomal subunit protein uS12 (RPS23)	2
2-oxoglutarate (2OG) and ferrous iron dependent oxygenases	2
Latrophilin structure	2
binding-impaired mutant	2
endogenous FLRTs	2
binding-impaired mutants	2
high-affinity interactor FLRT2	2
stripe assays	2
FLRT-Latrophilin binding surfaces	2
conserved calcium-binding site	2
Olf β-propeller fold	2
mouse Latrophilin3 lectin and olfactomedin-like (Olf) domains	2
endogenous cell adhesion molecule FLRT	2
adhesion type G-protein-coupled receptors	2
spider venom α-latrotoxin	2
viral spike proteins	2
virion membrane	2
bilayer lipid and protein species	2
Forssman glycolipid	2
microsecond-scale coarse-grained molecular dynamics simulations	2
intact influenza	2
membrane envelope	2
LPS transport pathways	2
LPS transport related residues	2
strands β1C and β26C of the barrel of LptD	2
lumen gate	2
core oligosaccharide and O-antigen	2
acyl tails of LPS	2
hydrophobic slide	2
N-terminal domain of LptD	2
LptD/E complex	2
LptD/E translocon	2
(LPS)	2
refined model	2
proton pump	2
half channel	2
different c ring stoichiometries	2
rotor axle/membrane pump interface	2
conserved	2
stator network of the V-ATPase	2
lower-resolution yeast model	2
peptide binding site	2
periplasmic or cytoplasmic gate	2
first two helices of each of the four inverted-topology repeat units	2
current structures of MFS transporters	2
several salt bridges	2
two bacterial oligopeptide transporters, PepTSo and PepTSt	2
central ligand binding site	2
two six-helix bundles	2
major facilitator superfamily (MFS) of membrane transporters	2
SummaryProton-coupled oligopeptide transporters	2
low-homology cases	2
molecular replacement models	2
SummaryPredicted structures	2
NoRC complex	2
PHD-bromodomain modules	2
key basic residue, KacXXR	2
H3 and H4 acetylation marks	2
bromodomain	2
unmodified H3 histone tails	2
independent structural module	2
PHD finger	2
H3 and/or H4 histones	2
PHD zinc finger and bromodomains from human TIP5 and BAZ2B	2
site-specific histone tails	2
reader modules	2
TIP5 domains	2
promoter-bound TTF-I, pRNA, and acetylation of H4K16	2
largest subunit of NoRC	2
rDNA promoter	2
chromatin remodeling complex NoRC	2
alternative cofactors	2
number of putative FIC AMPylators	2
wild-type HYPE	2
membrane vicinity	2
a transmembrane helix	2
TPR-motifs	2
structurally and functionally integrated FIC-domains	2
stable dimers	2
eukaryotic FIC-domain protein	2
first structure	2
structure of human HYPE	2
one FIC-domain protein, HYPE	2
FIC-domain	2
protein-protein interaction assays	2
EFF-1 and HSV1 gB	2
Caenorhabditis elegans cell-cell fusion proteins AFF-1 and EFF-1 and the glycoprotein B (gB) from Herpes simplex virus type 1 (HSV1)	2
three integral type I membrane proteins	2
tedious detergent screens	2
genuine biological membranes	2
intact membrane proteins	2
SummaryMembrane protein-enriched extracellular vesicles (MPEEVs)	2
human p53 interactome	2
flexible, intrinsically disordered region	2
structured	2
extended p63/p73-like domain	2
last common ancestor	2
vertebrate p53 family oligomerization domains	2
zebrafish p53 tetramerization domain	2
human p53	2
stable tetramers	2
tetramerization domain	2
tetrameric transcription factors p53, p63, and p73	2
Phosphatidylinositol-3 kinase-like kinases (PIKKs)	2
gating network	2
physically interacting residues	2
extensive, state-dependent network	2
190 mutants	2
different X-ray structures of an inwardly rectifying potassium channel (Kir1.1)	2
-ray crystallography	2
peptidoglycan synthase PBP1A.	2
two extended flexible regions	2
 full-length LpoA	2
series of helix-turn-helix tetratricopeptide-repeat (TPR)-like motifs	2
all-α-helical fold	2
C-terminal domain of LpoA	2
outer-membrane-anchored lipoprotein LpoA.	2
major peptidoglycan synthase PBP1A	2
cytoskeletal elements	2
membrane-anchored synthases	2
stress-bearing peptidoglycan layer	2
bacterial cell envelope	2
product mimic	2
S. pneumoniae LdcB	2
LAS superfamily	2
zinc-carboxypeptidase fold	2
bacterial cell wall tetrapeptides	2
Streptococcus pneumoniae, Bacillus anthracis, and Bacillus subtilis	2
LD-carboxypeptidases LdcB	2
LD-carboxypeptidases	2
tetrapeptide	2
stem pentapeptide	2
terminal D-alanine	2
well-characterized DD-carboxypeptidases	2
tetra- and tripeptides	2
Nascent peptidoglycan	2
target of antibiotics like β-lactams and glycopeptides	2
glycan strands	2
bacterial cytoplasmic membrane	2
secondary structure elements	2
cis proline peptide bond	2
new polar interaction network	2
helix (EGFPG4Δ)	2
termini of strands	2
short and long loops, helical elements	2
enhanced green fluorescent protein (EGFP)	2
protein’s backbone	2
TTT complex	2
Hsp90 chaperone system	2
CK2 phosphorylation sites	2
domain in Pih1D1	2
Hsp90-Tah1-Pih1, Hsp90-Spagh, and Pih1D1-Tel2 complexes	2
biochemistry	2
connection	2
Pih1 (Pih1D1 in humans)—that	2
(Spagh/RPAP3 in metazoa)	2
AAA-ATPases Rvb1 and Rvb2,	2
TTT (Tel2-Tti1-Tti2), and R2TP complexes	2
chromatin remodeling complexes	2
snoRNPs, RNA polymerases, PI3-kinase-like kinases	2
client and Hsp90	2
substrate lactose	2
domain 3	2
one end of the TIM-barrel	2
antibody binding site	2
scFv13R4 counteracts	2
β-gal subunit	2
crevice between domains 1 and 3	2
scFv13R4 binding site	2
antibody scFv13R4	2
complex between β-gal	2
antibody-mediated enzyme formation mutants	2
several inactive point mutants	2
Escherichia coli β-galactosidase (β-gal)	2
single-chain Fv antibody	2
E2s	2
Ube2T	2
specific and extensive network	2
FANCL RING-Ube2T complex	2
E3-E2 pair, FANCL-Ube2T	2
Fanconi Anemia pathway	2
E3 ubiquitin-ligase	2
mutant collagen VI tetramers	2
protein interaction interface	2
wild-type and a muscular dystrophy-associated mutant structure	2
two hydrophobic patches	2
core domain	2
extension	2
ten N-terminal domains of the collagen VI α3 chain	2
multiple VWA domains	2
“beads-on-a-string” arrangement	2
opposite ends	2
C-terminal extensions	2
disease-causing point mutant	2
collagen VI VWA domain	2
1.2 Å crystal structures	2
protein interaction domains	2
Willebrand factor A (VWA) domains	2
Ca2+ binding sites	2
large positively charged patch on the protein surface	2
fluorescence-based thermal shift assays	2
secondary lower-affinity site	2
high-affinity Ca2+ binding site	2
native dimeric state	2
human metapneumovirus M	2
matrix protein (M) of paramyxoviruses	2
“lateral gate	2
inhibitor binding site	2
initial substrate docking site	2
membrane-embedded base	2
nicastrin ectodomain	2
peptidomimetic γ-secretase inhibitors	2
human presenilin complexes	2
library screens	2
fly Pygo	2
classical Pygo orthologs	2
humanized fly Pygo derepresses Notch targets	2
semi-aromatic cage recognizing asymmetrically methylated arginine 2 (R2me2a)	2
Drosophila PHD-HD1 complex	2
conspicuous groove	2
histone pocket-divider	2
fly Pygo orthologs	2
Pygo to Armadillo/β-catenin	2
HD1 domain of their Legless/BCL9 cofactors	2
lysine 4	2
histone H3 tail	2
PHD fingers	2
Wnt targets	2
target G proteins	2
RhoGAP domain	2
juxtaposed domains	2
Rho-family GTPases and Ral simultaneously	2
two RLIP76 domains	2
RLIP76 RhoGAP domain	2
RhoGAP-GBD dyad	2
RhoGAP domain and a Ral binding domain (GBD)	2
master regulator Ras	2
Ral small GTPases	2
atomic structures	2
two broad fields	2
cryo-electron tomography	2
heterogeneous subtomograms	2
different biologically relevant conformations	2
FUN-EGF3	2
heparin interaction site	2
EGF1 and EGF2 domains	2
short, flexible linker	2
rod-like domain pairs	2
fibrillin unique N-terminal (FUN) and the first three epidermal growth factor (EGF)-like domains (FUN-EGF3)	2
fibrillin N-terminal fragment	2
head-to-tail assembly	2
recombinant fibrillin fragments	2
10- to 12-nm-diameter microfibrils	2
human extracellular matrix glycoprotein fibrillin-1	2
inserted α helix	2
 P. aeruginosa	2
flexible disordered RNAs	2
structured hairpin loops	2
RsmN dimer	2
domain-swapped dimeric structure of RsmA homologs	2
distinctly different protein fold	2
uniquely inserted α helix	2
hairpin from the sRNA, RsmZ	2
family member	2
rsmA mutant in Pseudomonas aeruginosa	2
global posttranscriptional regulators	2
highly conserved RsmA/CsrA family	2
cytochrome c.	2
extended form of the enzyme	2
P450 mono-oxygenase drug-metabolizing system	2
-cytochrome P450 reductase	2
outer membrane leaflet	2
fusion loops	2
MPR-lacking form	2
MPR	2
membrane proximal region (MPR)	2
gB-bilayer complex	2
electron cryotomography structure	2
two gB ectodomain forms	2
complex herpesvirus fusion machinery	2
SummaryGlycoprotein B (gB)	2
smaller interfaces	2
series of homomeric and heteromeric protein complexes	2
compact subunits or subcomplexes	2
unfolded subunits	2
gas phase	2
conserved His-Ser/Thr dyad	2
curacin A polyketide synthase catalytic module	2
GCN5-related N-acetyltransferase superfamily	2
MCD catalytic domain	2
intersubunit interfaces	2
helical domains	2
four structures	2
N-terminal helical domain	2
MCD monomer	2
four crystal structures of MCD from human, Rhodopseudomonas palustris, Agrobacterium vitis, and Cupriavidus metallidurans	2
SummaryMalonyl-coenzyme A decarboxylase (MCD)	2
U5 snRNP	2
mature U5 snRNP	2
seven Sm proteins	2
precursor complex	2
degenerative eye disease retinitis pigmentosa	2
human Prp8	2
residues in the Jab1/MPN domain	2
N-terminal helicase cassette	2
Jab1/MPN domain	2
Jab1/MPN domain of Prp8	2
structure of yeast Brr2	2
active center of the spliceosome	2
intricate RNA network	2
U6 snRNA	2
U4/U6 small nuclear RNA (snRNA) duplex	2
U5 small nuclear ribonucleoprotein particle (snRNP) helicase Brr2	2
highly conserved region of the virus	2
entire region	2
earlier functional assays	2
previously unpredicted motifs	2
short nuclear-magnetic-resonance-solved regions	2
folded 3D model	2
240-nt region	2
experimentally reassessed secondary structure elements	2
working model	2
three-dimensional (3D) conformation	2
sequential conserved structural motifs	2
noncoding 5′ region	2
rhomboid inhibitors	2
enzyme-inhibitor complexes	2
β-lactam inhibitor binding	2
S2′ substrate binding site of GlpG.	2
rhomboid proteases	2
β-lactams	2
hydrophobic N-substituent of β-lactam inhibitors	2
oxyanion hole	2
the carbonyl oxygen of the inhibitor	2
catalytic serine	2
Escherichia coli rhomboid GlpG in complex with β-lactam inhibitors	2
known rhomboid functions	2
evolutionarily conserved serine proteases	2
tyrosine autophosphorylation activity	2
DYRK1A wild-type and Y321F mutant	2
strictly proline-directed kinase	2
substrate motifs	2
library of naturally occurring peptides	2
DH box	2
second tyrosine of the activation loop YxY motif	2
Ser/Thr kinases	2
current activation model	2
DYRK2 including NAPA and DH (DYRK homology) box regions	2
ATP-mimetic inhibitor and consensus peptide	2
one representative member of each DYRK subfamily	2
SummaryDual-specificity tyrosine-(Y)-phosphorylation-regulated kinases (DYRKs)	2
pharmaceutical target	2
autocleaving fusion protein	2
interaction hub of immune factors	2
zinc-free, disulfide-linked conformation of the TRASH motif	2
base, acid, and nucleophile	2
putative catalytic water	2
catalytically relevant elements	2
pre- and postcleavage intermediates	2
N-terminal part of the viral polyprotein	2
bovine viral diarrhea virus	2
key effector protein of pestiviruses	2
bacterial capsule	2
novel outer-membrane lectin	2
K30 polymer	2
mutants functionally deficient in vivo	2
K30 carbohydrate polymer	2
specific extracellular loops	2
periplasmic end	2
extracellular entrance	2
long extracellular loops	2
18-stranded β-barrel fold	2
group 1 capsules	2
integral outer-membrane protein	2
polysaccharide capsule	2
herpes viruses	2
activating receptor	2
CD200-expressing cells	2
NH2 terminal domains	2
two Ig-like domains	2
CD200 and CD200R	2
complex between CD200R and CD200	2
activating receptor CD200RLa	2
 the inhibitory	2
X-ray crystallography structures	2
“paired receptor	2
closely related proteins	2
inhibitory receptor (CD200R)	2
widely distributed membrane glycoprotein	2
fixed annular “shell” of lipids	2
annular and bulk lipids	2
broadly conserved protein/lipid interface	2
surface of Aqps	2
distinct, high-specificity lipid binding sites	2
Aqp structural proteome	2
Aqps	2
protein-lipid contacts	2
simple phospholipid bilayer	2
aquaporin (Aqp) family of membrane proteins	2
human DNA ligases	2
conserved VPF motif	2
first helix of LigIV	2
continuous epitope of Artemis	2
DNA-binding domain of LigIV	2
Artemis peptide	2
catalytic region of LigIV (residues 1–609)	2
specialized DNA ligase	2
catalytic region of DNA ligase IV (LigIV)	2
components of NHEJ	2
partner proteins or components of peptidoglycan	2
anchor point	2
remaining part of EssB	2
substrates or secretion system partners	2
N-terminal segment	2
segment	2
exterior of the membrane	2
Geobacillus thermodenitrificans EssB	2
bacterial type VII secretion system	2
membrane-bound EssB	2
mammalian TLRs	2
LRR 14	2
Drosophila cell-based assay	2
Spz signaling	2
first ten LRRs blocks	2
Toll-1 orthologs	2
cysteine-rich cap	2
first 201 amino acids	2
N-terminal domain of the receptor	2
cytokine-like receptor for Spätzle (Spz) protein	2
prototypical receptor	2
humans, the Toll-like receptor (TLR) family	2
important family of pathogen-recognition receptors	2
melanogaster Toll	2
common interaction domains	2
PLCγ isoforms	2
autoinhibitory surfaces	2
autoinhibitory interface	2
nSH2 and cSH2 domains	2
fibroblast growth-factor receptor signaling	2
PLC-core	2
cSH2 domain	2
regulatory region center	2
four interaction domains	2
many of these proteins	2
structural organization	2
proteins incorporating interaction domains	2
RelB2E2 heterotetramers	2
two adjacent RelB2E heterotrimeric units	2
ribbon-helix-helix (RHH) dimerization domain	2
V-shaped heterotetrameric complex	2
RelB	2
RelB dimerization domain	2
RelB-inhibited RelE	2
intact Escherichia coli RelB2E2 complex	2
antitoxin, RelB	2
toxin, RelE	2
toxin-antitoxin complex	2
bacterial relBE locus	2
as-yet-unexplored dynamic spectrum	2
AMPAR GluA4 NTD	2
similar, interconvertible conformational subspaces	2
two subfamilies	2
variety of computational tools	2
subfamilies	2
AMPAR subfamily	2
NMDA receptor subfamily of iGluRs	2
receptor channel	2
LBD binds L-glutamate	2
membrane-proximal ligand-binding domain (LBD) and the distal N-terminal domain (NTD)	2
two extracellular domains	2
SummaryIonotropic glutamate receptors (iGluRs)	2
CDK9 tail	2
CDK9 mutants	2
possible reaction intermediate	2
ATP binding site	2
CDK9/cyclin T complex	2
CDK9 C-terminal tail sequence	2
CDK9 and cyclin T	2
human P-TEFb complex	2
transcription elongation factors	2
kinase of positive transcription elongation factor b (P-TEFb)	2
flagellar tomograms	2
dynein-c structures	2
AAA+ modules	2
middle	2
“linker” domain	2
key sites	2
cytoplasmic dynein motor domain	2
native flagellar dynein-c	2
3D maps	2
AAA+ superfamily of ring-shaped enzymes	2
largest known cytoskeletal motors	2
viable target cells	2
specifically bound	2
phosphocholine headgroup and one acyl tail	2
diverse set of eukaryotes and prokaryotes	2
pore-forming proteins	2
popular SM-labeling reagent	2
sphingomyelin (SM)	2
earthworm Eisenia fetida	2
SummaryPore-forming proteins	2
LigIV/XRCC4/XLF-Cernunnos complex	2
catalytic region	2
LigIV, XRCC4, and XLF-Cernunnos	2
LigIV in complex	2
LigIV orthologs	2
BRCT/XRCC4 complex	2
subdomain of the nucleotidyltrasferase domain of human LigIV	2
XRCC4 and XLF-Cernunnos	2
architecture of DNA ligase IV (LigIV)	2
additional residues	2
bucindolol and carvedilol	2
thermostabilized avian β1AR mutant	2
either inverse or partial agonists	2
G protein-independent signaling	2
carvedilol and bucindolol	2
human β1AR	2
β1-adrenoceptor (β1AR)	2
mRNP export complexes	2
fingers 5-7	2
polyadenosine-RNA	2
nuclear RNA export adaptor, Yra1	2
Structure-guided Nab2 variants	2
rat8-2 allele of RNA helicase Dbp5	2
RNA-binding compromised Nab2-C437S mutant	2
single structural unit	2
Zn fingers	2
solution structure of fingers 5-7	2
CCCH Zn fingers	2
polyadenosine-RNA-binding protein, Nab2	2
mature mRNPs	2
DDR1 subunits	2
DS domains	2
DDR1 dimer	2
collagen-binding site	2
conserved surface patch in the DS domain	2
following DS-like domain	2
collagen-binding discoidin (DS) domain	2
Fab fragment of mAb 3E3	2
monomeric DDR1 extracellular region	2
constitutively dimeric receptor tyrosine kinases	2
filament packing	2
unstructured NMIIA tail	2
A431 human epithelial carcinoma cells	2
S100 family	2
Ca2+-dependent binding sites of each subunit	2
surface of S100A4	2
continuous helix	2
 a single myosin heavy chain	2
S100A4 dimer	2
small Ca2+-binding protein, S100A4	2
nonmuscle myosin IIA (NMIIA)	2
different calmodulin-target complexes	2
distinct conformational landscapes	2
biomolecules (membranes, modifying enzymes)	2
region of the intrinsically disordered protein myelin basic protein (MBP145–165)	2
diverse and versatile cellular signals	2
spatiotemporal-dependent dynamic environment	2
mild disease mutants	2
Conformational disease intermediates	2
disease-relevant intermediate	2
conformer-specific neo-epitope	2
forme fruste deficiency variant of α1-antitrypsin (Lys154Asn)	2
dynamic equilibria	2
pathological intermediates	2
native protein conformers	2
Electron Microscopy Data Bank and Protein Data Bank public data archives	2
three-dimensional electron microscopy (3DEM) density maps	2
group of scientists	2
Unified Data Resource for 3DEM (http://www.emdatabank.org)	2
HIV-1 accessory protein Vpu and the Kaposi sarcoma-associated herpesvirus (KSHV) ubiquitin ligase K5	2
tetherin (BST-2/CD317)	2
antiviral cell-surface proteins	2
UBAP1-containing ESCRT	2
SOUBA	2
three rigidly arranged overlapping UBAs	2
 a solenoid of overlapping UBAs (SOUBA)	2
C-terminal region of UBAP1	2
stable 1:1:1:1 complex with Vps23/TSG101, VPS28, and VPS37	2
subunit of human ESCRT-I	2
ubiquitin associated protein 1 (UBAP1)	2
retroviral budding	2
MVB biogenesis	2
ubiquitinated cargo	2
GG(D/E)EF-type diguanylate cyclase	2
cyclic di-GMP biosynthesis	2
stressosome	2
switch kinase	2
PP2C type phosphatase MtX	2
switch kinase, MtT	2
B. subtilis RsbR	2
N-terminal domain of MtR	2
scaffold, MtS	2
presumed sensor, MtR	2
Moorella thermoacetica	2
stressosome-regulated biochemical pathway	2
alternative sigma factor σB	2
stressosome complex	2
N terminus of Ddn	2
tail of PA-824	2
Nocardia farcinica	2
catalytically competent homolog	2
without bound F420 deazaflavin coenzyme	2
truncated, inactive Ddn protein core	2
Several structures	2
full-length, enzymatically active enzyme	2
multiple conformations	2
N-terminal 30 residues of Ddn	2
lethal reactive nitrogen species	2
deazaflavin-dependent nitroreductase (Ddn) from Mycobacterium tuberculosis	2
bicyclic nitroimidazoles an important new class of therapeutics	2
complexes of Raver2	2
PTB paralogues	2
Raver1 complexes	2
PTB-Raver1 interactions	2
functional models	2
PRI motif	2
specific hydrogen bonds	2
shape-matched apolar contacts	2
Raver1 PRI3	2
helical face of the second RNA recognition motif (RRM2)	2
four PTB-Raver1 interacting motifs (PRIs)	2
α-tropomyosin	2
polypyrimidine tract-binding protein (PTB)	2
binding Blinkin	2
several BUBR1 residues	2
novel Blinkin motif	2
unanticipated BUBR1 region	2
Blinkin motif	2
macromolecular assembly	2
BUB1 and BUBR1 kinases	2
referees and editors	2
applicable resolution class	2
full PDB	2
existing database	2
components of macromolecular crystals	2
deposited structures	2
worldwide Protein Data Bank (PDB)	2
e.g., glycophorin A.	2
αIIb/β3 interface	2
published NMR structure (PDB: 2K9J)	2
helix-helix interface	2
stable, right-handed dimer	2
WT helices	2
wild-type (WT) and mutated sequences of the αIIb and β3 integrin TM helices	2
integrin TM helix heterodimers	2
transmembrane (TM) α helices of membrane receptors	2
riboswitch	2
sequence-variant k-turns	2
k-turn within the riboswitch	2
terminal loop	2
essential standard k-turn sequence	2
SAM-I riboswitch	2
tertiary interactions	2
k-turn structure	2
G⋅A and A⋅G pairs	2
acute kink	2
widespread RNA motif	2
cysteine in a CsgG transmembrane helix	2
nascent class of helical outer-membrane macromolecular exporters	2
structure and oxido-reductase capability	2
N-terminal domain of DsbD	2
outer-membrane subunit translocator CsgG.	2
first structural model	2
curli specific genes (csgA-G)	2
curli biogenesis	2
extracellular fimbriae	2
functional amyloid fibers	2
PIP2-containing membranes	2
catalytic subunit	2
Binding RTK phosphopeptides	2
C terminus of p110δ	2
helical domain	2
nSH2 and cSH2 domains of p85α	2
class IA subunit	2
p85-regulatory subunit	2
lymphocytic leukemias	2
SummaryPhosphoinositide 3-kinase δ	2
specific GRP1-PH-PI(3,4,5)P3 interactions	2
flanking loops	2
mutating hydrophobic residues	2
PI(3,4,5)P3-containing DPC micelles	2
 GRP1-PH	2
surrounding membrane environment	2
bound complex	2
 the plasma membrane	2
(PH) domain of the general receptor for phosphoinositides 1 (GRP1)	2
pleckstrin homology	2
common icosahedral ancestor	2
lineage of viruses	2
human adenovirus and the bacteriophages PRD1 and PM2	2
 a lineage of large icosahedral double-stranded DNA viruses	2
major capsid proteins	2
pseudo-hexagonal trimers	2
 a double β barrel “jelly-roll” subunit	2
major scaffolding protein	2
initial spherical immature virus particle	2
transitory, stabilizing lattice	2
VACV D13 protein	2
Trimeric capsomers	2
vaccinia virus (VACV)	2
unbound proteins	2
intrinsically disordered sequences	2
large set of protein complexes	2
either monomeric proteins or bound subunits	2
mRNAs of proteins	2
RNA-binding specificity	2
U-rich 3′ ends	2
zinc-dependent nuclease	2
In vitro nuclease activity assays	2
U-rich sequences	2
contiguous KH domains	2
metallo-β-lactamase nuclease and the β-CASP domains	2
putative nuclease	2
archaeon Methanothermobacter thermautotrophicus	2
SummaryMTH1203, a β-CASP metallo-β-lactamase family nuclease	2
benchmarks	2
AmtB, GlpG, Mhp1, GlpT, EmrD, NhaA, and LacY	2
seven membrane proteins	2
number of sodium and proton-dependent transporters	2
small micelle detergents	2
fluorescent-based unfolding assay	2
24 eukaryotic and prokaryotic membrane proteins	2
F2 mutant	2
/β transmembrane dimer	2
α	2
F2-F3 in complex	2
talin/membrane interactions	2
F2-F3	2
F2 binding surface	2
four basic residues (K258E, K274E, R276E, and K280E)	2
F2-F3) domain	2
talin head (	2
membrane-binding surfaces	2
integrin β cytoplasmic tail	2
talin head domain	2
one surface of the talin head	2
PtdIns(4,5)P2-enriched microdomains	2
talin head	2
F3 binds β-integrin tails	2
additional domain F0	2
novel FERM domain	2
N-terminal head of the integrin-associated cytoskeletal protein talin	2
compact cloverleaf structure	2
three separately folded domains (F1, F2, F3)	2
membrane interfaces	2
diverse superfamily of signaling and adaptor proteins	2
SummaryFERM domains	2
TSPO/PBR protein family	2
substrate translocation pathways	2
transmembrane domains of individual TspO subunits	2
monomeric TspO	2
helical crystals	2
Rhodobacter sphaeroides	2
homologous protein, TspO	2
polytopic mitochondrial outer membrane protein	2
18 kDa TSPO protein	2
GVMGFO-binding sites of DDR2 and SPARC	2
DDR2 surface loops	2
buried salt bridge	2
functionally critical tryptophan residue	2
amphiphilic pocket	2
two collagen chains	2
GVMGFO motifs	2
triple-helical collagen peptide	2
discoidin domain of human DDR2	2
matricellular protein SPARC	2
III is a GVMGFO motif (O is hydroxyproline)	2
major DDR2-binding site	2
widely expressed receptor tyrosine kinases	2
PKD domain	2
nonnative hydrogen bonds	2
PKD domains	2
, RNA	2
emerging structures	2
various functions (Bonneau et al., 2009)	2
eukaryotic exosome complex	2
assembled subunits	2
new crystal structure	2
B class Eph receptor conformations	2
structural chameleon	2
class B Eph receptors	2
binding ephrinB2	2
Eph receptors	2
previously reported Eph receptor structures	2
class A than class B ligands	2
vitro binding	2
ligand binding face	2
set of structures	2
(1) ephrinB2 and (2) ephrinA2	2
EphA4 ligand binding domain	2
B class ephrins	2
currently known class A Eph receptor	2
EphA4 tyrosine kinase cell surface receptor	2
two NBDs	2
homologous protein MalK.	2
C-terminal regulatory domain	2
Neisseria gonorrhoeae ferric iron uptake transporter	2
NBD, FbpC,	2
nucleotide-binding domains (NBDs) of ABC transporters	2
phosphotyrosine binding pocket	2
secondary binding sites	2
phosphotyrosine specific interaction modules	2
fold universe	2
overlaps	2
nonredundant structures	2
different folds	2
small, recurring super-secondary motifs (e.g., αβ-motifs, α-hairpins)	2
different fold groups	2
evolutionary conserved core	2
highly populated superfamilies	2
distinct folds	2
low resolution electron density map	2
selenomethionine derivatives of single methionine mutants	2
extended polypeptide chain	2
anomalous scatterers	2
weakly diffracting and radiation sensitive P1 crystals	2
accurate anomalous signals	2
rods and slabs	2
α helices and β sheets	2
5.5 Å resolution electron density map	2
one RNA	2
nine proteins	2
functional core of human U1 snRNP	2
KTN dimer hinge	2
KefC variants	2
ancillary subunit, KefF	2
C-terminal, KTN-bearing domain of the E. coli KefC K+ efflux system	2
associated membrane-integrated components of the channel or transporter	2
two Rossmann folds	2
dimers within the asymmetric unit	2
KTN (RCK) domains	2
transmembrane pore-forming counterparts	2
various K+ channels and transporters	2
cytoplasmic regulatory complexes	2
nucleotide-binding folds	2
SummaryKTN (RCK) domains	2
10–12 nm microfibrils	2
hyb2-cbEGF10 interface	2
extensive interfaces	2
neighboring cbEGF domains	2
previous fibrillin-1 and LTBP-1 fragments	2
crystal structure of a fibrillin-1 cbEGF9-hyb2-cbEGF10 fragment	2
extracellular 10–12 nm diameter microfibrils	2
8-cysteine-containing transforming growth factor β-binding protein-like (TB) and hybrid (hyb) domains	2
like (cbEGF) domains	2
calcium-binding epidermal growth factor-	2
superfamily of structurally-related proteins	2
β binding proteins (LTBPs)	2
latent transforming growth factor-	2
splicing factors like ASF/SF2	2
CLK specific β7/8-hairpin insert	2
related mitogen activating protein kinases (MAPKs)	2
substrate docking grooves	2
previously unseen helix αH.	2
CLKs the SRPK1 docking site	2
splicing factor targeting kinases	2
specific docking interaction	2
splicing factors	2
SR protein (SRPK) and cdc2-like kinase (CLK) families	2
eukaryotic mRNA	2
serine/arginine-rich (SR) proteins	2
restraining geometries	2
individual structures	2
large set of experimentally phased and molecular replacement structures	2
partial protein model	2
chemically unassigned atoms	2
density map	2
electron density map	2
protein model	2
residue interactions	2
VRK3 still	2
active site region	2
closest active relative	2
pseudokinase, VRK3	2
enzymatically inactive pseudokinases	2
checkpoint-activated cells	2
one region	2
residues of human BUB1	2
native and site-specific mutants	2
three divergent units of the tetratricopeptide motif	2
N-terminal region of BUB1	2
1.74 Å resolution crystal structure	2
mitotic kinetochore protein Blinkin	2
central mitotic checkpoint component BUB1	2
γ subunits	2
 a proteolysed activated form of PhK	2
number of smaller particles	2
PhK preparation	2
kinase subunit	2
ends of the lobes	2
PhK holoenzyme	2
catalytic γ subunit	2
three-dimensional structure	2
two lobes	2
PhK heterotetramer (αβγδ)4	2
active glycogen phosphorylase a.	2
inactive glycogen phosphorylase b (GPb)	2
SummaryPhosphorylase kinase (PhK)	2
dithiolane ring	2
lipoyl domain	2
H271α side chain	2
active-site loops	2
key residue	2
acetyl group with the lipoate	2
proton donor	2
electrostatic catalyst	2
next active site	2
mobile lipoyl domain	2
surface loops	2
structures implicate residues	2
prereaction complex and the postdecarboxylation product	2
Geobacillus stearothermophilus PDH E1p subunit	2
acetyl coenzyme A and reducing equivalents	2
SummaryThe pyruvate dehydrogenase multienzyme assembly (PDH)	2
paxillin/α-parvin system	2
inter-CH domain linker	2
canonical fold	2
rim	2
common binding site on α-parvin-CHC	2
Cocrystal structures	2
LD1, LD2, and LD4	2
C-terminal calponin homology domain (CHC) of α-parvin	2
α-parvin	2
variety of focal adhesion proteins	2
five conserved leucine-rich (LD) motifs	2
adaptor protein paxillin	2
subset of substrates	2
structured RNA substrates	2
triphosphate cap	2
two RNA-binding domains	2
E. coli RNase E catalytic domain	2
structured RNA precursors	2
essential bacterial endoribonuclease	2
SummaryRNase E	2
RbAp46 and RbAp48 complexes	2
helix 1 of histone H4	2
histone H3/H4 dimer (or tetramer)	2
complex with ASF1, another histone chaperone	2
either the nucleosome	2
blade six	2
N-terminal α helix	2
seven-bladed β propeller structure	2
crystal structure of human RbAp46	2
highly homologous histone chaperones	2
RBBP7 and RBBP4, respectively)	2
RbAp48 (pRB-associated proteins p46 and p48	2
bound ssRNA	2
3′ end of the RNA ligand	2
last two nucleotides	2
conserved set	2
RNA complexes	2
different LaNTD	2
3′ end of the RNA	2
La motif and RRM domains	2
purely single-stranded RNA	2
partially duplex RNA	2
previously published LaNTD:RNA complex	2
different single-stranded RNA oligomer	2
four LaNTD:RNA complexes	2
N-terminal domain of La (LaNTD)	2
3′ ends of such RNAs	2
nascent RNA polymerase III transcripts	2
3′ poly(U) sequences	2
eukaryotic La protein	2
many transmembrane receptors	2
domain class	2
SLT-1/Slit coreceptor	2
receptor-attached examples of RBL	2
structure of a complex with L-rhamnose	2
long structured loops	2
unique α/β fold	2
mouse Lat-1	2
neuronal axon guidance molecule SLT-1/Slit	2
recently discovered coreceptor	2
metazoan transmembrane proteins	2
ectodomains	2
eggs of marine species	2
RBL domains	2
rhamnose binding lectin (RBL)-like domain	2
extracellular portion of Lat-1	2
putative G protein-coupled receptor	2
α-Latrotoxin	2
target receptor	2
SummaryLatrophilin-1 (Lat-1)	2
wide range of ligands	2
classical allostery models	2
C-terminal domain of CaM	2
complex-like substates	2
-CaM state	2
Ca2+-CaM state	2
myosin light chain kinase (CaM-MLCK)	2
calcium-bound state (Ca2+-CaM)	2
calmodulin (CaM)	2
OmpF-lipid interface	2
artificial OmpF dimers	2
N-terminal helix of the pore-forming domain	2
OmpF-bound LPS	2
major lipid of the outer leaflet interface	2
protein-lipid interface	2
porin trimer	2
translocation pathway	2
outer membrane protein F (OmpF)	2
unusually simple translocation pathway	2
atypical kinase structural motif	2
GTPase domain	2
interaction domain	2
MPSK1 interaction partner and specific substrate	2
GTPase DRG1	2
aliphatic residue	2
preferred substrate sequence of X-X-P/V/	2
nonclassical activation segment	2
MAST kinases	2
members of the MPSK1 family	2
similar activation segments	2
large α-helical insertion	2
β sheet	2
human MPSK1	2
atypical activation segment architecture	2
GH-receptor	2
high affinity SOCS4 substrate	2
STAT3 site in EGFR (pY1092)	2
subfamily	2
extended N- and C-terminal regions	2
distinct SH2-SOCS box interface	2
CIS/SOCS1–SOCS3 family C terminus	2
N-terminal ESS helix	2
distinct SOCS structural class	2
SOCS4-ElonginC-ElonginB complex	2
strictly conserved C terminus	2
Variable C-termini in SOCS4–SOCS7	2
ElonginB/C-cullin ubiquitin ligases	2
SH2 domain substrate recognition modules	2
suppressors of cytokine signaling (SOCS)	2
negative feedback inhibitors	2
SummaryTyrosine kinase signaling	2
ATP mimetic inhibitors	2
determined high-resolution structure of ASK1	2
wild-type ASK1	2
three identified in vitro autophosphorylation sites (Thr813, Thr838, Thr842)	2
known ASK1 phosphorylation sites	2
head-to-tail fashion	2
human ASK1 catalytic domain	2
JAK-STAT signaling cascade	2
components of the complex	2
gp130-containing signaling complex	2
Interleukin 11(IL-11)-IL-11 Receptor-gp130 extracellular complex	2
30 Å resolution cryo-electron microscopy (cryo-EM) structure	2
several hematopoietic cytokines	2
shared signal-transducing membrane-associated receptor	2
bacterial systems	2
transient mammalian expression	2
single residues	2
endoglycosidase H	2
N-glycosylation processing inhibitors, kifunensine or swainsonine	2
glycoproteins transiently	2
center of the bilayer	2
electrostatic field	2
arginine side chains of S4	2
lipid phosphate groups	2
center of the VS and bilayer	2
zwitterionic and in anionic lipid bilayers	2
archaebacterial potassium channel KvAP	2
isolated VS domain	2
positively charged S4 helix	2
Kv channels	2
voltage-sensor (VS) domain	2
voltage-activated ion channels	2
tri-substituted purine inhibitor	2
potent PAK inhibitors	2
active conformation	2
glycine-rich loop, αC	2
αC N terminus	2
helix αC	2
number of catalytically productive and nonproductive conformers	2
active, monophosphorylated group II catalytic domains	2
Group II PAKs (PAK4–6)	2
Summaryp21-activated kinases	2
aspiring computational data analysts	2
easily accessible data sources	2
omics data analytics	2
large omics data sets	2
bench-side biologists	2
appearance of resources	2
APOBEC oligomerization	2
non-sequence-specific nucleic acid binding sites	2
potential substrate-specific binding sites	2
mono- or oligonucleotides	2
high-resolution co-crystal structures of APOBECs	2
select (deoxy)cytidines to (deoxy)uridines	2
RNA and single-stranded DNA (ssDNA)	2
11-member APOBEC (apolipoprotein B mRNA editing catalytic polypeptide-like) family of zinc-dependent cytidine deaminases	2
RNA polymerase (RNAP)	2
native environment of proteins	2
growing scientific community	2
protein N-terminal modifications	2
diverse disciplines	2
N-term 2017	2
early secretory pathway	2
ER lumen	2
ultimate electron donor	2
Artemis-dependent c-NHEJ	2
c-NHEJ proteins	2
majority of DSBs	2
canonical nonhomologous end joining (c-NHEJ)	2
mammalian G1- and G2-phase cells	2
novel framework	2
prevailing theory	2
cellular functions	2
vitro and in vivo experiments	2
vitro and in vivo data	2
countercurrent models	2
new LTPs	2
LTP field	2
Lipid transfer proteins (LTPs)	2
OxPhos complexes	2
recently obtained structures	2
mitochondrial RNA granules (MRGs)	2
mitochondrial epitranscriptome	2
proteins of the oxidative phosphorylation (OxPhos) system	2
mitochondrial gene expression machinery	2
mitochondrial gene expression	2
types of omics data sets	2
spectral libraries and spectral archives	2
public proteomics data	2
data scientists	2
other, more mature ‘omics’ disciplines	2
acetyl-CoA and NAD+	2
key metabolites	2
several examples	2
surfactant and interfacially active proteins	2
wide range of organisms	2
liquid–air interfaces	2
plant TPC structures	2
animal endo-lysosomes	2
second messenger NAADP	2
plant vacuoles	2
acidic Ca2+ stores	2
-permeable ion channels	2
important molecules	2
medicinal targeting	2
MBLf enzymes	2
redox (e.g., ETHE1) and hydrolytic processes (e.g., Glyoxalase II, SNM1 nucleases, and CPSF73)	2
zinc and iron ions	2
(h)MBLf enzymes	2
clinically important anticancer medicines	2
human enzymes	2
MBL core protein fold	2
almost all β-lactam antibiotics	2
αββα metallo β-lactamase (MBL) fold (MBLf)	2
RNA polymerase III transcripts	2
newly synthesized RNAs	2
associated nuclease Rrp44	2
RNA-bound exosome	2
RNA helicases Mtr4 and Ski2	2
nuclear and cytoplasmic cofactors	2
nine-subunit eukaryotic core (EXO-9)	2
eukaryotic and archaeal complexes	2
RNA backbones	2
ligand, double-stranded RNA	2
related receptor TLR3	2
Mal and TRAM	2
MyD88-independent pathway	2
different bridging factor, TRAM	2
adapter protein, MyD88	2
bridging factor, Mal	2
different cellular locations	2
pathogen-recognition receptors	2
normal and oncogenic cells	2
evolutionarily conserved and essential self-monitoring system	2
mitotic checkpoint	2
BUBR1 (Mad3 in yeast, worms and plants)	2
multidomain protein kinases BUB1 and	2
fly model systems	2
candidate risk factor gene	2
“hits	2
Fly models	2
fruit fly genetics	2
P2X researchers	2
new 3D structure	2
membrane ion channels	2
zebrafish P2X4.1	2
three-dimensional (3D) crystal structure	2
non-selective cation channels	2
P2X receptors	2
four individual modules	2
variety of regulatory proteins and ligands	2
complex array of intra- and inter-molecular interactions	2
key signalling and regulatory molecules	2
cellular RNAs	2
encoding MDA5	2
IFIH1 gene	2
several classes of viruses	2
virus presence	2
one such sensor	2
viral nucleic acids	2
major bottlenecks	2
infected whom	2
transmission chains	2
contaminated sinks	2
environmental sources of recurrent infections	2
hard-to-treat infections	2
polysaccharide antigens	2
bacterial diversity-generating machines	2
Genetic loci	2
bacterial polysaccharide antigens	2
bacterial ecology	2
capsules and lipopolysaccharides	2
diverse surface polysaccharides	2
Bacterial pathogens and commensals	2
human and animal microbiomes	2
SIP technologies	2
host-associated microbes in vivo and ex vivo	2
complex host-associated microbiotas	2
ecophysiology of microorganisms	2
host-associated microbiomes	2
diverse communities of microorganisms	2
Humans and animals	2
Salmonella pathovars	2
immune compromised populations	2
new niche	2
thousands of variants of Salmonella	2
multiple institutions	2
Fungal Immunology	2
Medical Mycology	2
receptor-cleaving neuraminidase (NA) proteins of IAV and IBV or the ICV HEF protein	2
New viruses	2
haemagglutinin (HA) proteins of IAV and IBV, or the haemagglutinin-esterase-fusion (HEF) proteins of ICV	2
humans, influenza viruses	2
similar pandemics	2
H5 and H7 subtypes	2
‘Great Influenza’ pandemic	2
pandemic strains	2
segmented genomes	2
different host species	2
Influenza A, B and C viruses (IAV, IBV, and ICV) infecting humans	2
many vertebrates	2
Influenza viruses	2
influenza pandemics	2
seasonal influenza	2
wide range of bacterial species	2
given species	2
‘germline’ lineage of viruses	2
ability	2
different bacteria	2
distinct metabolisms	2
particular bacterial populations	2
surface waters	2
dissolved organic matter	2
Bacterioplankton (bacteria and archaea)	2
unforeseen bacterial and eukaryotic connections	2
genome segregation machines	2
lineages of this domain	2
microbiome data	2
sequencing technology	2
highly divergent lineages	2
transmissible strains	2
Populations of P. aeruginosa	2
cystic fibrosis (CF) lung	2
Pseudomonas aeruginosa populations	2
asthma patients	2
role bacteria	2
chronic asthma	2
recently discovered asthma airway microbiota	2
subgroup of sufferers	2
key virulence factors	2
host-imposed stresses and antifungal drugs	2
diverse host niches	2
Candida albicans, a major fungal pathogen of humans	2
tip of the nascent structure	2
core of the flagellum	2
flagellum base	2
type III export machinery	2
thousands of structural subunits	2
bacterial surface	2
helical propellers	2
series of global maps	2
confirmed instances	2
single type	2
DENV types	2
DENV spread	2
four types	2
dengue virus (DENV)	2
Mycobacterium leprae and Mycobacterium tuberculosis	2
ancient and modern genomes	2
alternate hypotheses	2
wider range of environmentally representative cultures	2
ammonia-oxidisers	2
acidic soils	2
sufficient physiological diversity	2
genomes, cultures, field studies	2
soil AOA and AOB	2
soil nitrification	2
Autotrophic archaeal and bacterial ammonia-oxidisers (AOA and AOB)	2
external and focal settings	2
focal virulence site	2
virulence evolution theory	2
non-parasitic contexts	2
many opportunistic pathogens (OPs)	2
mucosally active vaccines	2
suitable adjuvants	2
combination of innate, humoral and cell-mediated immunity	2
nasopharynx	2
elderly and immunocompromised individuals	2
Pneumococcal pneumonia	2
known modulating ligands	2
BKPyVN versus TCMR renal biopsies	2
inflammatory cell infiltrates	2
CD45+	2
nuclear AHR expression	2
BKPyVN grafts	2
AHR, CD68 and CD45.ResultsAHR transcription	2
available frozen material	2
BKPyVN (n=8)	2
kidney grafts	2
BKPyVN with T-cell mediated rejection (TCMR)	2
renal grafts	2
aryl hydrocarbon receptor (AHR) - a transcription factor	2
patients with aGVHD.ConclusionOur findings	2
aGVHD-related biomarkers	2
rTM-treated group	2
sVCAM-1, PAI-1, elafin, REG3α and ST2	2
225 patients	2
study cohort	2
recombinant soluble thrombomodulin (rTM)	2
patients undergoing allogeneic HSCT	2
soluble vascular cell adhesion molecule: sVCAM-1 and plasminogen activator inhibitor: PAI-1)	2
activation normal T-cell expressed and secretes: RANTES, elafin, REG3α and ST2)	2
tumorigenicity 2 (ST2), elafin and regenerating islet-derived 3α (REG3α)	2
effector apparatus	2
tissue-resident NKT cells	2
key mediators	2
conventional T (CD4+ or CD8+) (p=0.11) cells	2
NKT cells (p=0.0025)	2
cells (CD3εKO)	2
liver tissue sections	2
serum alanine aminotransfersase (ALT)	2
vivo murine model	2
role T cells	2
organ's blood supply	2
overview of biomarkers	2
irreversible nephron	2
glucocorticoids alone	2
IL-12 and IL-2 induced CD69 expression and IFNγ production	2
IFNγ and perforin production	2
IL-12 induced IFNγ and perforin production	2
IFNγ production	2
CD69 and CD25 (IL-2 condition only)	2
ISD	2
NK-cell STAT4 and STAT5 phosphorylation	2
selected NK-cell receptors	2
STAT4 and	2
selected ISD (tacrolimus, cyclosporin A, mycophenolic acid, dexamethasone) treatment	2
ISD, NK-cells and/or MSCs	2
graft-versus-leukemia	2
NK-cells	2
immunosuppressive drugs (ISD)	2
Mesenchymal stem cells (MSCs)	2
heart–lung transplant recipients	2
EBV-seronegative recipients	2
lowest dose of rATG	2
patients receiving antiviral prophylaxis	2
overall transplant population	2
kidney and heart transplantation	2
maintenance therapies	2
historical patient cohorts	2
rabbit antithymocyte globulin (rATG)	2
anti-ETAR(−) patients	2
presence of anti-ETAR Abs 4/55 (7.2%)	2
ETAR(−) patients	2
1.51±0.5 in anti-ETAR(−) pts	2
serum creatinine in anti-ETAR (+) patients (pts)	2
anti-ETAR(−) group	2
anti-ETAR(+) group	2
analyzed recipients	2
-ETAR antibodies	2
Anti-ETAR antibodies	2
anti-HLA antibodies	2
consecutive renal transplant recipients	2
heart transplant patients	2
receptor (anti-ETAR) antibodies	2
Anti-endothelin-1 type	2
vascular receptors	2
BackgroundNon-HLA antibodies (Abs)	2
cardiac transplantation model	2
systemic graft-versus-host model	2
mutated Vav1	2
knock-in mice	2
central signal transducer	2
GDP exchange factor (GEF) Vav1	2
medical devices	2
impregnated polymer materials	2
antimicrobial agent	2
potential antimicrobial agents	2
polymer based medical devices	2
polymeric medical devices	2
conditioning films	2
bacterial retention and conditioning film	2
cells and conditioning agents	2
Staphylococcus aureus or Staphylococcus epidermidis	2
whole blood conditioning agents	2
bovine serum albumin	2
titanium nitride (TiN) or titanium nitride/silver (TiN/14.94 at.%Ag or TiN/19.04 at.%Ag)	2
medical grade stainless steel substrata	2
conditioning film	2
medical implant	2
surgical site	2
Implanted medical devices	2
hygienic surfaces	2
rhodium and/or ruthenium metal ions	2
E. faecium	2
metal ion combination	2
three tested bacteria	2
rhodium/ruthenium combination	2
rhodium metal ion solution	2
(FBC) assays	2
nine metal ion solutions (yttrium, indium, niobium, titanium, tantalum, rhodium, ruthenium, zinc and gallium)	2
New biocidal products	2
Klebsiella pneumoniae, Acinetobacter baumannii and Enterococcus faecium	2
initial one	2
Methylobacterium DSM 18358	2
trihalomethanes in drinking water	2
haloacetic acids	2
another major group of chlorine disinfection by-products	2
Methylobacterium species	2
chlorination by-products	2
trihalomethanes	2
water treatment and distribution systems	2
chlorine disinfection by-products	2
continuously operated bioreactors	2
Microbial films and mobile polymers	2
microbial biopolymers	2
co-products of biofuel industries	2
SMP and EPS production	2
EPS- and SMP-polysaccharides	2
SMP-fraction, polysaccharides and uronic acids	2
EPS-uronic acids	2
EPS-polysaccharide and protein	2
respective extracts	2
total polysaccharide	2
readily soluble microbial products (SMP)	2
microbial EPS	2
refined glycerol or crude unrefined biodiesel co-product (BCP)	2
native microbial biomass	2
microbial EPS in soils	2
variety of environments	2
bacterial community diversity	2
non-silver controls	2
non-oiled microcosms	2
member of Bacteroidetes	2
one DGGE band	2
silver-exposed sediments	2
 dws	2
L−1 cAgNPs	2
non-oiled sediments	2
oil-amended sediments	2
uAgNPs, cAgNPs and Ag2SO4	2
estuarine sediments	2
hydrocarbon-degrading microbial communities	2
dissolved Ag2SO4	2
uncapped AgNPs (uAgNPs), capped AgNPs (cAgNPs)	2
sewage treatment works	2
boat traffic	2
Colne estuary	2
estuarine microbial communities	2
silver nanoparticles (AgNPs)	2
3D matrix	2
actin-rich protrusions	2
3D microenvironments	2
2D substrates	2
physiologically relevant environments	2
distinct cell populations	2
mesenchymal cells of the dermis	2
several stem cell populations	2
diverse populations of epidermal cells and dermal fibroblasts	2
zebrafish infection	2
wide variety of pathogenic bacteria	2
macrophages and neutrophils	2
fully functional innate immune system	2
Zebrafish (Danio rerio) larvae	2
dynamic networks of communicating organelles	2
individual mitochondria	2
intercellular projections	2
evolutionarily conserved structure	2
immobilized mitochondria and transport proteins	2
mitochondrial nanotunnels	2
matrices of non-adjacent mitochondria	2
thin double-membrane protrusions	2
biological units	2
complex physiological systems	2
cellular nutrients	2
excess, aggregated, or damaged proteins and organelles	2
catabolic pathway	2
(Macro)Autophagy	2
unusual TRIB pseudokinase conformation	2
TRIB3 homologs	2
canonical MAPK and AKT modules	2
context-specific E3 ligases	2
regulated binding platform	2
atypical pseudokinase domain	2
Tribbles (TRIB) pseudokinases	2
existing optogenetic tools	2
cells, tissues, and organisms form	2
cell biological bases	2
pulse of laser light	2
unexpected cellular locations	2
regulatory inputs	2
digital systems	2
multiple signals	2
cilia-mediated signaling itself	2
diverse regulatory inputs	2
eukaryotic Smc complexes	2
dosage compensation complex	2
cohesin, condensin, Smc5-6	2
ubiquity	2
almost all organisms	2
two structural maintenance of chromosomes (Smc) proteins	2
large ring structure	2
multiple conflicting stimuli	2
individual actin regulatory pathways	2
diverse set of different actin regulators	2
bacterium and an archaeon	2
ever-closer symbiotic partnership	2
bacterial genes and membranes	2
relatively simple cell	2
archaeal ancestor	2
future mitochondrion	2
archaeal ancestor of eukaryotes	2
‘Loki’ cells	2
archaeon whose genome	2
first true eukaryotic cell	2
list of available software tools	2
Computational methods and tools	2
invasive tumor cells	2
embryonic germ lineages	2
induced pluripotent stem (iPS) cells	2
vitro counterpart, embryonic stem (ES) cells	2
pluripotent cells in the embryo	2
interconnected network of transcription factors	2
Pluripotent cells	2
new modulators	2
ligand-stimulated epidermal growth factor receptor (EGFR)	2
resulting data mountain	2
field of MS and proteomics	2
system-wide characterisation of proteins	2
MS instruments	2
important systems-level regulator	2
endosomal crosstalk	2
putative crosstalk-mediating endosomal scaffolds	2
one distinct pathway	2
endosome-associated scaffold proteins	2
‘signaling endosomes’	2
incoming signals	2
genes in ES cells	2
polycomb repressive complex 2	2
family of chromatin modifiers	2
mesenchymal (or indeed non-mesenchymal) cell derivatives	2
dental stem cells	2
biological implants	2
complete or partial tooth structures	2
periodontal ligament	2
vital pulp tissue	2
autologous stem cells	2
Dental stem cells	2
periodontal ligament and growing roots	2
parts of the tooth	2
damaged	2
dental pulp stem cells	2
Notch, Wnt and Fgf pathways	2
Three signalling pathways	2
molecular oscillator	2
vertebrate segmentation clock	2
bacteriophage components	2
endogenous mRNAs	2
labeled antisense probes	2
labeled transcripts	2
mRNA in living cells	2
fixed tissue	2
Localized mRNA	2
possible cell surface proteins	2
cells in vitro	2
clockwork	2
complex disorders	2
tumour suppressors	2
Period genes	2
myriad cell systems	2
ancient timekeeper	2
network of transcriptional and/or post-translational feedback loops	2
hypothalamic suprachiasmatic nuclei	2
behavioural, physiological, cellular and neuronal processes	2
Circadian rhythms	2
open source tools	2
bioimage informatics	2
men with CRPC	2
androgen-sensitive organs	2
human chorionic gonadotropin-treated male rats	2
sexually mature male cynomolgus monkeys	2
murine VCaP xenograft model	2
significantly tumour growth	2
androgen-dependent VCaP and LNCaP cells	2
dihydrotestosterone (DHT) and testosterone (T)	2
prerequisite enzyme	2
AR signaling axis	2
patients with castration-resistant prostate cancer (CRPC)	2
novel nonsteroidal dual-action compound, ODM-204	2
diet and microbial populations	2
total unconjugated bile acids	2
unconjugated cholic acid	2
1.7μm particle size reversed-phase C18 LC column	2
common bile duct	2
individual bile acids	2
gastrointestinal malignancies	2
25(OH)D availability	2
total and free 25(OH)D	2
1,25(OH)2D and DBP	2
total and free 25(OH)D.	2
total 1,25(OH)2D	2
calculated free vitamin D metabolites (P<0.01)	2
British and Chinese	2
total 1,25(OH)2D, DBP, albumin and calculated free 25(OH)D	2
plasma total 25(OH)D	2
oxysterol deregulation	2
ceramides and oxysterols, specifically 25-hydroxycholesterol (25-OH)	2
cultured keratinocytes	2
various lipids	2
Skin photoaging	2
androgen receptor	2
several previously published data sets	2
malignant prostate tissue	2
list of frequently reported genes	2
GR related cofactors	2
large array	2
GR	2
intracellular GC receptors (GR)	2
Glucocorticoids (GCs)	2
control plasma	2
3β,5α-dihydroxycholest-7-en-6-one and 7α,8α-epoxycholesterol	2
novel hydroxy-8-dehydrocholesterol	2
SLOS patients	2
tissues and blood plasma	2
cholesterol precursor 7-dehydrocholesterol (7-DHC)	2
cholesterol synthesising enzyme 7-dehydrocholesterol reductase (Δ7-sterol reductase, DHCR7, EC 1.3.1.21)	2
combination of ATRA and 1,25D.	2
AML cell lines	2
RARα agonist	2
RARα protein	2
RARα agonists	2
exon 1a	2
VDR transcriptional variant	2
retinoic acid receptor α (RARα)	2
different AML cell lines	2
differentiation-inducing agents	2
either all-trans-retinoic acid (ATRA) or 1,25-dihydroxyvitamin D3 (1,25D)	2
malignant immature myeloid precursors	2
Acute myeloid leukemia (AML)	2
alternative cell types	2
true associations	2
CYP2R1)	2
priori defined candidate genes (CYP24A1, CYP27B1,	2
set of CpG sites	2
cord blood DNA	2
Avon Longitudinal Study of Parents and Children (ALSPAC).Across 473,731CpG DNA methylation sites	2
Norwegian Mother and Child Cohort (MoBa)	2
maternal plasma	2
active forms	2
steroid regulatory element-binding proteins (SREBPs)	2
bile acid and steroid hormone biosynthetic pathways	2
oxygenated forms of cholesterol or its precursors	2
active hormone	2
black women	2
combined cohort	2
CC-MOD reference group	2
white women	2
Black women	2
combined cohort datasets	2
Charleston County, South Carolina March of Dimes (CC-MOD)	2
NICHD and TRF studies	2
race/ethnic group	2
mother and newborn	2
supplemental vitamin D	2
NICHD (n=346) and Thrasher Research Fund (TRF, n=163) studies	2
isoallopregnanolone, UC1011, GR3027 and 17PA	2
allopregnanolone/THDOC-increased GABA-mediated GABAA receptor activity	2
effective GAMSA	2
GAMSA isoallopregnanolone	2
rat the GAMSA UC1011	2
hippocampal LTP	2
Hippocampal slices	2
increased brain ammonia	2
humans an allopregnanolone challenge	2
Allopregnanolone and THDOC	2
specific antagonists	2
various 3β-hydroxy-steroids	2
3α-hydroxy-neurosteroids, notably allopregnanolone and tetrahydrodeoxycorticosterone (THDOC)	2
GABAA receptor	2
GABA-evoked currents	2
GABAA receptor modulating steroid antagonists (GAMSA)	2
two laboratories	2
well validated LC–MS/MS assays	2
Endocrine Sciences	2
1,25-(OH)2D assay	2
conventional competitive formats	2
liganded-LBD	2
liganded-LBD’s conformational change	2
vitamin D binding protein	2
capture molecule	2
VDR’s ligand binding domain (LBD)	2
four pillars	2
novel 1,25-(OH)2D assay	2
fully-automated chemiluminescent assay	2
abundant metabolites	2
hormonal form of vitamin D	2
D (1,25-(OH)2D)	2
Inflammatory cytokines	2
conjugated estrogen	2
OSE and EOC cells	2
cancer (SKOV3) cells	2
EST (P<0.01)	2
[3H]-E1S	2
[3H]-E2	2
[3H]-E1	2
EOC cell lines	2
[3H]-E1S or [3H]-E2S	2
free [3H]-E1	2
OSE cells	2
free estrogen	2
total mRNA	2
aromatase and 17BHSD1 expression	2
primary cell cultures of OSE and EOC	2
(17BHSD2)	2
Steroid sulphatase (STS), estrogen sulfotransferase (EST), 17β-hydroxysteroid dehydrogenases 2	2
normal human ovarian surface epithelium (OSE), EOC and selected EOC cell lines (SKOV3 and PEO1)	2
malignant ovarian tumors	2
Epithelial ovarian cancer (EOC)	2
17th Vitamin D Workshop	2
calcitriol gradually	2
MR calcifediol	2
24,25-dihydroxyvitamin D3	2
plasma iPTH	2
IV calcifediol	2
serum 25-hydroxyvitamin D3 and calcitriol	2
Single doses of oral MR	2
intact parathyroid hormone (iPTH)	2
kidney and parathyroid gland	2
calcitriol and FGF23	2
Bolus IV calcifediol	2
vitamin D deficient rats	2
bolus intravenous (IV) or oral MR calcifediol	2
Single doses	2
modified-release (MR) oral formulation of calcifediol (25-hydroxyvitamin D3)	2
vitamin D2 or D3 regimens	2
stage 3 or 4 CKD patients	2
transformed ducts	2
vitamin D system in the pancreas	2
CP patients	2
PDAC patients	2
PDACs in the transformed ducts	2
endocrine pancreas	2
endocrine	2
VDR and the CaSR protein	2
adjacent non-tumorous tissue	2
pancreatic ductal adenocarcinomas (PDAC)	2
different regions of the pancreas	2
vitamin D receptor (VDR), 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1), and the calcium-sensing receptor (CaSR)	2
diseased pancreas	2
kidneys and bones	2
target genes in the intestine (TRPV6, calbindin-D9k, and VDR)	2
kidneys (VDR, TRPV5, and calbindin-D28k) and bone (VDR, FGF-23, and RANKL)	2
serum phosphorus	2
FGF-23, and urinary calcium excretion	2
serum calcium	2
compound in the blood	2
calcitriol in the blood	2
administered dosage	2
calcitriol and eldecalcitol	2
normal rats	2
VDR gene knockout mice	2
vitamin D receptor (VDR) in target tissues	2
exogenous eldecalcitol	2
serum FGF-23	2
vitamin D analog	2
parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF-23)	2
essential hormone	2
Calcitriol (1α,25-dihydroxyvitamin D3, 1α,25(OH)2D3)	2
serum 1,25(OH)2D	2
low tertile	2
vertebral fractures	2
corresponding tertile of the alfacalcidol-treated group	2
eldecalcitol-treated group	2
vertebral and osteoporotic fractures	2
lumbar and hip BMD	2
native vitamin D3	2
serum 25(OH)D.	2
1,25D3, TNFα, and IL-6	2
Caco2/AQ cells	2
Coga1A (p<0.01)	2
moderately differentiated (Coga1A) colon cancer cell line	2
differentiated (Caco2/AQ)	2
1,25D3, tumor necrosis factor alpha (TNFα), and interleukin (IL)-6 on CaSR expression	2
1,25-dihydroxyvitamin D3 (1,25D3) and NF-κB, STAT, and SP1 binding sites	2
vitamin D elements	2
CaSR promoter	2
calcium in the colon	2
calcium ion channel TRPV6	2
vitamin D activating enzyme CYP27B1	2
expression of CYP27B1	2
cyclooxygenase 2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase	2
several vitamin D target genes	2
genes activating and catabolizing 1,25-D3 (1α-hydroxylase (CYP27B1), 24-hydroxylase (CYP24A1))	2
1,25-dihydroxyvitamin D3 (1,25-D3), IL-6, TNFα, and with combinations of these compounds	2
6, 12, and 24h	2
colon cancer cell line COGA-1A	2
colonic epithelial cells	2
Interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα)	2
novel radiotherapeutics and taxanes, and immunotherapeutic approaches	2
growth factor inhibitors	2
endothelin receptor antagonists	2
bone targeting and antiangiogenic agents	2
new androgen receptor blockers	2
hormone synthesis inhibitors	2
new therapeutic agents	2
castration-resistant prostate cancer (CRPC)	2
Prostate cancer	2
11β-	2
11β-HSD1-deficiency or inhibition	2
11β-HSD1)	2
11β-HSD	2
type 1 (11β-HSD1)	2
enzyme 11β-hydroxysteroid dehydrogenase	2
active glucocorticoid	2
desulfonation, hydroxylation and methoxylation	2
oestrogen	2
co-repressor binding	2
prostate cancer cells	2
co-repressors	2
VDR inappropriately	2
target-gene promoter regions	2
VDR-binding regions	2
two VDR target genes	2
1α,25(OH)2D3-recalcitrant prostate cancer cells (PC-3)	2
non-malignant prostate epithelial cells (RWPE-1)	2
VDR ligand, 1α,25(OH)2D3	2
hepatocyte growth	2
FXR	2
classic PXR-regulated CYP3A4 gene in human hepatocytes	2
direct PXR activator	2
hepatic NF-κB activity	2
hepatotoxin CCl4	2
NF-κB)	2
luciferase gene	2
3x-κB-luc fibrotic mice	2
PXR−/− mice	2
PXR+/+ mice	2
liver monocytes/macrophages	2
PXR and PXR activators	2
SJL/J-PXR−/−. Monocytic cells	2
SJL/J-PXR+/+	2
SJL/J mice	2
transplanted patients	2
primary biliary cirrhosis (PBC)	2
steroid metabolites (precursor metabolite/product metabolite)	2
steroid metabolites	2
multiple hormone metabolites	2
“Achilles heel	2
every steroid excreted	2
scanned run	2
Lemli–Opitz syndrome	2
steroid disorder metabolomes	2
specific compounds	2
novel metabolomes	2
panels of such compounds	2
individual steroids	2
sample volumes	2
single physical framework	2
intra-protein interaction network	2
mutated site	2
significant fraction of protein residues	2
de novo enzyme	2
closely related natural enzymes	2
recently reported C45 maquette	2
de novo metalloenzymes	2
metabolic pathways of living cells	2
plug-and-play components	2
useful chemicals and materials	2
de novo enzymes	2
new designs	2
chromatin remodelers and epigenetic regulators	2
pre-initiation complexes	2
eukaryotic RNA polymerases	2
large, flexible and often transient transcription complexes	2
atomic or near-atomic resolution structures	2
transmembrane β-barrel pore	2
Soluble protein monomers	2
hosts and pathogens, β-pore-forming proteins (β-PFPs)	2
Bragg analysis	2
protein conformational ensemble	2
cryptic binding pockets	2
allosteric binding sites, modulators and communication pathways	2
new classes of drugs	2
distant site	2
one site on a protein	2
high-throughput experimental tools	2
new artificial enzymes	2
flexible catalysts	2
new catalytic and non-catalytic functionality	2
structural domain	2
three nuclear RNA polymerases	2
DNA-dependent-RNA polymerase I and III	2
rRNAs, tRNAs and U6 snRNA	2
non-protein-coding RNAs	2
membrane-less organelles	2
long disordered regions	2
less well biophysically characterized subset of proteins	2
revolution	2
specific TF–TF–DNA complexes	2
individual regulatory elements	2
multiple TFs	2
molecular systems	2
larger genomes	2
higher organisms	2
long DNA motifs	2
individual transcription factors (TFs)	2
crowded cellular milieu	2
diverse crRNP effector nucleases	2
target nucleic acids	2
spacer-derived guide segment	2
Cas protein(s)	2
crRNA	2
repeat-derived invariant and spacer-derived variable segments	2
crRNA-guided effector nucleases	2
crRNA ribonucleoprotein (crRNP) effector complexes	2
multiple or single Cas proteins	2
CRISPR RNA (crRNA)	2
prokaryotic CRISPR-Cas adaptive immune systems	2
spectroscopies and imaging	2
protein conformers	2
hybrid-FRET	2
optimal distance networks	2
networks of FRET pairs (hybrid-FRET)	2
integrative structural modeling	2
Förster Resonance Energy Transfer (FRET)	2
Protein anisotropy	2
macromolecular crowded environments	2
structural biological	2
18 autophagy-related (Atg) proteins in yeast	2
double-membrane organelle, the autophagosome	2
degradation targets	2
intracellular degradation system	2
POT family	2
bacterial and plant members of the family	2
PepT1 and PepT2, the mammalian homologues	2
peptide-based pro-drugs	2
plant defence compounds and hormones	2
plants the family	2
di- and tri-peptide transporters	2
archaea	2
members of the family	2
inwardly directed proton electrochemical gradient	2
POT family of membrane transporters	2
bi and multi-specific formats	2
host of architectures	2
antibody combining site (variable regions)	2
antibody-based protein therapeutics	2
class of intriguing biocatalysts	2
intriguing enzymes	2
Cofactor-independent oxygenases (and oxidases)	2
enzymes containing redox metal and/or organic co-factors	2
reactant	2
common organic substrates	2
diradical (3O2)	2
ground state	2
potentially strong oxidant	2
Molecular oxygen (O2)	2
small membrane organelles	2
realistic models	2
larger scale simulations	2
protein–lipid interaction simulations	2
lipid binding sites	2
specific lipids	2
atom and coarse-grained simulations	2
membrane proteins and systems	2
flavoenzymology field	2
new flavin based species	2
superoxidized flavin-N5 oxide species	2
flavoenzyme chemical repertoire	2
diverse family of flavoenzymes	2
isoalloxazine ring system	2
one of the most versatile cofactors	2
humans and other organisms	2
partially characterized or un-characterized JmjC oxygenases	2
formaldehyde and the demethylated product	2
relatively unstable hemiaminals	2
Nɛ-methyl lysine demethylation	2
chemically stable alcohol products	2
2OG oxygenases	2
Jumonji-C (JmjC) subfamily of 2-oxoglutarate (2OG)-dependent oxygenases	2
different lipid-binding scenarios	2
nonselective annular contacts	2
lipid subsets	2
hydrophobic lipid environment	2
Proteins in the membrane	2
Biological membranes	2
protein epitopes	2
two classes of macromolecules	2
Aptamers and antibodies	2
diversity-enhancing side chains	2
modified aptamers	2
completely novel motifs	2
specific functional groups	2
known nucleic acid motifs	2
precise three-dimensional structures	2
flexible phosphodiester backbone	2
aptamer–protein structures	2
aptamer–protein interactions	2
ultrastable, all-gold substrate	2
vacuum of the electron microscope	2
electron cryomicroscopy (cryo-EM)	2
group II intron-like catalytic RNA core	2
U2.U6.U5 complex	2
U4/U6.U5 tri-snRNP structure	2
post-catalytic intron lariat spliceosome containing U2 and U5 snRNPs, NTC (nineteen complex), NTC-related proteins (NTR), U6 snRNA, and an RNA intron lariat	2
spliceosomal complex	2
Schizosaccharomyces pombe	2
30 proteins	2
snRNA duplex	2
tri-snRNP	2
Saccharomyces cerevisiae U4/U6.U5	2
numerous non-snRNP factors	2
small nuclear ribonucleoprotein particles (U1, U2, U4/U6 and U5 snRNPs)	2
pre-mRNA substrates	2
ions, ligands and proteins	2
3D structure modeling	2
complex three-dimensional (3D) structures	2
supramolecular assemblies	2
micro-domains	2
β-barrel OMPs	2
promiscuous protein–protein interactions (PPIs)	2
outer membrane proteins (OMPs)	2
higher-order assemblies	2
main classes of multi-drug transporters	2
entire cell envelope	2
virulence agents	2
drugs and other harmful compounds	2
tripartite assemblies	2
energy-transducing components	2
hazardous environments	2
enormous range of harmful compounds	2
super-system	2
collective body	2
clinically applied therapeutic agents	2
harmful substances	2
energy-dependent trans-membrane transporters	2
membrane proteins and complexes	2
detectors and software	2
labile protein complexes	2
large amounts of protein	2
medically important protein structures	2
membrane protein structural biology	2
receptor hetero-oligomers	2
many receptors	2
human and mouse receptors	2
pathogen-binding C-type lectins on cells of the innate immune system	2
endogenous mammalian glycans	2
adhesion and endocytic receptors	2
C-type lectin-like domains	2
any, natural structures	2
protein-structure space	2
entirely new proteins	2
natural protein structures	2
Protein scientists	2
range of host cells	2
‘cell factory	2
recombinant host cells	2
many recombinant membrane proteins	2
biochemically characterised, recombinant targets	2
high-quality protein	2
endoglycosidase overexpression	2
phage integrases	2
Lentivirus system	2
stable cell pools	2
volumetric product yield	2
stable mammalian cell lines	2
important expression hosts	2
mammalian cell lines HEK293	2
constructs and cell strains	2
receptors, channels and transporters	2
eukaryotic co-translational and post-translational processing systems	2
widely used recombinant expression host	2
novel analogs of the natural products	2
peptide cleavage and peptide macrocyclization	2
amino acid heterocyclization	2
closely related products	2
heterocycle oxidation	2
peptide macrocyclization	2
complex framework	2
patellamide and related natural products	2
abundant organic molecule	2
bacterial integral membrane protein complex	2
structure of the human O-GlcNAc transferase	2
bacterial oligosaccharyltransferase	2
biologically or medically relevant molecules	2
diverse range of saccharides and glycoconjugates in nature	2
Glycosyltransferases (GTs)	2
specific and complex tasks	2
molecules in and out of the cell	2
flexible molecular machines	2
common ancestors	2
closely similar structures	2
sugar-binding domains	2
single-celled organisms	2
specific oligosaccharides	2
Protein modules	2
X-ray crystallography of enzymes	2
conformational itineraries	2
cognate GHs	2
anomeric and other ring positions	2
wide variety of complex carbohydrates	2
sequence-based families	2
Glycoside hydrolases (GHs)	2
exemplar	2
isomerases	2
individual EC class	2
active translocation site	2
signal peptide of the substrate protein	2
Tat translocation site	2
TatA and TatC proteins	2
specific N-terminal signal peptides	2
translocates proteins	2
thylakoid membrane of plant chloroplasts	2
cytoplasmic membrane of prokaryotes	2
Tat protein transport system	2
∼3MDa assembly	2
T4S system components	2
double membrane of Gram-negative bacteria	2
large 1MegaDalton (MDa) structure	2
T4S system core complex	2
T4S system subassemblies	2
diverse range of prokaryotic and eukaryotic target cells	2
DNA and protein substrates	2
Bacteria use type IV secretion (T4S) systems	2
evolutionary distant organism	2
common RNA/reverse transcriptase core	2
medium resolution EM density maps	2
catalytic protein subunit	2
protein and RNA subunits	2
human telomerase	2
ciliate telomerase	2
two holoenzyme complexes	2
human and ciliate telomerase	2
telomerase reverse transcriptase	2
homologous modular protein assemblies	2
different niches	2
ancillary components of the T3SS	2
non-flagellar T3SS (NF-T3SS)	2
flagellar T3SS	2
two highly homologous families	2
periplasmic and extracellular spaces	2
bacterial cytoplasm	2
type III secretion system (T3SS)	2
macromolecular nanomachines	2
kinetic intermediates	2
several topologically, structurally and/or evolutionarily related proteins	2
interactomes of syndecans and integrins	2
short cytodomain	2
integrins	2
short cytoplasmic tail	2
cytoplasmic signals	2
protein core	2
syndecan ectodomains	2
syndecan family of transmembrane proteoglycans	2
active protein kinases	2
components of signalling networks	2
enigmatic subset	2
catalytic motifs	2
number of kinases	2
signal transduction networks	2
Protein kinases	2
SH2	2
active Csk and Abl	2
SH2 and the kinase domains	2
regulatory helix	2
SH2–kinase domain of Fes	2
many nonreceptor tyrosine kinases	2
Src family members	2
catalytic kinase domain (SH1)	2
many signaling molecules	2
sequence-specific phosphotyrosine-binding module	2
(SH2) domain	2
Src homology 2	2
solved crystal structures	2
α-helical membrane proteins	2
experimentally tractable proteins	2
partially hydrophobic surfaces	2
unique structures	2
native and non-native interactions	2
even the smallest proteins	2
ubiquitous stepping stones	2
small, single-domain proteins	2
fascinating species	2
popping cress fruits	2
eject seeds	2
touch-me-not species with similar fruits	2
Finite element models	2
developmental questions	2
physical forces	2
specific embryo growth zones	2
embryo of a mature seed	2
various layers	2
various seed compartments	2
plant seed/fruit structures	2
erythrocytic variant (rs1050828)	2
non-glycemic variants	2
multiple genomic loci	2
Glycated hemoglobin (HbA1c)	2
set of 411 proteins	2
complement of RBPs	2
several RNA-binding proteins (RBPs)	2
established and emerging model systems	2
live-cell imaging	2
conserved proliferative signaling pathways	2
xenobiotic compounds	2
classic invertebrate systems of Caenorhabditis elegans and Drosophila melanogaster	2
chemotherapeutic compounds	2
cytotoxic compounds	2
conserved proliferative pathway genes	2
xenobiotic exposures	2
niches	2
proliferative signaling pathways	2
chemical compounds and pathogens	2
complex niches	2
explicit models	2
computational simulations	2
many taxa	2
genetic material between species	2
mouse naïve cells and the preimplantation human epiblast	2
human naïve-like stem cells	2
better PSCs	2
conventional mouse and human PSCs	2
human material	2
comparable, stable cell lines in mouse	2
Pluripotent stem cells (PSCs)	2
cell-free circulating DNA	2
cancer-specific methylation biomarkers	2
regulatory elements and networks	2
activator and repressor binding sites	2
Transcriptional enhancers	2
PINK1/Parkin mitophagy	2
potent mitochondrial toxins	2
two Parkinson’s disease genes, PINK1 and parkin	2
pro-apoptotic factors	2
damaging reactive oxygen species	2
essential organelles	2
organizational checkpoint model	2
embryonic, post-embryonic, and life cycle spanning transcriptomes	2
polarity axes	2
female reproductive organ	2
complicated plant structures	2
particular tissues	2
Multicellular organisms	2
various groups of vertebrates	2
numerous tissues	2
nerve-associated glial progenitors	2
different, more specialized, cell type	2
nerve-dwelling population of the neural crest	2
different subtypes	2
mature Schwann cells	2
melanocytes/melanophores, parasympathetic and enteric neurons, endoneural fibroblast	2
variety of fates	2
neural crest-derived nature	2
neural crest-derived Schwann cell precursors (SCPs)	2
homeodomain transcription factors	2
many transcriptional partners	2
developing and adult organisms	2
entire eukaryote kingdom	2
Homeodomain proteins	2
efficient computational tools	2
parametric models	2
fine-scale structure	2
individual origins	2
discrete population models	2
haplotypic modeling	2
multiple areas	2
large samples	2
important organisms	2
basic schistosome biology	2
developmental underpinnings	2
flatworms of the genus Schistosoma	2
animal organ systems	2
single xenacoelomorph ‘model’ species	2
recent common ancestor	2
bilaterian cell types and organ systems	2
sister group of the Nephrozoa (Protostomia+Deuterostomia)	2
Xenacoelomorpha	2
kinds of exaggeration and other model species	2
hemimetabola	2
selection of holometabolous insects	2
naturalists and evolutionary biologists	2
unicellular ancestor	2
evolutionary origins	2
dominant pathways	2
popular model system	2
Dictyostelium discoideum	2
genes and gene-related DNA	2
part of the genome	2
gene space	2
‘junk’ DNA	2
small genomes	2
angiosperms (flowering plants)	2
repertoire of molecules	2
functional sites and surfaces	2
ubiquitous and promiscuous superfamilies	2
CATH-Gene3D domain classification resource	2
transcriptional enhancers	2
patients’ DNAs	2
chromosomal compartments	2
long-range enhancer clusters	2
individual and the clinician	2
fascinating organ system	2
transcription factors, transmembrane proteins	2
familiar signalling pathways	2
anterior neural plate	2
one of the several ectodermal thickenings	2
secretory cells and supporting cells	2
sensory hair cells	2
Almost all cell types of the inner ear	2
auditory (hearing) and vestibular (balance) functions	2
sensory organ	2
vertebrate eye	2
cultured embryonic stem cells	2
forming eye	2
underlying mesendoderm	2
neural and non-neural ectoderm	2
Novel single cell sequencing and blood-based subclonal tracking technologies	2
cancer subclones	2
Intratumour heterogeneity	2
mammalian enzymes	2
bacterial Endonuclease V enzymes	2
Endonuclease V	2
specialized enzymes	2
deaminase enzymes	2
nucleobases in DNA and RNA	2
archaic hominins	2
developmental gene regulatory elements and RNA genes	2
many HARs	2
Human accelerated regions (HARs)	2
animal evolutionary tree	2
z-disk	2
key modules	2
various metazoan genomes	2
diverging lineages	2
T- and B-cells of the immune system	2
smooth and striated muscle cells	2
origin of neurons	2
specific subfunctions	2
cellular modules	2
sporadic colorectal and endometrial cancers	2
somatic EDMs	2
multiple colorectal adenomas	2
human POLD1 and POLE	2
germline exonuclease domain mutations (EDMs)	2
Pol ɛ homologues	2
exonuclease domain of Pol δ and	2
Yeast models	2
Pol δ and Pol ɛ	2
lagging and leading strand	2
Pol α, Pol δ or Pol ɛ	2
Three DNA polymerases — Pol α, Pol δ and Pol ɛ	2
amplification products	2
cell's nucleic acids	2
chromosome domains	2
insulator proteins	2
H3K27me3 TADs	2
one class of TADs	2
Chromatin regions	2
many topologically associating domains (TADs)	2
large genomic domains	2
genomic domains	2
Pc nuclear foci	2
long genomic domains	2
associated H3K27me3 histone mark	2
key developmental genes	2
cancer genome sequencing and biological models	2
large-scale biological models	2
tomorrow's biomarkers and drug targets	2
powerful experimental designs	2
novel oncogenic drivers	2
vivo imaging	2
high-throughput transgenesis	2
candidate cancer genes	2
new candidates	2
previously implicated genes (Rarb and Stmn2)	2
new modifiers	2
complex crosses	2
variant CJD	2
UK CJD cases	2
new loci	2
prion protein gene (PRNP)	2
animals and Creutzfeldt–	2
scrapie and bovine spongiform encephalopathy (BSE)	2
transmissible, fatal neurodegenerative diseases	2
embryonic heart	2
clinical imaging	2
cardiac tissues	2
developing vascular system	2
valves sculpted	2
heart in vertebrate embryos	2
nephrocytes and renal tubules	2
filtration nephrocytes and Malpighian (renal) tubules	2
Drosophila excretory system	2
diverse animal species	2
excretory organs	2
body of toxins	2
animal excretory systems	2
versatile molecular devices	2
HDAC complexes	2
Sin3, NuRD, CoREST and NCoR/SMRT Class	2
multisubunit protein complexes	2
transcription silencing machinery	2
essential catalytic components	2
Histone deacetylases (HDACs)	2
non-living microcompartments	2
synthetic genetic circuits	2
engineered genetic circuits	2
molecular communication channels	2
Cell-free transcription-translation (TXTL) reactions	2
highly orthogonal, genetically encoded communication pathways	2
populations of living cells	2
antifungal peptides	2
LAB solutions	2
lactic acid bacteria (LAB)	2
added chemical preservatives and stabilizers	2
healthy, fresh and natural foods	2
conscious consumers	2
B vitamin group	2
innovative bioprocesses	2
corresponding metabolic pathways	2
vitamins naturally	2
Many microorganisms	2
hazardous waste	2
non-renewable sources	2
food, feed, cosmetics, chemical and pharmaceutical industries	2
demand	2
human and animal diets	2
essential compounds	2
blood protein panels	2
preterm birth	2
different areas	2
microbial oleochemicals	2
fatty acid-derived products	2
abundant biomass feedstocks	2
oleochemicals	2
detergents, lubricants, biodiesel, plastics, coatings, and other products	2
animal fats and plant oils	2
Traditional oleochemical industry	2
protein–protein interactions	2
transcription factors, polymerases, proteases, DNA-binding proteins	2
recent phage-based selection systems	2
bacteriophages (phages), viruses	2
new fuel additives	2
existing pathways	2
lignocellulosic waste	2
waste biomass	2
microorganism engineering	2
lignocellulosic biomass	2
mixed carbon components	2
non-native and de novo pathways	2
metabolic solutions	2
inorganic carbon	2
nature's arsenal	2
carboxylation-only counterparts	2
best carboxylases	2
best CO2 reducing enzymes	2
CO2-capturing enzymes	2
latter mechanism	2
formate or carbon monoxide	2
existing metabolite	2
Carbon dioxide	2
developing and adult organism	2
emerging aberrant cells	2
‘loser’ cells	2
stronger cells	2
weaker cells	2
biofortified staple crops	2
iron-biofortified crops	2
random effects models	2
serum ferritin	2
hemoglobin, serum ferritin, soluble transferrin receptor (sTfR), C-reactive protein, alpha-1 acid glycoprotein)	2
rice, pearl millet, and beans	2
iron-biofortified staple food crops	2
staple crops	2
micronutrient content	2
various lipid classes	2
lipids in a sample	2
truly complete overview	2
signaling mediators	2
structural components of cells	2
large array of molecules	2
aqueous samples	2
fresh water bodies	2
biofuels and -chemicals	2
microbial production strains	2
high performance strains	2
biobased society	2
Supercritical fluid chromatography	2
two columns	2
complete complement of metabolites (small organic biomolecules)	2
vivo clinical applications	2
NMR results	2
isotope labels	2
omics layers	2
metabolome of a biological system	2
important functional layer	2
multi-omics datasets	2
productive cells	2
new engineering discipline	2
genetically encoded biosensors	2
pharmaceuticals and plastics	2
valuable metabolic products	2
inexpensive renewable resources	2
Biosynthetic pathways	2
many devices	2
free single molecules	2
novel nanodevices	2
investigated sample in the evanescent field	2
even single fluorescent molecules	2
Total internal reflection fluorescence microscopy (TIRFM)	2
transiently-expressed plant-made VLPs	2
vaccine candidates	2
potent immune response	2
infectious genomic material	2
convincing look-alikes of viruses	2
Virus-like particles (VLPs)	2
water, carbon dioxide and sunlight	2
simple inorganic nutrients	2
Plant-based expression	2
specific tissue models	2
field of vasculature	2
microfluidic 3D culture	2
signaling gradients	2
fluids in micrometer-sized channels	2
biomimetic tissue models	2
2D to 3D cell culture techniques	2
recent examples of compounds	2
recently discovered PPI modulators	2
Protein–protein interactions (PPI)	2
several nanotechnologies	2
exometabolome	2
medical diagnostics	2
many biotechnologies	2
pharmaceutical production systems	2
new computational and experimental tools	2
pharmaceuticals and other high-value chemicals	2
major enzyme classes	2
metabolic network	2
unspecific chemical reactivity	2
modern metabolic network	2
general concepts	2
every living system	2
complex cell cultures	2
chip-based technologies	2
small volume analysis applications	2
reported applications and approaches	2
hyphenated systems	2
interesting examples	2
microfluidic chips	2
Lab-on-a-Chip concept	2
sophisticated circuits	2
increasingly complex biological computers	2
well-characterised components	2
wealth of artificial S–R systems	2
natural genetic, enzymatic and neural networks	2
quantitative basis	2
communication systems	2
Sender–receiver (S–R) systems	2
beneficial insects	2
repelling pests	2
mainstream arable farming systems	2
New semiochemical tools and delivery systems	2
regions and farming ecosystems	2
lepidopterous stem borers	2
plant secondary metabolites	2
combination of companion plants	2
push–pull	2
stimulo-deterrent diversionary strategy or push–pull system	2
Farming systems	2
novel bioactive substances	2
plant host	2
range of different types of metabolites	2
plant microsymbionts	2
bacterial endophytic microbiome	2
microfluidic “toolbox”	2
Microfluidic technology	2
nitrogenase enzyme	2
nitrogen fixing bacteria	2
cereal crops	2
atmospheric nitrogen	2
Bacteria and Archaea	2
small-holder farmers	2
developing world inorganic fertilisers	2
class A, rhodopsin-like GPCR family	2
dimers and oligomers	2
dimers and even higher-order oligomers	2
trans-plasma membrane proteins	2
variety of complex signalling networks	2
Rho-family GTPases	2
cell–cell and cell–matrix adhesions	2
molecular switches	2
core regulators	2
Rho family of GTPases	2
metastatic cancer cells	2
Statistical and analytic models	2
quantitative models	2
ligand-binding free-energy landscape	2
supramolecular assembly of GPCRs in native membranes	2
cancer-EMTs	2
developmental-EMTs	2
developmental contexts	2
nuclear F-actin cytoskeleton	2
nuclear actin-regulating factors in mammalian cells	2
transient and dynamic nuclear actin filaments	2
nuclear compartment of mammalian cells	2
intranuclear actin filaments	2
regulated, functional and dynamically assembled actin filaments	2
nuclear proteome	2
intracellular compartmentalization	2
exports material	2
endomembrane organelles	2
Well-defined machinery	2
intracellular membrane trafficking system	2
largest megafauna and flora	2
unicellular protists	2
cell types and environments	2
2D versus 3D environments	2
lamellipodia	2
differentiated columnar cells	2
proliferating basal layer stem cells	2
lung bronchus	2
columnar epithelial cells	2
basal layer stem cells	2
basal Integrin adhesions	2
Stratified squamous epithelia	2
Drosophila Yki	2
Crumbs, Expanded, Merlin and Kibra	2
well-differentiated apical membrane domain	2
Monolayered columnar epithelia	2
deuterostomes (e.g.: stratified squamous skin of mammals) and protostomes (e.g.: monolayered columnar epidermis of Drosophila)	2
YAP/TAZ in mammalian cells	2
C-terminal PDZ-binding motif	2
sole YAP/TAZ homolog Yorkie (Yki)	2
Integrin beta1 (ITGB1)	2
mouse skin	2
TAZ (also called WWTR1)	2
YAP (also called YAP1)	2
YAP/TAZ co-activators	2
Integrin adhesions	2
mammalian skin	2
one of these ligands	2
transforming growth factor β (TGF-β) family	2
peroxisome biogenesis pathway	2
new insulin-producing beta cells	2
pancreatic or non-pancreatic cells	2
different cell types in the pancreas	2
right stress stimuli	2
essentially all cell types within the pancreas	2
adult pancreas	2
recent in vivo models	2
ER and other cellular membranes	2
individual classes of lipids	2
lipid transfer proteins (LTPs)	2
ideal location	2
opposite membrane	2
proteins in one membrane	2
two organelles	2
membranees	2
almost every other organelle	2
membrane contact sites (MCS)	2
largest membrane bound organelle	2
mechanotransducers	2
tissue crowding	2
ERK1, ERK2 and ERK5 MAP kinases, and PI-3 kinases	2
canonical and non-canonical NF-κB pathways	2
CD19 co-receptor	2
B cell antigen receptor (BCR) and BAFFR	2
transcriptional co-activator Yorkie/YAP	2
intracellular tug-of-war	2
crucial signalling network	2
mammalian mitophagy	2
vertebrate mitophagy	2
Parkinson’s disease (PD)-associated protein kinase, PTEN-induced putative kinase1 (PINK1), and ubiquitin E3 ligase Parkin	2
global cues	2
rhizomers	2
immediate environment	2
lateral root primordium	2
basal root tip	2
single lateral root	2
primed site	2
large set of autonomous cells	2
swarm of coupled multi-cellular structures, rhizomers	2
architecture of the plant	2
autonomous entities	2
Cells within tissues	2
actomyosin contractility	2
multicellular tissues	2
WASH complex	2
one of the major sorting station	2
master controller	2
cellular organelles	2
cell–cell and cell–matrix adhesion molecules	2
injury stem cells	2
populations of stem cells	2
potential biological systems	2
characteristic nuclear structures	2
cognate molecules/structures	2
two structurally distinct nuclear pore complexes	2
histone-independent condensed chromatin	2
nuclear structures	2
yeasts and metazoans	2
cell-matrix contacts	2
adhesion proteins	2
nucleus or centrosomes)	2
so-called adhesion proteins	2
variety of technologies	2
networks of proteins	2
multi-molecular scaffolding and signalling complexes	2
intracellular adhesion proteins	2
digital-analogue computer	2
specific signalling adaptors and effectors	2
entry pathways and endosomal compartments	2
activated receptors	2
ligand binding	2
chemical or physical signals	2
different membrane biogenesis pathways	2
lysosomal degradation pathways	2
extracellular components	2
ubiquitinated membrane proteins	2
endosomal membrane system	2
certain pathogens	2
cytoplasm, protein aggregates	2
ESCRT-III complex	2
transposable membrane-fission machinery	2
cytokinetic abscission	2
enveloped retroviruses	2
less-well characterized members of the Rho family	2
Rho GTPase	2
chemical stimuli	2
Dictyostelium discoideum amoebae	2
complex tissue settings	2
challenging environment of a tissue maze	2
tissue culture settings	2
types of tissues	2
professional migratory cells	2
intra-chromosomal and inter-chromosomal DNA interactions	2
global regulators	2
condensin protein complexes	2
biomedical and private sectors	2
nanocomposites and biomimetic derivatives	2
assembly	2
first crystallographic-based model of vimentin	2
ER the UPR	2
cytosolic effector domains	2
lumenal stress sensing domains	2
ER-localised transmembrane (TM) proteins	2
IRE1, PERK and ATF6	2
three known ER stress transducers	2
unfolded proteins and chaperones	2
lumen of the endoplasmic reticulum	2
highly dynamic populations	2
pathway mediators	2
renewing tissue	2
m6A and m5C RNA methylation pathways	2
epitranscriptome’	2
N6-methyladenosine (m6A) and 5-methylcytidine (m5C)	2
organism of all kingdoms of life	2
SCAR/WAVE complex	2
formins, Ena/VASP proteins	2
PDGF/Vegf-related ligands	2
altered self	2
vertebrate macrophages	2
population of blood cells called hemocytes	2
conflicting models	2
organelle multiplication	2
relevant players	2
centromere proteins	2
regular H3 particles	2
specific DNA sequence elements	2
new centromeres	2
active centromeres	2
H3 related protein	2
canonical histone H3	2
Specialised chromatin	2
primary tumours	2
cancer cell niche	2
altered stromal and ECM tumour microenvironment	2
mammary stem cells	2
ECM-integrin axis	2
signalling networks	2
two major classes of cell-matrix adhesion receptors, integrins and syndecans	2
strong substrate attachment	2
contractile actomyosin cortex	2
primary cilia and IS architecture	2
residual actin network	2
protein at the centrosome	2
neural crest or cancer cells	2
classic Cadherins	2
migratory epithelial cell sheets	2
individuals or large groups	2
arrays of nucleosomes	2
's of based pairs of DNA	2
nucleic acid polymerase's	2
array of well spaced nucleosomes	2
nucleosome depleted region	2
diverse range of eukaryotes	2
[1,2].	2
octameric complex of core histones	2
∼147bp of DNA	2
basic unit of chromatin	2
nucleoprotein form called chromatin	2
vertebrate chromosomes	2
definitive proteome	2
countless journal cover illustrations	2
iconic structures	2
Mitotic chromosomes	2
3D nuclear space	2
aggregate-prone proteins and pathogens	2
apoptotic insults	2
cytoplasmic substrates	2
spindle midzone, equatorial cortex and midbody in late mitosis	2
inner centromere	2
member of the Chromosomal Passenger Complex (CPC)	2
Aurora B	2
conserved Aurora family of protein kinases	2
collagens V and XI (the nucleators)	2
fibronectin and integrins (the organizers)	2
working hypothesis	2
collagen XI	2
thin collagen II-containing fibrils in cartilage	2
fibronectin, fibronectin-binding and collagen-binding integrins, and collagen V.	2
collagen I-containing fibrils	2
Collagens I and II	2
D-periodic (where D=67nm) fibrils	2
collagens and collagen-related proteins	2
cell–ECM interface	2
triple helical proteins	2
mature, fusion-competent MVB	2
Cytoskeletal motors	2
intralumenal vesicle formation	2
endosomal-sorting complex	2
cell centre	2
tubular extensions	2
perimeter membrane	2
intralumenal vesicles	2
Many lysosomally directed membrane proteins	2
different destinations	2
endocytosed proteins	2
Multivesicular endosomes/bodies (MVBs)	2
range of other pathways	2
epidermal tumour suppressor	2
hair follicle, sebaceous gland and interfollicular epidermal lineages	2
embryonic and adult skin	2
Notch ligands, receptors and effectors	2
different types of markets	2
balanced project portfolio	2
sustainable business model	2
next-generation and novel vaccines	2
clean water	2
B cell repertoire	2
antigen-specific naive B cell repertoires	2
antigen-specific and epitope-specific naive B cell repertoires	2
repertoire of B cells	2
neutralizing antibodies (nAbs)	2
viral vaccines	2
diverse adaptive immune system	2
lymphocyte output	2
fetal and postnatal life	2
bone marrow hematopoietic stem cells (HSCs)	2
wide spectrum of lymphocyte subsets	2
adult adaptive immune system	2
monophosphoryl lipid A	2
TLR4 agonist	2
pertussis and human papillomavirus vaccines	2
new adjuvants	2
non-infectious subunit vaccines	2
nervous system and leukocytes	2
specialized proresolving mediators	2
novel group of autacoids	2
innate and adaptive arms	2
central player	2
modern societies	2
vaccines or immune-modulatory therapeutics	2
bacterial reporters	2
host cell subsets	2
beta cell neoantigens	2
CD4 and CD8 autoreactive T cells	2
inflammatory microenvironment	2
insulin-producing beta cells	2
new adjuvanted vaccines	2
right antigen/adjuvant combination	2
portfolio	2
synthetic immune potentiators	2
localized activation signal	2
influenza, hepatitis B, cervical cancer, and malaria	2
new generation of adjuvants	2
several vaccines	2
local immunity	2
(gut) microbiome	2
certain bacteria and respiratory viruses	2
various metastatic cancer types	2
infused T-cells	2
several metastasized malignancies	2
autologous or redirected tumor-specific T-cells	2
acute infection	2
) T-cells	2
non-self metabolites by Vγ9/Vδ2 T-cells, mucosal-associated invariant T (MAIT) cells and germline-encoded mycolyl-reactive (GEM	2
entirely novel antigen presenting pathways	2
microbial compounds	2
invariant or semi-invariant TCRs	2
unconventional human T-cells	2
particular cells	2
Phenotypic-based and function-based definitions	2
cell areas of secondary lymphoid organs	2
versatile controllers	2
patients, vaccinees and healthy controls	2
promising adjuvants	2
novel antigen candidates	2
Reverse and structural vaccinology	2
novel antigens, adjuvants and vectors	2
pair of proteins	2
mice lacking HLA-DO	2
class II substrate	2
long-awaited structures of HLA-DM	2
HLA-DM and HLA-DO	2
spectrum of MHC-bound epitopes	2
HLA-DM	2
class II MHC molecules in endosomal compartments	2
collective microbiome	2
virome and endogenous retroelements	2
additional microbial symbionts	2
mammalian intestinal microbiota	2
new genetic models	2
IL-5, IL-9 and IL-13 producing ILC2	2
transcriptional regulators RORα and Gata3	2
lymphoid progenitors in the bone marrow	2
type-2 innate lymphoid cells (ILC2)	2
innate lymphoid cell (ILC) family	2
dislodge parasites	2
activated leukocytes and innate defence molecules	2
CD4+ Th2 cells	2
IL-4, IL-5 and IL-13	2
‘alarmin’ cytokines (IL-25, IL-33, TSLP)	2
Innate cells	2
cells and cytokines	2
fields of allergy	2
short-lived effector T cells	2
senescence signalling pathways	2
highly differentiated CD45RA re-expressing memory T cells	2
cellular therapies	2
functional reporter mice	2
experimental transplant models	2
regulatory cells (Treg)	2
safe and effective antigen-SIT	2
treatment agents	2
immunodominant and potentially pathogenic epitopes	2
potentially disease-inducing epitopes	2
regulatory T (T reg) cell subsets	2
antigen-specific immunotherapy (antigen-SIT)	2
TLRs	2
CARD9 and Raf-1	2
Syk kinase	2
archetypical non-toll-like pattern recognition receptor	2
β-glucan receptor Dectin-1	2
Co2+ to sites A and/or	2
site B.	2
high-affinity site FA2	2
free fatty acids (FFAs)	2
main plasma carrier	2
new consistent molecular basis	2
NTS	2
site B	2
Co2+ ions	2
NTS site	2
free thiol	2
site A, site B, the N-terminal site (NTS)	2
four primary metal binding sites	2
albumin cobalt-binding (ACB) assay	2
ischemic patients	2
form of albumin	2
Ischemia-modified albumin” (IMA)	2
selected fatty acids	2
plasma lipids	2
breast milk ALA	2
receiving SQ-LNS	2
daily either: 1) iron-folic acid (pregnancy); 2) multiple micronutrients (pregnancy and lactation); or 3) SQ-LNS (pregnancy and lactation)	2
n=1,391)	2
subsample of women	2
breast milk fatty acids (wt%)	2
novel small-quantity lipid-based nutrient supplement (SQ-LNS) containing alpha-linolenic (ALA) and linoleic acids	2
growth plate	2
dilated ER cisternae	2
knock-out chondrocytes	2
sulfation	2
chondrocytes from Cant1 knock-out mice	2
DBQD1 phenotype	2
Cant1 knock-in and knock-out mice	2
ER/Golgi calcium activated nucleotidase 1	2
CANT1 gene	2
chondrodysplasia	2
Desbuquois dysplasia type 1 (DBQD1)	2
integrin binding site	2
capillary-like structures	2
E1-E933A-derived lymphatic endothelial cells	2
ex vivo thoracic-duct ring assays	2
functional in vitro tubulogenesis assays	2
lymphangiography assays	2
aberrant narrowed structures	2
collector valves	2
anchoring filaments	2
dense, tortuous and irregular networks	2
α4 or α9 integrin	2
E933A-mutated EMILIN-1 (E1-E933A)	2
E933 residue of α4 and α9β1 integrins	2
Emilin1−/− mice	2
first ECM protein	2
Lymphatic vessels (LVs)	2
human SOC	2
ET-1R-driven β-arr1/IQGAP1 interaction	2
ETAR/β-arr1/IQGAP1	2
vinculin, phospho-cortactin and membrane type 1-MMP	2
invadopodia effectors	2
ET-1R/β-arr1 signalling	2
dual antagonist macitentan	2
either IQGAP1 or β-arr1	2
invasive structures	2
ET-1R deactivates Rac1	2
invadopodia-related pathways	2
focal adhesion components	2
SOC cells	2
adhesion components	2
signal-integrating module	2
signalosome with endothelin-1 (ET-1)/β-arrestin1 (β-arr1) network	2
F-actin core	2
polarity protein IQ-domain GTPase-activating protein 1 (IQGAP1)	2
integrin-related proteins	2
Growth factor receptors	2
extracellular matrix (ECM) degradation	2
actin-based protrusions	2
serous ovarian cancer (SOC) cells	2
perlecan requires collagen IV	2
basement membrane proteins	2
unwounded epithelial basement membranes	2
distant tissues	2
local epithelium	2
distant adipose and muscle tissues	2
damaged basement membranes	2
new matrix proteins	2
four protein components	2
thickened and disorganized matrix scars	2
four main basement membrane proteins – laminin, collagen IV, perlecan, and nidogen	2
basement membrane of the Drosophila larval epidermis	2
embryonic basement membranes	2
repairing basement membranes	2
basement membrane components	2
undamaged ones	2
repaired basement membranes	2
tissues like muscles and nerves	2
simple and complex epithelia	2
highly conserved sheet-like extracellular matrix	2
Basement membrane	2
bioactive N-terminal cleavage fragment	2
extracellular proteases	2
downstream site	2
mutant BMPER	2
bioactive cleavage fragment	2
mutated protein	2
acid-catalysed cleavage site	2
N-terminal BMP-binding and C-terminal cell-interactive regions	2
active cleavage fragment	2
cell surface heparan sulphate proteoglycans	2
N-terminal BMP-binding region	2
human BMPER	2
BMP-binding endothelial cell precursor-derived regulator (BMPER)	2
essential signalling molecules	2
direct target of miR-324-5p	2
human GPC1	2
real-time RT-PCR, immunoblotting and 3′UTR-luciferase reporters	2
miR-324-5p target	2
Glypican 1 (Gpc1)	2
Amino acids in Cell culture (SILAC)	2
established targets GLI1	2
mouse C3H10T1/2 cells	2
human mesenchymal stem cells (MSCs)	2
Hedgehog (Hh) signalling pathway	2
co-injected materials	2
lung hyaluronan content	2
exogenous hyaluronidase	2
CD44-expressing macrophages	2
endothelial cells and fibroblasts	2
hyaluronan synthase 2	2
lung extracellular matrix	2
lung matrix	2
ATF6 isoforms	2
two ATF6 isoforms	2
paralogue	2
ATF6β and	2
ER stress-associated metaphyseal chondrodysplasia type Schmid (MCDS)	2
mutant forms of type X collagen	2
ATF6α & β	2
paralogue ATF6β	2
vitro expanded islets	2
isolated and cultured mouse islets	2
α5-laminin-coated polydimethylsiloxane membranes	2
110–150 mouse islets	2
spherical islets	2
layers of 1–3 cells	2
Adhering islets	2
natural components of islet basement membranes	2
cadaver-derived islets	2
PRIDE partner repository	2
ProteomeXchange Consortium	2
tube-like structure	2
proteolytically released N-terminal fragment	2
terminal amine isotope labeling of substrates	2
Thrombospondin-1, an angiogenesis modulator	2
polarized culture system	2
retina pigment epithelial (RPE) secretome	2
HTRA1-ARMS2 locus	2
regenerating scarred tissue	2
remaining healthy tissue	2
chronic tendinopathy	2
anisotropic tissues	2
connexin43 gap junctions	2
numerical model	2
‘scarred’ isotropic counterparts	2
collagen, matrix metalloproteinases MMPs, tissue inhibitors of MMPs)	2
‘unscarred’ anisotropic tissue	2
highly anisotropic (unscarred/aligned)	2
isotropic (scarred/non-aligned)	2
tissue organization	2
next generation tissue platform	2
suitable in vitro tissue platforms	2
3D extracellular matrix	2
tendon-derived cells	2
remaining healthy (anisotropic) tissue	2
affected (disorganized) tissue	2
randomly distributed cells	2
disorganized ECM	2
diseased tissue	2
aligned extracellular matrix (ECM)	2
mechano-chemical environment	2
collagen cross-linking site KGHR	2
fibrillar collagen I and II	2
chondroadherin in solution	2
GAOGPSGFQGLOGPOGPO (O is hydroxyproline)	2
triple-helical peptide	2
chondroadherin in collagen II	2
unique binding site	2
Collagen Toolkits	2
C-terminal cap region of chondroadherin	2
integrin α2β1	2
previously identified binding site	2
neither fibromodulin	2
prototypical SLRP, decorin	2
human fibromodulin and chondroadherin, two collagen-binding SLRPs	2
small leucine-rich proteoglycans (SLRPs)	2
antioxidant Nrf2/Keap1 pathway	2
Ltbp4S−/− mice	2
Pdgfrβ-controlled alveolar maintenance programs	2
Sesn2 knock out mice	2
antioxidant protein Sestrin 2 (Sesn2)	2
Ltbp4S−/−)	2
Ltbp4S knock out mice	2
structural component of extracellular matrix (ECM)	2
fibrillin/LTBP family of proteins	2
Latent transforming growth factor beta binding protein 4 (LTBP4)	2
heparanome of SCs	2
N-acetylated HS mimetic	2
known major promoter	2
oversulfated HS mimetic	2
differentiating SC cultures	2
HS mimetics	2
heparanome of ageing muscle	2
6-O sulfation	2
N-acetylated disaccharides	2
6-O and 2-O-sulfation	2
muscle HS	2
highly variable biomolecule	2
sulfated polysaccharide heparan sulfate (HS)	2
existing damaged fibres	2
new muscle fibres	2
healthy muscle fibres	2
Satellite cells (SCs)	2
novel antiangiogenic factor	2
MMP substrates	2
angiogenic brake	2
proangiogenic MMPs	2
CCN matricellular proteins/cytokines	2
MMP8 and MMP9	2
MMPs 8, 9, and 1	2
several MMPs	2
MMP1, 8 and 9	2
cleaved CCN5	2
aortic ring vessel outgrowth model	2
CCN1, 2 and 3	2
MMP1, 3, 7, 8, 9 and 15	2
MMP14 and other MMPs	2
previously unknown substrates of MMPs	2
MMP14 substrates	2
yeast two-hybrid protease substrate trapping platform	2
MMP14 “inactive catalytic domain capture” (ICDC)	2
novel substrates of MMP14 (membrane-type 1-matrix metalloproteinase, MT1-MMP)	2
CCN family of matricellular proteins	2
main collagen-binding integrin	2
terminal domains of collagen II	2
C-terminus of collagen II	2
Collagen II	2
integrins α1 and α2	2
equivalent locus (Q214)	2
positively-charged GROGER	2
unique arginine residue (R215)	2
molecular modelling	2
domain sequence	2
α10β1, an important collagen receptor	2
N-terminal domain of collagens I and III	2
specific collagen hexapeptide motifs	2
collagen glutamate residue	2
metal ion-dependent site	2
Mg2+ ion	2
inserted (I) domain	2
LE4–LE5 junction	2
regular LE array	2
first eight domains of the laminin β1 chain	2
uninterrupted LE tandems	2
consecutive LE domains	2
α-helical region	2
short arms of laminin α and γ chains	2
L4 domains	2
bacterial family 35 carbohydrate binding modules	2
β-sandwich	2
laminin β2 LE5-LF-LE6 region	2
LE5 and LE6 of the laminin β1 and β2 chains	2
single LF domain	2
globular domains	2
repeats of laminin-type epidermal growth factor-like (LE) domains	2
short arms	2
cross-shaped laminin heterotrimer	2
three short arms	2
ADAMTS-4, -5 and TIMP-3	2
cartilage extracellular matrix	2
ADAMTS-5 and TIMP-3	2
-5 or TIMP-3	2
ADAMTS-4	2
MMP-13 binding site	2
MMP-13 and ADAMTS-4, -5 or TIMP-3	2
clusters II and III of low-density lipoprotein (LDL) receptor-related protein 1 (LRP1)	2
pro- and activated MMP-13	2
adult human tissues	2
powerful, potentially destructive proteinase	2
arthritis, cancer, atherosclerosis	2
collagenous extracellular matrix	2
Matrix metalloproteinase 13 (MMP-13)	2
partially cleaved chordin	2
BMP-antagonist	2
BMP-agonist	2
Tsg and mammalian tolloid	2
C-terminal region of chordin	2
globular monomer	2
human Tsg	2
chordin by tolloid-family proteinases	2
BMP agonist	2
BMP (bone morphogenetic protein) antagonists	2
Twisted gastrulation (Tsg)	2
mesenchymal stem/stromal cells	2
endogenous cells of a tissue	2
irreversible fibrotic deposits	2
Matrix Metalloproteinase-1 (MMP1) binding site	2
favourable sites	2
fibrillar environment	2
single collagen molecule	2
covalent intra-molecular glucosepane cross-link	2
fully atomistic molecular dynamics simulations (MD)	2
respective cross-link sites	2
collagen molecules	2
covalently cross-linked glucosepane formation	2
AGEs	2
abundant AGE, glucosepane	2
advanced glycation end products (AGEs)	2
low-sulphated KS	2
proteoglycans in the cornea	2
anterior and posterior stromal regions	2
deeper stromal regions	2
sclera	2
low-sulphated epitopes	2
outer-periphery	2
high-sulphated epitopes	2
high- and low-sulphated KS	2
limbus	2
peripheral cornea	2
high- and low-sulphated epitopes of KS	2
DMMB assays	2
outer periphery of the cornea	2
outer periphery	2
collagen fibril architecture	2
(DS) distributions	2
Chondroitin sulphate (CS) and dermatan sulphate	2
keratan sulphate	2
High and low-sulphated epitopes	2
centre of the cornea	2
Freshly excised adult bovine corneal tissue	2
central to peripheral corneal regions	2
keratan sulphate (KS) glycosaminoglycan (GAG) epitopes	2
possible target	2
autocrine and paracrine activities	2
many carcinomas	2
multifunctional cytokine	2
perlecan, collagen XVIII	2
follicles	2
heparan sulfate products	2
healthy and atretic follicles	2
heparan sulfate glycosaminoglycans	2
stem cell niches	2
antibodies 7D4, 3C5, and 4C3]	2
chondroitin/dermatan sulfate epitopes	2
larger blood vessels	2
hitherto unknown groups of cells	2
bovine antral follicles	2
decorin or an inter-α-trypsin inhibitor family member	2
one other non- or 6-sulfated N-acetylgalactosamine proteoglycan(s)	2
antral follicles	2
predominant 4-sulfated N-acetylgalactosamine proteoglycan	2
4-sulfated N-acetylgalactosamine	2
disaccharides	2
thecal layers	2
N-acetlyglucosamine	2
heparan sulfate-derived Δuronic acid	2
6-sulfated N-acetylgalactosamine	2
chondroitin sulfate-derived ∆uronic acid with 4-sulfated N-acetylgalactosamine and ∆uronic acid	2
membrana granulosa	2
major disaccharides in thecal layers	2
stratified epithelial granulosa cells of healthy (n=6) and atretic (n=6)	2
specialized stromal theca layers	2
cross-linking HA in the matrix	2
nodal molecule	2
molar excess of FGF2	2
mammalian preovulatory follicle	2
N-terminal PTX3 tetrameric oligomerization	2
multiple HCs of IαI and/or TSG-6	2
cross-linking HA polymers	2
octameric structure of PTX3	2
IαI and TSG-6	2
HCs of IαI and TSG-6	2
cumuli from Ptx3-null mice	2
different oligomeric arrangement	2
(N_PTX3)	2
distinct Cys/Ser mutants of recombinant N-terminal region of PTX3	2
unique N-terminal sequence of the protomer	2
cumulus	2
cumulus matrix	2
combination of non-covalent interactions and disulfide bonds	2
identical protomers	2
ovulated eggs	2
cumulus oophorus	2
hyaluronan-rich matrix	2
Pentraxin 3 (PTX3)	2
collagen IV receptor	2
DDR2 construct	2
corresponding DDR1 residues	2
DDR2-collagen complex	2
basement membrane collagen IV	2
certain non-fibrillar collagens	2
DDRs	2
Triple-helical peptides	2
Toolkit peptides	2
collagens	2
several DDR2 binding sites	2
Collagen II and Collagen III Toolkits	2
sets of overlapping triple-helical peptides	2
DDR binding sites on collagen III	2
homologous DDR1	2
collagen II	2
additional DDR2 binding sites	2
I–III	2
major DDR2 binding site	2
GVMGFO (O is hydroxyproline)	2
cell surface receptor tyrosine kinases	2
non-muscle myosin II-derived forces	2
tendon constructs	2
procollagen synthesis	2
Live-cell imaging and 14C-proline metabolic labeling	2
blebbistatin (a small molecule inhibitor of non-muscle myosin II)	2
actin cytoskeleton)	2
solubilise membranes	2
Triton X-100	2
embryonic chick metatarsal tendons	2
embryonic tendon cells	2
tendon-like constructs	2
embryonic tendon-like tissue	2
TGFβ3 protein	2
BM-MNCs in fibrin gels	2
exogenous TGFβ3 protein	2
TGFβ inhibitor SB-431542	2
MSCs upregulated genes encoding type I collagen	2
MSCs and BM-MNCs	2
fibripositors (actin-rich, collagen fibril-containing plasma membrane protrusions)	2
narrow-diameter collagen fibrils	2
transforming growth factor (TGF) β3	2
human mesenchymal stem cells (MSCs) and bone marrow-derived mononuclear cells (BM-MNCs)	2
tendons and ligaments lost	2
stem cells in vitro	2
Tendon-like tissue	2
injured tendons	2
suture in tensioned tendon	2
cells necrosed	2
formation of the acellular zone	2
flexor tendons	2
single grasping sutures	2
Acellular zone formation	2
mouse tendon	2
“acellular zones	2
suturing tendon	2
normal and damaged tendons	2
collagen gels	2
-5 mRNA	2
monolayer cultures	2
tendon cells in collagen gels	2
TGF-β-stimulated cells	2
mature and processed forms of ADAMTS-4	2
immunoreactive proteins	2
cultured Achilles tendon cells	2
processed ADAMTS-4 (53 kDa)	2
ruptured tendons	2
68 kDa)	2
mature ADAMTS-4	2
ruptured tendon	2
human Achilles tendon and tendon-derived cells	2
tendon extracellular matrix	2
principal large proteoglycan	2
Metalloproteinase with ThromboSpondin motifs) family	2
(A Disintegrin	2
Several members of the ADAMTS	2
investigated ionic liquids	2
C. albicans’ membranes	2
tested chiral ionic liquids	2
plastic surface	2
detached fungal cells	2
C. albicans filamentation	2
identified multidrug resistance efflux pumps	2
Candida strain	2
Ionic liquids	2
fungus Candida albicans	2
chiral ionic liquids with (1R,2S,5R)-(−)-menthol [Cn-Am-Men][Cl] (n=10, 11 or 12)	2
PcLRR-RK1	2
germ tube	2
highly branched fluffy hyphae	2
PcLRR-RK1-silenced P. capsici transformants	2
solanaceous and cucurbitaceous vegetable crops	2
major plant destroyer	2
oomycete specie	2
Phytophthora capsici	2
LRR-RK (PcLRR-RK1) gene	2
Leucine-rich repeats (LRRs) domain containing kinase proteins (LRR-RK)	2
three hydrophobic residues	2
positively charged residue (arginine)	2
Rvs167-3 SH3 (RΦxΦxΦ)	2
novel, proline-independent, binding sequence	2
residues in the extended n-Src loop of Rvs167-3 SH3	2
canonical PxxP binding pocket	2
peptide ligand	2
Rvs167-3 SH3 recognition	2
proline	2
single proline residue (RΦxΦxΦP, where x is any amino acid and Φ is a hydrophobic residue)	2
SH3 domain of Candida albicans Rvs167-3 binds peptides	2
proline-based sequences	2
proline-x-x-proline (PxxP) containing motifs	2
small protein-protein interaction modules	2
Src-homology 3 (SH3) domains	2
lymphatic vasculature	2
central proteins	2
(ADAMTS3).This minireview	2
disintegrin and metallopeptidase with thrombospondin type 1 motif 3	2
Collagen and calcium binding EGF domains 1 (CCBE1) protein	2
extracellular protein complex	2
VEGF-C	2
VEGFR-3 is vascular endothelial growth factor-C (VEGF-C)	2
major activator	2
major tyrosine kinase receptor	2
Vascular endothelial growth factor receptor-3 (VEGFR-3)	2
universal LEC marker	2
master transcriptional regulator	2
Prospero homeobox protein 1 (PROX1)	2
venous endothelium	2
lymphatic structures	2
blood vascular endothelial cells (BECs) and cells of the hematopoietic lineage	2
molecular biologists	2
lymphatic vessels	2
blood and lymphatic vessels	2
uniform road map	2
anatomical data	2
narrative reviews	2
fibrogenesis-related targets (Ppib, Serpinh1, and Bcl2l1)	2
gene-targeting siRNAs	2
untransfected and transfected slices	2
gene-targeting siRNA (Gapdh, Ppib, Serpinh1, and Bcl2l1)	2
siRNA (untransfected), non-targeting siRNA (control)	2
murine lung slices	2
Accell siRNA	2
lung slices	2
self-deliverable siRNA (Accell siRNA)	2
animal or human tissue	2
viable explants	2
precision-cut tissue slices	2
vitro and in vivo models	2
disease-related genes	2
function of genes	2
messenger RNA (mRNA) and protein	2
Small interfering RNA (siRNA)	2
rabies family viruses	2
RABV particle populations	2
antigenic rabies viruses	2
rabies glycoprotein (G protein) conformational epitope	2
formulated rabies virus (RABV)	2
trehalose/pullulan-based ODFs	2
ovalbumin in air-dried ODFs	2
freeze-dried ODFs	2
Ovalbumin loading	2
Lysozyme and β-galactosidase	2
ODFs	2
three model proteins	2
trehalose and film-forming ability	2
two carbohydrates	2
blends of trehalose/pullulan	2
protein loaded orodispersible films (ODFs)	2
administration route	2
pharmaceutical market	2
weakly aversive compounds	2
high and medium aversive compounds	2
BATA model	2
rats IC50	2
human taste panels	2
rat BATA model	2
quinine hydrochloride dihydrate, 6-n-propylthiouracil, sildenafil citrate, diclofenac sodium, ranitidine hydrochloride, caffeine citrate, isoniazid, telbivudine and paracetamol)	2
nine marketed APIs	2
rat brief-access taste aversion (BATA) model	2
acceptable palatable formulations	2
new active pharmaceutical ingredients (APIs)	2
prescribed medicines	2
hollow MN	2
hollow MNs	2
free antigen in dissolving MNs	2
hollow MN-delivered NPs	2
NP:HA weight ratio 1:4)	2
free antigen	2
dissolving MNs in mice	2
ex vivo human skin	2
PLGA nanoparticles (NPs) co-encapsulating ovalbumin (OVA) and poly(I:C)	2
hyaluronan (HA)-based dissolving microneedles (MNs)	2
particulate subunit vaccines	2
immunisation site	2
dry powders	2
Medium199, glutathione and maltodextrin	2
best formulation	2
sIPV serotype 3	2
serotype 1 and 2	2
trehalose/monosodium glutamate and maltodextrin/arginine combinations	2
Serotype 3	2
D-antigenicity	2
D-antigenicity of serotype 1	2
Serotype 1 and 2	2
D-antigen	2
excipient	2
promising formulations	2
fractional factorial design	2
respective sIPV serotypes	2
Excipient combinations	2
spray dried	2
monovalent sIPV	2
trivalent sIPV	2
native conformation (D-antigen)	2
three serotypes of Sabin inactivated polio vaccine (sIPV)	2
stable spray dried formulation	2
armamentarium of nail medicines	2
ungual nail patches	2
backing membrane	2
PSA	2
one release liner	2
one backing membrane	2
two PSAs	2
release liners	2
Twelve pressure-sensitive adhesives (PSAs), four backing membranes	2
simple drug-in-adhesive ungual patch	2
onychomycosis, a common condition	2
nail diseases	2
drug carriers	2
Nail patches	2
micron-sized ingredients	2
wide variety of drugs and bio-macromolecules	2
oral drug formulations	2
pH-sensing MPs	2
macropores on MPs	2
proof-of-concept microencapsulation system	2
Encapsulated lactase/pravastatin	2
model drugs (fluorescent beads, lactase, and pravastatin sodium) encapsulated MPs	2
Eudragit® L100-55 polymer)	2
poly(methacrylic acid-co-ethyl acrylate)	2
micron-sized macropores	2
pH-responsive MPs	2
destabilizing environment	2
microparticles (MPs) based oral biopharmaceuticals delivery systems	2
micro- and nanocrystalline drugs	2
Oral drugs	2
internalizing VHH[PS]-CPP	2
VHH[PS] conjugates	2
patients with high-grade serous ovarian cancer	2
surgically obtained ascites	2
EGFR-expressing cells	2
EGFR expressing cancer cell lines	2
VHH[PS] and VHH[PS]-CPP conjugates	2
near-infrared (NIR) light	2
cell-penetrating peptide (VHH[PS]-CPP).Here	2
VHHs	2
PS (IRDye700DX)	2
VHH 7D12	2
full size antibodies	2
low molecular weight llama single domain antibodies (VHHs, nanobodies)	2
tumor-associated antigens	2
conjugates of photosensitizers (PS)	2
light-accessible malignancies	2
poorly water miscible solvent ethyl acetate	2
fully water miscible solvent ethanol	2
organic solvent	2
processing solutions	2
type of organic solvent (ethanol or ethyl acetate)	2
atomizing airflow	2
diazepam as a model drug	2
hydrophilic matrix	2
Solid dispersions	2
solid dispersions	2
microneedle technologies	2
regulatory dossiers	2
microneedles field	2
interleukin 1-β	2
0.5–1.5mgml−1 for Immunoglobulin G	2
skin of hairless mice	2
poly(ethyleneglycol) 10kDa	2
aqueous blends of and	2
58kDa and hydrogel-forming microneedle arrays	2
w poly(vinyl pyrrolidone)	2
w/	2
Gantrez® S-97 BF	2
aqueous blends	2
Dissolving microneedle arrays	2
multiple occasions of polymeric microneedle arrays	2
emerging drug delivery solutions	2
current products	2
ocular tissues	2
natural protective mechanisms of the eye	2
vernal keratoconjunctivitis	2
cyclosporine A (CsA)	2
film forming transdermal drug delivery systems	2
particular drugs	2
drugs in polymers	2
individual polymers	2
drug in the film formulation	2
methylphenidate hydrochloride	2
polymeric film	2
model membrane	2
ability of films	2
hydrochloride salt in two polymethacrylate copolymers, Eudragit RS (EuRS) and Eudragit E (EuE)	2
individual film forming polymers	2
Film forming systems	2
micro-environmental hook	2
cancer stroma	2
highly sulfated chondroitin sulfates	2
breast, lung and colon cancer	2
variety of solid tumors	2
CS-E rich stroma	2
CS-E rich micro-environment in vitro lyophilisomes	2
CS-E.	2
ovarian cancer stroma	2
Antibody-functionalized lyophilisomes specifically	2
CS-E	2
single chain antibodies	2
stroma of ovarian carcinomas	2
drug-loaded lyophilisomes (albumin-based biocapsules)	2
ovarian cancer extracellular matrix	2
highly sulfated chondroitin sulfate (CS-E)	2
“stroma”)	2
tumor’s extracellular matrix (	2
suitable sugar	2
larger sugars	2
smaller sugars (disaccharides)	2
traditional theories	2
theories	2
solid state	2
proteins by sugars in the solid state	2
dosage form	2
theophylline drug	2
likely areas	2
fluid inside the DCM tube	2
highly soluble drug, theophylline,	2
proximal human colon	2
smooth muscle	2
realistic environment	2
novel biorelevant Dynamic Colon Model (DCM)	2
powerful in vitro dissolution model	2
biorelevant media	2
complex and dynamically changing colonic environment	2
modified dosage forms	2
favourable site	2
human proximal colon	2
highly-tailored multifunctional delivery vehicles	2
graphene	2
solutes, proteins or cellular systems	2
graphene molecules	2
cells or tissues both in vitro and in vivo	2
Graphene based nanomaterials	2
optimum patch formulation	2
neonatal porcine skin	2
poly(vinylpyrrolidone) or poly (methyl vinyl ether co-maleic anhydride/acid) (Gantrez®) polymers	2
plasticised films	2
donepezil hydrochloride containing film	2
hydrogel-forming microneedles	2
integrated patch	2
Alzheimer’s drug, donepezil hydrochloride	2
integrated microneedle patch	2
microneedle array	2
created channels	2
drug loaded reservoir	2
Hydrogel-forming microneedles	2
marketed transdermal products	2
microfiber-based dispersions	2
pure drugs	2
corresponding crystalline physical mixtures	2
Fourier transform infrared spectra	2
crystalline drug	2
case of piroxicam-loaded microfibers	2
drug and carrier	2
bead-free drug-loaded microfibers	2
poorly water-soluble drugs olanzapine and piroxicam (both BCS Class II)	2
sucrose-based microfibers	2
fiber-based dispersion	2
many Biopharmaceutics Classification System (BCS) Class II drugs	2
outpatient settings	2
Hydrogel-forming MN	2
lower dose	2
higher dosed rats	2
different doses	2
lithium carbonate	2
lithium citrate	2
excised neonatal porcine skin	2
MN	2
poly(ethyleneglycol), imbibed interstitial fluid (ISF)	2
aqueous blends of hydrolysed poly(methyl-vinylether-co-maleic anhydride)	2
lithium in vitro and in vivo	2
first time, hydrogel-forming microneedle (s) (MN) arrays	2
keratin binding	2
small molecular weight, hydrophilic antifungal agent	2
nail fungal infection	2
hydrophobic molecules	2
hydrophilic molecules	2
nail pores	2
hydrophobic drugs	2
hydrophobic molecules terbinafine and amorolfine	2
healthy nails	2
hydrophilic caffeine	2
thicker, diseased nails	2
porous barrier	2
healthy and diseased nails	2
healthy and onychomycosis infected, full thickness, human nail plate sections	2
caffeine, terbinafine and amorolfine (clogD at pH 7.4 of −0.55, 3.72 and 4.49 respectively	2
three compounds	2
diseased state	2
nail barrier	2
infected plates	2
patient’s nail	2
patient use	2
several potent antifungal agents	2
ionic liquids	2
lidocaine alone patch	2
etodolac alone patch	2
either lidocaine or etodolac alone	2
lidocaine and etodolac in ionic liquid form	2
ionic liquid-containing patch (Etoreat patch)	2
transformed ionic liquid	2
free drug	2
etodolac with lidocaine (1:1, mol/mol)	2
poorly water-soluble drug, etodolac	2
transdermal drug delivery systems	2
active pharmaceutical ingredients (APIs)	2
tightly bound drug aggregates	2
unionised species	2
larger tetracaine aggregates	2
apical surface of the membranes	2
ionised microspecies	2
unionised molecules	2
solutions with mixtures of the unprotonated and protonated drug microspecies	2
unprotonated form of tetracaine	2
different types of tetracaine aggregates	2
series of solutions	2
two hydrophobic membranes	2
ungual research	2
onychomycosis and psoriasis	2
efinaconazole affinities	2
nail–	2
nail–terbinafine HCl, nail–amorolfine HCl and nail–ciclopirox olamine affinities	2
hoof HSPs	2
Fingernail and toenail HSPs	2
solvents	2
mass of nail plates	2
Many solvents	2
main constituent of the nail plate	2
drug and nail HSPs	2
organic liquids	2
drugs terbinafine HCl, amorolfine HCl, ciclopirox olamine and efinaconazole	2
model for the nail plate)	2
hoof membrane	2
lyophilized cake	2
small pores	2
either closed pores	2
porous cake structure	2
lower protein concentration formulations	2
Three protein formulations	2
Lyophilized protein formulations	2
SIC based b2 data	2
catalase and concanavalin A	2
non-aggregated protein systems	2
protein solution species	2
four proteins – lysozyme, recombinant human lactoferrin, concanavalin A and catalase	2
aerosols	2
delivering ‘extrafine’ particles	2
NEXThaler	2
size range	2
best (Turbuhaler) and worst performing DPI (Elpenhaler)	2
inhaler	2
Symbicort Turbuhaler, Seretide Diskus, Rolenium Elpenhaler and Foster (Fostair) NEXThaler ICS/LABA combination DPIs	2
particles in the range	2
small airways	2
so-called ‘extrafine’ aerosols	2
influenza vaccine field	2
cross-reactive influenza vaccines	2
next generation of influenza vaccines	2
landscape of influenza vaccines	2
certain populations	2
current influenza vaccines	2
different lipid loads	2
1M NaOH	2
leaving groups	2
FAs	2
mixed micelles	2
TGs	2
TGs, 2-monoglycerides (2-MGs) and FAs	2
pancreatic lipase	2
vitro lipolysis model	2
porcine pancreatic lipase	2
co-administered drug	2
oral lipid-based formulations	2
Triglycerides (TG)	2
oral dissolution model	2
two simulated salivary fluids	2
simulated salivary fluids	2
unstimulated (US) and stimulated (SS) human saliva	2
vitro dissolution medium	2
biological fluid	2
Human saliva	2
64Cu-cyclam-RAFT-c(-RGDfK-)4-based internal radiotherapy	2
l-Lysine	2
healthy or αVβ3-positive tumor-bearing mice	2
co-injection with Gelofusine (GF), a succinylated gelatin solution, and/or l-lysine (Lys)	2
dose-limiting organs	2
positron emission tomography (PET)	2
potential theranostic compound	2
64Cu-cyclam-RAFT-c(-RGDfK-)4, an αVβ3 integrin-targeting tetrameric cyclic RGD peptide probe	2
nanoencapsulated therapeutic agents	2
viable skin layers	2
released dye	2
depot dye-rich reservoirs	2
MN-created channels	2
confocal laser scanning microscopy imaging	2
skin proteins	2
MN-treated skin	2
MN array	2
full thickness porcine skin	2
poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs)	2
Rhodamine B (Rh B) and fluorescein isothiocyanate (FITC) as model hydrophilic and hydrophobic small/medium-size molecules	2
microneedle (MN)-treated skin	2
nanoencapsulated model dyes	2
cytoplasm of P. bursaria	2
C. variabilis	2
glycosaminoglycans on the cell wall	2
intracellular symbiosis	2
N-acetylglucosamine and sialic acid	2
FITC-WGA and FITC-LFA	2
cellulose, N-acetylglucosamine, sialic acid, and glycosaminoglycans	2
Calcofluor stains β-d-glucopyranose polysaccharides	2
Paramecium host cells	2
algae	2
different polysaccharides	2
three fluorescent reagents (calcofluor white M2R, FITC-WGA, and FITC-LFA)	2
free-living one	2
symbiotic C. variabilis	2
cytoplasm of Paramecium bursaria	2
symbiotic alga	2
Chlorella variabilis	2
pellicle complexes	2
specific pellicle-complex components	2
Serpenomonas and Entosiphon	2
related cytokinesis model	2
canal rims	2
pellicle microtubules	2
one master microtubule	2
canal	2
mt2/3 pair	2
nanotubule-bridge-A assembly	2
new mt2/3/bridge-B assembly, sub-heel scission	2
old mts2/3	2
daughter strips	2
toe-nanotubule-associated epiplasmic scission	2
epiplasmic growth	2
morphogenetic centre microtubule mt2/3 pair	2
euglenoids	2
strip heel/toe junctions	2
epiplasm-associated components	2
alternating wide and narrow daughter strips	2
new strip junctions	2
unifying euglenoid and kinetoplastid pellicle morphogenesis	2
new pellicle microtubules	2
kinetoplastid Euglenozoa	2
longitudinal proteinaceous, epiplasmic strips	2
euglenoid pellicles	2
new diplonemid family Hemistasiidae for Hemistasia	2
orders Entosiphonida, Rapazida, Bihospitida; and seven new euglenoid families (Entosiphonidae, peranemean Neometanemidae, Rapazidae, two stavomonad, two ploeotiid) and three new postgaardian, and three kinetoplastid families (Neobodonidae, Rhynchomonadidae, Parabodonidae)	2
three new, Anisonemida (posterior gliders), Natomonadida (swimmers including phagotrophic new suborder Metanemina and osmotrophic suborder Rhabdomonadina), and Acroglissida (anterior gliders with cytoproct)	2
Peranemida (anterior gliding, protrusible rods	2
four orders	2
strip joints	2
numerous spirally arranged, often slideable, strips (clade Peranemea/Euglenophyceae)	2
derived superclass Spirocuta	2
Stavomonadea (Petalomonadida, Decastavida and new order Heterostavida) and Ploeotarea (Ploeotiida) with contrasting oral cytoskeletons	2
i.e. new classes	2
longitudinal rigid strips	2
basal superclass Rigimonada	2
Dipilida ancestrally	2
three feeding rods	2
two new infraphyla	2
glycosomes (Kinetoplastea, Diplonemea)	2
new subphylum Glycomonada	2
uniquely modified feeding apparatuses	2
surface bacteria	2
anaerobic Postgaardia (class Postgaardea)	2
Euglenoida with pellicular strips	2
three subphyla	2
first site-heterogeneous 18S rDNA trees	2
ultrastructure and sequence phylogeny	2
numerous new taxa	2
Heteronema scaphurum	2
new genus Teloprocta	2
taxon-rich site-heterogeneous	2
sphagnophila comb.	2
Biundula (=Petalomonas)	2
pellicle cross section	2
new genus	2
former Petalomonas	2
lumped with it)	2
Decastava/Entosiphon Hsp90	2
Decastava Hsp90 genes	2
spiral often slideable strips	2
derived clade Spirocuta	2
rigid longitudinal strips	2
Basal euglenoids	2
earliest euglenoid branch	2
cytostome)	2
dorsal jaw support	2
unreinforced microtubule pairs loop	2
Serpenomonas-like feeding apparatus	2
Ploeotia and Serpenomonas (phylogenetically and cytologically distinct genera)	2
bifurcate ridges	2
cusp-like joints	2
broad strips	2
18S rDNA trees	2
Keelungia forming new clade Decastavida	2
Calycimonas-like microtubule-supported cytopharynx	2
flush joints	2
pellicular strips	2
actively beating cilium	2
Scytomonas and Decastava ultrastructure	2
Entosiphon oblongum	2
Decastava edaphica	2
18S rDNA and Hsp90 sequencing	2
three new phagotrophic euglenoid species	2
aquatic phagotrophic protists	2
protist functional ecology	2
phagotrophic protists in food webs	2
protist populations	2
Independent Response Model	2
conceptual issues	2
phagotrophic, i.e. heterotrophic and mixotrophic, protists in aquatic food webs	2
Functional ecology	2
morphology and other gene trees	2
250 eukaryotes	2
α-tubulin trees	2
rDNA sequence	2
major novel deep-branching eukaryote lineage	2
trees combining protein and rRNA sequences	2
amoeboflagellate heterolobosean percolozoan	2
four protein-gene sequences (Hsp90; α-tubulin; β-tubulin; actin)	2
terrestrial actinocephalid gregarines Hoplorhynchus	2
cooling-tower water	2
stained-glass windows	2
isolated deep-branching excavate	2
percolatean flagellates (Stephanopogon, Percolomonas)	2
undescribed percolozoan	2
amoeboflagellate culture ATCC 50646	2
DNA of very different species	2
sequenced ‘monoprotist’ samples	2
new genera	2
nail-like nor basket scales	2
Former Paraphysomonas species	2
n.)	2
distinct rDNA clade (Clathromonadidae fam.	2
two new species	2
new genus, Clathromonas	2
basket scales	2
former Paraphysomonas species	2
dense margins	2
base-plates	2
subspecies (Paraphysomonadidae)	2
23 new species	2
nail-like spine scales	2
18S ribosomal DNA	2
59 clonal cultures	2
previously sequenced	2
uncultured environmental samples	2
50 named species	2
ubiquitous phagotrophs	2
genus Paraphysomonas	2
Heterotrophic chrysomonads	2
Dujardin, 1841	2
Article 70.3.2 of the Code, Dileptus margaritifer (Ehrenberg, 1833)	2
misidentified Amphileptus margaritiferEhrenberg, 1833, a common species	2
Amphileptus anser sensu Ehrenberg (1838)	2
Zoological Nomenclature	2
type species of the genus DileptusDujardin, 1841	2
dileptids, Vďačný and Foissner (2012)	2
solid dosage microcapsule forms	2
readily available microfluidic chips	2
microencapsulation of phages	2
simulated intestinal fluid (SIF)	2
Encapsulated phages	2
encapsulation matrix	2
antacids	2
gelled microparticles	2
Felix O1	2
high viscosity formulations	2
smaller beads	2
Bigger microparticles	2
simulated gastric fluid (SGF)	2
dispersed and continuous phases	2
generated monodispersed droplets	2
phage research community	2
phage encapsulated microparticles	2
co-flow microfluidic devices	2
specialist research facilities	2
bespoke in-house fabricated glass capillary devices	2
readily available low cost microfluidic chips	2
commercially available microfluidic droplet generation devices	2
biopolymer sodium alginate	2
pH responsive methacrylic acid copolymer Eudragit® S100	2
pH responsive polymer formulation	2
Salmonella specific bacteriophage Felix O1 (Myoviridae)	2
certain archaeal plasmids, proviruses and membrane vesicles	2
minor pleolipoviral structural proteins	2
integrase gene	2
new extremely halophilic betapleolipovirus, Halorubrum pleomorphic virus 9 (HRPV9)	2
various archaeal genetic elements	2
countless homologues	2
Pleolipoviruses comprise single-stranded or double-stranded, circular or linear DNA genomes	2
recently described archaeal virus family Pleolipoviridae	2
genus Betapleolipovirus	2
saturated salt	2
Certain pleomorphic archaeal viruses	2
Gram-negative pathogens	2
two transmembrane helices	2
ancestral protein	2
N and C-terminal halves	2
several very highly conserved amino acid sequence motifs	2
PACE family proteins	2
recently acquired mobile genetic elements	2
core genomes	2
Genes encoding PACE family proteins	2
many important Gram-negative human pathogens	2
disinfectants and antiseptics	2
range of biocides	2
PACE family transport proteins	2
proteobacterial antimicrobial compound efflux (PACE) family of transport proteins	2
RND efflux pumps	2
complex machineries	2
unrelated compounds	2
bacterial RND-type multidrug efflux pumps	2
lactic acid and lactobacilli probiotics	2
acidifies the vagina	2
vaginal environment	2
multiple anaerobes	2
vaginal dysbiosis (e.g. bacterial vaginosis, BV)	2
beneficial lactobacillus-dominated microbiota	2
Vaginal eubiosis	2
thiol homoeostasis	2
U(VI)	2
mM U(VI)	2
A. ferrooxidans	2
metal-contaminated environments	2
acidophile	2
Acidithiobacillus ferrooxidans	2
Campylobacter bacteriophage	2
ecology	2
host and bacteriophage	2
chemotactic response signalling genes cheV, cheA and cheW.	2
major flagellin flaA	2
stress response genes	2
early exponential phase cultures	2
extra-intestinal environments	2
Host bacteria	2
host bacteria	2
virulent bacteriophages	2
foodborne pathogen Campylobacter jejuni	2
sophisticated gene tools	2
range of clostridial species	2
hypoxic/necrotic regions	2
obligate anaerobes	2
intravenously injected spores	2
anti-cancer drugs	2
tumour delivery vehicle	2
endospore forming Clostridium species	2
effective and accessible therapies	2
Mobile genetic elements	2
toxin producers	2
non-toxigenic strains	2
toxin genes themselves	2
challenging environments	2
antibiotic resistance	2
mobile genetic elements	2
Clostridium difficile genome	2
botulinum neurotoxin genes	2
different neurotoxin gene clusters	2
different types of neurotoxin	2
complete genome DNA sequences	2
Clostridium botulinum Group I (proteolytic C. botulinum) and C. botulinum Group II (non-proteolytic C. botulinum)	2
OC	2
OC locus	2
lipooligosaccharide	2
OCL1 intact	2
insertion sequence (ISAba1 or ISAba23) interrupted OCL1	2
Three mutants	2
OCL1, OCL3 or a new locus, OCL5	2
GC1 isolates	2
GC2 genomes	2
outer core (OC) of the lipooligosaccharide	2
different forms of the locus	2
82 Acinetobacter baumannii global clones 1 (GC1) and 2 (GC2) isolates	2
genus and of pathogenic species	2
E. histolytica parasites	2
amoebic dysentery	2
higher level structures	2
B. subtilis cytoplasmic membrane	2
major early sporulation-specific transcription factor, Spo0A.We	2
SpoIISA expression	2
sporulation-inducing medium	2
Heterologously expressed SpoIISA–SpoIISB	2
SpoIISA toxin	2
spoIIS coding sequences	2
antitoxin	2
toxin–antitoxin system	2
previously identified spoIIS locus	2
DNA repair protein in B. fragilis	2
RecA protein	2
B. fragilis strain	2
ultraviolet light	2
strand breaks	2
recA mutant DNA	2
intact double-stranded DNA	2
DAPI staining	2
A B. fragilis recA mutant	2
two upstream genes	2
recA gene	2
B. fragilis genomic DNA	2
Mtz and other DNA damaging agents	2
DNA repair protein, RecA	2
DNA damaging agent	2
metronidazole (Mtz)	2
anaerobic abscesses	2
human gut commensal	2
Bacteroides fragilis	2
KgmB, i.e. G1405	2
antibiotic rRNA binding sites	2
40S subunits	2
Neither methylase	2
G-418-resistant yeast transformants	2
mRNAs in yeast cells	2
18S rRNA A-site	2
encoded prokaryotic methylases	2
yeast expression vector	2
Streptomyces tenebrarius	2
Micromonospora zionensis	2
aminoglycoside resistance genes sgm	2
miR-382-5p/PTEN axis	2
up-regulated miR-382-5p	2
PML nuclear bodies (NBs)	2
cell cycle regulator cyclinD1	2
specific PTEN inhibitors	2
ATRA-regulated tumor suppressor gene PTEN	2
APL cell line NB4	2
miR-382-5p mimics, inhibitors, or negative control (NC)	2
APL cell line	2
miR-382-5p expression	2
microRNA-382-5p (miR-382-5p)	2
acute promyelocytic leukemia (APL), all-trans retinoic acid (	2
inhibiting ACTL6A	2
Sox2 and Notch1 signaling pathways	2
activator of p53	2
all-trans retinoic acid-treated NB4 and HL-60 cells, and phorbol myristate acetate-treated HL-60 cells	2
APL patients	2
APL cDNA microarray (GSE12662)	2
BAF chromatin remodeling complexes	2
Actin-like 6A (ACTL6A)	2
classical EGF gene targets	2
classical EGF-regulated genes	2
EGF/β-catenin pathway	2
mitogen activated protein kinase)	2
different combinations and concentrations of EGF and Wnt ligands	2
MSC reporter cell lines	2
β-catenin in human MSCs	2
canonical Wnt signalling pathway	2
primary human MSCs	2
individual MSC clones	2
skeletal lineages	2
Bone marrow mesenchymal stem/stromal cells (MSCs)	2
multifaceted cytokine	2
pleiotropic cytokine	2
downstream signalling proteins	2
transforming growth factor-beta (TGFβ)	2
vessel lumen	2
NRAS in cells	2
oncogenic NRAS	2
MEK/ERK, but not AKT	2
panel of clinically important kinase inhibitors	2
RAC1 knockdown	2
cancer-associated kinase signalling pathways	2
UPR connection	2
N92I RAC1	2
Small Rho family GTPases	2
down-regulating apoptotic pathways	2
cell-survival signalling pathways	2
striated and smooth muscle cells	2
members POPDC1, POPDC2 and POPDC3	2
Popeye domain containing (POPDC) family	2
novel family of cAMP effector proteins	2
cyclic-nucleotide gated channels	2
cAMP (EPAC)	2
exchange factor	2
eukaryotes three effector proteins	2
ancient signal transduction pathway	2
cyclic 3′,5′-adenosine monophosphate (cAMP) signalling pathway	2
different pro-hypertrophic mediators	2
ETA receptors	2
adult rat heart	2
neonatal rat ventricular myocytes (NRVM)	2
pro-hypertrophic GPCR agonist endothelin-1 (ET-1)	2
pro-hypertrophic hormone agonists of GPCRs	2
MAPK signalling cascade	2
Huntingtin (HTT) gene itself	2
novel signalling pathway	2
transforming growth factor-beta pathway	2
cells expressing mutant huntingtin	2
kinase signalling pathways	2
dynamic model	2
human blood and post-mortem caudate	2
multiple animal and cell models	2
potential target of YAP	2
yes-associated protein (YAP)	2
human ECs	2
HECW2 physically	2
endothelial cell-to-cell junctions	2
novel EC ubiquitin E3 ligase	2
AMOT family	2
(AMOT) family	2
angiomotin	2
endothelial barriers	2
Cell-to-cell junctions	2
ribose-5-phosphate isomerase (RPIA)	2
individual metabolic enzymes	2
Ral-RalBP1-ARNO-Arf6 pathway	2
Active Ral	2
T24 cells	2
raft microdomains	2
anchorage independent active Ral	2
oncogenic H-Ras containing bladder cancer T24 cells	2
RalB	2
re-adherent mouse fibroblasts (MEFs)	2
small GTPase Ral	2
growth factor signalling	2
isoform-specific IP6K1 inhibitor	2
4NQO-induced invasive carcinoma	2
invasive carcinoma	2
mice lacking IP6K1	2
oral carcinogen	2
IP6K1 knockout MEFs	2
inactive IP6K1	2
adhesion-dependent signaling	2
mouse embryonic fibroblasts (MEFs) lacking IP6K1	2
equally abundant and ubiquitously expressed IP6K1 isoform	2
oral carcinogen 4-nitroquinoline-1-oxide (4NQO)	2
mice lacking this protein	2
isoform	2
Three isoforms of IP6Ks	2
5-diphosphoinositol pentakisphosphate (5-IP7) from inositol hexakisphosphate (IP6)	2
Inositol hexakisphosphate kinases (IP6Ks)	2
ceramide synthase	2
anti-oxidant nuclear factor (erythroid-derived 2)-like 2 (Nrf-2)	2
potent sphingosine kinase 1 inhibitor, PF-543	2
sphingosine kinase 1 selective inhibitor, PF-543 and a sphingosine kinase 1/ceramide synthase inhibitor, RB-005	2
Sk1−/− mice	2
bioactive lipid, sphingosine 1-phosphate	2
intestinal mucosa	2
iron-depleted cells	2
PP2A	2
REDD1 siRNA	2
protein phosphatase 2A (PP2A)	2
mTOR substrates, S6K1 and 4E-BP1	2
iron-regulated proteins (TfR, transferrin receptor and DMT1, divalent metal transporter	2
human intestinal epithelia	2
well-established in vitro model	2
iron chelator, deferoxamine (DFO)	2
mammalian or mechanistic target of rapamycin complex 1 (mTORC1)	2
indispensable micronutrient	2
PDE4/CD271 complex	2
NGF or TGF-β1	2
CD271 ligand	2
normal human skin fibroblasts	2
nerve growth factor (NGF) receptor CD271	2
myofibroblasts (DM)	2
dermal fibroblasts (DF)	2
psoriatic dermis	2
anti-inflammatory mediators	2
number of pro-inflammatory cytokines	2
peripheral blood mononuclear cells (PBMC)	2
PDE4D mRNA	2
PDE4 inhibitors	2
proinflammatory enzymes	2
Phosphodiesterases 4 (PDE4)	2
mTORC1 inhibition.eEF2K	2
Inhibiting mTORC1	2
nutrient-deprived cells	2
mammalian target of rapamycin complex 1 (mTORC1)	2
nutrient-sensitive signalling pathways	2
known substrate	2
Eukaryotic elongation factor 2 kinase (eEF2K)	2
protein kinase Akt	2
PI3-kinases	2
cell interior and surface	2
glucose transporter GLUT4	2
CD36, V-ATPase	2
fatty acid transporter FAT/	2
several intracellular cargoes	2
Rab11 effector protein	2
different PDEs	2
PKA subsets	2
PKA isoforms	2
individual phosphodiesterase (PDE) isoforms	2
cAMP/PKA compartmentalisation	2
targeted reporters	2
primary adult rat ventricular myocytes	2
distinct downstream targets	2
spatially confined pools of cAMP	2
different subcellular compartments	2
PKA-I and PKA-II	2
isoforms of PKA	2
different hormonal stimuli	2
cAMP/protein kinase A (PKA) signalling	2
heart compartmentalisation	2
Src- and JNK-dependent signaling cascade	2
several receptor tyrosine kinases	2
Dyn2 K44A	2
dominant-negative Dyn2 K44A mutant	2
dynamin 2 (Dyn2)	2
growth factors or cytokines	2
Jun and Fos proteins	2
AP-1 transcription factors	2
D1-class dopaminergic receptors	2
critical intramolecular interactions	2
crystallized structures	2
many Family A GPCRs	2
parent receptors	2
inverse agonists	2
ST1 mutants	2
Ser and Thr of IL1 and IL1/TM2 juncture	2
human D1-class receptor mutants (hD1-ST1 and hD5-ST1)	2
Ser and Thr	2
several polar residues	2
adjacent transmembrane (TM) regions	2
first intracellular loop (IL1)	2
many G protein-coupled receptors (GPCRs)	2
Src-containing autophagosomes	2
FAK-regulated signalling module PDK1-Akt-p70S6K	2
biochemical complex	2
Src and p70S6K	2
PDK1-Akt-p70S6K signalling pathway	2
selective inhibitor	2
p70S6K	2
autophagy protein LC3	2
FAK deficient cells	2
activated c-Src (p-Src)	2
multiple agents	2
Akt-p70S6K-S6	2
p70S6K and S6	2
squamous cell carcinoma (SCC) cells	2
stabilise junctions	2
newly-formed contacts	2
pre-formed cell aggregates	2
EGFR RNAi phenotype	2
E-cadherin-induced Rac1 activation	2
DOCK180 RNAi	2
another EGFR family member, ErbB3	2
cadherin contacts	2
two Rac1 GEFs, SOS1 and DOCK180	2
HIF-1α- and lipin-1-dependent manner	2
cancer and normal cells	2
direct target of HIF-1	2
chromatin binding HIF-1 complex	2
heterodimerization partner ARNT	2
CK1δ phosphorylates HIF-1α	2
inducible subunit of HIF-1	2
transcriptional activator Hypoxia Inducible Factor-1 (HIF-1)	2
EPAC isoforms	2
nuclear fractions	2
naturally occurring EPAC2 isoform, EPAC2B	2
nuclear binding sites	2
conserved NPLS	2
cAMP-binding domain of EPAC2A (CNBD1)	2
catalytic domains of the cAMP-sensors	2
EPAC1)	2
conserved nuclear pore localisation signal (NPLS	2
remaining core catalytic domain interface	2
UCR1 module	2
short forms	2
core catalytic domain	2
UCR modules	2
PDE4 long isoforms	2
two PDE4D5 molecules	2
conserved PDE4 catalytic unit	2
second dimerization site	2
PDE4 catalytic unit	2
additional interface	2
PDE4D5 homodimers	2
DD1 cluster	2
Arg173, Asn174 and Asn175 (DD1) cluster	2
long, but not short, PDE4 isoforms	2
regulatory UCR1 region	2
Critical residues	2
Key residues	2
entire PDE4D5 sequence	2
overlapping peptides	2
25-mer library	2
recombinant purified PDE4D5 fusion protein	2
potential dimerization sites	2
long PDE4 isoforms	2
bait and prey in a yeast 2-hybrid system	2
widely found PDE4D5 isoform	2
PDE4 family cAMP phosphodiesterases	2
predominantly TxA2-dependent and ADP-independent pathway	2
enhancements	2
washed platelets	2
collagen-induced thrombus formation	2
vitro whole blood perfusion assay	2
collagen-activated platelets	2
CXCR4 inhibition	2
human washed platelets	2
CXCR4 and CXCR7	2
chemokine stromal cell-derived factor (SDF)-1α	2
mice overexpressing PLD2 enzyme	2
basic amino acid Arginine	2
polar inositol ring	2
PH domain of PLD2	2
novel PIP2 binding site	2
existence of binding sites	2
bacterial PLD crystal structure	2
secondary structure regions	2
756	2
442 and water	2
phosphatidylcholine head group (but not phosphatidylethanolamine or phosphatidyl serine)	2
442/His 756	2
N- and C-terminal histidines of the HKD motifs	2
PLD2	2
mammalian PLDs	2
crystallized protein	2
key intracellular lipid second messenger phosphatidic acid	2
cell membrane phospholipids	2
phospholipase D (PLD) superfamily	2
targeted PDE4 inhibitor	2
lung neutrophilia	2
ferret lung neutrophilia model	2
either T or B cells	2
5mg/kg/day p.o.)	2
transgenic T-cell and B-cell transfer murine model	2
T-cell cytokine production	2
plasmacytoid dendritic cells	2
NF-κB transcriptional activity	2
activating transcription factor-1	2
protein kinase A substrates CREB	2
target of thalidomide action	2
glutarimide ring	2
apremilast and thalidomide	2
PDEs, kinases, enzymes, or receptors	2
100nM. Apremilast	2
four sub-families (A1A, B1, B2, C1, and D2)	2
Apremilast inhibited PDE4 isoforms	2
models of innate and adaptive immunity	2
psoriatic arthropathies, and Behçet's syndrome	2
oral small molecule inhibitor of phosphodiesterase 4 (PDE4)	2
exactly PKC signalling pathways	2
putative connections	2
prototypical calcium-dependent PKC subtypes	2
differentiating chondroprogenitors	2
Signalling components	2
mature articular chondrocytes	2
PKC isoenzymes	2
protein kinase C (PKC) subtypes	2
key target proteins	2
chondroprogenitor cells	2
complex intracellular signalling pathways	2
major proapoptotic pathways	2
P23H RHO rod photoreceptors	2
P21–P30 P23H RHO retina	2
cytochrome C and AIF	2
P23H RHO photoreceptors	2
P23H-3 RHO retina	2
P23H RHO retina	2
mTOR/AKT pathways	2
Bcl2 family proteins	2
Ca2+-regulated proteins	2
P23H rhodopsin (RHO) retinas with autosomal dominant retinitis pigmentosa (ADRP)	2
human carcinomas of the colon and rectum	2
epithelial cell signaling circuitry in vivo and in vitro	2
adult epithelial stem cells in the gut	2
undifferentiated progenitors	2
epithelial stem cells	2
secreted glycoproteins of the Wnt family	2
essential Ca2+-sensing role	2
PM STIM1	2
myosin, DOCK10, thrombospondin-1 and actin	2
collagen-coated capillaries	2
surface-exposed	2
portion of STIM1	2
Fura2-labelled cells	2
surface exposure	2
agonist-stimulated Ca2+ entry	2
N-terminal region of STIM1	2
antibody GOK/STIM1	2
outside medium	2
store-operated Ca2+ entry	2
Orai channels	2
STIM1 senses	2
cAMP signalling pathway	2
Amoebozoan encystation	2
RegA critically	2
Acanthamoeba encystation	2
effective inhibitors	2
RegA inhibitors	2
Acanthamoeba RegA	2
P. pallidum	2
RegA gene	2
social and pathogenic amoebas	2
cAMP phosphodiesterase RegA	2
Polysphondylium pallidum	2
dictyostelids	2
social amoeba Dictyostelium discoideum forms spores in multicellular fruiting bodies	2
vision-destroying Acanthamoeba keratitis	2
pathogenic amoebas	2
encapsulated cysts	2
GRK2	2
Rho-dependent ERK MAPK scaffolding	2
GRK2 expression	2
ERK scaffolding	2
RhoAGTP binding	2
Exogenous GRK2	2
catalytic domain of the kinase	2
ERK MAP kinase cascade	2
RhoA-activated scaffold protein	2
RhoA effector	2
novel binding partners	2
number of non-receptor substrates and binding partners	2
families of receptors	2
GRKs	2
phosphorylating and desensitising G protein-coupled receptors (GPCRs)	2
G protein-coupled receptor kinases (GRKs)	2
inactivates PTEN	2
TOPK phosphorylates	2
CHFR ubiquitinates	2
lipid phosphatase	2
TOPK/PBK	2
checkpoint protein	2
CHFR (Check point protein with FHA and RING domains)	2
N-terminal and C-terminal domains of ANXA1	2
disordered conformation	2
N-terminal α-helix	2
Ca2+-free conformation	2
α-helix structure	2
polyubiquitination site	2
nuclear export signal	2
Ca2+ and SUMO-1	2
hot spot	2
ANXA1 SUMOylation	2
N-terminal Y21	2
C-terminal calcium-binding DA3 repeat domain	2
SUMOylation consensus motif	2
calcium-binding annexin A1 protein (ANXA1)	2
annexin family	2
Mouse prostate membrane-associated proteins	2
specific microRNA expression	2
numerous protein coding gene sequences	2
DNMT transcripts	2
DNA methyltransferases (DNMTs)	2
combination of microRNAs	2
previously uncharacterized, functional growth inhibitor	2
known inducers	2
Fbxl12 overexpression	2
early G1	2
Thr170 and Thr197 in mouse cells	2
Thr157 and Thr198 in human cells	2
cyclin D1/cdk4 complex assembly	2
ubiquitin E3 ligase component, F-box protein Fbxl12	2
D1/cdk4 complex	2
cyclin	2
Ca2+/CaM-dependent kinase 1 (CaMKI)	2
Myosin 1c	2
molecular motor myosin 1c	2
Cellular signaling pathways	2
PCTAIRE-1 kinase	2
PCTAIRE-1 and cyclin Y	2
Point mutants of cyclin Y	2
cyclin A2	2
cyclin Y	2
novel cyclin family member, cyclin Y	2
basic residue	2
proline residue immediately C-terminal to the phosphoacceptor site (+1)	2
CDKs	2
widely used generic CDK substrate peptide	2
Recombinant PCTAIRE-1	2
peptide substrate	2
bona fide substrates	2
preferred consensus motif	2
robust assay	2
CDK family of protein kinases	2
highly conserved serine/threonine kinase	2
PCTAIRE-1 (cyclin-dependent kinase [CDK] 16)	2
serine 188	2
dominant-negative inhibitor	2
non-phosphorylatable Ser188Ala RhoA mutant	2
RhoA on serine 188	2
constitutively active Gln63Leu-mutated RhoA	2
Rho kinase	2
protein kinase A	2
androgen-independent neuroendocrine cell population	2
simplified mathematical model	2
p38 and ERK pathways	2
DUSPs 10	2
siRNA targeting DUSPs 10	2
EGF and PDBu on ERK-dependent transcription (Egr-1 luciferase activity)	2
protein kinase C activator PDBu (phorbol 12,13 dibutyrate)	2
two p38/JNK MKPs (DUSPs 10 and 16)	2
ppERK1/2 (dual phosphorylated ERKs 1 and/or 2)	2
MAPK phosphatases (MKPs)	2
dual specificity phosphatases (DUSPs)	2
exogenous ATP	2
leukemia inhibitor factor (LIF)	2
essential pro-survival signal	2
selective P2X7 antagonist	2
undifferentiated mouse ES cells	2
ATP-gated P2X7 receptors	2
important extracellular signalling molecule	2
nucleotide ATP	2
pluripotent embryonic stem (ES) cell population	2
oxygen sensor	2
true dioxygenases	2
novel class of histone demethylases	2
complex chromatin structure	2
prolyl-hydroxylases (PHDs), enzymes	2
molecular dioxygenases in cells	2
family of oxygen labile transcription factors, Hypoxia Inducible Factor (HIF)	2
[cAMP]i	2
known regulatory inputs	2
Rag GTPases, TSC2, PKB, MAPK and AMPK	2
TSC2 knockout (TSC2−/−) MEFs	2
upstream negative regulator of mTORC1	2
signalling cascades (i.e. PKB, MAPK and AMPK)	2
human embryonic kidney 293 (HEK293) cells	2
mouse embryonic fibroblasts (MEFs) and	2
two signalling pathways	2
cAMP and mTOR signalling pathways	2
PAR2 or P2Y2 receptors	2
GF109203X and YM25480	2
novel Gq/11 inhibitor YM25480	2
PKC inhibitor, GF109203X.	2
PKC activator PMA	2
JNK alone	2
novel PAR2 antagonist K14585	2
cells expressing PAR4	2
p38 MAP kinase nor ERK activation	2
specific activating peptide SLIGKV-OH	2
PAR2 expressing NCTC2544 cells	2
calcium sensitive AC3 isoform	2
FP receptor-Gαq-Ca2+-calmodulin pathway	2
candidate gene, Spermidine/N1-acetyltransferase (SAT1)	2
AC3) isoform	2
adenylyl cyclase 3 (	2
siRNA molecules	2
calcium effectors using calmodulin antagonist (W7) or Ca2+/calmodulin-dependent kinase II (CaMK-II) inhibitor (KN-93)	2
protein kinase C (PKC)	2
phospholipase C (PLC) and inositol phosphate receptor (IP3R)	2
PGF alone	2
FPEP2 cells	2
receptors (FPEP2 cells)	2
EP2 and FP prostanoid receptors in Ishikawa cells	2
opposing intracellular signaling pathways	2
specific G protein-coupled receptors (GPCRs)	2
either agent	2
protein kinase (	2
NO	2
primary human aortic smooth muscle cells (1° AoSMCs)	2
clonal cells over-expressing TPα or TPβ	2
TPα and TPβ	2
prostacyclin and/or NO	2
vasodilators prostacyclin and nitric oxide (NO)	2
TPα and TPβ isoforms of the TXA2 receptor	2
endogenous signalling proteins	2
cellular fractionation	2
immunoprecipitation and enzyme assay	2
PIPkin IIβ	2
DT40 PIPkin IIβ gene	2
one of the alleles	2
12, 763–771 2005	2
epitope tag (Mosedale et al.	2
endogenous PIPkin IIβ	2
J. 364, 587–591 2000	2
putative novel nuclear localisation sequence (Ciruela et al. Biochem.	2
4-kinase (PIPkin IIβ)	2
Type IIβ PtdIns5P	2
acidic α-helix	2
acutely transfected HeLa cells	2
β-arrestin-independent tonic internalization pathway	2
either β-arrestin1 or β-arrestin2	2
wild type TPβ	2
non-palmitoylated TPβC347,373,377S	2
unique carboxyl-terminal domain	2
TPα and TPβ isoforms of the human prostanoid thromboxane (TX) A2 receptor (TP)	2
M. amblycephala livers	2
short read (100 bp) next-generation RNA sequencing (RNA-seq)	2
juvenile Megalobrama amblycephala	2
previously reported AvrPi7	2
SNP on chromosome 1	2
chromosome 1, 2, 3, 4 and 7	2
five SNPs	2
local and improved rice varieties	2
rice (Oryza sativa)	2
seventy three isolates of M. oryzae	2
ultra-high coverage next-generation sequence data	2
one of only three genome-enabled echinoid species	2
draft genome	2
model species L. variegatus	2
novel mitogenomes	2
two members of the genus Strongylocentrotus (S. pallidus and S. droebachiensis)	2
Echinometridae, Toxopneustidae, and Strongylocentrotidae	2
epiphyses of the jaw	2
echinoids with tooth supports	2
superfamily Odontophora	2
(Lytechinus variegatus) and one for the Red Urchin (Mesocentrotus franciscanus)	2
Green Urchin	2
camarodont echinoid mitogenomes	2
publically available next-generation sequence data	2
host and pathogen species	2
reference genome assemblies	2
unmapped reads	2
BVD virus strains	2
several parasite and virus genome reference assemblies	2
bovine reference genome assemblies	2
live virus	2
genuine virus sequence contigs	2
multispecies NCBI databases	2
bovine genome assemblies	2
unmapped RNAseq reads	2
double-stranded RNA virus	2
new fatal disease Bovine Neonatal Pancytopenia	2
recent RNAseq project	2
target species' reference genome	2
transcriptome sequencing data	2
post-weight loss regulatory network	2
glucose transport pathways	2
obese, pre-menopausal women	2
rectal mucosa biopsies	2
colorectum	2
continuous and discrete data	2
hybrid models	2
discrete and continuous Cox proportional hazards models	2
complex LCR regions	2
LCR22-2 genes and pseudogenes	2
two karyotypically normal cell lines	2
DNA fibers	2
different multiple color combinations	2
LCR22-2 proximally and distally	2
two single-copy BAC-clones	2
Four fosmid clones	2
LCR	2
challenging genomic regions	2
LCRs direct visualization	2
Low-copy repeats (LCRs)	2
NOD embryonic stem (ES) cell lines	2
BAC libraries	2
CHORI-29	2
191,841 single nucleotide polymorphisms (SNPs)	2
Ensembl genes	2
reference mouse genome assembly	2
male donor	2
Ensembl mouse genes	2
reference mouse genome sequence	2
BAC end-sequences	2
two commonly used NOD substrains	2
NOD/MrkTac (DIL NOD) and NOD/ShiLtJ (CHORI-29)	2
bacterial artificial chromosome (BAC) libraries	2
insulin-secreting β-cells	2
Non-obese diabetic (NOD) mice	2
NFAT	2
neurons of the mouse brain	2
NFAT mRNAs	2
adult human hippocampus	2
NFATC1, NFATC2, NFATC3, and NFATC4 mRNAs	2
Ca2+-regulated	2
NFAT family members	2
NFAT proteins	2
alternatively spliced NFAT mRNAs	2
various mouse and human tissues and brain regions	2
different NFAT mRNAs	2
NFATC1, NFATC2, NFATC3, and NFATC4	2
novel splice variants	2
human and mouse NFAT genes	2
immune, cardiovascular, musculoskeletal, and nervous systems	2
-regulated transcription factors	2
Four members of the nuclear factor of activated T cells (NFAT) family (NFATC1, NFATC2, NFATC3, and NFATC4)	2
dsRNA duplexes	2
BDNF and antiBDNF transcripts	2
approved gene symbol BDNFOS)	2
antiBDNF gene	2
BDNF gene locus	2
noncoding natural antisense RNAs	2
tissue and brain-region specifically	2
functional promoters	2
transient overexpression assays	2
BDNF promoters	2
human BDNF transcripts	2
adult human tissues and brain regions	2
alternative transcripts	2
member of the nerve growth factor family of neurotrophins	2
Brain-derived neurotrophic factor (BDNF)	2
recombinant vaccines	2
flanking IS elements	2
28 strains	2
two and three copies	2
12- and 8-kb genetic loci	2
European outbreaks	2
Africa and Australia	2
13-kb genetic locus	2
mycoides SC strains	2
24-kb genetic locus	2
African, European, and Australian field and vaccine strains	2
type strain PG1	2
insertion sequence (IS) elements	2
large repeated segments	2
mycoides small-colony type	2
type strain PG1 of Mycoplasma mycoides subsp.	2
transcriptome dataset	2
gram-negative binding proteins, thioester proteins, scavenger receptors, galectins, signaling pathway factors, caspases, serpins, and peroxidases)	2
secreted and membrane-anchored hydrolytic enzymes)	2
digestive physiology	2
gut (peritrophins, microvillar proteins, glutamine synthase)	2
database sequence	2
described sand fly genes	2
10,203 contigs	2
16,608 clones	2
whole adults	2
normalized cDNA library	2
sand fly vector	2
expressed sequence tag library	2
EPS-synthetizing genes	2
α-(1–6) glycosidic bonds	2
least five different dextransucrases	2
L. citreum FDR241	2
glucosyltransferases genes (GH70)	2
sourdough of 2–2.6 fold	2
lactic and acetic acid	2
sourdoughs	2
wheat flour type I sourdough propagation (back-slopping)	2
dextran producer Leuconostoc citreum	2
two illustrative examples	2
AlvisIR Food on-line semantic search engine	2
OntoBiotope ontology	2
knowledge resources	2
food microbiology domain	2
Alvis text mining platform	2
large collections	2
food microbial diversity	2
fluorescent enteric control strains	2
XLD agar	2
one lactose operon	2
closed whole genome sequences	2
Lac+ on Mac Conkey and Hektoen Enteric agar plates	2
Lac− on Xylose Lysine Deoxycholate (XLD) agar plates	2
S. Tennessee Sal66	2
parent strain	2
new strains	2
Enterica serovar Gaminera, S. Mbandaka, S. Tennesse, S. Minnesota, S. Senftenberg and S. Typhimurium	2
Escherichia coli O157:H7, Shigella sonnei, S. flexneri, Salmonella enterica subsp.	2
following species on selective or non-selective plates	2
collection of strains which express Green Fluorescent Protein (GFP)	2
cross-contaminating samples	2
positive controls	2
naturally-occurring bacterial strains	2
exosporium of Group I C. botulinum spores	2
likely composition	2
many other Group I strains	2
C. botulinum Prevot 594	2
third cysteine-rich protein (CsxC)	2
CsxB.	2
cysteine-rich proteins CsxA	2
collagen-like repeat domain	2
high molecular weight protein bands	2
bulk exosporium	2
major individual SDS-PAGE-separated protein bands	2
purified exosporium	2
exosporium of C. sporogenes strain NCIMB 701792	2
several appendages	2
paracrystalline array	2
sac-like outermost layer of spores of these species	2
Group I (proteolytic) neurotoxin-producing Clostridium botulinum strains	2
non-pathogenic close relative	2
food processing industry	2
nanoemulsified antimicrobials	2
food constituents	2
carrot juice system formulation	2
juice constituents	2
carrot juice system	2
carrot juice	2
antimicrobial	2
food products	2
Listeria monocytogenes in culture media	2
-limonene	2
spore coat	2
aperture	2
coat shell	2
enlarged aperture	2
largely intact exosporium	2
pre-existing aperture	2
hole in the spore coat	2
germinated cell	2
spore coats	2
C. sporogenes spores	2
spore structures	2
food spoilage	2
highly heat resistant endospores	2
anti-inflammatory targets	2
cannabis, cocaine, opioids, amphetamines, anabolic androgenic steroids)	2
certain brain areas and neural circuits	2
neurotransmitter systems	2
cortical and subcortical structures	2
slowly adapting mechanoreceptor	2
St II units	2
deep vibrissal nerve	2
St I units	2
6–50 week old rats	2
different types of slowly adapting mechanoreceptor units	2
fine acuity tactile perception	2
slowly adapting type I mechanoreceptor units	2
Merkel nerve endings	2
hippocampal dentate gyrus neurons	2
diet containing milk fat globule membrane, lactoferrin and a polydextrose/galactooligosaccharide prebiotic blend	2
weanling rats	2
prebiotics, milk fat globule membrane	2
superficial brain	2
healthy newborn infants	2
newborn infants	2
body core	2
scalp surface	2
superficial structures	2
zero-heat flux tissue thermometer	2
Thirty-two healthy newborn infants	2
unsedated newborn infants	2
non-invasive monitoring tools	2
non-invasive cot-side monitors	2
drug-resistant P. aeruginosa strains	2
several innovative therapeutic technologies	2
multidrug-tolerant persister cells	2
Strains of Pseudomonas aeruginosa	2
key SELEX steps	2
single strand DNA separation	2
wide variety of targets	2
bio-sensing	2
short single-stranded nucleic acid sequences	2
expression cassettes	2
DNA parts	2
recently developed synthetic biology tools	2
dedicated genetic toolbox	2
non-native metabolites	2
certain compounds of interest	2
non-conventional oleaginous yeast Yarrowia lipolytica	2
primary and specific targets	2
Differentially expressed genes	2
CRISPR-Cas systems	2
crisprTFs and gene drives	2
advanced CRISPR-related applications	2
Komagataella phaffii, Kluyveromyces lactis, Candida albicans and C. glabrata) yeasts	2
non-conventional (Yarrowia lipolytica, Pichia pastoris syn.	2
conventional (Saccharomyces cerevisiae and Schizosaccharomyces pombe) and	2
CRISPR-Cas system	2
activated Nrf2	2
diabetes-linked and Nrf2-susceptible forms	2
many phytochemicals	2
nuclear factor erythroid 2-related factor 2 (Nrf2)	2
collection of paradigms	2
alternative operational paradigms	2
central management	2
company	2
various locations or regions	2
Decentralised manufacturing	2
personalised therapies	2
nanotechnological applications	2
engineered actin filaments	2
fluorophores, antibodies, oligonucleotides or various macromolecular complexes e.g. nanoparticles	2
motor partners	2
lab-on-a-chip devices	2
miniaturized sensor systems	2
associated motor systems	2
actin and myosin)	2
microtubules with dynein and kinesin motors	2
intracellular cargoes	2
self-assembled protein polymers	2
recombinant antibody and aptamer efforts	2
1999 National Academy of Sciences	2
modern affinity reagents	2
nucleic-acid-based	2
protein-based reagents	2
non-animal technologies	2
two types of affinity reagents	2
higher quality affinity reagents	2
Affinity reagents	2
large scale bioreductions	2
o-chloroacetophenone to (S)-1-(2-chlorophenyl)ethanol	2
set-up	2
specific chiral alcohol	2
decision-tree	2
development chain	2
option	2
cell-free and whole cell reduction system	2
free enzymes in solution	2
coupled oxidoreduction	2
cheap co-substrate	2
precursor ketones	2
chiral alcohols	2
respective plant sources	2
compound amount	2
advanced plant-derived natural products	2
natural sources	2
high throughput screening (HTS) platforms	2
drug discovery source	2
libraries of synthetic compounds	2
novel drug leads	2
Medicinal plants	2
enzymatic transglutaminase- and glycotransferase-based approaches	2
unnatural amino acids, aldehyde tags	2
engineered reactive cysteine residues (THIOMAB)	2
ADCs	2
conjugated molecules per antibody	2
various drug-loaded forms of ADCs	2
various populations of the ADCs	2
conjugation sites	2
cysteine or lysine residues	2
Conventional ADCs	2
either cleavable or stable linker	2
highly potent drug	2
tumor surface antigen	2
bioconjugate	2
ADC	2
Food and Drug Administration (FDA)	2
two of them, Adcetris® (brentuximab vedotin) and Kadcyla® (ado-trastuzumab emtansine)	2
antibody–drug conjugates (ADCs)	2
selected enzymes	2
non-natural substrate scope	2
SAM-dependent enzymes	2
terpene cyclases	2
three- to six-membered carbo- and heterocycles	2
heterologously expressable biocatalysts	2
different types of enzymes	2
resurrection plants	2
resurrection species	2
novel drug substances	2
e.g. antibacterial, anticancer, antifungal, and antiviral activities	2
particular secondary metabolites	2
extracts of resurrection species	2
diverse array of sugars, phenolic compounds	2
unique metabolites	2
protective metabolites	2
stress-associated genes	2
group of land plants	2
Resurrection species	2
Keap1–Nrf2 protein complex	2
sulforaphane, and other cysteine-reactive inducers	2
Keap1 and Nrf2 in single live cells	2
multiphoton fluorescence lifetime imaging microscopy (FLIM)	2
isothiocyanate sulforaphane	2
commonly used edible plants	2
one of the richest sources	2
cruciferous vegetables	2
Many inducers	2
electrophiles and oxidants (termed inducers)	2
Cullin3/Rbx1 ubiquitin ligase	2
substrate adaptor protein	2
nearly 500 genes	2
negative regulator Kelch-like ECH associated protein 1 (Keap1)	2
transcription factor NF-E2 p45-related factor 2 (Nrf2)	2
“smart” libraries	2
mutant library preparation	2
overlapping PCR and megaprimers	2
complementary overhangs	2
high quality mutant library	2
wild type pncA)	2
melting curve assay	2
118 isolates	2
Mycobacterium tuberculosis complex isolates	2
prototype assay	2
selected pncA regions	2
non-wild type genotype	2
pncA gene	2
drug susceptible tuberculosis	2
key antibiotic	2
37 PenA variants in B. multivorans, and Pen-like β-lactamases from other species within the Burkholderia cepacia complex	2
purified PenA	2
anti-PenA peptide antibody	2
48 clinical isolates of B. multivorans	2
18 amino acids)	2
highly conserved peptide	2
PenA variants	2
specific regions of the protein	2
entire β-lactamase	2
primary amino acid sequences	2
5 groups	2
37 variants	2
individuals with cystic fibrosis	2
different strains of Burkholderia multivorans	2
37 novel variants)	2
β-lactamase of the PenA family	2
major β-lactam resistance determinant	2
multiple antibiotics	2
human, animal, and plant pathogens	2
complex subset of gram-negative bacteria	2
Multidrug-resistant gram-negative pathogens	2
AAF/II fimbria	2
concomitant presence of aar, pic, agg4A, and capU genes	2
aar and pic genes	2
aafC gene	2
aaiC and aatA genes	2
EAEC VRGs	2
multiplex PCRs	2
Positive samples	2
virulence-related genes (VRGs)	2
enteroaggregative E. coli (EAEC) infection	2
CDC assay	2
primer binding sites	2
chikungunya RNA	2
nsp4 gene of the discordant positive sample	2
74 febrile samples	2
reference standard	2
(CDC) chikungunya qRT-PCR	2
contemporary strains	2
chikungunya E1 gene	2
qRT-PCR assay	2
A. fumigatus, A. lentulus and A. felis	2
Y121F marker	2
L98H and Y121F markers	2
TR34 target	2
AsperGenius® resistance PCR	2
control A. fumigatus (n=3), A. lentulus (n=6) and A. felis species complex (n=12) strains	2
biopsy proven invasive aspergillosis and	2
(i) 2 A. lentulus and A. felis strains	2
Aspergillus section Fumigati	2
2 rare but intrinsically azole-resistant sibling species	2
A. fumigatus Cyp51A mutations TR34/L98H/T289A/Y121F	2
several Aspergillus species	2
AsperGenius® assay	2
Brilliance VRE agar	2
nursing home residents	2
vanA Enterococcus raffinosus and vanB E. faecium	2
two vanC and eight vancomycin-susceptible enterococci	2
manufacturers’ instructions	2
three vanA Enterococcus faecalis isolates	2
vanA Enterococcus faecium	2
enterococcal isolates	2
vancomycin-resistant enterococci (VRE)	2
Brilliance VRE media	2
ChromID VRE	2
mitis group	2
S. mitis/oralis	2
0/13 S. pseudopneumoniae	2
9/11 S. pneumoniae	2
Microflex	2
12/13 S. mitis/oralis	2
Streptococcus pseudopneumoniae	2
lytA, Spn9802, and recA as reference standard	2
Streptococcus mitis group	2
Vitek MS and Microflex MALDI-TOF mass spectrometry platform	2
agars	2
116 positive samples	2
298 stools	2
extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae	2
Brilliance ESBL agar	2
ESBL agar and	2
1 μL loop culture	2
automated microscopy	2
remnant bronchoalveolar lavage specimens	2
Staphylococcus aureus and Pseudomonas spp	2
loop culture	2
patient specimens	2
live, surface-immobilized bacteria	2
ventilator-assisted pneumonia (VAP)	2
toxigenic Clostridium difficile	2
Hs27 Human Foreskin Fibroblast ReadyCells	2
Health Protection Agency microbiology laboratories	2
commonly used commercial enzyme immunoassay (EIA) method and toxigenic culture (TC) reference standard	2
bacterial meningitis	2
Vietnamese adult patients	2
S. suis infections	2
Streptococcus pneumoniae and Neisseria meningitidis combined	2
Culture-negative but PCR-positive CSF samples	2
prospectively collected CSF samples	2
culture-confirmed clinical samples	2
cps2J gene	2
cerebrospinal fluid (CSF) samples	2
S. suis serotype 2	2
emerging zoonotic pathogen	2
Streptococcus suis serotype 2	2
1H and 13C NMR spectra	2
catalysis systems	2
subsurface systems	2
extremophilic bacteria	2
mixed-phase chemical and microbial systems	2
supercritical methane/CO2 in clays and other minerals	2
Geochemical systems	2
wide variety of biotic and abiotic mixed-phase systems	2
WHiMS rotor design	2
sealing mechanism	2
check valve	2
bushings	2
mating groove	2
o-ring equipped polymer bushing	2
solid and liquid portions of the sample	2
head space	2
high pressure gas	2
liquid/supercritical solvent	2
solid catalyst	2
mixed phase systems	2
rotors	2
new MAS-NMR rotor (the WHiMS rotor)	2
rapidly changing systems	2
data corrupted	2
successive image volumes	2
highly efficient data capture	2
heart and lung	2
physiologically mobile organs	2
 k-space lines per cardiac R-wave	2
cardio-respiratory gating	2
cardiac and respiratory motion desensitised MRI	2
FFC-MRI scanners	2
signal in the background	2
image regions	2
line of k-space	2
fast amplifiers	2
resistive magnets	2
main magnetic field B0	2
free breathing acquisition	2
whole-heart volumes	2
non-Cartesian reconstructions	2
self-gated non-Cartesian trajectories	2
several frameworks	2
whole heart 3D Cartesian cardiac	2
MRI data	2
preclinical MRI coils	2
dedicated MRI imaging coil	2
suitable flow cell system	2
embryonic and early stage forms of the subject	2
vivo imaging tools	2
range of biomedical and biological research areas	2
power measurement devices	2
coil array	2
transmit element	2
power	2
transmitter	2
electric fields	2
multiple transmission channels	2
term-born peers	2
EP subjects	2
EP adolescents	2
brains of a group of term-born controls	2
EP participants	2
cohort of 19-year-old adolescents	2
adult life	2
Many survivors	2
PK model applications	2
frequently indicated error category	2
nearly all tumours	2
sub-regions	2
majority of voxels	2
eTM	2
imaged slice	2
PK model parameter maps	2
model arterial input function (AIF)	2
metastatic renal cell carcinoma	2
Eleven patients	2
dynamic contrast-enhanced (DCE-) MRI data	2
i.v.	2
fibrocartilage disc	2
ConclusionsT1(Gd) maps	2
Results2D-IR sequences	2
Magnevist™	2
(Gd-DTPA)2-, i.e.	2
Gd-diethylenetriamine pentaacetic acid ion	2
dedicated coil	2
six asymptomatic volunteers	2
right and left TMJ	2
temporomandibular joint (TMJ)	2
Cartilage (dGEMRIC)	2
surface quadrupolar relaxation (SQUARE) pulmonary MRI contrast	2
ex vivo rat lungs	2
parenchymal regions	2
main bronchi	2
krypton inhalation	2
ex vivo rodent lung	2
isotopically enriched 83Kr	2
porous model system	2
Hyperpolarized 83Kr	2
templates	2
Huntington’s disease mouse brain	2
striatum and cortex	2
GM maps	2
live transgenic and control mice	2
R6/2 model	2
grey matter	2
human imaging	2
estimated original ICV	2
table skull thickening	2
community-dwelling ageing cohort	2
representative older adults	2
frontal inner table	2
skull	2
large, long-range white matter fiber connections	2
three different samples	2
genotype groups	2
genu of the corpus callosum	2
major allele at rs1344706	2
minor allele carriers	2
unaffected relatives of bipolar patients	2
one German sample	2
left and right dorsolateral prefrontal cortices	2
genomewide supported susceptibility gene	2
Dynamic cardiac phantoms	2
mouse phantom	2
rat phantom	2
PVA material	2
gear pump	2
stiff water-filled tubing	2
polyvinyl alcohol (PVA) Cryogel	2
MRI.Cylindrical phantoms	2
animal laboratory	2
magnetic resonance imaging (MRI)	2
appropriate control group	2
suitable model	2
healthy and diseased living human tissue	2
subtle disorders	2
abnormal white matter	2
different tissue types	2
intracranial tumors and multiple sclerosis	2
traditional applications	2
blood–brain barrier (BBB) function	2
live avian embryos	2
control embryos	2
static magnetic fields	2
radiofrequency (rf) pulses	2
quail embryos	2
different regions within the eggs	2
extra-embryonic fluid (EEF)	2
extra- and non-embryonic components	2
latebra	2
non-embryonic structures	2
main body axis	2
live Japanese quail embryos	2
language system	2
range of fMRI domains	2
hemisphere	2
volumes of interest	2
left and right hemispheres contributions	2
name Candidatus Amarolinea aalborgensis	2
phylotype	2
order Caldilineales of Chloroflexi	2
proposed novel family Amarolineaceae	2
Amarolinea phylotype	2
Ca	2
near complete population genome	2
Illumina and Oxford Nanopore sequencing	2
filamentous bulking	2
Danish full-scale activated sludge systems	2
uncultured Chloroflexi phylotype, Candidatus Amarolinea	2
biovolume	2
phylum Chloroflexi	2
filamentous bacteria	2
Settleability of particles in activated sludge systems	2
identified isolates TUTMJM5, TUTMIITA5A and TUTLBC2B	2
plant-available P	2
soybean rhizobia in the agricultural soils of Mozambique	2
Mozambican soils	2
preferred dominant microsymbiont of soybean	2
B. elkanii group	2
test soybean isolates	2
nifH and nodC sequences	2
soybean nodulating isolates	2
two housekeeping genes (glnII and gyrB)	2
concatenated phylogeny	2
Bradyrhizobium species	2
16S rRNA-RFLP cluster	2
representative soybean isolates	2
16S rRNA sequences	2
B. elkanii species	2
bacterial diversity	2
whole-plant growth	2
43 bacterial isolates	2
farmers’ fields	2
Indigenous soybean rhizobial strains	2
high-quality MAGs	2
four major uncultured prokaryotic lineages	2
nomenclature type material	2
metagenome-assembled genomes (MAGs) or single amplified genomes (SAGs)	2
taxa lacking cultured representatives	2
Candidatus names	2
axenic cultures	2
legitimate names	2
nomenclature types	2
uncultured Bacteria and Archaea	2
native rhizobia	2
known lineages	2
phylogenetic clusters	2
P. vulgaris-nodulating rhizobia	2
Kenyan soils	2
effective native rhizobial strains	2
Rhizobium tropici CIAT 899, a commercial inoculant strain	2
ten isolates	2
nitrogen (N2)	2
nodC gene alleles	2
Rhizobium leucaenae, Rhizobium sophoriradicis and Rhizobium aegyptiacum	2
Rhizobium paranaense	2
Infrequently, isolates	2
possibly novel Rhizobium species	2
Rhizobium phaseoli	2
Rhizobium genospecies	2
P. vulgaris in Kenya	2
PCR-RFLP and 16S rRNA, atpD, recA and nodC gene sequences	2
genomic DNA fingerprints	2
root nodules of P. vulgaris	2
178 isolates	2
rhizobia	2
Phaseolus vulgaris (common bean)	2
reservoir of novel groundnut-nodulating Bradyrhizobium and Rhizobium	2
groundnut Rhizobium and Bradyrhizobium in South African soils	2
legume	2
phylogenetically diverse	2
native groundnut-nodulating rhizobia	2
representative isolates of each RFLP-cluster	2
rDNA, atpD, gyrB, gltA, glnII and symbiotic nifH and nodC genes	2
16S rDNA, IGS of 16S	2
five main clusters	2
IGS types	2
intergenic spacer (IGS) region of 16S-23S	2
groundnut-nodulating native rhizobia in South African soils	2
economically important N​2-fixing legume	2
Mpumlanga Province	2
Groups II and III	2
Limpopo Province	2
Group I isolates	2
grouping of isolates	2
novel soybean-nodulating bradyrhizobia	2
important reservoir	2
soybean Bradyrhizobium in South African soils	2
glnII gene phylogeny	2
16S rDNA	2
isolates with type strains of Bradyrhizobium	2
Bradyrhizobium diazoefficiens and Bradyrhizobium japonicum in Mpumalanga, Limpopo and Gauteng Provinces	2
symbiotic gene	2
single and concatenated housekeeping genes (atpD, glnII and gyrB)	2
six major clusters	2
eight reference type strains	2
different agro-climatic regions	2
slow- and fast-growing soybean root nodule bacterial isolates	2
sophisticated bioreactor	2
transitional mucus	2
abundant bacterial clades	2
fermentative area	2
digestive leftovers	2
patchy fermentative area	2
10–30μm broad unstirred transitional layer	2
separate mucus layer	2
colonic biomass	2
group A_Sb	2
stool cylinders analyzed	2
S. boulardii prophylaxis	2
A_Sb group	2
A/Sb group	2
combined antibiotic regimen	2
three groups of women	2
bacterial groups	2
Sections of fecal cylinders	2
viral coat protein	2
concatenated epitopes	2
F and HN epitopes of NDV	2
tobacco plant	2
plant-based systems	2
plant genome	2
tobacco (Nicotiana tabacum) plant	2
CaMV35S promoter and NOS terminator	2
genes encoding Hemagglutinin–Neuraminidase (HN) and Fusion (F) epitopes of Newcastle Disease Virus (NDV)	2
plant expression binary vector pBI121	2
poultry vaccines	2
cost-effective system	2
Transgenic plants	2
biotechnological application	2
glycine oxidase	2
substrate and the isoalloxazine ring of FAD	2
conserved GHYRNG loop	2
ConclusionAsn336 site	2
random coil between β-18 and α-10	2
residue Asn336	2
N336A and N336G	2
N336H, N336K and N336R	2
substrate docking	2
structure modeling	2
kinetic assay	2
residue N336 in glycine oxidase	2
homogeneous enzymes	2
residue N336	2
random mutant library	2
tested substrate	2
variant of N336K	2
Bacillus cereus HYC-7	2
new glycine oxidase (BceGO)	2
several fields	2
type of d-amino acid oxidase	2
BackgroundGlycine oxidase (GO)	2
species-specific markers	2
5s rDNA	2
18s regarding	2
18S and 5S rDNAs in A. tequilana genome	2
absolute quantitative qPCR assay	2
A. tequilana genome	2
18S and 5S rDNAs	2
rDNAs in the genome	2
alcoholic beverages and bioenergy	2
producing strains	2
precipitated preparation of polymers	2
resulting EPS	2
Candida strains	2
C. famata in medium containing EPS	2
EPS yield	2
C. guilliermondii and C. famata	2
C. guilliermondii	2
maltose, lactose, glycerol, sorbitol)	2
EPS by Candida famata and Candida guilliermondii strains	2
selected carbon sources	2
cosmetic and pharmaceutical industries	2
exopolysaccharides (EPS)	2
cultured L. japonica	2
algin	2
Bacillus amyloliquefaciens WB1	2
microbe	2
large amount of algin	2
A. japonicas	2
feedstuff in Apostichopus japonicas farming	2
food and aquatic animal feedstuff	2
economically important brown seaweed	2
alga Laminaria japonica	2
stably express GDNF	2
GDNF expression	2
lane of infected cells	2
specific PCR amplified product band	2
touchdown PCR	2
transduction and control groups	2
EGFP positive cell	2
infected HEK293T cells	2
rAAV-2/EGFP-GDNF and rAAV-2/SVAV2 virus	2
Rep genes and SV40 promoters (pSVAV2)	2
glial cell line-derived neurotrophic factor (GDNF).ResultsRecombinant vector with enhanced green fluorescent protein (EGFP) and GDNF (pTR-P5-EGFP-IRES-GDNF)	2
recombinant adeno-associated virus 2 (rAAV-2)	2
B. tequilensis	2
thermo-alkali stable cellulase-free xylanase	2
cellulase-free xylanase	2
crude xylanase	2
presence of the basal medium containing birchwood xylan (1.5% w/v) and yeast extract (1% w/v)	2
xylanase and biomass yield	2
cell biomass of Bacillus tequilensis strain ARMATI	2
cellulase-free xylanase production	2
simple monomer units	2
complex biomolecules	2
xylanolytic enzyme	2
AACM.3 and AACM.3.4	2
VR 4	2
insoluble form	2
AAC variants	2
AAC and AACM.4	2
favorable strain	2
(DE3)-RIL	2
RIPP peptide (AACM.3.4).ResultsE. coli	2
fourth VR	2
four VY peptides	2
four VY peptides (AACM.3)	2
unmodified amarantin acidic subunit (AAC)	2
recombinantly expressed other derivatives of the amarantin protein	2
modified protein (AACM.4)	2
VY antihypertensive peptides	2
C-terminal in the fourth VR of AAC	2
antihypertensive peptides	2
third variable region (VR)	2
acidic subunit of amarantin (AAC)—the predominant amaranth seed storage protein	2
thermotolerant yeast	2
thermotolerant yeasts	2
Thermotolerant yeast strains	2
separate hydrolysis and fermentation (SHF) process	2
cost-intensive inputs	2
lignocellulosic (LC) biomass	2
second-generation biofuel feedstock	2
abundant renewable source of energy	2
Lignocellulosic biomass	2
Chrysanthemum leaves	2
early- and late-flowering cultivars	2
mature Chrysanthemum leaves	2
inhibitor phenolic compounds of cornelian cherry juice	2
samples containing L. casei TD4	2
sample containing L. casei T4	2
probiotic	2
‘Natural juice’	2
tolerant Iranian strain	2
industrial types	2
Iranian native probiotic strain (L. casei T4)	2
cornelian cherry juice	2
nondairy probiotic products	2
dairy products	2
aggregate forms	2
Cry9Aa655 C14 and C16C	2
Cry9Aa655 polypeptides	2
oligomers of Cry9Aa	2
Cry9Aa655 protein	2
C14A–C16A mutant	2
Plutella xylostella	2
oligomers in solution	2
double C14A–C16A mutant	2
single C14A and C16A mutants	2
cysteine residues, C14 and C16	2
Cry1A.ResultsCry9Aa655 protein	2
different Lepidoptera	2
Cry9A proteins	2
Cry oligomers	2
high molecular weight oligomers or aggregates in solution	2
different Cry toxins	2
different insect midgut proteins	2
thuringiensis Cry toxins	2
Malawi farmers	2
five varieties	2
markers – CCB1, CCB7, Ccac035, CCttc003, Ccac026 and CCttc019	2
five most popular cultivated varieties	2
cultivated land races	2
released varieties	2
commonly cultivated varieties	2
4 clusters	2
popular varieties	2
pigeonpea varieties	2
polymorphic SSR markers	2
natural outcrossing	2
intercropping systems	2
source of food and income	2
semi-arid tropics of Asia and Oceania, Africa and America	2
genus Cajanus	2
cultivated species	2
tolerant legume of the Fabaceae family	2
BackgroundPigeonpea (Cajanus cajan (L.) Millsp.)	2
new bacteriophages of the serovar Choleraesuis	2
different strains of Escherichia coli and other serovars of Salmonella	2
restriction endonucleases HaeIII and HindIII	2
distinct recognition sites	2
bacteriophage P22	2
double-stranded DNA genomes	2
FC, FP, and FQ	2
order Caudoviridae	2
Salmonella enterica serovar Choleraesuis	2
three bacteriophages (FC, FP, and FQ)	2
different sites in the V Region	2
bacteriophage lysates	2
original host	2
alternative nonpathogenic bacterium	2
bacteriophages of pathogenic bacterial hosts	2
reduced-representation libraries	2
appropriate enzymes	2
module	2
easy-to-use Perl module	2
different genome regions	2
digested fragments	2
restriction sites	2
sequences of the fragments	2
Perl module	2
simulation tool	2
R package	2
computer programs	2
restriction enzyme(s)	2
reduced-representation sequencing libraries	2
BackgroundReduced-representation sequencing technology	2
sponges, corals, ascidians, seaweeds and seagrasses	2
larger amount of organisms	2
field assays	2
sponges and corals	2
natural product based antifoulants	2
toxic chemicals	2
natural product antifouling compounds	2
marine sectors	2
marine macroorganisms	2
marine macroorganims	2
hard surfaces	2
crops in marginal lands	2
shoot and root biomass and chlorophyll (a and b) contents	2
Bacillus subtilis LK14	2
isolated strains	2
indole-3-acetic acid (IAA)	2
endophytic bacteria	2
ACC deaminase	2
strain of Bacillus subtilis LK14	2
Methylobacterium genus	2
Sphingomonas sp.	2
5 endophytic bacteria	2
bacterial endophytes	2
medicinal plant	2
Moringa peregrina	2
hTopoI in P. pastoris	2
Mut+ strain; X33 (0.75ng/mL	2
hTopoI heterologous protein	2
MutS strain (KM71H)	2
transfected KM71H culture supernatant	2
transfected P. pastoris strain	2
transfected P. pastoris	2
shake flask system	2
transfected KM71H and X33 P. pastoris strains	2
hTopoI recombinant vector	2
hTopoI in KM71H (MutS) and X33 (Mut+) strains of Pichia pastoris	2
cost-effective and target specific hTopoI inhibitors	2
in-house enzyme	2
essential cellular enzyme	2
LIBGSS_039019)	2
Sequence Read Archive	2
Genomic sequences	2
tested cultivars	2
palm characterization tools	2
developed microsatellite markers	2
within cultivars	2
overall cultivars	2
Twenty-two primers	2
penta nucleotide motives	2
genomic SSRs	2
date palm	2
-three novel simple sequence repeat markers	2
32 date palm (Phoenix dactylifera L.) representing common cultivars	2
1,074-bp ORF	2
Eighteen members	2
Shimai 15	2
1BL/1RS translocation line cv	2
conserved and non-conservative sequences	2
Class-1 spacers	2
N-terminal of the ω-secalin gene	2
two pseudogenes	2
1074-bp open reading frame (ORF)	2
18 ω-secalin genes	2
clone BAC125	2
head-to-tail	2
six other ω-secalin genes	2
contig	2
BAC contig	2
1BL/1RS translocation wheat cultivar	2
three bacterial artificial chromosome (BAC) clones	2
physical map	2
short arm of rye chromosome 1R (1RS)	2
ω-secalins	2
1BL/1RS translocation lines	2
DALI, FatCat and PhyreStorm	2
structural alignment servers	2
CE, DALI and PhyreStorm	2
reference	2
CATH	2
servers	2
web-based servers	2
six most popular and publically available servers	2
protein structure alignment tool	2
large number of protein structure alignment methods	2
known group of proteins	2
whole-cell biosynthesis	2
3.0% (W/V) alginate, 1.5% (W/V) diatomite, 0.05% (W/V) CaCl2	2
modified Luria-Bertani (LB)	2
whole-cell immobilization	2
optimal medium	2
d-hydroxyphenylglycine (d-HPG)	2
d-carbamoyl-p-hydroxyphenylglycine (d-CpHPG)	2
certain adjuncts	2
calcium alginate	2
d-hydantoinase	2
d-hydantoinase and d-carbamoylase	2
pesticides, and β-lactam antibiotics	2
important chiral molecular building-block of antibiotic reagents	2
-Hydroxyphenylglycine	2
lignocellulosic raw materials	2
ground substrate	2
pine raw materials ground	2
di- and trisaccharides	2
lignocellulosic substrates	2
stages II–III	2
Wnt4b	2
gills, brain, and spleen	2
gonads, gills, spleen, brain, and fin	2
17α-methyltestosterone (MT)	2
two Wnt4 genes	2
teleost fish	2
purified fibrinolytic enzyme degraded fibrin clot	2
effective substrate	2
ConclusionsWheat bran	2
fibrin net of blood clot	2
wheat bran medium	2
optimum medium	2
two-level full factorial design	2
Bacillus halodurans IND18	2
BackgroundAgro-wastes	2
degenerate primers	2
quantitative reverse transcription (qRT)-PCR)	2
genogroups 1	2
Chilean IPNV varieties	2
primer-binding sites	2
primer-binding regions	2
resulting sequences	2
segments A and B.	2
several infectious pancreatic necrosis viruses (IPNVs)	2
DHA yield	2
shake-flasks culture	2
ResultsDHA production	2
docosahexaenoic acid (DHA) synthesis	2
citrate/malate and transhydrogenase cycles	2
suitable kinetic model	2
shake flasks culture	2
key variables	2
Luedeking–Piret kinetic model	2
mixed growth and non-growth associated components	2
Mcl-PHA	2
fatty acids consumption and mcl-PHA production	2
kinetic modeling	2
bacterial culture in the shaken flask system	2
mcl-PHA	2
mixed free fatty acids consumption	2
Pseudomonas putida BET001	2
medium-chain-length poly-3-hydroxyalkanoates (mcl-PHA)	2
low cost renewable substrate	2
palm kernel oil (PKO)	2
corn steep dry	2
yeast extract 10g/L	2
optimal media	2
nitrogen sources	2
carbon sources	2
main medium components	2
acetoin in B. subtilis SF4-3	2
Japanese traditional fermented food natto	2
acetoin-producing strain, Bacillus subtilis SF4-3	2
research hotspot	2
pSUZM1a-GA.ConclusionsThese	2
pSUZM2a-GA and pSUZM3a-GA	2
glucoamylase activity	2
plasmids pSUZM1a-GA, pSUZM2a-GA and pSUZM3a-GA	2
pSUZM1(2, 3)a	2
alkaline phosphatase gene of Z. mobilis	2
signal peptide sequence	2
Aspergillus awamori	2
codon-optimized glucoamylase gene	2
expression vectors pSUZM1(2	2
shuttle vectors	2
pyruvate decarboxylase gene	2
promoter Ppdc (a)	2
three shuttle vectors	2
two native plasmids (pZZM401 and pZZM402) of Z. mobilis ZM4	2
shuttle vectors (pSUZM1, pSUZM2 and pSUZM3)	2
foreign genes	2
novel platform	2
FTIR and TG-DSC results	2
TG-DSC results	2
functional groups of the precipitates	2
FTIR	2
precipitations	2
Paenibacillus mucilaginosus	2
carbonate ions	2
Zn2+ pollution	2
bacterial strain	2
MSL2 strain	2
pH4.0.	2
cellulase	2
IL, 1-ethyl-3-methylimidazolium acetate ([C2mim][OAc]) concentration	2
purified cellulose	2
cellulase assay	2
rice paddy field soil	2
, MSL2 strain	2
ResultOne Bacillus sp.	2
potential IL-tolerant cellulase producing bacterium	2
remaining IL in the hydrolysis buffer	2
efficient pretreatment and hydrolysis enzymes	2
biofuel and valuable chemicals	2
inexpensive resource	2
CYP78A98 in transgenic tobacco seeds	2
INNER NO OUTER promoter (pINO)	2
hydrophobic domain	2
CYP78A98 protein	2
leaf and developing seed	2
stem apex	2
female flower	2
male flower	2
homologue of CYP78A5	2
CYP78A98 gene	2
shrub	2
undomesticated plant	2
rapidly emerging biofuel crop	2
Jatropha)	2
curcas L.	2
split-GFP	2
visualization system	2
embryonated eggs	2
inserted sequence encoding GFP11	2
recombinant AIV in embryonated eggs	2
GFP1-10 expression vector	2
recombinant AIV in cultured chicken cells	2
modified NP segment	2
recombinant AIV	2
co-express GFP11 of self-assembling split-GFP	2
viral nucleoprotein (NP) segment of AIV	2
influenza virus-infected cells	2
self-assembling split-green fluorescent protein (split-GFP) system	2
highly pathogenic avian influenza viruses (HPAIVs)	2
domestic and wild birds	2
BackgroundAvian influenza viruses (AIVs)	2
Penicillin-resistant S. pneumoniae	2
monoglucoside, curcumin diglucoside	2
docked ligand–protein complexes	2
active site of the enzyme	2
Penicillin Binding Protein of S. pneumoniae	2
Penicillin-resistant strains	2
curcumin diglucoside	2
curcumin monoglucoside	2
three different strains of Streptococcus pneumoniae (Penicillin-susceptible, Penicillin-intermediate and Penicillin-resistant)	2
curcumin and its derivatives	2
free κ-carrageenase	2
κ-carrageenase-CMNPs	2
326.0U·g-1·κ-carrageenase-CMNPs	2
free and immobilized κ-carrageenase	2
20mg of magnetic nanoparticles	2
13.9U κ-carrageenase	2
bonding	2
magnetic iron oxide nanoparticles	2
κ-carrageenase from Pseudoalteromonas sp	2
potassium permanganate	2
BackgroundCarboxyl-functionalized magnetic nanoparticles	2
Doudoroff Pathway	2
Entner–	2
major anaplerotic pathway	2
glyoxylate shunt	2
two major phenotypes	2
phosphoenolpyruvate carboxylase, pyruvate carboxylase or glyoxylate shunt	2
selected anaplerotic paths	2
biomass and osmolyte synthesis	2
AAD12 cells	2
Halomonas sp.	2
oxygen radicals and radiation	2
effective methanogenic bacteria inhibitor	2
acetic, propionic and butyric acid	2
first, second and third feedings	2
chlortetracycline hydrochloride (CLOR)	2
inhibitory compounds	2
(Km=2.2mM).ConclusionA. carbonarius tannase	2
tannic acid	2
methyl gallate (Km=1.42mM)	2
Tannase II	2
solvents and detergents	2
heterodimeric glycoprotein	2
tannase from peak II (tannase II)	2
Sepharose CL-6B chromatographic column	2
second peak (peak II)	2
DEAE-Cellulose	2
tannase activity peaks	2
moisture agent	2
substrate/carbon source	2
green tea leaves	2
filamentous fungus A. carbonarius	2
Aspergillus carbonarius	2
multi-tolerant tannase	2
potent molecular tool	2
samples of P. pachyrhizi	2
simple collection of urediniospore	2
country sampled	2
samples group	2
production fields	2
naturally SBR-infected plants	2
P. pachyrhizi DNA	2
P. pachyrhizi	2
one of the most economically important fungal pathogens	2
Phakopsora pachyrhizi Syd. & Syd.	2
soybean rust (SBR)	2
commercial planting	2
clone Iran 100	2
(−)-epigallocatechin-gallate, (−)-epicatechingallate and caffeine	2
clone Iran	2
lowest	2
leaf extract of the clone Iran 100	2
1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging assay	2
-catechin, (−)-epicatechin, (−)-epigallocatechin, (−)-epigallocatechin-gallate, (−)-epicatechingallate, gallic acid and caffeine	2
phenolics and flavonoids	2
high yielding tea clones	2
well-known beverage	2
BackgroundTea (Camellia sinensis)	2
V. parahaemolyticus infections	2
V. alginolyticus and other related strains	2
V. parahaemolyticus specific marker	2
Vibrio alginolyticus and other related strains	2
slightly smaller tlh gene	2
V. parahaemolyticus specific tlh	2
thermolabile hemolysin (tlh) PCR product	2
diarrhea cases	2
pathogenic strains	2
specie-specific virulence factors	2
three different hemolysin genes	2
Vibrio parahaemolyticus in the Chilean coast	2
yeast strain	2
chemical oxygen demand (COD)	2
5% glycerol	2
yeast in a medium	2
investigated strain	2
source of carbon and nitrogen	2
glycerol and potato wastewater	2
deproteinized potato wastewater	2
glycerol and nitrogen compounds	2
Rhodotorula glutinis	2
two by-products	2
environmental and industrial areas	2
native isolates	2
caatinga soil	2
Aspergillus niger	2
catalase, glutathione-S transferase, glutathione peroxidase, peroxidase, polyphosphate, acid and alkaline phosphatases	2
soil systems	2
efficient enhancers	2
sugar cane molasses	2
Bacillus sp	2
packed columns	2
crude and the isolated biosurfactant	2
biosurfactants and synthetic surfactants	2
oil	2
contaminated sand	2
Triton X-100.ResultsBoth crude and isolated biosurfactants	2
Tween 80	2
low-cost substrates	2
bacterium Bacillus sp.	2
yeast Candida sphaerica	2
laccases in brown rot fungi	2
first identified thermo activated and thermostable laccase	2
/mg	2
(ABTS) and 2,6-dimethoxyphenol (DMP)	2
2,2′-azino-di-(3-ethylbenzothialozin-6-Sulfonic acid)	2
Pichia pastoris GS115	2
brown rot fungus Postia placenta MAD-698-R	2
laccase isoform Pplcc2	2
white rot fungi	2
lignocellulose by wood rot fungi	2
diversity in plants	2
mitochondrial genomes	2
amplified products	2
blast	2
rep-PCR gels	2
random sequences	2
Jatropha curcas	2
Jatropha gossypifolia	2
natural hybrid	2
Jatropha tanjorensis	2
subgenus peltatae	2
REP marker	2
BOX and REP	2
Euphorbiaceae family using REP and BOX primers	2
17 species	2
inter-specific diversity	2
diversity in germplasm collections	2
uncoated fruits	2
/SO and Q/CH edible films	2
CH, Q/CH	2
strawberries coated	2
coating application	2
different coating groups and the uncoated group	2
Q/CH	2
Coated strawberries	2
mold and yeast growth	2
film-forming CH, Q/CH and Q/CH/SO solutions	2
fungal decay	2
fresh strawberries	2
Q/CH and Q/CH/SO	2
chitosan (CH), quinoa protein-chitosan (Q/CH) and quinoa protein-chitosan-sunflower oil (Q/CH/SO)	2
edible coatings	2
BackgroundStrawberries are non-climacteric fruits	2
S1 and S3	2
endophytic fungus L10Q37	2
4 compounds	2
anti-acetylcholinesterase activity	2
H. serrata	2
endophytic fungal strains	2
endophytic fungi of H. serrata	2
Two compounds	2
Active components	2
endophytic fungi of Huperzia serrata	2
two strains, L10Q37 and LQ2F02	2
numerous endophytic fungi	2
endophytic fungal products	2
similar biologically active substances	2
healthy plant	2
endophytic fungus	2
Non Pareil and Carmel almonds	2
tested PBRs	2
Carmel	2
longest pollen tube growth	2
2014 growing season	2
pollen germination	2
fruit set in almond cultivars Non Pareil and Carmel	2
plant bioregulators (PBRs): brassinolide (BL), gibberellic acid (GA3) and kinetin (KN)	2
plant bioregulators (PBRs)	2
almond trees	2
Webb] orchards	2
commercial almond [Prunus dulcis (Mill.)	2
sub-genomes	2
polyploid species	2
multiple copies of the gene	2
CqAHAS1 and CqAHAS2	2
similar fragments	2
third copy, CqAHAS3,	2
NR Database	2
AHAS mRNA sequences	2
CqHAS1 and CqAHAS2 variants	2
several other species	2
gene copies	2
Chenopodium quinoa Regalona-Baer cultivar	2
branched-chain of the essential amino acids valine, leucine, and isoleucine	2
first enzyme	2
enzyme acetohydroxy acid synthase (AHAS, EC 2.2.1.6)	2
technology called Clearfield®	2
novel heme-thiolate enzyme	2
multi-clonal antibody preparation	2
activity assay	2
solid foundation	2
full length coding sequence of CcCAS-1	2
leaves and the petioles	2
rhizome	2
leaves and the petiole tissues	2
leaves of C. chinensis	2
leaf, petiole and rhizome tissues	2
polypeptide of 491 amino acids	2
complete open reading frame (ORF)	2
novel (S)-canadine synthase gene (designated as CAS-1)	2
functional genes	2
Coptis chinensis	2
important active ingredient	2
PRLR	2
PRL	2
preovulatory follicles	2
examined samples	2
F4 and small yellow follicles (SYFs)	2
small white follicles (SWFs)	2
examined follicles	2
F1 follicles	2
postovulatory follicles (POFs)	2
hierarchical follicles (HFs)	2
ovarian follicles	2
ovary and follicles of the Sichuan white goose	2
goose ovary	2
(PRL)	2
stress-tolerant crops	2
N. benthamiana	2
JcCPI in E. coli	2
transgenic plants expressing JcCPI	2
tobacco plants	2
transgenic E. coli	2
petiole	2
plant cystatins	2
conserved domains	2
CPI gene	2
Escherichia coli and Nicotiana benthamiana	2
Jatropha curcas CPI (JcCPI) gene	2
BackgroundCysteine proteinase inhibitor (cystatin, CPI)	2
Zebu breeds	2
assessed loci	2
favorable alleles	2
CAPN4751 and CAST loci	2
favorable C allele of CAPN316	2
five Zebu breeds	2
registered cattle	2
Calpain and Calpastatin polymorphisms	2
Validated genetic markers	2
diverse group of breeds	2
Zebu cattle	2
MYB transcription factor	2
leaves and floral tissue of any of the transgenic lines	2
RsMYB1 in chrysanthemum	2
key biosynthetic genes	2
non-transgenic line	2
transgenic chrysanthemum	2
three key biosynthetic genes (CmF3H, CmDFR, and CmANS)	2
Shinma’.ResultsThe RT-PCR	2
RsMYB1 isolated from radish (Raphanus sativa) on chrysanthemum cv.	2
several plant species	2
R2R3 MYB transcription factors	2
BackgroundSeveral MYB genes	2
ethanol, DNase I, and RNase A	2
DNase I and RNase A	2
DNA and RNA contamination	2
storage buffer	2
precipitate	2
enzyme in Escherichia coli	2
small amount of DNA.ResultsWe	2
Taq Pol	2
Thermus aquaticus	2
DNA polymerase (Taq Pol Ι)	2
model microorganism	2
plant pathogen	2
certain sequence markers	2
validations	2
polymorphic bands	2
gastric probiotic	2
strain L. salivarius UCO_979C-1	2
acclimated variant	2
acclimated variant strain	2
pH2.6)	2
human gastric derived probiotic strain Lactobacillus salivarius UCO_979C-1 (wild type) and L. salivarius UCO_979C-2	2
recombinant AnFaeA	2
two-copy strain	2
4-nitrophenyl ferulate	2
+,	2
Ca2+, Mg2+, Cu2	2
expressed protein (recombinant AnFaeA)	2
antibiotic Zeocin	2
YPDS plates	2
pPICZαA-AnFaeA plasmid	2
shaker flask	2
two-copy engineered yeast	2
gene AnFaeA	2
feruloyl esterases	2
soybean seed germination	2
total and HCl-extractable Ca, Cu and HCl-extractable Mn	2
HCl-extractable Fe	2
total and HCl-extractable Zn	2
ACS expression	2
Ca, Zn, Mn, Cu and Fe content	2
ACC synthase (ACS) expression	2
(ddH20)	2
ethylene synthesis inhibitor aminoethoxyvinylglycine (AVG) and ethylene precursor 1-aminocyclopropane-1-carboxylic acid (ACC), and double distilled H2O	2
Fe, Cu, Mn, and Zn in mature seeds	2
laccase in P. sanguineus	2
simple nitrogen sources (urea)	2
surface response model	2
yeast extract (2g/L) and ethanol (3g/L)	2
P. sanguineus	2
, or without ethanol	2
submerged cultures of P. sanguineus	2
Pycnoporus sanguineus	2
ethanol laccase	2
laccase inducer	2
A. alternata	2
synthetic chemical products	2
phenylpropanoid and several types of N-glycan	2
oxidoreductases, transferases, hydrolases, lyases, and ligases	2
CAP3 software	2
sequence assembly	2
expressed sequence tags (ESTs)	2
clones of an Alternaria alternata strain resistant to 2-propenyl ITC (2-pITC)	2
subtractive library	2
ITC-resistant strains	2
synthetic fungicides	2
phytopathogenic fungi	2
plants of the Brassicas family	2
BackgroundIsothiocyanates (ITCs)	2
carboxymethylcellulase (CMCase), xylanase, and β-xylosidase activities	2
enzymatic extract	2
initial substrate moisture	2
fungus on wheat bran	2
various agroindustrial residues	2
Lichtheimia ramosa by solid-state fermentation (SSF)	2
food, pharmaceutical, and biofuel industries	2
cellobiose and cellodextrins	2
-Glucosidases	2
animal feed, or juice and wine industries	2
xylobiose, xylotriose, xylotetrose and larger xylooligosaccharides	2
oat spelts and birchwood xylan	2
protein-1 (Xyl II)	2
protein-1 (Xyl I)	2
detergent SDS	2
ion Hg2+	2
crude extracellular extract of a Trichoderma inhamatum strain	2
xylanases, Xyl I and Xyl II	2
soluble expression and bioactive functions of ScFv in Escherichia coli	2
bacterial culture	2
recombinant ScFv	2
Sumo protease	2
supernatant liquid of Sumo-ScFv	2
0.5mM Isopropyl-β-d-thiogalactopyranoside (IPTG)	2
recombinant bacteria	2
Sumo (Small ubiquitin-related modifier)	2
novel single-chain Fv (ScFv) against FGFR3	2
Fibroblast growth factor receptor 3 (FGFR3)	2
vitro and in vivo regenerated plants	2
flavonols, hydroxybenzoic and hydroxycinnamic acid derivatives	2
growth regulators (PGRs) and PAs	2
individual polyphenolic compounds	2
Rooted plants	2
50μM putrescine	2
root induction medium	2
well-developed shoots	2
50μM spermine	2
1.5μM GA3	2
shoot elongation medium	2
Regenerated shoots	2
shoots per explant)	2
maximum number of shoots	2
75μM spermidine	2
combination of 3.0μM TDZ	2
Skoog (MS) medium	2
vitro regenerated and in vivo plants	2
leaf explants of gherkin (Cucumis anguria L.)	2
cytokinins (TDZ and BAP) and auxin (IBA)	2
polyamines (PAs)	2
polycosanols	2
oncogenic cell lines	2
CHO-K1 cells	2
human melanoma cells	2
CHO-K1 and human melanoma cells	2
CHO-K1 and CRL-1974 human melanoma cell lines	2
cellulose (specifically from Pinus radiata, Pinus taede, and Eucalyptus globulus)	2
black liquor soaps	2
tall-oil pitch	2
hyperproliferative cell lines	2
herpes simplex virus)	2
various viruses	2
antiproliferative agents	2
butyric acid>isobutyric acid	2
isovaleric acid	2
electronic nose	2
Ascorbic acid	2
substrate and glucose as a carbon source	2
l-phenylalanine	2
butanol, isobutyric acid, butyric acid, and isovaleric acid	2
main by-products	2
natural 2-PE	2
aroma of roses	2
important flavoring	2
2-phenylethanol (2-PE)	2
wet cell	2
10L fermenter	2
50mL/250mL shake flask	2
L IPTG	2
3% yeast extract powder added)	2
M9 medium	2
rMBP-NAP in shake flask	2
varying medium	2
Escherichia coli TB1	2
recombinant maltose-binding protein fused to neutrophil-activating protein (rMBP-NAP) of Helicobacter pylori	2
GRNN and SVM	2
iturin A	2
fed-batch fermentation conditions	2
suitable ANN model	2
GRNN	2
MLFNs	2
SVM.ResultsThe GRNN	2
different ANNs	2
General regression neural network (GRNN), multilayer feed-forward neural networks (MLFNs)	2
iturin	2
asparagine (Asn), glutamic acid (Glu) and proline (Pro) (mg/L)	2
iturin A.	2
subsequent seedlings	2
radicle and cotyledon	2
normal roots	2
lot	2
six varieties	2
round fruits	2
indeterminate plants	2
lots of hybrid tomato seeds	2
corresponding seedlings	2
osmoprotectant genes	2
many single genes	2
improved varieties of crop plants	2
food, feed, and fiber	2
growing and expanding populations	2
Global agriculture	2
PBD, SAM and BBD (RSM)	2
DMP-degrading strain Bacillus sp.	2
shake-flask cultivation	2
DMP-degrading bacteria	2
response surface contour plots	2
shake-flask cultures	2
dimethyl phthalate (DMP)-degrading strain Bacillus sp.	2
laundry industry	2
extracellular alkaline protease	2
enzyme yield	2
soda lakes	2
new halotolerant alkaliphilic alkaline protease producing Bacillus sp.	2
Organic nitrogen	2
new potent alkaline protease producing halotolerant alkaliphilic isolate NPST-AK15	2
new alkaline producing alkaliphilic bacteria	2
alkaline proteases	2
important classes of industrial hydrolytic enzymes	2
hospital laboratories	2
PCR-RFLP	2
etiological agents: C. neoformans (n=3) and C. gattii (n=1) in CSF samples, H. capsulatum (n=1) in bone marrow and C. albicans (n=2) in blood cultures	2
PCR	2
PCR-RFLP with biological samples	2
90 cultures of agents of invasive mycoses	2
chosen reference strains	2
reference strains (Candida albicans, Candida parapsilosis, Candida tropicalis, Candida krusei, Candida guilliermondii, Cryptococcus neoformans, Cryptococcus gattii and Histoplasma capsulatum)	2
culture, microscopy, and biochemical testing).ResultsThe assays	2
PCR-RFLP results	2
120 biological samples (blood, cerebrospinal fluid and bone marrow)	2
fungal agents	2
cultures of agents of invasive mycoses	2
types of organic acids	2
-PS1	2
malic acid	2
best nitrogen source	2
Na-glutamate	2
favored carbon source	2
Malic acid	2
methane fermentation broth of an UASB reactor	2
No. KC478552)	2
KKU-PS1 (GenBank Accession	2
ResultsRhodobacter sp	2
five different environmental sources	2
potential photosynthetic bacteria	2
nifH and nifD	2
intramuscular fat	2
two breeds	2
tail adipose, subcutaneous adipose and longissimus dorsi muscle of Tan sheep and Shaanbei fine-wool sheep	2
tail adipose, subcutaneous adipose, and longissimus dorsi muscle	2
Shaanbei fine-wool sheep	2
different tail-type sheep	2
PPARγ, FAS and HSL in different parts of the carcass	2
key messenger	2
PPAR-α	2
goat diet	2
fatty acid (FA) conversion (SCD and PPAR)	2
high α-linolenic acid diet	2
liver of goats	2
SCD gene	2
PPAR-α gene expression	2
liver of FSO-treated goats	2
C18:3n-3 and C20:5n-3, C22:5n-3, C22:6n-3	2
peroxisome proliferator-activated receptors (PPAR-α) and stearoyl-CoA-desaturase (SCD)	2
control diet without added flaxseed oil (CON)	2
high α-linolenic acid	2
flaxseed oil (FSO) supplemented diet	2
fourteen goats (Capra aegagrus hircus)	2
diets containing high α-linolenic acid (C18:3n-3)	2
mitochondrial membrane	2
random amplified polymorphic DNA (RAPD)	2
acetic acid	2
lignocellulosic hydrolysate	2
recycle beneficial	2
repeated batch of Z. mobilis ZM4	2
batch culture	2
ZM4 biofilm	2
TISTR 551 biofilm	2
two biofilms	2
rice bran hydrolysate containing toxic inhibitors	2
heterogeneous biofilm	2
Z. mobilis TISTR 551	2
DEAE fiber	2
homogeneous biofilm	2
mobilis ZM4	2
morphologies	2
DEAE cellulose	2
mobilis ZM4 and TISTR 551	2
toxic inhibitors	2
Zymomonas mobilis biofilm	2
medicinal Ganoderma variety of G. lucidum production	2
G. neojaponicum	2
immunomodulating agents	2
IPSs and EPSs of G. neojaponicum	2
dried G. neojaponicum mycelium	2
oral toxicity test	2
macrophage (RAW264.7) cell lines	2
EPSs and IPSs	2
total carbohydrate, β-glucan and α-glucan content	2
2L STR reactor	2
STR reactor	2
intracellular polysaccharides (IPSs) and extracellular polysaccharides (EPSs) of G. neojaponicum	2
immunomodulatory agents	2
Ganoderma neojaponicum (Imazeki)	2
Ganoderma lucidum	2
Ganoderma species of fungi	2
genetic base of popcorn accessions	2
analyzed microsatellite loci	2
heterozygous accessions	2
popcorn accessions	2
ARZM 05 083	2
accessions TATU 2	2
dendrogram	2
genetically differentiated clusters	2
31 accessions	2
accession BOZM 260 (Ho=0.30)	2
heterozygous plants	2
30 evaluated loci	2
microsatellite primers	2
popcorn accessions of the germplasm bank	2
dental infections	2
various antibiotics	2
tested E. faecalis strains	2
Saudi patients	2
tested dental root canal specimens	2
intermediate resistant/resistant strains	2
one isolate (E-16)	2
one strain (E-12)	2
tested strains	2
Streptococcus viridians, Leuconostoc mesenteroides, Staphylococcus aureus, Streptococcus mitis, and Pediococcus pentosaceus	2
dental root canal specimens	2
E. faecalis in dental root canals	2
endodontic infections	2
one of most prevalent species	2
antibiotic substance	2
antibacterial agent	2
structure of hepcidins and antibacterial activity	2
Gram positive bacterium Staphylococcus aureus and Gram negative bacteria Escherichia coli and Aeromonas hydrophila	2
Synthetic peptide	2
zebrafish hepcidin	2
human hepcidin	2
prodomain	2
signal peptide	2
predicted prepropeptide	2
prepropeptide	2
ORF of 273bp	2
liver of Chinese rare minnow	2
hepcidin gene	2
hepcidin	2
model animal	2
endemic cyprinid fish	2
rare minnow (Gobiocypris rarus)	2
several fish species	2
kind of cysteine-rich antimicrobial peptides	2
manganese peroxidase	2
~470g of biomass	2
whole plant	2
chloroplast genome of tobacco plants	2
hydrolytic genes PelA	2
Neither transplastomic plant	2
pectin lyase	2
transplastomic events	2
wild type plants	2
young transplastomic plants	2
mature plants	2
rrn16S and 3′rps′12	2
inverted repeats of the intergenic region	2
3′UTR from rbcL gene	2
synthetic rrn16S promoter	2
PelA and MnP-2 synthetic genes	2
pPV111A plasmid	2
ResultspES4 and pES5 vectors	2
chloroplast genome	2
manganese peroxidase (MnP-2 gene)	2
Pectin lyase (PelA gene)	2
adsorbent in extractive fermentation	2
Amberlite IRA 400	2
clavulanic acid in Erlenmeyer flask cultures	2
ResultsIRA 400	2
adsorbent	2
activated carbon, calcined hydrotalcite, and Amberlite IRA 400 anionic exchange resin	2
adsorbents clinoptilolite	2
Clavulanic acid	2
actinomycete Streptomyces clavuligerus	2
important beta-lactamase inhibitor	2
two strains JMU-MVP14 and JMU-17W	2
P. rhodozyma strains JMU-VDL668	2
intracellular protein	2
P. rhodozyma JMU-VDL668	2
kind of sugar metabolic product	2
astaxanthin-overproducing mutant strain of the yeast P. rhodozyma, called JMU-MVP14	2
three other strains	2
astaxanthin in cells	2
variations	2
four mutant Phaffia rhodozyma strains	2
intracellular protein and fatty acids	2
intracellular anabolism	2
second-order polynomial model	2
tannase yield	2
Plackett–Burman design	2
tea stalks	2
Aspergillus tubingensis	2
pure and crude glycerol	2
intracellular modifications	2
batch culture operation	2
fermentation medium	2
metabolically active biomass	2
easy assay set-up	2
microbial fermentation broth	2
rapid assay	2
standard glycerol detection kit	2
real fermentation samples	2
chemically undefined and a chemically defined media	2
two different fermentation media	2
subsequent assay	2
fermentation broth	2
PPARγ and FAS	2
fat tails	2
proliferator-activated receptor (PPARγ), fatty acid synthase (FAS) and hormone-sensitive lipase (HSL) mRNA and protein expression	2
feedstock chemicals	2
single copy on the chromosome	2
expression plasmids	2
/L.ConclusionsThe expression system	2
genetic element	2
accumulated n-butanol in the broth	2
medium containing extra glucose	2
butanol synthetic enzymes	2
native anaerobic promoter Phya	2
pENA-TA	2
plasmid pCNA-PHC	2
coli strain Bw2V	2
targeted native loci	2
two butanol synthetic operons	2
linear DNAs	2
two mother vectors	2
linear DNA fragments	2
novel DNA kit	2
native anaerobic promoter	2
E. coli strain	2
inducible elements	2
n-butanol naturally	2
BackgroundEscherichia coli	2
cryopreserved dormant grapevine buds	2
freeze-dried dormant grapevine bud tissue	2
-quality RNA	2
extracted total RNA	2
freeze-dried dormant buds	2
grapevine buds	2
‘Flame Seedless’)	2
dormant grapevine buds (Vitis vinifera L. cv.	2
fresh tissues	2
BackgroundPlant tissues	2
farmer	2
DNA-based pedigree records	2
twenty-eight MST loci	2
studied panel	2
flocks	2
private farm flock	2
Three different flocks of Australian Merino sheep	2
Merino sheep	2
(MST) markers	2
parent-offspring, full-sibs or half-sibs	2
lignocellulose-degrading enzymes	2
sodium dodecyl sulfate and RENEX-95	2
Ariel®	2
Ultra Biz®	2
laundry detergent	2
cellulases	2
avicelase and CMCase	2
avicelase (0.83UmL-1) and CMCase (0.29UmL-1) activities	2
ResultsBacillus sp.	2
thermophilic Bacillus sp.	2
high-viscosity carboxymethyl-cellulose (CMC), avicel, cotton linter, filter paper and avicel but not starch, xylan, chitin, pectin and p-nitrophenyl α-d-glucopyranoside	2
cell-bound fraction	2
intracellular fraction of the recombinant clone	2
B. subtilis UMC7	2
endoglucanase gene	2
heterologous host	2
extracellular endoglucanase	2
Macrotermes malaccensis	2
gut of termite	2
BackgroundBacillus subtilis UMC7	2
important medicinal plant	2
6–10 bands	2
ISSR primers	2
different cultivars of A. sinensis	2
8–14 bands	2
amplified bands	2
Twenty six RAPD primers	2
ten Angelica cultivars	2
DNA materials	2
different locations of China	2
A. sinensis cultivars	2
well-known traditional Chinese medicinal plant	2
BackgroundAngelica sinensis	2
reliable scientific basis	2
DPPH and ABTS assays	2
781.25μg/mL	2
Bacteroides vulgatus (390.62μg/mL) and Bacteroides stercoris	2
tested human pathogens	2
second order polynomial model	2
2,2-diphenyl-2-picrylhydrazyl and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) assays	2
oral disease and wounds	2
bacterial and fungal species	2
TJL yield	2
triterpenoids from Jatropha curcas leaves (TJL)	2
multifunctional secondary metabolites	2
root tip cells	2
Arabidopsis genomic and offspring's	2
soil or plant	2
18S rDNA methylation	2
18S rDNA	2
Arabidopsis root tip cells	2
nucleolar structure	2
T0 generation seedlings	2
methylation-sensitive amplified polymorphism (MSAP) molecular markers	2
NiCl2	2
nickel chloride (NiCl2)	2
nickel (Ni)	2
microalgal biomass	2
flue gas and manure wastewater	2
manure wastewater	2
nitrogen and phosphorus	2
CO2)	2
flue gas	2
cost effective system	2
newborn tissue samples	2
tail and blood samples	2
phalanx samples	2
ear and tail samples	2
ear samples	2
biopsied distal phalanx	2
hair and fecal pellets of AM	2
blood, check cells (via buccal swabs)	2
tail and ear of YM and AM	2
12weeks old	2
YM; 10d old) and adult mice (AM;	2
identified set	2
88 samples	2
tested finger millet germplasm	2
bulked leaf or bulked DNA samples	2
single samples	2
informative set	2
diverse accessions	2
finger millet	2
published SSR markers	2
nutritious neglected staple cereal	2
finger millet (Eleusine coracana)	2
Sardinian and Apulian almond germplasm	2
commercial germplasm	2
Apulian accessions	2
commercial varieties	2
two genetic clusters	2
Sardinian germplasm	2
ResultsEleven SSRs (microsatellites)	2
collections	2
Italian collections	2
local genetic materials in almond	2
Local populations of the tree in Sardinia	2
almonds produced	2
central Asia	2
Mediterranean Basin	2
BackgroundSweet-seeded domesticated almonds	2
black glutinous rice	2
Rc protein	2
RD 6.ConclusionThe protein spot S1 (AP005098.4)	2
two rice cultivars	2
spots	2
leaves of the two rice varieties	2
LC–MS/MS.ResultsThe proteins	2
white glutinous rice RD 6	2
Black glutinous rice Br	2
anthocyanins in grains of thirty black glutinous rice varieties	2
glutinous rice	2
RAPD and SCAR markers	2
SCAR marker L7-16	2
five L. chinensis samples	2
L11-26	2
SCAR marker	2
L. chinensis samples	2
SCAR marker L9-6	2
6 samples of L. chinensis and other plants	2
24 different samples	2
L7-16, L9-6, and L11-26	2
SCAR markers	2
specific primers	2
clone L9-6	2
clone L7-16	2
cloned RAPD fragments	2
sequence-characterized amplified region (SCAR) markers	2
subtropical evergreen tree	2
Litchi (Litchi chinensis Sonn.)	2
fat and oil contaminants	2
biodiesel production	2
detergent formulations	2
COM-4A lipase	2
water-miscible organic solvents	2
CMW supplemented	2
important extracellular hydrolytic enzymes	2
coconut oil mill waste (CMW)	2
nutrient media	2
pasteuri COM-4A	2
Staphylococcus pasteuri and Bacillus subtilis	2
COM-4A and COM-6B	2
two isolates	2
oil mill effluent	2
effluents	2
Lipase-producing microbial strains	2
receiving water bodies	2
treatment units	2
grease laden wastewaters	2
carbon and energy source	2
contribution of coconut aroma	2
produced aroma	2
coconut aroma	2
δ-dodecalactone	2
γ-dodecalactone	2
, γ-undecalactone,	2
Saturated lactones, δ-octalactone, γ-nonalactone	2
major identified volatile compound	2
unsaturated lactone, 6-pentyl-α-pyrone (6-PP)	2
coconut aroma in solid state fermentation (SSF)	2
Trichoderma viride EMCC-107	2
Trichoderma species	2
adequate substrate	2
BackgroundSugarcane bagasse	2
pretreated biomass	2
partially delignified material	2
solid fraction	2
renewable resource	2
promising grassy plant	2
one these biomasses	2
Arundo donax	2
lignocellulosic biomasses	2
potential strain	2
Streptomyces sp.	2
protease production	2
polynomial model	2
22 factorial experimental design	2
protease and fibrinolytic production	2
BackgroundStreptomyces sp.	2
functional food ingredients	2
Maillard reaction	2
lysine (CML)	2
Nε-(carboxymethyl)	2
lactose–lysine model solutions	2
lotus seedpod oligomeric procyanidin (LSOPC) concentrations	2
toxic advanced glycation end products (AGEs)	2
food processing	2
farmer-preferred varieties of Sub-Saharan Africa	2
Arachis genome	2
informative markers	2
MGV5 and ICGV-SM 90704	2
closest related varieties	2
appropriately diverse parents	2
dissimilarity matrix	2
best performing polymorphic markers	2
remaining 423 markers	2
amplified alleles	2
817 loci	2
farmer preferred and other cultivated African groundnut varieties	2
799 markers	2
Groundnut Rosette Disease, rust and aflatoxin contamination	2
Early Leaf Spot	2
informative Simple Sequence Repeat (SSR) markers	2
embryonic tissue	2
New molecular marker	2
fertility restorer plants	2
single copy gene)	2
cotyledonary embryos	2
desired MDE genotypes	2
regenerated microspore-derived embryos (MDEs)	2
single dominant nuclear fertility restorer (Rfo) gene	2
desirable genotypes	2
microspore-derived embryos	2
CMS Ogu-INRA	2
fully homozygous fertility restorer lines	2
doubled haploid system	2
pollination systems	2
Cytoplasmic male sterility system (CMS)	2
homozygous doubled haploid (DH) lines and F1 hybrids	2
κ-caseín, β-casein and β-lactoglobulin	2
A1 (0.19), A3 (0.05), B (0.04) and C (0.01)	2
β-casein allele	2
C alleles	2
B (0.72)	2
β-lactoglobulin	2
(0.26) and E (0.05)	2
B allele of κ-casein	2
whole genes	2
Twenty eight breed specific SNP primers	2
Mexican Jersey Cattle Association	2
453 Jersey individuals	2
Blood and frozen semen samples	2
β-casein, κ-casein and β-lactoglobulin genes	2
genotype and environment	2
typical habitats	2
populations of Pantaneiro sheep	2
locus studied	2
UFGD	2
(Corumbá/MS/Brazil).ResultsThe population of Pantaneiro sheep	2
(Dourados/MS/Brazil) and Embrapa Pantanal	2
Experimental Farm of the Universidade Federal da Grande Dourados (UFGD)	2
Pantaneiro sheep	2
different source of carbon	2
another fermentation formula	2
portion of metabolically active biomass	2
successive portions of fermentation media	2
entire quantity of the culture broth	2
polyesters and polyurethanes	2
raw material	2
1,3-propanediol (1,3-PD)	2
Pichia expression system	2
single major protein	2
15L fermenter	2
recombinant Pichia pastoris	2
shake flask	2
recombinant P. pastoris SMD1168	2
human lysozyme (HLZ)	2
well-recognized bacteriolytic activity	2
biotechnologically important crops	2
inulin degrading enzyme	2
special equipment	2
crude plant extracts	2
hexokinase, phosphoglucose isomerase and glucose-6-phosphate dehydrogenase	2
enzymatic one	2
i.e. copper(II)–neocuproine and 3,5-dinitrosalicylic acid	2
fructans in plants	2
Fructan exohydrolase (β-d-fructan fructohydrolase, FEH, EC 3.2.1.80)	2
crude plant extract	2
inulin synthesizing and degrading enzymes	2
inulin, monosaccarides and disaccharides	2
tubers and roots	2
roots of chicory and the tubers of Jerusalem artichoke	2
several drought-related genes	2
differentially expressed candidate genes	2
differentially expressed ESTs	2
either hypothetical or known proteins	2
unique transcripts	2
non-redundant sequences	2
several drought-induced genes	2
preharvest aflatoxin contamination	2
peanut yields	2
important economic and oilseed crop	2
BackgroundPeanut (Arachis hypogaea L.)	2
tissue specific JcIPI	2
IPI multigene family	2
Ricinus communis	2
IPIs	2
NUDIX motif	2
metal binding sites	2
conserved active sites	2
deduced amino acid sequence	2
crucial interconversion of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP).ResultsA full-length JcIPI cDNA	2
one of the rate limiting enzymes	2
isopentenyl diphosphate isomerase (IPI) gene	2
anti-bacterial, anti-fungal, anti-cancer, insecticidal, rodenticidal, cytotoxic and molluscicidal	2
rich reservoir of pharmaceutically active terpenoids	2
ABA-independent pathway and biosynthesis pathway genes	2
ABA/stress-responsive genes	2
MaASR1 in Arabidopsis	2
L38 integrated one and two copies of MaASR1	2
transgenic lines L14	2
nucleus and plasma membrane	2
MaASR1 protein	2
fruits, rhizomes and flowers	2
143 amino acids	2
432bp open reading frame (ORF)	2
banana fruit	2
banana ASR genes	2
plant-specific hydrophilic transcriptional regulators	2
BackgroundAbscisic acid (ABA)-, stress- and ripening-induced protein (ASR)	2
biologically active rSjLys-C	2
highly soluble product	2
expressed rSjLys-C	2
SjLys-C molecular structures	2
helix-loop-helix motif	2
typical hydrophilic peptide	2
native rSjLys-C.	2
heat-treated rSjLys-C	2
tested Gram-positive and Gram-negative bacteria	2
rSjLys-C	2
soluble and highly stable product, an approximate 26kDa recombinant SjLys-C protein (rSjLys-C)	2
Escherichia coli Rosetta(DE3)pLysS.ResultsThe fusion protein system	2
C-terminal amino acid residues 70–146 of the sea cucumber lysozyme in Stichopus japonicus (SjLys-C)	2
novel antimicrobial peptides	2
non-enzymatic lysozyme	2
Gram-negative and Gram-positive bacteria	2
family of invertebrate lysozymes	2
suitable combination	2
individual application	2
cytokinins	2
plant growth regulator	2
MS basal medium	2
fresh medium of the same constituents	2
Proliferated shoots	2
individually or in combinations	2
6-benzylaminopurine (BAP) and Kinetin (Kn)	2
shoot buds	2
seeds and tubers	2
aphrodisiac and impotence supplement	2
tubers of C. borivilianum	2
forest of India	2
rare medicinal plant	2
two marker systems	2
ISSR and SRAP marker systems	2
polymorphic loci (P)	2
M. wufengensis	2
endangered endemic Magnolia taxa	2
inter simple sequence repeat (ISSR) and sequence-related amplified polymorphism (SRAP) molecular markers	2
populations and subpopulations of Magnolia wufengensis, a new and endangered endemic species	2
porcine probiotics	2
strain sources	2
endogenous animal cellulase	2
BY-2 strain	2
high and stable amount of enzyme	2
best nitrogen sources	2
2% peptone and yeast powder compound	2
corn flour	2
best carbon source	2
source of probiotics	2
basic theory	2
forage grass	2
Qinghai–Tibet plateau	2
pig breed	2
mammalian FAS	2
FAS in duck preadipocytes	2
avian FAS orthologs	2
2515 amino acid protein	2
cloned fragment	2
FAS gene	2
Peking duck adipocytes	2
7654bp fragment	2
full-length coding sequence of Peking duck FAS	2
Anas platyrhynchos	2
Mus musculus	2
Gallus gallus,	2
BackgroundFatty acid synthase (FAS)	2
potted Masson pine seedlings	2
potted Masson pine seedlings (Pinus massoniana Lamb).ResultsAfter	2
nutrient of the leaf and soil	2
forest ecosystem	2
world's third largest acid rain region	2
immobilization matrix	2
reduced yeast biomass	2
immobilized cell systems	2
homogeneous and heterogeneous phases (immobilized systems	2
auxotrophic strains of S. cerevisiae	2
prototrophic ones	2
auxotrophic yeast strains	2
prototrophic strains	2
auxotrophic strains	2
S. cerevisiae BY4741.ResultsThe	2
another auxotrophic strain	2
S. cerevisiae T5bV, a strain	2
corresponding prototrophic strain	2
auxotrophic S. cerevisiae CEN.PK strains	2
parental prototrophic strains	2
different auxotrophic mutants of Saccharomyces cerevisiae	2
new yeast strains	2
head smut resistance genes	2
head smut of maize	2
maize mapping bin 2.09	2
CLAVATA1, bassinosteroid insensitive 1-associated receptor kinase 1 and LOC100217307 with leucine-rich repeat (LRR) conserved domains	2
Three head smut resistance-related candidate genes	2
head smut	2
benzoxazinoid biosynthesis pathways	2
natural killer cell mediated cytotoxicity	2
physiological and biochemical pathways	2
total probes	2
3,532 genes	2
S. reilianum	2
highly susceptible inbred line	2
disease resistant near isogenic line (NIL)	2
∼14,850 probes	2
head smut in maize	2
f. sp. zeae (Kühn),	2
Sporisorium reilianum	2
smut of maize	2
SSD population	2
SSD and DH populations	2
semi-dwarfing gene	2
sdw1/denso semi-dwarfing gene	2
chromosome 3H	2
partial linkage map	2
closest	2
Bmag0013, Bmag0877, Bmag0306b markers	2
Microsatellite markers (SSR)	2
Maresi (with a semi-dwarfing gene) and Pomo cross combination	2
single seed descent (SSD) and 60 doubled haploid (DH) lines	2
Many different QTLs	2
one type of population	2
newly-bred crop cultivars	2
breeding program	2
prebiotic-rich and super nutritious crops	2
health-imparting prebiotics	2
high fructan	2
Transgenic maize, potato and sugarcane	2
prebiotic carbohydrates	2
diversity in germplasm)	2
reduced subsets	2
major quantitative trait loci and gene-based markers	2
barley, chickpea, lentil, wheat, yacon, and Jerusalem artichoke	2
prebiotic-rich crop germplasm	2
barley, chickpea, lentil, lupin, and wheat	2
prebiotic-rich grain crops	2
best-known sources of prebiotic carbohydrates	2
fruit crops	2
Many vegetable, root and tuber crops	2
best-characterized plant prebiotics	2
Bifidobacteria and Lactobacillae in the gastro-intestinal tract	2
energy and short chain fatty acids	2
non-digestible complex carbohydrates	2
Microbiota in the gut	2
synthesized enzyme	2
resultant model	2
nitrogen source in the culture	2
Plackett–Burman screening plans	2
intracellular prolyl endopeptidase (PEP) by Lactobacillus acidophilus 5e2.ResultsThe application	2
prolyl endopeptidase	2
proteolytic preparations	2
immunoreactivity of proteins of cereal grains	2
BackgroundLactic acid bacteria	2
pEGFP-FST vector	2
FST).ConclusionsThe duck	2
duck myoblasts	2
FST and myostatin (MSTN).ResultsThe duck pEGFP-FST vector	2
Lipofectamine™ 2000	2
cultured duck myoblasts	2
pEGFP-FST eukaryotic expression vector	2
myoblast proliferation	2
duck FST	2
secreted glycoprotein	2
(FST)	2
pheasant spermatogonial stem cell line	2
recipient gonads	2
Donor SSCs	2
gonads of recipient chickens	2
9.48% c-kit/CD117-positive cells	2
PKH 26 fluorescent dye	2
donor SSC	2
recipient embryos	2
GDNF family receptor alpha1 (GFRα1) marker	2
Pheasant SSCs	2
established SSC line	2
co-culturing STO (SIM mouse embryo-derived thioguanine and ouabain resistant) cells	2
surgically removed testis of a pheasant	2
interspecies germ line chimeras between pheasant (Phasianus colchicus) and chicken (Gallus gallus)	2
BackgroundSpermatogonial stem cells (SSCs)	2
PNSB growth	2
heterotrophic bacteria	2
abiotic control and treatment sets	2
total sulfide	2
PNSBsi	2
indigenous PNSB (PNSBsi).ResultsThe addition	2
non-sterile rubber sheet wastewater (RAW) with fermented pineapple extract (FPE)	2
purple nonsulfur bacteria (PNSB)	2
toxic H2S.	2
rotten-egg odor	2
latex rubber sheet wastewater	2
TSSM infestation	2
quality fruit	2
soluble solids	2
TSSM-infested plants+biological	2
TSSM-infested plants	2
Phytoseiulus macropilis Banks).ResultsStrawberry	2
TSSM-infested strawberry plants	2
strawberry plants	2
Koch infestations	2
Tetranychus urticae	2
two-spotted spider mite (TSSM)	2
food market	2
Brazilian strawberry production	2
strawberry fruit	2
ascorbic acid and phenolic compounds	2
temperate climate regions	2
pseudofruit	2
phage cocktails	2
contaminated food sources	2
fresh and processed)	2
ten food matrices	2
three phages	2
two phages	2
foodborne pathogen Salmonella enterica serovar Enteritidis (SE).ResultsWe	2
five phage isolates	2
different food matrices	2
food related infections	2
bacterial viruses	2
BackgroundLytic bacteriophages	2
surface of carbon paste electrode (CPE)	2
graphene–chitosan (GR–CS) nanocomposite	2
presence of ascorbic (AA) and uric acid (UA)	2
dopamine (DA)	2
D. zingiberensis suspension cell and seedling cultures	2
endophytic fungus F. oxysporum Dzf17	2
oligosaccharides	2
suspension cell and seedling cultures	2
PAL, PPO and POD	2
PPO and POD	2
seedling cultures	2
suspension cell cultures	2
host plant Dioscorea zingiberensis cultures	2
defense-related enzymes, namely phenylalanine ammonia lyase (PAL), polyphenoloxidase (PPO) and peroxidase (POD)	2
endophytic fungus Fusarium oxysporum Dzf17	2
exopolysaccharide (EPS), water-extracted mycelial polysaccharide (WPS) and sodium hydroxide-extracted mycelial polysaccharides (SPS)	2
corresponding polysaccharides	2
BackgroundThree oligosaccharides (EOS, WOS and SOS)	2
5L fermentor	2
total nitrogen	2
jiean-peptide (JAA)	2
monoculture system	2
P. carneus on T. maxima	2
P. carneus	2
T. maxima	2
indigenous fungi	2
MgSO4, CaCl2 and MnSO4 concentrations	2
KH2PO4, FeSO4 and inoculum (P<0.05)	2
(NH4)2SO4 and MnSO4	2
non-inoculated T. maxima	2
co-cultures I3 and I5	2
Paecilomyces carneus	2
Trametes maxima	2
ascomycete Trichoderma spp.	2
filamentous microfungi	2
single fungal strains	2
ligninolytic enzymes	2
tested varieties	2
different carotenoids	2
Callus cultures of T. erecta accumulated pigments	2
lutein, zeaxanthin, β-cryptoxanthin and β-carotene	2
extracts of the WF callus	2
lutein and zeaxanthin	2
extracts from YF callus	2
several carotenoids	2
callus cultures	2
9.0μM 4-dichlorophenoxyacetic acid (2,4-D) and 8.8μM benzyladenine (BA)	2
leaf explants on Murashige and Skoog (MS) medium	2
WF) varieties	2
ResultsFriable callus of T. erecta yellow flower (YF) and white flower (	2
carotenoid source	2
Asteraceous ornamental plant	2
Marigold (Tagetes erecta)	2
target products	2
natural food colorants	2
β-carotene, β-criptoxanthin and lutein	2
poultry products (manly marigold flower extracts)	2
natural, food-quality colorants	2
synthetic ones	2
antioxidants, functional, medical, and nutraceutical	2
natural pigments	2
null mutant strain	2
must	2
null mutant	2
industrial strain EC1118	2
wine yeasts	2
One of the genes	2
genetically related strains	2
wine-making industry	2
main microorganism	2
BackgroundSaccharomyces cerevisiae	2
fish pathogens	2
source of antimicrobial compounds	2
C. rubrum seaweed	2
whole extract	2
one hydrocarbon	2
fatty acid esters	2
dichloromethane extract	2
concentrated extract	2
Pacific coast of Chile	2
lipophilic extract of C. rubrum on Y. ruckeri and S. parasitica	2
Ceramium rubrum	2
Ceramium genus	2
many pharmacologically active substances	2
potential new drugs	2
algae, sponges and corals	2
Marine organisms	2
Sanitary problems	2
important illnesses	2
bacteria Yersinia ruckeri and the oomycete Saprolegnia parasitica	2
banana fruits	2
Musa germplasm	2
SNP-based molecular markers	2
banana accessions	2
AGPase enzyme isoforms	2
2nd exon in the LSU of AGPase	2
distinct haplotypes	2
insertions/deletions (indels)	2
ten Musa accessions	2
810-base pair amplicons of the AGPase large sub-unit (LSU) gene	2
Musa accessions	2
representatives of wild ancestors (AA and BB genomes), dessert bananas (AA, AAA, AB and AAB genomes), plantains (AAB genome) and cooking bananas (ABB and AAA genomes)	2
accessions of the genus Musa	2
gene encoding one of the large subunits of the enzyme	2
family Musaceae)	2
bananas (Musa spp.	2
reported variants or isoforms of the AGPase enzyme	2
starch biosynthesis pathway	2
BackgroundADP-glucose pyrophosphorylase (AGPase)	2
non-toxic and biodegradable stabilizing agent	2
low-cost biosurfactant	2
whole organisms or partially purified biological extracts	2
existing systems	2
Transmission Electron Microscope (TEM)	2
reverse micelles	2
UV–vis absorption spectra	2
micellar solution	2
biosurfactant reverse micelles	2
liquid phase	2
distilled water	2
2.5% corn steep liquor	2
vegetable oil refinery residue	2
low-cost medium	2
different regions of Jordan	2
Awassi sheep	2
Awassi sheep breed	2
geographical sampling areas	2
number of population	2
ancestral populations	2
four populations	2
studied predefined populations	2
separated cluster	2
sheep populations	2
AlSalt and Dead Sea	2
two populations of the middle region	2
middle regions of Jordan (Karak, Madaba, Amman, AzZarqa and Mafraq)	2
studied populations	2
chromosomes 2 and 6 of sheep genome	2
ovine and bovine MS	2
intron 3	2
g.1514G	2
g.1496G>	2
5′untranslated region (5′UTR) of exon 1	2
g.1514G>	2
Three SNPs g.244T	2
CDIPT gene single nucleotide polymorphism (SNP)	2
638 Qinchuan cattle	2
Qinchuan cattle	2
bovine CDIPT gene	2
fatty acid metabolic pathway	2
phosphatidylinositol (PtdIns)	2
cytoplasmic side of the Golgi apparatus and the endoplasmic reticulum	2
BackgroundCDIPT (CDP-diacylglycerol–inositol 3-phosphatidyltransferase, EC 2.7.8.11)	2
sarcopenia	2
sample of active, well-functioning 85-year-olds	2
mitochondrial respiratory chain enzymes	2
complexes I and IV	2
Seven participants	2
Sixteen participants	2
young controls	2
subunits of complex I and IV of the respiratory chain	2
vastus lateralis muscle	2
phosphocreatine in the calf muscles	2
τ1/2 PCr	2
Timed Up-and-Go and bioimpedance analysis	2
general practitioner	2
11 female)	2
19 participants	2
healthy 85-year-olds	2
old	2
lower leg	2
anterior and posterior MT × 	2
right lower leg (L)	2
right side	2
intracellular water (ICW) and total water (TW)	2
aging global population	2
public health systems	2
M.tb control (IFN-γ, IL-10)	2
adults: 25–44 years; elderly	2
2 age groups	2
skin of elderly individuals	2
tuberculin-purified protein derivative	2
Mycobacterium tuberculosis (M.tb) infection or disease	2
elderly individuals	2
global population	2
patient and graft survival	2
Corneal transplants	2
threshold	2
liver, kidney, pancreas, heart, lung and cornea transplantation	2
underutilized resource	2
shared metabolic pathways	2
two long-lived mutants	2
C18:0, C17:1, C19:1, C20:0 and C22:0 fatty acids	2
amino acid pool	2
adenine, xanthine, and AMP	2
wild-type strain N2	2
long-lived worm strains, i.e. daf-2 (impaired IIS) and eat-2 (CR model)	2
IIS and CR worm models	2
longevity pathways	2
nematode C. elegans	2
Impaired insulin/IGF-1 signaling (IIS)	2
low-glucose environments	2
Seahorse assay	2
MR-Egger and weighted median MR methods	2
26 SNPs	2
liver enzymes	2
SNP)-AD associations	2
single nucleotide polymorphism	2
similar measures	2
three physical tests	2
2+ medications	2
final clinical prediction model	2
physical tests	2
British birth cohort participants	2
banded mongooses	2
cartilage TL	2
Leukocyte TL	2
banded mongoose, Mungos mungo	2
wild cooperative mammal	2
highly replicative cells	2
minimally replicative cells	2
long-lived animals	2
survival and maintenance pathways	2
genetic switch model	2
longest lived man	2
Jiroemon Kimura (J.K.)	2
social and natural sciences	2
long-lived individuals	2
agrin and LDL Receptor Related Protein 4 (LRP4)	2
NMJ formation-related genes	2
6-month old young mice	2
abnormal NMJs	2
extensor digitorum longus muscle	2
14-month old control mice	2
aging mice	2
milk fat globule membrane (MFGM)	2
sympathetic stimuli	2
aging community	2
older Irish adults	2
Act-Belong-Commit indicators	2
social networks	2
adjusted model	2
Validated scales	2
analytical sample	2
Act-Belong-Commit behavioral domains	2
community organizations	2
safe and promising exercise prescription	2
intra-ventricular septum diastole (IVSd) (P<0.05)	2
SED (Phase B)	2
(LEX; n=17, aged=61.1±5.4yrs)	2
aging male participants (SED; n=22, aged 62.7±5.2yrs	2
age matched masters athletes	2
aging men	2
sedentary (SED)	2
translational models	2
septic doses of lipopolysaccharide	2
tau species	2
extracellular toxic tau oligomers	2
immune phagocytes in the central nervous system	2
Microglial cells	2
post-tangles epitopes	2
biosynthesis	2
age-related genetic pathways	2
younger workers	2
B. terrestris	2
Dnmt3 expression	2
workerless queens	2
social environment	2
eusocial insect queens	2
queen ovary	2
COQ7 expression	2
taxonomically widespread age-related pathways (coenzyme Q biosynthesis protein 7, COQ7; DNA methyltransferase 3, Dnmt3; foraging, for; and vitellogenin, vg)	2
four candidate genes	2
primitively eusocial bumble bee Bombus terrestris (Linnaeus)	2
long-lived queens and flexible aging schedules	2
Eusocial insects	2
vitamins	2
older Central and Eastern Europeans	2
cognitive domains	2
vitamin quartiles	2
sub-sample of participants	2
women aged 45–69	2
three Central and Eastern European populations	2
middle-aged and older adults	2
folate and vitamin B-12	2
B vitamins	2
healthy controls (p=0.008)	2
non-depressed hip fracture patients	2
monocytes of hip fracture patients	2
monocyte subsets	2
hip fracture group	2
28 females	2
healthy age matched controls	2
female)	2
101 hip fracture patients	2
aged immune system	2
elderly populations	2
brain health domains	2
meat intake	2
white and gray matter, P=0.03)	2
meat and meat products	2
Mediterranean countries	2
Uppsala Seniors cohort	2
Vasculature	2
cognitively healthy individuals	2
Reduced IIS	2
germ line	2
mammalian liver and white adipose tissue)	2
several components of this network	2
insulin/insulin-like growth factor and Target of Rapamycin signalling network	2
number of different protein encoding and RNA encoding genes	2
entire mitochondrial genome	2
subunits of multiple complexes	2
individual subunits of complexes I–IV	2
complexes of the respiratory chain	2
(cytochrome c oxidase (COX)) of the respiratory chain	2
colonic crypt stem cells	2
number of ageing tissues	2
mNSC function	2
DILP2 in fly heads	2
dilp2, dilp3 or dilp5 mRNA	2
mNSC	2
three of the Drosophila insulin-like peptides (DILPs)	2
median neurosecretory cells (mNSC)	2
neuronal tissue	2
adult neurons	2
whole flies	2
rodent skeletal muscle mitochondria	2
adult Drosophila melanogaster	2
ubiquitous, pan-neuronal or neurosecretory cell-specific expression of human UCP3 (hUCP3)	2
Uncoupling proteins (UCPs)	2
key terms	2
efficient, valid and reliable clinical tool	2
novel gadget	2
communication networks	2
family relationships	2
ageing parents and their children	2
lacking social relationships	2
social contact	2
crisis	2
adult child	2
reference category	2
Adult children	2
adult children, other relatives, friends/neighbours, paid/professional care	2
partner or spouse	2
2135 participants	2
population-based birth cohort study set	2
social relationships	2
late sixties	2
baby-boomers	2
final models	2
women providing intensive care	2
Women caregivers	2
non-caregivers	2
dependent children	2
9408 participants	2
Allied Dunbar scale	2
set of eight biomarkers	2
ageing population	2
wider range of settings	2
diverse settings	2
intervention studies	2
standing balance test	2
manual and iCap	2
stopwatch and measurement tape	2
single accelerometer-based monitor (lower back)	2
74 adults	2
manual recordings	2
objective markers	2
sensory and affective components	2
disease pathology	2
unpleasant respiratory sensations	2
multidimensional sensation	2
patients, families and the healthcare system	2
disease-specific treatments	2
two growing populations	2
obese	2
respiratory, cardiovascular, and neuromuscular diseases, cancer and panic disorder	2
caffeine in coffee, tea and energy drinks	2
Oral rescue drugs	2
young people (divalproex, topiramate, metoprolol and propranolol)	2
migraine equivalent	2
Abdominal migraine	2
younger ones	2
older patient	2
older person	2
Central and Eastern Europe populations	2
oral contraceptives	2
vitamin and mineral supplements	2
random samples of populations	2
three urban populations	2
care	2
review paper	2
informal care	2
mortality	2
less healthy individuals	2
married counterparts	2
unmarried individuals	2
Epigenetic marks	2
epigenetics marks	2
common genetic susceptibility variants	2
life course frameworks	2
different theoretical models	2
physical health domain	2
‘recovering’ group	2
Childhood enuresis	2
four groups of women	2
983 British women	2
biological and social pathways	2
reasons	2
nulliparous women	2
1–2 children	2
heavier women	2
431 women	2
1583 women	2
nationally representative British cohort	2
British women	2
1946 cohort	2
1958 cohort	2
1946 and 1958 British birth cohort studies	2
milk in FMD-endemic countries	2
milk tankers	2
bulk tanks	2
individuals)	2
typical-sized dairy herd	2
one acutely-infected milking cow	2
field and experimentally-infected animals	2
milk samples	2
FMDV in milk by rRT-PCR	2
characteristic foot lesions	2
different RT-PCR chemistries	2
Milk and blood	2
FMD virus (FMDV: isolate O/UKG/34/2001)	2
non-milking Jersey cows	2
milking Jersey cows	2
cloven-hooved animals	2
foot-and-mouth disease (FMD)	2
non-invasive sample type	2
important pig pathogen	2
18 serovars of A. pleuropneumoniae	2
complete capsular loci	2
different serovars	2
complete sequences	2
capsule biosynthetic genes	2
specific amplicons	2
causative agent of porcine pleuropneumonia	2
number of PCRs	2
four vaccine or field strains of mycoplasmas or viruses	2
flocks sampled	2
subtype B.	2
aMPV positive samples	2
Arkansas (23.8%) and Massachusetts (9.5%)	2
IBV S1 gene sequencing	2
ST2 (MS-H-like), ST6 and ST43	2
majority of positive Ms	2
TS-11 vaccine	2
TS-11-like isolates	2
Mg 6/85	2
Mg TS-11	2
mgc2 gene of the Mg isolates	2
IBV, Mg/Ms and aMPV respectively	2
17,633 birds	2
98)	2
= 	2
Chicken flocks	2
1 quail and 1 partridge flock	2
6 pheasant and 5 turkey flocks	2
birds per flock	2
Oropharyngeal (OP) swabs	2
infectious bronchitis virus (IBV), avian metapneumovirus (aMPV), Mycoplasma gallisepticum (Mg) and Mycoplasma synoviae (Ms)	2
healthy or problematic flocks	2
four economically important respiratory pathogens	2
Respiratory diseases	2
two new serovars of A. pleuropneumoniae	2
specific serovar 17 and 18 sequences	2
16 known serovars	2
new CPS loci	2
representative isolates	2
ApxII (apxIICA structural genes, and apxIBD export genes).Rabbit polyclonal antisera	2
NT and ‘K2:O7’ isolates	2
serovar 7	2
‘K2:O7’ isolates	2
serovars 3, 6, 8, and 15	2
previously NT isolates	2
serovars 1, 4, 12, 14 and 15	2
cpsA gene	2
unique three-gene type II CPS locus	2
two ‘K2:O7’ isolates	2
serovars 2, 3, 6, 7, 8, 9, 11 and 13	2
common cpsABC genes	2
six-gene type I CPS locus	2
NT isolates	2
recent biovar 2 NT isolate	2
two biovar 1 ‘K2:O7’ isolates of A. pleuropneumoniae	2
previously designated biovar 1 NT	2
capsule (CPS) loci	2
serovar-specific amplicons in PCR assays	2
‘K2:07’	2
non-typable (NT)	2
peak viraemia	2
BTV-endemic countries	2
(2008) and VetMAX assays	2
single BTV-positive animal	2
onset of infection sample	2
pooled EDTA blood samples	2
BTV RNA	2
published real-time RT-PCR assay (Hofmann et al., 2008) and a commercial assay (ThermoFisher VetMax™ BTV NS3 kit)	2
BTV surveillance programs	2
BTV-affected countries	2
European Union (EU) member states	2
Bluetongue virus (BTV)	2
multiple BTV serotypes in Trinidad	2
trapped samples	2
six Culicoides species	2
cattle predominantly trapped Culicoides insignis Lutz 1913 species	2
Light-suction traps	2
BTV-5 in Trinidad	2
presence of BTV serotypes 1, 2, 3, 5, 12 and 17	2
serotype-specific rRT-PCR	2
original blood samples	2
BTV serotype-specific rRT-PCR	2
multiple serotypes	2
BTV-RNA	2
BTV antibodies	2
species of Culicoides biting midges	2
cattle enclosure	2
CDC light traps	2
BTV- naïve imported cattle	2
circulating serotypes of BTV in Trinidad	2
exporting and importing country	2
serotypes of Bluetongue virus (BTV)	2
trading cattle	2
IncF replicons	2
resistance and virulence determinants	2
typically pathogenic strains	2
vulnerable patient populations	2
commensal E. coli strains	2
horizontally-transferred resistance supplements uropathogenic strains of E. coli	2
clonally distinct commensal backgrounds	2
MDR E. coli strains	2
vulnerable patients	2
specific cases	2
multiple plasmids	2
MDR strains	2
IncF replicon type	2
clonal group of IncI1 plasmids	2
Plasmid-mediated AmpC (CMY-2) beta-lactamase resistance	2
multiple distinct families of plasmids	2
complete genomes of E. coli strains	2
urinary tract infections	2
multi-drug resistant (MDR) Escherichia coli strains	2
competent A. pleuropneumoniae strain, MIDG2331	2
conjugal donor strain (E. coli MFDpir)	2
partial mobC sequence	2
Mobilisation genes	2
Escherichia coli MFDpir	2
broad host range plasmid	2
partial strB sequence	2
various florfenicol resistance plasmids	2
lysR gene	2
florfenicol resistance plasmids	2
member of the Pasteurellaceae	2
smallest florfenicol resistance plasmid	2
Southeastern Brazil	2
Actinobacillus pleuropneumoniae clinical isolate	2
small (3.9kb) plasmid (p518)	2
28 mouth swabs	2
foot swabs	2
community types	2
mouth swabs	2
32/49 foot-	2
F. necrophorum community in DNA	2
sample sites	2
isolates of both subspecies	2
46/52F. necrophorum isolates	2
MLVA scheme strain	2
isolates and communities of F. necrophorum	2
F. necrophorum genome	2
Seventy-three tandem repeat regions	2
isolates and mixed communities of bacteria	2
specific reservoirs	2
reservoir sites	2
tonsillar epithelium	2
Reservoirs (sites where the pathogen	2
new sterile catheters and implants	2
intra- and post-procedural prophylactic antibiotics	2
47 dogs	2
similar population	2
54 dogs	2
supervising cardiology specialist	2
author	2
local or systemic antibiotics	2
ductal ampulla	2
Amplatz duct occluder)	2
least one metal implant (a coil	2
authors’ clinic	2
digital archives	2
owners or the referring veterinarians	2
single tertiary veterinary referral center	2
client-owned dogs	2
retrospective case series	2
bacterial endocarditis	2
implant-related infective endocarditis	2
veterinary cardiologists	2
post-procedural prophylactic antibiotics	2
effective selective culture medium	2
M. hyorhinis tested	2
UK and Danish strains	2
four antimicrobials	2
M. hyopneumoniae and M. hyorhinis strains	2
viable organisms	2
acidity in liquid medium	2
DEAE-dextran	2
Purified agar	2
Niels Friis	2
solid medium	2
M. hyopneumoniae in primary culture	2
fast-growing M. hyorhinis	2
clinical and pathological samples	2
reliable solid medium	2
fastidious porcine respiratory pathogen Mycoplasma hyopneumoniae	2
isolates from known clinical cases or disease-free pigs	2
S. suis	2
NCC than CC isolates	2
five or more classes of antimicrobials	2
aminoglycosides, cephalosporins, fluoroquinolones, pleuromutilins, potentiated sulphonamides and tetracyclines	2
penams, pleuromutilins, potentiated sulphonamides	2
NCC isolates	2
isolate subsets	2
ECOFF	2
ECOFF and non-wild type (NWT)	2
antimicrobials (nine classes)	2
clinical cases of disease (CC) and non-clinical case (NCC) pigs	2
diseased animals	2
global zoonotic pathogen of pigs	2
Streptococcus suis	2
unvaccinated SZC	2
breed	2
vaccinated SZC	2
effective combination	2
atAlHV-1+Emulsigen®	2
immunized cattle	2
+bacterial flagellin	2
bacterial flagellin (FliC) and (iii) Emulsigen®	2
Emulsigen®	2
three adjuvant combinations	2
FH and SZC cattle	2
East African breed, the shorthorn zebu cross (SZC)	2
Friesian-Holstein (FH) cattle	2
attenuated vaccine (atAlHV-1)	2
wildebeest excreting alcelaphine herpesvirus 1 (AlHV-1)	2
CMY-2-E. coli in this broiler parent flock	2
CMY-2-E. coli	2
several E. coli MLST types	2
pAmpC gene	2
ESC-resistant isolates	2
ESBL/pAmpC-E. coli	2
ESBL/pAmpC-E. coli presence	2
Environmental samples	2
laying period two groups	2
pen	2
separate pens	2
One-day old chickens	2
broiler parent flock	2
ESBL/pAmpC-Escherichia coli	2
Extended Spectrum Cephalosporins (ESC)	2
Extended-spectrum β-lactamase and plasmid mediated AmpC β-lactamase (ESBL/pAmpC) producing bacteria	2
so-named ‘TOV-serotyped BTV’	2
outer capsid proteins VP2 and VP5 of TOV	2
TOV-VP5	2
ancestor BTV	2
incorporated TOV proteins	2
TOV proteins	2
respective TOV proteins	2
Genome segments Seg-2[VP2], Seg-6[VP5], Seg-7[VP7], and Seg-10[NS3/NS3a]	2
viremic blood	2
naïve animals	2
Culicoides cells	2
Corsica, France	2
serotype 25 (Toggenburg Orbivirusor TOV)	2
new BTV serotypes	2
recognized serotypes or neutralization groups	2
Bluetongue virus (BTV) is the prototype orbivirus (Reoviridae family, genus Orbivirus)	2
many inflammatory genes	2
lymphoid tissue	2
uninfected brain homogenate	2
Affymetrix Ovine Gene arrays	2
genes and physiological pathways	2
lymph node	2
prescapular lymph nodes	2
drainage area	2
Susceptible VRQ homozygous New Zealand Cheviot sheep	2
peripheral lymphoid tissue	2
many transmissible spongiform encephalopathies (TSEs)	2
misfolded prion protein, PrPSc in the central nervous system (CNS)	2
farm environment	2
genetically diverse GARV strains	2
new viruses	2
different building	2
predominant VP7 genotype	2
P[32] sequences	2
G4P[32]	2
predominant genotype combination	2
almost every combination	2
four VP7 genotypes (G2, G3, G4 and G5) and three VP4 genotypes (P[6], P[7] and P[32]	2
multiplex PCRs and sequencing	2
six batches of pigs	2
GARV on a conventional farrow-to-finish farm	2
porcine GARV	2
young pigs	2
Group A rotaviruses (GARV)	2
safer and more ethical vaccine	2
A. centrale in tick cells	2
Dermacentor variabilis cell line DVE1	2
subcultures in RAE25 cells	2
respective genes	2
sequenced PCR products	2
16S rRNA, groEL and msp4 genes	2
A. centrale in the RAE25 cells	2
cultures of the Rhipicephalus appendiculatus cell line RAE25	2
vaccine-inoculated tick cells	2
cell-free supernate	2
Giemsa-stained cytocentrifuge smears	2
13 ixodid tick species	2
25 cell lines	2
pathogenic Anaplasma marginale	2
live blood vaccine	2
Anaplasma centrale	2
Pasteurellaceae species	2
replication and mobilisation genes	2
florfenicol resistant isolate of Actinobacillus pleuropneumoniae	2
complete nucleotide sequence of a 7.7kb mobilisable plasmid (pM3446F)	2
genotypically diverse AstV in the faeces of calves	2
different viruses	2
several calves	2
multiple AstV lineages	2
AstV and RVA	2
rotavirus Group A (RVA)	2
specific AstV lineage	2
adult cattle	2
healthy adult cattle	2
healthy and diarrhoeic calves	2
diverse AstV lineages	2
single-stranded, positive-sense RNA viruses	2
Astroviruses (AstV)	2
feet of the group of housed ewes	2
naturally occurring populations of D. nodosus	2
feet of lambs	2
mother's feet	2
sources(s)	2
Mother offspring pairs	2
populations on ewes and lambs	2
feet of both ewes and lambs	2
mixed population of D. nodosus	2
swabs on individual feet	2
community DNA	2
marker gene, pgrA	2
Multiple genotypes	2
naturally occurring D. nodosus	2
feet of newborn lambs	2
samples of bedding, pasture, soil and faeces	2
mothers 5–13h post-partum	2
D. nodosus in foot swabs of lambs	2
Specific qPCR	2
newborn lambs	2
essential causative agent of footrot	2
Dichelobacter nodosus (D. nodosus)	2
two CaAstV strains	2
full-length genomes	2
UK dogs	2
capsid protein	2
ORF1a and ORF1b	2
astroviruses	2
two UK CaAstV strains	2
four CaAstV strains	2
capsid sequences	2
healthy dogs	2
dogs with gastroenteritis	2
CaAstV positive samples	2
CaAstV by qPCR	2
pet dogs	2
identified strains	2
UK dog population	2
Canine astrovirus (CaAstV)	2
range of domestic and wild animal species	2
PCV2 infected pigs	2
conventional status pigs	2
additional pathogen	2
PCV2b infection	2
separate, environmentally controlled rooms	2
PCV2-free pigs	2
defined PCV2b strain	2
pig	2
secondary pathogen	2
PCV-associated diseases (PCVAD)	2
underlying infectious component	2
Porcine circovirus type 2 (PCV2)	2
F. necrophorum cell counts	2
D. nodosus cell counts	2
D. nodosus and F. necrophorum populations	2
healthy, ID- and SFR-affected feet	2
interdigital skin biopsies	2
D. nodosus, F. necrophorum and the domain Bacteria	2
feet of sheep	2
Fusobacterium necrophorum and other bacteria	2
ovine FR	2
underlying epidermis	2
hoof horn	2
interdigital dermatitis (ID)	2
ovine footrot (FR)	2
potential reservoirs	2
healthy and not healthy cats	2
Group 2	2
60 cats	2
large multi-cat household	2
Memphis cohort (Group 2)	2
households of ≤2 cats	2
Chicago cohort (Group 1)	2
two cohorts of privately owned, naturally infected cats	2
lethal strains of the virus	2
different concentrations of 3-AB	2
enhancer factor	2
PRRSV infected cells	2
PARP-1 small molecule inhibitor, 3-AB	2
adenosine diphosphate ribose	2
N protein including poly [ADP-ribose] polymerase 1 (PARP-1)	2
PRRSV N protein	2
cellular factors	2
nucleocapsid (N) protein	2
swine industry and food security	2
Porcine reproductive and respiratory syndrome virus (PRRSV)	2
3 genome segments of BTV-8	2
two different serotypes, BTV-1 and BTV-8	2
groups of BTV-susceptible sheep	2
reassortant virus	2
different organs, kidney and thymus	2
two different ovine cell lines	2
backbone of an attenuated strain of BTV-1	2
3 most variable genes, S2, S6 and S10 of a recent isolate of BTV-8	2
different serotypes of BTV	2
wild and domestic ruminants	2
Reoviridae family	2
non-enveloped bluetongue virus (BTV)	2
D75 (e.g. CHRNA6, GRM1, HCN2)	2
Several neurological receptors	2
common Bio Functions	2
Affymetrix gene arrays	2
transcriptome of the thalamus and obex (medulla)	2
VRQ genotype of the PRNP gene	2
New Zealand Cheviot sheep	2
misfolded prion protein	2
Sheep scrapie	2
porcine rotavirus genotypes	2
UK pig	2
human genotype P[8] rotavirus	2
human Irish rotavirus isolate	2
P[8]	2
P[8] genotype	2
G9 and P[6] genotypes	2
single P[8] isolate	2
G types (VP7); G2, G3, G4, G5, G9 and G11 and six P types (VP4); P[6], P[7], P[8], P[13], P[23]	2
wide range of rotavirus genotypes	2
rotavirus (GARV) in UK pigs	2
diversity of group	2
rotavirus enteritis	2
diarrheic pigs	2
porcine rotavirus	2
pig farms	2
veterinary practitioners	2
recent human clinical cases	2
detected ARoVs	2
various combinations (G2, G3, G4, G5, G9, G11 and P[6], P[13], P[23], and P[34]	2
P types	2
different G types	2
predominant circulating genotypes of ARoVs on pig farms	2
livestock producers	2
Group A rotaviruses (ARoVs)	2
resistant phenotypes	2
diverse range of bacteria	2
predicted proteins	2
diverse range of acetyltransferases and unusual transporter genes	2
Common β-lactamases	2
phenotypic resistant clones	2
Resistance genes	2
gentamicin, neomycin, ampicillin and ciprofloxacin	2
Metagenomic libraries	2
diversity of resistance genes	2
waste water treatment plant (WWTP) effluent	2
mobile elements	2
adaptive genes	2
environmental reservoirs	2
clinically important bacteria	2
novel and extant resistance genes	2
uncultured bacteria	2
cells expressing MHCII	2
adherent porcine bone marrow (pBM) cells	2
porcine CD163 on cell lines	2
larvae and adult bees	2
apiary environment	2
ubiquity of Aspergillus spp.	2
least pathogenic of the isolates	2
two Aspergillus fumigatus strains	2
adult honey bees	2
Three isolates (A. flavus, Aspergillus nomius and Aspergillus phoenicis) of the ten species	2
adult worker bees	2
frequently occurring isolates	2
laboratory reared larvae	2
Aspergillus spp. fungi	2
apiary	2
hive substrates	2
many insects, plants, animals and man	2
worker bees	2
stonebrood and diseased brood	2
genus Aspergillus	2
OURT88/3 isolate	2
strain Benin 97/1	2
key inflammatory chemokines	2
low virulence strain OURT88/3	2
Benin 97/1 infected macrophages	2
Benin 97/1 isolate	2
supernatants from macrophages	2
CXCL8 and CCL2 protein	2
high virulence isolate Benin 97/1	2
low virulence isolate OURT88/3	2
CXCL10 mRNAs	2
CCL4, CXCL10 and chemokine receptor CCR7	2
CCL3L, CXCL2 and chemokine receptors CCR1, CCR5, CXCR3, CXCR4	2
chemokines CCL2	2
porcine macrophages	2
low virulence isolates	2
domestic pigs	2
large DNA virus family	2
Asfarviridae	2
I. scapularis cells	2
canine strains	2
pathogen in I. ricinus cells	2
I. scapularis cell line ISE6	2
two A. phagocytophilum isolates	2
A. phagocytophilum human HZ strain	2
16S rRNA genes	2
bilayer membrane	2
individual bacteria	2
pleomorphic organisms	2
one of the isolates	2
L15/L15B medium	2
buffy coat cells	2
treating veterinarians	2
two dogs	2
two new canine strains of A. phagocytophilum	2
IRE/CTVM20	2
Ixodes ricinus-derived cell line	2
human promyelocytic cell line HL60	2
tick Ixodes scapularis	2
various species of livestock and companion animals	2
granulocytic anaplasmosis	2
intracellular tick-borne rickettsial pathogen	2
Anaplasma phagocytophilum	2
(Pmps10G and 18D)	2
different members of the Pmp family	2
Pmps	2
specific Pmps	2
visualised inclusions	2
Pmp10G positive inclusions	2
C. abortus	2
McCoy cells	2
Pmp positive inclusions	2
pmps	2
Chlamydia abortus (C. abortus; formerly Chlamydophila abortus) infection	2
Type V autotransporter protein family	2
polymorphic membrane proteins (Pmps)	2
regional or subtype-specific protective vaccine	2
intersubtype recombinants	2
novel subtypes	2
full spectrum of subtype	2
FIV in the UK	2
isolates worldwide	2
representative subtype	2
Subtype A strains	2
likely subtype A/C recombinant	2
predominant subtype	2
bar one sequence	2
environs	2
47 FIV strains	2
novel env sequences	2
single subtype	2
FIV strains	2
monovalent vaccines	2
five distinct subtypes (A–E)	2
domestic and non-domestic felids	2
Feline immunodeficiency virus (FIV)	2
distinct haemoplasma species	2
surface of a RBC	2
intracellular electron dense structures	2
oval organism	2
discoid-shaped organisms	2
wild felids	2
Swiss pet cat	2
turicensis’ (CMt)	2
Candidatus M.	2
cats: Mycoplasma haemofelis (Mhf), ‘Candidatus Mycoplasma haemominutum’ (CMhm)	2
haemotropic mycoplasmas	2
nov.	2
sp.	2
Candidatus Mycoplasma aoti’	2
name ‘	2
existence of a novel haemoplasma species in an owl monkey	2
fixed, stained and archived blood smears	2
haemoplasma DNA	2
generic haemoplasma qPCRs	2
‘Candidatus Mycoplasma kahaneii’	2
haemominutum clade of haemoplasmas	2
owl monkey haemoplasma	2
Sequence data	2
Partial 16S rRNA and ribonuclease P ribosomal gene fragments	2
haemoplasma species	2
host DNA	2
qPCRs	2
amplification control	2
human glyceraldehyde-3-phosphate dehydrogenase qPCR	2
generic haemotropic mycoplasma (haemoplasma) quantitative real-time PCR (qPCR)	2
archived fixed and stained blood smears	2
captive owl monkey (Aotus trivirgatus)	2
RefSeq herpesvirus accessions	2
One of the most promising secondary databases	2
secondary databases	2
knowledge base	2
Nucleotide sequence accessions	2
3 subfamilies	2
Herpesvirales	2
former family Herpesviridae	2
International Committee on Taxonomy of Viruses	2
archived Mongolian Goatpox virus strain	2
recent goatpox outbreaks	2
gene from virus	2
2008 Mongolian Goatpox virus strain	2
previously published sheeppox strains	2
2006–2007 Mongolian Sheeppox virus strain	2
archived 1967 strain of Goatpox virus	2
Mongolian sheeppox and goatpox viruses	2
communal herding	2
geographically distant areas of Mongolia	2
two outbreaks	2
commonly detected canine haemoplasma species	2
amplifiable sample DNA	2
internal control	2
canine haemoplasma qPCR assays	2
dually infected	2
CMhp alone	2
184 remaining Trinidadian samples	2
canine GAPDH DNA	2
One Trinidadian sample	2
Tanzanian samples	2
non-target canine haemoplasma species	2
sequence-specific plasmid	2
106 copies	2
sequence-specific haemoplasma plasmid	2
canine glyceraldehyde-3-phosphate dehydrogenase (GAPDH)	2
16S rRNA gene sequence data	2
Trinidadian veterinary hospital	2
canine blood	2
endogenous internal control	2
quantitative real-time PCR assays (qPCRs)	2
anaemic splenectomised dog	2
“Candidatus Mycoplasma haematoparvum” (CMhp)	2
splenectomised or immunocompromised dogs	2
Two canine haemoplasma species	2
cold and warm reactive erythrocyte-bound antibodies	2
‘Candidatus M. turicensis’ infection	2
‘Candidatus M. haemominutum’	2
Group TU	2
cats antibodies	2
Groups HM and TU	2
Groups HM and TU cats	2
Group HF cats	2
Cats in Group TU	2
haematology, Coombs’ testing	2
‘Candidatus M. haemominutum’ (Group HM: 3 cats) or ‘Candidatus M. turicensis’ (Group TU: 3 cats	2
either Mycoplasma haemofelis (Group HF: 10 cats	2
Dof genes	2
MeDof duplicates	2
21 MeDof duplicates	2
Dof family genes	2
cassava (Manihot esculenta, Euphorbiaceae), the sixth major staple crop	2
plant-specific transcription factor family	2
Dof proteins	2
ItGRP genes	2
roots, stems, young and mature leaves and flowers	2
I. trifida, Arabidopsis thaliana, Zea mays L. and Oryza sativa	2
GRP family members	2
progenitor of the sweet potato	2
genome of I. trifida	2
genome of sweet potato	2
Ipomoea plant species	2
GRP gene family	2
one of the most important crops	2
genus Ipomoea	2
Sweet potato	2
N- or C-terminus	2
Glycine-rich RNA-binding proteins (GRPs) contain RNA recognition motif (RRM) and glycine-rich domains	2
EGFR/AKT signaling	2
CCA patients	2
EGFR/AKT	2
NTS-depleted cholangiocarcinoma cells and control cells	2
PI3-K inhibitor LY294002 or EGFR inhibitor Erlotinib	2
EGFR/AKT pathway	2
cholangiocarcinoma cell metastasis	2
cholangiocarcinoma vs. non-cancerous tissues	2
endocrine agent	2
Neurotensin (NTS)	2
AMD (C3, CFH, CFHR5, CFI, and DNMT3A) and RA (KRTAP13-4)	2
genic regions	2
8836 samples	2
exome dataset	2
whole genome sequenced samples	2
genotype-on-phenotype reverse regression	2
large sequencing datasets	2
disease subjects	2
Myzus persicae	2
atypical (3799aa) IP3R receptor	2
manually curated ORFs	2
insect orders	2
unique introns	2
less well conserved organisation	2
IP3Rs	2
two channels	2
highly conserved mutually exclusive splice site	2
5′ end of the channels	2
majority of conserved introns	2
fewest introns)	2
simplest genes	2
different insect orders	2
major insect orders	2
different insects	2
manually curated ryanodine receptor (RyR) and inositol 1,4,5-trisphosphate receptor (IP3R) ORFs	2
insect classes	2
two major ion channels	2
FSHR and ERβ in the ovaries	2
ERβ and FSHR mRNAs and proteins in the ovaries	2
FRBI-2, FRBI-3 and FRBI-4 groups	2
FRBI-treated mice	2
FRBI-2, FRBI-3 and FRBI-4	2
secondary follicles of FRBI-3 and FRBI-4 groups	2
FRBI-4 group	2
FSHR and ERβ mRNAs and proteins in mouse ovaries	2
Mice of FRBI-1, FRBI-2 and FRBI-3, FRBI-4 were intramuscularly	2
normal ovarian tissues	2
FSH receptor (FSHR) and estrogen receptor-beta (ERβ) in the mice ovaries	2
characters	2
PER and TIM	2
transgenes present	2
heterospecific coevolved module	2
TIM and PER	2
pair of hemizygous transgenes	2
corresponding arrhythmic D. melanogaster mutant (per01 or tim01)	2
D. pseudoobscura per or tim transgenes	2
circadian clock feedback loop	2
two important negative regulators	2
interacting clock proteins	2
genetically arrhythmic Drosophila melanogaster hosts	2
loading-related stimuli	2
cells in aged bone	2
young than aged	2
similar signalling cascades	2
Loading regulates genes	2
inter-related transcription factors	2
TNFα and TGFβ superfamily components	2
aged bone	2
MAPK, Wnt and cell cycle components	2
non-loaded aged bones	2
mice per loading group	2
mice per age group	2
cortical shells	2
19-week-old) and aged (19-month-old) female mice	2
Young adult (	2
underlying mutations	2
similar *2001 and *0301 multi-marker haplotypes	2
several breeds	2
three breeds	2
*2001 haplotype	2
*0301 haplotype	2
lifetime lambs	2
haplotypes tested	2
Rambouillet, Columbia, and Polypay sheep	2
DRB1 SNP haplotypes	2
important MHC gene DRB1	2
tightly linked vertebrate genes	2
organized cluster	2
intron-containing end-processed tRNA precursors	2
CCA sequence	2
CCA1 gene encoding ATP(CTP):tRNA nucleotidyltransferase	2
3′ end of pre-tRNAs	2
auxiliary CCA nucleotides	2
glucose medium	2
deleted gene encoding Maf1 (maf1Δ)	2
medium with glucose to medium with glycerol, a non-fermentable carbon source	2
protein Maf1	2
cultivars genetically	2
309.52Kb region	2
chromosome 5	2
QTL cluster in C5-1–C5-2	2
set of BC4F2 lines	2
thirty-one QTLs	2
elite indica line Big Grain1 (BG1) and a japonica line Xiaolijing (XLJ)	2
set of recombinant inbred lines (RILs)	2
functional variants	2
M. persicae channel	2
highly conserved transmembrane region	2
insect and vertebrate RyRs	2
aphid RyR	2
M. persicae	2
complete open reading frame of the RyR	2
cloned cDNAs	2
large endoplasmic calcium release channel	2
ryanodine receptor (RyR)	2
diamides	2
aphid populations	2
synthetic diamide insecticides	2
many insecticidal classes	2
agricultural pests	2
peach potato aphid, Myzus persicae	2
One region	2
telomerase catalytic subunit (TERT)	2
KEGG group map04080	2
general linear models	2
adult peripheral blood	2
46 samples	2
27578 CpG sites	2
healthcare system	2
aging population	2
p53-independent pathways	2
limited subset of genes	2
common sets of genes	2
identified datasets	2
various cellular models	2
genes encoding ribosomal proteins	2
Toll-like receptor 2 genes	2
multiple binding regions	2
two regions of the extracellular domain	2
localised positively-selected sites	2
artiodactyl and primate lineage	2
mammalian phylogeny	2
gene in sheep breeds	2
TLR2 gene	2
wide variety of pathogens	2
diverse range of environments	2
1400 breeds of sheep	2
range of pathogenic groups	2
intracellular Toll/Interleukin 1 receptor domain	2
membrane spanning region	2
extracellular leucine-rich repeat domain	2
bacteria, fungi, protozoa and viruses	2
wide repertoire of pathogens	2
inflammatory responses	2
mouse dendritic cells	2
target gene locus	2
endogenous proteins of interest	2
MTT1 promoter	2
codon-optimized pac	2
puromycin dihydrochloride	2
codon-optimized pac gene	2
pac gene	2
maker gene	2
puromycin-N-acetyltransferase gene (pac)	2
Val108/158Met polymorphism	2
Mexican (63% Met allele) population	2
Asian (29% Met allele) and African (34% Met allele) populations	2
Caucasian (54% Met allele)	2
common allele	2
common single nucleotide polymorphism (SNP) Val108/158Met of the COMT gene	2
studied population	2
functional variant Val108/158Met (rs4680)	2
studied polymorphism	2
COMT gene	2
Catechol-O-methyltransferase (COMT) inactivates the catecholamines adrenaline, noradrenaline and dopamine	2
long, internally repetitive, TIRs of Galileo and other Foldback-like elements	2
large genome	2
THAP recognition sequence	2
fully active transposase	2
THAP domains	2
Galileo copies	2
higher-order multimers of the transposase	2
complicated structure	2
Galileo ends	2
tandem repeats	2
transposon end	2
proximal DNA binding site	2
DNase I footprinting	2
respective Galileo TIRs	2
constituent THAP domains	2
three species of Drosophilids	2
Galileo transposase	2
consensus and ancestral sequences	2
Foldback elements	2
unusually long terminal inverted-repeats (TIRs)	2
P-element superfamily	2
DNA transposon	2
pitfalls	2
ADA-SCID, SCID-X1, CGD and WAS	2
different viral vectors	2
different PIDs	2
patient-derived autologous hematopoietic stem cells (HSCs)	2
therapeutic transgene via viral vectors	2
several primary immunodeficiency disorders (PIDs)	2
Turkish patient	2
Gln233*)	2
members of the families	2
coding regions of SLC19A2	2
anemia	2
healthy family members	2
SLC19A2 gene	2
complex network of mechanisms	2
VK.This study	2
Culex pipiens pallens	2
rhodopsin receptor gene	2
acetylcholinesterase and the GABA receptor	2
target site resistance genes	2
cytochrome P450 genes, CYP6P3 and CYP6Z2	2
carbamate resistant mosquitoes	2
pyrethroids/DDT and dieldrin resistance	2
L1014F kdr	2
pyrethroids, DDT and dieldrin	2
Vallée du Kou (VK)	2
principle malaria vector Anopheles gambiae	2
haptoglobin or haptoglobin-related protein	2
adjacent genes	2
HPR/apo-L complex	2
cholesterol system	2
i.e. linking HPR	2
Haptoglobin-related protein binds Hb and apolipoprotein-L	2
derived Hp2 allele of the HP gene	2
CNV	2
single markers	2
British Women's Heart and Health Study	2
LDL-C	2
different possible haptoglobin complexes	2
HP (Hp1/Hp2)	2
free Hb	2
bind	2
haptoglobin and haptoglobin-related protein	2
related and contiguous genes	2
telomeric G-quadruplex structures	2
helicase resolves telomeric G-quadruplex structure	2
telomerase	2
cells in S-phase	2
telomerase or the helicase	2
various eukaryotes and E. coli	2
human RecQ protein-like 4 helicase	2
G-quadruplex structures	2
G-quadruplex structure	2
replication telomeric G-quadruplex structure	2
telomere-end-binding proteins (TEBPs)	2
ciliate telomeres	2
G-quadruplex DNA structures	2
CEH-63 co-ordinately activates mbr-1	2
mbr-1 promoter	2
CEH-14 and CEH-63 individually	2
helix–turn–helix transcription factor MBR-1	2
LIM-homeodomain protein CEH-14	2
transcriptional regulatory cascade	2
DVC axon projection	2
potential ceh-63 null mutant	2
head and tail	2
additional unidentified cells	2
full-length CEH-63	2
encoding GFP	2
reporter gene fusion	2
reproductive hermaphrodites	2
two pairs of uterine cells	2
interneuron DVC	2
152 amino acids	2
single-homeodomain transcription factor	2
C. elegans homeobox gene ceh-63	2
Homeobox proteins	2
proximodistal axis	2
Prod 1 promoter	2
AL1 cells	2
separate site 1 or site 2 mutants	2
contralateral distal blastemas	2
(site 1+site 2) mutant promoter	2
contralateral distal blastema	2
proximal blastema	2
axolotl limb blastemas	2
promoter constructs	2
Meis site 2	2
Meis site 1	2
Prod 1 and Meis 1 and 2	2
cultured axolotl limb cell line	2
nucleofecting AL1 cells	2
various combinations in promoters	2
two candidate sites	2
axolotl Prod 1 promoter	2
three finger protein Prod 1	2
salamanders the blastemal cells	2
either isolated mitochondria	2
nuclear backgrounds	2
cultured A549 human lung carcinoma cells	2
either haplogroup H or haplogroup T	2
transmitochondrial cybrids harbouring mitochondria	2
nuclear genes or other factors	2
bearing haplogroup T.	2
mitochondria bearing haplogroup H	2
common European mitochondrial DNA haplogroups	2
mouse promoter sets	2
promoter sets	2
ATG deserts	2
promoters (both classes)	2
TSS	2
CpG island associated promoters	2
core promoters	2
rigid regions	2
TATA box and TSS	2
human and mouse promoter sequences	2
DBTSS database	2
30,954 human and 18,083 mouse transcripts	2
silico the promoters	2
ad/abaxial side of petals	2
V. faba flowers	2
conical petal epidermal cells	2
conical cells	2
32 genotypes of the crop Vicia faba	2
genera and families	2
surface of bee-pollinated flowers	2
conical shaped petal epidermal cells	2
petal epidermal cells of a flower	2
cell wall degrading enzymes of the pod wall	2
chemical structure	2
sclerenchymatous dorsal bundle caps	2
pod wall	2
surrounding tissues or external agents	2
cells at the separation layer	2
two halves	2
mesocarp	2
lignified fiber cap cells in the suture	2
cells of the inner sclerenchyma layer	2
dorsal and ventral dehiscence zones	2
pod walls	2
binding sites of its margins	2
abscission layers	2
Soybean pod	2
pod shattering	2
targetable rearrangements	2
ALK FISH	2
multiplexed targeted next generation sequencing assay (Oncomine Solid Tumor Fusion Transcript Kit, Thermo Fisher Scientific)	2
EML4-ALK, EZR-ROS1 and KIF5B-RET fusions	2
EZR-ROS1 (1/52 cases), KIF5B-RET (1/52 cases) and MET-MET (4/52 cases) fusions	2
OFA panel	2
ALK rearrangements	2
non-ALK rearranged, and 24 untested cases	2
ALK rearranged	2
gene fusions	2
panel of predictive cancer tests	2
national pathology community	2
tight time frame	2
different EGFR antibodies and detection systems	2
34 institutions	2
cytoplasmic versus membranous staining	2
7 panel institute	2
correctly assessed sample	2
EGFR-positive and 2 negative lung sqNSCLC samples	2
German speaking countries	2
institutes of pathology	2
identical cases	2
selected panel	2
additional pathology institutes	2
appropriate cancer samples	2
Two lead institutes	2
reliable and reproducible, immunohistochemically based biomarker test	2
German pathology community	2
squamous non-small cell carcinoma (SqNSCLC)	2
monoclonal anti-EGFR antibody Necitumumab	2
downstream signaling pathway	2
IL-8 and SP-D (P<0.05) and MMP2 and MMP8 expression (P<0.05)	2
COPD+hAEC group	2
MMP2 and MMP8	2
IL-8 and SP-D (P<0.05)	2
COPD rat model	2
Smoke fumigation	2
radioimmunoassay, surfactant protein D (SP-D)	2
placenta of healthy donors	2
model establishment rats in the AEC group	2
control, COPD, and COPD+hAEC groups	2
Twenty-four specific pathogen-free Wistar rats	2
human amniotic epithelial cell (hAEC)	2
analysis software	2
reclassified cases	2
digital D-Sight Fluo 2.0 microscope	2
tissue slide	2
Her2 immunohistochemistry	2
invasive breast cancer	2
Software analysis products	2
optical microscope	2
pathologist	2
AimHer2 protein	2
HER-2 DNA Probe Kit	2
PathVysion®	2
manual HER2 IQFISH pharmDx™ assay	2
reliable and robust assay	2
HER2 IQFISH pharmDx (Dako Omnis)	2
gene and centromere signals	2
non-toxic buffer	2
Dako Omnis	2
automated staining platform	2
(Dako Omnis)	2
HER2 IQFISH	2
Different slide-based assays	2
number of different HER2 inhibitors	2
breast cancer the human epidermal growth factor receptor 2 (HER2)	2
RCCs	2
TSC/6 non-TSC)	2
1 RCC	2
epithelioid AML	2
AMLs	2
Hamartin stained myoid cells	2
luminal PT-like stain	2
Eosinophilic cysts	2
hamartin and cytoplasmic staining	2
distal tubules/collecting ducts	2
proximal tubules (PT)	2
controls and study cases	2
large eosinophilic cells	2
eosinophilic cysts (EC)	2
14 TSC cases	2
clear cell RCCs	2
sporadic cases of AML	2
tumor nephrectomies	2
non-neoplastic kidney	2
TSC-associated renal cell carcinomas (RCC)	2
18 cases	2
hamartin and tuberin protein expression	2
multiple angiomyolipomas (AMLs)	2
possible TSC cases	2
TSC cases	2
hamartin and tuberin	2
Tuberous sclerosis complex (TSC)	2
individuals whose metabolism	2
cold-acclimated amphipods	2
thermal acclimation groups	2
Cold-acclimated amphipods	2
warm-acclimated group	2
cold-acclimated group	2
aquatic ectotherm Gammarus fossarum (Koch, 1836)	2
sufficient oxygen	2
fully transparent physiological model	2
physiological sensor data-driven predictive models	2
training and mission planning tools	2
military applications	2
Givoni-Goldman equilibrium body core temperature prediction model	2
HSDA	2
pragmatic applications	2
Physiological models	2
EH product	2
non-heated controls	2
group of animals	2
white blood cells in rats	2
erythrocyte structure	2
pre-treated with PBS	2
erythrocytes in rats	2
concentration of vesicles	2
bloodstream of heat-stressed rats	2
serum of these animals	2
heat	2
yeast fermentate EpiCor (EH)	2
special diet and probiotics	2
human and animals	2
ICI + SMI combination	2
corresponding targeting agents	2
major immune checkpoint molecules	2
immune checkpoint inhibitors (ICIs)	2
attractive combination partner	2
small-molecule inhibitor (SMI)	2
therapeutic regimens	2
promising anti-cancer target	2
immune checkpoint molecule	2
MSC-derived EVs content	2
extracellular vesicle (EVs)	2
many cellular elements	2
tumour environment	2
epigenetic factors EZH2, HDAC2, HDAC6 and BRD2	2
DNA repair proteins PARP and ATR	2
ovarian clear cell carcinoma	2
ARID1A mutant context	2
deleterious mutations	2
SWI/SNF complexes	2
SMARCA4	2
ATPases SMARCA2	2
DNA targeting members ARID1A and ARID1B	2
SWI/SNF complex	2
Mutual exclusive subunits	2
SWI/SNF chromatin remodeling complexes	2
Dr. Robert A. Gatenby	2
neutral passenger mutations	2
drifting population	2
surviving offspring	2
individuals in the population	2
first two components	2
LSCs in HSC niches	2
LSCs in niches	2
HSC niche	2
endosteal, reticular and perivascular niches	2
three types of HSC niches	2
red blood cells, megakaryocytes, myeloid cells and lymphocytes	2
mature blood cells	2
blood cell precursors	2
normal HSCs	2
leukemic stem cells (LSCs)	2
Acute myeloid leukemia and acute lymphoblastic leukemia cells hijack hematopoietic stem cell (HSC) niches	2
list of hallmark-specific genes	2
multiwell readers	2
hallmark	2
in-depth data collection	2
available equipment	2
experimental cancer researchers	2
mutated/altered candidate genes	2
key anti-cancer targets	2
transcriptionally silenced TSGs	2
tumor suppressor genes (TSGs)	2
effective anti-cancer medicines	2
cancer stromal cells	2
oncoprotein-targeted anticancer drugs	2
immune-suppressive environment	2
immune modulating agents	2
poorly immunogenic cells	2
cytokine screens	2
tumor microenvironment (TME)	2
secreted cell–cell signal networks	2
cancerous and immune cell types	2
wide spectrum of immune cell types	2
multiple cytokine signals	2
multiplexed immunoassays	2
cytokine antibody arrays	2
secreted signal proteins	2
cytokine antibody array	2
complex signaling network	2
advances mouse models	2
entire cancer genomes	2
human and mouse genome sequence	2
vast space	2
suitable surfactants	2
well-diffracting membrane protein crystals	2
shorter alkyl chains	2
Protein crystals	2
resulting protein-detergent complex	2
suitable mixture of detergents	2
single detergent compound	2
well-balanced hydrophilic and hydrophobic detergent portions	2
successful detergents	2
successful compounds	2
online data bank	2
unique membrane protein X-ray structures	2
native membrane	2
sufficiently stable hydrophobic environment	2
expression yields	2
pharmaceutical targets	2
major group of proteins	2
whole leaves	2
single macrodomains	2
negative band	2
typical split signal	2
normal leaf tissue	2
cultivated maize leaves	2
maple leaves	2
chlorophyll a absorbance band	2
photosynthetic machinery	2
intact plant leaves	2
SPR chip surface	2
every molecule	2
two sides	2
amine-coupling immobilized ligands	2
kind of antibodies	2
Anti-G4 antibody specificity	2
G4 antigens	2
SPR biosensing	2
G4 structures	2
anti-G4 antobody	2
antibody of interest	2
two leading molecule	2
Dextran-functionalized sensor chips	2
G4 and non-G4 oligonucleotides	2
binding antigens	2
anti-G4 antibody on the SPR sensor chip	2
G4s in cells	2
Anti-G4 antibodies	2
guanine-rich sequences	2
nucleic acids secondary structures	2
efflux pumps	2
polyspecific transporters	2
potentially strong substrate-protein interactions	2
water layer	2
internal surface of the transport channel	2
layer of structured waters	2
substrate doxorubicin	2
multi-bias molecular dynamics simulations	2
three monomers	2
inner-membrane trimeric antiporter AcrB	2
most-studied polyspecific transporter	2
Resistance-Nodulation-cell Division superfamily	2
anti-inflammatory bioactivity	2
autophagic cellular recycling machinery	2
geraniin and urolithin A in M1(LPS) macrophages	2
widely consumed dietary ellagitannins	2
urolithin A-treated macrophages	2
impaired Akt/mTOR (mammalian target of rapamycin) signaling	2
urolithin A.	2
p65 (NF-kB; nuclear factor kB)	2
M1 (LPS) macrophages	2
Urolithin A	2
NO, ROS and pro-inflammatory proteins	2
stronger inhibitor	2
ResultsUrolithin A	2
reactive oxygen species (ROS) and nitric oxide (NO)	2
luminescence-based assays	2
murine J774.1 macrophages	2
geraniin and urolithin A	2
ellagitannin	2
orally consumed geraniin	2
constituent geraniin	2
Phyllanthus muellerianus	2
Biomolecular Systems	2
dynamic molecular complexes	2
biological macromolecular structures	2
dynamic biological macromolecules	2
techniques and equipment	2
exposed aromatic residues tryptophan and tyrosine	2
glycopeptide antibiotics vancomycin	2
screened ligands (glycopeptide antibiotics vancomycin and teicoplanin, and peptidoglycan components N-acetylmuramic acid, D-Ala-D-Ala and Ala-D-y-Glu-Lys-D-Ala-D-Ala)	2
purified VanSA protein	2
range of potential ligands	2
characterise ligand(s)	2
activating ligand	2
partner response regulator VanRA	2
histidine sensor kinase VanSA	2
VanRASA two-component system	2
leading hospital acquired infectious agent	2
“last-line” glycopeptide antibiotic vancomycin	2
acidic IMCD (pH<5.5)	2
acid-induced Cl− current	2
inner medullary collecting duct (mIMCD-3 cells)	2
acidic extracellular solution	2
Cl− channel inhibitors (4,4′-diisothiocyanatostilbene-2,2′-disulfonate, DIDS; flufenamic acid, FFA)	2
ClC-K2/barttin	2
larger anions	2
Cl− channels	2
NPPB-sensitive Cl− channels	2
Cl− channel inhibitor 5-Nitro-2-(3-phenylpropylamino) benzoic acid (NPPB)	2
immortalized mouse distal convoluted tubule (MDCT) cells	2
Na+ reabsorption	2
photosynthetic cyanobacteria	2
iron the suf operon	2
NifJ and other Fe-S cluster proteins	2
pyruvate:ferredoxin oxidoreductase	2
photosystems I and II	2
pre-selected target proteins	2
PCC 6803.MethodsThe approach	2
transcriptional repressor SufR	2
oxygen-evolving photosynthetic cyanobacteria	2
protein-bound cofactors	2
BackgroundIron-sulfur (Fe-S) clusters	2
K.P. Schmidt	2
non-front-fanged colubroid snake venoms	2
antivenom	2
venom	2
D. typus venom	2
three-finger toxin (3FTx); phospholipase A2 (PLA2); cysteine-rich secretory proteins (CRISP); snake venom (SV) serine proteinase (SP); C-type lectin-like (CTL); SV metalloproteinases (SVMPs); and disintegrin-like/cysteine-rich (DC) proteolytic fragments	2
seven protein families	2
venom proteins	2
immunocapture boomslang venom proteins	2
Professor Karl Patterson Schmidt	2
snake	2
venom of Dispholidus typus (boomslang)	2
small number of species	2
venoms	2
snakes	2
extant ophidian species	2
BackgroundNon-front-fanged colubroid snakes	2
Dr. Concetta Giancola and Dr. Daniela Montesarchio	2
Special Issue entitled "G-quadruplex" Guest Editor	2
involved nucleic acid regions	2
steric hindrance	2
G4s containing long loops	2
G-tracts	2
longer loops	2
oligonucleotide/loop sequence	2
complex sequences	2
G4s in promoter regions	2
telomeric G4 target sequences	2
purified full-length human NCL	2
G bases	2
dimethylsulfate footprinting	2
circular dichroism	2
NCL/G4 binding determinants	2
Nucleolin (NCL)	2
G-rich sequences	2
four-stranded nucleic acid structures	2
appropriate software tools	2
multiple variants	2
first mechanistic basis	2
specific IscU-IscS movements	2
CyaY in the IscS-IscU-CyaY complex	2
IscS-IscU interface	2
catalytic loop of IscS	2
experimentally-based model of a ternary IscS-IscU-CyaY complex	2
extensive molecular dynamics simulations	2
functionally binary and ternary complexes	2
prosthetic FeS cluster groups	2
biological machine	2
bacterial orthologue of frataxin	2
IscU and CyaY	2
bacterial proteins IscS	2
data and MD models	2
ordered complex system	2
two equivalents of each ligands	2
dimer structure of GFAP	2
relevant putative binding site of either ceftriaxone or phenytoin	2
GFAP-ceftriaxone (phenytoin) interactions	2
cellular model	2
phenytoin sodium	2
misfolded mutated GFAP	2
ceftriaxone a multi-potent β-lactam antibiotic	2
Jacob diseases	2
scrapie, Alzheimer's and Creutzfeld–	2
mature astrocytes	2
major intermediate filament protein	2
cellular glycosylation machinery	2
antibody glycoforms	2
defined antibody glycoforms	2
Fc glycans	2
cellular Fc receptors	2
effector molecules	2
multiple glycoforms	2
Human serum IgG	2
immunological system	2
monophosphate sodium	2
TNF (tumor necrosis factor) or 6-Bnz cAMP (N6-benzoyladenosine-3′,5′-cyclic	2
Plasmodium falciparum Proliferating-Cell Nuclear Antigen 1	2
thapsigargin or EGTA (ethylene glycol tetraacetic acid)	2
purinergic receptor agonists KN62 and A438079	2
second messenger of the pathway	2
intracellular parasitemia	2
wheat germ agglutinin staining	2
parasite asexual stage	2
infected erythrocyte cytoadherence	2
Tumor necrosis factor (TNF)	2
host signals	2
complex biology	2
Professor Gordan Lauc	2
plasma N-glycome of an individual	2
plasma N-glycome	2
five healthy donors	2
blood plasma samples	2
plasma N-glycome of individuals	2
plasma N-glycomes	2
glycan biomarkers	2
plasma N-glycans	2
biocompatible substances	2
RT B chain in Vero cells	2
lactose-conjugated Sepharose	2
RT B chain	2
1μg eGCG	2
RT in Vero and THP-1 cells	2
100μM eGCG	2
human macrophage cell line THP-1	2
ricin toxin (RT)	2
number of protein toxins	2
green tea	2
catechin, epigallocatechin gallate (eGCG)	2
General significanceThis intermediate	2
intermediate containing product	2
tighter bindings	2
amino group in 2′ and 6′	2
positively charged amino groups of aminoglycosides and Glu or Asp residues of APH	2
electrostatic bonds	2
Aminoglycoside 2″-phosphotransferase IVa, APH(2″)-IVa,	2
several clinically used aminoglycoside antibiotics	2
large class of bacterial enzymes	2
O-phosphotransferases	2
formation pores	2
bacterial wall theory	2
~0.1−1nm	2
spherical defects	2
peptidoglycan monomers	2
small defects	2
bacterial wall	2
wall of Gram-positive bacteria	2
major wall component	2
insulator (the bilayer membrane	2
lipid bilayer membrane of eukaryotic cells or Gram-negative bacteria	2
small or large chemicals	2
two NOX isoforms	2
Keap1-KD cells and tissues	2
WT counterparts	2
Nrf2-KO cells and tissues	2
Nrf2, i.e. Nrf2-knockout (Nrf2-KO), wild-type (WT), and Keap1-knockdown (Keap1-KD).ResultsWe	2
explants slice cultures	2
brain hippocampal glio-neuronal cultures	2
antioxidant proteins	2
cytoplasmic Kelch-like ECH associated protein 1 (Keap1)	2
crucial transcription factor	2
BackgroundNuclear factor (erythroid-derived 2) factor 2 (Nrf2)	2
glycogen and trehalose biosynthesis	2
glucose-1-phosphate/ADP-glucose node	2
UDP-glucose	2
glucose-1-phosphate between glycogen and trehalose in M. tuberculosis H37Rv, namely: ADP-glucose pyrophosphorylase, glycogen synthase, UDP-glucose pyrophosphorylase and trehalose-6-phosphate synthase	2
recombinant enzymes	2
metabolic pathways of glycogen and trehalose	2
Gram-positive actinobacteria	2
hostile environments	2
pathogenic prokaryote	2
asymmetric (i.e. activated) kinase	2
JM-A helices	2
start of the JM-A domain	2
positively charged residues	2
JM domain	2
R645–R647 motif of the JM domain	2
PIP2 and other lipids	2
JM	2
PIP2-containing and PIP2-depleted lipid bilayer membranes	2
transmembrane helix plus JM region (TM–JM) dimer (PDB:2M20)	2
intracellular leaflet of the cell membrane	2
anionic lipid phosphatidylinositol 4,5-bisphosphate (PIP2)	2
EGFR juxtamembrane (JM) domain	2
mammalian cell membranes	2
head-groups of Asp85 and Asp212.General significanceA	2
two aspartate residues (Asp85, Asp212)	2
retinal Schiff Base	2
water molecule (Wat402)	2
illuminated crystals	2
helices A, B and G.	2
cytoplasmic portion of helix F	2
helix G	2
extracellular portion of helix C	2
hierarchal tree	2
illuminated bR crystals	2
wild-type bR structures	2
hierarchal trees	2
independent research groups	2
electron diffraction	2
X-ray diffraction	2
simplest known light driven proton pump	2
(bR)	2
medically important transporter superfamily	2
poorly absorbed compounds	2
antibiotics and antiviral medications	2
many pharmaceutically important drug molecules	2
mammalian members of this family	2
bacterial and eukaryotic homologues	2
PTR family	2
bacterial PTR family transporters	2
reviewRecent crystal structures	2
short di- and tri-peptides	2
amino acids and nitrogen	2
bacteria peptides	2
PTR family of proton-coupled peptide transporters	2
Diverse in vitro tests	2
General significanceScarce and dispersed populations	2
wild-type or mutant proteins	2
gene encoding lysosomal alpha-galactosidase	2
functional sites	2
Ca2+ oscillations	2
NF-κB, CaMKII, MAPK and calpain	2
multiple Ca2+ binding residues	2
radio signal	2
intracellular downstream effectors	2
intracellular biological information	2
ubiquitous signals	2
organelle and the nucleus	2
Autophagic machinery	2
discrete mitochondrial genome	2
specific AQPs	2
particular membrane	2
plant and microbial AQPs	2
human AQPs	2
diverse cell membranes	2
selective pores	2
brain oedema	2
key systems of the human body	2
AQPs	2
passive channels	2
(AQP) aquaporin water channels	2
wide range of channels and receptors	2
animal neurotoxins	2
extensively disulfide-reticulated proteins	2
insecticidal Bj-xtrIT	2
fusion-carrier	2
disulfide-linked scorpion toxin	2
sub-population of misfolded Bj-xtrIT	2
four-disulfide-bridged Bj-xtrIT toxin	2
recombinant toxin	2
cells co-expressed the chaperones	2
robust expression	2
Expressed Bj-xtrIT	2
SurA and FkpA)	2
four chaperone enzymes (DsbA, DsbC,	2
Hottentotta judaica	2
β-scorpion peptide toxin Bj-xtrIT	2
multiple disulfides	2
novel therapeutics and insecticides	2
valuable probes	2
neurotoxin peptides	2
new subunit vaccines	2
vivo-induced Campylobacter jejuni antigens	2
analyzed genes	2
9 genes	2
ProS, CJBH_0976, CSU_0396 and hypothetical protein cje135_05017	2
PorA,	2
, DmsA	2
MetK,	2
CheW, TufB, DnaK,	2
identified proteins include CadF (CadF-1 and CadF-2)	2
duplicate gel	2
pre-adsorbed human sera	2
PVDF membrane	2
immunoreactive spots	2
total cell proteins	2
potential vaccine candidates	2
Bacterial in vivo-induced antigens	2
C. jejuni by chickens	2
human campylobacteriosis	2
ideal vaccine	2
Humans and chickens	2
important food-borne and zoonotic pathogen	2
traditional medicine	2
promising new pharmaceutical lead or dietary supplement	2
partial non-adipogenic PPARγ agonist	2
diabetic KKAy mice	2
3T3-L1 pre-adipocytes	2
clinically used full agonist pioglitazone	2
PPARγ-mediated luciferase reporter assay	2
purified PPARγ ligand-binding domain (LBD)	2
PPARγ ligand binding pocket	2
traditional Chinese herbal drug Magnolia bark	2
natural product honokiol	2
partial novel PPARγ agonists	2
silico, in vitro, cell-based and in vivo models	2
new PPARγ activators	2
proliferator-activated receptor gamma (PPARγ)	2
Serum Albumin	2
albumin in blood plasma	2
FA2 site	2
major binding site	2
plasma Zn2+	2
particular ligand	2
multiple ligands (including metal ions)	2
fatty acids, hormones, metal ions and drugs	2
range of small molecules	2
BackgroundSerum albumin	2
Christine Winterbourn	2
reactive oxygen species - pros and cons and biophysics of membrane proteins	2
flies and mice	2
one of these compounds	2
mitochondria-targeted probes	2
endogenous biomolecules	2
exomarker and the precursor probe	2
intact organism	2
exogenous probe compounds	2
small damaging and signalling molecules	2
four different species	2
ovum	2
sperm cell	2
different prostasome types	2
functional ATP-forming enzymes	2
four types of prostasomes	2
extracellular adenosine triphosphate (ATP)	2
dog prostasomes	2
prostasomes of different species	2
four different species proteins	2
prostasomal protein systems	2
various prostasomes	2
human, canine, equine and bovine species	2
seminal plasmas	2
extracellular context	2
multivesicular body of late endosomal origin	2
called “storage vesicle	2
another larger vesicle	2
mitochondria-targeted antioxidants, probes and pharmacophores	2
brain and liver	2
heart, white fat, muscle and kidneys	2
liver of transgenic mice	2
triple transgenics	2
brain of two hydrophobic TPP compounds, MitoQ and MitoF	2
Bcrp	2
two isoforms of P-glycoprotein (Mdr1a/1b)	2
triple transgenic mouse model	2
lipophilic compounds	2
P-glycoprotein (Mdr1a/b) and breast cancer resistance protein (Bcrp) ATP binding cassette (ABC) transporters	2
TPP-conjugated compounds	2
(TPP) cation	2
lipophilic triphenylphosphonium	2
T/C variant GPX4 (rs713041)	2
selenoprotein hierarchy	2
T/C variant GPX4 (rs713041) sequences	2
C variant	2
C variant 3′UTR	2
selenoprotein reporter gene (iodothyronine deiodinase)	2
3′UTR.MethodsThe two variant 3′UTR sequences	2
GPX4 gene	2
3′untranslated region (3′UTR) of the mRNA	2
stem-loop structure	2
specific tRNA	2
glutathione peroxidases (GPx)	2
yeast populations	2
genes and regulatory sequences	2
budding yeasts	2
high throughput sequencing technologies	2
NCS-1 or other NCS family proteins	2
live mammalian cell system	2
NFAT-GFP reporter construct	2
NCS-1 or NCS-1 mutants	2
various NCS proteins	2
NCS proteins	2
neuronal calcium sensor (NCS) proteins	2
members of the calmodulin super-family	2
vitro evidence	2
calcium-sensing protein calmodulin	2
ubiquitous phosphatase calcineurin	2
NFATs 1-4	2
five mammalian NFAT isoforms	2
Nuclear Factor of Activated T-cells, (NFAT) proteins	2
nutrient adequate diets	2
F-line birds	2
tibia and femur mineralisation	2
infected birds	2
E. maxima genome copies	2
birds	2
F birds	2
jejunumat d6pi	2
parasite genome copies	2
nitric oxide metabolites	2
vitamins E and A	2
plasma carotenoids	2
0 (control), 2500 (low-dose), or 7000 (high-dose) sporulated E. maxima oocysts	2
chickens of fast (F) or slow (S) growing lines	2
coccidian challenge	2
Eimeria parasites	2
potentially less pathogenic species	2
either benzimidazoles or ivermectin	2
highly dual-resistant population of T. circumcincta	2
particular farm	2
UK farms	2
resistance-associated mutations	2
individual T. circumcincta	2
Cooperia curticei, Chabertia ovina, Oesophagostomum venulosum and Trichostrongylus spp	2
pre-treatment populations	2
highly resistant population of T. circumcincta	2
susceptible species	2
β-tubulin isotype-1 gene	2
T. circumcincta population	2
benzimidazole resistance-associated genotypes	2
vitro bioassays	2
commercial sheep farm	2
benzimidazole and ivermectin resistance	2
primary pathogen	2
many different strongyle species	2
Ovine parasitic gastroenteritis	2
larger sample of sheep	2
Blackface lambs	2
either of the populations	2
mixture of nematodes	2
population of free-living Soay ewe lambs	2
population of domestic Scottish Blackface ewe lambs	2
twelve SNPs	2
genomic DNA of Scottish Blackface lambs	2
IL23R, RORC2 and TBX21	2
DM herbage	2
ostertagi L3/kg	2
TST implementation	2
digenean species	2
UK G. truncatula populations	2
intermediate host	2
UK’s native G. truncatula populations	2
respective cercariae	2
 F. hepatica infected G. truncatula	2
cercarial stages	2
daubneyi infected G. truncatula snails	2
G. truncatula habitats	2
F. hepatica egg outputs	2
C. daubneyi egg outputs	2
respective fluke eggs	2
Haplometra cylindracea	2
sampled G. truncatula snails	2
 G. truncatula snails	2
Welsh farms	2
F. hepatica, H. cylindracea and other parasites	2
C. daubneyi lifecycle	2
intermediate snail host G. truncatula	2
prominent parasite of livestock	2
rumen fluke (Calicophoron daubneyi)	2
infected sows	2
nearest neighbour	2
Infected sows	2
feeding trough	2
enrichment	2
research facilities	2
 T. solium naturally infected	2
naturally infected sows	2
target farms	2
much of Asia and Africa	2
polarised region- and system-specific distribution	2
south India	2
production systems	2
E. tenella	2
E. necatrix	2
large-scale broiler farms in the north	2
studied regions	2
three distinct clusters	2
poultry farm typologies	2
Eimeria occurrence	2
107 farms	2
one of the largest poultry producers	2
future subunit vaccines	2
anticoccidial drugs	2
drivers	2
least one species, Eimeria tenella	2
global poultry industry	2
spleens of cattle	2
T. parva DNA	2
lymphoid and non-lymphoid	2
infected host tissues	2
Theileria parva infected lymphocytes in bovine host lymphoid organs	2
farmers, veterinary practitioners and parasitologists alike	2
individual farmers	2
specific farms	2
mindset of farmers	2
simple tools	2
apply anti-parasite forages	2
immune system of sheep in general	2
group of farmers	2
newly purchased animals	2
sheep	2
minority of the farms	2
faecal egg counts	2
ewes	2
Ewes and lambs	2
worm species	2
Nematodirus battus	2
two most important nematodes	2
entered questionnaires	2
sheep husbandry	2
PCR-RFLP panel	2
full dataset	2
UK and Irish parasite populations	2
UK and Irish broiler chickens	2
E. tenella samples	2
original 244 isolates	2
subset of SNP markers	2
polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)	2
Eimeria tenella isolates	2
different chicken production systems	2
Eimeria species and strains in different regions	2
new, cost-effective anticoccidial vaccines	2
T. solium neurocysticercosis	2
negative control pig	2
fibrotic scars	2
one non-infected control pig	2
four pigs	2
seven pigs	2
brain tissue sections	2
pigs with T. solium neurocysticercosis	2
collagen in brain tissue	2
A. platys	2
dogs and small ruminants	2
A. platys and T. ovis in camels	2
Anaplasma platys and Theileria ovis	2
Theileria/Babesia spp. positive cases	2
Theileria/Babesia spp.	2
twenty-two samples	2
dromedary camels	2
L3s of Cylicocyclus species 42days	2
examined L3s	2
3 genera	2
cyathostomin species	2
Cylicostephanus longibursatus	2
Cylicocyclus nassatus	2
Per cyathostomin species	2
reverse line blot	2
Cultured infective larvae (L3s)	2
2 groups	2
horses per farm	2
egg producing adults	2
commonly used anthelmintics	2
macrocyclic lactones (MLs), moxidectin (MOX) and ivermectin (IVM)	2
cyathostomins in horses	2
anthelmintics currently	2
small ruminant	2
grazing systems	2
dairy cattle and sheep	2
loci or regions	2
whole genome sequence data	2
genetic markers (Single Nucleotide Polymorphisms, SNPs)	2
artificial challenges	2
natural infections	2
different host breeds	2
different nematodes	2
developing and emerging countries	2
extensive low-input/output smallholder systems	2
report outputs	2
experimental and commercial flocks	2
bioactive forages	2
copper oxide wire particles	2
gastrointestinal nematodes (GIN)	2
naturally infected calf populations	2
model parasitological outputs	2
varied inputs	2
Key model inputs	2
infected calf	2
prevalent and economically important gastrointestinal parasite of cattle	2
dynamic, deterministic model	2
useful targets	2
T. circumcincta infected sheep	2
vesicles-enriched material	2
activation-associated secreted proteins	2
proteolytic enzymes	2
metabolic proteins	2
nuclear proteins	2
structural proteins	2
unique proteins	2
vesicle-enriched and vesicle-free fraction	2
vesicle-enriched fraction	2
vesicle-enriched and vesicle-free Tci-L4ES	2
fourth stage larvae (Tci-L4ES)	2
excretory-secretory (ES) products	2
exosome-like extracellular vesicles	2
nematode species	2
temperate climatic regions	2
ovine parasitic gastroenteritis	2
brain cysticerci	2
foamy salivation	2
two infected pigs	2
cysticerci counted	2
dribbling, salivating, eye blinking, walking in circles	2
infected and 15 non-infected control pigs	2
cysticerci in brains of naturally infected pigs	2
promising system	2
resource-poor farmers	2
entire herd	2
untreated herds	2
enrolled farmers	2
cultural context	2
small ruminants, most commonly goats	2
TST system	2
low-income economies	2
gastrointestinal nematodes (GINs)	2
livestock farmers	2
intronic regions	2
exons	2
number RT-qPCR	2
resistant animals	2
ALOX15 exon 9 and IL13	2
resistant and susceptible sheep	2
Susceptible sheep	2
Th2 T cells	2
larval colonization	2
Resistant animals	2
common abomasal nematode parasite	2
veterinary parasitic helminths	2
reliable functional genomic platforms	2
vitro culture systems	2
schistosome and liver fluke RNAi	2
specific and sensitive diagnostic biomarkers	2
schistosome and filarial parasites	2
specific parasites	2
many parasitic helminths	2
3′UTR	2
target mRNA sequences	2
short, non-coding RNAs	2
particular zones	2
agroecological zones	2
three other, pathogenic parasites	2
indigenous cattle	2
mostly benign T. mutans	2
four haemoparasites (T. parva, T. mutans, A. marginale and B. bigemina)	2
Theileria parasites	2
two most common Anaplasma species	2
T. taurotragi	2
sable and T. mutans, and T. parva	2
Theileria sp.	2
T. velifera	2
several of the Theileria parasites	2
seven most prevalent haemoparasites	2
pCS20 gene region	2
species-specific PCR	2
pathogenic species Ehrlichia ruminantium	2
haemoparasites	2
minor occurrences	2
(sable) (32.7%), T. parva (12.9%) and T. taurotragi (8.5%)	2
Omatjenne (42.7%), A. bovis (39.9%), Theileria sp.	2
Theileria mutans (71.6%), T. velifera (62.8%), Anaplasma sp.	2
453 calves	2
final visit samples	2
calves	2
intensively studied cohort of indigenous calves	2
tick-borne parasites	2
microbial DNA	2
animal trypanosomosis	2
combination of various VSGs	2
seven purified proteins	2
sera samples	2
naturally T. vivax-infected bovine sera	2
two trypanosome isolates, TeGu-N/D1 and TeGu-TeracayTrino	2
soluble VSGs	2
cattle in a Venezuelan trypanosome-endemic area	2
infected bovine sera	2
various soluble VSGs	2
cross-reacting conformational epitopes	2
VSG glycosyl-phosphatidylinositol cross-reacting determinant epitope	2
sera from animals infected with either T. evansi or Trypanosoma (Dutonella) vivax	2
cross-reacting antigens	2
purified VSGs	2
VSGs from Trypanosoma (Trypanozoon) brucei and Trypanosoma (Trypanozoon) evansi	2
different gene products	2
purified soluble VSGs	2
concanavalin A-binding proteins	2
predominant VSGs	2
Soluble forms	2
adult albino rats	2
several geographical areas of Venezuela	2
TeGu-TerecayTrino, TeGu-Terecay03 and TeGu-Terecay323	2
Seven cryopreserved animal trypanosome isolates known as TeAp-ElFrio01, TEVA1 (or TeAp-N/D1), TeGu-N/D1, TeAp-Mantecal01	2
large repertoire of VSG genes	2
one variant surface glycoprotein (VSG)	2
Salivarian trypanosomes	2
effective formulation	2
Advocate® spot-on	2
rescue dose of Advocate®	2
animals in Group C	2
one dog	2
dogs in Group T	2
Animals in Group T	2
two different study groups	2
nasal capillariosis	2
rhinoscopy or species-specific PCR-coupled sequencing assays	2
Sixteen dogs	2
Eucoleus boehmi)	2
Capillaria boehmi (syn.	2
spot-on formulation containing 10% imidacloprid and 2.5% moxidectin (Advocate®, Bayer Animal Health GmbH, Leverkusen, Germany)	2
adult parasites	2
T. cati larvae	2
kittens and adult cats	2
Infected treated cats	2
enlarged pulmonary arteries	2
Thoracic radiographs	2
Lung lesions	2
untreated cats	2
treated cats	2
cats in the infected groups	2
infected treated group	2
uninfected controls	2
adult worm infections	2
feces of most but not all cats	2
infected untreated adults	2
infected untreated kittens	2
Adult T. cati	2
thoracic radiographs	2
bronchial–alveolar lavage (BAL)	2
cats	2
infected untreated adult group	2
2- to 3-year-old adult multiparous female SPF cats	2
infected treated group (topical moxidectin and imidacloprid, Advantage Multi for Cats, Bayer Healthcare LLC)	2
uninfected untreated control group	2
infected untreated group	2
(SPF) kittens	2
Four-month-old specific pathogen free	2
oral doses of L3 T. cati larvae	2
Cats in infected groups	2
adult cats	2
preventative medication	2
Toxocara cati eggs	2
definitive hosts bears, giant pandas and raccoons (occasionally dogs)	2
three Baylisascaris species: B. transfuga, B. schroederi and B. procyonis	2
mammals including humans and in birds	2
Baylisascaris spp.	2
intermediate hosts larvae	2
definitive and intermediate hosts	2
second-stage larva	2
faeces embryonate	2
relatively host-specific, parasite species of carnivores, omnivores, herbivores, carnivorous marsupials or rodents	2
nematode genus Baylisascaris (order Ascaridida, superfamily Ascaridoidea)	2
veterinary and public health professionals	2
pet owners	2
dogs and cats	2
Human toxocarosis	2
vectors or intermediate hosts	2
human environment	2
excreting eggs	2
zoonotic nematodes	2
Pet dogs and cats	2
egg contamination	2
primary source of eggs	2
public areas	2
total egg output	2
sympatric cats, dogs and foxes	2
specified areas	2
different definitive host populations	2
different sympatric definitive host populations	2
eggs from soil and other environmental reservoirs	2
companion and wild animals	2
many different regions and situations	2
Toxocara species in definitive hosts	2
larvae in both the paratenic and the definitive host	2
presented species	2
variety of possible paratenic hosts	2
paratenic hosts	2
definitive hosts or humans	2
infected paratenic hosts	2
so-called paratenic hosts	2
animal species	2
zoonotic roundworms Toxocara canis and T. cati	2
tissue-phase parasites	2
cultured larvae	2
four mRNAs	2
vitro-cultivated larvae	2
new and more accurate diagnostic tests	2
antigenic determinants	2
closely related Toxocara cati	2
T. canis-specific	2
mono-methylated trisaccharide	2
anti-lectin antibodies	2
trisaccharides	2
blood-group-like trisaccharide	2
multiple glycan side-chains	2
mucins	2
newly vacated focus	2
host antibodies and cells	2
parasite epicuticle	2
specialised mucin-rich surface coat	2
infected sites	2
mammalian lectins	2
one lectin (CTL-1)	2
lectins, mucins and enzymes	2
‘excretory–secretory’ products	2
larval stages invading musculature, brain and the eye	2
intestinal tract of its definitive canid host	2
tissues of diverse vertebrate species	2
key biological questions	2
Toxocara species	2
‘-omic’ technologies	2
parasite–host interactions	2
ecology of Toxocara species	2
humans with toxocarosis	2
MHC polymorphisms	2
TGF-β1 polymorphism	2
TGF-β1 variant Leu10Pro	2
local organs	2
beneficial environment	2
potential susceptibility loci HLA class II molecules	2
mouse small intestine, liver, muscle, and brain	2
regulatory (Treg) cells	2
+-expressing	2
Foxp3+ CD4+CD25	2
HLA class II	2
HLA class II molecules	2
human leucocyte antigen (HLA)	2
environmental and host genetic factors e.g. MHC class I and II	2
asymptomatic CT	2
visceral larva migrans (VLM), ocular larva migrans (OLM) or covert toxocarosis (CT)	2
contaminated food	2
embryonated eggs or encapsulated larvae	2
direct assay	2
human BAL fluid	2
DNA in bronchoalveolar lavage (BAL) of experimentally-infected mice	2
Superfamily Ascaridoidea	2
Toxocara canis and other nematodes	2
parasite eggs in faeces	2
parasite in tissue biopsies	2
serological assays	2
parasite-specific antibodies	2
Toxocara spp. of dogs and cats	2
eosinophil cationic protein (ECP)	2
IgG4 or circulating Ag	2
subclasses	2
IgE and IgA	2
classes of immunoglobulins	2
specific IgM	2
specific IgG	2
bacterial, viral or protozoal (toxoplasmosis) infections	2
ongoing clinical and laboratory context	2
residual antibodies	2
residual specific antibodies	2
helminthosis	2
infected subjects	2
benign infection	2
Covert toxocariasis	2
covert toxocariasis	2
generalised forms of toxocariasis, visceral larva migrans (VLM)	2
ascarid worms	2
larvae of Toxocara spp	2
helminth zoonosis	2
COWP-treated goats	2
treated versus the non-treated goats	2
humanely slaughtered	2
concrete pens	2
pasture	2
treated (COWP) and eight non-treated (CONTROL) goats	2
Haemonchus contortus-infected pasture	2
indigenous male goats	2
grazing goats	2
copper oxide wire particles (COWP)	2
tapeworm infections	2
TSOL16–TSOL18 vaccines	2
viable cysts	2
5mg Quil-A. Necropsies	2
local villagers	2
one vaccinated and one control animal	2
n=137)	2
Pairs of pigs	2
TSOL16 and TSOL18	2
combination of two recombinant antigens	2
pair-matched vaccination trial field	2
Oncosphere antigens	2
similar agro-ecological zones	2
farming system	2
Haemonchus contortus in indigenous goats	2
pre- and post-treatment faecal cultures	2
Haemonchus spp.	2
n=73)	2
COWP-treated group	2
FAMACHA© system	2
Faecal egg counts	2
goat in the treated group	2
4g COWP bolus	2
treated or control group	2
15 herds	2
female goats	2
summer rainfall season	2
indigenous goats	2
Copper oxide wire particles (COWP)	2
chemical anthelmintics	2
tropics and subtropics	2
nodule-dwelling Wolbachia-positive Onchocerca spp.	2
haematoxylin and eosin	2
Tissue sections	2
frozen worms	2
DNA extracts	2
Wolbachia-specific sequences	2
specific anti-Wolbachia surface protein antibody	2
n=54)	2
O. armillata adult worms	2
O. volvulus in humans	2
certain Onchocerca spp	2
host inflammatory cell environment	2
primitive species	2
abundant parasite of African cattle	2
unknown Wolbachia status (Onchocerca dukei and Onchocerca armillata)	2
Wolbachia-positive (Onchocerca gutturosa and Onchocerca ochengi)	2
West African cattle	2
relevant, analogous host–parasite model system	2
genus Wolbachia	2
tissues endosymbiotic, Rickettsia-like bacteria	2
all, filarial nematodes	2
filarial nematode Onchocerca volvulus	2
River Blindness	2
Human onchocerciasis	2
ticks fed	2
parasite population	2
immunising genotype	2
immunised calf	2
mixed parasites	2
resulting stabilates	2
parasite populations	2
naïve cattle and ticks	2
8.5Mb genome	2
available polymorphic markers	2
new satellite markers	2
4 T. parva chromosomes	2
newly identified PCR-RFLP markers	2
additional polymorphic markers	2
large segments of the genome	2
recently described panel of satellite markers	2
field populations of the parasite	2
T. parva stocks	2
one or two dominant antigens	2
T. parva	2
tick-borne protozoan parasite Theileria parva	2
species of Anaplasma and Ehrlichia	2
wild type A. marginale	2
native tr region of A. marginale	2
entire plasmid pHimarAm-trTurboGFP-SS	2
insertion site	2
brightly fluorescent Anaplasma	2
combination of spectinomycin and streptomycin	2
tick cell culture	2
A. marginale St. Maries	2
A. marginale tr promoter	2
fluorescent and the selectable markers	2
trans constructs	2
A. marginale chromosome	2
Himar1 allele A7	2
TurboGFP and spectinomycin/streptomycin resistance genes	2
transposase expression plasmid, pET28Am-trA7)	2
transposon bearing plasmid, pHimarAm-trTurboGFP-SS	2
plasmid constructs	2
human anaplasmosis agent	2
prokaryotes in the genera Anaplasma, Ehrlichia, and Rickettsia	2
cattle farming	2
ruminants and ixodid ticks	2
tick-borne pathogen, Anaplasma marginale	2
extremely virulent T. congolense strains	2
T. congolense strains	2
PCV	2
group of six mice	2
one of three strains	2
Groups of six mice	2
trypanosomiasis focus	2
Trypanosoma congolense strains	2
established H. contortus infections	2
conventional anthelmintics	2
COWP boluses	2
4-g COWP	2
2-g COWP	2
ESTGRP goats	2
2-g and 4-g COWP boluses	2
ESTGRP	2
abomasa and small intestines	2
38 goats	2
H. contortus larvae	2
4-g COWP bolus each	2
“developing” infection group (DEVGRP)	2
4-g COWP bolus	2
“established” infection group (ESTGRP)	2
ca.1200 infective larvae of H. contortus	2
male faecal egg-count-negative goats	2
H. contortus	2
copper oxide wire particle (COWP) boluses	2
major anthelmintic groups	2
trypanosomiasis endemic areas	2
major livestock species	2
cattle, pigs and goats	2
trypanosome infections	2
59 villages	2
324 pigs	2
333 goats	2
plateau of the Eastern Province of Zambia in Katete and Petauke districts	2
main food source of tsetse	2
game animals	2
different livestock species (cattle, pigs and goats)	2
oesophageal epithelium	2
adult mouse oesophageal epithelium	2
Tff3, villin, K8 and E-cadherin	2
p63, K14, K4 and loricrin	2
normal SSQE	2
oesophageal organ culture system	2
HNF4α in human biopsy samples	2
adult murine oesophagus	2
new organ culture system	2
Biopsy samples	2
primary organ cultures	2
two transcription factors, Cdx2 and HNF4α	2
stratified squamous epithelium	2
oesophageal adenocarcinoma	2
morphological precursor	2
myogenin transcription	2
IGF-I	2
myogenin and IGF-	2
MyoD and IGF-I mRNAs	2
gastrocnemius muscle of broilers	2
ED16 (raised myogenin, IGF-I)	2
raised myonuclei, MyoD and PCNA)	2
pectoral muscle of broilers	2
(ED)	2
pectoral (selected) and gastrocnemius (unselected) muscles of chick embryos	2
egg-layers	2
pectoralis major of broilers	2
leg muscularity yield	2
greater pectoral	2
food supplies	2
ligated glands	2
SMG-B	2
adult regenerating gland	2
adult stage	2
intercalated ductal cells	2
proteins SMG-B	2
AB/PAS positive acinar cells	2
embryonic-like branched structures	2
Regenerating tissue	2
several normal-looking acini	2
regenerated glands	2
duct	2
chorda lingual nerve	2
main duct of the submandibular gland	2
metal clip	2
existing acini	2
Rat submandibular gland	2
modern archaea	2
last archaeal/eukaryotic ancestor	2
MCM helicase	2
co-activator	2
evolutionarily-related archaeal GAN and bacterial RecJ	2
essential replication factor	2
gap region of the collagen fibril	2
lysine and arginine AGEs	2
abundant glucosepane cross-link	2
intra-molecular 3-deoxyglucosone-derived imidazolium cross-link (DOGDIC)	2
collagenous tissue	2
Covalently cross-linked advanced glycation end products (AGE)	2
possible targeting protein	2
loop residues	2
two consensus-based secondary structure mutations (A-U→C-G)	2
apical stem-loop of hepatitis B virus	2
Flexible parts	2
similar nanoparticles	2
nano-bio interface devices	2
range of hydrophobic nanoparticles and related materials	2
intractable carbon nanotubes	2
1:1 protein:C60 stoichiometry	2
stable aqueous dispersions	2
natural surfactant proteins latherin and ranaspumin-2 (Rsn-2)	2
pristine C60 in water	2
C60 fullerene	2
standard sample	2
HJ	2
Holliday junction (HJ) DNA in solution	2
one of the few proteins	2
parameter	2
folded and unfolded species	2
sequential imaging format	2
H and O isotopes	2
purified biological molecules	2
fibroblast cells	2
functional multidrug resistance transporter NorA	2
diffusing assemblies	2
proteins and lipids	2
micelles, liposomes and aggregates in heterogeneous mixtures	2
microliters of sample	2
nanoscale assemblies	2
air–water and other interfaces	2
previously discovered hydrophobins of fungi	2
salivary, oral and upper respiratory tract proteins	2
horse sweat	2
unique chromophoric crosslink	2
different species of frog	2
Ranasmurfin, a blue protein	2
developing eggs and embryos	2
stable, biocompatible, protective foam environment	2
range of proteins	2
tropical frog foam nests	2
ranaspumins	2
variety of biological sources	2
Naturally occurring foam constituent and surfactant proteins	2
dietary lipids	2
LPS-induced low-grade endotoxemia	2
peripheral gustatory pathway	2
saturated high fat diet	2
fat in lean mice	2
oily solution	2
lingual taste buds	2
circumvallate papillae (CVP)	2
gustatory papillae	2
gustatory tissue	2
lipopolysaccharides (LPS), Gram-negative bacteria-derived endotoxins	2
taste bud cells (TBC)	2
DPPH free-radical quenching assay	2
porphyra-334 and shinorine	2
MAAs in cells	2
primary skin fibroblasts	2
Nrf2 targeted genes encoding oxidative stress defense proteins	2
cytoprotective Keap1-Nrf2 pathway	2
MAAs	2
cyanobacteria and marine algae	2
UVR-absorbing metabolites	2
Mycosporine-like amino acids (MAAs)	2
bound zinc(II) ion	2
human ISCU	2
human Fe-S assembly system	2
SDA complex	2
ISCU variants	2
wild-type and variants	2
zinc-bound and zinc-depleted conditions	2
M140I, M140L, and M140V variants	2
wild type ISCU	2
zinc-depleted and zinc-bound forms of ISCU	2
SDA alone	2
zinc(II) ion	2
SDAU desulfurase activity	2
purification batches	2
zinc-bound and zinc-depleted forms	2
E. coli orthologue	2
recombinant human ISCU binds zinc(II) ion	2
Fe-S cluster biosynthesis	2
Ile, Leu, Val, or Cys	2
yeast ISCU orthologue Isu	2
NFS1-ISD11-ACP (SDA) complex	2
NFS1-ISD11-ACP-ISCU complex (SDAU)	2
accessory protein ISD11, acyl carrier protein ACP, scaffold protein ISCU, and allosteric activator frataxin (FXN)	2
cysteine desulfurase NFS1	2
Human de novo iron-sulfur (Fe-S) assembly complex	2
involvement of CYP7B1	2
7α,24- and 7α,25-dihydroxy acids	2
hereditary spastic paraplegia type	2
acids	2
enzymes CYP46A1 and CYP3A4	2
25 R- and 25 S-epimers of 7α,12α-dihydroxy-3-oxocholest-4-en-26-oic acid	2
7α,24-dihydroxy-3-oxocholest-4-en-26-oic acid	2
(25 R)26-carboxylic acid group	2
enzyme CYP27A1	2
7α,12α-dihydroxy-3-oxocholest-4-en-26-oic and 7α,x-dihydroxy-3-oxocholest-4-en-26-oic (where hydroxylation is likely on C-22 or C-23)	2
7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in cerebrospinal fluid (CSF)	2
Dihydroxyoxocholestenoic acids	2
preparative applications	2
relevant published paper	2
large libraries	2
harsh cleaning agents	2
single chain oligonucleotide ligands (aptamers)	2
human brown adipose tissue	2
browning agents	2
therapeutically valid browning agents	2
adult humans	2
thermoneutrality	2
adipose tissue depots	2
classical brown tissue	2
alternative browning agents	2
predominant site	2
UCP1 protein	2
brite/beige adipose depots	2
potent model browning agent	2
brown and brite/beige adipose tissues	2
i.e. agents	2
“browning agents	2
non-β-lactam compounds	2
wide range of class A β-lactamases	2
proposed binding mode	2
identified compound	2
molecular class A β-lactamases	2
allosteric site	2
non-covalently	2
catalytic serine in the active site	2
entrance	2
fluorescence quenching	2
bacterial β-lactamase TEM-171	2
low-affinity inhibitors	2
natural phenoxyaniline	2
new type of non-β-lactam β-lactamase inhibitor PA-34	2
reduced Mthfd1L expression	2
de novo folate-dependent biosynthesis of nucleotides (thymidylate and purines)	2
supplemental formate	2
labelled thymidine and adenine	2
liver of supplemented dams	2
formyl-THF	2
neurulation-stage embryos	2
curly tail embryos	2
FOCM reactions	2
Mitochondrial FOCM	2
Mthfd1L locus	2
partially congenic wild-type strain	2
ct/ct embryos	2
key component of mitochondrial folate one-carbon metabolism (FOCM)	2
Grhl3 expression	2
hypomorphic allele of grainyhead-like 3 (Grhl3)	2
spina bifida	2
major ct gene	2
folic acid	2
spina bifida and exencephaly)	2
curly tail mouse	2
peptidase	2
least one other substrate	2
entry sequences	2
UniRef50 database	2
substrate protein sequences	2
tools on the website	2
display	2
protein substrate	2
amino acids or groups of amino acids	2
logo, distribution matrix	2
displays	2
substrate cleavage collection	2
various displays	2
disparate proteins	2
556 peptidases	2
UniProt protein sequence database	2
different peptidases	2
collection of cleavages in substrates	2
MEROPS database (http://merops.sanger.ac.uk)	2
proteins, peptides and synthetic substrates	2
One peptidase	2
vibrant field	2
corresponding cellular compartments	2
pathological settings	2
plant and human isoforms	2
endopeptidase activity	2
different milieus	2
newly recognized functions	2
asparaginyl endopeptidase (AEP) or vacuolar processing enzyme (VPE)	2
mammalian and the plant legumain field	2
two largely uncoupled research arenas	2
legumain biology	2
domain families	2
comprehensive function annotation resources	2
CATH and SCOP resources	2
100,000 protein structures	2
SCOP database	2
protein structure classification database CATH	2
plant-based expression platform	2
human anti-HIV-1 antibody 2F5	2
endopeptidase	2
human counterpart	2
C-terminal dipeptides	2
far less efficient peptidyldipeptidase	2
human cathepsin B.	2
mammalian homologue cathepsin H	2
processing enzyme	2
cathepsin L-like PLCP	2
precursor of NbCathB	2
aleurain-like protease (NbALP) and cathepsin B (NbCathB)	2
two major N. benthamiana PLCPs	2
plants involves papain-like cysteine proteinases (PLCPs)	2
recombinant biopharmaceuticals	2
versatile expression platform	2
tobacco-related plant species Nicotiana benthamiana	2
channel regulators	2
general eukaryotic genomes	2
certain lineages	2
phylogenetic tree of eukaryotic genomes	2
domain sets	2
set of domains	2
distinct domain architectures	2
lysosomal galactosidase	2
diagnostic purposes	2
flexible sites	2
pathological missense mutants	2
widespread functional modules	2
currently available collection of archaeal (and bacterial) genomes	2
putative archaeal membrane-associated functional systems	2
bifunctional lysylphosphatidylglycerol synthase and flippase	2
flippase domain of bacterial multipeptide resistance factor MprF	2
membrane flippases	2
C-terminal domain of N-glycosylation protein AglD	2
vast family of archaeal proteins	2
bacteria, eukaryotes, and euryarchaea	2
highly diverged orthologs of the membrane	2
crenarchaea	2
several novel components of predicted secretion, membrane remodeling, and protein glycosylation systems	2
last archaeal common ancestor gene set	2
archaeal membrane proteins	2
remarkable toolbox	2
protein synthesis apparatus	2
unchangeable entity	2
RNA and protein elements	2
complex multi-component assembly	2
aforementioned calmodulin antagonists	2
calmodulin antagonists trifluoperazine, chlorpromazine and W7	2
anti-schistosomal drug praziquantel	2
Fasciola hepatica proteins	2
cadmium, manganese, magnesium, strontium and barium ions	2
manganese, strontium, iron(II) and nickel ions	2
SmTAL1 and SmTAL2	2
intrinsic fluorescence	2
two EF-hand-like structures	2
two functional calcium binding sites	2
three proteins’	2
three members of this family: SmTAL1 (Sm22.6), SmTAL2 (Sm21.7) and SmTAL3 (Sm20.8)	2
potential drug or vaccine targets	2
parasitic flatworms	2
family of calcium binding proteins	2
tegumental allergen-like (TAL) proteins	2
MTP and apoB in chicken tissues	2
YS of 15- and 20-day old embryos	2
MTP protein	2
YS, embryonic liver, and kidney	2
YS, liver, kidney, and small intestine	2
developing yolk sac (YS)	2
embryonic liver, small intestine	2
microsomal triglyceride transfer protein (MTP) and apolipoprotein B (apoB)	2
Two key components	2
kidney and the embryonic yolk sac	2
liver and intestine	2
chicken major sites	2
example	2
domain networks	2
complex ancestor	2
protein world	2
trees	2
selecting models	2
single organelles	2
green to red fluorescence	2
single peroxisomes	2
novel genetic tool	2
brain of resulting transgenic mice	2
myelin-specific Cnp1 promoter	2
fusion gene	2
peroxisomal targeting signal type 1 (PTS1)	2
photoconvertible mEos2	2
fluorescently tagged peroxisomes	2
novel line of transgenic mice	2
intact cells and tissues	2
myelin peroxisomes	2
oligodendroglial peroxisomes	2
various cell types of the brain	2
non-myelin peroxisomes	2
cytoplasmic channels of “non-compacted” myelin	2
oligodendrocytes and Schwann cells numerous peroxisomes	2
affected proteins	2
relatively undefined subject	2
mitochondrial single strand break repair (SSBR)	2
two enzymes, tyrosyl-DNA-phosphodiesterase 1 (TDP1) and aprataxin (APTX)	2
bacterial ancestors	2
mRNA-specific translational activators and mRNA-nonspecific accessory initiation factors	2
mitochondria-specific components	2
mIF3	2
bacterial-like general initiation factors mIF2	2
mitochondrial translational system	2
respiratory chain complex	2
handful of transmembrane components	2
highly streamlined mitochondrial genome	2
extracellular membrane vesicles (EVs)	2
MSC- and NPC-secreted factors	2
cytokines, chemokines and growth factors	2
stem cell secretome (SCS)	2
stem cells (secretome)	2
biologics	2
paracrine hypothesis	2
immune modulatory or neurotrophic paracrine factors	2
experimental central nervous system (CNS) disease models	2
mesenchymal (MSCs) and neural/progenitor stem cells (NPCs)	2
non-haematopoietic stem cells	2
parts of the intestine	2
and/or tri-hydroxycholanoyltaurines, monosulphated dihydroxycholanoates and monosulphated dihydroxycholanoylglycine	2
di and/or trihydroxycholanoates, di- and/or trihydroxycholanoylglycines, di-	2
dominant bile acids	2
Crohn's disease patients	2
ileal fluid	2
Bile salts	2
intestinal fluid	2
11β-HSD1 inhibitors	2
arterial wall	2
inter-convert 7-KC and 7βOHC.These	2
type 2 isozyme of 11β-HSD	2
Renal homogenates	2
oxo-reductase, inter-converting 7-KC and 7βOHC	2
isolated mouse aortic rings	2
aortic wall of chow-fed C57Bl6/J mice	2
7-oxysterols	2
noradrenaline-induced contraction (Emax)	2
endothelium-dependent (acetylcholine) or -independent (sodium nitroprusside)	2
glucocorticoid-metabolizing enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)	2
atherogenic 7-oxysterols, 7-ketocholesterol (7-KC) and 7β-hydroxycholesterol (7βOHC)	2
multiple enzymes	2
murine cytomegalovirus	2
primary bone marrow derived macrophage cells	2
ordinary differential equation model	2
single enzyme	2
principle pharmaceutical agents	2
statin based drugs	2
nerve growth factor	2
tips of growing neurites of PC12 cells	2
neural districts	2
corresponding mammalian proteins	2
zebrafish proteins	2
first PDZ-domain	2
protein containing RING-finger and PDZ-domains	2
D. rerio Pdzrn3	2
brain cDNA products	2
phage display library	2
Repeat-rich Membrane Spanning) an adaptor of neurotrophin receptors	2
/Ankyrin	2
novel partner of Kidins220/ARMS (Kinase D-interacting substrate	2
clustered DNA lesions	2
ssDNA region or AP sites	2
AP site-containing DNA	2
Tdp1 H493R (SCAN1) and H263A mutants	2
bulky fluorescein adduct	2
Tdp1 hydrolyzes AP sites	2
ssDNA containing AP site	2
bubble-DNA structure	2
3′ DNA phosphate termini from apurinic/apyrimidinic (AP) sites	2
variety of other DNA 3′ damaged termini	2
phosphodiester linkage	2
Tyrosyl-DNA phosphodiesterase 1 (Tdp1)	2
type III galactosemia	2
M284K-hGALE	2
in vivo and in vitro data	2
bundle of three α-helices	2
unpaired positive charge	2
corresponding protein in Escherichia coli	2
M284K allele	2
M284K	2
endogenous UDP-galactose 4′-epimerase	2
Saccharomyces cerevisiae strain	2
three artificial alleles (Y105C, N268D, and M284K)	2
Five disease-associated alleles (G90E, V94M, D103G, N34S and L183P)	2
enzyme UDP-galactose 4′-epimerase	2
current non-coding RNA landscape	2
types of non-coding RNA	2
types of small non-coding RNAs	2
smaller molecules	2
subset of archaea	2
ancient class of small non-coding RNAs	2
Small nucleolar RNAs (snoRNAs)	2
promoter of a proto-oncogene	2
human genomic DNA G-quadruplex sequences	2
Single molecule fluorescence resonance energy transfer (FRET)	2
octahedral predispositions	2
hexatopic linkers	2
underlying nets	2
3D polymeric structures	2
octahedrally disposed connector	2
discrete metal-based nodes	2
linker hexakis(4-carboxyphenyl)disiloxane (L-H6)	2
hybrid inorganic–organic siloxane	2
(IMP-30), and [Zn2(L-H2)(4,4′-bipy)2]	2
[Ce2(L)(DMF)2(H2O)2] (IMP-29), [Y2(L)(DMF)2(H2O)2]	2
[Cd3(L)(DMA)2(H2O)2] (IMP-28),	2
hexatopic connectors	2
Four metal–organic frameworks	2
trans-octahedral cation	2
[EuI2(OPPh3)4]I3·1.5MeCN	2
[EuI2(OPPh3)4] in MeCN solution	2
[LnX2(OPPh3)4]+	2
corresponding trivalent cations	2
dry O2 or I2	2
[LnX2(OPMe3)4] complexes	2
cis-octahedral geometry	2
six-coordinate Eu(II)	2
[EuI2(OPPh3)4]·MeCN	2
microanalysis, IR, UV–Vis and 31P{1H} NMR spectroscopy	2
divalent lanthanide ions	2
SmI2 and OPR3 in dry, degassed thf	2
[SmI2(OPR3)4]	2
divalent lanthanide complexes [LnX2(OPR3)4] (Ln = Yb, Eu, X = I; Ln = Eu, X = Br)	2
OPR3 (R = Me, Ph) with YbI2, EuI2 and EuBr2 in rigorously anhydrous MeCN under N2	2
Gd(III) ions	2
{Co3Gd3}	2
{Cu3Tb2}	2
3d/4f complexes	2
new heterometallic 3d/3d′ complexes	2
heterometallic syntheses	2
Cu(II) or Co(III)	2
3d ions	2
potential ligand donor atoms	2
simple complexes such as {Ni4} to spectacular 3d/3d′ {Cu8Zn8} or {Mn18Cu6} complexes	2
(3d or 4f) and heterometallic (3d/3d′ or 3d/4f) complexes	2
one such a polydentate ligand	2
new molecular architectures	2
wide array of polydentate ligands	2
Polymetallic complexes	2
new chemical elements	2
periodic table – nihonium, moscovium, tennessine and oganesson –	2
isothiocyanate ligand	2
“tube” motifs	2
[Cr(NCS)5NH3]2− ion	2
(acetonitrile)	2
small solvent molecule	2
“tube” motif	2
four donor molecules	2
stack of donors	2
solvent (nitrobenzene)	2
BEDT-TTF layers	2
two trans-oriented isothiocyanate ligands	2
[Cr(NCS)6]3−	2
radical cation salts	2
RuII→bpz MLCT	2
lowest energy visible absorption band	2
Def2-SVP (on all other atoms) in acetonitrile	2
M06 functional and basis sets Def2-QZVP (on Ru) and	2
selected complexes	2
Vis spectra	2
MLCT bands	2
visible region	2
metal-to-ligand charge-transfer (MLCT)	2
intense intraligand π→π∗	2
UV–Vis spectra display	2
known species where n=2 and L–L=2,2′-bipyridyl, 4,4′-dimethyl-2,2′-bipyridyl or 2,2′-bipyrimidine	2
PF6− and Cl− salts	2
L=N″,N′″-dimethyl-4,4′:2′,2″:4″,4′″-quaterpyridinium)	2
L=4,4′-bis(tert-butyl)-2,2′-bipyridyl, 4,4′-diphenyl-2,2′-bipyridyl, 4,4′-dichloro-2,2′-bipyridyl, 4,4′-diamino-2,2′-bipyridyl, 4,4′-bis(trifluoromethyl)-2,2′-bipyridyl, 4,4′-bis(methoxycarbonyl)-2,2′-bipyridyl: n=4; L–	2
L–	2
(bpz=2,2′-bipyrazyl: n=2;	2
form cis-[RuII(bpz)2(L	2
Seven new complexes	2
nuclear waste facilities	2
components in HAL	2
elongated cuboidal zirconium citratomolybdate ([ZrMo2O7(OH)2]·2H2O·[(MoO2)2O(cit)2])	2
citratomolybdate complex	2
zirconium salt	2
cubic Zirconium molybdate	2
spherical ceasium phosphomolybdate particles	2
spent nuclear fuel	2
highly active liquors (HAL)	2
[ZrMo2O7(OH)2]·2H2O) solids	2
Caesium phosphomolybdate (Cs3PMo12O40·xH2O) and zirconium molybdate (	2
similar spectra	2
solid powders	2
atoms in the lattice	2
short contacts	2
PPN cation	2
Hydrogen bond chains	2
normal Au–C bonds	2
gold atom	2
monohydrate	2
acetone molecule	2
monocation PPN, bis(triphenylphosphane)iminium	2
(acetylido)(cyanido)aurate(I) anion	2
Two new compounds	2
SiF62− anion	2
imine rings	2
bridging SiF62− groups	2
chain polymer	2
[Pb(terpy)3][BF4]2, but Pb(SiF6) produced [Pb(terpy)(H2O)(SiF6)]	2
coordinated water molecules	2
κ2-SiF62− group	2
[Pb(phen)2(H2O)2(SiF6)]	2
“cis” diimines and two κ2-BF4− groups	2
eight-coordinate and mononuclear	2
[Pb(phen)2(BF4)2]	2
bridging fluoroanions	2
two diimines	2
lead	2
[Pb(bipy)2(SiF6)], [Pb(phen)2(SiF6)] and [Pb(bipy)2(BF4)2]	2
aqueous/MeCN	2
ligand and lead salt	2
2,2′-bipyridyl, 1,10-phenathroline and 2,2′:6′,2″-terpyridyl	2
Lead(II) tetrafluoroborate and hexafluorosilicate complexes	2
several [Au(NHC)(OH)]	2
[Au(NHC)(OH)]	2
mixture of 0.5M HNO3 and 0.5M H2C2O4	2
0.5M HNO3	2
extracted metal ions	2
one of the ligands	2
U(VI), Pu(IV) and Am(III) ions	2
hexagonal bi-pyramidal geometry	2
uranyl group	2
2 and 4	2
two of the compounds	2
uranyl nitrate	2
[C7H6(SCH2CONR2)2] (where R=iC4H9)	2
Dithio-diglycolamide ligands of the types [(CH2SCH2CONR2)2] (where R=iC3H7, C4H9, iC4H9, C8H17) and	2
complex 1	2
azido group and the methyl moiety of adjacent molecules	2
hydroxido bridged complex	2
iron centers	2
azido group	2
complex 2	2
methoxido and hydroxido groups in complexes 1 and 2	2
iron center	2
distorted octahedral environment	2
chelating tridentate Schiff base and a terminal azido group	2
compound 2	2
two hydroxido ions	2
compound 1	2
methoxido ions	2
two FeIII atoms	2
single hydroxido-bridged dimer (2)	2
methoxido-bridged dimer (1)	2
H-atom	2
–CH3 group on the secondary amine group of the N,N-dimethyldiamine fragment of the Schiff base	2
two tridentate NNO-donor Schiff base ligands HL1{(2-[(3-methylaminoethylimino)-methyl]-phenol)} and HL2 {(2-[1-(2-dimethylaminoethylimino)methyl]-phenol)}	2
Two new Fe(III) complexes of formulas [FeL1(N3)(OMe)]2 (1) and [FeL2(N3)(OH)]2·H2O (2)	2
recent polymeric materials	2
3d, 3d–4f and 4f molecular compounds	2
field of magnetic refrigeration	2
zero-dimensional compounds	2
[M(CO)2(α-diimine)][BF4].	2
(M=Rh, Ir, COD=1,5-cyclooctadiene) with fluorine- and non-fluorine-substituted aryl α-diimines yields cationic rhodium(I) and iridium(I) complexes	2
[M(COD)(MeCN)2][BF4]	2
new fluorine-substituted aryl α-diimines, ArFNCHCHNArF; ArF=4-C6H4F and 2,4,6-C6H2F3	2
2,4,6-C6H2F3]	2
glyoxal with fluoroarylanilines [ArFNH2; ArF=4-C6H4F; 2,4-C6H3F2;	2
Pg-3-glc and PGA	2
tumor necrosis factor-α, IL-1β, IL-6, and IL-8	2
opsonized or nonopsonized Escherichia coli	2
cytometric bead array kit	2
selected cytokines (tumor necrosis factor-α, interleukin [IL]-1β, IL-6, IL-8, and IL-10)	2
lipopolysaccharide in the presence or absence of the test compounds	2
diluted whole blood	2
commercially available test kits	2
whole blood culture model	2
selected pro- and anti-inflammatory cytokines	2
3 of its plasma metabolites (4-hydroxybenzoic acid, protocatechuic acid, and phloroglucinaldehyde [PGA])	2
predominant strawberry anthocyanin, pelargonidin-3-O-glucoside (Pg-3-glc)	2
N-terminal region of proBNP	2
human proBNP	2
current BNP assay system	2
immunoreactive-BNP	2
BNP5-32	2
BNP4-32	2
BNP3-32	2
Mature BNP	2
mature BNP1-32 and NT-proBNP	2
Uncleaved proBNP	2
BNP1-32 and N-terminal proBNP (NT-proBNP)	2
human BNP precursor proBNP	2
minor forms	2
ProANP and β-ANP	2
bioactive α-ANP	2
secretion proANP	2
healthy atrial tissue	2
three molecular forms, α-ANP, β-ANP, and proANP (or γ-ANP)	2
Human ANP	2
intracellular cyclic guanosine monophosphate (cGMP)	2
natriuretic peptide receptor-A (NPR-A or guanylyl cyslase-A)	2
ANP and BNP	2
cardiac hormones	2
three biologically active peptides: atrial natriuretic peptide (ANP), brain (or B-type) natriuretic peptide (BNP), and C-type natriuretic peptide (CNP)	2
natriuretic peptide family	2
modified amino acids	2
peptide backbone–receptor interactions	2
α-helical peptides	2
orexin receptors	2
bioactive peptides	2
central and N‐terminal modifications	2
peptide C‐terminus	2
two α-aminoisobutyric acid residues	2
staple	2
suggested hinge region	2
four different sites	2
peptide stapling	2
N-terminal truncations	2
truncated peptides	2
similar 19‐amino-acid C-termini	2
endogenous agonists of the orexin receptors	2
peptides orexin-A and −B	2
glucagon receptor	2
exogenous glucagon	2
nutrients, bile acids, fatty acids and bitter compounds	2
capsules, microcapsules or pellets	2
variety of agents	2
stimuli in capsules or pelleted form	2
upper GI tract	2
glucagon-like peptide-1 (GLP-1) and peptideYY (PYY)	2
distal gastrointestinal tract	2
food-related stimuli	2
pro-inflammatory cytokines IL-8, TNF-α, MMP-2 and TLR2	2
CEN1HC-Br and Clindamycin	2
interleukin IL-12p40, IL-6, IL-1β, TNF-α and TLR2 in monocytes	2
IL-8, TNF-α, MMP-2 and TLR2	2
rat ear	2
P. acnes-induced ear edema	2
pro-inflammatory cytokines IL-6, IL-8, IL-1β, TNF-α, IL-12	2
HaCaT cells	2
green sea urchin	2
antimicrobial peptide named CEN1HC-Br	2
commensal bacterium	2
Propionibacterium acnes	2
smaller drinks	2
smaller beverages	2
large drink	2
small drinks	2
single beverages	2
high-carbohydrate occasions	2
five beverages	2
single drinks	2
serum active GLP-1	2
one drink	2
high-carbohydrate drinks	2
visual-analogue scales)	2
150kcal portions	2
large beverage	2
drinks	2
750kcal drink	2
seven women	2
satiety-associated hormones	2
epithelial LKR	2
Malpighian tubule cell-specific LKR	2
DH44 and LK signalling pathways	2
Malpighian tubule-specific LKR	2
DH44-expressing neurons	2
stellate cells of the Malpighian tubules	2
DH44 neurons	2
leucokinin receptor gene, LKR	2
Drome-kinin receptor	2
intact fly	2
DH44 in neurons of the pars intercerebralis and DH44 receptor (DH44-R2) in Malpighian tubule principal cells	2
CRF-like diuretic hormone 44 (DH44) and Drosophila melanogaster kinin (Drome-kinin, DK)	2
identified neurons	2
multiple neuropeptides	2
critical organs	2
Malpighian tubules	2
healthy volunteers or patients with type 2 diabetes	2
healthy or type 2 diabetic participants	2
ad libitum meal	2
encapsulated ileal-release glutamine (3.6 or 6.0g)	2
Fasting participants	2
glucagon-like peptide 1 (GLP-1)	2
Glu-3 peptides	2
rat receptors	2
Glu-3 counterparts	2
oxyntomodulin analogues	2
amino acid position 3	2
glucagon receptor activation glutamate (Glu/E)	2
series of representative analogues (OXM14 and OXM15) and their Glu-3 equivalents (OXM14E3 and OXM15E3)	2
Oxyntomodulin analogues	2
ghrelin, gastrin, cholecystokinin (CCK), glucose-dependent insulinotropic hormone (GIP), glucagon-like peptide 1 (GLP-1), peptide YY (PYY), oxyntomodulin, insulin, glucagon and somatostatin	2
sleeve gastrectomy and the Roux-en-Y gastric bypass	2
gastric banding	2
calcium sensing receptor (CaSR), transient receptor potential (TRP) channels and Q-type voltage gated calcium channels (VGCC)	2
intracellular calcium in L-cells	2
meat peptone	2
L-amino acids Phe, Trp, Gln and Ala (20 mM each), and the dipeptide glycine-sarcosine (20 mM)	2
Meat, casein and vegetable-derived peptones (5 mg/ml)	2
primary small intestinal L-cells	2
insulinotropic hormone	2
Glucagon like peptide-1	2
GPR119 in L-cells	2
Less GPR119-dependence	2
colonic cultures	2
interpretationGPR119 ligands	2
small intestinal L-cells	2
primary epithelial cultures	2
GPR119 ligands	2
-cell specific knockout	2
proglucagon promoter	2
cAMP FRET sensor	2
single primary L-cells	2
controls after lipid gavage	2
mice lacking GPR119 in proglucagon-expressing cells	2
panel of GPR119 ligands	2
murine primary cell cultures	2
ingested lipid	2
primary murine L-cells	2
lipid derivative receptor	2
incretin hormone	2
hypothesisGlucagon-like peptide-1 (GLP-1)	2
western style diet	2
many L-cell specific genes	2
primary small intestinal cultures	2
nutrient stimuli	2
nutrient sensing machinery (Slc5a1, Slc15a1, Abcc8, Gpr120) and enteroendocrine-specific transcription factors (Etv1, Isl1, Mlxipl, Nkx2.2 and Rfx6)	2
encoding gut hormones (Gip, Cck, Sct, Nts), prohormone processing enzymes (Pcsk1, Cpe), granins (Chgb, Scg2)	2
L-cell specific genes	2
Purified small intestinal L-cells	2
GIP positive cells	2
GLP-1 positive cells	2
weeks HFD	2
primary intestinal cultures	2
Enteroendocrine cell populations	2
yellow fluorescent protein, Venus	2
MethodsTransgenic mouse models	2
Glucagon-like peptide-1 (GLP-1)	2
APJ mRNA and functional protein	2
riboprobe hybridization	2
strong receptor binding	2
posterior pituitary and PVN and SON	2
lung, heart, adrenal cortex, renal medulla, ovary and uterus	2
strong hybridization	2
posterior pituitary	2
paraventricular (PVN) and supraoptic (SON) nuclei of the hypothalamus	2
APJ riboprobes	2
mouse tissues	2
APJ mRNA	2
APJ knock-out mice (APJ KO)	2
mouse or human tissues	2
many physiological systems	2
endogenous peptide apelin	2
G protein-coupled apelin receptor (APJ)	2
male-derived Aea-HP-1	2
A. aegypti	2
mosquito sex peptide/myoinhibitory peptide receptor	2
MAG peptidases	2
blocked N- and C-termini	2
unusual 4-hydroxyproline	2
amidated carboxyl	2
pyroglutamic acid at the N-terminus	2
anterior portion of the MAG	2
mosquito head extracts	2
biologically active decapeptide, Aea-HP-1 (pERPhPSLKTRFamide)	2
MAG	2
MAGs	2
hitherto no behavior-modifying molecule	2
egg-laying and mating refractoriness	2
seminal fluid components	2
yellow fever mosquito, Aedes aegypti	2
post-mated female	2
many of the seminal fluid proteins and peptides	2
Male accessory glands (MAGs) of insects	2
poor microbiology and infection control services	2
Health Belief Model	2
adult hospital patients	2
broad-spectrum antibiotic use	2
acute medical patients	2
MRSA-BSI	2
hospital-acquired infections	2
ICU settings	2
adult ICU	2
paediatric ICU (PICU)	2
reduced MRSA-BSI	2
hypothetical scenarios	2
Transmission dynamic and decision analytic models	2
intensive care units (ICUs)	2
meticillin-resistant Staphylococcus aureus bloodstream infections (MRSA-BSIs)	2
middle-income country	2
healthcare workers	2
real-time	2
wash-hand basin water	2
linked isolates	2
intensive care unit (ICU)	2
six environmental samples	2
patient isolates	2
P. aeruginosa outbreak	2
aeruginosa healthcare outbreaks	2
general and acute hospital beds	2
hospital beds	2
Bed-days	2
six winters	2
bed closures	2
acute trusts	2
National Health Service (NHS)	2
individual's capability	2
selected PPE	2
evidence base	2
training	2
PPE in a simulated ETU	2
60 clinical personnel	2
robust protective barrier	2
West African EVD treatment regimens	2
many existing ETUs	2
medical personnel	2
ETU	2
infectious material	2
doffing area	2
doffing outer layers	2
mucosal membranes	2
medical staff	2
PPE solution	2
Kerry Town Ebola Treatment Unit (ETU)	2
British and Canadian military medical personnel	2
personal protective equipment (PPE)	2
nurse-taken swabs	2
Self-taken nasal swabs	2
persistent carriers	2
nurse or self-swab	2
self-swab	2
Ninety-nine patients	2
least one site	2
S. aureus carriage	2
multi-site swabbing	2
one self-swabs	2
self-swabs	2
S. aureus isolates	2
multi-site swabbing (nose, throat, and axilla)	2
general practices	2
single nasal swab	2
nurse- versus self-swabbing	2
anatomical sites	2
postoperative infections	2
Targeted decolonization	2
room	2
surface contacts	2
patient contact	2
six care types	2
single-bed UK hospital ward	2
patient rooms	2
healthcare workers (HCWs) touch surfaces	2
central databases	2
high-risk clones	2
largely undefined extra-institutional but genetically highly diverse reservoir	2
unknown origin	2
multi-institutional clusters	2
majority of clustered isolates	2
specific multi-locus variable number of tandem repeat analysis (MLVA) clonal complexes	2
MRSA of unknown origin (MUOs)	2
2966 isolates	2
MRSA clonal lineages	2
Dutch Staphylococcal Reference Laboratory	2
MRSA isolates	2
potential unobserved reservoirs	2
multi-institutional clusters of MRSA isolates	2
unknown reservoirs	2
Dutch hospitals	2
meticillin-resistant Staphylococcus aureus (MRSA) in hospitals	2
local teams	2
potentially important issues	2
one area	2
organizational structures	2
specific infections	2
healthcare workers and managers	2
qualitative datasets	2
English hospitals	2
influenza RNA	2
viable viruses	2
influenza RNA copies	2
detectable viral RNA	2
Air samples	2
controlled experimental chamber	2
Collison nebulizer, aerosols of influenza (A/Udorn/307/72 H3N2)	2
positive MRSA colonizations	2
CPOE system	2
MRSA decolonization antimicrobials	2
locally developed CPOE system (Prescribing Investigation and Communications System: PICS)	2
patients' first MRSA decolonization antimicrobials	2
meticillin-resistant Staphylococcus aureus (MRSA)-colonized	2
COS PIVC	2
PIVCs in place	2
Sixteen catheters	2
642 inpatients)	2
1199 PIVCs	2
closed-system (COS) PIVCs with open-system (MOS) PIVCs	2
peripheral intravenous catheters (PIVCs)	2
SummaryBackgroundCatheter-related infections (CRIs)	2
O&G surgery	2
telephone calls	2
dedicated staff	2
low-income hospital setting	2
954 patients	2
Telephone calls	2
patients having major obstetric or gynaecological surgery (O&G)	2
Centers for Disease Control and Prevention – National Healthcare Safety Network (CDC-NHNS) risk index	2
American Society of Anesthesiologists (ASA) scores	2
surgical wound class (SWC)	2
single Kenyan hospital	2
various components	2
hospital-acquired infection	2
surgical site infections (SSIs)	2
injured kidney	2
draining renal lymph nodes	2
CD45.1+ cells	2
adoptively transferred CD45.1+ cells	2
enzyme dissociated kidneys	2
CD45.2+ mice	2
CD45.1+ bone marrow-derived macrophages	2
GM-CSF skewed macrophages	2
GM-CSF ratio ∼30:1)	2
M-CSF:	2
obstructed murine kidneys	2
chemokine receptor CCR7	2
latex beads	2
DC medium	2
murine bone marrow-derived macrophages and DCs	2
GM-CSF-containing DC medium	2
M-CSF-containing macrophage medium	2
Macrophage-colony stimulating factor (M-CSF) and granulocyte macrophage-colony stimulating factor (GM-CSF)	2
resting lymphocytes	2
secretome	2
miRNA-enriched therapeutics	2
second biomanufactured therapeutic (IA2;	2
cancer cell (HeLa and SH-4 melanoma)	2
resting CD3+ (CD4+ and CD8+)	2
miRNA-enriched fractions	2
IA1 therapeutic	2
acellular pro-inflammatory agent (IA1)	2
less robust T cell alloresponse	2
serum of infected mice	2
phagocytose B. burgdorferi	2
infected wt and mrp14−/− mice	2
wildtype (wt) and mrp14−/− mice	2
joints of patients with Lyme arthritis	2
spirochete	2
Borrelia burgdorferi	2
activated neutrophils and monocytes	2
Myeloid-related protein (MRP)8 and MRP14 form a complex (MRP8/14)	2
broader spectrum of IFV strains	2
cross-reactive hnMAbs function	2
hnMABs	2
wide surface area of HA protein	2
distinct binding epitope	2
hnMAbs	2
HA1 globular head	2
hemagglutinin 1 (HA1) amino acid residues 111–120	2
two antibodies	2
binding epitope	2
somatic hypermutations	2
distinct germ line repertoires	2
Ig genes	2
one of the most potent hnMAbs	2
A/H1N1pdm09 strains	2
2009 pandemic strains	2
A/H1N1 strains	2
various but distinct influenza virus (IFV)	2
human monoclonal antibodies (hMAb) 206-2-4 and 201-6-8	2
human C3d based adjuvants	2
human C3 and human CR2	2
murine versions of C3d based adjuvant compounds	2
receptor 2.These	2
either mouse or even human complement	2
human C3d	2
mouse C3	2
vitro and in vivo analysis	2
anti-TTCF antibody responses	2
groups of mice	2
model antigen, tetanus toxin C fragment (TTCF).High molecular weight, C3d-containing oligomeric vaccines	2
oligomeric arrayed scaffold	2
C4b-binding protein (C4BP)	2
human C3d further	2
various test protein antigens	2
monomeric forms of C3d	2
complement receptor 2	2
“natural” adjuvant	2
final degradation product of complement protein C3	2
metabolically aberrant micro-environment	2
existing pharmaceuticals	2
relevant metabolic pathways	2
pathogens in chicken and other avian species	2
structurally well-characterized and functionally active RcMBL	2
Salmonella Typhimurium	2
terminal fucose and GlcNac residues	2
high-mannose glycans	2
oligomeric protein (mixture of trimers and oligomerized trimers	2
native chicken MBL (NcMBL)	2
HeLa R19 cells	2
recombinant chicken MBL (RcMBL)	2
lectin pathway	2
broad range of pathogens	2
human and mouse studies	2
serum collagenous C-type lectin	2
Mannose binding lectin (MBL)	2
functional trimeric rfhSP-A molecule	2
native human SP-A	2
rfhSP-A	2
human bronchial epithelial (AALEB) cells	2
Trimeric rfhSP-A	2
rfhSP-A in Escherichia coli	2
spider silk proteins (‘NT’)	2
novel expression tag	2
oligomerise)	2
functional trimeric recombinant fragment of human (rfh)SP-A	2
SP-A oligomeric structure	2
recombinant trimeric fragment of the closely related molecule (surfactant protein D)	2
trimeric units	2
pathogens including RSV.SP-A	2
carbohydrates on the surface of pathogens	2
SP-A	2
pulmonary surfactant	2
important innate immune molecule	2
Surfactant protein A (SP-A)	2
B cell-follicles	2
follicular dendritic cells	2
B cell-follicles of c-Rel-deficient mice	2
ubiquitin D	2
CCL20 and ubiquitin D	2
Peyer’s patches of c-Rel-deficient mice	2
differentiating M cells	2
RANK in Peyer’s patches	2
NF-κB subunit c-Rel	2
multiple target genes	2
nuclear factor-κB (NF-κB) family of transcription factors	2
variety of cell surface receptors	2
subepithelial stromal cells	2
receptor activator of nuclear factor-κB ligand (RANKL)	2
uncommitted precursors in the FAE	2
lumen of the intestine	2
mucosal immune system	2
unique phagocytic epithelial cells	2
gut-associated lymphoid tissues	2
follicle-associated epithelium (FAE)	2
multi-drug resistant pathogen Klebsiella pneumoniae	2
pore-forming complex	2
LPS and gram-negative bacteria	2
gram-negative bacteria Escherichia coli BL21, Pseudomonas aeruginosa, and Neisseria meningitidis	2
whole blood with LPS	2
granzyme M (GrM)	2
tumor cells and virally infected cells	2
serine proteases	2
human and mouse CD4+ T cells	2
TCR-stimulated murine and human CD4+ T cells in vitro and in vivo	2
IL-33 alone	2
IL-33 polarizes Th1 cells	2
murine CD4+	2
important Th1 cytokine-IFN-γ inducer	2
pro-Th2 cytokine IL-33	2
cytokine-rich environment	2
proximal draining lymph node	2
site of inflammation	2
pro-inflammatory T cells	2
atherosclerosis and rheumatoid arthritis (RA)	2
Treg presence	2
Regulatory T cells (Treg)	2
Th2 challenge	2
healthy heart resident macrophages	2
collagen content	2
Ly6ChighCCR2+ monocytes	2
Ym1, RELMα and CD206 (mannose receptor)	2
mice with helminth parasites	2
healthy myocardium	2
Ym1, Arg 1, RELMα and IL-10)	2
‘M1’ (IL-1β, TNF and CCR2)	2
phagocytose fluorescent beads	2
myocardial homogenates	2
cardiac macrophages	2
left and right ventricular free walls and septum	2
GFP positive macrophages	2
sparse population	2
hearts from CSF-1 receptor (csf1-GFP; MacGreen) and CX3CR1 (Cx3cr1GFP/+) reporter mice	2
healthy murine heart	2
Tissue resident macrophages	2
MLR	2
older donors	2
young or old DCs	2
allogeneic MLR	2
young T cells	2
infantis CCUG 52486	2
B. longum bv.	2
cytokine production (TGF-β, TNF-α)	2
young and older DCs	2
CD40, CD80 and CCR7	2
four probiotics	2
DCs and T-cells from young and older donors	2
allogeneic mixed leucocyte reaction (MLR) model	2
, Lactobacillus rhamnosus GG (L.GG) and L. casei Shirota (LcS)	2
infantis CCUG 52486, B. longum SP 07/3	2
probiotics, Bifidobacterium longum bv.	2
vitro or in vivo	2
alternative activation markers RELM-α or Ym1	2
nematode implanted wild type (WT) or MyD88-deficient mice	2
peritoneal exudate cells	2
arginase, RELM-α or Ym1	2
alternative activation markers	2
MyD88-deficient bone marrow derived macrophages	2
core TLR adaptor molecule, MyD88	2
Toll-like receptor (TLR) signaling	2
integrin αvβ8	2
TGFβ receptor complex	2
inactive complex	2
many different cells of the immune system	2
important cytokine	2
cells of the innate and adaptive immune systems	2
central region of FH	2
Excess zinc	2
sub-retinal pigment epithelial deposits	2
Tyr402 allotype	2
His402 allotype of FH	2
FH and C-reactive protein (	2
host-cell surfaces.(iv)Reinvestigation	2
two-site interaction model	2
heparin complexes	2
oligomeric FH–	2
FH–heparin complex	2
polyanionic host cell surface	2
analogue	2
one FH molecule	2
two C3b molecules	2
cleaved forms C3b and C3d show multimerisation	2
hydrolysed form C3u	2
–C3b	2
multiple data sets	2
major FH–ligand interactions	2
five major ligands (below)	2
central complement protein	2
major plasma regulator	2
Factor H (FH)	2
important susceptibility genes	2
CD46, CD55 and CD59	2
variants in CFH, CFB and C3	2
CD46, CD55 or CD59.ConclusionsIn a case–control sample	2
additional subjects	2
ophthalmologist	2
CD55 (decay accelerating factor, DAF) and CD59 (protectin)	2
genes encoding complement factor P (CFP, properdin), CD46 (membrane cofactor protein, MCP),	2
complement factor H.	2
Western populations	2
ObjectivesAge-related macular degeneration (AMD)	2
C3a/C5a	2
intracellular signalling pathways	2
PI3K/AKT, ERK and NF-κB signalling	2
C3aR or C5aR on human monocytes derived DCs (moDCs)	2
C3a and C5a.	2
human monocytes derived DCs	2
C5a	2
Anaphylatoxins C3a	2
blood, plasma or serum	2
active thioester proteins	2
promising robust, enzyme- and antibody-free chemical method	2
relatively unstable reagents	2
C3-specific haemolytic assays	2
active C3 and inactive breakdown products	2
nephelometry)	2
active C3 in clinical assays	2
patient sera	2
active C3 in serum	2
gel bands	2
biotinylated nucleophile and streptavidin-coated resin	2
C4 from sera	2
α-2M	2
full-length C3,	2
unprocessed thioester-containing proteins	2
whole, intact thioester protein	2
bioreporter molecule	2
signature thioester bond	2
thioester moiety	2
thioester proteins	2
thioester bond	2
intrachain thioester bond	2
evolutionarily ancient and conserved family	2
members of the C3/α-2M thioester protein family	2
complement serum proteins C3 and C4 and the protease inhibitor α-2 macroglobulin	2
Wiskott–Aldrich Syndrome protein (WASp)	2
DCL-1, mannose binding lectin and surfactant proteins A and D.	2
mannose receptor, Dectin-1, dendritic cell-specific ICAM grabbing non-integrin (DC-SIGN)	2
number of C-type lectins	2
several PRRs	2
host defence systems	2
conserved microbial structures	2
germ-line encoded pattern recognition receptors (PRRs)	2
key protein fragments	2
MASPs	2
complexes comprising mannose-binding lectin (MBL) or serum ficolins and MBL-associated serine protease-2 (MASP-2)	2
patterns of sugar moieties	2
cephalopods and large-brained vertebrates	2
novel challenging niches	2
external shell	2
simple social environments	2
flexible behavioural repertoires	2
large brains	2
large-brained vertebrates	2
HMD holistically	2
certain species or genotypes	2
landscapes and natural vectors	2
highly structured African prehistory	2
shifting and fractured habitable zones	2
variety of paleoecological settings	2
regionally distinct Pleistocene material culture	2
H. sapiens clade	2
morphologically varied populations	2
Pleistocene human fossils	2
single population and/or region of Africa	2
species, Homo sapiens	2
strategic infrastructure	2
innovative biotechnologies	2
15	2
diverse and international team	2
seafood resources	2
human nutrition	2
global forests	2
canopies	2
new technologies and infrastructure	2
global research networks and databases	2
forests and the atmosphere	2
CO2, water, and trace gases	2
food webs	2
strata	2
vertically stratified ecosystems	2
complex microhabitats	2
buffered microclimates	2
organisms and atmosphere	2
dynamic interfaces	2
Forest canopies	2
Eberhard’s book	2
communities and biomes	2
priority areas	2
vouchered collection	2
key unifying theme	2
respective fields	2
long-term permanent plots	2
tropical forests	2
ecologists, systematists, and evolutionary biologists	2
invasive marine species	2
diverse international team	2
novel issues	2
complex, multihost communities	2
new host populations	2
diverse wildlife–livestock–human interfaces	2
urban landscapes	2
emerging wildlife-borne zoonoses	2
rapidly changing environments	2
largely understudied interaction	2
anthropogenic-commensal niche	2
anthropogenic commensals (anthrodependent taxa	2
unified conceptual framework	2
different ideologies	2
government policies	2
artificial oceanic islands	2
testosterone in the aquatic environment	2
electric pulse trawling	2
artificial superintelligence	2
managed bees	2
researchers, practitioners, professional horizon scanners, and journalists	2
conservation community	2
global biological diversity	2
Making code	2
ecological research	2
interacting individuals	2
groups or aggregations	2
groups, populations, or communities	2
human and nonhuman animals	2
classic and modern hypotheses	2
cetaceans and insects	2
natural populations of humans	2
many species in captivity	2
females of some species	2
entire ecosystem	2
abiotic environment	2
highly diverse systems	2
Tropical forests	2
metabolic bacterial genes	2
bacterial genes	2
archaeal lineages	2
distantly related organisms	2
major organismal lineages	2
environmental decision support systems	2
decision-makers	2
relevant science	2
environment or natural resources	2
many organisations	2
best-available science	2
unstructured models	2
stage-structured population models	2
perceptual processes	2
cognitive world	2
unique cognitive world	2
Every animal	2
contents of a Trojan horse	2
sperm of the gift-provider	2
fertilise ova	2
female	2
nuptial gift	2
haploid interests	2
paternally imposed suppressors	2
relatedness markers	2
thousands of different RNAs	2
paternal haplotype	2
transcriptionally inactive vehicles	2
within and between populations	2
single paternity	2
single male	2
long-studied fossil groups	2
digital reconstructions	2
incomplete remains	2
fossil organisms	2
complex multihost systems	2
adaptive management frameworks	2
infection reservoirs	2
multihost systems	2
Many pathogens	2
natural spaces	2
Human health	2
conservation organisations	2
Many people	2
macroalgal cultivation	2
15 topics	2
team of professional horizon scanners, researchers, practitioners, and a journalist	2
Phanerozoic	2
dynamic system	2
extant organisms	2
equatorial to polar regions	2
multiple assays	2
experimental framework	2
free-living animals	2
punisher and target	2
current and historic human populations	2
human beings	2
coy, choosy females	2
promiscuous, undiscriminating males	2
females	2
male fruit flies	2
Angus J. Bateman	2
hematopoietic and non-hematopoietic cells	2
CD40-CD40L axis	2
Non-hematopoietic cells expressing CD40	2
activated CD4+ T cells	2
binding partner, CD40L	2
B cell-expressed CD40	2
immune and non-immune cells	2
TNF receptor superfamily member	2
iron oxide, silver, gadolinium and gold nanoparticles	2
innovative therapeutic metallic nanoparticles	2
metal-based nanoparticles	2
pharmalogical agents	2
disseminated tumor cells	2
tumor margins	2
tumor resection	2
aggressive malignant brain tumor	2
follow-on versions of nanomedicines	2
drug innovation	2
follow-on versions	2
substandard complex drug products	2
agenda	2
stakeholders and experts in the field	2
science-based discussion platform	2
follow-versions	2
nanomedicine follow-on versions	2
non-clinical biodistribution assay	2
complex products	2
authorized parenteral colloidal iron follow-on versions	2
bioequivalence in blood plasma	2
reference product	2
heterogeneous structures	2
large molecule biologics	2
non-biological complex drugs	2
nanosimilars in the EU	2
Nanomedicines and follow-on versions	2
new drug candidates	2
disease modeling	2
liver MPS	2
recently established MPS	2
hepatocyte-like cells (HLC)	2
vivo like microenvironment	2
advanced liver-on-chip systems	2
3D bioprinting	2
microfluidic cell culture	2
conventional cell culture and animal models	2
human liver functionality	2
microphysiological models (MPS)	2
Complex cell culture models	2
new drugs and other therapeutics	2
microfluidic organ-on-chip technology	2
advanced experimental models of blood vessels	2
tissue- or organ-level physiology	2
perivascular cells	2
three-dimensional (3D) co-cultures	2
near physiological scaffolds	2
‘organ-on-chip’ technology)	2
‘microfluidic chips’	2
human endothelial cells (ECs), pericytes and vascular smooth muscle cells (VSMCs)	2
experimental in vitro models	2
healthy individuals and patients	2
new drug entities	2
drugs and therapeutics	2
organs and tissues in our body	2
vascular system	2
stem cell-based retina models	2
distinct layering	2
major retinal cell subtypes	2
organoids	2
so-called retinal organoids	2
distinctly differentiated retinal subtypes	2
two-dimensional (2D) cultures	2
pluripotent stem cell models	2
endogenous stem cells	2
animal and human cells of origin	2
stem cell-based models	2
various animal models	2
numerous models	2
patients' blood and tissues	2
hydrophilic agents	2
systemic inflammatory mediators	2
unique population of critically ill patients	2
unique markers and signaling pathways	2
relevant cell populations	2
active agents	2
endogenous flexible tools	2
astrocytes and reactive astrocytes	2
adult NSPCs	2
Adult neural stem and progenitor cells (NSPCs)	2
above-mentioned organs and tumor microenvironment	2
liver, kidneys and lungs	2
three major organs	2
origin of myofibroblasts	2
organ fibrosis	2
spray devices	2
keratinocyte transplantation	2
cell carriers	2
chitosan, alginate, fibrin and collagen	2
cell carrier and cell delivery systems	2
spray system	2
single-cell solutions	2
burn wounds	2
hydrogels and spray devices	2
therapeutic cell delivery options	2
keratinocyte transplantation in burn wounds	2
critical barriers	2
unique anatomical, physiological, and immunological barriers	2
critical organ	2
Malignant brain tumors	2
additional vascular beds	2
SFA treatment options	2
clinicians and patients	2
DCB technology	2
LUTONIX® drug coated balloon catheter	2
engineering, chemistry and medical science	2
new class of combination products	2
superficial femoral artery (SFA)	2
several drug coated balloon (DCB) technologies	2
drug reservoir in the artery wall	2
anti-proliferative drug paclitaxel	2
balloon catheter systems	2
anti-proliferative drug	2
Heparin Surface)	2
BioActive Surface	2
CARMEDA®	2
non-eluting heparin coatings	2
variety of medical devices	2
covalently immobilized surface coating	2
anticoagulant drug heparin	2
Numerous surface coatings	2
coagulation cascade	2
implantable medical devices	2
nucleic acid-based therapeutics	2
CPP-based drug delivery systems	2
cell culture and animal models	2
nucleic acids and their ON analogs	2
cell-penetrating peptides (CPPs)	2
short delivery peptides	2
many different drug delivery systems	2
target tissues/cells	2
group of gene therapeutic compounds	2
synthetic oligonucleotide (ON) analogs	2
resident microvascular network	2
ischemic tissues	2
cell and molecular therapies	2
therapeutic angiogenesis	2
Adult patients	2
vascular anatomical defects	2
associated hyphenated tools	2
various conventional and emerging Raman instrumentations	2
finished products	2
innovative drug delivery systems	2
diverse biomedical areas	2
optimised fibre-optic Raman probes	2
samples from new patients	2
“training” datasets	2
Raman spectra	2
multivariate calibration and classification models	2
visible or near-infrared spectral range (lasers, microscopes, fibre-optics)	2
advanced optical technologies	2
vibrating molecules	2
several ABC-transporters	2
P-gp or analogous transporters	2
silico models	2
drugs and drug candidates	2
metabolic organs (liver, kidney)	2
major barriers (intestine, blood–brain barrier, blood–placenta barrier)	2
xenotoxic compounds	2
ABC-transporters	2
P-glycoprotein (P-gp)	2
intravenous fluids and inotropes	2
hydrophilic antimicrobials	2
mainly hydrophilic antimicrobials	2
Critically ill patients	2
literature and marketed products	2
paediatric rectal forms	2
aforementioned items	2
parents and care givers	2
mucoadhesive gels and suppositories	2
unconscious or vomiting children	2
emergency	2
Rectal forms	2
paediatric population	2
rectal route	2
inhaled medicines	2
new generation of inhaler devices and formulations	2
emerging particle engineering technologies	2
high resistance device	2
dry powder inhalers	2
fine particle fraction	2
new formulations	2
first generation capsule inhalers	2
Multiple-unit dose and multi-dose devices	2
first dry powder inhaler	2
marketed products	2
excipients used	2
paediatric oral dosage forms	2
taste masking APIs	2
paediatric oral formulations	2
Many active pharmaceutical ingredients (APIs)	2
regulatory authorities	2
oral paediatric medicinal products	2
diverse patient population	2
paediatric medicines	2
cell culture and transduction methodology	2
healthcare industry	2
novel class of therapies	2
existing medicines	2
potential advanced therapy medicinal products (ATMPs)	2
range of metabolic disorders	2
epidermolysis bullosa, epilepsy and leukodystrophy	2
several paediatric cancers	2
ATMPs	2
childhood cancers and PIDs	2
bone marrow transplants	2
Paediatric patients	2
novel medicines	2
advanced therapy medicinal products (ATMPs)	2
mature, functional molecules	2
whose 5′ and 3′ ends	2
RNA Polymerase II	2
small nucleolar RNAs	2
noncoding RNA classes	2
polymerase complex	2
majority of noncoding RNAs	2
Transcribing RNA Polymerase II	2
diverse high-throughput omics data	2
molecular, physical, and kinetic inter- and intracellular interactions	2
Omics data	2
yeast counterpart, Rad5	2
helicase-like transcription factor (HLTF) and SNF2 histone-linker PHD-finger RING-finger helicase (SHPRH)	2
population genomic datasets	2
mitochondria-adapted CRISPR/Cas9 platform	2
mtZFN and mitoTALEN	2
Re-engineered protein-only nucleases	2
organellar genome	2
major biochemical hub	2
engineered cells	2
live vaccines	2
C-terminal binding protein interacting protein (CTIP), a DNA-end resection factor	2
hydrolysing deoxynucleotides	2
(sterile α motif and histidine (H) aspartate (D) domain-containing protein 1)	2
future technologies	2
multiple molecular types	2
first experimental approaches	2
one molecular type (RNA, methylated DNA or open chromatin	2
bulk samples	2
biochemical and in vivo studies	2
ATP-dependent chromatin remodeller	2
gene encoding chromodomain helicase DNA binding protein 7 (CHD7)	2
competing hypotheses	2
previously noncoding genomic regions	2
newly designed vaccine products	2
lead targets	2
vaccine candidate antigens	2
first human genome	2
eukaryotic pathogens	2
appropriate data analysis platforms	2
primary diagnostic tool	2
currently available drugs	2
modern healthcare	2
intergenic lncRNAs	2
distal binding sites	2
multiple chromosomes	2
several thousand different locations	2
Several nuclear localised intergenic long noncoding RNAs (lncRNAs)	2
multiple bidirectional links	2
statistical physicists	2
single cell probabilistic trait loci (PTL)	2
interface of immunity and the environment	2
Larger cells	2
giant neurons	2
tiny lymphocytes	2
eggs and oocytes	2
reprogram cells	2
disease-discordant monozygotic twins	2
underlying sources	2
next-generation sequencing technologies	2
complex phenotypes	2
different RBPs	2
diverse RBPs	2
set of positional principles	2
single RBPs	2
RNA splicing maps	2
protein–	2
RNA-binding proteins (RBPs) and pre-mRNA	2
three superkingdoms	2
DBD families	2
origins of DBD families	2
diverse taxonomic lineages	2
three major superkingdoms (Bacteria, Archaea and Eukaryota)	2
completely sequenced genomes	2
known DBDs	2
sequence-specific transcription factors (TFs)	2
DNA-binding domains (DBDs)	2
obesity-associated genes	2
silico, in vitro, and in vivo	2
breakthrough association	2
FTO or neighboring genes	2
FTO the first locus	2
fat mass and obesity-associated (FTO) gene region	2
final integration point	2
MCPH loci	2
relatively large brain and expanded cerebral cortex of humans	2
SlP14a-PPC20-expressing plants	2
inoculated wild-type control plants	2
bacterial populations in stems	2
SlP14a-PPC20	2
genetically-modified tomato plants	2
R. solanacearum in vitro	2
Recombinant SlP14a-PPC20	2
outer membrane proteins	2
human elastase	2
potential antimicrobial	2
plant compartment	2
antimicrobial peptide	2
apoplast-targeted protein	2
SlP14a (part of a pathogenesis-related protein)	2
phosphoenolpyruvate carboxylase)	2
PPC20 (a linear AH-peptide	2
plant protein sequences	2
eight alpha-helical (AH) cationic peptides	2
transgenic applications	2
animal source	2
Ralstonia solanacearum	2
different phytopathogenic bacteria	2
Cecropin-B (CecB)	2
plant hormone ethylene	2
signaling and biosynthetic pathways	2
whole body of animals and unicellular organisms	2
TRX enzymes	2
different redox-mediated immune signalling pathways	2
oxidized residues	2
different TRX immune targets	2
numerous immune signalling proteins	2
specific TRX enzymes	2
plant immune system	2
cysteine reductases	2
conserved superfamily of Thioredoxin (TRX) enzymes	2
growing number of immune signalling proteins	2
redox-sensitive cysteine residues	2
reactive oxygen and nitrogen species (ROS/RNS)	2
elaborated metabolic architectures	2
alternative carbon fixation pathways	2
Calvin Cycle	2
several enzymes	2
Rubisco’s catalysis	2
next generation of metabolic solutions	2
hanging fruit	2
agricultural productivity	2
breeding crops	2
new resources	2
Na+ ions	2
ion transport pathways	2
lignin and suberin in endodermal and exodermal cells	2
specific root cell types	2
water limited roots	2
root elongation zones	2
cellulose microfibril orientation and non-cellulosic polysaccharide deposition	2
cell wall modifying enzymes	2
key lipids and pathways	2
relative the extremophile Eutrema salsugineum	2
signal transduction molecules	2
cell membranes lipids	2
surface lesions	2
many economically important crops	2
A, gsand Wirevealed	2
photosynthetic products	2
hybrids/parental lines	2
leaf rust in groundnut	2
Fusarium wilt and Ascochyta blight in chickpea	2
superior lines	2
legumes	2
marker genotyping platforms	2
millions of SNPs	2
comprehensive genetic and physical maps	2
draft genome assemblies	2
large-scale genomic resources	2
genomics resources	2
chickpea, pigeonpea and groundnut	2
Legume crops	2
constructed SNP array	2
3 F2 segregating populations	2
Affymetrix microarray	2
14 useful allele	2
143-plex markers	2
Golden Gate platform	2
16 target genes	2
Affymetrix Rice 44K SNP microarray	2
parental varieties	2
Golden Gate SNP array	2
genotyping platforms	2
SNP markers	2
rice genome	2
Single nucleotide polymorphisms (SNP)	2
Akenohoshi allele	2
distal end of long arm of chromosome 2	2
Koshihikari genetic background	2
Akenohoshi segments	2
chromosome segment substitution lines	2
long arm of chromosome 2	2
quantitative trait locus (QTL)	2
paddy field	2
Akenohoshi and Koshihikari	2
elite commercial rice cultivar, Koshihikari	2
high-yielding rice cultivar, Akenohoshi	2
high oleate ILs	2
recurrent parents	2
linoleic acid	2
MABC and 387 MAS derived introgression lines (ILs)	2
genetic background of ICGV 06110, ICGV 06142 and ICGV 06420	2
SunOleic 95R	2
FAD2 mutant alleles	2
large number of plants	2
DNA markers	2
three major fatty acids, oleic, linoleic and palmitic acids	2
linkage group a09 (ahFAD2A) and b09 (ahFAD2B)	2
peanut products	2
High oleate peanuts	2
physiologically essential metalloido-porins	2
NIP channel proteins	2
metalloid-permeable NIP aquaporins	2
environmentally important metalloids	2
primitive to higher plants	2
uncharged metalloid species	2
aquaporin plant water channel protein family	2
Several Nodulin 26-like intrinsic proteins (NIPs)	2
plant body	2
efficient membrane transport systems	2
consumers of metalloid-contaminated plants	2
Arsenic, antimony, germanium, and tellurium	2
highly toxic	2
group of physiologically important elements	2
sufficient nutrients	2
abnormal root system of hy5	2
NIR1, AMT1;2 and NIA genes	2
several other genes	2
ammonium transporter gene AMT1;2	2
nitrite reductase gene NIR1	2
HY5 positively	2
selected nitrogen assimilation-related genes in hy5 mutant	2
essential macronutrient	2
Soil nitrogen	2
(Long Hypocotyles 5)	2
gall tissues	2
Phylloxera transcriptionally	2
heterogenous plant organs	2
Erd6-like sugar transporters	2
tonoplast monosaccharide transporter	2
two SWEET proteins	2
one sucrose transporter	2
glucose-6-phosphate translocater	2
carbohydrate transporters	2
gall	2
source tissues	2
root galls	2
carbon sinks	2
heterotrophic structures	2
meristematic tissues	2
Gall forming phylloxera	2
IWGSC	2
454 platform	2
∼5700 genes	2
virtual map	2
homeologous 4B	2
common reference	2
bin-mapped 4D ESTs	2
tauschii chromosome 4	2
Ae	2
published high density map	2
wheat gene models	2
wheat orthologous gene loci	2
Scaffolds annotation	2
chromosome 4	2
Aegilops tauschii draft genome (DD)	2
Single ends (SE) and long mate pairs (LMP)	2
flow-sorted 4DS (7.2×) and 4DL (4.1×) arms	2
survey sequence	2
chromosome 4D.	2
different and complementary set of data	2
bread wheat (Triticum aestivum L.) genome (AABBDD)	2
wildtype plants	2
Col-0)	2
Col-0 and vtc2-1)	2
ascorbate and glutathione in chloroplasts	2
cell compartments	2
nuclei of vtc2-1	2
mitochondria of pad2-1	2
ascorbate and glutathione deficient mutants vtc2-1 and pad2-1	2
ascorbate and glutathione contents	2
functional regulatory element sequences	2
promoter components	2
gene expression tools	2
Synthetic promoters and introns	2
predicted regulatory sequences	2
several plants	2
contributing cis-acting elements	2
toolbox of available promoters	2
resultant transgenic genotypes	2
multiple independent genes	2
tree crops	2
multiple or changing environments	2
forest trees	2
solar energy, water, and mineral nutrients	2
timber, fiber, pulp, paper, and bioenergy	2
deficit	2
semiquinone radicals	2
pool of fast antioxidants	2
specific isoflavonoid synthesis pathway	2
Si+SNP axes	2
+Si+SNP axes phenylalanine ammonia-lyase activity	2
free isoflavone aglycones	2
sucrose (+Si+SNP/+Si+GSNO)	2
SNP/GSNO	2
infection in tissues	2
exogenous nitric oxide (SNP or GSNO) and non-pretreated axes	2
genistein glucoside in axes	2
f. sp.	2
pathogenic fungus Fusarium oxysporum	2
Juno.	2
isoflavonoids in embryo axes of Lupinus luteus L. cv	2
exogenous nitric oxide (NO) and sucrose	2
different membranes	2
two dyes	2
small molecules and metabolites	2
ultrathin epoxy films	2
epoxy based resin	2
biobased economy	2
life sciences and other industrial sectors	2
cascades	2
full factorial design	2
whole cell biocatalysis	2
2 enzymes	2
natural and low cost feedstocks	2
cofactor, substrates, additives and buffer system	2
corresponding ketones	2
tested amines	2
various amine or ketone substrates	2
HEPES buffer	2
phosphate group binding cup	2
PLP phosphate group	2
enzyme and pyridoxal-5'-phosphate (PLP)	2
different ATAs	2
chiral amines	2
attractive enzyme	2
amine transaminase from Vibrio fluvialis (Vf-ATA)	2
genus of Streptomyces	2
complete genome sequence	2
new, taxonomically distinct Streptomyces species	2
Streptomyces formicae KY5	2
antibacterial formicamycins	2
type 2 polyketide synthase encoding cluster	2
gene clusters	2
Illumina MiSeq sequencing	2
terminal inverted repeats	2
single linear chromosome	2
PacBio and 454 platforms	2
S. formicae	2
Tetraponera fungus growing ants	2
new species Streptomyces formicae KY5	2
complete genome	2
bacteriocins, proteases and hemolysins	2
Bacillus thuringiensis MYBT18247	2
virulence and cry toxins	2
three cry toxin genes, (cry6Ba2, cry6Ba3 and cry21-like)	2
Gram-positive spore forming bacterium Bacillus thuringiensis MYBT18247	2
many analysis tools	2
established resource	2
Döring et al., 2008).ResultsThe SeqAn library	2
efficient data types	2
SeqAn library	2
actual algorithmic components of tools	2
practical BWT based read mappers	2
human genome (Venter et al., 2001)	2
terminology services and information systems	2
Good quality terminology services	2
domain experts	2
various terminology services	2
metadata content	2
heterogeneous data sets	2
various domains	2
umbrella vocabulary	2
PANGAEA thesaurus of classifying terms	2
different terminologies	2
term concepts	2
basic syntax and rule set	2
data ingest	2
terminology catalogue (TC)	2
environmental science data	2
information system PANGAEA	2
German network on Bioinformatics Infrastructure	2
BiGi Center	2
different taxa	2
commonly used platforms	2
several software tools and platforms	2
available microbial genomes	2
next generation sequencing technology	2
important software suites	2
RNA structures	2
computational biology	2
underlying primary sequences	2
many classes of RNAs	2
Secondary structures	2
nucleic acid structures	2
” (de.STAIR)	2
pro-, eukaryotic and mixed dual RNA-Seq (meta-transcriptomics) experiments	2
workflows and use cases	2
ready-to-use computing infrastructures	2
best-performing tools	2
RNA-Sequencing (RNA-Seq)	2
recent metaproteomics software	2
dedicated algorithms and software	2
redundant proteins	2
waste water treatment plants	2
biogas plants	2
Comprehensive taxonomic and functional knowledge	2
nature microorganisms	2
academia and industry	2
SILVA database	2
European Ribosomal RNA Database Project	2
rDNA databases	2
SILVA alignments and trees	2
16S/18S rDNA and 23S/28S rDNA sequence datasets	2
validly described cultivated representatives	2
clades of uncultivated (environmental) sequences	2
rDNA database project	2
SILVA web dataset	2
various flavours	2
full SILVA releases	2
EMBL-EBI/ENA release 89	2
first SILVA release	2
central graphical user interface	2
common analysis tools	2
Thousands of users	2
workbench	2
Microbial Genomics and Bioinformatics Research Group	2
corresponding rRNA databases SILVA	2
software system ARB	2
DNA sequence data	2
sequence reference datasets	2
ARB project	2
SSU and LSU rDNA marker genes	2
Bacteria, Archaea, and Eukaryota domains	2
aligned ribosomal RNA gene (rDNA) sequences	2
high-quality datasets	2
comprehensive web resource	2
SILVA (lat. forest)	2
systems biology projects	2
data, models, and experimental methods storage	2
NBI-SysBio services	2
three tools (SABIO-RK, Excemplify, SEEK)	2
NBI network (German Network for Bioinformatics Infrastructure	2
de	2
systems biology data management service center	2
NBI-SysBio	2
Prot ticket system: bioinfraprot@rub.de)	2
BioInfra	2
manifold fast communication channels	2
Prot services	2
particular components	2
workflow	2
NBI service center BioInfra	2
structure libraries	2
structural bioinformatics solutions	2
all-in-one web service platform ProteinsPlus (http://proteins.plus)	2
life science areas	2
tools, resources and services	2
standard tools and pipelines	2
Galaxy Docker	2
virtualized version of Galaxy	2
Galaxy framework	2
example applications	2
RBC	2
tools, services and databases	2
German Network of Bioinformatics Infrastructure	2
RNA-based data	2
RNA–protein interactions	2
active developer community	2
multiple sources of support	2
updated training materials	2
non-developers	2
185 tools	2
C++ and Python	2
MS data	2
versatile open-source framework	2
potential analysis software	2
proteins, lipids and metabolites	2
biologically active components	2
embedded network visualizations	2
stoichiometric and constraint-based metabolic models	2
MATLAB package	2
One such software suite	2
dedicated software tools	2
used microorganisms	2
fucose content	2
main monosaccharides in most strains	2
highest producer	2
hydrocarbon production	2
AC768 strain	2
six culture collections	2
16 B. braunii strains	2
different strains of Botryococcus braunii	2
biopolymer building blocks	2
promising industrial organism	2
long-chain hydrocarbons	2
Botryococcus braunii	2
mammalian hybridoma cell culture	2
ensemble modeling	2
single “best fit” model	2
personalised microbiology	2
zoonotic micro-organisms	2
taxonomy, metagenomics approaches on clinical samples	2
16S-23S rRNA region	2
medical microbiology diagnostic laboratory	2
MiSeq (Illumina) and the Ion PGM™ (ThermoFisher)	2
common NGS platforms	2
outbreak-specific screening test	2
single sequence run	2
complete bacterial genome	2
Next generation sequencing (NGS)	2
cost-effective, disposable, single-use manufacturing	2
AEX membrane	2
soluble product aggregates	2
Protein A step	2
harvested cell culture fluid (HCCF)	2
two Cadence BioSMB PD multi-column chromatography systems	2
Protein A capture, viral inactivation, flow-through anion exchange (AEX), and mixed-mode cation exchange chromatography (MMCEX)	2
consumables	2
batch mAb purification chromatography platform	2
phosphorothioate modifications	2
ends of the donor DNA	2
protruding 3′ homology arms	2
dsDNA donor	2
epitope tag	2
larger insertions	2
5′ end	2
insertion/repair cassette	2
base homology arms	2
asymmetric single stranded donor molecules	2
donor DNAs	2
restriction site	2
longer FLAG epitope tag	2
short double stranded DNA oligonucleotide	2
Cas9 RNP and donor DNA	2
pooling material	2
investigated human stool	2
different locations in one piece of human stool	2
multiple replicates	2
taxonomic distribution of organisms	2
different microbial samples	2
human clinical setting	2
mouse and hamster models	2
patients undergoing CRT	2
wild type cells the mutant cultures	2
microalgal cultures	2
mutant culture	2
Mediterranean location	2
outdoor microalgal raceway pond production system	2
wild type Chlorella sorokiniana	2
mass cultures	2
wild type microalgae	2
lignin or lignin-derived products	2
several other bacterial enzymes	2
DyP-type peroxidases	2
Two major classes of bacterial lignin-modifying enzymes	2
several types of enzymes	2
dedicated ligninolytic enzyme systems	2
lignocellulosic feedstocks	2
polysaccharide polymers	2
highly heterogeneous polymer of 4-hydroxyphenylpropanoid units	2
linked cell-bank	2
collaborative online-database	2
normal cells and organotypic slices	2
appropriate tumour cells	2
vitro modelling	2
WNT and Group 4 subgroups	2
SHH cell-lines	2
subgrouped cell-lines	2
established medulloblastoma cell-lines	2
current model systems	2
40 medulloblastoma cell-lines	2
recently-defined four molecular subgroups of medulloblastoma	2
recombinant Epo-Fc production	2
Chinese hamster ovary (CHO) cell line expressing an erythropoietin fusion protein (Epo-Fc)	2
biphasic cultivations	2
broad-spectrum anti-infective capability	2
host pathways	2
myeloid-derived cells	2
tissue-resident cells	2
vivo and primary cell culture studies	2
standard of care antibiotics	2
intracellular or extracellular bacteria	2
Gram-negative and Gram-positive bacterial infections	2
lead clinical IDR, SGX94	2
key signaling nodes	2
intracellular adaptor protein	2
host innate immune system	2
Innate Defense Regulators (IDRs)	2
homologous DNA cassettes	2
optimized CRISPR/Cas9 system	2
gRNAs and RNA Polymerase II promoters	2
RNA Polymerase III and RNA Polymerase II promoters	2
different gRNA sequences	2
various codon optimized DNA sequences of CAS9	2
specifically integrating cassettes	2
recombination machinery	2
methylotrophic yeast Pichia pastoris (Komagataella phaffii)	2
homologous site	2
Δtku70 mutant	2
I-SceI enzyme	2
expression cassette with homologous flanks	2
I-SceI mediated DSB	2
tku70 mutant	2
tku70 gene	2
engineered Trichoderma reesei (Hypocrea jecorina) strain containing a I-SceI recognition site	2
double strand DNA break (DSB)	2
total intracellular glutathione pool	2
S-sulfocysteine	2
sequence of the monoclonal antibody	2
modified amino acid	2
two feed system	2
S-sulfocysteine process	2
neutral pH feeds	2
new derivative, S-sulfocysteine	2
l-cysteine	2
l-tyrosine and l-cysteine	2
separate alkaline feed	2
slight acidic main feed	2
initial growth	2
protein or peptide based affinity reagents	2
puromycin-linker	2
immunoglobulin G.	2
B domain of protein A	2
FLAG epitope	2
surface plasmon resonance (SPR) system	2
3-cyanovinylcarbazole nucleoside	2
ultrafast photo-cross-linker	2
selected candidate clones	2
huge library	2
powerful in vitro display technology	2
repeated batch culture	2
Erlenmeyer flask batch culture	2
product of interest	2
runs	2
harvest line	2
first run	2
real-time biomass sensor	2
different sampling locations	2
nutrients and metabolites	2
bottom of the bioreactor	2
centrifugal pump	2
cell-free medium	2
non-woven polyester matrix	2
novel perfusion culture system CellTank	2
Recombinant Chinese Hamster Ovary (CHO) cells producing IgG monoclonal antibody	2
conventional chromatography media	2
cytochrome c. The SMB system	2
BSA and	2
2-component protein solution	2
packed bed resins	2
SMB system	2
continuous chromatography systems	2
typical beaded systems	2
flow distribution device	2
nanofiber system	2
porous bead resins	2
DEAE adsorbents	2
anion exchange nanofiber adsorbent	2
surface area material	2
non-woven fiber structure	2
alternative ligand support surface	2
Electrospun polymeric nanofiber adsorbents	2
simple bioseparation	2
new adsorbent material (cellulosic nanofibers)	2
expensive media	2
mathematical modelling	2
non-oncology applications	2
vitro experiments	2
anti-cancer agent	2
published in vitro and in vivo work	2
CDKs Seliciclib	2
anticancer agent	2
inhibitor of CDKs	2
Seliciclib (R-Roscovitine)	2
range of cell types	2
brain tumours	2
model cytotoxic drug etoposide (0.3–100μM)	2
reproducible single co-culture spheroids	2
ultra-low attachment 96-well plates	2
two supravital fluorescent dyes (CDCFDASE, Celltrace Violet)	2
human medulloblastoma cell line UW228-3 and human foetal brain tissue	2
3D human brain tumour co-culture model	2
novel treatments and drug delivery systems	2
biological analytical platforms	2
Physiologically relevant in vitro models	2
Bacteroidetes, Firmicutes, and Proteobacteria	2
operational taxonomic units (OTUs)	2
shock	2
4.5L swine wastewater anaerobic completely stirred tank reactor (CSTR)	2
digestate and biogas	2
organic wastes	2
intracellular adenosine nucleotides	2
separation columns	2
final sample	2
residual filter filaments	2
washed cells	2
commercially available components	2
intracellular metabolites from CHO (Chinese hamster ovary) suspension cells	2
vacuum pump	2
cell pellet	2
complex media	2
mammalian cell cultures	2
labile metabolites	2
resulting pictorial decision tree	2
Monte Carlo stochastic simulation datasets	2
biomanufacturing facilities	2
expensive product	2
legacy biopharmaceutical purification suites	2
candidate sequences	2
grove	2
citrus trees	2
CLas bacteria	2
D. citri nymphs	2
truncated abnormal wing disc (Awd) gene of D. citri	2
CTV-RNAi	2
citrus phytoene desaturase gene	2
CTV-based vector	2
RNA silencing suppressors	2
CLas, D. citri and CTV	2
phloem tissue	2
Asian citrus psyllid, Diaphorina citri	2
Candidatus Liberibacter asiaticus (CLas)	2
Huanglongbing (HLB)	2
Citrus tristeza virus (CTV)	2
transient expression vector	2
cell engineering target	2
miRNA–mRNA interactions	2
specific productivity	2
cell pools	2
protein productivity	2
CHO growth	2
cluster miR17-92a	2
Chinese hamster ovary (CHO) cells	2
many cellular pathways	2
Dicer dependent microRNAs	2
growth-correlating microRNA transcripts	2
Dicer, Drosha and Dgcr8)	2
CHO suspension cell lines	2
mammalian cell line	2
cells aggregates (clumps)	2
CompacT SelecT automation platform	2
feeder-free and chemically defined medium	2
human induced pluripotent stem cell lines	2
cell-based therapy products	2
manufacturing facility	2
de novo pathways	2
IEMR system	2
chiral pharmaceutical intermediate, ABT	2
initial 60mM (HPA and GA each) and 6mM (MBA) substrate concentration mixture	2
immobilized TAm converted ERY into ABT using (S)-α-methylbenzylamine (MBA) as amine donor	2
second unit of the IEMR	2
lithium-hydroxypyruvate (HPA) and glycolaldehyde (GA) to l-erythrulose (ERY)	2
first enzyme, TK	2
packed bed reactors	2
Ni-NTA agarose beads	2
IEMR using His6-tagged TK and TAm	2
two enzymes, transketolase (TK) and transaminase (TAm)	2
simple achiral substrates	2
chiral amino alcohol	2
single diastereoisomer of 2-amino-1,3,4-butanetriol (ABT)	2
building block	2
interesting compound	2
microreactor synthesizing chiral molecules	2
de novo designed enzyme pathways	2
immobilized enzyme microreactors (IEMR)	2
novel synthetic pathways	2
positions in the network	2
natural variants	2
beneficial single mutants	2
critical networks of co-evolved residues	2
recombining active-site mutants	2
active transketolase mutant	2
previously identified D469T	2
previous transketolase mutant	2
D469S and R520Q	2
Protein expression	2
D469, E498 and R520	2
triple mutant cluster	2
remaining sites	2
D469 variants	2
library of random single, double and triple mutants	2
best D469 mutants	2
one double mutant	2
large multiple sequence alignment	2
many double mutants	2
singles into double mutants	2
either glycolaldehyde (GA), or the non-natural substrate propionaldehyde (PA)	2
number of transketolase single mutants	2
modified chondroitinase gene	2
axons in the mammalian central nervous system	2
proteoglycans	2
active chondroitinase	2
selected N-glycosylation sites	2
functional enzyme	2
mammalian translation system	2
Chondroitinase ABC	2
potential N-glycosylation sites	2
bacterium Proteus vulgaris	2
chondroitinase ABC	2
prokaryotic proteins	2
eukaryotic N-glycosylation system	2
bacterial protein	2
transfected bacterial cells	2
many eukaryotic proteins	2
cell permeable peptides	2
downstream effector molecules	2
vitro, ex vivo and in vivo experiments	2
dominant-negative domain of the same TIRAP protein	2
cell permeable sequence of the Toll-receptor 4 (TLR4) adaptor protein (TIRAP)	2
One of these peptides	2
biologically active cargo	2
intact cellular membranes	2
panel of lysine and/or arginine-rich peptides	2
cargoes	2
membrane of living cells	2
short polybasic peptides	2
Even patients	2
daily IG	2
delivered and planned spinal cord D2%	2
C1 and the superior thyroid notch (TN)	2
Planned (DP) and delivered (DA) spinal cord D2	2
Elastix software	2
H&N patients	2
spinal cord dosimetry	2
dynamic acquisitions	2
retrospectively subsampled acquisitions	2
colour-intensity projection images	2
respiratory phases	2
Volunteer imaging	2
image-derived respiratory surrogates	2
whole thorax	2
thick slices	2
slice-selective implementations	2
4D-T2w	2
multicenter database	2
esophagus EUD	2
toxicity model	2
IL-4, IL-5, IL-8, IL-13, IL-15, IL-1α, TGFα and eotaxin	2
platelet-poor plasma samples	2
III NSCLC	2
total of 129 patients	2
non-small cell lung cancer (NSCLC) patients	2
cytokine markers	2
non-adaptive abdominal SBRT	2
64/97 fractions	2
adaptive plans	2
initial and adaptive plans	2
daily setup MR-image-set tumor/OAR	2
Daily real-time online-adaptive plans	2
Initial plans	2
) abdominal malignancies	2
) and non-liver (n = 	2
oligometastatic or unresectable primary liver	2
abdominal malignancies	2
organs-at-risk (OAR)	2
oligometastatic or unresectable primary abdominal malignancies	2
prone/lateral decubitus positioning	2
IMRT use	2
similar regimens	2
0.8 Gy)	2
lateral decubitus	2
tangents in prone	2
axilla/supraclavicular fossa	2
whole breast/chest wall	2
anatomical regions	2
breast cancer radiotherapy regimens	2
breast cancer radiotherapy	2
lung radiation doses	2
schedules	2
appropriately-dosed hypofractionated LNRT	2
START-pilot	2
START-A or START-B.	2
patient- and physician-assessed symptoms	2
hypofractionated and control groups	2
385 START-pilot, 318 START-A, 161 START-B	2
patients given LNRT.Results864/5861 (14.7%) patients received LNRT	2
similarly-hypofractionated breast/chest wall radiotherapy (	2
hypofractionated LNRT	2
selected axillary node positive women	2
metal implant	2
spine implants	2
DECT VM	2
spine case	2
dental and hip cases	2
non-MAR reconstructions	2
observers	2
implant site	2
metal artefacts	2
patient images	2
specially designed phantoms containing metal implants (dental, spine and hip)	2
computed tomography	2
oesophageal cancer patients	2
adenocarcinoma/undifferentiated tumours	2
Meier’s curves	2
SCOPE1 trial	2
definitive chemoradiotherapy (dCRT)	2
derived neutrophil–lymphocyte ratio (dNLR)	2
technique	2
FB and DIBH.Materials and methodsPlans	2
intensity modulated radiation therapy (IMRT) in free breathing (FB) and DIBH	2
patients with Hodgkin lymphoma (HL)	2
rectal cancer	2
radiotherapy treatments	2
radiation transport code PENELOPE.ResultsGiven	2
Tumour dosimetry	2
131I-mIBG in excised lesions	2
control (untreated)	2
131I-mIBG alone	2
EBRT alone	2
EBRT 6days	2
SK-N-SH neuroblastoma xenografts	2
c nu/nu mice	2
different schedules	2
[Gy]=183.8	2
two further cohorts	2
NTCP model	2
Lyman-Kutcher-Burman (LKB)	2
abdominal radiotherapy	2
planned DSMs	2
Accumulated EUD	2
rectal bleeding	2
discrete isodose cluster	2
ellipse	2
Accumulated-DSMs	2
109 patients	2
rectal wall	2
Material and methodsDose–surface maps (DSMs)	2
megavoltage computed tomography (MVCT) image guidance scans	2
rectum	2
anthracycline-containing chemotherapy	2
right-sided	2
left-sided breast cancer	2
also	2
19,464 women	2
Danish National Patient and Cause of Death Registries	2
Danish Breast Cancer Cooperative Group	2
women receiving anthracycline-containing chemotherapy	2
segments of the left ventricle and main coronary arteries	2
cardiac atlas	2
field edge	2
regimens and segments	2
coronary artery segments	2
coronary arterial segments	2
cardiac segments	2
different breast cancer regimens	2
radiation oncologists tested the atlas	2
written guidelines	2
Reference atlas contours	2
two cardiologists	2
cardiology models	2
radiotherapy CT-planning scans	2
left ventricular and coronary arterial segments	2
cardiac substructures	2
complex anatomical organ	2
ATR inhibitor VX-970	2
effective chemo/radiosensitizer	2
tumor cell kill	2
carboplatin and radiation	2
radiation in vitro and in vivo	2
esophageal cancer cell lines	2
ATR inhibitor, VX-970	2
pelvic bones	2
-specific set up	2
LR, CC and AP set	2
inguinal and anal targets	2
suggested margins	2
pelvic CBCT auto-match	2
single institution	2
three different targets	2
pelvic nodes, inguinal nodes	2
anal cancer	2
single radiotherapy plan	2
Investigator GTV volumes	2
NTCP using reference contours	2
oncologist investigators	2
target structures	2
two oncologists and one radiologist	2
clear surgical margins	2
borderline-resectable pancreatic cancer (BRPC)	2
RT planning	2
diagnostic-quality planning scans	2
RT plans	2
central review team	2
CT scans	2
SCALOP trial	2
patients undergoing radiotherapy	2
RFCstandard	2
dose–volume-based models (standard)	2
(RFC) models	2
predictive model of mucositis	2
head and neck (chemo)radiotherapy	2
acute mucositis	2
TV or OARs	2
MR and CT images	2
eight implants	2
internal surface of the acetabulum	2
metal artifacts	2
hip replacement patients	2
spinal canal	2
pelvic girdle	2
pelvic structures	2
prostate patients	2
spinal canal and spinal cord	2
bilateral hip replacements	2
six patients	2
spine fixation devices	2
SEMAC MR protocols	2
metallic implants	2
MLC tracking	2
air-tissue-interfaces	2
1.5T magnetic field	2
SBRT treatments	2
secondary electrons	2
radiotherapy doses	2
Nelfinavir in Europe	2
hypoxia (18F-Fluoromisonidazole-PET) and perfusion (perfusion CT)	2
weekly gemcitabine	2
locally advanced inoperable pancreatic cancer (LAPC).Materials and methodsRadiotherapy	2
162 patients	2
-automated ABS	2
automated MSC and OCC structures	2
test cohort	2
automated and manual MSC structures	2
DSC and HD	2
additional clinician	2
oral cavity contours (OCC)	2
three different clinicians	2
MSC structures	2
independent test cohort	2
mucosal surface contours (MSC)	2
oral mucosal surfaces	2
oral cavity volume	2
oral mucositis normal tissue complication probability models	2
active PBM	2
IMRT group	2
Regression models	2
PBM and sub structures	2
materialsTwo groups	2
intensity modulated radiotherapy (IMRT)	2
pelvic bone marrow (PBM)	2
centres and health care systems	2
primary diagnosis	2
chest	2
large UK cancer centre	2
radiotherapy episodes	2
retrospective cohort study	2
NHS	2
ArtpO2 and MABP	2
animals breathing air	2
tumour pO2	2
freeze-clamped tumours	2
precursor-product model	2
slice-localised 13C magnetic resonance (MR) spectra	2
femoral vein of anaesthetised rats	2
Hyperpolarised 13C1-pyruvate	2
oxygen-sensitive probes	2
inspired gas	2
hyperpolarised 13C1-pyruvate	2
oral mucosa surfaces	2
anatomically accurate contours	2
GEC-ESTRO	2
Physics Committee	2
working project	2
entire treatment course	2
clinical BT	2
target, organ, applicator	2
pelvic region	2
high-energy sources	2
non-deeply seated implants	2
low energy sources	2
dose calculation	2
clinical brachytherapy	2
synthetic microbial consortia	2
synthetic biology tools	2
communities of interacting microorganisms	2
synthetic consortia	2
natural microbial ecosystems	2
inexpensive carbon sources	2
medicines, biofuels, and biomaterials	2
microbial consortia	2
Microbial consortia	2
downstream processing applications	2
biological sources	2
agriculture in sub-Saharan Africa (SSA)	2
Clustered regularly interspaced short palindromic repeats (CRISPR) technology	2
personal use	2
commercial pharmaceuticals	2
‘home-brewed’ insulin	2
number of new insulin production ecosystems	2
US regulatory environment	2
cheaper insulin	2
generic manufacturers	2
Open Insulin Project	2
initiative	2
complex intellectual property and regulatory landscape	2
New innovation ecosystems	2
gas-phase analytes	2
artificial olfaction	2
biological units (ORs, OBPs, and peptides)	2
gas biosensors	2
odorant molecules and ORs or OBPs	2
gas-phase biosensors	2
molecular recognition units	2
native sensing units	2
proteins, olfactory receptors (ORs) and odorant-binding proteins (OBPs)	2
Animals’ olfactory systems	2
proposal	2
deadlock	2
genetically modified organisms (GMOs)	2
European Union (EU) regulatory framework	2
sophisticated multifunctional synthetic cells	2
microfluidics and DNA nanotechnology	2
versatile cytoskeletons	2
complex endomembrane systems	2
large outer compartments	2
nature’s own prototype	2
synthetic eukaryotes	2
reverse-engineer and recombine functional parts	2
synthetic cells	2
fast-growing library	2
complex environment	2
cellular phenomena	2
hundreds of thousands of single cells	2
even one company	2
potential aging-associated interventions and targets	2
short-lived model organisms	2
new crop of anti-aging companies	2
Myriad genes and pathways	2
specific molecular probes	2
optical windows	2
primary and metastatic sites	2
multi-omics assays	2
genome, epigenome, transcriptome, proteome, and metabolome profiling	2
Pioneering single-cell assays	2
genome-wide assays	2
engineering field	2
modern biotechnology	2
synthetic biology applications	2
complex megadimensional datasets	2
epistemic tools	2
broader set	2
Engineering biological systems	2
several disparate fields of research	2
expressive, high-level languages	2
laboratory automation	2
underlying systems	2
detailed empirical models	2
sophisticated tools	2
important transporters	2
much greater extracellular space	2
efflux transporters	2
Influx transporters	2
Cinderella subject	2
Novel optimized aAPCs	2
various types of acellular aAPCs	2
artificial APCs (aAPCs)	2
autologous natural APCs	2
co-stimulatory signals	2
literature corpus	2
Pichia (Komagataella) pastoris	2
many industrial microbes	2
model organism databases	2
microbial model organisms	2
research communities	2
tailor-made chemistry	2
XNA ligands, enzymes, and nanostructures	2
range of synthetic genetic polymers (XNAs)	2
nanoscale building materials	2
Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli	2
three main microbials	2
full length antibodies	2
important biopharmaceutical products	2
Monoclonal antibodies (mAbs) and antibody fragments	2
racemate	2
secondary alcohols or vicinal diols	2
epoxide hydrolases and dehalogenases	2
inverting or retaining sulfatases	2
stereocenter	2
enantiomerically pure products	2
prochiral or meso forms	2
racemic compounds	2
complex scaffold micro- and nanostructures	2
scaffold fabrication	2
wound beds	2
growth factor (GF) or stem cell (SC)	2
finely orchestrated nature	2
Skin wounds	2
collagen, elastin and de novo designed self-assembling peptides	2
recombinant self-assembling biomaterials	2
food industry	2
safe organisms	2
appropriate animal clones or plant lines	2
transgenic organisms	2
custom-made peptides	2
therapeutic drug-release applications	2
3D tissue engineering scaffolds	2
Self-assembling peptide-based biomaterials	2
optical nanosensors – nanometre-sized sensors	2
ion- or metabolite-sensitive dyes	2
deep in tissues and/or terminally differentiated)	2
new generation of fluorescent dyes	2
gene gun	2
Transporting fluorescent dyes	2
hand-held gene gun	2
quorum sensing-independent manner	2
control strain expressing β-galactosidase	2
Escherichia coli LsrB-type AI-2 QS system	2
either 96- or 384-well format	2
whole-cell bioreporter assay	2
AI-2 QS	2
novel compounds	2
multiple bacterial species	2
AI-2 QS system	2
bacterial quorum sensing (QS) signaling	2
CT immunoblot	2
individual CT antibodies	2
183 patients	2
case and control group	2
Mikrogen CT immunoblot	2
one well	2
Mikrogen CT IgG ELISA	2
Dutch Caucasian infertile women	2
individual antibodies in serum	2
Mikrogen recomLine CT immunoblot	2
new multi-target Mikrogen recomWell CT IgG ELISA	2
currently used mono-target CT serology test	2
many fertility clinics	2
trachomatis (CT) IgG serology	2
Enterobacteriaceae and P. aeruginosa	2
MBT STAR-Carba	2
RAPIDEC® CARBA NP test (BioMerieux)	2
carbapenemase producing Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp	2
MBT STAR-Carba kit (Bruker Daltonics)	2
affordable test	2
commercial qPCR diagnostic assay	2
research applications	2
commercially marketed comparator test	2
quality control panel	2
8/8 core specimens	2
Ct DNA.ResultsThe qPCR assay	2
human and	2
five different DNA extraction kits	2
molecular diagnostics quality control standards and clinical samples	2
commercial assay (artus C. trachomatis Plus RG PCR, Qiagen)	2
Homo sapiens DNA	2
endogenous positive control	2
one genomic and one plasmid Ct target	2
multiplex qPCR test	2
standard real-time thermocyclers	2
readily available reagents	2
commercial platforms	2
Many commercial platforms	2
intracellular bacterium Chlamydia trachomatis (Ct)	2
T-DNA	2
hpt resistance cassette	2
Agaricus bisporus and Cryptococcus neoformans	2
green fluorescent protein gene (gfp)	2
hygromycin B phosphotransferase (hpt) selection marker	2
binary T-DNA vector	2
Malassezia furfur	2
highly efficient Agrobacterium-mediated genetic transformation system	2
transformation system	2
normal human and animal mycobiota	2
Malassezia spp.	2
B. mycoides	2
various B. mycoides strains	2
strain EC18	2
environmental Bacillus mycoides strains	2
weaker hydrolysers	2
OXA-48 type carbapenemases	2
31 OXA-48-like producing isolates	2
meropenem in the media	2
either IMP, NDM or KPC	2
13 isolates	2
unaided eye or colorimetry	2
OXA-244 producer	2
carbapenemase producing isolates	2
remaining meropenem	2
isolates in growth media	2
unaided eye	2
Neo-Rapid CARB kit	2
carbapenemase negative Enterobacteriaceae isolates	2
either an imipenemase (IMP; n=8), New Delhi metallo-β-lactamase (NDM; n=3), or Klebsiella pneumoniae carbapenemase (KPC; n=2)	2
OXA-48-like producing isolates	2
Enterobacteriaceae isolates	2
OXA-48-like carbapenamases	2
plasmidless, markerless recombinant strains	2
different sites in one strain	2
multiple copies in the chromosome	2
desired fragment	2
λint/xis genes	2
CmR-marker	2
Dual-In/Out approach (Minaeva et al., 2008)	2
selected site	2
cloned sequence	2
ori-less circular recombinant DNA	2
DNA ligase	2
SceI endonuclease	2
pGL2-based recombinant plasmids	2
λ-attL/attR sites	2
excisable CmR marker	2
ϕ80-attP site of ϕ80 phage	2
ori of pSC101	2
plasmid vector pGL2	2
important but neglected human pathogen Orientia tsutsugamushi	2
cytoplasm, nucleic acids, cell membrane or peptidoglycan of living bacterial cells	2
four different classes of probes	2
eukaryotic cell systems	2
new organism	2
well-characterised species and strains	2
low endemic settings	2
Shigella/EIEC	2
Bacterial GE	2
molecular reference tests	2
1168 patients	2
bacterial pathogens causing gastroenteritis	2
new commercially available multiplex real-time PCR kit Amplidiag® Bacterial GE	2
P. pastoris samples	2
purified genomic DNA (gDNA)	2
genomic target locus	2
particular yeast species	2
biotherapeutic proteins	2
methylotrophic yeast Pichia pastoris (P. pastoris)	2
industrial settings	2
synthetic yeast genomes	2
synthetic DNA	2
E. coli K12 MG1655	2
kb DNA fragment	2
developed iBAC(cav)-mediated system	2
yellow fluorescent protein (mVenus) expression	2
B. subtilis-specific antibiotic resistance	2
engineered integrative bacterial artificial chromosome iBAC(cav)	2
well-characterized amyE target locus	2
DNA assembly and editing tools	2
well-characterized model bacterium	2
intravenous immunoglobulin and convalescent serum	2
Lancefield assay	2
Streptococcus pyogenes research	2
surrogate-of-immunity assay	2
intact frozen native faecal matrix	2
suitable storage buffer	2
faecal sample	2
Intact faecal samples	2
extracted proteins	2
protease assays	2
sodium azide	2
protein extracted	2
variety of storage buffers	2
3 healthy volunteers	2
functional proteome	2
historical native faecal samples	2
host proteins and structures	2
host interactome	2
second axis of the microbiome	2
atypical solvent system	2
intact bacteria	2
lipid A	2
Gram-negative bacterial lipid A	2
fields of food safety	2
serotype-level classification of microorganisms	2
mixed samples	2
2 different E. coli strains (K-12 as a non-O157 representative and O157)	2
three biomarkers	2
O26 and O111 strains	2
O157 strains	2
O115, O121, O128, O145, O157, O159, and untyped serotypes	2
O26, O91, O103, O111,	2
E. coli isolates	2
novel software named Strain Solution	2
S10-spc-alpha operon gene-encoded ribosomal protein mass spectrum (S10-GERMS) method	2
important O serogroups of enterohemorrhagic Escherichia coli	2
O157, O26, and O111	2
germination sites	2
Penicillium spp	2
Propionic acid	2
growing hyphae	2
96 well microplate	2
tilted focus plane	2
optical detection system	2
range of dairy-associated bacteria	2
Propionic acid and diacetyl are antifungal compounds	2
colony growth or biomass	2
many food and clinical environments	2
Mold growth	2
novel anti-fungals	2
disc-diffusion and broth micro-dilution anti-fungal assays	2
fungal-SPOTi	2
mycelial plugs	2
fungal-SPOTi assay	2
solid agar-based spot culture growth inhibition assay (SPOTi)	2
common fungal pathogens	2
different CMhm and CMt strains	2
phylogeny	2
CMhm and CMt sequences	2
Mhf sequences	2
GenBank sequences	2
universal 16S rRNA gene primers	2
16S rRNA gene sequences	2
novel haemoplasma species-specific primers	2
co-infected cats	2
Haemoplasma 16S rRNA gene sequences	2
haemoplasma infections	2
CMhm/CMt	2
Mhf/CMhm	2
two or more feline haemoplasma species	2
haemoplasma-infected cats	2
11.1%) and CMt	2
13.8% of cats)	2
Feline haemoplasmas	2
Brazil's capital and surrounding areas	2
haemoplasma species in cats	2
feline haemoplasmosis	2
Mycoplasma haemofelis (Mhf), ‘Candidatus Mycoplasma haemominutum’ (CMhm) and ‘Candidatus Mycoplasma turicensis’ (CMt)	2
well-described pyruvate dehydrogenase complex	2
His- and Strep-tags	2
Strep tag	2
His–Strep–	2
either an N- or C-terminal	2
constitutive and regulatable versions	2
Gateway-adapted vector system	2
formaldehyde crosslinking system	2
conserved hypothetical proteins	2
large number of predicted open-reading frames	2
16S rRNA gene sequencing, GEN III and MALDI-TOF MS	2
weighted scoring system	2
100 strains	2
isolates of veterinary interest	2
Biolog GEN III identification system (hereafter, GEN III)	2
atypical or novel isolates	2
phenotypic and chemotaxonomic methods	2
highly viable M. leprae	2
Octo Dissociator	2
current purification protocol	2
athymic nude mouse footpads (FPs)	2
etiologic agent	2
viable microbes	2
cell sorting	2
culturable and VBNC bacteria	2
flow cytometry (FC)/fluorescent activated cell sorting (FACS)	2
real-time quantitative PCR (RT-qPCR or qPCR), reverse transcriptase (RT-PCR), propidium monoazide-PCR	2
live probiotic bacteria	2
hospitable host environment	2
viable but non-culturable state (VBNC)	2
live probiotic microbes	2
probiotic strains	2
Probiotics are live microorganisms	2
hVISA and VISA phenotypes	2
Microscopy-based hVISA population analysis profiles (PAPs)	2
clindamycin-resistant and 75/75 clindamycin susceptible strains	2
CDC organisms	2
concurrent cefoxitin disk diffusion and D-test references	2
progeny clones	2
individual immobilized progenitor cells	2
automated microscopy system	2
3 clinical isolates and reference strains	2
characterized CDC isolates	2
growing clones	2
S. aureus isolates (MRSA/MSSA, clindamycin resistance/susceptibility and VSSA/hVISA/VISA)	2
susceptible from non-susceptible responses	2
immobilized live bacterial cells	2
leading, virulent pathogen	2
filamentous fungus Aspergillus carbonarius	2
selective plasmids and plasmids	2
PfuTurbo Cx polymerase	2
USER™ enzyme mix	2
DNA cloning	2
Johne's disease	2
naturally infected blood	2
10 animals	2
one herd	2
set of samples	2
5 animals	2
accredited Johne's disease free herd	2
MAP	2
PMMS-phage	2
15 animals	2
milk-ELISA positive	2
isolated buffy coat	2
clinical bovine blood samples	2
MAP signature sequences (IS900)	2
commercially available blood	2
MAP cells	2
clinical blood samples	2
paratuberculosis (MAP)	2
viable Mycobacterium avium subsp.	2
CampF7/R7) specific PCR assays	2
C. fetus (CampF4/R4) and the C. fetus venerealis (	2
C. fetus fetus and C. fetus venerealis	2
Green PCR assays	2
two Real Time SYBR®	2
1071 isolates	2
recent molecular based assays	2
biotyping methods	2
C. fetus fetus	2
C. fetus venerealis	2
Campylobacter fetus venerealis	2
kit Z (H′=2.30 and 1.27) and kit QS (H′=2.16 and 0.94)	2
DGGE and T-RFLP	2
selected target bacteria	2
Automated kit QS	2
five kits	2
terminal restriction fragment length polymorphism (T-RFLP)	2
human faeces	2
Three bacteria	2
total genomic DNA	2
human faecal samples	2
PowerSoil® DNA Isolation Kit (kit P))	2
MiniPrep™ (kit Z), QIAamp® DNA Stool Mini Kit (kit QA), Ultraclean® Fecal DNA Isolation Kit (kit U) and	2
Five widely used commercial deoxyribonucleic acid (DNA) extraction kits (QIAsymphony® Virus/Bacteria Midi Kit (kit QS)	2
faecal microbiota	2
important cell organelle	2
fungal vacuoles	2
ions and molecules	2
intracellular components	2
Fungal vacuoles	2
Haemophilus spp	2
capsulate and non-typeable H. influenzae	2
RP4 mobilisation region	2
E. coli and H. influenzae	2
Escherichia coli and H. influenzae and H. parainfluenzae	2
shuttle vector, pEJ6	2
effective shuttle vector	2
various haemophili	2
mycobacterial mutant strains	2
sacB or a lacZ gene	2
two pairs of LIC sites	2
modified version of p1NIL	2
making of pNILRB5	2
pNILRB plasmid series	2
two flanking regions	2
widely-used suicide delivery vector (p1NIL)	2
suicide delivery vector	2
given gene	2
lppQ− mutant vaccine strain	2
wild type strains	2
ex vivo bronchoalveolar lavage fluids of cows	2
mycoides SC	2
lppQ gene	2
CBPP in cattle	2
potential live DIVA (Differentiating Infected from Vaccinated Animals) vaccine strain	2
mycoides SC.	2
lipoprotein LppQ	2
T1lppQ− mutant strain	2
Janis et al., 2008)	2
lppQ− mutant of the existing vaccine strain T1/44	2
live attenuated strains of the organism	2
mycoides small-colony type (SC)	2
Mycoplasma mycoides subsp.	2
Contagious bovine pleuropneumonia (CBPP)	2
debilitating and often fatal conditions	2
inflammatory and neurodegenerative disorders	2
key signalling modules	2
MAP kinase pathways	2
distinct MAP kinase cascades	2
MAP kinase isoforms	2
family of dual-specificity MAP kinase phosphatases (MKPs)	2
first non-cyclic nucleotide EPAC1 agonist	2
I942 and 007	2
cell adhesion molecule, VCAM1	2
cyclic AMP-elevating agents, forskolin and rolipram (F/R)	2
EPAC1-selective cyclic AMP analogue, 007	2
broad-spectrum protein kinase A (PKA) inhibitor, H89	2
EPAC1 antagonist, ESI-09, and EPAC1 siRNA	2
SOCS3 expression	2
non-cyclic nucleotide EPAC1 agonist, I942	2
JAK/STAT3 pathway	2
suppressor of cytokine signalling 3 (SOCS3) gene	2
vascular endothelial cells (VECs)	2
cyclic AMP (EPAC1)	2
Exchange protein	2
calcium permeable ion channels	2
superfamily of transient receptor potential (TRP) channels	2
specialized ion channels	2
stromal cell decidualization	2
endometrial cell	2
endometrium	2
counteracting phosphatases	2
actin-binding protein phostensin	2
enriched components	2
endophilin-3 interactome	2
autolysosome formation	2
endophilin-3 expresses	2
two novel direct targets of miR34a, endophilin-3 and cathepsin B (CTSB, a previously reported enzyme for Aβ degrading (Sun et al.))	2
Aβ fibrils	2
molecular rationale	2
autophagy-lysosome machinery (Ries and Sastre; Cho et al.)	2
extracellular Aβ	2
brain immune system	2
aberrant Aβ metabolism (Qiang et al.; Sevigny et al.; Ittner et al.)	2
amyloid-β (Aβ) plaques	2
Matheoud et al.; Ashkenazi et al.)	2
CaV1.2 clusters	2
CaV1.2 vesicles	2
microtubules and actin filaments	2
vesicular structures	2
functional channel clusters	2
adjacent CaV1.2 channels	2
L-type CaV1.2 channels	2
wild-type p53-containing cancer	2
three lysine residues	2
tumor cell growth	2
BH3-only member of the BCL-2 family	2
second messenger, NAADP	2
acidic organelles	2
+-permeable endo-lysosomal ion channels	2
so-called autophagy receptors	2
core ATG proteins	2
key players of macroautophagy	2
autophagy-related (ATG) genes	2
stem cell stemness	2
unwanted cellular components	2
novel regulatory pathway	2
primary controls	2
MLLr cell lines	2
small molecule inhibitors (MLN4924 and C1)	2
various MLL-rearranged (MLLr) AML subtypes	2
MllN and MllC subunits of Mll1 (Mixed-lineage leukaemia 1)	2
Cks1 and Cks2 proteins	2
p27 and Cyclin A.	2
Notable targets	2
E3 ubiquitin ligase complexes SCFSkp2 and APCCdc20	2
Cdc28 protein kinase subunits, Cks1 and Cks2	2
Christian Ungermann and Benoit Kornmann	2
Membrane Contact Sites	2
last universal common ancestor	2
bacterial TULIP	2
E. coli protein YceB.	2
silk polymer	2
previously unreported TULIPs	2
known TULIPs	2
intracellular membrane contact sites	2
synaptotagmin, mitochondrial and lipid binding proteins)	2
SMP domains	2
bacterial permeability-inducing protein (BPI) and cholesterol ester transfer protein (CETP)	2
large family of extracellular proteins	2
TULIP domains	2
TULIP proteins	2
hydrophobic molecule	2
hydrophobic lining	2
internal pocket	2
tubular domain	2
membrane contact sites	2
lipid traffic	2
Tubular lipid binding proteins (TULIPs)	2
calcium-sensing receptor	2
colon of mice fed high calcium diet	2
main molecules	2
fed mice	2
G protein-coupled receptor	2
probe sets	2
extracellular calcium ([Ca2+]o)	2
industrialised societies	2
Colorectal cancer	2
Claus Heizmann, Joachim Krebs and Jacques Haiech	2
ECS Meeting	2
MICU1 patient cells	2
patient derived or control fibroblasts	2
pyruvate dehydrogenase (PDH)	2
patient but not control cells	2
sodium calcium exchanger (NLCXm)	2
resting [Ca2+]m	2
patient derived fibroblasts	2
protein MICU1	2
IMS proteome	2
recently discovered new components	2
import pathways	2
newly identified IMS proteins	2
multiple organelles	2
smallest sub-compartment of mitochondria	2
IMS	2
proteins and other signalling molecules	2
mitochondrial proteostasis	2
key protein import components	2
complex internal architecture	2
fundamental organelles	2
autism and amyotrophic lateral sclerosis	2
individual metabolic pathways	2
tissue- and cell type-specific contributions	2
peroxisomal metabolites	2
human patients and mouse models	2
Jacques Haiech, Claus Heizmann, Joachim Krebs, Thierry Capiod and Olivier Mignen	2
new allosteric drug compounds	2
prostate and breast tumours	2
colorectal or parathyroid tumours	2
parathyroid or colon	2
many types of benign or malignant tumours of the breast, prostate, parathyroid, and colon	2
highly divergent downstream signalling pathways	2
multiple G protein subtypes	2
plethora of ligands	2
Marcus Schaub and Hughes Abriel	2
Heart	2
Developmental and Environmental Cues	2
Cardiomyocyte Biology	2
diseased heart	2
two major cytoskeletal multiprotein complexes	2
fully differentiated tissues	2
Pex19 and Pex16 in mammals	2
functioning peroxisomes	2
neurodegenerative and other disease models	2
significant cell subpopulations	2
native fluorophores, flavins, bound and free NADH and retinoids	2
Cellular maps	2
healthy from diseased cells	2
endogenous source of contrast	2
human metabolic disease MELAS (mitochondrial myopathy, encephalomyopathy, lactic acidosis, stroke-like syndrome	2
cell model	2
patient olfactory neurosphere-derived cells	2
spectral and spatial image information	2
Hyperspectral imaging	2
Peter Ruvolo and Gregg L. Semenza	2
leukemia cells	2
white blood cells	2
standard FTIR equipment	2
bioassay reagents	2
1024cm−1)	2
Spectral regions	2
MTT assays	2
amide bands	2
attenuated total reflection (ATR) crystal	2
HeLa, PC3, and Caco-2 cells	2
chemotherapy drug	2
common anti-cancer drug doxorubicin	2
three different cancer cell-lines	2
specific cancer types	2
certain types of cancer	2
ezrin-Thr567Asp	2
PKA phospho-mimetic mutants of ezrin	2
cell arborisation	2
actin, ezrin-Arg579Ala	2
ezrin-Thr567Ala	2
key PKA phosphorylation site	2
inhibitory ezrin mutants	2
–EPAC1	2
EPAC1-activation alone	2
ezrin phosphorylation	2
ezrin on Thr567	2
cAMP phosphodiesterase inhibitor, rolipram	2
adenylate cyclase activator, forskolin	2
EPAC1 and PKA	2
EPAC-selective analogue, 8-pCPT-2′-O-Me-cAMP (007)	2
EPAC1) cells	2
HEK293T–	2
HEK293T (	2
cAMP-sensor, EPAC1	2
actin binding protein, ezrin	2
dominant-negative mutant (R185Q)	2
negative allosteric modulator, NPS 2143	2
positive allosteric modulator of CaSR, NPS R-568	2
wild-type CaSR	2
CRC cells	2
CaSR.In vitro	2
colons of CaSR/PTH double knock-out mice	2
CRC.In human colorectal tumors	2
calcium-sensing receptor (CaSR), a calcium-binding G protein-coupled receptor	2
dietary calcium intake	2
13th European Symposium	2
dendritic regions of primary neurons	2
somatic regions	2
genetically encoded indicator of intracellular redox potential (Grx1-roGFP2)	2
special issue	2
particular Ca2+ sensor proteins	2
Ca2+ signalling pathways	2
various Ca2+ sensor proteins	2
Ca2+ signal	2
single signalling ion	2
intracellular free calcium concentration ([Ca2+]i)	2
whole D. melanogaster flies	2
putative D. melanogaster lysosomal sorting receptor lysosomal enzyme receptor protein	2
carbohydrate moiety	2
cathepsin L.	2
intracellular dCREG	2
D. melanogaster S2 cells	2
putative orthologue (dCREG)	2
lysosomal glycoprotein	2
E1A-stimulated genes	2
Mammalian cellular repressor	2
AIF and AIF cleavage	2
human neural stem cells (hNSCs) expressed PAD2 and PAD3	2
citrulline (citrullination/deimination)	2
protein-bound arginine	2
calcium-dependent enzymes	2
PADs (peptidylarginine deiminases)	2
glucagon excess	2
novel glucagon receptor antagonists	2
6-phosphofructo 2-kinase/fructose 2,6 bisphosphatase-2 (PFK2/FBPase2)	2
rat hepatocytes	2
regulatory protein (GKRP)	2
Gli-dependent transcriptional outcome	2
efficient inhibitor	2
either Shh or TGF-β	2
Ulk3 RNAi	2
functional Shh signaling axis	2
cultured ASCs	2
human adipose tissue derived multipotent stromal cells (ASCs) and mouse immortalized progenitor cells	2
endogenous Gli1/2 proteins	2
different cell-based experimental models	2
compound targeting Gli1/2 proteins	2
inhibitor of Ulk3 catalytic activity	2
Gli1/2 transcriptional activators	2
Shh signaling pathway	2
Gli proteins	2
serine/threonine kinase Ulk3	2
attractive pharmaceutical targets	2
Transforming Growth Factor β (TGF-β) signaling axis	2
(Shh) signaling pathway	2
Sonic Hedgehog	2
Glioma-associated transcription factors Gli1 and Gli2 (Gli1/2)	2
Thomas Sommer and Dieter H. Wolf	2
Proteasome System	2
novel class of ubiquitin ligases (E3), termed ULS (E3-S) or STUbL	2
SUMO (small ubiquitin-related modifier)	2
translational targets of mTORC1	2
human neuroglioma cells	2
specific inhibitor	2
Leucine Rich Repeat Kinase 2 (LRRK2)	2
TGFβ signalling pathway	2
multiple protease and matrix genes anabolically	2
cell based luciferase assay	2
selected cultures	2
TGFβ1 and TGFβRI inhibitor	2
Flexcell™ tissue train system	2
type I rat tail collagen gels	2
Primary Human Achilles tenocytes	2
metalloproteinase and matrix gene expression	2
paxillin localisation	2
selective activators of EPAC and PKA	2
cAMP (EPAC) and protein kinase A (PKA)	2
exchange protein	2
two primary cAMP effectors	2
cellular migratory apparatus	2
cAMP effectors	2
PANC-1 and other pancreatic ductal adenocarcinoma (PDAC) cell types	2
Hsp70 machinery	2
nucleoid association	2
Mdj1 variants	2
J-domain containing fragment	2
Hsp70-interacting J-domain	2
Mdj1 variant	2
nucleoids, DNA-protein complexes	2
great majority of Mdj1	2
functional mtDNA	2
Hsp40 co-chaperone of Hsp70 in the mitochondrial matrix	2
ubiquitous proteins	2
autophagy inhibitors (i.e. clinically-used Chloroquine)	2
subpopulation of cells	2
tested cancer cell lines	2
prostrate-, breast cancer cells	2
commonly used autophagic inducer Rapamycin	2
TatA-type complexes	2
another B. subtilis TatA complex, TatAc	2
translocation channel	2
TatAd pore	2
E. coli TatE complexes	2
one end	2
potential pores	2
ring-shaped complexes	2
Escherichia coli TatA complexes	2
first 3D model	2
TatAd complex	2
substrate-binding TatC-containing complex	2
membranes in bacteria and chloroplasts	2
fully folded proteins	2
SOCE proteins	2
S-type cells	2
S-type cells SOCE	2
differentiated N-type cells	2
ER Ca2+ sensor and store-operated Ca2+ channel (SOC)	2
STIM1 and Orai1 expression	2
N-type cells	2
STIM1, Orai1 and TRPC1	2
proliferating and differentiated N- and S-type cell populations	2
Store-operated Ca2+ entry	2
β-tubulin III, vimentin and Bcl-2	2
N- and S-type cells	2
parental SH-SY5Y neuroblastoma cell line	2
N- and S-type cell populations	2
non-neuronal substrate-adherent S-type cells and intermediate I-type cells	2
neuroblastic N-type cells	2
distinct cell phenotypes	2
Neuroblastoma cell lines	2
ARL6 in trypanosomes	2
ARL6 RNAi	2
site of exogenous BBS1	2
endogenous ARL6	2
unicellular eukaryotes	2
vesicles and cytoplasmic microtubules	2
ARL6 interacting partner	2
related protein ARL-3A in T. brucei	2
N-myristoylation	2
electron-dense vesicles	2
human Arl6	2
flagellated model eukaryote Trypanosoma brucei	2
octomeric BBSome complex	2
small GTPase Arl6	2
chloroplast envelope	2
stroma, chaperones (e.g., Hsp70, Cpn60, cpSRP43)	2
second, parallel complex	2
stromal Hsp70	2
one such motor complex	2
stromal Hsp100-type chaperone, Hsp93	2
ATP-driven motor complexes	2
trans side of the inner membrane	2
chloroplast surface	2
TOC complex	2
Hsp90, Hsp70 and 14-3-3	2
Cytosolic factors	2
Several chaperones and cochaperones	2
intermembrane space, and the stroma	2
outer and inner envelope membranes	2
different cellular and organellar compartments	2
Outer/Inner envelope membrane of Chloroplasts)	2
TOC and TIC (Translocon	2
envelope complexes	2
preproteins	2
endosymbiotic origin	2
underlying receptor-β-arrestin signalling complex	2
Y1 receptor-β-arrestin BiFC complexes	2
Y2 receptor mutant	2
mutations (6A)	2
Y2-GFP receptor	2
HEK293 cell plasma membranes	2
Y1 and Y2-GFP receptors	2
Diffusion co-efficients (D)	2
Y1 receptor-β-arrestin complexes	2
novel GFP-based bimolecular fluorescence complementation (BiFC) system	2
GFP-tagged neuropeptide Y (NPY) receptors	2
β-arrestin adaptors	2
microdomains of single living cells	2
G protein coupled receptor complexes	2
distinct proteins, DNA ligase III and RNase H1	2
mitochondrial replication system	2
DNA ligase I	2
RNA primers	2
neither flap endonuclease 1 (FEN1) nor DNA2	2
single strand nicks	2
replication intermediates	2
ribonuclease (RNase) H1	2
human mitochondria	2
DNA ligase III	2
replicating mtDNA molecules	2
Heat Shock Protein 90 (HSP90)	2
client proteins and co-chaperones	2
Hsp90's active site	2
specific co-chaperones	2
different co-chaperone complexes	2
variety of co-chaperones	2
cytosolic Hsp90	2
different orthologues of Hsp90	2
regions of the Hsp90 dimer	2
catalytically active unit	2
Hsp90's clientele	2
clientele and co-chaperones	2
variety of complexes	2
deadly organelle	2
common pathway	2
cytosolic E3 ubiquitin ligase parkin	2
mitochondrial kinase PINK1	2
autophagic-lysosomal pathway	2
several key molecular pathways	2
cyclin-binding helix	2
Molecular dynamic simulations	2
defective cdks	2
active kinase	2
mutant cdk2	2
regulatory cyclin subunit	2
cdk	2
central motif	2
proline in the PSTAIRE helix	2
leucine	2
mutant form of cdk2	2
Cyclin-dependent kinase 2 (cdk2)	2
sarcolemmal KATP channels	2
AV-SUR2A	2
inactive mutant of muscle lactate dehydrogenase	2
K+ current	2
mutant form of Kir6.2	2
Adenoviral SUR2A construct (AV-SUR2A)	2
subunit of ATP-sensitive K+ (KATP) channels	2
CXCL8 expression	2
AP1 and NFAT binding sites	2
NFAT signaling pathway	2
calcineurin–	2
calcium–	2
protein kinase C–	2
another CXCR2 ligand	2
CXCR2 ligand CXCL1	2
PGF2α-F-prostanoid (FP) receptor	2
neoplastic epithelial and vascular cells	2
chemokine (C-X-C motif) receptor 2 (CXCR2)	2
prostaglandin (PG) and chemokines	2
Pro-inflammatory mediators	2
endometrial cells PROK1	2
RCAN1-4 endogenous expression	2
RCAN1-4 overexpression	2
specific chemical inhibitors	2
/NFAT signaling pathway	2
AP1 and NFAT motifs	2
human first trimester decidua	2
prokineticin receptor 1	2
endometrial epithelial Ishikawa cells	2
prokineticin 1 (PROK1)	2
various cellular compartments	2
926 cells	2
endothelial EA.hy	2
structural determinant(s)	2
carboxyl terminal (C)-tail domain of the hIP	2
enlarged endocytic vesicles	2
GTPase deficient Rab5aQ79L	2
dominant negative Rab5aS34N	2
cytosol/soluble fraction of the cell	2
Rab5a-containing endocytic vesicles	2
human embryonic kidney 293 cells	2
human prostacyclin receptor (hIP)	2
tau and α-synuclein	2
common tyrosine kinase	2
primary residue	2
tyrosine 18	2
tyrosine residues of tau	2
expressed exogenously	2
tau kinase	2
synucleinopathies	2
Parkinson's disease	2
tyrosine kinase Syk	2
putative tyrosine kinases of tau	2
serine and threonine residues	2
AIRE transactivation ability	2
Thr68 and Ser156	2
reporter promoters	2
AIRE phosphorylation sites	2
AIRE positive mTEC cell population	2
DNA-PKcs	2
residues Thr68 and Ser156 are DNA-PK phosphorylation sites	2
vitro phosphorylation assays	2
novel interaction partner	2
Ku70, Ku80 and DNA-PK catalytic subunit (DNA-PKcs)	2
heterotrimeric complex of DNA-Dependent Protein Kinase (DNA-PK)	2
co-immunoprecipitation	2
autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)	2
AIRE gene	2
thymic medullary epithelial cells (mTEC)	2
many antigens	2
tissue specific antigens	2
autoimmune regulator (AIRE) protein	2
HESX1–DNMT1 complexes	2
portion of the N-terminus of DNMT1	2
entire HESX1 protein	2
developing Rathke's pouch	2
anterior forebrain	2
HESX1 binding protein	2
DNA methyltransferase 1 (DNMT1)	2
Hesx1 deficient mice	2
highly conserved homeobox gene	2
NOS/sGC/PKG pathway	2
C-tail domain	2
Ser331 and Thr337	2
endogenous eNOS	2
nitric oxide synthase (NOS), soluble guanylyl cyclase (sGC) and PKG inhibitors l-NAME, LY 83583 and KT5823	2
phospho-targets	2
unique C-tail domain	2
key phospho-target	2
Ser145 within intracellular domain (IC)2	2
TXA2 mimetic	2
inositol 1,4,5 trisphosphate generation)	2
TPα isoform	2
(PK) C.	2
G protein-coupled receptor kinase (GRK)	2
TPβ isoform of the human TXA2 receptor (TP)	2
Thromboxane (TX) A2	2
numerous candidates	2
ever expanding datasets	2
useful comparative resource	2
epifluorescence images	2
inventory	2
T. brucei genome	2
every protein	2
specific structure/organelle	2
fluorescently tagged protein	2
highly structured cellular organisation	2
kinetoplastids Trypanosoma brucei and Leishmania mexicana	2
stably transformed clones	2
genetically modified populations	2
episomal and integrative constructs	2
electroporated parasites	2
epimastigote cultures	2
scavenger receptor cysteine-rich modules	2
LAP1 chiefly	2
LAP1, LAP2 and LAP3	2
abundant complexes	2
reporter-tagged LAPs	2
series of parasite lines	2
P. berghei	2
unique parasite organelle	2
crystalloid	2
LAPs	2
LCCL lectin domain adhesive-like proteins (LAPs)	2
family of six modular proteins	2
Plasmodium berghei in vector mosquitoes	2
lipid anchoring	2
adjoining inner membrane complex	2
SPN	2
alveolin palmitoylation	2
non-palmitoylated IMC1c	2
conserved cysteine motif	2
alveolin IMC1c	2
cortical cytoskeleton	2
subpellicular network (SPN)	2
individual parasite molecules and structures	2
Plasmodium proteins	2
mitochondrion itself	2
proliferating bloodstream forms of T. brucei	2
several essential pathways	2
complex I deficient background	2
NDH2 null mutants	2
ubiquinone oxidoreductase, NDH2	2
second NADH	2
stage	2
Multiple components of mitochondrial complex I, NADH:ubiquinone oxidoreductase	2
Trypanosoma brucei mitochondria	2
slender bloodstream form	2
terminal cysteine motifs	2
amino- or carboxy-terminal cysteine motif	2
transgenic Plasmodium berghei parasites	2
conserved cysteine motifs	2
Plasmodium alveolin family	2
sporozoite-expressed IMC1a	2
cysteine motifs	2
ends of the polypeptides	2
three closely spaced cysteine residues	2
conserved motifs	2
subset of alveolins	2
tandem repeat sequences	2
core alveolin structure	2
conserved family of proteins	2
chloroplast of the related peridinin dinoflagellate algae	2
Apicomplexa	2
Plasmodium transcripts	2
Chromera and Vitrella transcripts	2
polyU tail	2
photosynthetic chloroplast	2
related algae Chromera and Vitrella	2
tRNA, mRNA and rRNA molecules	2
single RNA polymerase	2
plant chloroplasts	2
numerous genes	2
Many members of the Apicomplexa	2
host organism	2
secreted immunoregulatory parasite proteins	2
host cells and tissues	2
range of immuno-modulatory mediators	2
Helminths are metazoan organisms	2
vanillic acid based inducible expression system	2
two different genes in the same cell	2
Another independent inducible system	2
genes and dsRNA	2
real cells	2
complex trafficking apparatus	2
vesicle traffic systems	2
metaphorical hourglass	2
hypothetical vesicle traffic systems	2
hypothetical cells	2
compartments exchange vesicles	2
Boolean mathematical model	2
traffic systems	2
compartment and vesicle of such a system	2
diverse taxon-specific specialized endomembrane organelles	2
ER, Golgi, endosomes, and plasma membrane	2
basic secretory and endocytic system	2
different microbial taxa	2
glycosomes of kinetoplastids	2
peroxisome-derived metabolic compartments	2
rhoptries and micronemes of apicomplexans	2
specialized secretory organelles	2
endomembrane organization	2
Microbial eukaryotes	2
eIF2α on threonine 169	2
arrested stumpy forms in mice	2
proliferating bloodstream form cells	2
phosphorylation site, threonine 169	2
single eIF2α gene	2
guanine nucleotide exchange factor	2
alpha subunit of initiation factor eIF2 (eIF2α)	2
proliferating equivalent	2
Nearly all arrested cells	2
stumpy bloodstream forms	2
non-dividing ‘stumpy' forms	2
proliferating ‘slender' bloodstream forms	2
insect-midgut procyclic form	2
mammalian bloodstream form	2
relevant insect and/or mammalian host	2
series of developmental forms	2
MTZ-resistant bacteria and protists	2
ajoene and MTZ	2
natural ajoene oil	2
synthetic drug MTZ	2
recommended oral dose	2
MTZ flakes	2
fed	2
faecal trophozoite count	2
0.5% (v/w) MTZ	2
S. vortens-infected Pterophyllum scalare angelfish dosed orally	2
ajoene oil	2
Ajoene oil	2
(Z)-ajoene (MIC 16μg/ml	2
S. vortens growth	2
ajoene crude oil	2
diallyl disulphide (DADS) and diallyl trisulphide (DATS)	2
mixture of the (E) and (Z)-ajoene isomers	2
ajoene extract	2
S. vortens	2
ajoene oil crude extract	2
primary biologically active component of garlic	2
stable transformation product	2
Ajoene ((E,Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxide)	2
garlic (Allium sativum)	2
fish farms	2
drug of choice, metronidazole (MTZ)	2
Pterophyllum scalare	2
freshwater angelfish	2
Spironucleus vortens	2
rRNA, snoRNA and mRNA quality control	2
exosome subunits RRP44 and RRP6	2
eYFP-fusion proteins	2
oligocistronic mRNAs	2
NMD helicase UPF1	2
cytoplasmic 5′-3′ exoribonuclease XRNA	2
missed splice site	2
polycistronic mRNA molecules	2
long polycistronic precursors	2
two introns	2
cytoplasmic NMD machinery	2
Intron-containing mRNAs	2
parasite membrane and micronemal proteins	2
novel, hypothetical model	2
VPS proteins	2
trafficking complexes	2
(VPS) homologues	2
core set	2
Toxoplasma gondii and other apicomplexan parasites	2
various organelles	2
rhoptries, micronemes and dense granules	2
three morphologically distinct secretory organelles	2
highly complex endomembrane system	2
phylum Apicomplexa	2
A. suum UNC-29 subunit	2
single line of worms	2
thrashing assay	2
unc-29 VC1944 (ok2450)	2
C. elegans null mutation	2
H. contortus UNC-29.1 subunit	2
A. suum UNC-38	2
null deletion mutant VC2937 (ok2896)	2
UNC-38 subunit of H. contortus	2
relevant C. elegans promoters	2
parasite cDNAs	2
unc-38 and unc-29 genes	2
Caenorhabditis elegans strains	2
Haemonchus contortus and Ascaris suum	2
two well-conserved nicotinic receptor subunits, UNC-38 and UNC-29	2
multiple different subunits	2
nematode neuromuscular junctions	2
levamisole-sensitive nicotinic acetylcholine receptor	2
FIKK subfamily	2
NTE	2
apicomplexan species	2
FIKK8 orthologues	2
N-terminal extension (NTE)	2
soluble and active FIKK constructs	2
arginine in the +3 and −3 positions	2
FIKK8 targets serine	2
arrayed positional scanning peptide library	2
substrate specificities	2
Recombinant protein samples	2
non-Plasmodium parasites	2
member of the family	2
Cryptosporidium parvum orthologue (CpFIKK)	2
Plasmodium falciparum FIKK8 (PfFIKK8)	2
distinctive sequence motifs	2
minimal binding region of PfEMP1	2
specific interaction site	2
minimal IgM binding region of a PfEMP1 domain	2
IgM binding site	2
charged amino acids	2
adjoining parts of subdomains 1 and 3	2
central region of the DBL domain	2
minimal IgM binding region	2
rosette-mediating PfEMP1 variant, DBL4ζ of TM284var1	2
IgM binding domain	2
diverse P. falciparum Erythrocyte Membrane Protein One (PfEMP1) family	2
parasite ligands	2
erythrocyte rosetting	2
P. falciparum strains	2
surface of infected erythrocytes	2
coating of IgM	2
Fc-region of human IgM molecules	2
host immunoglobulin	2
β-tubulin:GTP complex	2
face of the β-helix fold	2
binding nucleotide	2
orthologous human GTPase activating protein	2
another face solvent	2
One face of the prism	2
triangular prism	2
five turns	2
right-handed β-helix	2
single domain	2
selenomethionine derivative	2
C-terminal domain of tubulin-binding cofactor C	2
2.2 Å resolution crystal structure	2
two ancillary cofactors	2
super-complex of tubulin monomers	2
heterodimeric α/β-tubulin	2
ABSTRACTTubulin-binding cofactor C	2
0.3 female and 1.8 male gametocytes per microlitre of blood	2
gametocyte specific RT-qPCR assays	2
female (Pfs25) and male (Pfs230p)	2
Pfs25 mRNA	2
mature female and male gametocytes	2
sexual stages (gametocytes) in the blood	2
enzyme in the pathway	2
vaccine target	2
genetically attenuated parasite vaccine	2
FASII-deficient forms	2
human malaria parasite P. falciparum	2
rodent malaria models	2
range of compounds	2
FASII pathway	2
type II fatty acid synthesis (FASII) pathway	2
several plant-like metabolic pathways	2
relict, non-photosynthetic plastid	2
malaria parasite Plasmodium	2
African trypanosomes (Trypanosoma brucei spp.)	2
conference	2
Marine Biological laboratory	2
Molecular Parasitology conference	2
membrane protein CTDs	2
EBA175 CTD	2
MTRAP and RH1 CTDs	2
CTDs	2
Aldolase binding	2
merozoite actin	2
filamentous (F-) actin and globular (G-) actin	2
rabbit and Pf actin	2
apical organellar proteins	2
members of the erythrocyte binding antigen (EBA) and reticulocyte binding protein homologue (RH) protein families	2
micronemal proteins	2
CTD of members of the thrombospondin-related anonymous protein (TRAP) family	2
Plasmodium falciparum (Pf)	2
certain type 1 membrane proteins	2
cytoplasmic tail domains (CTDs)	2
outside of the cell	2
actomyosin motor	2
genomes of P. knowlesi and vivax	2
peripherally-localised PHISTb proteins	2
cross-linkers	2
PHISTb proteins	2
known spectrin-binding domain	2
cytoskeleton-binding domain	2
novel targeting-domain	2
preceding sequence	2
PRESAN domain	2
one protein	2
PHISTb sub-class of PHIST proteins	2
nine members	2
numerous members in Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi	2
common ‘PRESAN’ domain	2
exported family	2
Poly-Helical Interspersed Sub-Telomeric (PHIST) proteins	2
host erythrocyte	2
new VSG gene	2
coordinated transcriptional switch	2
single transcribed locus	2
new VSG	2
VSG genes	2
advanced early branched eukaryote	2
conserved-among-eukaryotes	2
conserved-among-trypanosomatids	2
Variant Surface Glycoproteins (VSGs)	2
copy of the chromosome	2
nitroheterocyclic pro-drugs	2
nitroreductase (TcNTR)	2
single parasite population	2
three clones	2
LCCL protein repertoire	2
sexual blood stage parasites	2
corresponding genes	2
ookinete	2
distinctive multivesicular organelles	2
family members PbLAP1, PbLAP2 and PbLAP3	2
family of six proteins	2
Plasmodium LCCL proteins	2
T. gondii lipid extracts	2
presence of IPC	2
recombinant TgSLS	2
well characterised AUR1p inhibitor aureobasidin A.	2
functional orthologue of the yeast IPC synthase (AUR1p)	2
mutant cell line	2
related model parasite, Toxoplasma gondii (TgSLS)	2
bona fide sphingolipid synthase	2
causative agent of malaria)	2
apicomplexan Plasmodium falciparum	2
putative SM synthase	2
single copy orthologue	2
apicomplexan protozoan parasites	2
sphingolipid biosynthetic pathway	2
anti-fungals and anti-protozoals	2
IPC synthase	2
evolutionarily related inositol phosphorylceramide (IPC) synthase	2
yeast, plants and some protozoa	2
well characterised SM synthase	2
primary complex sphingolipid	2
Mammals produce sphingomyelin (SM)	2
eukaryotic cell membranes	2
SIR2 proteins	2
Trypanosoma and Leishmania	2
Plasmodium, and other protozoan parasites	2
members of the sirtuin families	2
kingdoms of life SIR2 proteins	2
one group of environment sensors	2
SIR2 family of NAD+-dependent protein deacetylases	2
functional LCCL protein complex	2
PbLAP1 and PbLAP3 interact	2
PbLAP1 present	2
GFP-based fluorescence	2
Selected and validated double mutants	2
parasite line expressing GFP-tagged PbLAP3	2
PbLAP1 null mutant parasite	2
P. falciparum LCCL proteins	2
multi-protein complex	2
six family members	2
conserved family of LCCL-lectin adhesive-like domain proteins (LAPs)	2
unusual histone modification motif	2
S-phase or G2 nuclei	2
Naturally occurring and meganuclease-induced γH2A and RAD51 double-positive repair foci	2
meganuclease-induced DNA double strand breaks	2
Nuclear γH2A foci	2
candidate phosphorylation site	2
replication-dependent histone H2A	2
γH2A in Trypanosoma brucei	2
serine phosphorylated histone H2A (variant)	2
γH2A(X)	2
divergent protozoa	2
expressed VSG or ESAGs	2
tagged BES	2
silent bloodstream expression site (BES)	2
selectable marker	2
resistant T. b. brucei	2
expressed VSG or expression site associated genes (ESAGs)	2
TLF-1 resistant T. b. brucei cell lines	2
haptoglobin/hemoglobin receptor (HpHbR) expression	2
gene for SRA	2
T. b. gambiense	2
serum resistance associated protein (SRA)	2
T. b. rhodesiense	2
human sleeping sickness pathogens Trypanosoma brucei gambiense or Trypanosoma brucei rhodesiense	2
veterinary pathogen Trypanosoma brucei brucei	2
minor subclass, Trypanosome Lytic Factor-1 (TLF-1)	2
Human high-density lipoproteins (HDLs)	2
potent, parasite specific DHCH inhibitors	2
trypanosomatid sequences	2
human homologue	2
cytosolic enzymes	2
Sequence alignments	2
L. major	2
bifunctional apo-DHCH	2
2.7Å resolution crystal structure	2
essential intermediate N10-formyltetrahydrofolate	2
N5,N10-methylenetetrahydrofolate dehydrogenase/N5,N10-methenyltetrahydrofolate cyclohydrolase (DHCH) and N10-formyltetrahydrofolate ligase (FTL)	2
protozoan	2
unique intracellular niches	2
individual apicomplexan parasites	2
apicoplast biosynthetic pathways	2
intraerythrocytic stages	2
FASII pathway components	2
P. falciparum intraerythrocytic growth	2
B. bovis intraerythrocytic growth	2
specific drug targets	2
FASII biosynthesis	2
asexual erythrocytic stages of P. falciparum	2
B. bovis asexual stages	2
specific pharmacologic inhibition	2
apicoplast lumen	2
key components [acyl carrier protein (ACP) and 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (LytB)	2
type II fatty acid (FASII) and isoprenoid (MEP) biosynthesis pathways	2
asexual intraerythrocytic and hepatic stages	2
intraerythrocytic asexual stages in the mammalian host	2
common and unique stages	2
apicoplast pathways	2
different parasites	2
different parasite genera and species	2
highly specialized organelle	2
virulent and attenuated strains	2
virulent parent and attenuated daughter T2Bo strains	2
virulent T2Bo strain	2
attenuated daughter strain	2
virulent parent Babesia bovis strain	2
∼2000 copies)	2
short transposable elements	2
T. congolense (70 copies), T. vivax (32 copies) and T. brucei (22 copies) genomes	2
SIDER elements	2
active retroposons	2
retroposon-encoded endonuclease binding site	2
ingi6 subclade	2
Tvingi retrotransposition machinery	2
TvSIDER1a/b elements	2
TvSIDER1a and TvSIDER1b groups	2
genome of T. vivax	2
three TvSIDER1 families	2
African trypanosome species	2
retroposon subfamily	2
T. cruzi and Leishmania spp	2
genome of Salivarian (African) trypanosomes, Trypanosoma brucei, T. congolense and T. vivax	2
new family of short non-autonomous retroposons of the ingi clade	2
active autonomous ones	2
retrotransposition machinery	2
short non-coding elements	2
RIME and NARTc	2
long autonomous elements (ingi, L1Tc)	2
trypanosomatid genomes	2
abundant transposable elements	2
Retroposons of the ingi clade	2
surface disposed proteins	2
haptoglobin–hemoglobin receptor	2
pteridine transporter	2
amino acid transporter	2
surface protease GP63	2
congolense epimastigote specific protein (CESP)	2
well-studied variant surface glycoproteins (VSGs), invariant surface glycoproteins (ISGs) 65 and 75	2
several membrane molecules	2
new, previously uncharacterized T. congolense proteins	2
Six proteins	2
hypothetical proteins	2
annotated hits	2
1291 most confidently identified proteins	2
T. congolense proteome	2
∼9000 proteins	2
unique protein sequences	2
corresponding source proteins	2
Wellcome Trust's Sanger Institute's semi-annotated T. congolense database	2
relatively quantify proteins	2
Cellular proteins	2
major life cycle stages	2
cloned parasite	2
T. congolense IL3000	2
four life cycle stages	2
complete biological replicates	2
infected mice	2
three main insect stages and bloodstream stage parasites	2
culture-derived parasites	2
livestock in Africa	2
bloodstream-form T. brucei RNAi libraries	2
loss of amino-acid transporter (AAT6) function	2
amino-acid analogue, eflornithine	2
related drug, benznidazole	2
Human African Trypanosomiasis	2
Eflornithine Combination Therapy (NECT)	2
Nifurtimox–	2
genome-scale RNA interference (RNAi) library	2
Loss-of-function screens	2
externally disposed proteins	2
antibodies on live cells	2
C-terminal VSG domain	2
cognate whole VSGs	2
C-terminal domain antibodies	2
membrane proximal VSG C-terminal domain	2
VSG surface coat	2
VSG monolayer	2
invariant surface proteins	2
VSG	2
variant surface glycoprotein (VSG)	2
densely packed protein coat	2
Trypanosoma brucei cell surface	2
distinct MSH2 isoforms	2
various DNA damaging agents	2
T. cruzi and T. brucei	2
msh2 mutants	2
different parasite strains	2
oxidative stress-induced DNA	2
distinct isoforms of this protein	2
key component of MMR	2
T. cruzi MSH2 gene	2
T. cruzi population	2
number of molecular markers	2
pool of strains	2
highly heterogeneous population	2
DNA mismatch repair (MMR) pathway	2
emerging new flagellum	2
TbKif13-2 homologue	2
new flagellum	2
kinesin	2
procyclic T. brucei	2
tip of the flagellum	2
member of the microtubule-depolymerising Kinesin-13 family	2
EMBO J 2009;28:2650–61	2
paucimannose and/or complex N-glycan	2
Man5GlcNAc2 structure	2
T. brucei oligosaccharyltransferase	2
Asn58 N-glycosylation sequon	2
relatively acidic environment	2
complex N-glycan at Asn58	2
galactose, residues	2
conserved Man3GlcN-myo-inositol glycosylphosphatidylinositol anchor glycan core	2
-6)Manβ1-4GlcNAcβ1-4GlcNAc	2
Galβ1-4GlcNAcβ1-2Manα1-3(Galβ1-4GlcNAcβ1-2Manα1	2
N-glycan	2
glycosylphosphatidylinositol membrane anchor	2
complex N-linked glycan at Asn58	2
disulphide-linked homodimer	2
Variant surface glycoprotein MITat1.8	2
latter uncharacterized variant surface glycoprotein	2
Lister strain 427 Trypanosoma brucei brucei parasites	2
variant surface glycoprotein MITat1.4	2
dsRNA, mRNA or siRNA	2
inducible RNAi reporter system	2
tudor-sn null mutants	2
African trypanosome Tudor-SN	2
RISC in humans, flies and nematodes	2
Tudor staphylococcal nuclease (Tudor-SN)	2
component of the RNA induced silencing complex (RISC)	2
Slicer endonuclease	2
small interfering (si)RNA	2
double-stranded (ds)RNA	2
Dicer endonuclease	2
RNA interference (RNAi) pathway	2
well-described phosphatomes	2
kinetoplastid phosphatomes	2
many higher eukaryote protein phosphatases	2
set of trypanosomatid-specific phosphatases	2
diverse environments	2
trypanosomatid phosphatomes	2
five trypanosomatid genomes	2
changing environment of the vector and host organism	2
additional signaling pathways	2
Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp.	2
unicellular parasites	2
basic metabolism	2
mRNA translation	2
gene transcription	2
tyrosine (Tyr), serine (Ser) and threonine (Thr) side chains of proteins	2
protein phosphatases and protein kinases	2
known living organisms	2
myc-tagged or untagged)	2
TbARL2 overexpressing cells	2
extreme C-terminus	2
excess of untagged protein	2
cellular microtubules	2
total α-tubulin	2
multinucleated cells	2
cleavage furrow formation	2
bloodstream form parasites	2
protozoan parasite Trypanosoma brucei	2
Arl2 orthologue	2
member of the Ras superfamily	2
D. Arl2 also	2
tubulin-specific chaperone cofactor	2
Metazoan Arl2	2
Arf-like (Arl) small GTPases	2
transmissible stages	2
gametocytogenesis’	2
asexual blood stage counterparts	2
gamete precursors	2
infected host bloodstream	2
Male and female gametocytes	2
binucleated cells	2
Tp-gp34 and Ta-gp34	2
central spindle and midbody	2
cytosol of COS-7 cells	2
Ta-gp34	2
Epitope-tagged Tp-gp34	2
GPI anchor signal	2
gp34 signal peptide	2
schizonts of both Theileria species	2
GPI-anchored protein	2
schizont surface proteins	2
predicted Theileria annulata and T. parva proteomes	2
outbreak strains	2
multiple diverse MSA-1 genotypes	2
individual animal	2
single copy gene in a haploid genome	2
variant MSA-1 genotypes	2
five animals	2
predominant genotypes	2
Five animals	2
genotypically distinct MSA-1 sequences	2
distinct MSA-1 genotypes	2
reservoir host population	2
individual infected animals	2
member of the VMSA family	2
defined population	2
previously vaccinated animals	2
variable merozoite surface antigen (VMSA) genes	2
Plasmodium, Toxoplasma, Cryptosporidium and Theileria	2
related Apicomplexans	2
populations of animal reservoir hosts	2
Multiple genetically distinct strains of a pathogen	2
previously validated folate pathway of P. falciparum	2
potential new drug target	2
PfDHFS–FPGS	2
FPGS 0.091μM	2
alkyl phosphinate	2
aryl phosphinate analogue	2
DHFS- and FPGS-catalysed glutamylation	2
tetrahedral intermediates	2
two phosphinate analogues of 7,8-dihydrofolate	2
pterin moiety	2
dihydrofolate, folate and the folate analogue methotrexate (MTX)	2
polyglutamylated forms	2
tetrahydrofolate (THF)	2
FPGS assays	2
22.8μM for ATP	2
catalytic and inhibitory sites	2
principal substrate, dihydropteroate (DHP)	2
high co-substrate (glutamate and ATP) concentrations	2
recombinant PfDHFS–FPGS	2
single bifunctional protein	2
eukaryote, the malaria parasite Plasmodium falciparum expresses dihydrofolate synthase (DHFS) and folylpolyglutamate synthase (FPGS)	2
glutathione synthetase	2
host enzyme	2
parasite enzyme	2
Homo sapiens and Saccharomyces cerevisae	2
small domain	2
two dimers in the asymmetric unit	2
T. brucei enzyme crystal structure	2
group of enzymes	2
ATP-grasp family	2
product glutathione	2
dimeric enzyme	2
l-γ-glutamyl-l-cysteine and glycine	2
low molecular mass thiol glutathione	2
Glutathione synthetase	2
LCCL proteins	2
two other LCCL protein family members	2
modular multidomain proteins	2
member of the Plasmodium LCCL protein family	2
parasite protein PbSR	2
mosquito-specific ookinete and early oocyst stages of the parasite	2
unique organelles	2
Malaria crystalloids	2
highly motile organisms	2
Trypanosoma brucei and Leishmania major parasites	2
lethal pathogens	2
WHO	2
kinetoplastid parasites	2
P. falciparum infected red blood cells	2
cytoadherent trophozoite-stage	2
younger ring stage parasites	2
maintained presence of PfEMP-1 on the surface of drug-treated infected red blood cells	2
untreated parasite cultures	2
range of antimalarials binding	2
hospital admission	2
endothelial cell receptors	2
surface of infected red blood cells	2
parasite protein PfEMP-1	2
trophozoite-stage infected red blood cells in the microvasculature	2
major N-myristoylated protein, ARL1	2
wild-type or slightly enlarged Golgi apparatus	2
Induced parasites	2
enlarged flagellar pocket	2
induced cells	2
Trypanosoma brucei and Leishmania major	2
N-terminus of target proteins	2
fatty acid myristate	2
enzyme myristoyl-CoA:protein N-myristoyltransferase (NMT)	2
trypanothione reductases	2
clomipramine, trifluoperazine, thioridazine and citalopram	2
CNS-active drugs	2
range of chemotypes	2
NADPH-regenerating system	2
either direct (NADPH oxidation) or DTNB-coupled assay	2
T. cruzi enzyme	2
recombinant trypanothione reductase	2
protease inhibitors	2
P. berghei mutants	2
flagellated gametes	2
male (micro) gametocytes	2
sugar transporters	2
previously reported models	2
ungallated catechins (−)-epicatechin (EC) and (−)-epigallocatechin (EGC)	2
(−)-Epicatechin-gallate (ECG) and (−)-epigallocatechin-gallate (EGCG)	2
mammalian facilitative glucose transporters, GLUT1 and GLUT5	2
Plasmodium falciparum hexose transporter (PfHT), the Babesia bovis hexose transporter 1 (BboHT1)	2
green tea catechins	2
mammalian immune system	2
key receptors or pathways	2
individual helminth mediators	2
helminth secreted molecules	2
“excretory–secretory” products	2
“modified Th2” environment	2
regulatory T cells and alternatively activated macrophages	2
immunoregulatory cell populations	2
masterful immunoregulators	2
ribosomal RNA tandem gene-repeats	2
recombinant constructs	2
ribosomal RNA-spacer target	2
site-specific DNA double-strand breaks (DSBs)	2
DNA constructs	2
coagulation system	2
coagulation factors	2
catalytically active recombinant protein	2
GST fusion	2
truncated form of TbCK1.2	2
null mutant of the highly homologous casein kinase 1 isoform 1 (Tb927.5.790)	2
casein kinase 1 isoform 2 (TbCK1.2, Tb927.5.800)	2
erythrocytic-stage Babesia infections	2
cytochalasin B and β-glucogallin	2
glucose-depleted bovine erythrocytes	2
vitro growth assays	2
Compound 3361	2
relatively potently BboHT1	2
long-chain O-3 hexose derivative (compound 3361)	2
cytochalasin B	2
O-4 and O-6	2
hydroxyl positions	2
d-glucose analogues	2
saturable, Na+-independent, stereo-specific hexose transporter	2
human (GLUT1) and Plasmodium falciparum (PfHT) hexose transporters	2
Babesia bovis genome	2
two predicted hexose transporters (BboHT1 and 2)	2
tick-transmitted haemoprotozoan parasites	2
microfilaria in the mosquito	2
one such product	2
store of material	2
intestine and pharynx	2
inner body and pharyngeal thread	2
vesicle-like structures	2
microfilariae	2
pharyngeal thread	2
IEM	2
sheathed microfilarial species	2
inner body of the microfilariae	2
chitinase	2
B. malayi	2
B. malayi microfilarial chitinase	2
Onchocerca volvulus (O. volvulus, Ov) infective-stage larval chitinase (Ov-CHI-1)	2
microfilariae of the parasitic nematode Brugia malayi (B. malayi, Bm)	2
fly transmissible version of 427	2
bloodstream forms and procyclics	2
ancestral line of present day 427 lab isolates	2
molecular karyotype	2
3 microsatellite loci	2
identical alleles	2
variant surface glycoprotein genes	2
lab isolates	2
another strain of T. b. brucei	2
40-year-old cryopreserved line of strain 427	2
TREU 927	2
strain 427	2
fly transmissible, mating competent strain TREU 927	2
genome sequencing project	2
T. b. brucei strain 427	2
published genome sequence	2
Like yeast, Trypanosoma brucei	2
Sligo and Oberon	2
two resistant isolates	2
susceptible Cullompton isolate	2
isotype RT-PCR fragment sequences	2
glutamic acid	2
one had leucine	2
two had phenylalanine	2
β-tubulin	2
three of the fluke isotypes	2
proposed benzimidazole binding site on β-tubulin	2
trematode clades	2
trematode and nematode tubulin sequences	2
two of the β-tubulins	2
α-tubulins	2
β-tubulin isotypes	2
fluke α-tubulin	2
adult Fasciola hepatica	2
five α-tubulin and six β-tubulin isotypes	2
procyclic cells	2
insect stage of the parasite	2
host bloodstream form of Trypanosoma brucei	2
orthologue of Arf1	2
Ras small GTPases	2
highly conserved subfamily	2
ADP ribosylation factors (Arfs)	2
parasite plasma membrane	2
principal folate uptake pathway	2
ATPase inhibitor concanamycin A	2
H+ ions	2
close folate analogue methotrexate	2
antifolate drugs pyrimethamine and sulfadoxine	2
specific folate transporters	2
anion-channel blockers probenecid and furosemide	2
free parasites	2
glycolytic pathway	2
different sugars	2
mono- or divalent metal ions	2
negative-inward electrochemical gradient	2
dianionic species	2
synchronised parasite cultures	2
key cofactors	2
novel pathways	2
different parasite life cycle stages	2
conserved eukaryotic cell cycle regulators	2
trypanosome orthologues	2
many regulators	2
component parts of the cell	2
intricate and interconnected signal transduction pathways	2
two other putative Plasmodium metacaspases	2
functionally redundant gene	2
downstream mosquito stages	2
pbmc1 gene	2
P. berghei ookinetes	2
green fluorescent reporter gene	2
PbMC1coding sequence	2
Plasmodium berghei parasites	2
Plasmodium metacaspase 1 (PxMC1)	2
predicted cysteine protease	2
vertebrate and insect hosts	2
wide range of proteases	2
C-terminal parasite EF-hand domains	2
higher eukaryotic relatives	2
kinetoplastid and other eukaryotic PPEFs	2
catalytic and fused C-terminal domains	2
N-myristoyl transferase	2
N-terminus of LmPPEF	2
single-copy genes	2
PPEF-like phosphatases	2
L. major and T. brucei	2
sensory cells of higher eukaryotes	2
Protein Phosphatase with EF-Hand (PPEF) proteins	2
N-myristoylated protein phosphatase	2
previously characterised and novel molecules	2
putative N-myristoylated proteins	2
TriTryp species, Leishmania major, Trypanosoma brucei and Trypanosoma cruzi	2
essential enzyme N-myristoyl transferase	2
potential downstream targets	2
susceptible strain	2
unexposed resistant snails	2
susceptible ones	2
exposed resistant snails	2
unsubtracted controls	2
subtracted libraries	2
resistant strain	2
iron-storage and immunoregulatory molecule, ferritin, and HtrA2, a serine protease	2
two transcripts	2
haemocytes of resistant and susceptible snail strains	2
eight libraries	2
parasite-exposed resistant and susceptible samples	2
haemocytes and the haemopoietic organ	2
Separate libraries	2
resistant snail line	2
schistosome-exposed and unexposed snails	2
parasite-exposed schistosome-resistant and a susceptible strain of B. glabrata	2
suppression subtractive hybridization (SSH)	2
subtractive cDNA libraries	2
medically important schistosome	2
intermediate snail host	2
Biomphalaria glabrata	2
DBLα1-like domains (Group A or B/A)	2
B and C-related var gene groups	2
(hyperparasitaemia patients	2
Group A or B/	2
var genes with DBLα1-like domains	2
unrousable coma	2
children with cerebral malaria	2
P. falciparum isolates	2
Malian children	2
var gene DBLα domain	2
expressed sequence tags	2
three major groups (A, B and C) and two intermediate groups (B/A and B/C)	2
Var genes	2
var gene family	2
Plasmodium falciparum variant erythrocyte surface antigens	2
new kind of vaccines	2
HLA-E cell-surface expression	2
HIV-1-derived target peptides	2
YG9	2
binding candidates EI9, MD9, NR9, QF9	2
two separate assays	2
HLA-E*01:03 on the cell surface	2
15-mer binders	2
4 novel 9-mer peptides PM9, RL9, RV9 and TP9	2
400 HIV-1-derived 15-mer peptides	2
HLA-E-specific monoclonal antibody	2
HLA-E*01:03 molecules	2
HLA-E*01:01 or	2
three independent assays	2
HIV-1 Gag, Pol and Vif proteins	2
novel HLA-E binding peptides	2
HLA-E	2
one reported human leukocyte antigen (HLA)-E-binding peptide	2
pathogenic SIV challenge	2
Non-classical class Ib MHC-E molecule	2
+ T cells	2
IL-17+ CD8	2
cells in humans and mice	2
Tc17 cells	2
IL-17+ CD8+ T cells	2
various other immune cell subsets	2
specific subset of CD4+ T cells (the so-called Th17 cells)	2
many groups	2
(IL-17)	2
pro-inflammatory cytokine interleukin-17A	2
Th17 producing T-cells	2
Skap1-/- mice	2
joint infiltrating T-cells	2
CII peptide	2
presence IL-17+ (Th17)	2
Skap1-deficient (skap1-/-) mice	2
‘inside-out’ signalling pathway	2
T-cell receptor	2
immune cell adaptor	2
low molecular weight compounds	2
key checkpoint	2
IL-2, IFNand TNFα	2
key cytokine genes	2
transplantable and spontaneous tumors	2
orphan nuclear receptor NR2F6 (nuclear receptor subfamily 2 group F member 6, also called Ear-2)	2
alternative checkpoints	2
effector immune cells	2
additional cancer therapeutic targets	2
CTLA-4 and PD-1	2
immune checkpoints	2
OT1 transgenic Skap1−/−T-cells	2
cleavage resistant form of talin (L432G)	2
Skap1−/−T-cells	2
OT-1 T-cells	2
dendritic cells (DCs) presenting OVA peptide	2
antigenic beads	2
contact interface of T-cells	2
Skap1−/− T-cells	2
associated adaptor RIAM	2
α-chain of the same integrin	2
immune cell adaptor SKAP1 (SKAP-55)	2
β-chain of LFA-1	2
cytoskeletal protein talin	2
PKC-β and ϵ	2
positive regulators of IL-6 and TNF-α production	2
PKC-α and -θ	2
one conventional and one novel isoform	2
PKC-α, -β -ϵ, and -θ in mouse BMMCs	2
PKC isoform KO mice	2
worm product	2
human bone marrow-derived mast cells (BMMCs)	2
various immune system cells	2
filarial nematode Acanthocheilonema viteae	2
bronchodilators, antihistamines and local corticosteroids	2
TG and the PG	2
PG and the TG	2
PG	2
One hundred and sixty patients	2
anti-allergic drugs	2
subgroup of allergic patients	2
placebo controlled, multi-center clinical trial	2
Lantigen B®, a chemical BL	2
bacterial lysates (BL)	2
different signaling modules of GRB-2/VAV1 and LAT/ADAP pathways	2
LAT expression	2
GRB-2 binding partner and guanine nucleotide exchange factor, VAV1	2
CD28 NF-κB activation	2
GRB-2 siRNA	2
primary T-cells from CD28 Y170F mutant knock-in mice	2
CD28 YMN-FM mutant	2
CD28 deficient Jurkat T-cells	2
binding partner SKAP1	2
adaptor ADAP	2
anti-CD3 stimulation	2
primary T-cells from adap−/− mice	2
Anti-CD28	2
NF-κB reporter and EMSA assays	2
primary and Jurkat T-cells	2
Anti-CD28 ligation	2
distinct pathways	2
TCR and CD28	2
transfected Jurkat T-cells	2
various knock-out (Cd28−/−, adap−/−) and knock-in (i.e. Cd28 Y-170F) mice	2
different intracellular signaling pathways	2
antigen-receptor and CD28	2
siglec-F ligands	2
lung eosinophilia	2
aerosolised ovalbumin	2
intranasal ovalbumin	2
siglec-F-deficient mice	2
two commonly used models	2
antibodies or glycan ligands	2
sialylated and sulphated glycans	2
human and murine eosinophils	2
paralogous membrane proteins	2
Siglec-8 and	2
donor population	2
monocyte studies	2
continuous population of cells	2
common parasites Plasmodium falciparum and Schistosoma haematobium	2
monocyte populations	2
CD16 and CX3CR1 expression	2
PBMCs	2
monocyte subtypes	2
surface markers HLA-DR, CCR2 and CX3CR1	2
CD14 and CD16 expression	2
Human monocytes	2
soluble antigen	2
future vaccines	2
important agents	2
novel adjuvants	2
adjuvants	2
widely approved adjuvants	2
Aluminium adjuvants (alum)	2
different cellular and immune contexts	2
exogenous and endogenous ligands	2
encoded inhibitory receptors	2
cells of the myeloid lineage	2
additional genes	2
self and non-self	2
natural killer gene complex	2
SKAP1 expression	2
primary T-cells	2
anti-CD3 induced LFA-1 adhesion	2
resting SKAP1+/+ and SKAP1−/− T-cells	2
SKAP1−/− and SKAP1+/+ primary, activated T-cells	2
resting, primary T-cells	2
SKAP1 deficient (SKAP1−/−) and wild type (SKAP1+/+)	2
LFA-1 activation	2
Immune adaptors SLP-76, ADAP and SKAP1 (SKAP-55)	2
either nematode parasite	2
ex vivo intracellular staining of CD11c+ DCs	2
MLNC	2
longer lived Heligmosomoides polygyrus	2
anterior site of infestation	2
mesenteric lymph nodes	2
CD86hi-CD8αint-CD11b− subset	2
draining mesenteric lymph node dendritic cell population	2
vivo transfer	2
Th2 responses	2
vitro-derived dendritic cells	2
rodent gastrointestinal nematode Nippostrongylus brasiliensis secretes products	2
yet unidentified pathway	2
dominant Th2 responses	2
Helminth parasites	2
MHC Class II-restricted peptides	2
contaminating macrophages	2
naïve OVA-specific CD4+	2
Antigen-pulsed neutrophils	2
green-fluorescent protein reporter	2
OVA323–339/MHC Class II complex	2
MHC Class II-expressing neutrophils	2
green fluorescent reporter	2
ovalbumin peptide 323–339 (OVA323–339)	2
transgenic T cell receptor	2
murine T cell hybridoma	2
costimulatory molecules CD80 and CD86	2
major histocompatibilty complex (MHC) Class II	2
antigen presenting cells	2
numerous cell surface proteins	2
short lived, terminally differentiated phagocytes	2
women who deliver preterm	2
women who deliver	2
CVF RANTES and IL-1β	2
IL-1β in mid-trimester of pregnancy	2
term women	2
women who experienced sPTB	2
Bacteroides, Fusobacterium and Mobiluncus	2
vaginal anaerobes	2
+0–28	2
64 samples	2
bacterial 16S rDNA	2
preterm- and term-delivered women	2
cervicovaginal fluid (CVF) cytokine and fetal fibronectin (FFN)	2
choriodecidual space	2
CD4+ CM and EM cells postpartum	2
EM cells	2
CD4+ T-lymphocytes	2
human peripheral blood	2
pre-pregnancy CD4+ memory cell pool	2
CD8+ memory cells	2
CD4+ cells	2
CD4+ EM, CD4+ CM and activated memory T cells	2
primigravid women	2
12 primigravid	2
(CM) T-lymphocytes	2
peripheral human memory T-lymphocyte populations	2
maternal immunity	2
maternal immune system	2
healthy and preeclamptic pregnancy	2
intermediate monocytes	2
classical, intermediate and non-classical monocytes	2
3 subpopulations of monocytes	2
short-lived cells	2
fetal haematopoiesis	2
NRBC counts	2
(monocytes, neutrophils, eosinophils, immature granulocytes)	2
preterm birth complicated controls	2
195 controls	2
PE cases	2
Rotterdam Periconceptional Cohort	2
newborn umbilical cord blood cell populations	2
UCBC populations	2
PE deranges fetal haematopoiesis	2
newborn umbilical cord blood cell (UCBC) populations	2
maternal peripheral blood	2
recurrent miscarriage group	2
uni- and multivariate logistic regression models	2
95 women	2
HLA-C specific antibodies	2
polymorphic classical HLA I antigen	2
low CCL2	2
CCL2 (MCP-1)	2
early SPTB	2
cervical epithelial cells	2
blood-borne monocytes	2
mucosal macrophages	2
remaining cells	2
polymorphonuclear cells (PMN)	2
host-derived cells	2
Cervical leukocytes	2
leukocyte sub-populations	2
Cytokines and chemokines	2
cytobrush	2
120 women	2
cervical leukocyte populations	2
vascular endothelial growth factor A [VEGFA] and placental growth factor [PlGF])	2
competitive inhibitor	2
cell surface VEGF receptors	2
maternal endothelium	2
Soluble FLT1	2
maternal circulation	2
endoplasmic reticulum or immunological	2
normal term controls	2
human first-trimester placental villi	2
local oxygenation	2
intrauterine environment	2
multifunctional organ	2
endothelial structures	2
high-RI dNK cells	2
tumour necrosis factor-α expression	2
endothelial intercellular adhesion molecule-1	2
normal-RI dNK cells	2
endothelial tube-like structures	2
high-RI pregnancies	2
normal-RI pregnancies	2
dNK culture supernatant	2
first-trimester pregnancies	2
normal pregnancies	2
first-trimester dNK cells	2
dNK–endothelium interactions	2
maternal–fetal interface	2
dNK) cells	2
Decidual NK (	2
affordable and easily accessible therapy	2
sFlt-1 release	2
women with preeclampsia	2
sFlt-1 and sEng in animal models	2
CO or bilirubin	2
first trimester	2
trophoblast	2
women with healthy pregnancies	2
circulating sFlt-1	2
Hmox system	2
novel therapeutic agents	2
statins and Hmox1 activators	2
soluble Flt-1 (sFlt-1) and soluble Endoglin (sEng)	2
Hmox1/carbon monoxide (CO) pathway	2
endogenous system	2
Heme oxygenase (Hmox)	2
mid-luteal phase Fallopian tube	2
CD45+ leukocytes, CD68+ cells	2
CD11c+ dendritic cells	2
CD123+ dendritic cells	2
+ and CD11c+) dendritic cells, monocytes, neutrophils, and CD56dimCD16− natural killer	2
(CD123	2
Populations of CD3+ (CD4+ and CD8+) lymphocytes	2
lymphoid and myeloid cell populations	2
Immune cell populations	2
Lymphoid and myeloid cell populations	2
primary players	2
normal pregnancy	2
type 1 cytokine IFNγ	2
women diagnosed with preeclampsia	2
mother and baby	2
type 1 cytokines	2
Invariant natural killer T (iNKT) cells	2
long chain ω3 fatty acids	2
explored model	2
Phaeodactylum tricornutum	2
Thalassiosira pseudonana	2
two most commonly exploited diatoms	2
essential ω3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)	2
commonly studied green microalgal species (chlorophytes)	2
better feed stocks	2
medium-chain fatty acids	2
ecosystems and the environment	2
dominant phytoplankton species in oceans	2
blood EPA+DHA	2
Westernized food habits	2
indigenous populations or populations	2
erythrocyte equivalents	2
blood fraction	2
plasma phospholipid	2
plasma total lipids	2
various blood fractions	2
global map	2
omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)	2
stable isotope-labeled ALA	2
DHA-fed animals	2
animals fed ALA-only diets	2
orally administered ALA	2
oral ALA dose	2
ingested ALA	2
body from α-linolenic acid (ALA)	2
HDL subgroups	2
HDL proteome	2
members of the complement pathway	2
iron transport proteins	2
proteomics technology	2
plasma lipoprotein classes	2
small, protein-rich	2
therapeutic context	2
isoform-specific inhibitors	2
Phosphatidylinositol 4-kinases	2
phosphatidylinositol 4-kinase isozymes	2
proteins such as AP-3 and the E3 ubiquitin ligase Itch	2
isoform-specific structural motifs	2
four mammalian phosphatidylinositol 4-kinases	2
amylin with copper, zinc, iron, nickel, gold, ruthenium, and vanadium	2
amylin and other amyloidogenic peptides	2
amylin and specific metal ions, e.g., copper(II), zinc(II), and iron(II)	2
pancreatic islet β-cells	2
37-amino-acid peptide hormone	2
Islet Amyloid Polypeptide (IAPP)	2
current clinical platinum drugs	2
cultured cancer cell monolayers	2
solid tumour	2
interior of A2780 human ovarian cancer cell spheroids	2
organo‑osmium metallodrug candidate [(ŋ6-p-cym)Os(Azpy-NMe2)I]+ (p-cym = p-cymene, Azpy-NMe2 = 2-(p-([dimethylamino]phenylazo)pyridine)) [1]	2
Os LIII edge	2
dihydroxylated product	2
peroxygenase P450	2
2,3-hydroxylated fatty acid product	2
2,3-dihydroxydodecanoic acid	2
undec-1-en-1-ol, 2-hydroxydodec-2-enoic acid	2
Secondary turnover products	2
major product	2
several products	2
tetradecanoic acid bound	2
E. coli expression system	2
heme spectrum	2
peroxygenase counterpart P450SPα (CYP152B1) from Sphingomonas paucimobilis	2
methylotroph Bacillus methanolicus MGA3	2
novel CYP152 family member – CYP152K6	2
fatty acid substrates	2
bacterial peroxygenases	2
CYP152 family of cytochrome P450 enzymes (P450s or CYPs)	2
porphyrin ring system	2
purified MroUPO	2
carbons (C21, C20) of the steroidal side chain	2
enzyme's access channel	2
bulky cortisone molecule	2
crystal structure data of MroUPO (Marasmius rotula unspecific peroxygenase)	2
Protein models	2
glycolic acid or glyoxylic acid	2
two carbon atoms	2
fission products	2
carbon dioxide)	2
formic acid and carbonic acid	2
adrenosterone (4-androstene-3,11,17-trione)	2
corresponding α-ketocarboxylic acid (e.g. cortisone 21-oic acid)	2
stable geminal alcohol (e.g. cortisone 21-gem-diol)	2
terminal carbon (C21)	2
cortisone, Reichstein's substance S and prednisone	2
hydroxyacetyl and hydroxyl functionalities at C17 -	2
basidiomycetous fungi Marasmius rotula and Marasmius wettsteinii oxidized steroids	2
Two unspecific peroxygenases (UPO, EC 1.11.2.1)	2
redox-active metals	2
non-redox metals	2
superfamilies of metalloenzymes	2
metal sites	2
examples in our dataset	2
surrounding protein matrix	2
metalloenzyme superfamilies	2
enzymes of a superfamily	2
structural scaffold	2
new anticancer agent	2
enlarged nuclei	2
nuclei of A2780 cells	2
fluorescently-labelled DLasiL	2
A2780 cells	2
A2780 and PC3 cells	2
(Canavalia maritima) and DSclerL (Dioclea sclerocarpa)	2
lectins ConBr (Canavalia brasiliensis)	2
several human carcinoma cell lines including A2780 (ovarian), A549 (lung), MCF-7 (breast) and PC3 (prostate)	2
dinuclear Ca/Mn and sugar-binding sites	2
seeds of the Dioclea lasiocarpa	2
lectin DLasiL	2
vanadium complexes	2
active-site cleft of the kinase domain of DPP-IV	2
oxidovanadium complexes 1 and 2	2
blood of alloxan-diabetic mice	2
complexes 1 and 2	2
dipeptidyl peptidase IV (DPP-IV) inhibitors	2
4,5-dichlorobenzene-1,2-diamine and salicylaldehyde derivatives	2
Two oxidovanadium(IV) complexes carrying Schiff base ligands	2
differently metallated MBLs	2
Fe(II)-substituted MBLs	2
MBLs	2
di-Zn(II) enzymes	2
BcII and di-Fe(II)	2
di-Zn(II) structure	2
di-metal bridging water	2
di-Zn(II) enzyme	2
crystal structure of di-Fe(II)	2
zinc enzymes	2
clinically relevant B1 subclass Verona integron-encoded metallo-β-lactamase 2 (di-Fe(II) VIM-2)	2
BcII)	2
di-iron(II)-substituted metallo-β-lactamase II from Bacillus cereus (di-Fe(II)	2
iron ions	2
copper, cadmium and manganese	2
transition metal ions	2
Isolated MBLs	2
one or two zinc ion cofactors	2
latest generation carbapenems	2
almost all β-lactam antibacterials	2
Metallo-β-lactamases (MBLs)	2
non-abundant and refractory proteins	2
EPR-active centres	2
mammalian respiratory complex I.	2
intramolecular electron-transfer relay	2
terminal [4Fe-4S] cluster (N2)	2
EPR samples	2
large and complex proteins	2
co-active alongside antibiotics	2
chelators	2
1,4,7-tris(3-hydroxy-6-methyl-2-pyridylmethyl)-1,4,7-triazacyclononane, the best Fe3+ chelator	2
best tested novel chelators	2
structure of the chelator	2
biostatic agents	2
range of pathogenic bacteria	2
hexadentate chelators	2
family of coordinating groups	2
novel protective group	2
novel chloromethyl derivative of 1-hydroxy-2(1H)-pyridinone	2
bacterial siderophores	2
potential powerful Fe3+ chelators	2
triaza macrocyclic backbone scaffold	2
1-hydroxy-2(1H)-pyridinone coordinating groups	2
Several novel chelators	2
first, second and third generation β-lactam antibiotics	2
clinical isolate	2
two Escherichia coli, a laboratory strain	2
human colon cancer cell line HCT116p53	2
cisplatin- and oxaliplatin-resistant cell lines	2
human cancer cell lines A2780, A549, HCT116, and PC3	2
clinical drug cisplatin	2
chloride and two oxygen atoms of the chelated fluoroquinolone ligand	2
p-cymene ring	2
typical pseudo-octahedral ‘piano-stool’ geometry	2
1·1.3H2O·0.6CH3OH and 2·CH3OH·0.5H2O	2
analogue of the antibiotic ciprofloxacin, and its ruthenium(II) complex [Ru(η6-p-cymene)(CipA-H)Cl], (2)	2
7-(4-(Decanoyl)piperazin-1-yl)-ciprofloxacin, CipA, (1)	2
transfer hydrogenation	2
non-toxic doses of formate	2
A2780 human ovarian cancer cells	2
complex 3	2
chelating ligand and the Cpx ring	2
hydride donor	2
Complexes 1–9	2
aqua adducts	2
chlorido complexes 1–10	2
[Cp*Rh(bpy)Cl]+ (4)	2
(4–6) compounds	2
phen (7–9) and bpy	2
CpX ring	2
en complexes (1–3)	2
Cp*	2
> phen	2
N,N-chelated ligand bpy	2
hydride source	2
N,N′ is ethylenediamine (en), 2,2′-bipyridine (bpy), 1,10-phenanthroline (phen) or N-(2-aminoethyl)-4-(trifluoromethyl)benzenesulfonamide (TfEn), and Cpx is pentamethylcyclopentadienyl (Cp*), 1-phenyl-2,3,4,5-tetramethylcyclopentadienyl (CpxPh) or 1-biphenyl-2,3,4,5-tetramethyl cyclopentadienyl (CpxPhPh)	2
Rh(III) complexes of general formula [(Cpx)Rh(N,N′)(Cl)]	2
catalytic drugs	2
Organometallic complexes	2
infectious disease antigens	2
alternative adjuvant depot	2
2-deoxy-2-aminoglucose backbone on MPL® and aromatic ring of l-tyrosine in MCT	2
l-tyrosine in MCT formulations	2
different MATA-MPL allergy immunotherapy formulations	2
Allergoid and MPL® adsorption	2
IgE antigenicity	2
1040–170QAU/mL. MATA-MPL supernatant samples	2
desirable IgE antigenicity	2
Unmodified drug substance samples	2
MATA-MPL samples	2
MPL®	2
MCT in MATA-MPL allergy immunotherapy formulations	2
allergoid and MPL®	2
vaccine antigen adjuvant adsorption	2
IgE mitigated allergy	2
MATA-MPL allergy immunotherapy formulations	2
Adsorbed allergoids and MPL®	2
vaccines and allergy immunotherapies	2
group of compounds	2
various Ga hydrolysis and ME0163 protonation states	2
monomeric 1:1Ga–ME0163 complexes	2
excessively strong complexing agent	2
2,4,6-trihydroxybenzaldehyde and oxamic acid hydrazide building blocks	2
target 2-oxo-2-[N-(2,4,6-trihydroxy-benzylidene)-hydrazino]-acetamide (ME0163) hydrazone species	2
hydrazone–gallium aqueous solutions	2
bacterial and biofilm growth-suppressing agents	2
gallium ion	2
Salicylidene acylhydrazides (hydrazones)	2
society	2
Ga(III)–citrate and Ga(III)–ME0163 complexes	2
Ga(III)–ME0163 complex	2
5- and 6-membered chelating rings	2
promising ligand, 2-Oxo-2-[N-(2,4,6-trihydroxy-benzylidene)-hydrazino]-acetamide (ME0163) with Ga(III)	2
Ga(III) on P. aeruginosa	2
library of hydrazones	2
Pseudomonas aerugionosa	2
several Gram-negative pathogens	2
salicylidene acylhydrazides (hydrazones)	2
Ga(III) ions	2
i.e. bacterial systems	2
called virulence factors	2
new types of antibiotics	2
bacterial biofilms	2
traditional antibiotics	2
Bacterial biofilms	2
complementary strand at or near the first cleaved site	2
one strand	2
superoxide radical, ·O2−	2
two metal complexes	2
types of DNA	2
super-coiled and double stranded DNA (scDNA and dsDNA)	2
[M(2,2′-bipyridine)2(NO3)](NO3) (M(bpy)2, M=Cu(II), Zn(II) and Cd(II))	2
extracellular InsP6 (e.g. in plasma)	2
protein- or membrane-bound	2
cytosolic/nuclear InsP6	2
InsP6 in mammalian cells	2
soluble Mg5(H2L)	2
+ (Ca5(H2L)·16H2O) solids	2
Mg2+ and Ca2	2
InsP6–Mg2+–Ca2+ system	2
fully deprotonated InsP6	2
neutral complex	2
Mg5(H2L)	2
protein-free soluble InsP6	2
828–840]	2
Biochem.	2
[J. Torres, S. Dominguez, M.F. Cerda, G. Obal, A. Mederos, R.F. Irvine, A. Diaz, C. Kremer, J. Inorg.	2
myo-inositol hexakisphosphate (InsP6)	2
terminal pathway components	2
complement system in females of frequently used mouse strains	2
serum of age-matched female and male C57BL/6 mice	2
female and male mice	2
recently developed complement assays	2
mouse complement	2
mouse complement system	2
Experimental mouse models	2
functional epitopes	2
set of antigen–antibody complexes	2
structural epitopes	2
epitope's residues	2
B-cell epitopes	2
particular plasmid type	2
β-lactamase resistance genes	2
backbone mosaicism	2
MOBP and MOBQ types	2
finer-resolution groups (replicon and pMLST types	2
MOB types	2
replicon families	2
curated plasmids	2
plasmid multilocus sequence type (pMLST)-level	2
silico replicon and MOB typing schemes	2
complete Enterobacteriaceae plasmids	2
curated dataset	2
complete plasmids	2
plasmid sequences	2
replication loci and relaxase proteins	2
Bcc species Burkholderia cenocepacia and B. lata, and in the non-Bcc species, B. thailandensis	2
improved suicide vectors	2
Bcc	2
series enhanced suicide vectors, pSHAFT2, pSHAFT3 and pSHAFT-GFP	2
Bcc and related species	2
chloramphenicol or trimethoprim effectively	2
improved antibiotic-resistance cassettes	2
Burkholderia cepacia complex (Bcc)	2
members of the genus Burkholderia	2
selected antibiotic-resistance markers	2
wild-type gene	2
genome of the host organism	2
antibiotic-resistance marker	2
gene in bacteria	2
ecosystems of different bacterial species	2
powerful labeling tool	2
mixtures of differentially labeled pathogenic Escherichia, Shigella and Salmonella species	2
bacterial population	2
pUltra constructs	2
another plasmid series encoding fluorescent proteins	2
labeling	2
fluorescence and confocal microscopy	2
expressed fluorophore	2
broad range of Enterobacteria	2
strong synthetic promoter	2
constitutively a fluorescent protein gene (GFP, RFP, YFP or CFP)	2
Fluorescent labeling	2
donor to recipient cells	2
investigated module	2
type IV secretion system module	2
six genes of the investigated module of ICEHin1056	2
number of related genomic islands	2
module on the 5′ extremity of ICEHin1056	2
functional type IV secretion system	2
harbors modules	2
modular structure	2
genomic island	2
Haemophilus influenzae genomic island ICEHin1056	2
genomic islands	2
HIB-1B preadipocytes	2
truncated aP2 promoter	2
pLenti TRE / rtTA adv	2
white (3T3-L1) and brown (HIB-1B) preadipocytes cell lines	2
combination of Tetracycline Responsive Element (TRE) and reverse tetracycline-controlled TransActivator advanced (rtTAadv)	2
adipose-specific promoter	2
tetracycline inducible (Tet on) lentiviral expression vectors	2
P1 loxP.	2
PepA and ArgR still	2
natural P1 context	2
proposed binding site	2
XerCD recombinases	2
ColE1 cer recombination site	2
regulatory DNA sequences	2
P1 lysogeny	2
Two Escherichia coli DNA-binding proteins, PepA and ArgR	2
P1 monomeric	2
phage-encoded Cre protein	2
low copy-number circular plasmid	2
bacteriophage P1	2
type 6 adenylyl cyclase and IP3R2	2
signalling junctions	2
three IP3R subtypes	2
cAMP-dependent protein kinase (PKA)	2
three subtypes of IP3R	2
ubiquitous intracellular messengers	2
cAMP	2
weakly responding recipients	2
unforeseeable cases	2
bone-replacing device	2
scaffold permanence	2
strongly- and weakly-responding animals	2
periphery of the defect	2
strongly-responding animals	2
interior of the scaffold	2
bone ingrowth	2
cylindrical metaphyseal defect	2
stiff titanium and compliant polyamide	2
Scaffolds 3D-	2
distal femur of sheep	2
combined TEC-nanofibrous scaffold	2
fibrocartilaginous tissue	2
TEC-combined nanofibrous scaffolds	2
meniscal defects	2
untreated control groups	2
either scaffold	2
MSC-based TEC-combined nanofibrous scaffolds	2
meniscal circumferential fibers	2
synovial mesenchymal stem cells (MSCs)	2
tissue engineered construct (TEC)	2
aligned electrospun nanofibrous scaffold	2
medial meniscus	2
Meniscal radial defects	2
rabbit model	2
damaged meniscal hoop structure	2
cell-seeded nanofibrous scaffolds	2
weight bearing area	2
meniscus	2
NTA/His6-tag bond	2
Co3+ vs. Ni2	2
Ni2+	2
gold (Au) nanopatterned polyacrylamide (PAA) hydrogels	2
protein-surface bond	2
biomimetic material functionalization	2
bond between NTA and the His6-tagged proteins	2
Co2+	2
nitrilotriacetic acid (NTA) with the hexahistidine tag (His6-tag)	2
bioactive surfaces	2
patients with metaphyseal defects	2
two bioactive molecule immobilized biomaterials	2
metaphyseal defect	2
cortices bridged	2
Gel-CaS-HA containing ZA and rhBMP-2+ZA	2
cancellous defect	2
CM with or without rhBMP-2	2
cortical defect	2
Gel-CaS-HA	2
bone in the cancellous defect	2
Gel-CaS-HA scaffold	2
ZA or Gel-CaS-HA	2
Gel-CaS-HA alone, Gel-CaS-HA	2
established tibia defect model	2
muscle pouch model	2
rhBMP-2 and ZA	2
rhBMP-2 and a bisphosphonate, (zoledronate = ZA)	2
Gel-CaS-HA cancellous defect filler	2
bone morphogenic protein-2 (rhBMP-2)	2
thin collagen membrane (CM)	2
cancellous defect filler	2
combination of a macroporous gelatin-calcium sulphate-hydroxyapatite (Gel-CaS-HA) biomaterial	2
cancellous and cortical bone	2
IBD, gastrointestinal cancers and viral infections	2
various drugs	2
porous nanoparticles and stimuli-responsive materials	2
numerous hierarchical structured vehicles	2
release drugs	2
developed hierarchical structured and programmed vehicles load	2
microenvironment of inflamed intestine	2
negatively charged hybrid nanoparticles	2
spatially variable physiological environments	2
drug loaded hydrogels	2
embedded hybrid nanoparticles	2
pH-responsive matrix	2
hierarchical structured (nano-in-nano-in-micro) vehicle	2
enzyme-responsive hydrogel and pH-responsive polymer	2
hyaluronic acid functionalized porous silicon nanoparticle	2
Orally administrable drug delivery vehicles	2
human femoral head tissue	2
stiffer ones	2
softer scaffolds	2
hBM-MSCs	2
4 weeks	2
chondrogenic and osteogenic lineages	2
human bone-marrow derived mesenchymal stem cells (hBM-MSCs)	2
family of indirectly 3D printed elastomeric nanohybrid scaffolds	2
molecular structure	2
Engineering scaffolds	2
dynamic physiological settings	2
static models	2
tissue engineering	2
conventional artificial matrices or scaffolds	2
remodeling tissues	2
cell-derived biomaterial scaffolds	2
preclinical drug testing platforms	2
conventional osteogenic assays	2
aberrant micro- and ultra-structural tissue organisation	2
crystalline mineral	2
less protein	2
bone-like tissue	2
human bone-marrow derived mesenchymal stromal cells (hMSC) form	2
degradation machinery	2
bone-like tissue formation	2
cell-derived, in vitro model	2
protein degradation apparatus	2
range of receptors	2
specific THPs	2
flowing blood	2
tyrosine 740	2
either COS-7 or HEK293 cells	2
derivatised films	2
specific THP	2
GST and Fc fusions, respectively)	2
recombinant VWF A3 domain	2
photoreactive moiety, diazirine	2
collagen III-derived active sequence, GPRGQOGVNleGFO	2
THP	2
specific triple-helical peptide (THP)	2
von Willebrand Factor (VWF) and Discoidin Domain Receptor 2 (DDR2)	2
amino acid side chains	2
Collagen-based scaffolds	2
bioengineered platform	2
functional relevance	2
TGFβ and hedgehog signalling pathways	2
livers of immune-deficient mice	2
2D and 3D controls	2
resultant organoids	2
type I collagen	2
ICC scaffolds	2
iPSC derived hepatic progenitors (IH)	2
hepatic progenitors	2
extracellular niche	2
inverted colloid crystal (ICC)	2
fully defined liver organoid platform	2
resultant structures	2
immortalized cell lines	2
Matrigel)	2
animal derived matrices	2
human organoids	2
canine	2
structural and functional “neuronal relay	2
transplanted MSC-derived neural network tissue	2
synapse-like contacts	2
5-HT nerve fibers	2
regenerating corticospinal tract nerve fibers	2
MSC-derived neuron-like cells	2
canines	2
SCI canines	2
synapse-like structures	2
neuron-like cells	2
TrkC overexpressing MSCs	2
neurotropin-3 overexpressing Schwann cells in a gelatin sponge scaffold	2
adult beagle dog	2
canine MSC-derived neural network tissue in vitro	2
larger animals	2
complete spinal cord injury (SCI) rat model	2
“neuronal relay”	2
injury/graft site of spinal cord	2
bone marrow mesenchymal stem cell (MSC)-derived neural network scaffold	2
many other oral lesions	2
OLP and RAS	2
clinically active drugs	2
mucosal tissue	2
electrospun patches	2
in vivo animal model	2
Clobetasol-17 propionate-loaded patches	2
ex vivo porcine mucosa	2
tissue-engineered oral mucosa	2
Electrospun polymeric mucoadhesive patches	2
novel mucoadhesive patches	2
mouthwashes, creams or ointments	2
erosive and/or painful oral lesions	2
clinically relevant, highly regenerative cells	2
ex vivo native-like niches	2
HD cultures	2
glycoprotein-rich PCM	2
glycoprotein-rich pericellular matrix (PCM)	2
high-density (HD) cultures	2
matrix- and non-matrix-mediated cues	2
hyaluronic acid-based hydrogels	2
single cell suspensions of human mesenchymal stem cells (hMSC)	2
soluble and non-soluble signals	2
native stem cell niches	2
modifiable hydrogels	2
FGFs in vivo	2
mouse limb explant model	2
purely inorganic nanoparticles	2
de novo constructed chimeric protein	2
ND-FGF interaction	2
amino acids long	2
evolutionarily conserved FGF recognition motif	2
growth factor systems	2
multiple FGF ligands	2
low nanomolar solutions of detonation NDs	2
family of extracellular signalling molecules	2
synthetically installed (bio)organic interface	2
nanosized diamond crystals (nanodiamonds, NDs)	2
(bio)organic molecules and/or polymers	2
“artificial proteins	2
specific protein-protein interactions	2
hypertrophic chondrocytes	2
osteochondral interface	2
mineralized and non-mineralized tissue	2
robust osteochondral tissue constructs	2
bone morphogenetic protein 2 in agarose hydrogels	2
range of biomaterial systems	2
biochemical gradients	2
glycosylated superparamagnetic iron oxide nanoparticles	2
facile and rapid platform	2
bioengineered tissue constructs	2
in vitro setting	2
bioactive signals	2
tissue engineering scaffolds, and medical devices	2
drug delivery constructs	2
CCGs	2
biocompatible Caffeine Catalyzed Gels (CCGs)	2
novel poly(ester-ether) gel synthesis platform	2
tri-functional crosslinking agent	2
diglycidyl-ether functionalized monomers	2
mild base	2
commonly available food grade ingredients	2
covalently cross-linked materials	2
batch synthesis platform	2
biologics and sensitive compounds	2
Covalently cross-linked gels	2
group of tissue repair-related genes	2
rat heart failure models	2
donor MSCs	2
beating heart	2
PM-MSC complex	2
easy pipetting	2
“instant” 2PM-MSC complexes	2
MSCs (epicardial PM-MSC therapy	2
instantly-produced PM hydrogel	2
PuraMatrix® (PM; 3-D Matrix, Ltd)	2
self-assembling peptide hydrogels	2
successful biomedical applications	2
various types of PIPAAm-based thermoresponsive surfaces	2
separation systems	2
pharmaceutical proteins and therapeutic cells	2
thermoresponsive bioseparation systems	2
Thermoresponsive microcarriers	2
dishes	2
Thermoresponsive cell culture dishes	2
poly(N-isopropylacrylamide) (PIPAAm)	2
Thermoresponsive surfaces	2
current CAB LAP formulations	2
human adult lymphocyte reconstituted NOD/SCID/IL2Rγc−/− mice	2
CAB LAP	2
reticuloendothelial system depot formulation	2
nanoparticles (NMCAB)	2
MCAB formed crystals	2
myristoylated CAB prodrug (MCAB)	2
virus infected and susceptible people	2
every other month parenteral administrations	2
highly potent integrase inhibitor	2
One new LAP is cabotegravir (CAB)	2
Long-acting parenteral (LAP) antiretroviral drugs	2
HES-based matrix	2
adjuvanted antigen	2
commercially available aluminum-adjuvanted HBsAg vaccine	2
HES-based MNAP	2
saponin QS-21 as adjuvant	2
swines, hepatitis B surface antigen (HBsAg)	2
hydroxyethyl starch (HES) and chondroitin sulphate (CS)	2
MNA patch (MNAP)	2
dissolvable microneedle arrays (MNA)	2
construct growth online	2
live cell TE constructs	2
R2 = 0.84) and glycosaminoglycans (GAGs)	2
TE constructs	2
multivariate curve resolution model	2
live cell cartilaginous TE constructs	2
Diffuse near-infrared fiber-optic Raman spectra	2
large (>3 mm), live cell TE constructs	2
ECM biomolecules	2
situ biochemical characterization	2
histological staining	2
engineered cartilage	2
engineered tissues in vitro	2
patients with osteoarthritis (OA)	2
classical fluorescent probes	2
in vitro and in cellulo	2
aggregating protein systems	2
live SH-SY5Y cells	2
aggregating protein	2
cellulo and in vivo	2
supramolecular assembly	2
lysozyme, fibrinogen and amyloid-β peptide (Aβ(1–42))	2
lysozyme and insulin	2
monomers of interest	2
‘molecular rotors’	2
viscosity sensitive fluorophores	2
macromolecular crowding	2
downstream lymphatic collecting vessels	2
lymphangiogenesis locally	2
extracellular matrix deposition	2
FB-VEGF-C-induced lymphangiogenesis	2
diabetic wounds	2
hyperplastic lymphatics	2
Leukocyte intravasation	2
downstream collecting vessels	2
lymphatic capillaries	2
local lymphangiogenesis	2
free VEGF-C	2
implanted fibrin containing FB-VEGF-C	2
novel wound healing model	2
infiltrating cells	2
fibrin-binding variant of vascular endothelial growth factor C (FB-VEGF-C)	2
local capillary lymphangiogenesis	2
either IL-1ra or IL-1β	2
galectin-3 and chitosan	2
IL-1ra	2
Specific chitosan preparations	2
novel library of twenty chitosans	2
family of glucosamine and N-acetyl glucosamine polysaccharides	2
PEA-driven organization of FN	2
scaffold pores	2
murine fat pad	2
FN and VEGF	2
3D scaffolds	2
integrin binding site of FN	2
impaired integrin binding site (FN-RGE)	2
mutant FN molecules	2
soluble VEGF	2
FN nanonetworks	2
PEA)	2
synergistic interfaces	2
integrin/GF binding domains	2
control polymers (poly(methyl acrylate), PMA)	2
material platform	2
growth factor binding (FNIII12-14) and integrin binding (FNIII9-10) regions	2
critical binding domains	2
(PEA)	2
Poly(ethyl acrylate)	2
polymer-based microenvironments	2
human tracheal scaffold	2
in vitro and in vivo cellular integration	2
well-decellularized tracheal scaffolds	2
in vivo chick chorioallantoic membrane (CAM) and subcutaneous implantation assays	2
primary human airway epithelial cells	2
human donor tracheae	2
accelerated vacuum-assisted decellularization (VAD) protocol	2
clinically applied detergent-enzymatic method (DEM)	2
naturally derived extracellular matrix (ECM) scaffolds	2
compassionate-use clinical cases	2
Decellularized human donor tracheal scaffolds	2
decellularized or synthetic tracheal scaffolds	2
large tracheal lesions	2
other, tissues	2
easy-retrievable, scaffold-free human tissues	2
surrounding host tissue	2
implants in a rabbit corneal model	2
fully-differentiated, stratified corneal epithelium	2
thicker tissues	2
corneal stromal SLATEs	2
near-UV radiation	2
randomly-oriented constituents	2
aligned collagen fibrils	2
corneal stromal Self-Lifting Analogous Tissue Equivalents (SLATEs)	2
native stromal lamellae of the human cornea	2
self-lifting tissues	2
corneal stromal cells	2
multi-functional peptide amphiphile-coated surfaces	2
human transplantable tissues	2
smart surface templates	2
implantable biomaterials	2
components and microarchitectures	2
specific physical and physiological roles in vivo	2
HER2-positive metastatic abdominal cancer	2
nanocarriers	2
intraperitoneal tumour-bearing mice models	2
non-targeted ΔHBc particles	2
HER2-expressing tumours	2
HER2 expressing cancer cells	2
HBc particles surface	2
ZHER2 affibodies	2
specific HER2-targeting	2
sequence encoding arginine-rich domains	2
wild type HBc particles	2
(HER2)-expressing cancer cells	2
human epidermal growth factor receptor-2	2
genetically modified HBc particles	2
receptor binding sequences	2
i.e. receptors	2
functional motifs	2
various drugs and other biomolecules	2
core monomers	2
hollow nano-particles	2
HBc particles	2
drug delivery vehicles	2
(HBc) particles	2
Hepatitis B Virus core	2
cross-SSC culture tools	2
mitogen activated protein kinases	2
nanotopographical surface	2
large numbers of multipotent SSCs	2
skeletal stem cells, SSCs)	2
isolated bone marrow mesenchymal stem cells	2
cell-cell and cell-matrix interaction	2
in vitro platforms	2
cancer biomass	2
invasive clones	2
migrated population	2
controlled architecture	2
anisotropic scaffolds	2
MDA-MB-468	2
invasive MDA-MB-468 and non-invasive MCF-7 cells lines	2
invasive breast cancer cell line MDA-MB-231	2
Anisotropic scaffolds	2
cross-linked collagen scaffolds	2
directional/anisotropic or non-directional/isotropic porous architectures	2
seeded cells	2
routine biochemical and immunological assays	2
complex tissues in vitro	2
3D collagen scaffolds	2
3D in vitro assays	2
many clinical microbubble formulations	2
polyethylene-glycol	2
molecules in cell membranes	2
microbubble coatings	2
acoustofluidic system	2
artificial and biological membrane bilayers	2
phospholipid-coated microbubbles	2
retinal prosthetic devices	2
CNTs and the retina	2
viable bio-hybrids	2
RGCs and the CNT electrodes	2
CNT assemblies	2
inner retina	2
CNT electrodes	2
RGC responses	2
bio-hybrid interface	2
carbon nanotube (CNT) electrodes	2
highly corrosive environment	2
neural prosthetic devices	2
messenger, micro, and genomic viral RNA	2
highly selective RNA-targeting agents	2
peptide and oligonucleotide components	2
linker regions	2
best candidate (i.e. DC6)	2
catalytic peptide	2
single-stranded RNA region	2
two spatially-separated recognition motifs	2
DCs	2
free C-terminal carboxylic acid functionality of the same peptide	2
3′-acceptor stem-targeting oligonucleotide	2
N-terminus of the amphipathic peptide sequence	2
TΨC-targeting oligonucleotide	2
unique peptidyl-oligonucleotide ‘dual’ conjugates (DCs)	2
TΨC loop and 3′- acceptor stem of tRNAPhe	2
two RNA recognition motifs	2
amphipathic RNA-cleaving peptides	2
novel class of catalytic biomaterials	2
disease-relevant RNAs	2
specific RNA sequences	2
expressed proteins	2
disease states	2
tumor vasculature	2
radiolabeled polymeric magnetic nanocapsules	2
colon (CT26), breast (4T1), lung (Lewis lung carcinoma) cancer and melanoma (B16F10)	2
range of subcutaneously implanted murine tumors	2
magnetic targeting	2
different tumor vascularization	2
magnetic field gradient	2
therapeutic adjunct	2
HA hydrogel	2
glial, neuronal or immature/progenitor states	2
stroke core	2
encapsulated human neural progenitor cells (iPS-NPCs)	2
optimized HA hydrogel	2
matrix metalloproteinases (MMP)	2
hydrogel crosslinkers	2
transplant	2
adjacent brain	2
HA cell scaffold	2
complex combination	2
hyaluronic acid (HA)-based self-polymerizing hydrogel	2
QD photoluminescence	2
axillary and thoracic regional lymph nodes	2
quantum dots	2
paw of rats	2
regional lymph nodes	2
novel type of heavy metal-free/cadmium-free and biocompatible QD nanoparticles (bio CFQD® nanoparticles)	2
core of the QDs	2
toxic heavy metal cadmium	2
photoluminescence probes	2
Quantum dots (QDs)	2
tumour−derived antigen, CpG and αCD40	2
OVA−expressing B16F10 melanoma cells in subcutaneous or lung pseudo−metastatic tumour models	2
CpG and αCD40	2
co−loaded OVA	2
MWNTs	2
co−incorporation	2
second immunoadjuvant	2
CpG−mediated adjuvanticity	2
APC	2
co−deliver OVA and CpG	2
OVA−expressing tumour cells	2
model antigen ovalbumin (OVA)	2
cytosine−phosphate−guanine oligodeoxynucleotide (CpG) and anti-CD40 Ig (αCD40)	2
harnessing MWNT	2
antigen presenting cells (APCs)	2
different types of immunoadjuvants	2
co−delivering antigen	2
tumour antigen nanocarriers	2
multi−walled carbon nanotubes (MWNTs)	2
soluble contrast agent	2
IV contrast	2
hepatic arteries	2
LC Bead LUMI™	2
fluoroscopy, DSA and single X-ray snapshot imaging modalities	2
targeted lobe(s) of the liver	2
sedimented bead volume	2
swine model	2
sterilized device	2
new intrinsically radiopaque bead (LC Bead LUMI™)	2
various types of polymeric or metallic scaffolds	2
trabecular-like and cortical bones	2
vascularized and mineralized bone tissue	2
newly formed bone	2
polyelectrolyte film coating	2
polyelectrolyte film as BMP-2 carrier	2
commercially-available PLGA	2
polymeric scaffold (3D hollow tube)	2
osteoinductive surface coating (2D)	2
critical size volumetric bone femoral defect	2
bone morphogenetic protein (BMP)-2	2
Bioactive proteins	2
large non-healing defects	2
highly adaptable and well defined platform	2
multiple enzymatically degradable peptides	2
novel collagen–mimetic protein	2
bimodal enzymatically degradable biological platform	2
hydrogel system	2
dual degradation motifs	2
combined peptide hydrogels	2
single peptide	2
degradable peptides	2
combination of matrix metalloproteinase 7 (MMP7)– and aggrecanase (ADAMTS4)–cleavable peptides	2
recombinant Scl2 protein	2
chondrogenesis and	2
heparin–binding, integrin–binding, and hyaluronic acid–binding peptide sequences	2
like 2 (Scl2) protein	2
backbone of a Streptococcal collagen–	2
precisely defined three–dimensional system	2
bioactive and biodegradable peptide sequences	2
well–defined biological ‘blank template’	2
recombinant bacterial collagens	2
dynamic and complex biochemical microenvironment	2
regenerating articular cartilage	2
many organic carbon skeletons	2
photoreactive diazirine	2
collagen films or scaffolds	2
integrins α2β1 and α1β1	2
HT1080 and Rugli cell lines	2
integrin-dependent cell attachment	2
ligand-binding I domain of integrin α2β1	2
GFOGER-derivatized collagen films	2
collagen film	2
end-stapled THP	2
photoreactive Diazirine group	2
resulting THP	2
short diglutamate-containing peptide	2
end-stapled peptide strands containing GFOGER	2
high-affinity binding site	2
active cell-recognition motif, GFOGER	2
THPs are ligands	2
structure of collagen	2
synthetic triple-helical peptides (THPs)	2
cross-linked type I collagen film	2
cell-surface integrins	2
carboxylate-containing amino acid sidechains	2
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS)	2
collagen scaffold	2
synthetic scaffolds	2
non-porous surfaces	2
POSS-PCU nanocomposite scaffold integration	2
large porogens	2
POSS-PCU scaffolds	2
surface modifications	2
primary human bronchial epithelial cells (HBECs)	2
larger porogens	2
Surface porosity	2
porogens	2
surface porosity	2
material surface	2
porogens (sodium bicarbonate (NaHCO3), sodium chloride (NaCl) and sucrose)	2
POSS-PCU	2
synthetic implants	2
bioscaffold	2
versatile nanocomposite biomaterial	2
silsesquioxane poly(carbonate-urea) urethane (POSS-PCU)	2
Polyhedral oligomeric	2
future drug delivery carriers	2
source of biological material	2
murine membrane	2
murine (i.e., syngeneic) source	2
cellular coating	2
source of cellular membrane	2
dubbed Leukolike Vectors (LLV)	2
murine and human leukocyte cellular membrane	2
unmodified multistage nanovectors and particles	2
synthetic particles	2
cellular materials	2
drug delivery vectors	2
pathological tissues	2
surface of nanotherapeutics	2
DNA-Gd-AuNPs	2
In vivo MR images	2
DNA-Gd@Au nanoparticle (DNA-Gd@AuNP)	2
in vivo transplanted human neural stem cells	2
Cy3 moiety	2
red fluorescent	2
modified deoxythymidine oligonucleotides bearing Gd(III) chelates	2
gold nanoparticle conjugate	2
sarcomere organization	2
native ventricular myocardium	2
genetically engineered cells	2
cardiomyocyte-specific proteins	2
pharmacological histone deacetylase inhibitor, valproic acid (VPA)	2
key co-activator	2
myocardin sumoylation	2
stemness” factors	2
permissive environment	2
histone H3 acetylation (AcH3)	2
microgrooved substrate	2
cardiomyocyte-like cells	2
topographical cues	2
key transcription factors	2
de novo cardiomyocytes	2
anti CEACAM6 mAb	2
xenotransplanted A549 cells	2
cellular CEACAM6 expression	2
8F5 binding	2
resected lung adenocarcinoma tissue sections	2
A549 and CEACAM6-Fc recombinant protein	2
B domain of CEACAM6	2
Clone 8F5	2
naked anti CEACAM6 mAb	2
anti CEACAM6 monoclonal antibody (mAb)	2
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6)	2
radio-resistant cancer cells	2
radiomimetic drug	2
neocarzinostatin (NCS)	2
β-galactosidase activity	2
large γ-H2AX foci	2
three human radioresistant cancer cell lines	2
oxygen species	2
Hydrogenated nanodiamonds (H-NDs)	2
superior biomaterials	2
large-scale screen	2
chemical moieties	2
co-polymer	2
anti-cancer drug doxorubicin	2
in vitro toxicity assay	2
gelatin control	2
co-polymer of isobornyl methacrylate and tert-butylamino-ethyl methacrylate	2
synthetic substrates	2
promising 3 polymers	2
20 polymers	2
growth substrates	2
Almost 700 polymers	2
serum-free fully defined culture system	2
functional cardiomyocytes	2
synthetic, chemically defined cellular niche	2
growth factors within serum and insoluble components	2
culture system	2
Soluble components	2
diamond	2
small diamond microcrystals	2
boron doping	2
neuronal culture	2
diamond crystalline structure	2
dopant	2
diamond microstructure	2
undifferentiated pluripotent stem cells	2
microcrystalline synthetic thin-film diamond substrates	2
mature, electrically active neurons	2
electrically active component of a neural sensor	2
culturing cells	2
potential substrate material	2
traumatic or degenerative neurological conditions	2
Brain Computer Interfaces (BCI)	2
combined antimicrobial and anti-endotoxic functions	2
new biomaterials	2
thrombin-derived HDPs	2
antiseptic substance polyhexamethylenebiguanide (PHMB)	2
E. coli infected hAD	2
significant amount of peptide	2
dermal substitute	2
(THP-1 cells)	2
peptide-functionalized hAD	2
Gram-negative Escherichia coli, Pseudomonas aeruginosa and Gram-positive Staphylococcus aureus bacteria	2
functionalized hAD	2
human acellular dermis (hAD, i.e. epiflex®)	2
thrombin-derived host defense peptides	2
brain capillaries and parenchyma fractions	2
heparinized saline	2
radioactive tracers	2
PBEC layer	2
MWNT-NH3	2
in vitro BBB model	2
multi-vesicular bodies	2
PBEC monolayer	2
radiolabelled f-MWNTs	2
primary porcine brain endothelial cells (PBEC) and primary rat astrocytes	2
co-culture BBB model	2
Blood-Brain Barrier (BBB)	2
amino-functionalized multi-walled carbon nanotubes (MWNTs-NH3+)	2
novel nanocarriers	2
Carbon nanotubes (CNTs)	2
functional tissue engineered constructs	2
novel biomaterial	2
hMSCs	2
HA-binding peptides	2
CS-binding peptides	2
glycosaminoglycan-binding peptides	2
matrix metalloproteinase 7 (MMP7)-sensitive peptide	2
hyaluronic acid (HA) or chondroitin sulfate (CS)-binding peptides	2
Streptococcal collagen-like 2 protein	2
single construct	2
bioactive and biodegradable moieties	2
modular template	2
collagen-mimetic proteins	2
complex and dynamic biochemical and biomechanical functions	2
biocompatible neural implants	2
3D-nanostructured BDD	2
long-term hippocampal cell cultures	2
acute whole embryonic hindbrain-spinal cord preparations	2
microelectrodes	2
20-μm-diameter 3D-nanostructured BDD microelectrodes	2
two BDD nanolayers	2
carbon nanotube template	2
high aspect ratio structure	2
chemically stable material	2
innovative material	2
3D-nanostructured boron doped diamond (BDD)	2
ideal electrode material	2
long-term neural implants and neuroprostheses	2
functionalised biomimetic prosthetic implant surfaces	2
IL8, TNFα,	2
fibroblasts on biomimetic surfaces	2
vinculin and collagen 1	2
commercially available implant surfaces	2
ADM PDMS surfaces	2
qRT-PCR and cytokine array	2
commercially available smooth and textured silicone implant surfaces	2
PDMS surfaces	2
Human breast derived fibroblasts (n = 5)	2
polydimethylsiloxane (PDMS)	2
synthetic implant surfaces	2
acellular dermal matrix (ADM)	2
extracellular matrix topographical cues	2
in vivo evaluation	2
biocompatible materials	2
technology platform	2
autograft control	2
injury gap	2
thy-1-YFP-H mouse common fibular nerve injury model	2
in vitro neuronal, Schwann and dorsal root ganglion culture	2
photocurable poly(ethylene glycol) resin	2
∼50 	2
3D constructs	2
405 nm laser source	2
custom built laser-based microstereolithography (μSL) setup	2
existing regulatory approved materials	2
short and large injury gaps	2
nerve guidance conduits (NGCs)	2
promising new cellular biomaterial	2
artificial tissue construct	2
autologous therapeutic cells	2
empty tube controls	2
EngNT-dADSC	2
distal stump	2
empty conduit and nerve graft controls	2
rat sciatic nerve	2
NeuraWrap conduits	2
peripheral nerve repair constructs	2
EngNT-dADSC sheets	2
aligned collagen matrix	2
columns of aligned dADSCs	2
engineered neural tissue (EngNT-dADSC)	2
tethered type-1 collagen gel	2
differentiated cells (dADSCs)	2
Schwann cell-like phenotype	2
Adipose-derived stem cells	2
microvascular bypass networks	2
angiogenic cells	2
human scale porcine chronic vascular occlusion model	2
robust, clinically relevant angiogenesis	2
endothelial cell colonies	2
ICDD	2
Implanted SMC	2
proximal left circumflex (LCx) artery	2
porcine model of chronic total occlusion (CTO)	2
intravascular cell delivery device (ICDD)	2
angiogenic molecule (VEGF)	2
Smooth muscle cells (SMCs)	2
versatility of percutaneous vascular access technology	2
specific disease sites	2
larger and more sustained cell/gene payloads	2
cardiovascular field	2
rat brains of siRNA	2
non-PEGylated anionic counterparts	2
cationic nanocomplexes	2
spherical particles	2
anionic PEGylated nanocomplexes	2
cationic targeting peptides	2
anionic PEGylated liposomes	2
anionic, siRNA nanocomplexes	2
cationic formulations in vivo	2
cationic nanoparticles	2
cationic liposomes and polymers	2
silicate-based counterparts	2
fluorinated phosphate glasses	2
bioactivity	2
phosphate-based glasses	2
non-bridging fluorine atoms	2
bridging oxygen atoms	2
fluorinated bioactive glasses	2
glass network	2
F–P bonding	2
two compositions of fluorinated phosphate-based glass	2
accurate first-principles molecular dynamics simulations	2
phosphate glass	2
Phosphate-based bioactive glasses containing fluoride ions	2
protein and surface	2
hydrophobic methylated surface	2
denser, less hydrated layer	2
hydrophilic silica surface	2
highly diffuse and hydrated layer	2
high molecular weight albumin	2
“soft” proteins	2
liquid/solid interface	2
protein layers	2
adsorbed protein layers	2
MR and PET	2
dual modal probes	2
molecular imaging	2
Al(OH)3 coated magnetic NPs	2
radioactivity solution	2
64Cu-bisphosphonate conjugate	2
18F-fluoride	2
[18F]-fluoride and bisphosphonate groups	2
Magnetic nanoparticles (NPs)	2
hepatic cell culture	2
promising materials	2
standard 2D culture environment	2
albumin and CYP3A4 transcripts	2
pre-differentiated HepaRG cells	2
3D hydrogel cultures	2
HepaRG cell cultures	2
hepatocyte markers (albumin and CYP3A4)	2
3D hydrogel	2
Cell culture	2
biliary compartment	2
canalicular membranes	2
hepatobiliary drug transporters, MRP2 and MDR1	2
functional bile canaliculi-like structures	2
3D multicellular spheroids	2
undifferentiated HepaRG cells in NFC and HG hydrogels	2
wood-derived nanofibrillar cellulose (NFC) and hyaluronan-gelatin (HG) hydrogels	2
3D culture environment	2
two-dimensional (2D) format	2
three-dimensional (3D) culture of human cells	2
Physiologically relevant hepatic cell culture models	2
nervous tissue	2
neural implants	2
CNS glial cells	2
stiff portions	2
composite foreign bodies	2
inflammatory genes and proteins	2
primary rat microglial cells and astrocytes	2
nervous tissue and electrodes	2
electrodes	2
CNS implants	2
paracrine factors	2
secretome-treated animals	2
APOSEC-treated pigs	2
downregulated caspase genes	2
myogenic factor Mefc2	2
APOSEC-affected areas	2
tumor necrosis factor and other inflammatory genes	2
APOSEC vs. controls	2
normal myocardium	2
border zone	2
infarct core	2
cardiac MRI	2
MI border zone	2
medium solution (control; n = 8)	2
porcine APOSEC (n = 8)	2
mid-LAD	2
109 apoptotic peripheral blood mononuclear cells (APOSEC)	2
hydroxyapatite nanoparticle vectors	2
SCC	2
Agglomerate dispersion	2
surface-connected compartment (SCC)	2
truly intracellular	2
extensive, interconnected membrane labyrinth	2
dispersant Darvan 7	2
Particle citration	2
agglomerates in biological medium	2
hydroxyapatite nanoparticles	2
varied 3-dimensional niche architectures	2
HPAs	2
stem cell marker, p63α	2
numerous layers	2
BLCs	2
surface of the constructs	2
Human limbal epithelial cells	2
stromal crypts of the human limbus	2
surface of the thin collagen constructs	2
custom moulded micro-ridges	2
hydrophilic porous absorbers (HPAs)	2
collagen hydrogels	2
bioengineered limbal crypts (BLCs) in a collagen construct	2
complex microenvironments	2
various stem cell niches	2
variety of neighbouring niche cells	2
physically protected microenvironment	2
base of limbal crypts	2
specialised stem cell niche	2
human corneal epithelium	2
Limbal epithelial stem cells	2
single dose	2
anionic RTN formulations	2
anionic RTNs	2
rhodamine fluorophore	2
brain sections	2
RTNs	2
Anionic, receptor-targeted nanocomplexes (RTN) containing a neurotensin-targeting peptide	2
spread	2
cell-surface anionic moieties	2
anionic nanocomplexes	2
Non-viral, nanocomplexes	2
gene therapies	2
class of PDMS-urethanes	2
cardiac leads	2
contact surface	2
smooth wear surface	2
ethylene tetrafluoroethylene (ETFE) jacketed cable	2
P35 and E2A	2
buffered water	2
commercially available examples, PurSil 35 (denoted as P35) and Elast-Eon E2A (denoted as E2A)	2
tough and easily processed thermoplastic elastomers (PDMS-urethanes)	2
polydimethylsiloxane and polyether soft segments	2
Segmented polyurethane multiblock polymers	2
reconstructed muscle tissue	2
3D cell orientation architecture	2
several layered cell sheets	2
fabricating thick tissue	2
anisotropic cell sheet	2
3D myotube constructs	2
gelatin gel	2
single anisotropic cell sheet	2
human skeletal muscle myoblasts	2
micropatterned thermoresponsive surface	2
cells and/or extracellular matrixes	2
parts of native tissues	2
artificial neural tissue	2
anisotropic engineered tissues	2
critical-sized 15 mm gap	2
device containing rods of rolled-up sheets	2
initial in vivo tests	2
nerve grafts	2
stable tissue-like biomaterial	2
interstitial fluid	2
tethered type-1 collagen matrix	2
aligned cellular biomaterials	2
lung architecture and ECM	2
alveolar and vascular architecture	2
sheep lungs	2
collagen, elastin, GAG and laminin	2
fresh lungs	2
intact capillary network	2
intact alveolar network	2
pulmonary micro-architecture	2
acellular scaffold	2
lung respiration	2
entry points	2
nuclear material	2
intratracheal route	2
rat lungs	2
scaffold architecture	2
lung natural acellular scaffold	2
creating scaffolds	2
autologous lung tissue	2
embryonic and post-natal gut environment	2
cell-seeded elastomeric fibrous sheet	2
enteric neural crest (ENC) progenitor cells	2
elastomeric mesh	2
ex vivo and in vivo trials	2
PGS core and PLLA shell	2
spun fibrous materials	2
core/shell electrospinning technique	2
(PLLA)	2
chemically crosslinked elastomeric poly(glycerol sebacate) (PGS) and thermoplastic poly(l-lactic acid)	2
non-linearly elastic biomaterials	2
non-linearly elastic host tissue	2
biomaterial vehicle	2
dynamic organ	2
efficient delivery system	2
degradable osteoconductive bone repair cement	2
pyrophosphate material	2
orthophosphate, silicate and carbonate salts of calcium	2
biologically responsive inorganic material	2
inorganic pyrophosphate ions	2
healing bone	2
pyrophosphate phase in the cement matrix	2
non-pyrophosphate containing control	2
self setting pyrophosphate based calcium cement system	2
pyrophosphate ion	2
phosphatase enzymes	2
Pyrophosphate ions	2
cell–surface interaction	2
bone related genes	2
telomeric ends of the chromosomes	2
deregulated genes	2
chromosome 1	2
phenotypical genes	2
fluorescence in situ hybridization (FISH) and Affymetrix arrays	2
human skeletal or mesenchymal stem cells	2
nucleus, nucleoskeleton and chromosomes themselves	2
fastidious cell types	2
model of adult myocardium	2
adult myocardium	2
structured tissue culture	2
organised sarcomere	2
PDMS microgrooved culture substrates	2
unstructured PDMS membrane	2
fibronectin coated microgrooved polydimethylsiloxane (PDMS) scaffolds	2
in vitro models	2
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM)	2
reference cartilages	2
growth factor-treated explants	2
surface structural protein collagen type I	2
smoother surfaces	2
growth factor-treated immature cartilages	2
native immature and mature cartilage	2
immature cartilage	2
growth factors FGF2 and TGFβ1	2
joint lesions	2
biomaterial constructs	2
joint surfaces	2
flexible tri-modal imaging agent	2
DSPE-PEG2000-stabilized liposomes	2
n-EG spacers of the DOTA lipids	2
7% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethyleneglycol)2000] (DSPE-PEG2000)	2
conventional shielded liposomes	2
range of tumour cells	2
n-EG	2
short n-EG spacer	2
shielded liposomes	2
radionuclide tracers	2
functional MR contrast agents	2
multimodal liposomes	2
fluorescent lipids	2
111In3+	2
short n-ethylene glycol (n-EG) spacers	2
lipid head group	2
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) macrocycle	2
member of the series	2
series of metal-chelating lipid conjugates	2
peptide-targeted nanocomplexes	2
gadolinium lipid conjugate contrast agent	2
fluorescently labelled nanocomplex formulations	2
non-targeted controls	2
neurotensin-targeted nanocomplexes	2
subcutaneous Neuro-2A tumours	2
Neuro-2A cells	2
non-targeted nanocomplexes	2
Neurotensin-targeted nanocomplexes	2
ApoE, neurotensin and tetanus toxin	2
one of three different peptide ligands	2
self-assembling mixtures of liposomes	2
nanocomplex formulations	2
nucleic acids in vivo	2
new platform	2
micro-epidermis	2
original tumours	2
micro-patterned rings	2
Squamous cell carcinoma cells	2
non-adhesive centre	2
central suprabasal location	2
stratified micro-tissue	2
μm diameter circular collagen-coated disks	2
100 	2
Epidermal stem cells	2
human keratinocytes	2
stratified micro-epidermis	2
recreate tissues	2
valid support	2
native architecture and connective tissue components	2
cellular elements	2
functional intestinal tissue	2
natural intestinal scaffold	2
detergent-enzymatic treatment (DET)	2
pores within scaffolds	2
way cortical astrocytes	2
range of pores	2
two different cell types (fibroblasts and cortical astrocytes)	2
static and perfusion cultures	2
defined pores	2
porous PCL or poly-dimethylsiloxane (PDMS) membranes	2
miniaturized bioreactors inside Petri dishes	2
transplantable tissues	2
complex three-dimensional structure	2
ɛ-polycaprolactone (PCL)	2
tubular scaffolds	2
assembled membranes	2
Open pores	2
scaffolds in tissue engineering	2
series of recombinant self-assembling peptides	2
primary human dermal fibroblasts	2
chemically synthesised peptide	2
pure recombinant P11-4	2
recombinant self-assembling peptide	2
peptide-fusion protein yields	2
cyanogen bromide	2
peptide biomaterials	2
series of other P11-family peptide expression vectors	2
unimer P11-4 production system	2
antiparallel β-sheet conformation	2
random coil conformations	2
11 amino acid peptide	2
P11-4	2
excellent starting materials	2
self-assembling systems	2
Synthetic nanostructures	2
state-of-the-art technologies (fluorescence microscopy, FRET)	2
patterns	2
ultra-thin gold and glass substrates	2
POEGMA brushes	2
extra-cellular matrix (ECM) proteins on unprotected areas	2
large areas (a microscope slide) and scale (substrates	2
soft lithography	2
(POEGMA)	2
poly(oligo(ethylene glycol methacrylate))	2
automated systems	2
cell microenvironment on model patterned substrates	2
mature tendon	2
developing tendon	2
membrane-enclosed fibrils	2
cell extensions	2
integrin α5	2
fibronectin network	2
collagen III, XII and XIV	2
collagen type	2
extracellular matrix of parallel collagen fibrils	2
3D linear fibrin gels	2
semitendinosus and gracilis tendons	2
mature fibroblasts	2
Tendon fibroblasts	2
effective prognostic biomarker	2
cell cycle and p53 signaling pathway	2
critical components	2
p53 signaling pathway	2
GC patients	2
normal gastric tissues	2
GC tissues	2
GC, normal gastric, chronic gastritis, intestinal metaplasia, and intraepithelial neoplasia	2
following tissue types	2
eukaryotic translation elongation factor eEF1Bα	2
Gastric cancer (GC)	2
two-domain structure of the RuBisCO subunit	2
non-native RuBisCO - GroEL complexes	2
Rhodospirillum rubrum	2
stringently GroE-dependent substrate enzyme RuBisCO	2
complexes of E. coli GroEL	2
subset of essential substrate proteins	2
ubiquitous molecular chaperones	2
chaperonins (GroEL and GroES in Escherichia coli)	2
small-molecule DTP3 analogues	2
recognition surfaces	2
MKK7_KD Δ(101–136) variant lacking Trp135	2
MKK7 peptides	2
kinase enzymatic pocket	2
GADD45β loop 2 (region 103–117)	2
GADD45β and MKK7 kinase domain (MKK7_KD)	2
GADD45β-overexpressing cancer cells	2
small peptide inhibitor	2
JNK kinase, MKK7	2
GADD45β physically	2
Multiple Myeloma cells	2
HT29 cell line	2
human colon cell line HT29	2
pure gelatin	2
clinical isolates of Escherichia coli	2
subpopulations of bacteriophages	2
fibronectin, gelatin, heparin	2
human extracellular matrix molecules	2
different bacteriophages	2
host matrix mucin glycoproteins	2
antimicrobial defense	2
bacteriophage and metazoan host	2
multiple host cellular components	2
one of the crucial proteins	2
refolded glucosaminidase	2
fibronectin, gelatin and heparin	2
refolded amidase	2
N-terminal histidine tagged proteins	2
parental wild type and complemented mutant strains	2
atl mutant	2
fibronectin, gelatin and heparin coated microtiter plates	2
atl mutant strain	2
Atlwithfibronectin, thrombospondin 1, vitronectin and heat shock cognate protein Hsc70	2
host matrices	2
Atl enzymes (amidase and glucosaminidase)	2
amidase and glucosaminidase domains	2
Major autolysin (Atl) of Staphylococcus aureusis a cell surface associated peptidoglycan hydrolase	2
pure and uniform lignin fraction	2
three lignin samples	2
practically free from carbohydrates and inorganics (ash)	2
three lignins	2
exceptionally pure and homogeneous lignin	2
fractionated lignins	2
higher molar mass fractions	2
carboxylic acid moieties	2
phenolic hydroxyl groups	2
obtained fractions	2
softwood kraft lignin	2
wheat straw soda lignin	2
three different sources (wheat straw organosolv lignin	2
Technical lignins	2
individuals with G6PD deficiency	2
G6PD Songklanagarind	2
G6PD Union+Viangchan	2
G6PD Bangkok noi	2
native G6PD	2
G6PD Canton+Bangkok noi	2
G6PD Bangkok	2
five clinical G6PD variants—G6PD Bangkok, G6PD Bangkok noi, G6PD Songklanagarind, G6PD Canton+Bangkok noi, and G6PD Union+Viangchan	2
many G6PD variants	2
Resulting fibres	2
samples crosslinked	2
726±43–844±85MPa)	2
Ph)	2
activated 1,3-phenylenediacetic acid (	2
gelatin and HFC samples	2
wet-spinning solvent (i.e. 2,2,2-trifluoroethanol and dimethyl sulfoxide) and coagulating medium (i.e. acetone and ethanol)	2
widely available linear amino-acidic chains	2
Gelatin and hydrolysed fish collagen (HFC)	2
collagen-derived polypeptides	2
wet-spun fibres	2
wet stable fibrous architectures	2
naturally derived materials	2
thermostable transaminase	2
l-serine and α-ketoglutaric acid	2
commercially expensive compound	2
β-Hydroxypyruvate	2
l-arabinose and β-hydroxypyruvate	2
Deinococcus radiodurans	2
Thermostable transketolases	2
sugar beet pulp	2
predominant monosaccharide	2
l-arabinose	2
higher value chemical	2
high value added chemical building blocks	2
putative genes	2
BxyH and multi-functional β-cellobiosidase/xylosidase XynF	2
β-xylosidases BxyF	2
α-l-arabinofuranosidase AfsB,	2
Four interesting enzymes	2
subset of these in BioBrick format	2
bacterium Cellulomonas fimi	2
putative biomass degrading genes	2
biochemically characterised examples	2
cellulosic biomass degradation enzymes	2
cellulolytic bacteria	2
natural substrates	2
biocatalytic pathways	2
amine acceptor	2
α-transaminase	2
broad range of amine acceptors with serine as amine donor	2
ω-transaminases	2
ABT and HPA	2
transketolase)	2
aminate erythrulose	2
two-step recycling cascade	2
serine, pyruvate and glycolaldehyde as substrates	2
two transaminases and one transketolase)	2
(2S,3R)-2-amino-1,3,4-butanetriol (ABT)	2
hydroxypyruvate (HPA) as a two-carbon donor	2
transaminase/transketolase cascade	2
transaminase enzyme	2
transketolase enzyme	2
de novo metabolic pathway	2
least two chiral centres	2
biopharmaceutically relevant protein	2
Tris-buffered intermediate bulk	2
Numerous biopharmaceuticals	2
nitration sites	2
tyrosine residues	2
mono- and bis-nitrated lysozyme	2
BDD electrode surfaces	2
mono- and bis-nitrated HEWL	2
tyrosine phenolate anion	2
BDD electrode	2
total nitroprotein yield	2
effective substitute material	2
boron-doped diamond	2
Platinum electrodes	2
hen egg white lysozyme (HEWL)	2
non-metallic electrode material, boron-doped diamond (BDD)	2
neuropeptide Y, brain-derived neurotrophic factor and γ-amino butyric acid	2
immune stimulants	2
tryptophan metabolites	2
short-chain fatty acids	2
microbiota-related metabolites	2
two groups of molecular links	2
immune, metabolic and nervous systems	2
communication network	2
continuous stream of microbial, endocrine, metabolic and immune messages	2
microbiota-gut-brain axis	2
concept of bioactives	2
dietary bioactives (food constituents	2
dietary flavanols and procyanidins	2
types of stem cells	2
field of exosomes	2
injured heart	2
numerous cell types	2
nano-sized vesicles	2
post-mortem brain analyses	2
non-esterified DHA	2
key enzymatic regulators	2
brain phospholipids	2
primary sources	2
non-esterified-DHA and lysophosphatidylcholine-DHA	2
several plasma pools	2
circulating lipid pools	2
DHA locally	2
abundant n-3 polyunsaturated fatty acid in the brain	2
nutritional biomarkers	2
health)	2
group of bioactives (non-essential dietary components	2
dietary intake	2
large populations	2
Nutritional epidemiology	2
inflammation-initiating molecules	2
specialized pro-resolving mediators (SPM)	2
novel group of mediators	2
self-resolving infections	2
many frontline antibiotics	2
persistent, recurrent, nosocomial and secondary infections	2
sepsis survivors	2
certain infections	2
carbolic acid	2
Joseph Lister	2
pro-inflammatory molecules	2
roles of transporters	2
transporters (including GLUT1/SLC2A1)	2
water soluble vitamins	2
list of transporters	2
known SLC and “non-SLC” transporter genes	2
HGNC	2
nomenclature	2
relevant databases	2
Bioparadigms SLC Tables	2
solute carriers	2
existing online resource	2
SLC families	2
HUGO Gene Nomenclature Committee (HGNC) website	2
list of these genes	2
transporter genes	2
SLC (solute carrier) gene series	2
fetal growth	2
Silver–	2
first imprinted gene	2
variant histone genes	2
isocitrate dehydrogenase genes IDH1/2	2
core epigenetic machinery	2
‘cancer stem cell’ models	2
Three distinct areas	2
glioblastoma multiforme	2
common primary adult brain cancer	2
particular developmental lineage	2
large intergenic domains	2
PRC2-associated H3K27me3	2
first PRC1-associated H2AK119Ub	2
transcription and chromatin	2
female mouse embryonic stem cells	2
extra-embryonic lineage	2
paraspeckle organization	2
partner p54nrb	2
paraspeckle component Neat1	2
nuclear granules	2
histone H3R26	2
methyltransferase CARM1	2
embryonic and extra-embryonic lineages	2
SummaryNuclear architecture	2
Peptidase-generated oligopeptide QS signals	2
paracrine signal	2
secreted trypanosome oligopeptidases	2
parasite differentiation	2
E. coli POT	2
 bacteria	2
oligopeptide transporters (POT)	2
SIF signal	2
slender form” trypanosomes	2
bloodstream “	2
surface GPR89-family protein	2
G protein-coupled receptor signaling	2
host bloodstream	2
promising new class of antimicrobial drug	2
in vitro, in cellulo and in vivo	2
potent antibiotics	2
several bacterial targets	2
non-toxic “lipid-altered” tunicamycins	2
substrate UDP-GlcNAc	2
naturally-occurring bactericidal nucleoside analogues	2
(GPT/E.C. 2.7.8.15	2
dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1	2
multiple regions	2
Clovis-associated genome	2
ancient individuals	2
later South Americans	2
Chile, Brazil, and Belize	2
oldest Central and South Americans	2
Clovis culture	2
oldest North American genome	2
Central Andes	2
North and South America	2
previously unappreciated streams	2
Native Americans	2
early branches	2
common ancestral population	2
Southern Cone	2
parallel time transects	2
49 individuals	2
genome-wide ancient DNA	2
many membrane proteins	2
TMDs co-translationally	2
EMC-knockout cells	2
multiple GPCRs	2
N-terminal signal peptide	2
next TMD	2
Purified EMC and SRP receptor	2
proportion of TMD1	2
first transmembrane domain (TMD)	2
β1AR biogenesis	2
conserved ER membrane protein complex (EMC)	2
β1-adrenergic receptor (β1AR) and other G protein-coupled receptors (GPCRs)	2
endoplasmic reticulum (ER) membrane	2
type 2 diabetes drug metformin	2
immunosuppressant rapamycin	2
longevity and health span-affecting drugs	2
hdPCA accurately	2
3,500 yeast proteins	2
drugs, toxins	2
gene functions	2
non-coding variation	2
coding variants	2
gene coding sequence	2
68,379 cases	2
individual families	2
common genetic variants	2
variable loci in the next generation	2
Variably methylated IAPs	2
rare instances	2
murine IAPs	2
multiple C57BL/6J	2
genetically identical individuals	2
alternative promoter	2
the agouti coat-color locus	2
endogenous retrovirus (ERV) of the intracisternal A particle (IAP) class retrotransposed	2
Agouti viable yellow (Avy) locus	2
vertebrate CNS	2
cranial and spinal neurons	2
anterior or posterior regions of the nervous system	2
primary regionalization”	2
established model	2
active filament network organization	2
motors	2
microtubule plus- and minus-end growth	2
either polar or nematic networks	2
kinesin-14 HSET	2
human mitotic motors kinesin-5 KIF11	2
different motors	2
distinct self-organizing capacities	2
spindle center	2
“nematic” network of aligned microtubules	2
polar arrays	2
bipolar spindle	2
mitotic motors	2
CeA	2
inhibitory CeA pathway	2
BLA projections	2
CeA.	2
BLA-damaged humans	2
chemogenetically silenced BLA	2
natural-selective bilateral BLA lesions	2
basolateral amygdala (BLA) and central amygdala (CeA)	2
fibroblastic reticular cell-associated genes, IL-33, and Lysyl oxidases	2
TNF superfamily member 14 (TNFSF14)	2
activated mesenchymal population	2
SOX6, F3 (CD142), and WNT genes	2
epithelial crypts	2
niche population	2
pericytes and myofibroblasts	2
divergent transcriptional regulators and functional pathways	2
four subsets of fibroblasts	2
16,500 colonic mesenchymal cells	2
pair of these neurons	2
mushroom body output neurons	2
parallel competing memories	2
mushroom body output neuron network	2
different places	2
intracellular calcium traces	2
specific dopaminergic neurons	2
aversive memories	2
normal and clinically aberrant samples	2
systemic autoimmune disease (MRL/lpr)	2
normal murine spleen	2
protein receptors on immune cells	2
cellular neighborhood	2
tightly packed tissues	2
fluorescent dNTP analogs	2
DNA barcodes	2
antibody binding events	2
CODEX iteratively	2
murine spleens	2
normal and lupus (MRL/lpr)	2
multiplexed datasets	2
glycan-binding motifs	2
neurexin diversity	2
hundreds of HS-binding proteins	2
neurexin interactome	2
Neurexin HS chains	2
canonical synapse-organizing complexes	2
intrinsic glycan and protein domains	2
postsynaptic partners neuroligins	2
HS directly	2
central synapses	2
Neurexin’s	2
prototypical synapse-organizing complex neurexin-neuroligin	2
fundamental units	2
new, lineage-specific transcripts	2
older LINEs	2
insulation	2
RNA motifs	2
LINEs and the surrounding intronic regions	2
evolutionarily young LINEs	2
around LINEs	2
multivalent binding sites	2
dozens of RNA-binding proteins (RBPs)	2
LINE-derived sequences (LINEs)	2
RNA processing machinery	2
mammalian introns	2
actin nucleation	2
WASP nano-template	2
circular nanoscale template on the membrane	2
WASP family proteins	2
100,000 endocytic sites	2
 endocytic proteins	2
a self-assembled macromolecular machine	2
orally bioavailable	2
closely related R15A-PP1c	2
recombinant R15B-PP1c holoenzyme	2
phosphorylated substrate	2
selective inhibitor of R15B.	2
negative regulator of proteostasis	2
regulatory subunit of protein phosphatase 1, PPP1R15B (R15B)	2
selective serine/threonine phosphatase inhibitors	2
selective phosphatase inhibitors	2
key glutamate and glycine neurotransmitters	2
distinct, regionally restricted astrocyte types	2
neurotransmitters and neuropeptides	2
developmental anatomical units	2
mouse nervous system	2
specialized, precisely positioned, and interacting cell types	2
brain-spanning circuits	2
freely available EM volume	2
olfactory projection neurons	2
KC dendrites	2
postsynaptic partners	2
previously unknown cell type	2
intrinsic neurons of the MB	2
Kenyon cells (KCs)	2
mushroom body (MB)	2
brain-spanning circuitry	2
entire brain of an adult female fly	2
custom high-throughput EM platform	2
100,000-neuron brain	2
rich repertoire of innate and learned behaviors	2
CRISPR systems	2
phage-encoded immune suppressors	2
CRISPR-Cas immunity	2
Acr-phage	2
second Acr-phage	2
host CRISPR-Cas immune system	2
first phage	2
Acr-phages	2
Acr-encoding phage	2
acr genes	2
bacterial CRISPR-Cas immune systems	2
SummarySome phages encode anti-CRISPR (acr) genes	2
genetic circuit	2
Seipin-dependent membrane bridges	2
nuclear lipid droplets	2
S. cerevisiae cells	2
adaptable membrane territory	2
ER and ONM	2
ONM	2
outer nuclear membrane (ONM)	2
force-generating actin platform	2
spatiotemporally the plasma membrane	2
developing pit	2
planar region of the plasma membrane	2
flat F-BAR domain	2
unusual SH3-SH3 interaction	2
scaffold protein intersectin	2
endocytic pits	2
protein FCHSD2	2
mammalian clathrin-mediated endocytosis (CME)	2
cohesin’s hinge	2
CEN loading sites	2
Smc1 moiety of Smc1/3 hinges	2
three highly conserved lysine residues	2
, DNAs	2
Smc-kleisin fusions	2
entrap DNAs	2
hinge domain whose positively charged lumen	2
individual DNAs	2
cohesin loads	2
circular minichromosomes	2
αβc KCs	2
αβc KC dendrites	2
voltage-gated potassium channel Shal (KV4)	2
forkhead box P transcription factor (FoxP)	2
odor-evoked synaptic inputs	2
αβ core Kenyon cells (αβc KCs) in the mushroom bodies of fruit flies	2
pancreatic metastases	2
primitive ancestral clones	2
solitary metastasis	2
monoclonal structure	2
multiple tissue sites	2
100 patients	2
primary and 335 metastatic biopsies	2
SummaryClear-cell renal cell carcinoma (ccRCC)	2
FUS condensation	2
methylated and hypomethylated FUS	2
physiological molecular chaperone of FUS in neuron terminals	2
neuron terminals	2
stable intermolecular β-sheet-rich hydrogels	2
arginines in structured C-terminal domains	2
tyrosines in the LC domain	2
intrinsically disordered low-complexity (LC) domain of FUS	2
membrane-free organelles	2
ribonucleoprotein granules	2
cell, structural, and systems biologists	2
mitotic cell	2
biophysical environment	2
intrinsically disordered and mitotically phosphorylated proteins	2
cell-cycle factors, polymerases, and chromatin remodelers	2
Various cellular pathways and components	2
subclonal drivers	2
highly branched tumors	2
multiple mutational and copy number drivers	2
evolutionary subtypes	2
TRACERx Renal	2
101 patients	2
1,206 primary tumor regions	2
clear-cell renal cell carcinoma (ccRCC)	2
transposase-DNA structure	2
peptide antagonist	2
suitable target DNA	2
transposon DNA	2
diverse genomic sites	2
Tn916-like conjugative transposons	2
circular transposon DNA intermediates	2
conserved Y-transposase of Tn1549 complexed	2
severe drug-resistant infections	2
antibiotic vancomycin	2
Tn1549 conjugative transposon	2
diverse bacterial pathogens	2
non-clients	2
constitutive HSP90 clients	2
HSP90 clients	2
estrogen receptor modulators	2
JQ1 proteolysis targeting chimera	2
bromodomain inhibitor JQ1	2
emerging research tool	2
sporadic tumors	2
inherited and sporadic cancers	2
tumor’s most recent common ancestor	2
childhood or adolescence	2
MYC-MAX-MAD1 repressor	2
5′ UTR of TERT	2
95 biopsies	2
several tumor suppressor genes	2
short arm of chromosome 3	2
cell renal cell carcinoma (ccRCC)	2
age-matched projection neurons of the upper layers	2
the cortical interneuron cohort	2
migrating cortical interneurons	2
carboxypeptidase 1	2
genetic-encoded information	2
extracellular cues	2
appropriate cortical layers	2
multiple tangential paths	2
L-forms	2
dormant persisters	2
innate immune effectors	2
cell wall-deficient “L-form” bacteria	2
exogenous lytic enzymes	2
class A penicillin-binding protein	2
various Gram-positive bacteria	2
Summaryβ-lactam antibiotics	2
tumor-derived PGE2	2
cellular and molecular checkpoint	2
NK cell-cDC1 axis	2
NK cells and cDC1	2
XCL1, and XCL2 transcripts	2
intratumoral CCL5	2
cDC1 chemoattractants CCL5 and XCL1	2
mouse tumors	2
1 dendritic cells (cDC1)	2
SMC complex	2
stable dsDNA-dsDNA cohesion	2
Second-ssDNA capture	2
cohesin loader complex	2
initial double-stranded DNA (dsDNA) embrace	2
second DNA	2
purified fission yeast cohesin complex	2
one DNA	2
SMC rings	2
multi-subunit ATPases	2
ring-shaped structural maintenance of chromosome (SMC) complexes	2
critically short telomeres	2
telomerase inappropriately	2
RTEL1-deficient cells	2
 a pathological substrate	2
DNA secondary structures	2
telomeric repeats	2
microglial contributions	2
human fetal microglia	2
male embryos and female adults	2
adult males and females	2
embryonically seeded macrophages	2
innate link	2
germinal center cells	2
interfollicular NKT cells	2
pre-TfH wave of IL-4	2
Zika-virus-infected macaques	2
 neutralizing antibodies	2
innate immunity arm	2
total IL-4-producing cells	2
early wave of IL-4	2
antigen-experienced B cells	2
innate signals	2
interfollicular areas of lymph nodes	2
population of innate-like T lymphocytes	2
follicular helper T (TfH) cells	2
germinal centers	2
class-switched antibody-secreting cells (ASCs)	2
SummaryB cells	2
GPCR variants	2
certain variants of μ-opioid and Cholecystokinin-A receptors	2
drug- and effector-binding sites	2
68,496 individuals	2
FDA)-approved drugs	2
Food and Drug Administration	2
108 G-protein-coupled receptors (GPCRs)	2
immune suppressive stroma	2
Myc extensively	2
returning NK cells	2
CD4+CD8+ T cells	2
established adenocarcinomas	2
adaptive T and B cells and innate immune NK cells	2
T and B cells	2
macrophages, angiogenesis, and PD-L1-dependent expulsion	2
principal instructing signals	2
epithelial-derived signaling molecules CCL9 and IL-23	2
highly inflammatory, angiogenic, and immune-suppressed stroma	2
highly proliferative and invasive adenocarcinomas	2
KRasG12D-driven adenomas	2
mouse lung model	2
two oncogenes KRas	2
J domain co-chaperones	2
default, dimeric, and active state	2
IRE1 dimers	2
luminal stress-sensing domain of IRE1α (IRE1LD)	2
luminal Hsp70 BiP	2
selective IRE1 repressor	2
ER luminal co-chaperone ERdj4/DNAJB9	2
conserved transmembrane ER stress receptor	2
non-dividing primary cells	2
off-the-shelf reagents	2
a wide range of target proteins	2
unmodified native proteins	2
genome or mRNA	2
sexual differentiation pathway	2
host-derived physiological signals	2
essential membrane component phosphatidylcholine	2
exogenous LysoPC	2
host-derived lipid lysophosphatidylcholine (LysoPC)	2
sexual parasites	2
 the Plasmodium life cycle	2
non-small-cell lung cancers (NSCLCs)	2
human leukocyte antigen (LOHHLA)	2
cell type-specific enhancer-promoter contacts	2
neural transcription factors	2
extensive Polycomb network	2
inactive TADs	2
active TADs	2
exon-rich, active genes	2
highest-resolution Hi-C maps	2
yet-to-be-discovered cancer genes	2
endometrial and colorectal cancers	2
thyroid and testicular cancers	2
outside known cancer genes	2
7,664 tumors	2
large-sized chromatin loops	2
anchoring condensin complexes	2
kleisin loop around DNA	2
safety belt	2
peptide loop of the kleisin subunit	2
conserved, positively charged groove	2
DNA co-crystal structures	2
Ycg1Cnd3 HEAT-repeat and Brn1Cnd2 kleisin subunits	2
eukaryotic condensin complex	2
direct DNA-binding site	2
topology	2
replicated genomes	2
SummaryCondensin protein complexes	2
complex branched epithelial structures	2
neighboring ducts	2
equipotent tips	2
mouse mammary gland, kidney, and human prostate	2
pathogenic strains of human papilloma virus (HPV)	2
Clinical Research	2
Lasker-DeBakey Prize	2
target of rapamycin, TOR	2
Scc2/4 cohesin loading complex	2
conserved kinase, DDK	2
Ctf19 kinetochore protein	2
budding yeast centromere	2
One such locus	2
defined loci	2
distant DNA domains	2
ring-shaped cohesin complex	2
necessary elements	2
transgenic or gene-targeted mice and embryonic stem (ES) cell lines	2
multiple cell clones	2
multiple genes and regulatory elements	2
large DNA constructs	2
Inducible functional genetic mosaics	2
M. leprae PGL-1	2
reactive nitrogen species	2
PGL-1 induces nitric oxide synthase	2
macrophages infected with M. marinum-expressing PGL-1	2
areas of intimate contact	2
 infected macrophages	2
M. leprae	2
transparent zebrafish larvae	2
M. leprae-specific phenolic glycolipid 1 (PGL-1)	2
peripheral neuropathy	2
mycobacterial diseases	2
neighboring mesenchymal partners	2
alveolar compartments	2
Distinct Lgr5+	2
Lgr6+	2
Wnt-Fgf10 cooperation	2
airway epithelia	2
subpopulation of smooth muscle cells	2
well-known markers of stem cells in epithelial tissues	2
organoid culture approaches	2
single individual	2
multiple distinct tumor immune microenvironments co-	2
predicted neoepitopes	2
specific T cell subsets	2
CD8+ and CD4+ T cells	2
regressing and stable metastases	2
progressing metastases	2
multiple chemotherapy regimens	2
high-grade serous ovarian cancer	2
Plasmodium parasites	2
single-celled organism	2
parasite-host interface	2
expanded gene families	2
two-thirds of genes	2
phenotype database	2
mice of 2,578 barcoded Plasmodium berghei knockout mutants	2
essential genes and pathways	2
genomes of malaria parasites	2
new antitubercular	2
first-line TB drug isoniazid	2
drug-susceptible and drug-resistant clinical isolates of M. tuberculosis	2
benzofuran class inhibitor of Pks13	2
lead, TAM16	2
mycolic acids	2
polyketide synthase Pks13	2
lead molecule	2
first-line TB drugs	2
 neural circuits in vivo	2
virtually unlimited temporal window	2
traced network	2
self-inactivating ΔG-rabies virus (SiR)	2
Monosynaptically restricted rabies virus	2
specific networks	2
fundamental computational unit of the brain	2
SummaryNeural networks	2
amphipathic helices in the BAR domain	2
protein-scaffolded tubes	2
motors pull tubes	2
 a frictional barrier	2
underlying tube	2
tubular membranes	2
protein scaffolds	2
vitro, and in vivo experiments	2
tubular membrane necks	2
BAR domain proteins	2
large, LZ:CM2-interaction-dependent assemblies	2
micron-scale assemblies in vitro and Cnn-scaffold assembly	2
micron-scale structures	2
LZ	2
unusual tetramer	2
helical dimers	2
CM2 complex	2
2:2 complex	2
conserved leucine zipper (LZ) and Cnn-motif 2 (CM2) domains	2
phosphorylation-dependent scaffold	2
flies, Centrosomin (Cnn)	2
large-scale chromosome structures	2
dynamic, transcriptionally responsive chromatin mesh	2
SAF-A and caRNAs	2
large-scale chromatin structure	2
SAF-A oligomerization	2
protein oligomerization	2
ATPase domain	2
SAF-A’s AAA+	2
human interphase chromatin structures	2
RGG domain	2
chromatin-associated RNAs (caRNAs)	2
structural nuclear protein	2
scaffold attachment factor A (SAF-A)	2
dynamic models	2
nuclear organization	2
stable matrix	2
complex interphase chromatin structures	2
topologically constrained functional domains	2
eukaryotic chromosomes	2
dynein-1 tail	2
microtubules and dynactin	2
open form	2
cargo binding dynein tail	2
phi-particle	2
complete 1.4-megadalton human dynein-1 complex	2
cryoelectron microscopy structure	2
own	2
transport machine	2
dynein-1 binds dynactin and cargo adaptor proteins	2
living mice	2
set of immobile electrodes	2
currents	2
neurons of the overlying cortex	2
neurons in the hippocampus of living mice	2
electric field envelope	2
 the living mouse brain	2
prominent electric field envelope	2
multiple fields	2
brain multiple electric fields	2
electrically stimulating neurons	2
aberrant RNA-DNA hybrids (R-loops)	2
Ribonuclease H1	2
alcohol catabolite	2
additional cellular proteins	2
DNA replication forks	2
ubiquitous environmental toxin	2
a cellular metabolite	2
single copy of the tumor suppressor, BRCA2	2
correctly structure chromosomes	2
nuclear compartmentalization	2
making	2
polyclonal collections of loops	2
cohesin structures chromosomes	2
topologically associated domains (TADs)	2
SCC2/SCC4 complex	2
incorrectly oriented CTCF sites	2
Cohesin’s DNA release factor WAPL	2
cohesin embraces DNA	2
CTCF sites	2
3D genome	2
origin of transfer DNA	2
two conformers	2
recipient cell	2
helicase activity	2
resulting 5′-phosphate end	2
DNA strand	2
trans-esterase activity	2
bifunctional enzymes	2
host metabolism	2
fluoropyrimidine effects	2
nucleoside diphosphate kinase ndk-1	2
bacterial deoxynucleotide pools	2
bacterial vitamin B6, B9, and ribonucleotide metabolism	2
bacterium E. coli	2
two tractable genetic models	2
truly transformative drugs	2
commercial partners	2
academic drug discovery centers	2
coding and non-coding transcript isoforms	2
ASCC3 gene	2
protein-coding isoform	2
non-coding ASCC3 isoform	2
encoded protein	2
shorter ALE isoform	2
protein-coding ASCC3 mRNA	2
alternative last exons (ALEs)	2
shorter isoforms	2
long mRNAs	2
promoter-proximal ∼25 kb	2
ascending touch pathways	2
somatosensory processing region	2
spinal cord interneurons and corticospinal neurons	2
LTMR classes	2
LTMR-RZ interneuron subtype	2
LTMR-RZ interneuron subtypes	2
excitatory and four inhibitory subtypes of interneurons	2
dorsal horn LTMR-recipient zone (LTMR-RZ)	2
neuronal components	2
an array of mouse genetic tools	2
low-threshold mechanoreceptor (LTMR) information	2
poorly characterized spinal cord region	2
deep dorsal horn	2
wild-type cells expressing multiple cyclin-CDK complexes	2
single cyclin-CDK	2
different CDK substrates	2
CDK substrates	2
multiple different cyclin-CDK complexes	2
reprogrammed loci	2
human in 	2
checkpoint stringency	2
In vivo structure-function rescue assays	2
totipotent embryo	2
totipotent zygote	2
appropriate decoding factor⋅GTPase complex	2
peptidyl transferase center	2
decoding factors	2
ribosomal decoding center	2
intermediates of translation elongation (aminoacyl-tRNA⋅eEF1A), termination (eRF1⋅eRF3), and ribosome rescue (Pelota⋅Hbs1l)	2
decoding factor⋅GTPase complexes	2
family of translational GTPases	2
different genome regulatory domains	2
allelic architecture	2
173,480 European-ancestry participants	2
causal genes and pathways	2
diverse genomic inputs	2
345 unique immune disease loci	2
molecular trait QTLs	2
cis-genetic and epigenetic factors	2
three major human immune cell types (CD14+ monocytes, CD16+ neutrophils, and naive CD4+ T cells)	2
bat cells	2
EBOV GP	2
different human and bat cell lines	2
panel of pseudoviruses	2
Mutant GPs	2
earliest reported isolate	2
synthetic glycoprotein (GP) construct	2
several viral lineages	2
animal reservoir	2
Ebola virus (EBOV)	2
essential chromosome segregation machinery	2
the KMN assembly	2
near-complete structural model	2
functional regions of NDC80C and KNL1C	2
MIS12:CENP-C	2
fragment of CENP-C	2
human MIS12C	2
CENP-C.	2
chromosome-proximal domain of the kinetochore	2
KMN	2
KNL1C, MIS12C, and NDC80C)	2
10-subunit KMN assembly (comprising KNL1, MIS12, and NDC80 complexes	2
multisubunit protein assemblies	2
primary cell promoter interactomes	2
disease-candidate genes	2
putative target promoters	2
non-coding disease variants	2
Interacting regions	2
hematopoietic tree	2
Promoter interactomes	2
epigenetically marked enhancers	2
human primary hematopoietic cell types	2
31,253 promoters	2
regulatory elements and gene promoters	2
human midbrain development	2
molecular programs	2
adult classes	2
two mature fetal dopaminergic neuron subtypes	2
four progenitors	2
five subtypes of radial glia-like cells	2
 molecularly defined human cell types	2
commonly used rodent models	2
human embryonic ventral midbrain	2
underexplored space	2
metabolism regulatory network	2
functional annotation	2
far uncharacterized yeast genes	2
metabolomic signatures	2
physical and genetic interaction networks	2
exponentially growing cells	2
metabolic regulators	2
functional metabolomics	2
the Saccharomyces amino acid metabolome	2
primary T lymphocytes	2
different DNA binding platforms	2
targeted locus	2
engineered transcriptional repressors	2
highly expressed genes in somatic cells	2
endogenous retroviruses’ silencing machinery	2
formylmethionyl-tRNA (fMet-tRNAfMet)	2
IF3 and tRNA	2
formylmethionyl moiety	2
IF1 provides key anchoring points	2
initiator tRNA, mRNA, and IFs 1–3	2
complex of bacterial 30S subunit	2
single-particle cryo-electron microscopy (cryoEM) reconstructions	2
P site of the 30S ribosomal subunit	2
three initiation factors (IFs 1–3)	2
powerful probes	2
nucleolar precursors of the 60S subunit	2
Nsa1 particles	2
inhibitor-sensitive or inhibitor-resistant cells	2
Midasin function	2
diverse cellular activities) protein	2
essential ∼540-kDa AAA+ (ATPases	2
Rbins’ physiological target	2
potent and reversible triazinoindole-based inhibitors	2
ribozinoindoles (or Rbins)	2
potent validated chemical probes	2
tools or drugs	2
ribosome function	2
Several chemical inhibitors	2
biobank	2
high-throughput platform	2
short-term cultured PDTCs	2
short-term cultures of PDTX-derived tumor cells (PDTCs)	2
PDTXs	2
integrated platform	2
originating tumor	2
large collection of breast cancer patient-derived tumor xenografts (PDTXs)	2
local T cell compartments	2
organ-specific BTNL/Btnl genes	2
Vγ4+ cells	2
human colonic	2
BTNL8	2
human gut epithelial cells	2
intestinal Vγ7+ cells	2
TCRαβ+ repertoires	2
microbial or food antigens	2
local TCR-Vγ7+ γδ compartment	2
murine enterocytes	2
thymic epithelial cells and suprabasal keratinocytes	2
Skint1, a butyrophilin-like (Btnl) gene	2
DETC repertoire	2
TCR)-Vγ5 chains	2
T cell receptor (	2
murine dendritic epidermal T cells (DETCs)	2
organ-specific γδ T cell compartments	2
body surfaces	2
particular phospholipids	2
pilus type	2
stoichiometric protein-phospholipid units	2
two F family pili, the F and pED208 pili	2
F plasmid	2
F “sex” pilus	2
widespread bacterial appendages	2
monkey brain	2
dopamine neurons in non-human primates	2
reward-predicting stimuli	2
optical stimulation	2
light pulses	2
Infected neurons	2
 two viral vectors label dopamine neurons	2
Rhesus monkeys	2
cell-type-specific channelrhodopsin expression	2
expanded behavioral repertoire	2
well-defined neurons	2
HIV bnAb responses	2
mature VRC01-class	2
partially mature VRC01-class antibodies	2
boosted mAbs	2
fully native HIV	2
near-native isolates (N276A)	2
germline VRC01 heavy chains	2
previously primed VRC01-class precursors	2
boosting immunogens	2
priming immunogen	2
engineered priming immunogen	2
precursor B cells	2
important vaccine leads	2
ORAS patients	2
anti-TNF neutralizing antibodies	2
LUBAC in B and T cells	2
M1-linked polyubiquitin	2
Four independent OTULIN mouse models	2
OTULIN-related autoinflammatory syndrome (ORAS)	2
human OTULIN	2
M1-specific deubiquitinase OTULIN	2
M1-linked chains	2
(M1)-linked ubiquitin chains	2
another system	2
aggregated and misfolded proteins	2
UBQLN2 recognizes client-bound HSP70	2
HSP70-HSP110 disaggregase machinery	2
reversibly bound shuttles	2
stoichiometrically bound ubiquitin receptors	2
polyubiquitylated substrates	2
proteasome shuttle factor UBQLN2	2
new pathway	2
misfolded and aggregated proteins	2
naturally occurring human autoantibodies	2
anti-cytokine antibodies	2
neutralizing type I interferons (IFNs)	2
high-affinity, neutralizing autoantibodies	2
many APS1/APECED patients	2
many thousands of human proteins	2
81 patients	2
self-proteins	2
unique sets	2
B cell autoreactivity	2
APS1/APECED patients	2
many self-antigens	2
transcript ends	2
coding sequence ends	2
translation machinery	2
standard amino acids	2
64 codons	2
two of these species	2
variant genetic codes	2
standard stop codons	2
the nuclear genetic code	2
nuclear genetic code	2
selected cancer sub-populations	2
analysis and datasets	2
265 drugs	2
1,001 molecularly annotated human cancer cell lines	2
29 tissues	2
11,289 tumors	2
large 3D cellular volumes	2
nuclear pores, cilia, and synaptonemal complexes	2
complex molecular architectures	2
diverse research fields	2
entire mammalian cells	2
optical nanoscope	2
whole-cell 4Pi single-molecule switching nanoscopy (W-4PiSMSN)	2
thin samples	2
thick samples	2
SummaryFluorescence nanoscopy	2
topological model	2
AL resemble pore scaffolds	2
Drosophila blastoderm embryos	2
NPC storage pools	2
annulate lamellae (AL)	2
endoplasmic reticulum (ER) membrane sheets	2
metazoan oocytes and early embryos	2
SummaryNuclear pore complexes (NPCs)	2
signaling receptors	2
endosomal system’s architecture	2
cell’s periphery	2
deubiquitinating enzyme USP15	2
diverse vesicles	2
various vesicle adaptors	2
ubiquitin-binding domains (UBDs)	2
p62/sequestosome 1 (p62/SQSTM1)	2
catalytically competent RNF26	2
entire endosomal system	2
endoplasmic reticulum (ER)-located ubiquitin ligase Ring finger protein 26 (RNF26)	2
highly dynamic peripheral contingent	2
relatively immobile perinuclear vesicle “cloud”	2
cell’s interior	2
network of progressively maturing vesicles	2
influenza virus-infected humans	2
structurally characterized cross-reactive antibodies	2
large portion of the fusion peptide	2
hydrophobic groove in the fusion domain	2
highly conserved epitope	2
HA proteins	2
H5 or H7	2
mice and ferrets	2
anti-stem antibodies	2
heavy-chain VH6-1 gene	2
hemagglutinin (HA) subtypes	2
isolation, evolution, and structure of a broad-spectrum human monoclonal antibody (mAb), MEDI8852	2
much broader spectrum of habitats	2
unknown glacial refugium	2
northern latitudes	2
ancestral habitats	2
relict populations	2
native Eurasian and North African range	2
1,135 high-quality re-sequenced natural inbred lines	2
sequence elements	2
common upstream regulators	2
Translationally co-regulated mRNA subsets	2
Adult axons	2
axon-specific roles	2
enriched genes	2
evolving subset	2
embryonic-to-postnatal axonal translatome	2
developing and adult retinotectal projection	2
retinal ganglion cell axons	2
ribosome-bound mRNAs	2
receptor extracellular face	2
different elements	2
peptide agonists	2
receptor-ligand complex	2
pathway-specific signaling	2
receptor core	2
peptide N terminus	2
class B G protein-coupled receptors	2
better, safer therapeutics	2
AGRP, POMC, or paraventricular hypothalamic neurons	2
voltage-gated sodium channel Nav1.7 (Scn9a)	2
near-perfect synaptic integrators	2
multiple types of hypothalamic neurons	2
Brassicaceae plant family	2
endocarp b cells	2
fruit wall tissues	2
fruit wall	2
relative of Arabidopsis thaliana	2
Cardamine hirsuta	2
cells, tissues, and organs	2
key therapeutic targets	2
memory places macrophages	2
damage receptor Draper	2
calcium-induced JNK signaling	2
apoptotic corpse	2
adaptive system	2
multifunctional cells	2
single mRNA molecules in live cells	2
individual mRNA molecules in the same cell	2
specific 5′ UTR sequences	2
cell-cycle gene Emi1	2
the same cell	2
individual mRNAs	2
single mRNAs	2
single mRNAs in vivo	2
IGF1R/AXL-AKT axis	2
cell-autonomous KRASG12D	2
total proteome	2
tumor cell phosphoproteome	2
reciprocal KRASG12D	2
cell-autonomous KRASG12D.	2
regulated signaling nodes	2
additional kinases	2
heterotypic fibroblasts	2
Tumor cell KRASG12D	2
pancreatic ductal adenocarcinoma (PDA) cells	2
multivariate phosphoproteomics	2
 stromal cells	2
oncogenic KRAS (KRASG12D)	2
tumor cells and adjacent stromal cells	2
transcriptional atlas	2
biallelic expression	2
X chromosome genes	2
three lineages	2
Female cells	2
trophectoderm, epiblast, and primitive endoderm lineages	2
human preimplantation embryos	2
1,529 individual cells	2
comprehensive transcriptional map	2
highly microbicidal first-responding macrophages	2
tobacco smoke particulates	2
human smokers	2
newly infecting mycobacteria	2
unengulfed apoptotic macrophages	2
tuberculous granuloma	2
lysosomal storage	2
unengulfed cell debris	2
undigested lysosomal material	2
mutant macrophages	2
lysosomal cysteine cathepsins	2
hypersusceptible mutant	2
Mycobacterium marinum	2
K+-selective filter	2
one-way “check valve	2
inactive selectivity filter	2
high electric field	2
four ions	2
canonical voltage-sensing domain	2
SummaryTwo-pore domain (K2P)	2
histone H3R26-methylase CARM1	2
differentiation regulator Cdx2	2
extra-embryonic than pluripotent progeny	2
decreased Sox21	2
blastomeres of the 4-cell embryo	2
master pluripotency regulators Oct4 and Sox2	2
ensemble of coupled genetic oscillators	2
ordered macroscopic spatial arrangement of ePSM	2
several miniature emergent PSM structures (ePSM)	2
precursor of vertebrae	2
lipid microdomains	2
several pathogens	2
major molecule	2
microtubule minus ends	2
single microtubule	2
many dyneins	2
microdomains on the membrane of a phagosome	2
dynein motors	2
lipid membranes	2
DRN dopamine neurons	2
place avoidance	2
DA neurons in the dorsal raphe nucleus (DRN)	2
cellular substrate	2
dopamine (DA) neurons	2
distinct sub-populations	2
Nnat, Peg3, Cdkn1c, and Plagl1	2
imprinted gene network	2
isogenic animals	2
Trim28+/D9mutant mice	2
, “on/off” manner	2
non-Mendelian	2
Trim28-dependent network	2
monomeric lectins	2
oligomeric assembly	2
five-bladed lectin propellers	2
ancestral motifs	2
extant propellers	2
natural genomes	2
short propeller-like motifs	2
globular and symmetric fold group	2
β-propeller proteins	2
structurally distinct protein folds	2
molecular functions	2
3.8 Å resolution cryo-electron microscopy reconstruction	2
P pilus	2
secretion pore	2
nascent growing pilus	2
helical quaternary structure	2
long pilus rod	2
top	2
thin, short tip fibrillum	2
chaperone-usher pathway	2
pili	2
prototypical bacterial cell-surface appendages	2
1 and P pili	2
members of the SMC family	2
DNA sensor	2
cohesin ring	2
Wapl subunit	2
SMC head interface	2
DNA-sensing lysines	2
fission-yeast cohesin	2
pair of ATPase heads	2
two SMC subunits	2
proteinaceous rings	2
chromosome (SMC) complexes	2
tailored vesicles	2
membrane-proximal and membrane-distant faces	2
distinct hexagonal lattices	2
protein layer	2
Cellular electron cryo-tomography	2
coated vesicles	2
nuclear egress complex (NEC)	2
two viral proteins	2
capsid envelopment	2
progeny herpesvirus capsids	2
structural underpinning	2
large cargoes	2
lung and breast cancer	2
central redox-sensing transcription factor	2
Brf2 redox-sensing module	2
human Pol II and Pol III pre-initiation complexes	2
Brf2-dependent Pol III promoters	2
natural promoters	2
human Brf2-TBP complex	2
U6 spliceosomal RNA and selenocysteine tRNA genes	2
type III gene-external promoters	2
Brf2 recruits RNA polymerase (Pol) III	2
family of TFIIB-like core transcription factors	2
SummaryTFIIB-related factor 2 (Brf2)	2
article	2
luciferase and behavioral assays	2
various genotypes	2
calcium, calmodulin, and SOL protease	2
temperature input	2
corresponding author’s laboratory	2
critical circadian pacemaker proteins	2
animal circadian clocks	2
authors/editors	2
human populations of Eurasia	2
plague infection	2
bubonic plague	2
Yersinia pestis lineage	2
known Yersinia pestis	2
ancient plague strains	2
human teeth	2
Yersinia pestis	2
human pandemics	2
bacteria Yersinia pestis	2
intact NPCs	2
single molecule in-cell assays	2
FG-Nup	2
NTR	2
multiple, minimalistic, low-affinity binding motifs	2
rapidly fluctuating FG-Nup	2
nuclear magnetic resonance	2
disordered phenylalanine-glycine-rich nucleoporins (FG-Nups)	2
Ifnb mutant mice	2
neuronal homeostasis	2
familial Parkinson’s disease model	2
Recombinant IFN-β	2
senescent mitochondria	2
α-synucleinopathy	2
nigrostriatal region	2
α-synuclein-containing Lewy bodies	2
neurodegenerative disease-causing mutant proteins	2
cytokine interferon-β (IFN-β) signaling	2
a single Rpn12 α helix	2
nascent lid	2
final lid subunit, Rpn12	2
two large subcomplexes, the lid and base	2
26S proteasome complex	2
regulatory particles (RPs)	2
proteolytic core particle (CP)	2
short-lived eukaryotic proteins	2
many different biological contexts	2
core of lipid droplets	2
diet-derived linoleic acid	2
many types of macromolecules	2
droplets	2
niche glia	2
Lipid droplets	2
neuroblast proliferation	2
glial cell niche	2
specialized microenvironments	2
FAK inhibitors	2
small-molecule FAK kinase inhibitor, VS-4718	2
normal keratinocytes	2
cancerous squamous epithelial cells	2
FAK-expressing tumors	2
antigen-primed cytotoxic CD8+ T cell activity	2
chemokine/cytokine and ligand-receptor networks	2
nuclear-targeted FAK in squamous cell carcinoma (SCC) cells	2
SummaryFocal adhesion kinase (FAK)	2
cancer (Creixell et al., 2015 [this issue of Cell]	2
independent groups of residues	2
non-conserved residues	2
sparse networks	2
αC1, αC3, and APE-7 residues	2
several DoS	2
high-fidelity capability	2
SummaryProtein kinases	2
tumor-specific networks	2
functional NAMs	2
kinase-inactivating hotspots	2
phospho-threonine signaling	2
mutant molecular logic gates	2
kinome	2
appearance of kinases	2
PKD1 D665N	2
PKCγ M501I	2
several NAMs	2
global cancer genome repository	2
ovarian cancer cell lines	2
exomes and quantitative (phospho-)proteomes	2
computational platform (ReKINect)	2
COX inhibitors	2
human cutaneous melanoma biopsies	2
classic anti-cancer immune pathways	2
breast or colorectal cancer cells	2
NrasG12D melanoma	2
BrafV600E mouse melanoma cells	2
cyclooxygenases (COX) or prostaglandin E synthases	2
mutant BrafV600E mouse melanoma cells in an immunocompetent host	2
melanoma and other cancer cells	2
multiple cell-types	2
newly formed blood vessels	2
“tracks	2
polarized vasculature	2
macrophages within the bridge	2
migrating cords of Schwann cells	2
severed nerve	2
‘bridge’ of new tissue	2
fully cut nerve	2
circadian transcriptional axis	2
Zfhx3Sci/+SCN slices	2
SCN slices	2
motifs in the promoters of these neuropeptide genes	2
mutant ZFHX3	2
 neuropeptides	2
core clock genes	2
consensus AT motifs	2
predicted AT motifs	2
short circuit (Zfhx3Sci)	2
SCN transcription factor Zfhx3	2
pharmacological target	2
Ras-Erk-ETS pathway	2
highly specific inhibitor of Ras-Erk-ETS signaling	2
drug trametinib	2
E-twenty six (ETS) transcriptional repressor, Anterior open (Aop)	2
reduced insulin/IGF-1 (IIS) signaling	2
template duplex	2
Rad51 filament	2
stabilized, “open,” and flexible conformation	2
pre-synaptic filaments	2
RFS-1/RIP-1 binds	2
heterodimeric Rad51 paralog complex	2
critical mediators	2
early human germline transcriptional network	2
evolutionarily young and potentially hazardous retroelements	2
week 5–7 in vivo hPGCs	2
TET-mediated hydroxymethylation	2
DNA methylation pathways	2
unique gene regulatory network	2
naive pluripotency genes TFCP2L1 and KLF4	2
somatic specifiers	2
human primordial germ cells (hPGCs)	2
systemically share molecules	2
within distant tumors	2
malignant tumor cells	2
Cre-LoxP system	2
non-EV-receiving cells	2
heterogeneous populations of extracellular vesicles (EVs)	2
Pol II CTD S2P-specific manner	2
gene ends	2
downstream exons	2
serine 5 position (S5P)	2
cleaved upstream exon transcripts	2
associated RNA processing intermediates	2
active site of RNA polymerase II (Pol II)	2
Nascent RNA	2
mammalian chromatin (mNET-seq)	2
native elongating transcript sequencing technology	2
mechanotransducer	2
flowing actin networks	2
transient stress fiber	2
inter-cellular actin-clutch	2
inter-cellular adhesion	2
colliding actin networks	2
hemocytes in vivo	2
Drosophila hemocytes	2
embryonic tissues	2
human SERPINE1	2
progeny viruses	2
extracellular airway proteases	2
gene SERPINE1, encoding plasminogen activator inhibitor 1 (PAI-1)	2
virus (IAV) infection	2
late stages of influenza	2
individual ISG effectors	2
SummaryInterferon-stimulated genes (ISGs)	2
various adhesive and non-adhesive environments	2
biochemical or mechanical stimuli	2
Progenitor cells	2
Stable-bleb cells	2
almost all liver promoters	2
mammalian genomes	2
H3K4 trimethylation	2
noncoding regions of the genome	2
less fit cells	2
gene, azot	2
less fit cell population	2
SummaryViable yet damaged cells	2
mouse and human PGC specification	2
endodermal and other somatic genes	2
hPGC-like fate	2
CD38 cell-surface marker	2
germline seminoma	2
embryonic hPGCs	2
germline competent pluripotent stem cells	2
hPGC-like cells (hPGCLCs)	2
tractable experimental model	2
primary adult liver stem cells	2
in vivo pathology	2
Alagille syndrome patients	2
α1-antitrypsin deficiency and	2
functional hepatocytes in vitro	2
expanded cells	2
adult bile duct-derived bipotent progenitor cells	2
functional hepatocytes in vitro and in vivo	2
epithelial organoids in vitro	2
single mouse Lgr5+ liver stem cells	2
neurogenic RGPs	2
transcription factor transiently	2
deep and superficial layers	2
∼8–9 neurons	2
individual RGPs	2
Double Markers	2
nearly all neocortical neurons	2
glial progenitors (RGPs)	2
AUG codon	2
context nucleotides	2
regulatory domain of eIF2α, eIF1A, and ribosomal elements	2
entire mRNA cleft	2
N-terminal tail of eIF1A	2
codon-anticodon duplex	2
yeast preinitiation complex	2
stable conformation (PIN)	2
AUG start codon	2
scanning mRNA	2
P decoding site	2
ground-state pluripotency in human cells	2
functional control circuitry	2
conventional human pluripotent stem cells	2
ground-state transcription factors, TFCP2L1 or KLF4	2
teratomas in vivo	2
Reset cells	2
protein kinase C	2
elements of the network	2
mouse embryonic stem cells (ESC)	2
transcription factor circuitry	2
complex of eIF3, 40S, and the hepatitis C internal ribosomal entry site RNA	2
mammalian 43S preinitiation complex	2
translation initiation machinery	2
opposite ends of the mRNA channel	2
key initiation factors	2
Yeast eIF3	2
extended, modular arrangement of eIF3 subunits	2
40S⋅eIF1 complex	2
major components of the minimal, six-subunit Saccharomyces cerevisiae eIF3 core	2
large, multiprotein eIF3 complex	2
ambient light	2
locomotor-ciliated cells	2
vertebrate-type opsin-based phototransduction cascade	2
brain photoreceptors	2
marine annelid Platynereis dumerilii	2
zooplankton model	2
“hormone of darkness	2
nucleotide signaling molecules	2
bipartite RXD-X8-RXXD signature	2
c-di-GMP tetramer	2
C-terminal domains	2
two subunits of BldD	2
vegetative growth	2
 sporulation genes	2
sporulating actinomycete bacteria	2
transcription factor, BldD	2
cyclic dinucleotide c-di-GMP	2
ER-retained misfolded protein	2
ER-export receptors	2
export receptors	2
resident ER chaperones	2
misfolded glycosylphosphatidylinositol-anchored proteins	2
defective proteins	2
secreted polypeptide	2
Sec61 channel	2
idle and translating complexes	2
the exit tunnel	2
nascent polypeptide	2
A/P and P/E hybrid-state tRNAs	2
near-complete atomic model	2
ribosome-bound Sec61 channel	2
translating ribosome	2
Nascent polypeptides	2
piRNA precursors	2
canonical RNA polymerase II transcripts	2
long primary transcripts	2
robust in vitro model	2
noncanonical HCMV open reading frames	2
HCMV canonical genes	2
natural killer and T cell ligands	2
1,200 cell-surface proteins	2
>8,000 cellular proteins	2
Human cytomegalovirus (HCMV)	2
host and viral proteins	2
surprising PRC1-dependent logic	2
variant PCGF1/PRC1 complex	2
variant PRC1 complexes	2
polycomb domain	2
repressive chromatin domains	2
polycomb repressive complexes PRC1 and PRC2	2
first codon of the mRNA	2
elongation factor 2 (eEF2)	2
IRES	2
pretranslocation	2
decoding center of the A site of the 40S ribosomal subunit	2
pseudoknot PKI	2
ribosome of the yeast Kluyveromyces lactis	2
host initiation factors	2
viral mRNA	2
folded structure	2
SummaryThe cricket paralysis virus internal ribosome entry site (CrPV-IRES)	2
flexible ensemble	2
robustness module	2
endocytic-dependent routes	2
ectothermic animals	2
transcribed region of genes	2
genes and common fragile sites	2
breakpoints of lost regions	2
general elongation factor	2
RECQ family of helicases	2
root of the eukaryotic tree	2
 a distinct set of proteins	2
kinetoplastid genome	2
conventional kinetochore components	2
core kinetochore	2
macromolecular protein complex	2
embryo’s stem cells	2
completely revised model	2
similar polarized rosettes	2
extracellular matrix (ECM) proteins	2
rosette of polarized cells	2
amorphous epiblast	2
mouse blastocyst implants	2
cup-shaped epithelium	2
pluripotent epiblast cells	2
V. cholerae norspermidine biosynthetic pathway	2
planktonic growth	2
wild-type B. subtilis biofilms	2
biofilm exopolysaccharide	2
endogenous norspermidine	2
B. subtilis biofilm formation	2
equivalent of the Vibrio cholerae biosynthetic pathway	2
related polyamine norspermidine	2
polyamine spermidine	2
extracellular matrix of exopolysaccharide and protein	2
Bacillus subtilis biofilms	2
basic biology	2
midbodies, membrane-based structures	2
nondividing cells	2
isolated lipids	2
live dividing cells	2
specific chemical structures	2
vascular architecture	2
nutritional cues	2
specific tracheal subsets	2
local and systemic insulin- and VIP-like neuropeptides	2
distinct populations of nutrient- and oxygen-responsive neurons	2
mammalian blood vessels	2
network of oxygen-delivering tubules	2
Drosophila tracheal system	2
target-derived signals	2
nonimprinted genes	2
nonimprinted loci	2
nonimprinted candidate genes, Man1a2 and H2-ab1	2
outbred mice	2
simple circuit logic	2
electrical changeover switch	2
bidirectional switch	2
switch gene	2
third-order neurons	2
pheromone input	2
female-responsive cluster	2
male-responsive cluster	2
fruitless transcription factor	2
sex-specific wiring reroutes pheromone information	2
common input pathway	2
One cluster	2
two clusters of third-order olfactory neurons	2
in vivo whole-cell electrophysiology	2
circuits deeper	2
sex genes	2
second-order olfactory neurons	2
Drosophila sex pheromone cVA	2
Mutation carriers	2
commonly prescribed antidiabetic drug, metformin	2
Raf-MEK-ERK pathway	2
1,536 controls	2
2,101 individuals	2
intracellular scaffolding protein	2
suppressor of Ras 2 (KSR2)	2
single RIP module	2
second signaling protease, SpoIVB	2
PDZ-gated channel	2
self-compartmentalizing protease	2
minimal version	2
PDZ domains	2
tunnels	2
two narrow tunnels	2
ring-like protein scaffold	2
activating protease CtpB. Crystal structures	2
adult fat body	2
phosphorylated MEF2	2
distinct TATA box sequence	2
TATA binding protein	2
MEF2 changes	2
lipogenic and glycogenic enzymes	2
associated target genes and physiologies	2
underlying connections	2
many contexts	2
primordial autophagy activator	2
VAMP3-dependent heterotypic fusions	2
ATG16L1-containing vesicles	2
another source of autophagosome membrane	2
ATG16L1-containing vesicles	2
autophagic compartments	2
many sites	2
transmembrane autophagy protein	2
distinct membrane sources	2
TGF-β-Smad2/3 pathway	2
cell-cycle regulators cyclin D1–3	2
FUCCI reporter system	2
Rvbs	2
limited region of the nucleosome core particle	2
two independently assembled multisubunit modules	2
catalytic subunit Swr1	2
single heterohexameric Rvb1/Rvb2 ring	2
major functional components	2
AAA+ ATPases Rvb1 and Rvb2	2
different polypeptides	2
1 megadalton complex	2
histone-depleted regions	2
canonical H2A/H2B dimer	2
variant histone H2A.Z/H2B dimer	2
SummaryThe ATP-dependent chromatin-remodeling complex SWR1	2
SCN	2
Per1 and Sik1	2
coactivate CREB	2
salt inducible kinase 1 (SIK1) and CREB-regulated transcription coactivator 1 (CRTC1)	2
light-regulated transcriptome of the SCN	2
new time zone	2
individual cells of the suprachiasmatic nuclei (SCN)	2
Per genes	2
SummaryRetinal photoreceptors	2
nuclear surveillance machinery	2
subset of “lncRNA-like” mRNAs	2
Hrp1 and Nab2 proteins	2
transcriptome-wide targets	2
5′ caps and poly(A) tails	2
LncRNAs and mRNAs	2
heterogeneous ensemble of mRNAs and long noncoding RNAs (lncRNAs)	2
SummaryEukaryotic genomes	2
chromatin-remodeling enzymes	2
ancient DNA translocases	2
chromatin-remodeling ATPases	2
partner TFs	2
cobound TFs	2
combinatorial binding	2
bound sequence motifs	2
TF regions	2
TF binding locations	2
six rodents	2
tissue-specific TFs	2
previously mapped loci	2
Many of the rat loci	2
strain-specific selective sweeps and gene clusters	2
structural variants	2
respective control strains	2
inbred laboratory rat strains	2
continuous deubiquitination	2
cultured cells of degraded and nondegraded clients	2
viral-mediated degradation pathway	2
ubiquitin ligase complexes	2
synthesized membrane proteins	2
free ribosomes	2
healthy yeast cells	2
start of transcripts	2
slow codons	2
short genes	2
endogenous Saccharomyces cerevisiae genes	2
every ribosome, tRNA, and mRNA molecule	2
detailed snapshots	2
defined S1’ and S2 Ub-binding sites on the OTU domain	2
ubiquitinated sequence in the substrate	2
Additional Ub-binding domains	2
without Ub substrates	2
five crystal structures	2
unstudied atypical Ub chains	2
defined subset	2
human OTU enzymes	2
(Ub) chain linkage specific	2
Several OTU DUBs	2
ovarian tumor (OTU) family deubiquitinases (DUBs)	2
ubiquitinated RIPK1	2
LUBAC, TNFα, and poly(I:C)	2
Ub Glu16	2
catalytic triad of the protease	2
proximal Ub	2
Met1-specific Ub-binding sites	2
OTULIN catalytic domain	2
previously unannotated human DUB, OTULIN (also known as FAM105B)	2
dedicated DUB	2
Deubiquitinases (DUBs)	2
Met1-linked (also known as linear)	2
Ras superfamily members	2
canonical GTP/GDP switch	2
Rnd2, and geranylgeranylated Rap1A	2
farnesyl moiety	2
hydrophobic groove	2
phosphorylated, farnesylated Rnd3 peptide	2
Ser218 by ROCK and/or Ser210 by protein kinase C (PKC)	2
Ser240 phosphorylation site	2
both the Cys241-farnesyl moiety and a Rho-associated coiled coil containing protein kinase (ROCK)-dependent	2
C terminus of Rnd3	2
high-affinity 14-3-3-binding site	2
atypical constitutively GTP-bound Rho proteins	2
Rnd proteins	2
Several Rho GTPases	2
GTP- and GDP-bound states	2
miRNA-target binding	2
miRNA species	2
5′ contacts	2
bulged or mismatched nucleotides	2
5′ seed region	2
high-confidence miRNA-mRNA interactions	2
human AGO1	2
miRNA-target RNA duplexes	2
human miRNA targets	2
Flcn-Fnip1/2	2
ground-state pluripotency	2
cell-intrinsic rheostat	2
pluripotency circuitry	2
nuclear Tfe3	2
bHLH transcription factor Tfe3	2
Fnip1 and Fnip2	2
mammalian target of rapamycin (mTOR)	2
tumor suppressors Folliculin (Flcn) and Tsc2	2
large-scale small interfering RNA (siRNA) screen	2
neutrophils of endothelial cells	2
intravascular housekeepers	2
Tlr7host+/+BM−/− mice	2
neutrophil recruitment	2
Cx3cr1−/−mice	2
Nr4a1−/−, Itgal−/−, and Tlr7host−/−BM+/+	2
TLR7-dependent nucleic acid “danger” signal	2
kidney cortex	2
lumenal side	2
scavenge microparticles	2
Nr4a1-dependent Ly6Clow monocytes	2
protein assembly	2
protein complex assembly pathways	2
fully sequenced genomes	2
several heteromeric complexes	2
dietary restriction mimetic	2
worm methionine synthase (metr-1) and S-adenosylmethionine synthase (sams-1)	2
nematode predator/host	2
biguanide drug metformin	2
L1-mediated retrotransposition	2
candidate liver oncogene	2
Mdr2−/− mice	2
HCC nodules	2
L1	2
tumor-specific L1 insertion	2
oncogenic β-catenin/Wnt signaling	2
colorectal cancers (MCC)	2
4/19 (21.1%) donors	2
 hepatocellular carcinoma (HCC) genomes	2
New L1 insertions	2
SummaryLINE-1 (L1) retrotransposons are mobile genetic elements	2
constitutive particles	2
generation of peptides	2
26S constitutive and immunoproteasomes	2
intracellular inclusions	2
constitutive proteasomes	2
alternative forms of proteasomes	2
experimental ESC-heterokaryons	2
virtually all successfully reprogrammed somatic nuclei	2
somatic partner nuclei	2
heterokaryon and hybrid assays	2
centrifugal elutriation	2
genome-wide sentinel	2
previously suppressed Alu exons	2
many genuine and cryptic splice sites	2
splicing factor U2AF65	2
 the RNA-binding protein hnRNP C	2
Quantitative iCLIP	2
mature transcripts	2
transcribed regions	2
Hsp70 chaperones	2
Hsc70 T38	2
mitotic CDK Cdk1 phosphorylates T36	2
stress CDK Pho85 phosphorylates T36	2
the G1 cyclin Cln3	2
cochaperone and client interactions	2
Hsp70 proteins	2
cyclin-dependent kinase (CDK) consensus site	2
Ssa1 T36	2
Hsp70 chaperones Ssa1–4	2
Cell-cycle-regulated transcription	2
distinct subset	2
long, noncoding RNAs	2
integrated data set	2
 a eukaryote	2
first comprehensive reference	2
transcriptomes and proteomes in fission yeast	2
cellular functions and biological systems	2
α-kleisin	2
Smc1/3 interface	2
proposed entry gate	2
Smc3/α-kleisin interface	2
pericentric chromatin	2
α-kleisin’s N-terminal domain	2
Smc3’s nucleotide binding domain	2
cohesin complexes	2
cohesin on pericentric chromatin	2
cohesin’s Wapl subunit	2
α-kleisin subunits	2
cohesin’s Smc1, Smc3, and	2
male germ cell	2
lead compound	2
blood:testis boundary	2
new contraceptive	2
spermatocyte and round spermatid stages	2
JQ1-treated males	2
BRDT acetyl-lysine binding pocket	2
testis-specific member BRDT	2
selective small-molecule inhibitor (JQ1) of the bromodomain and extraterminal (BET) subfamily of epigenetic reader proteins	2
prolonged microtubule attachments	2
track-binding domain	2
detachment signal	2
dynein's ATPase domain	2
“clutch”	2
individual dynein motors	2
microtubule-binding stalk	2
dynein's AAA+ ring	2
main ATPase site	2
primary minus-end-directed microtubule motor	2
cytoplasmic dynein	2
lissencephaly protein Lis1	2
nuclear RNAi/chromatin pathway	2
two putative histone methyltransferases, SET-25 and SET-32	2
HP1 ortholog HPL-2	2
germline-specific nuclear Argonaute HRDE1/WAGO-9	2
core set of nuclear RNAi and chromatin factors	2
germline nuclear small RNA/chromatin pathway	2
APOBEC family of cytidine deaminases	2
cytosine at TpC dinucleotides	2
Regions of kataegis	2
BRCA1 or	2
appreciable mass	2
dominant subclone	2
long-lived, quiescent cell lineages	2
subclones	2
dominant subclonal lineage	2
Every tumor	2
fraction of tumor cells	2
many emerging late	2
narrative	2
disrupted cancer genes	2
commonly occurring endogenous nucleotide base lesion	2
key mammalian genome surveillance enzyme	2
single (or di-) ribonucleotides	2
RNase H2 null embryos	2
embedded ribonucleotides	2
Ribonuclease (RNase) H enzymes	2
ribonucleotides in genomic DNA	2
hypothalamic AMPK	2
thermogenic protein	2
key hypothalamic nuclei	2
mature BAT	2
source of cytotoxic species	2
stable oligomers	2
added soluble protein	2
cellular protective machinery	2
rat primary neurons	2
stable, more compact proteinase-K-resistant oligomers	2
initially formed oligomers	2
permissive chromatin context	2
RNA polymerase II promoter-proximal pausing	2
fewer bivalent domains	2
repressive histone modification H3K27me3	2
lineage-affiliated genes	2
2i-treated cells	2
inhibitors of two kinases (Mek and GSK3)	2
defined medium	2
common structural link	2
stabilizing structural cap	2
microtubule-end region	2
CH domain	2
exchangeable GTP-binding site	2
microtubule seam	2
Mal3 CH domain	2
end regions of growing microtubules	2
calponin homology (CH) domain of the fission yeast EB Mal3	2
pseudoatomic model	2
extended region	2
End-binding proteins (EBs) autonomously	2
cellular substructures	2
transient binding platforms	2
microtubule ends	2
folding chamber	2
potential docking site	2
kinetically trapped, misfolded substrates	2
binding surfaces	2
binding domains	2
polypeptide substrate	2
set of distinct GroEL-ATP conformations	2
GroES-capped, hydrophilic folding chamber	2
hydrophobic binding sites	2
substrate polypeptide	2
cochaperonin GroES	2
nascent or stress-denatured polypeptides	2
older cells	2
recently born cells	2
older hippocampal granule cells	2
synaptic output	2
emerging target family	2
diverse diacetyl-containing peptides	2
singly acetylated sequences	2
combinations of marks	2
new BRD substrates	2
systematic histone-peptide arrays	2
representative BRDs	2
BRD families	2
eight families	2
61 BRDs	2
ε-N-lysine acetylation motifs	2
protein interaction modules	2
SummaryBromodomains (BRDs)	2
Arf and Sar proteins	2
amphipathic helices per BAR domain	2
scaffolds of N-BAR domains	2
amphipathic helices	2
endophilin, amphiphysin, GRAF, and β2-centaurin	2
BAR-domain scaffolds	2
ENTH domain of epsin	2
crescent-shaped BAR scaffolds	2
parallel lineages	2
one geographical area	2
parasitic clonal lineage	2
104 geographically and temporally distributed Tasmanian devil tumors	2
devil cancer genome	2
female Tasmanian devil	2
two geographically distant subclones	2
Tasmanian devil genome	2
living cancer cells	2
largest marsupial carnivore	2
Tasmanian devil (Sarcophilus harrisii)	2
axonally synthesized lamin B	2
LB2-deficient axons	2
Axonal LB2	2
axons in vivo	2
lb2 mRNA	2
unexpected major target	2
intermediate filament protein lamin B2 (LB2)	2
proteome ofXenopus retinal ganglion cell (RGC) axons	2
unbiased screen	2
thousands of different transcripts	2
Polycomb repressors	2
protein RYBP	2
catalytic subunits of PRC1	2
 a complex	2
H3K27me3-independent pathway	2
wild-type and PRC2-deficient mouse embryonic stem cells (mESCs)	2
closely overlapping sites	2
histone H2A	2
associated monoubiquitylation	2
catalytic subunit of PRC1	2
second complex, PRC2	2
trimethyl histone H3K27 (H3K27me3)	2
chromodomain of the core protein Polycomb	2
SummaryPolycomb-repressive complex 1 (PRC1)	2
mammalian lineages	2
deeply conserved CTCF-binding regions	2
fossilized repeat elements	2
chromatin and transcriptional insulators	2
rodents, dogs, and opossum	2
six mammals	2
highly conserved, robust, and tissue-independent CTCF-binding locations	2
33/34-mer motif	2
CTCF-binding sites	2
DNA elements	2
SummaryCTCF-binding locations	2
downstream transcriptional network	2
systems modeling	2
Shh signaling	2
in vivo reporter	2
Sonic Hedgehog (Shh)	2
small R-SNAREs	2
endocytic clathrin-coated vesicles	2
R-SNAREs	2
R-SNARE endocytosis	2
SNARE interface	2
CALM	2
CALMANTH domain	2
N-terminal halves of their SNARE motifs	2
ubiquitously expressed, PtdIns4,5P2-binding, endocytic clathrin adaptor CALM/PICALM	2
plasma membrane and endosomes	2
R-SNAREs VAMP8, VAMP3, and VAMP2	2
correct membranes	2
partner SNAREs	2
the SNARE protein VAMP7	2
early Atg16L1 precursors	2
fully formed autophagosomes	2
endoplasmic reticulum and mitochondria	2
Inactive cognates of enzymes	2
intrinsic quality control machinery of the ER	2
potential rhomboid substrates	2
epidermal growth factor receptor pathway	2
these “pseudoproteases”	2
key catalytic residues	2
rhomboid intramembrane serine proteases	2
conserved subfamily of proteins	2
complex domain-domain interactions	2
transactivation domain	2
oligomerization domain of p63	2
phosphorylation-triggered tetramerization of TAp63α	2
inactive dimeric state	2
C-terminal transactivation inhibitory domain	2
undamaged oocytes	2
homolog of the p53 tumor suppressor	2
central hub of the cartwheel	2
coiled-coil rods	2
nine homodimers	2
C. reinhardtii	2
related protein Bld12p	2
C. elegans and human cells	2
rod-shaped homodimers	2
centriolar protein SAS-6	2
cilia, flagella, and centrosomes	2
ancient organelle	2
related basal body	2
uncouple neuroblasts	2
neuroblast growth	2
insulin/IGF receptor pathway	2
population of glial cells	2
nutrition-dependent signal	2
hitherto unknown pathway	2
Drosophila neural stem cells (neuroblasts)	2
cancer-causing lesion	2
bone cancers	2
many subtypes	2
stamp of chromothripsis	2
involved regions	2
sacculus growth	2
γ-proteobacteria	2
PBP-docking regions	2
LpoB-PBP1B complex	2
 the sacculus	2
new PG	2
cognate PBP	2
Lpo protein	2
major E. coli bifunctional PG synthases	2
PBP1B	2
LpoA and LpoB	2
OM lipoproteins	2
outside of the sacculus	2
inside the cell	2
Cytoskeletal elements	2
bacterial inner and outer membranes (OM)	2
mesh-like peptidoglycan (PG) sacculus	2
mouse gut	2
Crohn's disease susceptibility gene	2
TMDs of a particular organelle	2
post-ER organelles	2
early and late parts of the secretory pathway	2
different organelles	2
TMDs of proteins	2
fungi and vertebrates	2
bilayers	2
sequences of transmembrane domains (TMDs)	2
various membranes of eukaryotic cells	2
PtdIns4,5P2/cargo-containing membranes	2
two endocytic motif-binding sites	2
AP2's four PtdIns4,5P2-	2
 the previously unstructured μ2 linker	2
cargo-binding sites	2
orthogonal face of the complex	2
C-μ2	2
parts of β2	2
C-terminal domain of μ2 (C-μ2) and [ED]xxxL[LI] on σ2	2
two endocytic motifs	2
AP2's binding sites	2
“locked” cytosolic form	2
transmembrane protein cargo	2
endocytic clathrin scaffold	2
SummaryThe AP2 adaptor complex (α, β2, σ2, and μ2 subunits)	2
adherens junction	2
nonepithelial cells	2
aPKC targeting and specificity factor	2
apical/lateral border	2
adherens junction components apically	2
mislocalized Baz	2
Crumbs complex	2
Baz/aPKC interaction	2
apical aPKC domain	2
apical/lateral junction	2
PAR-6 and aPKC	2
SummaryBazooka (PAR-3)	2
RITS on centromeric transcripts	2
euchromatic locus	2
chromatin-modifying CLRC complex	2
RNAi effector Ago1	2
LIM domain protein, Stc1	2
transcript-bound RITS	2
H3K9 methylation	2
histone methyltransferase Clr4	2
CLRC complex	2
nascent homologous transcripts	2
Argonaute-containing RITS complex	2
Noncoding RNAs	2
centromeres, telomeres, and the mating type locus	2
kinase-dead Braf	2
Kinase-dead BRAF	2
oncogenic BRAF	2
CRAF activation, and MEK–ERK signaling	2
kinase-dead BRAF	2
bacterial ribosome	2
RelE and 16S	2
site codon bases	2
second nucleotide of the codon	2
programmed Thermus thermophilus 70S ribosomes	2
E. coli RelE	2
ribosome and mRNA	2
ribosome-dependent endonuclease, RelE.	2
dynamin family members	2
rat dynamin 1	2
GMPPNP and lipid	2
paddle region	2
GTPase effector domain (GED)	2
tube surface	2
BDLP GTPase domain	2
entire filament	2
BDLP crystal structure	2
lipid tube	2
bacterial dynamin-like protein (BDLP) helical filament	2
electron cryomicroscopy reconstruction	2
forcing regions	2
dynamin superfamily	2
nascent epiblast	2
dedifferentiated intermediates	2
pluripotent hybrids	2
embryonic and induced pluripotency	2
homeodomain protein Nanog	2
epiblast, founder tissue	2
zebrafish retinal neuroepithelial cells	2
embryonic vertebrate central nervous system	2
rapidly expanding epithelium	2
chromosome-engineered mouse model	2
neurons of mice	2
 a 5-HT2cR agonist	2
serotonin 2c receptor (5-HT2cR)	2
increased MBII52 snoRNA	2
mouse chromosome 7	2
conserved linkage group	2
human chromosome 15q11-13	2
dynein's structure	2
AAA2 and the stalk base	2
lever-like linker	2
stalk base	2
primary ATPase site (AAA1)	2
hexameric ring of AAA+ modules	2
heart of the motor	2
tagged and truncated Dictyostelium cytoplasmic dynein constructs	2
subdomains	2
six AAA+ modules	2
ring-like head	2
diverse microtubule-based motilities	2
phosphatome resource	2
“inhibitory wedge” model	2
“head-to-toe” dimerization model	2
catalytically inert protein phosphatases	2
four diverse catalytic loop (WPD) conformations	2
potential secondary substrate-binding pocket	2
classical PTP family	2
human PTP crystal structures	2
tyrosine phosphatases (PTPs)	2
p38δ-PKD pathway	2
p38δ-deficient islets	2
pivotal regulator	2
protein kinase D (PKD)	2
mitogen-activated protein kinase (MAPK)	2
insulin-producing pancreatic β cells	2
integrated structures	2
active Fes and Abl pro-oncogenic kinases	2
SH2 and catalytic domains	2
distinct SH2-kinase interface	2
SH2 domain of the active Abl kinase	2
cooperative SH2-kinase-substrate interactions	2
kinase αC helix	2
kinase N-terminal lobe	2
prototypic SH2-kinase unit of the human Fes tyrosine kinase	2
postfusion SNARE complex	2
longin domain	2
SNARE helix of VAMP7	2
cell's surface	2
clathrin adaptors	2
unstructured regions	2
folded VAMP7 longin domain	2
clathrin adaptor and ArfGAP	2
SNARE VAMP7	2
post-Golgi trafficking pathways	2
appropriate vesicles	2
target membrane	2
oskar mRNA complex	2
weakly polarized cytoskeleton	2
mRNA anteriorly	2
mago, barentsz, and Tropomyosin II mutants	2
living oocytes	2
oskar mRNA particles	2
anterior and lateral cortex	2
plus end-directed motor, kinesin	2
abdomen and germ cells	2
posterior of the Drosophila oocyte	2
GET complex	2
newly synthesized TA proteins	2
Get proteins	2
Get3-TA complexes	2
Get1/Get2 receptor	2
Get3-TA protein complexes	2
Get3 recognition	2
yeast homolog of the TA-interacting factor Asna1/Trc40	2
single C-terminal transmembrane domain (TMD)	2
SummaryTail-anchored (TA) proteins	2
pathogen secretion system	2
adhesin	2
parasite adhesin PfEMP1	2
novel trafficking machinery	2
infected host red cells	2
known and candidate oncogenes (Mmp13, Slamf6, and Rreb1) and tumor suppressors (Wwox and Arfrp2)	2
Notch1	2
genes like Flt3 	2
candidate tumor suppressor genes	2
Flt3, mmu-mir-106a-363, Smg6, and Ccnd3)	2
either p19ARF-deficient, p53-deficient or wild-type mice	2
20 genes	2
300 loci	2
10,806 retroviral insertion sites	2
p19ARFare tumor suppressors	2
particular cellular region	2
path of the compacted chromosomal DNA	2
independent replication forks	2
fixed replication factory	2
sister forks	2
DNA polymerase	2
Sister replisomes	2
initiation replisomes	2
genetic loci in live Escherichia coli	2
sister replication forks	2
fixed “replication factories	2
exposed N or C termini	2
polypeptide loops	2
large cavity	2
conserved coiled-coil arginines	2
greatly expanded cavity	2
packing	2
AAA+ domains	2
prominent coiled-coil domain	2
unusual arrangement of AAA+ modules	2
denatured proteins	2
homologs in bacteria and plants	2
various cellular activities) superfamily	2
yeast protein-remodeling factor of the AAA+ (ATPases	2
pro-α factor retrotranslocation	2
pro-α factor photocrosslinked derlin-1	2
putative retrotranslocation channel protein, derlin-1	2
19S regulatory particle of the 26S proteasome	2
PA700	2
cytosolic proteins	2
protein disulfide isomerase	2
lumenal proteins	2
nonglycosylated pro-α factor	2
dye-labeled substrates	2
cytosolic quenchers	2
selected cytosolic proteins	2
fluorescence-quenching agents	2
mammalian microsomes	2
one fluorescence-labeled ERAD substrate	2
SummarySecretory proteins	2
fat cells	2
three major sites	2
hypothalamus, the brain stem, and the autonomic nervous system	2
Numerous circulating peptides and steroids	2
olfactory input	2
specific subsets of PN axons	2
dendrites of single LH neurons	2
anterior-ventral LH	2
candidate pheromone-responsive PNs	2
posterior-dorsal LH	2
PN partners of ORNs from different sensillar groups	2
MB	2
PN inputs	2
several groups of LH neurons	2
 input PN channels	2
MB and LH	2
mushroom body (MB) and lateral horn (LH)	2
olfactory information	2
Uniglomerular projection neurons (PNs)	2
corresponding glomeruli	2
classes of olfactory receptor neurons (ORNs)	2
human homolog of Tuba1	2
existing mouse models	2
guanosine triphosphate (GTP) binding pocket of α-1 tubulin (Tuba1)	2
laminar architecture of the hippocampus and cortex	2
hyperactive N-ethyl-N-nitrosourea (ENU)-induced mouse mutant	2
abnormal lamination of brain structures	2
eosinophils and respiratory epithelium	2
blood in children	2
IL5RA and KCNH2.ConclusionNovel loci	2
approved or experimental drugs	2
Several implicated genes	2
many asthma-associated CpGs	2
Functional annotation	2
asthma-relevant immune processes	2
nasal respiratory epithelium	2
179 CpGs	2
9 cohorts, 631 cases	2
35 regions	2
8 cohorts, 668 cases	2
prospective analyses	2
school-age asthma	2
Pregnancy And Childhood Epigenetics consortium	2
cross-sectional studies	2
relevant studies	2
Global Health	2
persistent wheezers	2
derived phenotypes	2
current wheeze	2
3167 participants	2
multigenerational human cohorts	2
experimental animal models	2
prior exposures	2
previous generations	2
parental generation	2
utero exposures	2
early life	2
unparalleled resource	2
IL36RN disease alleles	2
GPP (0.19) and ACH (0.16;	2
patients with PPP (0.03)	2
AP1S3 alleles	2
473 cases	2
multiple diagnoses	2
extended patient cohort	2
acute systemic (generalized pustular psoriasis [GPP]) or chronic localized (palmoplantar pustulosis [PPP] and acrodermatitis continua of Hallopeau [ACH]) presentation	2
concurrent psoriasis vulgaris	2
neutrophil-filled pustules	2
EP2/EP4 signaling	2
IL-23/TH17 pathway	2
human psoriatic skin biopsy specimens	2
IL-17A+ and IL-17A+IFN-γ+ pathogenic Th17 cells	2
EP2 and EP4	2
various inflammation-related genes	2
nuclear factor κ light chain enhancer of activated B cells (NF-κB)	2
signal transducer and activator of transcription (STAT) 3, cAMP-responsive element binding protein 1	2
IL-23 receptor subunit gene, Il23r	2
PGE receptors EP2 and EP4 in these cells	2
encoding COX2 in TH17 cells	2
psoriatic skin	2
mouse TH17 cells in culture	2
IL-23–driven pathogenic TH17 cells	2
pathogenic IL-17–producing helper T (TH17) cells	2
patients with PGA	2
inhaled corticosteroids	2
improved biomarkers	2
cohorts of studies	2
induced sputum cell counts	2
patients with stable asthma	2
neutrophils in sputum or blood	2
mixed granulocytic asthma, and paucigranulocytic asthma (PGA)	2
neutrophilic asthma	2
LRR-LRR interface	2
inflammasome activation	2
/p	2
LRR domain of NLRC4	2
LRR-LRR oligomerization	2
L1012, and p.	2
D1011, p.	2
D1010, p.	2
One key set of residues (p.	2
opposing LRR domain of the oligomer	2
2 interfaces	2
p.W655	2
NLRC4 cDNA	2
either wild-type or mutant	2
THP-1 cells	2
lentiviral transduction	2
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 techniques	2
apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) specks	2
G1965C, p.W655C)	2
leucine-rich repeat (LRR) domain of NLRC4	2
NOD-like receptor family CARD-containing 4 protein (NLRC4).ObjectiveHere	2
inflammasome-forming proteins	2
phyla Actinobacteria and Firmicutes	2
type 1 mediators (CXCL10, CXCL11, and IFN-γ)	2
Cluster 3	2
bacterial phylum Bacteroidetes	2
type 2 mediators (IL-5, IL-13, CCL13, CCL17, and CCL26)	2
Cluster 2	2
bacterial phylum Proteobacteria	2
proinflammatory mediators (IL-1β, IL-6, IL-6 receptor, TNF-α, TNF receptors 1 and 2, and vascular endothelial growth factor)	2
Three exacerbation biologic clusters	2
microbiome communities	2
panel of sputum mediators	2
Biologic clusters	2
Sputum mediators	2
moderate-to-severe COPD	2
asthma and COPD exacerbations	2
in vivo lymphoma model	2
healthy donor cytotoxic T lymphocytes	2
gene-corrected cytotoxic T lymphocytes	2
T follicular helper cell function	2
Gene-corrected T cells	2
NP-specific antibody responses	2
gene-modified T cells	2
in vivo lymphoblastoid cell line lymphoma xenograft model	2
in vitro cytotoxicity and T follicular helper cell function assays	2
equivalent lentiviral SAP vector	2
CD3+ cells	2
T-dependent antigen 4-hydroxy-3-nitrophenylacetly chicken gammaglobulin (NP-CGG)	2
sublethally irradiated Sap-deficient recipients	2
gammaretroviral vector encoding human SAP cDNA	2
+ lymphocytes	2
SAP gene–corrected T cells	2
good donor match	2
hemophagocytic lymphohistiocytosis	2
cell–dependent humoral function	2
T, natural killer (NK), and NKT cells	2
SH2D1A gene encoding SLAM-associated protein (SAP)	2
subepithelial cells expressing interferon/PRRs	2
IFN-α/β–expressing monocytes/macrophages	2
subepithelial interferon/PRR-expressing inflammatory cells	2
epithelial and subepithelial PRR expression	2
bronchial subepithelial monocytes/macrophages expressing IFN-α/β	2
nonasthmatic nonatopic control subjects	2
atopic asthmatic patients	2
Toll-like receptor 3, melanoma differentiation–associated gene 5, and retinoic acid–inducible protein I	2
PRRs	2
IFN-α, IFN-β	2
atopic asthmatic patients and control subjects	2
bronchial mucosal type I interferon and PRR expression	2
basophils and MCs	2
5 clusters	2
component-resolved diagnostics and basophil activation tests	2
MAT	2
peanut-sensitized subjects	2
prostaglandin D2 and β-hexosaminidase release)	2
surface activation markers (CD63 and CD107a)	2
allergen-specific and dose-dependent degranulation	2
sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy	2
blood-derived MCs	2
cohort of peanut-sensitized subjects	2
existing diagnostic tools	2
patients' sera	2
peripheral blood precursors	2
mast cell activation test (MAT).MethodsPrimary human blood-derived mast cells (MCs)	2
novel diagnostic tool	2
immunoglobulin-producing B cells	2
clinically affected cases	2
disease-causing variant	2
increased CD21low B-cell population	2
certain pedigrees	2
sporadic and familial cases	2
common variable immunodeficiency (CVID) cases	2
novel heterozygous truncating, missense, and gene deletion variants	2
subunit 1 (NFKB1)	2
principally sporadic unrelated PID cases	2
predominantly European study population	2
Rare Diseases cohort	2
NIHR BioResource–	2
diagnostic and prognostic biomarkers	2
multiple allergen components	2
grass/cat cluster	2
dust mite cluster	2
“Profilin”	2
“PR-10	2
“PR-10/profilin”	2
Cat” cluster and	2
new clusters	2
“Grass/cat” cluster	2
additional grass components	2
single-component “Grass” cluster	2
Dust mite” cluster	2
Broad” cluster	2
1 sensitization cluster	2
112 components	2
allergenic proteins (components)	2
uncleared dying eosinophils	2
aerosolized methacholine	2
Mer-deficient mice	2
apoptotic human and mouse eosinophils	2
eosinophil apoptosis	2
Fluorescently labeled apoptotic cells	2
apoptotic eosinophils	2
bone marrow macrophages	2
receptor tyrosine kinase Mer	2
important family	2
significant computationally accessible resource	2
established signaling pathways	2
known human interleukins	2
complete set	2
classification	2
Neo4J graph database	2
REpresentational State Transfer (REST)-based content service	2
Reactome content	2
human-readable reports	2
Pathway diagrams and analytic result displays	2
custom user data sets	2
Protein-protein and compound-protein interactions	2
Reactome pathways	2
overlay	2
analytic tools	2
2,179 pathways	2
New content	2
associated Web site	2
interactive diagrams	2
editorial staff	2
Reactome curators	2
expert biologists	2
supporting software	2
entire database	2
downloadable data sets	2
pathway diagrams	2
formal and open data structure	2
interconnected molecular events	2
human biological pathways	2
freely accessible knowledge base	2
expert reader	2
incomplete stylized representations	2
human CD8 T cells	2
Patients' cells	2
wild-type CD8 T cells	2
Prf−/− gene–corrected CD8 T cells	2
Prf−/− mice	2
PRF1-encoding lentiviral vector	2
One patient sample	2
gene-corrected and uncorrected mice	2
epitope–transfected murine lung carcinoma cell tumor model	2
Prf−/− mouse model	2
murine CD8 T cells	2
gammaretroviral vector	2
autologous gene-corrected T cells	2
various organs	2
perforin 1 (PRF1) gene	2
patients with CHS	2
large lytic granules	2
subsynaptic actin	2
LYST-deficient NK cells	2
cell-cell contact site	2
actin meshwork openings	2
endolysosomal compartments	2
enlarged lytic granules	2
human NK cell line, NK92mi	2
normal and LYST-deficient NK cells	2
F-actin and lytic granules	2
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology	2
human cell model of CHS	2
patients with CHS.MethodsWe	2
cytotoxic lymphocytes	2
lysosome-related organelles	2
giant lysosomes	2
lysosomal trafficking regulator gene (LYST)	2
cutaneous responses	2
IL-6 and TNF-α	2
oral small-molecule p38 mitogen-activated protein kinase inhibitor (Losmapimod; GlaxoSmithKline, Brentford, United Kingdom)	2
old subjects	2
p38 mitogen-activated protein kinase–related proinflammatory cytokine production	2
young subjects	2
young (<40 years) and old (>65 years) subjects	2
challenge site	2
skin biopsy specimens	2
intradermal VZV antigen injection	2
VZV antigen challenge system	2
blood leukocytes	2
varicella zoster virus (VZV)	2
Pseudomonas aeruginosa growth	2
Airway samples	2
nasal lavage fluid, sputum, and bronchoalveolar lavage fluid	2
2 population-based cohorts	2
mid-onset-resolving AD	2
prevalent class	2
2 cohorts	2
latent classes	2
established AD-genetic risk variants	2
typical itchy and/or flexural rash	2
Netherlands (PIAMA)	2
IRF8-regulated transcripts	2
Cell-specific gene expression	2
fewer memory cells	2
TH1, TH17, and CD8+ memory T-cell differentiation	2
blood, dermis, and lung lavage fluid	2
BATF/JUN interactions	2
Ets/IRF composite element or interferon-stimulated response element	2
neither mutant	2
BXH2 IRF8-deficient mouse	2
antigen receptor profiling	2
IRF8 alleles	2
granuloproliferation, and intracerebral calcification	2
compound heterozygous R83C	2
interferon regulatory factor 8 (IRF8)	2
fungal and bacterial microbiota	2
3-month stool samples	2
fecal short-chain fatty acids acetate and caproate	2
carbohydrate and taurine metabolism	2
several fungal taxa	2
different bacterial taxa	2
Ecuadorian babies	2
Canadian infants	2
fecal short-chain fatty acids	2
Genes and Genomes ontology	2
Kyoto Encyclopedia	2
Bacterial metagenomes	2
16S and 18S sequencing	2
bacterial and eukaryotic gut microbiota	2
rural Ecuador	2
nonindustrialized setting	2
distinct developing world environment	2
mice and Canadian infants	2
specific prebiotics	2
partially hydrolyzed protein infant formula	2
Eubacterium and Anaerostipes species	2
lactate-utilizing bacteria	2
first 26 weeks	2
bacterial genera of Enterobacteriaceae and Parabacteroides species	2
standard cow's milk formula	2
infants receiving partially hydrolyzed protein formula	2
fecal microbiota	2
partially hydrolyzed protein formula	2
138 infants	2
susceptible subjects	2
guinea pig and human sensory nerves	2
urban air pollution	2
transient receptor potential ankyrin-1 on nociceptive C-fibers	2
aryl hydrocarbon receptor	2
major constituents of DEPs	2
Polycyclic aromatic hydrocarbons	2
transient receptor potential ankyrin-1 antagonist	2
guinea pig and human vagus	2
cleaned particles	2
organic extract (DEP-OE)	2
DEPs activated airway C-fibers	2
anesthetized guinea pigs	2
DEP and airway C-fiber afferents	2
human vagus	2
airway sensory afferents	2
airway afferents	2
DEP exposure	2
vagal afferent nerves	2
Respiratory reflexes	2
Europe's largest cities	2
exhaust particles (DEPs)	2
patients with severe COPD	2
soluble sputum	2
sputum NETs	2
sputum NET complexes	2
Ex vivo airway	2
Haemophilus species operational taxonomic units	2
sputum microbiome	2
soluble sputum and serum from patients with COPD	2
neutrophil biomarkers	2
cell-free DNA	2
protein complexes (DNA-elastase and histone-elastase complexes)	2
extracellular traps (NETs)	2
AD trials	2
validated AD severity instruments	2
Well-controlled weeks (WCWs)	2
atopic dermatitis (AD)	2
inhibitory and activating signals	2
cells of the immune system	2
many different soluble and cell-surface molecules	2
wide variety of viral, bacterial, and nonmicrobial (toxins and irritants) agents	2
array of sensors	2
tissue-resident immune cells	2
ions and macromolecules	2
mucociliary apparatus	2
inhaled air	2
patients with cDGS	2
Autoimmune regulator expression	2
transplanted tissue	2
prophylactic antimicrobials	2
acquired later	2
pre-existing infections	2
 T cells)	2
106/L)	2
One infant	2
autoimmune thrombocytopenia	2
allogeneic cultured thymus	2
athymic complete DiGeorge syndrome (cDGS).MethodsTwelve patients	2
epidermal proteome and transcriptome	2
clinically active AE skin	2
lesional biopsy specimens	2
KLK7 (1.8-fold) and PPIA (0.65-fold) proteins	2
protease activity	2
Molecular pathways	2
shNT/shFLG LSEs	2
A (PPIA; 0.9-fold), and cofilin-1 (CFL1, 1.3-fold)	2
kallikrein-7 (KLK7; 2.2-fold)	2
differentially expressed proteins	2
normal and AE skin biopsy specimens	2
independent LSE samples	2
key targets	2
(nontargeting control short hairpin RNA [shNT]) and FLG knockdown (FLG knockdown short hairpin RNA [shFLG])	2
paired control	2
AE.MethodsDifferentially expressed proteins	2
skin of patients	2
–equivalent (LSE) models	2
living skin	2
human epidermal	2
key epidermal barrier protein	2
filaggrin (FLG)	2
human anaphylaxis	2
venom allergy	2
Hymenoptera allergy	2
134 patients	2
CCL2, CCL5, CCL11, IL-3, and thymic stromal lymphopoietin)	2
whole-blood FCER1A, carboxypeptidase A3 (CPA3), and L-histidine decarboxylase (HDC) gene expression	2
basophil activation markers (CD63 and CD203c)	2
Hymenoptera venom	2
31 patients	2
emergency department study	2
early-life vaccines	2
agonist–encapsulating polymersomes	2
TLR8 agonist–adjuvanted Ag85B peptide 25 formulation	2
TLR8 agonist polymersomes	2
neonatal DCs	2
alum-adjuvanted vaccines	2
humanized TLR8 neonatal mice	2
TLR8 agonist adjuvanted antigen 85B (Ag85B)/peptide 25–loaded BCG-mimicking nanoparticle formulation	2
live attenuated BCG vaccine	2
conventional adjuvants and licensed vaccines	2
TLR8 agonist–encapsulating polymersome formulations	2
–derived DCs	2
neonatal human monocyte-derived DCs and humanized TLR8 mouse bone marrow	2
range of TLR8 agonist–encapsulating polymersome formulations	2
murine DCs in vivo	2
amphiphilic block copolymers	2
similar but morphologically distinct nanocarriers	2
TLR8 agonist	2
polymer nanocarriers	2
rational engineering and age- and species-specific modeling	2
newborn DCs	2
ObjectiveSmall-molecule imidazoquinoline Toll-like receptor (TLR) 8 agonists	2
age-specific vaccine formulations	2
Targeting newborn dendritic cells (DCs)	2
distinct immune responses	2
ILC2 activators	2
receptors for IL-33 and IL-25.ConclusionCysLTs, particularly LTE4	2
LTE4 and epithelial cytokines	2
CysLT1 antagonist	2
type 2 and other proinflammatory cytokines	2
IL-25, IL-33, and TSLP	2
human ILC2s in vitro	2
LT receptor CysLT1	2
human mast cell supernatants	2
endogenous cysLTs	2
flow cytometric assays	2
chemotaxis, apoptosis, ELISA, Luminex, quantitative RT-PCR	2
PGD2, IL-33, IL-25, TSLP, and IL-2 alone or in combination	2
fresh blood	2
ILC2 stimulators	2
Cysteinyl leukotrienes (cysLTs), including leukotriene (LT) C4, LTD4, and LTE4	2
Epithelial cytokines (IL-33, IL-25, and thymic stromal lymphopoietin [TSLP]) and mast cell mediators (prostaglandin D2 [PGD2])	2
common clinical AD phenotypes	2
first switch	2
key network motif	2
concatenated bistable switches	2
“double switch	2
multiscale mathematical model	2
biological, microbial, physical, and chemical environmental stressors	2
novel and potentially treatable signaling axis	2
short hairpin RNA knockdown keratinocytes	2
Skin of CTSH-deficient mice	2
protease CTSH	2
keratinocyte cell cultures	2
protease cathepsin H (CTSH)	2
V-Akt murine thymoma viral oncogene homolog 1 (AKT1)	2
mechanistic target of rapamycin complex 1/2 protein subunit regulatory associated protein of the MTOR complex 1 (RAPTOR)	2
skin's barrier	2
 basic scientists, clinicians, data analysts, and epidemiologists	2
carefully characterized birth and patient cohorts	2
health care data	2
panacea	2
“big data	2
TH2 surface marker CRTH2	2
control arm	2
symptom-free days	2
intradermal treatment group	2
treatment arms	2
Skin biopsy specimens	2
histamine control	2
Phl p 5 major allergen)	2
induced allergic rhinitis	2
grass pollen–	2
allergic rhinitis	2
primary bronchial epithelial cells	2
submucosa and epithelium in children with STRA	2
IL-17RA–positive cells	2
Submucosal and epithelial IL-17A–positive cells and BAL	2
Submucosal neutrophils	2
maintenance inhaled steroids	2
Neutrophilhigh patients	2
increased intraepithelial neutrophils	2
without budesonide	2
Primary bronchial epithelial cells	2
BAL and biopsies	2
IL-17A and IL-22	2
Neutrophils, IL-17A, and IL-17RA–expressing cells	2
endobronchial brushings	2
bronchoalveolar lavage (BAL)	2
controls without asthma	2
miR-155/LXR pathway	2
epigenetic LXRα target	2
IPF and miR-155−/− fibroblasts	2
lung fibroblasts and macrophages	2
miR-155 target gene the liver X receptor (LXR)α	2
alternatively activated macrophages	2
loss-and-gain of function assays	2
mouse lung fibroblasts and macrophages	2
collagen, and profibrotic gene expression	2
wild-type and miR-155−/− mice	2
murine lung macrophages and fibroblasts, IPF lung fibroblasts	2
novel pathogenic pathways	2
SEEs in SEE–anti-SEE IgE-FcεRI complexes	2
CDRs and framework regions	2
“superantibodies”	2
anti-SEE IgEs	2
Anti-SEE IgG1s	2
framework regions of anti-SEE IgE in anti-SEE IgE-FcεRI complexes	2
anti-SEE.ConclusionsSEEs	2
IgG1 or antigen-binding fragments of each anti-SEE	2
SEE-induced basophil degranulation	2
anti-SEE	2
nonoverlapping epitopes	2
anti-SEE antibodies	2
2 each for SEA, SED, and SEE	2
anti-SAE clones	2
-seven SAE-specific, IgG- or IgA-expressing B cells	2
basophil degranulation assays	2
IgE and antigen-binding fragments	2
specific SAEs	2
“matched” heavy and light chains	2
single SAE-specific B cells	2
staphylococcal enterotoxin (SE) A, SED, and SEE	2
complementarity-determining regions (CDRs) or framework regions	2
anti-SAEs	2
nearly all patients	2
chronic rhinosinusitis	2
IgE antibodies against Staphylococcus aureus enterotoxins (SAEs)	2
key pathways	2
asthma susceptibility gene	2
endoplasmic reticulum–associated degradation pathway	2
activating transcription factor 6–mediated arm	2
airway eosinophilia	2
airway epithelial cells of Ormdl3 knockout mice	2
adeno-associated viral vector	2
fungal aeroallergen Alternaria alternata	2
Ormdl3-deficient mouse	2
ORM (yeast)-like protein isoform 3 (ORMDL3) gene locus on human chromosome 17q	2
skin immunity	2
12-month-old infants	2
infants affected	2
antecubital fossa	2
affected skin	2
patients and control subjects	2
noticeably dysbiotic communities	2
infantile AD	2
randomly selected control infants	2
antecubital and popliteal fossae, nasal tip, and cheek	2
skin sites	2
longitudinal birth cohort	2
50 children	2
Staphylococcus aureus dominance	2
low-diversity skin microbiota	2
helminth infection	2
selective PI3Kδ inhibitors	2
Thoracic imaging	2
developing murine central nervous system	2
herpesvirus infections	2
nonneoplastic lymphoproliferation	2
patients with APDS.ResultsRecurrent sinopulmonary infections	2
radiology, histopathology	2
large genetically defined international cohort	2
gene encoding the catalytic subunit of phosphoinositide 3-kinase δ (PI3Kδ).ObjectiveWe	2
BackgroundActivated phosphoinositide	2
particulate inhalation	2
phagocytic killing	2
pneumococcal nasopharyngeal carriage	2
bacterial autolysis	2
key pneumococcal toxin pneumolysin	2
Sahel region of Niger	2
Sahel region of West Africa	2
DC-derived Ccl24 production	2
HDM-pulsed Map3k8−/−DCs	2
T cells, B cells, or LysM+ cells	2
IL-4, IL-5, IL-13, and IgE production	2
dendritic cell (DC) transcripts	2
IgE, type 2 cytokines	2
Flow cytometry and quantitative PCR	2
lung sections	2
bronchoalveolar lavage fluid	2
adoptive transfer models	2
conditional knockout mice	2
Mixed bone marrow chimeras	2
wild-type and Map3k8−/−mice	2
Toll-like receptor, TNFR1, and IL-1R stimulation	2
MEK1/2-extracellular-signal regulated kinase 1/2 MAP kinase signaling pathway	2
(TPL-2) (COT, MAP3K8) kinase	2
molecular and cellular pathways	2
Targeting PVT1	2
lncRNA	2
corticosteroid-insensitive severe asthma	2
corticosteroid-sensitive nonsevere asthma	2
one lncRNA (PVT1)	2
lncRNA expression	2
primary ASMCs	2
lncRNA plasmacytoma variant translocation 1 (PVT1)	2
relevant biological pathways	2
mRNA and lncRNA expression	2
changed expression	2
healthy primary airway smooth muscle cells (ASMCs)	2
T-cell receptor activation	2
PTEN-PHLPP phosphatase network	2
T- and B-cell immunity	2
phosphatase network	2
normal human Treg cells	2
phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)	2
FOXP3+ T cells	2
blood and intestine	2
T- and B-cell subsets	2
peripheral lymphoid hyperplasia	2
forkhead box P3 (	2
3-kinase (PI3K) pathway	2
phosphatase and tensin homolog deleted on chromosome 10 (PTEN)	2
DEP+HDM-exposed Rag2−/− mice	2
combined DEP+HDM	2
DEP+HDM-exposed mice	2
functional ILC2s and TH2 cells	2
sole DEPs	2
bronchoalveolar lavage fluid and lung tissue	2
saline, DEPs, or house dust mite (HDM)	2
Rag) 2−/− mice	2
-type, Gata-3+/nlslacZ (Gata-3–haploinsufficient), RAR-related orphan receptor α (RORα)fl/flIL7RCre (ILC2-deficient), and recombination-activating gene (	2
components and pathways	2
diesel exhaust particles (DEPs)	2
newly identified type 2 innate lymphoid cells (ILC2s)	2
multiple pathogenic strains of RSV	2
RSV-induced IL-13–producing ILC2 response	2
2 additional RSV clinical isolates	2
airway mucus	2
RSV strain 01/2-20	2
MethodsWild-type (WT) BALB/c, thymic stromal lymphopoietin receptor (TSLPR) knockout (KO), or WT mice receiving an anti-TSLP neutralizing antibody	2
clearest target group	2
childhood–onset wheezing	2
remitting wheeze	2
continuous wheeze	2
12,303 participants	2
COPD and asthma subgrouped	2
49)	2
equivalent mothers	2
evaluable EIG participants	2
every comparison	2
every food	2
every food in the EIG	2
thousand three hundred three infants	2
cow's milk, peanut, hard-boiled hen's egg, sesame, whitefish (cod), and wheat	2
early introduction group (EIG)	2
exclusively breast-fed infants	2
mature Langerhans cells in nonlesional skin	2
monocyte-derived dendritic cells	2
epidermal CD83+ Langerhans cells	2
cis- and trans-UCA	2
Monocyte-derived dendritic cells	2
nonlesional skin	2
filaggrin breakdown product	2
cis isomer of urocanic acid (UCA)	2
subjects with and without AD	2
FLG-null alleles	2
epidermal structural protein	2
neutrophilic inflammation	2
clinicopathobiologic clusters	2
2 distinct cohorts	2
myeloperoxidase, IL-8, IL-6, and IL-6 soluble receptor	2
intricately connected inflammatory pathways	2
severe particularly eosinophilic forms	2
mixed granulocytic	2
geographic cohorts	2
6 clinicopathobiologic clusters	2
3–like protein 1 (YKL-40) and matrix metalloproteinase (MMP)	2
sputum chitinase	2
2 separate centers	2
ninety-four asthmatic patients	2
clinicopathologic endotypes	2
 patients	2
+ polyp T cells	2
peripheral blood T cells	2
TH17-related genes	2
healthy nasal mucosal and polyp populations	2
Abundant IL-17–producing T cells	2
common antigen	2
different subjects	2
several identical T-cell receptor variable β-chain complementarity-determining region 3 sequences	2
polyp–derived TH2 cells coexpressed ST2 (IL-33 receptor)	2
IL-17RB+CD4+	2
healthy nasal mucosa	2
nasal polyp tissue	2
receptor (IL-17RB)–expressing TH2 effector cells	2
immunoSEQ assay	2
T-cell receptor variable β-chain analysis	2
/intracellular cytokines	2
short-term explant model	2
Control nasal biopsy specimens	2
patients undergoing nasal polypectomy	2
patients with CRSwNP.MethodsPolyp tissue	2
IL-25/IL-33 axis	2
IL-5 and IL-13	2
Type 2 innate lymphoid cells	2
house dust mite and cat	2
laboratory equipment	2
25 centers	2
3206 adults	2
common aeroallergens (house dust mite, cat, and grass)	2
serum specific IgE	2
cohort of European adults	2
-sectional studies	2
house dust mites and perennial allergens	2
wheeze in early childhood	2
geohelminth parasites	2
maternal ascariasis	2
mite and other perennial allergens	2
Maternal stool samples	2
rural district	2
cohort of 2404 neonates	2
wheeze, and atopy	2
geohelminth infections	2
type 2 innate lymphoid cells in the skin	2
IL-5–producing type 2 innate lymphoid cells	2
BALB/c background	2
ResultsFilaggrin-deficient mice	2
Independently recruited AD case collections	2
proallergic BALB/c background	2
aberrant immunologic milieu	2
different HLA alleles	2
individual mechanisms	2
in vivo evidence	2
in vitro findings	2
T-cell receptors (the pharmacologic interaction hypothesis)	2
HLA-B*15:02	2
carbamazepine-induced Stevens-Johnson syndrome	2
HLA-B*57:01	2
abacavir hypersensitivity	2
health care and industry	2
 desmosomal proteins	2
DSG1 and DSP	2
desmoplakin polypeptide	2
amino acid substitution p.His586Pro	2
desmoplakin gene (DSP)	2
patient and his parents	2
desmosomal and other skin structural genes	2
Whole-exome sequencing data	2
rare genodermatosis	2
desmoglein 1 gene (DSG1)	2
metabolic wasting	2
multiple allergies	2
BackgroundSevere dermatitis	2
heterozygous and wild-type patients	2
homozygous/compound heterozygous FLG patients	2
corneodesmosin abundantly	2
all, VPs	2
anti-corneodesmosin antibody	2
investigated corneocyte area	2
15 children	2
patients with AD.MethodsWe	2
filaggrin breakdown products (natural moisturizing factor [NMF])	2
FLG genotype	2
prominent villus-like projections (VP)	2
food allergies and eczema herpeticum	2
multiple allergens	2
11-year-old children	2
different protein families	2
allergen components	2
1.38-4.61).ConclusionsLatent variable modeling	2
biological source	2
nonhomologous proteins	2
different biological sources	2
12 protein families	2
components of plant, animal, and fungal origin	2
3 protein families	2
components of mite allergens	2
plant protein families	2
27 components	2
3 component groups (CG1, CG2, and CG3	2
61 allergen components	2
multiplex array (Immuno Solid-phase Allergen Chip)	2
112 allergen components	2
asthma, eczema, and hay fever	2
broad range of allergen components	2
recognized allergen components	2
expanded IgE repertoire	2
certain allergen components	2
children without asthma	2
nDer p 1,	2
certain HDM allergens	2
panel of 7 HDM allergens (nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer	2
nonatopic nonasthmatic children	2
n = 53)	2
HDM allergy (	2
clinically well-characterized asthmatic children	2
nonasthmatic atopic children	2
children with allergic asthma	2
comprehensive panel of HDM allergens	2
dust mites (HDMs)	2
ASM cell proliferation	2
TGF-β–	2
healthy nonsmokers and patients with COPD	2
Healthy smokers	2
mitochondria-targeted antioxidant MitoQ	2
mitochondrial complex I, III, and V expression	2
mitochondria-targeted antioxidant MitoQ.ResultsMice	2
mice and human ASM cells	2
Human ASM cells	2
lung inflammation	2
ozone-exposed mice and human airway smooth muscle (ASM) cells	2
autoimmune-associated CD19+CD21−CD35− and CD21low B cells	2
bone marrow and the periphery	2
B-cell subsets	2
Lentiviral vector-transduced progenitor cells	2
peripheral blood of all patients	2
transduced B cells	2
Wiskott-Aldrich syndrome protein	2
autologous hematopoietic stem cells	2
gene–corrected autologous hematopoietic stem cells	2
recurrent infections	2
vitamin D responder immunophenotypes	2
immunologic pathways	2
IFN-γhigh immunophenotypes	2
calcitriol-treated patients	2
oral glucocorticoids	2
dexamethasone-induced IL-17A production	2
Oral calcitriol	2
SS asthma	2
oral calcitriol	2
Cytometric Bead Array	2
anti-CD3 and IL-2 with or without dexamethasone	2
SR asthmatic patients	2
steroid-sensitive (SS)	2
small population of patients	2
steroid-resistant AHR	2
functional receptor for IL-33.ConclusionPediatric SAFS	2
ST2−/− mice	2
inhaled budesonide	2
maintenance oral steroids	2
neonatal mouse model	2
alternata	2
airway immunopathology	2
Aspergillus fumigatus, Alternaria alternata, or Cladosporium herbarum	2
IL-33.MethodsEighty-two children	2
disease mechanistic networks	2
MAIT cells	2
atopic (type 2 cytokine–high) and nonatopic forms	2
novel clusters	2
blood and lung tissue	2
TH17 cells and γδ-17 cells	2
IL-13–secreting T cells	2
basophil mediators	2
Adaptive and invariant T-cell subsets, cytokines, mast cells	2
bronchoalveolar lavage, and blood samples	2
endobronchial biopsy	2
granulocyte mediators	2
diverse cells and mediators	2
major peanut allergens	2
Blocking IgG4 antibodies	2
children with PA and PS children	2
Ara h 3	2
Ara h 1	2
plasma of children with PS (and POIT)	2
nonsensitized nonallergic children	2
Ara h 3–sIgG4/Ara h 3–sIgE	2
h 2–sIgG4/Ara	2
Ara h 1–sIgG4/Ara	2
patients with PA and PS patients	2
plasma from patients with PA	2
inhibition assays	2
peanut oral immunotherapy (POIT)	2
PS subjects	2
mast cell line	2
IgE-stripped basophils	2
nonsensitized nonallergic subjects	2
108 patients	2
hundred twenty-eight children	2
peanut-specific IgG4 (P-sIgG4)	2
IgE inhibitor	2
children with peanut allergy (PA) and peanut-sensitized but tolerant (PS) children	2
detectable peanut-specific IgE (P-sIgE)	2
 children	2
parent-reported wheeze	2
Eight children	2
thirty-three doses	2
secondary/tertiary centers	2
patients with egg allergy	2
egg protein	2
United Kingdom immunization schedule	2
intranasal vaccine	2
BackgroundLive attenuated influenza vaccine (LAIV)	2
asthma exacerbations	2
BECs from asthmatic patients	2
mouse lung macrophages	2
primary human epithelium	2
primary BECs	2
rhinovirus infection	2
bronchial epithelial cells (BECs)	2
mutant SOCS1 constructs	2
 vitro	2
tissues from asthmatic patients	2
suppressor of cytokine signaling (SOCS) 1	2
IFN-α/β/λ	2
linear regression model	2
itchy flexural rash	2
SCORing Atopic Dermatitis clinical tool	2
skin barrier protein filaggrin (FLG)	2
weight growth	2
9723 children	2
early infancy	2
eliciting agent	2
patients and health care providers	2
young people	2
drug- and insect sting–induced anaphylaxis	2
all-cause anaphylaxis	2
food, drugs, and insect stings	2
fatal anaphylaxis	2
prospective fatal anaphylaxis registry	2
crosschecked fatalities	2
national databases	2
atopically inflamed skin	2
peanut SPT sensitization	2
final multivariate model	2
peanut skin prick test (SPT) sensitization	2
likely allergy	2
highly atopic children	2
recombinant PreS-fused grass pollen allergen peptides	2
recombinant hypoallergenic grass pollen allergy vaccine (BM32)	2
4 major allergens of grass pollen	2
patients' IgE binding	2
allergen-specific IgG antibodies	2
 grass pollen allergens	2
patients' PBMCs	2
BM321, BM322, BM325, and BM326	2
vaccine termed BM32	2
4 hypoallergenic fusion proteins (BM321, BM322, BM325, and BM326) representing Phl p 1, Phl p 2, Phl p 5, and Phl p 6	2
allergen-specific blocking IgG antibodies	2
hypoallergenic PreS fusion proteins	2
PreS fusion proteins	2
patients with grass pollen allergy	2
Recombinant PreS fusion proteins	2
hepatitis B virus	2
PreS protein	2
4 major timothy grass pollen allergens	2
nonallergenic peptides	2
recombinant hypoallergenic derivatives of the major timothy grass pollen allergens Phl p 1, Phl p 2, Phl p 5, and Phl p 6	2
grass pollen allergy vaccine	2
TH2 cells and neutrophils	2
PGD2 and LTE4 pathways	2
diverse nonclassical TH2 inflammatory mediators, including IL-22, IL-8, and GM-CSF	2
montelukast, an antagonist of cysteinyl leukotriene receptor 1.ResultsPGD2 and LTE4	2
antagonist of chemoattractant receptor-homologous molecule	2
Luminex, flow cytometry	2
quantitative RT-PCR	2
specific inflammatory pathways	2
human TH2 cell gene expression	2
human TH2 cells	2
PGD2 and cysLTs (notably cysteinyl leukotriene E4 [LTE4])	2
lipid mediators	2
D2 (PGD2) and cysteinyl leukotrienes (cysLTs)	2
CD63 peanut/anti-IgE and CD-sens values	2
anti-IgE (CD63 peanut/anti-IgE)	2
CD63+ basophils	2
124 children	2
patients with peanut allergy	2
epinephrine autoinjector	2
critical binding site	2
normal pigmentation	2
patients with FHL	2
Griscelli syndrome type 2	2
known FHL-related genes (PRF1, STXBP2, and UNC13D).ResultsWe identify patients	2
RAB27A, LYST, and AP3B1 in patients	2
oculocutaneous albinism	2
hemophagocytic lymphohistiocytosis (FHL)	2
DP2-selective antagonist AZD6430.ConclusionsDP2	2
number of MUC5AC+ and involucrin-positive cells	2
air-liquid interface cultures	2
13, 14-Dihydro-15-keto prostaglandin D2	2
Squamous metaplasia	2
 asthmatic patients	2
submucosal DP2+ cells	2
selective DP2 agonist 13, 14-dihydro-15-keto prostaglandin D2	2
expressed on TH2 cells)	2
chemoattractant receptor–homologous molecule	2
D prostanoid receptor 2 (DP2;	2
an impaired skin barrier	2
children without FLG mutations	2
children with wild-type FLG	2
peanut sensitization	2
oral food challenges or component-resolved diagnostics [CRD]	2
Peanut sensitization	2
first year of life	2
household peanut consumption	2
 household dust	2
peanut allergen	2
larger trials	2
daily emollient	2
intervention arm	2
participating families	2
eligible families	2
trained investigator	2
Parents in the control arm	2
Parents in the intervention arm	2
124 neonates	2
high-risk neonates	2
children and families	2
dermatitis (atopic eczema)	2
 healthy control subjects	2
patients with AR	2
 peripheral blood	2
nasal biopsy specimens	2
changes in IgE repertoires	2
local and peripheral blood IGH repertoires	2
IgE and IgG classes	2
blood and nasal biopsy specimens	2
grass pollen season	2
antibody classes	2
IgE clonotypic repertoires	2
immunoglobulin heavy-chain variable region gene families 1 (IGHV1) and 5 (IGHV5)	2
total of 97,610 IGH (including 8,135 IgE) sequences	2
454 GS FLX+ System	2
–related AR	2
patients with grass pollen	2
n = 3)	2
nonallergic healthy control subjects	2
matched peripheral blood and nasal biopsy specimens	2
immunoglobulin heavy-chain gene (IGH) repertoires	2
immunoglobulin gene sequences	2
British and Dutch hypotheses	2
distinct and overlapping groups of subjects	2
test study	2
validation subgroups	2
Validation subjects	2
mixed eosinophilic and neutrophilic	2
cluster 3	2
asthma and COPD overlap	2
TH2 cytokines	2
3 biological clusters	2
validation subjects	2
) cohorts	2
independent severe asthma	2
sputum cytokines	2
Biological subgroups	2
86 subjects	2
therapeutic IgG anti-IgE antibodies	2
specific allergen	2
IgE-sensitised basophils	2
free and FcεRI-bound IgE	2
human FcεRI.ResultsIgG autoantibodies	2
specific IgE on a rat basophilic cell line	2
presence and absence of allergen	2
IgE-sensitized human blood basophils	2
sera using ELISA	2
-specific IgG autoantibodies	2
activate IgE-sensitized basophils	2
serum of all subjects	2
occurring IgE-specific IgG autoantibodies	2
non–peanut-sensitized nonallergic children	2
peanut-allergic children	2
independent population	2
) children	2
non–peanut-sensitized nonallergic	2
MethodsPeanut-allergic	2
oral food challenges (OFCs)	2
clinical peanut allergy	2
peanut-sensitized children	2
filaggrin haploinsufficiency	2
subset of FLG wild-type cases	2
“extracellular space	2
Gene ontology terms	2
Cases and control subjects	2
nonatopic teenage control subjects	2
site-matched samples	2
26 pediatric patients	2
Uninvolved skin biopsy specimens	2
minimal tissue samples	2
atopic skin	2
expressed genome in the skin of children with AD	2
Dietary lipids	2
bacterial members of the pollen microbiome	2
invariant natural killer T cells	2
predisposed subjects	2
so-called pollen-associated lipid mediators	2
 the pollen coat and furry animals	2
house dust mites and cockroaches, and lipocalins	2
certain inhalant allergens	2
pollens and fruits	2
Bet v 1–like and nonspecific lipid transfer proteins	2
certain seed storage proteins	2
hydrophobic cavities	2
lipid ligands	2
Several members of major allergen families	2
allergen source	2
small molecular compounds	2
T-cell precursors	2
CD4 T-cell immunity	2
donor T-cell chimerism	2
NK+ recipients	2
alternative donors	2
matched sibling donor/matched family donor transplants	2
children who	2
host NK cells	2
SCID phenotypes	2
adenosine deaminase deficiency SCID	2
SCID-X1 and Janus kinase 3 forms of SCID	2
Natural killer (NK) cell populations	2
functional T cells	2
infants with SCID	2
BackgroundSevere combined immunodeficiency (SCID)	2
-specific serine protease activity	2
exacerbation model	2
Alternaria serine protease–IL-33 axis	2
common aeroallergen house dust mite	2
protease activated receptor-2 and adenosine triphosphate signaling	2
common aeroallergens	2
Alternaria (with or without serine protease activity)	2
inhaled house dust mite, cat dander, or Alternaria	2
IL-33 receptor	2
wild-type and ST2−/− mice	2
fungal allergen Alternaria alternata	2
Preterm birth	2
children born preterm	2
term-born children	2
147,252 children	2
individual studies	2
entire Bet v 1 surface	2
 epitopes	2
grafted regions	2
rBet v 1.0101	2
4 chimeras	2
single chimera	2
Api-Bet-3, and Api-Bet-4	2
Api-Bet-2	2
Api-Bet-1	2
Api-Bet-4 bound IgE	2
inhibition ELISA.ResultsrApi g 1.0101, Api-Bet-1, Api-Bet-2, Api-Bet-3, and	2
direct ELISA	2
birch pollen allergy	2
Bet v 1–sensitized subjects	2
64 sera	2
Api-Bet-4	2
chimeras Api-Bet-1	2
scaffold of its homolog, Api g 1.0101	2
distinct areas of Bet v 1	2
binding IgE	2
major birch pollen allergen Bet v 1.0101	2
specific surface areas	2
IgE-binding epitopes of allergens	2
airway-specific primary ganglion neurons	2
glycopyrrolate and atropine	2
isolated guinea pig vagal tissue	2
structurally similar muscarinic antagonist	2
Tiotropium and ipratropium	2
clinically relevant tussive stimulant	2
transient receptor potential (TRP) V1 agonist capsaicin	2
guinea pig	2
isolated airway neuron tissue–	2
isolated vagal sensory nerve	2
conscious cough model	2
submucosal glands	2
long-acting muscarinic receptor antagonist tiotropium	2
optimized antitussive compounds	2
small- and intermediate-conductance calcium-activated potassium channels	2
sensory nerves	2
cigarette smoke exposure model	2
calcium-activated potassium channels	2
isolated vagus and patch clamp	2
airway-specific neurons	2
human and guinea pig vagus in vitro	2
single C-fiber afferents in vivo	2
guinea pig model	2
guinea pig challenge models	2
human and guinea pig vagal sensory nerve activity	2
cough reflex	2
optimized compounds	2
family doctor	2
antitussive agent	2
NK-cell NKG2D and granzyme B	2
granzyme B.ConclusionsThese	2
NKG2D-deficient mice	2
wild-type NK cells (but not CD3+ cells)	2
-deficient mice	2
multiple HDM-allergen exposures	2
serum IgE	2
airway TH2 cells	2
lacked NKG2D	2
wild-type and NKG2D-deficient mice	2
NK-cell effector functions	2
major NK-cell activating receptor NKG2D	2
innate lymphocytes	2
Natural killer	2
asthma phenotyping	2
cluster 2 subjects	2
cluster 3 subjects	2
novel, quantitative, CT-based asthma clusters	2
segmented airway tree	2
novel, quantitative, CT-based asthma phenotypes	2
-five asthmatic patients	2
different regions of the world	2
different populations of infants	2
extracellular and endosomal but not cytosolic PRRs	2
3 other sites	2
cells from infants	2
South African infants	2
4 continents	2
4 continents (Africa, North America, South America, and Europe).ResultsWe	2
2-year-old infants	2
different continents of the world	2
common SNP in MATT	2
human MATT gene	2
10,558 population-matched control subjects	2
4,245 AD cases	2
house dust mite allergens	2
Mattftmice spontaneously	2
skin of mutant mice	2
encoded protein mattrin	2
Tmem79/Matt gene	2
independently recruited AD case collections	2
matted gene	2
congenic single-mutant strains	2
matted and Flg mutations	2
matted mutant gene in mice	2
unknown gene, matted	2
persons homozygous for G allele	2
A allele	2
fetal exposure	2
maternal alcohol dehydrogenase (ADH)1B genotype (rs1229984)	2
white mothers and children	2
large population-based birth cohort	2
alcohol intake	2
western pregnant women	2
TNF-α or src kinases	2
severe asthmatic airways	2
bronchial biopsies	2
E-cadherin and p120	2
severe asthmatic air-liquid interface cultures	2
endogenous TNF-α, IL-6, IL-1β, IL-8, thymic stromal lymphoprotein, and pro–matrix metalloprotease 9 release	2
p120 catenin and E-cadherin from adherens junctions	2
-α	2
src kinase and other inhibitors	2
subjects with severe asthma	2
differentiated human bronchial epithelial air-liquid interface cultures	2
differentiated primary cultures	2
differentiated human bronchial epithelial cultures	2
without src-family kinase inhibitor SU6656	2
cultures of severe asthmatic cells	2
bronchial epithelial cells	2
IFN-I	2
KO DCs	2
IFN-I reporter mice	2
antiviral CD8+ T-cell immunity	2
WASP-deficient (WAS KO) mice	2
associated immunopathology	2
many immune cell lineages	2
Wiskott-Aldrich syndrome protein (WASP) expression	2
IL-33–driven, ILC-dependent inflammation	2
IL-33–dependent ILC, macrophage, and eosinophil accumulation	2
wild-type ILCs to IL-33 receptor–deficient (St2−/−) mice	2
IL-33–induced mTOR-dependent cytokine production	2
ribosomal protein S6 kinase 1	2
ribosomal protein S6 kinase 1 inhibitor	2
TH2 cells and ILCs	2
p110δ phosphoinositide 3-kinase	2
recently described type 2 innate lymphoid cells (ILCs)	2
CD4+ TH2 cells	2
Several cell types	2
IL-1 family cytokine IL-33	2
CRACM-channel blockers	2
HLMC Ca2	2
CRACM-like current	2
ex vivo tissue	2
histamine, leukotriene C4, and cytokines (IL-5/-8/-13 and TNFα)	2
3 μM GSK-7975A	2
blockers	2
GSK-7975A and Synta-66	2
2 distinct and specific CRACM-channel blockers	2
known blockers	2
La3+	2
inositol triphosphate	2
HLMCs dialyzed	2
CRACM1 and -2 proteins	2
, -2, and -3 mRNA transcripts	2
isolated human bronchus	2
purified HLMCs	2
protein, and functional expression	2
–activated Ca2+ current	2
CRACM/Orai ion channel family	2
newly synthesized autacoids and cytokines	2
preformed granule-derived mediators	2
human lung mast cells (HLMCs)	2
extracellular Ca2+	2
murine homologue	2
IL-1β and IL-1RA mRNA.ConclusionsADFLGis	2
Flgft/Flgftmice	2
patients with ADFLG	2
murine IL-1α, IL-1β, and IL-1RA.ResultsSC IL-1 levels	2
murine skin	2
primary murine keratinocytes	2
maFlgft/maFlgft(flaky tail) mice	2
Flgft/Flgft (FlgdelAPfal) mice	2
93 patients	2
SC tape strips	2
IL-1α, IL-1β, IL-18, IL-1 receptor antagonist (IL-1RA)	2
mice).MethodsOne hundred thirty-seven patients	2
(Flgft/Flgft[FlgdelAPfal]	2
ADNON-FLG	2
controls and patients with ADFLGversus patients	2
 the uninvolved skin	2
corneocytes in patients with atopic dermatitis (AD)	2
proinflammatory IL-1 cytokines	2
reduced stratum corneum (SC) natural moisturizing factor (NMF) components	2
KCa3.1-channel blockers	2
K+ channel KCa3.1	2
fibrocyte growth	2
Channel blockers	2
transwell migration assays	2
specific and distinct KCa3.1 blockers (TRAM-34 and ICA-17043)	2
fibrocytes cultured	2
KCa3.1 ion-channel blockers	2
ion currents	2
Whole-cell patch-clamp electrophysiology	2
peripheral blood of healthy subjects	2
KCa3.1 K+ channel	2
fibrocyte migration	2
α-smooth muscle actin expression	2
bone marrow–derived CD34+ collagen	2
Canadian study	2
food challenge–positive patients	2
coexistent atopic dermatitis	2
Canadians	2
R501X, 2282del4, R2447X, and S3247X	2
Europeans	2
white Canadian population controls	2
peanut-specific IgE ≥15 kUL−1)	2
peanut ≥8 mm	2
skin prick test wheal	2
white Canadian patients	2
non peanut-sensitized English population controls	2
positive patients	2
English, Dutch, and Irish oral food challenge	2
 proteins	2
healthy skin	2
decreased pH.ConclusionS aureus	2
iron-regulated surface determinant	2
colonization (clumping factor B, fibronectin binding protein A) and immune evasion (protein A)	2
secreted and cell wall–associated proteins	2
fibronectin binding proteins, protein A, iron-regulated surface determinant A, and the serine-aspartate repeat proteins	2
clumping factor B	2
Cell wall–associated proteins	2
Cell wall extracts	2
MethodsS aureus	2
filaggrin breakdown products urocanic acid (UCA) and pyrrolidone carboxylic acid (PCA)	2
filaggrin (FLG) gene	2
Staphylococcus aureus in individuals	2
established moderate-to-severe AD	2
FLG genotype subgroups	2
undetected mutations	2
outlying patients	2
subset of FLG-associated AD	2
non–FLG-associated AD	2
132 well-characterized patients	2
patients with moderate-to-severe AD.MethodsThe composition	2
complex repetitive gene	2
(FLG)	2
genuine eczema susceptibility locus	2
nucleotide polymorphism rs7927894	2
well-established FLG risk alleles	2
4 most common FLG null variants	2
Irish controls	2
Irish pediatric cases	2
moderate-severe eczema	2
2 novel variants	2
1q21.ObjectiveTo test	2
gene encoding hornerin	2
single nucleotide polymorphism (rs877776)	2
single nucleotide polymorphism on chromosome 11q13.5 (rs7927894)	2
Malawian adults	2
immunodeficiency in HIV-infected children	2
children under 2 years	2
Adult lymphocyte subsets	2
539 healthy HIV-uninfected Malawians	2
subsets in peripheral blood	2
healthy Malawians	2
absolute and relative lymphocyte subsets	2
African populations	2
children of mothers	2
7½ years	2
5810 children	2
prenatal exposure	2
MR:GR balance hypothesis	2
five questions	2
coregulators and transcription factors	2
synaptic metaplasticity	2
experience	2
glucocorticoid receptors (GRs)	2
mineralocorticoid receptors (MRs)	2
higher brain circuits	2
corticosterone in the rat hippocampus	2
GABA and positive GABA-A receptor modulating steroids like allopregnanolone	2
α4, βx, δ receptor subtype	2
α4, γ2, and α1, α3 subunits)	2
GABAA receptor (	2
humans and other mammals	2
energy-rich food	2
potent positive GABAA receptor modulating steroid (GAMS)	2
hypothalamic arcuate nucleus and paraventricular nucleus	2
GABAA receptors (primarily with α3 and α2 subunits)	2
gamma-amino-butyric-acid (GABA) stimulating food intake	2
excessive calories	2
GnRH and AVT neurosecretory pathways	2
gonadotropin-releasing hormone (GnRH) and arginine-vasotocin (AVT) neurons	2
orphan photopigments	2
rod-opsin; melanopsin (OPN4); neuropsin (OPN5); and vertebrate ancient (VA) opsin	2
Several candidates	2
opsin photopigment	2
action spectrum	2
medio-basal hypothalamus	2
Extraretinal photoreceptors	2
different latitudes within species	2
particular day	2
GnRH1 synthesis	2
GABAAR-active neurosteroids	2
endogenous neurosteroids	2
hypothalamic–pituitary–adrenocortical (HPA) axis activity	2
sex-specific, hormone-based therapeutic agents	2
intact and injured NSDA system	2
human and rodent females	2
disease modifying agents	2
NSDA system	2
endocrine cell networks	2
growth hormone and prolactin cells	2
distinct network motifs	2
various endocrine cell types	2
structural and functional networks	2
endocrine and non-endocrine cells of the pituitary gland	2
‘orphan’ GPCRs	2
GPCRs in PVN/SON	2
hypothalamic nuclei	2
repertoire of GPCRs	2
PVN/SON	2
either the PVN or SON	2
non-chemosensory GPCRs	2
Many modulators	2
paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus	2
multitude of different ligands	2
largest family of transmembrane receptors	2
Deficient feto-placental 11β-HSD2	2
fetal brain and placenta	2
dehydrogenase	2
hippocampal and neocortical 11β-HSD1	2
inactive 11-keto derivatives	2
active glucocorticoids	2
11β-hydroxysteroid dehydrogenases (11β-HSD)	2
Excess or insufficient glucocorticoids	2
in vitro (disease modelling) and in vivo applications	2
established mathematical model	2
cardiomyogenesis-supporting viscoelastic stroma	2
human heart muscle self-organization in vitro	2
fibroblasts and cardiomyocytes	2
Comparative RNA-sequencing data	2
stably contracting, force-generating EHM	2
cell-independent collagen gelation	2
collagen type I hydrogel	2
defined populations of fibroblasts and embryonic stem cell-derived cardiomyocytes	2
functional syncytium	2
surrounding collagen network	2
myocardial stroma	2
engineered human myocardium (EHM)	2
collagen-based engineered heart muscle	2
genetically-modified zebrafish	2
conditional transgenesis	2
Tol2 transposon, TALENs (transcription activator-like effector nucleases), and CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9)	2
gene and enhancer trap screens	2
existing zebrafish lines	2
uninitiated researcher	2
genetically engineered zebrafish lines	2
organ system organisation	2
relevant and useful vertebrate model species	2
different pathologies	2
EM radiation	2
low and high frequencies EM spectrum	2
non-ionizing EMFs on cells and organs	2
various in vitro, in vivo	2
effects	2
real hazards	2
literature and mass media	2
electromagnetic fields (EMFs)	2
model of the hERG channel	2
machine-readable language	2
competing models	2
Cardiac Electrophysiology Web Lab)	2
fully-open online repository	2
novel protocol language	2
modelling	2
experimental datasets	2
region of non-implausible parameter space	2
Emulator outputs	2
modelling communities	2
two detailed models	2
ion channels and exchangers	2
real cardiac cells	2
Cardiac cell models	2
pairs in the minor groove	2
DNA duplex	2
rather rigid construction	2
electrostatic component	2
DNA-DBD complexes	2
minor groove of DNA	2
extra hydrogen bond	2
strands	2
duplex	2
Heating DNA	2
DNA binding domains (DBDs) of transcription factors	2
double helix	2
cardiac myocyte	2
canine epicardial EP model	2
single ventricular myocytes	2
coupled models	2
ten Tusscher and modified O'Hara models	2
four human ventricular cell AP models	2
O'Hara model	2
Grandi model	2
Grandi and O'Hara models	2
ATP-sensitive inward-rectifying potassium current	2
single cell and tissue simulations	2
Grandi et al., 2010; Carro et al., 2011; O'Hara et al., 2011)	2
ten Tusscher and Panfilov, 2006;	2
four human ventricular action potential models	2
different animal species	2
myocardial microstructure	2
heart’s microstructure	2
intersection of the left and right ventricle	2
multiple V- and N-shaped sheetlet arrangements	2
cardiomyocyte and sheetlet organisation	2
eigenvector	2
contractured heart	2
primary eigenvector	2
slack heart	2
ex vivo rabbit hearts	2
macroscopic materialisation	2
Myocardial microstructure	2
model populations	2
ventricular myocyte action potential models	2
two experimentally-calibrated populations of rabbit-specific	2
multi-cellular simulations	2
rabbit-specific computational modelling	2
rabbit-specific models	2
Computational modelling	2
bioRxiv (Kell and Pretorius, 2016)	2
preprint	2
many other widely recognised (β-)amyloid proteins	2
blood clotting	2
true amyloids	2
amyloid-β (Aβ) protein	2
different diseases	2
samples from patients	2
Many other proteins	2
β-sheet structures	2
largely α-helical to largely β-sheet conformation	2
extensive β-sheets	2
‘knobs and holes’	2
mainly α-helical fibrinogen	2
chief and largely terminal element	2
promiscuous antibodies	2
two subsets of antibodies	2
panel of antigens	2
antibody CDR loop	2
Human B cells	2
sarcoplasmic reticulum, mitochondria and microtubules	2
T-tubular system	2
3D cardiomyocyte ultrastructures	2
sub-cellular domains	2
thin sections	2
dyadic couplons	2
specific ultra-structures	2
elaborate sub-cellular structures	2
highly compartmentalised cells	2
true 3D data collection	2
tissue and cell structure imaging	2
large, multidimensional data sets	2
cardiovascular research	2
various pathological settings	2
mechanical environment	2
integrated regulatory loops	2
mutated PPIs	2
many resources	2
interconnected networks of PPIs within and between cells	2
(PPI) interfaces	2
3 × 3 matrix	2
computational biology models	2
model's predictions	2
biology and biomedical science	2
regionally-ischemic human ventricles model	2
intramural reentry	2
electrotonically-triggered EADs	2
macro-reentry	2
ischemic human ventricle	2
human ventricular biophysically-detailed model	2
human ventricles	2
early afterdepolarizations (EADs)	2
potassium current blockers	2
cardiac and skeletal muscle	2
various types of cancer	2
striated muscle tissue	2
Popdc family	2
novel class of cAMP effector proteins	2
different classes of proteins	2
several subcellular compartments	2
multiple tissues and cell types	2
unique family	2
Popeye domain containing (Popdc) proteins	2
base of the S4–S5 linker	2
VSD	2
ensemble of channels	2
Macroscopic current	2
S6 tails	2
voltage sensor	2
S3–S4 complex (voltage sensor domain, VSD)	2
channel protein	2
Kv7.1 potassium channel	2
excitable tissues	2
“building blocks	2
single virtual physiological human paradigm	2
patient-specific modelling	2
experimentally-calibrated population of models	2
experimentally-calibrated populations of models	2
populations of cardiac cell models	2
several animal species	2
modelling frameworks	2
multiple individuals	2
individuals of the same species	2
simple dimerization models	2
fibroblast growth factor receptor (FGFR) and the MET receptor	2
two receptor tyrosine kinases	2
transmembrane signaling models	2
cells of living systems	2
phosphopeptides and BRCA1-BRCT domains	2
protein regions	2
strong anchor points	2
motif interaction interface	2
phosphorylated protein-sequence motif pSXXF	2
phosphoprotein-binding modules	2
successful chemical modulators	2
small chemical entities	2
larger grooves	2
small-volume but deep pockets	2
“orthosteric”, competitive chemical modulators	2
surface-exposed helix, flexible loop or chain extension	2
continuous epitope	2
protein partner	2
examples of interfaces	2
one partner	2
classical drug targets	2
well-defined large cavities	2
nature of interfaces	2
protein kinases, proteases or other post-translational regulatory enzymes using substrate, co-factor or transition state mimetics	2
yet untargeted proteome	2
high molecular weight assemblies	2
multi-protein complexes	2
biophysical assays	2
live animals and patients	2
DSI in vivo	2
multiple fibres	2
voxels in apical regions	2
subepicardium	2
subendocardium	2
right- to left-handed fibres	2
fixed ex vivo rat hearts	2
modified perfusion and coil setup	2
external RF coil	2
9.4T horizontal bore scanner	2
wet chamber	2
radio-frequency (RF) coil	2
optimised MRI-compatible Langendorff perfusion setup	2
isolated rat hearts	2
micro-structural basis	2
arrested hearts	2
isolated heart	2
small animal cardiac imaging	2
cardiac community	2
tissue histo-anatomy	2
altered gene expression	2
candidate mechanosensitive ion channels (MSCs) TREK-1 and TRPC1/6	2
control but not failing hearts	2
intact and skinned single myocytes	2
less stable substrate	2
sarcoplasmic reticulum Ca2+-ATPase (SERCA)	2
Right Ventricular Outflow Tract	2
conscious heart failure animals	2
ECG	2
given system	2
structured family of Petri net classes	2
biomodel engineering framework	2
alternating sheet-populations	2
myocardial tissue layers	2
alternating sheet-plane populations	2
histological sectioning	2
fixed myocardium	2
β+ and β− sheet-populations	2
sheet-angle projections	2
left ventricular long-axis	2
Two predominant sheet-populations	2
sub-endocardium	2
right-handed helical fibres	2
basal, equatorial, and apical sub-epicardium	2
baso-apical direction)	2
left-handed helical fibres	2
DTI-data	2
ventricles in the same living heart	2
regionally prevailing cardiomyocyte (fibre) and myolaminar (sheet) orientations	2
histo-anatomical basis	2
Scn5a+/− hearts	2
intact perfused hearts	2
Scn3b gene	2
WT myocytes	2
endocardium and epicardium	2
ventricles of Langendorff-perfused Scn3b−/− hearts	2
right ventricles of both Scn3b−/− and WT hearts	2
left	2
right ventricles	2
Scn1b mRNA	2
ventricles of wild-type (WT) hearts	2
Scn3b mRNA	2
Scn3b−/− mice	2
Scn3b gene (Scn3b−/−)	2
genetically modified murine model	2
phorate (or PHO)	2
(2) 2-PAM Cl	2
many other OPs	2
2-PAM Cl, HI-6 DMS, obidoxime Cl2, MMB4-DMS, and HLö7 DMS	2
five oximes	2
OP compounds	2
three species (rat, guinea pig and human)	2
recombinant AChE	2
phorate oxon (PHO)-inhibited AChE.	2
various oximes	2
bioactivated oxon metabolite	2
many other organophosphorus (OP) pesticides	2
highly toxic agricultural pesticide	2
N. lugens populations	2
N. lugens resistance	2
cytochrome P450s	2
Synergist bioassays	2
channel pore	2
transmembrane domain M2	2
N. lugens RDL channel	2
Drosophila melanogaster strain	2
two mutated subtypes	2
mutant Rdl subtypes	2
wild type, A301S and A301S+Q359E	2
three Rdl constructs	2
selected strains	2
two field N. lugens populations	2
fiprole resistant rice brown planthopper, Nilaparvata lugens populations	2
RDL GABA-gated chloride channel	2
lipid stores	2
adults and dauers of the model genetic nematode Caenorhabditis elegans	2
G. pallida J2s	2
hatched second stage G. pallida juveniles (J2s)	2
free-living nematode Caenorhabditis elegans	2
potato cyst nematode Globodera pallida	2
physiology	2
new nematicide	2
microplate format	2
continuous assays	2
susceptible H. armigera	2
allelic enzymes	2
isomers	2
Helicoverpa armigera	2
three esterases	2
sets	2
three most potent isomers tested	2
two sets of substrates	2
esterases	2
corresponding pyrethroid isomers	2
heterologously expressed insect esterases	2
individual isomers of the commonly used Type 2 pyrethroids, cypermethrin and fenvalerate	2
fluorogenic and more water-soluble analogues	2
meaningful assays	2
synthetic pyrethroids	2
promising new chemical entity	2
currently available nematicides	2
macrocyclic lactone ivermectin	2
carbamate aldicarb	2
organophosphates and carbamates and C. elegans mutants	2
classes of anthelmintic and nematicide	2
egg-laying, egg-hatching, feeding and locomotion	2
tractable experimental paradigm	2
Meloidogyne spp.	2
model genetic organism Caenorhabditis elegans	2
non-target insects and mammals	2
new nematicide of the fluoroalkenyl thioether group	2
non-target organisms	2
e.g. methyl bromide, organophosphates and carbamates	2
chemical controls	2
Plant parasitic nematodes	2
para- trifluoromethylphenyl amides	2
phenyl ring of the amide	2
2,6-dichloro- substitution	2
aegypti and Anopheles albimanus than meta- or para- trifluoromethylphenyl amides	2
female Ae	2
trifluoromethylphenyl amides with trifluoromethyl or alkyl group	2
ortho- trifluoromethylphenyl amides	2
aegypti larvae	2
aromatic ring	2
Phomopsis obscurans	2
potent fungicide	2
Compound 4c	2
Compound N-(2-(trifluoromethyl)phenyl)hexanamide (4a)	2
aegypti, 2,2,2-trifluoro-N-(2-(trifluoromethyl)phenyl)acetamide (4c)	2
female Ae.	2
repellency bioassays	2
two strains of D. melanogaster	2
Oregon-R and 1675 strains	2
Drosophila melanogaster adults	2
Compound 1c	2
aegypti larvae and adults	2
fipronil against Ae.	2
adults N-(2,6-dichloro-4-(trifluoromethyl)phenyl)-2,2,2-trifluoroacetamide (1c)	2
toxic compound	2
Aedes aegypti larvae, N-(2,6-dichloro-4-(trifluoromethyl)phenyl)-3,5-dinitrobenzamide (1e)	2
mosquito toxicants and repellents	2
noise, heat and cold shock	2
potential models	2
available mouse models	2
European network	2
COST Action MouseAGE	2
new animal models	2
multiple deficits	2
class of drugs	2
incredible little worm	2
aging research	2
selected topics	2
lifespan-extending compounds	2
small molecule signals	2
daf-2 gene	2
organisms age	2
short-lived nematode	2
animal-specific and patient-specific models	2
mouse experiments	2
fractured and non-fractured patients	2
Computed Tomography	2
subject-specific models	2
CT2S technology	2
bone drugs	2
set of in vivo imaging based subject-specific technologies	2
animal experimentation	2
vitro or in silico technologies	2
Pgc-1β-/-and WT hearts	2
Young and aged WT ventricles	2
young and old, regularly-paced, Pgc-1β-/-hearts	2
young and aged, peroxisome proliferator-activated receptor-γ coactivator-1β knockout (Pgc-1β−/−) and wild type (WT), Langendorff-perfused murine hearts	2
electrocardiographic and intracellular recordings	2
unchanged K+ current	2
intact young and aged, WT and Pgc-1β−/−, atrial cardiomyocyte preparations	2
energetically deficient murine Pgc-1β−/−hearts	2
constitutive signals	2
redox signalling pathways	2
ROS molecules	2
aged Pgc-1β−/−hearts	2
young Pgc-1β−/−hearts	2
Pgc-1β−/− hearts	2
extrasystolic stimuli	2
Young and aged Pgc-1β−/− hearts	2
murine hearts	2
Langendorff-perfused young (3–4 month) and aged (>12 month), wild type (WT) and peroxisome proliferator activated receptor-γ coactivator-1β deficient (Pgc-1β−/−)	2
telomerase activators and senolytics	2
tissues and specific markers	2
intercellular mediators	2
senescent fibroblasts	2
pro-inflammatory SASP	2
Cytokines IL-6	2
transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)	2
whole body optical imaging	2
preclinical positron-emission-tomography	2
preclinical magnetic-resonance-imaging	2
commonly used in vivo imaging modalities	2
least one longitudinal imaging modality	2
arthritis, diabetes, cancer, thrombi, dementia	2
four tissues (blood, lung, cerebellum and hippocampus) from male and female C57BL/6J mice	2
ELOVL2, GLRA1, MYOD1 and PDE4C genes)	2
high-confidence aDMPs	2
selected age-associated differentially methylated positions (aDMPs)	2
younger people	2
older than younger participants	2
MARK-AGE cohort	2
ageing models	2
healthy ageing biomarkers	2
miR, mRNA and plasma proteins	2
proteomic, transcriptomic and miR array	2
tightly-defined proband subsets	2
cellular material and plasma directly	2
stress model	2
endothelial progenitor cells	2
increased inflammatory cytokines	2
circulating sex hormones	2
Cx43 protein	2
trace of Cx43 protein	2
JNK inhibitor SP600125	2
Cx43 protein expression	2
activated JNK	2
JNK activator anisomycin	2
0.30±0.01m/s	2
0.38±0.01m/s	2
atria	2
phosphorylated Cx43	2
activated-JNK	2
C43 protein expression	2
Right atria	2
activated c-jun N-terminal kinase (JNK)	2
atrial muscle	2
Connexin43 (Cx43)	2
human immunosenescence	2
death receptor	2
antigen-specific receptor (TCR) and CD28 co-receptor	2
Resting mature T lymphocytes	2
expanded T cells	2
CZr in serum	2
copper (Cu) and zinc (Zn)	2
wild-type, PolgA+/mutanimals, and humans	2
70-year-old human subjects	2
proof-reading activity of mtDNA polymerase (PolgA+/mut)	2
good animal model	2
body iron	2
iron supplements	2
poor diet	2
circulating hepcidin	2
vulnerable brain structures	2
Tg-ArcSwe and wt mice	2
transgenic 12 months old mice	2
Polβ transcriptional expression	2
wildtype (wt) mice	2
Tg-ArcSwe	2
6 weeks, 4 months and 12 months old mice	2
8-oxoguanine glycosylase (OGG1), AP endonuclease 1 (APE1), polymerase β (Polβ) and poly(ADP-ribose) polymerase 1 (PARP1)	2
genes encoding BER enzymes	2
accumulating senile plaques	2
transgenic (Tg)-ArcSwe mouse model	2
aging human brain	2
fibrillar aggregates of amyloid-beta (Aβ)	2
normal to slow-conducting tissue	2
septa and free walls	2
Scn5a+/−and young male Scn5a+/−, old female Scn5a+/−, and old male WT	2
old male	2
Scn5a+/−compared to WT male	2
late conducting components	2
64-channel multi-electrode array	2
right ventricular (RV) epicardial activation	2
Scn5a+/−mice	2
Scn5a+/− and WT hearts	2
conduction pathways	2
long-lived daf-2 insulin/IGF-1 receptor mutants	2
t-BOOH	2
iron sequestering protein ferritin	2
iron chelator (deferoxamine)	2
tert-butyl hydroperoxide (t-BOOH) given 9mM Fe(III)	2
iron-sensitive reporter transgene pftn-1::gfp	2
free iron	2
functionally ‘efficient’ mitochondrial electron transport chain	2
citrate synthase	2
AL controls	2
DR mice	2
cytochrome c oxidase content	2
several mitochondrial associated proteins (Pgc-1α, Nrf1, Core 1, Cox IV, Atps)	2
permeabilised myofibres	2
proteins and mRNAs	2
age-matched ad libitum (AL) controls	2
male C57BL/6 mice	2
multiple repressor pathways	2
Wnt-4 expression	2
Wnt-4 target gene	2
connective tissue growth factor (CTGF)	2
Wnt receptors Frizzled (Fz)-4 and	2
PKCδ expression	2
protein kinase C (PKC) family of serine-threonine kinases	2
thymic epithelium	2
Wnt expression	2
mature T-cells	2
specific microenvironment	2
thymic epithelial cells (TECs)	2
Wnt family of secreted glyco-lipo-proteins	2
E1E2-Flag envelope glycoproteins	2
two genotypes tested (1a and 2a)	2
HCV infectious particles	2
high-titer, cross-reactive antibodies	2
purified E2-Flag mutants	2
crucial virus entry factor, CD81	2
hypervariable region 1 of E2	2
Flag tag	2
genotypes 1a, 1b and 2a	2
recombinant HCV envelope glycoproteins	2
cross-reactive and at the same time neutralizing antibodies	2
multiple sub-types	2
globally disseminated human pathogen	2
rs9340799 polymorphisms	2
non-smoking mothers	2
AA/AG genotype	2
right hand	2
ESR1 polymorphisms	2
G, dbSNP: rs9340799)	2
XbaI (A > 	2
C, dbSNP: rs2234693)	2
PvuII (T 	2
1800 children	2
photocopies of palms	2
Vernier calipers	2
estrogen receptors	2
androgen receptors	2
2nd and 4th digits	2
etonogestrel (ENG)	2
ester function	2
medroxyprogesterone acetate (MPA)	2
LNG-phenoxyacetic acid ester analog	2
compound’s molecular structure	2
first series	2
One single analog	2
human carbonic anhydrase II (hCA 2) ligands	2
sulfonamide function	2
LNG)-17-β esters	2
levonorgestrel (	2
single-dose, long-lasting (>6 months) injectable contraceptives	2
existing glucocorticoid drugs	2
glucocorticoid (agonist) and mineralocorticoid (antagonist) receptors	2
dissociative steroid	2
Asn564 of the glucocorticoid receptor	2
C-ring	2
adrenal axis	2
traditional glucocorticoid drugs	2
healthy adult males)	2
mineralocorticoid receptor	2
pro-inflammatory NFkB pathways	2
first-in-class steroidal multi-functional drug	2
PurposeVamorolone (VBP15)	2
highly effective anti-inflammatory agents	2
oxysterols and cholestenoic acids in CSF	2
panel of twelve sterols in mouse cerebrospinal fluid (CSF)	2
Oxysterols and cholestenoic acids are oxidised forms of cholesterol	2
7α-hydroxy-3-oxocholest-4-enoic acid	2
(25R)26-hydroxycholesterol	2
cholesterol metabolites 5α-hydroxy-6-oxocholesterol (3β,5α-dihydroxycholestan-6-one), 7β-hydroxycholesterol and 7-oxocholesterol	2
brain and the circulation	2
cholesterol metabolites	2
forearm vein	2
jugular vein	2
oxygenated forms of cholesterol	2
body’s cholesterol	2
accurate assays	2
three hormones	2
extraction and mass spectrometry assays	2
mass spectrometry assays	2
extraction assays	2
“direct” immunoassays	2
column chromatography	2
extraction” immunoassays	2
potent aromatase inhibitors	2
suitable assays	2
highly sensitive assays	2
certain laboratories	2
direct radioimmunoassays	2
ouabain-like steroids (not progestin)	2
ion channel-linked receptors	2
external loop (ATP1A1)	2
C-terminus (PAQR and MAPR-1)	2
variable LRR sequence	2
ion channels (pore-lining regions)	2
overlap TM helices	2
LRR domains	2
LRR kinases	2
ligand binding sites	2
plant membrane proteins)	2
highly conserved leucine-rich repeats (LRR,	2
ATP1A1, PAQR5/7/8, mPRα, and	2
steroid binding region	2
pore-lining regions	2
single TM helix	2
MAPR proteins	2
2–4 CB motifs	2
TM helices (TM-3 is a pore)	2
PAQR5, PAQR6, PAQR7, PAQRB8 and fish	2
putative progesterone receptors	2
pore-lining regions (ion channels), transmembrane (TM) helices, caveolin binding (CB) motifs and leucine-rich repeats (LRRs)	2
nuclear receptor (PRB)	2
progesterone receptor MAPR proteins	2
membrane progestin receptor alpha (mPRα)	2
progestin binding PAQR proteins	2
α1-subunit of the Na+/K+-ATPase (ATP1A1)	2
plasma membrane progestin receptors	2
5α-androst-3β,5,6β-triol	2
5α-androst-3β,5,6β-triol pretreated cultures	2
5α-Androst-3β,5,6β-triol	2
primary cultured cortical neurons	2
steroid compound 5α-androst-3β,5,6β-triol	2
S224A and S246A mutants	2
inducible methionine expression system	2
receptor derivatives	2
mutated GR derivatives T171A, S224A, S232A,	2
mineral bonds	2
soil compounds	2
microbial C sources	2
soil C pools	2
lignin, chitin, and protein depolymerization	2
immediately available alternative	2
microbial N source	2
chitin-derived C in the sum of dissolved organic, microbial and respired C)	2
13C-enriched lignin, chitin, and protein	2
native bulk soil organic matter (SOM)	2
N-rich compounds	2
different polymers	2
plants and microorganisms	2
soil C and N	2
major fraction	2
soil polymers	2
tropical montane and lowland ecosystems	2
complex C substrate	2
simple C substrate	2
lowland and montane forest soils	2
added nutrients	2
functionally active microorganisms	2
13C substrates	2
lower montane and lowland forest soils	2
externally supplied	2
without C)	2
upper montane forest and grassland soils	2
substrate-respired C	2
sources of C (substrate- or SOM-derived)	2
13C in CO2 and in phospholipid fatty acids; PLFA)	2
inorganic N, P and N + P.	2
simple and more complex 13C-labelled substrates	2
different tropical soils	2
tropical elevation gradient	2
C and nutrient inputs	2
Tropical lowland and montane soils	2
carbon (C) and nutrient inputs	2
root exudation	2
species specific inputs	2
plant communities	2
root exudate inputs	2
organic acid or sugar)	2
remaining five treatments	2
exudate analogues	2
tropical peats	2
root exudate analogues	2
sugars and organic acids	2
significant carbon store	2
Tropical peatlands	2
tree species	2
admixing oak	2
particular tree species	2
two or three different tree species	2
oak monoculture	2
plant-input	2
fungal growth	2
oak monoculture, and oak admixed with 1–3 other tree species)	2
young experimental plantation	2
plant-derived carbon input	2
Mixed planting	2
plant and soil microbial communities	2
active methanotrophs	2
phylogenetically distinct methanotrophs	2
uncultured methanotrophs	2
13C-DNA	2
non-acidic paddy soils	2
type I methanotrophs Methylosarcina	2
novel methanotrophs	2
13C-pmoA genes	2
acidic soil	2
aerobic methane-oxidizing communities	2
Methylosinus-like microorganisms of type II methanotrophs	2
five paddy soils	2
high-concentration methane	2
type I methanotrophs Methylosarcina and Methylobacter	2
SIP microcosm incubation	2
rice field soils	2
Methylocaldum 16S rRNA genes	2
uncultured novel type I methanotroph cluster (Rice Paddy Clusters)	2
type II methanotroph, Methylocystis	2
soil 16S rRNA and pmoA genes	2
geographically different paddy soils	2
phylogenetically distinct type I and type II methanotrophs	2
active methanotrophs in paddy soils	2
active methane-oxidizing bacteria	2
considerable sources	2
Rice paddies	2
biologically available C	2
deep soil horizons	2
deep subsoil	2
total C	2
SMB-C	2
surface population	2
topsoil and subsoil	2
Deep subsoil	2
three depth groups	2
14C-glucose mineralisation	2
soil solution (pH, dissolved organic C (DOC) and N, nitrate, ammonium, water extractable P)	2
soil microbial biomass (SMB)	2
Soil chemistry (C, nitrogen (N), phosphorus (P)	2
long-term pasture	2
two floodplain sites	2
land-ocean aquatic continuum	2
Floodplain soils	2
pertinent actors, stakeholders and end-users	2
novel indicators	2
land managers	2
Isolating aggregates	2
several unidentified genera	2
highly diverse microbial communities	2
independently sampled whole soil	2
Pedosphaerales, Planctomycetales, Syntrophobacterales, and Glomeromycota (arbuscular mycorrhizal fungi)	2
Large macroaggregates	2
microaggregate communities	2
indicator taxa	2
Fimbriimonadales, Acidimicrobiales, Actinomycetales, Alteromonodales, Burkholderiales, Gemmatimonadales, Rhodobacterales, Soligubrobacterales, Sphingobacteriales, Sphingomonodales, Spirobacillaes, Onygenales, Chaetosphaeriales, and Trichosporanales	2
diverse microbial communities	2
Bacteria and fungi	2
three land management systems	2
microbially-relevant scale	2
plot or field	2
homogenized soil cores	2
permafrost thaw	2
oxygen availability	2
collapse wetlands	2
CH4 emissions	2
C sinks	2
much larger stores of available C	2
collapsed peat plateaus	2
previously-frozen C	2
well-drained sites	2
previously-frozen sources	2
deep soil layers	2
peat plateau sites	2
relatively undisturbed ecosystems	2
sources of C	2
sporadic and discontinuous permafrost regions	2
climate models	2
globally significant amounts of carbon (C)	2
CH4 production	2
extracellular hydrolytic enzymes	2
peat	2
added labile carbon mixture	2
CO2 and CH4 production	2
mixture of sugars and organic acids	2
beneath canopy palms (Raphia taedigera) and broadleaved evergreen trees (Campnosperma panamensis) in an ombrotrophic wetland	2
peatland plant communities	2
large and labile carbon input	2
Root exudates	2
deeper rooting	2
C and N	2
similar abundance of ammonifiers and ammonia oxidizing bacteria (AOB) and archaea (AOA)	2
microbial population in subsoil	2
organic C and N substrates (glucose, amino acids, peptides, protein)	2
sand textured Eutric Cambisol	2
organic and inorganic N availability	2
plants and microbes in subsoil environments	2
soil profile	2
nutrients including organic and inorganic nitrogen (N)	2
cereal roots	2
topsoil (plough layer)	2
plant nutrition	2
two perennial bioenergy crops	2
recent plant derived C	2
SRC willow soil	2
fungal PLFA	2
labelled C. SRC willow	2
dry weight soil	2
Total PLFA	2
SRC willow (	2
plant tissues	2
recent carbon (C) assimilates	2
two contrasting UK perennial bioenergy crops, Short Rotation Coppice (SRC) willow and Miscanthus Giganteus (miscanthus)	2
(PLFA's)	2
phospholipid fatty acids	2
plant C inputs	2
immobilized labeled N	2
rapid NH4	2
either soil	2
15N-NH4+	2
majority of tracer	2
clay and/or humic substances)	2
+, dissolved organic N (DON), NO3− and the microbial N pool)	2
grassland	2
beech forest	2
mineral topsoil	2
live and sterile (autoclaved) soil	2
15N-NH4+ tracer	2
consumed 15N tracer	2
added 15N-NH4+ tracer	2
rewetting dried soils	2
air-dried	2
Two soils	2
dried partially	2
C.	2
type of microorganisms	2
potentially soluble C	2
protected pools	2
coarser pore waters	2
simpler C	2
fine pores	2
soluble C in coarser pores	2
soluble C in finer pores	2
7 day incubations	2
Trichoderma reseei (QM6a)	2
25439™	2
Cellvibrio japonicus (DSMZ 16018), Streptomyces cellulosae (ATCC®	2
major biochemical classes (i.e., lipids, proteins, lignin, carbohydrates, and condensed aromatics) of compounds	2
SOC	2
increasingly fine pore domains	2
intact soil cores	2
coarse- and fine-pore throats	2
soil C compounds	2
specialized decomposers, C, and other resources	2
microbially colonized locations	2
protected locations	2
SOC and other resources	2
soil pores	2
otherwise labile carbon (C)	2
soil organic carbon (SOC) in different sized pores	2
first order kinetic model	2
new C	2
neighbouring size fractions	2
greater portion of aggregates	2
effective tracer	2
measured aggregates	2
wet sieving of aggregates	2
soil respiration	2
13C-glucose	2
soil labelled with REO, iii) soil without REO but amended with 13C-glucose	2
13C-labelled glucose	2
13C g−1 soil	2
organic input	2
composite soil sample	2
REO tracers	2
0.25–2 	2
0.053–0.25 	2
isotopically labelled carbon (C) and rare earth oxides (REO)	2
pore networks	2
Bayesian belief network	2
respiratory response archetypes	2
green barley powder)	2
complex organic substrate	2
soil system	2
climate, environment	2
organic matter (OM)	2
C-rich forest soil	2
easily decomposable and stabilized SOM	2
warmed plots	2
root litter input	2
functionally different SOM pools	2
subsoil oPOM	2
N-bearing compounds in subsoil MaOM	2
subsoil fPOM	2
topsoil oPOM	2
three density fractions	2
spruce forest	2
three density fractions (free particulate organic matter, fPOM; occluded particulate organic matter, oPOM; and mineral associated organic matter, MaOM) of a C-rich soil	2
functionally different soil organic matter pools	2
SOM pools	2
Soil fractions	2
distinct SOM pools	2
debris of dead cells	2
remnant respiratory pathways	2
biochemical (outside membranes) and organismal (inside membranes) sources	2
flush	2
organismal or biochemical basis	2
carbonates) contribution	2
CO2 eflux	2
different modes	2
solutions of inhibitors (15% trichloroacetic acid or 1% silver nitrate)	2
intact cells) origin	2
free enzymes)	2
saprotrophic fungi	2
two or three distinct pools	2
continuous pool	2
organic C	2
new conceptual model	2
labile C pool	2
fungal and bacterial populations	2
recalcitrant and a labile C pool	2
labile C	2
labile C by fungi	2
mycorrhizal fungi	2
labile substrates	2
classical soil food web model	2
sympatric earthworm lineages of cryptic sibling species	2
L. rubellus	2
genotype-specific water-soluble chemicals	2
kindred genotype	2
un-worked control soil	2
extracts from worked soil	2
different genotype on each side	2
water extracts of soils	2
filter papers	2
choice design	2
genetically similar or dissimilar individuals	2
individually genotyped worms	2
two major genetic lineages	2
earthworm Lumbricus rubellus in the UK	2
isotopic pool dilution	2
isotopic-C in soil	2
key C pools	2
substrate-C	2
new empirical model	2
isotope addition	2
isotopically labelled 13C/14C	2
agricultural soil	2
14C-labelled alanine	2
individual C compounds	2
experimentally parameterise models	2
isotopic tracers	2
carbon (C) through soil	2
chamber walls	2
urine patch	2
total extractable N and WFPS	2
water-filled pore space (WFPS)	2
sheep urine amended Eutric Cambisol mesocosms	2
dissolved organic carbon and nitrogen,NO3−andNH4+)	2
urine patch N2O emissions	2
pasture response area	2
ruminant urine patch	2
livestock grazed ecosystems	2
Urine patches	2
decomposer invertebrates	2
ryegrass and herbivorous invertebrates	2
complex nature of soil	2
ryegrass treatment	2
herbivorous Symphypleona	2
clovers and chicory treatment	2
detritivorous Poduromorpha	2
collembolan superfamilies	2
two ryegrass treatments	2
herbivores	2
clovers and chicory treatments	2
fungal feeders	2
Nematode functional groups	2
anecic earthworms	2
overall earthworm abundance	2
number of biological groups	2
soil mesofauna, nematodes and earthworms	2
Soil faunal samples	2
Plots of chicory (Cichorium intybus), red clover (Trifolium pratense), white clover (Trifolium repens) or perennial ryegrass (Lolium perenne)	2
soil faunal diversity	2
different forage crops	2
Different forage species	2
growing plants	2
peptide-C	2
amino acid-C	2
Microbial decomposers	2
control and plant residue treatment field soils	2
effective management tool	2
total soil OM	2
synthetic root exudate mixture	2
field soils	2
extra additions	2
total soil organic C (SOC)	2
additional inputs of straw/chaff	2
winter crop	2
semi-arid rainfed field trial	2
root exudate additions	2
N2O) emissions	2
nitrous oxide (	2
semi-arid rainfed cropping soils	2
applied fertiliser and organic matter (OM) decomposition	2
growing global population	2
food production	2
surface soil layer	2
archaeal amoA gene	2
field dry soil	2
field replicates	2
research site	2
ammonia oxidiser populations	2
soil organic matter contents	2
gross nitrification	2
nitrification inhibitor nitrapyrin	2
subsequent nitrification	2
organic matter mineralisation	2
hot, dry environments	2
agricultural soils	2
Water pulses	2
extracellular investment of N (as EPS peptides)	2
EPS-AAs	2
alanine, glycine, proline, phenylalanine and tyrosine	2
inorganic source	2
hydrophobic EPS-AAs (leucine, isoleucine, phenylalanine, hydroxyproline and tyrosine)	2
extracellular polymeric substance (EPS)	2
resulting total soil peptide (TSP) and extracellular pools	2
large pool of refractory SOM	2
15N labelled NH4NO3)	2
inorganic source of N	2
extracellular matrix in soil	2
newly synthesised peptides	2
N (including enzymes and structural components)	2
extracellular structures	2
recalcitrant soil organic matter (SOM)	2
soil science	2
rhizosphere and aboveground biomass	2
root system	2
recently assimilated photosynthates	2
labile carbon compounds	2
rain pulses	2
respiration from controls (RS)	2
stem girdled	2
73 trees	2
Mediterranean maritime pine (Pinus pinaster) forest	2
Azores	2
multiple mitochondrial lineages	2
parthenogenetic A. corticis	2
São Miguel	2
mitochondrial cytochrome oxidase I (COI) and 16S ribosomal RNA genes	2
‘outlier’ populations	2
putative source populations	2
localities on São Miguel Island	2
Amynthas gracilis and Amynthas corticis	2
Asian origin	2
cosmopolitan megascolecid earthworms	2
local biodiversity	2
Invasive species	2
invertebrate decomposer diversity	2
field decomposer-biomass	2
decomposer diversity	2
alpine soils	2
common and functionally diverse invertebrates (earthworms, millipedes and sciarid larvae)	2
alpine ecosystems	2
mineral subsoils	2
topsoil horizons	2
organic topsoils	2
ecosystems in mineral subsoil horizons	2
mineral horizons	2
latitudinal transect	2
seven ecosystems	2
mineral topsoil horizons	2
extracellular enzymes (cellobiohydrolase, leucine-amino-peptidase, N-acetylglucosaminidase, chitotriosidase, phosphatase and phenoloxidase)	2
Enzyme patterns (i.e. distance-matrixes	2
subsoil microbial communities	2
organic carbon	2
Soil horizons	2
easily metabolisable resource	2
l-trialanine	2
temperate grassland soils	2
rapidly cycling LMWDON compound	2
model peptide l-trialanine	2
N	2
C	2
N and carbon (C)	2
LMWDON compounds	2
amino acids and peptides (and LMW dissolved organic matter; LMWDOM as a whole)	2
low molecular weight dissolved organic N (LMWDON) compounds	2
dissolved organic N (DON) pool	2
nitrogen (N)	2
Plants and microorganisms	2
deeper layers of permafrost soils	2
organic carbon or nitrogen, e.g.	2
permafrost soils	2
extracellular enzymes	2
additional nitrogen	2
cryoturbated material	2
glucose or cellulose	2
amino acids or protein	2
cryoturbated horizon	2
complex components of SOM	2
microbial decomposer community	2
glucose, cellulose, amino acids, protein)	2
mineral subsoil	2
subsoil horizons	2
organic compounds	2
soil organic carbon	2
13C-labeled glucose, cellulose, a mixture of amino acids, and protein	2
poorly decomposed topsoil material	2
mineral subsoil, and cryoturbated subsoil material	2
organic topsoil	2
central Siberian Arctic	2
active layer of a permafrost soil	2
older SOM	2
decaying fine roots	2
plant-derived organic compounds	2
related artefacts	2
humified soil organic matter	2
EPS extracts	2
cation exchange resin	2
microbial ATP	2
dilute sulphuric acid	2
glomalin related soil protein (GRSP)	2
humic artefacts	2
humic acid equivalent (HAE)	2
Humified organic matter	2
microbial biomass of a moist soil	2
labile C (glycerol)	2
intracellular and extracellular contamination	2
soil-EPS content	2
biofilm exclusive of microbial cells	2
soil-EPS	2
embedded microbial cells	2
extracellular polymeric substances (EPS: predominantly polysaccharides, glycoconjugates, and proteins)	2
Many soil microbes	2
VPH source	2
biochar amendment	2
decaying and newly formed biomass	2
VPH fate model	2
soil with and without biochar	2
cell abundance	2
VPH spreading	2
biochar-enhanced sorption	2
column study samples	2
soil bacterial communities	2
VPH addition	2
batch study samples	2
cut bands	2
biochar and/or mixtures of volatile petroleum hydrocarbons (VPHs)	2
dominant bacterial taxa in gravelly sand	2
soil extracts	2
extract protein	2
protein and non-protein origin	2
added protein	2
Bradford assay	2
soil protein	2
model protein (BSA) and polyphenol (Sigma H1675-2)	2
standard additions	2
citrate)	2
factorial combination	2
distinct pools in microbial biofilms	2
protein and humic substances	2
rapid quantification protein	2
Bradford colorimetric assay	2
dissolved humified organic material	2
Soil extracts	2
cryoturbated soil horizons	2
cryoturbated horizons	2
microbial community of each horizon	2
soil horizons	2
Siberian sites	2
Greenland	2
sites and horizons	2
amino acids and NH4+	2
different soil horizons of three tundra sites	2
cryoturbated organic matter	2
poorly decomposed organic material	2
soil layers	2
Turbic Cryosols (permafrost soils	2
Sordariales and Hypocreales	2
Major affected phylogenetic groups	2
diseased community	2
ammonium nitrogen (NH4+–N)	2
Soil organic matter	2
counterpart network	2
one network	2
soil variables	2
OTU sets	2
significant module memberships	2
generalists/specialists	2
network members	2
different sets of shared OTUs	2
diseased soil	2
majority of fungi	2
healthy soil	2
diseased soils	2
certain set	2
OTUs in healthy soils	2
marginal generalist OTU	2
diseased	2
generalist OTUs	2
functionally interrelated operational taxonomic units (OTUs)	2
two networks	2
constructed healthy and diseased networks	2
internal transcribed spacer sequences	2
yield-invigorating (healthy) and -debilitating (diseased) soils	2
archaea and bacteria	2
DCD and nitrapyrin	2
soil and liquid culture	2
three nitrification inhibitors (allylthiourea (ATU), dicyandiamide (DCD) and nitrapyrin)	2
abundant ammonia oxidising archaeal lineage	2
soil archaeon	2
more, smaller pores	2
experimental soils	2
AMF inocula	2
Microbial biomass-C	2
every combination of the fungal species	2
Glomus intraradices	2
Glomus mosseae	2
Glomus geosporum	2
Plantago lanceolata	2
three species of arbuscular mycorrhizal fungus (AMF)	2
soil fungi and roots	2
labile carbon	2
dead extra-matrical mycelium	2
free-living soil fungi	2
decaying ectomycorrhizal mycelium	2
dynamic community of functionally active soil fungi	2
fungal DNA	2
glycogen and chitin-glucan	2
key biochemical constituents of soil	2
functionally active soil fungi	2
13C-labelled mycelium of the ectomycorrhizal fungus Pisolithus microcarpus	2
energy source	2
identity of microbes	2
free-living microorganisms in forest soils	2
Ectomycorrhizal mycelial necromass	2
younger and more labile sources	2
roots, litter/humus, and SOM	2
permanent collars	2
autotrophic and heterotrophic components	2
components derived from root, litter/humus, and SOM sources	2
warm Mediterranean forest	2
soil-atmosphere system	2
heterotrophic and autotrophic contributions	2
old soil C (SOM)	2
PRP/HC	2
HC and patients with PRP	2
individuals to SSc and HC/PRP groups	2
novel capillaroscopy system	2
healthy controls (HC).Methods50 patients with SSc	2
primary Raynaud's phenomenon (PRP)	2
patients with systemic sclerosis (SSc)	2
nailfold capillaroscopy	2
ischaemic DU centre	2
fingertip and extensor)	2
microvessels of the DUCore	2
DU centre (‘DUCore’) and periphery (‘DUPeriphery’)	2
placebo ointment	2
6 fingertip, 10 extensor) DUs	2
fingertip and extensor lesions	2
topical glyceryl trinitrate (GTN)	2
fingertip digital ulcers (DUs)	2
thermographic video camera	2
laser Doppler imager (LDI)	2
lamp	2
skin of healthy subjects' hand dorsum (n=8)	2
laser Doppler imager	2
thermal imaging camera	2
detailed, high-contrast 3-D maps	2
adult murine spleen	2
effective and safe drugs	2
off-target organs	2
surrounding renal parenchyma	2
athymic mice	2
human and mouse islet grafts	2
intra-pancreatically transplanted islets	2
rat endogenous pancreatic islets	2
renal capsule of male athymic mice	2
human and mouse islets	2
pancreas of male Lewis rats	2
individual endogenous and transplanted islets	2
Platinum micro-electrodes	2
imaging biomarker	2
0 and 30mg/kg cohorts	2
corrosion casts	2
three treatment groups	2
tumour vascular bed	2
resin	2
200mg/kg group	2
resulting tumour vascular casts	2
low viscosity resin	2
subcutaneous SW1222 colorectal xenografts in mice	2
vascular corrosion casts	2
animal tumour models	2
CHF patients	2
patients with CHF	2
two vasodilators	2
age- and sex-matched group of healthy controls (HC)	2
β1-blocker (Bisoprolol)	2
17 patients	2
iontophoretically-administered acetylcholine and sodium nitroprusside	2
carcinoembryonic antigen-related cell adhesion molecule 1	2
L-IDE-KO mice	2
gluconeogenic genes Pck1 and G6pc	2
cellular nuclei	2
downstream signaling molecules, AKT1 and AKT2	2
ResultsL-IDE-KO mice	2
liver-specific deletion of Ide (L-IDE-KO)	2
metalloprotease	2
insulin-degrading enzyme (IDE)	2
various stressors	2
physically active populations	2
thermogenic beige adipocytes	2
energy storing white adipocytes	2
adipocyte pre-cursors	2
existing adipocytes	2
BAT thermogenesis	2
β-adrenoceptor (β-AR) pathway	2
thermogenic organ	2
adipose tissue (BAT)	2
majority of athletes	2
sport nutrition	2
n-3 PUFA	2
oily fish and fish oil supplements	2
family of fatty acids	2
N-3 PUFA (n-3) polyunsaturated fatty acids (PUFA)	2
patients with co-existent NAFLD	2
retrospective series	2
appropriate oral hypoglycaemic agent or injectable therapy	2
patients with NAFLD	2
healthy comparison group	2
LDLR gene	2
LDL-C raising SNPs	2
exon 7 of PCSK9	2
APOB gene	2
region of exon 26	2
exons of LDLR	2
south-eastern region	2
unrelated subjects	2
understudied Polish population	2
LDLR, APOB and PCSK9 genes	2
non-Mediterranean populations	2
wine, dairy products	2
single components	2
Linear and logistic regression models	2
non-Mediterranean countries	2
validated food frequency questionnaire	2
Eastern Europe (HAPIEE) cohort study	2
Polish arm	2
monounsaturated fatty acids	2
larger particles	2
n-6 polyunsaturated fatty acids	2
palm CRLPs	2
olive and corn CRLPs	2
CRLP types	2
apolipoprotein B48	2
olive CRLPs and control incubations	2
palm or corn CRLPs	2
olive CRLPs	2
d less than 1.050–g/mL fraction	2
TG, cholesterol, and apolipoprotein B48	2
cultured hepatocytes	2
triacylglycerol (TG) from palm, olive, or corn (enriched in saturated, monounsaturated, or n-6 polyunsaturated fatty acids) oil	2
Chylomicron remnant–like particles	2
cultured rat hepatocytes	2
chylomicron remnant–like particles (CRLPs)	2
low-density lipoprotein (VLDL)	2
(H2CHx)(CO3)·4H2O –	2
(H2CHx)(SO4)·3H2O and	2
Two salts of the chlorhexidine di-cation (H2CHx2+)	2
Hirshfeld surfaces and fingerprint plots	2
two-dimensional molecular scaffold	2
three-dimensional hydrogen-bonded network	2
corresponding Hirshfeld surface	2
crystalline phase	2
corresponding co-crystal	2
novel compound	2
corresponding diastereoisomer (1)	2
single enantiomer (1S,2S)-2-benzyl-2,3-dihydro-2-(1H-inden-2-yl)-1H-inden-1-ol (2),	2
pure mammalian cell lysates	2
MST technology	2
either covalently attached or intrinsic fluorophores	2
infrared laser	2
investigated specimen	2
temperature gradient	2
layer structure polymorphs of tazofelone	2
RCI–III	2
streaked diffraction spots	2
metastable RCI and RCIII	2
phase pure samples	2
newly-discovered, but closely related, polymorph RCIII	2
racemic polymorphs	2
layer structure	2
low energy structures	2
low energy racemic structures	2
racemic solid solution (SS)	2
single enantiomer	2
racemic compound	2
racemic form II (RCII)	2
abnormality in non-cancer tissues	2
hair medulla section	2
α-helix proteins	2
healthy people	2
cancer patients’ hair tissue	2
ribosome-binding resistance factor VmlR	2
50S ribosome subunit	2
translational GTPase BipA	2
ABCFs Uup	2
ATPase-deficient mutants of all four E. coli ABCFs (EttA, YbiT, YheS and Uup)	2
important human pathogens	2
antibiotic producers	2
ABCF family tree	2
bacterial and eukaryotic phyla	2
distinct subfamilies of ABCFs	2
4505 genomes	2
ABCF subfamilies	2
peptidyl transferase center and exit tunnel of the ribosome	2
biochemically characterized VgaA	2
Several other ABCFs	2
ribosomal translation factors	2
Saccharomyces cerevisiae and EttA	2
ABCF family members eEF3	2
larger ABC superfamily of ATPases	2
sAD and familial patient fibroblasts	2
amount	2
AD patient tissue	2
PSEN1 fibroblasts	2
sAD fibroblasts	2
sporadic AD (sAD) and PSEN1 fibroblasts	2
several animal models	2
members of the poorly characterized tripartite tricarboxylate transport family	2
main chain of two conserved loops	2
ligand proximal carboxylic group	2
two water molecules	2
bound malate	2
2.1-Å crystal structure	2
C4-dicarboxylates	2
l- and d-malate	2
periplasmic binding protein	2
first member of the tripartite tricarboxylate transport family	2
photosynthetic bacterium Rhodopseudomonas palustris	2
MatBAC system	2
extracytoplasmic solute binding protein	2
Ten different families of secondary transporters	2
anaerobic bacteria	2
key metabolic intermediates	2
Gram-positive and Gram-negative bacteria	2
wide range of protein fibers	2
functional amyloid or amyloid-like fibers	2
functional biofilm matrix	2
fibrous proteins	2
single species biofilms	2
extracellular, self-produced, biofilm matrix	2
natural and man-made environment	2
membrane complex-specific scoring functions	2
analysis scripts	2
resulting set of docking decoys	2
membrane systems	2
soluble complexes	2
unbound structures	2
diverse functions and folds	2
first membrane protein–protein docking benchmark	2
MMTV gRNA	2
important viral/host factor binding site(s)	2
mirror repeat	2
major splice donor	2
novel cis-acting element	2
genomic MMTV transcripts	2
multiple primer pairs	2
unspliced and spliced mRNAs	2
Gag and Env protein	2
genomic and spliced nuclear RNAs	2
Quantitative real-time RT-PCR of actinomycin D-treated cells expressing MMTV	2
stably transfected Jurkat T cells	2
small mutant subset	2
gRNA	2
MMTV or human cytomegalovirus promoters	2
Mutant clones	2
24-nt region	2
3′ RmRE	2
5′ end of the genome	2
additional RmRE	2
unspliced genomic (gRNA) and spliced mRNAs	2
Rem-responsive element (RmRE)	2
3′ cis-acting RNA element	2
Signal peptide	2
cleavage product of envelope and Rem proteins	2
functional signal peptide	2
mouse mammary tumor virus (MMTV)	2
PolD correctly base-paired a single ribonucleotide opposite rNMP-containing DNA templates	2
three DNA Pols bypass rNMP-containing DNA templates	2
sequence context	2
three DNA Pols	2
RNase HII	2
genome of wild-type Thermococcales cells	2
p41/p46 complex	2
family-B DNA Pol	2
family-D DNA Pol (PolD)	2
Pyrococcus abyssi cells	2
Bacteria and Eukarya	2
replicative DNA polymerases (DNA Pols)	2
deoxyribonucleotides (dNTPs)	2
ribonucleotides (rNTPs)	2
Rev and Env/Vpu transcripts	2
essential splicing factors	2
heterodimeric auxiliary factor U2AF65/35	2
Walker A, Walker B (DEAD), Q motif and the glycine doublet motif	2
RNA binding motifs	2
distinct RNA binding motifs	2
cellular Tetherin	2
A1 splice acceptor	2
regulatory and accessory proteins	2
splice acceptor group	2
close paralog DDX5	2
3′ splice site cluster	2
intrinsically weak A4/A5	2
partially spliced and fully spliced transcripts	2
splice donor and eight splice acceptor sequences	2
full-length human sHsp heteromer	2
anti-parallel shared ACD dimer grooves	2
ACD pockets	2
IXI/V motifs	2
flexible “nuts and bolts”	2
non-intersecting approximate dyads	2
flattened tetrahedron	2
four α-crystallin domains (ACDs)	2
HspB2/B3 tetramer	2
hetero-tetramer	2
structure of human HspB2/B3	2
neuromuscular cells	2
extensively truncated homomers	2
Atomic coordinates	2
co-assembling oligomers	2
inter-converting	2
part of the protein	2
small heat shock proteins (sHsps)	2
affordable and dramatically more powerful VR and graphics hardware	2
researchers and educators	2
Consumer VR headsets	2
Molecular Zoo	2
three VR applications	2
conventional computing environment	2
VR technology	2
research literature	2
two-dimensional tasks	2
trackpad, mouse and keyboard excel	2
Conventional computer displays	2
3D data	2
6-degree-of-freedom hand controllers	2
molecular architectures	2
immersive display	2
Virtual reality (VR)	2
immune system cells	2
x-ray density maps	2
electron microscopy	2
accurate atomic models	2
three-dimensional (3D) microscopy	2
vitro protein phase separation assays	2
high-quality proteins	2
phase-separating proteins	2
liquid condensates	2
membrane-less compartments	2
cytoplasm and nucleoplasm	2
membrane-less organelles and compartments	2
current dCas tools	2
dCas tools	2
comprehensive toolbox	2
Diverse dCas tools	2
nuclease-dead Cas molecules (dCas9 and dCas12a)	2
Cas9 and CRISPR	2
committed polarized system	2
cell polarity modules	2
polarity modules	2
“core cell polarity modules	2
forms of tissues	2
cell polarity	2
protein fusion libraries	2
opposite termini	2
N or C terminus of budding yeast proteins	2
tags in experimental setups	2
fusion counterparts	2
cellular compartment	2
cell envelope	2
T7SS apparatus	2
intercellularly transferred TelC	2
culture supernatants	2
endogenous or overexpressed TelC	2
tipC gene	2
S. intermedius cells	2
TelC-inhibitory activity	2
predicted β-sheet of TipC	2
concave surface	2
seven-stranded β-sheet	2
three α-helices	2
crescent-shaped fold	2
soluble domain of TipC proteins	2
non-protective TipC paralogue	2
1.9-Å X-ray crystal structure	2
inner wall zone	2
C-terminal TelC-inhibitory domain	2
N-terminal transmembrane segment	2
TipC immunity protein	2
sister cells	2
inner wall zone of Gram-positive bacteria	2
interbacterial competition	2
T7SS-exported lipid II phosphatase	2
Streptococcus intermedius	2
TelC protein	2
type VII secretion system (T7SS)	2
disordered ensembles	2
osmolyte and proline mutation	2
folded domains	2
disordered CytR	2
Semi-quantitative statistical mechanical modeling	2
target promoter	2
conserved proline residue	2
osmolyte	2
excited state	2
Ising-like statistical mechanical model	2
folded-like excited state	2
disordered DNA-binding domain	2
two macrostates	2
unfolded and folded-like forms	2
Many intrinsically disordered proteins	2
newly described functional amyloid secretion system	2
glutamine layer	2
extensive hydrogen-bonding network	2
single buried tyrosine residue	2
novel asymmetric trimeric coiled coil	2
N-terminal periplasmic domain	2
periplasmic domain	2
membrane-spanning domain of the amyloid subunit transporter FapF	2
unfolded amyloid substrates	2
specialized outer-membrane protein channel	2
bacterial functional amyloid	2
amyloid subunits	2
specialized biogenesis machineries	2
reduced leuco-MT form of the molecule	2
MT moiety	2
PHF-like filaments	2
PHF-core tau unit	2
predominantly reducing environment of living cells	2
leuco-MT	2
stable reduced form	2
PHF core	2
methylthioninium (MT) moiety	2
contemporary genetic cohorts	2
patient similarity networks	2
Patient similarity networks	2
heterogeneous data	2
rich genomics data	2
ribosome tunnel	2
terminal strands	2
β-sheets	2
sufficiently stable folding nucleus	2
case of MATH	2
wild-type MATH	2
arrest peptide force-profile assays	2
N and C terminal strands	2
structured region	2
residues and secondary structure elements	2
β-sandwich domain	2
spatial contacts	2
residues in a polypeptide chain	2
protein folding pathways	2
tissue systems	2
tissue structures	2
single molecular building block	2
interbead region	2
fibrillin dimer	2
linear prongs	2
outer ring and interwoven core	2
microfibrils	2
tomograms	2
tissue microfibrils	2
bead and interbead regions	2
hollow tubular structures	2
fibrillin microfibrils	2
purified microfibrils	2
fibrillin-binding proteins	2
cross-bridges	2
zonule	2
zonule fiber periphery	2
meshwork	2
smaller fibers	2
individual zonule fibers	2
circumferential wrapping fibers	2
bundles of zonule fibers	2
nano-scale individual microfibrils	2
ciliary zonule	2
micro-scale fiber bundles	2
fibrillin structure	2
mammalian elastic tissues	2
evolutionarily ancient, structurally complex extracellular polymers	2
CHEVI complex	2
CORVET/HOPS	2
protein complex containing VPS33B and VIPAR	2
VPS33B/VIPAR	2
human cell lysates	2
member of the CCC complex	2
canonical CORVET/HOPS domain architecture	2
several subunits of CORVET and HOPS	2
many components of class III phosphatidylinositol 3-kinase (PI3KC3) complexes: PIK3C3, PIK3R4, NRBF2, UVRAG and RUBICON	2
VPS33A and VPS33B	2
interactomes of VPS33A and VPS33B.	2
two subunits of a novel multi-subunit tethering complex (named “CHEVI”)	2
CORVET or HOPS complexes	2
VPS33A. Metazoans	2
Sec1/Munc18 protein subunit	2
two such complexes	2
Class C core vacuole/endosome tethering (CORVET)	2
Multi-subunit tethering complexes	2
down-regulated PPAR and MAPK signaling pathways genes	2
metabolic pathway genes	2
repetitive DNA elements	2
mammalian enzyme	2
S-adenosylhomocysteine hydrolase (SAHH/AHCY)	2
strong inhibitor of DNMT1	2
DNA (cytosine-5) methyltransferase 1 (DNMT1)	2
key questions	2
FapC fiber-forming subunit	2
sequence covariance-based in silico model	2
amyloid exporter FapF	2
dedicated machinery	2
Fap system	2
functional amyloid of Pseudomonas (Fap)	2
highly coordinated system of amyloid subunits, molecular chaperones and transport systems	2
mature biofilms	2
biofilm growth	2
many bacteria	2
Functional amyloids	2
large macromolecular structures	2
diffusing species	2
target site	2
diffusing protein	2
photo-activated fluorescent proteins	2
local and global environment	2
exclusive, isoform	2
full-length, TAp73α	2
complex and sometime controversial field	2
p73 C-terminal isoforms	2
distinct C-terminal splice forms of p73	2
N-terminal isoforms of p73 (TAp73 and ΔNp73)	2
multiple alternatively spliced C-terminal isoforms	2
N-terminally deleted dominant-negative isoforms	2
transcriptional factor	2
p53 related protein	2
TP73 gene)	2
proline (A1603P)	2
composite structure of part of the coiled coil	2
sarcomeres in adult rat cardiomyocytes	2
eGFP-tagged β-MHC	2
cultured skeletal muscle myotubes	2
M-line of sarcomeres	2
Mutant eGFP-tagged β-MHC	2
glutathione S-transferase–light meromyosin fusion proteins	2
heptad and light meromyosin constructs	2
A1603P and K1617del in vitro	2
coiled-coil tail	2
cardiac and slow muscle fibers	2
heavy chain (β-MHC)	2
β-cardiac myosin	2
functional peroxisomal E3 ligase complex	2
cells lacking members	2
peroxisomal membrane protein Pex13p	2
Pex20p family of co-receptors	2
ubiquitin E3 ligases Pex2p, Pex10p and Pex12p	2
ubiquitin-conjugating enzyme Pex4p	2
peroxisomes in yeast	2
[1–8].	2
novel therapeutic compounds	2
general principles	2
variety of models	2
alkyl sulfate esters	2
AS	2
alkaline phosphatase superfamily members	2
conserved active site residues	2
different packing and protomer–protomer interfaces	2
dimeric ASs and tetrameric phosphonate monoester hydrolases	2
alkaline phosphatase superfamily	2
quaternary ammonium group of the choline substrate	2
conserved glutamate (Glu386)	2
buried, largely hydrophobic active site	2
2.8-Å resolution X-ray structure	2
arylsulfate 4-nitrophenyl sulfate	2
alkyl sulfate choline-O-sulfate (kcat/KM=4.8×103s−1M−1)	2
Sinorhizobium meliloti choline sulfatase (SmCS)	2
C–O bond of alkyl sulfates	2
alkyl sulfatases	2
sulfate sugars	2
arylsulfatases (ASs)	2
classification of enzymes	2
aromatic sulfates and sulfated sugars	2
primary and secondary alkyl sulfates	2
either sulfur (S–O bond cleavage) or carbon (C–O bond cleavage)	2
organic sulfate esters	2
high-resolution image	2
final adjusted protein image	2
residues, side chains and protein surfaces	2
Web page	2
molecular structure files	2
software molecular visualization system	2
http://www.sbg.bio.ic.ac.uk/ezmol/.	2
software wizard	2
molecular visualization Web server	2
hybrid H3–H4 tetramer-like subcomplex	2
least two copies of histone H3 and one copy of H4	2
UAF-specific subunit	2
histones H3 and H4	2
transcriptionally active UAF complex	2
recombinant Escherichia coli-based system	2
Rrn9, Rrn5, Rrn10, Uaf30, and histones H3 and H4	2
downstream Pol I factors	2
ribosomal DNA promoter	2
two multi-subunit complexes	2
Upstream Activating Factor (UAF)	2
Pol I	2
Y. bercovieri Anbu operon	2
ATP-grasp protein	2
YbAnbu peptidase or amidase activity	2
conserved candidate catalytic residues Thr1, Asp17 and Lys32(33)	2
putative S1 pocket	2
Ntn-hydrolase fold	2
highly symmetric or pseudosymmetric multimer structures	2
presented structure	2
solution and negative-stain electron microscopy images	2
defined multimers	2
low-rise left-handed staircase	2
dimers (“protomers”	2
Anbu specific C-terminal helices	2
defined 12–14 subunit multimers	2
crystal structure of the Anbu particle from Yersinia bercovieri (YbAnbu)	2
negative-stain electron microscopy micrographs	2
“ancestral” form of proteasomes	2
Ancestral β-subunit (Anbu)	2
bovine pancreatic trypsin inhibitor	2
set of diverse proteins	2
near-UV	2
near-UV bands	2
far-ultraviolet (UV)	2
intense bands	2
regular, repeating, chiral nature of secondary structure elements	2
(modeled or experimental) protein structure or ensemble of structures	2
electronic circular dichroism spectrum	2
web server DichroCalc (http://comp.chem.nottingham.ac.uk/dichrocalc)	2
optical spectroscopy	2
protein conformation	2
fully quantitative theory	2
YidC	2
Ffh subunit of SRP	2
TMD of DjlC and Flk	2
TAMPs	2
DnaK and insertase YidC	2
receptor FtsY	2
signal recognition particle (SRP)	2
known E. coli membrane targeting and insertion factors	2
fluorescent reporter mNeonGreen	2
TMDs	2
bona fide Escherichia coli TAMPs	2
bacterial TAMPs	2
well-studied eukaryotic TAMPs	2
subcellular targeting signal	2
hydrophobic TMD	2
single transmembrane domain (TMD)	2
Tail-anchored membrane proteins (TAMPs)	2
integrative conjugative plasmids	2
highly diverse integrated mobile genetic elements	2
identified AEPs	2
archaeal primases	2
recently discovered PriX subunit	2
non-catalytic, large subunit of archaeal and eukaryotic primases	2
AEP domains	2
PriCT-1 and PriCT-2 domains	2
novel families of helicases	2
bacterial AEPs	2
PolpTN2 primase–polymerase	2
arginine residue	2
novel AEP families	2
supergroup, PrimPol-PV1	2
highly diverse phyla	2
AEP homologs	2
pTN2 plasmid	2
archaeal primase–polymerase PolpTN2	2
AEP genes	2
DnaG family	2
archaeo-eukaryotic primase (AEP)	2
Archaea and eukaryotes encode enzymes	2
structurally unrelated, non-homologous DNA primases	2
Cellular organisms	2
small 8-stranded OMP	2
hybrid barrel formation	2
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) liposomes	2
transmembrane domain of BamA	2
synthetic liposomes	2
sequential chaperone model	2
β-barrel and polypeptide transport-associated (POTRA) domains	2
BamA β-barrel domain	2
Skp:tOmpA complex	2
prefolded BamA	2
model OMP (tOmpA)	2
central subunit of the BAM complex	2
Escherichia coli periplasmic chaperones Skp and SurA	2
β-barrel assembly machinery (BAM)	2
periplasmic chaperones	2
outer-membrane proteins (OMPs)	2
long and highly ordered PHFs	2
C322A variant	2
C322A substitution	2
tau(297–391)	2
PHF-like fibrils	2
full-length tau)	2
truncated 95-amino-acid tau fragment	2
neuronal cell bodies	2
Tau protein	2
oligomers and fibrils	2
tau and amyloid β proteins	2
fibrillar aggregates	2
non-crosslinked seeds	2
DiY-stabilized α-syn fibrils	2
DiY formation	2
preformed α-syn fibrils	2
DiY group	2
unmodified α-syn	2
intrinsically disordered α-syn	2
α-syn fibril formation	2
α-syn and nine tyrosine-to-alanine mutants	2
α-syn in Lewy bodies	2
Lewy bodies	2
protein α-synuclein (α-syn)	2
potential and species-specific drug target	2
human FBPases	2
effector site	2
inactive rotated T-state	2
key catalytic dynamic loop	2
side chain of Arg48	2
dimer–dimer interface	2
side chain of His23	2
“effector loop”	2
large and small interfaces	2
three structures	2
dimer pairs	2
inactive form of the tetramer	2
allosteric inhibitor AMP	2
third crystal structure of LmFBPase complexed	2
dynamic loops	2
catalytic product phosphate	2
disordered “dynamic loops	2
homotetramer	2
apoenzyme form of LmFBPase	2
allosteric inhibitor	2
three crystal structures of Leishmania major fructose-1,6-bisphosphatase (LmFBPase)	2
gluconeogenic enzyme fructose-1,6-bisphosphatase	2
cellular 2OG	2
TCA cycle metabolite pro-drug esters	2
cells ectopically overexpressing KDM5B	2
immunofluorescence antibody-based assays	2
C-1 carboxylate/C-2 keto groups	2
C-4 carboxylate	2
active site metal	2
succinate, fumarate, L-malate, oxaloacetate, pyruvate and D- and L-2HG	2
D- and L-2HG	2
poor or moderate KDM5B inhibitors	2
tested TCA intermediates	2
current medicinal chemistry target	2
associated metabolites D- and L-2-hydroxyglutarate (	2
tricarboxylic acid (TCA) cycle intermediates	2
Fe(II) and 2-oxoglutarate (2OG)-dependent oxygenases	2
JmjC KDMs	2
JmjC) KDM5 subfamily	2
Jumonji C (	2
histone demethylases	2
lysine-4 of histone H3 (H3K4men)	2
oncogene protein c-Myc	2
disordered peptide	2
extended disordered regions	2
distinct sequence and/or structure	2
fibril surface	2
GAG and charged residues	2
sulfate moieties	2
fibril three-fold apices	2
fibril	2
GAG	2
2-O-sulfate of iduronate within heparin	2
N-sulfate or 6-O-sulfate of glucosamine	2
library of short heparin polysaccharides	2
corners of the 3Q fibril structure	2
interaction site	2
GAG–3Q fibril complex	2
Aβ42 fibrils	2
alternative structures	2
three-fold-symmetric (3Q) morphology	2
GAG low-molecular-weight heparin (LMWH)	2
non-proteinaceous components	2
protein fibrils	2
extracellular plaques	2
Aβ peptide	2
mycobacterial infections	2
oncology drugs	2
screening libraries	2
AIDS antivirals	2
HIV protease	2
potential inhibitor-binding sites	2
enzyme structures	2
synthetic insulins	2
long-lasting zinc-insulin crystals	2
group of Dorothy Hodgkin	2
John Kendrew	2
50s and 60s	2
ligand–residue interactions	2
inactive conformation	2
receptor and ligand	2
allosteric sodium ion	2
norbuprenorphine-bound receptor	2
distinct set	2
buprenorphine-bound receptor	2
receptor transmembrane domains	2
sodium ion-coordinating residues W2936.48 and N1503.35	2
common morphinan scaffold	2
different subsets of residues	2
MOPr	2
diprenorphine an antagonist	2
buprenorphine a low efficacy agonist	2
high efficacy agonist	2
293 cells	2
human embryonic kidney	2
norbuprenorphine, buprenorphine, and diprenorphine	2
structurally similar opioid ligands	2
Gi/o proteins	2
clinically important G protein-coupled receptor	2
μ-opioid receptor (MOPr)	2
miR-7 biogenesis pathway	2
pri-miRs	2
RRM-containing protein/s	2
pri-miR-16	2
HuR and MSI2 proteins	2
pri-miR-7	2
pre-miR/protein complexes	2
HeLa cell extracts	2
proteins containing RNA recognition motifs (RRM)	2
oleic acid (OA)	2
brain-enriched miR-7 formation	2
Musashi homolog2 (MSI2)	2
Hu antigen R (HuR)-mediated binding	2
primary miRs (pri-miRs) and precursor-miR transcripts (pre-miRs)	2
Different sets of RNA-binding proteins	2
MicroRNAs (miRs)	2
non-intuitive targets	2
synthetic lethality	2
non-small cell lung cancer	2
epidermal growth factor receptor (EGFR) inhibitors	2
core pluripotency machinery	2
ESC pluripotency	2
diverse phosphorylation systems	2
protein kinase complement	2
kinase pathways	2
transforming growth factor (TGF)β family	2
Wnt-GSK3 signalling	2
leukemia inhibitory factor (LIF)-JAK-STAT3 axis	2
PI3K-AKT	2
fibroblast growth factor (FGF)-ERK1/2 pathway	2
adult body	2
Embryonic stem cell (ESC) pluripotency	2
Ub cascade	2
newly developed reagents	2
currently available ABPs	2
ABPs and assay reagents	2
Ub system	2
activity-based probes (ABPs) and assay reagents	2
Ub-activating, -conjugating, and -ligating enzymes	2
Ub-like modifiers	2
ubiquitin (Ub) and	2
developing central nervous system	2
3′UTR extensions	2
neural tissue	2
CFI proteins	2
UAS/Gal4 system	2
late embryonic central nervous system	2
CPA factor expression	2
mammalian CPA factors	2
Drosophila orthologues	2
general cleavage and polyadenylation factors (CPA factors)	2
Drosophila nervous system	2
extensions	2
long 3′UTRs	2
microRNAs and RNA-binding proteins	2
different sets of RNA regulators	2
different 3′-ends	2
undecorated side of a sugar or multiring ligand	2
rigid hydrophobic contact surface	2
centers of tightly packed internal regions	2
vicinal disulfides	2
cis-trans interconversions	2
genuine examples of cis or trans vicinal disulfides	2
distinct protein families	2
reliable from dubious cases	2
growing database	2
cis and trans forms	2
isolated curiosity	2
sequence-adjacent cysteine residues	2
Vicinal disulfides	2
novel therapeutic antibodies and proteins	2
artificial aggregation gatekeeper residues	2
antigen binding region	2
Cvt machinery	2
vacuole in budding yeast cells	2
vacuolar hydrolases	2
Cytoplasm-to-vacuole targeting (Cvt)	2
specific cargos	2
non-specific cargos	2
lysosomes or vacuoles	2
damaged organelles and protein aggregates	2
various materials	2
endosomes/lysosomes	2
closed autophagosome	2
phagophore or isolation membrane	2
open membranous cistern	2
number of highly conserved autophagy-related proteins	2
pre-autophagosomal structure or phagophore assembly site	2
cytosol and organelles	2
degradative pathway	2
non-small cell lung cancer cell lines	2
mitogenic signaling	2
TACC3 from cells using small hairpin RNA (shRNA)	2
mitogen-activated protein kinase and AKT pathway	2
transforming acidic coiled-coil proteins (TACC) 3	2
oncogenic, hyperactive EGFR variants	2
novel interaction partners of EGFR	2
mutated EGFR	2
multiple signaling cascades	2
epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (TK)	2
IL-13 helices A and D	2
Asp50, Asp51, Ser30 and Lys31	2
paratope	2
core of binding	2
network of hydrogen bonds	2
variable light complementarity-determining region 2	2
light chain complementarity-determining regions	2
residues in helices D and A of	2
tralokinumab epitope	2
human IL-13	2
IL-13-neutralising human IgG4 monoclonal antibody	2
Tralokinumab (CAT-354)	2
IL-13Rα1, IL-4Rα and/or IL-13Rα2	2
IL-13-neutralising antibodies	2
decoy or a key mediator	2
IL-13 also	2
heterodimeric receptor complex	2
pleiotropic T helper type 2 cytokine	2
Interleukin (IL)-13	2
PyMOL session files	2
user-submitted macromolecule structures	2
specific atom–aromatic ring (cation–π, donor–π, halogen–π, and carbon–π) and aromatic ring–aromatic ring (π–π) interactions	2
van der Waals', ionic, carbonyl, metal, hydrophobic, and halogen bond contacts, and hydrogen bonds	2
proteins and protein, DNA, or small-molecule ligands	2
specific interatomic interactions	2
pluripotency gene regulatory network	2
transcription factor subunits	2
tryptophan repeat	2
homeodomain	2
structural core of Nanog	2
residues at the WR termini	2
Sox2 heterodimerization	2
WR	2
functional and dimerization assays	2
tryptophan, the tryptophan repeat (WR)	2
every fifth residue	2
simple repeat region	2
dimerization domain	2
Nanog protein	2
portals	2
user-friendly interfaces	2
GPGPU-accelerated EGI grid resources	2
local CPU resources	2
broad community	2
putative location of the ligand	2
putative interface residues	2
atomic structures in cryo-electron density maps	2
GPGPU-accelerated software packages	2
atomic subunits	2
two software packages PowerFit and DisVis	2
data source	2
highly specialized software	2
SCOPe 2.06	2
expression tags	2
new superfamilies	2
sequences and structures of proteins	2
several databases and tools	2
ASTRAL compendium	2
fully hand-curated SCOP releases	2
highly precise automated tools	2
majority of protein structures	2
majority of proteins	2
expert-curated ordering of domains	2
Structural Classification of Proteins (SCOP) database	2
glycan contacts	2
combined data set	2
antibody/gp120 interface	2
antibody residues	2
three experimental surface plasmon resonance data sets	2
glycans on the surface of gp120	2
large bulky residues	2
three antibody–gp120 complexes	2
gp120 envelope glycoprotein of HIV-1 and three broadly neutralizing antibodies (bNAbs) of the VRC01 class	2
generally applicable computational method	2
transcription-blocking lesions	2
transcription-blocking lesion	2
elongating RNAP2	2
RNA polymerase II (RNAP2)	2
autophagic protein machinery	2
role of lipids	2
lipids including phospholipids, sphingolipids, and sterols	2
numerous protein–lipid interactions	2
double-membrane organelles	2
RNA stem-loop packing	2
actin fibre	2
myosin-V dimer “walking”	2
20,000 objects	2
large systems	2
laptop computer	2
Brownian-like diffusion	2
lower-level objects	2
higher-level objects	2
identical data structure	2
domains, molecules, and multimers	2
α-carbon or phosphate backbones	2
high-level application programming interface	2
integral graphical viewer	2
structural hierarchy	2
complex macromolecules	2
SimGenis a stand-alone computer program	2
archeal surrogates	2
hundreds of liganded structures	2
biochemical and biophysical assays	2
surrogate proteins	2
BRC repeats	2
Stepwise humanisation	2
fourth BRC repeat	2
chimeric archaeal human protein	2
BRC repeat binding sites	2
monomerised RadA	2
Pyrococcus furiosus	2
surrogate protein system	2
tumour suppressor BRCA2	2
recombinase RAD51	2
PPI	2
humanise” thermophilic archeal surrogate proteins	2
stable, unliganded target proteins	2
Protein–protein interactions (PPIs)	2
presence metal ion	2
pore of MOMP	2
transverse electric field	2
negative charges	2
narrow constriction zone	2
water-filled channel of MOMP	2
18-stranded, not 16-stranded, β-barrel	2
recombinant MOMP	2
otherwise identical structure	2
2.1-Å crystal structure of C. jejuni MOMP	2
nutrients and antibiotics	2
one, termed major outer membrane protein (MOMP)	2
two major porins, OmpC and OmpF, C. jejuni	2
Gram-negative organism Campylobacter jejuni	2
living cells and organisms	2
functional intracellular antibodies	2
mintbody	2
critical amino acids	2
H4K20me1-mintbody in mouse and nematode cells	2
dosage-compensated X chromosomes	2
yeast mutants	2
H4K20me1-mintbody in living cells	2
histone H4 Lys20 monomethylation (H4K20me1)	2
new mintbody specific	2
useful visualization tool	2
single-chain variable fragment	2
genetically encoded probe called mintbody (modification-specific intracellular antibody)	2
σ–RNAP interface	2
different regions of σ70 and σ54	2
major and major variant σ factor interacting surfaces	2
bacteriophage-encoded transcription regulatory proteins	2
major variant form of the host RNAP	2
cognate promoter	2
major variant bacterial σ factor, σ54	2
σ70 factor	2
host RNAP	2
phage protein P7	2
major bacterial σ factor, σ70	2
Bacteriophage-encoded small proteins	2
bacterial transcription machinery	2
different classes	2
key flavin adenine dinucleotide-binding domain	2
cofactor-dependent enzymes	2
classes A, B, E, F, and G	2
powerful biotechnological tools	2
key physiological roles	2
Flavin-dependent monooxygenases	2
3′–5′ proofreading exonuclease activity	2
Archaea	2
Afu Pol-D	2
alternate strand of a replication fork	2
deaminated base	2
copied DNA strand	2
trans”	2
Uracil and hypoxanthine slowed Afu Pol-D	2
deaminated base binding site	2
isolated DP2	2
weaker inhibitor	2
template strand hypoxanthine	2
C terminal	2
+ ion	2
single, critical Zn2	2
cluster nearest the C terminus	2
two conserved cysteine clusters	2
C-terminal region of DP2	2
(Afu Pol-D)	2
Archaeoglobus fulgidus	2
one of the least studied polymerase families	2
Pol-D	2
large (DP2) polymerase subunit	2
proofreading subunit	2
small (DP1)	2
Archaeal family-D DNA polymerases (Pol-D)	2
enlarged EspG/TfR/Rab11 positive, EEA1/Clathrin negative stalled recycling structures	2
newly formed endosomes	2
host cell surface	2
small GTPases ARF6 and Rab35	2
conserved EHEC and EPEC effector EspG	2
Type III secretion system	2
gut mucosa	2
Enteropathogenic and enterohaemorrhagic Escherichia coli (EPEC/EHEC)	2
nucleus and the cytosol	2
preformed and active sub-modules	2
core deacetylase and chromatin-remodeling sub-modules	2
one of core components (MBD3)	2
CHD4 in live mouse embryonic stem cells	2
MultiBac system	2
possible combinations of different components	2
chromatin remodeler CHD4	2
stable core of subunits	2
endogenous Drosophila NuRD complex	2
stable and functional sub-modules	2
chromatin modifying machines	2
highly conserved regulator	2
nucleosome remodeling deacetylase (NuRD) complex	2
transcription preinitiation	2
cytosol of cells	2
distinct preformed submodules	2
TFIID itself	2
core promoter	2
first GTFs	2
20 subunits	2
megadalton-sized multiprotein complex	2
General Transcription Factors (GTFs), RNA polymerase II (RNA pol II), co-activators, co-repressors, and more	2
plethora of proteins and protein assemblies	2
Preinitiation Complex (PIC)	2
reported and proposed kinase substrates	2
vacuole or a lysosome	2
cell organelles	2
single proteins	2
cytosolic structures	2
intracellular degradation pathway	2
repeat proteins	2
putative dimerisation interface	2
specific, highly populated stable intermediate	2
terminal α-helix	2
CTPR ensemble	2
variant CTPR protein	2
helices within CTPR ensembles	2
new helix deletion series of consensus tetratricopeptide repeat proteins (CTPRs)	2
sophisticated heteropolymer Ising model	2
repeated motifs)	2
series of identical interacting subunits	2
homozipper Ising models	2
linear Ising models	2
modular repetitive construction	2
quasi one-dimensional non-globular structures	2
Repeat proteins	2
gap junction channels	2
channel pore pathway	2
cytoplasmic side	2
cytoplasmic entrance and extracellular gap region	2
chordate connexin channels	2
single INX-6 gap junction channel	2
three-dimensional reconstruction	2
N-terminal deleted INX-6 proteins	2
three-dimensional structure of two-dimensionally crystallized Caenorhabditis elegans innexin-6 (INX-6) gap junction channels	2
recombinant innexin channels	2
connexin gap junction channels	2
small signaling molecules	2
intercellular channels	2
Innexins are invertebrate-specific gap junction proteins	2
improved protein structures	2
series of validation resources and facilities	2
associated loader protein	2
Mol.	2
Escherichia coli fork	2
DnaC protein	2
DnaB helicase	2
DnaB6–DnaC6 complexes	2
excess DnaB	2
replicative helicase and helicase loader	2
sites on the chromosome	2
origins of replication	2
accessory replicative helicase Rep	2
PriA-specific initiation	2
oriC-specific initiator DnaA	2
DnaC mutant	2
wild-type DnaC	2
DnaB6–DnaC6 complex	2
helicase loader DnaC	2
Escherichia coli replicative helicase DnaB	2
initiators and helicase loader proteins	2
cationic antimicrobial peptides	2
basic and aromatic residues	2
C-terminal helix	2
biologically active Slf fragment	2
non-enzymatic class of the DinB fold	2
three short helices	2
four-helix bundle	2
surprising version	2
DfsB homologues	2
new crystal structures	2
secreted precursor protein, DfsB	2
distant ones	2
neighbouring colonies	2
lethal protein (Slf)	2
Paenibacillus dendritiformis	2
mβ2m	2
mouse β2m (mβ2m)	2
absence of NaCl	2
human β2m (hβ2m)	2
various algorithms	2
mouse and human β2-microglobulin protein orthologs	2
situ architecture	2
cell's nucleus	2
110-MDa complex	2
protein building blocks	2
regulatory agents	2
antisense small RNAs	2
two riboregulators	2
cognate, independent targets	2
cis-repressing 5′ untranslated region	2
reverse complement of a known riboregulator	2
framework of riboregulation	2
preexisting genes	2
Saccharomyces cerevisiae Dbp5 ATPase cycle	2
intrinsic and regulator-activated Dbp5 ATPase cycle	2
endogenous small molecule InsP6)	2
several regulatory factors (e.g., RNA, nucleoporin proteins	2
DEAD-box protein Dbp5/DDX19	2
biomaterials and peptides	2
increasingly large and therefore complex sets	2
several sequences	2
36 pairs	2
eight-peptide interactome	2
32 hypothetical off-target interactions	2
1,180,416 member interactome	2
varied residues	2
parallel dimeric coiled-coil motif	2
preferentially interacting peptides	2
resulting interactome	2
large virtual libraries of peptide sequences	2
derived peptides	2
designed protein–protein interactions (PPIs)	2
naturally occurring proteins	2
MS2 virions	2
pilin-binding domains	2
N-terminal regions	2
related phages	2
MP sequences	2
two sections of the N-terminal half of the protein	2
MP	2
RNA-binding peptides	2
protein-free RNA	2
PSs	2
protein-free genomic fragments	2
multiple, dispersed and degenerate RNA sites	2
discrete and similar contacts	2
CP subunits	2
every viral particle	2
MP)–RNA interfaces	2
coat protein (CP)–RNA and maturation protein (	2
genomic RNA of bacteriophage MS2	2
capsid proteins	2
peptide and oligonucleotide sequences	2
new synthetic enzymes	2
uncharacterised sequences	2
wide range of superfamilies	2
different catalytic machineries	2
different superfamilies	2
enzymes active site	2
detailed examples	2
one superfamily	2
Many superfamilies	2
379 structurally defined protein domain superfamilies	2
range of computational tools and resources	2
biological catalysts	2
individual enzymes in the FASII pathway	2
NAC fatty acid mimics	2
P. aeruginosa FabA protein	2
co-complex structure of N42FTA	2
direct mimic	2
Escherichiacoli acyl carrier protein and FabA	2
P. aeruginosa FabA. N42FTA	2
3-hydroxydecanoyl-NAC	2
N-(4-chlorobenzyl)-3-(2-furyl)-1H-1,2,4-triazol-5-amine (N42FTA)	2
diverse small molecules	2
high-throughput enzyme coupled fluorescence assay	2
key target in the FASII pathway	2
FabA, the bifunctional dehydration/epimerization enzyme	2
existing UV absorbance assay	2
Pseudomonas aeruginosa using (E)-2-decenoyl-NAC	2
assay of FabV	2
natural acyl carrier protein pathway intermediates	2
N-Acetylcysteamine (NAC) fatty acid thioesters	2
several existing antibacterial agents	2
human FAS	2
human FAS pathways	2
bacterial FASII pathway	2
fatty acid synthase (FAS) biosynthetic pathways	2
Eukaryotes and prokaryotes	2
majority of structures	2
similar structures	2
rich and intuitive user interface	2
PhyreStorm Web server	2
structurally similar proteins	2
role of IL-22	2
broad range of bactericidal compounds	2
IL-22RA1–IL-10R2 receptor complex	2
local immune system	2
epithelial layer	2
intestinal barrier	2
interaction interfaces	2
initiation factor complexes	2
PTMs	2
interacting subunits	2
eukaryotic initiation factors	2
dynamic heterogeneous protein complexes	2
related proteins	2
muscle-specific splice isoform	2
H1′ helix of the tail domain of metavinculin (MVt)	2
Vt helical bundle	2
N-terminal “strap” and helix 1	2
vinculin tail (Vt) domain	2
pseudo-atomic model	2
8.5-Å-resolution cryo-electron microscopy reconstruction	2
filamentous actin	2
intracellular binding partners	2
membrane-bound integrin and cadherin receptors	2
essential adhesion protein	2
set of rules	2
two conformational classes	2
adenine bases of the G·A and A·G pairs	2
number of key cross-strand hydrogen bonds	2
two minor grooves	2
RNA kinks	2
G·A and A·G pairs	2
three-nucleotide bulge	2
standard k-turn	2
members of the L7Ae family	2
widespread structural elements	2
Kink turns (k-turns)	2
subunits of multimeric complexes	2
crystal	2
APC/C, regions of Apc4	2
3.6-Å-resolution cryo-electron microscopy map	2
α-helical fold	2
long α-helical domain	2
WD40 domain	2
crystal structures of Apc4 and the N-terminal domain of Apc5 (Apc5N)	2
holo-complex	2
cell cycle proteins	2
large multisubunit complex	2
overall multimeric complex	2
capping protein CapZ.	2
α-actinin links	2
terminal 5–7nm of the actin filaments	2
reconstruction	2
antiparallel overlapping ends	2
α-actinin	2
four to six layers of links	2
tomograms of rat cardiac muscle	2
fast skeletal muscles	2
Z-bands	2
slow skeletal and cardiac muscles	2
longitudinal sections	2
small-square lattice	2
transverse-section electron micrographs	2
vertebrate striated muscle crosslinks actin filaments	2
cAMP signalling genes	2
amoebozoan encystation	2
unicellular amoebozoan ancestors	2
cell–cell communication systems	2
four major groups of Dictyostelia	2
eukaryotes and prokaryotes	2
spore-bearing fruiting body	2
Aggregative multicellularity	2
non-telomere controls	2
eukaryotic single-stranded DNA binding protein	2
specific TG-rich telomere sequence	2
control DNA	2
isolated DNA binding domain of Cdc13	2
bacteriophage λ	2
model exonuclease	2
recessed strand	2
telomere-specific CST complex	2
3′ single-stranded extension	2
TG-rich double-stranded region	2
stem–loop	2
oligodeoxynucleotide	2
exonuclease-catalyzed degradation (resection) of telomeres	2
biochemical assay	2
5′ CA-rich recessed strand	2
single-stranded 3′ TG extension	2
repetitive TG-rich DNA	2
ends of all eukaryotic chromosomes	2
two distinct groups	2
DNase–Immunity pairs	2
unfulfilled hydrogen bond	2
Pro in DNase loop 4	2
Asp-to-Gly substitution	2
DNase backbone	2
Asp	2
Im helix III	2
DNase–Immunity protein binding interface	2
immunity protein binding energy hotspot, helix III	2
important class of high-affinity protein complex	2
Im subfamilies	2
divergent DNase–	2
AP41 DNase–ImAP41	2
Pseudomonas aeruginosa, pyocin S2 DNase–ImS2 and pyocin	2
Im complexes	2
closely related colicin-like bacteriocins	2
high-affinity protein–protein interactions	2
colicin DNase–	2
exogenous DNase bacteriocins	2
inhibitory immunity (Im) proteins	2
colicin DNase domains	2
ultra-high-affinity protein–protein interactions	2
different structural regions	2
disease-causing SAVs	2
SAV.In	2
individual amino acids	2
core or rim residues	2
remaining non-interacting surface	2
interface rim	2
rim (p<0.01)	2
interface core	2
human single amino acid variations (SAVs)	2
protein–protein complex	2
small subset of residues	2
two main regions	2
non-uniform surface areas	2
called interfaces	2
protein–protein interaction sites	2
single protein only (eIF-5A)	2
complex bi-directional membrane transport system	2
ubiquitin-independent proteasomal degradation	2
antizyme and an antizyme inhibitor	2
essential class of metabolites	2
polyamines (PAs) spermidine, spermine, putrescine and cadaverine	2
disease-associated amyloid fibrils	2
species in solution	2
scFv–peptide complex	2
scFv:HTT(1-17) complex	2
dimeric C4	2
β-sheet interface	2
asymmetric unit	2
HTT(1-17) complex	2
scFv:	2
region of another C4	2
Residues 12–17 of the peptide	2
hydrophobic face	2
antibody fragment	2
amphipathic helix	2
residues 3–11	2
crystal structure of the complex of C4 scFv and HTT(1-17)	2
exon1 fragments of huntingtin	2
first 17 residues of huntingtin [HTT(1-17)]	2
C4 single-chain Fv antibody (scFv)	2
fragments of mutant forms of the huntingtin protein (mHTT)	2
local helical contacts	2
all-α Greek key protein FADD (Fas-associated death domain)	2
angucyclinone ketoreductase	2
keto group by SimC7	2
DNA gyrase inhibitor	2
NAD(P)H-dependent ketoreductase	2
angucyclinone moiety	2
normal tetraene linker	2
novel simocyclinone, 7-oxo-SD8	2
Streptomyces coelicolor strain	2
simocyclinone heterologously	2
single phage artificial chromosome clone	2
entire ~72-kb sim cluster	2
two modules of the polyketide synthase	2
monofunctional enzymes	2
two monofunctional enzymes	2
modular type I polyketide synthase	2
tetraene linker	2
hypothetical biosynthetic pathway	2
simocyclinone (sim) biosynthetic gene cluster	2
Streptomyces antibioticus Tü6040	2
potent DNA gyrase inhibitor	2
protists, fungi, plants and animals	2
pentameric nucleoplasmin-like NPL domain	2
new family of proteins	2
dimer of pentamers	2
Arabidopsis thaliana histone deacetylase type 2 (HD2) and Saccharomyces cerevisiae Fpr4	2
two other chromatin proteins	2
unrelated Drosophila protein	2
first structure of a nucleoplasmin-like domain (NPL)	2
nucleoplasmin family	2
doughnut-like structure	2
pentameric core domain	2
pentameric N-terminal domain	2
mitochondrial/cytosolic components of the ERMES complex	2
ERMES complex	2
peroxisomes and mitochondria	2
gene encoding the fourth, endoplasmic-reticulum-associated component of the complex	2
mitochondrial and cytosolic components of the ERMES complex	2
MDM10, MDM12 and MDM34	2
temperature-sensitive essential gene mutants	2
non-essential gene deletion mutants	2
yeast Pex11	2
peroxisomes the mitochondrial fission machinery	2
Saccharomyces cerevisiae Pex11	2
one of the three mammalian paralogs	2
peroxisomes in eukaryotic cells	2
peroxin	2
mutant DDX3X	2
important mRNA targets	2
cancer-associated mutants G302V and G325E	2
ded1 temperature-sensitive strain of Schizosaccharomyces pombe	2
residues G302 and G325	2
D1 domain	2
double-stranded RNA	2
two conserved RecA-like helicase domains, D1 and D2	2
DEAD-box helicases	2
ABL	2
N-terminal extension (“ATP-binding loop”, ABL)	2
pediatric medulloblastoma	2
DEAD-box RNA helicase DDX3X	2
various import pathways	2
dedicated machineries	2
ER (endoplasmic reticulum	2
organelles of the endomembrane system	2
DDs of CD95 and FADD	2
quasi- but non-exact equivalent environments	2
PIDD-DD	2
monodisperse 5:5 complex	2
mutant RAIDD-DD	2
asymmetric complex	2
non-equivalent sites	2
high-molecular-weight species	2
5:5 core	2
heaviest species in solution	2
5:5, 6:5 and 7:5	2
RAIDD-DD:PIDD-DD stoichiometries	2
DDs	2
PIDD-DD and RAIDD-DD in solution	2
additional two RAIDD-DDs	2
second layer	2
one layer	2
PIDD-DDs	2
asymmetric three-layered arrangement	2
PIDDosome core complex	2
PIDDosome	2
oligomeric signaling complexes	2
eIF4E1a 2-fold	2
amino acids differentiating eIF4E1b	2
protein's core	2
linker from Sepharose	2
phosphate chain	2
benzyl group at N7 position of guanine	2
cap-binding residues	2
eIF4E1b proteins	2
N7 of guanine	2
critical amino acids: Trp56, Trp102, Glu103, Trp166, Arg112, Arg157 and Lys162 and residues of the C-terminal loop	2
cap-binding pocket	2
eIF4E proteins	2
cap analogues	2
Xenopus and human eIF4E1b interactions	2
4E-T.	2
binding eIF4G	2
m7GTP-Sepharose	2
additional RNA-binding proteins	2
Xp54/DDX6 RNA helicase	2
eIF4E-binding protein 4E-Transporter	2
CPEB mRNP translation repressor complex	2
mouse, Xenopus and zebrafish oocytes	2
canonical translation initiation factor 4E (eIF4E1a), cap-binding protein	2
alternative nucleophile	2
selected C-extein sequence	2
targeted enzyme	2
selected sequences	2
Three different proteins	2
wild-type Cys+1 intein	2
extein sequences	2
C-extein cysteine nucleophile (Cys+1)	2
frequently used Nostoc punctiforme	2
synthetic or biological origins	2
molecular marvels	2
native peptide bond	2
surrounding extein fragments	2
precursor proteins	2
TJ architecture	2
extracellular variable regions	2
claudin dimer	2
edges of the extracellular β-sheets	2
dimerize face	2
antiparallel double rows	2
claudin protomers	2
backbone of TJ strands	2
claudin molecules	2
pore-lining surfaces	2
large extracellular domains	2
claudin	2
basolateral space	2
apical	2
tight barriers	2
cells in epithelial sheets	2
main cell–cell adhesion molecules of tight junctions (TJs)	2
fully functional membrane proteins	2
radioligand binding assays	2
heterologously expressed mammalian membrane proteins	2
correctly folded membrane proteins	2
sodium dodecyl sulfate or foscholine-12	2
either digitonin or dodecylmaltoside	2
misfolded membrane proteins	2
stable inducible mammalian cell lines	2
mammalian membrane proteins	2
commonly used expression systems	2
authentically folded eukaryotic membrane proteins	2
eukaryotic GEN1	2
excellent enzyme	2
latter protein	2
bacterial, phage and mitochondrial junction-resolving enzymes	2
second strand	2
discrete homodimer	2
DNA junctions	2
two strands	2
four-way DNA junctions	2
N-terminal 487-amino-acid section	2
thermophilic fungus Chaetomium thermophilum	2
protein–DNA complexes	2
recombination enzymes	2
blocked replication forks	2
polymerases at the fork	2
multiple bonds	2
replicative barriers	2
many barriers	2
constitutive heterochromatin	2
null chromatin	2
Polycomb-repressed chromatin	2
chromatin type adorning a TAD	2
Topologically associating domains (TADs)	2
Metazoan genomes	2
localized intragenic site	2
specific Polycomb complexes/H3K27me3	2
Arabidopsis plants	2
flowering locus C (FLC)	2
interconnections	2
trans-acting factors, histone modifications and non-coding RNAs	2
biological ion channels	2
model nanopores	2
part of the pore	2
lining of a hydrophobic pore	2
macroscopic descriptions	2
narrow confines of a sub-nanometer hydrophobic pore	2
nanoscale transmembrane pores	2
Biological ion channels	2
midbody microtubules	2
nucleotide-free states of myosins	2
configuration	2
kinesins	2
central β-sheet	2
bound ADP	2
dramatically opened ATP-binding pocket	2
ADP-bound form of the KIF14 motor domain	2
mouse KIF14 motor domain	2
mitotic kinesin motor protein KIF14	2
synthetic biology production line	2
various extant molecular biology tools	2
versatile and efficient tools	2
new areas	2
tyrosine and serine integrases	2
two major families of integrases	2
multi-cellular eukaryotes	2
diverse micro-organisms	2
ϕC31 and its relatives	2
bacteriophage integrases	2
SQLite database	2
modern browsers	2
VariBench benchmarking dataset	2
available batch methods	2
single amino acid variants (SAVs)	2
clinical indications	2
ABL P-loop	2
DDR and ABL kinases	2
ATP pocket	2
P-loop residues	2
cage-like structure of ABL	2
DDR1 P-loop	2
Abelson kinase (ABL)	2
activation loop and αD helix	2
DFG-out conformation (DFG, Asp-Phe-Gly) of the kinase domain	2
Co-crystal structures of human DDR1	2
potent molecule	2
selective type II inhibitor DDR1-IN-1	2
multi-targeted cancer drugs imatinib and ponatinib	2
unusual receptor tyrosine kinases	2
discoidin domain receptors (DDRs), DDR1 and DDR2	2
/scopResults.jsp].	2
interactive census of domains	2
Source code and software binaries	2
Web	2
enzyme classes	2
large manually curated benchmark	2
protein chains	2
protein tertiary and quaternary structures	2
ancillary domains	2
single conserved domain (often the nucleoside triphosphate binding domain)	2
overall chemistry group	2
C–N forming ligases	2
type of bond	2
associated protein families	2
ligases [Enzyme Commission (EC) Class 6]	2
SD8 and	2
previously observed complex	2
new apo structure of the GyrA N-terminal domain	2
GyrA dimer	2
two SD8 molecules	2
truncated form of the GyrA N-terminal domain fragment with and without SD8 bound	2
two symmetry-related SD8s	2
protein dimer	2
tetramer of the protein	2
four SD8 molecules	2
N-terminal domain of the DNA gyrase A protein (GyrA)	2
previous structure of SD8 complexed	2
Streptomyces antibioticus	2
catalytically inactive EAL domains	2
EAL domains	2
BLUF domain	2
EAL active site	2
EAL dimerization region	2
BLUF and EAL domains	2
allosteric communication pathway	2
different functional BlrP1 states	2
c-di-GMP levels	2
EAL phosphodiesterase domain	2
covalently linked system of a sensor of blue light using FAD (BLUF)	2
blue-light-regulated phosphodiesterase 1 (BlrP1) of Klebsiella pneumoniae	2
c-di-GMP concentrations	2
second messenger cyclic dimeric GMP (c-di-GMP)	2
One central signaling molecule	2
aggregates of IgG4	2
intact IgG4 molecules	2
Fc–Fc interactions	2
known hydrophobic aggregation motifs	2
CH2–CH3 interface	2
IgG-Fc	2
consensus binding site	2
extensive interaction surfaces	2
Fc–	2
crystals of IgG4-Fc	2
lower hinge region	2
FG loop	2
IgG1 and	2
FG loop in the CH2 domain	2
CH3–CH3 interface	2
human recombinant and serum-derived IgG4-Fc	2
FcγRII and FcγRIII, and complement	2
monovalent but bispecific antibodies	2
least abundant of the four subclasses of IgG in serum	2
Human IgG4	2
axle of the V-ATPase rotary motor	2
existing mechanistic models	2
region at the base of V1	2
three-dimensional reconstructions	2
endogenous subunit H	2
recombinant subunit C	2
H subunit	2
stator filament	2
one open active site	2
Inactivated V1	2
domains of the V-ATPase	2
flexible rods	2
unsupported filaments	2
mechanical stator	2
three peripheral stalks	2
Manduca sexta	2
deactivated V1	2
asymmetric motors	2
membrane-bound proton pump Vo	2
cytoplasmic V1 domain	2
vacuolar H+-ATPase (V-ATPase)	2
forms of streptavidin	2
ultra-stable labeling	2
monovalent streptavidin	2
hexaglutamate tag	2
adjacent biotin-binding site	2
one ligand	2
cis and trans binding sites	2
small biotinylated protein	2
cis-divalent but not trans-divalent streptavidin	2
Biotinylated DNA	2
biotin ligand	2
defined divalent streptavidins	2
tetravalent streptavidin	2
trans-divalent streptavidins	2
Dead streptavidin variant	2
crystal structures of cis-divalent streptavidin	2
mixture of monomers	2
negatively charged tags	2
specific subunits	2
precise arrangement, cis or trans	2
two biotin-binding sites	2
streptavidin tetramers	2
four biotinylated molecules	2
biotinylated surface/nanoparticle	2
one molecule	2
multimerizing biomolecules	2
structured α-spectrin tail	2
intrinsically disordered β-spectrin tail	2
previously studied spectrin domains	2
non-covalent three-helix bundle domain	2
“spectrin tetramer domain	2
N-terminal tail of α-spectrin	2
intrinsically disordered C-terminal tail of β-spectrin	2
R state	2
MWC (Monod–Wyman–Changeux) allosteric model	2
19 non-native amino acids	2
every residue	2
entire mutability landscape	2
Many computational tools	2
effect and neutral variants	2
protein residues	2
particular genomic DNA fragments	2
distinct populations of locations	2
Cse4 octamer	2
canonical yeast octamer	2
recombinant frog and native chicken histones	2
centromere-specific histone variant, Cse4	2
yeast chromatin	2
chicken, frog and yeast core histones	2
genomes of sheep, drosophila, human and yeast	2
four plasmid DNAs	2
aggregation-prone OMPs	2
OMPs in the periplasm	2
complex folding environment	2
partially redundant parallel chaperone pathways	2
combination of spectroscopic and SDS-PAGE assays	2
[1,2-dilauroyl-sn-glycero-3-phospho-(1′-rac-glycerol)]	2
negatively charged 80:20 diC12:0PC:diC12:0PG	2
(1,2-dilauroyl-sn-glycero-3-phosphocholine) liposomes	2
zwitterionic diC12:0PC	2
OMP, PagP.	2
Skp and SurA	2
two chaperones	2
unfolded outer membrane proteins (OMPs)	2
molecular associations	2
14-3-3-ζ/integrin tail interactions	2
β1A variant	2
short β2 phospho-peptide	2
consensus 14-3-3-ζ binding motif	2
α4 phospho-peptide	2
α4 complex	2
14-3-3-ζ/	2
cytoplasmic tails of α4, β1, β2 and β3 integrins	2
α4 integrin tail	2
β2/14-3-3-ζ interactions	2
threonine in the β2 integrin tail	2
phosphorylated sequence motifs	2
a member of the 14-3-3 family of dimeric proteins	2
various other adaptors	2
one well-known intracellular activator	2
flexible cytoplasmic tails of the α- and β-integrin subunits	2
family of heterodimeric (α+β) adhesion receptors	2
name	2
novel regulatory scaffold	2
conventional calpains	2
identified cleavage sites	2
COS7 cells expressing CAPN3	2
transcriptional co-regulator	2
CTBP1 (C-terminal binding protein 1)	2
CAPN3 homologs	2
PLEIAD homologs	2
SIMC1/C5orf25 (SUMO-interacting motif containing protein 1/chromosome 5open reading frame 25)]	2
Platform element	2
novel CAPN3-binding protein, PLEIAD	2
non-sarcomere-associated CAPN3	2
giant molecule	2
CAPN3 and connectin/titin	2
skeletal-muscle-specific member of the calpain protease family	2
bEBP regulatory domain	2
first two helical domains	2
adjacent PspF subunits	2
PspF hexamer	2
self-association interface	2
σ54 binding loop 1	2
PspF W56 loop residues	2
‘YLW’ patch	2
tightly packed hydrophobic cluster	2
surface-exposed ‘W56 loop’ of PspF	2
three key binding determinants	2
side of a PspF hexameric ring	2
phage shock protein A (PspA)	2
Escherichia coli phage shock protein F (PspF)	2
ring-shaped hexameric self-assemblies	2
various cellular Activities) protein family	2
AAA+ (ATPases	2
Bacterial enhancer binding proteins (bEBPs)	2
previously unknown complexes	2
large heteromeric complex	2
clamp loader–SSB4 complex	2
SSB4 complex	2
ψχ–SSB4 (108kDa)	2
assemble models	2
clamp loader and a single-stranded DNA (ssDNA) binding protein (SSB4)	2
one form of the full clamp loader complex, γ3δδ′ψχ (254kDa)	2
sliding clamp (β2)	2
seven-subunit clamp loader complex	2
subassembly	2
strands of the chromosome	2
decameric 420-kDa assembly	2
DNA polymerase III	2
similar protein fold	2
residues in AE1	2
AE1 point mutants	2
electrogenic component	2
several AE1 point mutants	2
wild-type AE1	2
several mutants	2
E. coli ClC transport mechanism residues	2
Escherichia coli ClC channel structure	2
three-dimensional homology model	2
recent electron microscopy structure	2
high-resolution structure	2
renal collecting duct	2
plasma membrane of erythrocytes and type A cells	2
specific cocaine-bound conformation	2
HEK293 cell lines stably expressing the mutants	2
[3H]serotonin	2
wild-type transporter	2
thermostabilised SERT mutants bound [125I]RTI55 (β-CIT)	2
thermostabilised mutants SAH6 (L99A+G278A+A505L) and SAH7 (L405A+P499A+A505L)	2
point mutants	2
cocaine-sensitive rat serotonin transporter (SERT)	2
mammalian integral membrane proteins	2
genomes of bacteriophages	2
known subgroup of bacteriophage tubulin/FtsZ-like proteins	2
constituent protofilaments	2
ΦKZ TubZ filaments	2
Pseudomonas bacteriophage subgroup of tubulin/FtsZ-like proteins	2
canonical tubulin/FtsZ-like protofilament	2
ΦKZ TubZ	2
monomeric and protofilament states	2
Pseudomonas bacteriophage ΦKZ	2
tubulin/FtsZ-like protein TubZ	2
bacterial host	2
replicated bacteriophage virions	2
group of related tubulin/FtsZ-like proteins	2
Pseudomonas ΦKZ-like bacteriophages	2
multiple RNA packaging signal–CP interactions	2
STNV genome	2
longer RNA fragments	2
appropriately orientated helical RNA stems	2
helical extension	2
trimeric capsomere	2
plausible model	2
STNV CP	2
particle 3-fold axes	2
N-terminal helices	2
B3-containing virus-like particle	2
T=1 capsids	2
loop sequence	2
stem–loop presenting the tetra-loop sequence ACAA	2
CP, B3	2
RNA aptamer sequence	2
first 11 residues of the protein	2
previous crystal structures	2
positively charged N-terminal extension	2
β-barrel domain	2
CP	2
viral genomic RNA	2
satellite tobacco necrosis virus (STNV)	2
order of subunits in native type 1 pili	2
various pilus subunits	2
FimD usher	2
nascent pilus	2
outer membrane assembly platform	2
bladder cells	2
uropathogenic Escherichia coli	2
conserved chaperone/usher pathway	2
class of bacterial surface structures	2
Type 1 pili	2
unstructured region	2
folded domain	2
E60 and K64	2
intermolecular salt bridges	2
thioredoxin fold	2
unstructured N-terminal region	2
normal endoplasmic reticulum protein	2
Anterior gradient 2 (AGR2)	2
straight L and R filaments	2
available electron cryo-microscopy structures	2
flagellin	2
intermediate helical forms	2
“extreme” straight forms	2
distinct helical forms	2
“canonical” family	2
flagellin building block	2
“mechanical” model	2
near-longitudinal protofilaments	2
~30,000 identical flagellin molecules	2
range of distinct helical forms	2
flagellar filaments	2
surface of bacteria	2
corkscrew-like flagellar filaments	2
pore-forming cytolysins and cells	2
first example	2
intracellular actin-binding factors	2
PLY in a biochemical environment	2
lipid bilayer of giant unilamellar vesicles	2
major neurotoxin of Streptococcus pneumoniae	2
pore-forming, cholesterol-dependent cytolysin pneumolysin (PLY)	2
actin effector proteins	2
evolutionarily well-established pathogen target	2
eukaryotic actin cytoskeleton	2
Fab regions	2
top of its Fc region	2
Fc receptor and complement C1q	2
intact rabbit IgG structures	2
tip-to-tip contacts	2
two pairs of Fab regions	2
maximally extended hinge structures	2
Fab pairs	2
Fab–Fc and Fab–	2
different buffers	2
monomeric rabbit IgG	2
unchanged structures	2
250mM NaCl buffer	2
137mM NaCl buffer	2
high salt	2
buffers	2
dimeric species	2
principally monomeric species	2
Rabbit IgG	2
rabbit IgG	2
multitude of strains of different serotypes	2
capsule genes	2
remaining 7	2
major human gastrointestinal pathogen Campylobacter jejuni	2
capsular polysaccharide biosynthetic pathway	2
neighbors	2
CCP 14	2
CCP 13	2
module pairs 13–14	2
CCPs 12, 13 and 15	2
compact and intimate arrangements of CCP 14	2
CCP 10	2
CCPs 8 and 9	2
CCPs 10–15 and 8–15	2
longer recombinant segments	2
CCPs 10	2
immediate neighbors	2
CCPs 10–13	2
S-shaped structure	2
previously solved CCP 12–13 structure	2
CCP 12	2
recombinant triple‐module fragment	2
three-dimensional structure of CCPs 10–12	2
overlapping recombinant CCP pairs	2
intervening CCPs 9–18	2
covalently attached, activation-specific, fragments of complement component C3	2
polyanion-rich host surfaces	2
CCPs 1–4, CCPs 6–8 and CCPs 19–20	2
foreign organisms	2
self-tissue	2
complement control protein (CCP) modules	2
155-kDa plasma glycoprotein factor H (FH)	2
membrane tubes	2
even higher‐order oligomers	2
dimeric structures	2
vesiculated structures	2
CG MD simulation	2
preformed lipid tubules	2
preformed membrane tubules	2
different ENTH-bound membrane morphologies	2
N-terminal helix (H0) of the ENTH domain	2
phosphatidylinositol 4,5‐bisphosphate	2
phosphatidylinositol 4,5-bisphosphate‐lipid‐targeting and membrane‐curvature‐generating element	2
conserved epsin N-terminal homology (ENTH) domain	2
p53 interactome	2
ankyrin repeat and SH3 domains	2
site of the p53 mutational hotspot R175	2
loop in p73	2
divergent L2 loop	2
p73 structure	2
ankyrin repeat and SH3 domains of the pro-apoptotic factor ASPP2	2
p73 DBD	2
viral oncoproteins	2
DNA-binding domain (DBD) of p73	2
p53 function	2
family of stress-responsive transcription factors	2
Tumor suppressors p53	2
variants of R16 and R17	2
correct register	2
two helices	2
C-helices	2
much smoother, more typical landscape	2
homologue R15	2
rough energy landscape	2
elongated three-helix‐bundle spectrin domains R16 and R17 fold	2
relaxed (open) state	2
tense (closed) state	2
pore-lining helices of the αγ and δ subunits	2
region of the gate	2
central hydrophobic gate	2
closed channel	2
β-subunit helices	2
narrow membrane-spanning pore	2
juxtaposed ends of α-helices	2
extracellular portion of the β subunit	2
ligand-binding domain	2
ACh-sprayed and freeze-trapped postsynaptic membranes	2
open-channel form	2
nicotinic acetylcholine (ACh) receptor	2
foreign epitope	2
native core shells	2
pairs of epitopes	2
shell	2
flanking linker regions	2
preS1 region of hepatitis B virus surface antigen	2
foreign epitope, DPAFR	2
DNA containing shells in virions	2
modified shells	2
T=4 shells	2
native T=3 shell	2
quasi-atomic model	2
T=3 shells	2
T=4 shell	2
T=3 and T=4 icosahedral shells	2
Recombinantly expressed core protein	2
model epitope	2
core shells	2
exterior of the shell	2
tips of spikes	2
potent immune stimulator	2
core shell of hepatitis B virus	2
Cascade	2
duplex DNA	2
CRISPR R-loops	2
ribonucleoprotein complexes (“Cascades”)	2
Clustered Regularly Interspersed Short Palindromic Repeats)	2
prokaryotic immune system	2
research papers	2
RNA strand into duplex DNA	2
Stable RNA–DNA hybrids	2
overall shape and domain interactions	2
three-dimensional structural model	2
PHD and chromo domains	2
N-terminal plant homeodomain (PHD) and chromo domains	2
helicase-domain-containing ATPase CHD4 (Mi-2β) subunit	2
mammalian NuRD complex	2
crucial epigenetic regulator	2
NuRD (nucleosome remodeling and deacetylase) complex	2
effector signal of therapeutic antibodies	2
mAb in serum	2
engineered mAb and endoglycosidase in serum	2
engineered mAb	2
serum IgG	2
oligomannose-type glycans	2
engineered IgG Fc	2
type found on IgG	2
complex-type glycans	2
EndoS (endoglycosidase S)	2
therapeutic mAb	2
Fc from FcγRs and (ii) a modification	2
cell-surface Fcγ receptors (FcγRs)	2
monoclonal antibody (mAb)	2
E. coli Hfq	2
V. cholerae and	2
divergent CTRs	2
E. coli CTR	2
intersubunit interface	2
V. cholerae hexamer	2
folded core	2
variable CTR	2
conserved NTD	2
star-shaped hexameric structure	2
C-terminal regions (CTRs)	2
N-terminal domain (NTD) of the two proteins	2
Escherichia coli Hfq	2
V. cholerae Hfq structure	2
four Hfq-dependent small RNAs	2
bacterial RNA binding protein	2
DNAs	2
nucleosome positioning sites	2
corresponding MNase cleavage sites	2
nucleosomal dyad	2
CAD cleavage sites	2
CAD nuclease	2
preferred cleavage sites	2
chicken or frog histone octamer binding sites	2
internucleosomal (linker) DNA	2
either micrococcal nuclease (MNase) or caspase-activated DNase (CAD)	2
either chicken or frog histones	2
genomic DNA molecules	2
evolutionary conserved nexus	2
Spt5-like factors	2
transferred DNA	2
termination factors	2
bacterial homologue NusG	2
one RNAP-associated transcription factor—Spt5	2
three domains of life	2
core subunits of RNAPs	2
Evolutionary related multisubunit RNA polymerases (RNAPs)	2
helices I, II and IV	2
regions of the polypeptide chain	2
four helices	2
local clusters of hydrophobic residues	2
urea-denatured state	2
unfolded species	2
L19A–	2
unfolded species of L18A–	2
–L37A)	2
three amino acid substitutions (L18A–L19A	2
sequence of Im7	2
four-helix protein, Im7 (immunity protein 7)	2
unfolded ensemble in aqueous solution	2
multiple, competing folding routes	2
fast pathway	2
1,2-dilauroyl-sn-glycero-3-phosphoserine	2
mixed 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine:	2
1,2-dilauroyl-sn-glycero-3-phosphocholine (diC12:0PC) liposomes	2
liposome surface	2
tryptophan fluorescence	2
bacterial outer membrane protein PagP.	2
domain/domain interface	2
two tandem pairs	2
tandem pairs	2
tandem protein	2
domains in A168–A169	2
large population of intermediates	2
single cooperative unit	2
tandem domain pairs	2
continuous β-strand	2
tightly associated domain arrangements	2
A-band of the giant muscle protein titin	2
tandem immunoglobulin (Ig) domain pairs A164–A165 and A168–A169	2
multidomain environment	2
HdeB monomer	2
one of the key intersubunit interactions	2
dimeric interface	2
monomer of HdeB	2
HdeB protein	2
acid-denatured proteins	2
exposed hydrophobic surfaces	2
exposed dimeric interface	2
dimeric HdeA	2
acid-activated chaperones	2
highly expressed and related proteins	2
many bacterial proteins	2
Escherichia coli and Gram-negative bacteria	2
clustering of sites	2
PP2C enzymes	2
two or three metal ions	2
active site of SpoIIE	2
single manganese ion	2
PP2C phosphatases	2
flap region	2
PP2C-type phosphatases	2
five-stranded β-sheets	2
principal form in solution	2
phosphatase domain of SpoIIE	2
anti-sigma factor SpoIIAB	2
RNA polymerase sigma factor σF	2
anti-sigma factor antagonist SpoIIAA	2
smaller forespore cell	2
polar Z-rings	2
mid-cell	2
polar cell division sites	2
smaller classes in data sets	2
statistical framework	2
Cryo-EM structures	2
cryo-electron microscopy (cryo-EM) images	2
different isoforms	2
tetramers	2
p73 homotetramers	2
mixed tetramers	2
p53 and p63 tetramers	2
p53 family homotetramers	2
second helix (H2)	2
Like p73	2
intramolecular β-sheet and hydrophobic helix packing (H1)	2
primary dimers	2
highly intertwined monomers	2
human p63 tetramerization domain	2
DNA response elements	2
p53, p63 and p73—plays	2
p53 family of transcription factors	2
GT	2
allosteric activator	2
putative macrolide binding site of EryCIII	2
EryCII subunits	2
center of the complex	2
extensive self-complementary dimer interface	2
EryCIII subunits	2
EryCIII·EryCII complex	2
macrolide scaffold	2
nucleotide-activated sugar	2
partner EryCII	2
clinically important antibiotic erythromycin D, the glycosyltransferase (GT)	2
SpoVT/AbrB-type DNA-binding domains	2
large and globular hetero-octameric assembly	2
four molecules of each protein	2
VapBC TA complex	2
intact Shigella flexneri	2
enteric vapBC TA loci	2
promoter regions of the cognate TA operon	2
cellular mRNA and tRNAs	2
Many toxins	2
active regulators	2
archaea and prokaryotes	2
Toxin–antitoxin (TA) loci	2
single cluster	2
convincing tilt-pair parameter plot	2
Tilt pairs	2
exposure	2
Smaller particles	2
largest particles	2
Single particles	2
particle image	2
individual single particles	2
pair of electron microscope images	2
AcsD and other members of the non-ribosomal peptide synthetase-independent siderophore superfamily	2
l-serine	2
enzyme class	2
product complex	2
first X-ray crystal structure	2
citryl-adenylate intermediate	2
also amides	2
esters	2
AcsD enzyme	2
homochiral ester	2
enzyme-bound citryl adenylate by l-serine	2
citric acid with l-serine	2
D. dadantii achromobactin biosynthesis protein D (AcsD) enzyme	2
siderophore achromobactin	2
Dickeya dadantii	2
non-ribosomal peptide synthetase-independent siderophore biosynthetic pathway	2
new antibacterial agents	2
amino acid substitution models	2
amino acid-level and codon-level models	2
protein-coding DNA sequence	2
time-homogeneous Markovian substitution model	2
Markov models	2
autolysin and motility genes	2
SinI and (ii) the SinR-like protein	2
(i)	2
pair of SinR consensus sequences	2
oligonucleotide duplex, 5′-TTTGTTCTCTAAAGAGAACTTA-3′	2
tetramerisation core	2
DNA binding domains	2
intact SinR tetramer	2
residues at the C-termini of the four chains	2
SinR–SinI complex	2
SinR(74–111) chain	2
SinI-binding fragment (residues 74–111)	2
DNA-binding fragment of SinR (residues 1–69)	2
SinR tetramer	2
intermolecular four-helix bundle	2
pair of α-helices	2
heterodimer-forming surface	2
biofilm genes	2
DNA-binding functions of SinR	2
SinR–SinI heterodimer	2
dimeric protein	2
tetrameric repressor of genes	2
short-chain detergents	2
ZM241385 binding pocket	2
agonist-bound conformation	2
mutant A2AR-GL26	2
bound agonist [3H]5'-N-ethylcarboxamidoadenosine (NECA)	2
natural agonist adenosine	2
bound inverse agonist ZM241385	2
cytoplasmic loop 3	2
antagonist-bound conformation	2
agonist adenosine	2
G-protein-coupled receptor	2
adenosine A2A receptor (A2AR)	2
multidomain proteins	2
nonnative DBD–DBD interactions	2
Trp91/Arg174 packing	2
disordered proline-rich N-terminal domain	2
residues 94–292	2
DNA-binding domain (DBD) of human p53	2
X-ray crystallography	2
certain segments of the protein	2
truncated variants	2
structured and intrinsically disordered regions	2
emerging class of oligomeric, multidomain proteins	2
tetrameric tumor suppressor p53	2
C-protein dimer	2
DNA completely	2
unusual positively charged surface	2
palindromic recognition half-sites	2
largely AAAA tracts	2
DNA binding site of the protein	2
extra helices	2
protein subunit	2
previously solved C-protein structures	2
novel class of controller proteins	2
R–M genes	2
bacterial restriction–modification (R–M) systems	2
Controller proteins	2
subretinal deposits	2
functionally important SCR-6/8 domains	2
daisy-chained oligomers	2
zinc binding sites	2
Predicted SCR-6/8 dimer structures	2
SCR-6 and other domains	2
Metal site prediction web servers	2
putative partial surface zinc binding sites	2
known zinc binding sites in crystal structures	2
SCR-1/5 and SCR-16/20 fragments	2
μM zinc	2
FH and SCR-6/8 allotypes	2
recombinant SCR-6/8 allotypes with Tyr/His402	2
native Tyr402 and the AMD-risk His402 homozygous allotypes of FH	2
large amounts of oligomers	2
homozygous FH	2
short complement regulator (SCR) domains	2
Tyr402His polymorphism of complement factor H (FH)	2
potentially hundreds of genes	2
5′ and 3′ genetic elements	2
integrated luciferase reporter cassette	2
proliferating cell nuclear antigen (Pfpcna)	2
prototypical housekeeping gene	2
bxb1 integrase system	2
human malarial parasite Plasmodium falciparum	2
large soluble oligomers	2
αB R120	2
equivalent of Arg120	2
Hsp27, Hsp20, αA- and αB-crystallin sequences	2
extended set	2
two new salt bridges	2
His83 and Asp80 on movable arches	2
extensive array of charged interactions	2
closed groove	2
R120G ACD dimer	2
ACD dimer	2
large assemblies of full-length αB-crystallin	2
flat extended “bottom sheet	2
deep groove	2
Wild-type excised ACD dimers	2
several recently determined wild-type vertebrate ACD dimer structures	2
R120G	2
excised ACD dimer of human αB	2
αB-crystallin	2
lens and neuromuscular system	2
several human small heat shock protein family members	2
ACD	2
conserved arginine	2
sequence extensions	2
“α-crystallin domain” (ACD)	2
large cytosolic assemblies	2
Small heat shock proteins	2
highly similar conformation	2
DNA-binding domain of PARP-1	2
different DNA lesions	2
nicked or gapped DNA ligands	2
two-finger fragment	2
DNA single-strand breaks	2
F1+F2 fragment	2
24-kDa DNA-binding domain (F1+F2)	2
independent fragments	2
F1 and F2 fingers of human PARP-1	2
PARP-1 itself	2
polyadenosine-ribose (PAR)	2
F1 and F2	2
two zinc fingers	2
DNA single- and double-strand breaks	2
higher eukaryotic cell nuclei	2
highly abundant chromatin-associated enzyme	2
Poly(ADP-ribose)polymerase-1 (PARP-1)	2
detergent molecule	2
detergent substitutes	2
completely delipidated detergent environment	2
Virtually identical two-dimensional crystals	2
Lipid molecules	2
well-ordered and partly ordered lipid molecules	2
lipid bicelles	2
structure of GlpG	2
crystals of GlpG, an Escherichia coli rhomboid protease	2
structural artefacts	2
nonnative detergent environment	2
active-site residues	2
core of six transmembrane helices	2
prokaryotic homologue of rhomboid proteases	2
separate but overlapping genes	2
separate gene products	2
intron of GANP	2
promoter for MCM3AP	2
N-terminally truncated region of GANP	2
MCM3AP and GANP genes	2
carboxy terminus of GANP	2
entire MCM3AP sequence	2
much larger GANP sequence	2
MCM3 acetylase DNA sequence	2
MCM3 acetylase (MCM3AP) and germinal-centre associated nuclear protein (GANP)	2
rotor of the enzyme	2
two molecules of ATP	2
final inhibited complex	2
aqueous cavities	2
long α-helix of IF1	2
Several conserved charged amino acids	2
residue R408 in the C-terminal domain of the βDP-subunit	2
residue E30 in the inhibitor	2
C-terminal domains of the βDP-subunit and βTP-subunit	2
residues in the long α-helix of IF1	2
F1Fo-ATPase	2
N-terminal region of IF1	2
mutant inhibitor protein	2
individual amino acid residues	2
five of the nine subunits of F1-ATPase	2
α-helical inhibitor	2
residues 1–60 of the bovine inhibitor protein IF1	2
structure of bovine F1-ATPase	2
two lysine residues	2
sulfate group	2
mannose binding sites	2
Glu-Pro-Asn signature motif	2
C-type carbohydrate-recognition domain	2
axial 4-OH group of the galactose residue in 6SO4–Galβ1–4GlcNAc also coordinate Ca2	2
equatorial 3-OH group	2
fucose residue	2
nonreducing terminal galactose	2
fucose-containing oligosaccharides	2
glycan	2
fucose moiety of the blood group B trisaccharide Galα1–3(Fucα1–2)Gal	2
single glucose residue	2
β-glucan fragment, Glcβ1–3Glcβ1–3Glc,	2
second Ca2+-independent binding site	2
single mannose residue	2
Oligomannose compounds	2
vicinal hydroxyl groups	2
mannose, fucose, and glucose residues	2
blood group B antigen, and a fragment of β-glucan	2
series of oligomannose compounds	2
human langerin	2
carbohydrate-recognition domain	2
microarray of bacterial polysaccharides	2
bacterial lipopolysaccharides	2
mannose-containing O-specific polysaccharides	2
unusually diverse number of endogenous and pathogenic cell surface carbohydrates	2
fibronectin micropatterns	2
–myosin IIA	2
A431/SIP1 cells	2
cytoplasmic [Ca2+].	2
micromolar region	2
equilibrium	2
myosin monomer	2
turbidity assays	2
end of the coiled-coil region of myosin	2
myosin heavy chain IIA	2
minimal binding site	2
peptide competition assays	2
coiled-coil fragments	2
myosin target fragments	2
EF2 domain of S100A4	2
C-terminal fragments of nonmuscle myosin heavy chain IIA	2
calcium-binding protein S100A4	2
chaperone:effector complex InvB	2
homologous Salmonella sp	2
Spa15 complex	2
hydrophobic pockets	2
spin-labeled Spa15	2
attached spin labels	2
human Ras-like Rho guanosine triphosphatase RhoG.	2
mimic	2
number of effectors	2
chaperone of the type 3 secretion system	2
C8α-MACPF region	2
C8γ protrusion	2
C8β-MACPF	2
C8α-MACPF (membrane attack complex/perforin)-C8γ co-crystal structure	2
intersubunit organization	2
C8 heterotrimer	2
C8 subunits	2
important antibacterial immune effector	2
Complement component C8	2
P. aeruginosa and related Gram-negative bacteria	2
Improved drugs	2
frontline antibiotic ceftazidime	2
Escherichia coli PBP1b/ceftoxamine complex	2
PBP3/ceftazidime complex	2
PBPs	2
β-lactam-based inhibitors	2
key interactions	2
two β-lactams in the active site	2
substrate-binding cleft	2
purified PBP3	2
carboxy-terminal transpeptidase domain	2
amino-terminal membrane-proximal domain	2
apo and acyl complexes	2
two important β-lactam antibiotics, carbenicillin and ceftazidime	2
first crystal structures of a penicillin-binding protein (PBP), PBP3	2
FIV ψ	2
structure of SL2	2
individual regions of SL2	2
packaging completely	2
different palindromic sequence	2
palindrome within gag	2
structure of the LRI	2
alternative, non-wild type (wt) LRI sequence	2
R/U5 and gag	2
conserved heptanucleotide LRI	2
trans-complementation assay	2
viral dimerization initiation site	2
gag open reading frame	2
small palindromic stem–loop	2
conserved 150 nt stem–loop (SL2)	2
conserved heptanucleotide interaction between R/U5 and gag	2
ψ region	2
5′ and 3′ sequences	2
5′ 511 nt	2
two or more discontinuous regions	2
FIV packaging signal (ψ)	2
FIV-based vectors	2
potential small animal model	2
human immunodeficiency virus (HIV)	2
lentivirus	2
feline immunodeficiency virus (FIV)	2
one substrate	2
competitive inhibitor (2R,3R)-2,3,4-trihydroxy-N,N-dipropylbutanamide	2
wild-type E. coli N-acetylneuraminic acid lyase in the presence and in the absence of pyruvate	2
20 variants of the enzyme	2
N-alkylcarboxamide analogues of N-acetylneuraminic acid	2
N-acetylmannosamine, yielding N-acetylneuraminic acid	2
Escherichia coli N-acetylneuraminic acid lyase	2
modified histone H3 tails	2
PHD proteins	2
PHD subclass of Zn fingers	2
signature residue	2
highly conserved tryptophan	2
PHD structural core	2
T3 channel	2
Pygo PHD fingers	2
BCL9 co-factors	2
surface of the T3 channel	2
histone H3 alanine 1 and methylated lysine 4	2
two adjacent binding pockets	2
histone H3 threonine 3 (T3)	2
binding channel	2
conserved isoleucine residue	2
methylated histone H3 tail	2
PHD–HD1 interface	2
Pygo2 PHD–BCL9-2 HD1 complex	2
Pygo1 complexes	2
methylated histone H3 tail peptides	2
Pygo2 complexes	2
two human Pygo paralogs	2
histone-binding residues	2
rear PHD surface	2
BCL9 co-factors whose homology domain 1 (HD1)	2
methylated histone H3 tails	2
normal and malignant tissues	2
Zn-coordinated PHD fingers of Pygopus (Pygo) proteins	2
smaller core	2
cross-β core	2
two types of human lysozyme amyloid structures	2
fibrillar deposits	2
different types of aggregates	2
Cys196 (TM5) and Asp189 (extracellular loop 2)	2
series of hydrophilic residues	2
amino-terminus	2
terminal regions of NDP-MSH	2
retinal in rhodopsin	2
Met292 (TM7) equivalent to Lys(7.45) (Ballesteros numbering scheme)	2
Ile125 of TM3 on the MC4R.	2
d-Phe7 on the ligand	2
side chains of residues in the core region of the peptide ligand	2
Asp122, Ile125, and Asp126 of transmembrane (TM) helix 3, His264 (TM6), and Met292 (TM7)—to Cys residues	2
Leu106 of extracellular loop 1	2
human MC4R	2
ligand NDP-MSH	2
active state (R⁎)	2
model of human MC4R	2
bound ligand [Nle4,d-Phe7]melanocyte-stimulating hormone (NDP-MSH)	2
receptor residues	2
conserved sequence His6-Phe7-Arg8-Trp9	2
MC4R	2
Peptide agonists	2
Melanocortin-4 receptor (MC4R)	2
catalytic intermediate	2
cofactor position	2
eight residues	2
one side of the active site	2
cluster of non-polar residues (Ile489, Phe490, and Leu493)	2
carboxylate and hydroxyl groups	2
Five basic residues (Arg32, Arg106, Arg409, Arg428, and Lys299)	2
medium-resolution (2.35 Å) crystal structure of Bacillus subtilis MenD	2
thiamine diphosphate and metal-ion-dependent 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexadiene-1-carboxylate synthase (MenD)	2
menaquinone (vitamin K2)	2
Par-4 and VASA peptides	2
aspartate-containing sequences	2
flanking sites	2
consensus peptide motif	2
EL/DI sequence	2
loop D	2
ELNNN binding site	2
number of SPSB2 residues	2
divergent protein SPSB2	2
SPSB4	2
three SPSB proteins	2
three Asn residues	2
Par-4 and VASA	2
DEAD-box RNA helicase VASA (DINNNN)	2
Drosophila orthologue GUSTAVUS	2
human Par-4 (ELNNNL)	2
SPRY domain	2
Substrate recognition sites	2
SOCS box family of E3 ubiquitin ligases	2
mammalian SPRY domain- and SOCS box-containing proteins, SPSB1	2
“metamorphic proteins	2
BC and DE β-turns	2
global IgC-like fold	2
TcR crystal structures	2
Cα domain	2
Vα, Vβ, and Cβ domains	2
canonical main-chain conformations	2
2.0-Å-resolution structure	2
autoantigen myelin basic protein	2
αβ TcR	2
V-type domain and a C-type domain	2
extracellular regions of the α and β chains	2
Ig superfamily	2
αβ T-cell receptors (TcRs)	2
misfolded aggregation-prone intermediate	2
sensitive fluorescent-based assay	2
familial forms of amyotrophic lateral sclerosis (ALS)	2
affected protein	2
highly structured protein	2
copper-zinc superoxide dismutase-1 (SOD1)	2
homologous rather than heterologous subunits	2
amyloid-like fibres	2
immunoglobulin domains	2
amyloid-like fibres and amorphous deposits	2
strand-swapped dimer	2
immunoglobulin light-chain-like domain, CTLA-4,	2
broken ends of fibrils	2
model of collagen fibril growth	2
tip projections	2
seed fibrils	2
smoothly tapered tip	2
single tip projection	2
C-terminal end	2
twin spurs	2
N-terminal end of seed fibrils	2
single growth spur	2
fractured ends of fibrils	2
fibril length fragments	2
tendon in liquid nitrogen	2
purified collagen solution	2
avian embryonic tendon	2
seeding system	2
spatially organised arrays	2
principal tensile element	2
E2/E3BP core	2
rE2 counterpart	2
tE2/E3BP and truncated bacterial E2 crystal structures	2
substitution model	2
rE2/E3BP, rE2 (full-length recombinant E2-only) and tE2/E3BP	2
open pentagonal faces	2
truncated bacterial E2 core crystal structure	2
native and recombinant core structures	2
pentagonal core faces	2
(bE2/E3BP)	2
first ever low-resolution structures of human recombinant full-length PDC core (rE2/E3BP), truncated PDC core (tE2/E3BP) and native bovine heart PDC core	2
two conflicting models of PDC (E2+E3BP) core organisation	2
peripheral enzymes (E1 and E3)	2
two subunit types (E2 and E3BP)	2
central pentagonal dodecahedral core	2
acetyl-CoA.	2
key multi-enzyme assembly	2
Mammalian pyruvate dehydrogenase complex (PDC)	2
low-resolution structural models	2
symmetrical sequence GAAN7TTC	2
single S subunit	2
two copies of the N-terminal domain of the HsdS subunit of EcoR124I	2
engineered R–M system	2
asymmetric sequence (GAAN6RTCG)	2
trimeric methyltransferase (M2S)	2
R–M system EcoR124I	2
iso-energetic unfolded, but compact conformations	2
0 M urea	2
sodium sulfate	2
Ieqm variants	2
native states of each variant	2
center of helices 1 and 4, 1 and 3, or 2 and 4	2
side chains of cysteine residues	2
pairs of fluorophores	2
unfolded, intermediate, and native states	2
highly compact native state	2
ensemble of unfolded conformers	2
four-helical Im7 (immunity protein 7)	2
+-associated anti-σ factor	2
/RslA interactions	2
promoter DNA and RNA polymerase binding sites	2
−35-element recognition domain of σL, σ4L,	2
σL/RslA complex	2
bound Zn2+	2
proximal cysteines in the CXXC motif of RslA	2
reducing environment	2
membrane-associated protein,	2
cytosolic anti-σ domain	2
cell-wall and polyketide syntheses	2
M. tuberculosis σ factor σL	2
environment of host alveoli and macrophages	2
redox stimuli	2
best current template-free models	2
coarse-grained protein model	2
simulated cell	2
12 small domains	2
Macromolecular crowding	2
induced IgG	2
chondroitin sulphate proteoglycan	2
recombinant VAR2CSA binding	2
full-length VAR2CSA	2
glycosaminoglycans	2
human chondroitin sulphate proteoglycan	2
VAR2CSA alone	2
complete extracellular region of VAR2CSA secreted	2
bridging molecule	2
specific binding site	2
domains of native VAR2CSA	2
VAR2CSA-expressing IEs	2
VAR2CSA domains	2
PfEMP1 proteins	2
Duffy-binding-like domains	2
VAR2CSA molecules	2
Several Duffy-binding-like domains	2
chondroitin sulphate A (CSA)	2
IEs	2
single and unique member of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family named VAR2CSA	2
vascular endothelium or placenta	2
infected erythrocytes (IEs)	2
Plasmodium falciparum malaria	2
dTDP and dTDP-β-l-rhamnose	2
substrate (dTDP-β-l-rhamnose)	2
acceptor (the growing rhamnan chain)	2
first such rhamnosyltransferase	2
enzymes in the pathway	2
enzyme WsaF.	2
repeating units of three rhamnose sugars	2
Geobacillus stearothermophilus NRS 2004/3a	2
S-layer glycoprotein glycan	2
commercially important polysaccharides and glycoconjugates	2
almost paracrystalline array	2
protein and carbohydrate polymers	2
S-layer of many Gram-positive organisms	2
medically and industrially important	2
Carbohydrate polymers	2
specifically packed core	2
regions of the Im7 core	2
Overpacking residues	2
regions of the native Im7 core	2
overpacking core residues	2
solvent-exposed	2
short helix III	2
30 Im7 variants	2
core residues	2
Val→Thr or Phe→Tyr substitutions	2
Im7 hydrophobic core	2
folding intermediate and rate-limiting transition state	2
compact three-helical intermediate state	2
small, four-helix protein	2
hydrophobic core packing	2
bacterial immunity protein Im7	2
water-soluble globular proteins	2
tightly packed hydrophobic core	2
scanning-arrested conformation	2
eIF3b/PRT1 RRM and eIF1A on the ribosome	2
small ribosomal proteins RPS2 and RPS23	2
human eIF3j	2
ribosomal binding site	2
scanning preinitiation complexes	2
properly formed preinitiation complexes	2
overexpressed eIF1A	2
key tryptophan residues	2
either j/HCR1	2
NTA	2
N-terminal half of eIF3j/HCR1	2
eIF3b/PRT1 in vitro and in vivo	2
eIF3j/HCR1 association	2
yeast orthologue	2
corresponding “pocket” residues	2
human eIF3b RNA recognition motif (RRM)	2
helix α1 and loop 5 hydrophobic pocket	2
human eIF3j N-terminal acidic motif (NTA)	2
conserved tryptophan residue	2
individual subunits of eukaryotic translation initiation factor (eIF) 3	2
L. donovani NMT	2
carboxy-terminal lobe	2
protein substrate binding site	2
unliganded NMT structures	2
flap	2
N-terminal lobe	2
fatty acyl-CoA	2
two protein lobes	2
extended and curved substrate-binding groove	2
14-stranded twisted β-sheet	2
non-hydrolysable substrate analogue S-(2-oxo)pentadecyl-CoA	2
scintillation proximity assays	2
overproduce active recombinant enzyme in Escherichia coli	2
open reading frame of L. donovaniNMT	2
insect stages of the pathogenic protozoan parasite, Leishmania donovani	2
hydrophobic domains of other partner peptides	2
amino-terminal glycine residue of a subset of eukaryotic proteins	2
14-carbon saturated fatty acid, myristate	2
N-Myristoyltransferase (NMT)	2
multiple receptor oligomers	2
multivalent glycoprotein ligands	2
individual receptor oligomers	2
individual glycoproteins	2
multiple glycans on a single glycoprotein	2
receptor oligomer	2
oligomeric forms of these receptors	2
multiple CRDs	2
multiple branches of a glycan	2
glycans on a glycoprotein surface	2
branched glycans	2
single CRD	2
extended binding sites	2
single carbohydrate-recognition domains (CRDs)	2
dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) and the macrophage galactose lectin	2
two model membrane receptors	2
different assay formats	2
Engineered receptor fragments and glycoprotein ligands	2
PH domain superfamily	2
eukaryotic innovation	2
additional families of PHb domains	2
β-strands of adjacent protomers	2
conserved hydrophilic surface	2
PHb domains	2
molecular assemblies	2
similar but much larger ring	2
additional helical hairpin	2
third structure	2
dome-shaped, oligomeric ring	2
single PHb domain	2
first two structures	2
PH-like domains in bacteria (PHb)	2
three members of an uncharacterized protein family (Pfam PF08000)	2
(PH) domains	2
Pleckstrin homology	2
central portion of fH	2
CCP module (CCP 13)	2
smooth bend	2
CCPs 10–15	2
successive modules	2
CCPs 12	2
fH11–14 and fH10–15)	2
flanking modules	2
two CCPs	2
unusually long fH12–13 linker	2
prominent electropositive patch	2
laterally protruding helix-like insertion	2
module 13	2
archetypal CCP structure	2
module 12	2
NMR-derived structure of fH12–13	2
middle of fH.	2
long linkers	2
two functional ends of fH	2
longer-than-average linkers	2
generally small CCPs 10–15	2
Intervening fH CCPs	2
C3b and polyanionic carbohydrates	2
complement factor H (fH)	2
first eight and the last two of 20 complement control protein (CCP) modules	2
neck domain	2
different numbers of repeats	2
variant forms of DC-SIGNR	2
DC-SIGNR	2
neck	2
isolated neck region	2
almost-complete extracellular portion of the receptor	2
distal end of the neck region	2
previously determined overlapping structure	2
isolated neck domain	2
short, non-helical linkers	2
series of four-helix bundles	2
neck region	2
repeats in the crystal	2
α-helical	2
observed crystallographic asymmetric unit	2
multiple unit cells	2
fragment of the neck domain of DC-SIGNR	2
largely conserved 23-amino-acid sequence motif	2
extended neck domains	2
glycan-binding receptors DC-SIGN (dendritic-cell-specific intercellular adhesion molecule 1-grabbing nonintegrin; CD209) and DC-SIGNR (DC-SIGN-related receptor, also known as L-SIGN and variously designated CD209L and CD299)	2
Carbohydrate-recognition domains (CRDs)	2
major component, FliC5	2
day 5	2
fliC2, fliC4, and fliC6 genes	2
fliC5 mutant	2
newly formed part of the elongated filament	2
nutrient-deficient buffer	2
newly born progeny cells	2
small amount of FliC3 at the proximal end	2
flagellin species	2
knockout mutants	2
several similar flagellin species	2
flagellar filament	2
flagellin genes	2
tapered wave	2
midpoint	2
single polar flagellum	2
Bdellovibrio bacteriovorus cells	2
kindlin-1, kindlin-2, and kindlin-3	2
kindlin F0	2
Potential sites	2
kindlin-1 F1 domain	2
probable interface	2
kindlin-1 and talin F0 domains	2
talin F0 and F1 domains	2
kindlin-1 F0 domain	2
different kindlins	2
talin F1	2
even larger insert	2
kindlin F1 domain	2
domain structure	2
F2 and F3 domains	2
kindlin FERM domain	2
previously unrecognized domain, F0	2
large insert in F1	2
F1, F2, and F3 domains	2
FERM domains	2
kindlin family of FERM domain proteins	2
β-integrin cytoplasmic domain	2
membrane-proximal sequences	2
talin FERM (four-point-one, ezrin, radixin, moesin) domain	2
integrin family of heterodimeric cell adhesion molecules	2
crystal contact interfaces	2
extended physiological ligands	2
terminal disaccharides	2
terminal mannobiose	2
bound ligand	2
binding-pocket flanking residue, Arg343	2
three different subunits in the homotrimer	2
environment in the crystal	2
glycosidic linkage	2
bound terminal sugar	2
non-terminal sugar and protein	2
similarly positioned pair of mannose-type O3′ and O4′ hydroxyls	2
series of bound ligands	2
biologically and therapeutically active recombinant homotrimeric fragment of human lung surfactant protein D	2
single defined heteromeric regulatory complex	2
apparent PspA–PspF dodecameric assembly	2
–PspF complex	2
inhibitory PspA	2
four helical domains	2
36-mer	2
four putative helical domains of PspA	2
least two different oligomeric assemblies	2
PspF subunits	2
PspA–PspF regulatory complex	2
inhibitory	2
36-mer ring complex	2
psp-specific transcriptional activator PspF	2
bifunctional protein	2
central component	2
seven proteins	2
E. coli Psp system	2
membrane-damaging agents	2
phage secretin pIV)	2
variety of adaptive systems	2
equilibrium and kinetic molten globules of other proteins	2
kinetic molten globule	2
low pH A-state	2
N-terminal and C-terminal regions of the α-domain	2
long-range hydrophobic contacts	2
calcium-binding loop	2
acidic amino acid residues	2
equilibrium molten globule	2
human α-lactalbumin (α-LA)	2
equilibrium and kinetic species	2
kinetic species	2
equilibrium molten globule states	2
molten globules	2
high-affinity complex	2
co-repressor	2
adjacently bound RelB dimers	2
half-site	2
bipartite binding site	2
four 6-bp repeats	2
RHH motif	2
face of the DNA helix	2
operator (relO) DNA	2
crucial DNA–backbone contacts	2
RelB–DNA	2
subset of these mutant RHH proteins	2
N-terminal RHH motif of RelB. Analysis	2
relB mutants	2
relBE model operon	2
Lon protease substrate	2
transcriptional co-repressor	2
strong relBE promoter	2
relBE toxin–antitoxin locus of Escherichia coli	2
, the ribbon–helix–helix (RHH) repressor	2
VAR2CSA in placental malaria	2
structure of DBL domains	2
various carbohydrates	2
DBL3X	2
erythrocyte surface	2
distal side of subdomain 2	2
positively charged surface	2
CSPG-binding site of DBL3X.	2
DBL6ɛ domain	2
concave surface of the domain	2
positively charged patch and sulfate-binding site	2
multiple CSPG-binding domains	2
placental chondroitin sulfate proteoglycans (CSPG)	2
surface of infected-erythrocytes	2
VAR2CSA protein	2
parasite-infected erythrocytes in the placenta	2
core and cross-interface contacts	2
protein L I60F	2
interfacial contacts	2
core packing	2
protein L L10F	2
two further variants	2
mechanical interface	2
hydrophobic contacts	2
highly native transition state	2
ΔxuI60V–WT=0.2	2
WT=−36 pN	2
wild type (ΔFI60V–	2
five thermodynamically destabilised variants	2
single conservative hydrophobic volume deletion mutants	2
series of protein L variants	2
simple model protein	2
single protein molecules	2
atomic force microscope	2
three-helical species	2
canonical three-helical intermediate	2
redesigned protein	2
extended helix III	2
natural 6-residue helix III	2
juxtaposed C-terminal	2
Asn-Pro-Gly capping motif	2
Glu-Arg salt bridge	2
eight-amino-acid polyalanine-like helix	2
side chains of residues	2
α-helical secondary structure	2
short (6-residue) helix III	2
three of four native helices	2
kinetic intermediate	2
cells producing colicin E7)	2
colicin E7	2
small (87-residue) α-helical protein Im7 (an inhibitor protein	2
site-directed mutagenesis and structural data	2
completely different structures	2
Wzb and CpsB	2
tyrosine phosphatase	2
first solved structure	2
apo-CpsB and a phosphate-complexed CpsB.	2
corresponding autokinases	2
corresponding cognate phosphatase	2
CpsCD complex	2
Gram-positive bacterium Streptococcus pneumoniae	2
cognate phosphatase Wzb	2
integral membrane tyrosine autokinase Wzc	2
Escherichia coli K-30	2
polysaccharide surface layers called capsules	2
Many Gram-positive and Gram-negative bacteria	2
electrostatic mimicry of Ocr	2
bent DNA molecule	2
modified Ocr	2
carboxylate groups	2
model type I restriction/modification system	2
carboxylate groups per Ocr monomer	2
negative charges on the Ocr surface	2
bent 24-bp DNA molecule	2
phosphate backbone of DNA	2
surface of Ocr	2
bacterial type I restriction/modification system	2
highly effective competitive inhibitor	2
molecular mimic	2
homodimeric Ocr (overcome classical restriction) protein of bacteriophage T7	2
R16 and R17	2
A- and C-helices	2
folding landscape	2
many mutants	2
15th, 16th, and 17th repeats of chicken brain α-spectrin (R15, R16, and R17, respectively)	2
agonist-binding conformation	2
antagonist SR48692	2
NTS1-7	2
putative ligand-binding site	2
distant part	2
transmembrane helix bundle	2
unliganded NTS1-7m	2
variety of detergents	2
best receptor mutant NTS1-7m	2
peptide agonist NT	2
neurotensin (NT) receptor NTS1	2
adenosine A2a receptor	2
β1 and β2 adrenergic receptors	2
unfolded chains	2
acid-unfolded β2-microglobulin	2
single region	2
persistent structure	2
acid-denatured state	2
100-residue protein human β2-microglobulin	2
altered subtelomeric cis sequence	2
var promoter and intron	2
var repertoire	2
parasite strains	2
var gene repertoire	2
exclusively transcribed var genes	2
P. falciparum erythrocyte membrane protein 1	2
Plasmodium falciparum var multigene family encodes P. falciparum erythrocyte membrane protein 1	2
Greek key domains	2
central core	2
four central elements of secondary structure	2
all-beta Greek key immunoglobulin-like domains	2
principal determinant	2
(b) other Greek key proteins	2
all-alpha-helical proteins	2
Greek key structure	2
anti-parallel alpha helices	2
100 amino acid domain	2
FADD DD	2
death domain (DD) from human FADD	2
amyloid fold	2
complex superstructure	2
homopolymeric assembly	2
different subunit interfaces	2
tetrameric units	2
hierarchical fibril structure	2
99-residue protein	2
full-length β2-microglobulin	2
set of three-dimensional structures of amyloid fibrils	2
assembly contacts	2
local β-strand packing	2
residues forming cross-β-strands	2
model peptide assemblies	2
non-native fold	2
constituent polypeptides	2
ordered polymers	2
Amyloid fibrils	2
essential co-factor	2
phenylalanine side chains	2
RNA bases	2
tapered channel	2
centre of the PNPase ring	2
Rrp45 and Rrp46 subunits	2
structurally homologous human exosome	2
pseudo-continuous anti-parallel β-sheet	2
periphery of its ring-like architecture	2
homotrimeric PNPase engages RNase E	2
recognition site from RNase E	2
E. coli PNPase	2
scaffolding domain of the endoribonuclease RNase E.	2
multi-enzyme assembly	2
proportion of the PNPase	2
many bacterial species	2
ribosomal RNA precursors	2
Polynucleotide phosphorylase (PNPase)	2
DC-SIGNR tetramers	2
C-terminal end of the neck domains	2
repeat sequences	2
polymorphic forms of DC-SIGNR	2
Neck domains	2
autonomous tetramerization domains	2
neck domains in DC-SIGN and DC-SIGNR	2
C-terminal C-type CRDs	2
fully helical neck regions	2
glycan-binding receptors	2
tetrameric extracellular portions of the receptors	2
neck domains of DC-SIGN and DC-SIGNR	2
C-terminal ends of necks	2
C-type carbohydrate-recognition domains	2
receptors DC-SIGN (CD209) and DC-SIGNR (L-SIGN, CD299)	2
glycans on pathogens and on mammalian cells	2
monomeric protein	2
wild-type (M) protein	2
native conformation	2
eukaryotic cell model	2
adjacent F helix	2
helix F–β-sheet	2
2.2 Å structure of Thr114Phe α1-antitrypsin	2
Xenopus oocyte model	2
wild-type native α1-antitrypsin	2
surface cavity	2
Thr114Phe and Gly117Phe mutations	2
important proteinase inhibitor	2
common Z mutant (Glu342Lys) of α1-antitrypsin	2
scaffolding	2
structure of SufI	2
metal cofactors	2
multicopper oxidase superfamily	2
dividing cell	2
SufI-GFP (green fluorescent protein) fusions	2
Tat (twin arginine translocation) protein transport system	2
SufI protein	2
cell division apparatus	2
Escherichia coli protein SufI (FtsP)	2
unique target	2
Nek2 selective inhibitors	2
Nek2 inhibitors	2
cancer target	2
individual kinases of the human genome	2
Aurora-A and Cdk2	2
two nucleotides	2
previously reported inhibitor-bound structure	2
conformations	2
several different but well-defined conformations	2
nucleotide-binding site	2
Nek2 structure	2
non-hydrolyzable ATP analog	2
T175A mutant	2
crystal structures of wild-type human Nek2 kinase domain	2
Nek family of serine/threonine kinases	2
polymerisation interface	2
Mixing IncC1 and IncC2	2
DNA alone	2
IncC1 NTD	2
nucleotide-stimulated dimerisation	2
N-terminal extension	2
oligomeric form containing dimers, tetramers and octamers	2
two forms, IncC1 (364 aa) and IncC2 (259 aa)	2
alternative start codons	2
parA (incC) of IncP-1 plasmids	2
Walker ATPases	2
sites in the RB and Met genes	2
multiple CpG dinucleotides	2
methylated versus non-methylated sequences	2
consensus p53 DNA binding sequence	2
CpG dinucleotide	2
large number of DNA sequences	2
binding sites of transcription factors	2
tumour suppressor genes	2
different enzyme populations	2
RecB-like nuclease motif II or III	2
EcoR124I complexes	2
physically linked domains	2
great many other DNA processing enzymes	2
linkage	2
single polypeptide	2
nuclease and helicase domains	2
stoichiometry HsdR2/HsdM2/HsdS1	2
three subunits	2
type I restriction–modification enzyme EcoR124I	2
highly intertwined domain	2
N-terminal passenger domain	2
C-terminal translocator domain	2
extended version of the Hia translocator domain	2
nonadhesive repeat	2
HiaBD1 and HiaBD2 adhesive repeats	2
repeats of structurally distinct domains	2
modular architecture	2
trimeric autotransporter subfamily	2
Hia autotransporter of Haemophilus influenzae	2
specific epitope of osteopontin	2
antibody–antigen interactions	2
framework region L2 of 23C3	2
complementarity-determining region loops	2
residues ArgH50, ArgH52, SerH53, and AsnH56 of the antibody	2
AlaL34, TyrL36, LeuL46, TyrL49, PheL91, and MetH102	2
two key residues of the peptide	2
two tandem β-turns	2
collagen type II	2
joint tissues	2
murine collagen-induced arthritis model	2
novel anti-RA monoclonal antibody	2
M. bouvieri	2
satellite DNA	2
well-characterized mariner transposon Mos1	2
genetic in vitro hop assay	2
one plasmid	2
Mboumar-9 transposase	2
Mos1 of Drosophila mauritiana	2
full-length open reading frame	2
Several copies of the transposon	2
Messor bouvieri	2
satellite DNA of the ant	2
mariner-family transposon, Mboumar	2
naturally occurring elements	2
mariner transposons	2
4Z,15Z-bilirubin-IXα	2
sound structural framework	2
natural bilirubin pigment	2
fusidic acid	2
co-crystal structure of HSA	2
sub-domain IB	2
L-shaped pocket	2
4Z,15E-bilirubin-IXα isomer	2
co-crystallised bilirubin	2
human serum albumin (HSA)	2
configurational isomers	2
4Z,15E-bilirubin	2
soluble and excretable isomers	2
biosynthetic 4Z,15Z-bilirubin-IXα	2
heme catabolism	2
insoluble yellow-orange pigment	2
specific regulators	2
Global regulators	2
specific ones	2
global TFs	2
multi-element circuits	2
core of the network	2
crucial metabolites	2
short regulatory pathways	2
biofilm and chemotaxis	2
subnetworks	2
subnetwork	2
Short pathways	2
regulatory motifs	2
sigma factors	2
115 transcription	2
circular variant	2
highly robust folding pathway	2
smallest αβ protein	2
symmetrical βααβ arrangement	2
structured residues	2
lysin motif (LysM) domain from Escherichia coli membrane-bound lytic murein transglycosylase D.	2
different vertebrate lineages	2
RNases ZF-1	2
obstructive C terminus	2
catalytically efficient homologues	2
RNase ZF-3e the same region	2
angiogenin)	2
RNase ZF-1a the active site	2
vertebrate classes	2
three disulphide bonds	2
mammalian angiogenins and amphibian ribonucleases	2
ribonuclease structures	2
zebrafish ribonucleases, RNases ZF-1a and-3e	2
first X-ray crystal structures	2
e and-4	2
–d,-3a–	2
RNases ZF-1a–c,-2a	2
four known homologues	2
available zebrafish DNA sequences	2
non-ichthyic homologues	2
conserved protein scaffold	2
widespread and functionally varied members of the ribonuclease A (RNase A) superfamily	2
protonated Schiff base in Meta III	2
Meta III state of the mutant	2
counterion	2
protonation	2
Meta III	2
primary counterion, Glu113	2
activation pathway of rhodopsin	2
Meta II	2
classical pH-dependent Meta I/Meta II conformational equilibrium	2
active state Meta II	2
photoproducts of the mutant	2
native-like lipid membranes	2
UV-absorbing photoreceptor	2
stabilized E113Q counterion mutant	2
H7 and Glu113 on H3	2
retinal protonated Schiff base	2
interhelical salt bridge	2
mixed disulfide reaction intermediate	2
C32S TrxA dimer	2
low-GC Gram-positive bacterium	2
thioredoxin homodimer	2
high-resolution (1.5Å) X-ray crystallographic structure	2
abundant dimer, C32S,	2
mixed enzyme–substrate disulfides	2
remaining active-site cysteine residue	2
stable homodimers	2
single-cysteine mutant TrxA proteins	2
N-terminal active-site cysteine	2
active-site cysteine	2
active-site cysteine residues	2
covalent disulfide-bonded reaction intermediates	2
pure proteins	2
CxxC active site	2
either one or both of the two cysteine residues	2
three mutant TrxA proteins	2
wild-type TrxA	2
low-GC Gram-positive bacterium Bacillus subtilis	2
essential thioredoxin A (TrxA)	2
specific sets of substrates	2
intramolecular disulfide bonds	2
cysteine-containing proteins	2
major thiol–disulfide oxidoreductase	2
folding pathways	2
multidomain construct	2
folded neighbour R15 (the 15th α-helical repeat from chicken brain α-spectrin)	2
R16	2
two-domain construct R1516	2
spectrin R16 (the 16th α-helical repeat from chicken brain α-spectrin)	2
folded neighbouring domain	2
interdomain interactions	2
structural, functional, and evolutionary components of proteins	2
complementary interface	2
residues 62–70	2
highly hydrophobic and aromatic-rich region	2
non-random structure	2
regions 29–51 and 58–79	2
two hydrophobic clusters	2
region of the polypeptide chain	2
part of the β2m sequence	2
aromatic-rich region of the polypeptide chain (residues 62–70)	2
wild-type β2m and 12 variants	2
seeded and spontaneous (unseeded) fibril growth	2
human β2-microglobulin (β2m)	2
initial monomeric precursor	2
long, straight and unbranched proteinaceous fibrils	2
highly ordered form of aggregate	2
tandem C2 domain structure	2
apposed membranes	2
Firm cross-linking of membranes	2
several novel assays	2
individual C2 domains	2
rapidly cross-link phospholipid membranes	2
Drosophila synaptotagmin	2
several calcium-sensitive synaptotagmin isoforms	2
mammalian family	2
vesicular proteins	2
components of the T3SS	2
negatively charged patch	2
one face of the molecule	2
Shigella and Yersinia structures	2
Yersinia sp.	2
homologue	2
cytoplasmic and inner membrane proteins	2
extracellular needle	2
inner and outer bacterial membranes	2
cytoplasmic bulb	2
T3SS	2
type 3 secretion system (T3SS)	2
complex macromolecular machine	2
Many Gram-negative pathogenic bacteria	2
monomers	2
regions in the EmrE dimer	2
planar drugs	2
three planar drugs	2
ligand-free and TPP+-bound forms of EmrE	2
three structurally different planar drugs, ethidium, propidium and dequalinium	2
EmrE two-dimensional crystals	2
diverse chemical nature	2
three from each monomer of the asymmetric EmrE homodimer	2
six of the α-helices	2
negatively charged glutamate residues	2
tetraphenylphosphonium (TPP+), ethidium, propidium and dequalinium	2
hydrophobic cationic drugs	2
Small Multidrug Resistance transporter (SMR) family member	2
CagYrpt2 region	2
repeat modules	2
CagYrpt2 assembly	2
motif subunits	2
substantially different repeat 2 motif organisations	2
CagY proteins	2
larger CagYrpt2 structure	2
discrete structural subunit motifs	2
Isolated motifs	2
single copies of the second repeat (motif B)	2
repeats terminally	2
tandem arrays	2
abundant of which (motif A)	2
two highly thermostable and acid-stable α-helical structural motifs	2
repetitive motifs	2
second and major repeat region (CagYrpt2)	2
two defined repeat regions	2
extensive repetitive sequence	2
large cag-pathogenicity-island-encoded protein CagY.	2
surface filament structure	2
Cag type IV secretion system	2
plasma membrane of gastric epithelial cells	2
effector protein CagA	2
cag-pathogenicity-island-encoded type IV secretion system	2
soluble FGFR1 proteins	2
NCAM FN3 tandem	2
FN3 tandem	2
contiguous patch	2
domain interface	2
NCAM FN3 domain	2
two putative FGFR1-binding segments	2
electron micrographs	2
FN3 domain linker	2
second crystal form	2
non-conserved surface residue (M610R)	2
acutely bent domain arrangement	2
NCAM FN3 domain tandem	2
fibronectin type 3 (FN3)-like domains of NCAM	2
neural cell adhesion molecule (NCAM)	2
Mlp1 C-terminal domain	2
protein:protein interaction site	2
distinctive hydrophobic patch	2
PWI-containing proteins	2
several other RNA-binding proteins	2
solution and crystal structures	2
mRNA export factor, Gfd1	2
C-terminal globular domain of the nuclear pore-associated protein, myosin-like protein 1 (Mlp1)	2
N-terminal domain of Nab2 (residues 1–97)	2
essential yeast heterogeneous nuclear ribonucleoprotein	2
RNA-binding protein 2 (Nab2)	2
Nuclear abundant poly(A)	2
HsdS–HsdM complex	2
N-terminal and central domains	2
enzymatic core	2
single molecule	2
HsdR	2
monomeric in solution	2
last 17 amino acid residues	2
published sequence	2
HsdR subunit of EcoR124I	2
HsdM–HsdS complex	2
individual HsdS and HsdM subunits	2
recognition site	2
base-pairs	2
unmethylated DNA	2
translocates DNA	2
HsdS-HsdM complex	2
adenosine residues	2
target DNA sequence	2
HsdM	2
three different subunits	2
large, multifunctional enzymes	2
Type I restriction-modification (RM) systems	2
surface and loops	2
parent protein	2
parent proteins	2
hydrophobic core of TNfn3	2
“outside” (surface and loops) of FNfn10	2
core-swapped protein	2
chimeric protein, FNoTNc	2
folding transition state	2
common core of key residues	2
Two homologous fibronectin type III (fnIII) domains, FNfn10 (the 10th fnIII domain of human fibronectin) and TNfn3 (the third fnIII domain of human tenascin)	2
four buried hydrophobic residues	2
novel member of the fnIII superfamily whose nucleus	2
interacting hydrophobic residues	2
fnIII) superfamily	2
fibronectin type III (	2
immunoglobulin superfamily	2
nucleating residues	2
core of the protein	2
set of structurally equivalent residues	2
number of β-sandwich immunoglobulin-like domains	2
late chaperones	2
late subunit signal	2
heterologous type III export substrate	2
early subunit signal	2
early subunit N-terminal export signal regions	2
chaperoned late subunits	2
Late filament subunits	2
recombinant subunits	2
early and late subunits	2
early subunits	2
wild-type ATPase	2
membrane-associated FliI ATPase	2
multiple flagella	2
late filament subunits	2
hook	2
Early rod-and-hook subunits	2
growing flagellum	2
bacterial flagellum	2
O-antigen precursor UDP-2,3-diacetamido-2,3-dideoxy-l-galacturonic acid	2
oxidoreductase	2
serine/threonine component of the SDR triad	2
positionally conserved cysteine (Cys133) and basic side chain (His90 or Asn213)	2
WbmF active site	2
otherwise feature-poor active site	2
TYK triad	2
typical SDR catalytic TYK triad	2
uridyl nucleotides	2
three enzymes	2
substrate-binding domain	2
coordinate NAD	2
SDR architecture	2
WbmF, WbmG and WbmH.	2
small-molecule soaks	2
co-crystals	2
native proteins	2
SDR family members	2
putative sugar nucleotide substrates	2
O-antigen expression	2
short-chain dehydrogenase/reductase (SDR) family, wbmF, wbmG and wbmH	2
O-antigen cluster	2
polymer of 2,3-diacetamido-2,3-dideoxy-l-galacturonic acid	2
lipopolysaccharide O antigen	2
pathogenic bacteria Bordetella parapertussis and Bordetella bronchiseptica	2
remodelling enzymes	2
Chd1 and Isw2 remodelling enzymes	2
spectrum of remodelled products	2
RSC complex	2
differentially acetylated nucleosomes	2
Chd1, Isw2 and RSC remodelling complexes	2
specifically modified chromatin templates	2
modified histones	2
many chromatin remodelling enzymes	2
active dimer	2
one inactive dimer	2
stable intermediate	2
single dimer	2
wild-type SfiI	2
single site	2
DNA sites	2
tetrameric in solution	2
tyrosine hydroxyl	2
dimeric units	2
otherwise hydrophobic interface	2
DNA-binding clefts	2
complex of SfiI	2
specific DNA	2
two clefts	2
opposite side of the protein	2
second cleft	2
dimeric unit)	2
tetramer of identical subunits	2
single DNA-binding cleft	2
many Type II restriction enzymes	2
myosin family	2
myosin motors	2
group of myosin motors	2
bovine cardiac myosin	2
bovine masseter myosin	2
rabbit soleus MHC-II-1	2
masseter	2
slow skeletal muscle fibres	2
predominant isoform	2
Bovine MHC-II-1	2
fast skeletal isoform	2
bovine left ventricle muscle	2
multiple actomyosin–ADP complexes	2
slow isoforms	2
Isoform II-1	2
MHC-II isoforms 1 and 2 of the rabbit	2
MHC-II-2	2
slow myosins (MHC-II-1, also known as β-myosin) and	2
Fast myosins (myosin heavy chain (MHC)-II-2)	2
Several heavy chain isoforms of class II myosins	2
membrane-inserted PagP	2
clamp	2
helix of PagP	2
refolded variant proteins	2
variants in diC12:0PC liposomes	2
wild-type PagP	2
W17A variant	2
wild-type PagP.	2
variants R59L, W17A/R59L and Δ(1-19)	2
helix or helix–barrel interactions	2
micelles and liposomes	2
large vesicles of diC12:0-phosphatidylcholine (diC12:0PC)	2
detergent micelles of cyclofos-7	2
6 M guanidinium chloride	2
perfluoro-octanoic acid	2
altered (W17A or R59L)	2
helix–barrel interactions	2
19-residue amphipathic α-helix	2
eight-stranded barrel	2
Escherichia coli outer membrane β-barrel enzyme PagP	2
B strands	2
key acidic residues	2
peripheral strands	2
number of critical hydrogen bonds	2
fibronectin (FNfn10)	2
tenth type III domain	2
extracellular matrix protein fibronectin	2
Steered molecular dynamics simulations	2
primary RNA binding domain	2
distal C-terminal domain	2
primary RNA binding domain (Y80C)	2
mutants (Y274D, G324D and N340S)	2
primary RNA binding domain and Q-loop	2
(P279S, P279L) and R-loop (G324D)	2
two important structural elements	2
C-terminal ATP binding domain (Y274D, P279S, P279L, G324D, N340S, I382N)	2
N-terminal RNA binding domain (G51V, G53V, and Y80C)	2
different termination defective mutants of Rho	2
elongation complex	2
releasing RNA	2
RNA:DNA hybrid	2
transcription termination factor Rho of Escherichia coli	2
C5a cleavage site	2
C5 convertase	2
tick lipocalins	2
fatty acid-derived inflammatory modulators	2
ricinoleic acid	2
fatty acid derivative	2
recombinant OmCI	2
soft tick Ornithodoros moubata	2
16 kDa protein	2
expressed OmCI	2
potent innate immune defence system	2
complement (C) system	2
mutant TtgR	2
phloretin binding	2
native and mutant TtgR proteins	2
plant antimicrobial	2
Pseudomonas strains	2
DOT-T1E strain	2
unique residue	2
second one	2
mainly hydrophobic residues	2
two distinct and overlapping ligand binding sites	2
common antibiotics and plant secondary metabolites	2
solvent-tolerant strain DOT-T1E	2
high-resolution crystal structures of TtgR	2
efflux pump	2
different classes of natural antimicrobial compounds	2
reported repressor	2
antibiotics, solvents and toxic plant secondary products	2
Pseudomonas putida	2
key efflux pump	2
membrane-bound efflux pumps	2
outer extremities	2
highly mobile regions	2
extended portion of the M subunits	2
globular regions of the two M subunits	2
two S subunits	2
core of the MTase	2
much more elongated and extended structure	2
subunit dimer	2
Z-shaped structure	2
low-resolution structural model	2
entire MTase	2
one or other of the subunits	2
deuterated S subunits	2
M.AhdI enzyme	2
type I MTase	2
170 kDa tetramer	2
DNA methyltransferase M.AhdI	2
endonuclease	2
specific base	2
methyltransferase (MTase)	2
Two genes (M and S)	2
multisubunit/multidomain enzymes	2
Type I restriction-modification (R-M) systems	2
residues in the binding site	2
protein backbone	2
arabinose-binding protein (ABP) with its ligand, d-galactose	2
five metal binding transporters	2
alternate conformations of secondary shell stabilizing residues	2
highly charged metal chelating mobile loop region	2
extra α-helix	2
C-domain disulfide bond	2
bound and release states of metal transporters	2
periplasmic ligand binding protein structures	2
Mn2+ transporters	2
periplasmic metal binding protein	2
first native (non-recombinant) protein structure	2
high-affinity zinc transporter ZnuA	2
several pathogenic and non-pathogenic bacteria	2
ATP-binding cassette superfamily of periplasmic metal transporters	2
two DNA sites	2
Type I enzymes	2
Type II enzymes	2
requisite sequences	2
DNA substrates	2
Ten Type IIB nucleases	2
Type IIB enzymes	2
archetype, BcgI.	2
short DNA fragment	2
two double-strand breaks	2
Type IIS enzymes	2
specified phosphodiester bonds	2
Type I sites	2
bipartite sequences	2
IIB systems	2
subset of Type II enzymes	2
many Type II nucleases	2
translocating Type I and Type III systems	2
two target sites	2
restriction endonucleases	2
modified force-fields	2
focused subsets	2
one mutant	2
new series of procarboxypeptidase mutants	2
high-resolution crystal structure and solution NMR structure	2
designed protein	2
activation domain of human procarboxypeptidase A2	2
underlying design force-fields	2
designed proteins	2
sequence and structure of proteins	2
native fold	2
region of the protein	2
three-helix core	2
H3G3/H3G6 and L53AI54A/YY	2
hydrophobic cores	2
native-like secondary structure of Im7	2
native-like secondary structure in helices I and IV	2
L53AI54A and YY	2
four variants	2
two native tyrosine residues (Tyr55 and Tyr56)	2
fourth variant	2
three (H3G3) or six (H3G6) glycine residues	2
native helix III	2
six residues	2
two hydrophobic residues within helix III	2
Four variants	2
four native α-helices	2
transiently populated, on-pathway intermediate	2
large internal cavity	2
TetR family of repressors	2
pore-forming toxin hemolysin II	2
regulator of the gene	2
crystal structure of B. cereus HlyIIR	2
number of transcriptional regulators	2
Bacillus cereus and Bacillus anthracis toxins	2
pro form and active form of the human enzyme	2
human proMMP-1	2
active site zinc	2
first MMP-1 structure	2
active form of human MMP-1	2
interstitial collagen types I, II, and III	2
Matrix metalloproteinase 1 (MMP-1)	2
collagenases	2
MMP-1, MMP-8 and MMP-13	2
matrix metalloproteinases	2
Interstitial collagen	2
whole heart patient-specific models	2
calcium-driven systems	2
myosin-level models	2
early theoretical frameworks	2
multiple experimental assays	2
formal framework	2
cardiac specific, species specific, human specific and finally patient specific calculations	2
mathematical models and simulation	2
critical mechanisms	2
functional MLP	2
non-sarcomeric protein MLP	2
newly generated mouse model	2
associated heat shock proteins	2
MLP C58G	2
two further HCM-causing CSRP3 mutations (L44P and S54R/E55G	2
KI/+ mice	2
KI/KI mice	2
homozygous KI/KI mice	2
knock-in mouse (KI) model	2
non-sarcomeric	2
recognised HCM disease genes	2
well-established disease gene	2
Cysteine and glycine rich protein 3 (CSRP3) encodes Muscle LIM Protein (MLP)	2
MCT + BB myocytes	2
Sarcoplasmic reticulum Ca2+	2
vehicle (MCT)	2
metoprolol (MCT + BB)	2
β1–adrenoceptor blocker metoprolol	2
right ventricular (RV) myocytes	2
specific therapeutic target	2
Pulmonary Artery Hypertension (PAH) patients	2
lines and/or groups of cells	2
conduction blocks	2
core of the re-entries	2
re-entries	2
HL1-6 myocytes	2
fluorescence optical mapping	2
re-entry cores	2
homogeneous subclone of the HL1 atrial-derived cardiomyocyte cell line, HL1-6	2
perfusion line	2
potassium channel blocker	2
clofilium (100 nmol/L)	2
isolated innervated rabbit hearts	2
specific B56δ-PP2A substrates	2
PP2A regulatory subunit isoform B56δ	2
specific phosphorylated residues	2
distinct kinase substrate motifs	2
phospho-serine/threonine residues	2
ARVM expressing GFP-B56δ-WT or GFP-B56δ-S573A with antibodies	2
GFP-B56δ-S573A.	2
endogenous C and A subunits	2
GFP-B56δ-S573A	2
non-phosphorylatable (S573A) B56δ	2
adenoviruses expressing wild type (WT) or	2
β1AR subtype	2
β-adrenergic receptor (βAR) agonist isoprenaline (ISO)	2
B56δ in adult rat ventricular myocytes (ARVM)	2
regulatory B subunit isoform B56δ	2
PP2A in cardiomyocytes	2
B subunits	2
multiple cardiac phosphoproteins	2
catalytic C subunit	2
regulatory B subunit	2
scaffold A subunit	2
(PP2A) enzymes	2
2A protein phosphatase	2
exosome-release inhibitor spiroepoxide	2
VSMC media	2
intracellular endosome-like vesicles	2
CaP particle-treated VSMCs	2
SYK inhibitor R406	2
spleen tyrosine kinase (SYK) (increased phospho-Y525/526)	2
ATP, nigericin and monosodium urate crystals	2
Potential inflammasome agonists	2
proliferating and senescent human VSMCs	2
atherosclerotic fibrous caps	2
small CaP particles	2
(IL-1β)	2
mature interleukin-1β	2
forms of crystals and particles	2
AimsCalcium phosphate (CaP) particle deposits	2
electron dense deposits	2
misfolded protein aggregates	2
heat shock protein 90	2
cleaved caspase-12 and endoplasmic reticulum (ER) stress markers	2
apoptotic cardiomyocytes	2
(Fkbp8+/+) mice	2
Fkbp8−/− and control wild type littermates	2
(Fkbp8−/−) mice	2
Cardiac-specific FKBP8-deficient	2
HEK293 cells or H9c2 myocytes	2
yeast mitophagy receptor, autophagy-related 32 protein	2
FK506-binding protein 8 (FKBP8)	2
novel mitochondria-specific autophagy (mitophagy) receptors	2
mitochondria and misfolded proteins	2
“high impact” journals	2
biomedical papers	2
oxygen carrying systems	2
contractile machinery of cardiomyocytes	2
fast-twitch skeletal muscle troponin isoforms	2
foetal isoforms of cardiomyocyte genes (creatine kinase, Ckm, and eukaryotic elongation factor Eef1a2)	2
circulating primitive erythrocytes	2
definitive-lineage haemoglobin Hbb-bt	2
Hic2 embryos	2
transcription factor Hic2	2
disparate cell types	2
erythrocyte haemoglobins	2
myocyte sarcomeric proteins	2
conventional heterologous expression systems	2
tsA201 cells	2
wild-type and mutant channels	2
Patient-derived iPS-CM	2
tsA201 cells heterologously expressing sodium channels	2
patient and control iPS-CM	2
Patient and control iPS-CM	2
beating clusters and sheets	2
R367H)	2
iPS-CM	2
heterologous models	2
Patient-specific induced pluripotent stem (iPS) cell-derived cardiomyocytes (iPS-CM)	2
native cardiomyocytes	2
Commonly used heterologous expression models	2
cardiac circadian clock	2
several compounds	2
cardiac clock	2
two core clock genes, Bmal1 and Per2	2
neonatal rat cardiomyocyte model	2
convenient in vitro model	2
Several clinical and animal models	2
molecular clocks	2
atrial output	2
3D atrial electromechanical coupled model	2
Na+/Ca2+ exchanger	2
L-type calcium current (ICaL)	2
Multiscale electromechanical models	2
KCNA5 mutations	2
(D469E, Y155C, P488S) of IKur channels	2
atrial-specific ultra-rapid delayed rectifier current, IKur)	2
A305T, D469E, Y155C, P488S)	2
E48G	2
mitochondrial fission proteins	2
Bcl-2 family members	2
VDAC1 oligomerisation	2
control hearts	2
mitochondria-bound hexokinase 2 (HK2)	2
surface fluorescence	2
intracellular reactive oxygen species (ROS)	2
Complex I	2
succinate-fuelled reverse electron flow (REF)	2
normal haemodynamics	2
ECM cross-linking enzyme, transglutaminase-2	2
mature primordial mitral valve leaflets	2
extracellular matrix (ECM) proteins fibrillin-2, type III collagen and tenascin	2
chick HH29 outflow tract banded hearts	2
endocardial cushions	2
shear stress responsive gene and extracellular matrix markers	2
smaller and dysmorphic mitral valve primordia	2
HH26 outflow tract banded hearts	2
Outflow tract-banding	2
ligature	2
outflow tract of the chick heart	2
abnormal haemodynamics	2
valve anomalies	2
Intracardiac haemodynamics	2
high-pressure frozen samples	2
geometric primitive	2
fluorescent probes (FM4-64 and calcein, respectively)	2
optical microscopy	2
key structures	2
Transverse-axial tubules (TTs)	2
hCAM derived peptides	2
adjuvant-injected mice	2
IgG1 and IgG2c antibodies	2
mouse MHCII genes	2
human HLA-DR4 transgenic mice	2
hCAM-induced myocarditis model	2
human cardiac α-myosin (hCAM) and the DR4 allele of human major histocompatibility II (MHCII)	2
suitable candidate gene	2
sarcomeric TPM1	2
ventricular trabeculae formation	2
atrial septation	2
cardiac looping	2
TPM1 morpholino-treated embryos	2
IVS1+2T>C, I130V, S229F and a polyadenylation signal site variant GATAAA/AATAAA	2
TPM1 gene	2
CHD cases	2
alpha myosin heavy chain	2
number of sarcomeric proteins	2
essential sarcomeric component	2
Tropomyosin 1 (TPM1)	2
titin isoforms	2
synthetic Tβ4	2
short titin isoforms	2
Tβ4 null mice	2
non-muscle cells	2
actin monomers	2
Thymosin β4 (Tβ4)	2
Many sarcomeric genes	2
Sarcomeric components	2
Sarcomere assembly	2
distinct low conductance monovalent non-selective cation channels	2
IB,Na	2
simulated 1D-strand	2
spontaneous activity	2
AVN cell simulations	2
pH6.3)	2
extracellular acidosis	2
La3+ (100μM)	2
Flufenamic acid	2
ruthenium red (100μM), or amiloride (1mM)	2
Ni2+ (10mM)	2
charge carrier	2
Na+ (Rb+>K+>Cs+>Na+>Li+)	2
monovalent cations	2
IB,	2
rabbit cells	2
rabbit and mouse AVN cells	2
Na+-containing extracellular solution	2
selective pharmacological inhibitor of IB,Na	2
major voltage- and time-dependent conductances	2
AVN of adult male rabbits and mice	2
heart's secondary pacemaker, the atrioventricular node (AVN)	2
IB,Na in cells	2
inward sodium current (IB,Na)	2
mitochondrial localization, kinesin family member 5b (Kif5b)	2
gene encoding a motor protein	2
mitochondrial encoding proteins	2
intact NRVCs	2
permeabilized NRVCs	2
mitochondrial electron transport chain (ETC) (state 3)	2
insulin like growth factor 1 (IGF1) or phenylephrine (PE)	2
neonatal rat ventricular cardiomyocytes (NRVCs)	2
, i9	2
hydrophobic pocket of cTnC.	2
covalent complex	2
C84 of cTnC	2
covalent Ca2+ sensitizer (i9)	2
troponin C (cTnC)	2
levosimendan and other sensitizers	2
calcium (Ca2+) sensitizers	2
adult mouse and human cardiomyocytes	2
fish heart	2
zebrafish model	2
zebrafish and mammalian hearts	2
cardiac isoforms	2
skeletal isoforms	2
troponin I and myozenin 1	2
ventricular isoforms of myosin light chains	2
differentiated adult cardiomyocytes	2
myofilament proteins	2
hearts of adult mice	2
neonatal and 4days old mice	2
cardiac proteome	2
DNA synthesis-related proteins	2
neonatal and adult mouse hearts	2
18months old) hearts	2
>8weeks old)	2
hearts from neonatal and adult mice	2
adult zebrafish hearts	2
hearts of neonatal, but not adult mice	2
adult human myocardium	2
new target	2
pro-mitogenic genes	2
YAP/TAZ–	2
constitutively-active YAP or TAZ.ConclusionTaken	2
YAP and TAZ function	2
constitutively-active YAP or TAZ phospho-mutants	2
pro-mitogenic genes, CCN1, CTGF, c-MYC and TGFB2	2
TEAD-luciferase	2
constitutively-active RhoA	2
Latrunculin-B.	2
actin-polymerisation	2
downstream kinase, ROCK, with Y27632	2
physiological agonists, Cicaprost or adenosine	2
forskolin, dibutyryl-cAMP	2
transcription factor TEAD and its co-factors YAP and TAZ in VSMC.Methods	2
growth-regulatory Hippo pathway	2
vascular smooth muscle cell (VSMC) proliferation	2
canine APs	2
cardiac electrophysiology models	2
many scientific areas	2
majority of mathematical models	2
Cardiac electrophysiology models	2
potential novel mediators	2
cardiac collagen matrix	2
aged animal models	2
aged heart	2
cardiac extracellular matrix (ECM)	2
ventricles (ΔTAT)	2
virtual patients	2
cardiac electromechanics	2
multi-scale biophysical model	2
combined INCX, INaL and ICaL block	2
-calibrated populations of human AP models	2
selective block	2
Multichannel block	2
CaT. Na+/Ca2+ exchanger (INCX) block	2
HCM cardiomyocytes	2
populations of human non-diseased and HCM AP models	2
(CaT) recordings	2
Ca2+-transient	2
single and multichannel inward current blocks	2
human HCM	2
force-generating myosin cross-bridges	2
cTnC in trabeculae	2
situ structure	2
demembranated ventricular trabeculae	2
site 1	2
regulatory domain of cTnC	2
cardiac troponin C (cTnC)	2
Ca2+-binding regulatory protein in heart muscle	2
mutation L29Q	2
transgenic mouse models	2
MQF filtered	2
non-phosphorylatable form of phospholemman	2
transgenic PLM3SA mouse	2
cohort of wild type mouse hearts	2
shift reagent	2
mouse heart	2
extracellular sodium pool	2
54.7° flip-angle pulse	2
extracellular sodium	2
total TQF signal	2
intracellular sodium pool	2
triple quantum filtered (TQF) signal	2
Langendorff perfused mouse heart	2
principal binding determinant	2
S6 F656 residue	2
inner cavity	2
hERG channel	2
MthK-based homology model	2
V625A and F656A	2
G648A, Y652A, F656A) mutations	2
pore-helix/selectivity filter (T623A, S624A V625A) and S6 helix (	2
WT IhERG	2
N588K and S631A attenuated-inactivation mutants	2
charged form of the drug	2
charged and uncharged flecainide analogues	2
[K+].	2
Wild-type (WT) IhERG	2
hERG expressing cells	2
hERG current (IhERG)	2
hERG” potassium channels	2
class Ic antiarrhythmic drug flecainide	2
potential ventricular therapeutic target	2
cardiac energetics	2
creatine kinase expression	2
steeply negative, failing phenotype	2
healthy myocytes	2
intact healthy myocytes	2
exogenous creatine kinase	2
saponin-skinned failing myocytes	2
failing right ventricle	2
single enzymatically dissociated myocytes	2
anesthetized animals	2
saline-injected control animals	2
t-tubular ICa	2
protein kinase A with H-89	2
t-tubule and surface membranes	2
voltage- and Ca-sensitive fluorophores	2
intact and detubulated myocytes	2
L-type Ca current (ICa)	2
t-tubules of ventricular myocytes	2
disrupted t-tubule structure	2
mammalian cardiac ventricular myocytes	2
pro-inflammatory and pro-fibrotic transcription factors	2
old normotensive individuals	2
young hypertensive patients	2
large and small arteries	2
voltage-clamped cells	2
HF cells	2
HF than control cells	2
control and HF cells	2
voltage-clamped HF cells	2
Inhibiting the L-type Ca2+ current (ICa-L)	2
voltage clamped cells	2
single left atrial myocytes	2
atrial myocytes	2
β-adrenergic (β-AR) stimulation	2
systolic Ca2+	2
mRNA and protein expression	2
wild-type but not SRE-mutated CCN1	2
Constitutively-active MKL1	2
CCN1 promoter	2
actin-dependent SRF co-factor, MKL1	2
latrunculin B	2
CCN1 mRNA	2
constitutively active RhoA	2
downstream kinase, ROCK	2
balloon injured rat carotid arteries	2
pre-spliced CCN1 mRNA and CCN1-promoter activity	2
CCN1 mRNA and protein expression	2
Adding db-cAMP	2
Boyden chamber	2
Recombinant CCN1	2
wound healing assay	2
cultured rat VSMC	2
dietary substrates	2
maternal milk	2
high-fat, low carbohydrate diet	2
standard post-weaning diet	2
representative of suckling)	2
surviving MCD−/− mice	2
total adenine nucleotide pool	2
MCD−/− hearts	2
MCD−/− plasma	2
MCD−/− mice	2
knockout mice (−/−)	2
malonyl-coenzyme A decarboxylase (MCD)	2
key physiological stimulus	2
neonate at birth	2
ambient oxygen	2
two metabolic pathways	2
embryonic cardiac cardiomyocytes	2
embryonic cardiac mitochondria	2
adult cardiomyocytes	2
oxygen in utero	2
Fetal cardiomyocyte	2
10month old mdx-XistΔhs mice	2
dystrophin expression	2
mdx-XistΔhs mice	2
corresponding genetic backgrounds	2
dystrophin-negative mdx mice	2
2, 6 and 10-month-old female mdx-XistΔhs mice	2
recipient hearts	2
Perfusates of IPC hearts	2
donor hearts	2
non-preconditioned recipient hearts	2
IPC donor hearts	2
coronary perfusate	2
IPC effluent	2
group of recipient hearts	2
another set of recipient isolated hearts	2
Coronary perfusates	2
coronary perfusates	2
group of donor hearts	2
Hearts of male Wistar rats	2
proteins, mRNAs and microRNAs	2
extracellular vesicles [EVs]	2
Exosomes and microvesicles/microparticles	2
remote area of the heart	2
remote organ	2
myeloid and mesenchymal fibroblasts	2
myeloid fibroblasts	2
monocytes and T lymphocytes	2
mesenchymal fibroblasts	2
aging mesenchymal cells	2
chemoattractant protein-1 (MCP-1)	2
TGF-β signaling pathway components	2
mesenchymal fibroblasts expressing collagen	2
reduced expression of TGF-β receptor I (TβRI)	2
transforming growth factor beta (TGF-β)	2
mesenchymal stem cells (MSC) and fibroblasts	2
SLIT3 expression	2
engineered tissues	2
vivo xenogenic implant	2
functional human blood vessels	2
receptor ROBO4 in ECs	2
SLIT3 in MSCs	2
organizing 3D vascular networks	2
“non-pericytic” MSCs	2
networks in engineered tissue	2
ROBO4-positive endothelial cells	2
pro-angiogenic vascular guidance molecule SLIT3	2
so-called “pericytic” MSCs	2
two functionally distinct human MSC clones	2
stable, functional blood vessels	2
pericytes/mesenchymal stem cells (MSCs)	2
supportive mural cells	2
vascular structures	2
engineered tissue grafts	2
key pharmacological target	2
Na+–K+ pump molecular complex	2
nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase)	2
intracellular Na+	2
Na+–K+ pump	2
membrane Na+–K+ pump	2
cardiac glycosides	2
phospholemman phosphorylation	2
PLM3SA mouse hearts	2
l-arginine)	2
l-NAME	2
SBFI-AM-loaded rat myocytes	2
l-NAME or PKC-inhibitor (2μM Bis)	2
phosphorylated)	2
PLMWT but not PLMKO or PLM3SA myocytes	2
Exogenously added NO (spermine-NONO-ate) stimulated Na/K-ATPase (EC50=3.8μM; n=6/grp)	2
NOS inhibition l-NAME (1mM)	2
p<0.05, n=6)	2
western-blotting and biochemical assay	2
DAF-FM dye	2
Na/K-ATPase activity	2
endogenous NO	2
rat ventricular myocytes	2
endogenously synthesized NO	2
NO-donors)	2
cardiac intracellular Na+ and Ca2+	2
NCX)	2
intracellular Na+ and Ca2	2
Proinflammatory cytokines TNF-α, IFN-γ and IL-1β	2
nucleus of human adult cardiac fibroblasts and myocytes	2
HACF, HACM and HCASMC	2
NF-κB p50 and p65 subunits	2
recombinant human IL-33	2
human cardiac fibroblasts and myocytes	2
sST2 antigen	2
ST2 mRNA	2
cardiac fibroblasts and vascular SMC	2
ST2 isoforms (ST2L and sST2)	2
specific mRNA	2
human macrovascular (aortic and coronary artery) and heart microvascular endothelial cells	2
ST2 isoforms (sST2 and transmembrane	2
human cardiac and vascular cells	2
ST2 protein	2
IFN-γ (r=0.591, p=0.001) and TNF-α (r=0.408, p=0.035)	2
patients undergoing heart transplantation	2
IFN-γ-induced IL-33 production	2
, IFN-γ-, and IL-1β-induced and Janus-activated kinase inhibitor	2
TNF-α-	2
Mitogen-activated protein/extracellular signal-regulated kinase inhibitor U0126	2
p50 and p65 NF-κB subunits	2
nuclear factor-κB (NF-κB) inhibitor dimethylfumarate	2
human coronary artery smooth muscle cells (HCASMC)	2
Tumor necrosis factor (TNF)-α, interferon (IFN)-γ and IL-1β	2
nuclear IL-33	2
primary human adult cardiac fibroblasts (HACF) and human adult cardiac myocytes (HACM)	2
human adult cardiac myocytes and fibroblasts	2
soluble ST2 (sST2)	2
normal and pressure overloaded human myocardium	2
IL-33/ST2 system	2
Interleukin-33 (IL-33)	2
cultured cardiomyocytes	2
heart slices	2
reversible dimers	2
freshly isolated embryonic cardiomyocytes	2
muscarinic receptors	2
murine cardiomyocytes	2
dissociated cardiomyocytes and heart slices	2
pre- and post-natal mice	2
plasma membrane of transformed CHOM2 cells, a cardiac cell line (HL-1), primary cardiomyocytes and tissue slices	2
inward potassium current	2
M2 muscarinic acetylcholine receptors	2
aged failing hearts	2
cardiac ECM	2
young failing (P<0.05) and aged failing (P<0.01) animals	2
serum procollagen type I C-pro peptide (PICP)	2
aged hearts	2
Secreted protein acidic and rich in cysteine (SPARC)	2
aged HF group	2
Reduced tissue inhibitor of metalloproteinase (TIMP) expression (TIMPs 3 and 4, P<0.05)	2
aged control and young HF groups	2
aged HF	2
young HF	2
aged (P<0.05)	2
young and aged animals	2
non-paced animals	2
aged sheep	2
actin–myosin chemomechanical crossbridge cycle	2
adenine nucleotide pool	2
cellular [dATP]	2
cardiomyocytes expressing GFP-only	2
Cell length and ratiometric (Fura2)	2
adult rat cardiomyocytes	2
ribonucleotide reductase (Rrm1 and Rrm2) complex	2
ATP with 2 deoxy-ATP (dATP)	2
β2-AR-derived signalling	2
control and MBCD treated cells	2
phosphodiesterase (PDE), protein phosphatase (PP) and phosphoinositide-3-kinase (PI3K) inhibitors	2
caveolar constraint	2
cAMP in PKA II signalling domains of intact cells	2
phosphorylated phospholamban (pPLB)	2
caveolin-3 scaffolding interactions	2
cell-permeable inhibitor	2
cholesterol-depleting agent methyl-β-cyclodextrin (MBCD)	2
β2-ARs (with zinterol/CGP20712A)	2
adult rat ventricular myocyte	2
cholesterol and caveolin-3)	2
specialised sarcolemmal invaginations	2
β2-AR-derived cAMP-dependent signalling	2
β1-, but not β2-, adrenoceptors (ARs)	2
ventricular myocyte	2
subpopulation of receptors	2
PKA probe	2
FRET probes	2
freely diffusible Epac2-based probe	2
type II PKA-based probe	2
two different FRET-based biosensors	2
methyl-β-cyclodextrin	2
lipid raft domains	2
non-lipid raft fractions	2
lipid raft and non-lipid raft containing membrane fractions	2
adult rat ventricular myocytes	2
cholesterol-dependent lipid rafts	2
β1-Adrenergic receptors (β1ARs) and E-type prostaglandin receptors (EPRs)	2
intercalated disc in the hearts of SHRSP animals	2
SHRSP	2
hearts of WKY and SHRSP animals	2
cell–cell junctions	2
E-cadherin overexpression	2
primary rabbit myocytes	2
E-cadherin in rat H9c2 cells	2
connexin 43	2
intercalated disc of the myocytes	2
SHRSP animals	2
control and SHRSP animals	2
β, γ-, and α-catenin and T, N and R-cadherin	2
12-week old SHRSP animals	2
protein homogenates	2
Wistar–Kyoto control animals	2
hearts of the stroke-prone spontaneously hypertensive (SHRSP) rat	2
elastin)	2
collagens 1 and 3	2
cell membrane of cardiac myocytes	2
SAN tissue	2
leading pacemaker site	2
right atrial preparations	2
young adult and ∼69-year-old humans	2
pacemaker of the heart	2
sinoatrial node (SAN)	2
sGC–cGMP pathway	2
increased pre-synaptic substrate availability of NOS	2
SHR	2
Myocardial tyrosine hydroxylase protein	2
pre-synaptically	2
l-arginine fed (n=13) and non-fed SHR (n=10)	2
exogenous norepinephrine	2
WKY	2
non-fed SHR	2
l-arginine fed SHR	2
Soluble guanylyl cyclase	2
isolated spontaneously beating right atria	2
Atrial cGMP	2
plasma l-arginine	2
Separate control groups	2
10 g/L in drinking water)	2
 weeks	2
Male SHR and Wistar Kyoto rats (WKY)	2
impaired nitric oxide (NO)–cGMP pathway	2
Spontaneously hypertensive rats (SHR)	2
sweet and salty tastes	2
sapid cues	2
tested genes expressing cells	2
wide range of gustatory genes	2
wild-type Canton Special (CS) flies	2
taste defectflies	2
wing sensilla	2
LPS and tastants of each category	2
bitter molecules (Gr66a, Gr33a), sugars (Gr5a, Gr64f), or salt (IR76b)	2
taste receptors	2
caffeine, sucrose and salt	2
bitter, sweet and salty gustation	2
Drosophila wing chemoreceptors	2
commercially available LPS	2
specific taste receptors	2
contact chemoreceptors	2
Escherichia coli or lipopolysaccharides (LPS)	2
pathogens and parasites	2
individuals and the two Drosophila species	2
cosmopolitan and African populations	2
D. melanogaster and D. simulans	2
species in Drosophila	2
evolutionary biologists	2
diving air-breathing ectotherms	2
preferred habitats	2
intermittent, warmer rivers	2
gas-exchanging setae	2
subelytral air stores	2
gas exchange surface	2
beetle’s tracheal system	2
Hollow setae on the elytra	2
beetles	2
Deronectes diving beetles	2
number of ectotherm taxa	2
ectotherm	2
haemolymph sugar	2
massed and spaced conditioning tasks	2
robust long-term memory	2
antennae and mouthparts of honeybees	2
adult, worker honeybees (Apis mellifera)	2
lasting memories	2
sugar rewards	2
different methodologies	2
robustly-diapausing species	2
D. simulans	2
realistic winter simulation	2
pan-tropical regions	2
Surprisingly other Drosophila species	2
European, but not African D. simulans	2
African D. melanogaster populations	2
American D. melanogaster populations	2
sibling species D. simulans	2
European D. melanogaster populations	2
diapause in Europe	2
southern Italy	2
new diapause-enhancing timeless allele	2
diapause induction	2
eastern populations	2
North America and Australia	2
African D. melanogaster and the sibling species D. simulans	2
tropical sub-Saharan Africa	2
temperate Europe	2
European Drosophila melanogaster females	2
active and effective triggers	2
possible siRNA	2
mutated dsRPS6 triggers	2
Similar bioassays	2
siRNA	2
sugar meal	2
abdomen and the ovaries	2
delivery method	2
oocyte provisioning	2
dsRPS6 and dsRPL26 cohorts	2
dsRNA microinjection	2
four ribosomal proteins (RP) transcripts	2
mites and ticks	2
ribosomal transcripts	2
Ribosomal transcripts	2
higher flies	2
nematoceran flies	2
P. papatasi pk/pban	2
pk/pban genes	2
endoproteolytic cleavage sites	2
transcriptional isoforms	2
known pk/pban gene	2
developmental stages	2
functional peptide	2
PBAN-like amino acid sequence homologue SNKYMTPRL	2
diapause hormone	2
NP homologues	2
alternative mRNA splicing site	2
two pk/pban isoforms	2
sand fly Phlebotomus papatasi	2
PBAN domain	2
two isoforms of pk/pban cDNA	2
specific life stages	2
insect groups	2
family of peptides	2
common FXPRL-NH2 or similar sequence	2
pk (pyrokinin)/pban (pheromone biosynthesis activating neuropeptide) gene	2
major family of neuropeptides (NPs)	2
bacterial environment	2
tested faecal outputs	2
controlled microbiota	2
established diet-	2
bacterial environment of the flies	2
Ultimate Reader of Dung (T.U.R.D.)	2
fly excreta	2
free, stand-alone dedicated software tool	2
various labs	2
flies fed on a dye-supplemented diet	2
excreta	2
several amino acids	2
select amino acids	2
pre-fed isoleucine and proline	2
amino acid solution	2
bees pre-fed solutions	2
amino acid solutions	2
solutions containing amino acids	2
bees pre-fed sucrose solution	2
proboscis extension response	2
isoleucine, proline, phenylalanine, or methionine 24h	2
pre-feeding bees	2
correct balance of nutrients	2
long-term gregarious locusts	2
hind femora	2
key role of serotonin	2
nymphs and/or flying swarms	2
cohesive migratory bands	2
Gregarious locusts	2
Solitarious locusts	2
solitarious and gregarious phases	2
Desert Locusts	2
’s haemolymph	2
bee	2
carbohydrate, amino acid, or toxin-laced food solutions	2
5-HT in the haemolymph	2
abdomen of the bee	2
exogenous 5-HT	2
crop and proventriculus	2
entire gut	2
known receptors	2
cocktail of antagonists	2
crop and the midgut	2
four of the known bee 5-HT receptors (Am5-ht1A,2α,2β,7)	2
surface of the oesophagus, crop, proventriculus, and the midgut	2
5-HT immunoreactive processes	2
adult foraging honeybees	2
Serotonin (5-hydroxytryptamine, 5-HT)	2
°C reared individuals	2
CTmin of M. arctica	2
temperate and tropical species	2
A. antarcticus	2
mite, Alaskozetes antarcticus	2
polar Collembola, Megaphorura arctica and Cryptopygus antarcticus	2
polar terrestrial invertebrates	2
instances	2
High Arctic	2
Maritime Antarctic	2
maritime Antarctic	2
Signy Island	2
E. murphyi	2
ecologically relevant thermoperiodic cycle	2
exposed individuals	2
juvenile (L1–L2) and mature (L3–L4) larvae of E. murphyi	2
distribution	2
maritime Antarctic Signy Island	2
single location	2
sub-Antarctic South Georgia	2
midge, Eretmoptera murphyi	2
two mutant strains	2
electroretinograms recorded	2
low-intensity light stimuli	2
wild-type or the hclBT1flies	2
hclBT2flies	2
hclBT2(W111*, a null mutation)	2
Two D. melanogaster mutants, hclBT1(P293S)	2
orthologues	2
orthologues of hclB	2
insect species (Diptera, Hymenoptera, Coleoptera)	2
Insecta	2
member of the Cys-loop receptors	2
histamine-gated chloride channel subunit	2
gene hclB	2
oxygen-deprived tissues	2
tracheal branches	2
hypoxia-inducible proteins	2
Tracheal cells	2
HIF family	2
alpha subunit of oxygen-responsive transcription factors	2
specific prolyl-4-hydroxylases	2
different tissues of the body	2
larval stages	2
every organ and tissue	2
progressively thinner branches	2
continuous tubular network	2
insect tracheal system	2
reliable assay	2
CMV-EBV MIA	2
antibodies to measles, mumps, rubella and varicella zoster (MMRV)	2
ELISAs	2
separate ELISAs	2
antibodies against CMV and two antigens of EBV (EBV capsid antigen (EBV-VCA) and EBV nuclear antigen 1 (EBNA-1))	2
either CMV or EBV	2
commercially available ELISA-kits	2
Cytomegalovirus (CMV) or Epstein-Bar virus (EBV)	2
single target protein molecules	2
different label detection system	2
non-specific signals	2
polystyrene bead	2
detection antibody conjugates	2
conventional sandwich enzyme immunoassay (Sand-EIA) and ICT-EIA	2
2nd bead	2
1st bead	2
sandwich-shaped immune complexes	2
two types of beads	2
ICT-EIA	2
Immune complex transfer enzyme immunoassay (ICT-EIA)	2
cellular control samples	2
proficiency panel	2
4 participants	2
six devices	2
immuno-control kit	2
stable TCR mRNA	2
commonly used electroporation (EP) devices	2
large-scale TERS	2
commonly used T-cell immuno-assays	2
simple and robust TERS technology	2
antigen-specific T cells	2
TCR-engineered reference samples (TERS)	2
one lab	2
standard reagents	2
primary neutrophils	2
distinct HMGB1 and HMGB2 subcellular pools	2
Selecting specific antibodies	2
one HMGB1 antibody	2
HMGB1−/− mouse embryonic fibroblasts	2
five commercially-available anti-HMGB1 antibodies	2
distinct roles	2
DNA-interacting proteins	2
multicenter mass cytometry assays	2
prestained and the sites-stained samples	2
premixed antibody cocktail aliquots	2
individual center	2
prestained controls	2
mass cytometers and operators	2
commercially available reagents	2
healthy control human peripheral blood mononuclear cells (PBMCs)	2
one or few instruments	2
one laboratory	2
Pneumovax®23	2
ViCPS antibodies	2
alternative polysaccharide vaccine approach (Salmonella typhi Vi capsule (ViCPS))	2
current gold standard test	2
Pneumovax®	2
antibody repertoire	2
rare specificities	2
depleted serum	2
individual specimen	2
three monoclonal antibody species	2
low abundance species	2
corresponding species	2
binding reagents	2
high-titer antibody species	2
large random peptide display library	2
low abundance antibody species	2
past, present, and future	2
unique repository	2
human antibody repertoire	2
high-throughput assays	2
different IgG subclasses (IgG1, IgG2 and IgG3)	2
HIV-1 antigens	2
flexible, high-throughput microsphere based multiplex assay system	2
broadly neutralizing antibody (bnAb) based HIV-1 vaccine	2
menstrual cup	2
FGF cytokines	2
CVF cytokines	2
largest volume of sample	2
CVF collection	2
CF > CVF > plasma	2
IL-1β, IL-8 and IL-6	2
fluid types	2
IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13 and TNF-α	2
Multiplex chemi-luminescent assays	2
cervicovaginal fluid (CVF)	2
cervical fluid (CF)	2
polyvinyl acetal sponge collection	2
HIV-uninfected pregnant women	2
female genital tract fluid (FGF)	2
pro-B cell lines	2
distinct NHEJ-deficient pro-B cell lines	2
episomal CRISPR/Cas9 targeting vectors	2
v-Abl/Bcl2 pro-B cell lines	2
v-Abl pro-B cell lines	2
Abl kinase inhibitor Imatinib	2
v-Abl/Bcl2 pro-B cells	2
pseudo-physiological cellular system	2
Abl kinase-transformed pro-B cells	2
transgenic v-	2
NHEJ factors	2
joining (NHEJ) pathway	2
nonhomologous end	2
DNA double strand breaks (DSBs)	2
(RAG) nuclease	2
recombination-activating gene	2
Fcγ receptors, complement proteins, and lectins	2
antibody subclassing reagents	2
array of Fc-binding proteins	2
antigen-conjugated beads	2
Antigen-specific antibodies	2
antigen specificities	2
multiplexed assay	2
dmLT assays	2
developed ELISA	2
high-osmolarity buffers	2
stomach fluid	2
dmLT in glass and plastic containers	2
intact dmLT	2
Double mutant heat-labile toxin (dmLT)	2
anti-Trastuzumab antibodies (ATA) and anti-Cetuximab antibodies (ACA)	2
model drugs	2
Trastuzumab and Cetuximab	2
NanoLuc bridging immunoassay	2
ELISA format	2
antibody label	2
small (19kDa) but ultra-bright NanoLuc luciferase enzyme	2
new bridging immunoassay	2
proprietary reagents and instruments	2
widely available reagents and instruments	2
enzyme-linked immunosorbent assay (ELISA) or electrochemiluminescence (ECL) platform	2
“bridging” immunoassay	2
therapeutic antibody drugs	2
Anti-drug antibodies (ADAs)	2
EuroFlow standard operating procedures and reagent panels	2
non-member laboratories	2
EuroFlow QA	2
EuroFlow protocols	2
first-time participants	2
EuroFlow QA program	2
five continents	2
total 87 laboratories	2
EuroFlow reference sample database	2
non-EuroFlow member participant	2
EuroFlow members	2
external participants	2
members of the EuroFlow consortium	2
sample preparation and instrument setup	2
specific infections, autoimmunity or tumor settings	2
cells and NK cells	2
Tregs or T follicular helper cells (TFH)	2
TH1 phenotype cells	2
CD56hi versus CD56dim defined NK cell developmental stages	2
non-CD8 T cells	2
Gzm A, Gzm K and Gzm M expression	2
reduced perforin	2
granulysin, Gzm A, Gzm B and Gzm M	2
multiple cytotoxic molecules	2
humans: Gzm A, B, K, M and H)	2
one or both pore-forming proteins, perforin and granulysin and combinations of granzyme (Gzm) family effector proteases	2
cytotoxic granules	2
key T and NK cell effector function	2
infected or tumor cells	2
routine autoimmune laboratory	2
whole spectrum of assays	2
blots	2
tested DIA blots	2
IIF utilizing labs	2
intrinsic factor	2
EQC consensus	2
anti-parietal cell antibodies	2
anti-mitochondrial and anti-smooth muscle antibodies	2
participating labs	2
automated DIA (D-Tek)	2
Multiplex line/dot blots (LIA/DIA)	2
combination of tissues	2
dried single test tube format	2
ready-to-use reagents	2
dried tubes	2
multidimensional plots	2
dried tubes and liquid counterparts	2
specific lymphocyte populations	2
normal and/or on patient samples	2
tubes	2
primary immune deficiency orientation tube (PIDOT)	2
lymphocytosis screening tube (LST)	2
8-color 12-marker tubes	2
hematological malignancies and immune deficiencies	2
screening tubes	2
high throughput biophysical platform	2
subject groups	2
polyclonal samples	2
innate arm of the immune system	2
constant region (Fc)	2
antigen target	2
variable region (Fv)	2
vaccine antigen(s)	2
ELISA, neutralization, or agglutination assays	2
novel vaccine candidates	2
approved vaccines	2
variety of NHP	2
multiplex cytokine assays	2
panel of NHP species	2
well-defined immunoassays	2
pan-reactive mAbs	2
cynomolgus PBMC	2
antigen-specific IFN-γ and IL-2 responses	2
mAb pairs	2
Old and New World NHP PBMC supernatants	2
IFN-γ and IL-2	2
NHP peripheral blood mononuclear cells (PBMC).Pan-reactive mAb pairs	2
capture assays	2
Pan-reactive mAbs	2
(Ma's night monkey, squirrel monkey and common marmoset)	2
eukaryotically expressed recombinant IFN-γ and IL-2, respectively, from Old (rhesus, cynomolgus and pigtail macaques, African green monkey, sooty mangabey and baboon) and New World NHP	2
(IL)-2	2
human Interferon (IFN)-γ and Interleukin	2
new and established mAbs	2
many NHP species	2
monoclonal antibodies (mAb)	2
cross-reactive anti-human antibodies	2
infections and vaccines	2
important animal models	2
Non-human primates (NHP)	2
CD4 receptor	2
surface molecules	2
cell yield	2
Medimachine	2
either the enzymes Collagenase D or Liberase TL	2
single immune cell suspension	2
intestinal tissue	2
different blood collection tubes	2
CD9, CD63, CD81, CD142, and Annexin V.This study	2
surface- or surface-related markers	2
EV Array	2
small EVs	2
CD9-, CD63- and/or CD81-positive)	2
ExoQuick™)	2
blood collection tube	2
smaller EVs	2
cellular origin	2
small membrane-derived entities	2
liquid biopsies	2
various body fluids	2
research field	2
field settings	2
lateral flow assay	2
field environment	2
nonendemic pediatric sera	2
non-reference multiplex assay	2
eluted dried blood spots	2
serum and whole blood	2
dual sandwich capture assay	2
gold-conjugate and test line	2
ocular trachoma	2
causative agent of urogenital chlamydia infection	2
immunodominant antigen Pgp3	2
lateral flow-based assay (LFA)	2
non-biological molecular shapes	2
random libraries	2
random combinatorial library	2
potential diagnostic antibody ligand biomarker	2
libraries of random molecular shapes	2
plate-based ELISAs	2
Reactive peptoids	2
anti-HIV antibodies	2
peptoid/beads	2
theoretical variants	2
ten possible different amines	2
8-mer peptoid	2
one bead one compound combinatorial library	2
disease-specific antibodies	2
antigen-binding pocket	2
peptoids	2
antigen space	2
random “shape library	2
random combinatorial library of synthetic poly-N-substituted glycine oligomers	2
Non-biological synthetic oligomers	2
humans or non-human primates	2
new generation T cell line	2
optimized RFADCC assay	2
target cell markers GFP	2
detectable target cells	2
inactivated intact virions	2
monomeric gp120	2
HIV-specific targets	2
SNAP-tagged CCR5	2
EGFP-CEM-NKr cell line	2
rapid fluorometric antibody-mediated cytotoxicity assay (RFADCC)	2
high throughput assay	2
antibody-dependent cellular cytotoxicity (Wren et al., 2013)	2
mouse and human Langerhans cells	2
human and mouse skin XCR1+ DCs	2
novel and user friendly software	2
blood, spleen, skin or cutaneous lymph nodes	2
human and mouse mononuclear phagocyte subsets	2
several public datasets	2
DC and other mononuclear phagocyte subsets	2
tissue and animal species	2
varying antigens	2
mononuclear phagocyte subsets	2
one of these cell populations	2
DC subsets	2
several subsets	2
mononuclear phagocytes	2
Dendritic cells (DC)	2
variety of antigen-specific ASCs	2
tag-based detection systems	2
IgG subclass of antibodies	2
anti-IgG subclass detection reagents	2
different but related antigens	2
multiple ASCs	2
Assay variants	2
hybridomas and immunized splenocytes	2
four different tag systems and fluorophores simultaneously	2
fluorophore-conjugated streptavidin or tag-specific antibodies	2
biotin or peptide tags	2
single ASCs	2
vicinity of each of these cells	2
antibody-secreting cells (ASCs)	2
96-well filter membrane plates	2
anti-IgG antibodies	2
variety of antigens	2
functionally distinct T cells	2
several cytokines	2
fluorescent detection	2
FluoroSpot assay	2
antibody samples	2
antibody ration	2
chemistry and dye	2
amine and thiol chemistries	2
Trastuzumab (anti-HER2) and Cetuximab (anti-EGFR)	2
two different therapeutic antibodies	2
fluorescent reader	2
simple plate based assays	2
pHAb dyes	2
endosomal and lysosomal vesicles	2
antibodies against receptors	2
new hydrophilic and bright pH sensor dye (pHAb dye)	2
endpoint assays	2
cellular toxicity assays	2
fluorescent microscopy	2
antibody drugs	2
surface receptors	2
antibody drug conjugates (ADCs)	2
highly toxic drugs	2
several anti-cancer antibody therapeutics	2
infectious disease (Epstein–Barr virus, influenza A, and Ebola virus), autoimmunity (type 1 diabetes)	2
T-cell libraries	2
validated clone	2
peptide-reactive wells	2
96U-well library format	2
CD3/CD28 microbeads	2
CD8+ or CD4+ polyclonal T-cell populations	2
multiple peptide-specific human T-cell clones	2
monoclonal T-cells	2
costimulatory and coinhibitory receptors	2
triple parameter reporter T cell line	2
costimulatory molecule 4-1BB	2
Jurkat cells	2
costimulatory and inhibitory receptors	2
triple parameter reporter cells	2
costimulatory receptors CD2 or CD28	2
fluorescent proteins CFP, eGFP and mCherry	2
response elements	2
human Jurkat T cell line	2
triple parameter reporter	2
Three transcription factors	2
coinhibitory molecules	2
cell receptor complex	2
downstream applications	2
recovered antibodies	2
thiol- and amine-based chemistry	2
variety of fluorophores	2
HaloTag technology	2
Protein A and Protein G	2
porous and hydrophilic cellulose beads	2
High-capacity magnetic antibody capture beads	2
conjugated antibodies	2
cell media	2
high capacity-magnetic Protein A or Protein G beads	2
method (on-bead conjugation	2
labeling antibodies	2
fluorophore, biotin or drugs	2
components of the gastrointestinal microenvironment	2
confocal microendoscopy	2
multiple cohorts of mice	2
human disease	2
endoscopy technologies	2
luminal pathogens	2
underlying immune system	2
epithelial barrier	2
unique organ system	2
FNA samples	2
organ-derived sampling	2
single cell suspension	2
FNA-derived biopsy	2
liver-derived leukocytes	2
repeated fine needle aspirations (FNAs)	2
tissue sampling	2
organ-specific diseases	2
GFP positive cells	2
mRNA GFP construct	2
murine spleen	2
CD8+ T-cells	2
high viability CD8+ cells	2
Murine adoptive CD8+	2
epitope variants	2
HIV-1-infected humans and HIV-1-vaccinated humans, rhesus monkeys and guinea pigs	2
linear HIV-1 sequences	2
Los Alamos National Laboratory global HIV-1 sequence database	2
majority of HIV-1 sequences	2
HIV-1 proteome	2
6564 peptides	2
HIV-1-specific binding antibodies	2
vast array of different HIV-1 strains	2
integrin LFA1	2
CD45A subset	2
CD45RA subset	2
CD45RO subset of human CD8 T cells	2
reflection and fluorescence channels	2
motile T cells	2
DYNAMIK, Icy, Imaris, and Volocity	2
TIAM accurately	2
cells and cell-tracks	2
transmitted light, reflection and fluorescence channels	2
local segmentation	2
shorter segments	2
transmitted light images	2
MATLAB-based toolset	2
multi-channel time-lapse microscopy data	2
time-lapse microscopy images	2
Several computational algorithms and tools	2
recombinant Fowlpox vectored influenza nucleoprotein and matrix protein	2
IFNγ producing cells	2
responding cells	2
Splenocytes from birds	2
influenza virus antigens	2
IFNγ ELISpot assay	2
infected chicken kidney cells (CKC) in culture	2
activated effector T cells	2
cell integrin Leukocyte Function-associated Antigen-1 (LFA-1)	2
co-factors including costimulation and adhesion molecules	2
TCR-transgenic model	2
antigen-induced iTreg cells	2
iTreg cells	2
Foxp3+	2
anti-CD3 and anti-CD28 antibody	2
antigen-specific iTreg cells	2
antigen-specific, in vitro-induced Foxp3+ Treg (iTreg) cells	2
invidual samples	2
antigen non-coated blank wells	2
appropriate buffer system	2
Crohn's disease	2
patients with RA	2
Escherichia coli O111:B4, E. coli lipopolysaccharide (LPS) and peptidoglycan polysaccharide (PG-PS)	2
immunoglobulin in sample specimens	2
new buffer	2
conventional buffers	2
newly developed buffer system	2
patients with autoimmune diseases	2
potential environmental pathogenic and autologous antigens	2
conventional buffer systems	2
conventional ELISA buffers	2
variety of environmental agents and autologous components	2
potential environmental pathogens	2
promising HIV-1 vaccine candidates	2
“whole-genome” IMC-LucR viruses	2
cells from HIV-1 negative volunteers	2
96-well plate format	2
LucR read out	2
luciferase readout	2
Renilla luciferase (LucR) gene	2
complete proviral genome	2
replication-competent HIV-1 infectious molecular clones (IMCs)	2
novel VIA	2
culture supernatant	2
autologous CD4 T cells	2
viral inhibition assay (VIA)	2
new HIV-1 vaccine candidates	2
functional HIV-1 specific CD8 T-cell responses	2
relevant assays	2
IFN-γ ELISPOT responses	2
SIV and HIV specific CD8 T cells	2
appropriate 3-D model	2
direct contact	2
EC	2
Migrated cells	2
EC and then stroma)	2
matrix of collagen type 1	2
monolayer on a porous filter	2
stromal layer incorporating fibroblasts	2
Three-dimensional tissue-like constructs	2
lymphocytes through endothelium and its underlying matrix	2
endothelial cells (EC)	2
CD127, CD62L, CD27, and CD57	2
memory T-cell subpopulations	2
healthy donor populations	2
averaged models	2
pathway-specific cell subtypes	2
selection markers CD3, CD4, CD8, and side scatter (SSC)	2
combination of three markers, CD45RA, CCR7 (CD197), and CD28	2
four major CD8+ T-cell subsets	2
effector/memory CD8+ T cells	2
high-dimensional cytometric data	2
polychromatic data	2
larger series	2
Toxoplasma serodiagnosis	2
recombinant immunoconjugate	2
homogeneous bi-functional reagent	2
genetic fusion protein	2
T. gondii immune and non-immune patients	2
specific T. gondii antibodies	2
recombinant SAG1–AP	2
human toxoplasmosis	2
crude preparation SAG1–AP conjugate	2
recombinant fusion protein	2
bacterial alkaline phosphatase (AP)	2
SAG1 antigen	2
pLIP6 prokaryotic expression vector	2
full length sag1 gene	2
diagnostic antigen	2
important immunodominant target	2
surface T. gondii SAG1 protein	2
simple, rapid and highly sensitive reagent	2
novel candidates	2
BCG-lux assay	2
small blood samples	2
mycobacteria in whole blood samples	2
reporter-gene tagged BCG-lux assay	2
vaccine take	2
mycobacteria pre- and post-vaccination	2
functional in vitro approaches	2
unique clones	2
large Fab and scFv naïve phage libraries	2
native, FkpA	2
co-expressing Fab fragments	2
functional Fab fragments	2
E. coli cytosol	2
peptidyl prolyl cis-trans isomerase, FkpA, lacking its signal sequence (cytFkpA)	2
properly folded antibody fragments	2
E. coli periplasm	2
phage libraries	2
antibody candidates	2
small tissue samples	2
multiple low concentration cytokines	2
mucosal biopsies	2
IL-17 and IFNγ the MILLIPLEX kit	2
proper optimisation Luminex kits	2
inflamed and uninflamed gastric mucosa	2
selected kit	2
unspiked samples	2
endogenous cytokines	2
different tissue processing methods and extraction buffers	2
recombinant IL-17 and IFNγ	2
mucosal samples	2
three commercial Luminex kits (VersaMAP, Bio-Plex and MILLIPLEX)	2
Luminex assays	2
endoscope	2
small mucosal tissue biopsies	2
test than control wells	2
peptide pools	2
test and control wells	2
IL‐1β or IL‐10	2
TNFα, IL‐6 or IL‐8	2
human peripheral blood mononuclear cells in vitro	2
less well characterized preparations	2
first such preparations	2
normal human donor plasma	2
natural, authentic proteins	2
structurally and functionally intact, pharmaceutical grade preparations	2
systemic amyloidosis	2
human pentraxin proteins, serum amyloid P component (SAP) and C‐reactive protein (CRP)	2
novel TCR/pMHC complexes	2
Protein crystallography	2
current immune protein database	2
cell related protein structures	2
high quality TCR/pMHC complex crystals	2
‘intelligently designed’ crystallization screen	2
good quality TCR/pMHC protein crystals	2
pathogens and cancer	2
target cell surface	2
peptide-major histocompatibility complex (pMHC) molecules	2
clonotypic αβ T cell receptor (TCR)	2
milk allergic patients	2
larger study groups	2
milk proteins	2
validated statistical models	2
milk origin	2
particular IgE	2
total IgG and IgA	2
profiling array results	2
food allergy	2
pediatric reference center	2
clinicians	2
four classes of immunoglobulins	2
protein microarray system	2
matched serum and plasma samples	2
Danish blood donors	2
two CL-11-deficient individuals	2
two different monoclonal antibodies	2
CL-11 gene	2
mannose-binding lectin-associated serine protease 1 (MASP-1)	2
glycoconjugates on pathogen surfaces	2
collectin group of proteins	2
pattern recognition molecule	2
collectin kidney 1 (CL-K1)	2
Collectin 11 (CL-11)	2
cervical cytobrush-derived T cells	2
delayed processing cytobrushes	2
ex vivo	2
cryopreserved samples	2
CD3+ T cells	2
anti-CD3 and IL-2	2
thawed cervical lymphocytes	2
cytobrush-derived T cells	2
PMA, PHA and CEF peptides	2
Intracellular cytokine staining	2
Trypan and Annexin/PI staining	2
215 chronically HIV-infected women	2
cervical cytobrush specimens	2
cervical T cells	2
Cervical cytobrushing, biopsy, or lavages	2
tetanus toxoid (TT).Overall	2
Ki67 proliferation	2
BrdU or OG	2
proliferating T cells	2
Oregon Green (OG), a CFSE derivative	2
current flow cytometry based proliferation assays	2
human whole blood or PBMC with antigens	2
CD4+ and CD8+ T cells	2
nuclear protein, Ki67	2
blood and cytobrush	2
viable T cells	2
Dynabeads (1:1)	2
central memory T cells (CD45RO+CCR7+CD27+)	2
effector memory T cells (CD45RO+CCR7−CD27−)	2
blood (7.1-fold) and cervix	2
Dynal beads (1:1)	2
Culturing cells	2
cervical CD3+ T cells	2
Anti-CD3 and IL-2	2
CD45RO, CCR7 and CD27)	2
female genital tract and blood	2
HIV-infected women	2
anti-CD3, anti-CD3/CD28 or Dynal anti-CD3/CD28 beads) and cytokine combinations (IL-2, IL-7 and IL-15)	2
mucosal mononuclear cells	2
Cervical cytobrushing	2
blood-derived T cells	2
purified cells	2
starting population	2
CD4 and CD8 cells	2
trypan blue	2
propidium iodide (PI) staining	2
crude cell preparation	2
pure lymphocytes	2
human CD3 microbeads	2
Lymphocytic cells	2
nylon mesh	2
lung resection tissue	2
Lung T lymphocytes	2
bio-active IFN-γ present	2
functional IFN-γ signalling pathway	2
bio-active IFN-γ	2
IFN-γ signal	2
gamma (MIG), or CXCL9	2
ELISPOT assay	2
major assay	2
IFN-γ ex vivo ELISPOT	2
current technology	2
tumour-specific responses	2
cognate pMHC tetramers	2
background staining	2
human (CD8+ and CD4+) and murine T-cells	2
reversible protein kinase inhibitor (PKI) dasatinib	2
ex vivo samples	2
antigen-specific T-cells	2
fluorochrome-conjugated peptide-major histocompatibility complex (pMHC) tetramers	2
atopy-related molecule	2
FcεRI-β protein	2
mature α-chain expression	2
β-chain expression	2
cultured mast cells	2
membrane bound immunostaining	2
27 kDa protein	2
FcεRI-β antibody	2
human mast cells	2
anti-FcεRI-β chain antibody	2
atopy-associated genes	2
high-affinity IgE receptor (FcεRI)-β gene	2
commercial NF-κB activation reporter cell line	2
NF-κB rel	2
specialist imaging equipment or image analysis software	2
transcriptionally active components of NF-κB	2
conjugated forms of both hormones	2
free 11-ketotestosterone	2
freely circulating cortisol	2
small fish	2
Trinidadian guppies (Poecilia reticulata)	2
circulating glucocorticoids	2
standardized sampling protocols	2
species of interest	2
potential fields	2
wild and domesticated animals	2
domesticated and wild animals	2
males of both species	2
sexes of White-crowned sparrows	2
female Lapland longspurs and male white-crowned sparrows	2
either species	2
storm-free days	2
white-crowned sparrows (Zonotrichia leucophrys gambelii; 2014–2016)	2
Lapland longspurs (Calcarius lapponicus; 2012–2016)	2
arctic snowstorms	2
multiple days	2
stress hormone corticosterone	2
hypothalamic-pituitary adrenal (HPA) axis	2
short-term satiety hormone	2
gastric antrum region of the intestinal tract	2
proximal ileum	2
gastrointestinal CCK transcripts	2
gastrin in the chicken	2
two genes in birds	2
domestic chicken	2
vertebrate clades	2
related peptide hormones cholecystokinin (CCK) and gastrin	2
hypothalamic and pituitary endocrine circuits	2
seasonal calendar cell	2
PT-specific thyrotroph	2
primary transducer of photoperiodic input	2
pars tuberalis (PT) of the pituitary	2
photoperiod-sensing pathway	2
innate long-term timekeeping systems	2
highly predictive signal	2
environmental cues	2
hypothalamic pituitary gonad axis	2
additional feedback pathways	2
photostimulation of breeding	2
thyroid hormone-suppressed birds	2
Gambel’s white-crowned sparrows (Zonotrichia leuchophrys gambelii)	2
photostimulation of pre-nuptial molt	2
either triiodothyronine (T3) or thyroxine	2
seasonal species	2
normal pigs	2
watered ad libitum	2
lean and normal animals	2
groups, infected and controls pigs	2
infected pigs	2
T. solium infected	2
T. solium infected and 15 non-infected controls sows	2
Three hair patches	2
naturally Taenia solium infected and non-infected control pigs	2
young (2wk) chicks	2
pancreatic PPY	2
intestinal PYY	2
distal jejunum	2
chicken PYY	2
avian species	2
avian PYY	2
gene sequence	2
peptide YY (PYY) and pancreatic polypeptide (PPY)	2
PP-fold peptides	2
crustaceans) and “ACP”	2
arthropod lineage	2
paralogous GnRH-type peptides	2
“corazonin”	2
GnRH/corazonin-type neuropeptides	2
GnRH/corazonin-type neuropeptide signaling	2
extant animals	2
GnRH/corazonin-type peptide-receptor pathways	2
AKH and ACP signaling systems	2
vertebrates, urochordates and nematodes)	2
corazonin signaling	2
protostomes and deuterostomes	2
paralogous systems	2
deuterostomian invertebrate	2
distinct GnRH-type and corazonin-type signaling pathways	2
common European starfish Asterias rubens	2
either a GnRH-type receptor or a corazonin-type receptor in an echinoderm species	2
two neuropeptides	2
distinct GnRH-type and corazonin-type peptide-receptor signaling pathways	2
GnRH-type and corazonin-type receptors	2
lophotrochozoan protostomes (annelids, mollusks) and in deuterostomian invertebrates (cephalochordates, hemichordates, echinoderms)	2
GnRH-type receptors and corazonin-type receptors	2
family of related neuropeptides	2
corazonin and AKH/corazonin-related peptide (ACP)	2
AKH-like peptides	2
arthropod	2
GnRH-type receptor	2
adipokinetic hormone (AKH)	2
agnathans (e.g. lampreys) and urochordates (e.g. sea squirts)	2
chordates	2
GnRH-type signaling systems	2
Gonadotropin-releasing hormone (GnRH)	2
animals in wild populations	2
captive animals	2
female zebra finches	2
larger groups	2
Female birds	2
groups of five	2
Adolescent zebra finches	2
e.g. testosterone	2
vulnerable windows	2
Pre and post-natal periods	2
elevated glucocorticoids	2
periphery and the CNS	2
hypothalamic pituitary adrenal (HPA) axis	2
key hormonal systems	2
life physiological systems	2
egg yolk	2
egg T (LET) birds	2
High egg T (HET) birds	2
gonadotropin releasing hormone (GnRH)	2
Japanese quail	2
maternal testosterone (T) into egg yolk	2
adult neophobia	2
larger broods	2
fledged fewer chicks	2
parental neophobia	2
wild breeding jackdaws	2
developing offspring	2
highly neophobic species, jackdaws (Corvus monedula)	2
offspring animals	2
wild	2
neophobia and stress hormones	2
Many species	2
milk bioactivity	2
recent reports	2
tammar pouch young	2
major milk constituents	2
immature young	2
milk bioactives	2
Australian marsupial, the tammar wallaby (Macropus eugenii)	2
cell death)	2
range of bioactives	2
appropriate nutrition	2
study years	2
white-crowned sparrows	2
extended snow cover	2
extreme weather year	2
white-crowned sparrow (Zonotrichia leucophrys) and Lapland longspur (Calcarius lapponicus)	2
low arctic Alaska	2
two long-distance migrants	2
cortisol or corticosterone	2
extreme weather	2
residents females and males	2
female migrants	2
HPG axis	2
repeated GnRH	2
Male migrant and resident birds	2
resident females	2
overwintering grounds	2
migrant females	2
luteinizing hormone (LH)	2
shared over-wintering grounds	2
free-living resident and migrant juncos	2
‘control point’	2
juncos cohabitating on shared wintering grounds	2
habitat	2
(Junco hyemalis) populations	2
Dark-eyed junco	2
hypothalamo-pituitary-gonadal (HPG) axis	2
gonadally synthesized steroids	2
population of white-browed sparrow weavers	2
circulating T.	2
individual dominant males	2
subordinate males	2
dominant males	2
subtropical population of the year-round territorial white-browed sparrow weaver (Plocepasser mahali mahali)	2
seasonally breeding northern temperate species	2
song in male birds	2
circulating T	2
male vertebrates	2
granulosa cells	2
17-beta-estradiol	2
SLC27A1	2
fatty acid transporters CD36	2
proliferation marker PCNA	2
cell cycle regulator CCND2	2
steroidogenic genes STAR, CYP11A1, HSD3B1 and CYP19A1	2
gonadotropin hormone receptors, FSHR and LHCGR	2
cultured bovine granulosa cells	2
selected transcripts	2
follicular fluid	2
majority of dairy cows	2
urban – towhees	2
desert –	2
urban and desert areas	2
Abert’s towhees	2
non-urban and urban towhees	2
leaf foliage of urban trees	2
leaves on desert trees	2
ground arthropod biomass)	2
hypothalamo-pituitary–gonadal (HPG) axis	2
key food types	2
Melozone aberti	2
male Abert’s towhees	2
ecological and physiological bases	2
novel environment	2
individual phenotypes	2
unfamiliar and human altered environments	2
new habitat	2
“pioneers”	2
others contract	2
species’ ranges	2
appropriate habitat	2
highest ranking males	2
Faecal cortisol (but not androgen)	2
red deer faeces	2
androgen metabolites	2
faecal cortisol and androgen metabolites	2
wild red deer stags	2
wild animals	2
individuals within a population	2
anorexigenic ghrelin	2
ERVK retrotransposon in intron 0	2
saker and peregrine falcons	2
derived peptides ghrelin and obestatin	2
functional copy of GHRL	2
Thirty-one bird species	2
ghrelin gene (GHRL) of birds (class Aves)	2
key peripherally secreted appetite-regulating hormones	2
GH-secreting pituitary adenomas	2
acromegalic patients	2
Soluble Klotho	2
d3-GHR polymorphism	2
d3-GHR genotype	2
residual tumour masses	2
sera of patients	2
112 patients	2
useful supplementary tool	2
GH-producing adenomas	2
soluble Klotho (sKlotho)	2
GH receptor	2
somatomedin C	2
growth hormone (GH) and insulin like growth factor 1 (IGF-1) levels	2
hypothalamic TH signalling pathways	2
upstream pituitary/hypothalamic gene expression	2
TSH/Dio2/Dio3 system	2
plant metabolite 6-methoxy-2-benzoxazolinone (6-MBOA)	2
seasonal mammal species	2
female common voles (Microtus arvalis)	2
TSH/Dio2/Dio3 signalling pathway	2
nutritional and social cues	2
voles of the genus Microtus	2
seasonally breeding rodents	2
type II and III deiodinases (Dio2 and Dio3, respectively)	2
neighbouring hypothalamic cells	2
pars tuberalis (PT) of the pituitary stalk	2
thyroid-stimulating hormone (TSH) production	2
photoperiodic message	2
key hormonal relay	2
VSP antibodies	2
two human infective Giardia assemblages	2
two Giardia VSP proteins	2
anti-VSP5 IgG/M response	2
assemblage A and assemblage B Giardia lamblia	2
anti-VSP3	2
G. lamblia VSP proteins 3 and 5 (VSP3 and VSP5).ResultsSerum levels of anti-VSP5 and anti-VSP3 IgA	2
two recombinant antigens	2
Giardia specific IgA and IgG/M responses	2
returning travellers	2
Giardia-positive patients	2
Giardia assemblages	2
two Giardia variant-specific surface proteins (VSP)	2
vitro cultivation systems	2
unusual organism	2
variety of hosts	2
HIV/AIDS patients and transplant recipients	2
development of children	2
Cryptosporidium parasites	2
Plasmodium and Toxoplasma	2
well-known genera	2
phylum apicomplexa	2
Cryptosporidium species	2
wide range of animals including humans	2
genus of single celled parasites	2
underlying cytoskeleton	2
homogenously distributed	2
fluorescence	2
specific domains	2
lipid-anchored eYFP	2
inner plasma membrane leaflet	2
live trypanosomes	2
either norbornene or thiol moieties	2
poly(ethylene glycol)	2
biological structures in living cells	2
genome-wide distribution of nucleosomes or other DNA-binding proteins	2
host-derived nutrients	2
MF and adult stage filarial worms	2
heat labile molecules (likely a protein)	2
lipid-containing molecules	2
EOMA-produced factors	2
L. sigmodontis adult worms	2
lipid factors	2
factors microfilariae	2
direct co-culture	2
MF survival	2
transwell plates	2
Culturing EOMA cells	2
mouse endothelial cell line (EOMA)	2
10% fetal bovine serum (FBS)	2
Dulbecco's Modified Eagle Medium (DMEM)	2
filarial parasite of rodents	2
Litomosoides sigmodontis	2
microfilariae (MF)	2
novel anti-filarial agents	2
Leishmania spp.	2
Khyber Pakhtunkhwa	2
CL-causing L. tropica	2
visceralizing Kenyan and Indian L. donovani	2
third L. infantum isolate	2
Leishmania chagasi, L. infantum and L. donovani from Sudan and Ethiopia	2
Afro-Eurasian and American species of the Leishmania donovani complex	2
Two L. infantum isolates	2
distinct L. tropica genotypes	2
two genotype groups	2
Pakistan and other geographical regions	2
L. tropica strains	2
internal transcribed spacer 2 (its2)	2
gene sequences encoding cytochrome b (cytb)	2
geographical areas	2
Leishmania tropica, 3 Leishmania infantum)	2
Several species of the genus Leishmania	2
native parasites	2
small (captive-bred) populations	2
wild origin	2
captive bred vertebrate	2
inbred individuals	2
various arms of the immune system	2
gyrodactylid infections	2
inbred fish	2
Inbred fish	2
individual fish	2
guppy Poecilia reticulata	2
live bearing vertebrate	2
Gyrodactylus turnbulli infection	2
individuals bred	2
remote analysis service	2
central analytical laboratories	2
image	2
highly trained personnel	2
trained technicians	2
concentrated sediment	2
total suspended solids (TSS)	2
different species of helminth eggs	2
species of helminth eggs and other objects	2
objects in samples	2
system development	2
image processing system	2
Version one	2
different image processing tools	2
seven species of helminth eggs (Ascaris lumbricoides -fertile and unfertile eggs-, Trichuris trichiura, Toxocara canis, Taenia saginata, Hymenolepis nana, Hymenolepis diminuta, and Schistosoma mansoni)	2
mast cell populations in the ear	2
IFNγ mRNA	2
two SMAs	2
oxazolone-treated mice	2
ear inflammation	2
oxazolone-induced acute allergic contact dermatitis mouse model	2
SMA 12b	2
SMA 11a	2
two synthetic small molecule analogues (SMAs) of ES-62	2
covalently attached phosphorylcholine (PC) residues	2
rodent filarial nematode Acanthocheilonema viteae	2
major secreted protein	2
transgenic expression systems	2
bloodstream form cells	2
vector backbone	2
specific protein or cell line	2
ribosomal promoter	2
tool kit	2
cell biology	2
either wild type or mutant proteins	2
endocytic GTPase	2
GTPase and FYVE-domains	2
endosomal region	2
FYVE domain of TbFRP	2
Euglenazoa	2
TbFRP orthologs	2
phosphoinositol 3-phosphate (PI3P)	2
FYVE-domains	2
Ras-like GTPase	2
FYVE domain N-terminally	2
GTPase, TbFRP	2
restricted lineage	2
certain eukaryote lineages	2
GTPase paralogs	2
Ras-like small GTPases	2
tick-borne pathogens	2
tropical theileriosis	2
developed assay	2
single and mixed infections	2
non-target species	2
serially diluted DNA representing mixtures of T. annulata, B. bovis and A. marginale	2
single and multiplex PCRs	2
pathogen species	2
DNA preparations	2
DNA of different stocks of each pathogen and other Theileria, Babesia and Anaplasma species	2
primer pair	2
designed primer sets	2
genomic DNA of T. annulata, A. marginale and B. bovis	2
cytob1, MAR1bB2 and bovar2A	2
three primer sets	2
optimised multiplex PCR assay	2
candidate target genes	2
Theileria annulata, Babesia bovis and Anaplasma marginale	2
multiplex and single PCR assays	2
domestic cattle	2
tick-borne protozoan diseases	2
Tropical theileriosis	2
native GltX	2
GltX bipartite signal	2
nucleus and the mitochondrion	2
transcript of gltX	2
transient transfection system	2
putative bipartite signal of GltX	2
tRNA synthetase (GltX)	2
many non-Plasmodium apicomplexans	2
prokaryotic derived organelle	2
Plasmodium berghei transgenic model	2
mouse malaria	2
Ab class	2
MSP119-specific IgG1	2
vitro functional assays	2
NADPH-mediated oxidative bursts	2
parental human IgG	2
Murine IgG1	2
epitope-matched parental monoclonal antibodies (mAbs)	2
eight IgGs	2
homologous antigen from Plasmodium yoelii (P. yoelii)	2
mouse IgG1, IgG2a, IgG2b and IgG3 specific for the C-terminal 19-kDa region of Plasmodium falciparum merozoite surface protein 1 (PfMSP119)	2
different mouse IgG subclasses	2
rodent malarias	2
Murine immunoglobulin G (IgG)	2
dominantly active Rab11 mutant	2
none of the Rab5 mutants	2
clathrin heavy chain	2
Clathrin hemizygotes	2
several lines expressing mutant forms of Rab5 and Rab11	2
trypanosome clathrin heavy chain hemizygote	2
clathrin-associated receptor, epsinR	2
major coat protein clathrin	2
bona fide drug target	2
African trypanosome, Trypanosoma brucei	2
parasite–immune system interface	2
us (immunologists and parasitologists)	2
imaging technologies	2
‘conventional’ in vitro and in vivo approaches	2
trypanosome-specific ER-localized proteins	2
Surface biotinylation or immunoflorescence	2
major surface trans-membrane domain proteins	2
ER-associated protein	2
ERAP32	2
VSG abundance	2
candidate ER-resident proteins	2
trypanosomatid-specific genes	2
endoplasmic reticulum (ER) biosynthetic output	2
cell surface protein	2
Trypanosoma brucei the GPI-anchored variant surface glycoprotein (VSG)	2
Coartem®)	2
P. berghei and Plasmodium falciparum	2
LM-resistant line	2
PQ-resistant line	2
/ED90 of parent line]	2
[ED90	2
selected parasite lines	2
parent line	2
selected piperaquine (PQ) and lumefantrine (LM) resistant Plasmodium berghei ANKA parasite lines in mice	2
myophilin-like protein	2
schistosomiasis patients	2
non-infected humans	2
schistosome-infected rabbits	2
muscle of the adult worm	2
Confocal fluorescence microscopy	2
eggs, sporocysts, cercariae, hepatic schistosomula and adult worms	2
Sj myophilin-like protein mRNA	2
myophilin, calponin, Np22 and Mp20	2
Sj myophilin-like protein	2
deduced amino acid sequences	2
recombined protein (rSj myophilin-like protein)	2
Schistosoma japonicum myophilin-like protein	2
Δpplp5 and Δpplp3 ookinetes	2
hemocoel	2
midgut	2
midgut epithelial cells	2
loss-of-function mutants	2
three PPLPs	2
predicted pore-forming domain	2
Plasmodium perforin-like proteins (PPLPs)	2
vaccine/drug targets	2
different and specific cells	2
three invasive stages	2
malarial parasite Plasmodium	2
RhoA-ROCK1- phospho ERM pathway	2
ROCK1, phospho-ERM	2
E-cadherin, vimentin, N-cadherin and Slug	2
anti-ROCK1 siRNA	2
Bel-7402 and HepG2 cells	2
N-cadherin and Slug	2
xenograft tumors	2
ARHGEF10L RNA	2
lentivirus vectors	2
Bel-7402 cells	2
Tumor-bearing mice	2
anti-ARHGEF10L siRNA	2
ARHGEF10L-expressing plasmids	2
hepatocellular carcinoma cell Bel-7402 and HepG2 cells	2
E-cadherin expression	2
Rho-associated coiled-coil kinase-1 (ROCK1), phospho- Ezrin/Radixin/Moesin (ERM), vimentin, N-cadherin and Slug	2
ARHGEF10L locus	2
tag single nucleotide polymorphisms (tag SNPs)	2
Sequenom MassARRAY	2
Illumina GoldenGate microassay	2
RhoGEF family	2
Rho guanine nucleotide exchange factor 10-Like (ARHGEF10L)	2
Rho small G-proteins	2
single parasite transcriptomics	2
single parasites	2
variable gene families	2
expressed genes	2
, previously undefined, gametocyte stage specific genes	2
developing asexual and sexual stage parasites	2
intra-erythrocytic developmental cycle (IDC)	2
165 single infected red blood cells (iRBCs)	2
single-cell RNA-sequencing	2
capillary-based platform	2
mosquito and human hosts	2
primary human glioma cultures	2
murine glioma	2
p75 neurotrophin receptor (p75NTR)	2
hypoxia-inducible factors HIF-1α and HIF-2α	2
important apoptosis-regulatory proteins	2
miR-192-5p and miR-194-5p	2
anti-apoptotic proteins SODD and cFLIP	2
mimic of miR-194-5p	2
pro-apoptotic BIM	2
mimic of miR-192-5p	2
three microRNAs	2
potential target genes	2
identical seed sequences	2
miR-192-5p and miR-215-5p	2
miR-192-5p, miR-194-5p and miR-215-5p	2
vitro HepG2 cell model system	2
microRNA expression	2
SUMO target	2
U2OS osteosarcoma cells	2
MDA-MB-231 breast cancer cells	2
key component of FAs	2
proteins on lysine residues	2
Focal adhesions (FAs)	2
pro-survival and anti-apoptotic IGF-1 effects	2
recombinant IGFBP1	2
recombinant insulin-like growth factor 1 (IGF-1)	2
either thapsigargin (TG) or staurosporine (STS)	2
inducible plasmid encoding the HBV X protein (HBx)	2
HBV-replicating cells	2
insulin-like growth factor binding protein 1 (IGFBP1)	2
differentially expressed genes in HBV-replicating HepG2 cells	2
human HepG2 liver cells	2
oral carcinoma cells	2
FL cells	2
AK23 antibody	2
Matrigel® coated wells	2
Transwell	2
Δ560 cells	2
shorter form (Δ238)	2
3D assays	2
FL and both truncated constructs	2
EC1 domain of Dsg3	2
monoclonal antibody AK23	2
human Myogel TMEM matrices	2
rodent collagen and Matrigel	2
empty vector control (Ct) of buccal mucosa squamous cell carcinoma (SqCC/Y1) cells	2
C-terminally truncated Dsg3 (∆238 and ∆560), overexpressed full-length (FL) Dsg3	2
mutant constructs	2
tumour microenvironment mimicking (TMEM) matrices	2
Dsg3-modified carcinoma cells	2
adhesion receptor	2
transcription factor network	2
nuclear FOXA1 and GATA3 proteins	2
urothelial differentiation-associated claudin 3 tight junction protein	2
GATA3 or PPARy1	2
PPARG, GATA3 and FOXA1 genes	2
Normal human epithelial cells of buccal and urothelial derivation	2
homologous tissue	2
healthy autologous tissue-specific cells	2
tissue-specific pathways	2
Rho-GTPases and ND proteins	2
nephrocyte ultrafiltration	2
inter-dependent components	2
ND proteins Sns	2
actin cluster	2
endoplasmic reticulum structure	2
Rho-GTPases	2
unique cytoplasmic cluster of F-actin	2
Drosophila nephrocytes	2
ND	2
nephrocyte architecture	2
wastes and toxic products	2
filtration barrier	2
exceptional macromolecular assembly, the nephrocyte diaphragm (ND)	2
mammalian kidney podocytes	2
Insect nephrocytes	2
whole cell	2
Rho and Rap GTPase signaling	2
leukocytes, fluid and small molecules	2
blood and tissues	2
enigmatic structures	2
correctly folded structural units	2
N-terminal-dependent sequential interactions	2
human protein	2
CTP synthase inhibitor DON	2
mutated N-terminal alanine residue	2
heteromeric CTP synthase filaments	2
CTP synthase	2
three key amino acid residues	2
cytoophidium assembly	2
conserved N-terminal of Drosophila CTP synthase	2
cytoophidia in bacteria, yeast, fruit flies and human cells	2
long filamentous structures	2
CTP-generating enzyme CTP synthase	2
distinct intracellular structures	2
Several metabolic enzymes	2
HIF transcriptional cascade	2
transcription factor hypoxia-inducible factor (HIF)	2
series of 2-oxoglutarate-dependent oxygenases	2
erythropoietin gene	2
nesprin-2 giant	2
active β-catenin	2
N-terminal fragment of nesprin-2	2
nesprin-2 and β-catenin	2
nesprin-2 N-terminal variants	2
nesprin-2 variants	2
novel nesprin-2 N-terminal variants	2
signalling scaffolds	2
multi-isomeric family of proteins	2
biochemical signalling pathways	2
mineralisation inhibitor, pyrophosphate	2
Osteocalcin and TNAP mRNA expression	2
tissue non-specific alkaline phosphatase (TNAP) activity	2
allopurinol and oxypurinol	2
mature osteoblasts	2
differentiating and mature, bone-forming osteoblasts	2
purine degradation pathway	2
xanthine oxidase (XO) an enzyme	2
active metabolite	2
PHOX2A expression	2
PHOX2B expression	2
corresponding mRNA	2
PHOX2A protein	2
PHOX2A and PHOX2B expression	2
BE(2)C cell line	2
different NB cell lines and tumour samples	2
autonomic ganglia	2
two homeodomain proteins	2
paralogue gene PHOX2A	2
cell–matrix adhesion complexes	2
major force sensing and transmitting component	2
integrin-ECM adhesions	2
force transducing protein	2
integrin-mediated adhesions	2
several adhesion-based proteins	2
several types of adhesions	2
Rpa2 N-termini	2
potential model system	2
human domain	2
conserved kinases	2
human Rpa2 in human cells	2
human Rpa2 N-terminus (NT)	2
analogous yeast Rfa2 N-terminal phospho-mutants	2
N-terminus and the loop 3–4 region	2
domains/regions of human Rpa2	2
corresponding human RPA subunit	2
single yeast RFA subunit	2
human RPA	2
yeast Replication Factor A (RFA)	2
simpler systems	2
important regions	2
orthologous RPA subunits or regions	2
RPA complex	2
heterotrimeric single-stranded DNA (ssDNA) binding complex Replication Protein A (RPA)	2
wild-type keratinocytes	2
plectin-deficient and wild-type myoblasts	2
plectin-deficient and wild-type myoblasts and keratinocytes	2
cytoskeletal structures	2
plectin-deficient and wild-type keratinocytes	2
wild-type myoblasts	2
fibronectin-coated paramagnetic beads	2
wild-type and plectin-deficient keratinocytes	2
plectin-deficient myoblasts	2
cell stretching device	2
murine plectin-deficient myoblasts and keratinocytes	2
human plectin gene	2
scaffolding and docking platform	2
anchoring cytoskeletal filaments	2
intermediate filament (IF)-based cytolinker protein	2
exciting model system	2
whole genome sequencing	2
single genotoxin treated cells	2
single locus reporter assays	2
interdependence	2
exogenously applied genotoxins	2
endogenous DNA damaging metabolites	2
high throughput next generation sequencing (NGS)	2
various DNA lesions	2
Genetic information	2
dysregulated networks	2
normal haematopoiesis	2
TF-controlled gene regulatory networks	2
normal and dysregulated networks	2
attractive experimental system	2
haematopoietic system	2
increasingly accurate network models	2
genome-wide technologies	2
gene-regulatory networks	2
mature cell lineages	2
cultures of PiT1 overexpressing cells	2
attached cells	2
human PiT1 in MC3T3-E1 cells	2
human PiT1 in NIH3T3 cells	2
cultures of NIH3T3 cells overexpressing PiT1	2
non-proliferating cells	2
colonies in soft agar	2
transformation NIH3T3 cells	2
two strict density-inhibited cell lines, murine fibroblastic NIH3T3 and pre-osteoblastic MC3T3-E1 cells	2
human PiT1	2
inorganic phosphate transporter PiT1 (SLC20A1)	2
contiguous sheets	2
VEGF uptake	2
VEGFR2 positive ECs	2
α6 integrin	2
added laminin	2
different sized tubular structures	2
different developmental pathways	2
cells signalling angiogenic proteins	2
ECs in 3D collagen hydrogels	2
receptors VEGFR1 and VEGFR2 key components	2
vascular endothelial growth factor (VEGF)	2
Various cell types and growth factors	2
3D in vitro	2
RAF and ROS	2
pro-oxidants	2
Bim or Mcl-1 expression	2
GF starvation	2
activated RAF	2
promyeloid 32D cells	2
shared or distinct targets	2
survival signaling and antioxidants	2
Activated RAF, AKT, Bcl-2 and antioxidants	2
invadolysin morphant fish	2
distribution of melanophores	2
neuromast clusters	2
teleost Danio rerio	2
essential, conserved metalloprotease	2
lamellipodia and filopodia	2
pronounced actin-based membrane structures	2
Rac1 and Cdc42 activities	2
cell borders	2
Rac1 specific inhibitor (NSC23766)	2
dominant negative Rac1 mutant (N17Rac1)	2
endogenous Dsg3 colocalises	2
several epithelial lines	2
human Dsg3	2
desmoglein sub-family	2
Necrosome and Ripoptosome	2
TNFR1 complex I/II	2
several of these key multi-protein signalling platforms	2
specific stimuli	2
DISC, Apoptosome, Piddosome and Necrosome	2
distinct multi-protein complexes	2
multi-cellular organisms	2
endogenous cellular proteins	2
ubiquitin molecules	2
polyubiquitination of APPL1	2
ubiquitin ligase Nedd4	2
aggregates positive for ubiquitin	2
vimentin cage	2
perinuclear APPL1 clusters	2
endogenous APPL1	2
canonical early endosomes	2
APPL endosomes	2
endosomal adaptor APPL1	2
multiple membrane receptors	2
currently known ACRs	2
important molecular players	2
cognate chemokines	2
chemokine G-protein coupled receptors (GPCRs)	2
Atypical chemokine receptors (ACRs)	2
JIP scaffold proteins	2
caspase-3 inhibitor DEVD.fmk	2
JIP1/JNK complex	2
Apoptosis-Inducing Ligand (TRAIL) and staurosporine-induced apoptosis	2
c-Jun N-terminal Kinase (JNK) pathway scaffold protein, JNK Interacting Protein-1 (JIP1)	2
G2-phase cells	2
wild type SMC1	2
fully assembled complex	2
SMC1/3 subunits	2
hetero-tetrameric complex of SMC1, SMC3, Rad21 and Scc3	2
mitochondrial serine protease	2
endogenous OPA1	2
OPA1 alterations	2
protease mutant [S306A]Omi/HtrA2	2
wild-type Omi/HtrA2	2
soluble OPA1 protein	2
elongated mitochondria	2
Drosophila S2R+ cells	2
Omi/HtrA2 silenced human HeLa cells	2
Omi/HtrA2 knockout mouse embryonic fibroblasts	2
mitochondrial intermembrane space	2
pro-apoptotic factor	2
intracellular pathways	2
corneal fibroblasts	2
Ocular fibroblasts	2
novel simultaneous imaging and micro-culture force monitor system (SIM–CFM)	2
previously described culture force monitor	2
standard collagen matrix	2
human corneal, Tenon's and scleral fibroblasts	2
multiple mitotic kinases	2
Aurora B.	2
H2A kinase NHK-1	2
Polo kinase	2
Aurora B kinase complex	2
centromere regions	2
FFPE archives	2
fixed tissues	2
processing site	2
input DNA	2
2 kits	2
sequencing libraries	2
DNA extracted FFPE tissues	2
extracted nucleic acids	2
FFPE tissues	2
formalin-fixed paraffin-embedded (FFPE) tissues	2
cancer samples	2
linked clinical data	2
Pathology archives	2
Mtb antigens	2
TB-IRIS-group responses	2
focused and co-ordinated immunological pathways	2
Differentially-expressed non-IRIS-group proteins	2
innate-related pathways	2
apoptosis-related) pathways	2
“Fcγ receptor-mediated phagocytosis”	2
“inter-cellular interaction”	2
represented TB-IRIS-group immune-related pathways	2
TB-IRIS and non-IRIS patient-derived cells	2
heat-killed Mtb	2
Isolated mononuclear cells	2
Mycobacterium tuberculosis (Mtb).Patient blood	2
tuberculosis/human immunodeficiency virus co-infection	2
South African patients	2
AO extract	2
macrophage cell	2
herbs	2
individual herbs	2
ingredient	2
medicinal herbs	2
Crohn's disease, atherosclerosis, and cancer	2
cytokine cascade	2
variety of cytokines	2
first defenses	2
NF-кB (P65)	2
P38 MAPK signaling pathway	2
NF-кB	2
P38 MAPK inhibitor	2
downregulated Bcl-2 in A549 and H1299 cells	2
Bax and Caspase3	2
A549 and H1299 cells	2
co-expressions of Ki67 and HER2 in BC	2
Low-Ki67 High-HER2 subgroup	2
cancer cell membrane	2
cancer cell nucleus	2
co-expressions of Ki67 and HER2 in BC specimens	2
invasive breast cancer (BC)	2
key prognostic molecules	2
Ki67 and HER2	2
detected CpG sites	2
reported SNPs	2
CDKN2A-negative patients	2
control group of individuals	2
leukocyte methylomes of two groups of melanoma patients	2
melanoma cases	2
highly aggressive cancer	2
coral planulae	2
mesenterial filaments	2
staining cells	2
coenosarc between polyps	2
scattered staining cells	2
mouth	2
immunoreactive nerve ring	2
tentacles and oral discs	2
numerous staining cells	2
Adult polyps	2
adult polyp	2
aboral end of the planula	2
cells in areas	2
FMRFamide stain cells	2
AmLWamide expression	2
oral side	2
polyp	2
AmRFamide, expressing cells	2
AmLWamide-expressing cells	2
narrow projection	2
cell bodies of expressing cells	2
two ends	2
ectodermal cells of the developing planula	2
AmLWamide transcripts	2
tentacles	2
Expressing cells	2
newly settled polyp	2
AmRFamide expression	2
cell bodies of AmRFamide-expressing cells	2
oral end of the planula larva	2
AmRFamide transcripts	2
FMRFamide immunohistochemistry	2
Acropora millepora LWamide	2
coral	2
endocardial Yap	2
paracrine factor, neuregulin	2
endocardium of the developing heart	2
downstream genes	2
members of the Tead family	2
two partially redundant transcription cofactors, Yap and Taz	2
clock gene expression	2
cave populations	2
surface fish larvae	2
cave and surface populations	2
various strains	2
circadian pacemaker	2
surface and cave populations	2
cave strains of Astyanax in the laboratory	2
directly light entrainable circadian clocks	2
intriguing model system	2
Astyanax mexicanus	2
wide range of opsin photopigments	2
majority of tissues and cells	2
circadian pacemakers	2
endogenous circadian clocks	2
rhythmic light	2
animals and plants	2
A. mexicanus heart	2
river-dwelling morph	2
cave-dwelling morph	2
two morphs	2
parental populations	2
cave-dwelling and river-dwelling morph	2
first-generation cross	2
epigean morph	2
rounder ventricle	2
smaller heart	2
troglomorph	2
surface (epigean morph) and cave-dwelling (troglomorph) morphs	2
hearts of Astyanax mexicanus	2
adductor insertion of quail embryos	2
duck jaw adductor insertion	2
predicted mechanical force environment	2
species-specific jaw architecture	2
jaw complex in duck and quail	2
finite element models	2
NCM-derived connective tissues	2
chick and duck embryos	2
FGF and TGFβ signaling	2
equivalent cartilage	2
mandible	2
tendon insertion of their jaw adductor muscle	2
duck, chick, and quail	2
several compounds, e.g. proline, gamma aminobutyric acid (GABA), and putrescine	2
AtWIND1-activated explants	2
AtWIND1-activated B. napus explants	2
endogenous auxin/cytokinin	2
B. napus homologs of ENHANCER OF SHOOT REGENERATION1/DORNRÖSCHEN (ESR1/DRN)	2
Arabidopsis WIND1 (AtWIND1) in hypocotyl explants of Brassica napus (B. napus)	2
(WIND1)	2
AP2/ERF transcription factor, WOUND INDUCED	2
critical triggers	2
RNF220-like ubiquitin ligase	2
DV axis	2
several hitherto uncharacterized genes	2
ventro-epidermalised and dorso-neuralised	2
UV- and LiCl-treated embryos	2
ectodermal germ layer	2
ventral and dorsal cells	2
unperturbed gastrula embryos	2
dissected ventral and dorsal regions	2
LiCl-treated embryos	2
untreated embryos	2
UV-treated embryos	2
whole transcriptomes	2
so-called ventralised or dorsalised embryos	2
maternal Wnt mediator β-catenin	2
dorso-ventral (DV) axis	2
Ultraviolet (UV) or lithium chloride	2
Amphibian embryos	2
sclerotome and notochord	2
amniotes and teleosts including zebrafish	2
mature vertebral bodies and intervertebral discs	2
somite-derived annulus fibrosus	2
nucleus pulposus	2
vertebral bodies and discs in chick	2
chick notochord	2
ectopic notochord	2
surrounding sclerotome	2
vertebral bodies and discs	2
chick embryos	2
inner nucleus pulposus of the disc	2
sclerotome part of the somites	2
vertebrae and outer portion (annulus fibrosus) of the disc	2
head-tail axis	2
alternating series of vertebrae and intervertebral discs	2
various other organs	2
zebrafish lines	2
tissue specific drivers	2
healed epidermis	2
tdTomato marking basal epidermal cell membranes	2
GFP-collagen line	2
undamaged collagen	2
randomly orientated wisps	2
denuded domain	2
cross-hatch, orthogonal sub-epithelial network	2
fine filaments	2
basal epidermal cells	2
wild type larval skin	2
collagen ultrastructure	2
collagen meshwork	2
developing embryonic epidermis	2
-I fibril deposition	2
basal epidermal-specific expression	2
fusion zebrafish lines	2
GFP and mCherry collagen-	2
functional fibrils	2
GFP-fusion collagens	2
Fibrillar collagen	2
common spatiotemporal framework	2
axis growth	2
segmental units	2
three stripes of Pt-hh expression	2
intermediate thoracic region	2
presumptive head and opisthosomal regions	2
Pt-hh expression	2
sibling embryos	2
forming/formed Pt-hh stripes	2
posterior portion of the field	2
center of the germ disc	2
cell tracking	2
presumptive head and opisthosomal (or abdominal) regions	2
germ disc in the spider embryo	2
future body subdivisions	2
cell labeling	2
regions of the field	2
stripes of Pt-hh (a hh homolog) expression	2
spider Parasteatoda tepidariorum embryo	2
arthropod embryos	2
hedgehog (hh)	2
homologs of Drosophila segment polarity genes	2
putative nodose neuronal 'émigrés'	2
satellite glia	2
nodose	2
nearest ganglion	2
chicken	2
adjacent ganglia/nerves	2
glial marker proteolipid protein 1	2
adrenal chromaffin cell population	2
multipotent nerve-associated glial cells	2
neighbouring ganglia/nerves	2
glomus cell precursors	2
transcription factors Ascl1 and Phox2b	2
adrenal chromaffin cells	2
patient-specific cells	2
Carotid body glomus cells	2
father of the microtome	2
SCP's embryonic origin	2
proto-neural crest cells	2
lineage of early chordate animals	2
multipotent migratory cells	2
parental population	2
mature Schwann cells, melanocytes and other cell types	2
autonomic neurons	2
neuroendocrine cells	2
specific developing tissues	2
almost all locations in the embryonic body	2
SCP progenitors	2
developing peripheral nerves	2
multipotent embryonic progenitors	2
Schwann cell precursors (SCPs)	2
arteries and perivascular cells	2
vascular walls	2
variety of distinct cell types	2
nutrient highway	2
Arterial vasculature	2
GTP-binding domain and acidic domain	2
neuroblast cytoplasm	2
cell cycle repressor Prospero	2
putative GTPases	2
yeast and human Lsg1	2
nucleostemin 3 (ns3)	2
Grhl3 transcripts	2
neural plate and node-streak border	2
additional tissues	2
hindgut of wild-type embryos	2
hypomorphic Grhl3 allele	2
curly tail	2
spinal NTDs	2
spinal neural folds	2
caudal region	2
late-arising spinal NTDs	2
hindgut endoderm	2
node-streak border	2
neuroepithelial component of the neural folds	2
surface (non-neural) ectoderm	2
spinal neurulation Grhl3	2
Grainyhead-like3 (Grhl3)	2
living embryos	2
pre-migratory and migratory neural crest	2
two transgenic Xenopus laevis lines, Pax3-GFP and Sox10-GFP	2
key model systems	2
amphibians Xenopus laevis and tropicalis	2
modified genes	2
lineage tracers	2
either fluorescent proteins	2
neural crest specific enhancers/promoters	2
mouse, chick and zebrafish	2
amphibians and birds	2
Many animal models	2
variety of cell types	2
multipotent population of cells	2
ephrin-B molecules	2
receptor-like and ligand-like roles	2
GAD65-positive interneurons	2
neocortical radial glial cells	2
ephrin-B2	2
three EfnB genes	2
forebrain inhibitory neuron specific Cre driver	2
ephrin-B (EfnB1/B2/B3) conditional triple mutant (TMlz) mice	2
ephrin-B reverse signaling	2
ephrin-B/EphB bidirectional signaling	2
pupal eye	2
Drosophila JNK basket	2
Cindr (the CIN85 and CD2AP ortholog)	2
Drosophila pupal retina	2
Jun N-terminal Kinase (JNK) activity	2
Many signaling pathways	2
organs and tissues	2
SoxF paralogs sox7	2
important and conserved gene regulatory axis	2
sox7 or sox18	2
sox7 or sox18 expression	2
sox7 and sox18 expression	2
two SoxF family members, sox7 and sox18	2
specifically gata4-regulated transcripts	2
Xenopus and in mammalian systems	2
beating cardiomyocytes	2
transcription factors GATA4, GATA5 and GATA6	2
sigma-neoblasts	2
neoblast subclasses	2
sigma-class of the neoblast population	2
enlarged cells	2
‘giant’ cells	2
condensin I complex	2
properly condensed chromosomes	2
highly conserved condensin family genes	2
self-renewing stem cell population	2
sigma neoblasts	2
one sub-population	2
planarian stem cells	2
CCAP/bursicon neurons	2
SPEN and NITO	2
nito RNAi	2
SPEN and NITO activity	2
axon outgrowth	2
spen and nito	2
Cell-targeted loss-of-function alleles	2
soma growth	2
CCAP/bursicon cell axons	2
pruning back	2
CCAP/bursicon neurosecretory cells	2
two Drosophila representatives of this family, SPEN and Spenito (NITO)	2
different cellular contexts	2
two size classes	2
SPEN proteins	2
well conserved family of nuclear proteins	2
Split ends (SPEN)	2
juvenile	2
basic structural architecture	2
adult cnidarian nervous systems	2
Nematostella nerve net	2
juvenile polyp and adult stages	2
neural subtype	2
six neural subtypes	2
neural architecture	2
NvLWamide-like::mCherry transgenic reporter line	2
ectoderm and endoderm	2
developing nerve net	2
small subset of the Nematostella nerve net	2
nerve ring	2
overt structures	2
many cnidarians species	2
individual neuronal subtypes	2
nerve nets	2
randomly arranged neurites	2
cnidarian nerve nets	2
myodfh261mutant myotome	2
deep myotome	2
GSK3 antagonist BIO	2
existing fibres	2
wt siblings	2
cytoplasm per nucleus	2
myodfh261mutant fibres	2
DM	2
Pax7+ MPC population	2
multinucleate fast muscle fibres	2
muscle regulatory factor Myod	2
mutant zebrafish	2
wild type (wt) MPCs	2
proportion of MPCs	2
dermomyotome (DM) external cell layer	2
Muscle stem/precursor cell (MPCs) expressing Pax7	2
neuromasts and ampullary organs	2
fibroblast growth factor signaling pathway	2
Mississippi paddlefish Polyodon spathula	2
electroreceptive non-teleost ray-finned fish	2
elongating lateral line placodes	2
zebrafish migrating posterior lateral line primordium	2
flanks of the sensory ridge	2
electrosensory ampullary organs	2
many non-teleost species	2
crest of the ridge	2
line	2
sensory ridge	2
least some other teleosts (e.g. catfishes) and all non-teleosts, lines of cranial neuromasts	2
hair cells and supporting cells	2
line of neuromasts	2
trailing zone	2
epithelial rosettes	2
trunk	2
cell collective	2
posterior lateral line primordium in zebrafish	2
cranial lateral line placodes	2
types of sense organs	2
cranial lateral line ganglia	2
lateral line neurons	2
fields of electrosensory ampullary organs	2
head and trunk	2
lines of mechanosensory neuromasts	2
different organs and cell types	2
lateral line system	2
apical cell surface	2
tight junction	2
claudin family of tight junction proteins	2
apical tight junctions	2
neural epithelium	2
closed tube	2
flat neural plate	2
new interactive eLearning resource	2
third-party atlas models	2
cellular-resolution placental atlas	2
DMDD mouse phenotype database	2
web-services	2
eHistology atlas	2
EMAGE gene expression database	2
exploratory tools	2
spatial models	2
MGI/GXD database	2
gene-expression database	2
ontology	2
3D digital models	2
eMouseAtlas resource	2
BMP antagonist in vivo and in vitro	2
Signal Sequence Trap	2
ectoderm and mesoderm	2
avian and mammalian early embryo	2
“organizer”	2
Hensen's node	2
new tool	2
Reelin-positive cells	2
conditional mouse knockout	2
APP family members and other type I transmembrane proteins	2
mammalian progenitor cells	2
successfully regenerating species	2
developmental signalling systems	2
much larger and fully patterned adult spinal cord	2
resident spinal progenitor cells	2
Notch, Hedgehog (Hh), Bone Morphogenetic Protein (BMP), Wnt, Fibroblast Growth Factor (FGF), Retinoic Acid (RA) and neurotransmitters	2
many developmental signals	2
salamanders and larval and adult zebrafish	2
spinal circuitry	2
Anamniotes, fishes and amphibians	2
comparative genomics tools	2
deuterostome genomes	2
recently described pharyngeal cluster	2
specific developmental pathways	2
metazoan clades	2
gene and linkage content	2
micro- and macro-synteny	2
metazoan genomes	2
exogenous Wnt enhancer, R-spondin1	2
small intestinal organoids	2
final vector	2
annealed synthetic DNA oligos	2
‘gRNA concatemer vector’	2
multiple gRNA expression cassettes	2
multiple genes in organoids	2
adult stem cell-derived organoids	2
paralogous genes	2
patients with hypohidrotic ectodermal dysplasia (HED) (defect EDA pathway) and LADD syndrome (defect FGFR2b pathway	2
different subsets of glands	2
Steno's and maxillary sinus gland	2
Eda mutant mice	2
lateral nasal glands	2
group of glands	2
developing glands	2
expression of Fgf7	2
Fgfr2b mutants	2
Fgf10 homozygotes	2
medial nasal glands	2
neighbouring nasal glands	2
maxillary sinus gland	2
Steno's gland	2
Fgf10 null embryo	2
glandular epithelial cells	2
receptor Fgfr2	2
developing SMGs	2
murine nasal SMGs	2
branched structures	2
nasal SMGs	2
asthma and chronic bronchitis	2
respiratory submucosal glands (SMG)	2
pharyngeal precursors	2
cells types	2
post-embryonic PHA-4	2
PHA-4/FoxA transcription factor	2
distant cell lineages	2
intestine, pharynx, and somatic gonad	2
pharyngeal and somatic gonad cells	2
muscle- or ectoderm- promoting transcription factors	2
endoderm-promoting transcription factors	2
cells in the somatic gonad	2
Ubiquitous ELT-7 expression	2
epithelial tube	2
intestine-specific gene expression	2
cells of the uterus	2
one developing organ	2
ELT-7 GATA transcription factor	2
intestine-like organs	2
C. elegans proximal somatic gonad (hermaphrodite uterus and spermathecae, and male vas deferens)	2
fully formed organs	2
SoPIN1 clade	2
epidermal layer	2
subepidermal tissue layers	2
DR5:	2
entire-2 and wild type	2
auxin signaling reporter DR5:	2
main sympodial and inflorescence axes	2
sympodial growth	2
distichous and decussate patterns	2
entire-2 plants	2
(Solyc10g078370) mutant	2
loss-of-function SlSoPIN1a	2
PIN1 and the relatively uncharacterized Sister-Of-PIN1 (SoPIN1)	2
two sister clades	2
PIN1 genes	2
auxin efflux carrier PIN-FORMED1 (PIN1)	2
plant hormone auxin	2
placental endocrine compartment	2
“belts and braces” approach	2
second maternally expressed imprinted gene, Pleckstrin homology-like domain, family a, member 2 (Phlda2)	2
genetic cross	2
maternal decidua	2
P-TGC layer	2
spongiotrophoblast cells	2
junctional zone	2
Glycogen cells	2
Ascl2-Tg placenta	2
labyrinth	2
Elevated Ascl2	2
P-TGC cells	2
glycogen cell lineage	2
two additional trophoblast giant cell lineages (spiral artery and canal)	2
P-TGCs	2
ectoplacental cone	2
Trophoblast specific protein alpha (Tpbpa) positive cells	2
parietal trophoblast giant cell (P-TGC) lineage	2
maternally expressed imprinted gene	2
Ascl2 aka Mash2)	2
Achaete-scute complex homolog 2 (	2
one parental allele	2
global agriculture	2
C3 and C4 species	2
reproductive structures	2
shallow soil	2
root biomass	2
leaves, roots, and in reproductive structures	2
greenhouse gases	2
current organoid methods	2
unprecedented model system	2
novel gene editing tools	2
human embryonic and induced pluripotent stem cells	2
primitive erythropoiesis	2
zebrafish Gfi1aa	2
homozygous qmc551 carriers	2
normal primitive and definitive haematopoiesis	2
homozygous qmc551 fish	2
haematopoietic cells	2
gfi1aa mRNA	2
endogenous gfi1aa promoter	2
qmc551 transgenics	2
mammalian Gfi1 and Gfi1b proteins	2
transcriptional repressors	2
one of three zebrafish paralogs	2
intron 1 of the gfi1aa gene	2
larval and adult haematopoiesis	2
haematopoietic stem and progenitor cells (HSPCs)	2
haemogenic endothelial cells	2
zebrafish line qmc551	2
gastrula stage embryo	2
spatially localized lncRNAs	2
potential single- and multi-exon lncRNAs	2
classes of lncRNAs	2
smaller ncRNAs	2
vast number of transcripts	2
RNA sequencing technologies	2
transcription factor catalog	2
218 TFs	2
ventral mesoderm, ectoderm and endoderm	2
Spemann's organizer	2
early gastrula stage embryo	2
mammalian repertoires	2
zinc finger family members	2
X. tropicalis transcription factor genes	2
typical mammalian species	2
genes encoding DNA-binding transcription factors	2
diploid frog	2
catalog of transcription factors	2
short sequence motifs	2
Gene regulatory networks (GRNs)	2
D. discoideum gametes	2
female in complex organisms	2
type-III strain	2
-I and type-II strains	2
plant fertilization protein HAP2-GCS1	2
two homologs	2
gamete membranes	2
heterothallic mating system	2
chondrichthyan models	2
members of key developmental signalling pathways	2
core set of genes	2
regenerative structures	2
dawn of the vertebrate lineage	2
successive tooth generations	2
shark dentition	2
Hh, Wnt/β-catenin, Bmp and Fgf signalling pathways	2
bony vertebrates	2
catshark (Scyliorhinus spp.)	2
emerging chondrichthyan model	2
ancestor of all jawed vertebrates	2
dentition	2
important developmental model species	2
many other lineages	2
elaborate arrays of highly specialized teeth	2
sharks and rays	2
chick and other non-mammalian model systems	2
ENS	2
cerebrovasculature	2
clusters of hematopoietic cells	2
Ly6aGFP expressing	2
single hematopoietic cells	2
head vasculature	2
embryonic head HSCs	2
midgestation mouse aorta	2
hematopoietic cluster cells and hemogenic endothelial cells	2
postnatal mouse hematopoietic system	2
cerebrovascular specific endothelial cells	2
fully functional hematopoietic stem cells (HSC)	2
embryonic head	2
hematopoietic cell clusters	2
aorta, vitelline and umbilical arteries	2
temporally and spatially restricted set of hemogenic endothelial cells	2
midgestation mouse embryo	2
homeologs	2
X. laevis J strain animals	2
several F0 somatic tissues and germ cells	2
embryonic injections	2
tyrosinase homeologs	2
X. laevis	2
germline mutant X. laevis	2
inbred J strain animals	2
Xenopus laevis genome sequence	2
non-human system	2
mnx-morpholino injected embryos	2
IM-specific irx1b expression	2
Mnx functions	2
mutual exclusive regions in the IM	2
transcripts of irx1b and mnx genes	2
direct target of Mnx factors	2
Mnx regulated genes	2
pronephric lineage	2
one mnx gene, mnx2b	2
caudal IM	2
three mnx genes in zebrafish	2
glomerular capillary tuft	2
nephric mesoderm	2
simple yet genetically conserved model	2
homeobox transcription factor MNX1	2
mesoderm-derived osteoclasts	2
RANKL protein	2
MMP13 inhibitor	2
bisphosphonate, osteoprotegerin protein	2
TRAP, Mmp13, and Mmp9	2
quail-like jaw skeletons	2
duck host	2
quail donor NCM and osteoclasts	2
jaw skeleton	2
tartrate-resistant acid phosphatase (TRAP), Matrix metalloproteinase 13 (Mmp13), and Mmp9	2
bone-resorbing cells	2
long-billed duck	2
short-beaked quail	2
embryonic skeleton	2
predominant cells	2
molecular and histological programs	2
beak	2
ORFeome collection	2
Xenopus eggs and embryos	2
commercial distributors of the collection	2
ORFeome clones	2
end-users	2
Xenopus community database	2
original XGC collection	2
underlying ORF predictions	2
set of test clones	2
entire collection	2
Gateway system	2
2724 genes	2
non-redundant X. laevis gene complement	2
unique genes	2
ORFs	2
Gateway® donor vector	2
Xenopus Gene Collection (XGC)	2
first stage of the Xenopus ORFeome	2
many different applications	2
easily-accessible format	2
cloned open reading frames (ORFs)	2
extensive sets	2
pseudoenzyme	2
cardiac-specific protein	2
heart chambers	2
actin dynamics	2
Recombinant Adprhl1	2
numerous circular branch points	2
thin actin threads	2
Adprhl1-positive cells	2
actin-Z-disc boundary	2
Disarrayed myofibrils	2
cardiac myofibrillogenesis	2
full length (40kDa) Adprhl1 variants	2
5′-coding sequence of Xenopus adprhl1	2
tadpole hearts	2
Adprhl1 protein	2
cardiac-specific Gal4 binary expression system	2
resulting ventricles	2
ventricle	2
Adprhl1 variants	2
actively growing chamber myocardium	2
amphibian Xenopus laevis	2
member of the ADP-ribosylhydrolase protein family	2
etv5a deficient embryos	2
renal progenitor etv5a expression domain	2
small molecule inhibitor DAPT	2
populace	2
etv5a domain	2
ETS factors	2
posterior mesoderm	2
related gene	2
ets variant 4 (etv4)	2
MCC-specific markers outer dense fiber of sperm tails 3b (odf3b) and centrin 4 (cetn4)	2
MCCs in the nephron	2
zebrafish tissues	2
closely related ETS family members	2
transcription factor ets variant 5a (etv5a)	2
Notch signaling pathway	2
“salt-and-pepper”	2
various solute transporters	2
distinct tubule segments	2
Transportive cells	2
transportive and multiciliated cells (MCCs)	2
two types of epithelial cells	2
pronephros	2
embryonic zebrafish kidney	2
discrete nephron epithelial lineages	2
maternal resources	2
placenta's	2
fully wild type scenario	2
mutant and non-transgenic fetuses	2
excessive glycogen	2
wild type placentae	2
non-transgenic placentae	2
Phlda2 loss-of-function placentae	2
common progenitor	2
trophoblast giant cell endocrine lineages	2
spongiotrophoblast compartment of the placenta	2
loss-of-function and gain-in-expression mouse models	2
spongiotrophoblast endocrine compartment	2
imprinted Pleckstrin homology-like domain, family a, member 2 (Phlda2) gene	2
endocrine compartment	2
single parental allele	2
aberrant LVVs	2
mural cells	2
lympho-venous connections	2
LVV-ECs aggregate	2
luminal side of the veins	2
LVV-forming endothelial cells (LVV-ECs)	2
lymphovenous valves (LVVs)	2
critical calcium handling genes	2
Sema3c promoter	2
Chd7fl/fl;Mesp1-Cre mutant hearts	2
Class 3 Semaphorin and Slit–Robo signalling pathways	2
cardiac innervation	2
CHARGE patients	2
Mesp1-expressing anterior mesoderm	2
neural crest lineage	2
ATP-dependant chromatin remodeller chromodomain-helicase-DNA-binding protein 7 (CHD7)	2
orthologous protein	2
animally enriched novel gene, Slc35d1	2
either the dorsal–ventral or left–right axes	2
either the animal or vegetal blastomeres	2
908 mRNAs	2
four embryos	2
complete sets of blastomeres	2
single blastomeres	2
axes of the Xenopus tropicalis 8-cell stage embryo	2
maternal mRNA	2
dorsal–ventral or left–right axes	2
animal and vegetal poles	2
maternal gene products	2
specific molecular determinants	2
second asymmetric, or dorsal–ventral, axis	2
first axis	2
asymmetric, perpendicular axes	2
vertebrate body plan	2
neural fold	2
cultured embryos	2
DLHP formation	2
dorsolateral cell number	2
cells contact paraxial mesoderm	2
dorsolateral neural plate	2
neural folds	2
apico-basal axis	2
DLHP	2
cells in the dorsolateral neuroepithelium	2
median hinge point (MHP)	2
Neuroepithelial cells	2
spinal region of the mouse embryo	2
paired dorsolateral hinge points (DLHPs)	2
curated human disease-associated genes	2
full-ORF orthologs	2
Ciona coding genes	2
19,163 full-ORF cDNA clones	2
highly polymorphic marine invertebrate	2
first full-ORF collection	2
Gene Regulatory Networks	2
powerful model organism	2
highly polymorphic member of the divergent sister group of the vertebrates	2
ascidian Ciona intestinalis	2
well annotated model organisms	2
full-ORFs	2
highly polymorphic alleles	2
recent paralogs	2
N-terminal ends of proteins	2
full-ORF clone collections	2
well-annotated model genomes	2
Marine organism genomes	2
functional diversity	2
particular marine organisms	2
Non-model organisms	2
full-ORF clones)	2
complete proteins	2
collections of cDNA clones	2
Genome-wide resources	2
ysE.	2
embryonic endoderm of fetal liver	2
early embryonic endoderm	2
IAPEz retroviral repeats	2
Cystic EBs	2
fetal liver and ysE	2
cystic embryoid bodies (EBs)	2
vitro model of ysE	2
mid-gestation extra-embryonic tissue	2
homogenous in vivo model	2
Isolated ysE	2
visceral yolk sac endoderm (ysE)	2
placental trophectoderm lineages	2
mammalian imprinted genes	2
easily tractable and medically relevant system	2
different types of myeloid lineages	2
various transgenic lines	2
regenerate appendages	2
oncologist׳s arsenal	2
adaptable and multifunctional tool	2
prototypical oncological model system	2
developmental or induced tumour models	2
whole embryos	2
egg and oocyte extract system	2
developmental model organism	2
unique range of both in vitro and in vivo models	2
genetic pathways	2
zebrafish pronephric proximal tubule	2
DEAB treated wild-types	2
RA inhibitor diethylaminobenzaldehyde (DEAB)	2
sim1a knockdowns	2
sim1a expression	2
PST	2
RA treated wild-types	2
PCT segments	2
sim1a deficient embryos	2
sim1a expression domain	2
PST and CS	2
sim1a modestly	2
PST and CS populations	2
sim1a knockdown	2
proximal segments	2
caudal domain	2
genesingle minded family bHLH transcription factor 1a(sim1a)	2
rostral and caudal domains	2
zebrafish renal progenitors	2
endocrine glands	2
corpuscles of Stannius (CS)	2
proximal convoluted and straight tubules (PCT, PST)	2
nephrons	2
simplified yet conserved genetic model	2
zebrafish embryonic kidney	2
nephron segments	2
maternal and zygotic pools of Cdx2	2
Cdx2 maternal-zygotic null embryos	2
Cdx2 zygotic null embryos	2
large cohort of Cdx2 maternal-zygotic null embryos	2
Cdx2 transcripts	2
Cdx2 first	2
trophectoderm (TE)	2
future embryo	2
various approaches	2
localisation microscopy	2
commercial systems	2
super-resolution fluorescence microscopy	2
apical organ cells	2
apical organ of Nematostella	2
sea urchin larvae	2
subset of previously uncharacterized putative orthologs	2
long cilia of the apical organ	2
several conserved	2
structural and metabolic genes	2
apical organ	2
wildtype or an experimentally expanded apical organ	2
apical organ of the sea anemone Nematostella vectensis	2
standard model organisms	2
apical organs	2
groups of neurons	2
tuft of long cilia and receptor cells	2
many marine invertebrate larvae	2
sensory structures	2
Apical organs	2
zebrafish rab5 genes	2
rab5ab mRNA	2
four rab5 genes	2
Drosophila melanogaster and zebrafish	2
whole animal systems	2
Rab5 family proteins	2
human RAB families	2
RAB5 gene family	2
male UGS epithelia	2
mesenchymal factor	2
androgens and retinoic acid	2
female UGS	2
encodes the βA subunit of Activin	2
mouse organ cultures	2
absence of androgens	2
female tissue	2
male UGS	2
embryonic testis	2
embryonic female	2
sinus vagina	2
mammalian urogenital sinus (UGS)	2
constitutively active GPRx	2
wild-type GPRx	2
GPRx mutant	2
endogenous and overexpressed GPRx	2
trapped intracellularly	2
endosomal compartment	2
frog oocyte the GPR3/12 homolog GPRx (renamed GPR185)	2
constitutively active GPR3/6/12 family of G-protein coupled receptors	2
Vertebrate oocytes	2
local translation pathway	2
synaptic boutons	2
NMJs of staufen mutant larvae	2
staufen mutant larvae	2
glutamate receptor IIA subunit (GluRIIA)	2
orthologue of vertebrate band 4.1	2
Tropomyosin II	2
cora mRNA	2
Coracle protein	2
coracle mRNA and protein	2
Drosophila neuromuscular junction (NMJ)	2
postsynaptic side	2
evolutionary conserved dsRNA binding protein, Staufen	2
postsynaptic sites	2
vertebrate synapses	2
localised mRNAs	2
different arthropod lineages	2
insects, crustaceans and chelicerates	2
arthropod radiation	2
phylogenetically important group	2
myriapods	2
myriapod	2
closing blastopore	2
blastopore	2
single clutches	2
Strigamia embryos	2
member of the Myriapoda	2
Strigamia vasa and nanos orthologues	2
myriapod, the centipede Strigamia maritima	2
Slk ZRS	2
Slk ZRS allele	2
posterior limb	2
preaxial polydactyly	2
Growth/Morphogen models	2
posterior leg mesenchyme	2
SHH protein	2
long range limb-specific regulatory element of SHH	2
polydactylous Silkie (Slk) chicken breed	2
developing limb bud	2
numerous embryonic tissues	2
Sonic hedgehog (SHH)	2
cytoskeleton-dependent positioning of nuclei	2
apical nuclei	2
number of apical nuclei	2
nuclei of most – but not all – cells	2
8-cell embryo	2
conserved binding sites	2
transgenic vertebrate	2
conserved core of the vertebrate lens GRN	2
Ciona βγ-crystallin expression	2
interactive gene regulatory network (GRN)	2
Ciona lineage	2
lens of transgenic vertebrates	2
Ciona intestinalis βγ-crystallin gene	2
underlying basis	2
trans-activating environment	2
regulatory regions of invertebrate and vertebrate orthologues	2
conserved suites of binding sites	2
vertebrate orthologues	2
transgenic vertebrates	2
cross-species transgenesis	2
closest invertebrate relatives	2
conserved elements	2
combinations of sequence-specific transcription factors	2
numerous conserved non-coding elements	2
Vertebrate genomes	2
head–trunk interface	2
genetically rendered muscle precursors	2
occipital environment	2
non-migratory muscle precursors	2
various attractants	2
hypobranchial/hypoglossal muscle precursors	2
later emerging HMP, neural crest cells and hypoglossal nerve	2
stream	2
outflow tract of the heart	2
floor of the mandibular arch	2
floor of the pharynx	2
rostrally directed stream	2
two streams	2
occipital tissues	2
migratory muscle precursors	2
jawless vertebrates	2
stereotype path	2
throat and tongue (hypopharyngeal/hypobranchial/hypoglossal muscle precursors, HMP)	2
muscle precursors	2
extant jawed vertebrates	2
vertebrate head–trunk interface (occipital region)	2
highly specialized subtypes of neuronal cells	2
migratory neural crest stem cells	2
Olfactory and otic placodes	2
numerous, diverse neuronal subtypes	2
complex sense organs	2
thickened ectodermal placodes	2
region-specific factors	2
well-known signaling pathways	2
non-neuronal support structures	2
otic and olfactory neurons	2
many of the proteins and pathways	2
specialized neuronal populations	2
genetic determinants	2
numerous signaling molecules	2
nose	2
sensory cells in the ear	2
intricate morphogenetic layout	2
rodents and pigs	2
mural TE	2
TE of elongating embryos	2
extraembryonic mesoderm	2
phosphorylated SMAD1/5/8	2
neighbouring TE cells	2
differentiating epiblast	2
nascent mesoderm cells	2
situ hybridisation	2
nascent mesoderm of early gastrulating embryos	2
pig mural TE	2
Rauber's layer	2
mouse ExE	2
early ovoid embryos	2
periphery of the ED	2
phosphorylated MAPK/ERK	2
plasma membrane of TE cells of peri-elongation embryos	2
FGF4 ligand	2
epiblast and the trophectoderm (TE)	2
mammotypical embryonic disc (ED)	2
discernible ExE	2
developing mouse embryo	2
epiblast and the extraembryonic ectoderm (ExE)	2
inductive signals	2
epiblast and the trophoblast	2
unique distribution of macrochaetes	2
ac-sc expression	2
role emc	2
Calliphora vicina a species	2
repressor genes emc	2
Three genes, extramacrochaetae (emc), hairy (h) and stripe (sr)	2
sites where bristle precursors	2
Drosophila ac-sc expression	2
proneural genes achaete–scute (ac–sc)	2
Large bristles called macrochaetes	2
sensory bristles on the thorax of Diptera (true flies)	2
mecom and RA arbitrate proximodistal segment domains	2
mecom morphants	2
Notch signaling effector, Notch intracellular domain (NICD)	2
MCC formation	2
γ-secretase inhibitor DAPT	2
mecom and Notch signaling	2
discrete proximal and distal segments	2
transcription factor mecom (mds1/evi1 complex)	2
proximal and distal domains	2
intercalated transporting epithelial cells and multiciliated cells (MCC)	2
series of proximal and distal tubule segments	2
distinct epithelial regions	2
Zebrafish nephrons	2
conserved model	2
prematurely over-expressing Runx2 in chick embryos	2
smaller craniofacial skeletons	2
D-type cyclin expression	2
circulating minerals	2
duck host systemic environment	2
Runx2 and Col1a1	2
molecular and cellular programs	2
quail NCM	2
quail and duck embryos	2
Neural crest mesenchyme (NCM)	2
ENS in the hindgut	2
blood vessel networks	2
terminal hindgut	2
entire length of the gut	2
vitro Wnt1-Cre;Rosa26Yfp/+mouse model	2
Vegfa120/120or Tie2-Cre;Nrp1fl/− mice	2
pre-established vascular network	2
midgut and hindgut	2
vessel-rich areas	2
established vascular networks	2
foregut	2
enteric and vascular networks	2
nascent blood vessel networks	2
ENS formation	2
enteric neural crest cells (ENCC)	2
intestinal microvasculature network	2
mature organs	2
networked, tree-like architecture	2
vasculature and nervous system	2
revised model	2
Gbx and Fgf	2
rescued Fgf signaling	2
MHB genetic program	2
gbx1-;gbx2- double mutants	2
entire MHB genetic program	2
zebrafish gbx1	2
zebrafish mutants	2
various cerebellar neuron types	2
dorsal part of the anterior-most hindbrain segment, rhombomere 1 (r1)	2
non-overlapping domains of Wnt1 and Fgf8	2
MHB	2
midbrain/forebrain and anterior hindbrain	2
mutually repressive homeodomain transcription factors	2
MHB forms	2
well-known organizing center	2
placode development	2
gnathostome mmV	2
gnathostome mmV ganglia	2
maxillary and mandibular neurons	2
mmV neuron precursor territories	2
lampreys and gnatho-stomes	2
different branches of the mmV nerve	2
opV neuron precursors	2
mmV neuron precursors	2
opV placode-derived neurons	2
Pax3 (and its single Pax3/7 lamprey ortholog)	2
gnathostome Pax3	2
ophthalmic trigeminal (opV, profundal) placode-derived but not maxillomandibular trigeminal (mmV) placode-derived neurons	2
pan-Pax3/7 antibody	2
cranial sensory ganglia	2
lamprey	2
jawless fish, the sea lamprey Petromyzon marinus	2
placode-derived sensory neurons	2
first detailed fate-map	2
jawless fishes (agnathans)	2
representative jawed vertebrates (gnathostomes)	2
paired peripheral sense organs	2
Cranial neurogenic placodes	2
Jun N-terminal Kinase (JNK) and Janus Kinase	2
Rabaptin-5 and Rabex-5 mutant tissues	2
Rab5 GEF Rabex5	2
novel neoplastic tumour suppressor	2
Rab5 effector Rabaptin-5	2
Drosophila homologue	2
endocytic neoplastic tumour suppressor genes	2
exogenous FGF4	2
Fgf4 mutant embryos	2
PE specification	2
various genotypes of Fgf4 mutants	2
major FGF in the preimplantation embryo	2
FGF in the embryo	2
PE or EPI	2
ICM cells	2
E3.5 blastocyst	2
primitive endoderm (PE) and epiblast (EPI)	2
animal stem cell pluripotency	2
MBD proteins	2
(mbd2/3) gene	2
planarian methyl-CpG Binding Domain	2
Bilateria	2
Planarian adult stem cells (pASCs) or neoblasts	2
Wnt/Ca2+ pathway	2
Calpain2 function	2
Keller explants	2
mediolateral intercalation	2
mesodermal and neural tissues	2
dominant negative and a morpholino oligonoucleotide	2
Calpain inhibitor	2
Calpain2 in Xenopus laevis embryos	2
number of mouse knockouts	2
family of calcium-dependent intracellular cysteine proteases	2
Zic1 and Gli2	2
DNA-bound Pax3	2
Gli family members	2
endogenous Myf5 locus	2
10T1/2 mesodermal cell model	2
ES enhancer	2
essential Gli motif	2
novel homeodomain motif	2
conserved functional domains of the proteins	2
Myf5 epaxial somite (ES) enhancer	2
Gli2 and Zic1	2
paired-domain transcription factor	2
members of both families	2
Zic transcription factors	2
Glis	2
S-phase marker bromodeoxyuridine	2
superficial cortical layers	2
Cux1-positive neurons	2
mutant radial glia	2
subset of radial glia	2
conditional allele of Dicer1	2
cortex of E13.5 embryos	2
cre-recombinase expression vector	2
Dicer-dependent microRNA (miRNA) pathway	2
excitatory cortical neurons	2
neuroepithelial stem cells	2
mouse cerebral cortex	2
Radial glia	2
Merkel cell lineage	2
two distinct lineages in the skin	2
nerve cells	2
epithelial compartments	2
awl/auchene hair follicles	2
dermis and hypodermis	2
Sox2 in DP cells	2
mechanosensory Merkel cells	2
dermal papilla (DP) of guard/awl/auchene hair follicles	2
transcription factor Sox2	2
postnatal skin	2
vertebrate mesoderm	2
strongly posteriorly-enriched GFP-Dvl puncta	2
puncta	2
Dvl puncta	2
boundary-(NSB)-directed protrusions	2
Dvl in notochord–somite	2
bulk Dvl signal	2
cytoplasm-filling lineage marker dextran	2
yolk-free cytoplasm	2
mediolateral protrusions of chordamesodermal cells	2
mediolateral protrusions	2
Dishevelled (Dvl) protein	2
PCP core components	2
Drosophila epithelia	2
planar cell polarity (PCP) pathway	2
primary body axis	2
muscle satellite cells	2
bigger muscle fibres	2
quiescent myogenic cells	2
sphingosine-1-phosphate receptor 3 (S1PR3)	2
bioactive phospholipid, sphingosine-1-phosphate	2
myoblast progeny	2
mature muscle	2
resident stem cell population called satellite cells	2
germ layer	2
Strigamia pair rule genes	2
segmentation gene network	2
upper tiers	2
primary pair rule genes	2
wingless and engrailed	2
sloppy-paired	2
primary and secondary pair rule genes	2
early- and late-activated genes	2
pair rule genes	2
centipede Strigamia maritima	2
complete set of pair rule gene homologues	2
genomic resources	2
upstream patterning genes	2
parasegment boundary	2
segment polarity gene homologues	2
range of arthropods	2
Drosophila melanogaster pair rule and segment polarity genes	2
cartilage forming region	2
vivo and in vitro combination assay	2
nerve supply	2
contralateral skin graft	2
Fgf8, and Gdf5 applications	2
two inputs (Gdf5 and Fgfs)	2
additional Fibroblasts growth factor (Fgf) inputs	2
regeneration blastema	2
Gdf5-induced structure	2
nerve	2
blastema-like structure	2
Growth and differentiation factor-5 (Gdf5)	2
two signaling cascades (Fgf and Gdf5 signaling)	2
accessory limb model (ALM)	2
relatively new study system	2
nerve factors	2
nerve presence	2
dermis–blastema cells	2
undifferentiated cells called blastema cells	2
Urodele amphibians	2
Rab3Gap1 in Ppp2r2a knockdown cells	2
barrier competent epithelium	2
Ppp2r2a siRNA cells	2
Rab3 GTPase activating protein, Rab3Gap1	2
Ppp2r2a knockdown cells	2
Ppp2r2a siRNA	2
rat epidermal keratinocytes	2
Ppp2r2a regulatory subunit of the Pp2a phosphatase	2
developmental network	2
nasal peripheral retina	2
Wnt-responsive cells	2
Foxg1−/− nulls	2
target of Wnt/β-catenin signalling	2
β-catenin signalling	2
Wnt/	2
reporter allele	2
Foxg1 normally	2
Foxg1−/− null embryos	2
excess CM tissue	2
developing mouse retina Foxg1	2
Wnt/β-catenin signalling pathway	2
iris and the ciliary body	2
peripheral retina	2
ciliary margin (CM)	2
Frizzled/Starry night and Dachsous/Fat systems	2
gigantic cadherin molecule Fat	2
vertebrates and Drosophila	2
PCP itself	2
embryonic axes	2
best studied and technically most amenable system	2
PCP field	2
limited number of topics	2
Planar cell polarity (PCP)	2
chromatin-centered Ran–GTP gradient	2
new protagonist	2
functional Cdc42/N-WASP pathway	2
first polar body	2
activated MII oocytes	2
second polar body	2
polarized F-actin cap	2
meiotic chromosomes or chromatids	2
restricted cortical regions	2
many systems	2
thick F-actin cap	2
small polar bodies	2
overlying cortex	2
regulatory system	2
tll mutants	2
posterior segmentation gene expression domains	2
wild-type background	2
terminal gap gene tailless (tll) in Drosophila melanogaster	2
heat-shock proteins)	2
specific regulatory factors	2
PCP pathway	2
cell–cell contacts	2
mutant lung epithelia	2
adherens and tight junction proteins	2
embryonic lung	2
PCP protein Celsr1	2
Scrib knockdown lungs	2
lung explants and organotypic cultures	2
adherens and tight junctions	2
PCP proteins	2
Drosophila Scrib mutants	2
A/B polarity	2
ScribCrc/Crclungs	2
PCP pathway proteins	2
developing lung	2
core PCP gene Vangl2	2
Scrib genetically	2
visible, ‘open’ lumen	2
fewer airways	2
Scrib mouse mutant Circletail (Crc)	2
close epithelial cell–cell contacts	2
arborized network of tubes	2
cluster of T-box binding sites	2
Ntla and Tbx16	2
tailbud, PSM and somites	2
cis-regulatory module (CRM)	2
dlc expression	2
gastrulation and tailbud outgrowth	2
T-box transcription factors Ntla and Tbx16	2
deltaC (dlc)	2
unsegmented, presomitic mesoderm (PSM)	2
motoneuron development	2
Drosophila Oli and vertebrate family members	2
oli-deficient flies	2
vertebrate Olig2	2
postembryonic leg-innervating motoneuron lineages	2
Lim3, Islet and Hb9	2
conserved transcription factor ensemble	2
specific muscles	2
motoneurons	2
distinct ventral motoneuron subtypes	2
postmitotic progeny	2
embryonic nervous system	2
embryonic motoneurons	2
single Drosophila homolog Oli	2
one of the five Olig family bHLH transcription factors	2
motoneurons and myelinating glia	2
correct trajectories and target muscles	2
locomotion circuits	2
different modules	2
Otx/Gbx boundary	2
positional information	2
Otx2 and Gbx2	2
posterior otic placode	2
Otx2 targets	2
inner ear and trigeminal progenitors	2
placode territory	2
homeobox transcription factors	2
functional sense organs and sensory circuits	2
sensory placodes	2
sensory nervous system	2
central and peripheral components	2
sequentially deployed core regulators	2
key haematopoietic regulator	2
fully specified blood cells	2
Scl/Tal1	2
CD41/integrin alpha 2b gene	2
many haematopoietically expressed genes	2
global regulatory network model	2
complementary genome-wide datasets	2
wider regulatory networks	2
individual key regulators	2
powerful regulators	2
distinct subpopulation of cells	2
hair follicle epidermal cells	2
skin reconstitution fibroblasts	2
β-catenin-induced ectopic follicles	2
adult dermal fibroblasts	2
mitotically inhibited cells	2
disaggregated cells	2
non-DP dermal fibroblasts	2
dermal papilla (DP)	2
base of the follicle	2
population of fibroblasts	2
Ebf2	2
vitro preparations	2
proper cortical lamination	2
forebrain territories	2
cortical surface	2
cortical hem- and septum-derived CR cells	2
pallial–subpallial boundary	2
septum, cortical hem	2
forebrain signalling centres	2
cerebral cortex	2
Cajal–Retzius (CR) cells	2
vertebrate ectoderm	2
Hairy2a/Dlx5	2
Wnt signals	2
neural plate (NP) and NC genes	2
NPB genes Hairy2a and Dlx5	2
BMP and Wnt signals	2
specific NC markers	2
subset of neural plate border (NPB) makers	2
dorso-lateral marginal zone (DLMZ)	2
different known inducing tissues	2
series of explants	2
gastrula and neurula stages	2
developmental enhancers	2
pufferfish-mammal whole-genome comparisons	2
one of the CNEs	2
putative Sox binding sites	2
sox21b morpholino into zebrafish	2
reporter BAC	2
lens enhancers	2
two CNEs	2
different expression assays	2
embryonic lens	2
Sox21 locus	2
vertebrate	2
Highly conserved non-coding elements (CNEs)	2
chicken, Xenopus, zebrafish and mouse embryos	2
permissive and restricted areas	2
positive and negative regulators	2
several proto-oncogenes	2
complex network of transcription factors	2
partial or complete epithelium-to-mesenchyme transition (EMT)	2
myriad of tissues and organs	2
original territory	2
neural crest (NC) population	2
border of the neural plate	2
small GTPase Rho1	2
apical lamellipodia-like protrusions	2
polyploid larval epithelial cells (LECs)	2
diploid adult histoblasts	2
abdominal epithelium of Drosophila	2
pluripotent embryonic cells	2
unresolved double-strand breaks	2
Sin3a-null ICMs	2
Myc and E2F targets	2
E3.5–4.5 epiblast	2
embryos lacking Sin3a	2
transcription networks	2
Sin3a/HDAC co-repressor complex	2
rodent epiblast and ES cells	2
transient naïve pluripotent population	2
FGF inhibitors	2
Nanog-positive cells in embryos	2
hypoblast in the human	2
epiblast and hypoblast	2
key transcription factors (Cdx2, Oct4, Nanog and Gata6)	2
trophoblast, epiblast and hypoblast	2
three different lineages	2
Mouse embryos	2
RTK ligands	2
glossopharyngeal nerve	2
glossopharyngeal and vagus nerves	2
pharyngeal epithelia	2
sensory neurons and glia	2
epibranchial placodes	2
Spry1−/−;Spry2−/− embryos	2
facial, glossopharyngeal and vagus nerves	2
branchial nerves	2
two receptor tyrosine kinase (RTK) antagonists of the Sprouty (Spry) gene family	2
arches and associated structures	2
embryonic pharyngeal (branchial) arches	2
primary spermatocytes	2
spermiogenic genes	2
testis-specific TFIID complex	2
aly mutant testes	2
testis-specific gene expression	2
previously characterised tMAC mutants	2
known tMAC subunits	2
tMAC lin-9-related subunit Aly	2
lin-52 paralogue	2
wake-up-call (wuc)	2
MMB and orthologous complexes	2
specific subunits of tMAC, MMB or orthologous complexes	2
genes in the male germline	2
paralogous complex, tMAC	2
Drosophila somatic cells	2
many different target genes	2
conserved multi-subunit complex (MybMuvB, MMB)	2
members of the family of transcription factors	2
ChIP assays	2
new enhancer	2
TEA Domain (TEAD) transcription factor	2
ventro-caudal and ventro-rostral somitic compartments	2
second class, ECR111	2
new enhancer element	2
single enhancer	2
several enhancers	2
particular set of muscle progenitors	2
transcription balancing sequences	2
multitude of enhancers	2
Mrf4/Myf5 locus	2
DIF-induced cells	2
ecmB promoter	2
dimB− strain ecmB	2
neutral red staining	2
pstB or lower cup cells	2
dimB null (dimB−) strain	2
outer basal disc of the fruiting body	2
PstB cells	2
ventral surface of the posterior, prespore region	2
cluster of vital dye-staining cells	2
slugs DimB	2
bZIPtranscription factor	2
signalling polyketide DIF-1	2
monolayer Dictyostelium cells	2
genetic map and SSLP marker database	2
approximately 1300 scaffolds	2
X. tropicalis genome Assembly 4.1 (JGI)	2
linkage groups	2
mapped scaffolds	2
probes for genes	2
Situ Hybridization (FISH)	2
linkage group	2
smaller linkage groups	2
major linkage groups	2
2886-marker genetic map	2
F2 individuals	2
mapping cross panel of DNA samples	2
SSLPs	2
DNA from inbred Nigerian and Ivory Coast individuals	2
unique SSRs	2
Simple Sequence Repeats (SSRs)	2
X. tropicalis genome assembly 2.0 (JGI)	2
unique SSLPs	2
Simple Sequence Length Polymorphism (SSLP) markers	2
genetic map	2
diverse developmental signaling pathways	2
SH2 adaptor protein	2
lrrB-	2
CldA null mutant	2
another SH2 domain containing protein	2
DIF-1 induction assay	2
polyketide	2
basal disc cup	2
mutant fruiting bodies	2
ecmB gene	2
lrrB- slugs	2
pstO prestalk sub-region of the slug	2
elongated mound	2
dark the mutant	2
phototaxis and thermotaxis	2
slugs	2
parental strain	2
LrrB null (lrrB-) mutants	2
light	2
several specific genes	2
leucine-rich repeat, 14-3-3 and SH2 protein–protein interaction modules	2
novel domain configuration	2
functionally analyzed SH2 domains	2
non-metazoan	2
Va neuropeptide neurons	2
Hox genes	2
thoracic segments	2
A1 segment	2
abdominal A	2
segments	2
classes of neuropeptide neurons, the dMP2 and MP1 neurons	2
several RHG genes	2
Hox gene Abdominal-B	2
Hox homeotic genes	2
ventral nerve cord segments	2
second, third and fourth abdominal segments (A2–A4)	2
three pairs of Capability neuropeptide-expressing Va neurons	2
Drosophila ventral nerve cord	2
glycosyltransferase Lunatic Fringe	2
midbrain and hindbrain compartments	2
organiser signalling molecule FGF8	2
anterior hindbrain	2
anterior hindbrain cells	2
wing, leg and eye imaginal discs	2
adjacent compartments	2
trn/caps	2
/capricious (trn/caps) family	2
Drosophila tartan	2
Lrrn family	2
leucine-rich repeat (LRR) neuronal 1 (Lrrn1) protein	2
Cells in adjacent compartments	2
tectal and cerebellar compartments	2
organiser/signalling centre	2
activator of the pathway	2
Wnt4−/− kidneys	2
Wnt4−/− embryos	2
Cyclosporin A (CSA)	2
kidney rudiments	2
developing nephrons	2
transcription factor gene family	2
Nuclear Factor Activated in T cells)	2
Members of the NFAT (	2
early nephrogenic metanephric mesenchyme	2
canonical β-catenin signalling pathway	2
number of Wnt genes	2
Smoothened (Smo)	2
intact SSD	2
transporter domain	2
permease transporter domain GxxxD/E motif	2
key residues of the sterol sensing domain (SSD)	2
ptc-3::gfp translational reporter	2
ptc-3 mutant	2
essential gene	2
ptc-related (ptr) genes	2
highly related Patched gene homologs, ptc-1 and ptc-3,	2
Hh and Smoothened (Smo) homologs	2
rudimentary Hedgehog (Hh) signalling pathway	2
pro-apoptotic genes	2
pro-apoptotic Bcl genes puma and bax-a	2
hindbrain boundary gene expression	2
downstream apoptotic effectors	2
proneural and neuronal marker expression	2
MOs	2
adjacent para-boundary regions	2
Morpholino antisense oligonucleotides (MOs)	2
Tln1 mini-gene	2
Tie2-Cre endothelial cell-specific Tln1 knockout	2
newly forming blood vessels	2
talin1 gene	2
Tln1fl/fl;CreER mice	2
transgene insertion	2
metanephros	2
small secreted integrin ligand nephronectin (npnt)	2
metamorphosing anurans	2
retinal pigmented epithelium	2
driving element	2
developing RPE	2
murine scleral mesenchyme	2
mouse peri-ocular mesenchyme micromass culture	2
later cartilage marker Aggrecan	2
RPE alone	2
cranial mesenchyme	2
young retinal pigment epithelium (RPE) and retina	2
matrix protein	2
pre-committed cartilage	2
scleral layer	2
cuplike structure	2
eyeball	2
fibrous sclera	2
layer of hyaline cartilage	2
either N-cadherin or N-CAM otic cells	2
apically localised N-cadherin and N-CAM	2
Pax2, otic progenitors	2
transcription factor Pax2	2
adult ear	2
placode	2
inner ear precursors	2
developing ear	2
discrete patches of surface epithelium	2
vertebrate eye, ear and nose	2
Crucial components	2
trophectoderm-specific cytokeratin intermediate filament	2
trophectoderm-specific genes, Gata3 and Eomes	2
Cdx2-depleted embryos	2
Par3 and aPKC	2
cell polarity molecules	2
zygotic Cdx2	2
dsRNAi, siRNAi and morpholino oligonucleotides	2
maternal and zygotic Cdx2	2
maternally provided pool of Cdx2 mRNA	2
blastocyst cavity	2
trophectoderm-specific transcription factor Cdx2	2
outer cells	2
outer and apolar cells	2
polar cells	2
polarised blastomeres	2
non-permissive and permissive niches	2
bulge and sebaceous gland	2
hair follicle bulb	2
sebaceous gland-derived hair follicles	2
vitamin D receptor	2
sebaceous glands	2
subpopulation of cells at the base of the sebaceous gland	2
ΔK5ΔNβ-cateninER expressing hair follicles	2
Existing hair follicles	2
undamaged epidermis	2
IFE stem cell compartment	2
autonomy	2
either model	2
IFE	2
truncated K5 promoter (ΔK5)	2
sebaceous glands and base of the follicle (bulb)	2
keratin 15 (K15) promoter	2
hair follicle bulge	2
reservoir of stem cells	2
two different promoters	2
4-hydroxy-tamoxifen (4OHT) inducible, stabilised β-catenin transgene (ΔNβ-cateninER)	2
different epidermal cell populations	2
interfollicular epidermis (IFE) and sebaceous glands	2
existing follicles	2
adult mouse epidermis	2
postnatal follicles	2
conserved sites	2
non-conserved sites	2
vvl early tracheal enhancer	2
clusters of putative STAT binding sites	2
vvl and trh	2
STAT92E responsive enhancers	2
early trachea determinants	2
upstream transcriptional activator	2
tracheal tree	2
JAK/STAT signaling	2
Drosophila trachea	2
ventral veinless (vvl) and trachealess (trh) genes	2
Emx2 null mice	2
cochlear sensory epithelium	2
fewer cells	2
expression domain	2
utricular and saccular maculae	2
striola	2
vestibular epithelia	2
epithelial cues	2
classic planar cell polarity molecules	2
hair bundles	2
Many of the hair cells	2
supporting cells	2
outer hair cells	2
auditory hair cells	2
CNS, renal system	2
Homozygous null mice	2
homeodomain protein	2
key developmental regulator	2
pre-placodal markers	2
FGF8 expression	2
paraxial and intermediate mesoderm	2
Tbx6 paralogues	2
C-terminal regions of the proteins	2
anterior neural markers	2
two paralogues	2
conserved family of developmental regulators	2
divergent T-box gene	2
amphibian Xenopus	2
unique Tbx6 paralogue	2
T-box family transcription factors	2
alternate DIF-1 activation pathway	2
mutant lacking DIF	2
dimB− mutant	2
pstU cells	2
new prestalk sub-type	2
anterior and posterior regions of the slug	2
upper cup region	2
rtaA:galu expressing cells	2
outer basal disk	2
upper cup	2
three ancillary stalk cell structures	2
ALC	2
reporter construct containing ecmA and ecmB promoter fragments	2
ALC population	2
subset of the ALCs	2
promoter fusion reporter gene, rtaA:galu	2
slug	2
anterior-like cells (ALCs)	2
One especially enigmatic group of prestalk cells	2
DimB repressed genes	2
one of the MybE	2
ecmA these genes	2
DimB− cells	2
mybE− cells	2
even larger number of genes	2
many additional genes	2
parental, mybE− and dimB− cells	2
DimB and MybE transcription factors	2
monolayer assay	2
prototypic prestalk-specific gene, ecmA	2
number of specialized sub-types of prestalk cell	2
stalk and spore cells	2
mature fruiting body of Dictyostelium	2
Fos and Jun proteins	2
AP-1 transcriptional outputs	2
graded Bsk inputs	2
distinct JNK kinases	2
terminal targets	2
Hemipterous or Mkk4	2
upstream JNK kinases	2
Basket (Bsk)	2
MB axons	2
Drosophila JNK (Basket)	2
Drosophila mushroom body (MB) neurons	2
Jun N-terminal kinase (JNK) pathway	2
Signaling proteins	2
cell-cell or cell-matrix interactions	2
Apaf1 mutant	2
Adriamycin, Shh and Nkx2.1 models	2
fusing foregut epithelial ridges	2
Dying cells	2
Nkx2.1 and Sox2 expression	2
Nkx2.1 (ventral) and Sox2 (dorsal) expression	2
normal foregut morphogenesis	2
active septation	2
tracheo-oesophageal separation	2
foregut tube	2
three outstanding questions	2
dorsal (oesophageal) from ventral (tracheal) foregut components	2
Foregut division	2
regulator of polarity and apical junctions	2
small lens	2
lens epithelial cells	2
apical junctions	2
central effector of the PAR polarity complex	2
discrete region or modiolus	2
apical tips	2
earliest fibre cell derivatives	2
apical–basal axis	2
lens equator	2
fibre cells	2
eye lens	2
forming tissues	2
functional three-dimensional tissue	2
somite-derived and branchiomeric muscles	2
many occupants of the niche	2
functionally heterogeneous population	2
Satellite cells	2
EDL-derived and masseter-derived satellite cells	2
masseter-derived clones	2
differentiated and self-renewed progeny	2
limb muscles	2
masseter-derived satellite cells	2
masseter cells	2
MAS and EDL muscles	2
Satellite cell-derived myoblasts	2
masseter of the head	2
extensor digitorum longus (EDL) of the limb	2
different ontology	2
resident stem cells of muscle	2
cranial mesoderm	2
head muscles	2
body and limb	2
Skeletal muscles	2
different receptor utilisation	2
major receptor	2
regions of the optic pathway	2
Slit mutants	2
robo2 RGC axons	2
four vertebrate Robos	2
inhibitory guidance molecules, Slit1 and Slit2	2
optic disc	2
optic fibre layer (OFL) of the retina	2
retinal ganglion cell (RGC) axons	2
developing optic pathway	2
identifiable cardiac valves and trabeculae	2
compressed endocardium	2
dilated chambers	2
Muz hearts	2
cardiomyocyte cytoskeleton	2
cardiac myosin heavy chain gene myh6	2
muzak (muz) embryos	2
non-contractile hearts	2
first positional cloning	2
diffused oxygen	2
lower vertebrate embryos	2
cardiac morphogenesis	2
mammalian somatic cells	2
retinoblastoma protein, a cdk2 substrate	2
sea urchin	2
p27kip1 and roscovitine, cdk2 inhibitors	2
pronucleus and zygote nucleus	2
MEK inhibitor, U0126	2
male and female pronucleus	2
cyclinE/cdk2	2
Sea urchins	2
mammalian dentition	2
LIM homeodomain proteins Lhx6 and Lhx7	2
supernumerary pair of incisor-like teeth	2
maxilla	2
normal incisors	2
Lhx6/7-deficient animals	2
molar mesenchyme	2
molar teeth	2
Lhx6/7 deficient embryos	2
cranial skeleton	2
Double homozygous mice	2
combinations of wild-type and mutant alleles	2
cranial morphogenesis	2
first branchial arch (BA1)	2
ectomesenchyme of the maxillary and mandibular processes	2
Lhx6 and Lhx7	2
closely related members of this family	2
LIM homeodomain transcription factors	2
embryonic epithelial tissues	2
odontogenic epithelium	2
medial edge epithelium of the palate	2
craniofacial region	2
skull vault	2
flat bones	2
Keratin-14 promoter	2
basal epithelium	2
Hedgehog signalling pathway	2
principle receptor	2
PTCH1 gene on chromosome 9q22.3–q31	2
cleft lip and palate	2
skeletal anomalies	2
odontogenic keratocysts	2
mouse and chick	2
chick presomitic mesoderm	2
Wnt pathway genes	2
chick homologues	2
number of clock genes	2
ribs, vertebrae and certain dermis tissue	2
embryonic precursors	2
genetic pathway	2
catweasel mice	2
Six1 genetically	2
developing vestibulo-acoustic ganglion	2
Sox2 expression	2
ampullae and cochlea	2
utricle	2
severely truncated cochlea and semicircular canals	2
severe headshaking	2
glycine (G) in the Six1 homeodomain	2
conserved glutamic acid (E)	2
exon 1 of the Six1 gene	2
Six1, -4 and -6 genes	2
mild headtossing	2
Heterozygous catweasel mutant mice	2
novel N-ethyl-N-nitrosourea (ENU)-induced mutation	2
new mouse mutants	2
PUF-8 and MEX-3	2
germ cell tumors	2
meiotic entry-defective mutants	2
germ cell-specific P granules	2
puf-8(−) mex-3(−) double mutant gonads	2
mitotic germ cells	2
PUF-8 protein	2
KH domain translational regulator	2
another C. elegans member of the PUF family	2
members of the PUF family translational regulators	2
Drosophila Pumilio and Caenorhabditis elegans FBF	2
germ cell proteins	2
surrounding somatic cells	2
mitotically cycling germline stem cells (GSCs)	2
cardiogenic transcription factors and downstream cardiomyogenic differentiation genes	2
cardiogenic transcription factors	2
activated canonical Wnt/β-catenin signaling	2
heart muscle (myocardium)	2
abnormally large heart muscle	2
endogenous Wnt signal	2
heart muscle tissue (myocardium) and non-muscular heart tissue	2
heart forming potential (cardiogenic mesoderm)	2
Mesodermal tissue	2
different vertebrates	2
GABAergic and glycinergic neuronal fates	2
Pax2-expressing spinal neurons	2
GABAergic interneurons in the dorsal horn	2
many neurons	2
knocked-down	2
Pax2a, Pax2b and Pax8	2
Pax2/8 transcription factors	2
many of these cells	2
Pax2b and Pax8	2
Pax2a,	2
zebrafish most glycinergic and many GABAergic spinal interneurons	2
several distinct classes of neurons	2
vertebrate endodermal organogenesis	2
endodermal organogenesis	2
liver and pancreas	2
foregut endoderm	2
main islet	2
ectopic endocrine clusters	2
Histone deacetylase 1 (Hdac1) in endodermal organogenesis	2
chromatin remodelling factor and transcriptional repressor	2
organ-specific gene expression	2
temporal and spatial proximity	2
presumptive foregut	2
Liver, pancreas and lung	2
second signal - dM-DIF-1	2
much of the lower cup	2
anterior-like cells	2
dmtA− mutant	2
prestalk-O cells	2
stlB− mutant	2
dmtA− methyltransferase mutant	2
spore mass	2
fruiting body	2
subset of anterior-like cells	2
wild-type parent	2
prestalk cells	2
immotile prespore mass	2
Slugs of this polyketide synthase mutant (stlB−)	2
DIF-1 and its biosynthetic intermediate, dM-DIF-1 (des-methyl-DIF-1)	2
stalk cells in culture	2
Dictyostelium amoebae	2
embryos, organs and tissues	2
fate maps	2
types of data	2
modern genomic resources	2
3D expression domains	2
3D gene expression domains	2
common database	2
different labs	2
developing chick wing	2
wholemount and section in-situ hybridisation	2
many new developmentally important chicken genes	2
whole genome sequencing and EST projects	2
Chick embryos	2
developmentally-regulated genes	2
lysosomal and ribosomal proteins	2
wild type and srfB−strains	2
slug structures	2
nitrocellulose filters	2
agar plates	2
actin–cytoskeleton-related functions	2
srfB gene	2
prestalk AB, stalk and lower-cup cells	2
two more proximal promoters	2
three alternative promoters	2
SRF homologue	2
Dictyostelium discoideum srfB gene	2
Serum Response Factor (SRF)	2
Xsox17α1gene	2
TGF-β signals	2
Sox sites	2
functional, cooperating VegT and Sox-binding consensus sites	2
blastula and gastrula	2
two important control elements	2
Xenopus laevis Xsox17α1gene	2
Sox17 itself	2
maternal endodermal determinant VegT	2
become endoderm	2
entire region of the Xenopus blastula	2
Sox F-group transcription factor Xsox17α1	2
mutant backgrounds	2
Prickle and Diego	2
cytoplasmic components Dishevelled	2
Frizzled and Strabismus	2
Frizzled, Strabismus and Flamingo	2
core of the complex	2
three transmembrane proteins	2
complex component	2
proximodistal junctional region	2
asymmetric apicolateral complexes	2
distal cell edges	2
trichome production	2
“core” group of planar polarity genes	2
PAX6 expression	2
long-range control elements	2
floxed DRR	2
single-copy line	2
multicopy YAC transgenic line	2
internal promoter	2
short PAX6 isoform	2
proximal enhancers	2
distal regulatory elements	2
several novel tissue-specific enhancers	2
full-length and truncated versions of the YAC	2
downstream PAX6 locus	2
Five independent transgenic lines	2
genomic context	2
DNaseI hypersensitive sites	2
35 kb long, distant downstream regulatory region (DRR)	2
LoxP sites	2
YAC	2
PAX6 translational start site	2
420 kb YAC a tauGFP-IRES-Neomycin reporter cassette	2
human PAX6 locus	2
modified yeast artificial chromosome	2
set of mice	2
many other developmental regulators	2
eye, brain and pancreas	2
developmental control gene	2
cortical basal progenitor cells	2
lateral ganglionic eminence	2
Pax6 in developing cortical cells	2
telencephalic ganglionic eminences (Mash1, Dlx2 and Gsh2)	2
newly divided cells	2
cortical cells	2
cortex of Pax6+/+↔Pax6−/−chimeras early	2
basal progenitors	2
transcription factor Pax6	2
basal progenitor cells	2
embryonic dorsal telencephalon	2
Many cerebral cortical neurons and glia	2
larger data sets	2
vast majority of assays	2
first Alinity users	2
16 assays	2
given assay	2
Abbott ARCHITECT system	2
previously defined hierarchy	2
MethodsTotal allowable error (TEa) goals	2
independent laboratory sites	2
3 immunoassays	2
photometric assays	2
3 ion-selective electrodes	2
Alinity assays	2
early adopters	2
Abbott Alinity family of chemistry and immunoassay systems	2
large amount of SAA	2
extremely small or large particles	2
HDL fractions	2
SAA > 	2
248 patients	2
BackgroundSerum amyloid A (SAA)	2
total and individual BCAA	2
valine, leucine and isoleucine)	2
NMR and LC-MS/MS	2
total BCAA, valine, leucine, and isoleucine	2
-based BCAA assay results	2
119 subjects	2
Plasma BCAA	2
NMR-based BCAA assay	2
clinical NMR analyzer	2
nuclear magnetic resonance (NMR) metabolomics research platforms	2
branched-chain amino acid (BCAA) levels	2
molecular diagnostics tool	2
urinary cfDNA	2
long fragments	2
urine of hematopoetic stem cell and renal transplant recipients	2
allograft-derived donor-specific genetic markers	2
contributing tissue	2
single source	2
tissue of origin	2
Urinary cell-free (cf) DNA	2
GEMs	2
tandem GEMs	2
many analytes	2
afternoon saGEM	2
two GEMs	2
Radiometer ABL	2
ICU patients	2
two GEM 4000s	2
laboratory data repository	2
GEM 4000 BG analyzers	2
blood gas (BG) and hematology analytes	2
high-throughput, hospital-friendly sandwich ELISA format	2
promising biomarker	2
CIZ1b in native plasma	2
prospectively collected development set of plasmas	2
CIZ1b exon-junction specific antibody	2
lung cancer plasma	2
endogenous complex	2
CIZ1a (non-alternatively spliced exon 14	2
purified fibrinogen and CIZ1b	2
biomarker epitope	2
fibrinogen alpha chain	2
CIZ1b epitope	2
C-terminal fragment of CIZ1	2
denaturation-resistant complex	2
lung cancer patient plasma	2
CIZ1b biomarker	2
biomarker and interaction partners	2
quantitative immunoassay	2
two independent retrospective cohorts	2
CIZ1b plasma biomarker	2
-invasive tests	2
commercial BNP immunoassays	2
recombinant glycosylated proBNP	2
HEK cells	2
glycosylated proBNP	2
external calibrators	2
internal standards	2
f) recombinant glycosylated proBNP (CHO cells)	2
nonglycosylated proBNP (E. coli), e) recombinant glycosylated proBNP (HEK cells), and	2
six preparations containing BNP 1–32 motif a) synthetic BNP, b) recombinant BNP (E. coli), c) recombinant nonglycosylated proBNP (E. coli), d) recombinant His-tagged (N-terminal)	2
Abbott I-STAT, Beckman Access2 and ET Healthcare Pylon	2
Siemens Centaur XP	2
Alere Triage	2
commercial BNP assays	2
acute and chronic heart failure patients	2
EDTA-plasma samples	2
BNP-related proteins	2
different commercial BNP immunoassays	2
BackgroundCirculating B-type natriuretic peptide (BNP)	2
serum periostin	2
Periostin immunoassay	2
assay version	2
final assay	2
reagent lots	2
testing sites	2
potentially interfering substances and drugs	2
periostin in serum	2
candidate biomarker	2
Serum periostin	2
multifunctional cytokine IL-13	2
fasting insulin	2
fasting C-peptide	2
non-diabetic and prediabetic participants	2
/IU.ConclusionWe	2
factor 6.945	2
insulin	2
control pools	2
Cobas e411 (Roche Diagnostics, Switzerland)	2
insulin and C-peptide	2
623 consecutively recruited participants	2
C-peptide and insulin calibrators and immunoassays	2
four AU5822 analyzers	2
urine amylase and lipase	2
tobramycin and urine amylase	2
direct bilirubin	2
following groups	2
66 analytes	2
Complete data sets	2
Beckman Coulter AU5822 series chemistry analyzers	2
three academic institutions	2
25(OH)D assays	2
baseline [25(OH) D3-containing] versus six-month [25(OH)D2- and 25(OH)D3-containing] samples	2
Siemens ADVIA Centaur assay	2
oral vitamin D2	2
20) healthy adults	2
Siemens, DiaSorin, Roche, and Abbott Vitamin D Total assays	2
healthy vitamin D2-supplemented subjects	2
current immunoassays	2
neo-epitope-specific immunoassays	2
circulating IGFBP-4 fragments	2
patients' blood	2
PAPP-A-derived IGFBP-4 fragments	2
ACS patients' plasma	2
SEC.ConclusionsEndogenous NT- and CT-IGFBP-4	2
complexed forms of IGFBP-4 in patients' plasma	2
intact non-truncated and non-modified NT-IGFBP-4 (14626Da) and CT-IGFBP-4 (11346Da)	2
14kDa CT-IGFBP-4	2
18kDa NT-IGFBP-4	2
endogenous IGFBP-4 fragments preparations	2
analyte	2
neo-epitope-specific and the internal epitope-specific antibodies	2
ACS plasma samples	2
extracted fragments	2
internal epitopes	2
proteolytic neo-epitopes	2
pooled ACS plasma	2
CT-IGFBP-4	2
endogenous IGFBP-4 fragments	2
IGFBP-4 fragments	2
acute coronary syndrome (ACS) patients	2
circulating N- and C-terminal fragments of IGF-binding protein-4 (NT-IGFBP-4 and CT-IGFBP-4)	2
blood DNases	2
anticoagulant EDTA	2
exogenous and endogenous DNases	2
DNAse	2
endogenous DNAse activity assay	2
serial dilution of EDTA	2
Y chromosome-specific sequence DYS-14	2
male ccffDNA	2
ccffDNA	2
exogenous nuclease	2
DNAse I	2
women bearing male fetus	2
-plasma and serum	2
circulating cell-free fetal DNA (ccffDNA)	2
circulating cell-free DNA yield (ccfDNA)	2
plasma-EDTA and serum	2
HDL-P assay	2
NMR profiler	2
well-characterized HDL-P assay	2
HDL-P on the Vantera® Clinical Analyzer	2
HDL-P	2
routine, clinical laboratory setting	2
Vantera®	2
NMR-based clinical analyzer	2
NMR-measured HDL-P	2
HDL subclasses	2
total HDL particle number (HDL-P)	2
high-density lipoprotein (HDL) particles	2
NMR-based clinical assays	2
first automated NMR platform	2
30 substances	2
specimen collection tubes	2
LDL-P	2
serum pools	2
LDL-P assay	2
NMR-measured low-density lipoprotein particle number (LDL-P)	2
current immunosuppressive regimens	2
modern generation TAC assay	2
lung transplant samples	2
heart transplant samples	2
e 411	2
e 602	2
investigational site	2
external quality assessment scheme (EQAS) samples	2
organ transplant	2
post-transplantation immunosuppressant drug	2
(TAC)	2
already well characterized real time PCR data set	2
developed software	2
men of Uygur population	2
rs2280275 in CYP2J2 gene	2
SNP3 (rs2280275) alleles	2
total and men	2
(rs2280275) genotypes	2
real-time PCR instrument	2
three single nucleotide polymorphisms (SNPs) (rs890293, rs11572223 and rs2280275) of CYP2J2 gene	2
Han population	2
two independent case–control studies	2
Han and Uygur population	2
potent endogenous vasodilators	2
EETs	2
biologically active epoxyeicosatrienoic acids (EETs)	2
) 2J2	2
BackgroundCytochrome P450 (CYP	2
existing disease biomarkers	2
Immunoglobulin G (IgG) glycome	2
tissue-specific functions	2
signal-dependent transcription factors	2
tissue-specific signals	2
lineage-determining transcription factors	2
two distinct sets of transcription factors	2
mature tissue-resident macrophages	2
embryonal tissues	2
yolk sac and fetal liver	2
tissues of the body	2
first line	2
Tissue-resident macrophages	2
macrophages in the lung and liver	2
extra’ tissue-specific functions	2
tissue of residence	2
Distinct macrophage populations	2
acute, but not chronic ALI	2
alveolar passages	2
lungs of wild-type mice	2
DR3 expression	2
DR3 gene (DR3ko)	2
effector T cells and type 2 innate lymphocytes (ILC2)	2
Death Receptor 3 (DR3)/Tumour Necrosis Factor-like cytokine 1A (TL1A) axis	2
study children	2
transcripts encoding immunoactive proteins	2
buffers or enzymes	2
standard qPCR	2
target/GAPDH	2
Host mRNA	2
rural Malawian children	2
fecal samples	2
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)	2
fluorescent or non-fluorescent	2
counts droplets	2
small aqueous droplet	2
variety of key transcripts	2
quantified transcripts	2
fecal specimens	2
host transcripts	2
gut tissue	2
available analyte	2
freemartin calves	2
exquisitely tightly-regulated gene, anti-Müllerian hormone (AMH)	2
spectrum of mammalian TGF-β proteins	2
longlived, essentially tolerogenic, helminth parasites	2
Ray Owen	2
TGF-β homologues	2
downstream intracellular messengers	2
overlapping receptor structures	2
many members	2
ancient metazoan protein class	2
TGF-β superfamily	2
primitive precursors	2
tissue macrophages	2
circulating blood monocytes	2
intestinal macrophage pool	2
intestinal monocytes and macrophages	2
one of the most abundant leucocytes in the intestinal mucosa	2
galactosyl-lactose-derived oligosaccharides containing (α1→2) and (α→4) glucosidic linkages	2
Glucansucrases Gtf180-ΔN and GtfA-ΔN	2
(α1→2) linked moiety	2
reducing end	2
(α1→4) linked moiety	2
(α1→2)-linked moiety	2
reducing glucosyl unit	2
4′-galactosyl-lactose (β4′-GL) and 6′-galactosyl-lactose (β6′-GL)	2
single glucose moiety	2
3′-galactosyl-lactose (β3′-GL)	2
Gtf180-ΔN and GtfA-ΔN	2
3 commercially available galactosyl-lactose GOS compounds	2
hMOS in structure and function	2
additional compounds	2
various probiotic bacteria	2
GL34 mixture	2
minimum of 5 compounds (degree of polymerization 3–4) (GL34 mixture) with (α1→2/3/4) linkages	2
glucansucrases glucosylate lactose	2
α-glucans with (α1→6)/(α1→3) and (α1→4)/(α1→6) glucosidic linkages	2
Glucansucrases Gtf180-ΔN and GtfA-ΔN of Lactobacillus reuteri strains convert sucrose	2
human milk oligosaccharides (hMOS)	2
β-Galacto-oligosaccharides (GOS)	2
separated diastereoisomers	2
2R- and 2S- glycerol isomers	2
prymnesin backbones	2
two larger glyceryl diglycoside fragments of prymnesin-1, glycosylated with α-ʟ-arabinopyranose and α-ᴅ-ribofuranose	2
1,2-cis-furanoside	2
furanosyl imidate	2
1,2-cis-furanosides	2
furanosyl fluorides	2
1,2-trans-glycosides	2
prymnesin toxins	2
small fragment of the prymnesin backbone	2
various fragments of the glycosylated ichthyotoxins called prymnesins	2
suite of glycosylated glycerol derivatives	2
B. thailandensis	2
native CPS	2
deacetylated CPS conjugate	2
native, acetylated CPS	2
deacetylated CPS	2
mouse model of melioidosis	2
Hc fragment of tetanus toxin (TetHc)	2
native and de-O-acetylated CPS	2
CPS 2-OAc groups	2
glycoconjugate vaccines	2
CPS fragments	2
anti-CPS monoclonal antibody binding	2
B. pseudomallei	2
-3-)-2-O-acetyl-6-deoxy-β-d-manno-heptopyranose-(-1	2
O-antigen deficient strain of B. thailandensis E555	2
B. pseudomallei-like CPS	2
B. pseudomallei and B. mallei	2
B. thailandensis strain E555	2
containment level 3 laboratories	2
potential vaccine candidate	2
virulence determinant and protective antigen	2
capsular polysaccharide (CPS)	2
Tier 1 bio-threat agents	2
close relative B. mallei	2
variety of sialic acid derivatives	2
2,7-anhydro-Neu5Gc	2
2,7-anhydro-Neu5Ac	2
membrane-enclosed enzymatic synthesis	2
sialic acid aldolase	2
free sialic acid	2
2,7-anhydro-sialic acid from glycoproteins	2
Ruminoccocus gnavus IT-sialidase	2
containing different sialic acid forms such as Neu5Ac and N-glycolylneuraminic acid (Neu5Gc)	2
2,7-anhydro-sialic acid derivatives	2
transglycosylation product of bacterial intramolecular trans-sialidases (IT-sialidases)	2
Naturally occurring 2,7-anhydro-alpha-N-acetylneuraminic acid (2,7-anhydro-Neu5Ac)	2
glycobiology and glycobiochemistry	2
tool compounds	2
2-naphthyl β-d-GlcNAc and related glycosides	2
2-naphthyl β-d-GlcNAc and related acceptor-based glycosyltransferase inhibitors	2
enzyme-coupled glycosyltransferase assay	2
full acceptor substrate	2
commercial batch of the same enzyme	2
recombinantly expressed β-1,4-GalT	2
acceptor substrate of the inverting β-1,4-galactosyltransferase (β-1,4-GalT) from bovine milk	2
readily available starting materials	2
chemical tool compound	2
GlcNAc derivative	2
galactosyltransferase inhibitor	2
synthetic GlcNAc glycoside	2
donor or acceptor substrate of the respective enzyme	2
Many glycosyltransferase inhibitors	2
monosaccharide (CBP) and oligosaccharide (CDP) acceptor substrates	2
CBPs and other closely related enzymes	2
first X-ray crystal structure of CDP	2
non-natural donor α-D-glucosamine 1-phosphate	2
cellobiose acceptor	2
glucosamine addition product	2
Ruminiclostridium thermocellum	2
recombinant CDP	2
cellobiose from glucose and α-D-glucose 1-phosphate	2
cellobiose phosphorylase (CBP)	2
short β-1→4-glucans and α-D-glucose 1-phosphate	2
cellodextrin oligomers	2
GH94 glycoside hydrolase cellodextrin phosphorylase (CDP, EC 2.4.1.49)	2
interesting prebiotic compounds	2
lactose derived oligosaccharides	2
glucosyl residue (α1→2)-linked to the reducing glucose unit of lactose	2
glucosyl residue (α1→3)- or (α1→4)-linked to the non-reducing galactose unit of lactose	2
GtfA-ΔN and Gtf180-ΔN	2
GtfA-ΔN and (α1→3)/(α1→6)	2
(α1→4)/(α1→6)	2
glucosylated lactose products DP3-4	2
larger lactose-based oligosaccharides	2
glucansucrase Gtf180-ΔN	2
glucosylated lactose products	2
lactose plus sucrose	2
(N-terminally truncated versions of) these enzymes	2
different types of linkages	2
α-glucans	2
Lactobacillus reuteri strains	2
Gtf180	2
wide range of gluco-oligosaccharide and polysaccharide products	2
Glucansucrase enzymes	2
LPMO-generated C4-oxidized gluco-oligosaccharides	2
ketone group	2
sodium triacetoxyborohydride (STAB)	2
selective reducing agents	2
C4-position of LPMO oxidized oligosaccharides	2
ketone	2
labeled non-oxidized and C4-oxidized oligosaccharides	2
porous graphitized carbon	2
buffered mobile phases	2
RP-UHPLC	2
non-oxidized counterparts	2
non-reductive 2-aminobenzamide (2-AB) labeling	2
non-oxidized and C1-oxidized oligosaccharides	2
resulting products	2
C1 and/or C4 atoms	2
recalcitrant polysaccharides	2
chitin tetra- and pentaose	2
soluble and catalytically active form	2
thioredoxin fusion protein	2
Sinorhizobium meliloti chitin deacetylase NodB	2
preparative scale	2
LCO precursors	2
N-acyl group	2
acetyl group from the non-reducing end of chitin tetra- or pentaose	2
crustacean shells	2
abundant polysaccharide	2
chitin hydrolysate	2
various substituting groups	2
chitinoligosaccharide fatty acylated	2
Nod factors and Myc-LCOs	2
arbuscular mycorrhizal fungi	2
Myc-LCOs	2
Nod factors	2
nitrogen-fixing rhizobial bacteria	2
leguminous crops	2
plant-microorganisms symbiosis	2
Lipo-chitinoligosaccharides (LCOs)	2
naturally occurring carbohydrate moieties	2
steviol glycosides	2
(α1 → 6)-linked glucopyranose residues	2
RebA-G1	2
glucose residues	2
series of minor products	2
mono-(α1 → 6)-glucosylated derivative (RebA-G1)	2
steviol C-19 β-d-glucosyl moiety	2
specifically α-d-glucosylated	2
formed products	2
glucosyl donor	2
rebaudioside A	2
α-glucosylation of the steviol glycoside	2
Lactobacillus reuteri 180	2
wild-type Gtf180-ΔN glucansucrase enzyme	2
wider variety of glycans	2
glycan information	2
basic format	2
canvas	2
WURCS sequences	2
new GlycanBuilder	2
complex, diverse, and ambiguous structures of glycans	2
structures containing monosaccharides from bacteria and plants	2
wide variety of ambiguous glycans	2
“GlycanBuilder2”	2
latest glycan symbol nomenclature	2
monosaccharide compositions and cross-linked glycan structures	2
nested repeating units	2
cyclic glycans	2
glycan rendering system	2
new version of GlycanBuilder	2
newly proposed monosaccharide symbol standard called Symbol Nomenclature for Glycans (SNFG)	2
mammalian glycans	2
glycan structure editors	2
existing or new glycan structures	2
WURCS strings	2
glycans universally	2
existing formats	2
new sequence format called WURCS (Web3 Unique Representation of Carbohydrate Structures	2
GlyTouCan version 1.0	2
readily accessible fluorescent glycans	2
GlcT, Glc-P-T and GlcNAc-P-T activities	2
α-1,3- and α-1,2-ManT activities	2
benign protozoan alga Euglena gracilis	2
earlier radiochemical assays	2
trypanosomal membranes	2
β-GalT activities	2
mycobacterial membranes	2
triazolyl-coumarin adducts	2
α-1,6-linked disaccharide counterpart	2
Synthetic hexynyl α-D-mannopyranoside	2
substituted, short chitin oligomers	2
short chitin backbone	2
substituents	2
LCO decorations	2
bacterium Rhizobium sp.	2
key nod genes	2
collection of in-frame deletion mutants	2
Nod proteins	2
one or more substituents	2
NodC, NodB, and NodA	2
LCO backbone	2
variety of chemical substituents	2
lipo-chitooligomers (LCOs)	2
legume hosts	2
Soil-dwelling, nitrogen-fixing rhizobia	2
even very short glycan-APTS probes	2
galactose residues	2
glycan extension generated β-(1 → 4)-galactan chains	2
Arabidopsis microsomes	2
→ 4)-Gal3	2
APTS-labelled β-(1 	2
structurally similar sulfonated aromatic fluorophores ANDS and ANTS	2
APTS label	2
Arabidopsis galactosyltransferase acceptor substrates	2
alditol galactosylation	2
alditol portion of the labelled acceptor	2
aminopyrene fluorophore	2
alditol tether	2
single intact sugar ring	2
reducing terminal sugar unit	2
fluorophore	2
Arabidopsis microsome preparations	2
readily accessible acceptor substrates	2
Aminopyrene trisulfonate (APTS)-labelled disaccharides	2
carbohydrate derivatives	2
CuI-catalyzed azide-alkyne 1,3-dipolar cycloaddition CuAAC	2
functionally diverse carbohydrate derivatives	2
carbohydrate-based bioactive compounds and sensors	2
carbohydrate-mimetic diagnostics and drug candidates	2
inner core region of A. haemolyticus lipopolysaccharide	2
tri- to pentasaccharide structures	2
β-D-glucopyranosyl and isomaltosyl residues	2
trisaccharide acceptor	2
4,6-O-benzylidene N-phenyltrifluoroacetimidate glucosyl donor	2
suitably protected, α-(2→4)-interlinked Kdo-disaccharide	2
branched α-Glcp-(1→5)[α-Kdo-(2→4)]-α-Kdo trisaccharide motif	2
fragments of Acinetobacter haemolyticus LPS	2
position 5 of Kdo	2
α-D-glucopyranose	2
heptose-deficient inner core of the lipopolysaccharide of several pathogenic strains of the Moraxellaceae family (Moraxella, Acinetobacter) and of Bartonella henselae	2
uronic acids directly and/or l-Ara residues	2
long acidic oligosaccharides	2
tetrasaccharides, α-l-Fucp-(1→2)-β-GlcA-(1→6)-β-Gal-(1→6)-Gal and α-l-Fucp-(1→2)-β-4-Me-GlcA-(1→6)-β-Gal-(1→6)-Gal	2
lower polymerized (predominantly dp 4) acidic oligosaccharides	2
higher oligosaccharides with endo-β-(1→6)-galactanase	2
pentasaccharide α-l-Fuc-(1→2)-α-l-Araf-(1→3)-β-Gal-(1→6)-β-Gal-(1→6)-Gal	2
sequence, α-l-Fucp-(1→2)-α-l-Araf-(1→. This sequence	2
l-Ara residues	2
4-O-methyl-GlcA (4-Me-GlcA)	2
corresponding acidic derivatives	2
Gal residues	2
series of neutral β-(1→6)-galactooligosaccharides	2
exo-β-(1→3)-galactanase	2
α-l-arabinofuranosidase	2
carbohydrate moieties of a radish leaf AGP	2
l-Fuc-containing oligosaccharides	2
side chains	2
side chains of (1→6)-linked β-Gal residues	2
β-(1→3)-galactan backbones	2
carbohydrate moieties of arabinogalactan-proteins (AGPs)	2
uracil derivative	2
cytosine base	2
corresponding glycosyl urea	2
3,5-di-O-benzoyl-2-deoxy-2,2-difluororibose	2
number of cancers	2
gluco-configured substrates and 5-iodo-UTP	2
galacto-configured 5-substituted-UDP-sugars	2
5-iodo-UDP-sugars	2
5-iodo-UDP-Gal	2
corresponding 5-aryl derivatives	2
5-iodo-UDP-Glc	2
Erwinia amylovora	2
corresponding enzyme	2
5-substituted UDP-glucose with UDP-glucose	2
range of gluco-configured 5-substituted UDP-sugar derivatives	2
iodo compound	2
5-substituted UTP derivatives	2
UDP-sugar	2
5-iodo derivative	2
corresponding UDP-galactose derivatives	2
range of 5-substituted UTP derivatives	2
Glucose-1-phosphate uridylyltransferase	2
heparin fragments	2
site-specific sulfated saccharides	2
digest native heparin	2
pure, defined heparin-related disaccharide species	2
sulfation-varied matrix	2
heparin disaccharide	2
key most common biologically relevant sulfation-variable l-IdoA O-2 and d-GlcN O-6 and amino sites	2
l-iduronate components	2
GlcN–IdoA disaccharides	2
array of differentially sulfated	2
Lewis acid activator	2
reducing terminus	2
different linkers	2
‘terminating acceptors’	2
different acceptor alcohols	2
non-reducing to reducing end	2
fully acetylated thioglycoside mannosyl donor	2
acetylated poly-mannosides	2
glycoside products	2
reported phosphorylase enzymes	2
difficult to synthesise glycosides	2
phosphorylase enzymes	2
diverse carbohydrate structures	2
class of enzymes	2
sugar donors, acceptors and glycosidic linkages	2
donor substrates	2
accessible and relatively stable sugar phosphates	2
under-explored catalysts	2
Carbohydrate phosphorylases	2
4- and 5-positions	2
hydroxamic acid	2
trypanosome GPI pathway	2
first small molecule inhibitor	2
GlcNAc-PI de-N-acetylase inhibitor	2
salicylic hydroxamic acid	2
focused library of zinc-binding fragments	2
bloodstream form of Trypanosoma brucei	2
mature GPI anchors	2
zinc-metalloenzyme GlcNAc-PI de-N-acetylase	2
carbohydrate-based novel chemical entities	2
initial 3D-structure	2
stacked galactose and fucose pyranoses of sLea and sLex	2
rings	2
experiment and conventional (ns) simulations	2
pyranose ring flexing	2
Glycosidic linkage	2
constituent sub-sequences	2
mannosyl cores, sialyl Lewis (sLe) antennae	2
10μs simulations	2
rationally designed mimetic chemical probes, drugs, and biomaterials	2
3D-structural information	2
vast untapped repository	2
human glycome	2
beta-N-benzyl-(O-methoxy)-glucoside and beta-N-benzyl-(O-methoxy)-galactoside derivatives	2
beta-glucosidase and beta-galactosidase from almonds and Escherichia coli	2
Beta-O-benzyl glucose and beta-O-benzyl galactose	2
amino(methoxy) beta-glycosidic bond	2
hydrogen bonded aggregates	2
aromatic and alkyl structural fragments	2
highly interdigitated smectic A phase	2
novel non-symmetric liquid crystal dimer, 1-[3-O-(d-glucopyranos-3-yl)]-8-[(4-methoxyazobenzene-4′-oxy)]octane	2
α-GalCer dimer	2
various diynes	2
6″-azido-6″-deoxy-α-galactosyl ceramide derivative	2
two α-galactosyl ceramide (α-GalCer) units	2
library of dimeric CD1d ligands	2
N-ureido motif	2
aforementioned de-N-acetylase	2
previous N-ureido analogue	2
ZBG library	2
N-ureido	2
de-N-acetylase (EC 3.5.1.89)	2
putative metalloenzyme 2-acetamido-2-deoxy-α-d-glucopyranosyl-(1→6)-phosphatidylinositol	2
either monodentate ligand binding carboxylic acids or bidentate ligand binding hydroxamic acids	2
small zinc-binding group (ZBG) library of deoxy-2-C-branched-monosaccharides	2
3D-model	2
hexosamine OH-4 and OH-6 atoms	2
β(1→4) linkage	2
β(1→3) ψ dihedral	2
hexosamine OH-4 and the glucuronic acid O5 atoms across the β(1→3) glycosidic linkage	2
hydrogen bond	2
strong, persistent inter-residue hydrogen bonds	2
amide proton	2
hexasaccharide (PDB code 2KQO)	2
experimental 3D-model	2
tetrasaccharide	2
chondroitin sulfate and hyaluronan 3D-structures	2
homogenous oligosaccharides of unsulfated chondroitin (with and without 15N-enrichment)	2
glycosaminoglycan chondroitin sulfate	2
ultra-high-field spectrometers	2
hexasaccharide	2
1H-resonances	2
hexasaccharide of the highly repetitive glycosaminoglycan hyaluronan	2
degenerate chemical structures	2
ordered cellular actin-myosin ensembles	2
actin-myosin cross-bridges	2
myosin II motor domains and actin filaments	2
closely related homodimeric GPCRs	2
homodimeric receptors	2
sharing of interfaces	2
distantly related receptors	2
immediate subfamilies	2
known GPCR homodimers	2
type-4 BRET assays	2
induced multimerization	2
homo- and heteromeric interactions	2
type-4 BRET	2
targeted bioluminescence resonance energy transfer (BRET) assay	2
widely used assays	2
heteromeric GPCR interactions	2
certain GPCRs	2
largest and most pharmacologically important family of cell-surface receptors	2
smaller AuNP	2
unbound head	2
bound/unbound states	2
head of kinesin-1 labeled with AuNP	2
nm AuNPs	2
objective lens	2
AuNPs	2
axicon lens	2
annular illumination total internal reflection dark-field microscopy system	2
40 nm AuNP	2
isolated AuNP	2
scattering signal	2
various single biomolecules	2
Gold nanoparticles (AuNPs)	2
mammalian organisms	2
quantitative in vivo and in vitro analyses	2
different parts of the embryo	2
NANOG and GATA6 expression	2
far unknown local clustering	2
ICM organoids and mouse embryos	2
novel three-dimensional in vitro stem cell system	2
in vitro systems	2
mouse embryos and embryonic stem cell models	2
mammalian preimplantation	2
endocardial surface	2
trabecular ridges	2
delayed afterdepolarizations	2
highly idealized cylindrical endocardial structures	2
Computational bidomain models	2
identical-strength stimuli	2
ridge locations	2
endocardial grooves	2
rabbit ventricular wedge preparations	2
endocardial tissue surface	2
Previous computational models	2
experimental and clinical electrophysiology laboratory environments	2
electrical stimuli	2
cortex-free vesicles	2
rigid glass surfaces	2
minimal experimental model	2
chromatin fibers	2
two-start conformations	2
folded chromatin fibers	2
nucleosome repeat length fibers	2
folded nucleosomal arrays	2
(un)stacking of nucleosomes in one-start and two-start chromatin fibers	2
rigid basepair DNA model	2
30 nm fibers	2
presented harmonic potential well confinement model	2
homogeneous tags	2
binding-site environment	2
gold-nanoparticle-tagged ganglioside GM1 lipids	2
previously published interferometric scattering microscopy data set	2
harmonic potential well	2
confinement model	2
static structures	2
tautomeric and rotameric states of key residues	2
representative environment	2
putative “closed” protein	2
micelle	2
scissile bond	2
single water molecule	2
catalytic H122	2
representative outer membrane models	2
lipopolysaccharide molecules of the outer membrane	2
enzyme LpxR	2
outer membrane lipids of Gram-negative bacteria	2
fluorescence-lifetime imaging microscopy images	2
supercritical angle fluorescence objective	2
plasma membrane of live cells	2
Laurdan-stained model membranes	2
environmentally sensitive fluorophores	2
photoactivated ion-conduction pathway	2
atomistic model	2
analogous photoreceptors	2
previously known photoactivated structures	2
chromophore	2
chimeric ChR	2
atomic structural model	2
retinal chromophore	2
microbial light-gated ion channels	2
Channelrhodopsins (ChRs)	2
PYthon Microscopy Environment	2
live COS-7 cells	2
endoplasmic reticulum tubules	2
stimulated emission depletion images	2
fixed-cell and live-cell images	2
fluorophore distribution	2
fluorescent bead	2
point-like object	2
nonbiological proxy	2
one of its heads	2
single inactive motors	2
kinesin-1 motors	2
individual motors	2
crowded filaments	2
agent-based lattice gas model	2
kinesin-1 family	2
Molecular motors	2
optimized extraction tools	2
small nanodisks	2
rim of these pores	2
small, water-filled pores	2
membrane defects	2
multiple adsorbed copolymers	2
lipid bilayer interface	2
SMA copolymers	2
native lipid environment	2
so-called SMA lipid particles (SMALPs)	2
nanometer-sized membrane disks	2
styrene-maleic acid (SMA) copolymers	2
otherwise short-lived pre-power stroke state	2
mechanokinetic actomyosin models	2
isolated muscle fibers	2
in vitro motility assays	2
small molecular compound blebbistatin	2
active site of myosin	2
ATP-hydrolysis product, inorganic phosphate (Pi),	2
myosin II motors	2
cancer mutation Arg665Trp in PLCγ2)	2
Arg687Trp mutant in PLCγ1	2
molecular dynamics	2
tandem SH2 and γSA constructs	2
1H,15N-HSQC spectra	2
designed tandem SH2 constructs	2
sections of the cSH2-SH3 linker	2
tandem SH2 protein	2
Tyr783 phosphorylation site	2
activated growth factor receptor	2
split pleckstrin homology domain	2
SH3 domain	2
tandem Src homology 2 (SH2) pair	2
regulatory γ-specific array (γSA)	2
fibroblast growth factor receptor 1	2
intracellular membrane-associated second-messenger signaling protein	2
Cγ (PLCγ)	2
Phosphatidylinositol phospholipase	2
F(ab) heavy chain	2
specific loop region	2
similar regions	2
multiple MD structures	2
F(ab) structure	2
SAXS data	2
atomistic structures	2
F(ab)	2
crystal complex	2
structure of the F(ab)	2
inhibitory Fc-γ receptor in humans	2
F(ab) fragment	2
x-ray crystallographic structure	2
individual binding partners	2
atomistic three-dimensional models of macromolecules	2
HA-rich extracellular matrices	2
HA⋅hyaladherin complexes	2
HA⋅hyaladherin bonds	2
high affinity streptavidin⋅biotin bond	2
two members of the type C subgroup, i.e., with the longest HA-binding domains	2
cartilage link protein	2
aggrecan in complex	2
subgroup (i.e., with the shortest HA-binding domains; TSG-6 and HARE)	2
members of the type	2
HA-binding domain	2
hyaladherins	2
HA receptor CD44	2
HA receptor for endocytosis (stabilin-2/HARE)	2
proteoglycan versican, the inflammation-associated protein TSG-6	2
complex of the proteoglycan aggrecan and cartilage link protein	2
Link module superfamily	2
panel of hyaladherins	2
recently developed single-molecule force spectroscopy platform	2
supramolecular architectures	2
HA-binding proteins (hyaladherins)	2
supramolecular complexes and matrices	2
extracellular polysaccharide hyaluronan (HA)	2
artificial repeat proteins	2
natural repeat proteins	2
loop in the middle of a large array	2
two-repeat array	2
single loop	2
biomaterials and biomedicine	2
highly stable, modular proteins	2
Consensus-designed tetratricopeptide repeat proteins	2
LH sequence	2
residues in the LH	2
LH isoform, gH5	2
globular domain of D. melanogaster H1 (gH1) and the corresponding chicken (Gallus gallus)	2
Brownian dynamics simulations	2
useful model organism	2
single somatic isoform of the LH (H1)	2
common fruit fly (Drosophila melanogaster)	2
DNA in eukaryotic cells	2
Linker histone (LH) proteins	2
cells in colonies or sheets	2
cells mechanosense rigid materials beneath elastic hydrogels	2
periphery of colonies on thick hydrogels	2
thick hydrogels	2
Rho-associated protein kinase-mediated cellular contractility	2
defined area	2
exponential model	2
fluorescent fiducial-marker-labeled hydrogels	2
colonies of MG63 cells	2
soft (1 kPa) elastic extracellular-matrix-functionalized polyacrylamide hydrogels	2
underlying materials	2
cohesive colonies of cells	2
soft hydrogel materials	2
underlying stiff materials	2
Adherent cells	2
Lesser General Public License	2
individual endothelial cells	2
entire in vivo vascular networks	2
new scientific domain	2
large populations of cells	2
intricate cellular structures	2
single bacterial protein complex	2
spatial domain	2
single fluorescent molecules	2
new methodologies and vehicles	2
important model systems	2
two peptides	2
magainin 2	2
membrane-curvature-strain-mediated free-energy barrier	2
charge-neutral mammalian mimics	2
monounsaturated phosphatidylethanolamine	2
anionic bilayers	2
Gram-negative bacterial-inner-membrane mimics	2
frog peptides magainin 2 and PGLa	2
retinol binding protein	2
integral membrane receptor STRA6	2
ensembles of structures	2
multiple sources of information	2
cryo-electron microscopy density maps	2
macromolecular systems	2
many of these systems	2
complex macromolecular systems	2
adhesive coat filaments	2
elevated intracellular calcium	2
Intraerythrocytic calcium signals	2
egress-invasion assays	2
P. falciparum invasion targets	2
red blood cell populations	2
fluorescent calcium indicator	2
merozoite-red cell contacts	2
Plasmodium falciparum parasites	2
CONAN and its documentation	2
proteins or other biomolecules	2
CONAN a tool	2
α-synuclein mutant peptide	2
specific contacts	2
time-resolved contact maps	2
interresidue contacts	2
fluid bilayers	2
natural membranes	2
inner leaflet	2
energetically preferred location of POPE	2
either sample preparation	2
POPC inner bilayer leaflets	2
monolayers	2
POPE inner bilayer leaflets	2
solution NMR	2
palmitoyl-oleoyl-phosphatidylethanolamine (POPE;J0<0) and palmitoyl-oleoyl-phosphatidylcholine (POPC;J0∼0)	2
protein systems	2
interface and solvent exposed residues	2
cAMP responsive genes	2
disordered pKID region of CREB protein	2
bound complex of pKID:KIX	2
phosphorylated form	2
unphosphorylated KID	2
many other IDPs	2
KIX domain of CREB-binding protein	2
transcription factor CREB	2
kinase inducible domain (KID)	2
one such IDP	2
partner protein	2
IDP	2
Intrinsically disordered proteins (IDPs)	2
living cell membranes	2
Frizzled receptors	2
S2 receptor-plus (S2R+) cells	2
cells in close contact	2
flattened membranes	2
membranes of Drosophila Schneider 2 cells	2
labeled Wnt3A	2
Wnt protein	2
receptor, Frizzled	2
secreted, hydrophobic, lipidated proteins	2
disordered phase	2
coexisting phases	2
Hybrid lipids	2
Nanoscale domains	2
domains of two phases	2
hybrid lipid (with a saturated and an unsaturated chain)	2
liquid-ordered and a liquid-disordered phase	2
saturated lipid, an unsaturated lipid, and cholesterol	2
saturated and an unsaturated lipid	2
binary and a ternary mixture	2
MARTINI coarse-grained force field	2
model lipid bilayers	2
nanoscale domains	2
Nanoscale rafts	2
heterogeneous in-plane (lateral) distribution	2
multiple lipid and protein components	2
Cell membranes	2
plastoquinone exchange cavity	2
bulk membrane	2
cocrystallized lipids	2
plastoquinone exchange cavities	2
annular shell	2
monogalactosyldiacylglycerol and sulfoquinovosyldiacylglycerol lipids	2
coarse-grain MD simulations	2
thylakoid lipids	2
minor groove side	2
pendant methyl groups	2
major groove side	2
indole nitrogen atoms	2
terminal basepair	2
terminus of the dsRNA	2
Cy3 and Cy5	2
free end of RNA	2
L5 protein	2
RNA stem-loop	2
Cy3 and Cy5 on dsRNA	2
double-stranded (ds) DNA	2
positions	2
ends of the molecule	2
5′ phosphate group	2
double-stranded nucleic acids	2
donor-acceptor pairs	2
indodicarbocyanine fluorophores Cy3 and Cy5	2
thermal-shift assays	2
milder dodecylmaltoside	2
native-like environment	2
suitable environment	2
yeast mitochondrial ADP/ATP carrier (yAAC3)	2
dodecylphosphocholine (DPC)	2
native sources	2
carcinogenesis, and drug design	2
membrane-bound PI3Kα molecule	2
stable, membrane-bound PI3Kα complex	2
membrane-bound H-Ras	2
product PIP3	2
substrate PIP2	2
two anionic lipids (phosphatidylserine and PIP2)	2
receptor phospho-Tyr	2
platelet-derived growth factor receptor, a receptor tyrosine kinase) and H-Ras	2
receptor activation loop	2
supported lipid bilayer	2
six-component pathway	2
membrane-bound enzyme	2
two competing models	2
constitutive lipid phosphatidylinositol-4,5-bisphosphate (PIP2)	2
PI3K lipid kinases	2
specific isoforms of phosphatidylinositol-3-kinase (PI3K)	2
small G-proteins of the Ras superfamily	2
Cellular pathways	2
mitotic motor	2
fission yeast kinesin-5	2
Cin8 motors	2
individual Cin8 molecules	2
plus- and minus-end direction	2
microtubule gliding assays	2
purified budding yeast kinesin-5 Cin8	2
bidirectional kinesin-5	2
fungal kinesin-5 motors	2
unidirectional plus-end-directed motors	2
kinesin motors	2
bulkier diamagnetic spin label analog	2
transmembrane mutants	2
cytosolic mutants	2
spins in the system	2
cytosolic or the transmembrane region	2
spin label	2
heptameric channel of small conductance (MscS)	2
distinct bacterial mechanosensitive channels	2
PELDOR data	2
different regions of the structure	2
functionally significant but distinct conformational states	2
Membrane channel proteins	2
ever more complex biological systems	2
dynamic structure of a colicin T-domain	2
final model	2
flexible system	2
full-length ColN and its fragments	2
dynamic and complex system	2
high-resolution x-ray model	2
target bacterium	2
TolA	2
two different receptors	2
domains of the same colicin N molecule	2
ColN-T	2
T-domain of colicin N (ColN-T)	2
Escherichia coli outer membrane	2
disordered N-terminal translocation domains (T-domains)	2
resistant bacteria	2
colicin family	2
Antibacterial toxins	2
many biomolecular interactions and signaling pathways	2
Intrinsically disordered regions	2
neuronal membrane	2
intracellular electrode and an extracellular electrode	2
Gomes et 	2
physiological saline	2
two extracellular electrodes	2
Q pool	2
bL hemes	2
hemes bL and bH	2
independent data sets	2
 electrons	2
functional dimer model	2
functional monomer	2
many respiratory systems	2
important electron junction	2
Ubiquinol cytochrome c oxidoreductase (bc1 complex)	2
study targets	2
caveolae-dependent pathways	2
cardiac caveolae-dependent signaling	2
surface-sarcolemmal and transverse-tubular membranes	2
dynamic structures	2
transverse-tubular membranes	2
surface sarcolemma	2
intact heart	2
intact myocardium	2
caveolae in situ	2
fixed ventricular myocardium	2
New Zealand white rabbits	2
caveolae in intact tissue	2
rabbit single-ventricular cardiomyocytes	2
outer cell surface membrane	2
Caveolae are signal transduction centers	2
n-alcohol	2
liquid-ordered and liquid-disordered phases	2
16 carbons	2
ternary GUVs of dioleoyl-PC/dipalmitoyl-PC/cholesterol	2
concentrations of n-alcohols	2
several types of lipids, ratios of lipids, types of short-chain n-alcohols	2
cell-derived GPMVs	2
canonical ternary mixtures	2
ternary mixtures of a lipid	2
giant unilamellar vesicles (GUVs)	2
Coexisting liquid-ordered and liquid-disordered phases	2
giant plasma membrane vesicles (GPMVs)	2
model and cell membranes	2
general anesthetics	2
new amphiphiles (e.g., lipids, alcohols, peptides, or proteins)	2
membrane biophysics	2
single virus particles	2
plasma membrane of live cells	2
cell-derived membrane vesicles	2
polarity-sensitive membrane dyes Di-4-ANEPPDHQ, Di-4-AN(F)EPPTEA, and NR12S	2
potential nanodomains	2
Polarity-sensitive dyes	2
cellular plasma membrane	2
different solutions	2
membrane-penetrating antimicrobial peptide Temporin L	2
specific ions	2
supported fluid phospholipid bilayers	2
nanotexturing	2
molecular nanoordering	2
Ca2+ and Tris	2
NaCl, KCl, CaCl2, and Tris buffer	2
nanoordering	2
otherwise fluid bilayer	2
different saline solutions	2
supported 1,2-dioleoyl-sn-glycero-3-phosphocholine lipid bilayers	2
standard fluid mosaic model	2
lipids and proteins	2
different molecules	2
zipcode protein	2
specific regions	2
in vitro and in vivo data	2
human β-actin messenger RNA	2
whole-transcript in vitro and in vivo SHAPE-MaP	2
on-conformation	2
five classes of structures	2
Vibrio vulnificus add adenine riboswitch	2
conformational map	2
selective 2′ hydroxyl acylation by primer extension (SHAPE)-directed ensemble	2
stable 2D map	2
mutant suboptimal ensembles	2
diverse ensembles	2
given RNA sequence	2
stable map	2
in vitro versus in vivo comparisons	2
conformational ensemble of RNAs	2
energy landscape	2
Cellular molecules	2
single, well-defined conformation	2
ribonucleic acid (RNA) molecule	2
reporter cell lines	2
important pluripotency-sustaining positive feedback loops	2
genetic reporters	2
combination of mathematical modeling	2
fluorescent signal	2
genetically engineered reporter cell lines	2
individual embryonic stem cells	2
important pluripotency regulators	2
cells on different substrates	2
cell cytoskeleton	2
reversible single-molecule stiffness sensor	2
Protein complexes	2
first element of the pathways	2
nitrogen and carbon metabolisms	2
wild-type and two genetic knock-outs	2
glutamine synthetase, GlnB, and GlnK	2
active and allosteric sites	2
concise biochemical model of GlnB and GlnK	2
total and posttranslationally modified proteins	2
glutamine synthetase	2
transport proteins, and metabolic pathways	2
two paralogous proteins (GlnB and GlnK)	2
tail region of the protein	2
globular region of the rProtein	2
globular and tail regions of rProtein uL23	2
slightly anticooperative complexes	2
the intact uL23 rProtein	2
rRNA1-uL23tailn (n > 1) complexes	2
rRNA1-uL23tail1 complexes	2
DIIIcore rRNA	2
Domain III	2
tail	2
subdomain called “DIIIcore”	2
Domain III of the rRNA	2
assembled ribosome	2
core of the large ribosomal subunit	2
tail, uL23tail	2
rProtein and rRNA	2
ribosomal proteins (rProteins)	2
appropriate rRNA fragments	2
previously acquired components	2
subunit surfaces	2
small RNAs and peptides	2
Accretion Model	2
small folding-competent RNAs	2
ancient ribosome	2
realistic vessel networks	2
two reproducible example problems	2
complex 3D geometries	2
nutrients, growth factors and drugs	2
Microvessel Chaste	2
alternative computational formulations	2
in vivo or in vitro experiments	2
efficient, 3D models of vascularized tissues	2
detailed three-dimensional (3D) datasets	2
multiscale, multiphysics models	2
software library	2
Spatial models	2
ParA-type partition system	2
daughter foci	2
single-focus progenitor	2
Brownian ratchet	2
DNA carpet	2
parS-coated cargo	2
Multiple ParA-ParB bonds	2
ParA system	2
bacterial chromosome	2
centromere-like site	2
conserved tripartite ParA-type system	2
low-copy-number plasmids	2
high-copy-number plasmids	2
extrachromosomal DNA	2
Bacterial plasmids	2
low-copy-number proteins	2
bacterial nucleoid	2
mobile LacI molecules	2
lac operator regions on the chromosome	2
LacI in live cells	2
specific, near-specific, and non-specific DNA binding modes of LacI in vivo	2
single LacI molecules in live cells	2
LacI in live bacteria	2
well characterized transcription factor	2
lac repressor (LacI)	2
microstructural imaging	2
early-myelinating white matter	2
Late-myelinating white matter	2
particular white matter tract	2
brain white matter of nondemented volunteers	2
spin-echo T2is	2
cohort of clinically healthy adults	2
model of cylindrical magnetic field perturbers	2
tissue microstructure	2
T cells and embryonic stem cells	2
membrane, cytoplasmic, and nuclear proteins	2
several mammalian proteins	2
DHPSF	2
whole eukaryotic cell volumes	2
sample media	2
objective lens immersion liquid	2
relatively small prokaryotic cells	2
double-helix point spread function (DHPSF)	2
complicated three-dimensional environment	2
sigmoid functional response	2
CTL	2
killing	2
cellular Potts model	2
set of differential equations	2
CTLs form stable synapses	2
general functional response	2
simple linear DNA sequences	2
additional ligand-DNA contacts	2
supercoiled DNA minicircles	2
distal recognition sites	2
repressor protein	2
DNA triplex	2
large disordered lβphase domains	2
nucleated domains	2
lβphase	2
disordered solid phase	2
different mixtures	2
lβstate	2
three-phase region	2
gel (lβ) domains	2
lo and lβphase	2
biomimetic cell lipid membranes	2
coexisting lipid phases	2
useful model systems	2
Phospholipid ternary systems	2
either WL-PSI or FRL-PSI	2
Target models	2
charge-separating pigments	2
low-energy radiative trap	2
WL-PSI	2
resulting P700+•A1−• charge-separated state	2
case of FRL-PSI	2
FRL-PSI	2
normal, white-light (WL)-grown PSI (WL-PSI)	2
FRL-grown form of PSI (FRL-PSI)	2
small proportion of chlorophyll	2
nm)	2
>725	2
far-red light (FRL;	2
Photosystem I (PSI) from Chroococcidiopsis thermalis PCC 7203	2
aggregation-prone transient intermediate species	2
interface (I56V)	2
C-helix (I89V)	2
domain interface (I56V)	2
well-characterized I59T β-domain variant	2
destabilizing α-domain mutation (I23A)	2
α-domain	2
β-domain of lysozyme	2
transient intermediate species of disease-related lysozyme variants	2
intrinsic structure of peptides	2
bilayer environment	2
DMPC and POPC	2
two representative lipid bilayers	2
spin-labeled WALP24	2
semirigid unnatural amino acid 4-(3,3,5,5-tetra-methyl-2,6-dioxo-4-oxylpiperazin-1-yl)-l-phenylglycine (TOPP)	2
transmembrane WALP24 peptide	2
wide range of long RNAs	2
generic RNA structure prediction tools	2
single-stranded RNAs	2
long RNA molecules	2
multivalent cations	2
long RNAs	2
long noncoding regulatory RNAs	2
broad spectrum of biologically important RNAs	2
branched polymer model	2
branched polymers	2
highly ramified secondary structures	2
nonrepeating sequences	2
Long RNAs	2
long single-stranded RNAs	2
genomes in RNA viruses	2
Long RNA molecules	2
two different types of cardiac cell cultures	2
propagating waves	2
scientific CMOS cameras	2
inexpensive high-resolution detectors	2
high-resolution detectors	2
cardiac waves in optical mapping recordings	2
high-bandwidth detectors	2
cultured cardiac cell monolayer	2
popular biological model	2
Cardiac arrhythmias	2
outer-membrane model	2
extensive dimerization interface	2
external loops	2
globular C-terminal domain	2
large dimerization interface	2
phospholipids in the inner leaflet	2
asymmetric model of the outer membrane	2
full-length model of the OmpA dimer	2
peptidoglycan of the periplasm	2
outer membranes	2
multidomain protein	2
large number of microtubules in the asters	2
two spindle poles	2
Astral microtubules	2
centering machinery	2
microtubules or dyneins	2
independent motor elements	2
center of the spindle	2
microtubule-dependent machinery	2
early Caenorhabditis elegans embryo	2
liquid-phase plasma membranes	2
E. coli cells	2
e.g., eukaryotic cells, membranes of Bacillus vegetative cells	2
live cell membranes	2
live E. coli cells	2
membrane extract liposomes	2
E. coli membrane extracts	2
live E. coli cells, spheroplasts, and liposomes	2
molecular rotor BODIPY C10 in the membranes of live Escherichia coli bacteria	2
selectivity filter (T118 and L228)	2
pore domains	2
nonconserved residues	2
x-ray structure	2
multiple high-occupancy sites	2
extracellular cap	2
prototypical K2P channel, TWIK-1	2
expansive extracellular cap	2
nonidentical domains	2
two-pore domain family (K2P)	2
Potassium channels	2
tadpole behavioral assay	2
n-alcohol anesthetics	2
plasma-membrane-derived vesicles	2
several n-alcohol anesthetics	2
certain ion channels	2
Diverse molecules	2
Dickerson-Drew dodecamer	2
epigenetic mark 5-hydroxymethyl	2
bound peptide	2
class II major histocompatibility complex	2
protein and a DNA case study	2
proteins and nucleic acids	2
large computational resources	2
biomolecular systems	2
CaMKII dodecamer and the F-actin cytoskeleton	2
different F-actin binding modes	2
heterogeneously diffusing population	2
CaMKIIα isoform	2
αT286D mutant	2
ATP (βK43R and αK42M) or Ca2+/calmodulin (βA303R)	2
CaMKII mutations	2
CaMKII inhibitor tatCN21	2
another important synaptic protein interaction	2
F-actin binding	2
αT286D	2
mutations βT287D	2
interdomain linker	2
βE′ splice variant	2
CaMKIIβ (β)	2
CaMKIIα (α) isoform	2
colocalized, long-lived CaMKII tracks	2
actin stress fibers	2
evanescent field	2
oligomeric complexes	2
tag-RFP-labeled actin cytoskeleton	2
GFP-tagged CaMKII	2
dendritic spine synapses	2
Ca2+/calmodulin-dependent protein kinase II (CaMKII)	2
helix bundle crossing	2
multimeric ion channel	2
lipid nanodiscs	2
randomly labeled tetrameric KirBac1.1 potassium channels	2
subunits within a multimeric protein with acceptor and donor fluorophores	2
structurally heterogeneous subpopulations	2
different parts of the protein	2
Förster resonance energy transfer (FRET) between probes	2
native lipid bilayer	2
dynamic multimeric proteins	2
long-chain lipids	2
epithelial PtK2 cells	2
MBP-induced domains	2
myelin sheath region	2
undisturbed live PtK2 cells	2
MBP-rich domains of PtK2 cells	2
live epithelial PtK2 cells	2
micrometer-sized domains	2
myelin membrane sheets of cultured oligodendrocytes	2
different fluorescent lipid analogs	2
lipid constituents of myelin	2
adjacent cytoplasmic membranes of the myelin sheath	2
proteinaceous meshwork	2
myelin basic protein (MBP)	2
densely packed lipids	2
axonal fibers	2
multilayered membrane	2
heat-stimulated DNA switches or transistors	2
G3T multimers	2
first G3T monomer	2
tandem sequences	2
full-length tandem G3T monomers	2
 each other)	2
G3T multimers (G3T units covalently	2
single G3T molecules	2
monomolecular quadruplex	2
5′-GGGTGGGTGGGTGGG-3′ (G3T) sequence	2
K+ ions	2
either inverted or upright microscopes	2
patch-clamp setups	2
living cells on nontransparent substrates	2
intercalated disks of isolated cardiac myocytes	2
hair cell stereocilia	2
side surfaces	2
previously inaccessible areas of cells	2
upright optical microscope	2
islets of Langerhans, and of hippocampal neurons	2
nontransparent nanoneedle arrays	2
water immersion objective	2
patch-clamp pipette	2
standard patch-clamp micromanipulator	2
SICM scan head	2
magnification upright optics	2
optimal illumination	2
scan assembly	2
scanning probe microscopes	2
currently available SICM systems	2
stimuli or drugs	2
structure of interest	2
imaging nanopipette	2
three-dimensional (3D) images	2
imaging probe	2
glass nanopipette	2
compact human chromosomes	2
loop array	2
border	2
stable loops	2
analytically solved model	2
dynamic array of consecutive loops	2
loop-extruding factors (LEF)	2
enzymatic machines	2
stack of loops	2
arrays of closely stacked consecutive ∼100 kb loops	2
mammalian chromosomes	2
membrane-water interface	2
simple kinetic model	2
ND membrane-water interfaces	2
external buffers	2
lipid area	2
surface of cytochrome c oxidase	2
12 nm NDs	2
Fluorophore-labeled cytochrome c oxidase	2
individual pH-sensitive fluorophores	2
lipid nanodiscs (NDs)	2
membrane-bound proton transporters	2
proton-collecting antennae	2
Lipid membrane surfaces	2
multisite proteins	2
tyrosine kinase ZAP-70	2
disordered ζ-chain	2
cellular reconstitution	2
12 sites)	2
homodimer subunit	2
conserved immunoreceptor tyrosine-based activation motifs (ITAMs)	2
20 sites	2
prototypical multisite substrate	2
multisubunit receptor on the surface of T cells	2
T cell antigen receptor (TCR)	2
intermediate metastable configurations	2
porous networks	2
actin bundles	2
mature filopodia	2
conical-shaped filament bundles	2
cross-linking proteins	2
hollowed-out structure	2
central filaments in the bundle	2
porous structure of filopodial actin filament bundle	2
bundle core	2
bundle	2
cytosolic G-actin	2
cross-linker proteins	2
tight bundle	2
Actin filaments	2
filament barbed ends	2
filopodial base	2
filopodial tube	2
filopodial tip	2
structural core of filopodia	2
many eukaryotic cells	2
ubiquitous fingerlike protrusions	2
SOD1 homodimer	2
even single residues at the interface	2
lysine, arginine, proline and threonine carbonylation, and cysteine oxidation	2
oxidatively damaged SOD1 aggregates	2
homodimeric metalloenzyme	2
key antioxidant enzyme in human cells	2
Superoxide dismutase 1 (SOD1)	2
insoluble aggregates	2
multiprotein signaling pathways	2
PIP2-binding proteins	2
additional predictions	2
available in vivo data	2
activation module	2
Ca2+-PKC-MARCKS-PIP2-PI3K-PIP3 system	2
multiple active PI3K molecules	2
multiple PIP2 molecules	2
amplification module	2
docking target and substrate lipid	2
PIP2-binding peptide	2
together Ca2	2
protein components	2
key predictions	2
hypothesized Ca2+-PKC-MARCKS-PIP2-PI3K-PIP3 amplification module	2
lipid kinase phosphoinositide-3-kinase	2
phosphatidylinositol-4,5-bisphosphate (PIP2)	2
myristoylated alanine-rich C kinase substrate (MARCKS)	2
Ca2+-protein kinase C (Ca2+-PKC)	2
putative amplification module	2
leading-edge circuit	2
attractant gradient	2
cytoplasmic leaflet of the plasma membrane	2
complex leading-edge signaling circuit	2
chemotaxing ameboid cells	2
many thin fibers	2
fewer thick fibers	2
strongly connected protofibrils	2
protofibril connections	2
uniformly connected protofibrils	2
homogeneous cross section	2
fibrin fibers	2
homogeneous materials	2
fibrinogen glycation	2
end blood samples	2
age-, gender-, and body-mass-index-matched healthy individuals	2
uncontrolled diabetic patients	2
individual fibrin fibers	2
single fibrin fibers	2
mesh of fibrin fibers	2
blood clot	2
ordered structures	2
naive human mesenchymal stem cells	2
oriented structures	2
nanostructures	2
acto-myosin fibers	2
Adult human mesenchymal stem cells	2
competing hypotheses using models	2
particular channels	2
friendly interface	2
website (https://chaste.cs.ox.ac.uk/WebLab)	2
A simulation tool	2
computer-readable formats	2
model and protocol	2
different species, cell types, and experimental preparations	2
cardiac cellular electrophysiology	2
microscopic mechanisms	2
mRNA molecules	2
microscopic models	2
queueing theory	2
mRNA number	2
mRNA molecule	2
reaction mixtures	2
ex situ aggregation assays	2
designed and fabricated microfluidic devices	2
large sample volumes	2
reaction mixture	2
ex situ assays	2
β-sheet-rich aggregates	2
extrinsic dyes	2
normally soluble peptides and proteins	2
nanoscale amyloid aggregates	2
Chimera plugin	2
new application	2
domain-domain interactions	2
physical binding sites	2
the proposed interactions	2
structural templates	2
structurally resolved and predicted interacting regions	2
called hybrid models	2
EM three-dimensional maps	2
atomic coordinates	2
large and flexible structures	2
new generation of Direct Electron Detectors	2
T-tubules of cardiomyocytes	2
precise quantities of compounds	2
crest	2
delivery settings	2
flat surface	2
underlying Z-groove	2
T-tubule opening	2
high ion solution	2
SICM nanopipette	2
cell internal system	2
transverse-tubule (T-tubule) openings	2
highly elaborate, unique surface topography	2
heart muscle cells	2
molecules on the surfaces of various cell types	2
specific nanoscale structures	2
disulphide bond of MtrC	2
FMN-binding proteins	2
planar headgroup of FMN	2
heme 2	2
mildly preferred interaction site	2
known FMN-binding proteins	2
outer-membrane deca-heme cytochrome MtrC from Shewanella oneidensis and flavin mononucleotide (FMN in fully oxidized quinone form)	2
outer-membrane cytochromes	2
electron shuttle	2
soluble, biogenic flavins	2
mineral	2
outer membrane of the microbe	2
Specialized multiheme cytochromes	2
terminal electron sinks	2
extracellular metal oxide minerals	2
Certain dissimilatory bacteria	2
equilibrium allosteric model	2
adenine nucleotides	2
ATP-binding cassette family of transporters	2
four modulatory sulfonylurea receptor (SUR) subunits	2
four pore-forming Kir6.2 subunits	2
ATP-sensitive potassium	2
poles	2
elongated spores	2
B. megaterium	2
Ellipsoidal shell axes	2
widefield fluorescence micrographs	2
spherical protein shell	2
spheroidal fluorescent shell image	2
concentric protein layers	2
coat	2
Bacillus subtilis spores	2
bacterial spores	2
Multilayered protein coats	2
CD86 monomers	2
two Rhodopsin-family GPCRs, β2-adrenergic receptor and mCannR2	2
Glutamate-family GPCR dimer, γ-amino butyric acid receptor b2	2
improved assay	2
test proteins	2
cell fixation	2
homodimer CD28	2
i.e., the monomer CD86	2
well-characterized control proteins	2
single-molecule imaging assay	2
test receptor	2
unfixed control proteins	2
chance colocalizations	2
even transient dimers	2
dimerize transiently	2
constitutive receptor dimers	2
invariant oligomers	2
Rhodopsin family G-protein-coupled receptors (GPCRs)	2
surrounds	2
activated cells	2
Theoretical scattering models	2
surrounding intercellular matrix	2
normal cornea	2
keratocyte cytoplasm	2
live cells in vitro	2
bovine corneal stromal cells	2
surrounding extracellular material	2
Quiescent keratocytes	2
activated corneal stromal cells	2
incident visible light	2
primary refractive lens	2
peptidyl-prolyl peptide bond configurations	2
HSQC spectra	2
NMR and DSC	2
either the S or D state of IscU.	2
Fe-S clusters	2
two interconverting conformational states	2
complex energy landscape	2
scaffold protein for iron-sulfur (Fe-S) cluster biosynthesis	2
PS and PE lipids	2
larger transmembrane pores	2
peptide on the membrane	2
PS lipids	2
POPS (PS) and DOPE (PE)	2
MP1 with model membranes	2
cells’ surface	2
excess serine (phosphatidylserine (PS))	2
bioactive host-defense peptide	2
Polybia-MP1 (MP1)	2
spectral density functions	2
graphical representation	2
partially disordered transcription factor Engrailed	2
backbone NH pairs	2
eukaryotic proteome	2
Intrinsically disordered proteins and intrinsically disordered regions (IDRs)	2
specific pair of hydrogen-bonding residues	2
closely packed bundle of mutually aligned transmembrane helices	2
two interaction partners	2
thin membranes of the Golgi compartment	2
transmembrane segment of PDGFR	2
conventional DOPC, POPC, and DMPC membranes	2
moderately thick bilayers (DErPC and DEiPC)	2
E5 helix	2
exceptionally thick DNPC lipid bilayers	2
unusually long segment	2
E5 of ∼26 amino acids	2
long transmembrane helix	2
PDGFR transmembrane segment	2
fluid lipid membranes	2
E5 protein	2
one hydrogen-bonding residue	2
E5 transmembrane segment	2
transmembrane helix-helix interactions	2
platelet-derived growth factor receptor (PDGFR)	2
short (44 amino acids long) integral membrane protein	2
bovine papillomavirus	2
oncogenic E5 protein	2
apo and ligand-bound forms of the proteins	2
labeled sites	2
published x-ray crystal structures	2
Met20 catalytic loop region	2
single-site cysteine mutant of DHFR	2
lysine residues: calmodulin (CaM), maltose-binding protein (MBP), and dihydrofolate reductase (DHFR)	2
three well-characterized proteins	2
supported lipid bilayers	2
second-harmonic generation (SHG) active dye	2
tethering proteins	2
synaptic environment	2
intact iGluRs	2
iGluR LBD	2
the fold-related metabotropic glutamate and GABAB receptors	2
NMDA-type iGluRs	2
coarse-grained simulations	2
NTD in AMPA-type iGluRs	2
LBD and NTD	2
extracellular portion	2
agonists such as L-glutamate, and the distal N-terminal domain (NTD)	2
membrane-proximal ligand-binding domain (LBD)	2
transmembrane domain (TMD)	2
intracellular C-terminal domain (CTD)	2
four domains	2
unique modular architecture	2
tetrameric cation channels	2
Ionotropic glutamate receptors (iGluRs)	2
thick filament in skeletal muscle	2
three orientation populations	2
IHM-like conformations	2
majority of the myosin heads	2
relaxed skeletal muscle	2
so-called blocked and free heads in the IHM	2
myosin RLC region	2
dextran T500	2
C-terminal lobe of the myosin regulatory light chain (RLC)	2
bifunctional rhodamine probes	2
rabbit psoas muscle	2
relaxed demembranated fibers	2
light chain domain of the myosin heads	2
in situ conformation	2
resting skeletal muscle	2
interacting heads motif (IHM)	2
filament backbone	2
two head domains of each myosin molecule	2
many types of muscle	2
full open and closed states	2
sublevels	2
remaining SR K+ channel (TRIC-B) function	2
artificial membranes	2
Tric-a knockout mice	2
SR vesicles	2
homogeneous population of SR K+ channels	2
two subtypes of SR K+ channels (TRIC-A and TRIC-B)	2
developed kinetic models	2
SR K+ channels	2
voltage-regulated channels	2
Sarcoplasmic reticulum (SR) K+ channels	2
hybrid system	2
executable model	2
hybrid model	2
Caenorhabditis elegans germline	2
hybrid executable/physical model	2
building blocks of organs	2
Executable computer models	2
temporally and spatially regulated signals	2
like domains	2
Ld phase	2
coexisting Lo and Ld phases	2
raft-mimicking lipid multibilayers	2
heterogeneous lipid membranes	2
local excitatory networks	2
appropriate software environment	2
dedicated computer cluster	2
individual receptor interactions	2
54 excitatory synapses	2
realistic three-dimensional neuropil fragment	2
detailed Monte Carlo model	2
underlying biophysics	2
excitatory neurotransmitter glutamate	2
neural circuits in the brain	2
NMDA receptors (NMDARs)	2
central nervous system (CNS) tissue	2
ventral horn	2
dorsal horn	2
sagittal sections	2
subregions of the gray matter	2
isotropic material	2
matters	2
underlying cellular structures	2
three major anatomical planes	2
acutely isolated mouse spinal cord tissue	2
Many cell types	2
froda tool	2
first software suite	2
uncomplexed cyclophilin A	2
immunosuppressant cyclosporin A.	2
complex of cyclophilin A	2
protein folding cores	2
folding core	2
majority of simulations	2
cytosolic aqueous phase	2
TRPV1 and capsaicin	2
capsaicin in the bilayer	2
TRPV1 S1–S4 transmembrane helices	2
aromatic group of capsaicin	2
S1–S4 transmembrane helices of the TRPV1 in a lipid bilayer	2
opposing leaflets of the bilayer	2
intracellular TRPV1 binding site	2
capsaicin molecule	2
Equilibrium simulations	2
target S1–S4 transmembrane helices of TRPV1	2
1-palmitoyl-2-oleoyl phosphatidylcholine bilayer	2
S1 to S4 voltage-sensor-like domain	2
active ingredient of hot chili peppers	2
heat-sensitive ion channel	2
Transient receptor potential vanilloid subtype 1 (TRPV1)	2
myotonic dystrophy patients	2
embryonic splice variant CaV1.1e	2
calcium channel blocker nifedipine	2
calcium channel agonist Bay K 8644	2
L-type calcium channels	2
exon 29 inclusion	2
II-III loop	2
Musca channel	2
corresponding but nonfunctional loop	2
cytoplasmic II-III loop	2
chimeric CaV1.1e construct	2
either CaV1.1a or CaV1.1e	2
dysgenic (CaV1.1-null) myotubes	2
L-type current modulators	2
CaV1.1e expressing muscle cells	2
embryonic CaV1.1e variant	2
adult splice variant CaV1.1a	2
extracellular loop connecting transmembrane domains IVS3 and IVS4	2
exon 29	2
adult CaV1.1a splice variant	2
embryonic skeletal muscle	2
voltage-gated calcium channel splice variant	2
tagged versions of glutathione and glutathione S-transferase	2
donor and acceptor molecules	2
image pixel	2
bound donors and acceptors	2
EGFR homodimer	2
dimerize intracellularly	2
EGFR mutation (I706Q, V948R)	2
ensemble FRET/FLIM images	2
two EGFR subpopulations (interacting versus free)	2
anti-EGFR antibody (425 Snap single-chain variable fragment)	2
EGFR-specific DEP-1 phosphatase	2
EGFR ligand-bound homodimer	2
gefitinib (active conformation binder)	2
ATP-competitive small molecule tyrosine kinase inhibitors (TKIs)	2
Förster resonance energy transfer/fluorescence lifetime imaging microscopy (FRET/FLIM)	2
ectodomain loop	2
variety of human carcinomas	2
epidermal growth factor receptor (EGFR) signaling	2
prebound Kapβ1	2
brush extension	2
Kapβ1 binding	2
Nsp1p brushes	2
Nsp1p brush	2
FG repeat binding avidity	2
Nsp1p molecular brushes	2
NTF2 and karyopherinβ1 (Kapβ1)	2
Ran importer NTF2	2
NPC transport channel	2
molecular crowding	2
selectively permeable barrier	2
nucleocytoplasmic cargoes	2
karyopherins (Kaps)	2
various nuclear transport receptors (NTRs)	2
phenylalanine-glycine (FG)-repeat motifs (FG Nups)	2
transport channel of nuclear pore complexes (NPCs)	2
two ternary mixtures (DOPC/DSPC/CHOL and DOPC/DPPC/CHOL)	2
fully hydrated multilamellar vesicles	2
membrane domains	2
complexes with cognate ligands and small-molecule inhibitors	2
protein-protein interfaces	2
bridging water molecules	2
protein cavities	2
19 protein cavities	2
individual water molecules	2
protein cavity	2
inorganic crystals	2
internal cavities of proteins	2
synchrotron source x-rays	2
first images	2
karyotype the chromosomes	2
thick filament surface	2
 the dephosphorylated RLC region of myosin heads	2
RLC region of the myosin heads	2
actin-bound myosin heads	2
so-called J-motif conformation	2
filament surface	2
pair of heads	2
rigor)	2
isolated actin filaments	2
myosin head fragments	2
corresponding RLC lobes	2
C-lobe	2
RLC crystal structures	2
lobe	2
native cRLC	2
demembranated trabeculae	2
bifunctional sulforhodamine	2
surface-accessible cysteines	2
cRLC mutants	2
bifunctional sulforhodamine probes	2
rat heart	2
ventricular trabeculae	2
N- and C-terminal lobes of the cardiac isoform of the myosin regulatory light chain (cRLC)	2
model predictions	2
subcellular contractile machinery	2
contractile agonist	2
large component of the extracellular matrix (ECM))	2
intact airway	2
biomechanical model	2
paradox	2
isolated intact airways	2
airway smooth muscle (ASM) cells and tissue strips	2
asthmatic subjects	2
nonasthmatic subjects	2
constricted airways	2
Bet v 1 allergens	2
protein interior	2
solution Bet v 1.0101	2
presence of ligand	2
various ligand molecules	2
temperate climate zone	2
major birch pollen allergen Bet v 1	2
PR-10 family	2
Pathogenesis-related plant proteins of class-10 (PR-10)	2
BioNumbers repository	2
several example biological calculations	2
calculations	2
physical sciences	2
physical systems	2
DCM-causing mutation ACTC E361G	2
cardiac muscle myofibrils	2
nontransgenic myofibrils	2
ACTC E361G	2
Native myofibrils	2
troponin I and myosin binding protein C (MyBP-C) phosphorylation	2
single transgenic mouse heart myofibrils	2
intact contractile system	2
troponin C	2
troponin I	2
helical hairpin	2
α-helical hairpin	2
Josephin domain of ataxin-3	2
voltage-sensitive ion channels	2
mobile charge carrier	2
arginine guanidine cation	2
arginine side chains	2
two voltage sensor domains	2
hydrated POPC bilayer	2
molecular-dynamics simulation	2
hERG K+ channel model	2
phycoviolobilin	2
full-length form of Tlr0924	2
phycoviolobilin chromophore	2
blue-absorbing and green-absorbing, and blue-absorbing and red-absorbing	2
phycocyanobilin and phycoviolobilin chromophores	2
cyanobacteriochrome	2
photoconversions	2
bulk protein structure	2
bilin chromophore	2
photoreceptors	2
phytochrome superfamily of photoreceptors	2
actin filaments in NIH3T3 cells	2
cell’s cytoskeleton	2
atomic force microscopy nanoindentation	2
potentiometric dyes	2
infrared voltage-sensitive dye	2
living explants of rat brain	2
electrical activity	2
cultured rat neurons and cardiomyocytes	2
artificial neurons	2
intravenously administered contrast agent	2
infrared fluorescent dye	2
indocyanine green (ICG)	2
voltage-sensitive dye	2
hexameric ring	2
realistically simulated	2
sequence fragments	2
virus capsid	2
translocates RNA	2
hexameric viral helicase P4	2
large macromolecular assemblies	2
novel probes	2
biosensor architectures	2
single-chain intermolecular biosensor	2
oligomeric biosensors	2
biosensor oligomers	2
common biosensor architectures (single-chain FRET-based biosensors)	2
mechanistic mathematical models	2
signaling protein	2
specific signaling proteins	2
cellular signaling networks	2
parasite and host cell contributions	2
merozoite actomyosin motor	2
parasite-derived membrane	2
theoretical modeling	2
archetypal merozoite	2
parasite actomyosin motor contribution	2
human erythrocyte	2
blood stage malaria parasite	2
protein-ligand and protein-protein interactions	2
many TM protein families	2
G-protein coupled receptor family	2
, rhodopsin and the β1- and β2-adrenergic receptors	2
1), LeuT, a bacterial homolog of mammalian neurotransmitter sodium symporters	2
prototypical members of multihelical TM protein families	2
surrounding membrane	2
TM proteins	2
protein-membrane interface	2
adjacent polar and hydrophobic residues	2
multihelical TM proteins	2
corresponding computational models and tools	2
wide variety of transmembrane (TM) proteins	2
newly crystallized GPCRs	2
x-ray structures	2
predicted models	2
available x-ray structures	2
populated conformers	2
low-energy conformers	2
x-ray conformation	2
transmembrane domain	2
ECL2s	2
13 GPCRs	2
functionally important region of GPCRs	2
second extracellular loop (ECL2)	2
torque	2
basic rotor-stator interactions	2
residue-specific interactions	2
protrusionless construct	2
previous truncation mutants	2
every residue of the rotor	2
remaining axle residues	2
protruding portion of the rotor	2
rest of the rotor	2
submicron sized bead duplex	2
significant portions of the axle	2
thermophilic F1	2
globular protrusion	2
coiled coil of the amino- and carboxyl-terminal α-helices of γ	2
axle	2
alternately arranged α3β3 subunits	2
central rotor subunit γ	2
α3β3γ subunits	2
motor itself	2
powerful rotary molecular motor	2
complex landscapes	2
microbial colonies	2
shape of colonies	2
colony	2
cells in liquid culture	2
cylindrical colonies	2
growing colony	2
simple, versatile culture system	2
multicellular assemblies	2
experimental tools	2
planktonic cultures	2
freely growing colony	2
biofilms and colonies	2
complex multicellular assemblies	2
αMβ2 integrin activation	2
platelet activating factor (PAF)	2
human neutrophil preexposure	2
chemoattractant formyl-methionyl-leucyl-phenylalanine	2
microvasculature	2
fluid shear stress sensors	2
G-protein coupled receptors on neutrophils	2
concept of ceRNAs	2
various posttranscriptional cellular networks	2
miRNA-mRNA regulatory network	2
ceRNAs	2
involved miRNAs and targets	2
mathematical modeling and simulations	2
many nodes	2
dense, intertwined network	2
network of miRNA-target interactions	2
cellular networks	2
path of coregulated targets	2
posttranscriptional regulatory network	2
common targets	2
share targets	2
miRNA regulator	2
one target	2
microRNA (miRNA) coregulators	2
Competing endogenous RNAs (ceRNAs)	2
unbiased molecular dynamics simulations	2
GluCl crystal structure	2
intersubunit cavities of the GABAAR transmembrane domain	2
α and γ subunits	2
M1 and M3 transmembrane helices	2
previously unreported disulfide bridges	2
glutamate-gated chloride channel GluCl	2
human GABAAR	2
transmembrane domains of the GABAAR	2
subunit interfaces	2
structurally related modulators	2
cholesterol and other steroids	2
hypergutter framework	2
intermediate states	2
subspaces	2
native and nonnative contacts	2
intermediate subspaces	2
family of three-helix bundle proteins	2
coarse-grained model	2
search-space	2
narrow energetic alley	2
flat subspaces	2
low-dimensional representations	2
high-dimensional conformation space of a protein	2
polymeric molecules	2
cochlear and neural tuning	2
Tectb–/– TMs	2
TectaY1870C/+ TMs	2
nanoscale pores	2
basal cochlear turn	2
wild-type TMs	2
TectaY1870C/+ mice	2
Tectb–/– mice	2
tectorial membrane (TM)	2
cell-tissue interfaces	2
carbonated apatite mineral	2
hydrogen phosphate containing mineral phases	2
zebrafish fin bone	2
calcium fluorescent marker	2
newly formed bones	2
zebrafish (Danio rerio) larvae	2
confocal Raman microscope	2
cells and extracellular matrix	2
living tissues	2
Confocal Raman microspectroscopy and fluorescence imaging	2
background fluorescence	2
confocal fluorescence images	2
x-y image stacks	2
two-dimensional x-y image stacks	2
single row of pixels	2
line-scan images	2
polymer-coated nanopores	2
globular macromolecules (colloidal particles)	2
unstructured proteins	2
cross-linked network	2
transport barrier	2
polymer surface	2
transport receptors	2
channel wall	2
brushlike polymer arrangements	2
central polymer condensate (selective phase	2
NTRs	2
inter- and intramolecular interactions	2
nanopore confinement of the NPC central conduit	2
polymeric structure	2
unstructured proteins (polymers)	2
Nuclear transport receptors (NTRs)	2
new amyloid fibrils	2
β2-microglobulin in vitro	2
generic mathematical framework	2
heterogeneous supramolecular systems	2
key biomedical applications	2
several important classes of high-throughput NLO microscope designs	2
NLO microscopy throughput	2
basic implementations	2
different nonlinear optical (NLO) contrast mechanisms	2
weak interactions	2
stable and compact pore-filling meshwork	2
polymer theory	2
model films	2
bottom-up nanoscale model system	2
monolayers of end-grafted FG domains	2
nuclear pore	2
phenylalanine-glycine dipeptides (FG domains)	2
supramolecular assembly of intrinsically unfolded nucleoporin domains	2
selective permeability barrier	2
Nuclear pore complexes	2
digital camera	2
differential interference contrast	2
giant vesicle	2
lamellarity	2
statistically significant number of vesicles	2
lamellarity of giant vesicles	2
vesicle ensemble	2
free-standing bilayers	2
widely utilized model membrane system	2
Giant unilamellar vesicles	2
final stable adhesions	2
early transient integrin-dependent adhesions	2
kindlin-3-mediated high-affinity LFA-1	2
LFA-1-mediated attaching	2
leukocyte adhesion deficiency-III patients	2
one or more active conformations of the integrin LFA-1	2
firmly attached	2
rolling cells	2
cells in phase contrast images	2
bacterial adhesion	2
capture of nanoparticles	2
Shear flow assays	2
dodecyl maltoside	2
alkyl sugar detergents	2
nonionic alkyl sugar detergent	2
α-helical membrane protein	2
Zwitterionic detergents	2
protein-detergent complex	2
β-barrel membrane protein	2
detergent packing	2
two different detergent types (phosphocholines versus an alkyl sugar)	2
α-helical bundle versus a β-barrel)	2
membrane protein architectures	2
membrane-protein-detergent complexes	2
vacuum	2
amyloid aggregates	2
amyloid species	2
compounds tested	2
epigallocatechin gallate	2
confocal and cryo-electron microscopies	2
labeled lipid	2
β2m fibrils	2
polyphenols (epigallocatechin gallate, bromophenol blue, and resveratrol) and glycosaminoglycans (heparin and heparin disaccharide)	2
β2-microglobulin (β2m) fibrils	2
type II diabetes	2
intermediate resolution projection map	2
large and well-organized 2D crystals	2
prokaryotic inwardly rectifying potassium channel	2
good 2D crystals	2
native one	2
3D crystallography	2
2D crystallography	2
adjacent bilayer leaflet	2
nanoclustering of PIP2 molecules	2
membrane-bound auxilin-1 PTEN-like domain	2
C2 subdomain of the PTEN-like domain	2
three basic residues (R301E/R307E/K311E)	2
auxilin to lipid bilayers	2
Negatively charged lipids (especially PIP2)	2
phosphatidyl inositol phosphates	2
auxilin-1 PTEN-like domain	2
N-terminal PTEN-like domain	2
neuron-specific membrane-binding protein	2
larger organellar repertoires	2
new organelles	2
budding and fusion machinery	2
traffic system	2
compositionally distinct subsets	2
specific destination compartments	2
source compartments	2
coat proteins and adaptors	2
new nonendosymbiotic organelles	2
prokaryotic host cell	2
mitochondrial endosymbiont	2
endomembrane system	2
diverse membrane-bound organelles	2
dynamic traffic network	2
Extant eukaryotic cells	2
solution FGF1	2
4.2 saccharide units	2
longer heparin chains FGF1	2
dimerizing FGF1	2
Heparin octasaccharide	2
monodimensional lattice	2
sulfated domains of heparan sulfate	2
chemical analogs	2
Heparin fragments	2
FGF signaling complex	2
FGF-receptors	2
coreceptor	2
cell surface heparan sulfate	2
Fibroblast growth factors (FGFs)	2
variety of ions	2
polypeptide molecules	2
cations and anions	2
central excitatory synapses	2
PURE-LET	2
fluorescent Ca2+ transients	2
binomial filter	2
exponential rise and decay model	2
single Ca2+ transients	2
Ca2+ fluorescence transients	2
Ca2+-sensitive dyes	2
tissue slices	2
Postsynaptic Ca2+ transients	2
mutant PTEN	2
triple mutant R161E/K163E/K164E	2
membrane-binding surface	2
truncated PTEN structure	2
phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2)	2
tumor-suppressor protein	2
Phosphatase and tensin-homolog deleted on chromosome 10 (PTEN)	2
fraction of RNA	2
passive conformational selection model	2
extended intermediate	2
bound RNA	2
Cy3-Cy5-labeled RNA	2
immobilized L7Ae protein	2
L7Ae family	2
commonly occurring structural motif	2
Cys-loop receptors	2
RDL receptor	2
range of residues	2
R111 and E204	2
E204, S205, R111, S176, T251, and ionic interactions	2
, H-bonds	2
F206 and Y254	2
binding site residues	2
aromatic residues F206, Y254, and Y109 and hydrophilic residues E204, S176, R111, R166, S176, and T251	2
extracellular domain of RDL	2
GABA binding site in RDL receptors	2
insect CNS	2
GABA-activated inhibitory Cys-loop receptors	2
RDL receptors	2
spectrin tetramerization domain	2
fully structured, three-helix bundle	2
two partially structured, incomplete domains	2
α- and β-spectrin	2
One such system	2
completely structured domains	2
appropriate partner protein	2
IDPs	2
Many intrinsically disordered proteins (IDPs)	2
cardiac wild-type TnC	2
wild-type apo TnC	2
V44Q Ca2+	2
wild-type Ca2+	2
TnC hydrophobic patch	2
microsecond-timescale Anton molecular dynamics simulations	2
helix of another subunit, troponin I (TnI)	2
hydrophobic patch on TnC’s surface	2
troponin C (TnC)	2
thin-filament complex of cardiomyocytes	2
important regulatory protein	2
Troponin (Tn)	2
three-dimensional microenvironment	2
cells in stiffer gels	2
actin organization	2
softer gels	2
cells in the stiffer gels	2
cells in 1% and 3% agarose	2
isolated chondrocytes in suspension	2
linear elastic and hyperelastic finite-element models	2
three-dimensional hydrogels	2
isolated chondrocytes	2
C-terminal zippering	2
charged syb2 C-terminus	2
intravesicular end of the TM domain	2
vesicle's inner-leaflet lipid headgroups	2
synaptobrevin C-terminus	2
extravesicular end of the TM helix	2
extravesicular side of the membrane	2
syb2 membrane anchor	2
syb2 TM domain	2
coarse-grain molecular-dynamics simulations	2
single C-terminal transmembrane (TM) helix	2
neuronal vesicular SNARE protein synaptobrevin 2 (syb2)	2
neurosecretory vesicles	2
significant diffusion obstacles	2
intracellular structures	2
model solutions	2
cell in the microscope chamber	2
ADP in fluorometer chamber	2
fluorometer	2
fluorometer on cardiomyocyte suspensions	2
flow chamber	2
NADH and flavoprotein autofluorescence	2
permeabilized rat cardiomyocytes	2
cells in fiber preparations	2
permeabilized fibers or cardiomyocytes	2
ADP and other molecules	2
novel nanomedical therapeutic agent	2
CSCs (particularly EpCAM(+) cells)	2
HL/NBDPC	2
fluorescently labeled lipid (NBDPC)	2
cell membranes of CSCs	2
CSC sub-population of liver cancer cells	2
CD133(+)/EpCAM(+)	2
a"ctivating caspase-3	2
liver cancer cell growth	2
soft agar colony formation assay	2
cell surface marker proteins CD133 and EpCAM	2
trypan blue exclusion assay	2
dodecyl ether	2
10 mol% polyoxyethylene(23)	2
90 mol% L-α-dimyristoylphosphatidylcholine	2
CSC subpopulations in liver cancer cells (HepG2)	2
mixture of vesicular and micellar molecules in buffer solutions	2
nano-sized liposomal particles	2
Hybrid liposomes (HLs)	2
cytochrome C, caspase-3, caspase-9, and PARP	2
spliced form XBP-1	2
virus-infected host cells	2
Influenza-infected BST2-deficient cells	2
glycophosphatidylinositol (GPI)	2
N-terminal	2
enveloped virus at the plasma membrane	2
antiviral factor	2
differentially expressed lncRNAs	2
ceRNA-related differentially expressed mRNAs	2
three RNA-related CRC patients	2
adjacent non-tumorous tissues	2
colorectal cancer tissues	2
2083 mRNAs	2
TCGA (The Cancer Genome Atlas) database	2
obesity-inducible E3 ubiquitin ligase	2
WWP1 OE	2
WWP1 OE and KD cells	2
several antioxidative proteins	2
WWP1 expression	2
WWP1 overexpression (OE) and knockdown (KD) 3T3-L1 cells	2
obese WAT	2
HECT-type ubiquitin E3 ligase	2
WW domain containing E3 ubiquitin protein ligase 1 (WWP1)	2
main tissue	2
White adipose tissue (WAT)	2
mice fed a HFD	2
HFD-fed WT mice	2
HFD-fed KO mice	2
HFD-induced hypothalamic neurogranin	2
ventromedial hypothalamus (VMH)-specific neurogranin expression	2
arcuate nucleus	2
anorexigenic proopiomelanocortin	2
Myeloid SIRT1	2
hypothalamic neurogranin	2
Neurogranin, a calmodulin-binding protein	2
Hypothalamic inflammation	2
TRMT2A-deficient cells	2
TRMT2A-overexpressing cells	2
nucleus in HeLa cells	2
conserved uracil-C5-methyltransferase domain of the TrmA family	2
RNA recognition motif	2
TRMT2A) protein	2
mammalian tRNA methyltransferase 2 homolog A (	2
U54 methylation responsible enzyme	2
uracil at position 54 (m5U54) on tRNA	2
Trm2p protein in Saccharomyces cerevisiae	2
TrmA protein	2
5-Methyluridine (m5U)	2
transfer RNA (tRNA)	2
IGF-1-dependent and -independent manner	2
BMP-2 signal pathway	2
Smad Binding Element (SBE) reporter	2
bone morphogenetic protein-2 (BMP-2)	2
stabilizer and transporter of IGF-1	2
circulating system	2
ternary complex with IGF-1	2
IGF-binding proteins (IGFBPs)	2
one of the most abundant growth factors	2
Insulin-like growth factor-1 (IGF-1)	2
dental implantation	2
individual Gα molecules	2
GPCR-Gα	2
agonist-bound receptor	2
unconventional complex	2
activated Gα subunit	2
destination	2
cognate G proteins	2
Eukaryotic chemotactic cells	2
various sensory cells	2
HYD	2
combination of MNA and HYD	2
MNA alone	2
NAFL model rats	2
potent aldehyde oxidase inhibitor	2
hydralazine (HYD)	2
aldehyde oxidase	2
sirtuin 1 protein	2
N1-methylnicotinamide (MNA)	2
diagnostic ovarian cancer biomarker	2
Neu5Gc-glycans	2
patients with ovarian cancer	2
established ovarian cancer biomarker, CA125	2
surface plasmon resonance (SPR)	2
sera from patients with ovarian cancer	2
Neu5Gc-containing glycans	2
lectin, SubB2M	2
Neu5Gc containing glycans	2
Shiga toxigenic Escherichia coli	2
B subunit of the subtilase cytotoxin (SubB)	2
human tumor cells	2
N-glycolylneuraminic acid (Neu5Gc)-containing glycans	2
biological material	2
routine pipetting robot	2
mammalian Toll-like receptor	2
multi-ligand receptor	2
novel ligand	2
larva-derived extract	2
spz5 null mutant	2
Furin protease	2
member of the Spz family of proteins	2
spz mutants	2
larval extract	2
Drosophila larva-derived tissue extract	2
Spätzle (Spz)	2
invaded 5.0	2
U251MG cells	2
individual U251MG cells	2
lama5 expression	2
known attachment site	2
blood vessel dependent microtumors	2
U251MG dispersal	2
lama5 morpholino	2
endothelial cells in the brain	2
GBM cells	2
known adhesion site	2
extracellular matrix protein, laminin alpha 5 (lama5)	2
dynamic and complex environment	2
zebrafish brain	2
observable brain environment	2
embryo-larval zebrafish xenograft model	2
Glioblastoma (GBM)	2
similar gradient	2
potentially harmful bile acids	2
estrone-sulphate	2
estrone sulphate and taurocholate trans-stimulated glutamate efflux	2
term placental villous fragments	2
thyroid hormones T3 and T4 and the bile acid taurocholate	2
estrone sulphate	2
oocytes expressing OAT1, OAT3, OAT7 or OATP2A1	2
term human placental villous fragments	2
OAT and OATP transporter proteins	2
maternal facing microvillus membrane	2
metabolites, hormones and waste products	2
transport proteins	2
Organic anion transporters (OATs) and organic anion transporting polypeptides (OATPs)	2
Yes-associated protein (YAP) transcriptional coactivator	2
Olfml1 in osteoblasts	2
developing skeletal tissues	2
olfactomedin-like 1 (OLFML1) gene	2
spine	2
Congenital scoliosis	2
various biomedical sectors	2
nano-carriers and nano-drugs	2
missing functionalities	2
redox regulated species	2
redox signaling pathways	2
limited fabrication, functionalization, and in vivo functionalities	2
peptides/antibodies/proteins and biocompatibility)	2
modified nanostructures	2
cancer, neurological disorders and wound infections	2
biocompatible nanomaterials	2
onco-factor	2
/Smad signaling	2
downstream FoxG1-induced	2
downstream targets of FoxG1	2
FoxG1 protein	2
qRT-PCR assays	2
GBM cell models	2
Crystal violet staining and MTT assay	2
cancer-related biomarkers	2
glioblastoma multiforme (GBM) models	2
LACR technology	2
undifferentiated iPS cells	2
human iPS and TS cell co-cultures	2
trophoblast stem (TS) cells	2
A-LACR	2
computational image recognition/identification-discriminating technology	2
laser-assisted cell removing (LACR) technology	2
anti-differentiation inhibitors	2
selective medium	2
fine glass capillary or plastic tip	2
pluripotent stem cell culture	2
differentiated parts	2
undifferentiated cells	2
ag-miR-539 or in-miR-539	2
HCC cell	2
target of miR-539	2
Mitogen-activated protein kinase 1	2
potential target of miR-539	2
luciferase reporter assays	2
mircoRNAs (miRNAs)	2
less developed regions	2
Liver cancer	2
high resolution respirometry	2
physiological activator, thrombin	2
cyclooxygenase-dependent thromboxane A2 synthesis	2
haemostatic plug	2
bioactive phospholipids	2
small ions	2
tracer molecules	2
outside the membrane	2
occluding molecules	2
first and second pulses	2
extended model	2
second pulse	2
Extraordinarily large but short electric field pulses	2
PB1 and UBA domains	2
Lys-48-linked chains	2
GST–tagged full-length p62	2
p62 and ubiquitin	2
PB1 mutant or UBA-deleted p62 construct	2
RAW 264.7 macrophages	2
polyubiquitin chains or ubiquitinated proteins	2
UBA domain	2
PB1 domain	2
cytoplasmic aggregates	2
sequestosome 1	2
two major binding domains of p62	2
two domains of p62—PB1 and UBA	2
protein p62	2
ubiquitin-tagged defective ribosomal products	2
storage compartments	2
large, transient, cytosolic aggregates	2
FoxM1/Prx III axis	2
role Spalt like protein 4 (SALL4)	2
self-antioxidant capacity	2
endothelial mesenchymal transition (EMT) genes	2
SALL4 expression	2
pancreatic intra-epithelial neoplasms (PanINs)	2
PDGF family member	2
solid tumor types	2
7616 samples	2
Human Protein Atlas	2
cognate tyrosine kinase receptors PDGFRA and PDGFRB	2
platelet-derived growth factor (PDGF) family members PDGFA, PDGFB, PDGFC and PDGFD	2
Paracrine signaling	2
supportive and suppressive tumor microenvironment	2
ATG5 protein	2
ATG5 and autophagosome formation	2
proteasome inhibitor	2
small molecule chemical chaperone	2
4-phenyl butyric acid	2
autophagy-related genes-5 (ATG5)	2
free fatty acid palmitate	2
different players	2
two donors in the WBCA	2
cytokine-producing cells	2
widely used control agent, TGN1412 or its analog CD28SA	2
peripheral blood mononuclear cells with solid-phase articles (PBMC assay)	2
whole blood cytokine assay, WBCA)	2
whole blood with aqueous-phase test articles	2
two major testing platforms	2
N-glycosylation of proteins	2
metformin (Met)	2
2DG-treated cells	2
glucose response protein 78 (GRP78) and C/EBP-homologous protein (CHOP)	2
GFAT1 by AMP-activated protein kinase (AMPK)	2
uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)	2
glutamine: fructose 6-phosphate aminotransferase 1 (GFAT1)	2
pancreatic cancer cell line	2
wide range of cancer cell lines	2
glycolytic inhibitor 2-deoxy-d-glucose (2DG)	2
effective drug combinations	2
monitoring system	2
proteasome, autophagy, and aggresome formation	2
various drug combinations	2
ER stress indicator	2
IncuCyte cell imaging system	2
strong XBP1 splicing signal	2
ERAI-Venus vector	2
MDA-MB231 cells	2
quantitative assay	2
network system	2
coordinated intracellular network	2
microtubule organization center	2
clearance systems	2
docking proteins p62 and NBR1	2
Misfolded proteins	2
endoplasmic reticulum (ER) lumen	2
DDR2 mutants	2
key DDR2 signalling effector SHC1	2
early endosomes or lysosomes	2
cellular phosphorylated proteins	2
DDR2 and tyrosine phosphorylated proteins	2
collagen-binding receptor tyrosine kinase	2
Discoidin Domain Receptor 2 (DDR2)	2
NSC-derived neurons	2
subset of neuronal	2
transcription factor MEF2A	2
neuronal and/or glial lineages	2
Neural stem cells (NSCs)	2
tendon and homeostatic genes	2
complex strain environment	2
stiff RGD fibers	2
soft DGEA fibers	2
tendon (SCX and TNMD), collagens (COL1A1, COL3A1, COL11A1), and matrix remodelling (MMP1, MMP2, and TIMP3)	2
Ten genes	2
cell adhesion peptide (DGEA or YRGDS)	2
tenocytes seeded onto discontinuous fibers	2
fiber composite	2
TLR7/8 pathway	2
siRNA-mediated knockdown	2
TNF messenger RNA	2
p38 MAP Kinase	2
Bruton's tyrosine kinase (Btk)	2
exogenous pathogen-associated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs)	2
Tumour necrosis factor (TNF)	2
spines in the thalamus	2
GABAergic signalling genes	2
early developing period	2
ventral posterolateral and posteromedial regions	2
numbers of spines	2
neurites and neurons	2
vesicular GABA transporter	2
related genes	2
glutamate decarboxylase and GABA receptors	2
two terms	2
soft or chow diet	2
juvenile neural circuits in rats	2
K5/K14-IF network	2
dividing K5-positive cells of murine individuals	2
site- and phosphorylation-state-specific antibodies	2
major phosphorylation sites	2
murine K5	2
three mitotic kinases phosphorylate K5	2
basal layer cells of stratified squamous epithelia	2
Keratin 5 (K5) and K14	2
IFs	2
vimentin, GFAP, and desmin (type III intermediate filament [IF] proteins)	2
oxysterol biochemistry	2
global lipidomics approaches	2
many oxysterols	2
metabolic intermediates	2
1,25-dihydroxyvitamin D3	2
bile acids, steroid hormones	2
precursors post lanosterol	2
oxidised derivatives of cholesterol	2
expensive dyes	2
biosensor	2
native substrate, single-stranded DNA (ssDNA)	2
single stranded binding (SSB) protein	2
fluorescent biosensor	2
sensitive spectrophotometers	2
RNA polymerases (RNAP)	2
BRD4,TLR2, and TLR4 expressions	2
MCP-1, TGF-β, and TNF-α	2
proinflammatory cytokines, IL-1β,	2
TLR2, TLR4, MyD88, bromodomain-containing protein 4 (BRD4), phospho-p65	2
miR-29a overexpression	2
miR-29aTg mice	2
hepatic high mobility group box-1 expression	2
BDL	2
miR-29a mimic and inhibitor	2
Primary HSCs	2
miR-29a transgenic mice (miR-29aTg) and wild-type mice	2
hepatic stellate cells	2
bacterial lipoprotein and lipopolysaccharide	2
Toll-like receptor 2 (TLR2) and TLR4	2
microRNA-29a (miR-29a)	2
cellular and tissue-based products	2
dynamic actin–myosin XI system	2
myosin XI	2
actin-based motor protein	2
one of the three major cytoskeletal components	2
K48-linked Ub chains	2
active site of Pex4p	2
yeast Hansenula polymorpha	2
Pex4p alone	2
lysine 48 linked ubiquitin chains in vitro	2
peroxisomal membrane protein Pex22p	2
peroxisomal E2	2
myosin isoform	2
different tracks	2
different actin isoforms	2
plant myosins	2
different Arabidopsis actin isoforms	2
Arabidopsis myosins	2
muscle actin	2
three Arabidopsis actin isoforms (ACT1, ACT2, and ACT7)	2
two Arabidopsis myosin XI isoforms (MYA2, XI-B), and one Arabidopsis myosin VIII isoform (ATM1)	2
animal skeletal muscle α-actin	2
myosin VIII	2
two classes of myosin	2
junctional components ZO-1 and E-cadherin	2
dipeptidylpeptidase IV, villin, CDX2, HNF-1α, HNF-4α and transepithelial resistance	2
apical pole of the cells	2
differentiation marker sucrase-isomaltase	2
laminin α5 chain	2
well-characterized model	2
enterocytic-like Caco-2/15 cell line	2
adult intestine	2
epithelial basal lamina	2
three main types of laminins	2
α5-containing laminins (LAMA5)	2
variety of specific cell receptors	2
gut defense system of Drosophila	2
ingested microbes	2
roles of ROS	2
Gram-positive bacteria S. aureus	2
Gram-positive bacteria in the fly gut	2
ROS-resistant pathogens	2
antimicrobial peptides (AMPs)	2
infected microbes	2
Duox system	2
chitin and glycoproteins	2
Drosophila gut	2
orally transmitted pathogenic Gram-negative bacteria	2
suitable model animal	2
fruit fly of the genus	2
essential cytoskeletal protein	2
whole molecule	2
conserved cytoskeletal protein	2
discrete regions	2
amino-termini	2
discrete unfolding domains	2
cdc8.110 or cdc8.27 mutant alleles	2
fission yeast Tpm mutants	2
Temperature sensitive mutants	2
highly-conserved alpha-helical dimer	2
tropomyosin (Tpm)	2
One such actin-binding protein	2
actin polymer	2
regulatory actin-binding proteins	2
established muscle cell line	2
proteasome inhibitor MG-132	2
cells pre-incubated	2
MPB (e.g. serum starvation, Dexamethasone (Dex), tumour necrosis factor alpha (TNF-α) and MG-132))	2
protein synthesis inhibitor cycloheximide (CHX)	2
C2C12 myotubes	2
puromycin (1 μM)	2
translated polypeptide chains	2
MPB in cells	2
major proteolytic pathways	2
adenylate cyclase inhibitor	2
GPCR families	2
odorant receptors (ORs)	2
β2-adrenoceptor (β2AR)	2
single compartment	2
two GPCRs	2
exogenous HEK293 expression system	2
various subcellular compartments of neurons	2
various Gαs-protein-coupled receptors (GPCRs)	2
HCN channel family	2
hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) channel	2
mating genes PRM1 and PRM4	2
PRM1 transcription	2
three Ste12-binding sites	2
Ste12-binding sites	2
mating pheromone	2
either gene	2
ECM22 and UPC2	2
related transcription factors Ecm22	2
Budding yeast mating	2
paramylon groups	2
IL-1β, IL-6, IL-12 (p70), IFN-γ, and IL-10	2
Z and paramylon-treated groups	2
Euglena gracilis	2
Euglena gracilis Z and paramylon-treated groups	2
A/PR/8/34 (H1N1)	2
2% dietary mixture	2
β-1, 3-glucan structure	2
carbohydrate storage substance of Euglena gracilis Z	2
food or nutritional supplement	2
micro-algae	2
ADAMs	2
monocyte-endothelial adhesion	2
soluble ADAM9 ectodomain	2
soluble form physiologically	2
ADAM9 ectodomains	2
two adjacent cells	2
Co-cultures of cells	2
confluent endothelial monolayers	2
VE-Cadherin	2
Metalloproteinase-9 (ADAM9)	2
Disintegrin	2
SAMP1 mice	2
hypothetical heritable cytoplasmic elements	2
cytozoic bacteria	2
integrated SAMP1 mtDNA fragments	2
mtDNA-less P29 cells	2
integrated SAMP1 mtDNA fragment	2
nuclear DNA of P29mtSAMP1 cybrids	2
SAMP1 mtDNA fragments	2
B6 mtDNA	2
syngeneic B6 mice	2
genomes (nuclear DNA and mtDNA)	2
allogeneic SAMP1 mtDNA	2
tumors in syngeneic B6 mice	2
allogeneic strain SAMP1	2
C57BL6 (referred to as B6) mouse strain-derived P29 tumor cells	2
transmitochondrial P29mtSAMP1 cybrids	2
thick and long mucus bundles	2
rich in submucosal glands	2
respiratory tree of pigs and humans	2
goblet cell MUC5AC mucin	2
bundles	2
surface goblet cells	2
MUC5AC mucin	2
core made of MUC5B mucin	2
submucosal gland openings	2
long linear mucus bundles	2
tracheal explants of newborn piglets	2
Alcian blue	2
mucociliary clearance system	2
receiver, switch, and relay	2
fast-folding proteins	2
isobaric–isothermal molecular dynamics simulations	2
fast-folding proteins CLN025 and Trp-cage	2
microcanonical molecular dynamics simulations	2
native liquid state	2
various biological particles and micelles	2
casein micelles and milk-fat globules	2
whole-milk specimens	2
nanostructures of aqueous micelles	2
scanning electron microscopy	2
traditional optical	2
drug nanocarriers	2
milk-casein micelles	2
new type medicines	2
drug-delivery systems	2
aqueous nanoparticles	2
persisting LSC	2
leukotriene antagonists	2
targeting ALOX5 or CYSLT1 signaling	2
CFU-C and LTC-IC growth	2
inhibitor of CYSLT1	2
cysteinyl leukotriene receptors CYSLT1 and CYSLT2	2
single leukemic BCR-ABL+CD34+CD38− cells	2
BM CD34+CD38− cells	2
long-term culture-initiating cell (LTC-IC) and colony (CFU-C) assays	2
(BM) BCR-ABL+CD34+CD38− cells	2
primary human CML LSC	2
5-LO inhibitor zileuton	2
expression ALOX5, encoding 5-lipoxygenase (5-LO)	2
experimental mouse CML model system	2
leukemic stem cells (LSC)	2
chronic myeloid leukemia (CML)	2
BCR-ABL oncoprotein	2
Tyrosine kinase inhibitors	2
inactive eeAChE	2
plastic containers	2
Electrophorus electricus acetylcholinesterase (eeAChE)	2
glass container surface	2
common inhibitor	2
common enzyme	2
different inhibitors	2
NOTCH1 signaling	2
degenerated IVDs	2
tissue inhibitor of metalloproteinase-1 (TIMP1)	2
matrix metalloproteinases MMP1 and MMP13	2
HIF-1α-NOTCH1 pathway	2
collagen Π	2
NOTCH1 inhibitor DAPT	2
target gene hairy and enhancer of split-1 (HES1)	2
NOTCH1 ligand JAGGED1	2
NPs of NP-specific HIF-1α−/− mice	2
degenerated human intervertebral discs (IVDs)	2
NOTCH1 expression	2
extracellular matrix (ECM) of nucleus pulposus cells (NPCs)	2
hypoxia-inducible factor-lα (HIF-lα)	2
associated regulators	2
mitochondrial calcium uniporter (MCU)	2
dynamic organelles	2
PSC differentiation	2
Functional islet-like endocrine cell aggregates	2
closed-channel	2
Uniformly-sized spheroidal hPSCs aggregates	2
corresponding control system	2
closed-channel culture device	2
functional somatic cells	2
various regulatory factors	2
eukaryotic/archaeal RNA polymerase structures	2
different crystal forms	2
stalk and the clamp	2
known S. cerevisiae Pol II structures	2
central cleft	2
stalk and clamp modules	2
methylotropic yeast Komagataella pastoris (Pichia pastoris)	2
12-subunit protein complex	2
antidiabetic drugs	2
iGL cell line	2
living 3D-cultured cells	2
luminometer	2
iGL cells	2
secreted Insulin-GLase	2
2D- and 3D-cultured iGL cells	2
antidiabetic drug	2
cluster of iGL cells	2
named iGL	2
subclonal rat INS-1E cell line stably expressing Insulin-GLase	2
fusion protein of insulin and Gaussia luciferase (Insulin-GLase)	2
3D-cultured cells	2
spheroid of rat pancreatic beta cell line	2
isolated rat pancreatic islet	2
specific subsets of transcription factors (TFs)	2
TRIF-dependent signaling pathway	2
destabilizing actin cytoskeleton	2
hypoxia inducible factors (HIFs)	2
interferon regulatory factors (IRFs) and signal transducers and activators of transcription (STATs) related signaling	2
LPS-induced mouse macrophages	2
pineal gland	2
initial colonizer	2
NF-κB signaling pathways	2
SpxB-KO	2
TNF-α, IL-6 and Egr-1	2
S. oralis WT and SpxB-KO strains	2
S. oralis wild type (WT) and streptococcal pyruvate oxidase knockout (SpxB-KO)	2
oral streptococci	2
oral streptococcus including Streptococcus oralis (S. oralis)	2
oral mucosal surface	2
various species of these oral streptococci	2
commensal residents	2
mitis group streptococci	2
Fas-Fas Ligand pathway	2
intestinal cell	2
OPN in T cells	2
splenic and colonic CD8 T cells expressing Fas Ligand	2
colon and small intestine	2
Tumor necrosis factor-α, Interleukin-17A, and Interleukin-18 gene expression	2
Interferon-γ	2
small intestinal-GVHD	2
B6 and control groups	2
colons and small intestines	2
Bone marrow cells and spleen cells	2
control group (BDF1→BDF1), B6 group (B6→BDF1), and OPN-KO group (OPN-KO→BDF1)	2
allograft recipients	2
(C57BL/6 × DBA/2) F1 (BDF1) mice	2
acute GI-GVHD.MethodsOPN knockout (KO) mice and C57BL/6 (B6) mice	2
efficacious drug	2
ibuprofen sodium	2
range of simple in vitro assays	2
parent molecule	2
arginine source	2
ibuprofen salt, ibuprofen arginate (Spididol®)	2
cardiotoxic hormone	2
endogenous NO synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA)	2
NSAIDs	2
members of the class including ibuprofen	2
cyclooxygenase (COX)-2	2
Nonsteroidal anti-inflammatory drugs (NSAIDs)	2
informative readouts	2
primary mouse- and human pluripotent (embryonic) stem cell-derived cardiomyocytes	2
computational simulation	2
throughput noninvasive assay platform	2
newly developed drugs	2
human (induced) pluripotent stem cells	2
electrically active cells	2
Multi electrode arrays (MEAs)	2
murine lung alveolar type II epithelial cell line (LA-4 cells)	2
apoptosis and apoptotic pathways	2
0.5 h	2
recombinant amphiregulin or phosphate-buffered saline	2
female C57BL/6 mice	2
ventilator-associated lung injury model	2
damaged lung tissues	2
, amphiregulin	2
epidermal growth factor family	2
potential targets and pathways	2
novel spontaneous animal model	2
OM rat	2
high-cholesterol diet	2
high-cholesterol containing diet	2
inbred rat strains	2
atherosclerosis-prone and a premature-death rat strain	2
Osborne-Mendel (OM) rat	2
side-chain oxygen of Thr664 in Taq DNA polymerase	2
template-strand DNA	2
unnatural Ds base	2
replication position	2
unnatural or natural base	2
Deep Vent DNA polymerase complexes	2
Taq DNA polymerase	2
Ds–Px pair	2
unnatural base pairs and DNA polymerases	2
unnatural base pair between 7-(2-thienyl)imidazo[4,5-b]pyridine (Ds) and 2-nitro-4-propynylpyrrole (Px)	2
pterygium fibroblasts	2
laminin, and fibronectin	2
myofibroblast-related markers	2
primary cultured human pterygium fibroblasts	2
transforming growth factor-beta2 (TGF-β2)-induced myofibroblasts	2
immunomodulatory drug	2
Cyclosporine A (CsA)	2
lipophilic coatings	2
two commercially available lipophilic coatings	2
residual non-absorbed compound	2
cardiac drugs	2
test set	2
“Organs-on-Chip”	2
polymer polydimethylsiloxane (PDMS)	2
N-terminal residues	2
number of constructs	2
several expression systems	2
alkyl-DHAP synthesis	2
recombinant human DHAP acyl-transferase	2
inner side of the peroxisomal membrane	2
ether phospholipids species	2
essential precursor, alkyl-dihydroxyacetone phosphate (DHAP)	2
ether phospholipids	2
cell lineages and germ layers	2
class II bHLH proteins	2
optimally active phospho-mutant form of MyoD	2
multiple additional serine/threonine sites	2
Serine 200	2
previously well-characterised site	2
in vivo developmental and reprogramming system	2
proline-directed kinases	2
several neurogenic bHLH proteins	2
even terminally differentiated cells	2
lipid peroxides	2
lipid peroxides in biological systems	2
lipid hydroperoxides	2
multiple oxidizing compounds	2
family of binary actin ADPRTs	2
catalytic glutamate residue in the E-X-E motif of the ARTT loop	2
ARTT loop	2
catalytically important ADP-ribosylating turn-turn (ARTT) loop	2
C1′-N glycosidic bond of NADH	2
bound water molecules	2
binary actin ADP-ribosylating toxins (ADPRTs)	2
first crystal structure of BECa	2
NAD+-glycohydrolase and actin ADP-ribosyltransferase activities	2
C. perfringens	2
novel enterotoxin	2
components BECa and BECb	2
Binary enterotoxin of Clostridium perfringens (BEC)	2
therapeutic drugs	2
AIMS library	2
EGFR-expressing cancer cells	2
Eight anti-EGFR mAbs	2
various tumor-associated Ags	2
many human monoclonal Abs (mAbs)	2
large human Ab library	2
antigen (Ag)	2
V genes	2
whole repertoire of Abs	2
VH and VL genes	2
phage-display technology	2
various diseases	2
Ab-related fields	2
phage-display system	2
human antibody (Ab) libraries	2
STAT3	2
CSN5-TYK2 complex	2
major upstream regulator	2
OXGR1−/− hearts	2
STAT3 signalling pathway	2
COP9 signalosome complex subunit 5 (CSN5)	2
molecular complex	2
OXGR1	2
novel interacting partner and downstream signalling pathway	2
OXGR1 in neonatal rat cardiomyocytes	2
Oxgr1 in mice (OXGR1−/−)	2
receptor for α-ketoglutarate	2
family, the oxoglutarate receptor 1 (OXGR1)	2
G-protein-coupled receptors (GPCRs) family of proteins	2
multipass TMPs	2
smaller oligomeric complexes containing CRYAB	2
phosphomimetic substitutions	2
position 19, 45 and 59 of CRYAB	2
three phosphorytable serine residues	2
cytosolic side of the endoplasmic reticulum (ER) (D'Agostino et al., 2013)	2
multipass transmembrane proteins (TMPs)	2
unfolded protein	2
small heat shock protein (sHsp)	2
αB-crystallin (CRYAB)	2
disease specific	2
Many of the metabolites	2
significant metabolites	2
healthy control group	2
lymphoma and healthy controls	2
Age and gender matched samples	2
retrospective cohort of serum samples	2
clinically approved metabolite biomarkers	2
muscular mitotic cells in vivo	2
desmin-IFs	2
human rhabdomyosarcoma specimens	2
mitotic muscular cells of murine embryonic/newborn muscles	2
Aurora-B and Rho-kinase site mutations	2
Cdk1 sites	2
Desmin mutations	2
site- and phosphorylation-state-specific antibody	2
murine desmin	2
type of mitotic kinase, Cdk1	2
excellent substrate	2
two post-mitotic (daughter) cells	2
structures (IF-bridge)	2
unusual long bridge-like	2
Rho-kinase specifically	2
Aurora-B	2
muscular cells	2
Desmin is a type III intermediate filament (IF) component protein	2
serum LECT2	2
RD	2
obese mice	2
serum leukocyte cell-derived chemotaxin 2 (LECT2)	2
Siglec-F.	2
Anti-Siglec-F antibody	2
surface of the M cell membrane	2
PP tissue sections	2
mouse M cells	2
Sialic acid-binding immunoglobulin-like lectin F (Siglec-F)	2
molecular tags	2
M cell-specific receptors	2
PP	2
Peyer's patches (PPs)	2
(M) cells	2
Intestinal microfold	2
regenerating spinal cord of adult zebrafish	2
larval and adult zebrafish	2
larval zebrafish	2
caudal tissues	2
GSK-3β/β-catenin signaling pathway	2
BMSC osteogenesis	2
ARS-stained mineral nodules	2
over-expressing miR-199b-5p	2
human bone marrow stromal cells (BMSCs)	2
‘stratified siRNA silencing vector’	2
in vivo target	2
appropriate cell culture model	2
siRNA delivery systems (e.g. endosomolytic compounds	2
cell trafficking pathways	2
Calu-3 cells	2
endosomal disruption	2
H1299 cells	2
model system’s silencing	2
common lung epithelial origins	2
tested cell lines	2
pharmacological inhibitors	2
trafficking pathways	2
panel of lung epithelial cell lines, H1299, A549 and Calu-3	2
‘classical’ condensing agent	2
Model siRNA-polyplexes	2
siRNA delivery system design	2
in vitro cell culture models	2
fat content	2
Mstn knockout	2
WT littermates	2
KO rats	2
wild-type (WT) littermates, Knockout (KO) rats	2
detectable mRNA	2
full 376 amino acids	2
truncated peptide	2
early termination codon	2
knockout	2
skeletal myocytes	2
Myostatin (Mstn)	2
tripeptides	2
skin substitute	2
several oligopeptides	2
inward H+ gradient	2
epidermal PEPT2 localization	2
PEPT2-positive cells	2
three keratinocytes	2
three keratinocyte lines (normal human epidermal keratinocytes (NHEKs), immortalized keratinocytes, and malignant keratinocytes	2
oligopeptides and peptide-like drugs	2
proton-coupled oligopeptide transporter family	2
Peptide transporter 2 (PEPT2)	2
AR-V7 and wtAR (in 22Rv1)	2
C4-2)	2
HEK293 fibroblasts	2
C4-2 and 22Rv1 cells	2
22Rv1 cells	2
C4-2 cells	2
standard colony formation assays	2
CRPC cells overexpressing full-length AR (C4-2) or co-expressing wtAR and splice-variant AR-V7	2
mice bearing hormone-dependent cell line xenografts	2
established CRPC model cells	2
androgen antagonist enzalutamide	2
resulting tumors	2
CRPC cells	2
castrated mice	2
e.g., LNCaP and VCaP)	2
CRPC patient tumors	2
standard cell line models	2
hormone-dependent cells	2
castration resistant prostate cancer (CRPC) cells	2
Lys63-linked or other types of ubiquitin chain	2
TNF receptor 1	2
Met1-linked Ub chains	2
innate immune signaling systems	2
Receptor-Interacting Protein 1 (TNFR1 pathway) or Receptor-Interacting Protein 2 (NOD1 pathway)	2
TNFR1/TRADD, TLR3/TRIF- and NOD1/RIP2-signaling networks	2
Interleukin Receptor Associated kinase 1	2
(Ub) oligomers	2
Met1-linked ubiquitin	2
Lys63-linked	2
hybrid ubiquitin chains	2
MyD88-signaling network	2
carbamazepine in drinking water	2
fluoxetine or venlafaxine application	2
control dams	2
brain of embryos and livers of carbamazepine-treated mice	2
2H enrichment	2
dam liver and brain of developing embryos	2
drinking water of female mice	2
2H-isotope labeled pharmaceuticals	2
intestinal and placental barriers	2
brain of the developing embryo	2
psychoactive pharmaceuticals (fluoxetine, venlafaxine, and carbamazepine)	2
ASD-associated synaptic protein expression	2
autism spectrum disorders (ASD)	2
Altered gene sets	2
fathead minnows	2
enriched sets of genes	2
psychoactive pharmaceuticals (fluoxetine, venlafaxine and carbamazepine)	2
genetically susceptible individuals	2
environmental contaminants	2
Psychoactive pharmaceuticals	2
human insulin receptor	2
Myc-GLUT4-GFP	2
glucose transporter (GLUT4)	2
adipose and muscle tissue	2
azido fucose and 3H-labeled fucose using core-6 fucosyltransferase, FUT8	2
core-6-linked fucose	2
stalk region of the active form	2
inactive form (dimer and monomer) of the protein	2
active form (tetramer)	2
neuraminidase (NA) antigen of the virus	2
structure component	2
human history	2
1918 H1N1 influenza virus	2
P-gp	2
mutants L443C	2
S909C and V472C/S909C cross-linked	2
Mutants G471C/	2
S909C and V472C	2
Mutants L443C	2
intracellular loop 4 (TMD2) and NBD1	2
Human P-gp	2
inward- (open, NBDs far apart) and outward-facing (closed, NBDs close together) conformations	2
TMDs and NBDs	2
Drug substrates	2
transmembrane domain (TMD) and a nucleotide-binding domain (NBD)	2
wing	2
two wings	2
ABC proteins	2
P-glycoprotein (P-gp) is an ABC (ATP-Binding Cassette) drug pump	2
‘reserve pool’ of CaV3.2 channels	2
total neuronal population	2
LVA-positive DRG neurons	2
inflammatory mediators BK and ATP	2
population of LVA-positive neurons	2
ubiquitination inhibitor, MG132	2
population of LVA-positive DRG neurons	2
PLC inhibitor U-73122 and B2 receptor antagonist, Hoe-140	2
LVA-positive neurons	2
Ca2+ currents	2
low-voltage activated (LVA, T-type)	2
small-diameter neurons	2
cocktail of inflammatory mediators bradykinin (BK), adenosine triphosphate (ATP), norepinephrine (NE) and prostaglandin E2 (PGE2)	2
small-diameter cultured dorsal root ganglion (DRG) neurons	2
T-type Ca2+ channels	2
T-type Ca2+	2
nef-deleted HIV-1	2
wild type virus	2
Molecular inhibitors	2
HIV-1 infected T cells	2
237 genes	2
HIV-1 proteins	2
landscape of cellular transcriptome	2
Nef's footprint	2
individuals infected with nef-deleted strain of HIV	2
27 kDa Negative Factor or Nef protein	2
Human Immunodeficiency Virus-1 (HIV-1)	2
apoA-I mimetic peptides	2
alternative structural motif	2
smaller size HDL species	2
cells not expressing ABCA1	2
much longer amphipathic α-helical peptide	2
Type-II polypro helix	2
phospholipid bilayer	2
3 amino acid repeat units (Prop-Prog-Prop)	2
pyrrolidine ring	2
hydrophobic phenyl group (Prop) or a polar N-acetylgalactosamine (Prog)	2
modified prolines	2
Polypro peptides	2
ABCA1 transporter	2
amphipathic α-helix	2
-I mimetics	2
solvent exposed ones	2
large protein thermodynamics database	2
three-dimensional structure of proteins	2
centers of noncovalent long range interaction clusters	2
normal colonic crypts	2
PGE2, IL-1β, and LTD4	2
channel activity	2
forskolin and thromboxane A2	2
control crypts	2
two or more channels	2
basolateral patches	2
single 6.8 pS channels	2
KCNE3	2
forskolin (activator of adenylate cyclase) and UC-related proinflammatory cytokines	2
normal and active ulcerative colitis (UC) patients	2
distal colonic crypts	2
KCNQ1/KCNE3 channels	2
Small conductance basolateral (KCNQ1/KCNE3)	2
known small molecules	2
hyperbranched polymers	2
free dopamine	2
polymer structure	2
known inhibitor of α-synuclein fibril formation	2
dopamine moiety	2
hyperbranched polyethylene glycol structure	2
RAFT polymerization	2
anti-fibrillation applications	2
promising drug candidates	2
neurodegenerative maladies	2
new indications of drugs	2
off-target tissues	2
prediction	2
effect-related off-target tissues	2
proposed tissue protein – symptom matrix	2
successful repositioning drugs	2
Off-target tissues	2
tissue protein – symptom matrix	2
drug's off-target tissue	2
off-target tissues of a drug	2
target proteins of drugs	2
unintended effects	2
surfaces of liposomes	2
tumor-associated antigen-derived epitope peptides	2
GPC3-expressing tumor growth	2
GPC3-specific CTLs	2
incomplete Freund's adjuvant	2
conventional vaccine	2
pGPC3-liposome induced peptide-specific CTLs	2
GPC3-derived CTL epitope peptide (pGPC3-lipsome)	2
liposome-coupled	2
tumor reactive in vitro	2
vaccine-induced GPC3-peptide-specific CTLs	2
GPC3-derived peptide vaccine	2
oncofetal antigen	2
glypican-3 (GPC3)	2
structural assembly of oligomers and fibrils	2
less ordered molecular arrangement	2
fibrillar cross-β core	2
water-soluble acrylamide	2
Tyr10 fluorescence	2
monomeric, oligomeric and fibrillar forms of the 42-residue Aβ1-42	2
Aβ sequence	2
single tyrosine residue, Tyr10	2
amyloid-β (Aβ) peptides	2
Drosophila larva	2
Constitutively active aPKC	2
well-known cell polarity protein aPKC	2
autophagic vesicles	2
scaffold protein	2
apical membrane domain of epithelial cells	2
hippo signaling pathway	2
lysosomal proteases	2
bulk degradation system	2
conserved Wdr8-hMsd1/SSX2IP complex	2
converse	2
one of Wdr8 interactors	2
conserved spindle anchoring protein	2
proximal end of the mother centriole	2
fission yeast counterpart	2
novel centrosome protein Wdr8	2
parvin-β expression	2
ATP-binding site of Akt1(PDB ID: 3OCB)	2
GTP-bound Rac1 and Cdc42	2
dimethyl sulfoxide	2
peroxisome proliferator response element-like cis-element (ACTAGGACAAAGGACA) in the parvin-β promoter	2
electrophoretic mobility shift assay	2
parvin-β	2
T47D, SK-BR-3, or MDA-MB-231 cells	2
reverse transcription-PCR products of parvin-β (650 and 500 bp) and PPAR-γ2 (580 bp)	2
γ-oryzanol compounds	2
peroxisome proliferator-activated receptor (PPAR)-γ2 (GenBank Accession	2
AF237769)	2
parvin-β (GenBank Accession	2
breast cancer cell line MCF7 with 24-methylenecycloartanyl ferulate (24-MCF), a γ-oryzanol compound	2
integrin-linked kinase (ILK)	2
Parvin-β	2
aged WT mice	2
mesenchyme-specific Sirt6-deficient mice	2
osteophyte growth	2
aged Sirt6 ± HFD group	2
ubiquitin-binding proteins and ubiquitin linkage-specific deubiquitylases	2
particular ubiquitin chains	2
set of recommendations	2
ubiquitylation events	2
malarial antigens	2
B-cell population	2
unimmunized mice	2
infected RBC	2
Plasmodium berghei ANKA parasitemia	2
Plasmodium falciparum merozoites	2
KLH tagged or untagged peptides of Mpep3	2
peptide sequences (referred as Mpep3 and Mpep4) of region VI of EBA-175 (PfrVI)	2
Malaria specific IgA	2
endemic population	2
serum and breast milk	2
Plasmodium specific IgA	2
luciferase-based reporter assay	2
lysine	2
SUMO consensus site	2
SUMO1 and	2
complimentary target mRNAs	2
Argonaute-2 (Ago2)	2
One protein	2
potential SUMO substrates	2
SUMO E3 PIAS3	2
putative substrate recognition (PINIT) domain	2
E3 ligase enzymes	2
SUMO E2 conjugating enzyme Ubc9	2
E1, E2 and E3	2
small ubiquitin-like modifier (SUMO)	2
Foxp3 promoter	2
cytokine-neutralizing antibodies	2
regulatory T cells (Tregs)	2
IκB-ζ-deficient T cells	2
helper (Th) cell subsets	2
member of the nuclear IκB family of proteins	2
Inhibitor of kappa B (IκB)-ζ	2
RNase H1-dependent ASO	2
cytoplasmic XRN1	2
3′ fragment	2
small interference RNA (siRNA)	2
3′ fragments of mature mRNA	2
nuclear XRN2	2
3′ fragments of target pre-mRNA	2
3′ fragments	2
XRN1 and XRN2	2
two major 5′ to 3′ exoribonucleases (XRNs)	2
Antisense oligonucleotides (ASOs)	2
Complex lesions	2
sensor of anti-inflammatory epoxy-oxylipins	2
rich source	2
authentic epoxy-oxylipins	2
inducible nitric oxide synthase	2
sEH inhibitors TPPU or AUDA	2
dihydroxy-counterparts	2
primary epoxy-oxylipins	2
induced CYP2J4	2
epoxy-oxylipin products	2
epoxy-oxylipin production	2
pro-inflammatory TLR4 ligand LPS	2
CYP2C12, CYP2B1, but not CYP2J	2
eicosapentaenoic acid > docosahexaenoic acid > arachidonic acid > linoleic acid	2
epoxy-oxylipin CYP450 products	2
iSMC basally	2
rat aorta	2
paired intimal (iSMC) and medial (mSMC) cells	2
CYP450-oxylipin-sEH pathway enzymes	2
CYP450-oxylipin - soluble epoxide hydrolase (sEH) pathway	2
stable epithelioid or rhomboid phenotype in culture	2
intimal smooth muscle cell (iSMC)	2
pigs and rodents	2
complex human vascular lesions	2
morphologically distinct vascular smooth muscle cells	2
exercised tumor group	2
sedentary tumor group	2
exercised mice	2
isolated tumor cells	2
internal carotid artery	2
Highly metastatic tumor cells (murine Lewis lung carcinoma)	2
locked wheel (sedentary)	2
running wheel (exercise)	2
mature male mice	2
tight junction (TJ) proteins	2
highly protected microvascular environment	2
Tumor cell	2
feces of the HFD group	2
Control and STZ groups	2
interleukin (IL)-6, tumor necrosis factor-α, and IL-1β	2
Hepatic steatosis	2
Multiple HCC	2
STZ group	2
normal diet	2
STZ group containing mice	2
normal diet (Control), high-starch diet (Starch), and high-fat diet (HFD) groups	2
three feeding groups	2
7,12-dimethylbenz (a) anthracene	2
diabetes mellitus	2
T1 maps	2
superior sagittal sinus (SSS)	2
clinical low field settings	2
solute	2
Fick equation	2
SINV which infected HeLa cells	2
several cell cycle regulators (CDK4, CDK6, cyclin E, p21, cyclin A and cyclin B) in HeLa cells	2
SINV infection	2
cancer cell line, HeLa, and a non-cancerous cell line, Vero	2
peroxide-treated or FOXO3a-expressing cells	2
Chk2 inhibitor	2
either peroxide-treated or FOXO3a-expressing cells	2
FOXO3a-expressing cells	2
over-express FOXO3a	2
high serum media	2
peroxide treated cells	2
low serum media	2
peroxide-treated cells	2
1 pM hydrogen peroxide	2
primary human tenocytes	2
one member of the FOXO family, FOXO3a	2
musculoskeletal tissues	2
FOXO family of forkhead transcription factors	2
novel MFM disease genes	2
MFM gene-deficient zebrafish	2
MFM patients	2
MFM genes in zebrafish	2
known human MFM disease genes	2
MFM candidate genes	2
suitable model system	2
myofibrillar myopathies	2
several disease genes	2
human heart and skeletal muscle	2
Myofibrillar myopathies (MFM)	2
complement inhibitor CD59	2
related complement inhibitor CD59	2
rafts in pancreatic islets	2
human islets	2
CD55 expression	2
Atto-SM staining	2
832/13 cells	2
Diabetic human islets	2
human pancreatic islets	2
INS1 832/13 beta cells	2
membrane raft protein and complement inhibitor CD59	2
many important signaling proteins	2
Membrane rafts	2
GPI link	2
cell plasma membrane	2
cholesterol rich regions	2
complement C3 convertases	2
glycosylphosphatidylinositol-anchored protein	2
LAMP family proteins, LAMP1 and CD68/LAMP4	2
cytosolic sequences	2
arginine-rich motifs	2
scrambled form of the sequence	2
LAMP2C cytosolic sequence	2
wide range of RNA-binding proteins	2
RNA-recognition motif	2
arginine-rich motif	2
cytosolic sequence of LAMP2C.	2
RNA and DNA	2
short C-terminal cytosolic tail of LAMP2C	2
lysosomal membrane protein, LAMP2C	2
novel lysosomal systems	2
diverse cellular components	2
nanoparticles, nanotubes and organic and catalytic materials	2
scientific fields	2
diverse liquid samples	2
bacteria, viruses and protein complexes	2
existing FTE system	2
thermionic SEM	2
unstained biological samples	2
direct electron beam	2
various atmospheric holders or special equipment	2
atmospheric and/or wet biological specimens	2
bacteria, viruses and proteins	2
elevated isoaspartate and CPS-1	2
carbonic anhydrase-III (CA-III)	2
respective controls	2
cytosolic CPS-1 and betaine homocysteine S-methyltransferase-1	2
4-week ethanol-fed rats	2
liver proteome	2
PIMT in ethanol-fed rats	2
∼160 kDa protein target	2
Carbamoyl phosphate synthase-1 (CPS-1)	2
livers of PIMT knockout (KO) mice	2
Three major protein bands	2
exogenous PIMT and 3H-S-adenosylmethionine	2
rat liver cytosolic proteins	2
control or 4-week ethanol-fed rats	2
protein isoaspartyl methyltransferase (PIMT)	2
cryogenic structures	2
shortened C–H bonds	2
AMBER forcefield FF99	2
aggregated native state population	2
AMBER forcefield FF12SB	2
native β-hairpin conformation	2
fully-extended backbone formation	2
all-atom, isothermal–isobaric, 0.5-μs molecular dynamics simulations	2
 C–H bonds	2
current AMBER forcefields	2
high resolution cryogenic protein structures	2
protein folding simulations	2
protein crystal structures	2
adopting secondary structure elements	2
α-helix or β-strand conformation	2
β-strand conformation	2
α-helix conformation of AcO-(AAQAA)3-NH2	2
α-helix and β-strand	2
two β-strand conformations	2
consecutive covalent bonds	2
protein backbone atoms	2
protein secondary structure conformations	2
nonpolarizable charge model	2
6–12 Lennard-Jones potential	2
various cellular contexts	2
Oct4 PTM barcodes	2
physiologically-relevant PTM sites	2
common and distinct PTM regulatory pathways	2
particular cellular context	2
cell-free systems	2
Oct4 phosphorylation sites	2
various cell-free systems	2
Ni–NTA beads	2
reacted Oct4 proteins	2
variety of human cells	2
whole cell lysates	2
Escherichia coli-derived His-tagged Oct4 proteins	2
Oct4 protein samples	2
octamer-binding transcription factor 4 (Oct4)	2
well-defined antibody reagents	2
additional tags	2
fixed wholemount tissue	2
native antigen	2
formalin-treated embryonic zebrafish brains	2
ten antibodies	2
single plasmid	2
recombinant form	2
rearranged antigen binding regions of the antibodies	2
different antigens	2
entire ectodomain of neural zebrafish cell surface or secreted proteins	2
validated antibody reagents	2
popular vertebrate model	2
neuron cell bodies	2
Cell surface receptors and secreted proteins	2
hba3 expression	2
Xalas2-knockdown embryos	2
o-dianisidine staining	2
dorsal lateral plate	2
posterior ventral blood islands	2
primary hematopoiesis	2
primitive erythroid cells before hemoglobin alpha 3 subunit (hba3)	2
primitive amphibian erythrocytes	2
Xenopus alas2 gene (Xalas2)	2
Amphibian and mammalian blood cells	2
X-linked dominant protoporphyria	2
heme synthetase	2
aminolevulinate synthase 2 (ALAS2)	2
vertebrate’s lifetime	2
EF-hand-containing Rab protein	2
long variant of CRACR2A	2
Rab GTPase family	2
long variant in endothelial cells	2
CRACR2A. Full-length cloning	2
C-terminal Rab GTPase extension	2
variant transcript	2
CRACR2A. Reference	2
EF-hand-containing modulator of calcium-release-activated calcium (CRAC) channels	2
CRACR2A protein	2
future biotechnological and health applications	2
small nucleic acids	2
antisense region	2
mammalian transcriptomes	2
commodity computers	2
classical, all-atom, and isothermal–isobaric MD simulations	2
wide range of miniature proteins	2
low-mass MD simulation	2
original AMBER forcefields of FF12SB and FF14SB	2
Apple Mac Pros	2
multiple 500-ns MD simulations	2
explicit solvent	2
fully extended backbone conformation	2
classical, all-atom, and isothermal–isobaric molecular dynamics (MD) simulation	2
one of the smallest fast-folding proteins	2
large portion of this loop region	2
helper VP6 protein	2
BHK cells	2
VP6-truncated BTV	2
BTV reverse genetics system	2
One of the loops (amino acid position 34–130)	2
large loop regions	2
large structured domain	2
several truncated VP6 variants	2
his-tagged full-length VP6 (329 amino acid residues)	2
Multinuclear nuclear magnetic resonance spectra	2
viral capsid	2
ATP hydrolysis dependent RNA helicase	2
Bluetongue virus core protein VP6	2
catalytic sites	2
chain of cofactors	2
two subunits in a dimer	2
series of mutated hybrid cytochrome bc1-like complexes	2
Qo and Qi quinone catalytic sites of dimeric cytochrome bc1	2
domains of both	2
proneural proteins	2
conserved bHLH domains	2
N-terminus of NeuroD in particular	2
ubiquitylation alone	2
two structurally and functionally related proteins	2
highly unstable protein	2
Two key basic Helix-Loop-Helix transcription factors, Neurogenin 2 (Ngn2) and NeuroD	2
developing organisms and cycling cells	2
key transcriptional activators	2
nephrons and peritubular cells	2
mainly peritubular cells	2
intercalated cells	2
cortical nephrons	2
IN-IC cells	2
collecting ducts	2
β-intercalated or non α/non β-intercalated cells of the collecting ducts	2
erythropoietin mRNA	2
PCTs, DCTs, and CCDs	2
distal convoluted tubules (DCTs) and cortical collecting ducts (CCDs)	2
proximal convoluted tubules (PCTs)	2
human liver hepatocell (HepG2) and rat intercalated cell line (IN-IC cells)	2
erythropoietin and HIF PHD2	2
peritubular interstitial fibroblasts	2
24S,25-epoxide	2
enzyme oxysterol 7α-hydroxylase (Cyp7b1)	2
cholesterol in mouse	2
24S-hydroxycholesterol in brain of both rodents	2
adult mouse and rat	2
24S,25-epoxycholesterol in rodent brain	2
strong chromophore	2
sterol regulatory element-binding protein processing	2
liver X receptors	2
Res subunit	2
Mod2 core	2
complete Res1Mod2 enzyme	2
methylatable adenine	2
adenine analogue, 2-aminopurine	2
second adenine	2
Mod2 enzyme	2
298 (2000) 597–610	2
Biol.	2
Reddy and Rao, J. Mol.	2
adenine base	2
Mod2 dimer	2
DNA containing unmethylated target sequences	2
one copy of a restriction endonuclease (Res) subunit	2
two modification (Mod) subunits	2
Type III DNA restriction and modification enzyme	2
centromeric region	2
CDK1/Cyclin B1	2
centromeric heterochromatin markers	2
MTHFR immunocomplex	2
cyclin-dependent kinase 1 (CDK1)/Cyclin B1 complex	2
T34-phosphorylated form of MTHFR	2
phospho-specific antibody	2
priming phosphorylation site	2
active methyl donor S-adenosylmethionine	2
homocysteine remethylation	2
5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate	2
Methylenetetrahydrofolate reductase (MTHFR)	2
9p21 risk alleles	2
CDKN2B expression	2
subcutaneous adipose tissue (SAT)	2
tumor suppressor CDKN2B	2
panel of multiple human tissues	2
9p21-regulated genes	2
vascular tissues	2
9p21 locus	2
gene desert	2
Risk alleles	2
five mreB clades	2
one homolog	2
five clades	2
Spiroplasma mreB homologs	2
separate clade	2
Spiroplasma	2
related lineages	2
two genera	2
genomes of non-spherical bacteria	2
actin-like proteins	2
mreB gene family	2
human neural tissue	2
nuclear factor-like 2 (Nrf2) independent pathway	2
neuronal cell line (PC12D)	2
lutein, a carotenoid	2
urine sample	2
TMTH derivatisation	2
TMT group	2
specific mass reporter ions	2
underivatised molecules	2
carbonyl-reactive hydrazine group	2
chargeable tertiary amino group	2
“tandem mass tag hydrazine” (TMTH) carbonyl-reactive derivatisation reagent	2
oxosteroid identification	2
potential stable isotope labels	2
several modified Girard-like reagents	2
charged quaternary ammonium group	2
tagging sterols	2
oxysterols in biological samples	2
oxysterols in biological systems	2
nuclear and G protein-coupled receptors	2
bile acids and steroid hormones	2
oxidised forms of cholesterol	2
24S,25-epoxycholesterol,	2
parallel metabolite	2
cholesterol precursor, desomsterol	2
Cyp46a1−/− and wild type animals	2
22R-, 24R-,	2
side-chain oxysterols	2
cholesterol metabolite	2
wild type brain	2
dominant metabolite of cholesterol	2
cholesterol 24-hydroxylase knockout mouse (Cyp46a1−/−)	2
Oxysterols are oxidised forms of cholesterol or its precursors	2
24,25-dihydroxyvitamin D3 and other uncharacterised dihydroxy metabolites	2
3α-hydroxy epimer of 25-hydroxyvitamin D3	2
3α-hydroxy group	2
17β-Hydroxysteroid dehydrogenase type 10	2
newly formed 3-oxo group	2
3β-hydroxy group	2
Cholesterol oxidase	2
25-[26,26,26,27,27,27-2H6]hydroxyvitamin D3	2
adult serum	2
25-hydroxyvitamins D (25-hydroxyvitamin D3 and 25-hydroxyvitamin D2)	2
mM [Ca2+]e	2
Cx26 hemichannel model	2
γGlu47, Arg75 and Arg184	2
two conserved arginines (Arg75 and Arg184 in Cx26)	2
connexins	2
highly conserved glutammic acid	2
extracellular vestibule of the Cx26 hemichannel	2
favorable environment	2
several negatively charged amino acids	2
connexin 26 (Cx26) gap junction channels	2
different [Ca2+]e	2
Cx26 hemichannels	2
extracellular mouth	2
∼1mM) [Ca2+]e	2
Connexin hemichannels	2
Windows, Mac and Linux	2
wide community	2
Bioconductor project	2
CpG density promoters	2
trained replication-timing map	2
mouse embryogenesis	2
input data	2
supra-hexagonal map	2
omics data	2
genome-wide biological data	2
type II collagen and pro-inflammatory cytokine mRNAs	2
two mouse RA models	2
encodes C1q/TNF-related protein 3 (CTRP3)	2
HT1080 cells	2
multiple specific EGFR inhibitors	2
first a broad spectrum receptor tyrosine kinase inhibitor	2
Pro-MMP-9 expression	2
epidermal growth factor receptor (EGFR) tyrosine kinase expression and activity	2
highly functional second extracellular loop of CD9	2
human fibrosarcoma cell line (HT1080)	2
matrix metalloproteinases (MMPs)	2
surrounding extracellular matrix (ECM)	2
autophagy and lysosomal pathways	2
three central domains of LRRK2	2
primary fibroblasts	2
functional domains (ROC, COR and Kinase) of the protein product of this gene	2
one of the most important genetic contributors	2
atpgp1 mutants	2
new allele of atpgp1 mutants	2
atpgp1 mutant	2
atpgp1 atmdr1 double mutant	2
atpgp19 mutant	2
Plant two closely ABC (ATP-binding cassette) transporter, AtPGP1 and AtPGP19 (AtMDR1)	2
oleate alone	2
proapoptotic transcription factor Chop	2
chaperones Bip, Pdi, Calnexin and Grp94	2
palmitate treated cells	2
UPR specific proteins	2
FITC-Annexin/PI-staining	2
combination [0.5/1mM]	2
palmitate [0.5mM], oleate [1mM]	2
MethodsINS-1E β-cells	2
monounsaturated fatty acid	2
unsaturated FFAs, e.g. oleate	2
BackgroundSaturated free fatty acids (FFAs)	2
IH animals	2
C-peptide	2
insulin producing beta cells	2
IH treated animals	2
Twenty-five male pups	2
young rats	2
neonatal rat model	2
serum, insulin and growth factors	2
supernatants of endothelial cells	2
6-keto PGF1α	2
different proinflammatory mediators	2
human umbilical vein endothelial cells	2
TP receptor antagonist and thromboxane synthase inhibitor EV-077	2
thromboxane prostanoid (TP) receptor	2
cyclooxygenase and thromboxane synthase pathways	2
prothrombotic mediator thromboxane A2	2
osteoclast progenitors	2
surviving populations	2
M-CSF and RANKL treatment	2
receptor activator of nuclear factor kappa B ligand (RANKL)	2
monocyte/macrophage-colony stimulating factor (M-CSF)	2
osteoclasts in tissue culture dishes	2
Interleukin (IL)-3, a multilineage hematopoietic growth factor	2
diseased muscle	2
adult and normal counterparts	2
aged and dystrophic satellite cells	2
hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF)	2
age-matched wild-type mice	2
12 mo old MDX mice	2
aged satellite cells	2
adult satellite cells	2
satellite cell age group	2
co-culture setting	2
aged muscle donors	2
MVF co-	2
tubule formation	2
adult muscle donors	2
rat satellite cells	2
Microvascular fragments	2
rat adipose tissue microvascular fragments (MVF)	2
vitro culture model	2
resident stem cells or satellite cells	2
another transcription factor	2
GATA4 mutant	2
altered amino acid	2
control chromosomes	2
p.C271S	2
luciferase reporter assay system	2
mutant GATA4	2
unrelated ethnically matched healthy individuals	2
available relatives	2
GATA4 gene	2
whole coding region and splice junction sites	2
mutated GATA4	2
animal models and humans	2
cardiac transcription factor GATA4	2
antitumor drug	2
human GC cells	2
Rhoc	2
matrix metalloproteinases-2 (MMP-2)	2
reversion inducing cysteine rich protein with Kazal motifs (RECK), E-cadherin (E-cad)	2
activated caspase-3, caspase-8, caspase-9 and poly-ADP ribose polymerase (PARP)	2
Bcl-2, Bcl-xL and Survivin expressions	2
BGC-823 cells	2
cell matrix adhesion assay	2
Proliferation assay	2
three kinds of different differentiation stage GC cells (BGC-823, SGC-7901 and MKN-28)	2
gastric cancer (GC) cells	2
liver and lung cancer cells	2
herbal medicine Anemone raddeana Regel	2
triterpenoid saponins	2
endogenous DNA sequence	2
guide RNA (gRNA)	2
catalytically inactive form of Cas9 (dCas9)	2
tag(s)	2
engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP)	2
effective skin-whitening agent	2
mitogen-activated protein kinases (MAPK) and protein kinase A (PKA) signaling pathways	2
B16F1 cells	2
B16F10 and	2
melanin in B16F10 and B16F1 cells	2
[8]-gingerol (5–100μM)	2
melanogenesis-related proteins in B16F10 and B16F1 melanoma cells	2
melanin content	2
mushroom tyrosinase, tyrosinase activity	2
potential skin-whitening agent	2
active component of Zinger	2
[8]-Gingerol	2
Cd-treated PC-12 cells	2
Cd-treated groups	2
chloroquine (an autophagic inhibitor) and rapamycin (an autophagic inducer)	2
numerous autophagosomes	2
endogenous LC3-II	2
LC3-II proteins	2
PC-12 cells	2
mating inhibitors NCE102, PRR2 and RHO5	2
mating inhibitor	2
another target gene of Sut1 and Sut2	2
either SUT1 or SUT2	2
Sut1 and Sut2	2
sut1 sut2 double deletion mutant	2
genes NCE102	2
SUT1 and SUT2	2
zinc cluster proteins Sut1 and Sut2	2
COX-2 selective inhibitor	2
enhanced plasma interferon (IFNα,β,γ,λ) and related cytokine responses (IP-10, IL-12)	2
PAMPs	2
bacterial PAMP, LPS, and the viral PAMP, poly(I:C)	2
TLR agonists	2
inactivity, hunching, piloerection)	2
COX isoform	2
LPS, poly(I:C), MALP2 (TLR2/6), Pam3CSK4 (TLR2/1), R-848 (TLR7/8) or CpG ODN (TLR9)	2
Cox1−/−and Cox2−/−mice	2
plasma of wild-type,	2
panel of cytokines and interferons	2
Toll-like receptor (TLR)4, or with poly(I:C), a viral PAMP	2
either the prototypical bacterial pathogen-associated molecular pattern (PAMP), LPS	2
range of tissues in mice	2
Cox2 expression	2
knock-in luciferase reporter model	2
bacterial and viral infections	2
Cyclooxygenase 2 (COX)-2	2
patients with non-cirrhotic NASH	2
β-AR antagonists	2
death pathway	2
hepatocyte death	2
β-AR antagonist PRL	2
Fas receptor and caspase-8 proteins	2
primary hepatocyte cultures	2
apoptotic pathway	2
presence of PRL	2
lactate dehydrogenase, FASL and TNF-α from hepatocytes	2
α and β adrenoceptors	2
murine hepatocytes	2
supplemented with ethionine (HMCDE)	2
normal chow or a half methionine and choline deficient diet	2
β-blocker propranolol (PRL)	2
non-cirrhotic NASH	2
(AR) antagonist	2
Prazosin an α1-adrenoceptor	2
beta and vascular endothelial cells of mouse pancreatic islets	2
islets preparations	2
endothelial or cluster of differentiation 31 (CD31) positive cells	2
Cx30.2 reactivity	2
cytoplasms and cell membranes	2
cell cytoplasms	2
Abundant Cx30.2 tiny reactive spots	2
pancreases	2
Cx30.2 and Cx36 fluorescence	2
double-labeled pancreatic sections	2
insulin-positive cells	2
isolated islet preparations	2
mouse pancreatic islets	2
sole gap junction protein	2
connexin (Cx) 36	2
C.B-17/Icr-Prkdcscid/Prkdcscid-INS-TRECK-Tg mice	2
CD34+ human umbilical cord blood cells	2
C57BL/6 and xenogeneic transplantation	2
C.B-17/Icr-Prkdcscid/Prkdcscid-INS-TRECK-Tg model	2
examined strains	2
suitable dosage of insulin	2
diphtheria toxin (DT)	2
serum insulin	2
pancreatic β cells of all four of the generated C57BL/6-ins2(BAC)-TRECK-Tg strains	2
one of three Tg strains	2
C.B-17/Icr-Prkdcscid/Prkdcscid-INS-TRECK-Tg strain	2
mouse insulin II gene promoter	2
hDTR cDNA	2
strain, C57BL/6-ins2(BAC)-TRECK-Tg	2
human insulin gene promoter	2
diphtheria toxin receptor (hDTR)	2
first strain, C.B-17/Icr-Prkdcscid/Prkdcscid-INS-TRECK-Tg	2
two transgenic (Tg) murine lines	2
three mouse strains	2
mucin O-glycans	2
colorectal mucins	2
C57BL/6 and BALB/c	2
amoebic adherence	2
terminal Gal/GalNAc	2
mucins from C57BL/6 or BALB	2
potent inhibitors	2
Mucins from CBA mice	2
resistant C57BL/6 and BALB	2
colorectal mucin O-glycan of susceptible CBA mice	2
(GalNAc)12–27-HSA neo-glycoproteins	2
O-glycan content	2
susceptible and resistant inbred strains of mice	2
Rho-kinase	2
myosin downstream	2
wild-type Drok	2
known Rho-kinase orthologue	2
Aurora-A kinase (AurA)	2
SR protein family	2
SRp20 (SFSR3)	2
SIRT1 mutant mice	2
hippocampus CA1	2
8–9month-old mice	2
Alzheimer’s disease (AD)	2
grapes and red wine	2
Resveratrol (RSV)	2
yet-to-be-identified membrane embedded binding cavities of insect ORs	2
cover	2
silkworm moth, BmorOR1	2
predicted ECL-2 of the bombykol receptor	2
four Pro residues	2
ECL-2 loops	2
distant taxonomical group	2
backbone hydrogen bonds	2
Gly, Tyr, and Leu	2
“corner residues” of prolines	2
oviposition attractant 3-methylindole	2
Southern house mosquito three Pro residues	2
β-turns	2
“loops	2
Xenopus oocyte recording system	2
well-conserved residues	2
3–4 Pro residues	2
moth ORs	2
43 amino-acid-residue-long ECL2s	2
27 amino-acid-residue-long of the ECL-2s in mosquito	2
second extracellular loops (ECL-2s)	2
silkworm moth	2
Southern house mosquito	2
malaria mosquito	2
populations of agricultural pests and insects of medical importance	2
insect-inspired modern green chemicals	2
Odorant receptors (ORs)	2
DLG1 GK domain	2
rat DLG1 GK domain	2
adjacent symmetry-related DLG1 GK molecule	2
C-terminal tail of DLG1	2
GK domain of human DLG1	2
phosphorylated serine residue	2
C-terminal guanylate kinase (GK) domain of DLG1 binds peptides	2
molecular scaffolds	2
membrane associated guanylate kinase (MAGUK) family of proteins	2
neuronal and immunological synapses	2
Discs large homolog 1 (DLG1/SAP97)	2
DEN-3 protease	2
WYCW-NH2	2
octapeptides	2
shortened peptides	2
proteochemometric modeling	2
DEN-1–4 proteases	2
uncharged tetrapeptide, WYCW-NH2	2
prime side sequence	2
cationic substrate non-prime side residues	2
four proteases	2
protease substrates	2
proteochemometric models	2
four subtypes of dengue virus, DEN-1–4	2
NS2B–NS3 proteases	2
series of 45 peptide inhibitors	2
human adipose tissue TGR5 expression	2
bile acid receptor TGR5	2
new class of signaling molecules	2
STE20 family protein kinases	2
MO25 isoforms	2
interface residues Tyr223 of MO25β and Glu58 and Ile71 of MST3	2
pseudokinase STRADα	2
ATP-mimetic inhibitor	2
absence of ATP	2
closed, active, conformation	2
full length MO25β	2
MST3 catalytic domain (residues 19–289)	2
STE20 protein kinases	2
LKB1 tumour suppressor	2
pseudokinases (e.g. STRAD isoforms	2
number of STE20 family protein kinases (e.g. MST and SPAK isoforms)	2
MO25 scaffolding protein	2
heterooctameric complex	2
constitutively inactive mutant of PanD	2
PanZ with coenzyme A	2
PanD zymogen	2
[9].	2
enteric bacteria	2
fifth essential protein	2
Tln2cd/cd pups	2
Tln2cd/cd mouse embryo fibroblasts	2
major organs	2
Tln2cd/+ intercrosses	2
entire coding sequence (Tln2cd)	2
Tln2 allele	2
talin2 protein	2
several Tln2 gene targeted alleles	2
specific protein	2
donor lipid	2
oligosaccharyltransferase, PglB	2
exemplar protein	2
foreign proteins	2
elaborate human-type glycans	2
therapeutically relevant complex proteins	2
glycosylated therapeutic proteins	2
N-glycan outer chain	2
second mannose residues	2
α-methylmannoside as acceptor	2
O-mannans	2
fourth and fifth mannose residue	2
mannosyltransferases	2
generated products	2
Saccharomyces cerevisiaeO-mannans	2
α-methylmannoside and α1,2-mannobiose as acceptor substrates	2
recombinant forms of Mnt1	2
O-, N- and phosphomannosylation	2
set of multifunctional mannosyltransferases	2
KRE2/MNT1 family	2
highly glycosylated mannoproteins	2
cell surface of Candida albicans	2
bulk genome	2
linker histones	2
underlying structural matrix	2
sites of damage	2
soluble chromatin	2
γH2AX	2
KAP1 and phosphorylated KAP1	2
chemicals or ionising radiation	2
damaged sites	2
chromatin associated proteins	2
human cells DNA double strand break (	2
higher order chromatin fibres	2
ERK1/2, Akt or protein kinase C (PKC)	2
hCAT1 and hCAT2	2
cationic amino acid transporters	2
l-arginine transport inhibitor, l-lysine	2
extracellular l-arginine	2
dominant negative mutant Akt	2
cultured human aortic endothelial cells	2
eNOS substrate, l-arginine	2
Ser1177 and Ser615 by Akt	2
endothelial NO synthase	2
PIP5KIγ93 (which we now call PIP5KIγ_v3)	2
start of exon 16c	2
alternative splicing site	2
C-terminal exon of PIP5KIγ93	2
(2006) [6]	2
rodent neuron-specific PIP5KIγ93 Giudici et al.	2
exon	2
new rodent splice variant	2
humans Schill and Anderson (2009)	2
variants, PIP5KIγ_v1, 2, 4 and 5	2
Iγ (PIP5KIγ)	2
Phosphatidylinositol 4-phosphate	2
vascular homeostasis	2
endothelial derived nitric oxide	2
vessels from TLR4−/− mice	2
DHE staining	2
Mesenteric arteries	2
MnCl2 (a superoxide dismutase mimetic)	2
isometric wire myograph	2
dihydroethidium (DHE)	2
TLR4 receptor	2
mesenteric arteries	2
endotoxin and host derived ligands	2
endothelial and other cells	2
pattern recognition receptor	2
Toll like receptor (TLR)4	2
healthy volunteers (non-smokers and smokers)	2
HDAC1 knockdown	2
BEAS2B cells	2
acute cigarette-smoke exposed mice	2
Nrf2-regulated heme-oxygenase-1 (HO-1) expression	2
HDAC inhibitor, trichostatin A (TSA)	2
bronchial epithelial cell line (BEAS2B)	2
Nrf2 protein	2
histone deacetylase (HDAC) 2	2
multiple anti-oxidant genes	2
NSC pool	2
brains of embryonic and adult p73−/− mice	2
neurogenic areas	2
Sox-2 and Notch gene families	2
p73 null mice	2
neural stem cells (NSC)	2
member of the p53 family	2
MafA,	2
ChREBP in mouse pancreatic islets	2
Ins2, GcK and MafA gene expression	2
clonal pancreatic MIN6 β-cells	2
pancreatic β-cells	2
Carbohydrate responsive element-binding protein (ChREBP)	2
PDX1 at Ser-269	2
PDX1 S269E mutant	2
de-phosphomimetic residue alanine (S269A)	2
Ser-269 to phosphomimetic residue glutamic acid (S269E)	2
MIN6 β-cells	2
PDX1 S269A mutant	2
phosphate incorporation	2
Homeodomain interacting protein kinase 2 (HIPK2) phosphorylates PDX1	2
MIN6 β-cells and primary mouse pancreatic islets	2
phospho-Ser-269-specific antibody	2
C-terminal domain of PDX1	2
Pancreatic and duodenal homeobox 1 (PDX1)	2
M.EcoKI enzyme	2
DNA mimic	2
fluorescently-labelled ocr protein	2
fluorescently-labelled DNA duplexes	2
EcoKI restriction endonuclease	2
sequence-specific DNA methyltransferase	2
two HsdM modification subunits	2
DNA modification methyltransferase M.EcoKI	2
Type	2
C-terminus of the HsdS DNA sequence-specificity subunit	2
target-specific siRNA	2
SNAT1 mRNA	2
two distinct transport systems	2
14C-MeAIB uptake	2
SNAT1 subtype of system	2
total system	2
system A-specific substrate, 14C-MeAIB	2
term placenta	2
predominant subtype of system A in cytotrophoblast cells	2
trophoblast at term	2
SNAT4-mediated system	2
Placental system	2
subtypes (SNAT1, 2, and 4)	2
three system	2
neutral amino acids	2
farnesyl transferase substrates	2
Rab geranylgeranyl transferase substrates	2
prenyl transferase	2
H-Ras	2
Rab23, Rab23 prenylation motif mutants	2
Rab tested	2
Ras and Rho proteins	2
Rabs tested	2
‘prenylation block-and-release’ assay	2
HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase (HMGCR) inhibitor mevastatin	2
prenyl groups	2
membranes Ras-related GTPases	2
specific intracellular membranes	2
Ras super-family small GTPases	2
adverse extra-uterine environment	2
collagen gene expression	2
adverse suckling environment	2
standard chow diet	2
offspring of obese suckled	2
offspring of lean suckled	2
dams on the same or opposite diet	2
Female offspring	2
hypercalorific diet	2
embryonic bud	2
dysmetabolic and fatty liver (non-alcoholic fatty liver disease, NAFLD) phenotype	2
TRPC5 channel	2
receptor agonist sphingosine-1-phosphate	2
E543Q TRPC5	2
ion pore	2
extracellular residue (E543)	2
TRP channels (TRPM2 or TRPM3)	2
Control cells	2
over-expressing TRPC5 or other TRP channels	2
HEK 293 cells	2
Intracellular Ca2+ and whole-cell patch-clamp recordings	2
+)	2
divalent ion (Pb2	2
trivalent lanthanides	2
+-permeable ion channel	2
Transient receptor potential canonical 5 (TRPC5)	2
chromatin microenvironments	2
YFP–CBP	2
YFP–CBPΔ998–1087	2
C-terminally truncated mutants	2
SUMO-modified region	2
SUMO-defective CBP	2
endogenous SUMO-1/PML speckles	2
major SUMO acceptor sites	2
short lysine-rich domain	2
YFP-tagged CBP	2
PML or nuclear bodies	2
many gene promoters	2
lysine acetyltransferase CREB binding protein (CBP)	2
renin–angiotensin–aldosterone system	2
miR-124 and miR-135a	2
two different miRNAs	2
NR3C2 3′UTR	2
NR3C2 3′UTR reporter construct activity	2
miRNA component	2
post-transcriptional layer	2
heteromeric pore architecture	2
novel channels	2
XtKir5.1 subunit	2
markedly different long-lived, multi-level subconductance states	2
rat Kir4.1/Kir5.1	2
Heteromeric XtKir4.1/XtKir5.1 channels	2
genome of the amphibian, Xenopus tropicalis (Xt)	2
orthologs of Kir4.1 and Kir5.1	2
novel pH-sensitive heteromeric channels	2
members of the Kir4.0 subfamily	2
inwardly-rectifying potassium channel subunit Kir5.1	2
substrate 5-iodouracil (5IUR)	2
recombinant hTP	2
several solid tumors	2
Human TP (hTP)	2
platelet derived endothelial cell growth factor (PD-ECGF)	2
Thymidine phosphorylase (TP)	2
ribosomal protein	2
GTP/GDP binding	2
non-specific single and double-stranded RNA	2
30S assembly	2
RNA chaperone	2
GTP-bound form	2
small ribosomal (30S) subunit in bacteria	2
circularly permuted GTPase	2
aggregated Aβ	2
Tg2576 mice	2
tau-kinase glycogen synthase kinase-3	2
reduced tau-phosphatase PP2A	2
Aβ binding protein transthyretin	2
tau phosphorylation	2
2 null (Irs2−/−) mice	2
insulin receptor substrate	2
mice (Tg2576) over-expressing human amyloid precursor protein (APP)	2
domains I and III	2
eEF1α and histidine-tRNA ligase	2
MT-1 3′UTR	2
5-bp internal stem	2
one of the major MT-1 3′UTR binding proteins	2
histidine-tRNA ligase	2
3′UTR sequences	2
biotinylated MT-1	2
Full length recombinant rat eEF1α, and independently domains I and III	2
nucleotides 66–76	2
elongation factor 1 alpha (eEF1α) and other interacting proteins	2
3′untranslated region (3′UTR) and trans-acting binding proteins	2
perinuclear cytoskeleton	2
metallothionein-1 (MT-1) mRNA	2
small adipocytes	2
intact adipose tissue	2
isolated adipocytes	2
lean (P=0.027) and obese subjects	2
omental adipose tissue	2
n=78 pairs	2
lean sisters	2
Carboxylesterase 1 (CES1)	2
comorbidities	2
ALK7 and INHBB expression	2
obese (n=90) subjects	2
obesity discordant siblings	2
activin receptor-like kinase 7 (ALK7)	2
activin type I and II receptors	2
novel adipokine activin B.	2
inhibin beta B (INHBB)	2
Human adipose tissue	2
Carbonic anhydrase-III	2
betaine supplementation	2
S-adenosylhomocysteine	2
liver S-adenosylmethionine	2
methionine metabolic pathway enzymes	2
betaine supplemented ethanol diet	2
livers of rats	2
betaine homocysteine methyltransferase-1, methionine adenosyl transferase-1, and glycine N-methyltransferase	2
liver cytosolic proteins	2
control, ethanol or betaine supplemented diets	2
8	2
unusual predicted C-terminal transmembrane domain	2
model neuronal (Neuro2A) cell line	2
abundantly expressed brain proteins	2
multiple targets	2
+-binding proteins	2
small Ca2	2
CaBP family of EF-hand	2
ATP and GTP	2
nucleotides GTP/GDP/ATP/ADP	2
specific nucleotide-bound state of the protein	2
50S.	2
purified ribosomal subunits	2
30S and 50S ribosomal subunits	2
RNA components	2
16S and 23S	2
hflX gene in hflA operon	2
GTP binding protein	2
cardiac alteration	2
larger mammals	2
Action potentials	2
light and confocal microscopy	2
Ventricular myocytes	2
calcium tolerant cells	2
adult zebrafish ventricle	2
PKCα- and β-specific inhibitors	2
PKCαβ and δ in THP-1 cells	2
MAP kinase and phosphatidylinositol-3-kinase pathway inhibitors	2
EGC-induced HO-1 mRNA expression	2
EGC-induced HO-1 expression	2
NAD(P)H:quinone oxidoreductase 1, glutathione cysteine ligase and ferritin	2
ARE-regulated genes	2
HO-1 mRNA and protein expression	2
epigallocatechin (EGC)	2
Various kinases	2
haem oxygenase-1 (HO-1)	2
cellular anti-oxidants	2
Nrf2/anti-oxidant response element (ARE) pathway	2
highly hypoxia-inducible gene in human adipocytes	2
human (obese) subcutaneous and omental adipose tissue	2
MT-3 mRNA	2
hypoxia mimetics (CoCl2, desferrioxamine, dimethyloxalylglycine)	2
one gene, metallothionein-3 (MT-3)	2
leptin, angiopoietin-like protein 4	2
uncoupling protein 2)	2
arrays	2
Hypoxia-signalling pathway PCR arrays	2
myosin VI	2
calcium ions, PtdIns(4,5)P2 (PIP2)	2
specific adaptor proteins	2
Myosin VI	2
myosins	2
unique unconventional motor, myosin VI	2
Professor Setsuro Ebashi	2
RANKL/TNF-α	2
TGF-β-induced NFATc1	2
key osteoclastic transcription factor	2
One cytokine	2
distinct stimuli	2
mouse Nat2/human NAT1	2
Nat2 knockout and Nat2 wild-type mice	2
acetylated folate metabolite para-aminobenzoylglutamate	2
functional Nat2 gene	2
Mouse Nat2	2
estrogen receptor positive breast tumours	2
Human NAT1	2
xenobiotic arylamines	2
homologue (NAT1) in humans	2
mouse arylamine N-acetyltransferase 2 (Nat2)	2
cytochalasin B.	2
[3H]2-deoxy-d-glucose	2
GLUT-3 protein	2
GLUT-1 protein	2
GLUT-1 mRNA	2
key inflammation-related adipokines	2
apoE4 carriers	2
apoE4 macrophages	2
key redox sensitive transcription factor NF-κB	2
apoE4-cells	2
heme oxygenase-1 (a stress-induced anti-inflammatory protein)	2
tumour necrosis factor alpha (pro-inflammatory) and interleukin 10 (anti-inflammatory)	2
human apoE3 or apoE4	2
murine monocyte–macrophage cell line (RAW 264.7)	2
Ca2+/calmodulin-dependent protein kinase kinase	2
Ca2+/calmodulin-dependent protein kinase kinase inhibitor, STO-609	2
dominant negative mutant AMPK	2
Vascular endothelial growth factor (VEGF)	2
complex biochemical pathways	2
annexin 1 system (mediator and its putative receptors)	2
bone modelling cytokines interleukin-6 or interleukin-1	2
cell cytosol	2
annexin 1	2
FPR mRNA	2
Saos-2 cells	2
ligand and two G-coupled receptors termed formyl-peptide receptor (FPR) and FPR-like-1 (FPRL-1)	2
annexin 1 system	2
detailed physical models	2
position 191	2
E residue	2
high affinity Ca2+ block site	2
D in position 191	2
ion in the innermost site	2
E. Equilibrium Molecular Dynamics simulations	2
mutants of NaChBac channel	2
D and E residues	2
aspartate (D) and glutamate (E) residues	2
Selectivity Filter	2
accurate controls	2
fluorescent lipid analogs	2
lipid headgroup	2
PEG linker	2
liquid-ordered membrane environments	2
poly-ethyl-glycol (PEG) linkers	2
headgroup labeling	2
commonly used sphingomyelin-based lipid analogs	2
biomimetic membranes	2
non-labeled host lipids	2
complex membrane structures	2
Organic dye-tagged lipid analogs	2
DPPC in a (rippled-)gel phase	2
liquid crystalline DPPC	2
rippled gel-state	2
SC lipid membrane	2
skin surface	2
DPPC containing formulation	2
pure DPPC	2
phase separated	2
SC lipids).(Perdeuterated	2
model phospholipid, dipalmitoylphosphatidylcholine (DPPC) and synthetic ceramide-based mixtures	2
phospholipids and SC lipids	2
topical formulations	2
ceramides, free fatty acids and cholesterol	2
crystalline lipid matrix	2
natural physical barrier	2
stratum corneum (SC)	2
outermost layer of the skin	2
multiscale simulations	2
membrane leaflets	2
shorter-lived cardiolipin interaction sites	2
long-lived cardiolipin binding sites	2
phosphatidylcholine and phosphatidylethanolamine lipids	2
cardiolipin molecules	2
coarse-grain simulations	2
cardiolipin-binding sites	2
yeast and bovine ADP/ATP carriers	2
cardiolipin-containing membrane	2
Multiscale simulations	2
mitochondrial carriers	2
cardiolipin binding	2
members of the mitochondrial carrier superfamily	2
three equivalent sites of the ADP/ATP carrier	2
mitochondrial ADP/ATP carrier	2
sub-nm structures	2
dynamic region	2
native lipids and SMA polymer	2
exterior	2
C-terminal helix (TM12)	2
EM derived maps	2
Escherichia coli multidrug efflux transporter AcrB	2
native lipids (SMALPs)	2
styrene maleic acid co-polymers (SMA)	2
proteoliposomes, amphipols and nanodiscs	2
“native” like environments	2
EM field	2
Piezo, Ryanodine receptor, TRPV1 and the Glutamate receptor	2
short-chain 2:1 and 3:1 formulations of SMA	2
small membrane patches	2
clusters of complexes	2
densely packed and highly ordered photosynthetic membranes	2
solubilise reaction centre-light harvesting 1 (RC-LH1) complexes	2
dimeric, trimeric and tetrameric multimers	2
normally monomeric RCs	2
genetically-encoded coiled-coil bundles	2
solubilise RCs	2
2:1 and 3:1 formulations of SMA	2
short chain variants	2
solubilising RCs	2
styrene to maleic acid	2
formulations of SMA	2
photosynthetic membranes	2
solubilising Rhodobacter sphaeroides reaction centres (RCs)	2
various commercially-available formulations of the SMA copolymer	2
protein/lipid nanodiscs	2
amphiphilic copolymers such as styrene maleic acid (SMA)	2
protein complement	2
biological lipid bilayer membranes	2
electrolyte solution	2
stable, well-defined pores	2
3:1 phosphatidylcholine:cholesterol	2
MelP5 pores	2
planar lipid bilayer recordings	2
liposome membranes	2
MelP5 in lipid membranes	2
main active constituent of bee venom	2
26 amino acid peptide	2
safe, natural medicine supplement	2
hydrophobic chemical contaminants	2
aged subjects and chronically ill patients	2
lipid globules, liposomes	2
various intracellular membranes	2
cells the glycerolphospholipids	2
cellular sites	2
lipoproteins, lipid globules, lipid droplets, liposomes and other carriers	2
replacement glycerolphospholipids	2
cellular and intracellular membranes	2
damaged, oxidized, membrane phospholipids	2
fructooligosaccharides (for protection against oxidative, bile acid and enzymatic damage) and antioxidants	2
cell membrane glycerolphospholipids	2
functional, oral supplements	2
ceramides and other sphingolipid species	2
epidermal lipid barrier	2
epidermal CER[EOH], CER[EOS] and CER[EOP] ceramides	2
members of the ceramide families containing Non-hydroxy fatty acids and Sphingosine or Dihydrosphingosine bases (CER[NS] and CER[NDS], respectively)	2
number of sphingoid bases, phosphorylated sphingoid bases, and phosphorylated ceramides	2
EPA or DHA	2
Ex vivo skin explants	2
eicosanoids, docosanoids and endocannabinoids	2
n-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)	2
dermal and epidermal cells	2
various fatty acids	2
large number of ceramides	2
epidermal barrier	2
linoleic acid-Ester-linked Omega-hydroxylated ceramides of 6-Hydroxy-sphingosine, Sphingosine and Phytosphingosine bases (CER[EOH], CER[EOS] and CER[EOP], respectively)	2
multitude of species	2
hydrophobic residues within lid and active site flap regions (residues 94–110)	2
steered MD simulations	2
Thermomyces lanuginosus lipase	2
residues 235–283	2
lid region of M37	2
anionic lipid bilayers	2
M37 lipase	2
psychrophilic lipase M37	2
different interfaces	2
many lipases	2
Hydrophobic interfaces	2
hydrophobic and aqueous environments	2
biotechnological importance	2
IM30 protein family	2
AHb of PspA	2
full length PspA and Vipp1 protein functionalities	2
bona fide membrane-sensing AH's	2
unstructured to alpha-helical	2
AHa derived peptides	2
putative AH regions of PspA and Vipp1	2
purified peptides	2
adjacent amphipathic helix b (AHb) in PspA	2
putative amphipathic helix a (AHa)	2
PspA's and Vipp1's conserved N-terminal regions	2
thylakoid membranes	2
AAA+ ATPase PspF. PspA	2
IM	2
member of the IM30 peripheral membrane protein family	2
central component PspA	2
inner membrane (IM)	2
cholesterol crystalline domain formation	2
cholesterol-poor disordered domains	2
distinct cholesterol-rich ordered domains	2
cholesterol domains	2
EPA, glycyrrhizin, arachidonic acid, and alpha linolenic acid	2
pre-existing domains	2
eicosapentaenoic acid (EPA), other TG-lowering agents, docosahexaenoic acid (DHA), and other long-chain fatty acids	2
Omega-3 fatty acids	2
atherosclerotic membranes	2
Cholesterol crystalline domains	2
region comprising strand β4 (Trp-86) and β10-14 (Trp-160 and Trp-221)	2
stable barrel	2
barrel	2
micellar environments	2
folded hVDAC-2 barrel	2
strategically placed four intrinsic tryptophans of the human outer mitochondrial membrane protein, voltage-dependent anion channel isoform-2 (VDAC-2)	2
large number of well-studied α-helical and β-barrel membrane proteins	2
key residue of this aromatic belt	2
amphipathic interfacial environment	2
transmembrane region of the protein	2
characteristic ‘aromatic belt’	2
solvent-bilayer interface	2
unique bilayer environment	2
placenta and other transporting epithelia	2
certain groups of amino acids	2
individual accumulative, exchange and facilitative classes of transporters	2
distinct complement of transporter proteins	2
two plasma membranes	2
integrated system	2
human placental amino acid transfer	2
new computational model	2
different transporters	2
specific plasma membrane transporters	2
broad array	2
J.C. Gumbart and Sergei Noskov	2
intact virions	2
range of sources	2
complex viruses	2
lipid bilayer components of the envelopes of influenza A and of dengue virus	2
outer envelope	2
HIV-1, influenza A, and dengue virus	2
nucleic acid core	2
inner core of RNA or DNA	2
viral capsids	2
structures of viruses and their components	2
Molecular dynamics (MD) simulations	2
membrane-spanning glycoproteins	2
protein capsid	2
Ilpo Vattulainen and Tomasz Róg	2
elongated membrane-binding particles	2
upcoming field	2
non-crowded and crowded membranes	2
appropriate physical anomalous diffusion models	2
protein crowded membranes	2
monitored particles	2
measured particles	2
membrane embedded proteins	2
cholesterol or proteins	2
single component, pure lipid bilayers in simulations	2
lipid molecules and proteins	2
protein crowding	2
lipid bilayer model membranes	2
living biological cells	2
crowded membranes	2
membrane biophysics community	2
various particles and macromolecules	2
defensins in membranes	2
plane of the membrane	2
β-sheet structure	2
standard kinetic model	2
states	2
mixtures of diacylglycerophosphocholines (PC) with either diacylglycerophosphoglycerol (PG) or diacylglycerophosphoserine (PS)	2
simulated LD spectra	2
fluorescence and linear dichroism (LD) spectroscopies	2
defensin HNP-2 with negatively charged membranes	2
transporter mutants	2
mutant R70G	2
TetA(B)	2
mutants G44V and G346V bound tetracycline	2
purified transporters	2
valine, alanine or glycine (VAG scan)	2
transmembrane α-helices 6 and 7	2
TetA(B) mutants	2
medically important transporter	2
chemical potential gradient	2
Major Facilitator Superfamily	2
tetracycline antiporter TetA(B)	2
CorA channels	2
trans-membrane domain	2
trans-membrane segments	2
highly asymmetric domain structure	2
detergent solubilized Methanocaldococcus jannaschii CorA channel	2
homo-pentameric quaternary structure	2
two full-length CorA channels	2
essential magnesium ions	2
AH2 oligomers	2
second amphipathic N-terminal helix (AH2)	2
number of domains	2
viral replication complex	2
host cell's membranes	2
non-structural protein 4B (NS4B)	2
full spectrum of VGSCs	2
eel VGSC or rNaV1.3	2
human VGSCs examined	2
eel VGSC	2
VGSC from Electrophorus electricus	2
electric eel VGSC	2
human and rat VGSCs	2
mammalian and particularly human voltage-gated sodium channels (VGSCs)	2
EPS chains	2
surrounding medium	2
surface-grafted polyelectrolyte layer	2
rhodococcal EPS	2
denser EPS	2
late growth stage	2
nonspecific binding sites	2
Rhodococcal cells	2
bacterial cell probe	2
Rhodococcus RC291	2
SMALP scaffolds	2
equivalent DDM stabilised form	2
near-native lipid environment	2
model membrane protein	2
Escherichia coli secondary transporter AcrB	2
small disk of lipid bilayer	2
SMA lipid particles (SMALPs)	2
styrene maleic acid co-polymer (SMA)	2
natural membrane environment	2
lipidic cubic phase crystallisation	2
channel(s)	2
COX-1, COX-2 and COX-3	2
channel formers	2
D-channel model	2
multiple pore-lining regions	2
TM helix–turn–helix	2
pore-lining helix C-terminal	2
caveolin	2
two within	2
multiple cholesterol and caveolin-binding (CB) motifs	2
TM-6, TM-7, TM-10 and TM-11 of COX-1	2
CuA center of COX-2)	2
Heme a3 and the CuB sites	2
COX-3 are pore-lining regions (possible channel formers	2
5 of the 6 TM helices	2
helices in COX-2	2
subunit-1 (COX-1), subunit-2 (COX-2) and subunit-3 (COX-3)	2
transmembrane (TM) helix arrays	2
membrane channels	2
proton channel(s)	2
high-spin heme (a3) and copper atoms (CuB)	2
electron transfer chain	2
terminal enzyme	2
Cytochrome c oxidase (CcO)	2
variety of clinical diagnoses	2
aged subjects	2
high-energy molecules	2
phospholipids like cardiolipin and other molecules	2
mitochondrial inner membranes	2
membrane sites	2
specific and nonspecific transport systems	2
tissues and cells	2
circulating cells and lipoproteins	2
transport and carrier molecules	2
lipid receptors	2
phospholipids	2
phospholipid micelles	2
protective molecules	2
damaged, usually oxidized, membrane glycerophospholipids	2
cell membrane phospholipids and antioxidants	2
functional oral supplements	2
crowded membrane plane	2
specialized membrane structures	2
lipid rafts and protein complexes	2
smaller membrane nano- and submicro-sized domains	2
long-range, non-random mosaic macro-organization of membranes	2
membrane-associated cytoskeletal and extracellular structures	2
fenceposts and other structures	2
membrane-associated fences	2
tightly packed integral membrane protein complexes	2
particular membrane components	2
cell–cell and intracellular membrane-associated protein and cytoskeletal interactions	2
cell–matrix	2
lipid–lipid, protein–protein and lipid–protein interactions	2
membrane plane	2
many protein and lipid components	2
macrostructure of cellular membranes	2
newer data	2
membrane components	2
extracellular matrix structures	2
membrane-associated cytoskeletal fences	2
macrostructure	2
lipid rafts and protein/glycoprotein complexes	2
plant and animal cells and lower forms of life	2
variety of intracellular and cellular membranes	2
basic nano-structures	2
S. J. Singer and G. L. Nicolson, Science 175 (1972)	2
membrane matrix	2
membrane lipids and proteins	2
Fluid—Mosaic Membrane Model	2
normal and alternative amino-terminus	2
human testis	2
naturally-occurring TMEM16A isoform	2
alternative start codon	2
upstream non-ATG codon	2
M1X mutant	2
non-canonical start codon	2
mutant M1X	2
resulting mutant, Δ(1–116)	2
TMEM16A coding sequence	2
first 116 codons	2
second ATG	2
first ATG of the TMEM16A coding sequence	2
various TMEM16A domains	2
plasma membrane protein	2
fungal spoilage	2
new or improved antifungal formulations	2
bacillomycin L and other iturins	2
intracellular targets	2
amphotericin B, a polyene antibiotic	2
R. solani hyphae	2
Rhizoctonia solani Kühn	2
variety of agronomically important filamentous fungi	2
Bacillus amyloliquefaciens	2
natural iturinic lipopeptide	2
Bacillomycin L	2
Calcium channels	2
extracellular, membrane-associated proteins	2
α2δ subunits of these channels	2
auxiliary or accessory subunits	2
β and α2δ and sometimes γ subunits	2
T-type channels	2
main pore-forming α1 subunit	2
Voltage-gated calcium channels	2
natural ionophore	2
FtsZ ring	2
MinCD oscillation	2
cytoplasmic membrane of E. coli	2
proton ionophore	2
bacterial signalling molecule	2
human chronic wounds	2
wound edge keratinocytes of human chronic wounds	2
antisense gel	2
diabetic rats	2
wound edge keratinocytes	2
[4–7].	2
gap junction protein Cx43	2
specific and effective therapeutic agents	2
Western society	2
hard to heal wounds	2
lower limb	2
chronic wound	2
Western population	2
stalled or hard-to-heal chronic wounds	2
acute wounds	2
Skin lesions	2
hP2X4 and zfP2X4.1	2
models of DdP2XA	2
N-glycan usage	2
previously determined low-resolution hP2X4 structure	2
strong trimers in detergent solution	2
ATP-coupled resins	2
human P2X4 (hP2X4) and Dictyostelium discoideum P2XA (DdP2XA) in Sf9 cells	2
over-expression in baculovirus-infected Spodoptera frugiperda (Sf9) insect cells	2
3D-crystallization candidate	2
P2X research field	2
zebrafish (zf) P2X4.1	2
apo-, closed-state 3D crystal structure	2
Laurdan stained cell membranes	2
standard widefield fluorescence microscope	2
surface of living cells	2
2-photon confocal microscopy	2
Laurdan fluorescence microscopy	2
pseudopodia or flagella	2
features of the polarized cell	2
larger more visible liquid-ordered regions	2
microdomains or rafts	2
traditional microscopic techniques	2
heterogenous microdomains	2
polarized cell types	2
two tryptophan derivatives	2
non-transported blockers	2
5-Hydroxy-l-tryptophan and α-methyl-d,l-tryptophan	2
l-proline	2
neither 5-hydroxy-l-tryptophan nor α-methyl-d,l-tryptophan	2
5-hydroxy-l-tryptophan (IC50 1.6±0.4mM), α-methyl-d,l-tryptophan (3.5±1.5mM), l-tryptophan, 1-methyl-l-tryptophan and indole-3-propionic acid	2
l-Proline uptake	2
tryptophan derivatives	2
certain heterocyclic GABA derivatives (e.g. l-pipecolic acid)	2
proline derivatives	2
rat PAT2 in Xenopus laevis oocytes	2
non-transported inhibitors	2
number of proline, GABA and tryptophan derivatives	2
imino acid and glycine uria	2
renal proximal tubule	2
amino acids proline, glycine, alanine and hydroxyproline	2
H+-coupled amino acid transporter PAT2 (SLC36A2)	2
solute carrier	2
non-nutrient components of diet or orally-delivered drugs	2
substrate for the H+-coupled amino acid transporter hPAT1 (SLC36A1)	2
selective Na+/H+ exchanger NHE3 (SLC9A3) inhibitor S1611	2
phosphodiesterase inhibitor	2
apical membrane	2
dietary phosphodiesterase inhibitors caffeine	2
Caco-2 cell monolayers	2
brush-border membrane of the small intestinal epithelium	2
many orally-active drugs	2
di/tripeptides	2
(SLC15A1)	2
H+-coupled transporter hPepT1	2
original peptide sequences	2
UCN and AM	2
Uro-II	2
healthy patients	2
patients with specific CVDs	2
important therapeutic targets	2
(AM)	2
vasoconstrictor Urotensin-II (Uro-II) and the vasodilators Urocortins (UCNs) and Adrenomedullin	2
angiotensin II, endothelin, serotonin or natriuretic peptides	2
well-known vasoactive agents	2
Several peptides	2
esterase	2
plasma-derived HuBChE tetramers	2
milk-derived PoBChE	2
set of polyproline-rich peptides	2
polyproline-rich peptides	2
4 identical subunits	2
PoBChE and HuBChE.	2
HuBChE. Monoclonal antibodies 11D8, mAb2, and 3E8 (HAH 002)	2
BChE-specific inhibitors	2
PoBChE hydrolyzed acetylthiocholine	2
2 sources	2
HuBChE in minipigs	2
organophosphorus nerve agents	2
Human butyrylcholinesterase (HuBChE)	2
repeated blood sampling	2
provitamin A carotenoid bioconversion	2
carotenoid dose	2
vitamin A stores	2
retinyl esters plus β-carotene	2
retinyl esters	2
test dose of stable isotope-labeled β-carotene	2
single plasma sample	2
retinol (bioconversion)	2
provitamin A carotenoids	2
functional biomarkers	2
α-carotene or lycopene	2
Carotenoid-associated proteins	2
β-cryptoxanthin	2
lutein/zeaxanthin	2
child samples	2
Plasma proteins	2
high-abundance proteins	2
500 6–8 year old Nepalese children	2
6 common dietary carotenoids (α-carotene, β-carotene, lutein/zeaxanthin, β-cryptoxanthin, and lycopene)	2
recent vegetable and fruit intake	2
vitamin A precursors, antioxidants, anti-inflammatory agents	2
naturally occurring pigments	2
native exogenous Apaf-1	2
affinity column	2
native form	2
truncated Apaf-1 which lacks WD-40 repeats (ΔApaf-1)	2
cell based system	2
full length Apaf-1	2
extracts of the cells	2
complementary fragments of luciferase	2
cell based-system	2
either N-terminal fragment or C-terminal fragment of P. pyralis luciferase	2
cell-free and cell-based systems	2
split luciferase assay	2
WD-40 repeats of Apaf-1 molecule	2
apoptosis regulatory network	2
cytosolic multi-domain protein	2
biomacromolecular solutions	2
moderately sized macromolecules	2
near-native macromolecular solutions	2
intrinsically unfolded or specifically behaving proteins	2
NMR spectrum	2
natural cell	2
apoplastic H2O2 (and consequently hydroxyl radicals)	2
(1)	2
DKG in the pathway ascorbate → dehydroascorbic acid → DKG → (1)	2
reduction product of DKG (C6H8O7).In conclusion, compound (1)	2
un-ionised (1)	2
strongly acidic (pKa ≈ 2.3) compound	2
HPLC-enriched preparation of (1)	2
ascorbate oxidase	2
Compound (1)	2
major H2O2-generating and peroxidase-delaying principle	2
by-product, compound (1)	2
DKG preparations	2
several by-products	2
DKG itself	2
aromatic substrates	2
non-enzymically	2
2,3-diketogulonate (DKG)	2
One ascorbate metabolite	2
pro-oxidants and anti-oxidants	2
plant's l-ascorbate (vitamin C)	2
wide range of endogenous and environmental inducers	2
multiple cysteine sensors of Keap1	2
main negative regulator	2
large network of cytoprotective proteins	2
endogenously produced and exogenously encountered small molecules (termed inducers)	2
reactive cysteine residues	2
oxidants, electrophiles and pro-inflammatory agents	2
best-characterized substrate of Keap1	2
Cullin3 adaptor	2
homodimeric Keap1	2
CRL	2
Cullin3-based Cullin-RING E3 ubiquitin ligase (CRL) multisubunit protein complex	2
Kelch-like ECH associated protein 1 (Keap1)	2
papain-like cysteine proteinase	2
N. benthamiana orthologue of cathepsin H.	2
aleurain-like protease	2
proteome-derived peptide libraries	2
specificity-determining P2 position	2
aliphatic over aromatic amino acids	2
cathepsin H-like aminopeptidase activity	2
several synthetic endopeptidase substrates	2
mature protease	2
papain-like cysteine proteinases	2
C-terminal granulin domain	2
CP14 (NbCP14)	2
recombinant Nicotiana benthamiana	2
cathepsin H-like protease	2
distinct subfamily of papain-like cysteine proteinases	2
plant embryos	2
molecular module	2
cysteine protease CP14	2
three groups of processes	2
chemical factors (radicals and reactive oxygen/nitrogen species)	2
laser produced plasma (LPP)	2
electrical, chemical and biochemical ones	2
ATP, glutathione, citrate, ethylenediaminedisuccinic acid, nicotianamine, or bacillithiol	2
variety of low molecular weight zinc complexes	2
biochemical literature	2
water and inorganic and organic anions	2
low molecular weight ligands	2
donor atoms of ligands	2
s-block cations	2
d-block cation Zn2+	2
biological zinc ions	2
zinc or Zn2+	2
zinc oxide (ZnO)	2
zinc ions and nanoparticles	2
zinc ion species	2
proteins and chelating agents	2
biological inorganic chemistry	2
“mobile” zinc ions	2
zinc proteins	2
proteins zinc ions	2
catalytic or structural function	2
side chains of a few amino acids	2
oxygen, nitrogen, and sulfur donors	2
coordination environment	2
Epigallocatechin-3-gallate (EGCG)	2
uncoupling in vitro	2
recombinant troponin	2
donor heart troponin	2
quantitative in vitro motility assay	2
actin and human cardiac tropomyosin	2
thin filaments	2
troponin T (TnT)	2
sample environment	2
critical optical components	2
synchrotron beamline	2
instrumentation	2
membrane proteins, viruses and ribosomes	2
MX synchrotron beamlines	2
complete data set	2
synchrotron beamlines	2
challenging systems	2
large-scale facilities	2
stand-alone applications	2
complex protein mixtures	2
biological macromolecules (BioSAXS)	2
basolateral membrane	2
efflux system	2
uptake transporter	2
lateral plasma membrane sections	2
MCT1 protein	2
ferulic acid metabolites	2
apical to basolateral, but not basolateral to apical, direction	2
SLC16A1 (MCT1) and SLC16A3 (MCT4)	2
monocarboxylate transporters	2
phenolic acid	2
short chain fatty acid	2
colonic enterocytes	2
main energy source	2
major by-product of fermentation	2
Ferulic acid	2
example notebooks	2
notebooks	2
low-barrier entry point	2
IPython notebook interface	2
IPython notebooks	2
web	2
recently described platform	2
specialized computational infrastructure, software	2
new biological applications	2
unique, high-resolution mass spectra	2
Typical MSI datasets	2
biological applications	2
high fat diet	2
neither wild type nor FLAG-tagged variants of mouse sarcolipin in transgenic mice	2
synthetic mouse sarcolipin	2
mouse skeletal tissue	2
sarcoplasmic reticulum calcium pump	2
skeletal muscle sarcolipin	2
sarcolipin knockout mice	2
potential regulatory heme sensing and storage protein	2
low-spin ligand cyanide	2
stable hexamer	2
solution LmCld	2
putative substrate and heme entrance channel	2
chlorite-degrading chlorite dismutases	2
homopentameric crystal structure (2.0Å)	2
regulatory heme sensing protein	2
Gram-positive pathogen Listeria monocytogenes (LmCld)	2
large protein family	2
heme b-dependent oxidoreductases	2
functional chlorite dismutases	2
various fusion proteins	2
eukaryotic kingdoms	2
highly evolved and specialized clades of peroxidases	2
ancient prokaryotic roots	2
heme peroxidase superfamilies	2
four superfamilies	2
catalase, cyclooxygenase, chlorite dismutase or peroxygenase activities	2
(sub)families	2
myriad of organic and inorganic substrates	2
one-	2
Heme peroxidases	2
histidine or cysteine	2
posttranslationally modified heme	2
heme b	2
redox cofactor	2
Four heme peroxidase superfamilies (peroxidase–catalase, peroxidase–cyclooxygenase, peroxidase–chlorite dismutase and peroxidase–peroxygenase superfamily	2
placebo (n=15) or one of two L and Z supplements	2
69 subjects	2
collection of xanthophylls, lutein (L), meso-zeaxanthin (MZ) and zeaxanthin (Z)	2
macular pigment	2
Visual psychophysics	2
baseball)	2
many sports	2
stimulus	2
covalently bound FAD	2
covalent bond	2
variant H103Y.	2
wild-type and variant	2
anionic semiquinone radical	2
Agaricus meleagris PDH	2
covalent FAD attachment	2
several substrates	2
FAD (non-covalently)	2
8α-N(3) histidyl linkage	2
histidine 103	2
FAD cofactor	2
corresponding keto sugars	2
free, non-phosphorylated sugars	2
glucose–methanol–choline (GMC) family of oxidoreductases	2
monomeric flavoprotein	2
Pyranose dehydrogenase (PDH)	2
panoply	2
membrane mimetic environment	2
small, water-soluble proteins	2
site of mono-iodination	2
iodinating triiodide anion	2
tyrosine phenol ring	2
electrooxidisable anions	2
tyrosine residues in proteins	2
deleterious polyiodination	2
mechanistic enzymology	2
biologically active small molecules	2
useful catalysts	2
modified or expanded substrate repertoire	2
aldolase enzymes	2
wild-type aldolases	2
protein folding and aggregation pathways	2
complex, multidimensional protein energy landscapes	2
dynamic, heterogeneous and/or insoluble protein ensembles	2
amyloid fibrils and amyloid-related aggregates	2
protein energy landscapes	2
multiphoton near-infrared illumination	2
multiphoton photochemistry	2
emission	2
MPNO or tryptophan only	2
tryptophan and MPNO strong emission	2
titanium:sapphire laser	2
multiphoton excitation	2
Similar solutions	2
Solutions of tryptophan and N-hydroxypyridine-2-thione (mercaptopyridine-N-oxide, MPNO)	2
one locus	2
European men	2
6,175 case subjects	2
longitudinally followed population	2
complex structural variant	2
DUP4 genotype	2
village	2
population of a malaria-endemic village	2
glycophorin B-glycophorin A fusion gene	2
glycophorin locus	2
extra copies of a glycophorin A-glycophorin B fusion gene	2
complex structural genomic variant	2
parasite Plasmodium falciparum	2
red blood cell surface proteins	2
Glycophorin A and glycophorin B	2
searchable online database	2
mQTL database	2
1,702 genes	2
5,420 DNAm sites	2
1,246 DNAm sites	2
93,268 DNAm sites	2
2,907,234 genetic variants	2
Illumina EPIC array	2
DNA methylation (DNAm)	2
lipidated protein cargo	2
multiple ciliary proteins	2
network of proteins	2
guanine nucleotide exchange factor ARL13B	2
highly conserved Arg149 residue	2
lipid-modified proteins	2
small GTP-binding protein	2
encoded protein, ADP ribosylation factor-like GTPase 3 (ARL3)	2
UCSC Genome Browser hg 19)	2
chromosome 10	2
known JBTS-associated genes	2
appropriate transcripts	2
NDUFA6 RefSeq transcript	2
clinically relevant tissues	2
N-module	2
assembled complex III and IV holoenzymes	2
∼830 kDa complex I intermediate (consisting of the P- and Q-modules)	2
complex I.	2
subjects’ fibroblasts	2
NDUFAB1, NDUFA7, and NDUFA12	2
Q-module subunits	2
incorporated NDUFA6	2
subjects’ fibroblast cell lines	2
part of the Q-module	2
15 kDa LYR-motif-containing complex I subunit	2
four unrelated children	2
undiagnosed cohorts	2
complex I structural subunits or assembly factors	2
∼65 genes	2
protein translation	2
compound heterozygous affected individual	2
asymptomatic heterozygous carriers	2
bi-allelic combination of the SJV	2
SJV	2
brain calcifications	2
cerebral aneurysms	2
5′-splice junction non-coding variant (SJV)	2
beta chain of the alpha2beta2 phenylalanine-tRNA synthetase (FARS)	2
four families	2
Charcot-Marie-Tooth	2
different centers	2
variant types (missense and C-terminal truncating)	2
three affected individuals	2
upper lip	2
broad nasal tip	2
international collaborations	2
matchmaker databases	2
whole-exome and whole-genome sequencing technologies	2
two affected mothers	2
Tousled-like kinase 2 (TLK2)	2
clinical genetics services	2
MPT cohort	2
similarly ascertained MPT-affected individuals	2
two CPGs	2
truncating or splice-site CPG variants	2
relevant CPG	2
low-frequency structural variants	2
moderate- and high-risk CPGs	2
440 families	2
460 individuals	2
pre-assessed MPT individuals	2
cancer-predisposition genes (CPGs)	2
MPT-affected individuals	2
various causes	2
cancer survivors	2
Multiple primary tumors (MPTs)	2
previously reported genes	2
40 loci	2
2014 Psychiatric Genomics Consortium schizophrenia (SCZ) GWAS	2
post-mortem human brain samples	2
(GWAS) loci	2
Causal genes	2
human exosomopathies	2
spinal motoneuronopathy	2
portions of the cerebellum and hindbrain	2
exosc9 in zebrafish	2
whole multi-subunit exosome complex	2
C (p.Leu14Pro) and	2
compound heterozygous	2
homozygous c.41T>C (p.Leu14Pro) variant	2
different ethnicity	2
congenital fractures	2
progressive SMA-like motor neuronopathy	2
affected individuals’ fibroblasts and skeletal muscle	2
exosome components EXOSC3	2
conserved multi-protein complex	2
accessible and tractable corneal tissue	2
splicing factor proteins (MBNL1 and MBNL2)	2
nuclear RNA foci	2
CEC model	2
FECD subject-derived corneal endothelial cell (CEC) model	2
non-coding trinucleotide repeat	2
epithelial-like cell type	2
epithelial markers E-Cadherin and Cytokeratin 7	2
PPCD4 tissue	2
corneal “endothelium”	2
corneal endothelial cells in control tissue	2
PPCD4-affected individuals	2
GRHL2 regulatory variants	2
EMT-inducing transcription factors	2
(MET)	2
unrelated PPCD-affected families	2
+257delT and c.20+133delA)	2
intron 1 of GRHL2	2
three additional previously unsolved PPCD-affected families	2
intronic regulatory region	2
unique variant (c.20	2
autosomal-dominant corneal endothelial dystrophy, posterior polymorphous corneal dystrophy 4 (PPCD4)	2
female gonads	2
human “pro-ovary” and “anti-testis” sex-determining factor	2
fetal human ovary	2
FOXL2-negative stromal cell population	2
testicular tissue	2
external genitalia	2
children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)	2
one child	2
two of three children	2
NR2F2, encoding COUP-TF2	2
46,XX SRY-negative individuals	2
one pathway	2
mutually antagonistic male and female regulatory networks	2
(p.Val106Gly)	2
Pro82Leu)	2
G variants	2
ATP5F1D c.245C>T and c.317T>	2
wild-type human ATP5F1D.	2
fly head	2
developing eyes and brains	2
ATP5F1D homolog	2
Drosophila ATPsynδ	2
mitochondrial cristae	2
F1FO ATP synthase	2
Cultured skin fibroblasts	2
p.Val106Gly)	2
subject 2	2
(p.Pro82Leu)	2
c.245C>	2
Subject 1	2
subunit of mitochondrial ATP synthase	2
ATP synthase, H+ transporting, mitochondrial F1 complex, δ subunit (ATP5F1D; formerly ATP5D)	2
fruit fly and mouse orthologous genes	2
zebrafish orthologous gene	2
2nd and 3rd toes	2
Severe loss-of-function cases	2
Alkuraya-Kučinskas syndrome (MIM 617822	2
autosomal-recessive multi-system syndrome	2
13 individuals	2
brain, heart, and kidney development	2
nuclear, but not cytoplasmic, β-actin	2
ACTB haploinsufficiency	2
cytoplasmic β-actin	2
wild-type fibroblasts	2
lymphoblastic lines and fibroblasts	2
kidney, heart, and brain	2
β-actin expression	2
wild-type mouse embryos	2
prominent chin	2
wide mouth	2
wide nose	2
dense eyelashes	2
interrupted wavy eyebrows	2
recognizable facial gestalt	2
heart and the renal tract	2
internal organ malformations	2
33 individuals	2
abundant cytoskeletal housekeeping protein	2
ACTB encodes β-actin	2
established hundreds of loci	2
human height	2
additional loci	2
additional discovery samples	2
genome-wide significant loci	2
top variants	2
multiple variants (SOJO)	2
discovered locus	2
single causal variant	2
many loci	2
detected loci	2
gene promoter regions	2
relevant tissue types	2
histone mark peaks	2
Genetic variants and CpG sites	2
large-scale consortia	2
ADCY3 and ADIPOQ loci	2
analytical framework	2
wild-type, but not mutagenized	2
C1qbp−/−mouse embryonic fibroblasts (MEFs)	2
combined respiratory-chain enzyme deficiency of complexes I, III, and IV	2
individuals’ samples	2
later-onset myopathic cases	2
multisystemic involvement (liver, kidney, and brain)	2
four individuals	2
doughnut-shaped structure	2
homotrimeric complex	2
N-terminal mitochondrial targeting peptide	2
evolutionary conserved multifunctional protein	2
multi-compartmental protein	2
Complement component 1 Q subcomponent-binding protein (C1QBP; also known as p32)	2
ideal human model disease	2
many associated loci	2
surgical specimen-derived DD myofibroblasts	2
soluble WNT-antagonist SFRP4	2
additional variants	2
British, Dutch, and German individuals	2
largest GWAS	2
tissue-specific fibroses	2
digits	2
palmar fascia	2
multiple specialties	2
physicians and surgeons	2
existing FDA-approved drug, Nitazoxanide	2
two different families	2
encodes mGluR1	2
metabotropic glutamate receptor 1 (mGluR1)	2
particular diseases	2
present-day Zoroastrians	2
outside groups	2
sampled Iranian group	2
ancestors of Iranian Zoroastrians	2
ancient human remains	2
male line	2
Iranian Zoroastrian ancestry	2
local groups	2
Indian Zoroastrians (Parsis)	2
sampled groups in their respective countries	2
Zoroastrians in Iran and India	2
neighboring modern-day Indian and Iranian populations	2
Iranian and Indian Zoroastrians	2
genome-wide autosomal, Y chromosome, and mitochondrial DNA data	2
Persia (present-day Iran)	2
one of the oldest extant religions in the world	2
distant populations	2
Bronze Age or earlier Levantines	2
Lebanese	2
Canaanite-related population	2
ancestry	2
present-day Lebanese	2
mid-Holocene	2
Chalcolithic Iranians	2
eastern migrants	2
local Neolithic populations	2
Canaanite-related ancestry	2
pastoral nomads	2
farming societies	2
coast (Sidon) and inland populations (Jordan)	2
urban populations	2
Bronze Age Canaanite-related ancestry	2
present-day Lebanon	2
Eastern Mediterranean coast	2
city of Sidon, a major Canaanite city-state	2
∼3,700-year-old individuals	2
five whole genomes	2
ancient and present-day populations	2
ancient Near Easterners	2
Levant region	2
multiple loci	2
6,586 individuals	2
large non-coding fraction of the genome	2
particular class of variants	2
different subsets of variants in a locus	2
Association models	2
genomic datasets	2
allele frequency databases	2
pathogenic and non-pathogenic variants	2
association model	2
individuals in a study	2
baseline model	2
pathways of genes	2
brain and optic nerve	2
mouse ortholog	2
Affected members of the third family	2
Affected members	2
three families of different ethnic backgrounds	2
seven individuals	2
biologically relevant discoveries	2
cis expression QTLs	2
likely causal variants	2
previously reported regions	2
functional candidates	2
common- and low-frequency spectra	2
GWAS variants	2
two different tissues (blood and fetal brain	2
large DNA methylation quantitative trait locus (mQTL) datasets	2
actual genes	2
researchers and organizations	2
International Rare Diseases Research Consortium (IRDiRC)	2
disease-related genes and variants	2
complete catalog	2
challenging affected individuals	2
general clinical genetics setting	2
children and adults	2
molecularly confirmed diagnosis	2
somatically mutated cancer driver genes	2
611 genes	2
NSD1, EZH2, DNMT3A, CHD8, HIST1H1E, and EED—	2
epigenetic regulation genes	2
individuals with OGID	2
negatively charged linker DNA	2
histone H1.4	2
neurological intracellular trafficking disorder	2
K63-polyubiquitylated proteins	2
Plaa mutant neurons	2
ubiquitin adaptor protein PLAA	2
ubiquitin-proteasome system (UPS)	2
synaptic proteostasis	2
zebrafish embryos	2
K orthologs	2
phosphoinositide phosphatidylinositol	2
inositol polyphosphate-5-phosphatase K. Mutations	2
INPP5K	2
variable eye and central nervous system involvement	2
set of specific lipid kinases and phosphatases	2
small phospholipids	2
Dstyk in mouse melanocytes, keratinocytes, and fibroblasts	2
Cultured keratinocytes and fibroblasts	2
keratinocytes and fibroblasts	2
remaining melanocytes	2
Skin biopsies	2
3′ UTR of DSTYK	2
last two exons	2
three different families	2
another Israeli pedigree	2
established linkage region	2
four affected family members	2
DSTYK (dual serine-threonine and tyrosine protein kinase)	2
Palestinian-Jordanian SPG23 pedigree	2
chromosome 1q24–q32	2
Arab-Israeli pedigree	2
lower limb spastic paraparesis	2
β cell	2
Arap1 in β cells	2
high fat-fed animals	2
adult β cell	2
StarD10 in mice	2
STARD10 mRNA	2
T2D-risk allele carriers	2
three independent subject groups	2
islet transcriptomes	2
rs140130268 indel	2
several highly correlated T2D-risk variants	2
stretch-enhancer	2
5 kb region	2
causal variant(s)	2
β cell lines	2
steroidogenic acute regulatory protein (StAR)-related lipid transfer protein family	2
GTPase activating protein	2
ARAP1 (CENTD2)	2
novel pheochromocytoma and paraganglioma susceptibility gene	2
wild-type MDH2 cDNA	2
affected subjects’ fibroblasts	2
MDH substrate, malate, and fumarate	2
blood and cerebrospinal fluid	2
three unrelated subjects	2
MDH2 encodes mitochondrial malate dehydrogenase (MDH)	2
admixed Africans	2
Toubou	2
populations in northern Chad	2
East Africa	2
Near Eastern farmers	2
Chad R1b-V88	2
present-day Eurasia	2
closest relatives	2
Africa a Y chromosome lineage (R1b-V88)	2
southern Chad	2
people speaking the unclassified isolate Laal language	2
many populations	2
19 of them	2
480 samples	2
vast regions in Africa	2
 the rod photoreceptors	2
one RP-affected individual	2
Leu135Pro RP-associated variant	2
Reep6 knock-in mice	2
REEP6.1 frameshift mutant	2
>C [p.Leu135Pro]) and	2
Pro128Leu]	2
two missense variants	2
retina-specific isoform REEP6.1	2
Human 3D organoid optic cups	2
six variants	2
REEP/Yop1 family of proteins	2
Receptor Expression Enhancer Protein 6 (REEP6)	2
another pathway	2
protein of unknown function	2
iris and ciliary body	2
distal tips of the retinal neuroepithelium	2
lens, iris, cornea, and retina	2
developing human eye	2
in vivo or in vitro	2
splice-site mutations c.700+	2
third family	2
c.4549-1G>A	2
compound heterozygous frameshift, c.2352_2353insC (p.Arg785Glnfs∗23), and splice-site,	2
family 2	2
family 1	2
p. Ser1451Pro)	2
evolutionarily conserved alpha-2-macroglobulin (A2M) domain of CPAMD8, c.4351T>C (	2
CPAMD8 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein	2
corectopia, ectropion uveae	2
ectopia lentis	2
anterior segment of the eye	2
Anterior segment dysgeneses (ASDs)	2
proton sensor	2
GPR68 in the enamel organ	2
rat mandibles	2
proton-sensing G-protein-coupled receptor	2
hardest tissue	2
inflammatory classical complement pathway	2
easy bruising	2
skin and vascular fragility	2
pretibial hyperpigmentation	2
attached gingiva	2
subunit interfaces or inter-domain hinges of C1r and C1s	2
Pathogenic variants	2
C1q subunits	2
C1s of the first component	2
contiguous genes	2
genetic causes	2
individuals with pEDS	2
independent families	2
international consortium	2
approximately 5.8 Mb region	2
recombinant AAC1 mutant proteins	2
mitochondrial DNA-encoded subunits	2
three case subjects	2
mitochondrial ADP/ATP carrier AAC1	2
two candidate genes	2
FGF10 and MRPS30 promoter regions	2
enhancer element	2
SNP rs10941679	2
g (risk) allele of rs10941679	2
ER-negative (ER−) breast cancer (lead SNP rs6864776	2
estrogen-receptor-positive (ER+) breast cancer	2
single SNP rs10941679	2
least three independent signals	2
1 Mb region	2
3,365 genotyped and imputed SNPs	2
104,660 subjects	2
Rgs14 in a salt-sensitive mouse model	2
ancestral orthologs	2
SLC34A1 locus)	2
NFATC1 and RGS14	2
expression quantitative trait loci	2
DHS credible variants	2
human kidney cells	2
DNase I hypersensitivity sites (DHSs)	2
20 eGFR loci	2
Credible variants	2
“credible sets	2
lead SNPs	2
71,638 individuals	2
four tissues	2
web browser	2
subset of TwinsUK individuals	2
independent adipose RNA-seq dataset	2
variants overlapping adipocyte enhancers	2
ZNF423, rs3851570, p = 8.2 × 10−13)	2
53 genes	2
CHURC1, rs7143432	2
TwinsUK cohort	2
multi-tissue RNA-sequencing (RNA-seq) dataset	2
known complex trait loci	2
cardiomyopathy-associated protein	2
Recombinant PPA2 enzymes	2
normal and mutant PPA2-containing mitochondria	2
cardiac fibrosis	2
index family	2
nuclear-encoded mitochondrial inorganic pyrophosphatase (PPA2)	2
four unrelated pedigrees	2
ten individuals	2
ID and related syndromes	2
additional targets	2
BCL11A haploinsufficiency	2
cortex and hippocampus	2
amino-terminal region of human BCL11A	2
etiological missense variants	2
mouse behavioral, neuroanatomical, and molecular phenotyping	2
ID disease modeling	2
BAF swi/snf chromatin-remodeling complex	2
disease-associated genes	2
 the tenth complex I assembly factor	2
subject cell lines	2
viral rescue	2
TMEM126B variants	2
Gly212Val] and/or c.401delA [p.Asn134Ilefs∗2]	2
four unrelated families	2
six cases	2
proteins ACAD9, ECSIT, NDUFAF1, and TIMMDC1	2
mitochondrial complex I assembly complex	2
orphan genes	2
poorly understood or uncharacterized genes	2
clinical diagnostic setting	2
unbiased whole-exome sequencing (WES)	2
custom, targeted gene panels	2
assembly factors	2
well tolerated inhibitors	2
somatic alterations	2
member of the PI3K/AKT signaling pathway	2
endometrial cancer risk allele	2
positive regulator of AKT1	2
YY1 siRNA	2
YY1 transcription factor-binding site	2
rs2494737 risk A allele	2
PI3K/AKT/MTOR intracellular signaling pathway	2
member of the	2
silencer element	2
SNP rs2494737	2
best candidate causal SNP	2
37,925 controls	2
6,608 endometrial cancer cases	2
functional SNP(s) and target gene(s)	2
novel genetic risk locus	2
multiple genome-wide association and follow-up endometrial cancer case-control datasets	2
recently generated Hh-pathway inhibitors	2
substitution	2
identical nonsynonymous variant encoding p.Leu412Phe	2
medulloblastoma, ameloblastoma, and basal cell carcinoma	2
three mutation-positive individuals	2
brain MRI	2
mutation-positive individuals	2
nonsynonymous variant in SMO (c.1234C>T [p.Leu412Phe]), encoding smoothened (SMO), a G-protein-coupled receptor	2
skin lesions	2
single affected individual	2
Cerebellar medulloblastoma	2
myofibromas or hamartomas	2
iris colobomas	2
unicoronal craniosynostosis	2
FLAD1 variants	2
one of the variant proteins	2
mutant FADS proteins	2
Another group of individuals	2
biallelic FLAD1 frameshift variants	2
FLAD1 isoforms	2
FAD cofactors	2
molybdopterin binding (MPTb) domain	2
nine individuals	2
encodes FAD synthase (FADS)	2
clinically relevant variants	2
Multiple acyl-CoA dehydrogenase deficiencies (MADDs)	2
novel association	2
long intergenic non-coding RNA (lincRNA) gene (AC011288.2)	2
healthy infants	2
blood-culture-proven bacteremia case subjects	2
5,000 Kenyan children	2
Bacteremia (bacterial bloodstream infection)	2
multimeric interactions	2
Purkinje cells of the cerebellum	2
ITPR1-lined nucleoplasmic reticulum	2
mutant than control LCLs	2
ITPR1-positive cells	2
GS-derived lymphoblastoid cell lines (LCLs)	2
GS variants	2
disease-associated multimeric channels	2
homo-tetrameric structure	2
inositol 1,4,5-triphosphate-responsive calcium channel	2
Gly2539 missense	2
Glu2094 missense (one de novo, one co-segregating)	2
ultra-rare protein-altering variants	2
additional GS-affected individuals	2
Deciphering Developmental Disorders study	2
wild-type TRMT10C.	2
homozygous c.542G>T (p.Arg181Leu) variant	2
(p.Arg181Leu) and	2
detected variants	2
mt-RNA precursors	2
TRMT10C missense variants	2
stable complex of MRPP1	2
polycistronic precursor transcripts	2
5′ ends of mt-tRNAs	2
mitochondrial ribonuclease P (mt-RNase P) complex	2
TRMT10C (encoding the mitochondrial RNase P protein 1 [MRPP1])	2
several genes encoding factors	2
mitochondrial or nuclear genes	2
male-specific minor histocompatibility (H-Y) antigens	2
Neandertal Y	2
Neandertal Y chromosomes	2
modern human ancestors	2
A00 and other extant modern human Y-chromosome lineages	2
447–806 kya	2
recent common ancestor (TMRCA)	2
A00, the highly divergent basal haplogroup	2
modern human Y chromosomes	2
outgroup	2
Neandertal lineage	2
orthologous chimpanzee and modern human sequences	2
Neandertal individual	2
exome-captured Y-chromosome DNA	2
extinct hominids	2
chorea and other hyperkinetic movement disorders	2
basal ganglia circuitry	2
PDE10A mutations	2
GAF-B domain	2
altered residues	2
PDE10A catalytic domain	2
regulatory GAF-B domain	2
highly conserved amino acids	2
cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP)	2
phosphodiesterase highly and selectively	2
c.1000T>C [p.Phe334Leu] in one individual)	2
Phe300Leu]	2
symmetrical bilateral striatal lesions	2
main output projections	2
striatal medium spiny neurons (MSNs)	2
genome-sequenced and HPO-coded cases	2
composite phenotypes	2
Human Phenotype Ontology (HPO)	2
abnormalities spanning multiple organ systems	2
high-penetrance rare variants	2
cryptic cis-acting regulatory sequence binding sites	2
corresponding wild-type promoter	2
four mutated OVOL2 promoters	2
normal corneal endothelium	2
established PPCD-associated gene ZEB1	2
C2H2 zinc-finger transcription factor	2
OVOL2 encodes ovo-like zinc finger 2	2
conserved proximal promoter sequence (c.−274T	2
OVOL2 promoter	2
CHED1 and c.−370T>C for PPCD1)	2
c.−339_361dup for	2
index families	2
conserved region of the OVOL2 proximal promoter sequence	2
extensive pedigrees	2
short arm of chromosome 20	2
overlapping loci	2
 a protein	2
collagen XIII	2
acetylcholine receptor (AChR) clustering	2
C2C12 cell line	2
COL13A1 c.1171delG (p.Leu392Sfs∗71)	2
human muscle motor endplate	2
single transmembrane domain	2
alpha chain of an atypical non-fibrillar collagen	2
previously undefined CMS	2
known CMS-associated genes	2
genes encoding proteins	2
highly specialized postsynaptic membrane	2
terminal bouton	2
presynaptic nerve terminal	2
tripartite synapse	2
influenza A and EBV	2
Common HLA-DRβ1 haplotypes	2
probable causal variants	2
human leucocyte antigen (HLA) class II proteins	2
Merkel cell polyomavirus	2
virus, Epstein-Barr virus, JC polyomavirus	2
major histocompatibility complex region on chromosome 6	2
2,363 immunocompetent adults	2
pathogenic viruses	2
complex loci (e.g., human leukocyte antigen [HLA])	2
immune system genes	2
HS-affected family	2
six of them	2
retinal pigmentation	2
p.[Cys282Tyr];[Cys282Tyr] individuals	2
at-risk genotypes	2
variant coding for HFE p.Cys282Tyr	2
98 individuals	2
multicenter cohort	2
eMERGE Network	2
unselected samples	2
HFE variants	2
Cys282Tyr and p.	2
pathogenic HFE variants	2
case-parent trios, case-mother duos, and case-father duos	2
ambiguous trios	2
case-parent trios	2
one parent	2
murine coronal suture	2
engrailed 1	2
coronal suture	2
supraorbital regulatory center	2
Zic1 expression	2
localized domain	2
Xenopus embryo assay	2
target gene, engrailed-2	2
mutant ZIC1 transcripts	2
coronal sutures	2
severe craniosynostosis	2
final (third) exon of ZIC1	2
orthologous Zic1 gene	2
chromosome 3q25.1	2
nearby paralog ZIC4	2
one of five homologs of the Drosophila pair-rule gene odd-paired	2
Human ZIC1 (zinc finger protein of cerebellum 1)	2
HPO itself	2
10,000 rare and common diseases	2
HPO	2
HPO annotations	2
identified terms	2
comparable resource	2
translational research	2
next-generation sequence-variation data	2
rare disease community	2
embryonic stem cell DHSs	2
full peak bodies	2
summits of histone marks	2
potentially causal variants	2
DNase-I hypersensitive sites (DHSs)	2
expression quantitative trail loci	2
colocalizing annotations	2
enriched annotations	2
disease-associated variants	2
non-coding functional annotations	2
disease loci	2
causal from trait-associated variants	2
genomic annotations	2
LifeLines DEEP	2
LBCs	2
LBCs and BSGS	2
Dutch sample	2
Brisbane Systems Genetic Study (BSGS	2
LifeLines DEEP study	2
Dutch adults	2
Lothian Birth Cohorts	2
external samples	2
discovery samples	2
Genetic predictors	2
endoplasmic reticulum and Golgi	2
proposed interaction partner p31	2
mutant fibroblasts	2
additional six individuals	2
RALF or ALF	2
additional unrelated individuals	2
fever-dependent RALF	2
West Asia	2
Kalash and other populations	2
extant Eurasian populations	2
geographic neighbors	2
South Asian populations	2
extremely drifted ancient northern Eurasian population	2
Paleolithic Siberian hunter-gatherers	2
ancient hunter-gatherers and European farmers	2
Illumina HiSeq 2000	2
one male individual	2
Illumina HumanOmni2.5M-8 BeadChip	2
unrelated Kalash samples	2
autosomal loci	2
Previous Y chromosome and mitochondrial DNA markers	2
Hindu Kush mountain ranges	2
enigmatic isolated population of Indo-European speakers	2
putative risk loci	2
functional PTPN22 rs2476601 variant	2
non-HLA region	2
HLA class I and II molecules	2
PTPN22 (rs2476601, p = 1.73 	2
significant loci	2
HLA-DQα1 47	2
DRβ1 13	2
polymorphic amino acid positions	2
HLA-DRB1∗04	2
classical HLA alleles	2
amino acid of HLA-B	2
one class	2
class II amino acids of HLA-DRβ1 and HLA-DQα1	2
genomic region	2
Immunochip array	2
unrelated control subjects	2
1,651 case subjects	2
case-control cohort	2
giant cell arteritis (GCA)	2
voltage-dependent calcium channels	2
second independent kindred	2
gene encoding a neuronal calcium sensor protein	2
consanguineous kindred	2
genetic cause	2
fourth locus	2
dual-function enzyme	2
five other families	2
remaining cohort	2
studied families	2
homozygous PNKP (polynucleotide kinase 3′-phosphatase) mutation, c.1123G>T (p.Gly375Trp)	2
cohort of nine Portuguese families	2
genetically and clinically heterogeneous group of disorders	2
plasmablasts and plasma cells	2
SLE individuals	2
UBE2L3 risk allele	2
unstimulated B cells	2
preferred E2 conjugating enzyme	2
HOIL-1 and HOIP, components of the linear ubiquitin chain assembly complex (LUBAC)	2
(RBR) E3 ligases	2
HECT and RING-in-between-RING	2
UBE2L3 promoter region	2
SMN pre-mRNA processing	2
brain, heart, liver, kidney, and skeletal muscle	2
ExSpe U1	2
SMN2 transgene	2
corresponding intronic sequences	2
antisense oligonucleotide (AON)	2
SMN mRNAs	2
SMN pre-mRNA intermediate	2
E7 inclusion	2
single chromosome-integrated copy of ExSpe U1	2
survival motor neuron 2 (SMN2)	2
spinal muscular atrophy (SMA)	2
5′ splice site (ss)	2
intronic sequences	2
modified U1 snRNAs	2
snRNAs (ExSpe U1s)	2
Exon-specific U1	2
previously published data sets	2
previously unreported pleiotropic alleles	2
epidermal differentiation complex (chromosome 1q21.3), the Th2 locus control region (chromosome 5q31.1), and the major histocompatibility complex (chromosome 6p21–22)	2
independent disease-specific loci	2
opposing risk alleles	2
Dorset people	2
Norse Vikings	2
island	2
Inuit ancestry	2
individuals from the east, west, and north	2
Inuit genetic component	2
south	2
small villages	2
historically isolated areas	2
adult Greenlandic population	2
∼200,000 SNPs	2
Greenlandic population	2
present-day Greenlandic population	2
samples and genotyping technologies	2
mitochondrial tRNAs	2
Leigh syndrome	2
thalamus, putamen, and brainstem	2
five mitochondrial tRNAs	2
anticodon wobble position	2
5-taurinomethyluridine (τm5U)	2
mitochondrial GTP-binding protein 3	2
numerous pathways	2
mtDNA	2
cultured fibroblasts	2
cytoplasmic vacuolation	2
cellular protein containing Phox (PX) and regulator of G protein signaling (RGS) domains	2
distinct and recognizable syndrome	2
SNX14 in a third family	2
unrelated consanguineous families	2
Sorting Nexin 14 (SNX14)	2
last exon	2
5′ region of the gene	2
loss-of-function nonsense	2
infants	2
CMT2 families	2
immunoglobulin-helicase-μ-binding protein 2 (IGHMBP2) gene	2
recessive Charcot-Marie Tooth disease type 2 (CMT2)	2
English family	2
ciliary microtubules	2
axonemal docking machinery	2
ODAs	2
highly evolutionarily conserved ODA-DC-related protein	2
CCDC151-deficient zebrafish	2
ODA component DNAH5 and the ODA-DC-associated components CCDC114 and ARMC4	2
axonemal coiled coil protein	2
mouse Ccdc151Snbl mutants	2
Homozygous zebrafish ccdc151ts272a and	2
vertebrate left-right organizers	2
three independent families	2
chronic upper and lower respiratory infections	2
ODA assembly	2
ODA docking complex (ODA-DC) system	2
axonemal microtubular scaffold	2
ciliary or flagellar compartment	2
Multisubunit outer dynein arm (ODA) motor complexes	2
extracellular fluids	2
axonemal dyneins	2
various cellular transport systems	2
diverse family of cytoskeletal dynein motors	2
myoblasts and fibroblasts	2
recombinant, wild-type APOPT1 cDNA	2
COX holocomplex	2
Mutant fibroblasts	2
mature protein	2
N-terminal mitochondrial targeting sequence	2
six subjects	2
severely damaged protein variants	2
three additional unrelated children	2
posterior region of the cerebral hemispheres	2
three subjects	2
third Turkish individual	2
two Italian sisters	2
cell-cell and cell-matrix adhesion	2
Immortalized keratinocytes	2
(p.Ile482Lys)	2
c.1445T>	2
subjects in the other family	2
exon 9	2
C (p.Tyr398His)	2
one family	2
novel homozygous DNA variants	2
bronchial asthma	2
oral hyperpigmentation	2
hypodontia, enamel hypoplasia	2
marginal palmoplantar keratoderma	2
unrelated Kuwaiti families	2
highly conserved family of transcription factors	2
Grainyhead-like 2	2
causal variant	2
tag SNPs	2
epidemiological risk models	2
genomic data sets	2
DIDO1 protein	2
KARS lysyl-tRNA synthetase locus	2
68 Yoruba (YRI) HapMap lymphoblastoid cell lines (LCLs)	2
transcription factor and signaling protein isoforms	2
MHC	2
specific PsV subphenotypes	2
HLA-B amino acid position 45	2
psoriatic arthritis (PsA	2
two major clinical subtypes	2
PsV susceptibility (HLA-C∗12:03, HLA-B amino acid positions 67 and 9, HLA-A amino acid position 95, and HLA-DQα1 amino acid position 53	2
class II HLA genes	2
multiple HLA-C∗06:02-independent risk variants	2
HLA-C∗06:02	2
MHC HLA-like gene	2
class I and II human leukocyte antigen (HLA) genes	2
13,589 controls	2
9,247 PsV-affected individuals	2
MHC region	2
major histocompatibility complex (MHC) region	2
photoreceptor sensory cilium	2
several other ciliopathy-associated proteins	2
base of the photoreceptor connecting cilium	2
autosomal-recessive retinitis pigmentosa	2
POC1B. FAM161A	2
p.Arg106Pro and	2
coimmunoprecipitation and colocalization assays	2
binary interaction partner of	2
human retinal cDNA library	2
G mutant human POC1B mRNAs	2
c.199_201del and c.317C>	2
wild-type human POC1B mRNA	2
photoreceptor outer segments	2
p.Arg106Pro and p.	2
basal body of the primary cilium	2
encoded wild-type protein	2
human TERT-immortalized retinal pigment epithelium 1 cells	2
unrelated person	2
c.810+1G>T)	2
Gln67del]	2
three siblings	2
POC1 centriolar protein B	2
Arg106Pro])	2
c.317C>G	2
phenotypic spectrum	2
clinical diagnostics	2
67 genes	2
disease-causing variants	2
science and technology innovation centers	2
clinicians and scientists	2
Canada Consortium	2
Rare Disease Genes	2
whole-exome sequencing	2
Canadian consortium	2
causative mutations	2
sperm flagella in mice	2
base of the connecting cilium	2
human and murine retinae	2
sibling pair	2
homozygous missense change (c.1627G>A [p.Glu543Lys]	2
one proband	2
homozygous nonsense variant c.1627G>T (p.Glu543∗)	2
individuals with related phenotypes	2
 loss-of-function variants	2
likely disease-associated gene	2
tubulin glutamylase	2
internal exome data set	2
retinal-disease-associated genes	2
ABCA4 mutations	2
cone, cone-rod, and macular dystrophies	2
NR2F2 on target promoters	2
six coding sequence variants	2
atrioventricular septa	2
NR2F2 in mice	2
pleiotropic developmental transcription factor	2
multiplex family	2
splice donor site	2
additional CHD-affected families	2
5,194 control subjects	2
highly conserved gene NR2F2	2
rare missense variants	2
nonsyndromic AVSDs	2
parent-offspring trios	2
Nonsyndromic atrioventricular septal defects (AVSDs)	2
loss of SETD5	2
hand flapping	2
inguinal hernia	2
large, fleshy low-set ears	2
long, narrow upslanting palpebral fissures	2
long, thin, and tubular nose	2
full and broad eyebrows	2
prominent high forehead	2
Ser1258Glufs∗65]	2
c.3771dup [p.	2
frameshift (c.2177_2178del [p.Thr726Asnfs∗39]	2
c.1866C>G [p.Tyr622∗], and c.3001C>T [p.Arg1001∗])	2
Arg445∗]	2
Lys399∗]	2
nonsense (c.1195A>T [p.	2
known or candidate genes	2
Chinese hamster ovary cell lines	2
ethnically matched controls	2
A, c.314C>G	2
missense mutations c.275G	2
c.314C>G (p.Pro105Arg	2
homozygous variant	2
Asp305Gly)	2
compound-heterozygous variants c.439dupC	2
three affected children	2
GPI-anchored enzyme	2
PGAP3 region	2
Gly92Asp) variant	2
13.8 Mb region	2
siblings in a consanguineous Pakistani family	2
GPI anchor	2
Glycosylphophatidylinositol (GPI)-anchored proteins	2
off-target sequencing reads	2
Illumina’s Omni 2.5M genotyping array	2
African Americans	2
NHLBI Grand Opportunity Exome Sequencing Project	2
aligned bases	2
method SEQMIX models	2
local ancestry	2
chromosomal segment in an admixed individual	2
on-target reads	2
off-target reads	2
high-quality genotypes	2
genome-wide association study (GWAS) arrays	2
specific chromosomal regions	2
adipose DNA methylation	2
bisulphite sequencing	2
cg01884057 metQTL	2
BMI SNP rs713586	2
metQTL overlapping metabolic-trait or disease loci	2
disease associations	2
adipose reference epigenomes	2
promoter CpGs	2
adipose expression quantitative-trait loci (eQTL)	2
nearby SNPs	2
methylation quantitative-trait loci (metQTL)	2
metabolic phenotype-associated CpGs	2
individual CpGs	2
648 twins	2
Multiple Tissue Human Expression Resource (MuTHER)	2
mammalian dynein-IFT machinery	2
cytoplasmic dynein-1 and IFT dynein-2 motors	2
previously unrecognized link	2
dynein-1 light chain DYNLL1	2
axonemal staining	2
centrioles and basal bodies	2
Three-dimensional protein modeling	2
retrograde intraflagellar transport motor	2
Chlamydomonas FAP133	2
WD40 repeat-containing protein	2
targeted next-generation sequencing panel	2
exome sequencing	2
less well functionally defined subunits	2
heavy chain dynein ATPase/motor subunit, DYNC2H1	2
IFT dynein-2 motor complex	2
Bidirectional (anterograde and retrograde) motor-based intraflagellar transport (IFT)	2
dynamic actin cytoskeletal structures	2
endogenous and GFP-tagged kaptin	2
primary neuronal cell cultures	2
encoding kaptin	2
samples from families from the Amish community of Ohio	2
coordinated and intricate series of molecular and cellular cues and responses	2
multiple types of genetic variation (i.e., copy-number and exome variants	2
subset of autism cases	2
nonembryonic, synaptic FMRP targets	2
embryonically upregulated FMRP targets	2
FMRP targets	2
FMRP target genes	2
discrete FMRP-target subpopulations	2
detailed spatiotemporal maps	2
ASD-affected individuals	2
Fragile-X mental retardation protein (FMRP)	2
IFT-A.	2
additional IFT-B component, IFT172	2
group of skeletal ciliopathies	2
thorax and/or long bones	2
12 families	2
IFT-B-encoding gene IFT172	2
63 individuals with ATD	2
1,467 individuals	2
IFT-B-encoding genes	2
additional IFT-B components	2
IFT-B module	2
14 subunits	2
motor protein, DYNC2H1	2
six IFT-A components	2
two evolutionarily conserved modules, subcomplexes A (IFT-A) and B (IFT-B)	2
Intraflagellar transport (IFT)	2
mitochondrial protein	2
wild-type FBXL4 transcript	2
dynamic mitochondrial network	2
F-box protein	2
affected children	2
three unrelated consanguineous kindreds	2
cytoplasmic protein	2
fly model	2
another cytoplasmically localized protein	2
human ZMYND10	2
Tagged Drosophila ZMYND10	2
Val16Gly)	2
equivalent c.47T>G	2
Drosophila Zmynd10	2
immotile sperm	2
chordotonal sensory neurons	2
cells with motile cilia	2
Zmynd10 mRNA	2
homozygote individuals	2
Val16Gly (c.47T>G)	2
hypomorphic p.	2
conserved zinc-finger gene BLU (ZMYND10)	2
PCD-affected families	2
inner dynein arms (IDAs) and outer dynein arms (ODAs)	2
flanking markers	2
lactose digesters	2
several ethnic groups	2
derived alleles	2
LCT promoter construct	2
−14009∗G allele	2
in vitro functional tests	2
large lactose-tolerance-tested Ethiopian cohort	2
LCT enhancer sequence	2
three other alleles	2
extended haplotype	2
lactase gene LCT	2
single allele (−13910∗T, rs4988235)	2
mammals	2
many schizophrenia risk alleles	2
MGS AD sample	2
independent ED data set	2
MGS ED and MGS AD samples	2
measured SNPs	2
Molecular Genetics of Schizophrenia (MGS) data set	2
largest combined African descent (AD [n = 2,142]) and European descent (ED [n = 4,990]) schizophrenia case-control genome-wide association study (GWAS) data set	2
populations of European and African descent	2
obvious axoneme	2
centrosome or basal body	2
GLI2 transcription factor	2
wild-type human chondrocytes	2
base of the primary cilium	2
shared ancestry	2
Spanish individual	2
skeletal ciliopathy exomes	2
another affected family member	2
relatively uncharacterized gene	2
SRPS type III	2
affected Australian individual	2
ciliopathy disease spectrum	2
Jeune and Ellis-van Creveld syndromes	2
grouping	2
ribs and long bones	2
Short-rib polydactyly syndromes (	2
GMPPB ortholog in zebrafish	2
aggregates in the cytoplasm	2
wild-type GMPPB	2
wild-type GMPPB in fibroblasts	2
available fibroblasts	2
cytosolic mannosyltransferases	2
O-mannosylation of proteins	2
hypoglycosylated α-DG	2
guanosine diphosphate mannose (GDP-mannose) pyrophosphorylase B (GMPPB)	2
hypoglycosylation of α-dystroglycan (α-DG)	2
populations of the same ancestry	2
populations across the world	2
skin pigmentation	2
handful of genes	2
global populations	2
direct FOXP2 targets	2
key neurally expressed genes	2
significant network	2
Han Chinese, Japanese, or Yoruba populations	2
FOXP2 targets	2
given gene targets	2
Ensembl database	2
control genes	2
matched lists	2
given gene list	2
putative FOXP2 targets	2
FOXP2 in modern populations	2
highly conserved transcription factor	2
Forkhead box P2 (FOXP2)	2
T-loops	2
telomere ends	2
telomeric circles	2
ten HHS individuals	2
DC or DC-like cases	2
6/23 index cases	2
phenotypically severe variant, Hoyeraal-Hreidarsson syndrome (HHS)	2
Dyskeratosis congenita (DC)	2
LP-BER pathway	2
human DNA2	2
nuclease, helicase, and ATPase activities	2
purified mutant proteins	2
long-patch base-excision repair (LP-BER) pathway	2
helicase/nuclease family member	2
muscle mtDNA	2
adult-onset individuals	2
deoxyribonuclotides (ANT1 and RRM2B)	2
mtDNA replisome machinery (POLG, POLG2, and C10orf2)	2
several nuclear genes	2
autosomal-dominant form of PEO	2
multisystemic disorders	2
lower urinary tract	2
human fetal bladder	2
muscle bundles	2
nerve fascicles	2
leucine-rich repeats and immunoglobulin-like domains 2	2
subset of UFS-affected individuals	2
entire genomic DNA sequence	2
aberrant mRNA transcripts	2
Irish and Turkish populations	2
additional individuals	2
pseudoexon inclusion	2
affected individuals’ fibroblasts or lymphoblastoid cells	2
out-of-frame pseudoexon	2
cryptic splice donor site	2
471G>T HADH	2
c.636	2
overlapping ∼10 kb PCR amplicons	2
entire genomic regions of ABCC8 (117 kb) and HADH (94 kb)	2
>20 genes	2
coding regions and conserved splice sites	2
locus DYT23	2
endoplasmic-reticulum-dependent Ca2+ signaling	2
case and control fibroblasts	2
gene encoding a predicted Ca2+-gated chloride channel	2
moderately-sized UK kindred	2
isolated Dutch Volendam population	2
important diagnostic and therapeutic target	2
ciliated respiratory epithelium	2
ODAs in the axoneme	2
essential ciliary protein	2
immotile cilia	2
ciliary ODAs	2
human cilia	2
biflagellate alga Chlamydomonas	2
DCC2, an ODA microtubule-docking complex component	2
outer dynein arms (ODAs)	2
motile cilia and sperm flagella	2
additional disease alleles	2
primary literature	2
mutation databases	2
disease alleles	2
current predictions and databases	2
genomes of apparently healthy humans	2
probable Caenorhabditis elegans ortholog of UBE3B, oxi-1	2
highly conserved HECT domain	2
identified UBE3B variants	2
uncharacterized E3 ubiquitin ligase	2
paralog UBE3B.	2
ubiquitin ligase-encoding UBE3A gene	2
Angelman syndrome	2
revised kinship matrix	2
major-histocompatibility region	2
immune-related diseases	2
Wellcome Trust Case Control Consortium	2
first seven diseases	2
modified kinship matrix	2
realistic scenarios	2
genome-wide genotyping array	2
∼300,000 SNPs	2
unexplained motor neuronopathies	2
functional partners	2
group of conditions	2
hemicholinium-3-sensitive choline uptake	2
Choline-transport assays	2
cytosolic-C-terminus sequences	2
final transmembrane domain	2
encoded product	2
presynaptic choline transporter (CHT)	2
nerve terminal and muscle fiber	2
complex molecular architecture	2
specialized synapse	2
hedgehog and nodal family members	2
orthologous Megf8	2
mouse mutant	2
great arteries	2
multiple epidermal-growth-factor-like-domains 8 (MEGF8)	2
small GTPase	2
polysyndactyly of the hands and feet	2
multisuture craniosynostosis	2
underlying genetic architecture	2
complex trait loci	2
serum total protein	2
Hpn knockout mice	2
strongly associated serum albumin locus, HPN	2
potential causal variants	2
groups of European and Japanese ancestry	2
European-ancestry and 10,168 Japanese individuals	2
6q21.3, and ELL2	2
53,190 European-ancestry and 9,380 Japanese individuals	2
FRMD5-WDR76, and RPS11-FCGRT	2
SERPINF2-WDR81, TNFRSF11A-ZCCHC2	2
serum albumin (HPN-SCN1B, GCKR-FNDC4,	2
CP apparatus	2
nine PCD-affected persons	2
hy3 mouse model	2
stiff sperm flagella	2
High-speed videomicroscopy	2
Hydin-deficient Chlamydomonas	2
C2b projection of the central pair (CP) apparatus	2
HYDIN mutant respiratory cilia	2
isolated population	2
8.8 Mb shared haplotype	2
three Faroe Island PCD-affected families	2
six individuals	2
Lys307∗)	2
respiratory cells	2
aberrantly spliced transcripts	2
evolutionary conserved splice acceptor site	2
homozygous c.3985G	2
affected German siblings	2
chromosomal region	2
nearly identical 360 kb paralogous segment (HYDIN2)	2
chromosomal region 16q21-q23	2
PCD-associated locus	2
PCD-affected persons	2
recessive hydrocephalus model	2
hy3 mouse	2
sperm flagella	2
protein’s phosphorylated C terminus	2
mineral nucleation assay	2
putative extracellular matrix acidic phosphoprotein	2
autosomal-recessive AI-affected families	2
uncharacterized gene, C4orf26	2
Omani family	2
individual single-nucleotide variant	2
set of variants	2
heterozygous or homozygous genotypes	2
1,935 variants	2
1,830 controls	2
larger set	2
sequence data	2
subtypes of IGE considered	2
absence epilepsy	2
juvenile myoclonic epilepsy	2
two forms of IGE	2
exome-sequenced epilepsy cases	2
Rare copy-number variants	2
N-linked glycosylation pathway	2
larger subgroup	2
endplate region	2
acetylcholine-receptor subunits	2
DPAGT1-specific inhibitor tunicamycin	2
endplate acetylcholine receptors	2
two of the individuals	2
motor endplates	2
tubular aggregates	2
cholinesterase inhibitors	2
proximal limb muscles	2
group of individuals	2
neuromuscular synapse	2
individual disease-associated loci	2
Eleven loci	2
1000 Genomes Project	2
case-control samples	2
multiple independent SNPs	2
Many genetic loci and SNPs	2
FTLD-TDP	2
progranulin-deficient mice	2
frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP)	2
latter peak	2
progranulin gene (GRN, granulin precursor)	2
linkage peaks	2
neuronal ceroid lipofuscinosis (NCL)	2
plasmablast formation	2
heterozygous individuals	2
homozygous individuals	2
LRBA (lipopolysaccharide responsive beige-like anchor protein)	2
positional candidate genes	2
chromosome 4q	2
linkage interval	2
simplex cases	2
complement C4	2
C4A exon 29 CT insertion	2
UK and Spanish populations	2
known SNP and HLA-DRB1 associations	2
loss-of-function C4 exon 29 CT indel	2
northern and southern European ancestry	2
2,207 subjects	2
largest and most comprehensive complement C4 study	2
context of HLA-DRB1 and MHC region SNP polymorphism	2
paralogs, C4A and C4B.	2
C4 itself	2
major histocompatibility complex (MHC) class III region	2
complement C4 locus	2
complement component C4	2
broad nasal bridge	2
PCs	2
1,622 participants	2
2,185 adolescents	2
two laser scanners	2
3D high-resolution images	2
15-year-olds	2
population-based cohort	2
the general population	2
retina and brain	2
MGC1 patients	2
human fetal brain	2
developing human cornea and anterior segment	2
visual evoked potentials	2
topographic retinotectal projections	2
CHRDL1 encodes ventroptin, a bone morphogenic protein antagonist	2
MGC1 families	2
Chordin-like 1 gene (CHRDL1) on Xq23	2
deep anterior chamber	2
X-linked megalocornea (MGC1)	2
Chrm3 null mutant mice	2
bladder muscle	2
developing renal epithelia	2
M3 muscarinic acetylcholine receptor	2
muscarinic acetylcholine receptor M3 (	2
SREBP-1 binding site	2
aortic adventitia	2
TT homozygotes	2
CC homozygotes	2
arterial tissues	2
12q13.3 locus	2
either rs1466535	2
sample sets	2
6228 AAA and 49182 controls	2
intron 1 of low-density-lipoprotein receptor-related protein 1 (LRP1)	2
lead SNP	2
replication sample	2
nine loci	2
additional cases	2
1866 patients	2
Abdominal aortic aneurysm (AAA)	2
lens, trabecular meshwork, and cornea	2
antioxidant enzyme	2
cornea and lens architecture	2
cornea and lens epithelial layers	2
extracellular matrix-associated protein	2
consanguineous Cambodian family	2
consanguineous Pakistani families	2
peroxidasin (PXDN)	2
knee OA patients	2
humanized monoclonal antibody against NGF	2
MCF2L regulates a nerve growth factor (NGF)	2
risk locus	2
chromosome 13	2
small disease-associated set	2
previously unidentified risk locus	2
4894 controls	2
craniofacial bones and teeth	2
limb bones	2
Il11ra null mutant mice	2
two north European families	2
homozygous duplication, c.916_924dup (p.Thr306_Ser308dup)	2
Gln159X)	2
IL11RA (encoding interleukin 11 receptor, alpha) on chromosome 9p13.3	2
[p.Arg296Trp])	2
Ser245Cys]	2
Pro221Arg]	2
 all affected children	2
region in chromosome 9	2
unrelated consanguineous Pakistani families	2
supernumerary teeth	2
Craniosynostosis and supernumerary teeth	2
mitotic spindle of apical neural precursors	2
developing cerebral cortex	2
human and mouse embryonic brains	2
endogeneously expressed mutated protein	2
c.83	2
patient-derived cell line	2
NDE1	2
tagged NDE1 constructs	2
NDE1 exon 2	2
novel splice site	2
two families of Pakistani origin	2
c.684_685del (p.Pro229TrpfsX85)	2
Turkish family	2
+1G>T (p.Ala29GlnfsX114)	2
Other body systems	2
partially deficient cortical lamination (microlissencephaly)	2
three families whose offspring	2
deleted interval	2
0/47,929 controls	2
4/6,340 schizophrenia patients	2
2/1,182 ASD/neurocognitive impairment	2
large follow-up sample	2
0/4,519 controls	2
several with ASD	2
18/15,749 patients	2
gene responsible for renal cysts and diabetes syndrome (RCAD)	2
discovery sample	2
fertile male controls	2
entire coding sequence	2
control alleles	2
 men	2
developing and adult human gonad	2
steroidogenic tissue	2
hypothalamic-pituitary-steroidogenic axis	2
nuclear receptor, NR5A1 (also called steroidogenic factor 1)	2
LW/MW cone opsin gene array	2
pharmacological chaperone 9-cis-retinal	2
MW opsin	2
visual and nonvisual opsins	2
amino acid W177	2
MW gene	2
exon 3 sequences	2
long-wavelength-sensitive (LW, red) and medium-wavelength-sensitive (MW, green) cone opsin genes	2
cone opsin gene array	2
disease locus	2
marker DXS8045	2
RPGR exon ORF15	2
exon ORF15	2
X-linked cone and cone-rod dystrophies (XLCOD and XLCORD)	2
epilepsy patients	2
additional genomic regions	2
homologous interval	2
suggestive polymorphisms	2
ten 16p13.11-deletion patients	2
homologous chromosome	2
included genes	2
identically sized 16p13.11 deletions	2
1299 neurologically-normal controls	2
3812 patients	2
16p13.11 deletions	2
LIN28B tag	2
= 0.005	2
pubertal timing-associated marker rs7759938	2
8903 subjects	2
rs7759938 and rs314277	2
partially correlated LIN28B SNP	2
Correlated SNPs	2
potential genes	2
Finnish population cohorts	2
largely unknown genetic underpinnings	2
simplistic retrospective biomarker	2
increased 2D:4D	2
rs314277 variant	2
additional 3659 children	2
LIN28B gene	2
1507 11-year-old children	2
noninvasive retrospective biomarker	2
individual's second to fourth digit (2D:4D)	2
retinal vasculature	2
known FEVR genes	2
FEVR patients	2
seven mutations	2
FEVR cases	2
three genes (LRP5, FZD4, and NDP)	2
retinal vascular system	2
synaptic heterotrimeric G proteins	2
Heterotrimeric G proteins	2
independent population sample	2
synaptic heterotrimeric guanine nucleotide binding proteins (G proteins)	2
groups of genes	2
cleaved enamel matrix proteins	2
immature enamel	2
nearest homolog, WDR7	2
putative β propeller	2
Omani families	2
additional hypomaturation AI families	2
poorly characterized WDR72 gene	2
Sequencing candidate genes	2
chromosome 15q21.3	2
consanguineous Pakistani family	2
autosomal-recessive hypomaturation AI	2
enamel biomineralization	2
weak, creamy-brown opaque enamel	2
organic enamel matrix	2
One subset	2
hardest and most highly mineralized human tissue	2
Healthy dental enamel	2
large unselected cohort	2
language-impaired samples	2
encoding calcium-transporting ATPase, type2C, member2 (ATP2C2, minP = 2.0 × 10−5 at rs11860694)	2
encoding c-maf-inducing protein (CMIP, minP = 5.5 × 10−7 at rs6564903)	2
two genes in the SLI1 region	2
population cohort	2
two independent language-impaired samples	2
phonological short-term memory	2
nonword repetition	2
region of chromosome 16q	2
neighboring FOXC2 and FOXL1 genes	2
gastrointestinal atresias	2
(MMBIR)/Fork Stalling and Template Switching (FoSTeS)	2
perfect microhomology	2
portions of Alu elements	2
distinct microdeletions upstream of FOXF1	2
one microdeletion	2
additional ACD/MPV samples	2
sporadic ACD/MPV	2
candidate FOXF1 gene	2
patients with ACD/MPV	2
chromosome 16q24.1q24.2	2
FOX transcription factor gene cluster	2
overlapping microdeletions	2
pulmonary veins (ACD/MPV)	2
CRD gene	2
RPE basal deposits	2
outer nuclear layer (ONL)	2
20-month-old mice	2
photoreceptor outer segments (POSs) and the RPE apical surface	2
apical processes of the retinal pigment epithelium (RPE) cells	2
12-month-old knockout mice	2
Adam9 knockout mice	2
ADAM metallopeptidase domain 9 (ADAM9) gene	2
causative gene	2
tooth biomineralization	2
ameloblasts in the developing tooth	2
neural retina	2
putative metal transporter	2
CNNM4 gene	2
published and new families	2
teeth and visual function	2
ethnically diverse families cosegregating CRD	2
second small family	2
locus on chromosome 2q11	2
known ALS genes	2
deleterious allele of FIG4	2
patients with amyotrophic lateral sclerosis (ALS)	2
nonsynonymous variants of FIG4	2
lipid phosphatase FIG4	2
peninsula	2
North African ancestry	2
Sephardic Jewish component	2
specific haplogroups	2
Sephardic Jewish origin	2
North African (10.6%) and Sephardic Jewish (19.8%) sources	2
binary and Y-STR haplotypes	2
Iberian Peninsula and Balearic Islands	2
1140 males	2
Y chromosome haplotypes	2
North African Muslims and Sephardic Jews	2
geographical origins	2
two very different populations	2
Iberian Peninsula	2
genetic landscape	2
haplogroup J	2
offspring of female carriers	2
sub-branches of mtDNA haplogroup	2
m.3243A→G. m.14484T→C	2
mother's blood	2
15 offspring	2
matched maternal-blood samples	2
sequential live births	2
3168 neonatal-cord-blood samples	2
western European lineages	2
western Europe	2
common R1b STR-haplotype	2
Lebanese non-Christians	2
putative Christian source region	2
haplogroup R1b	2
Lebanese non-Muslims	2
putative Muslim source region	2
J∗(xJ2)	2
Y-haplogroup	2
Y-chromosomal SNP and STR markers	2
926 Lebanese men	2
Muslim, Christian, and Druze	2
wide variety of ethnicities and religions	2
eastern Mediterranean country	2
Urine Conditioning Buffer ®	2
convenience sample	2
stool and urine samples	2
Urine Conditioning Buffer ® (Zymoresearch)	2
Centre for Tropical Disease (CTD) of Negrar, Verona, Italy	2
S. stercoralis DNA	2
S. stercoralisinfection	2
tropical and subtropical areas	2
soil-transmitted helminth	2
Strongyloides stercoralis	2
timeline of JE cases	2
Pulau Langkawi (1974), Penang (1988), Perak and Negeri Sembilan	2
major outbreaks	2
brain of an encephalitis patient	2
first JEV	2
race horses	2
British prison	2
first human encephalitis case	2
human and horses	2
Japanese encephalitis virus (JEV)	2
Japanese encephalitis (JE)	2
vegetation cover	2
reservoir hosts	2
abundant infected persons	2
male and female volunteers	2
abundant asymptomatic infections	2
Ph. orientalis saliva	2
Phlebotomus orientalis	2
smectitic clay minerals	2
Vertisols or black-cotton soil	2
Satellite images	2
three villages	2
town	2
resident rural populations	2
Recent VL foci	2
Metema and Humera	2
lowland sesame fields	2
migrant agricultural laborers	2
districts	2
infants with SP	2
pfplasmepsin2 multiple copies	2
AL and DHA/PPQ	2
N51I/C59R/S108N+A437G/K540E.	2
(N51I/C59R/S108N+A437G) mutant	2
quadruple	2
triple pfdhfr mutant (N51I/C59R/S108N)	2
DAH/PPQ group	2
103 day-0 samples	2
non-synonymous pfk13 mutants (A578S, I646T)	2
278 samples	2
eligible children	2
piperaquine resistance	2
pfplasmepsin2 gene	2
Kelch 13 gene (pfk13) and dihydrofolate reductase/dihydropteroate synthase (pfdhfr/pfdhps) genes	2
ASAQ, AL and dihydroartemisinin–piperaquine (DHA/PPQ)	2
NMCP	2
artesunate + sulfadoxine–pyrimethamine (SP)	2
artesunate–amodiaquine (ASAQ) and artemether–lumefantrine (AL)	2
national malaria control programme (NMCP) of Sierra Leone	2
malaria mosquitoes	2
seven sentinel sites	2
collected indoor and outdoor	2
gambiae s.s	2
An. arabiensis and An.	2
Anopheles species	2
Anopheles funestus	2
Anopheles gambiae	2
sentinel sites	2
human landing catches (HLC) and pyrethrum spray collections (PSC)	2
main malaria vectors	2
mosquitoes in the domestic environment	2
mosquito species	2
Republic of Rwanda	2
eligible contacts	2
single dose rifampicin	2
two systems	2
efficient RACF	2
well-maintained national leprosy database	2
contacts of previously registered patients	2
PB leprosy patients	2
adult males	2
new patients	2
relation	2
routine passive case detection system	2
1,097 patients	2
untraced index patients	2
traced index patients	2
national leprosy database	2
index patients	2
previously diagnosed leprosy patients	2
small mobile teams	2
low-endemic settings	2
many health workers	2
human and porcine cysticercosis	2
T. solium in the Banke District of Nepal	2
randomly selected animals	2
viable cysticerci	2
hand knives	2
heart, liver, brain and half the body skeletal musculature	2
One hundred and ten animals	2
Banke district	2
Udaypur Village Development Committee (VDC) and Hirminiya & Betahani VDC	2
porcine cysticercosis in slaughter age pigs	2
natural intermediate host	2
human and dairy Sii	2
Sii faecal carriage	2
unexpected carrier group	2
persons with colon tumours	2
processed meat and alcohol	2
Logistic regression models	2
patients attending colonoscopy	2
193 controls	2
tFDP consumers	2
Streptococcus bovis/Streptococcus equinus complex (SBSEC)	2
108Streptococcus infantarius subspecies infantarius (Sii) per millilitre of spontaneously fermented milk	2
traditional fermented dairy products (tFDP) in Africa	2
leishmaniasis (VL and CL)	2
Tikil-Dingay and Gondar town	2
highland area	2
P. longipes a vector of L. aethiopica	2
P. orientalis a vector of L. donovani	2
P. orientalis, P. longipes, P. papatasi, and P. duboscqi	2
presence of leishmaniasis vectors	2
a.s.l in Adebay village	2
male and female sand flies	2
CDC light trap and sticky trap	2
less frequent catches	2
six Sergentomyia	2
Phlebotomus species	2
Sergentomyia clydei (25.87%), S. schwetzi (25.21%), S. africana (24.65%), S. bedfordi (8.89%), Phlebotomus orientalis (6.43%), and S. antennata (4.8%)	2
11 species in the genus Sergentomyia	2
11 species in the genus Phlebotomus	2
Twenty-two species	2
seven localities/towns	2
females)	2
sticky traps	2
standard CDC light traps	2
Kafta Humera	2
phlebotomine sand flies	2
visceral and cutaneous leishmaniases	2
infected female phlebotomine sand flies	2
protozoan parasites of the genus Leishmania	2
endophilic anthropophilic species	2
exophagic and zoophagic malaria vectors	2
An. funestus s.s.	2
corresponding control plots	2
gambiae s.s.	2
treatment plot two	2
arabiensis mosquitoes	2
treatment plot one	2
An. funestus s.s.)	2
arabiensis,	2
An. gambiae s.s.,	2
three species of anophelines	2
host source	2
sporozoite presence	2
Indoor mosquito collections	2
treatment (and buffer)	2
mechanical aspirators	2
houses	2
baseline mosquito collections	2
Four plots	2
capsule containing the active ingredient (AI) fipronil	2
complicated vector	2
Anopheles arabiensis	2
endophagic vectors	2
indoor residual spraying (IRS) and insecticide-treated nets (ITNs)	2
neighbouring, unprotected houses	2
treated bed nets	2
house-entry	2
pyrethroid-treated nets	2
insecticide- treated net	2
house-leaving and re-entering mosquitoes	2
eave	2
Treated nets	2
cameras	2
Anopheles gambiae sensu stricto strain tested	2
Complementary WHO bioassays	2
synthetic host-odour blend	2
house of different insecticide-treated bed nets (ITNs)	2
large screen house	2
eave of an experimental house	2
host-seeking malaria mosquitoes	2
Insecticide-treated nets	2
etc.)	2
different sample matrices (wastewater, sludge, compost, soil, vegetables	2
imaging soft-ware	2
basic equipment	2
eggs of different species of STHs	2
flotation solutions	2
articles	2
methodology and results sections	2
Original research articles	2
geographical locations	2
PubMed and Science Direct	2
STHs eggs	2
different samples matrices	2
STHs eggs in environmental samples	2
faecally contaminated water, soil or contaminated food	2
main species infecting people	2
roundworm (Ascaris lumbricoides), whipworm (Trichuris trichiura), and hookworms (Ancylostoma duodenale and Necator americanus)	2
tropical and subtropical regions of the world	2
soil-transmitted helminths (STHs) globally	2
African Muslim communities	2
untapped resource	2
change agents	2
Zanzibari society	2
additional Madrassa teachers	2
students	2
30 communities on Unguja and Pemba islands	2
8497 registered Madrassa students	2
Madrassa	2
schistosomiasis-teaching tools	2
local behavioral team	2
30 communities	2
influential institutions	2
Madrassa schools	2
mosquitoes Ae.	2
DENV	2
number	2
albopictus (p=0.005), East district (p=0.003)	2
four different periods and districts	2
collection in the three districts	2
DENV-infected Ae	2
p<0.05)	2
DENV-infected field-caught females	2
second season	2
Pampulha district (p<0.05)	2
field-caught Ae.	2
three selected districts	2
mosquitoes	2
Aedes albopictus	2
dengue-endemic risk city	2
Brazilian municipalities	2
recognized Dengue virus (DENV) vector in Asian countries, Aedes (Stegomyia) albopictus (Skuse)	2
Aedes (Stegomyia) aegypti (Linnaeus)	2
outcome funders	2
government of Chad, private investors and institutional donors	2
development impact bond (DIB) organizational structure and cash flow scenario	2
national Chadian canine population	2
dog numbers and cost items	2
Monte Carlo simulation	2
government sources	2
1,128,008–1,736,774 dogs	2
total canine population	2
rural zones of Chad	2
four rural zones	2
domestic dog	2
exposed humans	2
Clinical rabies	2
69,000 humans	2
volunteers living	2
dried blood samples	2
SYTO 16	2
real time-LAMP	2
green nucleic acid stain SYTO16,	2
Leishmania genome	2
newly identified repeated region	2
third LAMP system	2
different Leishmania species	2
shared regions of the ITS1 gene	2
Three LAMP systems	2
human blood or tissue samples	2
ITS1 and/or kDNA genes	2
genus Leishmania	2
Leishmania donovani eukaryotic protozoan parasite	2
significant spatial clusters	2
taeniasis in the study area	2
one cluster of porcine cysticercosis (p<0.001; n=24)	2
Two significant clusters of taeniasis (p<0.001; n=276 and n=9)	2
sampled pigs	2
5–10 years age group	2
Local clusters	2
B158/B60 monoclonal antibody-based antigen ELISA (sero-Ag ELISA)	2
willing participants	2
24 villages of the health zone	2
rural area of the Democratic Republic of Congo (DRC)	2
human and pig	2
less developed countries	2
solium infections	2
Culex mosquitoes	2
quinquefasciatus genes	2
pallens and Cx.	2
disease vectors	2
West Nile fever and lymphatic filariasis	2
important vectors	2
p. quinquefasciatus	2
Culex pipiens pallens and Cx.	2
human deaths	2
health system	2
rabies victims	2
poor sectors of society	2
international guidance	2
Cheap and easy to use tests	2
various test platforms	2
inactivated sample material	2
laboratory infrastructure	2
Diagnostic options	2
anthrax, bovine tuberculosis, brucellosis, echinococcosis, leishmaniasis, rabies, Taenia solium-associated diseases (neuro-/cysticercosis & taeniasis) and trypanosomiasis	2
selected, highly pathogenic neglected zoonotic diseases	2
kinetoplast and nuclear genetic material	2
contemporary parasite populations	2
recent natural hybrid lineages	2
aetiological agent	2
Many eukaryotic pathogenic microorganisms	2
canine echinococcosis	2
Hobukesar County	2
owned dogs in remote and semi-nomadic communities	2
dog owners	2
Echinococcus granulosus	2
necropsied dogs	2
coproantigen surveys	2
dog Echinococcus spp	2
dog necropsies	2
Six communities in Hobukesar County	2
canine Echinococcus spp.	2
Domestic dogs	2
cystic echinococcosis	2
Xinjiang Uyghur Autonomous Region	2
P. falciparum malaria parasites	2
Plasmodium falciparum infections (n=316)	2
genome-wide single nucleotide polymorphisms (SNPs)	2
highly effective artemisinin-based combination therapy, artemether-lumefantrine (AL)	2
insecticide-treated bed nets	2
targeted districts	2
indoor residual spraying	2
United States President's Malaria Initiative (PMI)	2
Global Fund	2
part of Vietnam	2
small household sample	2
southern households	2
‘problem’ households	2
government support program collaborators	2
villagers	2
mosquito borne diseases	2
Mesocyclops prevalence	2
Aedes abundance	2
Mesocyclops program collaborators	2
10 villagers, 2 teachers, 2 entomology officials)	2
1 villager leader, 1 local doctor	2
commune	2
Long Province	2
random households of Chanh An commune	2
Copepod Mesocyclops	2
Asian/European lineage	2
African IBDV genetic lineage	2
variants of the classical attenuated vaccine strain (D78)	2
virulent (vv) IBDVs	2
two genetic lineages	2
Ethiopian IBDVs	2
bursa or cell passaged material	2
IBDV genetic material	2
well characterised IBDV isolates	2
ten IBDVs	2
nucleotide and deduced amino acid sequence for VP2 hypervariable region	2
infectious bursal disease viruses (IBDV)	2
tegumental cells of both adults and newly excysted juveniles	2
outermost part of the tegument	2
native FhSAP2	2
F. hepatica whole-body extract	2
two clones	2
Monoclonal antibodies	2
miracidium stage	2
undeveloped eggs	2
FhSAP2–mRNA species	2
various developmental stages of F. hepatica	2
sera from humans with chronic fascioliasis	2
mice and rabbits	2
saposin-like protein (SAPLIP) family	2
amoebapores and other related proteins	2
adult fluke of Fasciola hepatica	2
novel antigen	2
DEN2-43 virus	2
moderately competent vectors	2
Ae. albopictus and Ae.	2
NGC and DEN2-43 virus strains	2
DEN2-43 antigen	2
infected salivary	2
mosquito salivary glands	2
infected midgets	2
midgut samples	2
DEN2-43 strain (t=2.893, df=7, P=0.024)	2
midgut infections	2
NGC strain	2
albopictus mosquitoes	2
Ae.	2
DEN2-43 vrius strain	2
albopictus, however, Ae.	2
DEN2-43 and NGC virus strains	2
DEN2-43 or NGC strain	2
artificial blood meal	2
viral strains in vector mosquitoes, Ae. albopoictus and Ae.	2
orally infected Ae	2
DEN2-43 antigens	2
DEN2-43 and New Guinea C (NGC) virus strains of Dengue 2 viruses	2
Aedes albopictus and Aedes aegypti	2
helminth zoonoses	2
international One Health diagnostic platform	2
accurate diagnostic tools	2
helminths	2
Schistosoma japonicum and Schistosoma mekongi	2
efficacious drugs	2
many most common but neglected intestinal trematodes	2
Opisthorchis and Clonorchis	2
zoonotic trematodes	2
three microsatellites	2
heterologous hypnozoite populations	2
recurrent-relapsing and primary infection isolates	2
paired clinical isolates	2
northwest of Colombia	2
endemic or non-endemic regions	2
recurrence-associated haplotypes	2
highly variable microsatellite markers	2
Plasmodium populations	2
back yards of houses	2
field-collected sand flies	2
blood-fed sand flies	2
blood meal sources	2
blood meal DNA	2
Leishmania (Leishmania) infantum chagasi, etiological agent of American visceral leishmaniasis	2
variety of wild and domestic animals	2
phlebotomine sand fly	2
epidemiologically related areas	2
trypanosomosis in Eastern Province	2
young stock	2
total of 354 head of cattle	2
cattle herd	2
various age categories	2
tsetse challenge	2
preferred host	2
source of food	2
Westwood (Diptera: Glossinidae),	2
plateau of eastern Zambia	2
medically important food borne trematode	2
multiple bands	2
individual worms	2
different enzyme loci	2
Forty-six enzymes	2
isolates of O. viverrini	2
northeast	2
one of the major food borne trematodes	2
liver fluke, Opisthorchis viverrini	2
widespread problem	1
individuals with spastic paralysis	1
reported case series	1
passive and active movement.•The injections	1
neurologically impaired individuals	1
Hyaluronidase injections	1
injections	1
upper limb joints	1
human recombinant hyaluronidase with saline	1
preterm child•Brief	1
Neu2 and/or Neu3	1
neuraminidase/neuraminidases	1
neuraminidase-1 on B-series ganglioside	1
HexA−/−Neu1−/−and HexA−/−Neu4−/−Neu1−/−mice models	1
neuraminidase	1
modulatory gene	1
neuraminidase Neu4	1
HexA and Neu4 genes	1
Neu4	1
GD1aand decreased GM1ganglioside in the brain	1
gangliosides like GM2	1
previously identified ganglioside metabolizing neuraminidase, Neu4,	1
still intact β-Hexosaminidase B iso-enzyme	1
GM2to GA2,which	1
sialic acid residue	1
neuraminidase(s)	1
β-Hexosaminidase A iso-enzyme	1
GM2to GM3ganglioside	1
HEXA gene coding for α subunit of lysosomal β-Hexosaminidase A enzyme	1
important LSDs	1
enzymatic and non-enzymatic defenses	1
CAT, SOD and SH	1
GD samples	1
activity of β-glucosidase (GBA)	1
patients with GD type I patients	1
catalase (CAT) and superoxide dismutase (SOD)	1
antioxidant enzymatic defenses	1
non-enzymatic antioxidant defenses by sulfhydryl (SH) content	1
carbonyl assay	1
thiobarbituric acid reactive substances (TBARS)	1
proteins, lipids and ADN	1
cell components	1
peroxides and free radicals	1
Gaucher disease (GD) patients	1
radioduransto DNA damaging agents	1
TheDeinococcus radioduransbacterium	1
accessible early divergent land plant model systems	1
`vulnerability’ hubs	1
independently evolved pathogens	1
flowering plants (angiosperms)	1
early diverging non-vascular lineages (bryophytes)	1
green plant genomes	1
angiosperm immune receptors	1
evolutionarily distant land plant lineages	1
pathogen effector molecules	1
green plant lineage	1
certain angiosperm models	1
similar set of host proteins	1
bacterial, fungal, and oomycete pathogens	1
independently evolved effectors	1
plant tissues and cells	1
host cellular machinery	1
Plant-associated microbes	1
promising systems	1
green plant lineage.•Bryophyte model plants	1
similar sets of host proteins	1
UK geneticists	1
glycans and polypeptide parts of a protein	1
glycomic component	1
IgG N-glycans	1
hundreds of enzymes, transcription factors, ion channels	1
corresponding gene	1
sequence of nucleotides	1
glycans and polypeptide parts	1
complex oligosaccharides	1
microscopic sections	1
HREM embryo images	1
milk samples.•50samples	1
milk.•Alkali dilution	1
breast milk	1
different toxicants	1
toxic and essential elements	1
acid matrix	1
volatile species such as HI and I2	1
methods	1
Mg, Ca, Zn and Cd	1
Li, Mg, Fe, Zn, Se and Cd (slopes 0.8–1.2)	1
Ca and Cd	1
Milestone Ultra CLAVE II microwave digestion system	1
HNO3at 250°C	1
1% NH4OH	1
0.05% Triton X-100	1
0.05% EDTA	1
breast milk samples	1
237 human breast milk samples	1
trace elements	1
patients with PCOS	1
regularly menstruating women	1
serum and lithium-heparin plasma	1
women with PCOS.ConclusionsThe Elecsys®	1
149 women	1
routine serum samples	1
modified version; Beckman Coulter Inc.)	1
European laboratories	1
diagnosed	1
Roche Diagnostics)	1
available enzyme-linked immunosorbent assays (ELISA)	1
Müllerian hormone (AMH)	1
OPN and Ang II	1
